PROPERTY OF THE NATIONAL LIBRARY OF MEDICINE \I* M. *S# -m^is&xfm&ftm-istfzmmmm 5 m 1994 H * pp B*H^I»titS# 1996 *BHiLE^El»tg£ril& ^ 5 Wl 1994 B^mfk 1996 ©1996 B*E^m»HtS# ^&J{»<7)^£/j(2#£&7jS;£> TjIU^1^^^^ (Universal Copyright Convention) %2& pRB ....................................................................V mitt ........................................................................vi mxmm .....................................................................vih LC53-SS ........................................................................ix 5H£*»tf>gE!tft ...............................................................x G* (*3E#S) ..................................................................xi /~^*e =&^ ^ff £pa :fr SSfxicffl ........................................................................XX11 5j-§ifflM*3l«ift ...............................................................xxiii ^5|(7)fgV^ .....................................................................xxiv #§il iISD#-^S/i(ifJ^H-^ ..........................................xxvii #§12 5HI&£<£>7t #><£>##:£$£.......................................xxxiv #113 NLM staff contributors................................................xxxv 55- n ^ ...........................................................................i £ if 3? 31 ........................................................................253 0*If^3l ........................................................................513 v1 * - jM Early Library in: Franciscus Philippus Florinus [pseud.] Oeconomus prudens et legalis Nurnberg, 1722. p. 125 18th c. (modified, 1994) m mfcmm±L^mMt(NLM: National Library of Medicine)5HS&1994^J&li, 1981 ^KtfiJKS fl. i992^{zumztitz%Ammmo ^m^smxn. ^m^^^^.^ntzi,(Dn mfrifrb^tf. %^i H. [§W%fll@lc(MeSH: Medical Subject Headings)^h&tii Llg£Mil Ltz i> (KXhho T^WM^mi^^tz^XH. &<tztz^tz0 Wen-min Kao r3§i|B^±^(i|i* %X$>Z>0 g§iOT<7)H-e&& Christa Hoffmann H. :^ynyx^KfIU uy\£^-9 ■ ^ ^ jl-^-v a >>X-rAtt(7)John CoxtW,t)ZfotZo z\c\XH. X 0 ttff^ v* T A -?&&> Evelyn Bain, Chong Chung, Grace Rawsthorne j3 J: 0s" Sharon Willis H. ^\\zU S$ns MeSHffl!S*£f£ftL, ^ffllSUWt-^^St^Srai^HEflLTv^c/fv^^o Emm Unl)fa7L*mZo MeSHg&F'!±St'C£>& Peri Schuyler t ZEflUF^t^ &|&£;c7)X ^7 7, Dr. Elizabeth Van Lenten, 3rt3IrOT"C NIH/National Heart Lung and Blood Institute ft # ^ Dr. Sue Goo Rhee<7) 3 At±, ^fl-^fl£> Wilma Bass Georgetown University, Dahlgren Memorial Library Elizabeth Crabtree American Hospital Association, AHA Resource Center Susan L. Gullion University of California Los Angeles, L. Darling Biomedical Library Lynn El-Hoshy Library of Congress, Cataloging Policy & Support Office Mary Kreinbring Northwestern University, The Dental School Library Robert Pisciotta University of Kansas Medical Center, Dykes Library Wendy Skinner Crouse Irving Memorial Hospital, School of Nursing Library Margaret Stangohr East Carolina University, Health Sciences Library Steven Squires University of North Carolina at Chapel Hill, Health Sciences Library Margaret Wineburgh-Freed University of Southern California, Norris Medical Library tz\;"tzt^^mi%%^%&i><7)x&&o Donald A.B. Lindberg, M.D. ifyfc Htl «NLMfr*gli, m¥k*<7)ffl&fr$?*fflmLtzi>o NLMfrgli, (tM) fft#0#lt ^^■/i(LC5^^)^^7XAUrllJP^^^7tj^M#-^QS-QZi>(Dx^^0 aw##j^(qm), m £t/¥ (QR) £5 «fc ^E^ (R) fc^ofcLCfr^f^li, NLM^^tM^1-*^T*NLMT*(i^fflL^V^0 NLM5MOf££(i, l944^UffiHS$n^fl?|S^gIi:||<7)pS^^#-C*^o ^o^^#-c \m M-^,£fR£!fc££-£/,:o 3I£*tc£, 5HI#M£^I£fi£;fl, Keyes D. Metcalf t Mary Louise MarshallMfcftLfco B^5W <7)HPm *> ^M^JEffi £ LT#fiO L£o HP^SM^t^ NLM WBiifi^#(7)^£U^a:o*^T, Marshall &£#, 1948^3Mf L£|imiS^[a#iB5Hi^1M MtlKli, FrankB. Rogers UioT&fT^ ft, $r LV^^W^ 1 »*, 1951 ^H^S^mE^IH* ft5HI^ (the U.S.Army Medical Library Classification)^: LTffiJKS ftfco -^5HW{£5j1i<7)flf$f<^ !*$£NLMT*eD5^ftfg£5Eif£-££o f@*<^if^flg(±, ffiJ^ff^ (fllx-tf, WE f£#^ ; WG'blllfiLi^) ^ff4L, NLM^^^ftjt-t-^iMfM^m^^aUcL/io - ft^5Hgfc^llg f^Co^-Cli, Ifi'ltL^-T^J:^ (mnemonic devices) UfI!£l-39 Ufi^t ^B^-^flTfe^T^ -© o gUrKHIi&^ofcffL-^ MeSHfflMH^U Sff^^ffl^It^ «t ? ^^?^HjiJrjn$nrv^0 a) ±SKabo£&^£#^#-5§-7&*&v>J#£% l^iJx.Ji\ WLi03.7ti#rLv*frg\ fitttMft^ (Psychoneuroimmunology)^7t:i6^i§*P$tl7,io $«bU, $f L^H^ti'J&^fc £ft& Mi" 7 ? H <£ o T*IHE53*£ft£-i:"e$£AU #&& b tf? ?<7)-5^<£>TKI±, A-Z£>JLtfJL.£iiflnL£o $lx.tf, QT37.5^t/IM^gffl^fl-^(i#^^ Mf7n**S-t7^7^ (.C4) h*°'J-7- (.P7) SriUflpLfco b) g££5Hg#^£±MU&fr#T#^£&41£-££J#£\ #!lxJ£\ WB101 (2#fr£3El±t£Mx./;#: c) fr^-^^KWSfu ^£«J#£\ #lx.tf, ffU^^f^ i8.2ifcWft£ d) ^S^Wt^lf LV^^#-^^f*llEt-?)/i^> ItfB (General Works) OT^F'JSW £:/&& V>li^ iii WG210^L«£/§^ LT, WmOtftfO.WL1&&t LT, WL140^$^^^f^i: LTi&tJP$ tt/jo Ufcrta 17o ^^M^If^-r&T^u, fftv^il^-f-^^^-r^^-e, £fto MfttLX, mmtWiOTYy x = mmtiwu507, PiM^)7 h^X = [El=f(i WU600.7-Cab^)o M%o \&%(n^\ZH^ "600.7" tV^#-^-{i WU600<7)^fd£ WU605<7)&®^£> ffl(DUmmmzmt&T h7* = g|§tK#1-*^#^fcLT#ASttTV>So MeSH £ J; MeSH^M*^^^ J^U53lM{£g, SlJfig, ^iffOMC^LTV^o MeSH 7'J- ftit (The MeSH Tree Structures) ti, 7^m±(Dm±^MWiznmL, m^m^^mzm&^tfLx ^h0 ftm±TtiL?)m MeSHffl|#^iiLT^^##HT^-bX-C§^0 f^|c7)Effi Lf£(i, 1995^ (DMeSHmmO&mt^ZfcVkZ^X^&o MUZ^ltXH, jrU#BS (see references) "C&o fz^m^^-^t^xmnx^^^^fzfzibK^ frm&^zzti^tiv&mLfrbtfLiom^tzo #^i iv NLM %m Wto pfffl m#t&(t &ft*tLx&mtz%®izftLxm®\,z±mfrmfrb%iit)2>o &>xwimnM^z x^xm^^n. tiT**)-\Hx*o fem n X *) is Lh. NLM^^LC^Hi^ffl 5jHI§-t(t &&mfti>(DX&&0 Ztgtft fa&wfrmiz-^xitiz, ^"<-Dfr(ni.m*m^fzmftn. ^(DWfrtiuizzixfrmzti&o ^mt^^tzi.o^^^^m^nm^i^^imji^ztmizx^x^m^ti^o imm\\^imj£iz±mmfrtix^zfrt*vfrizrM%%<, mm^^ftz^tttznmmzx^ xftmzti&o #fr^Ult Ut-DtDftm^. (Mx.lt WO 201-233.1) \Hmizit^-ri> 1-39 s:^.^l-cv^0 mi%. Mitt\zx&ftmn{$mtmmmz$^z> 13, wm, &%imizntz> 15 (dx 1 \z)^m\zxz>ftw.x ofitirv^o ^^^\zXhftmzt^h^>r-7s 1. W&M%* fj(il@^^^#uJ:^*# (A3^ £#^) ^i?f,lL l«, tM^lt&l^lt m^\wftw&^**>^-^h$k^\zH. zti?ti(DM^?f\zftmztiz>o frm*¥*-^k&yt*^\'Ettz\*ffiM:o -^, ffiwmfe*&\twM*m\zfrmzti%>0 2. l-39 fc° i - *, gi!jx-^^S (-&) H*M* 26.5, c7)j^i:(t iHglJKfr^Sft&o Mx.lt 'C^^^^tt^n^bfi-^^^l^lKi, WG26.5 \ZfrmZtl&o -77, >L«^#^^lt^^>^^--^li, WGl69lC5^^^tl^o 3. ^#-^iiit Tym^^o), &&^mo%mtLxm^zmimmzniximztiz>o m x.lt Tffi#rM^-^£J £ rifl^^fi-M^J w^i:^LtWMii!5Jfri$tL-60 WH £e>K, W^^^r xutfr^Mv w^3 WBi;i±^ffl£;M&^0 -e^ftfr^, BH^B^HI^ |g£tt WZH^^^ti^o ^<^?rM;#^it giif«^4x.^ti^f^fIg^fF^E^UH^LTv^^a6, MeSH7;U7 v T^7 h'JX r* (Medical Subject Headings-Annotated Alphabetic List)^Ii^^OMi^^9f: 191**6*, ttXHBUM*. ft£ 19 to* 19M (1801-1913) ^JjMr^Kit NLM^MT^^-$ti^fii^^«jiBj;rj^j^r^^±g^^L^ i* (letters) Kfi^l"* ffiB&±S^^^^ffl $ tl&0 Z(Dffi\fofrmi*1C^b-£}:frm(D&]£ #£ t LX W 1-6, W600, WX2£«£ IfM^-W 22izmhti&0 £^|I, WZ0i£fct LXM¥$.tf wvtfc^KftLxi&mztiZo Mm±m&NLMfrm », It^ ^F^^'J^i: ^vy^it^oWiI^li^SaWJ^i:!.*^^ wzi<7) wz 220-270Kfr® £ti&0 ^tLJboOTU W#tfirhi:f^7^77^7 Ml, iTtliT^V^iSfc^-^-CBB^J^^Lio (T^U^ilK (Dmmiz-ftLXtem. WWzmW^fot L-CWZ 2703:11 £)q lSOl^J^liiO^l^^^llf^^ji^ WZ290^5Hg-f&o NLM5^0|Ml*J<7)#f£lt ±i(:^t^ffi:^i?^ ^^^z^S:#-t(7)ffn>fTj-^/g)o NLM^it^iffl^^ISlt #I£l~ttt&LC#-^Z^5HS£tl&0 t^ciift £#^ii^| tc &ftm^Hmj*tm>xmmMijizttiximztiz>o vi »B)(7)fr\zmmztiz>m&i»te: #m%- ^^m^itic^it^-te^is^jSfij^ S^^UHtf^tl^-fe^g^^ff^iJiOV^^IijSflJtl (S only) -teE^UKIi-^^ff* (M only) #^^i?i;^it^iii#itco-^^^ii (mxmmz$ij) ^ rAIzS^?- :IIA-Ztv^ X n i;JHic$tl"C^& &<7) ZW 1 ZW 1 ZW 1 ZWB 100 Lcmz#-f Z 675.D3 Z 675.H7 Z 675.M4 Z 675 .N8 Z 675.P Z 675.V5 LC^m^)Z 675 NLMfr&!ftfc \\Ly 9 7, Mft: ZQii±-«:MfHMi& OlfiJft^) xt\-xmmr Y7*y 9W((nX i KWii? J 70(n$>(nH, M^ttizft L-r^ffl^ti^^^^^-e^i^ti^o Mx.it x% - immx^7*zfza&>xmmizrm y,9(*)xmnx£z>o mu^mtfNLMTrm^mmn^m&izH, ^nym®? 4 -7\z#lx viii LC^g: AfWBai^(QM), ^w¥(QR)&£tfm¥(R)itztt'tz>Lcftmmx. NLMfrmtmrntztztb, NLM"Cli^fflLiV>0 LCftmim^lzmi<z^miZMtZNLMftmZtg^LX^&c NLMHt iuz-m^^mi^w.^x, im{K)iznirz>Lcftm$:imix^z>0 &mzrmtfz:&^ * r&i:tt-T£LC^It(i1i£iE£H-C^;z>0 &$J&LCfr£lt B$i 0 mw^m^mm^HNLM^m^Qx^z^ m-ti>o QY 50-60 1:5^11-&o Am(D^^AZ^^Xo m&0 Mx.it ^^f wd 710-715, ^mUffi QT 1650 sf- mM^ — ^o NLM 5M £> QT liZ fr&t & o u- %m^—%w£fr\tz-z.\zftwrtho ix H^^tt £ fl/c#li&(D(Numbered Congresses) - W 3, W 3.5 & J:t> ZW 3 NLMli^IicOflJ^ft/^^li^^LTflJft^tl, ^-z5ljZtlfz^>XZ>mT^tt W 3\Zftm l^v^0 mi; w 3tc^ii2titz£m%2>&mi>£(Nurses' instruction) 1984^J^|^^II^^^^ffl*$tL^#glJ(7)±MUM-r^##»#li, f^^^glC#ltUnx.^tL/j "M&" ^V^ff^E^it^^f^^-C^M^tlTV^o 1984^m|t|CO^tL^(7)M^li, E^<7)# X (mmm%m -^ftm&iz&ij&Gmttt, mmMmm\ttzm*%mtztztb0 g ^(D\tm\zx oi&Egij^o7;u7T^7 Yimzm\\ztitznmtfvjmt%z>o frm&ftuz [cmt iz&zjm&.frmfrmi>Lo m\K[zH—D(Dm.^\1C^iJ^lhiiX^^o A-ry'j#£&S D -r y u #Arl f -^ux G -3-n y/\° H -77'J* J -fFi5mi:7v7 K - + -x hy'JT, Lz.a.-V-yy KMt£^i%A¥M L -AW^>K#lfH M — SB^ftlM P -UM& m^iHZZ-D(DX^t, tiv9-tt*i>t{zLtz-ffi5tzl*2ffiZo *^^ £^(iJMftffIit£, -^i^liglfc (7^ U^^^lll^^^li'ill^) £iH"o 7^'J ij^m&XlfJir') 7lzMLX(Dfr, Wttz&&ir&W&i&Z£llZ%7F&-%tf5'Z.btl2>0 t!t, ->h, ^^^^li-etium-r^^^^Pis^^^^^ii^ *\ AM3 AM3.1M7 AM3.2B2 — Maryland — Montogomery County — Baltimore y)-yy K DC2- DC2.1B8- DC2.2V2- Canada British Columbia Vancouver ;iy 9 —'<— FE5 FE5. 1M6 F35. 2L6 - England Middlesex London kli^jfl£;ri&v>G^>^#-tli rG^IS^/^#-^J UH«cL/c xi r*vii&Kmizmi-ztomto&£VT*vijgtt, nitrnji^xm (documents) n^m^fc u, z\tihmm(Dtzfr\z^\\&U% \ \HWi\zm-t Z> \ l^tlli "A" £4 X. •© o Al Department of Defense lUKfl&iEi A2 Department of the Army WW-^ A3 Army Air Forces (to 1947) W^-^Mt (1947 ^ t X) A4 Department of the Air Force 5i¥^i A5 Department of the Navy #£¥ii 7y tlZ>0 7y})iJ(D4^ttzH^niX±(Dm^mU (territories) \Zttz tf&mmzftLxi>^(Dmm*^tf^tf%^m&iztt, iron a a n>mMztiz>o &fm,ZH%\\*(D^tf-5-Z_htlX\;^o TfrllO^TIt -^-3-??tniO<7*AN7 ^V^glJ1@<7) G ^<£>l£JB1$!l 1. J|Mf*^£>l&E United States WZ70 Hume, Ruth Fox, 1922- AM3 Medicine in Maryland WA546 Ziegler, Mark V., 1891- AM3.1 A survey of the Health Department of Montgomery M7 County, Maryland/ ••■ WA546 United States. Bureau of the Census AC2.2 Social and health indicators system, Los Angeles L86 Foreign WZ70 Aiming, Stephen T. FE5 The history of medicine of Leeds WM 11 Psychoanalyse in Berlin GG4 xii WA900 Health on the march, 1948-1960, West Bengal J14.1 ("W5" represents West Bengal, the state) W5 2. mmxm^omm. yy v-h W2 United States. Army. Air Corps. Materiel Division A3 Air Corps technical report W2 Connecticut. Commission on Alcoholism AC Annual report yy u*ja# W2 Great Britain. General Register Office FA 1 Quarterly return of marriages, births, and death • • • W2 Saskatchewan. Bureau of Public Health DC2.1 Annual report S2 3. mjz&xmm^omm m^mmWi^ (wxd it *o T«fi&E&i::*H"&. 1 *. 2 (DioMfeizXZfflfrteLft^tf, ifi%7Fi-tztbliZ$>2>&o WX Cedars of Lebanon Hospital (Los Angeles, Calif) 2 Staff journal AC2 L8 WX Hahnemann Hospital tidings 2 AP4 P5 WX Lasarettet i Landskrona 2 Aarsberattelse GS8 L2 xiii G W.-WL* WX St. Luke's Hospital (Jacksonville, Fla.) 2 Annual report AF4 J2 %m(vii^tzmmmi£mmMLx^z>(DX\ mnmi)m\K^izm%:i-zm^vmn X\ ifclx^(24x.&^0 WX United States. Army. Walter Red General Hospital, Washington, D.C. 2 Annual report A2 D6 WX United States. Army. General Hospital No. 141 2 Year book A2 141 TABLE G-cont. ft A — United States (Federal Government) AA 1 — United States (as geographical area) D — Americas F — Great Britain G — Europe H — Africa J — Middle East and Asia K — Australasia L — Islands of the Pacific and Indian Oceans M — International Agencies P — Polar Regions A-7^'j^^^in (mmfc) AAl -7y U ijft^m (MM&ftt LX(D) D -7y u iiAH F - 4 *? ]) X G - 3 — O y /i H-77'J* 3-$*$£%.£ 7 i/7 K-*-Xr7'J7, -*-v-7>Ytm<»%±¥m% L-±¥&t4>mmM M-mmmM n. 7*viikf7E AF4 -7n'J ^ AG4 - v a - V 7 AG7 -£AtfIi&77 AH3 -^7^f AI2 -7^ ?"* AI3 - >f V V 'f AI6 -A yV7-f AI8 - 7 4 * 7 AK3 -#>+FX AK4 - 7- y 9 7 * - AL6 - ;W v 7 ?" AM2 - ^ - > AM3 - ^ U - y y K AM4 --7^-7^zT.~^y y AM5 - ^ i/ if y AM53-^UXnWMt AM56-7 y 'J ^fpffifB AM6 -l^V 9 AM7 - ^ v v 7 If AM8 - ^X-'J AM9 - ^ y 9 -f AN1 -*7*7 7si] AN2 -^^* AN25 - ~ j. - ^ > 7* 7 > K AN3 --a-/N>7°yt- XV TABLEG AN4 — zl 3. — v -V — V — AN5 - — jL-^^ri/n AN6 - — a. - 3 - 9 AN7 -^^.-3-7TfT AN8 -y-x*n^^f- AN9 - y - X ¥ u 9 A03 -t^^t A05 -t^7^7 A07 -t l/^> AP4 -^> v;W*—7 AR4 -n- K7^f 7 > K cont G S-^§ AS6 -^-^Xtjo^^t- AS8 -t7^/n^ AT2 - f ^ v - AT4 -f-^r-^X AU8 -Z2.9 AV5 -/s-^e> h AV8 -A-v-7 AW2 - 7 '> > h > AW4 -7x7>f A- v ji 7 AW6 -7U3>'» AW8 - 7 ^ * ^ y? N. T7* lJJJ±\ DAI -7^ 'J 77 AH DA15-7"7->7^ 'J 77 DA2-4b7^ 'J 77 DA3 -t£$:7y ]) 77 DA4-I%7y 'J 77 DA7 -7;Hf >f-> DB3 -a'/\7 DB34 -A;W* KX DB38-^U -X DB4 —/^ xl — ?" DB6 -**'J tf7 DB8 -7*r» ^M^7 7"li^M7-f £££ ^fl^ >yi77>li^'J-XBJ: DC2 -fii-y DC5 - f-'J DC7 -3D7H7 DC8 - 3 X ? 'J 77 DC9 -^ra-^ DD6- K^-**fP@ *7>yffi;¥7i-l*z})i-&*%£ DE2 -JZ97 K;U DF3 -7 t-9 yy Kit A; DG5 -^7777 DG6-77M7-7" DG8 -77>Xf^7t DH2 -/Wf- DH7 -*^yi7/ DJ2 -y't^O DM3 --7^tM~-X DM4 - ^ ^ i/ 3 DN4 -t7> ^f!7 > -^;l/ DN5 -~777 X'7 DP2 -^t7 DP3 -y^T-vii-^^^ DP4 -^y?74 DP6 —^;i/ — DP8 -7°3Z)V Y 'J 3 DS2 -•^WS-K-JI' DS9 -X'J-7-A DT7 - h U~^K h^*3 DU7 -7)V?7 4 DV4 -^|>Xx7 DV5 -A — V >|f ^ DW5 -MJ y Klf,ft v. -r^y* FAl -^'n fe5 - 4 y ? y > k Fi7 -4b7^;i/x> K FM2 --?y% FS2 - X 3 7 h =7 y K FW3 -7x-;VX xvi TABLE G- cont. -|% vl a-ny/\° GAl -3-D -y/N° GI6 - 7 ^ ;l/ 7 > K GA4 -7;UA-7 GI8 - 4 * 'J 7 GA5 - 7 y K y GL3 -7 h \£7 GA7 - 7 ;W ^ - 7 GL4 -'JHf>ya^> GA8 - * - X h U 7 GL5 -'J Y7-J GA85-7-tf;l/^ v> > GL8 -;i/7-fe>7>7* GA9 -7V*l/XHf^ GM2--7 7" K-7 (Ml\m GB4 -^;l/^r- GM3 - v ;l/ 9 GB5 - <1?X-7-A^7x3'tft GM4 -^e;u f>v* GB8 -7;l/#'J 7 GM5 -^7--7 GB9 -^7;l/-v GM6 - ^E > t ^ 7* O GC5 -^D7f7 GN4 -t7>/ GC7 -^rT'oX GN6 -/^7x- GC75-f-i3£f[]i] GP6 -*°-7> K GC8 -fi3Xn;^7 GP7 -#;i/ h 77 ;i/ GD4 - f* > v - ? GR8 -;l/--7xi7 GE7 --i-X h-T GR9 -D->7 GF5 - 7 1 y y y K GS3 -X77 yyt^'7 GF7 - 7 7 y X GS4 - -tr ;l/ tf 7 GG3 -7iVy7 GS45-XH7^7 GG4 - rM 7 GS5 -XU^^-7 GG5 -y'7'7i^^ GS6-X^^ > GG6 - 3r 'J V -V GS8 -XJi-T > GG7 -9^)~yyy K GS9 - X >f X GH8 -^>77'J - GU5 -777^7" GI3 - 7 ^ X 7 > K GY8 -3--zf7,y\£7 VIE. 77VJ3 HAl -7 7U77 HA12-+)-y^7#?lJ^lt HA14-fF^7 7'J/7 HA15-^7 7U 77 HA2-lt7 7i)X HA21-07 7'J^7 HA4 - 7 ^ '>* x'J7 HA6-7>3'7 HA7 -7 7'J77AH#efS HA71-7-bv a >^ HA72--tr> h-^PT-^ HA73- hn^-/-^t^l ysX h7> Klil^V h£££ ^f-^7-7-7> Kli*'7 7t^^i HB35-^-f y HB4-^7 7 7" HB8 - 7> y V HC3 - 77 y )V - > HC4 -iJ ^ — ^<)\/t* HC43-tF^7 7'J**fPil HC45--7L-V K HC5 -uyzf (77-*fH")V) n>rf (*>v-r^) li^f-f-;i/^*«t HC7 -n- fy^7-JV r*^(2^7->£JlJ: HD6 -y7f HE3 - i v 7° h HE7 - x V h 'J 7 HE8 -xf-t tf7 7 7>xflv-7'j7>K{iv7f-^£J; HG2 -##> HG3 -ify\f.7 xvii TABLE G- cont. :-M£ vii. yyvti HG6 -77-t HG66-3r-7 HG7 -^-7^7 HG9 -*il^~7 HK4 -7^7 HL3 -U7 Y HL5 -'J^'j7 HL6 ~')\£7 HM3 --7^77X77;l/ -77^-VxLK±it7fnil^'a-tf HM4 --yyy 4 HM45 -7'J HM48-JE-'J ?-7 HM5 - * U 7 u HM7 -^e+P>^-7 HN2 -7"^ ^7 HN4 - - v a. - ;l/ HN5 -ffyx'J7 xi7-9-7> Kli777^lJ: *> h#>i^-7li^-7tfy£JlJ: i^c^ ^n-xv7li^>^7^Iij; Sn-fy7li v > /s-7jl £ £ X hrs - ;i/ 7 y y HSl --te^#> HS3 -i/JLy V*%* HS5 - V V 'J 7 HS8 -TtM7 71J 77 X^ >fl^-7ttt}f ^-7£jrU HS86 -7-yy HS9 - X 7 v 7 > K ? y a'- - 77 li ? >Hf-7 £ jl =fc HT3 -? >-^f-7 HT6 - h - rf HT8 -f-jL-v'7 HU4 -yify y HU5 -#7 7'; * HZ15--9M~^ HZ2 -^f >lf7 ^>'>V*;W±?>-*f-7£JiU HZ7-v>y^7-x vm *T&M.tTv? JAl -7V7 JA2 -fp^ JA4 -7 7lf-7s$y JA7 -7y\Z7 JB15-'S?-H' > JB2 -^'>^7fvi tf;i/Tli^ 7>"7-^r£J: JC2 -# >^>7 -fe-f nxix'j 7>/7£JiLJ: JC6 — 4> HI 7*;i/^li£?g£JL JI8 - -Y 7 7 JI9 -^X7-n;u JJ3 -B# jj6 -3)1 y y 3K2-iJJf'7 7,9y JK6 -1/11$ JK8 - 7 7 x - h JK9 - * 'J 3r X JL2 - 7 t X JL4 - W*7 > JM1 --7 77^ JM2 -7l/-y7 V7t^ fr JM6 -^^it/'J 7 JM9 - ^ -V > "7 - JN4 -^7N°-;i/ JP2 -/^^ft JP3 -/^x? > JS2 -t7y77H7 JS6 - v>77*°-;l/ JS8 - X U 7 > 77 JS9 -y'J7 JT2 —^ JT23 - 9 V 9 JT3 - 9 4 1 JT5 -f-^7 h JT8 - h* ;U n XVIII TABLE G - com. G S—1% £ 3T9-Y)V9yy JV6-^hf"A JU9-*7X^7 JY4-jJZyiy k. t-/h7U7, -z±-y-z7>Ftim K x. ±m$t'(>mmM5 LAI - A¥#If M LM6 -^nv>7 LA2 - >f > K*£ft^ LN6--xt-77 lx K-7 LB6--tOM-/i- LP2-^7°7-xt-^-7 LB7 - 7;l/ * >f LP5 - 7 >f 'J tf > LC7 - 3 -t O LP7 - *° 'J * v 7 LF4 - 7 4 V- LR4 - 1/J-- * > \X4-iy K * v 7 LS5 - -fe >f v x ;l/ LM4 -^-'j ytX LV2-y^7 7 XI. SlgftlH] M - m 1^ $ HH (— & Z tz H \X TK 3\ I£ $ tl MP3 - £?fc JIS!(Pan American Union) Tl^V^CO) MP4 -^^A^\KVk^n^y9~ MA4 - ^1^? MS7 - jjCW 7 v 7 &#J#Mf (SEATO) MF6-@iit:fIjft*1tr^ (FAO) MS9 -JI^^H^H" MD-S^MIl (ILO) MU5-Sr&SI£ (UN) ML4 - gUggH (League of Nations) MU7 - _x * X 3 MP2 -^^^^^^^(Pan American Sanitary MU8 -.X —-fe7 Bureau) MW6-tfrW^fllf (WHO) XII. gifitt pa6 -n% PA7 -^ DA5 DG7 DH8 'b7 >t 4 fr^M &L tyyyvM^7t DS9 $f#yya77> DB38 xix TABLE G-cont. GT8 HB3 HC6 HF4 HF8 HM6 HN8 HR4 HR5 HS6 HT4 HZ3 JB8 JC4 JF6 JM3 JT7 LN4 MI8 g m~s ~$7Ec* h;i/n 77lJ1J y^'X h 7 y K ay^r (^.y^^^j-) 7 7>XfI^Jl7 7'Jy7 7 7>XfIH7 7'J 77 X^>f >||^-n y U -7-*tyy K n-r>7 7 7>XfIV7'J yy K ? >v —))/ f >y/^;V -tr-f n y 7tMt h 7 > x 3 ;u y y mmmm 47yA%m tffi^7F/£ JT8 HL3 HZ15 £L £L £L HM4 &L HM48 HD6 &L HT3 JM9 JS8 JT2 JC6 LI4 &L xx TABLE G-cont. G ^-m m%^&xm TEc7)t-X h7'J7feA^li^ S£ifP)»P^\ h&mZtz\m®.7>&&— ffifDm^^Z-D^Xti, Z\(DUz\ttfX£Z)o XIII. B * {%)* *(1R^7± : NLM ftm^zHK^tf, Byf(D%mt(D^M%7st lX>XV)Xi &#-t£4x-&<7y & 1 £ m oo Ik m it 01 HC * & 02 x. H 12 H Jr 24 t& ft 36 13 ft K 25 # ill 37 ft £ Jl| 14 m 3R 26 ^ J£ 38 03 #f fli 15 A K 27 ft £P 39 04 £ [U 16 & « 28 % 1*1 40 S ill 17 £ & 29 £ S 41 i 06 }g # 18 « I Hi 30 H: Hl| 42 Hi % 19 A $. 31 fg y^ 43 § if 20 ft *£ 32 A 5r 44 J 09 H£ JfL 21 ffl ill 33 ^" Hf 45 ffi 22 £ ft 34 Jt M ft 46 & 23 111 P 35 W & 47 m l-U ft 05 01 IS ft 07 ^ ^ 08 3f i 11 £ 01 : m^fl^*MI75r(i> JJ3 -!3^^liJJ3.i3 xxi ftmmmm PRECLINICAL SCIENCES mmm^ QS Human Anatomy QS A#JMJ3* QT Physiology QT £S^ QU Biochemistry QU £ft^ QV Pharmacology QV rnw^ QW Microbiology and Immunology QW «£&££&¥ QX Parasitology QX «£&^ QY Clinical Pathology QY v&mmm^ QZ Pathology QZ mm^ MEDICINE AND RELATED SUBJECTS E3*fc«fctfl3tljI±B w Health Professions W MM WA Public Health WA teWfcZi WB Practice of Medicine WB Wumm^ WC Communicable Diseases WC {X9kin WD 100 1 Nutrition Disorders WD 100 %mm% WD20C i Metabolic Diseases WD200 f««m WD30C i Immunologic and Collagen Diseases. Hypersensitivity. WD300 ft&mmtB&m. &&s WD40C i Animal Poisons WD400 w%&% WD50C i Plant Poisons WD500 tit/# WD60C i Diseases and Injuries Caused by Physical Agents WD600 vsmttftmizi&m&tmto WD7O0 i Aviation and Space Medicine WD700 ^m^t^m^ WE Musculoskeletal System WE ffi#te* WF Respiratory System WF mm?k WG Cardiovascular System WG 'iMlifili^ WH Hemic and Lymphatic Systems WH MMJhb V >/*£ WI Digestive System WI Mim% WJ Urogenital System WJ &mtm%% WK Endocrine System WK rt7>^m WL Nervous System WL ?«m WM Psychiatry WM mm^ WN Radiology. Diagnostic Imaging WN i&toim^. ®fti« WO Surgery WO mw WP Gynecology WP mxtw WQ Obstetrics WQ mw WR Dermatology WR mtw WS Pediatrics WS 'hmw WT Geriatrics. Chronic Disease WT %%-m^. *mt WU Dentistry. Oral Surgery WU mw. ummw WV Otolaryngology WV %M.wm&¥ WW Ophthalmology WW mw WX Hospitals and other Health Facilities WX 'mfttz^imummmmz: WY Nursing WY f-ff^ WZ History of Medicine WZ m¥& 19th Century Schedule wwfcyrmm xxii %mi®mm\mi. NLMfrm\zn-tZ>m?U±> MeSHM%¥&t\<*<^fr0 ^I^IR £i$ftT^£l-0 m^WWiizmrhfrm&^t, U^±.m®t£JLmMfrxbkm.£AznLx#J%xh*), z tzHZnhZKVk-f&^XJb&o ^ffcXH, Ei#I (see references) Klifr^lrlfcfEffcL&^o ^TifffilS (Indented terms) li, ±M£ «t "9 MfWlZ^ Ltz ^ illST OfrM^ fc H£ o £#-*§-£ ^1-*if£?)*>£>-C*>&o ^^Tlffflfgli, UiUi^Ztitz*), K#BB,-C & & & o ii#^#B?, 2 £ li> £ & £ <£ #H5 (see also references) li^3 lfflf§ <7)Tti7;i/7 7^7 vmizuMztifz^Tifmm^m\z$mztiz>o mm: Ufa QD571 £f£EfflI^ QT36 S^0»IJ$tff?£Ui3l7& WB 495 &7EW;£tt3imWttZ mz-ix, &mz&rtz> qyiss j3fc'h€1£ QT 36^ £ &£<£ LC7>^li, NlMfrmo MeSH±<7)$E^\ LCt>M^#-^U -HcL'fcv^Uli, ^oi: ^Sv^±^iit7c#-t^iil^tL^0 NLM7)?#HLC7>^^K^ (&#:) ztiim-t&ztfrb. mm\zM%Ltzmmmm*>*> (kid j^trL *£«<*># ^-zmitLx^Zo xxiii tom%*mmtztztbiiz&m2ti2>'<&x&2>o liLC7>illi, -^<7)##rtO#^<7)#^^^i*o*lt-r^)it-^1f#^-C*^o £ti£-<£"eab&o 4. «^Ni, NLM^/iliLCTJ-^^Eri^^^JtV^cMeSHfflM^^LTV^o ^O^P^t:\ MeSH7;V7 7^7 Mi U X M^XitOl-^T^MeSHflg £&-a LT V>&sR-?li & V>0 £ £ MeSH7;V77^7 hiHI'JX bOft^^-C^^V^o £ & ^fpU MeSHfl § £4*. ^>B#Uli, V*o f)7^77^7 MiUX b £##U-f-& Ih K&&0 ^iKIi&fBfc & < > igfil^^i^ U^i^0 ^tL^r±|E^li7;l/7 7^7 MIII'JX Yty})- (Tree Structures) ^ti^tL^## 5. m?\mm<7)T\z$)Z>^Ti0 dtu±, muz^^tz Ic7ilt£ffi£tu frm%K\*mtiX^%^0 fe^X. m&^Mmttzltffl&i-ZftmvmtiZ 7. +BH#hb :m^l^^ffl$ti^t@S#BSU(iTffi(7)^^70^^^0 7.1 Oio^f?|fflit:^tl, "££" #bs f& Att^^(Acquired Immunity) li ^.^ 5: £ £ 7.2 fc&O^lfflfgKtt't* "Mi" #M i;i:*ifLto "Hi" #M gf£(Abrasians)liglJJ&ffi ; M^mnfe ; Mmtmm*%X xxiv 7.3 ^\mm(DT(D "JU" #83 %?\m& £ E«fc" #-BS ^Tlfffll^^T^ "£*>££" #BS|i, ^Timmtzmzmtfii-Zo "£*>££" #BW± g£^3lffl!S£ltKlifl#1~&B#KI±, -r^Tco^TlffflI§i:-^#BS^^^^£o mmm*zo xxvi ami iiM^tt* & ^ TfdcouxMi, mi%-lzmiZtitz%4m±mz. «fL£ fc <7)T*&£0 G^OTKj&J&DSftfcS1 ^H. :w'jxM:ii^iitti»it»0 ir IS # 18.2 39 518.2 529 618.2 629 Q S A ft m %\ ¥ ^> K7 7 7*1 ^>K77^ii [n.n^] QS 18 QS518 QS539 QS618 QS639 18.2 29 36 37 37.5 260.5 261 QT £ m ¥ ^yK77 7^ ^mm. a-z »£i£IJK A-Z [3 J*ft&, X*°-7] QT 18 QT39 QT34 QT34 QT34 QT260 QT260 18.2 39 54 56 57 58.5 58.7 61 62 86 107 130.5 145.5 QU £ it ¥ ^y K7'y 9M * 7 Ujj-v K. 7^ytf K DNA RNA 7^ y. 7\yy 7^Y mm. f* QU18 &L QU55 QU58 QU58 QU58 QU58 QU60 QU60 QU85 QU100 QU130 QU145 18.2 39 77.2 350.5 qv m m ¥ /\y K77 9%. #te», a-z QV18 QV77 QV350 xxvii m IB # # 607 715 717 722 732 733 735 760 qv * m * ^y K77 9% qv mmmtmm^ 7 b7X=g]If a^ • &mm y^ K7 7 7 &L #0f QV17 QV22 QV32 QV33 &L * 18.2 25.5 39 50 55 518.2 525.5 539 540 545 573.5 575.5 630.5 18.2 39 45 18.2 39 18.2 39 275 18.2 20.55 26.55 49 85.5 130 132 QW 14 #£¥&. A-Z [ ^y K7 7 ^1 i~?~^7)\<. ^m mm. mm^ #5e3M& A-Z [^S7;a7^. ^ft] ^>K7'7 7l [%&&] %M (-fl£) ^MC, A-Z #5£#l#, A-Z #£#ll£#L#ll, A-Z QX ff 4 * ^ iWlttWr y^> K77 7^ m±^F4#ffi5IW^ QY ES J* ft 3 ¥ ^> K77 7|| QZ ft 3 £ WflftWr y^> K7'y 7^ w m m #^M^7 7X, a-z [g^we] #^hb°77X, A-Z [g#|f»...] ^yY7y7^ TE&flfriJ. ,&#<*>«#. £#*& QW18 #F7f QW4 QW518* &L QW 504* QW 504* QW 573* QW 575* QW 630* QX18 &F/f QY18 QZ18 QZ 200-269 W18 #3f #P/T W39 #F/T #F/T W125 xxviii IS xfcfflk... mmtk W600 &£¥£*&&£¥ /n> K7 7 ?£ WA & * % ± ^> K7 7 7^ g*J&*&. it#EM»9 WB BSI AE S ^ ^> K77 7^ -fe ;u 7 7" 7 WC ft ^ ^ y^ K7 7 9%. RNA7 4 )^7l&%k& WD100 %f Kl z\> K7 7 7^ WD200 ft IM 14 £ S s^y K7 7 7ii WD300 &&mmtBI$M MitfE /^> K7 7 7 Hi WD400 Id i i yN> K77 7^ WD500 fa *fa % ;\y K7 7 7^ WD600 4*3flWHU:j:5£Il£!iflJ /n> K7'y 7i W 100-275 W618 WA 18 WA540 #F7f WB 18 #FTf WC 18 WC500 WC500 WD 308 £L &L &L £L £L &L XXIX m # # i M IB # * 701 704 751 751.6 18.2 39 304 18.2 39 141.5 18.2 39 120 166.5 210 18.2 39 120 18.2 39 140 529 830 18.2 39 140 706 18.2 39 140 WD700 ;\y Y7 W9t ftH^S :*< t^SE^ WD750 ma mmmm we m # *& $ y^> K7 7 7^ 3 > tf a. — 9 WF Pf OS S§ £ ^> K7'7 9% #5e¥&, A-Z [*fc£. »...] WG 'jtfMiEIMft^ y^> K7 7 9%M #yJ£-/p^ri^ a-z wh M%i%tlJ>/m y^> K7'y 7^ iflLflK^t, wi ft fb 4* % y^ K7 7 7li 11$. *°'J-7° [£»] tt# (-*£) [IBM WJ $£££«$ ^> K7'y 7?g ®^ (-m m^mm WK ft # % £ ^> K7y y% l*J7>«,t WD 704 WE 18 WE 300 WF18 #FTf WG 18 &L WG 100 #F/f WG200 WH18 WH 100 WI18 WI 100 WI520 WI800 WJ18 WJ 100 WJ700 WK18 WK 100 XXX ± m IB # wl n m ^ ^> K7'y 9^ mmmm wm m n m ^ ^> K7 7 9^ '^mmmrn ^F- »t&s> a-z um^m nw)±. K77 7|g **>ffcjfelffi§l fel7t»ft^—7 t-^^77^- 4»7^7\ A-Z [$#«&] WL18 &L WL103 &L &L WL 100 #F7f WL340 WM 18 &L WM 100 WM 100 WM 145 #F/f WM270 #F7f WM420 WM425 WM475 WM475 WN 18 &L WN100 #F/f WN445 WB270 WN160 WB289 WN250 WN610 WN650 WN650 wo 9\- m y^ K77 7 ^ WO 18 WO200 m m >£ iTrW»f y^ K77 7|g WO500 ^^Wfif^S WO 218 WO 500 xxxi ± 11 IB * ^ Wp m x m ¥ y^ K77 7^ WP 18 WP 32-33 WP400 WQ jl £r ^y K7 7 7 ^E7>^ ¥ WQ 18 WQ 32-33 WQ150 WQ415 WR & ^ £r ^ y^ K77 9% rtif. ^-7'J >7* WR18 WR140 WS /h Ift¥ ^> K7'y 7^ i&mm. ^S7f^ WS 18 &L #F/f WS200 WS420 wt %*m¥. &&mm i mi ^> K77 7^ ^^14$]:^:. Alzheimerifi WT18 WT30 £L QU 145 WT 104 #F7f WT150 WT 150,WM 220 WT 100 WU y^> 7h ft*** K77 7^ ^ 7 h 7 h %m&. a-z [t«. t«. 7x=giif [mmm^] y7=mm [mmiE^] y7=mm [*f«»] yy=mm [nmm^] WU 18 WU39 WU 100 WU140 WU 141 WU17 WU 17 WU 400-440 #F/f WU 17 WU 17 xxxii m # * ± m IB # * 18.2 39 140 190 wv mimmm^ ^yK77 9^ WV 18 WV 100 WV 100 18.2 21.5 39 WW m *4 ¥ y^ K7y^i WW 18 #f7t 18.2 39 157.8 wx mf%z K77 7^ WX18 15 18.2 26.5 49 100.4 107 153.5 158.5 160.5 18.2 39 QS539 QS639 QT39 QW167 QW 168.5.R6 W39 WB289 WG 595.16 WG 625.16 WM612 WM615 WU39 WY39 WZ29 wy * m m fi-m. fft£&. 9-i yui; MfW*# &mmn¥. ^mr-9^m y^> K7'7 9M ^m7*7yyb. mmm wx.im%m x^fX/H IVfl :?JM@»fiMfI tt*£#«l WZ IS ^ * &to«t ^y K77 7^ HPJ & # # ±H ^> KX-y^l [Mffi ^yY7'y9m [H^^] yN7 K7y7i l"£g^] IIi§7^^X RNAlfo^^7^;l/X yN7 K77 9m [SH] jg^ft^^WfflJffl te^ijE te£M Hit |WJf« ^y K77 7^ [M?W] ^y Y7"y 9m WflfO ;^y Y7y 9m [IM^£] •ny\£a- — 9 WY 18 £L WY39 WY 100 &m WY158 WY160 WZ18 WZ29 QS529 QS629 QT29 QW160 QW168 W49 WN208 WG 595.B72 WG 625.B7 HQ447;WM611 HQ75-76.8;WM611 WU49 WY49 WZ39 xxxiii HB2 ftmVtfeOtzVXD&miCM Bergey's manual of determinative bacteriology. 9th ed. Baltimore: Williams & Wilkins; cl994. 787 p. Bergey's manual of systematic bacteriology. 1st ed. Baltimore: Williams & Wilkins; cl984- v. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, D.C: American Psychiatric Association; 1994. 886 p. Diagnostic and statistical manual of mental disorders: DSM-III-R. 3rd., rev. Washington, D.C: American Psychiatric Association; 1987. 567 p. Dorland's illustrated medical dictionary. 27th ed. Philadelphia; Saunders; 1988. 1888 p. The International classification of diseases; 9th revision, clinical modification: ICD-9-CM. 4th ed. Washington, D.C: U.S. Dept. of Health and Human Services, Public Health Service, Health Care Financing Administration: For sale by the Supt. of Docs., U.S. G.P. O.; 1991- v. Medical subject headings: annotated alphabetical list, 1994. Bethesda, Md.: National Library of Medicine; 1993.1-230, 1066 p. Medical subject headings: tree structures, 1994. Bethesda, Md.: National Library of Medicine; 1993. 1-124, 865 p. The Merck index; an encyclopedia of chemicals and drugs. 11th ed. Rahway, N.J.: Merck and Co.; 1989. 1 v. (various pagings) National Library of Medicine classification. 4th ed., rev. 1981. Bethesda, Md.: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health. National Library of Medicine; Washington, D.C: For sale by the Supt. of Docs., U.S. G.P.O.; 1981. 397 p. Shortliffe, Edward H.; Perreault, Leslie E., editors. Medical informatics: computer applications in health care. Reading, Mass,: Addison-Wesley Pub. Co.; cl990. 715 p. The Systematized nomenclature of human and veterinary medicine: SNOMED international. Northfield, III.: College of American Pathologists; Schaumburg, III.: American Veterinary Medical Association; cl993. 4 v. Walker, John M.; Cox, Micheal. The language of biotechnology, a dictionary of terms. Washington, D.C: American Chemical Society; 1988. 255 p. XXXIV Nil 3 NLM Staff Contributors Arenales, Duane W., Chief, Technical Services Division Armstead, Karen, Librarian, Technical Services Division Bain, Evelyn S., Librarian, Technical Services Division Charen, Thelma G., Technical Information Specialist, Medical Subject Headings Section Charuhas, Joe C, Public Affairs Specialist, Office of Public Information Chung, Chong C, Librarian, Technical Services Division Clausen, Carol. Librarian, History of Medicine Division Colaianni, Lois Ann, Associate Director, Library Operations Coleman, Ann D., Technical Information Specialist, Technical Services Division Coligan, Nelda C, Librarian, Technical Services Division Conkle. Yhorda, Secretary, Technical Services Division Cox, John W., Computer Specialist, Office of Computer and Communications Systems Demsey, Andrea M., Librarian, Technical Services Division Detweiler. Victoria L., Library Technician, Technical Services Division Eannarino, Judith C, Librarian, Technical Services Division Emanuele. Lora A., Library Technician, Technical Services Division Feng, Margaret S.C, Librarian, Technical Services Division Fitzgerald, Joe P., Visual Information Officer, Lister Hill Center Freidin, Mark, Librarian, Technical Services Division Gilkeson, Roger L., Assistant Chief, Office of Public Information Goodson, Luanne M., Librarian, Technical Services Division Gordner, Ronald L., Librarian, Public Services Division Hoffmann, Christa F.B., Head, Cataloging Section, Technical Services Division Horan, Meredith L., Librarian, Technical Services Division Humphreys, Betsy L., Deputy Associate Director, Library Operations Jacobs, Alice E., Assistant Head, Cataloging Section, Technical Services Division Kao, Wen-Min C, Principal Cataloger, Technical Services Division Kingsland, Lawrence C, Chief, Computer Sciences Branch, Lister Hill Center Kraly, Karen A., Computer Specialist, Office of Computer and Communications Systems Kurth, Sabra M., Librarian, Technical Services Division Licht, Pamela C, Librarian, Technical Services Division Lindsay, Schendell A., Clerk, Technical Services Division Murtagh, Eileen, Librarian, Technical Services Division Nguyen, Hien P., Librarian, Technical Services Division Nguyen, Janet C, Librarian, Technical Services Division Pothier, Patricia, Research Analyst, Bibliographic Services Division Powell, Tammy, Technical Information Specialist, Medical Subject Headings Section Rawsthorne, Grace C, Librarian, Technical Services Division Savage, Allan G., Technical Information Specialist, Medical Subject Headings Section Schuyler, Peri L., Head, Medical Subject Headings Section, Technical Services Division Sinn, Sally K., Deputy Chief, Technical Services Division Van Lenten, Elizabeth J., Technical Information Specialist, Bibliographic Services Division XXXV NLM^6(DJEi^; B*E^I xmm±&¥mmm (nlm) &mm%mmT;fofcl5-ti-L # ^Si tt IEM • iiin»U P.77 WB17 Atlases Pictorial works feJUJIlo P. 157 WM17 Pictorial works Atlases fcilJUo P. 176 WO205CD±f£ Collections (Gemeral) Collections (General) CliTIF,. ^B^gUS-ClifriESrAo P.230 WX162 ^12 •" on long term care of geriatric patients in WT30. #S##$!g WT30^WT31 P.236 WY154 Postanesthesia nuring Postanesthesia nursing {^UiEc &B*gJtR-ClifriE$f&o £K*5I B*mms\ &w • iiin»Ji P.254 Accounts Payable and Receivable see Accounting P.765 *&o£i:*iKA£f±£It Accounting 90 P.289 Calcium-Binding Proteins P.563 A^v^A^Sfil SHSS^iiSn QU55 P.306 Communism Special topics, by subject, e.g., State medicine in a communist country W275 P.345 Fenoterol P.359 Handbooks Metabolic diseases WD201 P.361 P.381 p.577 &mi.m ftmwnwm W275-W225 mMb\£y9y\x. ±mmz. KR*mMj3\x\its&fc&0 mmMmmx W225 P.739 7x/rn-;b P.361 Health Planning Support P.595 USatS^JS Health Services, Indigenous p.687 tmm^ummmv-^y Insurance, Psychiatric p.663 mmmmm% P.410 Moon P.694 n P.423 Object Attachment P.680 tmmn P.480 State Dentistry P.561 &mmmmm P.480 State Medicine P.561 &mmm®\m P.504 Veterans P.739 imwA Provision for vetrans mgWX-&&}% ttii;:c^St40 fa(D-U0 General works Classify here works on regional anatomy. If written for the surgeon, classify in WO 101 Surgical anato- my. Classify material on comparative anatomy in QS 124. fi-mir&o mm^tzsbizmfrtix ftm-f&o kmmmmt. qsi24k Collections (General) 5 By several authors 7 By individual authors mm mm • mm) (-«) 5 %ix 7 fflA<0*#£«*:3 Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-«) 11 History (Table G) 11.1 General coverage (Not Table G) 11 S£ (GUteffl) 11.1 ±& (Gmmm-et) * 13 Dictionaries. Encyclopedias *13 &*. s&m& * 15 Classification. Nomenclature. Terminology *15 ^H. 3j£>£. ^-^Py'' * 16 Tables. Statistics *16 !lt ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. (>i) ii "J 9 - sm t (i "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" CD W^^cD Z t X°fo 5 c QS HUMAN ANATOMY QS A ft ft 9J ¥ QS 17 Atlases. Pictorial works 17 77h-7^ = l2lig 18 Education Classify here works about education. 18.2 Educational materials Classify here ducational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. is m w -O o [z ti^w k m-t * ^ft * fi-mt *18.2 IftWW^H n^Ajt^U i] 9 u 9\ CAI^C 20.5 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. *20.5 W% (—USD m\zx nftmtz>o 21 Anatomy as a profession 21 *™fcl/TK777i ♦NLMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * mmtntffw, &xnftW-mm-tzzttftbM%c 2 QS HUMAN ANATOMY QS Aftmm^ QS 124 Comparative anatomy of humans and animals Classify works on artistic anatomy of humans and animals in NC 760-783.8; on comparative anatomy limited to animals in QL 801-950.9. 124 xwtmmm ft(iNC760-783.5 Kftmt & i Wk t:PIib;rlfcJ£!S^#J^liQL801-950.9 \z^m-thQ 130 Dissection manuals 130 ftgij^v- d.T)V * 132 Laws concerning dissection. Discussion of Law *132 mmzmtz&w • fewomm-mm HISTOLOGY ^ 504 General works 504 Collections (General) 505 By several authors 507 By individual authors mm (Mm • mm (-m 505 rnxommtzz 507 ffiX 509 Addresses. Essays. Lectures (General) 509 mm. mm. mmm (-m 511 History (Table G) 511.1 General coverage (Not Table G) 511 J§£ (GUte/B) 511.1 £ft (G^Uffltf) * 513 Dictionaries. Encyclopedias *513 3¥». W£HM$ * 515 Classification. Nomenclature. Terminology *515 #H. dp£>£. $—$.yny * 516 Tables. Statistics *516 :lf 517 Atlases. Pictorial works 517 Tby7, = \ 518 Education Classify here works about education. 518 & W •2) o KimiftzMt zmitzfrmt * 518.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *5i8.2ifcwam£i wc^mmA\zm-r ^^m-iz\ z.\z^ m-fz>o mx-is, mm. nmB&, 7° uyy^ia^. ii 9 u ?\ cai^o %mm\m$:\zm%%k° =L~* (-«) *529 /\>K7-y7^ 530 Experimental histology Classify works on cytology of normal tissue in QH. Classify works about research in QS 520. 531 Histocytochemistry 530 m^mmm Sf^U^1-*^^liQS520 Kfrmt Z> o 531 t 532 Types of normal tissue (General) Classify works on aging tissue of the elderly in WT 104; on lymphoid tissue in WH 700; on fetal mem- branes in WQ 210 or in QS 645 if written for the embryologist. 532 ]E^mm&&. 5-Vny- * 616 Tables. Statistics *616 m. Wtsf 617 Atlases. Pictorial works 617 TVy* = =t 1 =R71I2 618 Education Classify here works about education. 618 ffc W ^fiicw^w-r^^^^^^-r^o * 618.2 Educational materials Classify here educational materials, for example, outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *618.2|fcWttgr4 m.^mmA\zm-f^mmtz.z.\z5f stioM^if, mm. sciijsi^ y° u?y Afl#, iJ 9 u 9\ CAI^0 5H£-f£o 620 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. 620 WR {—WL) mt-mzm-tzmft*. z.z.kk 621 Embryology as a profession 621 mnmtbrtf *629 /\>K7-y?S 638 Sex determination (Embryogenic) 638 t£>*£ (BM&±;Mty}&M¥\* Q?. QLi fclJSFi::53*^1"£<> QT<7)flf£^§l$ QT 1-33.1 General QT 34-37.5 Physics, Mathematics, and Engineering QT 104-172 Human Physiology QT 180-275 Physiology and Hygiene QT 1-33.1 U it QT 34-37.5 ^If^. &3*43 iigu *\zmizftz>m 7ztt%£M%mz^ts0 mm%%m it. a% • &mmzfrmi-Zo ¥#< mmi±wuzftmt&0 General works, including comparative physi- ology Classify material on comparative physiology limited to animals in QP. mm\zm7EZKtzycm%Mmt. qp izfrm-tZo Collections (General) 5 By several authors 7 By individual authors ** mm • mm) (-«) 5 »A*#KJ:3 Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-*n 11 History (Table G) 11.1 General coverage (Not Table G) 11 m& (Gitteffl) 11.1 ±i* (Gitffltf) * 13 Dictionaries. Encyclopedias *13 mm. wi*** * 15 Classification. Nomenclature. Terminology *15 ftm. &£>£. *-$sny- 16 Tables. Statistics *16 17 Atlases. Pictorial works 17 7byz=mm 18 Education Classify here works about education. ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 18 %b Hf zzuzimnizm-tzmittfrm-tZo (>i) it -j 9 -Ifi^l- b It "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"CD^£gcD ZbX&%a QT PHYSIOLOGY qt £ m ^ QT 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *18.2 &WttS*H g-r*oflix.tf, mm. »&&&> 70 * 19 Schools, departments, and faculties of physi- ology or physical education * 19 £.m¥ $ tz (j#w^<7)^sb t ¥& 20.5 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. Cf QT 25 Experimental physiology. *20.5 W% (—Ml) w$t-mzm-tz>mft*. --£#£ 1"*o #jE±S^W^li, *£>±Si: 21 Physiology as a profession. Ethics. Peer review 21 mrmti>T<»£&&. -fifes. e?u * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 A£ -imm (GUteffl) *22.1 £tt (G*ffiffl-a-f) Laboratories, institutes, etc. 23 Collective 24 Individual (Cutter from name of agency) 03 jfe^^r) 24 m*(D («Mte*»e>*'y*-E**: 25 Laboratory manuals. Experimental physiolo- gy. Technique 25 H»f7Zj.77Vk ^8 * 26 Equipment and supplies Classify catalogs here. *26 $S£fflpnp i]9u9*\±Z\ l^St^o 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. 26.5 Efttitm¥. iWx-^ftiS. =i>b° Museums, exhibits, etc. 27 Collective 28 Individual (Cutter from name of museum, etc.) 27 m^K7-y?i * 32 Laws (Table G) * 32.1 General coverage (Not Table G) *32 &w (Gmi&m) *32.i £#■ (GUffiffl-^-r: * 33 Discussion of law (Table G) * 33.1 General coverage (Not Table G) *33 fewomm - mm (Gmmm) *33.i ±f* (Gmmmv?) ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * gmtWtrW. &&WfTm-&m-f5Zbtfti!,%zt 8 QT PHYSIOLOGY QT £ m ¥ QT PHYSICS, MATHEMATICS, AND ENGINEERING tt£¥*$^£X^ Include here only general works on physics, mathematics, and engineering as applied to physiological and medical phenomena. Classify works on their applications to specific problems by subject. 34 Biophysics Cf WN Radiology. Diagnostic imaging ¥tT¥lz-D\.^xfb .E4 nmn .G7 S ~h .H8 JS Jf .L5 thz .M3 fiS % .S8 Zb\s7 .U4 mHmtifz.ic$m3\zti ittkMWt. gf:-^£-sCDflJfflWB117 ; Mlft ^IJfflWB288 ; Vfj^WfOfflWB480 ; ^ftfflWD605 #Io 165 Body temperature regulation 165 W/nni 167 Physiological periodicity 167 ±mttmw\± 172 Exocrine glands (General) Classify works on specific glands with the system where located, e.g., Sebaceous glands WR 410. 172 ##$18 (HIS) iZfrmtZo $Jx.tfj£MlliWR4l0o PHYSIOLOGY AND HYGIENE tkm^tmsL^ 180 Physiology. General hygiene Include college level texts. 180 smm. -m&£& X^U^<)1(D-t^7 b £-a fr0 200 Teachers' manuals, books for nurses, etc., on physiology and hygiene Classify works about study and teaching of public health in WA 18. Classify works on informal health education (community, radio, etc.) in WA 590. 200 ±m^tm±^zmt^>^mm^-^ th. mmmmmmm ^nn^^m^t^m^zmthm m±. wAi8^ifi-&o #&5$& mm&ii (mm±£. yvtm u r^t^^^fiwA59o izfrm-tZo 210 School texts of physiology and hygiene Classify material on hygiene of adolescence in WS 460. Secondary izftm-t&0 210 *3>£[£]t7 215 Juvenile 225 Sex education Classify in HQ material on sex education other than school texts. 225 tt«W 230 Lighting. Air. Sunlight. Living space 230 mm. 2*1. *»#*!. ±%%m 10 QT PHYSIOLOGY ± m ¥ qt 235 Diet Classify works on particular foods and beverages in the numbers for diet in health and disease, WB 400- 449; on diets for particular diseases with the dis- ease. 235 mm t&#-^WB400-449 iz ; #^U: tttz>mmi**m&Kfrmtz>o 240 Cleanliness 240 m % 245 Clothing 245 &m=i 250 Recreation. Outdoor activities 250 I/7'JI-V3>. mum 255 Physical fitness. Gymnastics. Physical edu- cation Cf. WB 541 Medical gymnastics. 255 i*7j. ftjft. #W E^#M£$!WB541 #BB0 260 Athletics. Sports Classify works on first aid in WA 292. 260 9»tt&. ^, 260.5 Special activities, A-Z 260.5 ftftftfeW). A-Z .B2 Baseball .B3 Basketball .B5 Bicycling .B7 Boxing .D6 Diving .F6 Football .G6 Golf ,H6 Hockey J6 Jogging ,M3 Martial arts M9 Mountaineering R9 Running ,S6 Skiing ,S7 Soccer S9 Swimming T3 Tennis ,T7 Track and field W2 Walking W4 Weight lifting W9 Wrestling .B2 wm .B3 /^7^-y htf—Jl .B5 +r? .B7 #7V>7 .D6 m * .F6 7 7 h**-;u .G6 d';i/7 .H6 *-y$— J6 y 3^f>7' ,M3 It 51 ,M9 & 01 R9 y>->7 ,S6 7*- S7 Vyl3- S9 tK ># T3 x-* T7 ^±£S£ ,W2 ft # ,W4 M*(f W9 U*'j>7 261 Sports medicine Classify works on first aid in WA 292; on specific pathological conditions with the condition. 261 *JsK-yE3* !tt.*0!EliWA292H53181-£ ; #£ 265 Relaxation. Rest. Sleep (Hygiene) Classify works on therapeutic use of rest, etc. in WB 545; on disorders of sleep in WM 188; on physiolo- gy of sleep in WL 108. 265 U7777>. i*m. 8&E m±) tt#^£>fip*i?lftflJfflliWB545 [z ; IKItW(iWMi88 iz ; Bii£(7)^a tiWL108 H55-81-So =F 11 PHYSIOLOGY QT ± m QT Hygienic aspects of beauty culture Classify works on hair care in WR 465; on public health aspects of barber shops, beauty salons, and cosmetics in WA 744. #f£ (m). &xmm&<7)£?fcffi£. ft#H(2WA744 iZftm-i-Zo 12 QU QU BIOCHEMISTRY it it ^ * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries; annual reports, journals, etc. in WI. General works *1 ¥•«* (¥ •«***»&*?*-£ Collections (General) 5 By several authors 7 Bv individual authors mm mm • mm) (-«) 5 &x Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-m 11 History (Table G) 11.1 General coverage (Not Table G) 11 ssfc (Gmmm) 11.1 £f* (Gm&mvt) * 13 Dictionaries. Encyclopedias *13 mm. ~gnmi * 15 Classification. Nomenclature. Terminology *15 frm. ifc£&. ^-Vny- 16 Tables. Statistics Classify nutrition tables or food value tables in QU 145-145.5. *16 m. ttsi- s£*^£ fc(is£^fffi^(iQU145-145.5 17 Atlases. Pictorial works 17 Tby7=mm 18 Education Classify here works about education. 18 ft W Kli»WKIS1-*^ft£$Hrf * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. ♦18.2 m^wnm wcnmm^zm-t&mmt z. z. \z%- st^oMiii mm. nmfcn. y u9"y^^m. ii9u9\ CAI^0 m%m\m^\zrmt£0 ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * &mmftw, ^fijffw-ffii8i-5;:i:jwb**« 13 QL' BIOCHEMISTRY QU ± it ¥ Qu 21 Biochemistry as a profession 21 mrmtLxotkit^ * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 a£ -amm (G^ffl) *22.1 £& (G^ffiffl-y-f) 23 24 25 Laboratories, institutes, etc. Collective Individual (Cutter from name of agency) Laboratory manuals. Technique 23 24 25 mart° \zxy)frmirz>0 *32 >£i£ (Gl *32.1 £te (G t*-r: * 33 Discussion of law (Table G) * 33.1 General coverage (Not Table G) *33 *33.1 ±# (Gj mm (Gmmm) 34 Biochemical phenomena (General or not else- where classified) Classify here works on binding sites, diffusion, ener- gy transfer, osmosis, etc., when related to biochem- istry in general. 34 tkit^mmn (H»xttif£m6#s mm^^^it^-mzmmtx^^ * 39 Handbooks *39 /\>K777^ 50 Chemistry of food substances (General) 50 fcflfb* (HR) 54 Nitrogen and related compounds (General or not elsewhere classified) Classify works on nitrogen compounds that work primarily on a particular body system in QV. 54 mmtmmit^^i (H»xtt*fcu:* 14 QU BIOCHEMISTRY QU ± it ¥ QU 55 Proteins (General or not elsewhere classified) Classify here works on proteins in general or those in foods. Classify works on proteins that work pri- marily on a particular body system in QV; on those that are localized, by site, e.g., eye proteins in WW 101; on those that are enzymes or coenzymes in QU 135-141 or with the system acted upon; on blood proteins in WH or in clinical pathology QY 455; on immunoglobulins in QW 601; on other immunopro- teins in appropriate QW number. 56 Nucleoproteins 55 m&n. (Hurxiiifcicfc^ssnT ffll-sgegiiQvn ; ^£1-£®6 wwioi; m-mximw:%xhz>Wi& KliQUl35-l4l J.\±. ftfflfcgtt*^ \z ; Uli^SfigliWHXliElJ^^a^ QY455 K ; M^H7U X2QW601 [z ; *-<7Mt&<7)&*£S6S?liQW<7)ig^ 56 mm&m 57 Nucleosides. Nucleotides 57 2?l^*vK. 7?U**K 58 Nucleic acids and derivatives (General or not elsewhere classified) Classify works on derivatives acting on blood and blood formation in QV 185. 58 vmtmmi*. (hkxij if ;:££#£ jfli m t £ ifii \z ft m 1" £ If & * ii QVl85^5HS1"&o 58.5 DNA 58.5 DNA 58.7 RNA 60 Amino acids (General or not elsewhere clas- sified) 58.7 RNA 60 7S./S2 (HI5X(J£*CU:£#Si3ti 61 Amines. Amidines (General or not elsewhere classified) Classify works on catecholamines in WK 725; on amino alcohols in QV 82-84. 61 7<>. 7$v> (HKXtJfc'CK* * r ^ - ;l/ T 5 > (iWK725 ; 7 ^ 7 T ;l/ 3 - ;l/ (iQV82-84 U5H81" h o 62 Amides (General or not elsewhere classified) 65 Heterocyclic compounds associated with amino acid synthesis and metabolism e.g., Allantoin. Indoleacetic acids 62 T7^ K (HKXtt£*£lC£#S3tiT M : 7yy W y. -f > Y- 68 Peptides (General or not elsewhere classified) 68 ^7°f-K (HKXttfc'Cdfcfl-SSft 70 Nitrogen fixation 70 s$@£ 75 Carbohydrates Cf QY470 under Blood chemistry. 75 J^TMbtt jfiLtf£ffc^<7)T^QY470 #HB0 83 Polysaccharides and derivatives e.g., Dextrins. Glycogen 83 £tg££ft*ft #l: f*X r- v >. ^')3-y> 15 QL BIOCHEMISTRY QU ± it * QU 84 Sugar acids and their salts and esters (General or not elsewhere classified) 84 «»£#*<&* fci*x;u (-*rx 85 Lipids (General or not elsewhere classified) Cf. QY 465 under Blood chemistry. 85 fllfC (HBXttifCUfcfl-SStlT^ lflL^ik^<7)T^QU465 #HB0 86 Fats. Oils 86 II 87 Lipotropic factors Classify works on methionine in QU 60. 87 mfonmvm* 90 Fatty acids 90 m 93 Phospholipids e.g., Phosphatidylethanolamines 93 U/UISC 95 Sterols e.g., Cholesterol 95 XtU-)\, $\\ : u y 7. f n - ;i/ 98 Carboxylic acids and their salts and esters (General or not elsewhere classified) 98 *;U&##*<&££ I7,7-)\, (- 99 Aldehydes (General or not elsewhere classified) 100 Body composition 99 TJPfkK (-IRXttifCtC^^ti* 100 #ft£>*§$ 105 Body fluids Classify here works on acid-base equilibrium, hydrogen-ion concentration, and water-elec- trolyte balance in body fluids. Cf. WD 220 Water-electrolyte imbalance, etc. 105 ft m WD220 #HB0 107 Growth substances. Growth inhibitors (General or not elsewhere classified) 107 #£#i1C. AMftttff (HRXtt 110 Pigments (General or not elsewhere classi- fied) no &m (-i&s.tttfz.iz&frmztix 120 Metabolism Classify works on metabolism of a particular sub- stance with the substance, e.g., Metabolism of pro- teins in QU 55. 120 ft HI 125 Energy metabolism. Calorimetry 125 i*;u*-fm mmmiz% 130 Inorganic substances (General or not else- where classified) Cf. QY 480 under Blood chemistry. 130 mmn (-ttx«t"ctz^^si*tiT lfiL^fbf:^TOQY480 #BB0 16 QU BIOCHEMISTRY QU £ it ^ QU 130.5 Trace elements. 130.5 mmTtm 131 Organometallic compounds. Organophospho rus compounds. Organothiophosphorus com- pounds (General or not elsewhere classified) 131 Gm±mit*to. *mv Mi^to. *r to***)A.it&m (-«xttt*ctc* 133 Colloids (General or not elsewhere classified) 135 Enzymes. Coenzymes (General or not else where classified). Enzymology Classify works on enzyme deficiency in WD 105 or with the diseases resulting. 133 an-TK (HSXttifctcfc^&Sti 135 S¥$. ffiPS (-mRttifZHZbtt® 136 Hydrolases (General or not elsewhere classified) 136 Mfrmmm (-nsxttifctc*^ 137 Isomerases (General or not elsewhere classified) 137 mmtwtm (HKxtiifcK*^ 138 Ligases (General or not elsewhere classified) 138 a>&Mm (-mRttifziz&frmz 139 Lyases (General or not elsewhere classified) 139 iJ7-if=^mmm (HKXtt*: 140 Oxidoreductases (General or not elsewhere classified) 140 mitmjtmm (-m>w.t:zizt>fr mznx^tt^w,^) 141 Transferases (General or not elsewhere clasified) 141 W&mm=Vy>X7Ty—e (H Xtti:;:ic£#£3fiTVfci*»&) 142 Enzyme precursors (General or not elsewhere classified) 142 PSftrlEft (HKXttifctcfc^SS 143 Enzyme inhibitors (General or not elsewhere classified) 143 g?n»J3j (HisxiJifzKfc^gia 144 Enzyme reactivators (General or not elsewhere classified) 144 wtmw&vkwg (-«x«ifctc*^ 145 Nutrition. Nutritional requirements Classify works on infant nutrition in WS 115-125; on child nutrition in WS 115-130; on geriatric nutri- tion in WT 115. 145 $*. $*#H ?UBs£#(iWSl 15-125 ; /MB5£#{;£ WS115-130 ; ^As£#iiWT115 £# 111-^)0 145.5 Nutritive values of food 145.5 **®$«< 17 QU BIOCHEMISTRY QU £ it ^ QU 146 Nutritional surveys (Table G) 146.1 General coverage (Not Table G) 146 *mmm (GUfcffl) 146.1 £& (Gmmmvt) 160 Vitamins. Vitamin requirements Cf. QY 350 Assay of vitamins; QZ 109 Vitamin defi- ciencies; SF 98.V5 Vitamins in animal nutrition; WD 105 Deficiency diseases. 160 lf2S>. bf*$>#M \£9 I ><7)ffllJ^QY350 ; \£9 lyX ^4eQZ109 ; ifrt/<^#^&tt& \£ 9 I >SF98.V5 ; ft£jSEWD105 #BB0 165 Fat soluble vitamins 165 liJBt4lf*3> 167 Vitamin A, Al, etc. 167 tf£$>A, A1^ 173 Vitamin D, D2, etc. 173 t££S>Dx 02^ 179 Vitamin E 179 tf*S>E 181 Vitamin K 181 tf£S>K 185 Water soluble vitamins 185 *»t£fcf*$> 187 Vitamin B complex (General) 187 tf*$>B*&ft (-«) 188 Folic acid 188 m m 189 Thiamine 189 *7*> 191 Riboflavin 191 'J**77b'> 193 Nicotinic acids. Nicotinamide 193 -=13->M. -Z35L>77^ K 194 Vitamin B12 194 t££^>B12 195 Other factors associated with B vitamins e.g., Aminobenzoic acid. Biotin Classify works on choline and inositol in QU 87. 195 bf* S>B £R|5iL-fc*0)fl!<&H* n'j y £j j v h-;KiQU87U ftm-tho 210 Ascorbic acid 210 77.zi)\,\£>\ ll^S Other vitamins 220 ^ 18 QV QV PHARMACOLOGY II ££ Classify here works on pharmacology in general or on the pharmacology of individual drugs or types of drugs grouped according to their specific action. Classify works on an individual drug according to its principal action. Classify works on the use of an individual drug in the treatment of a particular disease with the disease. Classify works on the purely chemical or technological use of chemicals in the QD or the T schedules. Classify a drug derived from a plant with the drug. Classify works on vitamins in QU; on endocrine preparations (including synthetic substitutes) in WJ, WK, or WP; and non- endocrine biologicals in QW. Note that occasionally agents are classed together because they are frequently treated together regardless of their different actions, e.g., sulfur and sulfur compounds in QV 265. Classify works dealing with the general aspects of pharmacy and pharmaceutics in the section beginning with QV 701. Note that Pharmacy and Pharmaceutics section also has many of the early range or form numbers found under Pharmacology. zz.i,z imw^-%%. z tzim* (Dm® 0 \t^w&%mt*:(r>mto\z tr* s >IiQuc ; nfrmmm (^j&mz^ts) m±oy/\zfrmi-2>0 m%D\±&*-m\zftmztiz>z\ktfhz>^ fflx. mmkmmk^i±QV265 \zQ QV701 t*& ftzftm-f&o mm¥£Mm¥i>mm¥tmm QV 1-370 General QV 600-667 Toxicology QV 701-835 Pharmacy and Pharmaceutics QV 1-370 $£ QV 600-667 S1 QV 701-835 Hj GENERAL Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries; annual reports, journals, etc., in WI. * 1 ^-^# (¥-ffi#*#6*-y*-K mm&)$> £ v^igij* \zmi £ tiz ® a. a% • Q.mmizfrm-tz>0 *m. General works Collections (General) 5 By several authors 7 By individual authors ** mm • mm) (-«) 7 mxnmmizkz Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-«) 11 History (Table G) 11.1 General coverage (Not Table G) Classify works on the history of a specific drug with the drug. 11 JS£ (G 11.1 £ft (GiUffltf) ftfem®i£) * -y 9-^mb\t "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" CO ##£g CO Z b Xfo 3 „ * Wrmtwtrw, M&fmm~mmi-%zbtf&%:50 QY PHARMACOLOGY QV m ® ¥ QV 15 Classification. Nomenclature. Terminology *15 #*a. i&£>£. ^-ypy 16 Tables. Weights and measures. Statistics *16 Jf *ffi. Iffilt 17 Atlases. Pictorial works Classify pictorial works on medicinal plants or materia medica in QV 717. §f(iQV717 U5HI1-&0 18 Education Classify here works about education. * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. 18 I f zzizimi? liZM-tzmitzfrmt •O o *18.2 JSWtilXft ^mnmzm-f %>mft\$z z\zft it^o ®\\z.\f. mm. *dmfc&. 7° U9'y-U^m. Ji 9 u 9\ CAlf„ m*m\m^\zrmtz < ±ic x *) ftmt&o * 19 Schools and colleges Classify courses of study, catalogs, etc., in W 19.5. *19 £&-¥?*£*&*¥ £, 20 Graduate and continuing education in phar- macy (including fellowships, internships, resi- dencies, etc.) 20 £»mcfci7*:*:36|E»Wi:i (7in-yy7, <>^->x \sv? 20.5 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. Cf. QV 34 Experimental pharma- cology. 20.5 W% (HK) mft-&iz®tz>mmz. zziz^ m\zx t)ftm-fz>o m$kmm^QV34 21 Pharmacology as a profession. Pharmacy as a profession. Ethics. Peer review 21.5 Pharmacists' aides 21 mnmtbxcomm^. mrmtisx (ommm. -fifes. t?7nfa-=ra* 21.5 ^JBifiSj^ * 22 *22.1 Directories (Table G) General coverage (Not Table G) *22 x&'&pim (Gmfem: *22.1 ±ft (GSftffl^f) 23 24 25 Laboratories, institutes, etc. Collective Individual (Cutter from name of agency) Laboratory manuals, including those on micro- scopic and chemical analysis. Technique Cf. QV 744 Pharmaceutical chemistry. 24 m*e =L~$ (Htt) ^iiw/^offflii, ±m\zx t)ftmt&o 27 ij|*^(7) 28 m*K7y<7; 50 Dental pharmacology Cf. WU 180-190 Dental materials. 50 mnmmm S##"£rWU180-190 #BB.0 55 Drugs (General) C/ 0V 55 Drwg acft'on; 0V 704 Pharmacy; QY 450-490 Blood chemistry. 55 mm (HK) »f£fflQV38 ; H3IJ^QV704 ; lfo.fi fk^OTWQY450-490 #flB0 60 Dermatologic agents Classify works on topical anti-inflammatory agents here. Cf. QV 247 for other anti-inflammatory agents. Classify works on local anti-infective agents inQV220. 60 y-fJ&/83iJ Mpftm$;i$:&mi$ z z izftm-tz 0 •?-<7)fl&£>#LifoSE^iQV247 #BB0 ^}#f ft#L$&^liQV220 13^^1-^.0 ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * ##ii^tr*. &xW{fm~mmtz>zbtffc%:z>0 21 QV PHARMACOLOGY QV QV 63 Protectees e.g.. Adsorbents. Demulcents. Emollients 63 i%mm ■m. tttfHU. &Mmm 65 Irritants. Astringents 65 mxm. ©n/Lii 66 Gastrointestinal agents (General or not else- where classified) Cf. WI 703 Bile acids, salts, etc. 66 nmm (HKXtt£"::ic£#S£ftT 69 Antacids. Anti-ulcer agents 69 HI. mflltuWti 71 Antidiarrheals 71 Tffi±&b 73 Emetics. Antiemetics 73 «tt*. S>M£=aRtl 75 Cathartics 75 fISlli£=T3J 76 Antitussive agents 76 m^m=^±isb 76.5 Neuropharmacology. Drugs acting on the nervous system (General or not elsewhere classi- fied) 76.5 tt&mm^. nmrnzitrntzm (- f^Riti: ziz^^m^nx^t^^^) 77 Psychopharmacology 77 mnmm% 77.2 Psychotropic drugs (General or not else- where classified) 77.2 mnf?mm=fannm (H»xtt£ 77.5 Antidepressive agents 77.5 fiiy^l 77.7 Hallucinogens 77.7 fijfcl 77.9 Tranquilizers 77.9 m#!£'£m= h7>*7mfti>z\z[z 5HK1~£o ^0fJfcSNgQVHO-U5 82 Alcohols 82 -pj\,Zl-Jl> 22 QV PHARMACOLOGY QV QV 83 84 Methyl Ethyl 83 y 3-)l 84 JL3-JI 85 Hypnotics. Sedatives. Anticonvulsants 85 mmm. mmm. tammm 87 Bromides 87 m 88 89 Barbiturates Classify works on hexobarbital in QV 81. Opioid analgesics. Narcotics and narcotic antagonists Cf. QV 95 Anti-inflammatory analgesics. 88 /iji\fy- ^* y^)]/ \£9-)^ (iQV81 \Zft 89 *hr*-rKa«n. mmtmm\m.m n ft^t£§I«QV95#BB0 90 Opium alkaloids 90 n#7)li3U-( K 92 Morphine and derivatives 92 ^Ufc^fcRWft 95 Anti-inflammatory analgesics. Non-narcotic analgesics Classify general works on analgesics here. Cf. QV 89 Opioid analgesics; WO 234 Preanesthetic medication. 95 tt.&mmmm. imm&i&mm mfamizm-t2>mtttzzi,zfr ■tho t^*J Kilffi^QV89 ; 98 Gout suppressants 98 mmmm 100 Stimulants of the central nervous system 100 *mn&%7i^^>! 103 Convulsants 103 107 Xanthines e.g., Caffeine. Theobromine. Theophylline 110 Local anesthetics (General or not elsewhere classified) 107 *1*>*> rt7^'J> no mmmmm (-mRu^z^^^m^ 113 Cocaine and derivatives 113 iti'Okmmte 115 Synthetic local anethetics 115 ^$LM?f\WiM 23 QV PHARMACOLOGY QV m a * QV 120 Autonomic agents (General or not elsewhere classified) Classify general works on bronchodilator agents here. Classify works on theophylline in QV 107. Classify works on autonomic agents that are also anti-inflammatory agents in QV 247; that are also histamine antagonists in QV 157; that are also sym- pathomimetics in QV 129; that are also vasodilator agents in QV 150. 122 Parasympathomimetics e.g., Pilocarpine 120 nwn&ttmm (-$xtt£'-K*>7> mztix^tz^m^) %^^tm.m\tzz\z^m-f^o t *y 4 'J >tiQVi07 n5Hi1"£o fa &mmx i> *> & &mn&it%m& QV247 U5HE1"* ; £** - >J£#l !&«■?*> &&B»tt&ailiQVl57 iz; #mnmmmmxi>&z>&nn H^iiQvi29 i;; jflL^I£^Hl-ei* h gm^^^JiQviso n#$1-*0 122 mSSttSJlSS M\ tf n * ;nf > 124 126 Cholinesterase inhibitors and reactivators Neurotransmitters (General or not else- where classified) Classify works on epinephrine, norepinephrine, and other catecholamines in WK 725. 124 126 3ij>nr7 mm mtnm x.\£*7]) y. y )iJL\£^y i) y. ;t(Di$L<7)JJy-zi-)]s7^ y it WK725 H5Hg-f"£0 129 Sympathomimetics e.g., Ephedrine See note under QV 126 above. Classify works on amphetamines in QV 102. 129 zmw&mmm ±ISQV126 ^vilfiSrEcto 7yy x.9 ^ >®fiQVl02 H5HS1~£o 132 Sympatholytics. Parasympatholytics Classify works on cholinesterase reactivators in QV 124. 132 zmnmmmm. ii 3 'J >iX7"7--H QV124 KSHg-t&o ma, 134 Atropine and allied compounds 134 7hnv>tmmte 137 Nicotine 137 -=1^> 138 Non-metallic elements and their compounds, A-Z 77ie substances classed here are used largely in experimental pharmacology, toxicology, and/or bio- chemistry for various purposes. Classify by specific use where possible. 138 #±m7tf&t*0 mttzhit. %f%mm\\\zftmtz>o .Cl Carbon ,P4 Phosphorus .S5 Selenium .ci m m .P4 m .S5 -b 1/ > 140 Neuromuscular agents e.g., Curare Classify works on tranquilizers in QV 77.9. 140 #iig®5ftffli£ 09 : 9y-U mn%7EmitQvi7.9izfrMir &o 150 Drugs acting on the cardiovascular system 150 ^m'Mvm^mtim 153 Digitalis. Cardiac glycosides 24 153 ->'**';*. SS'fcEllft QV PHARMACOLOGY QV ^ 3 $ 155 Quinidine and related compounds 155 *-->*>i:MiHb*' 156 Nitrates, nitrites, etc. 156 ffi?j$?i£, E&$£^ 157 Histamine. Histamine antagonists. Histamine receptor blockaders 157 t*$S>. fc*$$>te*atoH. k 160 Diuretics. Antidiuretics 160 mmm. mmrnrn 170 Drugs acting on the reproductive organs 170 ±m%Btgi,zftmtz>m 173 Oxytocics 173 ^gJRffiH 174 Ergot and its derivatives 174 i;u=f- h£*0)gi3|ft 175 Abortifacient agents 175 3IE/1H 177 Contraceptives (including those with indirect action) Classify works on contraceptive devices in WP 640. 177 a«H(HSWfftfl£B12 it QUl94H&*5Hi1~&o 181 Hematinics 181 Mtiam 183 Iron. Iron salts 183 m. i 184 Liver extracts 184 rai^r* 185 Nucleic acid derivatives Cf. QU 58 for works on biochemistry of nucleic acid derivatives. 185 &igf£gft $&f§3£ft<7>£ 229 Oxidizing antiseptics e.g., Hydrogen peroxide. Potassium perman- ganate 229 SftbKiJSH 231 Halogen antiseptics e.g., Iodine 231 l\Uf>\ M : X 7 m 233 Detergents and other surface-active agents 233 :JkMk ■£(7)ffe(D^@>St4^J 235 Dyes C/ (7V 240 for general works on the pharma- cology of dyes, etc. 235 fe ?H fei^^77^ifctf£QV240 #BB.t 239 Boron compounds 239 mmit&to 240 Dyes and related compounds used in diagno- sis or as reagents, indicators, etc. 240 ^wfxtiKu, ftmmmtisXfcmz tiz&mtvmit'km 241 Tars. Balsams 241 $-;u. rtjwu 243 Urinary anti-infective agents e.g., Methenamine. Mandelic acids 243 m&fa®mm ffl : y-r-f-^y. -?yy*p'* 247 Anti-inflammatory agents (General or not elsewhere classified) Classify works on anti-inflammatory analgesics in QV 95; on topical anti-inflammatory agents in QV 60. 247 fa&mm (-ftxXtt^ci&THiSft fa&mLmmmtoy95\z; mm& ^^!iQV60lC^M1-^o 250 Anti-infective agents (General or not else- where classified) Classify works on local anti-infective agents in QV 220-239. 250 fammm (-ftxxciirctc&THisn JUtffftj#Ll&&^iliQV220-239 U5H£ n6 252 Antifungal agents. Antifungal antibiotics 252 faumm. fa-$mmK±tfo% 253 Anthelmintics 253 mm 254 Antiprotozoal agents (General or not else- where classified) 254 fam&m (-ftxX(j£*::t;:&7H££ 26 QV PHARMACOLOGY QV QV 255 Amebicides 255 7y-/i\ 256 Antimalarials 256 fa^ytJT 257 Cinchona and its derivatives 257 *i-mkz7$ K.ffiJtfc*(OHi (iQV356 KSHg 268.5 Antiviral agents (General or not elsewhere classified) 268.5 fa^-CJUXm (HBXttifCIlCfc^ 269 Antineoplastic agents. Antineoplastic antibiotics Cf. QZ 267 Drug therapy of neoplasms. Classify works on azaserine in QV 252 Antifungal antibiotics or in QW 920 Immunosuppressive agents. 269 mmmm. tmm&fa±toK ®5©<0»€&QZ267 #BB0 7-t£-fe 'J >(i|/LKMt4f7L^%SQV252 ££ ti^^P*IJ^QW920 i;^S1-*o 270 Water. Inorganic ions. Electrolytes (Gener- al or not elsewhere classified) Cf. QU 105 Water-electrolyte balance; WD 220 Water-electrolyte imbalance. 270 *. mk*>. mmm (-asxiJif ziz&ttmztix^K^m^) * • €f§?JCW quios; tK • IfSW ¥ir^7fWD220 #BB0 273 Water. Sodium salts 273 *. 7-blJ7l±i& 275 Cations and related compounds. Alkali and alkaline earth metals (General or not else- where classified) Cf. QV 290-298 Heavy metals and their com- pounds. 275 Jjj-tykm'Mit^W). 7)l±Vk7 M&M k ^<7)fb-a%QV290-298 #HB0 27 PHARMACOLOGY QV * m * QV 276 Calcium 276 *JUv^A 277 Potassium 277 t)lJ7 A 278 Magnesium 278 1"7'*yr7J* 280 Anions. Halogens Classify works on antiseptic halogens in QV 231. 280 7-*>. i\ufy ^'^/Nn7JXiQV231 K£H£1"£o 282 Fluorine. Fluorides Cf. QV 50 Dental pharmacology. 282 &-3m. <*y>4 ft#^S^QV50#BS 283 Iodine. Iodides and related compounds Cf. QV 231 for iodines, etc. as antiseptics. 283 efc9fn. koivfokmrnit^m mmn ttxziz\zfrm t£0 *u- bik&®-&i±zziz it&%}&%e)%Fj££mizfrmtz>o 292 Lead 292 tS 293 Mercury (General or compounds not else- where classified) 293 *§g (HKXlJJfCKfc^SiSnT 294 Arsenic (General or compounds not else- where classified) 294 i>m (-nsxttifcic^^ssnr 295 296 Antimony Gold 295 7>9^> 296 £ 297 Silver 297 £ 298 Zinc 298 IE 310 Gases and their compounds (General or not elsewhere classified) 310 mft (#*) t*>s a-z .C3 Cephalosporins .C5 Chloramphenicol .E7 Erythromycin .G3 Gentamicins 354 Penicillins 354 .C3 t7 7nx*,|J> .C5 7n7/»7ii3- -;i/ .E7 I'J7P7 .G3 y>^v-fv> ^'-v ■J> 356 Streptomycin 356 * KU7°hV 360 Tetracyclines 360 7-r-7iM?'J> 370 Tissue extracts Classify works on tissue therapy in WB 391; on ther- apy of specific diseases with the disease. Classify works on liver extracts in QV 184. 370 &&&&%) &*&&&{JWB391 iZ ; !frfcm£0 TOXICOLOGY m m ¥ (+»*) Classify general works on industrial poisons and poisoning in WA 465; general works on food poisoning in WC 268; on public health aspects of food poisoning in WA 695-722; on animal poisons in WD 400-430; on plant poisons in WD 500-530; on poisons acting on plants or animals in the appropriate LC schedules (See Index to this Classification). Classify works on agents that are primarily air, water, or soil pollutants in WA or WN. Classify works on chemicals used extensively in drug therapy or in experimental pharmacology in the pharmacology numbers. WA465 iz ; &tp#K|HI1-&*g:!Eliwc268 iz ; &tp#<7)&*ffi£ft#fS(iWA695-722 iZ ; W) t/<7)#t/fiWD400-430 \Z \ fit 2& £>#!&{* WD500-530 iz; tmximydizftft-tzm® \mM*Lc%.i,zfrmt2> (^ftm0 600 General works 600 2-<7)A£ -iifftm. tt% mmmmK7 7 7i 610 Inorganic poisons 610 ftEflti 612 Acids. Alkalies 612 M. T^UA'J 618 Irritant poisons Cf. QV664 Lung irritants; QV 666 Irritant gases. 618 $ij»t£3tt »Jif£t/SCQV664 QV666 #H?.o iam#* 627 Organic poisons 627 ^m 628 Alkaloids 628 7;U*P-TK 632 Non-alkaloids 632 ^7;U*P-fK 633 Hydrocarbons. Volatile poisons. Solvents 633 mt*m. wn&nto. ^m 662 Gas poisons and poisoning Cf. QV 81 Anesthetic gases; QV 310 Gases used in therapy. 662 tf^tfftttfc** &Bfcffl#*QV81 ; MCfflV^fL* #XQV310#flBo 663 Chemical warfare agents Classify here works on the agent even if its war use is not part of the discussion. 663 it^WLRWH i5c#-^£ffl1-£ - ktf±mx% < T 664 Lung irritants e.g., Chloropicrin. Phosgene Cf. QV 666 for works on irritant gases. 664 IftnJlfcttff $j: 9uu\z9 ]) y. *7s>fy J»IW*QV666#BS0 665 Tear gases. Toxic smokes 665 mmii*. m 666 Irritant gases Cf. QV 644 for general works on lung irritants. 666 wmkisx i!^KEiaQV664#BS0 667 Systemic poisons. Paralysants 667 ±&%nm. mmtefi* ♦NUMBER CAN BE LSED FOR BOTH MONOGRAPHS AND SERIALS. * ##I±1MJ§. 8*fflfr»Kttffl1-*3fc;fttdl*'5< 30 QV PHARMACOLOGY QV QV PHARMACY AND PHARMACEUTICS um^tmm^ Classify works on pharmacy as a profession in QV 21; on pharmacy education in QV 18-20. ^rmt Lx6*y*-SE mmitwuzftmt&o 704 m is Collections (General) 705 By several authors 707 By individual authors ** mm • mm) (-«) 705 mxY7'y7\ 736 Drug industry. Economics of pharmacy. Advertising 736 Einnnii. mmfD&mm. fc%^m 737 Pharmaceutical services. Community pharmacy services. Pharmacies Classify works on hospital pharmacy service in WX 179; on public health aspects in WA 730. 737 mm-v-^*. mmmmy-iiz. m m MfxMfmV—Vzitv/xm iz ; ^^ JtJ£ft#H!2WA730 CS'it-So ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 31 (>±) i) -) 9 -gfi^- b \t "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" £> ^t £ ^ ?'(iWB330 \z ; #^ i,lcfffl$fL^io * 772 Commercial preparations. Patent medicines Include here drug catalogs issued singly or serially. 773 Fraud in manufacturing of drugs *772 rfjis^. mm %.5kZtzimffittlz%fi2tiZ 773 H0)»!itlCi3tf*!fl& 778 Pharmaceutical processes. Drug compounding 778 SilXfflS. ►NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * S^li^tT*. **fJtr»l-ttffli-5 3fc*tm3U5t 32 QV PHARMACOLOGY 785 Types of pharmaceutical preparations. Dosage forms (General or not elsewhere classified) 786 Solutions 787 Tablets 800 Vehicles. Pharmaceutic aids 810 Flavoring agents 820 Preservatives Cf. QV 754 Collection and preservation of drugs. 825 Packaging 835 Labels and labeling Qv m m ¥ qv 785 wmmwrnm. ms-mm (-ttx« 786 * ft\ 787 & M 800 mmm. mmmm=mmi%m 810 mmm 820 tikftM m®Wm k ^^QV754 #ra0 825 ^ H 835 ^'Olk&m 33 QW QW MICROBIOLOGY AND IMMUNOLOGY «£*¥£&S *=£ Classify works on a particular species of bacteria with the order to which that species belongs, according to the classification in Bergey's Manual of Determinative Bacteriology. &&U<7)BWizmLXi$. "Bergey's Manual of Determinative Bacteriology" (D^lfS^t^o X. ztitmi-zBizfrmi-Zo QW 1-300 QW 501-949 Microbiology Immunology QW QW 1-300 501-949 MICROBIOLOGY * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL General works Classify here works on microbiology as a whole. Classify works on bacteriology alone in QW 50; on virology alone in QW 160-170; on mycology alone in QW 180-180.5, or appropriate LC numbers. Collections (General) By several authors By individual authors * 1 3&.tfi# (¥-t8££*>&**y*-K 8Mifa*£v>iigiJ*u!&Tf£ft&® u. a% ■ &rftmi,zfrm+z>o *m. mmi$wuzftmi-z>o 4 m ib zzizit^fek LXm. fr&£. ^-^Py- 16 Tables. Statistics *16 5tr 17 Atlases. Pictorial works 17 7Vy7. = mm 18 Education Classify here works about education. 'NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 34 18 « W (>i) ii v 9 -B^blt "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table (D^&^ff) ZbX&Zo * &mtWtrg. ^*f"ltr»{:ttffli-5Zi:*«ai**. QW MICROBIOLOGY AND IMMUNOLOGY QW flt£tt¥£&&¥ qw * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *18.2 »wwjm WL-nmm^izm-t ^>mftitz zizjf stio nx.ii. mm. nmfc&. 7"n^7A}|i, ii9u9\ CAI^o $mwimftizm{%% < ±mizx •? frmtZo 20.5 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. 20.5 fflft (HUx) wR-ftizm-tzmmz. zziz^ 21 Microbiology and immunology as professions 21 mrmt. bxmm * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 a£ -imm (G^ttffl) *22.i ±& (Gmi&mvf) Laboratories, institutes, etc. 23 Collective 24 Individual (Cutter from name of agency) mm?i®Mm 23 m^6*-y*-SE#£ #a.3) 25 Laboratory manuals. Technique 25 HBgTZ. n.7)V. ^S 25.5 Specific techniques, A-Z 25.5 &m^&. A-Z .M6 Microbial sensitivity tests .V7 Virus cultivation .M6 m£.W)m%\!ky-Z h .V7 ^-nuxigf^i * 26 Apparatus, equipment, etc. Classify catalogs here. *26 £■. ^SH ^irf&c 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. 26.5 ESttS^ B»7-'-24&S. a>tf ^-^ (HK) Museums, exhibits, etc. 27 Collective 28 Individual (Cutter from name of museum, etc.) 27 H-&0 28 m*(D mtynmn&mfrztiyz *32 *32.1 Laws (Table G) General coverage (Not Table G) *32 :&W (G *32.1 £ft (GUteffltf-f; *33 *33.1 Discussion of law (Table G) General coverage (Not Table G) *33 :,&nK7 7 7I 50 Bacteria (General). Bacteriology 50 mm (-«) 51 Morphology and variability of bacteria. Bacterial genetics Classify works on fungi in QW 180; on viruses in QW 160 or with the specific fungi or virus group. 51 Mmwm&tmmtk. tm&B¥ MM (iQwiso iz ; 7 4 ;i/ x (} qwi60 Xit^^Mm^7 4 )izyn> -7°izftmtZ>0 52 Physiology and chemistry of bacteria. Metabolism Classify works on fungi in QW 180; on viruses in QW 160 or with the specific fungi or virus group. 52 mmm 7L \Zfflfa 7 4 )V9, (iQW!63 o 65 Dental microbiology 65 um$i*k®¥ 70 Veterinary microbiology 70 mm.m3L®¥ 75 Industrial microbiology 75 xmm±m^ 80 Water and sewage microbiology 75 _L*fcT*<&*£tt3S 82 Air microbiology 82 &w»&tom 85 Microbiology of food, milk, and other beverages 85 &Bncu *F?L * 115 Actinomycetes and related organisms 115 773-y sizzmtmm 118 Coryneform group 118 n'j^sn 120 Propionibacteriaceae 120 7PWZ/\'77'J7Air! 125 Actinomycetales 125 773-y $-fe*B=«[*8BB 125.5 Specific organisms, A-Z 125.5 ftltJOS* A-Z .A2 Actinomycetaceae ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. .A2 77*y zizm^mm® * #^li*rr». &&WtfWH~femt5Zbfrli!l%:5c 36 QW MICROBIOLOGY AND IMMUNOLOGY QW mzLMmk&m^ QW .M9 Mycobacteriaceae .S8 Streptomycetaceae .M9 "7<=i/\''7x,J77-irx .S8 * hL^hS-fe*^ 127 Bacillaceae 127 /iyyizX 127.5 Specific groups, A-Z 127.5 !ft:£?;i/-7\ A-Z .B2 Bacillus .C5 Clostridium .B2 i^yyT. .C5 7U7.b-\)v7U 128 Gliding bacteria 128 TftJtXIM 131 Gram-negative bacteria (General). Gram-nega- tive aerobic bacteria (include cocci and rods) 131 ?7Aft1M (HIS). ?7A»14*F3l 133 Gram-negative anaerobic bacteria (include cocci and rods) 133 ?-7ARtt«miM (^Bfcffttfi* 135 Gram-negative chemolithotrophic bacteria 135 <7'yA\ 137 Gram-negative facultatively anaerobic rods (General or not elsewhere classified) 137 ^AfcttfcfcttffttB (HRXtiif 138 Enterobacteriaceae 138 nrt!im& 138.5 Specific organisms, A-Z 138.5 ¥ffcMm. A-Z 139 140 141 .E5 Enterobacter .E8 Escherichia .K5 Klebsiella .P7 Proteus .S2 Salmonella .S3 Serratia .S4 Shigella .Y3 Yersinia Haemophilus Pasteurella Vibrionaceae ,E5 I>tPM'7$ E8 r>i'J*7 K5 71/7VI7 P7 7pt77 S2 ■VJls^Zy S3 -tzKvT7 ,S4 yfy Y3 JLJly-7 139 s\"E74JlZ 140 /SZVisy 141 tf7«J#f4 142 Gram-positive bacteria (General or not else- where classified) 142 7yl*m\±m (HKXttfc'Ctcfc^ 142.5 Specific organisms, A-Z 142.5 ¥ffc$m. A-Z 37 QW MICROBIOLOGY AND IMMUNOLOGY QW WL±y>¥k&&¥ QW .A8 Asporogenous rods .C6 Cocci .as mfei-ftttm .C6 I*® 143 Mollicutes 143 Mollicutes 145 Phototrophic bacteria 145 Tfel 149 Rickettsias and chlamydias 149 Vry3-7m}z?y$.y7 150 Rickettsials 150 U^-y^T7! 152 Chlamydiales 152 77^v7-U7 153 Sheathed bacteria. Budding or appendaged bacteria 153 G^mm. aj£$fc«:tt«j 154 Spiral and curved bacteria 154 b-tf/U 155 Spirochaetales 155 ^tfP^\-^ 160 Viruses (General). Virology Classify works about a virus disease with the dis- ease. 160 7<)\<7» (HK). 7'(Jl'Z¥ 1"&0 161 Bacteriophages 161 /<7j|J^77-y 161.5 Specific phages, A-Z 161.5 ^77-A A-Z .C6 Coliphages .M9 Mycobacteriophages .S8 Staphylococcus phages .C6 *II7 7-V .M9 $3/^^t-'J*7 7-V .S8 #£r5&H77'-V 162 Insect viruses Classify works on diseases of insects in SB 942. 162 M*7<;U7s !i£<7)£Bl±SB942 K^t*, 163 Plant viruses Classify works on virus diseases of plants in SB 736. 163 ttft^-OU* fitt/f^ 4 ;VXl££,&liSB736 7>81-*o 164 Vertebrate viruses 164 **»tt^-r;u^ 165 DNA viruses 165 DNA 7 -OP* 165.5 Specific DNA groups, A-Z 165.5 #£DNA7;U-7\ A-Z 38 QW MICROBIOLOGY AND IMMUNOLOGY QW m±wi¥k$>m¥ qw 166 A3 Adenoviridae H3 Herpesviridae ,16 Iridoviridae P2 Papovaviridae ,P3 Parvoviridae P6 Poxviridae Oncogenic viruses 166 .A3 79y74)\s73& .H3 s\Jls74)l>ZW .16 4lJY74Jl*n .P2 /i*;/i74Jl>*& .P3 /*)\,#74n>*W .P6 i£y7 7.74)\s7J$ Mm%3i74JlZ 168 RNA viruses 168 RNA7<^^ 168.5 Specific RNA groups, A-Z 168.5 ftj£RNA7;U-7\ A-Z 169 .A7 Arboviruses A7 7-#74^73$ .A8 Arenaviridae A8 7\sy-74l\7$.77 74Jlo 190 Bacterial and fungal spores Classify works on bacterial spores alone in QW 51; on fungal spores alone in QW 180. 190 mmkumcnfe? ?)^(iQW180 iz^m-t^>o 300 Biological warfare 300 £&^WSK^=£ft!ft 39 QW MICROBIOLOGY AND IMMUNOLOGY QW *±tt¥fc**¥ QW IMMUNOLOGY & m * Classify works on immunologic diseases in WD 300-330. &^(2WD300-330 U5HS1"£o 501 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL *501 ¥ •»£ (3* •tt#**>6*'y^-E 'mu^h^^^i^\\^\zmi^fihm a. a% • temmizfrmtZo *m, &mm*v/uzfrm-tz>o 504 General works 504 504.5 Immunochemistry. Immunohistochemistry 504.5^^b^. &mmmt¥ Collections (General) 505 By several authors 507 By individual authors us mm • mm) (-*» 505 ttA<&*#lC«fc* 507 mx 509 Addresses. Essays. Lectures (General) 509 mm. mm. mmm (-») 511 History (Table G) 511.1 General coverage (Not Table G) 511 Jg£ (GUttffl) 511.1 £ft (GSttffl^f) * 513 Dictionaries. Encyclopedias *513 mm. &mmm * 515 Nomenclature. Classification. Terminology *515 ftm, $«&. $-§Sny- * 516 Tables. Statistics *516 m. Mt 517 Atlases. Pictorial works 518 Education Classify here works about education. 518 m w KimifKM'rzmi'EZfr&t * 518.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *518.2#WfitJttPr mi#}m\izm-thmfti$zzizfr m-t&o mitf, mm. nmfc&. 7° u ?y 2*%i%. ii 9 u 9\ CAI^o mmim^izrmttii.mizx*) 520 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. 520 W% (HE) mtt-mizmi-zmft*. zzizfr mzx vfrmt&o ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 40 (&) iJ-J 9-m^ib\t "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table <0?#£^cD Z b X'h -5 „ QW MICROBIOLOGY AND IMMUNOLOGY QW «£«?£&&$ QW [521] [This number not used] Classify works on immunology as a profession in QW21. [521] (*#*ttfcfflU4l*) M-f^Wik LTOft£^iiQW2n::# £I1-£o * 522 Directories (Table G) * 522.1 General coverage (Not Table G) *522 x% -itrnm (Gmmm) *522.i ^ft {Gmmmvti 523 524 525 Laboratories, institutes, etc. Collective Individual (Cutter from name of agency) Laboratory manuals. Technique Classify works on immunodiagnostic tests in QY 250-275. 523 m^(D 524 m* o 525.5 Specific techniques, A-Z 525.5 $££34$, A-Z .E6 Enzyme-linked immunosorbent assay .F6 Fluorescent antibody technique .13 Immunoassay .132 Immunoblotting .134 Immunoenzyme techniques .L6 Leukocyte adherence inhibition test .R15 Radioallergosorbent test ■R2 Radioimmunoassay .E6 ELISA ■F6 mitfai*& .13 $>&¥$}&•£% .132 M7Q7T<>^ .134 mmfami .L6 &mmmm\f-z h .R15 1&MU7l<)\,*?-VbmW£. .R2 yy^4Uy7yJa4 526 Equipment and supplies Classify catalogs here. *526 i^^nap| ii9u9'it^ ZizftWcthc 539 Handbooks *539 J\y Y7y7\ 540 Immunity (General or not elsewhere classified) 541 Natural immunity. Immunogenetics 540 &1Z (HKXlJifCKfctfSStlTl' 541 nmftm. fc&»i£9* 545 Autoimmunity 545 i5&*£ 551 Acquired immunity. Artificial immunity Classify preparations producing artificial immunity in QW 800-815. 551 mm&m. ai&s AX^SM^M^IJ(iQW800-815 II fr 552 Active immunity 552 tm*te 553 Passive immunity ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 553 $»&& * &mmnw, mt?mtin-#.mirszbi>w*&< 41 QW MICROBIOLOGY AND IMMUNOLOGY QW *£*93&fcfc*3* Qvv 563 Local immunity 563 mm-&m 568 Cellular immunity. Immunologic cytotoxicity. Immunocompetence. Immunologic factors (General or not elsewhere classified) 568 mte&f&m. &m¥#>Mfemw&. & mm*, tamm* (-«rx«ifztc« &mztixv%w&) 570 Antigens. Antibodies. Serology 570 fam. stft. mm¥ 573 Antigens 573 fa m 573.5 Specific antigens, A-Z 573.5 ¥ffcfaW~ A-Z .H6 Histocompatibility antigens .H7 HLA antigens .H6 .H7 575 Antibodies 575 St ft 575.5 Specific antibodies, A-Z 575.5 #£taft. A-Z .A6 Antibodies, Monoclonal .A6 ^y^p^--;ufetft 601 Immunoglobulins 601 M7n7y> 630 Toxins. Antitoxins Classify works on toxoids, antitoxins, etc., as preparations producing immunity in QW 800- 815. 630 mm. famm ftlzmtmik LX7Ph+y> 13 &mmm M3 Mffls&mnm M9 $=l h=5rv> N4 nmm ,R5 Uy> 640 Agglutination. Precipitation Classify works on immunodiagnostic tests in QY 265. 640 mm. &^H«^(iQY265 KfrmtZo 660 Lysis and bacterial action 660 mmt&mttm 42 QW MICROBIOLOGY AND IMMUNOLOGY QW m.±m^k^.m^ qw 680 Complement. Complement fixation Classify works on immunodiagnostic tests in QY 265. 680 ffift. &}£iW£S(iQY265 iZfrm-tZo 690 Phagocytosis 690 -kftm 700 Infection. Mechanisms of infection and resistance 700 &&. m^km^(DWtB 730 Virulence. Invasiveness 730 \£)liy>7.=m*. &H1£ 800 Biological products producing immunity Classify works on vaccines and vaccination for a specific disease, with the disease, e.g.. Smallpox vaccination, WC 588. 800 $Lmzm3LTz>£.y)¥ftmn =H€i^7^#fl(iWC588 o 805 Vaccines, antitoxins. Toxoids Classify works on toxins or antitoxins formed in the body in QW 630-630.5. 805 7?^>. fit**. r-*7-fK kwx-d< hti&mmximmm !iQW630-630.5 l,ZfrM1r&0 806 815 900 Vaccination Immune serums 806 ^mmm Anaphylaxis and hypersensitivity. Allergens Classify works on diseases of hypersensitivity in general in WD 300-375. Classify specific allergic reactions with the system affected. 815 %mm.m 900 7i~7 ty^v-kW&fs.. 7l<)l?y iS&14£B-#liWD300-375 [Zfrm. *%ijtz&\zfrm-tz>o 920 Immunosuppression. Immunosuppressive agents Classify transplantation immunology in WO 680. 920 &&jm. ftmmnm &ffifc*£¥tiWO680 IZfrm-tZo 940 Immunotherapy Classify works on therapy of a particular disease with the disease. 940 &mm:& •O o 945 Serotherapy 945 Jfil/1ftf& 949 Active immunotherapy 949 mmftmrnte 43 QX QX PARASITOLOGY 5 ± * ¥ Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL General works * 1 ¥ • &# (¥ • ii, a^ • &mmizfrmi-z>, &mmzvmzfrmtz>o Collections (General) 5 By several authors 7 By individual authors mm mm • mm) (-m) 5 SfcAflMlcj:* 7 1BA<&M(::j:5 Addresses. Essays. Lectures (General) 9 >1 I*. ft** (HK) 11 History (Table G) 11.1 General coverage (Not Table G) 11 m& (GiUffl) 11.1 £ft (Gmmm-er: 13 Dictionaries. Encyclopedias *13 mm. w*w 15 Classification. Nomenclature. Terminology *15 3H -^Py- * 16 Tables. Statistics *16 17 Atlases. Pictorial works 18 Education Classify here works about education. 18 & W \z\mi$\zm-$-z>m\t*frm-tz>0 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *18.2 tftWWJTO miwm*izmtz>mfti$zz\zft m-r&o Mz.it. mm. nmfcn. v u^y^^m. ii9u9\ CAI^c zmm&r^zm&K < iiia o 19 Schools, departments, and faculties of para- sitology *19 m±&m0 NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 44 (&) ii j 9-Umblt "C. A. Cutter's Cutter c,„ur„ ^S^jfTAuthor TAte"w****S3fc?*«. * #*fl±¥rrS, ^f\ftVilztim-tzz.ttffo*za QX PARASITOLOGY QX m £ * ¥ QX 21 Parasitology as a profession 21 mrv&tbx Museums, exhibits, etc. 27 Collective 28 Individual (Cutter from name of museum, etc.) 27 H^-£*$ (G *32.1 £ft (Gftteffl-tf?) *33 *33.1 Discussion of law (Table G) General coverage (Not Table G) *33 >£*$<7)!yi • mm (Gm *33.1 £ft (GmfeftV?) 39 Handbooks *39 J\>Y7'yy": 45 Host-parasite relations 45 ^±fr£ft*aS!H1* 50 Protozoa 50 £&»% 55 Sarcodina (Amoebae) 55 mn&m=fes.&%i. (7y-^m) 70 Mastigophora e.g., Giardia. Trichomonas. Trypanosoma. Leishmania 123 Sporozoa 70 H€£H M : y'7^y7l. HJ3^et7 II. HJ^7 7-7l. 'j-ya7 123 Jjfi1?1^ 135 Plasmodia ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 135 -?yl)7W& 45 QX PARASITOLOGY QX $ £ & * 140 151 352 353 355 365 400 442 Toxoplasma Ciliata 195 Cnidaria 200 Helminths 203 Nematoda 207 Trichuroidea 243 Strongyloidea 248 Trichostrongyloidea 271 Oxyuroidea 277 Ascaroidea 301 Filarioidea 350 Platyhelminths Turbellaria Trematoda Schistosoma Fasciola Cestoda Echinococcus 451 Annelida 460 Arthropods 140 h*77°-7*VJS 151 ifc^&m 195 mmm® 200 ££ £ 203 H&8 207 M;?;u*-L£r 243 X hn>=¥7U7;i:£r 248 %*£ifc!!E&±*4 271 301 !*_h£r 277 I!*±£r 7<7>j 7±n 463 Crustacea 350 mi&wito 352 SffcUUfi 353 9B£ffl 355 ftlfoiS&Jg 365 77***7^ 400 & £ 442 X*7=l-y;fc*Jg 451 is^n% 460 gfiSK^I 463 ¥»* 46 QX PARASITOLOGY QX £ Efe $ QX 467 469 Arachnida Scorpions 467 < «ffl 469 -9-7'J 471 Spiders 473 Acari 475 Sarcoptidae (Mites) e.g.. Sarcoptes scabiei 479 Ticks 483 Trombiculid mites 471 473 475 479 483 7 * #-B $j: \myy=. V#'~ yyjjzui/ 500 Insects Classify works on diseases of insects in SB 942. 501 Phthiroptera 500 f§ £ gi&Og|BliSB942 IZfrmtZ, 501 Phthiroptera 1 (f§£$<7)— S. V 502 Lice 502 V7 503 Hemiptera e.g., Bedbugs 505 Diptera 510 Mosquitoes 515 Anopheles 525 Aedes 503 ¥33 S ffl: byVy 505 3K@S 510 515 525 -\*7*Jg 530 550 555 560 565 Culex Siphonaptera (Fleas) Coleoptera (Beetles) Lepidoptera (Moths. Butterflies) Hymenoptera (Bees. Wasps. Ants) 530 550 555 560 565 (*7hAy) i («. m is (s&. -f-f&im «) 47 PARASITOLOGY QX * ± * * QX 570 Orthoptera e.g., Grasshoppers 570 flj : s*v 9 600 Insect control. Tick control Classify works on pest control in general and other public health aspects in WA 240. 600 m&m&. *-ki» ^#£&Sgl&-HK:&af* WA240 U59-^1"*o 650 Insect vectors 650 JMrKS 675 Mollusca 675 ttfttttt 48 QY QY CLINICAL PATHOLOGY ei j* m s ^ Classify here works on general clinical pathology and diagnostics. Classify works on tests for a particular disease or for diseases of a particular system with the disease or system., except for works on syphilis tests, which are classed here. zzizi$-bmt£W*mmm¥kwm£izmtz> QY 1-350 QY 400-490 General Blood QY 1-350 - AS QY 400-490 Jfll $ GENERAL Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify annual reports, journals, etc., in WL * 1 $ (3&-ia#*A»&a-y*-re ^awuzftm-f&o General works 4 U IS Collections (General) 5 By several authors 7 By individual authors mm mm • mm) i-m 7 mxommizj:* Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-m 11 History (Table G) 11.1 General coverage (Not Table G) 11 JS& (GStteffl) 11.1 £ft (Gmmmvt) 13 Dictionaries. Encyclopedias *13 mm. ~snm& 15 Classification. Nomenclature. Terminology *15 #m. &£&. ?-^nv- 16 Tables. Statistics *16 17 Atlases. Pictorial works 17 7Y-y7.=\ 18 Education Classify here works about education. is m w wmmzMi-zmitzfrmtz* ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 49 (>i) 1} -j 9 - mm b it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" CO ^^^^ CD ZbT't>%>0 QY CLINICAL PATHOLOGY QY gg ft m 3 ^ QY 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. *18.2 ffcWtf)S¥H &^Mm±izmi-z>Miwz\zizfr m~trz>o mz.i£* mm. %&&&. 7° U9~y2»%i^. ii 9 n 9\ CAI^C m*mim^.izrm% < umiz x *? ^^1-^0 * 19 Schools and colleges Classify courses of study, catalogs, etc., in W 19.5. *19 ¥»•¥&• ¥8 20 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. 20 ffl?E (HK) fifft-mzmtzmw*. zziz% 21 Medical technology as a profession. Ethics. Peer review 21 nitl/ti l/fcfo.-=|R|flFftf>J s. -fi«a. t°7 * 22 * 22.1 Directories of medical technology (Table G) Classify directories of all pathologists in QZ22. Directories of medical technology (Not Table G) *22 rum*£a« • femn (g mmm) ii^t^A^ • &mmtQZ22\zfr * 22.1 &m&mxz • i±mm (g mmmvt) Laboratories, institutes, etc. Classify hospital laboratories in WX 207. 23 Collective 24 Individual (Cutter from name of agency) 25 Laboratory manuals. Technique Classify works on specific tests by type. 25 H&^V-zLT^k %Ffflk&l*Z< 26 Equipment and supplies Classify catalogs here. 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. *26 m&tm& *9u91±ZZiZftmtZ>o 26.5 gamm^. i»x-^«!fa. =i>e i-* (HK) Museums, exhibits, etc. 27 Collective 28 Individual (Cutter from name of museum, etc.) 27 m^Y7y7l 50 Laboratory animals (General or not else- where classified) Classify works on diseases of laboratory animals in SF 996.5; on vivisection as experimental surgery in WO 50; and on antivivisection in HV 4905-4959. 52 Acquisition and transportation Classify catalogs in QY 26; directories of users and sources for obtaining, in QY 22. 50 n^m® (HKxiiifctcfc^ssft ^mm^)(D^BJtSF996.5 i,Z ; %& m\h L-cw^ftlS?S!liiwo50 ; £ ft»?glJRWi&liHV4905-4959 \Zfrm 1"*o 52 x^km& Jj9v91$QV261Z ; z.—*fkX^ :Mo 54 Care and breeding 54 mzk^m 56 Environment e.g., Germ-free life 56 m m 58 Experimental techniques Cf. QY 25 Laboratory manuals. 58 nm&m %WiM.y- J- T ;l/QY25#HB{ 60 Special classes of animals, A-Z 60 »to<0ftj£#JB. A-Z 90 A6 Amphibia .A6 fS]£ffl B4 Birds .B4 a m C2 Cats .C2 m ,D6 Dogs .D6 it ,F4 Fishes .F4 Ml m ,L3 Lagomorpha (Rabbits, etc.) .L3 ?<*£§ (ozzm) M2 Mammals (General or not else where classified) .M2 mztix^k^m^) [Zt P7 Primates .P7 imKxPl R6 Rodents .R6 ItoLi ,S8 emica Swine 1 techniques .S8 90 it¥®&% m 95 Cytological techniques Cf. QH 585 Methods in cytology. 95 Ul@¥tt&& tt^<07j&QH585 #BB0 100 Bacteriological techniques 100 mm^ftmik 110 Methods in medical mycology 110 E3*JIK3&u:fcW*;&& 120 Sputum ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 120 m * ^mtwtfm. s^fiifi^Kftra+aztaw**, 51 QY CLINICAL PATHOLOGY QY ft m a ¥ QY 125 Saliva 125 1 ft 130 Gastric and duodenal contents 130 n • +-*i 140 Liver tests 143 147 Bile pigments Function tests 160 Feces 140 ™&g 143 fll>tfe* 147 ®m&^. 160 xm-mm 175 Kidney function tests 185 Urinalysis 190 Semen 175 mmm 185 m&£ 190 ft ft 210 Puncture fluids (Peritoneal. Pleural. Peri- cardial) 210 £$ijft (MR. MR. /6J 220 Cerebrospinal fluid 220 JTaWSIft 250 Immunodiagnostic tests Cf. QW 525 for techniques of administering other immunologic tests. 250 &&$bm*£ %fc* 275 Serodiagnostic tests for syphilis 275 *Mt0>]Ai7jl¥ti)&GM*& (fifc) 330 Assay of hormones 330 fcJl^XDME. 335 Pregnancy tests 335 SSIx* h 350 Assay of vitamins 350 izZS.XDM'fc 52 QY CLINICAL PATHOLOGY QY Sfilf QY BLOOD tin $ 400 General works Classify works on morphology, physiology, and clin- ical aspects of diseases of blood in WH. Cf. WG for works on the cardiovascular system. 400 m IB 402 Cellular elements 402 idfflflS/£# 408 Physical examination e.g., Sedimentation. Volume index, etc. 408 S^fttSS M : *ifiL^rtPliiJtffliJ^. £«til 410 Coagulation e.g., Bleeding time, clotting time, etc. 410 m : WifiLB#W. jgH^K^. 415 Typing 450 Blood chemistry 455 Nitrogenous constituents 465 Lipids 470 Carbohydrates 480 Inorganic substances 415 ifaft^ij^: 450 Jfoftlb^ 455 nmit^ 465 JJi n 470 m*it® 480 nnrntm. 490 Enzymes 490 P 53 QZ QZ PATHOLOGY m s *=£ Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL * 1 *£.&# (¥'W>£%fr*>t)y$-E W^ZS-tlZ) m^^h^^itm^izmi^nh^ 5Ei$fc£M£&£3-tfo mmzm a. a% • izmmzfrm-tZo m &m%i*vfuzfrmi-Zo General works Classify material on comparative pathology in QZ 33. $m-mmmzQZ33izftmi-z>c Collections (General) 5 By several authors 7 By individual authors mm mm • mm) (-«) 5 »A0)M££. ?-^Py- 16 Tables. Statistics *16 WCnt 17 Atlases. Pictorial works Classify here atlases on tissue pathology in disease. 18 Education Classify here works about education. 17 7byZ=mm mmv®.®kmm¥mmz z z iz$-m is m w zzi,zimi?izMtz>mittfrmi-i< Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. *18.2 &^wmn ^M^mzmi- zmftitz zizfr m-r&o mta. mm. nmmn. 7° u^y^U^m. ii 9 u 9\ CAlllc m*wimjX:izmi%% < umiz x 0 5Hl1-£o * 19 Schools, departments, and faculties of pathol- ogy *19 mm^o^&t^m ►NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 54 (ji) *.y 9 -£^'*"C. A Cutters Cutter - Sanborn QZ PATHOLOGY qz m m & qz 20.5 Research (General) Classify material on cancer research in QZ 206. 20.5 fflft (-«) 21 Pathology as a profession. Ethics. Peer review 21 &nmkbxt° =>.-* (-m ftfe£.mK77 7! 40 Pathogenesis of disease Classify here works on causative factors and devel- opment. Classify works on diagnosis, therapy, etc., of the resultant disease with the disease or system. 40 mmw matm. ®m®m mwmzimitzi>%2_m 140 General manifestations of disease 140 mm 160 General reactions to injury and disease. Stress 160 mtotm0nz$&Tz±&5.x>. *h Is* 170 Circulatory disorders 170 wM^m 180 Degenerative processes. Disorders of metabolism Cf. WD 200-226 for clinical aspects. 180 $t*ag. itmmm E&)*#J#^WD200-226 #B3( 56 QZ PATHOLOGY QZ )s 1 f QZ 190 Local disorders of growth e.g.. Hyperplasia 190 mmttftttw 200 Neoplasms. Cysts (General) Classify works on neoplasms by site or tissue if applicable. 200 mm. sua (-«) mmir^t^hit. mzxitm \z%m-tz>o 201 Popular works Classify here popular works on all aspects of neo- plasms. 201 m®m\ mmizmt&mimftitzzizft 202 Etiology. Metastasis. Regression. Invasive- ness 202 m&. nn. jut. sat* 204 Precancerous conditions 204 mm^m 206 Research (General) Classify works on specific topics by subject, e.g., on experimental work on the etiology of neoplasms in QZ 202. 206 m?i (-fix) m-tz. MjummomRizm-tz H^W^^(iQZ202 iZfrm-fZo 241 Diagnosis 266 Therapy 267 Drug therapy 268 Surgical techniques 269 Radiotherapy 267 £&$& 268 *tf4¥ffi 269 &&&$& 275 Pediatric oncology. Adolescent oncology (Gener- al) Classify here all aspects of pediatric and ado- lescent neoplasms in general; classify works on particular neoplasms with the neoplasms. Clas- sify works on neoplasms by site or tissue if applicable. 275 >wnmmm. m^mwm^ (-m 'WMRtf^z-mmm-mzm txa mmizftmi-&0 mm^^Lxitu mwtt&mb&mzfrm-tZo Specific types of neoplasms Classify books on neoplasms by site when possible, especially when the emphasis is on dysfunction, symptomatology, and treatment. Emphasis in this section is on the pathology of tissues rather than on organ. Classify works on dental or oral tissue in WU 280. mmizM+zmmi*. Wizmzm^. m&¥&xmti0jzm£i)mfrtix ^&Jt£\ vsm%hi£tB'&lM 340 Connective, muscle, and vascular tissues 340 $£n\ Mfa> MWlRffi, 345 Sarcoma 345 ^ H 350 Leukemia. Lymphoma 350 &tin.M. [) >/\'ffl Cf. WH 250 and WH 525 for clinical aspects. I$tfc#J#^WH250 k WH525 # tin O 365 Glandular epithelial tissues. Carcinoma 365 BSLbJ&lfltt. 1&M (—^RltkZ (General or not elsewhere classified) $ #11 £ tl T l»x & Ix *§ n") 380 Nerve tissue 380 #iftlfc§$ 58 w w HEALTH PROFESSIONS Classify here general and miscellaneous material relating to the health professions. iizrmitz®M& xt/znmm* (Drn^z iz^-mt^o VV 1-96 General W1-96 W 100-275 Medical, Dental, and Pharmaceutical W 100-275 Service Plans W 322-323 W 322-323 Other Medical Services W 601-925 W 601-925 Forensic Medicine and Dentistry mmmmum mm¥kMW,m¥ GENERAL - ti * l Serials. Periodicals * 1 mmmm. mmm® * 2 Serial documents (Table G) Classify here government administrative reports and statistics, including administrative reports and statistics on several hospitals under governmental administration. Cf. WX 2 Hospital administrative reports and statistics. * 2 jUfcTUrf £* (G £tf iftlff fcv>0 :W3H# 3.5 Directories of congresses Classify bibliographies of congress publications in ZW 3. Note that as of July 1, 1988, NLM no longer assigns W 3.5 or ZW 3 to newly acquired publica- tions. * 3.5 £!!<£>£m £fi§iO#!St;£zW3 Izfrm-fZo NLM Xi$ 1988^7 R\ U&feffitzlZ A#LfcajJ&$JUlJW3.5XliZW3£ Dissertations, by university * 4 *^8ij*ttns: (Gmmm) 4A American dissertations, by author Classify dissertations which qualify as Americana in WZ270. * 4A mftwwmmtiLmx 7^'j uyzmkmfthti&mzmit (iwz270H5H!1~£o Miscellaneous reprint vol- Collections (General) 5 By several authors 6 Pamphlet volumes. urnes 7 By individual authors ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. ** mm - mm) (-«) 5 aAO^flcJ:* 6 'hfl&^ft. a*£t#&70|;>S:fc 7 mx(nwmiz&z> 59 w MEDICAL PROFESSION W IS * w 10 Addresses. Essays. Lectures (General) Classify works on specific topics by subject. Voyages. Expeditions. Travels 9 mm. mm. mmm (-«) 10 txm. as**. Jfeff 13 Dictionaries. Encyclopedias Classify material on medical shorthand here if it is the primary subject of book. ♦13 mm. ^mmm *%bi£, zzizfrm -fho * 15 Nomenclature. Terminology Classify works on classification of disease and on disease eponyms in WB 15. •MJfilryM 17S£#e#i(2WB15 \Zfrm 16 Tables. Statistics *16 ffitWT 18 Education Classify here works about education. 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. 18 Ift W O o izimisizm-thmftiftm ♦18.2 «wra*m Wiiiwm\\zm-$-z>mfti$zzizft ii-t^o mux. mm. *dmm&. y° U9^y^ta^. 1J 9 u 9\ CAI^o Schools and colleges *19 ^'mftt&mX'- Courses of study, catalogs, announcements, etc., of all schools (including schools of dentistry, nursing, etc.) (Table G) *19.5 ±m® (**** «»#»«*«?: roatiSs a*n?\ %%\m (g$ 20 Graduate and continuing medical education (Including fellowships, internships, residencies, etc.) 20.5 Medical research (General) Classify here material on the various aspects and accomplishments of medical research. Classify works on research limited to a particular subject with the subject. 20 **r«wtw*mwem (7ip- mti) 20.5 wmvt (HK) i d izim¥®t$co tZ>. Mx.(ff-IfliWYl60 Mn- fe(iW87 (15^11-&o 21.5 /<7>T-f^ • 7^77. mm. mmmrm m.n*i>omi>k£ *)imkmft kZZiZfrMt&o #^^7li, X t)%ffe%&^rtf$>til£ZZllfrm t&. #!lx.(£^1l!^(iWY193 o IS * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 xz-imm (Gmmm) *22.1 £ft (GiUffltf) 23 24 26 Laboratories, institutes, etc. Collective Individual (Cutter from name of agency) Equipment and supplies Classify here medical and surgical supply and instrument catalogs as well as catalogs of special equipment, e.g., tables and chairs in doctors' wait- ing rooms. Include works on history of instruments in general. 23 24 umwrnmnm morn ]£#6a'y*-E#""* *26 m%skm& zzizwmm^. flix-tfUBiiiff^ I«lil^T-^*^n7*lH kX*) FW • Tr^fffl naa k&tfL^1-^o 26.55 ftJfchfcT-y?*, A-Z ,A7 Artificial intelligence. Expert systems .A9 Automatic data processing ,C7 Computers .D2 Decision making, Computer- assisted Classify works on computer-assisted diagnosis (general) in WB 141; on com- puter-assisted therapy (general) in WB 300. .14 Information systems. Information storage and retrieval .S6 Software .A7 .A9 .C7 .D2 yy\zj-~91cm&m (H&) liWBi4i iz ; y y \zj.~ 9 WB300 \Zfr&fZ>0 .14 1tSh>*x/>. 1ta£E¥ (-») (G mSiffl) mmmmtrnffiz^tro am^ W700^#BBo *32.6 £ft (GlUffltf) *33 ii^^fitsiii (Gfl *33.1 £ft (Gjtteffl-e-f) 40 Licensure (Table G) 40.1 General coverage (Not Table G) 40 ft^F (GUteffl 40.1 £ft (Gfl «"f) 44 Malpractice (Table G) 44.1 General coverage (Not Table G) 44 mmmm (Gm^m) 44.1 £ft (Gmtem-e?) Handbooks *49 i\yV7'y7 50 Medical ethics 50 E0)1ifti 58 Advertising. Fee-splitting 58 /s^ii£. ^*aania)iE^ 61 Medical philosophy and logic 61 Eft&¥£ltil¥ 62 Social relations of the physician (including relations with patients; relations with public, clubs, societies, etc.) Attitude 62 &mm±£ttMm (Jt#£roHft;& ft, 777\ ¥ t?) mm -mtm&** 64 Referral and consultation (General) Classify here works on referral, etc., initiated by the physician. Classify works on particular medical problems by subject; works on problems referred by specialists with the specialty. 74 Medical economics. Health care costs (Gen- eral) Cf. W 58 for economic aspects of medical ethics. 64 m^kmm (-as) mffitz x -oxi&ib btitzm£%&z zizftm-t&o ^^^m^mmma iz x ^xw&ztitzmMitZ'vm*] izx ^oftmtho 74 mmmsm. &mm.mmm (huso ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * ##l±¥fr». &kftfrtol-tiim-tzz.b #&>*&< 62 \Y MEDICAL PROFESSION W e m w 76 Health manpower and services, distribution and characteristics Classify works limited to allied health manpower in W 21.5. 76 s\)it. . v^s/^-kumm®. se '*y y t 4 ii )V ■ t. 9 "j y tz W&. $n/j^^(iw2i.5 izftmt&o 79 Income of physicians 79 mmomm 80 Practice management (including business administration) Classify here medical secretaries ' handbooks. so mmmmwm (mmwmzmt;) :mmo 84.1 ±w (Gmmmvt) 84.3 mft (-m 84.5 Comprehensive health care. Community medicine Cf. WA 546 Community health service. 84.5 &mmm. mt&mm i&l&Umv-- tf*WA546 #BBC 84.6 Primary health care 84.6 7°y4~?lJ- • ^JIT, - *r7 84.7 Patient care planning. Progressive health care (General) Classify works on care of hospital patients in WX 162. 84.7 &$E*-»frli. m m (-m 84.8 Patient care team Classify works on hospital teams in WX 162.5. 84.8 B.^^7 - 3--A #!!%•?--A tiwxi62.5 izfrmir&o 85 Patients. Attitude and compliance. Satisfac- tion Classify works on attitude toward particular subject with the subject. 85 mm. m&tmm. ms. m7Ei.wizni-z>mmi$. ^±m 85.5 Right to die. Advance directives. Living wills Cf. WB 310 Hospice care. Terminal care. 85.5 w&mm. mmm% o 89 Family practice (As a specialty) Private practice Classify texts and treatises for general practition- er or family doctor in WB 110. 89 mmmm (*p^ut, 100 General works Cf.W 275 General service plans by country. 100 W275®giJE-l!Hfcl$ffHJJg£jLftmztix l*4t*»&) (G Steffi) 185.1 £ft (G^ttffl-S-f) 225 Medicine as function of the state (Table G) 225 II Classify here material on health protection for eve none as a function of the state, supported by tax- ation, with medical sen-ices subject to regulation by the state. 225.1 General coverage (Not Table G) 225.1 m.mmz&z>m.m (Gm&m) m^mmtix. mixKx^xt \£*x%Zti&&mRoW%:&) 250.1 ±w (Gm&mvt) 255 Nursing insurance 255 260 Dental insurance. State dentistry (Table G) 260.1 General coverage (Not Table G) 265 Pharmaceutical insurance (Table G) 265.1 General coverage (Not Table G) 260 nnutk. n^*f4E*«»ft,jJS (g 260.1 £ft (G^ffl^f) 265 mmm (Gmi&m) 265.1 £ft (G^ffiffl-&T") 270 270.1 Psychiatric insurance (Table G) General coverage (Not Table G) 270 mnnmrnuvk (Gmmm) 270.1 £ft (Gmmmv?) 275 Medical, dental, pharmaceutical and / or psy- chiatric service plans, by country (Table G) Classify here works covering both compulsory and voluntary plans. Cf. W 100 General works. 275 mwmm&mmm {mft-mmt** ^ ^ izimmjkm£&\m(nm%z$ ts%ftZftMtz>o wiooitia#Mc OTHER MEDICAL SERVICES ■*0>ftmmtmw&&¥ * 601 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. Collections (General) 605 By several authors 607 By individual authors *601 ¥•»# (^•tt#**>6*-y^-IH it. a% • izmmizfrmt*>o *n. mmttwuzftmt&o mm mm • mm) (-«) 605 $lX-VPy * 616 Tables. Statistics *616 sit 617 Atlases. Pictorial works Classify here atlases and pictorial works on any phase of forensic medicine, etc. 617 7by7. = m^ zizftm-fZo 618 Education Classify here works about education. 618 & W •h o * 618.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. *618.2»WW»ft wcnmm^izm-t zmftitz z\z% it^^iit mm. %m&£. y' U9*y2±fg^. ii9u9\ CAI^o mmimmzrmKiJimizx *) frmtz0 * 622 Directories (Table G) * 622.1 General coverage (Not Table G) *622 a^ -£m» (Gmmm) *622.1 ±ft (G^ffl^f) Laboratories, institutes, etc. 623 Collective 624 Individual (Cutter from name of agency) 623 m&0 w MEDICAL PROFESSION W E ft W 626 Equipment and supplies Classify catalogs in W 26. 626 m%skm& Jl9u91±W26iZ ftmi-&o 626.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. Museums, exhibits, etc., on medicolegal subjects 627 Collective 628 Individual (Cutter from name of agency, exhibit, etc.) 626.5E*t*»$. iftT-'-^ftta. =l>k° J--5 (Htt) K7'7 7! 700 General works Classify here works on medical and pathological examination of criminal evidence, as well as works including material on medical jurisprudence. Classify works on medical jurisprudence only, in W 32.5-32.6. 700 US IB ^■mmmma. zzizftmt ho &gl^O&(2W32.5-32.6^£HS tZo 705 Medicolegal dentistry 705 «B£E3 725 Medical evidence in the establishment of responsibility 725 JH£fcSEK*WSE3StflliE« 740 Forensic psychiatry Classify works on commitment in WM 32-33. 740 w&mn&m #jfi(iWM32-33 \zfrM1r&0 750 Examination of evidential material. Forensic chemistry 750 SE«*Mt0)fc$. jfcEib^ 775 Medicolegal examination 780 Examination of the living 783 Malingering 775 )£E3flUt*$ 780 £ft£>*£S 783 15. M 786 Identification 786 789 Legal establishment of the beginning of life 789 ±$>m±>MMiXWQ225 o T&BWlX liAIii^E^Mftffili WQ440 o AX:MMm±£&)% SliHQ767#BB0 900 Medicolegal aspects of insurance Classify works on liability insurance in form number 44 with malpractice when available in NLM schedules or in HG 9990 if general material. 910 Medicolegal aspects of compensation to victims of criminal violence 900 &m^ffM# ^■44(DUW.m%XiX. HG9990^5HI 910 *ffi*M*i«<&»E¥H#* 925 Medicolegal aspects of occupational disease and injury Cf. WV32for estimation of disability in otolaryngolo- gy; WW 32 for estimation of disability in ophthalmolo- gy- 925 mmmtizmnwotikm^mm 5#PHP&l#^Kfci7£l&#Jt±. ^-vpv- 16 Tables. Statistics *16 17 Atlases. Pictorial works 17 7h77=| 18 Education Classify here works about education. ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 69 18 t f \z\tm\zmz>m\t*%m-z>o (>±) % •■; 9 -$mblt "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" £>^££^<0 ZbX'fo50 WA PUBLIC HEALTH WA » * « £ WA 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *18.2 #WW**H iti-&0 flutf, mm. KMS&, y D^^A^Jf, * 9 u y. CAI^0 |&f4#(»:^P»& < ±IC «t *) ftm-tZo 19 Schools, colleges, and specialized departments and facilities Classify courses of study, college catalogs, etc., in W 19.5. *19 ¥Sfl, WMBftfcJItt •O o 20.5 Research (General) Classify here works about research in general. Classify research limited to a particular subject with the subject. 20.5 WR (HK) ffift-mzmtzmft*. zziz% mizx ^7>if1-£o 21 Public health as a profession. Ethics. Peer review 21 m?m£LX(D2;%®±. mm. \z7 * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 i±mm (Gmmm) *22.i £ft (Gmmmv?) Laboratories, institutes, etc. 23 Collective 24 Individual (Cutter from name of agency) 23 m^o 24 M*(D ( !**»&* ?*-£** 25 Laboratory manuals. Technique 25 W&m.-VZZ3.7)1. ^& 26 Equipment and supplies Classify catalogs in W 26. Classify works on safety equipment in general in WA 260; on industrial safe- ty equipment in WA 485. 26 ®l%i£m& JJ9U91XW26 \Zftm-tho &£\ £?-$:(2wa260 \z ; MM±.o 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. 26.5 emm^. smx-sj&s. n>tf n.-^ (-m ^^.i.m) 30 Social, economic, and environmental factors in public health (General) Classify works on rural health and hygiene in WA 390; on urban health and hygiene in WA 380. 30 a*if*tz*it««:*«, mm®** tfaWIWH* (HK) £ttfiMi£ffi£(iwA390 u ; fBrfitf) {£^K7 7 7! 54 Registration and certification of the dead 54 wtzmkwtzum 55 Registration of notifiable diseases 55 fcfcts&tfm&fcmmomm 100 General works 100 $i IB 105 Epidemiology Classify statistics in WA 900. 105 fSL ¥ ^It(iWA900 i::5Hg1~£o 106 Disease reservoirs 106 £^f$W# PREVENTIVE MEDICINE * RS 108 Preventive health services. Preventive medicine (General) 108 ^KWftttEStf—If*. TOE^ 110 Prevention and control of communicable dis- eases. Transmission of infectious diseases Classify works on immunological aspects in QW 700; on parasitological aspects of insect control in QX 600; on control of sexually transmitted diseases in WC 142. no tmm(Dsf'mkmi±. mm&omm ft£^fa#flliQW700 i; ; J^« ofjF£4^fi*z>c 71 PUBLIC HEALTH WA & m w £ WA 243 Diagnostic services Classify works on mass chest X-ray in WF 225; on mobile health units in WX 190. 243 &my--£z=BffiB% mux *|&H&^I*WF225 iz ; m ^f|g|5(iwxi90 lzfrmi~Z>c 245 Mass screening. Multiphasic screening 245 mmtm. &ftm®&& PREVENTION OF ACCIDENT AND OF INJURY m&tmwj*££tiWQ450 l^Stio WB(D$kMMW-?~^7)lsiX\Jrl396 \zfrmtZo HEALTH PROBLEMS OF SPECIAL POPULATION GROUPS ftJ£An*Ha>tt*MI 300 General works Classify general works on diseases generally associ- ated with particular ethnic groups in WB 720. Include works on particular groups not elsewhere classified. 300 it. WB720 izftmi-Zo £Zizi>ft mznx^tj;^m%.y^-y°itzz iZ^tSo 305 Mental health of special population groups Classify works on particular diseases in WM. Cf. WM 105 for general works on mental health. 305 &i£xnm®, 353 Universities and colleges 353 maxmkmnxm 380 Urban health and hygiene Cf. WA 546 Local health administration. 380 %m> 395 Health in developing countries 395 %mm±m7. m m 491 &1£<7)1iJgWA309 #HB0 495 Occupational mental health services 495 mnftwm±-y—t?z HEALTH ADMINISTRATION AND ORGANIZATION ummtm® 525 General works 525 n& bS 530 International health administration (Table G) 530.1 General coverage (Not Table G) 530 mmm£.n& (Gmmm: 530.1 £ft (Gm&m-et) 540 National and state health administration (Table G) 540.1 General coverage (Not Table G) 540 n*>r%&l3feliWD756 672 Inspection. Surveys (Table G) Classify works on inspection in particular areas by subject. 672.1 General coverage (Not Table G) 672 **$. mm (Giftffl) 672.1 ±ft {Gmmmvt) 675 Water. Water supply. Sources Include works on sanitary aspects of ice and ice making here. 675 *. H&*. *5B 686 Analysis C/0WS0 Water microbiology. 686 # tff *0£^QW8O#HBO 687 Saline water conversion 687 £*&& 689 Pollution Classify works on radioactive pollution in WN 615; general works on industrial seawater pollu- tion in WA 788; on pollution of bathing beaches in WA 820. 689 ftyk • ftm JtHr&7k^*tf)iSiei2WA788 \Z ', Jt&Jt£>^&liWA820 lZfr&~t2>o 690 Purification 690 -#*& 695 Food. Food supply. Food inspection 695 £4*. &pap&3£. ftfig?! 697 Pure food laws Classify here food and drug laws discussed together. Classify works on drug laws alone in QV 32-33. 697 &pnp3i£>£ ^&£>«&(iQV32-33 H^S1-^o 701 Adulteration and contamination Classify works on radioactive contamination in WN612. 701 ^mwMmkftw- Sfclt^&{iWN612 \Zfrm-fZo 703 Fresh foods (Vegetables. Fruits. Eggs. Fish) 703 £ja¥&pnp (»£. JH^. IP. &£) 707 Meat and poultry inspection 707 75 WA PUBLIC HEALTH WA & * m ± WA 710 Preserved foods (canned, dried, frozen, salted, smoked, etc.) 710 ft#&pap (ftlS* % /-p/^% Jm)B, 712 Food additives 712 :&pnq«l^ 715 Milk. Milk supply. Dairy products 715 *f¥L *«.#*. ?Ll^pnp 716 719 Analysis Pasteurization 716 # *f 719 ftiMB& 722 Fats. Oils. Margarine 722 flgflTJ. at -?-1SlJ> 730 Drugs. Drug adulteration and contamina- tion. Pharmacies Classify here works on refrigeration of biological products. Classify works on fraud in QV 773; on drug legislation in QV 32-33. 730 mm. m®^m®mft£&m&>m. mm ^¥wm\(Di%mzz\zizftmi- h0 f«(iQV773 \z ; MM&MWt QV32-33 \Z%Wrf~%>o 744 Cosmetics. Barbar shops. Beauty salons 744 ib*4pnp. mmm. m®i% m 750 Air sanitation and hygiene 750 X%SJ§. *5*y-JU 830 Toilet facilities 830 ¥&i\&£i£= s -r i< 840 Mortuary practice 840 K#mmn=mmm 844 846 847 Embalming Burial. Cemeteries Cremation 844 Kteffimf&W 846 tip. m% 847 4c P STATISTICS AND SURVEYS Wt it £ m 900 Public health statistics (including narrative reports on health conditions and health sur- veys) (Table G) Classify mortality statistics with causes of death here. Classify works on mortality statistics alone in HB. Classify works on nutrition surveys in QU 146- 146.1. 900.1 General coverage (Not Table G) 900 &ftfci£iffi!t (ffi£tt«g;&tfttj*H$ izmtzmsz^t;) (Gmmm) KmttKtzmfitzzizftm-f&c Kt:mi(Dfri$HBizftM1-z>o %m Sf^(iQUl46-l46.l iZfrmtZo 900.1 £ft (GUfeffl-tf-f) 950 Theory or methods of medical statistics Classify works on biometry in its broader sense in QH 323.5. 950 E3^It<7)IIi&X(i73>£ fc^MMx(iSU* U3Hf £ft&l£ £W£&Mfc»££-tro :fcfe» &mm*vjuzfrm-tZo Collections (on clinical medicine, diagnosis, special therapeutic systems) Classify collections on a specific subject with the subject. Cf. W5-7 on the medical profession. By several authors By individual authors mm mm • mm) u *m*%m&±mzmt*) !$;E?)±S<7>*#li, ^(D±miZX *)53HI1-£o E^W5-7#BB0 mx (WB900-962)o I o * 15 * 16 Classification. Nomenclature. Terminology Classify works that consist of general medical nomenclature or terminology in W15. Tables. Statistics *15 ftm, i&£&. ?-^Py- *16 ■frb JS^J^oTV^^Oli, W15 \zffl 17 Atlases e.g., those on special devices or forms of therapy, such as Acupuncture. Cf. QZ 17 for tissue patholo- gy of disease. 17 7hy7. = mB S^QZ17#BS0 'NUMBER CAN BE LSED FOR BOTH MONOGRAPHS AND SERIALS. * g*fli¥fT». &kntTfalz&>m-tZZbtftt,*Zt 78 WB PRACTICE OF MEDICINE WB E8 m E ¥ WB 18 Education Classify here materials on education in the special systems of therapeutics or other topics specific to this schedule. Classify materials on general medical education in W 18. * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. is m w z zizimm&m&x&xit^ftm Si:!|tifmizmtz>mfti*zzizfr m-tZo mux. mm. *dm&&. y° uyyAlHQ, il 9 U 9\ CAlfc m%mitft^izm{%% < ±mizx o * 22 Directories (of health resorts and / or special systems of therapeutics) (Table G) * 22.1 General coverage (Not Table G) *22 A£ • itmm (umm&tf/*.&&& fem:&x%(D) (Gmmm) *22.i ^ft (Gmi&m-ef) Institutes. Laboratories of experimental research 23 Collective 24 Individual (Cutter from name of agency) 24 m*<» («M* #6 ay*-£#'*'£ 5-7LZ) 25 Technique of research in internal medicine Classify works on technique of research limited to a particular subject with the subject. 25 pmrnrnftott ft%.0 26 Equipment and supplies Classify medical and surgical supply and instrument catalogs in W 26. Classify works on self help devices in WB 320. 26 ®%5km& fl# • nmm pDn k ®&o [26.5] [This number not used] Classify works on medical informatics, data pro- cessing or computers used in medicine in W 26.5 or by subject. [26.5] [d <£>#•§■ (*1$ffl U ftt^ m^iz&n&mmmm^. r-9m m Z tz a y y tf ^ - 9 -=151*85*. -H&*Pil£{iwxK ; *-&>£-. JRgft :&mm. vii^-K-7-7va7 'ffiW$£.MxWM29-29.l #BB0 ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * &mtWnW, m%.nfttoi-&.mir&z.b#li!,%it 79 WB PRACTICE OF MEDICINE WB B£ J* E ^ * 32 * 32.1 Laws relating to special systems of therapeu- tics (Table G) General coverage (Not Table G) *32 #»fc?&*s*lcM#Ufc>*» (Gm$ *32.1 £ft (G^ffl^f) * 33 ♦33.1 Discussion of law (Table G) General coverage (Not Table G) * 33 :,mK7 7 7! 50 Medical practice (Table G) Classify here works dealing only with private prac- tice. Classify works on health services in general in W 84-84.3. 50.1 General coverage (Not Table G) 50 H%g^ (G3l«ffl) $ iX W84-84.3 IZ ftm~t h 0 50.1 ±ft (G^ffltf) 100 General works 100 .158 IS 101 Ambulatory care (General) Cf. WX 205 Hospital outpatient clinics, ambulatory care facilities. 101 #*£* (-«) WX205 #0?^tm<&E*w#ijffl (-«) WB480 #BB0 120 Popular medicine (General) e.g., Household medical books. Self medication Example: Mayo Clinic family health book computer file. 120 mmmm (-«) mux. ^mm^m. gs&^ M: y 4 39 ') =-y 9 WMM^- ^ y \£a.-9 y r 4 )i< ►NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * #*fli¥f?*, **f>Jtr*^ttffl1-«^fc*«ffl**. 80 WB PRACTICE OF MEDICINE WB i* e m WB 130 General works for laymen Classify here books on general medicine written in sryle suitable for laymen. Example: The frontiers of medicine. 130 mxotcibfDmi mxfii&Kmfrtitz-tem^mzz zizftm-tZo m: m^nmmm GENERAL DIAGNOSIS - as m m ¥ 141 General works Cf. QY 4 General works on clinical pathology. 141.4 Health status 141 |£ 15 141.4 mmvim 141.5 Differential diagnosis 141.5 mmm 142 Prognosis. Monitoring 142 -*ft. "E-ZVy? 143 Symptomatology 143 mm% 146 Asthenia. Cachexia. Fatigue 146 rnxm. mmn. m.m 152 Chills. Fever 152 3fctt=»*. S8& 158 Dehydration. Edema 158 fl£**£. *i 176 Pain 176 *B#=3 182 Syncope. Coma 182 £#. 200 Physical diagnosis (General) 200 rnm^mm (-«) 205 Technique of physical examination 205 S^ftfcS&ffi 270 Temperature 270 ft 275 Inspection. Palpation 275 &m. mm& 278 Auscultation. Percussion 278 MWJk. fiW& 280 282 Blood pressure Pulse 280 fo. S. 282 M=Mfa 284 Respiration 284 81 WB PRACTICE OF MEDICINE WB J* E * WB 288 Diagnostic uses of non-ionizing radiation 288 #<*>ib##**&<0l*W^0)*lJffl 290 Medical history taking Classify works on medical record libraries and hos- pital records in WX 173. 290 mmwR mMW.£ffimiMiXwxm izMMt 293 Collections of clinical case reports Classify here miscellaneous collections. Classify case reports limited to one disease with the disease. 293 &mmmm£m m*o * Bizfrm-tZo THERAPEUTICS >a ?5k >£ /p 300 General works 300 $£• IE 305 Instructions or non-drug prescriptions for devices or therapy (General) Classify specific devices or therapies by subject. 305 &w3.a%m4"7. WWmfc. ?E&f#*iJW85.5 ; XM&%oMm WY152 #HB,0 320 Rehabilitation of the disabled (General) Classify here works on physical and medical reha- bilitation in general as well as those that include in addition educational, social, and vocational rehabil- itation. Classify works on specific types, by type, e.g., Physical therapy WB 460. Classify works with no medical slant in HD 7255-7256. 320 IftiifflJ'jAlf'Jf-yaV (- - v 3 y £ i> ^Astimftix & k x fj, -mzmt zmft* z zizftmt &o m7z9Jy°iX. 9 Jy°%\\izfrmtZ>, M HX^)m0ji;WB46O 0 U^MftlX &V>fc<7)li, HD7255-7256 K5M81" 325 327 330 Aftercare Cf. WM 29-29.1 for mental patients; WO 183 Post- operative care; WY 100 Nursing care. Self care Drug therapy Cf.QV Pharmacology. 325 775-^7 ftW&H± 82 WB PRACTICE OF MEDICINE HS ft m. ¥ WB 350 Oral 350 £ P 354 Injections. Infusions 354 &&. &A 356 Blood transfusion 356 fli) ifil 365 Various other therapeutic and diagnostic procedures (General or not elsewhere classi- fied) 365 *£. mmmm m : #?■&* 373 Punctures (General or not elsewhere clas- sified) 373 ^$ij (-m5Ut£Zl,Zt>ttmZftX 377 Spinal, cisternal and ventricular punc- ture 377 wti. *to£mmmm 379 381 391 400 Biopsy Bloodletting Tissue therapy. Organotherapy Dietetics. Diet therapy Classify works on diets to be used with particular diseases with the disease, e.g., atherogenic diet in WG 550. Classify works on nutrition and food values in QU 145-145.5. 379 /W*7*V-=4tt 381 L^lfll 391 mmm:&. m.%sm:& 400 -kmm&m. **m& ftfcfe&w'km&znm&izfrm -$%>. #]x.(£7-7-n-Aftf§;£(i WG550 o **i^pq{ItiQU145- 145.5 \Zfrm 1-&o 405 Dietary cookbooks (General) 405 -kmm&omm* (-«) 410 Special methods of feeding, e.g., par- enteral; tube 410 «&&**«*&£}*, mxum 420 422 Fasting Macrobiotic diet 420 && 422 424 Low sodium diets. Salt-free diets 424 83 WB PRACTICE OF MEDICINE WB * E ¥ WB 425 Fat control Classify works on reducing diets in WD 210- 212. 425 MM*:&(2WD210-212 iZffl 1-&o 426 Meat diets. Protein control 426 . w&n All Carbohydrate control 427 mmatmmm 428 Milk diets. Calcium control 428 *F*L*. *)Vv^L,Vm 430 Vegetable diets. Fruit diets 430 Wfi 431 Cereals. Grains. Seeds. Breads 431 5/vfjv. m*to. m*. j<> 432 Raw food diets 432 *Jni£ 433 Beverages 433 438 Coffee. Tea. Chocolate 438 3-k-. &. f-a3U-h 442 444 447 Water. Mineral waters Classify general works on hydrotherapy in WB 520. Wines. Liquors. Cordials. Beer Miscellaneous food preparations e.g., Yeast 442 444 447 **&&&*£!£IJWB520 \Zffl ■tZo (B*(D< o 750 tmm& 760 Health resorts (Table G) Includes history. 760.1 General coverage (Not Table G) 760 umm (Gmmm) 760.1 £ft (Gmfemvf) 880 Mental healing 880 m&m:& 85 WB PRACTICE OF MEDICINE WB m e m WB 885 Faith healing. Christian Science healing 890 Special systems of therapeutics. Alternative medicine (General or not elsewhere classi- fied) Classify works on cupping in WB 371; on diet fads in WB 449; on vegetarianism in WB 430; on mental healing in WB 880-885. Classify works on a specif- ic disease with the disease. 885 ft'C>*s*. ?i;*^*>-tn'i>7 890 4m4&*as*^. fiHEffi (-«8X M&I2WB371 ; #Sjt£>Mli WB449 ; H:£:±li(iWB430 ; m$% &(iWB880-885 iZftmt&0 #^£ §MZ(Dm&lZftmtZ>0 900 History of special systems or alternative medicine (General or not elsewhere classi- fied) 900 ftftx&Rtti-tumm (-ms.it £ 903 Anthroposophy (used in medicine) Cf. BP 595-597 General works. 903 X%\¥ (E^lCfcttS) &£f£BP595-597 #BS0 905 Chiropractic 905.6 History and philosophy 905 *-fn7"77f<7 7=»ftJ|JE* 905.6 M* £|J3£ 905.7 Chiropractic as a profession. Ethics. Peer review Classify works on education in WB 18. 905.7 mfm£LX(DiJ&&*f&^tz&%&)% m%km£ZZiZftmt&0 V> < -Dfrnm&m&itWM £fti;M$&<-i&K5HE1-ao Mx-imfc (WC202-209), ^#ij(WC280-285) ^(O^.—^'U *mirmmt%z>ws-w\*iz%k'Kztiz>m a. a% • &mmizfrmirZo %-^ mtmtwuzftmir&c Collections (General) 5 By several authors 7 By individual authors mm mm • mm) (-«) 5 %LX 7 mx£. 9-^Qy- 16 Tables. Statistics *16 ^. ffiSt 17 Atlases. Pictorial works Classify here also atlases on single infectious dis- eases. 17 7hy*=mm ^-^mmmmmbz z i:^t4. 18 Education Classify here works about education. 18 K f zizimiiizmir&mftttftm-t *NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 87 (>i) * y 9 -imb It "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" , ffl^ffi WC COMMUNICABLE DISEASES WC B * m%*. zzn^ mizx *)ftWctho * 22 * 22.1 Directories (Table G) General coverage (Not Table G) *22 xz -amm (Gmmm: *22.i £ft (Gmmm-ef) Laboratories, institutes, etc. 23 Collective 24 Individual (Cutter from name of agency) 23 24 ummnmrnm m^o 25 Laboratory manuals. Technique 25 HB£-7-i7;u. 26 Equipment and supplies Classify catalogs in W 26. 26 m&tm& jj9u9~itVJ26iZ'frmtZ>o 26.5 Medical informatics. Automatic data process- ing. Computers (General) Classify works on use for special subjects by subject. Isolation and quarantine hospitals, leprosaria, prophylaxis stations, clinics, dispensaries, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 26.5 wmmn^. isit-^mi. =i>t° 3-~* (-«) mjE3Lmo 27 ma? (Gmmm) 27.1 ±ft<7) (G^ffl^f) 28 1H*<0 (Glfffl) [32] [This number not used] Classify laws relating to infectious diseases under appropriate topics in WA Public Health. [32] [C0)##ttffifflU4^] m$k&izm%Ltz&W:iX. WA^t ffi*ko [33] [This number not used] Classify discussion of laws realting to infectious diseases under appropriate topics in WA Public Health. [33] [C0)##ttffifflU4^] mmmzm&Ltzmw^m ■ mm it. WA&&ffi£^^m 195 Infection. Cross infection. Laboratory infec- tion Cf. WX 167 for prevention and control of cross infection in hospitals. 195 &&. XHStfe. Hf*£rtJ£& WX167 #BB0 200 Bacterial infections (General or not elsewhere classified) Classify works on localized bacterial infections by site. 200 mmm^km (-mRituziz&frmz mmmmm^&itnmwiz^m-t Z> 0 89 WC COMMUNICABLE DISEASES WC fc * ^ WC 202 Pneumonia (General) 202 ffi& (-«) 204 Lobar pneumonia. Staphylococcal pneu- monia 204 *£1«&. #i:3Mt4W& 207 Viral pneumonia 207 •?-r*t4!ti& 209 Other 209 fCAffe 210 Streptococcal infections (General or not elsewhere classified) Classify works on endocarditis in WG 285; on impetigo in WR 225. 210 &*gx$B&&£ (-mz.lt£^izt> 'L>l*lE^:JiWG285 K ; -Y >^f- rT= t o 220 Rheumatic fever. Chorea in rheumatic fever Classify works on rheumatic heart disease in WG 240. 220 'J^V^flft. U^Vf-JHK&fii i; ^Tf-t4'L^BiiWG240 i:# g1"*o 230 Focal infection Cf. WU 290 in dentistry. 230 mM&yk M4^*i£-WU290 #HB0 234 Erysipelas 234 ft 240 Bacteremia. Septicemia. Toxemias Classfy works on pregnancy toxemias in WQ 215. 240 MtiaM.. f&tiMt. &ti0M %M*¥%mt. WQ215 U^lt^o 242 Listeria infections 242 'JXx'JT'^&E 245 Meningococcal infections 245 il^If^i 246 Mycoplasmatales infections 246 7& fju»(iww205 iz ; £ ^OTt«£iiwc204 t: ; &* #fiWC268 t;:5HJi1"£o 255 Wound infection Cf. WO 185 Surgical wound infection. 255 m%%& ^#ffJS^W0185 #HB0 90 WC COMMUNICABLE DISEASES WC in % in WC 260 262 264 Enterobacteriaceae and other enteric infec- tions Classify works on Yersinia infections in WC 350. Cholera Epidemics 260 I>xnM''7xlJ77-ti=JiFt3*ffl®*4 x;i/v^7/g£NiE(iWC350 Kfflg-t 262 3 1/7 264 3U"70)3ftff 266 268 Paratyphoid fevers Bacterial food poisoning Classify works on contamination of food by specific chemicals with the chemical involved. Classify works on food poisoning caused by pesticides in WA 240. Classify works on plant poisoning in WD 500-530. 266 liy*7 7 268 mmfe-k^n ftfcoit^niz x z-k&oft mt. fw{[:^Si:^it^c Skmizmmt &&43#(iwA24o \zfrmtZo tmizx&^mit WD500-530^53iS1~&o 269 Salmonella infections Classify works on salmonella food poisoning in WC 268; on paratyphoid fevers in WC 266. 269 *f)\'=E*y%&fc -t;i/^^'7^:4J#(iwc268 iz ; s* y -7- 7 7. itWC266 \Z ftM 1" Z> o 270 280 282 285 Typhoid Dysentery Bacillary dysentery Amebic dysentery. Amebiasis Classify works on amebic liver abscess in WI 730. 270 280 282 285 77. # ffi mm&fim 7*-J^izW\. 7*-/*fs. 7 ^ -^'lOTHIIf (iWI730 290 Escherichia coli infections 290 xmm&'&fc 302 Actinomycetales infections. Mycobacterium infections Classify works on leprosy in WC335; on maduromycosis in WR 340; on tuberculosis in WF, etc. 305 Anthrax 310 Brucellosis 318 Corynebacter 320 Diphtheria 302 7797~7-(-^7^myk^.=WiWM m H|{iWC335 i:;7X7^-y x = MiiWR340 Iw ; #£$(iWF mzftm-t&o 305 i* £ 310 ^;Hr-7ffi 318 ^iJ^/^rUOAi^S 320 v7tU7 91 WC COMMUNICABLE DISEASES WC IS * fc WC 330 Pseudomonas infections. Glanders 330 yiKtt^$&^- JMI 335 Leprosy 340 350 Bordetella infections. Whooping cough Yersinia infections. Plague 335 Si 340 #^fT7^t. WB^ 350 x;Uv "T7^^^. ^^ h 355 368 370 Epidemics Clostridium infections Classify works on botulism in WC 268; on bacil- lary hemoglobinuria in WJ 344. Tetanus. Trismus 355 *<7>b (Dffift 368 7P7h'J y7l*&ykfs. tfy 'j X A (iwc268 K ; lffll'tt^\ ^9~U\zyJ^mtWJ344 iZjfmt -?> o 370 tt«m. mnmm 375 Gas gangrene 380 Tularemia 390 Rat-bite fever 375 ti'ZiglB. 380 ¥}%m 390 m&m. 400 Spirochete infections 400 *\dW\-?.m%lE. 406 Borrelia infections. Lyme disease 406 ** HJ T'JKI&Se. Lyme 410 Relapsing fever 410 mmm 420 Leptospirosis. Weil's disease 420 U7>*bf-72iE. Weil^ 422 Treponemal infections Classify works on syphilis in WC 160-170. All hU*°^-7iM f£#(iWC160-170 \Zft%r$hc 425 Yaws 425 $■=*«$■ 450 Mycoses (General or not elsewhere classified) Classify works on dermatomycoses in WR 300-340; on fungal lung diseases in WF 652. 450 nmfc (HttXttifZlKfcaSISftT j£j*&#cffi^EliWR300-340 IZ ; ^f t»^BfiWF652 iZftmt&o 460 Coccidioidomycosis. Paracoccidioidomyco- sis 460 3 7VV*V#& -2) o Cryptococcosis. Sporotrichosis 475 7 lJ 7° h =i y 7 7,m. 7siit£ziz&ftmz RNA virus infections (General or not else- where classified) 501 RNA ^-OU^JKIfitfiE (HKXttif. Retroviridae infections (General or not elsewhere classified) 502 n*n^-r;u*spMB!fe£ (—U8X Acquired immunodeficiency syndrome. HIV infections 503 I-fX HIV!i*fe*E Diagnosis Therapy Etiology. Transmission 503.1 503.2 503.3 ^S. fc$t 4 41 Epidemiology (Table G) General coverage (Not Table G) 503.4 mm (Gmi&m) 503.41 £ft (Gmi&m-ef) Complications Prevention and control 503.5 503.6 ^E7j£fli'JJ± Psychosocial aspects 503.7 *±#'U>3ftJt.tf! Viral respiratory tract infections (General or not elsewhere classified) 505 ^-Oi/^ttSUMIfe (HKXtti: Common cold 510 *» -tf' Orthomyxoviridae infections (General or not elsewhere classified) 512 3j-;U7$?V"7-fJU*JBtfrSE (-US xttt*ctc*^a*tirt^^Ji-&) Influenza 515 -r>7;n>if 93 WC COMMUNICABLE DISEASES WC B & #1 WC 518 Paramyxovirus infections (General or not elsewhere classified) Classify works on measles in WC 580. 518 /•0 520 Mumps 520 3Mt1CTT** 522 Infectious mononucleosis 522 wmm»m=mmmmm 524 Arbovirus infections (General or not else- where classified) Classify works on epidemic encephalitis in WC 542; on lymphocytic choriomeningitis in WC 540. 524 7)l^7^)^7.m^m. (~mRlt£ mr\iBikitwc542 iz ; 'J y^m '\^m^^mmt^c54o k#8i-*0 526 Phlebotomus fever 526 ■y-vf-a^/AXj* 528 Dengue 528 9y7"%. 530 Yellow fever 530 ft f& 532 Epidemics 532 mnmf 534 Viral hemorrhagic fevers 534 7't )l*'&&m%k 536 Human viral hepatitis 536 th7<;U7xfF^ 540 Neurotropic virus diseases (General or not elsewhere classified) 540 ttHlRltt^-r-M>*#l (HEXlJif. 542 Epidemic encephalitis. Equine encephalomyelitis (in humans) Classify works on encephalomyelitis of the horse in SF 959.E5. 542 ^Tt»&. 7"7faWM^ (APbI £fclt3) •7-7^!a#il^liSF959.E5H7> 550 Rabies 550 nxm 555 Poliomyelitis 555 *°U*=WSiJ*S& 556 Prevention and control 556 ^m£MJ± 570 Infectious viral skin diseases (General or not elsewhere classified) 570 ^^^-Ol^ttJftJSMeft (HKX 571 Herpesvirus infections (General or not else- where classified) Classify works on infectious mononucleosis in WC 522; on Burkitt 's lymphoma in WH 525; on other infections with no skin manifestations inWC500. 571 ^JI'tZO'CJUZ&miSE (-«sx fE*14#^j£(iWC522 iz ; /*- * 7 r- 'J >^JifiWH525 i:; J£ ^liWC500H^fi1-*o 94 WC COMMUNICABLE DISEASES WC fc & 1ft WC 572 Chickenpox 575 Herpes zoster 578 Herpes simplex 580 Measles 572 575 578 580 * m $tft§*£=^tK'\Jl'/x'7s =!£Pbs\jl,so#t#| 600 Rickettsial and chlamydial infections. Tick- borne diseases (General or not elsewhere classified) 600 ^7^7^77^/71^. #- mitmi&L (-mz.it£i.izt)frm£ti 602 Trench fever 602 M*m?& 605 Epidemic louse-borne typhus 605 ^B^-7 7, 610 Epidemics 610 3m?-7'7>, W?LiX;g$L&&%m&itV/R345 ICt> 698 Parasitic intestinal diseases (General or not elsewhere classified) Classify works on amebic dysentery in WC 285. 698 m£.&&mmm (-mz.it£zizt> amztix^kw*) 7 * w^#jIliWC285 izftMi~z>0 700 705 Protozoan infections (General or not else- where classified) Classify works on amebiasis in WC 285; on tri- chomonas vaginitis in WP 258. See also other localized infections indexed. Trypanosomiasis 700 w.&mmfx. (-m5Lit£ziz^^m 7^-^(iWC285 IZ\ Mn* ^-*MifeliWP258 U^Ht^o % i>&x0 705 hU/\V7-7j| 715 Visceral leishmaniasis Classify general works on leishmaniasis and on mucocutaneous leishmaniasis in WR 350. 715 foW)-V3--?-7fz. ')-y^y=-7fc(nmiit. WR350^5Hi1~&o 725 Toxoplasmosis (General or not elsewhere classified) 725 b*7 7°yZ-?fc (-A8X(i£ 730 Coccidiosis 730 n7vv'7All 735 Balantidiasis 735 /^>^V7AJE 750 Malaria 750 77'J7 755 Epidemiology 755 mm. #* 765 Prevention and control 765 ^Vi£ms. 770 Therapy 770 800 Helminthiasis (General or not elsewhere clas- sified) 800 vA&m (-Kxtttiziz&ttmz 96 WC COMMUNICABLE DISEASES WC fe §fe 1ft WC 805 Trematode infections (General or not else- where classified) 805 W&ffl®'&& (HKXttifCIC* #££ ft Tl*&l **§«&) 810 Schistosomiasis 810 f±ifti5B£2E 830 Cestode infections (General or not else- where classified) 830 &&®mm (-mRit£ziz&# 838 Cysticercosis. Taeniasis 838 m&&=fe*km. &&m 840 Echinococcosis Classify works on hepatic echinococcosis in WI 700; on pulmonary echinococcosis in WF 600. 840 Q&m. JrT&£*E(iwi700 \z ; M^Sk ^E(iWF600 izft&t ho 850 Nematode infections (General or not else- where classified) 850 m&mmm (-m3.it£z.izt># 855 860 865 870 880 Trichinosis 855 Trichuriasis. Oxyuriasis 860 Strongyloidiasis 865 Ascariasis 870 Filariasis and related conditions (Gen- 880 eral or not elsewhere classified) JS^Sffi . %'&0&lE. mm&m m&m. 7ki*Efci*E=7 < y ij 7fc£mm 885 Onchocerciasis 885 *>=H?;i/*2£ 890 Hookworm infections (General or not elsewhere classified) 890 m&m&is. (-mz.it £ziz& 900 Ectoparasitic infestations (General or not elsewhere classified) Disinfestation Classify works on pediculosis in WR 375; on sca- bies in WR 365 or if veterinary in SF 810. Cf. WC 625 and WC 635 for tick and mite-borne rick- ettsial infections. 950 Zoonoses (General) Classify work on specific diseases of animals in SF. 900 H%t>m$.&'<>7 j:7.\t-vb y (-ms.it £ziz&ftmztix^% L"b^^^^tiWR375 tc ; #H$(i WR365 , J&(2U;|S^& h iXSF810 \zftm-fho ttz\zmfr£'btz\z mft]) 9- 7 f-7!S^^WC625 k WC635 #I0 950 xm#&fom\±mm (-m) m'Vwwfem&itsFizftm-f&o 97 WD WD The WD schedule consists of a series of small tables which deal with subjects that cannot be readily integrated into other schedules because of the underlying framework of the Classification. Classify works on history or societies in the general number for each table. wDftmmt. zufei,z&2>ifofe<7) tzsbizmcomz&%iz i k *bh Z k ri?aj5fc£i> o-rv^o m&ttzitm • w>£i±> *n?tio WD 100-175 Nutrition Disorders WD 200-226 Metabolic Diseases WD 300-375 Immunologic and Collagen Diseases. Hypersensitivity WD 400-430 Animal Poisons WD 500-530 Plant Poisons WD 600-670 Diseases and Injuries Caused by Physical Agents WD 700-758 Aviation and Space Medicine WD 100-175 WD 200-226 WD 300-375 WD 400-430 WD 500-530 WD 600-670 xmww &mmm£Bmm. mwm mm m%)M wim.mmizi:zmm£fiMM WD 700-758 JK^E^fc^ffiE* NUTRITION DISORDERS £ Classify works on nutrition disorders in infancy and childhood in WS 115-130; in the aged in WT115. fLiMM£'mmAXZm 120 122 Vitamin B deficiency Thiamine deficiency e.g., Beriberi 120 \l$$>BX2.m 122 y<<7$>x2.m. 124 Riboflavin deficiency 124 'J**7 7l:>^5g 126 Pellagra 126 ^-7 7 "7 140 Ascorbic acid deficiency e.g., Scurvy "NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. uo 7z=ui,e>m%zm M : maa.m 98 WD WD WD 145 Vitamin D deficiency e.g., Rickets 145 \z\$$.>DXZm ffl : < &m 150 Vitamin E deficiency 150 t£*$>E£2*£ 155 Vitamin K deficiency 155 tf£S>K£22l 175 Celiac disease. Sprue 175 -h\J7y7tfi. 7.y°)V- METABOLIC DISEASES ft it tt m m 200 General works Classify works on diabetes and related conditions in WK; on achlorhydria in WI 308. 200 m IB mw.mkmmmmitwKiz; i&mx ^mtwuos izfrm-t&o * 200.1 Handbooks *200.1/\>K7y7! 200.5 Specific diseases or groups of diseases not classified elsewhere, A-Z 200.5£Z:iI$7>^£ftT^&l^:££IlX ltmBo .A6 7 $. P < K*E .C2 mwimftm .H9 5H£ttSb''j;nf>iliiffi ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * ^mtwffm, ^wfcKteflH-szfcswti**. 99 WD WD WD L5 Lipid metabolism M3 Metal metabolism (General) Classify works on specific disorders separately. ,M4 Minerals P2 Paralysis, Familial periodic P6 Porphyria P8 Purine-pyrimidine metabolism Classify works on gout in WE 350. ,X2 Xanthomatosis .L5 .M3 .M4 .P2 .P6 .P8 XI &mixm (-m) 7*V>-\dV$v>ftW ^mtWE350iZjrymth, 210 Obesity Classify works on reducing diets here or in WD 212 below. 210 flCaSJE ^»^(i--X(iWD212^^^t^o 212 Popular works 212 ffl«*f*tt 214 Adiposis dolorosa. Lipomatosis. Lipodystro- phy Classify works on panniculitis in WR 220; on lipochondrodystrophy in WD 205.5. C2. 22to Water-electrolyte imbalance. Acid-base imbal- ance Classify works on water-electrolyte balance and acid base equilibrium in QU 105. 214 %mm®m. m^mm. ■;*•*>** kp 7<-=m®m%mm &TISJMI&£{iWR220 \z ; mm& fy'X r- 07^ -(iWD205.5.C2U7> 220 ^-mmnw-mm^. »££¥«*« QU105 iZftmt&o in 226 Acidosis Classify works on diabetic acidosis in WK 830; on renal tubular acidosis in WJ 301; on respira- tory acidosis in WF 140. Alkalosis 222 TvK-v* fffc#r&7 v K-v7UiWK830 iz ; m*ffift4 7 v K- v7.it WJ301 iz ; P«t£7v v-y9.it WF140 iZftmt&o 226 7)Vi3U-y7. IMMUNOLOGIC AND COLLAGEN DISEASES. HYPERSENSITIVITY &&£Jfe£MCft. W6M. This schedule is for works on diseases that are largely systemic. Classify works on the hematologic diseases in WH; on disorders associated with transplantation in WO 680; on phagocytic bacte- ricidal dysfunction and associated conditions in QW 690. Z(Dftmiti.£ LX£%&mB.tzib<7)X' hho iMgHUiWHH ; &mizft%im!gtf woeso k ; ±mm&Mftmmtt£tm&& WtQy/690l,Zfrmt2>o 300 General works Classify works on asthma in WF 553; on hay fever in WV 335; on dermatitis in WR 160; on respiratory hypersensitivity in WF 150. 300 &g IB t"ra.iJiWF553 IZ ; teMi£WV335 \z ; j£/f^JiWRi60 iz ; D«§££$ J&^liWFl50ll7>^1-*o 301 Handbooks *301 A>K7'7 7! ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * S^ii^rrtf. MXWiTW-mmirZZbtf&XZt 100 WD WD WD 305 Autoimmune diseases (General) 305 &E&&mm (-«?) 308 Immune complex disease. Immunologic defi- ciency syndromes (General or not elsewhere classified) Classify works on acquired immunodeficiency syn- drome (AIDS) and other HIV infections in WC 503- 503.7. 308 &mmittem. &m*±ftmm (-m xttifcicfc^HSSft-rv*^*^) x>rx (aids) £4r^I1"^o 310 Food hypersensitivity 310 &wM®m. 320 Drug hypersensitivity 320 mmmm.m. 330 Serum sickness 330 MMM 375 Collagen diseases and other connective tissue diseases (General) Cf. WE 346 Rheumatoid arthritis; WG 240 Rheumatic heart disease; WC 220 Rheumatic fever; WG 518 Periarteritis nodosa; WG 520 Throm- boangiitis obliterans; WR 152 Lupus erythemato- sus, Systemic; WR 260 Scleroderma, Systemic. 375 mw.m£jt(Dfk(Dm^mmmm (-m) ffittMISU 7vf-WE346 ; U7 7f 'ft 'b m ,t W G 2 4 0 I D 7 7f| WC220; &Si!1£i&MJ§fflifcwG5i8 ; Efl£14lfiL&lfiL^ifcWG520 ; ^t'ttx 'J TV h-fXWR152 ; ^JfeS WR260 #BB0 ANIMAL POISONS K) & *» 400 *401 405 410 General works Handbooks Marine forms Reptiles 400 m 12 *401 J\>¥7y7'\ 405 mn±ft 410 m&& 420 Spiders. Scorpions. Centipedes. Leeches 420 7"E. -9-V'J. 2**7*. t;u 430 Insects 430 fl * PLANT POISONS m & 500 General works Cf QV 627 Organic poisons. 500 H® IB ^1»t/QV627 #BB0 * 501 Handbooks ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. *501 M>K7y7tI 101 WD WD WD 505 Ergotism 515 Favism 520 Mushroom poisoning 530 Milk sickness 505 *S*£ 515 ^6S«)S 520 ZOZ^M 530 *$im DISEASES AND INJURIES CAUSED BY PHYSICAL AGENTS as w#h k «t * mm t mm 600 General works Classify material on burns in WO 704; on blast injuries in WO 820; on radiation injuries in WN 610. 600 & IE x m it W0704 u ; jf m. m ^ a WO820 u ; Sclt*ll8ISiiwN6io i: 7>^1"S0 601 Handbooks *601 J\yY7y7' 602 Electric injuries 602 m%mw,=n&m 605 Non-ionizing radiation injuries (General) 605 #-f*>fttta**« (-«) 610 Heat exhaustion. Sunstroke 610 mix. a%m 630 Motion sickness e.g., Seasickness. Airsickness 630 HM*BH*=»J8#! 640 Vibration disorders (General) Classify works on vibration as a cause of disease in QZ 57; on aviation effects in WD 735; on control in industry in WA 470; on therapeutic use in WB 535. 650 High air pressure. Submarine medicine 640 mwmm (-m) i£«IHfc LXmftltQT\60 ; #£P ffi;ftfi&liWO350 I^It-So "NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * ##l±¥fr#, **fiJrr1*{-ffiffli-5;i:jj»ai*5c 102 WD WD WD AVIATION AND SPACE MEDICINE m^mm£^^mm Classify works combining both atmospheric and space flight in WD 700-745; on Space flight alone in WD 750-758. Classify here works on diseases associated with high altitude on earth as well as in the air. M^IFHt k ^Mft^Wisi-IZ t tztf%> i> K7-y7! * 703 Dictionaries. Encyclopedias *703 &m. W£H 704 Research (General) Classify here works about research in general, in aviation medicine alone or in aviation medicine and space medicine combined. Classify works about research in space medicine alone in WD 751. Clas- sify works about research on a particular subject, by subject. 704 mn (-m) m^k^m^izm-t-zmftZ'Trm ±si;«t nftm-t&0 705 Personnel selection and fitness. Physical stan- dards 705 AjS^jIie. %i*mmm 710 Altitude effects 710 M&(D&W 111 Decompression sickness 712 :$.i±M 715 Anoxia. Inert gas narcosis 715 mmmm.. ^mfizmm 720 Speed. Acceleration. Deceleration. Gravita- tion. Rotation e.g., G force Classify works on airsickness in WD 630. 730 Psychological aspects e.g., Fear. Stress 720 &£. £Q££. i£& fi77-?l77. 0& M : Mfj ^ffi^(iWD630 izftmi-&o 730 'bmm$)%% M : Sft. 9.vyy 735 Fatigue. Effect of noise. Effect of vibration 735 m%. m^o&w. mwKom 740 Aviation accidents. Protective devices 740 $K%nm&. ftrnm 745 Aviation dentistry 745 mzmwm "NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * s^ii*ff«, &knftvn-&.m-tsz.bffl$l%zt 103 WD WD WD SPACE MEDICINE ¥ & £ ¥ 750 General works (including works on broad aspects of space flight) 750 J8£ («»*?<&£«*:*«£»■« 751 Research (General) Classify works about research on a particular sub- ject by subject. 751 w%. (-m) &7z5.m0 j£Jt£,tl±WRU5r1g1-£o WE 1-190 WE 200-600 WE 700-890 General By Tissue By Region WE 1-190 WE 200-600 WE 700-890 \m%\ GENERAL * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL m$ito&z^im*iz%ft2ti2>w it. a^ • frmmizfrm-tZo %-m. mmmtwuzfrm-fZo Collections (General) 5 By several authors By individual authors mm mm • mm) (-m) 5 mx 7 mx Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-m) 11 History (Table G) 11.1 General coverage (Not Table G) 11 m& (Gm&m 11.1 ±ft (Gmmm-eti 13 Dictionaries. Encyclopedias *13 g**. WI41 15 Classification. Nomenclature. Terminology *15 Km. t££>±. ?-^pv- 16 Tables. Statistics *16 17 Atlases. Pictorial works Classify atlases limited to a particular part of the system here also. 17 7t*yz = mm *&<7)&fc®frizm%.ztitzmm t zzizftm-t&o 18 Education Classify here works about education. 18 «_W -O o izix$ni?izmt zmfttftm-f *NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 105 (>±) ii -v 9 - Id-^ b It "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"'£>## £gc7) Z b T'fo 5 „ WE MUSCULOSKELETAL SYSTEM WE W, ® » & VVE * 18.2 Education materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *18.2 »ww*# &i?&)%nizmi- zmftixz zizft mi-&o minx. mm. «®&&, 7° U9"y^^^. ii 9 u 9\ CAI^C &&mi*&&lzM&% < ±HK «t 0 * 19 Schools, departments and faculties of ortho- pedics *19 m&m<»m&tm& 20 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. 20 w% (-m) mft-teizmtzmm*. zziz% 21 Orthopedics as a profession. Ethics. Peer review 21 mrmtisxammfm^. its. t° 77Hfi- = |S|flfttW * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 A£M±mi§ (Gmmm) *22.1 £ft (GSftltf) Laboratories, institutes, etc. 23 Collective 24 Individual (Cutter from name of agency) 24 m%fc° i~* (-«) izx nftmi-&o Hospitals, clinics, dispensaries, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 27 m^K77 7! 100 General works Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WE 140. 100 m ie mrwmft^zomrikmBizmt &mftitzzizftmtz>o iio* lCOV»T^)^^liWE140 ^£Hi1~&o 101 Anatomy. Histology. Embryology (General) 101 MMm. *§!•¥. 3£3* (Hfi) 102 Physiology. Biochemistry 102 ±mm. £.itm 103 Movement. Locomotion. Posture. Exer- tion 103 mm. nm. $»=#!&. $twmm 104 Kinesthesis. Weight perception 104 mmmtt. mmn 140 Diseases (General) 140 mm (-m) 141 Examination. Diagnosis. Diagnostic meth- ods. Radiography Classify material on a single organ with the organ. 141 &«. bm. mmft. x&«g& %.-^tltJtVj^tizftmir&o 168 Orthopedics (General) 168 mmw (-m) 170 Amputation 170 172 Prosthesis Classify catalogs in W 26. 172 7°Px--tr #*n?"iiw26 izftmi~Z>, 175 Fractures. Dislocations. Sprains 175 ##f. ikh. t&a 180 Fractures 180 3f 182 Open fractures 182 HSc#»f 185 Fracture fixation 185 #0fHJ£& 190 Reconstructive orthopedics. Transplanta- tion of bone and bones 190 nmmmw (M&tm). %®m ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * s^-ii^ff*. jg&WHK-teE-tszfctfai**, 107 WE MUSCULOSKELETAL SYSTEM WE 85 # tt ^ WK BY TISSUE m m. s'j 200 Bone and bones (General) Include works on structure and function of bones in general. Classify works on specific bones with part or system involved. %l±*tltf'£itlX\<*2>UtiLXl*% izftm-t&c 225 Bone diseases Classify works on eosinophilic granuloma in WH 650. 225 #^S tmm$.ftwmitv/H65o izfrmt&o 250 Congenital abnormalities. Disorders of metabolism, growth, or development Classify works on abnormalities of specific bones or regions with the bone or region. Classify works on systemic metabolic disorders involving the bones in WD 200-205.5. 250 tttkmn. iXWs til&RltftlJO ^^.(D^xitmtKDmtit. *0 #£3-k ^#f4ftHtltt:fiWD200-205.5 \Z ftm-tho 251 Osteomyelitis and other infectious diseases 251 ®ffi$k£*tifcS 108 WE MUSCULOSKELETAL SYSTEM WE fe £ WE 500 Muscles. Fascia Include works on structure and function. Classify works on diseases in general in WE 550. Classify works on specific muscles with part or system involved. 500 S5A. mm m*kkmm*zziz$tf0 £&-«: tiWE550 IzfrmtZo #££>#$£Ni Ztli!)i$itlX\<*2>MtiLJllt&lZfr mtZo 544 Myositis. Fibrositis. Rheumatism 544 r!ifilS&. 'J-7T* 545 Contracture Classify works on muscle contraction in WE 500; on muscle cramp and myoclonus in WE 550. 545 m AS ®5JR*g(iWE50O n ; ffim&k ^ * 9u-y,7. (iWE550 H7>^1- h 0 550 Muscular diseases. Neuromuscular diseases Classify works on neuromuscular diseases of the eve in WW 400-475. 550 mmmm. nm.mmm m<7)^mWimBAtWW400-415 Kft 555 Myasthenia gravis 555 [fcWj&ljlE. 559 Muscular dystrophy 559 V7s NP7<- 600 Tendons. Tendon sheaths 600 BY REGION SB fi 84 700 705 Head and trunk Head. Face Cf. WU 101 works for the dentist. Classify works on the jaw in WU; on the temporal bone written for the otolaryngologist in WV 201. 706 Injuries 700 ra^fttt 705 USB. m M&^(Dtz)sb\zmfrtitzmM&itwv2oi iz& 706 m % 707 Neoplasms (Head and neck) 707 m m mm&) 708 Neck 708 m SB 715 720 Thorax. Ribs Classify material on anatomy and physiology here as well as that on bone disorders and malforma- tions. Classify material on diseases of organs or systems within the thoracic cavity, as well as tho- racic surgery, in WF. Back 715 %wg£$m±i> tx*). nfto&'gxit&'DmBM. mm ft®£mmvmzfrmtz>o 720 IT (SB) 109 WK MUSCULOSKELETAL SYSTEM WE # tt £ WE 725 Spine. Vertebrae Classify works on lumbar and sacral vertebrae in WE 750; on spinal tuberculosis in WE 253. 715 mm. m® mmtimitwEiso u; ~#mt f£(iWE253 \Zfrm-fZo 730 Congenital anomalies e.g., Spinal dysraphism 730 tt\±m% 735 740 Curvatures e.g., Scoliosis. Kyphosis. Lordosis Intervertebral disks 735 frA.ffi 740 mmm 750 Lumbosacral region. Sacrococcygeal region. Pelvis 750 nfiijgB. flinttas. #i 755 805 810 Low back pain. Sciatica 800 Extremities Upper extremity Shoulder. Upper arm 755 mmm. ^#1 8oo m & 805 _t k 810 s. ±m 812 Axilla 812 820 Elbow. Forearm 820 M. ffiffi! 830 832 835 Wrist. Hand Infections of the hand Fingers. Toes 830 832 M. ¥ ¥m&itwYi63 iz^mt^0 WF 1-900 General WF 970-985 Thorax and Thoracic Surgery WF 1-900 - m WF 970-985 $SBc:ifegB*f£r GENERAL Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL Collections (General) 5 By several authors 7 By individual authors * 1 m-W,£ (¥-tt£*0»6*y*-E mmM&z>^^m*izwijztiz>% it. x% ■ temmizfrmtZo m mtMitwuzmit&o mm mm • mm) (-m) 5 ®.x%F<£Mft\zu%.ztitzmm> zzizftmtho 18 Education Classify here works about education. is m w -O o 'NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 112 (&) * "J *-&->* bit C. A. Cutter's Cutter - Sanborn Three-Figure Author Table" 7° n^7AP, ii 9 u 9\ CAlfo * 19 Schools, colleges, and specialized departments and facilities *19 £8^ WWfSrfcWK 20 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. 20 flfft (-AS) tm-mzmt&mmz. zziz& 21 Pneumology as a profession. Ethics. Peer review 21 *PTK£UT0)n¥Sa»9fi. lUS. tfT7 * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 x& -amm (G^ttffl) *22.1 :£# (G«ttffl-H-r) 23 24 Institutes. Laboratories of experimental research Collective Individual (Cutter from name of agency) 23 m-kt? ^-* (-US) Hospitals, sanatoriums, clinics, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 27 m^o (Gm&m 17A £ft (G^ffl^f) 28 m*V7'y7¥& 113 WF RESPIRATORY SYSTEM WF "f US & % 100 General works Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WF 140. 100 U IS j$f*]h 101 Anatomy. Histology. Embryology. Abnor- malities 101 mmm. ®&m. m^m. %•% 102 Physiology of respiration 102 nwsmm 110 Biochemistry of respiration and the respira- tory system no n^nykZs&ozLitm 140 Diseases of the respiratory system (General) 140 n^.^^kmm (-m) 141 Examination. Diagnosis. Radiography. Monitoring 141 B&. *-2'J >7 141.5 Specific techniques, A-Z 141.5 ^¥Ss A-Z .B8 Bronchial provocation tests .P7 Plethysmography, Whole body .B8 nw&mftu® .P7 ^7a\y97.=^7'y7>( 143 Symptomatology 143 mmm 145 Therapeutics 145 >&0>£ 150 Respiratory hypersensitivity (General) Classify localized reactions with organs affected, e.g., Hay fever in WV 335. 150 nw%s&m®m (-is.) 200 Tuberculosis (General) Classify works on tuberculosis of organs of other systems, with the organ or system. Classify here also legislation on tuberculosis. 200 til 4* (-«) &izfrmirZ>o zzizitttz^mi 205 Epidemiology 215 Pathology 220 Diagnosis. Prognosis 205 m m 215 m&m 220 mm. f-& 225 Mass chest X-ray 225 JfcSBX 250 Immunological aspects e.g., BCG vaccine 250 *.mm&%m ffl : bcg 7 9^-y 114 WF RESPIRATORY SYSTEM WF » £ WF 290 Lymph node tuberculosis. Scrofula 290 /m&&. mm 300 Pulmonary tuberculosis Classify works on silicotuberculosis in WF 654. 300 mmm mm%kmtwF654 izfrmtZo 310 Therapy 315 Diet. Rest. Exercise. Home care 315 m\&. ft*, mm. mmmm 330 Hospitalization. Climatotherapy. Helio- therapy 330 xm. %Mt&:,£. Bytm& 350 360 Surgery Drug therapy 380 Miliary tuberculosis 390 Pleural tuberculosis 405 Tuberculosis in the workplace 415 Tuberculosis in childhood 350 *r *4 360 mynmz 380 mnmm 390 mmmm 405 «*§<&*£« 415 'WJEI6« 450 Neoplasms (General) 450 mm (-m) 490 Pharynx. Trachea Classify works for the otolaryngologist in WV 410. Classify works on tracheoesophageal fistula in WI 250. 490 xM-mmtm^tzfrizmfrtitzmft it. WV410 iZfrm-fZo ^&i!-7 4 Xr;HiWI250 izftWctho 500 Bronchi 500 %m% 544 Bronchiectasis 544 %*&%wm. 546 Bronchitis. Tracheitis 546 %m%^i. %Wik 553 Asthma 553 »m ,1 600 Lungs Classify works on the pneumonias in WC 202-209; on pulmonary tuberculosis in WF 300-360. 600 B 2&(2WC202-209 U ; M&lfelt WF300-360 iZftmi~Z>o 115 RESPIRATORY SYSTEM WF n m ss ^ 645 Atelectasis 648 Emphysema 651 Lung abscess 652 Fungal lung diseases 654 Pneumoconiosis 645 %k%M=7y-\'7 7--Jd 648 % II 651 BBM 652 mm&Bmm 654 Iffi^E 658 Neoplasms Include works on lung neoplasms of bronchial origin. 658 m a££®£Olffi*f£!»*£ 668 Surgery e.g., Pneumonectomy 668 # £r 700 Pleura. Pleural cavity 700 mm. mmm. 744 Pleurisy. Pleuritis 744 ffim&=xhm$i 745 Empyema 746 Pneumothorax. Hemothorax 768 Artificial pneumothorax 800 Diaphragm 745 IS fa 746 *iflfc£=flflfc. 768 AI3US& 800 tiPiM 805 810 Functional disorders e.g., Hiccup Diaphragmatic hernia 805 mmm W : l * o < *) 810 ^IPili^^-T7 900 Mediastinum 900 ft H 116 THORAX AND THORACIC SURGERY m&tm&tm 970 General works Classify here works on two or more systems within the thoracic cavity, e.g., on respiratory and cardio- vascular systems. Classify works on anatomy, phys- iology, bone structure and abnormalities of the skeletal portion of the thorax in WE 715. 975 Diagnosis. Radiography 975 l&VBi. YMkffi&fe 980 Surgery 980 ft Pt 985 Injuries 985 S W> 970 m HE z.imwL&&£'bmtfn.ig%%&fr.bmtin.ig&£Zb WG 500-700 Ml ^ GENERAL * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc. in WL * 1 m-w,^ (¥-ia#*fl»&a-y*-E m%n&)& h ^ ligy 9 izmi £ ft*s it. xz -temmzfrmtz, mumtv/uzfrm-tZo Collections (General) 5 By several authors 7 By individual authors ** mm - mm) (-«) 5 &x(Dwmiz£z 7 1iA<0MlC&&. *-$ynv- * 16 Tables. Statistics *16 17 Atlases. Pictorial works Classify atlases limited to a particular part of the system here also. 17 7by7,=mm zzizftmtho 18 Education Classify here works about education. *18 ffc W iz\mnizmirz>mittftmt&o ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 118 (>±) i) -j 9 -fcnblt C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" (D^^&^tnz bX'fo&- * mmtwnm, mxnnyir-mmi-5zbfrtb*:Zc WC. CARDIOVASCULAR SYSTEM WG 't i In II WG * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *18.2 &WffJg*H Pk^Mmiizmi-zmftitzzizft m-tZo Mx.it. mm. ®&js&, 7° u9'yA^^. ii 9 u 9*. CAI^ m^itM^,izm%^ < ±MiZ X 13 5H!1-£o * 19 Schools, colleges, and specialized departments and facilities *19 m^-m^mnkmrn 20 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. Cf. WG 110 Experimental studies. 20 m$L (-m) fflft-nsLizm-tzmm*. zziz$- WG110#H?lO IfcfiW 9v 21 Cardiology as a profession. review Ethics. Peer 21 SFTOfc UTO'&K^. fmS. \ZT\s * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 A£ -i±mm (Giftffl) *22.1 £ft (Gifffltf) 23 24 Institutes. Laboratories of experimental research Collective Individual (Cutter from name of agency) 23 m^o Al'k mk AX'i^mmtwGm.s izfrm ■tZo AX^-7*-iJitZZizft mt&o xx^m^m£ ^wgi68 # 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. 26.5 mmmmm. swt-*-**^. =i>e 3.-2 (-m) ftfe3E.m±m \zx *)frmirZ>o Hospitals, clinics, dispensaries, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 27 m^o (Gmmm) 27.1 ±ft (G$ttffl*f) 28 m*bmm (-m) 106 Hemodynamics. Blood velocity, volume, pres- sure, etc. Classify works on hypertension and hypotension in WG 340; on measurement of blood pressure in clini- cal diagnosis in WB 280. 106 Mftim. MM. ifnM. HaE^ M&LJ±%.ti&ft\.J±.:lfcitWG340 iz ; P£j^WfK£lt'&lfiL]±S!l£fiWB280 izftm~$-z>o 110 Experimental studies Classify here works that discuss the experimental work itself. Classify works about research in WG 20. Classify works on specific subjects by subject. 113 Popular works Classify here works on heart and vascular diseases in general or on coronary disease and congestive heart failure in particular. Classify works on other specific disorders with the disorder. 110 H&fiDffl^ 113 *ifcftffl2u*-<7) & o #£±S(2 2.mmizfrm-tz>0 >bmitik!gi&&-i5LXimm£t®iz li!t'\±'l^£it. zzizftmtZc zbm&wmm (-mRit£^iz^^m 140 Electrocardiography. Vectorcardiography. Monitoring (General) 140 'fr£@8Bft&. /\'7 bJ\"bM®&®%. *-*V>7 (-HH) 141 Examination. Diagnosis. Diagnostic methods (General and heart specifically) 141 i*£. mm. »tf& (-m&vi®iz.b m) •NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * #^fi¥ff», &X.WttW~mmtZ>Zbtffo*Z>< 120 WG CARDIOVASCULAR SYSTEM WG '6 1 i II WG 141.5 Specific diagnostic methods, A-Z 141.5 ftmnm:&. a-z .A3 .A9 .B2 .C15 .C2 .E2 .F9 .K5 .K9 .P4 .P7 .R2 .R3 .T6 142 Pathology Angiocardiography Auscultation, Heart Ballistocardiography Cardiography, Impedance Catheterization, Heart Echocardiography Function tests, Heart (General) Kinetocardiography Kymography Phonocardiography Plethysmography Radiography (General) Radionuclide imaging Tomography 166 Therapeutics Classify works on drugs acting on the cardiovascu- lar system in QV 150. .A3 &LiB'bBM&:& .A9 'bMfe&fc Bl >b&®& .C15 -<>\d-#>7>>bWW£ .C2 'bMJjT — TJlfe .E2 'bm^HLffl&i .F9 'bmnm&A (-m) .K5 mg.&m&mm®& .K9 ^^77-f- .P4 'b^mfemte .P7 Zf\y^-7.^7'y7 <- .R2 xmmm& (-m) .R3 1&%Vk®mu-y>7' T6 mmffiBte 142 nmm 166 %m:& 'L^IlJflL ^^.izftmi-^mt. qviso izfrm-tz>o 166.5 Specific therapeutic methods, A-Z 166.5 ft£>6*au A-Z .A5 Angioplasty, Laser .B2 Balloon dilatation. Balloon angio- plasty .A5 U—y-HHtfJKric* bi /^u->tt3R&. m;u 168 Cardiovascular surgery. Artificial cardiac pacing Classify works on surgery for a particular disorder with the disorder. 168 'bmfomn&. xx'bmt&mtv ftfcmmmmizfrmt 169 Heart surgery. Heart transplantation Classify works on surgery of coronary vessels in general, heart valves, myocardium, etc., here. Classify works on surgery of the aorta in WG 410. Classify works on surgery of a particular disorder with the disorder. 169 >bm.ftpt=>bm.^m. &&&&. jg#JfiL^-«L L>®5^ (Qftmtzzizfrm-tZo xm SJRO7f#(iWG410 i:^Jit4o 169.5 Artificial heart. Mechanical heart 169.5 X-Z>bffi,. X-Z>bB'£W 170 Vascular surgery Classify works on surgery of arteries and veins in general here. Cf. WG 410 Aorta and numbers for other specific vessels. 170 fot&ftft mm. k &mb m m m Jk WG HEART 'L> m 200 General works Note that popular works are classed in WG 113; works on examination, in WG 140-141.5; on surgery, in WG 169-169.5. 201 Anatomy. Histology. Embryology 202 Physiology. Mechanism of the heart beat 200 205 Cardiac emergencies 210 Heart diseases (General or not elsewhere classified) 220 Congenital heart disease. Abnormalities of the heart and the cardiovascular system (General) ii^^i^t/fiWGin \z ; j£4ii WG140-141.5 \Z ; ^.f4fiWG169- 169.5 iZftmth0 201 mmm. mmm. %±m 202 ±mm. *bte<»mm 205 'C?K%& 210 >bmmm (-mRitifzizbttrnzn 220 ft^'brnmrn. >bB£>bmti&f§&b 280 Myocardium Classify material on myocardial infarct in WG 300. 280 'L\ >bffiUMltviG300 izftm-f&o 285 Endocardium 285 >bftm 298 Angina pectoris 298 1&>biiE 300 Coronary vessels. Coronary disease 300 fateful5, mmb. 122 WG CARDIOVASCULAR SYSTEM WG >b B tin. to I WG 320 Functional heart disease e.g.. Neurocirculatory asthenia 320 mfett'bmmm 330 Disorders of the heart beat 330 *bfeWm 340 Hypertension. Hypertensive heart disease. Hypotension 340 MtiRJ±m. MtiRJ±te.'bm&. fotitiEM 370 Congestive heart failure 370 yytitife'b^£ 410 Aorta Cf. WC 168 for aortic involvement in syphilis. 410 xmm KJ3l7£At&MI5|#WC168 # 420 Pulmonary embolism and related disorders. Pulmonary heart disease 420 mm^mtmmmm. mnk*bmm 460 Special cardiac problems in anesthesia, den- tistry, surgery e.g.. Choice of anesthetic Cf. WO 235 for general works on choice of anesthet- ic. Classify works on problems in pregnancy in WQ 244; in labor specifically in WQ 330. 460 m®. mn. #5f4c*jtt*«ft»&'Mi i#l©M izmiTZ t£fBW0235 #P.So ^A6Ui3lt*P«lSliWQ244 iz ; #i;5HfeU£it&R8&(iWQ330 \zfrm.tz>o BLOOD VESSELS mi ^ Classify works on blood supply of the extremities here, but classify works on blood supply of specific parts of other body systems with that system or part. Classify works on coronary vessels in WG 300; on the aorta specifically in WG 410; on circulation in WG 103-104; on vascular resistance in WG 106; on vascular surgery in WG 170. cn%fo&(DmjEU\tL(Dti&WLm§it. *<»&x \t%mz^m-f h o jg#JfiL^liWG300 \z; m uAibMiiwG4io \z ; ttS|iiwGi03-i04 \z ; ^.^mmt^Gioe tc ; if^f4(iwGi70 \z 500 General works. Radiography 500 ISSE. XUim&:& 510 Arteries (General or not elsewhere classified) 515 Inflammation 510 mm (-mRit£ziz^^m^tix^ 515 & fs. 518 Polyarteritis nodosa 518 &mk*imm&. 520 Thromboangiitis obliterans 520 mM\i.tinfetia.to% 530 Immersion foot. Frostbite 530 )i7K5:. 3KflS 123 WG CARDIOVASCULAR SYSTEM WG >b M tia. to % WG 540 Arterial embolism. Arterial thrombosis 540 mmmfefc. mmti^kfs. 550 Arteriosclerosis and related disorders 550 mmmtm£mmmm 560 Vasomotor regulation and disorders Classify material on carotid sinus syndrome here. 560 tiRtoWl mMWkMmmitzzizfrmtz>< 570 Raynaud's disease 570 \s/%i<WY 152.5 Cfr mtZo * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc, in WL Collections (General) 5 By several authors 7 By individual authors * 1 m- l# (3S-1fi#£*»6*-y*-rc 7E&)%£fk%m*^ts0 mm%m it. a^ • izmmizfrmtz. mtMitwiizftm-f&o ■m ** mm - mm 5 ®LX 7 mx Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-m) 11 History (Table G) 11.1 General coverage (Not Table G) 11 M&. (G^ffl) 11.1 £#■ (Glfffltf) * 13 Dictionaries. Encyclopedias *13 mnmrn * 15 Classification. Nomenclature. Terminology *15 MR, i££>£. $-^Py- * 16 Tables. Statistics *16 17 Atlases. Pictorial works Classify atlases limited to a particular part of the system here also. 17 7by7,=mm *%(osfrfc&mzmfe2titzmnb 18 Education Classify here works about education. * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, cat- alogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. 18 ft W •?> o ♦18.2 «ww*fi m.^mmAizmt hmftitzziz^- mtz0Mz.tf. mm. smisg, ^ u 9" y U^-%. ii 9 n 9\ CAI^o m^mimjXizm&K < ±sk £mp< 'NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 126 (>i) i) -j 9 -%^b\t "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" /^ WH 20 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. 20 w% (-m) ffift-mzmi-z^w*. zzizft mizx*)frmtz>o 21 Hematology as a profession. Ethics. Peer review 21 m^m£bx(Dm:ntm. fam. t°^7 * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 A* -ttm» (G *22.1 £ft (G^ffiffl-H-f) 23 24 Institutes. Laboratories of experimental research. Blood banks Collective Individual (Cutter from name of agency) wnm. n&:£. ti&fami 23 m^t° o.-* (-m) %f7E±mo 120 Hematologic diseases (General or not else- where classified) 120 tinfomm (HKXttifctzfc^ssti ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * ^mmnm, ^fljfffcKffiHH-sifctftn**, 127 WH HEMIC AND LYMPHATIC SYSTEMS WH mmis&if v>'*% WH 140 Hematopoietic system and hematopoiesis. Developmental theories. Blood cells (General) Classify material on blood chemistry in QY 450. 140 mm% £&&=&&%£■ £*sn. um* (-m) jfiLffi1t^{iQY450 IZfrm-tZo 150 Erythrocytes 150 fttintt 155 Anemia Classify works on neonatal anemia in WS 420; on splenic anemia in WH 600; on blood group incompatibility in WH 420. 155 m tin. #f£JH£lfiHiWS420 iZ (iWH600 \z ; ifiL ift S! ^ ii £ »i WH420 H55*li1"^o 160 Hypochromic anemia 160 fc^mtkntiR 165 Macrocytic anemia. Pernicious anemia 165 *#mu*ttJMH. SttJMB 170 Hemolytic anemia e.g., Sickle cell anemia Classify works on favism in WD 515; on hemoglobinuria in WJ 344; on kernicterus in WL 362. 170 )SiflH4IMIl m: $M»jftLstirifii ;tht£>fcitWD5l5 IZ ; ^^9 n tf >^(2WJ344 \z ; IfrMfe tiWL362 izfrmir&0 175 Anemias of bone marrow dysfunction e.g., Aplastic anemia 175 ifn. : IMfl=f!WMf 180 Polycythemia. Polycythemia vera 180 #Jfll#*!7Jn*E. IEMH 190 Hemoglobin and other hemeproteins. Por- phyrins (Associated with hemoglobin) Classify general works on porphyrins in QU 110; on porphyria in WD 205.5. P6. 190 '\:E7"\ZUi>£1;(D1b7^ v ymZitouwo iz ; *> y A 'J >jgEfiWD205.5.P6U5HB1'*o 200 Leukocytes. Leukocyte disorders (General) 200 sum. &na.Hmw (-m) 250 Leukemia Classify works on histology and pathology of leukemia in QZ 350. 250 &tin.m &m.m(r>tm.mt frmtbo iS^fiQZ350 300 Blood platelets 300 Jfll'hfiR 310 Mechanism of blood coagulation. Hemostasis Classify works on blood coagulation disorders in WH 322-325. 310 mmammm. ±m lfa^M@lfl:(iWH322-325 iZ^mt •O o 312 Hemorrhagic diathesis (General) Classify works on blood platelet disorders in WH 300. 312 amitt#H=tfiiflift« (-m) JfiL/M£K£#liWH300 lzfrmi~Z>o 314 Purpura (General) 314 mmm (-«) 128 WH HEMIC AND LYMPHATIC SYSTEMS WH Mfc«£cP;>/\0£ WH 315 320 Thrombopenic purpura Non-thrombopenic purpuras 315 lft'h£K2Pt£$aE£! 320 ?EllMi«tt4>t£$aBPi 322 Blood coagulation disorders (General) 322 rtnftUHrM (-«) 325 Hemophilia. Hemarthrosis 325 tinzkm. mmtin.m 380 Bone marrow. Bone marrow diseases (Gen- eral or not elsewhere classified) Sternal punc- ture Cf. WH 175 Anemias; WH 180 Polycythemia vera. 380 #tt. #!§£& (HRXfJifZUCfc^ g;ifilWH175 ; EjE^-i&l^whiso # 400 Fluid elements. Plasma. Serum. Blood pro- teins. Blood protein disorders Classify works on blood chemistry in QY 450-490; on inborn errors of protein metabolism in WD 205- 205.5. Cf. WH 540 Multiple myeloma. 400 #»##. ja*. mm. mmm&n. tin.mm&mw tilfoit¥&QYA50-A90 n ; 9cXi±M fiKftHtmt{iWD205-205.5 IZfrm 1" h 0 #3§tt#fIJjlWH540 #BH0 420 Blood groups. Blood group incompatibility (General) Classify works on blood typing in QY 415; on medi- colegal examination in W 791. 420 mm. mm*m& (-m) n\WLmmiEitQY4\5 ^; &mm&}# ^(2w79n;5Hl1~&o 425 Rh-Hr blood group system. Fetal erythro- blastosis Classify works on kernicterus in WL 362. 425 Rh-Hr XtiRntm. flSfJEffc^ffi $5t*B(±WL362 iZftmt&c 450 Whole blood. Blood derivatives. Plasma substitutes. Blood expanders 450 ±m. tiRmmm. Mtfum meh 460 Blood bank procedures e.g., Procurement, processing, preservation, storage, shipment, etc. Blood donors. Plasmapheresis Classify material on blood banks in WH 23 or WH 24; on blood transfusion in WB 356. 460 titintmimmi-m m: u&l. mit. u&. &m. mm iM$g;fri2WH233c(2WH24^ ; Witia. !iWB356 i:^it^0 500 Hodgkin's disease 500 *V>>5 525 Lymphoma e.g., Lymphosarcoma. Leucosarcoma Classify here works which deal collectively with subjects classed in WH 250 Leukemia, WH 500 Hodgkin 's disease, and WH 525 Lymphoma; include works on chemotherapy of hematological neoplastic disease. Classify works on histology and pathology of lymphomas in QZ 350. 525 U >/N°M WH250 &Jfr#^ WH500 Hodgkin #f. VVH525 'J >^!i^53lI$tl£±II£ %^mzm^ tz^ftit z z izftm-t h ; titiM^&totik&nit^mz* §ts0 })>'m o 540 Multiple myeloma 540 ^«tt#ffil 129 WH HEMIC AND LYMPHATIC SYSTEMS WH Ifll»*jJ:tf'J>/** WH 600 Spleen 600 m 650 Reticuloendothelial system Classify works on the lipoidoses alone in WD 205.5.L5. 650 i!MrtJ££=*Brt£ ])*°4 Ki£if£E/\#&. iJ>/^mm (-m) L-^(2WH140 iz; 9 4 7°SlJlfiL$ .itXizMMZtitz^izftmt 130 WI WI DIGESTIVE SYSTEM m it Classify general works on the digestive system and its diseases in WS 310-312 when related to children; in WY 156.5 when related to nursing. Classify works on nursing of patients with specific diseases in WY number also. Classify works on liver and biliary tract treated together in WI 700-740 and in WI 770 if applicable. Classify works on gallbladder and other specific parts in WI 750- 765 as indicated. 'W&izmi-zmit&%£zm&&vfS3io-3i2 iz ; #Hl(iWY 156.5 iz'MMi-Zo ftfem&t: tf-&lZtyt)mt>tltzWi'P&, WI700-740 RV HiZffli-Z>%ftit. ^$;flTl/>S#P< WI750- 765 l^if^o WI 1-250 General WI 1-250 - m WI 300-387 Stomach WI 300-387 m WI 400-575 Intestines WI 400-575 m WI 600-650 Anus and Rectum WI 600-650 lOTfcilM WI 700-770 Liver and Biliary Tract WI 700-770 sm£mm. WI 800-820 Pancreas WI 800-820 m m WI 900-970 Abdomen and Abdominal Surgery WI 900-970 m&tm&tm GENERAL — m Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL * 1 3*-ia# ($-18#*a>6a-y2-lE W*Z5-7LZ>) it. x% • &mmzfrm?2>o ¥#< mtMitwuzftm -t&o Collections (General) 5 By several authors 7 By individual authors mm mm • ma) (-«) 5 mxnmmiz&z 7 mxommiz^^, Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-«) 11 History (Table G) 11.1 General coverage (Not Table G) 11 m& (Gisfiffl) 11.1 ±& (Gm&mv?) 13 Dictionaries. Encyclopedias *13 S*». H*4*l * 15 Classification. Nomenclature. Terminology *15 tm. i££>£. *-VPy- 16 Tables. Statistics ♦ 16 17 Atlases. Pictorial works Classify atlases limited to a particular part of the system here also. 17 7Y>y*=WM zmfczntzmni* *NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 131 (ji) it -j * -tfi-^ b It "C. A. Cutter's Cutter - Sanborn Three-Figure Author Table"c WI DIGESTIVE SYSTEM WI >S it §§ & Wl 18 Education Classify here works about education. 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. 18 t f -O o W^ mtzmft&frmt *18.2 ftWttfttt $ki;m%ftizMi-zmm*zz\zft m-t&o Mx-H. mm. nmfc&. y n ^7 A Jig, ii 9 u 9\ CAI^0 %mmitr&\zm&% < nmz x ^ 19 Schools, departments, and faculties of gastroenterology *19 wmmmtr 3.-7. (-m) ^^.xm(Dtzib(D\tmit. ^<7)±s \zx t)ftm-fz>o 27 m^(D (GSftffl) 27.1 ±ft (GiiJffl^f) 28 m*8 it gg £ WI * 39 Handbooks *39 /\>K^'«y7^ 100 General works Classify works on surgery of the digestive or gas- trointestinal system in general in WI 900. 100 %& IB Wl9(XHC5ri!1-&o 101 Anatomy. Histology. Embryology 101 mmm. mt&m. m±m 102 Physiology. Biochemistry. Digestion 102 ±mm. ? (-») &&!&t o 143 Symptomatology. Manifestations of disease 143 mmm. mmb. PUtt 147 Abdominal pain 147 149 Neoplasms Classify works on neoplasms of specific organ with the organ. 149 Jjl %> o 150 Functional disorders 150 mmrnm 200 Lips. Mouth Classify works for the dentist in WU 140; on neo- plasms written for the dentist in WU 280. 210 Tongue. Taste buds 200 *g. P M^M(DtznbS it gg % WI STOMACH 300 General works Classify works on analysis of stomach contents in QY 130. 301 Anatomy. Histology. Embryology. Congenital abnormalities 302 Physiology 308 Achlorhydria 310 Gastritis 320 Neoplasms 350 Peptic ulcer 360 Stomach ulcer 370 Duodenal ulcer 380 Surgery. Postgas 387 Pylorus. Pyloric i 300 $S iE !rt#^5Mf(iQYl30 Kfr^t*, 301 mmm. m&m. %±m. *^tt*« 302 ±mm 308 mwtX2.m=mwtm 310 W & 320 m % 350 >mtt«* 360 H9 370 +-JI BRMi 380 #?4. lt7JI$&*El£i¥ 387 bsfi. w\mm. mrm^m INTESTINES 400 General works 402 Physiology 405 Symptomatology 407 Diarrhea 409 Constipation 412 Congenital malformations 400 m is 402 zmm 405 mmm 407 T ffi] 409 lEfilffi 412 %-%&&W* 134 WI DIGESTIVE SYSTEM M it §§ £ WI 420 Inflammation e.g.. Enteritis; inflammatory bowel diseases Classify works on regional enteritis in WI 512. 420 & m 425 Diverticulitis. Diverticulosis 425 »£&. »££ 430 Polyps. Polyposis 430 *°U-y. #'J-yffi.5*ffi 435 Neoplasms 435 ffl 450 Intussusception 450 mmmm=mm 460 Intestinal obstruction. Ileus 460 mmrnm. 0 530 Cecum 535 Appendix 560 Sigmoid 530 m m 535 £ £ 560 Stf 135 WI DIGESTIVE SYSTEM WI m it gg m WI 575 Peritoneum. Omentum. Peritoneal cavity. 575 Retroperitoneal space ANUS AND RECTUM 01 n £ 600 General works 600 38 IE 605 Hemorrhoids. Fissure in ano. Rectal fistula 605 m=mm. ws. m.m7<*7-ji 610 Neoplasms Classify works on colorectal neoplasms in WI 529. 610 M ^J *fl§Ii^t2WI529 iZftmtZ, 620 Proctoscopy. Sigmoidoscopy 620 iMfft&£&. s#mmm&£& 650 Proctological surgery 650 mmtm LIVER AND BILIARY TRACT fff m £ m at 700 General works 700 «£ IS 702 Physiology. Liver circulation 702 ±mm. xtrnm 703 704 Bile. Bile acids, alcohols, and salts. Jaundice (General or not elsewhere classified) Liver function in food metabolism 703 mn. m:,m. 7ji^-ji£^. n m (-isijutiiziztftmztixv 704 fctoftWlcfcitSfffflMi 720 Circulatory disorders. Portal system. Portal hypertension 720 mmrnm. nmm. rmE.xmm 725 Cirrhosis 730 Abscess 725 m%m 730 is m 735 Neoplasms 735 M & 740 Degenerative diseases. Hepatolenticular degeneration 740 $t4*». lffl/>Xtt$t4 750 Gallbladder. Bile ducts. Vater's ampulla. Cholecystography 750 mm. \m. mmmmx3. usse 136 WI DIGESTIVE SYSTEM WI >S it gg $ WI 755 Cholecystitis. Cholelithiasis 755 mm%. m^m 765 Neoplasms 765 IS 770 Surgery (General) 770 9m (-m) PANCREAS 800 General works Classify works on the islands of Langerhans in WK 800-885. 800 $& 15 7>y;WN>X^IJWK800-885 \Zft m-tZo 802 Physiology. Secretions 802 £.mm. #» 805 Pancreatitis 805 l$R$=l$$ 810 Neoplasms. Cysts 820 Cystic fibrosis 830 Surgery (General) 810 mm. mm 820 mmtk&mm 830 *m (-m) ABDOMEN AND ABDOMINAL SURGERY m sp £ n sb # *4 Classify works on surgery of the digestive or gastrointestinal system Mffcfif 3: fc (i Pi Jj§^#|>^r^$t(i CI CI H^HKI" &< in general here. 900 General works 900 !£ i5 940 Umbilical region 950 Hernia 940 Iff SB 950 *\JU—7 955 Ventral 955 0 960 965 970 Inguinal Femoral Neoplasms 960 ft 965 970 II 137 WJ WJ UROGENITAL SYSTEM S S £ * s * Classify general works on the urogenital system and its diseases in WS 320-322 when related to children; in WY 164 when related to nursing. Classify works on nursing of patients with specific diseases in WY numbers also. '^l&lzMtZ>BfiL!iLm&&£*m§Jt WS320-322U ; ♦s£C:|ltl1"&J£r£-(iWYl64i: ftm-tho #££&£#o,£#<7)#gHWYi: ftmt&o WJ 1-190 General WJ 300-378 Kidney WJ 400 Ureter WJ 500-504 Bladder WJ 600 Urethra WJ 700-875 Male Genitalia GENERAL WJ 1-190 - US WJ 300-378 m M WJ 400 J^ ^ WJ 500-504 B Wt WJ 600 J^ it WJ 700-875 #§tt£5i& - «L * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substancial lists with directo- ries. Classify annual reports, journals, etc., in WI. Collections (General) 5 By several authors 7 By individual authors \t. a% • &mmzfrmtz>, %mm±v/uzfrmt2>o » mm • mm) (-«) 5 %ix£. 7-^7 Uy- 16 Tables. Statistics *16 m. «tt 17 Atlases. Pictorial works Classify atlases limited to a particular part of the system here also. 17 7Vy7s=m = F51f£ zzizftmt&o 18 Education Classify here works about education. 18 & W izimitizmt&mftZfrMi- "NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 138 (;i) it -j 9 -|E^- b it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table "mm*. zzizft si;«t 053*^1-^0 21 Urology as a profession. Ethics. Peer review 21 mrm£ix(Dym%5&m. akm. t° * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 a*-terns (Gmmm) *ha ±w (Gmmmvt) Laboratories, institutes, etc. 23 Collective 24 Individual (Cutter from name of agency) 25 Laboratory manuals. Technique 24 m*t° i-2 (-m) Hospitals, clinics, dispensaries, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 27 m^\yY7'y7\ *NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * #^{i^tr», )S*fiJh-«H=ffiffl1-5ifc**{B*5« 139 WJ UROGENITAL SYSTEM WJ :s m %. e s ^ WJ 100 General works Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WJ 140. 100 &5 Ifi mn7~ -fho WJfc&\*oy\%5\zftWrtz>0 146 Urination and urination disorders 146 mm£mmmm 151 Urinary tract infections 160 Neoplasms (General) 151 mmmmm 160 mm (-m) 166 Urologic therapeutics Classify works on the pharmacodynamics of diuret- ics in QV 160; on the pharmacodynamics of anti- infective agents in QV 243. 166 %Elft%m:& m^.m<7)mt)^itQVl60iZ ■ #t!& PI^Hl7J^liQV243lC^^1"*o 168 Urologic surgery 168 mmrnm 190 Gynecologic urology Classify works that include obstetrical urology here. Classify those on urologic diseases in pregnancy (when treated separately) in WQ 260. Cf. WP 180 Vesicovaginal fistula. 190 mxmmmnmm m&m%.%*®mz$tsi><7)\t, zz (m®izM*)mt>tix^z>i§i&) wQ26oizftmi-z>0 mmM7i7f ;i/WP180#H?lO KIDNEY w m 300 General works Classify works on kidney functions tests in QY 175; on urinalysis in QY 185. 300 $g IS W$tl&£liQY175K ; Icf«(* QYlS5iZftmt&o 301 Anatomy. Histology. Embryology. Physiology. Abnormalities 301 mmm. mmm. %±m. ±mm. %% 302 Diagnosis. Radiography. Pyelography. Moni- toring 302 mm. xm&Bfe. 7*)>7" mmm. *- 140 WJ UROGENITAL SYSTEM WJ % m. £ m & ik WJ 303 Urinary secretion. Anuria (General) 303 m#m. mmm (-m) 340 Nephrosis 340 *7P--tr 342 Kidney failure. Crush syndrome 342 »*£. j±mmmm 343 Proteinuria. Albuminuria. Renal aminoaciduria 343 H6JIS. 7J17'* >£££. W&7 $. 7 344 Hemoglobinuria. Hematuria. Myoglobinuria 348 Uremia 344 ^^7n\i>mm. mm. >mm 348 %.Mm S*?ntf 351 Infections e.g., Pyelitis, Pyelonephritis 351 mmm 353 Nephritis 353 m & 356 Kidney calculi. Nephrocalcinosis 356 E&G. HGJikm 358 Neoplasms. Cystic kidney 358 mm. sssw 368 Surgery. Kidney transplantation 368 9m. n®m 378 Artificial kidney. Hemodialysis. Peritoneal dial- ysis Classify works on hemodialysis and peritoneal dial- ysis used in treatment of diseases of other parts of the body with the diseases or part. 378 aiwr. timmmm. mm&tf m&&%tkM.w-femit. fojiij mmizfrmt&o URETER Ji? & 400 Ureter 400 m m BLADDER m m, 500 Bladder. Cystoscopy. Cystoscopic surgery Classify works on vesicovaginal fistula in WP 180. 504 Neoplasms 500 mm. mmwL&^m. mmmmm mWk7 1 XriHiWP l80H5jiS1" 504 m % 141 WJ UROGENITAL SYSTEM WJ :s m $. si s ^ WJ URETHRA J^ j1 600 Urethra 600 m sm MALE GENITALIA m^ttm 700 General works Classify here also works which include both male and female genitalia. 700 m ib x(Dmft*z\z\zftm-tz>o 701 Anatomy. Histology. Embryology 701 mmm. mmm. %±m 702 Physiology 702 ±mm 706 Neoplasms (General) 706 mm (-m) 709 Impotence. Infertility Cf. WP 570 for general works on infertility. 709 -r>#x>;*=tt$*ii£. ^&m *&£*g:f£WP570#HBo 710 Male contraception Classify general works on medical aspects of con- traceptives in WP 630. Classify works on sociolog- ical and religious aspects in HQ 763-766.5. Classi- fy works on contraceptive drugs in QV 177. 710 m&m&m M18:M £ Jnfit^Jt Include works on related synthetic hormones M*M.<7) p*^^ A"^ > £ CI CI iZ^tSo here. Classify works on anabolic steroids in WK W\\t7 f n -f Vit. WK1501C5H8 750. 1"£0 143 WK WK ENDOCRINE SYSTEM rt ft :s s Classify general works on the endocrine system and its diseases in WS 330 when related to children; in WY 155 when related to nursing. Classify works on nursing of patients with specific diseases in the WY number also. ^MizmtZ\H7ym&tJtom&itws330iy, %Mizmtz>m&itwYi55izftmtz>0 #£ WK 1-190 WK 200-280 WK 300 WK 350 WK 400 WK 500-590 WK 700-790 WK 800-885 WK 900-920 General Thyroid Gland Parathyroid Glands Pineal Body Thymus Gland Pituitary Gland Adrenal Glands Islets of Langerhans Gonads WK 1-190 ida rax WK 200-280 f?m% WK 300 -h&'hf* WK 350 *&H1* WK 400 m m WK 500-590 TSft WK 700-790 i>f;u/\>^ WK 900-920 14 B GENERAL — fix. * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL * 1 $-tt£ (¥-tt**fr6*y*-E m.m.foh&^itm^izmTZtih^ it. a£ • ommzftm-th* %mm*w\\zftm.tz>o Collections (General) 5 By several authors 7 By individual authors mm mm - mm.) (-m) 5 ®.x&&. 7-$7ny- * 16 Tables. Statistics *16 0.. wfcpt 17 Atlases. Pictorial works Classify atlases limited to a particular part of the system here also. zzizftMt&o ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 144 (>i) it "J 9 -IS^- b it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"o 21 Endocrinology as a profession. Ethics. Peer review 21 mm£bxm. mm. ¥7 * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 a£ -amn (Gm *22.i ±& (Gmtemv? Laboratories, institutes, etc. 23 Collective 24 Individual (Cutter from name of agency) 25 Laboratory manuals. Technique. Experi- mental studies (General) smmmmm 23 m^e 3.-7 (-m) 100 Endocrine glands (General) Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WK 140. 102 Physiology. Biochemistry. Hormones and an- tagonists (General) 100 ftttmm (-m) z>mftitzzizfrm-tz>o •IfcB T <0 ^fNi WK 140 C 102 §imm. £itm. *»*>£#&** (-«) 140 Endocrine diseases (General) 140 «#»«.* (-m) 150 Steroid hormones (General or not elsewhere clas- sified) Classify works on hormones of a particular gland with the gland. 150 7.\tui k*;i>;e> (-mzitkziz ^7E(D%%(D^)V^yiX. %mzft m-t&o 170 Gastrointestinal hormones e.g., Secretin. Enterogastrone 170 b»*;u:e> M:-k9U^y. Jzy-j-uifyYu 180 Renal hormones 180 »K*;i^> 185 Other hormones e.g., Peptide hormones 185 * 187 Synthetic hormones (General or not elsewhere classified) Classify works on specific synthetic hormones with the hormones synthesized. 187 ^$*;u^> (-ms.it£zizt>ttm *)V*yi,zfrmt2>o 190 Hormone therapy 190 *)v=E>mm THYROID GLAND ¥ tt IK 200 General works 200 IS Ifi 201 Anatomy. Histology. Embryology. Abnormali- ties 201 mmm. mmm. «£*. n$ 202 Physiology. Biochemistry (including iodine met- abolism). Thyroid hormones and antagonists 202 $mm. £itm uomimztt). 250 Hypothyroidism and related disorders (Gener- al or not elsewhere classified) 250 wvt*mm&Tmtw&mm (-«x it£zizt>ftmzftx^%^®£) 252 Cretinism. Myxedema 252 7\s*>m. tt?ft*l 146 WK ENDOCRINE SYSTEM WK 259 Goiter Classify here works on goiter in general and on spe- cific goiters, except exophthalmic goiter which is classed in WK 265. 259 ?ttflM zizfrm-tio n u mim&i$. UtWK265iZftm-fZ>o 265 Hyperthyroidism. Thyrotoxicosis. Exoph- thalmic goiter 265 mmmmjimm. fpwm^nm. 267 Medical therapy 270 Neoplasms. Cysts 280 Surgery 267 270 mi 280 9[ & PARATHYROID GLANDS ± & 'h ft 300 Parathyroid glands 300 ±j£'h# PINEAL BODY & H ft 350 Pineal body 350 ft^tt THYMUS GLAND 400 Thymus gland 400 $ m PITUITARY GLAND T ft 500 General works 500 501 Anatomy. Histology. Embryology 501 mmm. mmm. m±m 502 Physiology. Biochemistry 502 ±mm. ±itm 510 Anterior pituitary gland (Adenohypophysis) Include here works on the pituitary-adrenal system. 510 Tmftmm (mTmi^) 515 Hormones and antagonists e.g., Corticotropin. Growth hormones Include works on release and release inhibiting hormones. 515 ^JU^>£^ifimn m : nm&mm*^*y. $lm *)V^y jfctfj*;i/* > kWu&mmXfr^y 147 WK ENDOCRINE SYSTEM WK f*3 ft :S % WK 520 Posterior pituitary gland (Neurohypophysis). Hormones and antagonists Classify works on antidiuretic vasopressin in QV 160; on oxytocin in QV 173. 520 Tmi*&m (nmTmit). *ji>*yk CTJJi^ v 7° y y yy (iQvi6oc ; t*y VyyitQvmizftmt&o 550 Diseases e.g., Diabetes insipidus. Pituitary dwarfism. Gigant- ism. Acromegaly. Hypopituitarism. Froehlich' s syndrome, etc. 550 $c M. m'-.^mm. rmit'^xm. um. ^^ux& (g«). rmfamm 585 Neoplasms Include works on the anterior and posterior pitu- itary glands here also. 585 M T^ftifli kfemi>z\z\iz$tr0 590 Surgery 590 *f *4 ADRENAL GLANDS 700 General works 700 701 Anatomy. Histology. Embryology. Abnor- malities 701 mmm. mmm. «£*. n® 702 Physiology. Biochemistry 702 ikmm. ±itm 725 Adrenal medulla. Epinephrine. Norepine- phrine and other catecholamines Classify works on methyldopa in QV 150 or with the disorder being treated. 715 iijfftttt. xfc?*7';>. /;ntf* 7 U > £ * <7)ffe(D ± y- 3 - J17 $ > mizfrmtZo 750 Adrenal cortex Classify works on neoplasms in WK 780; on surgery, in WK 790; on the pituitary-adrenal system, in WK 510. 750 wm&'. S10tiWK78OH ; 7^#fiWK790U ; Tmfoum&*£&itwK5ioizftmt •O o 755 Adrenal cortex hormones e.g., Cortisone 755 wm&n*j\<*> 757 Synthetic substitutes for cortical hormones Classify works on topical glucocorticoids in QV 60. 757 it&wm&m*** >Gmmn ^P/ffflUK^if-^ KliQV60l ftMt&o 760 Diseases of the adrenal cortex 760 fiiJH&ff^ 148 WK ENDOCRINE SYSTEM WK F*3 ft % £ WK 770 Adrenal cortex hyperfunction e.g., Adrenogenital syndrome. Virilism 770 am&wmmxfe 780 Neoplasms 790 Surgery 780 m 790 *r n ISLETS OF LANGERHANS -7>?J\s/\>7sMs 800 General works 800 if® IS 801 Anatomy. Histology. Embryology 801 mmm. mmm. %±m 810 Diabetes mellitus 810 mmm 815 Therapy 818 Diet 818 819 Diet lists. Diabetic cookery 819 &mm. mmmmm n *j ct * &mm kbxcDm mm &mrp o 850 mmmmmlJ>m. ralfll^^E. j£lfll$I£E 885 Neoplasms 885 m 149 WK ENDOCRINE SYSTEM WK F*3 ft xfc & WK GONADS tt ft 900 Gonads. Sex hormones (General) Cf. WJ 830 Testis; WP 320 Ovary; WJ 875 Andro- gens; WP 522 Estrogens; WK 515 Pituitary gonadotropins; WP 530 Corpus luteum hormones. 900 teflia (-m). tl*;u:E> (-m) fflmWJ830 ; 3PI4WP320 ; £1£*;U* >WJ875 ; XX h n^>WP522 ; Tl #«4«J$t*^>WK515 ; £ft ^;l/^>WP530#HSo 920 Placental hormones 920 i&«*;u;E> 150 WL WL NERVOUS SYSTEM » B Classify general works on the nen'ous system and its diseases in WS 340 when related to children; in WY 160.5 when related to nursing. Classify works on nursing of patients with specific diseases in WY also. 'W&izmi-z>mz&tjt(Dm!§Mws340iz; # mizMi-Z>i%<VJY\60.5lZfrmt2>o &%M WL 1-203 General WL 300-405 Central Nervous System WL 500-544 Peripheral Nerves WL 600-610 Autonomic Nervous System WL 700-710 Sense Organs WL 1-203 - m WL 300-405 cptEft^ WL 500-544 *$#*£ WL 600-610 §##*!£ WL 700-710 m%^ GENERAL — m * l Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc. in WL Collections (General) By several authors By individual anthors * 1 m-w,% (3&•«&#£*»&*?*-£ it. a^ • i±mmizftmi-z>o ¥#&. mtMitwuzftm-t&o mm mm • mm) (-m) 5 ®.x zzizftmt&o 18 Education Classify here works about education. 18 t I z zizimi^izmt zmftzftm-t Z> o *NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 151 (>i) it -v 9-Umblt "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"0 * &mt%nm. mxnftVni~®.mi-zzbtf&*z>0 WL NERVOUS SYSTEM WL ilS £ WI. * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. *18.2 tfcWtt«*H m&)%nizmi-z>%%itzzizfr m-tZo mux. mm. «gfcg, y°u9'y2,^^. J]9U9\ CAI^0 m^mim^izrm* < ina o ftm-^ho * 19 Schools, departments, and faculties of neurol- ogy *19 n&ml 26.5 Medical informatics. Automatic data processing. Computers (General) Classify works on use for special subjects by subject. Hospitals, clinics, dispensaries, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 26.5 B*1M¥. attx-^ftS. z\y\L 3.-7 (-m) tW7zi.mo m&. mmm. mm^mmm 27 rn^co (Gmi&m) 27.1 ±ft (G*ttflH*-f) 28 fi*<7) (GSttffl) 30 Administration of services e.g., Services for the epileptic 30 mmowm * 32 *32.1 Laws (Table G) General coverage (Not Table G) *32 mm (GS&ttffl) *32.i ±ft (Gmmmvt) ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * ##li¥ff». &knfttol-«.m-tZZbtftb*Z< 152 WL NERVOUS SYSTEM WL as ik WL * 33 Discussion of law (Table G) * 33,1 General coverage (Not Table G) *33 &ft0)!ftH *33.1 ±W (Gi mm (gi * 39 Handbooks *39 i\>Y7y7'. 100 General works Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WL 140. 101 Anatomy. Histology. Embryology. Abnormali- ties (General) 100 m ib hmft\tzzizftm-t^o fc&fr\Z'D\i*X 102.7 Motor neurons 102.7 l»Ii-P> 102.8 Synapses 102.8 yXzfT, 102.9 Nerve endings 102.9 tt«H* 103 Psychophysiology (General) Classify works on specific topics by subject. See MeSH tree structure F2 and Index to this Classifica- tion. 103 mn^mm (-m) #^ h \Lv 9 it±m%\\izftmi-&< MeSH7 'J-7 1^7 9 ^~ ^ ~¥2k^f ftm^mziz^Xo 103.5 Neuropsychology 103.5 tm*bmm 103.7 Psychoneuroimmunology 103.7 mnw&&&m 104 Neurochemistry 105 Neuroendocrinology 104 nmtm 105 wmftft&m 106 Reflexes Classify works on conditioned reflexes, etc., in BF 319-319.5. 106 & ^i^fxM^itBF3\9-3l9.5iZftmiT^o 108 Physiology of sleep Classify works on disorders of sleep WM 188. 108 mf&? (-m) 154 Echoencephalography 154 3W$£ttt£& 160 Nervous system neoplasms (General) 160 nm.?mm (-m) 200 Meninges. Blood-brain barrier Classify works on listeria meningitis in WC 242; on meningococcal meningitis in WC245; on viral meningitis in WC 540. 200 HI 'J 9.T U 7fUJH&(2WC242K ; Ml &M4J»M)]il£(2WC245i: ; 7 4 fl^MtMifcli, WC540U5HI1-£o 203 Cerebrospinal fluid Cf. QY220 Clinical analysis; WB 377 Spinal, cister- nal and ventricular puncture. 203 flgffffft ^$UWB377#HB0 CENTRAL NERVOUS SYSTEM *mnu% 300 General works (Include works on brain alone) Cf. WL 348 Brain diseases. Classify works on diag- nosis in WL 141 General ;WL 150 Electroen- cephalography ;WL 154 Echoencephalography;WL 405 Myelography or in a specific number for the disorder. 300 isia (Mo 302 Cerebrovascular circulation Cf. WG 595.C37 Cerebral arteries. 302 S&m&Wm. AJ$IMWG595. C37#HBe 307 Cerebrum. Cerebral cortex. Telencephalon Classify here works on basal ganglia, corpus callo- sum and cerebral ventricles. 307 XB. AFa&fl. m& i*iip> mmtm^itzzizft rt&o 310 Brain stem 310 312 Diencephalon. Thalamus 312 mm. *ij£ 314 Limbic system 314 xm^m^ 320 Cerebellum 320 'h 330 Cranial nerves (General or not elsewhere classified) 330 mms. (-mmtziziztiftmzti? 154 WL NERVOUS SYSTEM WL 15 £ WL 335 Localization of function. Cerebral domi- nance. Brain mapping 335 mmomte. xmmtfe&fe. mw \i>7 340 Neurologic manifestations (General or not elsewhere classified) Cf. WL 390 Movement disorders; WW 460 Neuro- logic manifestations of eye disease. 340 nmmft (-mRit£zizt>ftmz*i iIi<#WL390 ; BI£.tO#&^l* WW460#fi?.o 340.2 Communicative disorders. Speech-language pathology Classify here all works on communicative disor- ders except those of psychogenic origins. Classify communicative disorders of psychogenic origins in WM 475-475.6. 340.2 u$a-$—«>3>i«. mmrnm mmm &mfeftm2tix 348 Diseases of the brain 348 mmm 350 Congenital (General or not elsewhere clas- sified) 350 £^t$£S (-m3.lt£ZIZ$>ft$ 351 Inflammatory e.g., Abscess. Encephalitis. Encephalomyelitis Cf. WC 542 Epidemic encephalitis. 351 &m®.mm m: mm. m&. »«. mf\±mikwc542m$o 354 Traumatic e.g., Concussion. Skull fracture. Brain damage 354 #*14£JH m: mmrnm. mm.^n. mmm 355 Cerebrovascular disorders e.g., Cerebral hemorrhage 355 BMWmW ffl : HatfiJfiL 358 Neoplasms of the brain and of the central nervous system in general 358 mmm £ *mnm%mm-m 155 WL NERVOUS SYSTEM WL & Jk wi. 359 Degenerative e.g., Parkinsonism 359 £t£££ ; ji— df y 7 >'• 360 Multiple sclerosis 360 &%\0 370 Psychosurgery 370 mmm 385 Epilepsy 385 XAfrA, 390 Movement disorders (General or not else- where classified) Classify works on muscular diseases in WE 550- 559; on psychomotor disorders in WM 197. 390 jE»P» (-mZ.lt£i-lZ*>tt®Zft x^%^t%&) ^S^^.f liWE550-559U ; fitttlU m^itWM\91iZ^-mt^o 400 Spinal cord. Spinal nerves (General or not elsewhere classified). Nerve roots. Pyrami- dal tracts 400 WM. Wmn& (-mz.it £ziz *>%• 405 Myelography 405 WHJi^>± PERIPHERAL NERVES * m 500 General works Cf. WL 330 Cranial nerves; WL 400 Spinal nerves. 500 & IB ^ttlIWL330 ; #!&WflWL400#B?<0 544 Neuritis. Neuralgia 544 n&%. m AUTONOMIC NERVOUS SYSTEM &wnm% 600 General works Classify here works on specific autonomic nerve groups, not included below. 600 $& IB 9*)\<-y°itzz{zftm-$ho 610 Sympathetic nervous system. Parasympathet- ic nervous system Classify works on cranial nerves in WL 330. 610 %&&&&. !iJ£J§*m& flgttJ|i(iWL330U^^1"*. 156 WL NERVOUS SYSTEM WL n Jk WL SENSE ORGANS ii nt §5 700 General works Classify works on specific sense organs with the sys- tem involved. 700 m IB mzftm-t&o 702 Psychophysics. Sensation (General) Do not confuse with psychophysiology WL 103. 702 nmmm. ®n (-m) ftW£.mmv/Li03kfiL\s\L%\<*zko 704 Pain Classify works on individual sense organ and/or pain relating to it with the organ. 704 m H m* (Dmn&Rtf/xitztuzrm 705 Perception. Perceptual distortion Classify works on psychological aspects of percep- tion in BF 311. Classify works on perceptual distor- tion and disorders associated with psychoses in WM 204. Classify works on visual perception in WW 105; on auditory perception in WV 272, etc. 705 &:£. %\ft(DWfr M<0>L>Sf:#J#||(2BF311^5^ 1"&o ftftfiHZft-% $ %a$tftmzti S/t^S^ltl1WR280#BSo 157 WM WM PSYCHIATRY m n ¥ Classify material on medicolegal psychiatry in W 740; on child psychiatry in WS 350; on adolescent psychiatry in WS 463; on geriatric psychiatry in WT 150; on psychiatric nursing in general and on specific diseases in WY 160. Classify in WM, however, works on specific mental disorders of childhood, adolescence, or old age unless specifically instructed to do otherwise. &mmijmmmitw740iz; y&m%mmm\t WS350C ; W¥*ffll§f:J2WS463[; ; ^fS$ mmtwT\5oiz; mmMm-fo& xtf$fc% ,tiiWYi60U5Hi1-&o L3i»Li!4Jf), *£ m. m*mxit%*mMlc«fc3 Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-m) 11 History (Table G) 11.1 General coverage (Not Table G) 11 m& (Gmfem) 11.1 ±& (GSttffl-B-r: * 13 Dictionaries. Encyclopedias *13 £¥». W*W * 15 Classification. Nomenclature. Terminology *15 #m. i$£>£. 7-$7ny- 16 Tables. Statistics *16 ^. 17 Pictorial works 17 7hy*=m =, -7=1*112 18 Education Classify here works about education. is m w ■?) 0 :;: 18.2 Educational materials Classify here educational materials, eg., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. *18.2 ftffttlfttt miittm^zm-f zmftitz zizft mt&o m^it. mm. fi£^, 7* n^'7A^|, ii 9 u y, cai^c * 19 Schools and colleges Classify courses of study, catalogs, etc., in W 19.5. *19 m%£mw f^(JWl9.5U5H81~*o "NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 158 (ji) * -y 9 -E^bit "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table "cD^£^cD Z b X'h 5, WM PSYCHIATRY WM WM 19.5 Graduate and continuing education in psychia- try (including fellowships, internships, residen- cies, etc.) 19.5 mn&miz}$tfz>xm&&^£Mm8i m (7xn-yyy°. <>7->. \s y9yvm*t>ti) 20 Research (General) Classify here works about research in general. Clas- sify works about research on a particular subject by subject 20 w% (-m) fittt-mzmtzmm*. zzizft mizx ^ftm-t&o 21 Psychiatry, psychoanalysis, etc. as professions. Careers in mental health. Types of practice. Peer review Classify works for and about psychiatric aides in WY 160. 21 mm£bxe 3.-7 (-m) m7E±M(Dtzsb(Di£mit. -e^±a \zxY)frm-t2>0 mm. mmm. mm^mmm 'V&mri7~. u/Mfux- va>-tr>*-. *rmm. ®mmm wmm (vim-k-7-7v37 7°). 777-7-7. 9<-77 (G£ 29.1 £{* (G^ffiffl-H-f) 29.5 mm. m&£mm, ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * #^ii¥tf«, wxWffm~mmi-2>zb&fo*z>o 159 WM PSYCHIATRY wm tit n e m wm 30 Administrative psychiatry e.g., Management of hospitals, etc. Supervision of students. Mental health services. Cf. WM 401 for general works on crisis interven- tion; WA 305 for special population groups. 30 w&wftn&m fe$^o«^itKM1-*il&EwM 401 ; *r#£An£aWA305#BBo 30.5 Psychiatric social work 30.5 Htt^7-v + ^7-7 30.6 Community psychiatry (General) 30.6 Mwrnnmrn (-m) 31 Socioeconomic and environmental factors in mental illness 31 »ft#ltc*W'4tt#«»WH:Ft« 31.5 Preventive measures in psychiatry 31.5 flWE^lCfcttS^Bfia * 32 Laws (Table G) e.g., Commitment Cf. W 740 Forensic psychiatry. * 32.1 General coverage (Not Table G) Include international law. *32 mm (Gm&m) W]rSM^[S^W740#B8c *32.i ±& (Gmmm-et) mmm^tso * 33 Discussion of law (Table G) * 33.1 General coverage (Not Table G) *33 femomm • mm (guise: *33.i ±ft (Gmi&mit?) * 34 Handbooks *34 J\>¥7y7' 35 Practices in the care of the mentally ill e.g., Ward attendance. Use of restraints. Technique of home care Cf. WY 160 Psychiatric nursing. 35 mnmm77(Dnm ffi^f4*-IIWY160#BSo 40 Case histories (General) Classify here case books, biographies and autobi- ographies of the mentally ill. Classify case histories limited to one disease with the disease. Classify works on famous persons in WZ 313. 40 mm. (-m) gejsii (gfs) zzzzi\zfrmt?>< $>zmg.\z®ifeztixmfrtitziHw. \s^X(DiXV/Z3\3iZ/r}MtZ>o 49 Art and literature as related to psychiatry. Symbolic case histories e.g., Electra, Hamlet, Oedipus, Don Juan, etc. 55 Counseling on psychological problems 49 mn&mizm&LtzWffi£icm. mm wmm #j ; jl u 9 h y. v\ A U 7 r . ^f 4 7**. K> • vi7>|. 55 >b&m$)r$m-t? u >7" 61 Pastoral care 61 &g|i;dft ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * #^l±¥rr», a^flifrttKttffi-rsifcjWb**. 160 PSYCHIATRY WM » n e m WM 62 Social relations of the psychiatrist (including relations with patients ; relations with public, clubs, societies, etc.) Attitude. Ethics 62 mmmmt^mm (mm£b%m (-m). >b%m.m wncwr S«IB) fflW^a^^tt^it^^wi-^Eis liWM6HU£H£1"*o 100 General works Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WM 140. 100 m ib &mftitzzizftmi-z>o ^to* iZ-D\s^X bmm. mn^± m^^ft^)itwM75iz^m-tho * 7yjt]) y9itwM55iz^m-th0 140 Mental disorders (General) 140 mn^m (-«) 141 Psychiatric examination and diagnosis ui mwmm&mkn 145 Psychological tests (General or not elsewhere classified) Classify works on intelligence tests in BF 431-432.5. 145 'bmmttmm. (-mz.it£z.izt>fr® &mk£it, BF43l-432.5U^^1"S, 145.5 Specific tests, A-Z 145.5 !£&&$, A-Z .B4 Bender-Gestalt test .C3 Cattell personality factor questionnaire .15 Ink blot tests .M6 MMPI .N4 Neuropsychological tests .P8 Projective techniques .R7 Rorschach tests .R8 Rosenzweig picture-frustration study .S9 Szondi test .T3 Thematic apperception test .W9 Word association tests ,B4 Bender-^y 3.7)1/by7 b C3 catteii m=f-mx&mmnm m .15 07^7 by7b M6 MMPI ,N4 tt«'&33&Wx* h P8 Jfi»a R7 Rorschach tT. h ,R8 Rosenzweigfcnili'f "7.X h \s -ya>77? 4 S9 Szondiy-7 V T3 mmmtT7>Y>=±mwm Wt'Mi'm W9 s WMW.ir 7 h 161 WM PSYCHIATRY WM WM 165 Behavioral symptoms (General or not else- where classified) Classify here work on behavioral symptoms for which there are no classification numbers for relat- ed disorders. Classify specific symptoms with relat- ed disorders, e.g., Anxiety with Anxiety disorders in WM 172; Depression with Depressive disorder in WM171. 165 'nm±B^izftm^tf%^m± (Dmf:izmtz>mftitzzizftmtz>0 &7E#= 178 Phobic disorders. Hypochondriasis. Sick role Classify works on sick role associated with a par- ticular disease with the disease. 178 &fowm. >bnmmm)Z$b° B»<7)£3I^WL108 #fl?.o 162 WM PSYCHIATRY WM m n m. m WM 190 Personality disorders (General or not elsewhere classified) e.g., Inadequate personality. Passive-dependent per- sonality 190 xtem-% (-ms.it £z iz$>ft®£ n 193 Defense mechanisms Cf. WM 173.5 Convevsion reaction; WS 350.8 D3 Defense mechanism in children. Classify works on purely psychological aspects of various defense mechanisms in appropriate BF numbers. 193 m®mm fc&RJSWM 173.5 ; /hJB<7)| WS350.8.D3#flBo #tt£>R£ffi$M?|£> mmz^m^m^mit. bf(dmm% &^izfrm-tz>o 193.5 Special topics, A-Z 193.5 «8he7 7, A-Z .A2 Acting out .D3 Denial (Psychology) .D5 Displacement (Psychology) .P3 Perceptual defense .P7 Projection .Rl Rationalization .R2 Regression .R4 Repression .S8 Sublimation. Fantasy .A2 'imit='n%,it=iT%,m m D3 ^m (b m) P3 !®n&m®=%i£w& P7 ® m ,R1 ^mit ,R2 £ 'at ,R4 n j± S8 11 7£*1 197 Psychomotor disorders (General or not else- where classified) Classify specific disorders by subject, e.g., Apraxia WL 340. 197 mnmmmm (-mRit£zizt>ft® ftfcBmi*£.mMizfrm-rz>o m*. l^fr^WL340o 200 Psychoses 200 mwm 202 Functional 202 mm 203 Schizophrenia and schizophresnic syn- dromes 203 mnftmm^wimmm 203.5 204 Autism 203.5 Cognition and perceptual disorders asso- 204 ciated with psychoses \mm RwmizftomsatsniitBm 205 Paranoid disorders 205 Fattflmmr 207 Manic-depressive psychoses and affective syndromes Classify works on reactive depression and on non-psychotic affective symptoms in WM 171. 207 mo^m£mmmmm mtitwMmizftmi- z> 0 [210] [This number not used] Classify works on antisocial personality in WM 190. [2io) {i-ftmZh izftvmnm 270 Substance dependence. Substance abuse 270 ttl(tt#. ttffSJti 274 Alcohol 274 7)\/ZL\-)\, 276 Cannabis 276 *>^-fcf*J! 280 Cocaine 280 =3*<> 284 Narcotics 284 itt lit 286 Opium alkaloids 286 PRT>t77;i/*P< K 288 Diacetylmorphine 288 y77-tr5L;U"E;U7<> (APO] 290 Nicotine 290 "=l^> 300 Mental retardation. Down syndrome Classify works on mental retardation of children WS 107; on education of the mentally retarded in LC 4601-4640.5. 300 mn%mw)%. 7°mm& 'W&(nmWW-MWm(iwsi07i: ; \ WHitii-ffi^^W(iLC4601 -4640.51 7J mtz, 302 Case studies. Biographical accounts 302 mmrnm.. bieWisse 304 Evaluation. Prognosis 304 fFfflfi. ^« 307 Special problems, A-Z 307 ftsfcfcpgs, A-Z .C6 Communication ,M5 Mental disorders .S3 Sex problems (General) .S6 Social problems (General) .C6 3h^-va> .M5 mnmm .S3 \$.o 401 Emergency psychiatric services. Crisis inter- vention (including work with victims of rape and other crimes) Classify works on community mental health pro- grams in WM 30. 401 mttE3M£AE«r9--tf;*. fe«^ mmztt;) Mmmttffi£ ■/ n 9' y A (iWM30 164 WM PSYCHIATRY WM e m WM 402 Drug therapy 402 gg 405 Physical therapy (General or not elsewhere clas- sified) e.g., Induced hyperthermia 405 ®mm& (-ms.it£ziz&ft®2 ftTl*&^J#-£) 410 412 415 Shock. Insulin shock therapy Electric. Electronarcosis Hypnosis 410 412 415 y a y 7. -i sy 3. lJ > • y a y 7m& m%yay7 (m&m%). m% 420 Psychotherapy (General or not elsewhere clas- sified) Classify works on Psychotherapy in childhood in WS 350.2, in adolescence in WS 463, and in old age in WT 150. 420 mnm:A (-ms.ittiziz&imz ftT^&lM§-£) /MB^ffl#^S(iWS350.2, W^ j$ <7)^tU2 WS463, %%-MXit WTl50^5j1i1-&o 420.5 Special types, A-Z 420.5 JNm*<7\ A-Z ,A2 Abreaction. Catharsis .G3 Gestalt therapy .N8 Nondirective therapy ,P5 Psychotherapy, Brief .P7 Psychotherapy, Multiple .P8 Psychotherapy, Rational-Emotive .A2 mmfcrn. mnmt% .G3 ?y 3.7)1 hmft .N8 mm7Fm:& .P5 is.m®%mi%mnm& .P7 mmsmm ic & % mnm& .P8 mmm& 425 Behavior therapy 425 'imm:& 425.5 Special types, A-Z 425.5 «N5$fc*<7\ A-Z .A9 Aversive therapy .B6 Biofeedback (Psychology) .C6 Cognitive therapy .D4 Desensitization, Psychologic. Implosive therapy •R3 Relaxation techniqnes 426 Self-help groups .A9 Mwm:& .B6 /W*7<-K/<«y? ('6 mm) .C6 iS*n«>£ .D4 'bmrnwumft. $ijmb§ .R3 xim&fc 426 B%)7)l-7° 428 Socioenvironmental therapy 428 tt#9tttft& 430 Group psychotherapy 430 *Blfl!ttft» 430.5 Special types, A-Z 430.5 W&7<7*. A-Z .F2 Family therapy .F2 mmm& 165 WM PSYCHIATRY WM n n e m WM .H2 Disabled .M3 Marital therapy .P8 Psychodrama .S3 Sensitivity traning groups. Encounter groups Cf. HM 134 for general sociologi- cal works. .hi %&nmm .M3 **»Hffl&$#'b3ft$ .P8 'bmm=v-^zihy-7 .S3 «St4Bll»^;u-y=AM mmmvji-zf. tn$v us -«SW^tt#f-HM134 ^BS„ 440 Milieu therapy. Therapeutic community 440 mmm:&. %m#mi*=%mm 445 Residential treatment (General) 445 nmm& (-«) 450 450.5 Activity therapy Special types, A-Z .A8 Art therapy .B5 Bibliotherapy .D2 Dance therapy .M8 Music therapy .02 Occupational therapy .P5 Photography .V5 Videotherapy .W9 Writing 450 :/mm&=ttmm& 450.5 *fflk7<7*. A-Z .as nftf$& .B5 IjCsw/i .D2 7>7m&= .M8 #$&& .02 ttmm& .P5 ^H .V5 \d9tmft .W9 i<:t 460 Psychoanalysis. Psychoanalytic theory 460 flMWMf (¥). m###f*m 460.5 Special topics associated with psycho- analysis, psychoanalytic therapy or inter- pretation, A-Z 460.5 flKWMff (m). mwamnftsit izmm\stzb£y7. A-Z JB7 Bonding, Human-Pet C5 Communication ,C7 Creativeness D8 Dreams. Symbolism E3 Ego. Self ,E8 Existentialism. Logotherapy E9 Extraversion. Introversion ,F8 Free association .14 Identification 15 Individuation L2 Language M5 Memory M6 Motivation 02 Object attachment ,P3 Personality P5 Pleasure-pain principle P7 Political systms R2 Reinforcement R3 Religion. Church. Morals. Superego ,S3 Sex U6 Unconscious. Id W6 Women .B7 xm£s .C7 fJiite .D8 m. tm.it .E3 IS. BE .E8 n&±m. p^x7k° .E9 ttfiltt. rtfltt .F8 i &ii&& .14 E-tt .15 ffilttft .L2 C3 QP .M5 IB 11 .M6 vm-sii .02 *r***tt .P3 A ft .P5 tt-^tta)JSR»J .P7 i&>Sv*xA .R2 $ it .R3 mm. «£. *?». msm .S3 is .U6 &Bf£. w. m^mmm mm ttfit4<7) ^ ^ j. - 9- - v 3 > rn^it WL340.2 U^^l"-So 5 Aphasia Classify works on aphasia of neurologic origin in WL 340.5. 475.5 £!§£ nm&9zmmtv/L3Ao.5ilzfrmt %> o Dyslexia Classify works on dyslexia of neurologic origin in WL 340.6. 475.6 ^rnrn nm&&mmitwL3Ao.6izfrmi- -2) 0 Social behavior disorders (General) Cf. WS 350.8.S6for works about children. 600 *t£Wff»l« (-m) 'hlM iZ^D^^X liWS350.8.S6#B?lO Paraphilias e.g., Sadism. Fetishism. Transvestitism. Exhibition- ism. Pedophilia 610 t£ft£JJ& Psychosexual disorders (General or not else- where classified) Cf. WJ 712 Sex differentiation disorders; WP 610 Female sexual adjustment. 611 mwkmmtt&ttmw (-msit£z 1£$mi:imwj712 ; -k&n&tomm WP610#Mo 167 WN WN RADIOLOGY. DIAGNOSTIC IMAGING *=£ JSffl&Br Classify material on ionizing radiation used in the diagnosis and treatment of a specific disease, organ or system with the disease, organ or system. General diagnostic uses of ultrasound and magnetic resonance imaging are included here. Classify material on non-ionizing radiation in WB or other applicable numbers (See Index to this Classification). #5e£Iu i&txit&mmtimizmzh %>Jtyit1frMmt. *0 #4ts frmtz (*ftm^<»m\*fix)o WN 1-160 General WN 180-240 Diagnostic imaging. Radiography WN 250-250.5 Radiotherapy WN 300-340 Radium WN 415-665 Radioactivity (Excluding Roentgen Rays and Radium) WN 1-160 - ne wn 180-240 mmum. xmmtfc WN 250-250.5 tkM&mfe WN 300-340 y:77U WN 415-665 mM& (\y> V*f>%, yc77l±lX&.<) GENERAL Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or seperately. Classify annual reports, journals, etc., in WL * 1 m-w,£ (3&-ia£*a>6:fr'y*-ie m$L#}hZ>^iX%\\9izmi'ZtiZ>i!£ Collections (General) 5 By several authors 7 By individual authors mm mm • mm) (-m) 5 ®LXv>mmiz&% 7 mx Addresses. Essays. Lectures (General) mmm (-m) 11 History (Table G) 11.1 General coverage (Not Table G) 11 m& (Gmmm) 11.1 ±# (Gmi&m-ef) 13 Dictionaries. Encyclopedias *13 ®m. mnmm * 15 Classification. Nomenclature. Terminology *15 yJ-m. &&&. 7-$.7ny- * 16 Tables. Statistics *16 m. mt 17 Atlases. Pictorial works Classify atlases limited to a particular radiological subject here also. 17 7b77=mm mmi>. zzizftmz>o 18 Education Classify here works about education. ►NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 168 is m m zzwmifizMi-zmittfrmi-Zo >±) ft v 9 -$mblt "C. A. Cutter's Cutter - Sanborn Three-Figure Author Table" * 9 uyit. W26izftM-f & o 26.5 Medical informatics. Automatic data processing. Computers (General) Classify works on use for special subjects by subject. Hospitals, clinics, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 26.5 mmfnmm. s»t-*-* 3.-7 (-m) '%7E3Lm0 mm. mmrnm 27 ma>Zbtf&%:5< 169 WN RADIOLOGY. DIAGNOSTIC IMAGING WN i&Mnfem. mmm WN 100 General works. Steroscopy. Electrokymog- raphy 100 ISIS. 3H*8tfc3c>£. ^.%^^7'yl 105 Ionizing radiation 105 i*yitm&m 110 Health physics Include here works on the physics of radiation and nuclear medicine. no %m*mm mm t mBmowmm tz\ziz$ tfo 150 Equipment and supplies e.g., Film. Screens. Generators. Radiation counters Classify works on use of counters, etc., in radiation protection in WN 650. Classify catalogs in W 26. 160 Technology. Contrast media e.g., Positioning Classify works on contrast media for particular types of radiography with the specific type. Classify works on laboratory techniques in WN 25. 150 m&tm& m\7 4hU. 7.9 *)->{%%&). %n m. mmm^.m. mmmMiz&ix z>m7Em<7)im iZ^LXit. WN650U5Hit&o 1) *n^fiw26K£r$1"£o 160 &«. mmm m : Vf-ii &7E9 4 7'<7)XWLffiL%&&>m2ft X^ta^-^) 185 Magnetic resonance imaging 185 MR\=m%&*&Vk&& 200 Radiography (General or not elsewhere clas- sified) 200 xmrn^jk (-msit£zizt>frmz 203 Radionuclide imaging 203 tt*ttaHi-f^—>* 205 Thermography 205 t-:E777<- 206 Tomography 206 GBr!ffil£& 208 Ultrasonography 208 3W&tt£& 210 Foreign body localization 210 m^KDnm:^^. 220 Fluoroscopy 220 X&£%tt£ 170 WN RADIOLOGY. DIAGNOSTIC IMAGING WN MiM&m.m. ma WN 230 Dental diagnostic imaging 230 240 Pediatric diagnostic imaging 240 'WJt RADIOTHERAPY tt 4* t» * & 250 General works 250 %i IE 250.5 Special types, A-Z 250.5 W^7vv>n£7vkx ti&fejtmitzzizjym-f&o # jE.m&ximt^mm&jfcm±. ^oiix im'Mizftm-t&o 415 General works (On nuclear physics, atomic energy, radioisotopes slanted toward the bio- logical sciences) Classify works slanted toward the physical sciences in QC 415 &!B (3L®nmmj%*mmmm. w.* i*-Mr*-, WL®tm$Ljtmizmtz>) ®m®mmmmtQc\z5tm-tz>0 420 Radioisotopes. Radioactive elements Classify works on medical applications in WN 440- 450. 420 t/m&m$Ljtm. m.m^itm IM^^JSffl liWN440-450U5H!i1" h 0 440 Nuclear medicine 440 %m.m 445 Diagnosis Classify works on radionuclide imaging in WN 203. $ltl«S^ *-py ^JiwN203 izftMI-Zo 171 WN RADIOLOGY. DIAGNOSTIC IMAGING WN mm&&m. mm WN 450 Therapeutics 450 600 Radiobiology Classify here works on general effects of radiation toman, animals, and plant life. 600 wMta&m* xm. m®. m^o-ternm m^itzzizftmir&o 610 Radiation injuries Classify general works on radiation-induced abnor- malities in QS 681. 610 M&tifelfSS imm$%mizMirzmiit.QS6i\ izftmi-&0 612 Food contamination 612 &qnp>f*£ 615 Air, soil, and water pollution and pollu- tants (General) Classify general works on air pollution in WA 754; on industrial air pollution in WA 450; on soil pollution in WA 785; on water pollution in WA 689. 615 xu. ±mt*Ky5mi5&vft%m XyXft'MtBltWA754iZ ; ItC «t*A^^*liWA450H ; ±%ft ^liWA785H ; >fc®f^&(JWA689 KfrmtZo 620 Injurious effects on man and animals 620 AHfc»to^<&1WBrf1tf* 630 Injurious effects on plant life (related to human ecology) 630 ffifc^c&MWttffl (xm^mmi: m&btz) 650 Radiation protection Cf. WA 788 Industrial wastes. 650 m.Mmmm !tJWA788#B?.o 660 Radiometry 665 Radiation dosage 660 fa^mm^. 665 tmm 172 wo wo SURGERY ft n ^ Note form numbers used also under Anesthesia WO 201-233.1. lfc#&WO201-233.1Ki3V>Tfc^#-trt*fl WO 1-75 General WO 1-75 WO 100-149 General Surgery WO 100-149 WO 162-198 Surgical Procedure and Armamentarium WO 162-198 WO 200-460 Anesthesia WO 200-460 WO 500-517 Operative Surgery and Surgical WO 500-517 Techniques WO 600-640 WO 600-640 Plastic Surgery WO 660-690 WO 660-690 Transplantation WO 700-820 WO 700-820 Traumatic, Industrial, and Emergency WO 925-950 Surgery WO 925-950 Surgery in Special Age Groups -mtmm mmw£&wm& 9m±ffi£^& & m mm. mm£nm9m GENERAL — m * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WL * 1 3&.ffi# (3£-ffi£**»&*-y*-!E mwt&i*>z>^im*iz%inztiz>m £i$&£i!£&£3-tfo mm%%m it. A£ • ttffic^its. *m. m^itwiizftm-r&o Collections (General) 5 By authors 7 By individual authors mm mm • mm) (-«) 5 mmiz&% 7 mx Addresses. Essays. Lectures (General) 9 mm. be*, mmm (-m) 11 History (Table G) 11.1 General coverage (Not Table G) 11 ffi£ (Gilttffl) 11.1 ±t* (Gmmm-et) 13 Dictionaries. Encyclopedias *13 mm. sftmft 15 Classification. Nomenclature. Terminology *15 ftm. MS. 7-$7ny- 16 Tables. Statistics. Collected surgical case reports (General) *16 :it. tmmmmsm (-m) [17] [This number not used] Classify atlases in WO 517. [17] izi) * -y 9-i^bit "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" »^t£S H 9U9\ CAI^0 m^mim^izrm* < ±ac «t * * 19 Schools, departments, and faculties of surgery *19 9^£*$ (GH1$ffl) *32.1 £& (GmteRHtT) *33 *33.1 Discussion of law (Table G) General coverage (Not Table G) *33 temomm • mm (Gm&m) *33.1 £i* (GUteffltfT") ►NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * #^li¥rr*. Ji&fW?1*«-ftffl+S3fcjWb**c 174 wo SURGERY WO ft W m wo * 39 Handbooks *39 i\yY7y7- 50 Experimental surgery (General) Classify works on experimental work in a particular area by subject. Classify works about research in WO 20. 50 nmmm (-m) h0 «f^Uov>TliW020U^^1- & o 62 Social relations of the surgeon (including relations with patients, relations with public, clubs, societies, etc.). Attitude 62 #?SrlS' 192 Minor surgery. Ambulatory surgery (Gener- al) 192 'Jv^ffi. ***& (Htt) 198 Electrosurgery. Cautery. Laser and electroco- agulation (General) Classify works on use in particular fields with the field or the condition, e.g., in ophthalmology WW 168. 198 m%9m. mwfc. is—v-£nm B& (-«) ftjE7ymz&ijz>&mi±*6a-y*-!S Wm%*z.Z) m$t&)$>2>\<*im*iz%'ffztiz>m it. A£ • itrnmizfrmtZo %-m, &n$itv/uzfrmt2>o mm mm • mm) (-m) 205 %LX 0 *218.23&Wtf)g¥H gcgtfrmizmtzmftitzzizft mt&oMptix. mm. nrnfc^. 7 u 9*7 AJi#, ij 9 n 9\ CAI^< m^miu^izm^.^ < ±miz x ^ ftm-t&o * 219 Schools, departments, and faculties of anes- thesiology *219 ummi) * ®t%£R&i±wo2Ao\z; $ 9u9'itW26iZ77^t^o ftwn f|W0162#BS0 * 231 Handbooks *231 7\>F7y7'\ * 232 Laws (Table G) 232.1 General coverage (Not Table G) *232 >£*$ (GSSfcffl) 232.1 ±i* (Gmmm-et) * 233 Discussion of law (Table G) 233.1 General coverage (Not Table G) *233 fewomm - mm (gmjs) 233.1 £& (GjHSfiffl-H-T) 234 Preanesthetic medication. Preparation of pa- tient 234 mwtm®M. mmmm£ 300 Conduction anesthesia e.g., Regional anesthesia or local anesthesia 300 imBmfc m: &frmmxtefmmBm& 305 Spinal. Epidural 305 mteBmik. 340 Infiltration and topical 340 mmrnm £m% 350 Induced hypothermia, and related topics 350 Ail&ttSJ&fti: wangle 375 Diagnostic and therapeutic anesthetic proce- dures e.g., Nerve block 375 &\Bi£%m%Uto£lstzBWt&i M : WfeT'u y 9 440 Pediatric anesthesia 445 Geriatric anesthesia 450 Obstetrical anesthesia 460 Anesthesia in dentistry. Dental hypnosis 440 'Mfcjfclfci 445 *AJSB*& 450 mtmrnik 460 MftBm£. mftmrnz OPERATIVE SURGERY AND SURGICAL TECHNIQUES ft-n ¥ * £ ¥ & 500 General works Classify works on abdominal surgery in WI 900; on thoracic surgery in WF 980; on general surgery in WO 100. 500 U IB m$¥>9\-&itwi900iz ; ($)§[$y|#(i WF980K ; -HSLftmtV/OlOOlZfrm 510 Cryogenic surgery 511 Laser surgery 512 Microsurgery 510 3MS*rfSH*jS 511 is—v-ftm 512 mm9m^m 517 Atlases. Pictorial works Classify all types of surgical atlases in this number, except those relating to a particular body system or part. Classify the latter by system. 517 7hy7 = m U#81-*o i8lW7Z(D&XitU77 \zm%Ltzis<7)Zfe<0 &#{J£giJ iZTrm-f&o 179 wo SURGERY WO ft ft m wo PLASTIC SURGERY m & ft m 600 General works Classify material on plastic surgery of a condition, e.g., burns, with the condition. Classify material on plastic surgery of a region, system or organ with the area covered, e.g., plastic surgery of the nose, in WV312. 600 & IB X\t%'U:fc$Lft®\±%tiff%th 7if4(iWV312U0 610 Skin transplantation, tube grafts, etc. 610 &mnm. m®mxm 640 Prosthesis in plastic surgery Cf. WO 176 Artificial organs (General). 640 Ml8,9miZtSl7Z>7'nir-i> XXmm (-Ix) W0176#DB0 TRANSPLANTATION fc * (-tt) 660 General works Classify works on specific organs in the surgery number or lacking that, in the general number for the organ being replaced. Classify general works on artificial organs in WO 176. 660 &fcfttim®v>mfirxiwm% tfteijtiiX. )Ri)^x.f)ti5StW itwo\76izftmi~Z>0 665 Tissue preservation 665 m&fi& 680 Immunology Classify works on immunosuppressive agents in QW 920. 680 "^ jg'y' ^^?P*ljmiiQW920U59'«t*, 690 Legal, ethical, and religious aspects Classify the text of laws in WO 32. 690 :,mw. mmtois&vc TRAUMATIC, INDUSTRIAL, AND EMERGENCY SURGERY ftm. mni&&vik**m 700 General works 700 & IB 704 Burns 704 f&ffi=Xm=}?l7£ 800 Military surgery 800 wmftrn 807 Gunshot wounds 820 Blast injuries 807 M, ftj 820 m®.w,w 180 wo SURGERY WO ft ft m wo SURGERY IN SPECIAL AGE GROUPS tttt^mmotm 925 Pediatric surgery Classify works on pediatric anesthesia in WO 440; on surgery of individual organs in WS 260-360. 925 'Wjttmm 'W&B&WZWOAAOIZ ; 1@*£>3lir (D/W^ftmt WS260-360^5MI1" h 0 950 Geriatric surgery Classify works on geriatric anesthesia in WO 445. 950 %x*mm %XBmmtv/OAA5\zfrmi-2>0 181 WP WP GYNECOLOGY m a n * Classify general works on pediatric gynecology in WS 360; on gynecological nursing and nursing of gynecological diseases in WY 156.7. Classify works on male and female reproductive organs treated together in WJ 700-702; on human reproduction in WQ 205, etc. 'mmx&¥mzitws36oiz; m a## mt% A?mt^*iI(iWYl56.7^S(1-&o J§1£fe mart £ ^t^m^f &-m «^» ti-u> kWi<. WJ700-702H ; APaT<7)£?[I(iWQ205 mzfrm.-tz>0 WP 1-390 General WP 400-480 Uterus and Cervix Uteri WP 505-660 Physiology and Functional Disorders WP 800-910 Breast WP 1-390 - m WP 400-480 -?££^HII wp 505-660 %mm£mtm WP 800-910 ?L m GENERAL Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. *1 m-W,£ (3e-1fi#£*>6ay*-E Collections (General) 5 By several authors 7 By individual authors ms mm • r&) (-«) 5 ®.x£. 7-$.yny- * 16 Statistics. Tables *16 tm. 17 Atlases. Pictorial works Classify here also atlases on specific organs. ftTz&'gvmmbzzizftmi-Zc 18 Education Classify here works about education. 18 & W & o ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 182 (;i) * v 9-MS? bit "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" (D^&^tDZ b~Ci>Z>c WP GYNECOLOGY WP a ft m WP * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. *18.2 »WW*fl n^m^-mzm-r ^>^ftitz zizjy ni-£oi?ux.(i:\ mm. nmfc&. 7° v9"yAi%m. ii 9 u 9\ CAI^0 m*Wim$.izrm% < £Miz x 0 frmtZo * 19 Schools, departments, and faculties of gynecology *19 ^Xftm^m^£mft 20 Research (General) Classify here works about research in general. Clas- sify works about research on a particular subject by subject. 20 ffift (-m) mizxvfrmtZo 21 Gynecology as a profession. Ethics. Peer review 21 mnmtisXtomxmm. mm. \zt * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 a^ -\$.mm (Gmmm: *ha ±w (Gmi&mvf) Laboratories, institutes, etc. 23 Collective 24 Individual (Cutter from name of agency) 23 m^o 5-7LZ) 25 Laboratory manuals. Technique 25 W&M.-?-3_7)l. ^& 26 Equipment and supplies Classify catalogs in W 26. 26 n&tm& ij9uyi±v/26izfrm-t2>, 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. 26.5 nit'itmm. smy-z&m. =i>e 3.-7 (-m) W7z±m£*$ (Gfl1$ffl) *32.i ±& (Gmi&mvt: *33 * 33.1 Discussion of law (Table G) General coverage (Not Table G) *33 &ft 0 101 Anatomy 101 mmm 120 Popular works (General) 120 mzmftto (-m) 140 Diseases (General) 140 mm (-m) 141 Examination. Diagnosis. Radiography. Monitoring 141 &s. mm. xmffi&:£. *=.**) >7 145 Neoplasms. Cysts (General) Classify works on neoplasms of specific organs with the organ. 145 mm. mm (-*?) %ffc&'Umtei**!&'U\zfr 150 Embryology. Congenital abnormalities 150 %§im. ft^t£HE 155 Pelvis. Pelvic inflammations 155 #£. &&pi&m 157 Gonorrhea in the female 157 -k&COMm 160 Genital tuberculosis 160 sm^m 170 Perineal injuries 170 $m ^i&igm 180 Rectovaginal fistula. Vesicovaginal fistula 180 mmm7^7irj^ mwtmyiZTft 200 Vulva 200 *fM! 250 Vagina 250 HI 255 Vaginitis. Leukorrhea 255 m&. &&T=ZU1 258 Trichomonas vaginitis 258 VvZ\=E-7-7.m.'$. 21S Adnexa uteri 275 ^SftJiS ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * mmtWnm, ^fiJffftKttflH-azfcawti**. 184 WP GYNECOLOGY WP a ft m WP 300 Fallopian tubes Classify works on tubal pregnancy in WQ 220. 300 m w 320 Ovary Cf. WP 520 Endocrine functions of the ovaries. 320 W J»^rt5^Mf£WP520#BSc 322 Neoplasms. Cysts 390 Endometriosis 322 mm. mm 390 =F-g\*imm UTERUS AND CERVIX UTERI ^g £1-% 400 General works 400 $i 15 440 Uterine diseases 440 ^-%mm 451 Inflammations 451 '■& m 454 458 Displacements. Prolapse Neoplasms 454 ammn. mmm 458 J]I 459 Leiomyoma 459 460 Carcinoma. Sarcoma 460 465 Trophoblastic neoplasms e.g., Chorioadenoma. Hydatidiform mole 468 Surgery (General) 465 r-n*.7y7bmmm=u.%&m m=*mmmm 468 ftft (~m) 470 Cervix uteri 470 ^S! 475 Cervicitis 475 ^gSMSB^ 480 Neoplasms 480 Hi PHYSIOLOGY AND FUNCTIONAL DISORDERS 4i¥t«H»i 505 Physiology (General) 505 ±mm (-m) 185 WP GYNECOLOGY wp m x ft m 520 Endocrine functions of the ovaries 520 wm*;u^>x £#f1M8^ 530 Corpus luteum hormones and related com- pounds Classify works on progestational hormones here unless those produced by other organs are dis- cussed exclusively. 530 ftft*;u^E> £mMik^ty faft& ^z>sm. %%%, 555 Menorrhagia. Metrorrhagia 555 Rmm&. ^iE^gttlfil 560 Dysmenorrhea. Premenstrual tension 560 R&mmm. ai&mm&m 565 Fertility 565 £.mmti 570 Infertility (General). Infertility in the female Cf. WJ 709 Infertility in the male only. 570 T^t&m (-m). -kfen^Rm f§ 14 (D fr ft®ii o BREAST ?l m 800 General works 800 U K 815 Examination. Diagnosis. Radiography 815 «*$. mm. xnffiB% 825 Functional changes e.g., In pregnancy and lactation 825 mmmt Mii&mmkzuTftmM (mm) 840 Diseases of the breast 840 ?LS0)£J» 870 Neoplasms 870 m 900 Therapy Classify works on therapy of neoplasms in WP 870. 900 i%, 910 Surgery 910 ft ft 187 WQ WQ OBSTETRICS m <^ Classify works on obstetrical nursing in WY 157. :#*^tiWYi57i::#g1-£, WQ 1-175 WQ 200-260 WQ 300-330 WQ 400-450 WQ 500-505 General Pregnancy Labor Obstetrical Surgery Puerperium WQ 1-175 - m WQ 200-260 & m WQ 300-330 % fa WQ 400-450 mft9[ft- WQ 500-505 it W GENERAL US Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. Collections (General) By several authors By individual authors * 1 m-w,£ (¥-ia#*a»6ay*-ie it. a£ • ftmmzfrmtZo &mm*vtuzfrmt&o *s mm • mm) (-m) 5 $LX± m\zx*)frm-th 21 Obstetrics as a profession. Ethics. Peer re- view 21 mnm£bxt° 3.-7 (-m) ^^i.m(7jtzib(D\tmit. z<7j±m izxtiftm-fZo m m 27 m^o (Gmmm) 17A ±<& (G^ffiffl-e-f) 28 m*<» (GSttffl) * 32 Laws (Table G) * 32.1 General coverage (Not Table G) *32 &w (Gmmm) *32.i £& (Gmi&mvt) Discussion of law (Table G) General coverage (Not Table G) *33 foWHomm - mm (g* *33.i ±i* (Gmfem-et) 34 Malpractice (Table G) 34.1 General coverage (Not Table G) •NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 34 &m&m 34.1 ±& (Gjiteffl-e-f) 189 WQ OBSTETRICS WQ m ft m WQ * 39 Handbooks *39 i\yY7y7\ 100 General works 100 m ie 150 Popular works on pregnancy and childbirth 150 i&m^mzMTZj&mmtt® 152 Natural childbirth 152 g&#$ 155 Home childbirth 155 WMWfc 160 Midwifery 160 mmm 165 Manuals for midwives 165 ffiJitJiv- 3.7JI 175 Prenatal care 175 &±mmm=m& PREGNANCY £ m 200 General works 200 m IS 202 Diagnosis Cf. QY 335 Pregnancy tests. iHMy-9. r-QY335#HBc 205 Fertilization. Development of ovum. Gener- al physiology of reproduction 205 aw. m*£ 208 Artificial insemination 208 AXSW 209 Prenatal diagnosis. Fetal monitoring 209 m±mmm. wjl*-**)>? 210 Fetus. Fetal membranes. Umbilical cord. Perinatology (General) Classify works on fetal experimentation in general in W20.5. 210 i&jje. m &£ (■ . mmrnm (-«) $&—lxltW20.5lZft 210.5 Fetal anatomy, physiology, and biochem- istry 210.5 teutmmm. ±mmJSL^±nm 211 Fetal diseases (General or not elsewhere clas- sified) "NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 211 wjtmm (-ms.it£zizt>9rm2 tix^tz^m-k) 190 WQ OBSTETRICS WQ m ft m WQ 212 Placenta Cf. WK 920 Placental hormones. 212 m JHjSl*rt'Jt>WK920#flB< 215 Toxemias e.g., Eclampsia 215 &m*mm=t&&& 220 Ectopic pregnancy 220 ^tmm 225 Abortion. Fetal death Cf. WQ 440 Induced abortion; W 867 Criminal abortion. 225 mm. i&ifcjEt: AI&£gtH&WQ440 ; MJ]6VV867# 235 Multiple pregnancy 235 £J£»SI 240 Pregnancy complications (General or not elsewhere classified) Classify works on pregnancy toxemias in WQ 215. 240 nm^im (-ms.it£L-izt>7rmz J&M.*%&itWQ2l5 izfrm-t & o 244 Cardiovascular complications 244 'bmnn.m&'&ftfiE. 248 Diabetes 248 #§J^#! 252 Hematologic complications 252 HHyft^flfffi 256 Infectious diseases 256 &g-m 260 Urologic complications 260 mmm-sixm LABOR ft Wi 300 General works 305 Physiology. Clinical course 307 Presentation 300 U IB 305 $.mm. 307 J£ it 310 Dystocia 310 y7V-7 320 Disproportions of the pelvis 320 #&R£& PUERPERIUM 500 General works. Postnatal care 500 u ib. &.mmi 505 Puerperal infection 505 mmmwzm 192 WR WR DERMATOLOGY J£ it & 3* Classify general works on dermatology in WS 260 when related to children; in WY 154.5 when related to nursing. Classify works on nursing of patients with specific skin diseases in the WY number also. 'WMizM+z&nifwmzitv/siwiz; mmz fW1-£it£(iWYi54.5i:5HI1-&o ®7EfeMm * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. * 1 m-W,£ (3&-t8£*A>6*-y*-IE W-"&5-*.&) mfiL&j #>z^i*%\\*izf&?f z tizm it. a^ • temmizfrm-tZo %-m. mmitw\iz7ym'tz>o Collections (General) 5 By several authors 7 By individual authors mm mm • mm) (-m) 5 &x z z 18 Education Classify here works about education. 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, ragardless of for- mat, by subject. 18 Ife W -2) 0 wmifizMi- zmittftm-t ♦18.2 «wra*ft ftHtoumzM-tzmmtzzizfr mi-z>omiix. mm. nmfi&, 7° n 9 y 2*¥u^. ii 9 u 9\ CAl^t %r.®mi*&3:izM&% < lit: X *) ftmt&o 19 Schools, departments, and faculties of derma- tology *io &mftm<»mn£mft ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 193 (>i) fi v 9 -i^^bit "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"o 21 Dermatology as a profession. Ethics. Peer review 21 mnmti,Tc 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. 26.5 mmmnm. iif-$n. n>e 3.-7 (-m) Hospitals, dispensaries, clinics, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) m&. mmtmm. mmrnm 27 m^(D (GUffiffl) 27.1 ±k (Gmi&m-eti 28 m* T O^fMi WR140t: ftm-tZo 101 mmm. mmm. %±m 102 Physiology. Chemistry and metabolism of the skin. Sensory functions. Skin tempera- ture 102 ±mm. &m(Ditm£im. ®nm. "NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * &mt*.ftW. j&fcflJfT^-ttffl+SifcWb**. 194 WR DERMATOLOGY WR £ m ft m WR 105 Pathology 105 mmm 140 Skin diseases (General) 140 &mmm (-m) 141 Diagnosis. Monitoring 141 mm. *-7ij>7 143 Skin manifestations 143 j£/»*Ett 150 Erythemas e.g., E. multiforme. E. nodosum 150 u W. 152 Lupus erythematosus 152 &m.mm 160 Diseases associated with hypersensitivity. Dermatitis Cf. WD 300 for general works on hypersensitivity. Classify works on dermatitis herpetiformis in WR 200; on occupational dermatitis in WR 600; on neu- rodermatitis in WR 280. 160 mwimizwymB.. &&%. i§$^i£iBwD3oo#Bs0 mmt&M !fcliWR200U ; «Ht4j£/f i&(i WR600C ; m%&Mi&itWR2$0iZft 165 Drug eruptions 165 m 170 Urticaria. Angioneurotic edema Classify works on urticaria pigmentosa in WR 267. 170 uxzm. mwnmmvk*m feUtt ]Z ^ i ^(iWR267 \zftm-t •© o 175 Contact dermatitis Cf. WR 600 Occupational dermatitis. 175 ;14&jf£WR600#B3, 180 Dermatitis exfoliativa 180 «t£j£lf& 190 Eczema 190 M 0 200 Bullous skin diseases of obscure etiology Classify works on erythema multiforme in WR 150. 200 mm^wft 195 WR DERMATOLOGY WR £ m ft m WR 220 Infectious skin diseases (General, bacterial, or not elsewhere classified) Classify works on viral skin infections in WC 570- 590; parasitic skin diseases in WR 345. 220 mw-vk&mmm (-m. mm&zitk z.izt>ftmitixv%w&) 7 A fl'*ttJ£j*!&*3SEliWC570-590 \Z ; 3F££ttJ£j*£.tliWR345i:5}' Wrho 225 235 Impetigo. Ecthyma Furunculosis. Carbuncle 225 O^z^crtftK 235 7Jl>7Jim. 7JJI'7'>7-)1 245 Cutaneous tuberculosis e.g., Lupus 245 &m&mm 260 Scleroderma 260 fe&m 265 Pigmentation disorders e.g., Lentigo. Vitiligo 265 &*3kffK3 267 Of metabolic origin e.g., Hemochromatosis. Albinism 267 ftiHttieHfl) m: ifirfest^. e^ 280 Neurodermatitis and related sensory disor- ders Classify works on causalgia in WL 544. 280 #&&«&£ Mgsgm Jj7vifr3f-=foP*-MitWL544il'7r mrtho 282 Pruritus. Prurigo 282 :to&m=ftti>frm. && 300 Dermatomycoses 300 &n;&'Wimm=&i*mmm 310 Tinea. Tinea pedis 310 330 Tinea capitis 330 m^^m 340 Maduromycosis 340 7X7^3-y^=i 345 Parasitic skin diseases (General or not else- where classified) Classify works on mucocutaneous leishmaniasis in WR 350. 345 *£&tt&j*£ll (HttXtt^C* &M&mv-y3.-?-7mwKM izfrm-f&o 350 Tropical diseases of the skin (General or not elsewhere classified) e.g., Leishmaniasis Cf. WC 715 Visceral leishmaniasis. 350 Mt&&mmm (-m3.it £^£t>$ mztix^%^®£) #ij : 'j-yi7-7i ^l'J-yi7 - 7£eWC715#8?.o 360 Skin diseases caused by arthropods (General or not elsewhere classified) 360 tf£»tt(::«J:3&iff£A (HRXttJ: Zlzfl». > 410 Sebaceous glands. Disorders of the seba- ceous glands 410 mm. &m 415 Seborrhea 415 mmm 420 Epidermal cyst 420 iSSIS 430 Acne. Acneform lesions 430 \m=77*. mmrnm®. 450 Hair. Scalp. Diseases of the hair and scalp 450 €=%§§. m&. %*fcHfta>£A 455 460 Hypertrichosis Alopecia 455 &%M 460 M%m 465 Care of the hair 465 §§<7)¥An 475 Nails. Diseases of the nails 475 jk. jbcomm 500 Neoplasms. Keratosis (General or not else- where classified) 500 mm. mtm (-mnit£ziz^^\ 598 Decubitus ulcer and other skin ulcers Classify works on leg ulcer in WE 850. 598 mm&mm £ * %ft\t WS260-368 Kft&i-Zo 'MBOJM^fc^i mizM-tzmmtQsxitQTizfrmtZo m o mux^ o ff^J&CH^tl^ ,tiiws42i \zftm-tz>o $-m.%\zm.iiztii ^,€(iWS4l0tc^I1--2>o WS 1-141 WS 200-463 WS 260-368 WS 405-463 Genera] Diseases of Children By System By Age Group WS 1-141 - fig WS 200-463 /W1£A ws 260-368 m^wtm ws 405-463 %-<§mmm GENERAL - A3 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journal, etc., in WL * 1 $.tt£ (m-W,i*%fr6*y7-%l $i^ftfc*v>(igiJ*i;SMf3;t'i*§ it, a^ • &mmzftmtz>o muMitwuzftm-f&o Collections (General) 5 By several authors 7 By individual authors mm (Mm • mm) (-m) 5 %ix£. 7-$7By- * 16 Tables (development, height, nutrition, weight, etc.). Statistics *16 («*, %&. %m. fts«). nit 17 Atlases. Pictorial works Cf. QZ 17 for tissue pathology of disease. 17 mffi<7)m.®.ffimmQzn&m0 * NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 198 (&) iivf-Smt it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"CD^ £ ^CD Z b T* h 3 ■■ ws PEDIATRICS WS 'b % ft WS 18 Education Classify here works about education. * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. is m w zzizimi^izmtzmftzfrmt & o *18.2 |feWW»Jpr gcgmm^izm-tz^ftitzziZTr 81-a«, mux. mm. nmx&. 7° u 9*7 I*yg^. ii 9 u 9\ CAI^o m*mmmzm%% < ±miz x o * 19 Schools, departments, and faculties of pedi- atrics *19 >b%wm<»m&tmm 20 Research (General) Classify here works about research in general. Classify works about research on a particular sub- ject by subject. 20 W9i (-US) $m-mzmtz>Mft*. zzizn mizx*)frmi-z>0 21 Pediatrics as a profession. Ethics. Peer review 21 mrm£LX(D®iMlzM? zmmtzzizfrmtZo ^^m^. 6e 3.-7 (-m) fW^.i.m(Dtzib(Dmmit. -e-o±g izxvfrm-tZo Hospitals, dispensaries, etc. (including psychi- atric hospitals for children) Classify here works on psychiatric hospitals for children only. Classify works on community men- tal health services for children in WM 30. mm. mmwmmm (>b%(»m nmrntrnv) 'bfcMfw&mffi&ixzzKftmt femy—vzitwxsoizfrm-t&o "NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * &mtwtfw. m'AWzbtmkz>< 199 ws PEDIATRICS ws 'jv % ft m ws 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 27 **0 (Gftttffl) 27.1 ±*jit-j.t7;!/ * 32 *32.1 Laws (Table G) General coverage (Not Table G) *32 feW (GiUffl) ♦ 32.1 £ft (GSffiffltf) * 33 Discussion of law (Table G) * 33.1 General coverage (Not Table G) *33 >mb7'y7'\ 100 General works Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WS 200. 100 m ifi m?ibmmmm) ^mmmtDtiLmmmmz tp«g:fH(iwsii3 Kftmt O o m%\. sa. mm z2^3.~/r — va>. HHrrr m £&>*£. mmm. m. « *&&. aa (>bmmn) nm£.mmto&it£®%. <7)^]%(iWL705 XIJ*0 .D3 mm (&mo. mnom £ * #^li¥rr». ii*fllfi1*J-ttfflt*ii:A«ffl*«. .A8 .C3 .C7 .C8 .D2 200 PEDIATRICS WS >b % ft m ws .D8 .E5 .E8 .E9 .F2 .H2 .H7 .15 .M2 .M3 .M4 .M5 .P3 .P5 .S3 .S4 .S6 etc.) and security Dreams Emotions. Frustrations, etc. Evaluation of psychological devel- opment (General) External influences (literature, motion pictures, television, war, etc.) Family relations. Birth order. Only child. Twins. Parent-child relations. Father-child relations. Mother-child relations. Sibling relations, etc. Disabled child (Psychological prob- lems) Hospitalized child Cf. WA 310-320 Maternal and child wel- fare. Interpersonal relations (doctor, peer, stranger, etc.) Cf. WS 105.5.S6 Race relations. Classify works on dentist's relation to the child in WU 480; on nurse's relation to the child in WY 159. Memory Mental health Classify works on school mental health in WA 352. Morals Motivation Personality development Play Self Sex behavior Social bahavior. Social problems. Race relations Cf. WS 105.5.15 Interpersonal ralations. .D8 .E5 .E8 .E9 .F2 .H2 .H7 .15 mm mm. w&^mm 'bmtbftmn&m (-m) .Ml .M3 .M4 .M5 .P3 .P5 .S3 .S4 .S6 *m&w (*m. ww. ji/ mtmm. mmm^. i>£v y>=t. M=F. m=FM1$. tt* m&. m=f-mm. s.t5fcv mmm ***** ('bmm^mm) x^Jtm. ^i4i%tWA310-320 #BB,o nxmm (mm. ma. ji» 6&A*) A®K^WS105.5.S6#HHo wu480tc ; MMW;<77'b}fc£ IB ti nnm± ¥&WWffi£.itWA352 IZ ftm-t&o mm^n x&mmm iz ; ffitt&Sii!i$#&WiJLC460i- 4640.4 IZ ; JEfcAOffiflJ&itjiiflJ WM300(l5Hi1~&o Special topics when related to the ratard- ed child, A-Z 107.5 %mwmiizm&b tzftft h\iy7. A-Z .B4 Biochemistry. Genetics .B4 ±nm. mmm .C2 Case studies. Biographical accounts .C2 mrnvm. mzmm ,C6 Communication .C6 =l^o.-^r-va> .D3 Development. Prognosis .D3 mm. ^'te. .F6 Foster homes .F6 m m .14 Institutionalization .14 m mum- Cf. WS 27-28 Hospitals; WS 105.5.H7 #fl%WS27-28 ; ABcMS Hospitalized child (General). (—*t) WS105.5.H7#BB.o P7 Psychomotor problems .P7 MtiittaiM P8 Psychosocial problems .P8 'Oatt^wras R3 Rehabilitation and training .R3 lJ/\,;if7L-va>fc»l|« (General) (Htt) R4 Relations with doctor, nurse, etc. .R4 mm. mmrnm t 110 Learning disorders (physical, mental, and neurologic) Classify works on specific disorders in appropriate numbers, e.g., Aphasia WL 340.5. Classify works for the educator in LC 4704. no mmrnm (*#*k mn®. nmm *fr%.mBjzMM%&^\zfrmtz>0 0!Utf3c!&SEWL34O.5 o &^mu 'bmm&)%$gWS 105.5.C3#HB0 115 Nutritional requirements. Nutrition disorders 115 $*#h. %mmw 120 In infancy 120 mm 125 Breast feeding 125 ©¥l£^ 130 In childhood 130 /Jvi/a; 135 Prophylactic immunizations 135 f>m&m 141 Physical examination and diagnosis. Mass screening Classify works on examination and diagnosis of spe- cific age groups in WS 405-460. ui mm$)&m£&m. m\ t^^ia^M £ &m (iws405- 460 \zfr&tz>0 DISEASES OF CHILDREN Classify works on communicable diseases of children, not associated with a system, in the WC schedule. >b jib m m ^mt^o 200 General works 200 m IB 205 Pediatric emergencies 205 'biJt&&mm BY SYSTEM In the numbers for each system, include general works on the dis- eases of the organs of the system or on special groups of diseases of the system. Classify works on surgery of a single organ here in WS, e.g., Gastrectomy of the child in WS 310. Classify works on surgery of a system with the system, e.g., Neurosurgery of the child in WL 368. Classify works on particular diseases with the disease except for the three disease numbers in WS 312, 322 and 342. r s* $ a su &%m**<7)%izfrmtz>0 fflx.\£'b]JW *tpH7r£H2WL368 IZ0 VVS312 , 322/^.^342^ iZTrmtho 260 Skin 260 & 1* Musculoskeletal system ono 270 ®5 • #te£ PEDIATRICS WS 'b % ft m WS 280 Respiratory system 280 nyk$5?k 290 Cardiovascular system 290 'bmfo.mik 300 Hemic and lymphatic system 300 MM • '; >/\°£ 310 Digestive or gastrointestinal system 310 }mtt&*l'(2fl»£ 312 Diarrheal disorders 312 Tffim 320 Urogenital system 322 Enuresis 320 T&gL£M&% 322 i&mm 330 Endocrine system 330 rt#a&& 340 Nervous system 340 nm.% 342 Cerebral palsy 342 Eitt'W£tfM$ 350 Child psychiatry. Child guidance. Psychoses (General) Cf. WS 107 The retarded child. Classify works on specific disorders in WM. 350 mnmnmm. atm^m. mnm H3iM?§ JBwsi07 #bb0 #^**ii WMC^lt^o 350.2 Therapy Classify here works on all types of therapy for mental disorders of children. Classify therapy of a particular disorder with the disorder. 350.2 fe hh$>%>9 A 7°y 7 A-Z .A4 #«a*a (-m) 368 Medical rehabilitation of physically disabled children 368 *ft**!)Ba)E^W,;Ay Ifx-y BY AGE GROUP *^*h»j 405 Birth injuries 405 #$B#*IfS 410 Premature infants. Diseases of premature infants Classify specific diseases with the disease except those of the premature infants only. 410 *&jE=^jij/B. *m%mm 420 Newborn infants. Neonatology 420 m±m. m&jim 421 Diseases of newborn infants Classify specific diseases with the disease except those of the newborn only. 421 SMfei/E^S BitZ^mBiZfrMtZo 430 Infancy 430 ?L HE 440 Preschool child 440 UmmOti 450 Puberty 450 SU 460 Adolescence (General) 460 m*m (-m) 462 Adolescent psychology. Adolescent behavior 462 m&bmm. nzwmm 463 Psychiatric problems of adolescents. Behav- ior disorders. Psychotherapy. Psychoanaly- sis. Psychoses. Classify specific mental disorders with the disorder in WM. 463 ^5.®m. tf»w*. ft tt*& mnmfr m. nnm &7Ef^{JWYl52i:#®1-£o WT 1-39 General WT 100-166 Geriatrics WT 500 Chronic Disease WT 1-39 — m wt 100-166 %$mm WT 500 1i14£Ji& GENERAL - IB * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. Collections (General) 5 By several authors By individual authors * 1 m-1&& (¥-18#**»6*'y*-IE mffi&}$>z\<*im*izf&ftzti2>m it. a^ • &.mmizfrmirz>o %-m. &umi*mizfrmt2>o mm mm • mm) (-«) 5 »A<0*#£J:* 7 mx£. 7-$7 Oy 16 Tables. Statistics *16 17 Atlases. Pictorial works Cf. QZ 17 for tissue pathology of disease. 17 7hy7=m^ mffioMHx. mm. nmm^. 7 u9'yU^%. ii 9 u 9\ CAI^« tmmim#.\zw%% < isci *) Trmtho ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 205 (>i) * -v 9- ie-f- b it "C. A. Cutter's Cutter - Sanborn Three-Figure Author Table"(D^^Z^tDZ bX'&Z>a (3R#&) WT GERIATRICS. CHRONIC DISEASE WT ^^mm. 111££.* WT * 19 Schools, departments, and faculties of geriatrics *19 ^g^cD^gfl^ft 20 Research (General) Classify here works about research in general. Clas- sify works about research on a particular subject by subject. 20 w% (-m) 81-*0 #£±S< 26.5 Medical informatics. Automatic data processing. Computers (General) Classify works on use for special subjects by subject. Hospitals, dispensaries, clinics, old age homes, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 26.5 &mmmm. %m?-7tm. n>e 3.-7 (-m) &7z±m<77tzfto m&s mmmmm. mmm. *a*- i±m 27 m^b7'y7m GERIATRICS * * ¥ 100 General works Classify works on specific diseases with the disease in other schedules; on nursing of specific diseases in WY 152; on anesthesia in WO 445; on surgery in WO 950. 104 Anatomical, biochemical and physiological changes in senescence. The aging process Classify works on aging tissue here. Classify works on the aging organ or system with the organ or sys- tem. 100 m ib %ffcm&im2>*<»m£ iz ; #^^,to#li(iwYi52 iz ; m& &liW0445 K ; ftftfJWO950 izfrm 1-£0 104 zitommmtts ±nmw. ±mmw mt. &twm zimmtzzizftmt&o %it%$ txitztD&tximizftm-t&o 115 Nutritional requirements. Nutrition disorders 115 **#M=*»fM. xmmm 116 Longevity. Life expectancy. Death Cf. WS 200 for death of children, and other specific topics related to death, e.g.. Attitude to death BF 789.D4, etc. 120 Popular works (General). Geriatric hygiene Include here autobiographical case histories. Exam- ple: Mills. Notings of a nonogenarian. Classify pop- ular works on a particular subject by subject. 141 Physical examination and diagnosis 116 £$. ¥#!#lfc=#l&. 9c 'hJBO?Ews200 RVttlzffltZZO ftfe^TE h^y 9. Mz.iXK^(Dm JKBF789.D4^#BB0 120 ftissfttt (-m). %x®$l nm^&Mitzziz^tso M: m 7.^ Notings of a nonogenarian. ^rJE.i. mbmm. mnms. jtq.ffinmmitwnsoizfrmi-z, 150 Geriatric psychiatry. Mental disorders of senescence Classify works on specific disorders with the disor- der; on geriatric psychology in WT 145. 155 Senile dementia. Alzheimer's disease Cf. WM 220 for dementia and presenile dementia. 150 %*mmwm. zitomn&w &fcmwtezm%izfrmtz ; ^ ^kS3&liWT145 K5MS1-£0 155 *^tt«ift. Alzheimer^! ^&tffcJ5g14$5MWM220 #H?.o 166 Therapeutics (General or not elsewhere classi- fied) 166 %m:& (-m3.it£ziz$>ftmz*ix CHRONIC DISEASE 14 m « 500 General works 500 %& IB ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * &mtWffW, M%Wifm~mmi-z>zbtfia,%:5c 207 WU WU DENTISTRY. ORAL SURGERY tw. nte*m^ WU 1-290 General WU WU 300-360 400-440 Operative Dentistry Orthodontics WU WU 470-490 500-530 Special Groups Prosthodontics WU 600-640 Oral Surgery GENERAL WU 1-290 - m WU 300-360 MftUftm WU 400-440 MfttikiEm WU 470-490 ^^*Bl WU 500-530 Mftmmm WU 600-640 nj&9\-ftm — m. * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. Collections (General) By several authors By individual authors * 1 m-W,4z (m'W,£%friigiJ*i;|&fr$*i4§ it. A£ •tt^l^Sti, mmitwiiZTym-fZo mm mm • mm) (-m) 5 &xo 18 Education Classify here works about education. 18 ft W zzizitmazmt&mfttftwctzx ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 208 (>i) iiyf -%m b it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" Z< * &mtwc WU DENTISTRY. ORAL SURGERY wu mftrn. nmmm wu Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of format, by subject. *18.2 ifcwwjm mtb'm^izm-t zmftitz zizft mtz0 mux. mm. nmfc&. 7° 09'y^^^, ii 9 n 9\ CAlfc &®mimiS:izrm% <±nai) frm+Zo 18.5 Education of dental assistants, hygienists, and technicians 18.5 ftftB8¥, Mft®*k±£&l-±<»%M 19 Schools and colleges Classify courses of study, catalogs, etc., in W 19.5. *19 m^-mft£mftxm m^mm. mit%?itv/\9.5 iz^mt 20 Graduate and continuing dental education (including fellowships, internships, residen- cies, etc.) 20 Xm?%%.^£MftmMWt%Cg (71a -yyzf. <>7-y. \sy?>vm 20.5 Dental research (General) Classify here works about research in general. Clas- sify works about research on a particular subject by subject. 20.5 Mftm%. (-m) tm-mzmt&mft*. zziz$- mizxvfrm-tZo 21 Dentistry as a profession. Peer review 21 mm£Lx \f.3.-7 (-m) 'Wfc^.mvjtztfxDitmt. -e-o±s \zxy)%m-tz>o *NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * ^mtwnm. w&wzbtf&%:z>0 209 WI DENTISTRY. ORAL SURGERY WU *ft^. PJBflft^ Hospitals, clinics, dispensaries, etc. 27 Colletive (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) m&. mmm. mm^mmm 27 m^o (emmm) na £# (Gmtemvt) 28 m*(D (GJSttffl) 29 Dental care (including comprehensive dental care) Cf. W 260 Dental insurance. 29 mftmm (SfiEftE**afc *ft^PtW260#BSo 30 Surveys 30 91 * 32 Laws (Table G) * 32.1 General coverage (Not Table G) *32 :&W (G3H3WI) *32.1 £ft (Gil^ffl^f) 33 Discussion of law (Table G) 33.1 General coverage (Not Table G) *33 tewomm - mm (ghee: *33.i ±i$ (Gmmm^t) 40 Licensure of dentists and dental hygienists 40 (Table G) 40.1 General coverage (Not Table G) 40.1 Mfm£Mft®±±m (G ffl) £i* (G«flMH*-f) 44 Malpractice (Table G) 44.1 General coverage (Not Table G) 44 mm&m (Gmmm) 44.1 iki* (Gmmmvt) 49 Handbooks *49 i\yb7'y7' 50 Dental ethics 50 Mft&momm 58 Advertising. Fee-splitting 58 &£:tfE. Bmmnizmi- zMftitzzizftmt&o m&& i;ov»T<7)l:'f^(iwui40 U5HS1~£o *qst(r>M.?'\W.tzito\zmfrtitzM twizm-tz>mfti>zziz%jj0 101 mmm. mmm. mmm. m^m °m*^ho 101.5 Malformations and abnormalities of jaws, mouth, and/or teeth (General) 101.5 H#s nStf/XliftOSrifcfcSW (-«) 102 Physiology e.g.. Mastication Include works on the jaw. 102 £.mm m: mm 105 Dental emergencies (General) 105 ftft&5&E3& (-«) 113 Oral health and hygiene. Preventive and prophylactic dentistry Classify here works on school education and pro- phylactic programs. Cf. WA 350 School dental ser- vices. Classify popular works for the adult in WU 80. 113 nm o 113.7 Nutrition and oral health (General) Cf. WU 270 Caries. Etiology of caries. 113.7 VkmkumbSi (-m) ts L it. tf L If O^H!raWU270 # 140 Stomatognathic diseases (General). Oral pathology Classify works on mouth diseases written for the dentist here; classify works for the gastroenterolo- gist in WI 200; classify works on jaw diseases alone in WU 140.5. 140 nmmm (-m). nj&mmm M&fentztbizmfrtitzuj&m&n ■■ftitzzizftm-fz. i SBS*£^ W-- (Dtz)b x M ft it WU140.5 \z^^rtz>0 140.5 Jaw diseases Classify here works on temporomandibular joint syndrome also. Cf.WU 600-610. Injuries and surgery of the jaw. 140.5 w.mm mmm%Wiz^^^x(Dmfti> z z WU600-610 #BB0 141 Examination. Diagnosis. Diagnostic meth- ods (General) Classify works on X-ray diagnosis in WN 230. 141 mm. mm. mmz (-m) X !I#iff (iWN230 izfr&t2>0 211 WI DENTISTRY. ORAL SURGERY WU Sft^. nj&flft^ WU 141.5 Specific diagnostic methods, A-Z 141.5 ftfrmmz. a-z .C3 Cephalometry .02 Odontometry .C3 SlgPtt^J)* .02 *0)tr»J 150 Dental technology (General). Dental techni- cians Classify works on technology for particular proce- dures with that procedure. 150 mft&-T.m (-«). w&ai± Sfrfe%XU%tf £MBit WU610 C^gfio 166 Oral and dental therapeutics 166 PEfcJ:tftfft7S*ai 170 Dental chemistry (General) 170 mftitm (-m) 180 Dental alloys and metals 180 mftm^±£±m 190 Dental materials (General and those not classed in WU 180) 190 ftftffltm (HKL&tfWU180lC#gi3 210 Dentition 210 mm= 220 Enamel. Dentin 220 JL7-*J\,M=l3.7?>yn. *#i 230 Dental pulp. Tooth root. Root canals. Dental cementum (Endodontics) Classify works on reimplantation in WU 640. 230 mm. mm. mm. t^>hi («a mmm) 240 Periodontium. Alveolar process. Gingiva (Periodontics) 240 mmrnm. mmrnm. mte(mmm& m) 242 Periodontitis and related diseases 242 mm&tmmmm 250 Dental deposits 250 m^tm^ 270 Caries. Etiology of caries. Effect of fluori- dation 270 ?m=t;Lm. z>mm^m. &o#a& 280 Oral and dental neoplasms 280 nf^£m7°7> K gh^HM. f$fil Transplantation 214 WV WV OTOLARYNGOLOGY 5 OS ft :L *=* Classify works on nursing of patients with ear, nose, or throat diseases in WY 158.5. Note that the numbers WV 1-39 are assigned to works on the specialties otology, rhinology, and laryngology when treated individually as well as in combination. WV 100-190 are for general works only. n ■ &itzi±mizm&*ft^>&mtLX\<*2>9%fflt)MXL>tLZ>o WV100- \90imMizmxo WV 1-190 General WV 200-290 Ear WV 300-358 Nose and Paranasal Sinuses WV 400-440 Pharyngeal Region WV 500-540 Larvnx WV 1-190 WV 200-290 WV 300-358 WV 400-440 WV 500-540 ____ ilia rax &£m\m GENERAL * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. Collections (General) 5 By several authors By individual authors * 1 m-W,^ (3&-18££A»6a-y*-IE W*Z5-7L%) mm^h h mjgij* izmi £ ti& m it, a^ • Q.mm\zfrm-tZo %-^ miMitwuzTym-fZo mm mm • mm) (-m) 5 »A<0M£«fc* 7 mxommiz^z Addrssses. Essays. Lectures (General) 9 mm. mmm (—m) 11 History (Table G) 11.1 General coverage (Not Table G) 11 S£ (GUISE) 11.1 £& (Gm&m-er) 13 Dictionaries. Encyclopedias *13 &m. wft* 15 Classification. Nomenclature. Terminology *15 ftm. l££>±. 7-$7ny- * 16 Tables. Statistics *16 m. mi 17 Atlases. Pictorial works Classify here also atlases on a specific organ. 17 7^y7 = mm %ffc&'gmmiiz\ \zfrmtz, 18 Education Classify here works about education. is m w zzizi$wcPiizm-t h^ft^yymt &o *NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 215 (>i) i) -j 9-lt^bit "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"CD#^£i(D Z b X'~h Z> 0 mtm WY OTOLARYNGOLOGY WV 5*i«^ft^ WV 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, cat- alogs, computer-assisted instruction, etc., regardless of format. Classify textbooks, regardless of format, by subject. *i8.2»ww*ra ^M^nizm-tzmftitzzizfr m-r^omux, mm. nmfc&. 7 u9'yAf£m. ii 9 u 9\ CAl3£c «ft#li^a;KMfcfc<±HKJ:h. ftmirho * 19 Schools, departments, and faculties of oto- laryngology 20 Research (General) Classify here works about research in general. Clas- sify works about research on a particular subject by subject. * 19 juk®mftm<»m% £ mm 20 w%, (-m) Mft-mzmtzmft*. zziz$- mizx^ftmi-Zo 21 Otolaryngology as a profession. Ethics. Peer review 21 mrm£Lx (Gmmm) ia m*e 3.-7 (-m) \zx ^ftm-t&o mm. mmm. mm^mmm 27 mb7'y7\ ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * #^l±¥rr*. mkWtTVoi-femtZZbAWXZt 216 WV OTOLARYNGOLOGY wv ^ a m m ft m wv 100 General works Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WV 140. 101 Anatomy. Physiology. Biochemistry. Embryology. Abnormalities 100 U IB M?i]0 m&7 168 ENT surgery Classify works on surgery of a particular organ with the organ. 168 Mmmmfttm ^^^^^Mm £ f£^WV272 #HB0 210 Examination. Diagnosis 210 &$. 220 External ear 220 *f ^ 222 Ear canal. Foreign bodies. Cerumen 222 9mm. mm. w& 225 Tympanic membrane 225 m 230 Middle ear. Eustachian tube. Petrous bone 230 W. ^m. Mi*® 232 Otitis media (including aerotitis) 232 W& (IK^tt'Wifc*:**;: 233 Mastoid region 233 ?L*§£i£5gfl 250 Labyrinth 250 m 217 WV OTOLARYNGOLOGY 255 Vestibular apparatus. Equilibrium. Spa- tial orientation Classify works on motion sickness in WD 630. WV nmrnmrnm wv 255 mmK. w-mvzm. £H£i& ^tJ@^iiwD630 t:5Hi1~&o 258 Meniere's disease 258 Meniere ^=^<— X—Jim 265 Otosclerosis 265 ^wnm 270 Audiology. Hearing. Hearing disorders. Deafness 270 mnm=*-y*n*y-. mm. m=$m 271 Deafness and other hearing disorders in children 271 'biJt awf49o \zfrmrtZ>o 430 Tonsils. Adenoids 430 flgffl. 77T'V -T K 440 Cleft lip. Cleft palate 440 nw%t=fr-z><*>. Pi LARYNX * 500 General works on larynx, speech, and voice and their organic disorders Classify works on neurological speech disorders in WL 340.2-340.6; on psychogenic speech disorders in WM 475-475.6. 500 si, mtz.£jDLtf*£% 0 219 WW WW OPHTHALMOLOGY m w r^P Classify works on ophthalmic nursing in WY 158. BIft#ll!iWY158 i:^t*, WW 1-100 General WW 1-100 ____ ifia VOL WW 101-170 Eye WW 101-170 m WW 202-290 Parts of the Eye WW 202-290 IS0)SB# WW 300-320 Refraction and Errors of Refraction WW 300-320 fflfi\£mtixni& (m WW 350-358 Corrective Devices WW 350-358 &£.£ WW 400-460 Neuromuscular Mechanism WW 400-460 wm%oimm WW 475-480 Problems Associated with Eye WW 475-480 m&Blzftjffim Diseases WW 505-525 mmtnmmwm WW 505-525 Occupational and Traumatic WW 600-620 ttm® Ophthalmology WW 704-722.1 fc IS WW 600-620 Age Groups WW 704-722.1 Optometry GENERAL ft/y — mL * 1 Societies (Cutter from name of agency) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. Collections (General) By several authors By individual authors * 1 m-W,£ (¥-tS#£*>6*-y2-IB m%n&}&Z>^it%\\9izm7ZtlZ>^ it. x% ■immizftm-t&o mtMitwuzftmt&o mm mm • ms) (-m) 5 lfeA(D^#lZj;5 7 fflA<&MUlJ:3 Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-m) 11 History of ophthalmology and optometry (Table G) 11.1 General coverage (Not Table G) 11 mftm£&m(Dm& (g 11.1 ±i* (Gm&me?) * 13 Dictionaries. Encyclopedias *13 mm. wft»n 15 Classification. Nomenclature. Terminology *15 7>m. &£&. 7-17 Uy- 16 Tables. Statistics Classify tables used in optical dispensing calcula- tions in WW 352. *16 m. »tt mmt&yjn-feizitMzti&mt. ww 352^^^1-^c 17 Atlases. Pictorial works Classify here also atlases on a specific part of the eye. *Nl'MBER CAN BE LSED FOR BOTH MONOGRAPHS AND SERIALS. 220 17 7hy7=mm wftunfr^mm t> z\ z izjym-r •O o (>±) * -y 9 -$mb it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"cO##£gCD ZtX'&i* WW OPHTHALMOLOGY WW ft m WW 18 Education Classify here works about education. is ft m \zimi?izM-f2>mit*frmt * 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. *18.2&Wtf)gft ^mmAizmt z^ftitzzizfr mi-z>o minx, mm. «&&#, 7° U9'7U^%, ii9u9\ CAlfc m^mim^izrm* < ±nt: «t *> * 19 Schools and colleges Classify courses of study, catalogs, etc., in W 19.5. 20 Research (General) Classify here works about research in general. Clas- sify works about research on a particular subject by subject. *19 3:gB • :£*4 • :£& Z) o 20 m%. (-m) mR-mzm-tzmfti. zziz^ miz£t)frm-t&o 21 Ophthalmology as a profession. Ethics. Peer review Classify works on optometry and opticianry in WW 721. 21 mftmtisxnmnm. mm. eru< \z3.-=mmmi f£BIi:BSft^(2ww72l izfrmt •O o 21.5 Ophthalmic assistants 21.5 agftiw * 22 Directories (Table G) Classify directories of optometrists and/or opticians in WW 722. * 22.1 General coverage (Not Table G) *22 x&'&mu (Gmi&m) m&±Rv/xmmm, 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. Hospitals, clinics, dispensaries, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 26.5E*t»a^. nm9-7&m. =i> M3.-7 (-m) &fei.m(Dtzib(Dimit. -e-o±s \zx ^ftm-t&o mi*, mmm. mm^Wimm 27 m^(o (Gmmm) 17a ±w (Gmmm-et) 28 m*K7 7 7! 80 Popular works (General) so srasfttt (-m) 100 General works Classify works on specialty and on the specialty and diseases here. Classify works on diseases alone in WW 140. 100 $g IB Mft #£3 ft TV £*,**&) 141 Examination. Diagnostic methods Classify works on the examination of a part with the part. 141 mm. mm:£ hl^77<7)^^:it^£. mmowm 149 Neoplasms Classify works on neoplasms of parts of the eye with the part. 149 ]]! w.W7rizfri, 150 Color perception. Color blindness Cf. WW 105 Visual perception. 150 fefc. fe* l!£nf;vvwio5 #bb0 160 Diseases due to infection, hypersensitivity, etc. (General or not elsewhere classified) 160 ®mm. &mmmiz&&tzmm (- 166 Ocular therapeutics (Medical) 166 mftiz% ^0ffliWW23-24 \Zfrm-tko PARTS OF THE EYE X(iww358 Xiififif te£e<£>*tf>&£liWW260 \z%\ tZ>0 358 £ NEUROMUSCULAR MECHANISM nrnmomm 400 General works 400 ft$ IB 224 WW OPHTHALMOLOGY WW 0g ft m WW 405 Orthoptics (General) 405 mmm (-m) 410 Disorders of ocular motility 410 m&mmmm 415 Strabismus 415 m m 460 Disorders due to diseases of the central ner- vous system. Neurologic manifestations of eye diseases (General) 460 *mnm%mmizi&mtz>mn. m & v* itm 9 izmi £ n %> m it. a£ • 0 BlJ^ft (Mz.iX. Bulletin of the Johns Hopkins Hospital, Guy's Hospital Reports^) liWlH5H§1-&0 mtfizmt h 7E$flHftJW2#BS0 Collections (General) 5 By several authors 7 By individual authors mm mm • mm) (-m) 5 &x ?)v- 7°<7))§£wX27-28 #BB0 flr^M^y- WX215 iZ^-M-t^o 11.1 £& (Gmmm-et) *13 mm. wft¥# 15 Classification. Nomenclature. Terminology. Standardization. Accreditation *15 $yPv- mmit. w*i 16 Tables. Statistics *16 sit 17 Atlases. Pictorial works 17 ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 227 (>±) it v 9 -le-f b it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table" WW#^S» ZbX°foZa * ^mtwnm. m;kWifm~femi-z>zbtf}5!,*z0 WX HOSPITALS AND OTHER HEALTH FACILITIES wx mmzo * 9u^ityN26iz7ym-t^o 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. Hospitals and medical centers. Health facili- ties (General) Classify here non-serial hospital reports. Classify serial reports in WX 2; reports of army hospitals in UH 470-475; on those of naval hospitals in VG 410- 450. Classify works on special types of hospitals or of specialized departments of general hospitals in the appropriate schedule for the field, e.g., isolation hospitals in WC 27-28; on psychiatric departments of general hospitals in WM 27-28, etc. 27 Collective (Table G) 27.1 General coverage (Not Table G) 28 Individual (Table G) 26.5 mmmnm. i»f-^&i. =i>e 3.-7 (-m) ftfc±m>7-. ftm&m o&q9l (—m) imtmm&WL^zz z izfrmtZo mm&)WL^itwx2 k; mw.m^mn tiUH470-475 IZ ; j£¥#||£#u£li VG410-450 iZftmir&o Wfc9 47(» m&xim&m&vjwnmtz^m 7-£7°n7'y^ (Gmmm 29.1 £ft (G^ffltf) 'MUf'f • 9-7-te>?-WA310-320 ; ^Af-f • ^7-tr>?-WT29-29.1 ; m$t9\-*&mmwx205 #bb0 *32 :aw (Gmmm) *32.i £#■ {Gmmm-et) * 33 Discussion of law. Jurisprudence (Table G) * 33.1 General coverage (Not Table G) *33 fcrnnrnm-mm. fern (g *33.i £& (Gmmm-et) *39 100 140 Handbooks General works Health facility planning and construction Classify works on special facilities with the special- *39 i\>V7'y7i 100 U IB 140 wmwrnMSffsm^im £ mm rv-. 147 Equipment and supplies Classify catalogs in W 26. 147 £m& ii9n 9"itW26 izftm-fZ, HOSPITAL ADMINISTRATION m m m 150 General works 150 m ib 153 Utilization review. Quality of service. Medi- cal audit 153 mmmmi. u—truant. m.mm 155 Hospital administration as a career, e.g., Educational requirements. Professional opportunities 155 mm£Lxz Ziz^&o £.£ Lxmni&)%i)T<(7 #™&#i^%f:£Wmw322i: 159.8 Hf*3E# (m%z£m&ffim) 160 mmm (pr). ffii$H0Mft. Kg m& mn<»mm 161 mv%fa%B 162 mmmmnm. ®mttmmmm. m :,um m$t9-7(D&ZZZiZ7ymt2>o ,1 %&mxm<7)~imm&M%ftit W84.7-84.8£j£ffl1"£o M&« (D&mitiMitvi^izjrm-t&o 162.5 mmitm -*-u 165 -m'\fjp7*-\z:>7"=-mmmm. mmmmrn. mmm. mmrnm 167 ^mmm^m£MJ± {i^OEfSWC195 #HB0 168 m&ife'k^ 173 mmtm. &mtmwmm #|g«-fl£WB290 #.BS0 WX HOSPITALS AND OTHER HEALTH FACILITIES wx mm*mi5\ZtiX^^d:^^y--\z7. 203 mmrnm. <>$->. kmv-zlt7 ;u. #n*-7 - 3.7Jl£mmm -«Mv^i7^t^ipmi^ •7-j.r;Kiwxi59 izft&rt&o 205 Hospital outpatient clinics. Ambulatory care facilities Cf. WB 101 for works on general ambulatory care. 205 m&9wmm3n #*>s*jtia —^^'{aW.iZ-D\,^X(D^ftitWBlO\ 207 Clinical and pathological laboratories Classify works on laboratories not connected with hospitals in QY 23-24. 207 mmts&xfmmmmn ffi&izmm L& W£4^(2QY23-24 izfrm-tZo 215 Emergency service. Ambulance service Include here works on ambulance and general emer- gency health services not indexed elsewhere even if they are not connected with hospitals. Classify those connected with occupational medicine in WA 400- 495. 215 &JftE*-9—If*. &Jfe*U—If* tzkx.muizmmtx^^k' ZlZi>m?\2tLX\,*%\<*%r.M&'*r- tf * £-mtmmmmy-- tr * it zziz^tso li^i:fe^v^; ii $kmmw>mitz gmiiwG205; mmm-fcgM^te *£*PiJ$(iWG27-28 o 223 Physical therapy department 223 mmm&mn=mmm&mr\ 225 Occupational therapy department 225 #H0>iSB 231 WY WY NURSING *=* WY 1-100.5 General WV 101-145 Special Fields in Nursing WY 150-164 Nursing Techniques in Special Fields of Medicine WY 191-200 Other Nursing Services WY 300 By Country WY 1-100.5 - m wy 101-145 mmiztsuzmrwE wy 150-164 mmnnrmsiztsiizmm &$& WY 191-200 ;£<7Mti2<7)*II-y--tf* WY 300 SSIJSH GENERAL — flx * 1 Societies (Cutter from name of society) Includes ephemeral membership lists issued serially or separately. Classify substantial lists with directo- ries. Classify annual reports, journals, etc., in WI. * 1 m-m^s (3&-i8£**»&ay*-K mffi&}&z\<*im*iz%ftztiz>% it. x% ■ itmrnizfrmtZo *m. mmitwiizftmt&o Collections (General) 5 By several authors 7 By individual authors mm mm • mm) (-m) 5 mxnmmizkz 7 mx Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-m) 11 History (Table G) 11.1 General coverage (Not Table G) 11 ffi£ (GUteffl) 11.1 ±i* (Gifffltf; * 13 Dictionaries. Encyclopedias *13 &m. W£r*H * 15 Classification. Nomenclature. Terminology ♦is am. ft«&. 7-17Uy- 16 17 Nursing as a profession. Peer review Classify works on specific types of nursing in WY 101-200. Atlases. Pictorial works 16 mnmtLxmmm. \Z7\s\i3.-= MHfttt &%k9 4 7°CO^H(iWY101-200 iZjy 17 7by7=mm 18 Education Classify here works about education. 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify textbooks, regardless of for- mat, by subject. 18 it w zzizixmiizm-tzmfttfrmir Z) o *18.2 &Wtf)g¥H wcnmm^zmthmftitzzizjj mtz0Miix. mm. nm>&. zt u?yU%i%. ii 9 u 9\ CAI^c m*mixfm:izrm% < ±sk x *) •NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. 232 (>i) it y 9 — %m b it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"£>^%£*£> Z b T* 5 „ *&mtwftg. mxnftmzmm-fzzbtwxze WY NURSING WY WY 18.5 Graduate and continuing nursing educa- tion (including fellowships, internships, resi dencies, etc.) 18.5 xmmmm&vmmmmmmm (7 xn — yy/, -4y7 — y. i/yV 18.8 Practical nursing education is.s mmmmmm * 19 Schools of nursing Classify courses of study, catalogs, etc., in W 19.5. Include here works on the history of nursing schools. 20 Organization and administration of nursing schools *19 mmm® • mmm^ • mft m.mm. m%mtw\9.5 iz^mt ^mmtiwm&it z z ^&0 20 mmrnvKommtmrn 20.5 Research (General) Classify here works about research in general. Clas- sify works about research on a particular subject by subject. 20.5 mvi (-m) l^fei:|t^if^« zz\zfr mizx ^ftm-t&o * 21 Licensure. Certification. Registration (Table G) * 21.1 General coverage (Not Table G) *2i &i*. see. mm (Gmi&m) *21.1 £i* (GStteffl-tf-f) * 22 Directories (Table G) * 22.1 General coverage (Not Table G) *22 x%>i±mu (Gmmm) *22.i £& (Gmmmvt) 26.5 Medical informatics. Automatic data pro- cessing. Computers (General) Classify works on use for special subjects by subject. 29 Employment. Placement agencies 30 Personnel management. Collective bargain- ing 26.5 mmm wm. nm?-7$km. =i> \i3.-7 (-m) X *)5H!1-&o 29 mm. KH*s:ftm 30 xmmm. mi*%& 31 Statistics. Surveys 31 Iftlt. IPS *32 *32.1 Laws (Table G) General coverage (Not Table G) *32 MM (GUfeffl) *32.1 £ft (Gliffl^f) *33 *33.1 Discussion of law. Jurisprudence (Table G) General coverage (Not Table G) *33 >mbmm. mmK mmm 100.5 Nursing records. Nursing audit 100.5 MIBH. M£2 SPECIAL FIELDS IN NURSING HKfcttSHTOri? 101 General works. Primary nursing care e.g., Special nursing as a career; types of specialized fields in nursing Cf. WY 150 General works on nursing techniques in special fields of medicine. 101 mi. -tt-mmtt m : mm£ i-xcjwrmm; mmiz &ijZ>M?*\77%f(D9 J70 ft7E<7)M¥77%rX(Dm%iy:'4iizmt S—$ft£^f1;|iWY150#BBo 105 Administrative work. Supervisory nursing. Teaching 105 >7 mmrnm. #s=x<-? 106 Community health nursing Classify works on a particular kind of community nursing with the more specific type, e.g., Public health nursing WY 108. 106 tmw&mm J7°izftmtZ>. fll;itf&*ffi£* IIWY108 0 107 Transcultural nursing 107 mxummm 108 Public health nursing e.g., Federal, state, etc. Cf. WY 130 Governmental nursing services. 108 &&8i£M 3*5 M<0%Wty— tf *WY130 #B?,0 109 Office nursing 109 mxmmmmm=*71 zmrn 113 School nursing 113 mmm 234 WY NURSING WY m m WY 115 Home care services (including visiting nurs- ing and visiting nurse associations, and respite care) 115 mmmmv-v* mmrnm turn* ;^f ltu^mv V77) 125 Institutional nursing. Team nursing e.g.. In hospitals, sanatoriums, etc. Cf. WY 105 Administrative work. 125 mmrnm. i—u-x-yy? m : m&. y-i- h 'J 7A%?0 ir: $WY105 #Mo 127 Private nursing 127 ttS&nM 128 Nurse practitioners. Nurse clinicians 130 Governmental nursing services e.g.. Armed Forces. Veterans Administration. Indi- an Health Service, etc. Cf. WY 108 Public health nursing; UH 490-495 Army nursing. 128 t-7-777rr>3t nmmm 130 &mo m*. tf^l£!§<7)7t#>-O$rL#(iWOl00 iz, MmWto 150 m ib 151 Nurse anesthetists 151 mmmnmmm 152 Geriatric and chronic disease nursing. Life support care. Long term care. Terminal care 152 %A*B£11tt£MB. ±^mm >±. &m%m. *mmm 152.5 Cardiovascular nursing. Hemic and lymphat- ic disease nursing 152.5 'bmnummmmm. dus* • v >/*&m mmm 153 Communicable disease nursing 153 fcmmmm 235 WY NURSING WY mmm WY 153.5 AIDS/HIV nursing 153.5 AIDS/HIV^S 154 Emergency nursing. Critical care. Intensive care. Recovery room care. Postanesthesia nursing 154 m&mm. &&%:&mm. m+%\ w®w.77. wmmmm 154.5 Dermatological nursing 154.5 fcmptmm 155 Endocrine disease nursing 155 p&mmmmm 156 Oncologic nursing 156 tpxmm 156.5 Gastroenterologic nursing 156.5 mitnnmm 156.7 Gynecological nursing 156.7 mxm 157 Obstetrical nursing 157 mmrnm 157.3 Maternity nursing. Maternal-child nursing. Neonatal nursing. Perinatal nursing Classify here works on care of the mother and child shortly before and after the child is born. 157.3 mzmm. m=Fmm. m±nmm. mmmmm ^mmkon^y-rizmthmftit zzizfrm-tho 157.6 Nursing of diseases of the musculoskeletal system. Orthopedic nursing 157.6 m • mteJkmmnmm. mmnmm 158 Ophthalmic nursing 158 mmrnm 158.5 Otolaryngological nursing 158.5 Mmmmmmm 159 Pediatric nursing. Adolescent nursing Classify works on pediatric and adolescent nursing in special fields by type, e.g., on pediatric surgical nursing in WY 161. 159 /wjem. n*mm 7°izx^77mt^>. MiiX'bym® HICiWY161 0 160 Psychiatric nursing Include works on psychiatric aides and ward atten- dants here. Classify works on supervision of ward attendance in WM 35. 160 mnnmm mmmn®^ £ mnm&t zziz §tso mn&)^(7)i§mitwM35iz7y mtho 160.5 Neurological nursing 160.5 WiSf4*ai 161 Surgical nursing 161 9mmm 162 Operating room techniques 163 Nursing of diseases of the respiratory system 162 ¥«»a 163 n*««^£S0)*B 236 WY NURSING WY mmm WY 164 Urologic nursing 164 mmmmmm OTHER NURSING SERVICES *<&ft<&MhJ--tf;* 191 Male nurses 191 mm* 193 Nurses' aides, ward attendants and orderlies Classify ward attendants for psychiatric institutions in WY 160. 193 mmm*. mmm¥-£mtkmm&j* ■mmmm(Dmn&)^itwYi6o iz& m-tZo 195 Practical nursing 195 mmrnm 200 Home nursing 200 mmrnm BY COUNTRY mmrnm 300 Nursing by country (Table G) 300 mmrnm (Gm&m) 237 wz wz HISTORY OF MEDICINE *=£ sfe Classify history of a particular subject with the subject e.g., History of surgery WO 11. yWp^woiio WZ 1-40 General WZ 51-80.5 History, By Period, Locality, etc. WZ 100-150 Biography WZ 220-225 Manuscripts WZ 230-260 Early Printed Books WZ 270 Americana WZ 290-294 Modern Editions and Crititism of Early Works WZ 305-350 Miscellany Relating to Medicine WZ 1 -40 WZ 51-80.5 WZ 100-150 WZ 220-225 WZ 230-260 WZ 270 WZ 290-294 WZ 305-350 7*VtXM mmft^im*izmiztiz>ig %.m%£m%m*$tT0 mm%m a. a% • ftrnmizfrmtZo m mtmitwuzmit&o mm mm • mm) (-m) ®LX rnxowmiz^z Addresses. Essays. Lectures (General) 9 mm. mm. mmm (-«) [11] [This number not used] [11] iz.mmtmm\s*^] * 13 Dictionaries. Encyclopedias *13 3$*. W£r»l 17 Atlases. Pictorial works 17 7hy7=mm 18 Education Classify here works about education. 18 K f zzizitmizmtzmftZftrntZo 18.2 Educational materials Classify here educational materials, e.g., outlines, questions and answers, programmed instruction, catalogs, computer-assisted instruction, etc., regard- less of format. Classify- textbooks, ragardless of fomtat, by subject, *18.2 ftfftilXft m^mmA\zmthmftitzziz% %-tho mux. mm. sm&&, 7° u 9*y 2*%i%. iJ 9 u 9\ CAI^c %f.®mi±r*$:izm%% < mi: x n 77-mi-&o * 22 Directories (Table G) •NLMBER CAN BE LSED FOR BOTH MONOGRAPHS AND SERIALS. 238 *22 A£ -amm (Gmi&m) (>i) ij -j 9 -1£^- b it "C. A. Cutter's Cutter - Sanborn Three - Figure Author Table"?)??^££gcO ZkX'&Z, wz HISTORY OF MEDICINE WZ w m & wz * 22.1 General coverage (Not Table G) *22.i £& (GmmmvT) 23 Institutes (Cutter from name of institute) 23 mum (ffi&m£#6#y2-ia^£ Museums 27 Collective 28 Individual (Cutter from name of museum) 30 Chronologies 27 m^o (Gjiis&ffi) £4-;L5) 30 *ftm (*ftlB) * 39 Handbooks *39 I\yb7'y7\ 40 General works 40 ffi 15 HISTORY, BY PERIOD, LOCALITY, ETC. m&. *ft»k **saw Ejccepr /« WZ 51 (which see) prefer classification by locality if oTf£ & 0 ji LWZ51 applicable. (TtttR.X) %B<0 51 Ancient (to 476 A.D.) Include works on countries of the western world. Classify those on history of medicine in other coun- tries by locality in WZ 70. 51 "STft (A.D.476^&) it * IS^£(ii&itSiJ izwzioizfrmt %> o 54 Medieval (to 1453 A.D.) 54 +1* (A.D.1453^iE) 55 Modern (1454 A.D.- ) 55 aftlfi: (A.D.1454^-) 56 Early modern (to 1800 A.D.) 56 &MJ8B (A.D.1800^j^) 59 Late modern (1801 A.D.- ) 59 jfit&ftffi (A.D.1801^-) 60 19th century 60 191£*2 64 20th century 64 20t«:$5 70 History (By locality) (Table G) 70 ££ (*6*8iJ) (GUteffl: 80 History (Special groups, general or not else- where classified) 80 M& (¥ffc7"J\'-7°. -mRlt£Zi: ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * S^ffi^ff*. 3£*fiJfi:ftl=ffirai-«3i:j6*ffl*5, 239 wz HISTORY OF MEDICINE WZ e m * wz 80.5 Specific groups, A-Z 80.5 #£ma, a-z A8 Arabic and Islamic groups B5 Blacks H6 Hindu ,13 Indians, North American J3 Jews .06 Asian ,W5 Women BIOGRAPHY .A8 7y7£<7yUm .B5 m X .H6 t>X- .13 «<>f<7> J 3 J-7'^X .06 7y7X .W5 ■k t£ m 100 Individual biography (Cutter from name of biographee) Classify here biographies and bibliographies of per- sons in the medical field, the preclinical sciences and other related field. Cf. WZ 294 Modern criti- cism and bibliographies of early works. Include here works about two persons or a family, e.g., the Mayos. 100 mxomm (m^m^t>^tiy7-ii zzizitm^. &^&¥. t(7)m(D M&frmiz&iizxyoomzkmm tftmt&o ®mmftm£mmtt77mtz>0 z)<7)M&&)miit, LC5t^ * 112.5 By specialty , A-Z * 112.5 UTOk A-Z Classify biography of individuals in WZ 100 mxoimimriizrm* < regardless of specialty. WZ100 iZjrm-tho .C2 Cardiologists .C2 'bmmmnm .D3 Dentists .D3 mmm .15 Immunologists .15 &mmm .M4 Military physicians and sur- .M4 w E geons .N4 n&mm. *«*&£* .N4 Neurologists, neurosurgeons, ,N8 mmm etc. .05 mmrnm .N8 Nurses .07 mmm. &m±m .05 Oncologists .08 ^mmmnm .07 Ophthalmologists, optometrists, .P2 mmrnm etc. .P4 nmm .08 Otolaryngologists .P5 $.mmm .P2 Pathologists .P6 tmwm .P4 Pharmacists .S8 nmm .P5 Physiologists ±f£WZ112.5.M4#BB0 .P6 Psychiatrists .S8 Surgeons Cf. WZ 112.5.M4 above. 'NLMBER CAN BE LSED FOR BOTH MONOGRAPHS AND SERIALS. * S^±¥ff», 3S*filfi:1*i:ttffl1-*lfc*ltti**« 240 wz HISTORY OF MEDICINE WZ s m * WZ Collective biography (By period) Prefer specialty numbers above or if not applicable locality number below. * 121 Ancient (to 476 A.D.) * 124 Medieval (to 1453 A.D.- ) * 126 Early modern (to 1800 A.D.) * 129 Late modern (1801 A.D.- ) * 132 19th century * 134 20th century **W15E (B#ft»J) ±.m<7)Mrw^tfM$i^^tf, mm *121 *ft (A.D.476^&) *124 tptt (A.D.1453^&) *126 ft«J$ (A.D.1800^&) *129 i&W&m (A.D.1801-) *132 i9i&ife *134 2ot&iie * 140 Collective biography (By locality) (Table G) *140 *«&wi£ia (**sij) (Gmmm) * 150 Collective biography (Special groups) e.g., Women *150 maxim?, mizmm) m : -kfe MANUSCRIPTS * 220 Early Western manuscripts Note that at NLM western manuscripts produced before 1601 are classified in WZ 220, those pro- duced after 1601 are classified as MS B (Manuscripts Books), MS C (Manuscripts Collec- tions), or MS F (Manuscripts Oversize books). 220 tnmmftw* NLM T*{il601^jy.Hlf^)¥^liWZ220 iZfrmZtl&o 160l3^?£<7)& (Dit MSB, MSC, MSF klZfrMZtl&o 225 Other early manuscripts 225 mmmowmw* EARLY PRINTED BOOKS m m en m * Works published before 1801 (or later if considered Americana) are not classed by subject; instead, they are arranged alphabetically by author under classification number for period during which they were printed. 230 Incunabula pre-1501 I80l^fii (Xit7 f)Jiyzffik%z.htiZ>% hztiim) \z&WLZtitzmmi±. ±ssuk# mt%^'; **)Ztii!)*#im2titz%.i$ + 2j ? 7 =«0«8f IJ* 1501^J^lu 240 XVI century 240 161**2 250 XVII century 250 171&IS 260 XVIII century 260 181SIS ♦NUMBER CAN BE USED FOR BOTH MONOGRAPHS AND SERIALS. * g^awtfrn. m&nny>nztfimt%zbfim*5< 241 wz HISTORY OF MEDICINE WZ e m se wz For 19th century publications see separate schedule below. ^mttl}iWM}W. 1890^ T'yy^iftL 1890^ 7-t)>7-ft\. 1870*F jjlJ7*Jl-7M. 1875^ 3P7KW, 1876^ H*x-r*y bflk 18203F y'y7x7m. 1820^ District of Columbia, 1820 3P>fc:7M5SiJE% 1820^ Florida, 1860 Georgia, 1820 Hawaii, 1860 Idaho, 1890 Illinois (except Chicago), 1850 Chicago, 1871 7Py#ftU 1860^ yB-y7M. 1820^ /\7-rftU 18603F 7M#*tfk 1890^ -ry^-rw (y*^n<), isbo* ytizH, 1871^ Indiana, 1850 <>T<7m 1850^ 242 wz HISTORY OF MEDICINE WZ m m * wz Iowa, 1860 Kansas, 1875 Kentucky, 1830 Louisiana, 1820 Maine, 1820 Maryland, 1820 Massachusetts, 1820 Michigan, 1850 Minnesota, 1865 7< *7WU 1860^ ■t)>-v7M. 1875^ >Ty7y*-%. 1830^ lKy7tHis 1830^ *-f* >!ftL 1820^ ^ y-7>KW. 1820^ Titf-iL--b:'y,yW. 1820^ v#>flU 1850^ $*V*WU 1865^ Mississippi, 1840 Missouri, 1850 Montana, 1890 Nebraska, 1875 Nevada, 1890 New Hampshire, 1820 New Jersey, 1820 New Mexico, 1875 New York (except N.Y. City, Brooklyn, and Hudson River towns), 1850 New York City, 1820 Brooklyn, 1825 $vv-ye-W. 1840^ Xy-iftk 1850^ ^y7X%. 1890^ *77**WU 1875^ */<#WU 1890^ /\>7v + -flL 1820^ - 3.- • y^-y-m. 1820^ -3.- • >*'>affl% 1875^ 7;u«y ? y >, /\ Kv>j5rffoiirj £&. 1825^ 243 wz HISTORY OF MEDICINE WZ m m * wz Hudson River towns, e.g., Poughkeep- sie, Hudson, Troy, Albany, 1830 North Carolina, 1820 North Dakota, 1890 Ohio, 1840 Oklahoma, 1870 Oregon, 1875 Pennsylvania (except Philadelphia), 1830 Philadelphia, 1820 Rhode Island, 1820 South Carolina, 1820 South Dakota, 1890 Tennessee, 1840 Texas, 1860 Utah, 1890 Vermont, 1820 Virginia, 1820 Washington, 1875 West Virginia, 1830 Wisconsin, 1850 Wyoming, 1890 *--7°y-. i\b7>. hP<, T-J^-~. 1830$ 7-7. • * + P7flU 1875$ sOyJ\,/t-7W (7<77ib7 <7*B!<), 1830$ 7<7f7l'7-f7, 1820$ P-K • TM 7>KWk 1820$ ■V77 • ^P^-fT^tU 1820$ V77 ' #=l$Wx 1890$ 7-*y-W. 1840$ x^-tr^iJtL 1860$ ■l^il+L 1890$ J^-=E> h!NH. 1820$ /N'-V-T'iNi, 1820$ 7v>h>flk 1875$ ^i^h •/<-v^77flU 1830$ •5-T 7.^yyy$\. 1850$ 7-r*$>7flU 1890$ 244 wz HISTORY OF MEDICINE WZ m * wz MODERN EDITIONS AND CRITICISM OF EARLY WORKS wwmitomxm £ mmm* 290 Modern editions of early works 290 Classify here 1801- editions of works originally pub- lished before 1801, except for Americana (Cf. WZ 270). Classify by subject editions of Americana pub- lished after the closing date for the particular area, e.g., an 1825 edition of a work with a New York City imprint, originally published before 1820. mmmftomftm im^vmizmmz&KjiZtitzisoi $-/K«i, TtVillcm (WZ270 # SB) £&v*T, ZZiZjrm-f&o # fct&mzttirZ%&*E£i>£ 1820$ JM iZ Wft Ztltz-si--3- 9 TfJ 1S0\ tEvmomittstrmm (Mxwn ®*%ts) HZZiZftmi-Zo 2 % f#gljHWZ290 izfrm ■fho '■it\ mmmitowMWft £ m-mftomm i.k lti xxit2 h^m^^mzx %%mm Mftitzzizftm-tZo ftftftfem &A^liWB890-962 iZftmt&o 313 Biographical clinics (Diagnosis of diseases of famous persons, derived from records, mem- oirs, letters, portraits, etc.) 313 Btw&mmm mm. mmm. «t nmmp*>mm\sizmzxc 245 WZ HISTORY OF MEDICINE WZ m. m £ wz 320 Body snatching. Resurrectionists 320 wwv&m. ww%mm 330 Medicine etc., as depicted in art and litera- ture (critical studies) e.g., Medicine in the works of Rabelais Cf. WM 49 Art and literature as related to psychia- try. 330 mm£-$nmiz&wzfttzs$>£^x (~m) 350 Literary and artistic works by physicians and other association items Cf. WZ 330 Medicine in art and literature. 350 ESfiico qs mmm QS22 a£ • i±mm (G qsa mmm QSB §t±m qt ±mm QT22 xz-&.mm (Gmmm) qta m^m qu ±itm QU22 a£ -amm (Gmmm) ov mmm. mmm. mwm QV22 xz-itmm (Gmmm) qva mmii (&£) qvb mmm (*nm) qw m±mm QW22 A£ • ftmn (g mi&m: QWA &*£3& QX ??££¥ QX22 A£ • ferfiii (G QY BgJfcJgfS^ 247 [QY 22] [Directories. Use QZ 22] [QY22] [A*-ttm». QZHZfey) QZ Pathology qz mmm QZ 22 Directories (Table G) QZ22 A£"f±mt§ (GUfcffl) QZA Neoplasms QZA W Medicine (General) w mm (-m) Wl Serials. Periodicals W1 S^fUrfft. JtafOrffc W2 Documents W2 3t * W3 Congresses NLM no longer assigns W3 to newly acquired publi- cations. W3 £» (i§) NLM -Cli$Jffc£ffiJ»£W3 izitm^^xxit^^^o W4 Dissertations W4 mitm* W4A American dissertations W4A xmnrntiLmx. W5 Collections by several authors W5 $kX7\yy h W 22 Directories (Table G) W22 A£ "f±m§§ (GUftffl) W 600 Medical jurisprudence w6oo &mm WA Public health WA ®%ft± WA 22 Directories (Table G) WA22 X%'iSim& (GUteffl) WAA Sanitation and sanitary control waa mmm±tm±Mm WB Practice of medicine wb mmrnm WB 22 Directories (Table G) WB22 A*-ttJ»f« (Gm&m) WBA Popular medicine wba &®mm WBB Diagnosis WBB m 248 19TH CENTURY SCHEDULE 19 m *e # m m WBC Therapeutics (General) WBD WBE WBF WBG WBH WBI WBJ WBK WBL Dietetics Electric stimulation therapy Hydrotherapy Massage Climatology. Geography of disease Health resorts Special systems (General) Homeopathy Osteopathic medicine WC Communicable diseases (General) WC 22 Directories (Table G) WCA Sexually transmitted diseases WCB Cholera WCC Diphtheria WCD Influenza WCE Leprosy WCF Malaria WCG Plague WCH Smallpox WCI Typhoid fever WBC £&>£ (-m) wbd -kmmfem wbe W%M%im:,ik WBF *>&&& WBG 7 7t-y wbh n&mm. mm^mmm WBI ft^iti wbj &ft%%m:&x% (-m) WBK ***/\°v- wbl m^mm wc &&fc=fc'&m (-m) WC22 A£ • i±mm (g mfem) WCA tiff&^JE WCB 3 1/7 WCC y7j'J7 WCD <>7;ux>+f wce m=mm=y7*y WCF 77'J7 WCG ^7 h WCH *M=^IS&6 WCI 77 249 19TH CENTURY SCHEDULE 19is *b ft m m WCJ Typhus fever WCJ ^^^-7 7 WCK Yellow fever WCK * m WDA Deficiency diseases. Metabolic diseases (includ- ing obesity and disorders of acid-base balance) wda xzm. ftwmm (^mm£ WDB Hypersensitivity wdb 77u;u=¥'-=i WDC Animal poisons. Plant poisons wdc Sbtom. teVti WDD Diseases due to physical agents wdd ^?itfjfE@ tc J; 3 mm WE Musculoskeletal system we m • #te£ WE 22 Directories (Table G) WE22 a£ • amu (g WEA Fractures. Dislocations. Sprains wea mm. ma. &m WF Respiratory system WF TOS£ WF 22 Directories (Table G) WF22 a£ • itmm (g mmm) WFA Tuberculosis WFA IS & WG Cardiovascular system WG 'bMilnm% WG 22 Directories (Table G) WG22 XZx ' i±mU (G WH Hemic and lymphatic systems WH Iflljft. 'J>/\°^ WH 22 Directories (Table G) WH22 a£ • &mm (g mmm) WI Digestive system wi mtm% WI 22 Directories (Table G) W122 a£ M±mi§ (Gmmm: WIA Stomach WIA W IB Anus and rectum WTC Liver WIB JDmSfli WIC IF Hi 250 19TH CENTURY SCHEDULE 19 is *b ft m m WJ Urogenital system WJ 22 Directories (Table G) wj mm£.m&% WJ22 A£"f±mn (Gmmm) WJA Male genitalia wja mvk*km& WK Endocrine system WK F*37>$£ WK 22 Directories (Table G) WK22 a*-ttm» (Gmmm) WKA Diabetes WKA $§J§<^ WL Nervous system wl n&% WL 22 Directories (Table G) WL22 A£ • amm (g WLA Epilepsies WM Psychiatry WLA TA#A wm mnmm WM 22 Directories (Table G) WM22 a£ • i±mm (g mmm: WMA Substance dependence WN Radiology WN 22 Directories (Table G) WMA ^fftfc# wn tmrnm WN22 a£ • &mm (g mmm) WO Surgery WO 22 Directories (Table G) WOA Anesthesia wo 9mm W022 A£ • &mn (g mmm) WOA mw& WP Gynecology WP 22 Directories (Table G) wp mxnm WP22 a£ • i±mm (g mmm) WPA Breast WQ Obstetrics WPA ?L M WQ /t£r^ 251 19TH CENTURY SCHEDULE WQ 22 Directories (Table G) WR Dermatology WR 22 Directories (Table G) WS Pediatrics WS 22 Directories (Table G) WT Geriatrics. Chronic disease WT 22 Directories (Table G) WU Dentistry. Oral surgery WU 22 Directories (Table G) WV Otolaryngology. Nose WV 22 Directories (Table G) WVA Ear WVB Throat. Larynx WW Ophthalmology WW 22 Directories (Table G) WX Hospitals WX 2 Serial reports of hospitals (Table G) WX 22 Directories (Table G) WY Nursing WY 22 Directories (Table G) History of medicine Use schedule in full, as for twentieth century. 19 tt *e ft m m WQ22 a* • \±mn (g mmm) wr fenmm WR22 a* • &mm (g mmm) ws >b!mm WS22 a* • i±mm (g mmm) wt ttmm. turns WT22 A£ '&mn (Gmmm) wu mwm. nmmm WU22 A£-i±mn {Gmmm) wv -%mmmwm. m WV22 a£ • i±mu (g mmm) WVA m wvb mm. m$M ww mnm wwn a£ • i±mm (g mmm) wx m & wx2 mmomwtxm&m (Gmmm) WX22 a^-&mm (Gmmm) wy mm WY22 a* • i±mm (g mmm) mm* 2otJHe iz o v> x it ^ftmm^u * it m-tho A Fibers see Nerve Fibers, Myelinated Abate Agriculture SB 952.P5 Public health WA 240 Abattoirs WA 707 Abbreviations Chemistry QD 7 General P 365-365.5 Library symbols (U.S.) Z 881 Medical W 13 By specialties (Form number 13 in any NLM schedule where applicable) Organizations (General) AS 8 Periodical titles Z 6945.A2 Science (General) Q 179 Particular languages, by language in appropriate LC schedule Abdomen WI 900-970 Surgery WI 900-970 Abdomen, Acute WI 900 In infancy & childhood WI 900 Abdominal Cramps see Colic Abdominal Injuries WI 900 Abdominal Muscles WI 900 Abdominal Neoplasms WI 970 Abdominal Pain WI 147 Abdominal Wall see Abdominal Muscles Abducens Nerve WL 330 Abiogenesis see Biogenesis Abnormal Reflex see Reflex, Abnormal Abnormalities Congenital QS 675-681 Autosome see Autosome Abnormalities QS 677 Bone WE 250 Brain WL 350 Cardiovascular WG 220 Chromosome see Chromosome Abnormalities QS 677 Embryological QS 675-681 Etiology QS 675 Foot WE 883 Gynecological General WP 150 Pelvic WQ 320 Heart see Heart Defects, Congenital WG 220 Intestines WI 412 Jaw see Jaw Abnormalities WU 101.5 Medical curiosities WZ 308 Mouth see Mouth Abnormalities WU 101.5 Nervous system WL 101 Otolaryngology WV 101 Respiratory system WF 101 Sex chromosome see Sex Chromosome Abnormalities QS 677 Tooth see Tooth Abnormalities WU 101.5 Urogenital system WJ 101 Vertebrae WE 730-735 Veterinary SF 769 Developmental QZ 45 See also names of other organs affected or of specific abnormalities Abnormalities, Drug-Induced QS 679 Abnormalities, Multiple QS 675 Abnormalities, Radiation-Induced QS 681 Abomasum QL 862 Aborigines Indians E 51-99 Eskimos E 99.E7 Special topics, by subject See also Australoid Race GN 662-671 Abortifacient Agents QV 175 Abortifacient Agents, Non-Steroidal QV 175 Abortifacient Agents, Steroidal QV 175 Abortion WQ 225 Drugs provoking see Abortifacient Agents QV 175 Medicolegal aspects W 867 Religious and social aspects HQ 767-767.52 Abortion, Criminal W 867 Abortion, Habitual WQ 225 Abortion, Illegal see Abortion, Criminal Abortion, Incomplete WQ 225 Abortion, Induced Religious and social aspects HQ 767-767.52 Technique WQ 440 Abortion, Legal WQ 440 See also Family Planning HQ 763.5-767.7 Abortion, Missed WQ 225 Abortion on Demand see Abortion, Legal Abortion, Septic WQ 256 Veterinary SF 887 Abortion, Spontaneous see Abortion Abortion, Therapeutic WQ 440 Abortion, Threatened WQ 225 Abortion, Veterinary SF 887 Abrasions see Dermabrasion; Tooth Abrasion; Wounds and Injuries Abreaction WM 420.5.A2 Abruptio Placentae WQ 212 Abscess WC 195 Bone WE 251 Cerebral see Brain Abscess WL 351 General (requiring surgery) WO 140 Liver see Liver Abscess WI 730 Lung see Lung Abscess WF 651 Pelvic WP 155 Periapical see Periapical Abscess WU 230 Puerperal WQ 505 Subphrenic see Subphrenic Abscess WI 575 Surgery WO 140 Other localities, by site Abscess, Amebic, Hepatic see Liver Abscess, Amebic Abscess, Cerebral see Brain Abscess Abscess, Hepatic see Liver Abscess Abscess, Hepatic, Amebic see Liver Abscess, Amebic Abscess, Liver, Amebic see Liver Abscess, Amebic Abscess, Periapical see Periapical Abscess Abscess, Pulmonary see Lung Abscess Abscess, Subphrenic see Subphrenic Abscess Absence Seizures see Epilepsy, Absence ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 253 Absenteeism Absenteeism Workplace HD 5115-5115.2 School WA 350 Absorption Immunochemistry QW 504.5 Intestinal see Intestinal Absorption WI 402 Of drugs QV 38 Of foods WI 102 Of gases QC 162 Skin see Skin Absorption WR 102 Of other substances, with the substance Absorption, Intestinal see Intestinal Absorption Absorption, Skin see Skin Absorption Abstinence Syndrome, Neonatal see Neonatal Abstinence Syndrome Abstracting and Indexing Z 695.9-695.92 Abstracts Of subjects represented in NLM fc classification, appropriate classification number preceded by the letter Z Of other subjects, LC's Z schedule Abuse of Health Services see Health Services Misuse Academies and Institutes AS (Form numbers 23-24 in any NLM schedule where applicable) For other particular purposes, by subject Acanthocephala QX 200 Acantholysis Bullosa see Epidermolysis Bullosa Acanthosis Nigricans WR 265 Acari QX 473 Acariasis see Mite Infestations Acarina see Acari Acarus see Mites Acceleration WD 720 Accelography see Kinetocardiography Acceptability of Health Care see Patient Acceptance of Health Care Access to Health Care see Health Services Accessibility Accessibility of Health Services see Health Services Accessibility Accessory Cells, Immunologic see Antigen-Presenting Cells Accessory Nerve WL 330 Accident Insurance see Insurance, Accident Accident Prevention WA 250-288 In hospitals WX 185 In workplace see Accidents, Occupational WA 485-491 Radiation injuries WN 650 See also specific types of accidents, e.g., Prevention & control under Accidents, Traffic WA 275; Protective devices WA 260, etc. Accident Services see Ambulances; Emergency Health Services; Insurance, Accident; Occupational Health Services Accidental Falls In the home WA 288 Accidents First aid WA 292 In anesthesia WO 245 Medicolegal aspects Cause of death W 843 Disability evaluation W 900-925 See also Insurance, Accident W 100-250, etc. Accidents, Aviation WD 740 See also special topics under Accidents Accidents, Home WA 288 See also special topics under Accidents Accidents, Industrial see Accidents, Occupational Accidents, Occupational WA 485-491, etc. Of the eye WW 505-525 See also special topics under Accidents Accidents, Traffic WA 275 Prevention & control WA 275 See also special topics under Accidents Acclimatization QT 145 Cold climate QT 160 Hot climate QT 150 See also Desert climate QT 150, etc.; Tropical climate QT 150, etc. Accommodation, Ocular WW 109 Accounting Dental administration WU 77 Hospital administration WX 157 Medical administration W 80 Nursing administration WY 77 Pharmacy administration QV 736 In other specific fields, by subject Accounts Payable and Receivable see Accounting A Accreditation Dentists WU 40 Hospitals WX 15 Special (Form numbers 27-28 in any NLM schedule where applicable) Physicians W 40 Schools (Form numbers 18 or other appropriate education number in any NLM schedule where applicable) Other institutes, etc. (Form numbers 23-24 in any NLM schedule where applicable) Other professionals (Form number 21 in any NLM schedule where applicable) Acculturation GN 366-367 Of particular customs, by subject Of particular peoples, by race or country ACE Inhibitors see Angiotensin-Converting Enzyme Inhibitors Acephen see Meclofenoxate Acetabularia QK 569.D33 Acetabulum WE 750 Acetaldehyde QU 99 In alcohol metabolism QV 84 Organic chemistry QD 305.A6 Special topics, by subject, e.g., in experiments on muscle contraction WE 500 Acetanilides QV 95 Acetarsone see Arsenic Acetates QU 90 Organic chemistry QD 305.A2 Acetic Acids QU 90 Organic chemistry QD 305.A2 Acetoacetates QU 90 Organic chemistry QD 305.A2 Acetobacter QW 131 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 254 Acetonchloroform see Chlorobutanol Acetone In urine QY 185 Organic chemistry QD 305.K2 Acetone Bodies see Ketone Bodies Acetophenetidin see Phenacetin Acetyl Carnitine see Acetylcarnitine Acetyl Glyceryl Ether Phosphorylcholine see Platelet Activating Factor Acetylbenzoylaconine see Aconitine Acetylcarnitine QU 187 Acetylcholine QV 122 Acetylcholine Antagonists see Cholinergic Antagonists Acetylcholine Receptors see Receptors, Cholinergic Acetylcholinesterase QU 136 Acetylcholinesterase Inhibitors see Cholinesterase Inhibitors Acetylene Organic chemistry QD 305.H8 Plant and soil microbiology QW 60 Toxicology QV 633 Acetylformaldehyde see Pyruvaldehyde Acetylmuramyl-Alanyl-Isoglutamine QW 800 Biochemistry QU 68 Acetylsalicylic Acid see Aspirin Achalasia, Esophageal see Esophageal Achalasia Achievement BF 637.S8 In infancy & childhood Measurement WS 105.5.E8 Motivation WS 105.5.M5 Motivation BF 501-505 Personality development BF 698.9.A3 Success BJ 1611-1618 See also Educational Measurement LB 3050-3060.87 Achilles Tendon WE 880 Achlorhydria WI 308 Achondroplasia WE 250 Achromobacter see Alcaligenes Achromobacteriaceae see Gram-Negative Aerobic Bacteria Achylia Gastrica see Achlorhydria Acid Aspiration Syndrome see Pneumonia, Aspiration Acid-Base Equilibrium QU 105 Acid-Base Imbalance WD 220 Acid Etching, Dental WU 190 Acid Phosphatase QU 136 Acid Seromucoid see Orosomucoid Acidosis WD 222 Veterinary SF 910.W38 Acidosis, Diabetic see Diabetic Ketoacidosis Acidosis, Renal Tubular WJ 301 Acidosis, Respiratory WF 140 Acids Inorganic chemistry QD 167 Organic chemistry Aliphatic compounds QD 305.A2 Aromatic compounds QD 341.A2 Toxicology Inorganic QV 612 Organic QV 632 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Acromioclavicular Joint See also names of specific acids Aciphenochinolium see Cinchophen Aclacinomycin A see Aclarubicin Aclarubicin QV 269 Acne see Acne Vulgaris Acne Rosacea WR 430 Acne Vulgaris WR 430 Acneform lesions see Acne Acomys see Muridae Aconite Toxicology QV 628 Aconitine Toxicology QV 628 Acostals Disease see Altitude Sickness Acoustic Evoked Brain Stem Potentials see Evoked Potentials, Auditory, Brain Stem Acoustic Impedance Tests WV 272 Acoustic Nerve WL 330 Physiology of hearing WV 272 See also Cochlear Nerve WL 330; Vestibular Nerve WL 330 Acoustic Nerve Diseases WL 330 See also Neuroma, Acoustic WV 250 Acoustic Neuroma see Neuroma, Acoustic Acoustic Sense see Hearing Acoustic Trauma see Hearing Loss, Noise-Induced Acoustics Noise abatement General WA 776 Housing WA 795 Industrial WA 470 Public buildings WA 799 Physics QC 221-246 Sound recording industry TS 2301.S6 See also Hearing WV 270-280 Noise WA 776, etc. Acoustics, Speech see Speech Acoustics Acquired Immunity see Immunity Acquired Immunodeficiency Syndrome WC 503-503.7 General works WC 503 Complications WC 503.5 Diagnosis WC 503.1 Epidemiology WC 503.4 Etiology. Transmission WC 503.3 Nursing WY 153.5 Prevention & control WC 503.6 Psychosocial aspects WC 503.7 Therapy WC 503.2 Acridines Dyes As a disinfectant QV 235 As a stain, etc. QV 240 In amino acid biochemistry QU 65 Organic chemistry QD 401 Acrocephalosyndactylia WE 250 Acrocephaly see Craniosynostoses Acrodermatitis WR 218 Acrolein Toxicology QV 627 Acromegaly WK 550 Acromelalgia see Erythromelalgia Acromioclavicular Joint WE 810 !E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 255 Acronine Acronine QV 269 Acronycine see Acronine Acronyms Medical W 13 By specialties (Form number 13 in any NLM schedule where applicable) Acrosin QU 136 Acrosomal proteinase see Acrosin Acrylamides QU 62 Organic chemistry QD 305.A7 Acrvlstcs Chemical technology TP 1180.A35 In dentistry WU 90 In orthopedics WE 190 Pharmacology QV 50 Used in particular procedure, with the procedure Acrylic Resins Chemical technology TP 1180.A35 In dentistry WU 190 Pharmacology QV 50 Used for special purposes, by subject, e.g., in orthopedic surgery WE 190 See also Bone Cements WE 190 ACTH see Corticotropin ACTH-Releasing Factor see Corticotropin-Releasing Hormone Actihaemyl QV 370 Actin-Binding Proteins see Microfilament Proteins Acting Out WM 193.5.A2 In Adolescence WS 463 In infancy & childhood WS 350.8.D3 Actinic Rays see Ultraviolet Rays Actinides see Metals, Actinoid Actinium WN 420 Nuclear physics QC 796.A2 Actinoids see Metals, .Actinoid Actinomyces QW 125.5.A2 Actinomyces Infections see Actinomycosis Actinomycetaceae QW 125.5.A2 Actinomycetales QW 125-125.5 Actinomycetales Infections WC 302 Actinomycete Infections see Actinomycetales Infections Actinomycetes see Bacteria; names of specific organisms or groups, e.g., Coryneform group Actinomycin QV 269 Actinomycosis WC 302 Actinomycosis, Cervicofacial WC 302 Actinon see Radon Actinotherapy see Ultraviolet Therapy Action Potentials WL 102 Muscles WE 102 Other sites: classify in physiology number for the site or the general number if no physiology number exists. Activation Analysis QD 606 Activator Appliances WU 426 Active Immunity see Immunity, Active Active Site see Binding Sites Active Transport see Biological Transport, Active Activities of Daily Living Disabled HV 3011 Homemaking HV 3011 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Old Age WT 120 Orthopedic devices for WE 172 Catalogs for WE 26 Special disabilities or diseases, by subject Special types of activity not limited to a special group of people, by activity Activity Cycles QT 167 Activity Therapy In psychotherapy WM 450 In therapy of physical diseases WB 555 Actuarial Analysis HG 8779-8793 Related to specific service plans, by subject, e.g., Psychiatric insurance W 270 Acuity, Visual see Visual Acuity Acupoints see Acupuncture Points Acupuncture WB 369 Acupuncture Anesthesia WB 369 Acupuncture Points WB 369 Acupuncture Therapy WB 369 Acute Abdomen see Abdomen, Acute Acute Disease WB 105 In infancy & childhood WS 200 Acute Phase Proteins WH 400 Acute Phase Reactants see Acute Phase Proteins Acute-Phase Reaction QZ 150 Localized, by site Acute-Phase State see Acute-Phase Reaction Acycloguanosine see Acyclovir Acyclovir QV 268.5 Acyltransferases QU 141 Deficiency WD 105 Adamantinoma see Ameloblastoma Adams-Stokes Syndrome WG 330 Adaptation, Biological QH 546 Adaptation, Ocular WW 109 Adaptation, Physiological QT 140 Aviation WD 710 Space flight WD 752 Adaptation, Psychological BF 335 Aviation WD 730 In adolescence WS 462 In infancy & childhood WS 105.5.A8 Space flight WD 754 Other specific subjects, by subject Adaptation Syndrome see Stress Addictive Behavior see Behavior, Addictive Addison's Anemia see Anemia, Pernicious Addison's Disease WK 765 Addresses see Form number 9 in any NLM schedule where applicable Adenine In nucleic acids QU 58 Organic chemistry QD 401 Adenine Arabinoside see Vidarabine Adenine Nucleotides Biochemistry QU 57 Pharmacology QV 185 Adenitis see Lymphadenitis Adenocarcinoma QZ 365 Localized, by site Adenocarcinoma, Bronchiolo-Alveolar WF 658 Adenocarcinoma, Renal Cell see Carcinoma, Renal Cell USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 256 Adolescent Psychiatry Adenofibroma QZ 310 Localized, by site Adenohypophysis see Pituitary Gland, Anterior Adenoidectomy WV 430 Adenoids WV 430 Adenolymphoma WI 230 Adenoma QZ 365 Adenoma, Acidophil WK 585 Adenoma, Chromophobe WK 585 Adenoma, Eosinophilic see Adenoma, Acidophil Adenoma, Islet Cell WK 885 Adenoma, Prolactin-Secreting, Pituitary see Prolactinoma Adenoma, Prostatic see Prostatic Hypertrophy Adenoma, Sweat Gland WR 500 Localized, by site Adenoma, Virilizing WK 780 Adenomatous Polyposis Coli WI 520 Adenomyosis see Endometriosis Adenosine QU 57 Pharmacology QV 185 Adenosine Aminohydrolase see Adenosine Deaminase Adenosine Cyclic Monophosphate see Cyclic AMP Adenosine Cyclic 2',3-Monophosphate see Cyclic AMP Adenosine Cyclic 3',5-Monophosphate see Cyclic AMP Adenosine Deaminase QU 136 Adenosine Diphosphate QU 57 Pharmacology QV 185 Adenosine Diphosphate Ribose QU 57 Adenosine Diphosphoribose see Adenosine Diphosphate Ribose Adenosine Phosphates see Adenine Nucleotides Adenosine Pyrophosphate see Adenosine Diphosphate Adenosine Receptors see Receptors, Purinergic PI Adenosine Triphosphate QU 57 In general metabolism QU 120 Pharmacology QV 185 Adenosinetriphosphatase QU 136 Adenosinetriphosphatase, Calcium see Ca(2+)-Transporting ATPase Adenosinetriphosphatase, Calcium, Magnesium see Ca(2+) Mg(2+)-ATPase Adenosinetriphosphatase Fl see H(+)-Transporting ATP Synthase Adenosinetriphosphatase, Magnesium see Ca(2+) Mg(2+)-ATPase Adenosinetriphosphatase, Sodium, Potassium see Na(+)-K(+)-Exchanging ATPase Adenosis of Breast see Fibrocystic Disease of Breast Adenoviridae QW 165.5.A3 Adenoviridae Infections WC 500 Adenovirus Infections see Adenoviridae Infections Adenyl Cyclase QU 139 Adenylate Cyclase see Adenyl Cyclase Adenylpyrophosphate see Adenosine Triphosphate Adhesion, Bacterial see Bacterial Adhesion Adhesions Abdominal WI 900 Gynecologic WP 140 Localized, by site Adhesive Plaster see Bandages Adhesiveness QC 183 Chemical technology TP 967-970 Adhesives TP 967-970 Adipocere see Postmortem Changes Adipose Tissue QS 532.5.A3 Adiposis Dolorosa WD 214 Adjustment Disorders WM 171 Psychotic see Affective Disorders, Psychotic WM 207 Adjustment, Social see Social Adjustment Adjuvants, Anesthesia see Anesthesia Adjuvants Adjuvants, Immunologic QW 800 Adjuvants, Pharmaceutic QV 38 ADL see Activities of Daily Living Administration see Organization and Administration Administration, Cutaneous WB 340 Administration, Health see Public Health Administration Administration, Inhalation WB 342 Administration, Intranasal WB 342 Administration, Intravesical WB 340 Administration of Medicine see Administrative methods WB 340-356 under Drugs Administration, Oral WB 350 Administration, Rectal WB 344 Administration Research, Nursing see Nursing Administration Research Administration Schedule, Drug see Drug Administration Schedule Administration, Topical WB 340 Administrative Personnel Business administration HF 5549-5549.5 Hospital administration WX 155 Industrial management HD 28-70 Nursing administration WY 105 Public health administration WA 525-546 See also names of particular types of administrators, e.g., Medical record administrators WX 173 Administrative Work see Organization and Administration Administrators see Administrative Personnel Admission Tests, Routine see Diagnostic Tests, Routine Admitting Department, Hospital WX 158 Of specialty hospitals (Form number 27-28 in any NLM schedule where applicable) Adnexa Uteri WP 275-322 Adnexal Diseases WP 275-322 Adnexitis WP 275 Pelvic inflammations WP 155-157 Adolescence WS 460-463 Pregnancy see Pregnancy in Adolescence WS 462, etc. Adolescent Behavior WS 462 Adolescent, Hospitalized WS 460-463 Adolescent, Institutionalized WS 460-463 Adolescent Medicine WS 460 Adolescent Pregnancy see Pregnancy in Adolescence Adolescent Psychiatry WS 463 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 257 Adolescent Psychiatry As a career WS 463 Adolescent Psychology WS 462 Adoption Psychological aspects WS 105.5.F2 Sociological aspects HV 874.8-875.7 Adoptive Cell Transfer see Immunotherapy, Adoptive Adoptive Cellular Immunotherapy see Immunotherapy, Adoptive ADP see Adenosine Diphosphate ADP Receptors see Receptors, Purinergic P2 ADP Ribose see Adenosine Diphosphate Ribose ADP-Ribosyltransferase (Polymerizing) see NAD+ ADP-Ribosyltransferase Adrenal Cortex WK 750-770 Adrenal Cortex Diseases WK 760 Adrenal Cortex Function Tests WK 750 Adrenal Cortex Hormones WK 755 Synthetic WK 757 Adrenal Cortex Hyperfunction see Adrenal Gland Hyperfunction Adrenal Cortex Hypofunction see Adrenal Gland Hypofunction Adrenal Cortex Neoplasms WK 780 Adrenal Gland Diseases WK 700-790 Adrenal Gland Hyperfunction WK 770 Adrenal Gland Hypofunction WK 765 Adrenal Gland Neoplasms WK 780 Adrenal Glands WK 700-790 Adrenal Hyperplasia, Congenital WK 700 Adrenal Insufficiency see Adrenal Gland Hypofunction Adrenal Medulla WK 725 Adrenalectomy WK 790 Adrenalin see Epinephrine Adrenaline see Epinephrine Adrenergic Agents QV 129-132 Adrenergic Agonists QV 129 Adrenergic alpha-Agonists QV 129 Adrenergic alpha-Antagonists QV 132 Adrenergic alpha-Receptor Agonists see Adrenergic alpha-Agonists Adrenergic alpha Receptor Blockaders see Adrenergic alpha-Antagonists Adrenergic alpha-Receptors see Receptors, Adrenergic, alpha Adrenergic Antagonists QV 132 Adrenergic beta-Agonists QV 129 Adrenergic beta-Antagonists QV 132 Adrenergic beta-Receptor Agonists see Adrenergic beta-Agonists Adrenergic beta-Receptor Blockaders see Adrenergic beta-Antagonists Adrenergic beta-Receptors see Receptors, Adrenergic, beta Adrenergic-Blocking Agents see Adrenergic Antagonists Adrenergic Receptor Agonists see Adrenergic Agonists Adrenergic Receptors see Receptors, Adrenergic Adrenoceptors see Receptors, Adrenergic Adrenochrome QV 77.7 Adrenocorticotropic Hormone see Corticotropin ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHVt Adrenocorticotropin see Corticotropin Adrenogenital Syndrome see Adrenal Hyperplasia, Congenital Adrenoleukodystrophy WD 205.5.L5 Adrenolytics see Adrenergic Agents Adrenomimetics see Adrenergic Agents Adrenomyeloneuropathy see Adrenoleukodystrophy Adriamycin see Doxorubicin Adsorbents see Dermatologic Agents; Gastrointestinal Agents; Powders Adsorption Immunochemistry QW 504.5 Of drugs QV 38 Of gases QC 162 Chemical engineering TP 156.A35 Of matter QC 182 Of solutions QD 547 Virology QW 160 Of other substances, with the substance Adult Developmental psychology BF 724.5-724.85 Middle age BF 724.6-724.65 Other particular topics, by subject See also Aging WT 104 Adult Respiratory Distress Syndrome see Respiratory Distress Syndrome, Adult Adult T-Cell Leukemia-Lymphoma Virus I see HTLV-I Adulteration of Drugs see Drug Contamination; Legislation, Drug Adulteration of food see Food Contamination Advance Directives W 85.5 Advertising Alcoholic beverages HF 6161.L46 Cigarette HF 6161.T6 Dental WU 58 Medical W 58 Pharmaceutical QV 736 See also Drug Labeling QV 835 Tobacco HF 6161.T6 Other special subjects, by business in HF 6161 or other appropriate number Aedes QX 525 Aerobacter see Enterobacter Aerobic Exercise see Exercise Aerobiosis QU 120 Aeroembolism see Embolism, Air Aerophagy WI 150 Aerophobia see Phobic Disorders Aeroplanes see Aircraft Aerosols Disinfectant QV 220 Dosage form QV 785 Pollutant see Air Pollutants WA 450; WA 754 Used in inhalation therapy WB 342 Aerospace Medicine WD 700-758 Aviation medicine WD 700-745 Psychological aspects WD 730 General WD 700-745 Space medicine WD 750-758 Psychological aspects WD 754 Aerotherapy see Therapy WB 460 under Air AET WN 650 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFDZD 258 AIDS Seropositivity Affect BF 511-568 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Affective Disorders WM 171 In adolescence WS 463 In infancy & childhood WS 350.6 Affective Disorders, Psychotic WM 207 Affective Disturbances see Affective Symptoms Affective Psychosis, Bipolar see Bipolar Disorder Affective Symptoms In adolescence WS 463 In infancy & childhood WS 350.6 Neurotic WM 171 Psychotic WM 207 Affinity, Antibody see Antibody Affinity Afibrinogenemia WH 322 Aflatoxins QW 630 AFP see alpha Fetoproteins African Americans see Blacks African Green Monkey see Cercopithecus aethiops African Lymphoma see Burkittls Lymphoma African Swine Fever SF 977.A4 African Swine Fever Virus QW 165.5.16 Afterbirth see Fetal Membranes; Placenta Afterbrain see Cerebellum; Pons Aftercare In infancy & childhood WS 366 Of the mentally ill WM 29 Of the physically ill and disabled WB 325 Of particular diseases, with the disease See also Nursing Care WY 100; Postoperative Care WO 183; Surgical Nursing WY 161 Afterimage WW 105 Agammaglobulinemia WH 400 Agar QU 83 Cathartic QV 75 Culture medium QY 26 Agaric, Fly see Mushrooms Agaricaceae see Agaricales Agaricales QW 180.5.B2 Poisoning WD 520 Age Determination by Skeleton GN 70 Age Determination by Teeth GN 209 Animal SF 869 Age Factors As a cause of disease QZ 53 Demography HB 1531-1737 Related to other particular subjects, by subject See also Gestational Age WQ 210.5 Age-Related Osteoporosis see Osteoporosis Aged WT Anesthesia WO 445 Dentistry see Geriatric Dentistry WU 490 Mental health WT 145 Nursing see Geriatric Nursing WY 152 Nutritional requirements; Nutrition Disorders WT 115 Physical examination and diagnosis WT 141 Psychiatry see Geriatric Psychiatry WT 150 See also Dementia, Senile WT 155 Psychology WT 145 Social problems; Surveys WT 30 Surgery WO 950 Therapeutics (General) WT 166 See also Geriatrics Aged Abuse see Elder Abuse Aged, 80 and over WT See special topics under Aged AGEPC see Platelet Activating Factor Agglutination QW 640 Diagnostic reactions QY 265 See also Hemagglutination QW 640 Agglutination Tests QY 265 Agglutinins QW 640 Plant QW 640 Agglutinins, Plant see Lectins Aggression Animals QL 758.5 Psychology In adolescence WS 462 In adulthood BF 575.A3 In infancy & childhood WS 105.5.S6 Social behavior disorder In adolescence WS 463 In adulthood WM 600 In infancy & childhood WS 350.8.A4 See also Violence HM 281-283 Aggressiveness see Aggression Aging WT 104 Psychological changes WT 145 Agkistrodon rhodostoma Venom Protease see Ancrod Agkistrodon Serine Proteinase see Ancrod Agnosia WL 340 Agonistic Behavior QL 758.5 Agoraphobia WM 178 Agrammatism see Aphasia, Broca Agranulocytosis WH 200 Agraphia WL 340 Agricultural Chemistry see Chemistry, Agricultural Agricultural Workers' Diseases WA 400 See also Farmer's Lung WF 652 Agriculture S General works S 491-494.5 AH 5158 see Labetalol AHG-CDC Tests see Cytotoxicity Tests, Immunologic Aid to Families with Dependent Children HV 697-700 Public health aspects WA 320 Aid to the Blind see Social Security Aid to the Totally Disabled see Social Security AIDS see Acquired Immunodeficiency Syndrome AIDS Antibodies see HIV Antibodies AIDS-Associated Nephropathy WC 503.5 AIDS Dementia Complex WC 503.5 AIDS Encephalopathy see AIDS Dementia Complex AIDS-Related Complex WC 503-503.7 AIDS-Related Opportunistic Infections General WC 503.5 See also names of specific infections AIDS Seroconversion see HIV Seropositivity AIDS Serodiagnosis QY 265 AIDS Serology see AIDS Serodiagnosis AIDS Seropositivity see HIV Seropositivity ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSDTffiD 259 AIDS Virus AIDS Virus see HIV-1 Ainhum WE 835 Air Industrial hygiene WA 450 Public health aspects WA 750-776 Relation to personal health QT 230 Therapy Pharmacology QV 310 Physical medicine WB 460 See also Atmosphere WA 750-776, etc. Air Bladder see Air Sacs Air Conditioning WA 774 Air Defense see Aviation; Civil Defense; Military Science Air Ionization Physics Electricity QC 702 Meteorology QC 969 Physiology QT 162.A5 Public health hazard WA 750 Therapeutic use WB 460 For other uses, by subject Air Microbiology QW 82 Air Movements QC 880.4.A8 Clinical aspects of disease caused by Aviation problems WD 720 Extraterritorial environment WD 758 General works WD 600 Motion sickness WD 630 Vibration disorders WD 640 Etiology of disease QZ 57 Spread of pesticides WA 240 Wind (General) QC 930.5-959 Air Pollutants WA 754 See also names of specific pollutants Air Pollutants, Environmental WA 754 Air Pollutants, Occupational WA 450 Air Pollutants, Radioactive WN 615 Air Pollution WA 754 In industry WA 450 Legislation WA 32-33 Air Pollution, Indoor WA 754 Air Pollution, Radioactive WN 615 See also Air Pollutants, Radioactive WN 615; Radioactive Pollutants WN 615, etc.; names of specific pollutants Air Pollution, Tobacco Smoke see Tobacco Smoke Pollution Air Pressure High altitude WD 710 Underwater WD 650 Air Quality, Indoor see Air Pollution, Indoor Air Radiography see Pneumoradiography Air raid protection see Civil Defense Air Sacs QL 855 Air Swallowing see Aerophagy Air Travel, Accidents see Accidents, Aviation Aircraft As ambulances WX 215 Industrial diseases of aircraft construction and maintenance workers WA 400-495 Noise effects On aviators and passengers WD 735 ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C On animals and humans on the ground WA 776 Nursing service WY 143 Pollution WA 754 Relation to aviation and space medicine WD 700-758 Sanitation WA 810 Speed effects WD 720 See also Aviation WD 705, etc. Airsickness see Motion Sickness Airway Obstruction WF 140 In anesthesia WO 250 Airway Resistance WF 102 Tests WF 141 Akamushi Disease see Scrub Typhus Akinetic Mutism WL 348 Akinetic Petit Mai see Epilepsy, Absence Alalia see Speech Disorders Alanine Aminotransferase QU 141 Alarm Reaction see Stress Alaryngeal Speech see Speech, Alaryngeal Albers-Schoenberg Disease see Osteopetrosis Albinism WR 267 Albright's Disease see Fibrous Dysplasia of Bone Albumins QU 55 Serum see Serum Albumin WH 400, etc. Albuminuria WJ 343 Alcaligenes QW 131 Alchemy QD 23.3-26.5 Therapeutics WB 890 Alcohol Abuse see Alcoholism Alcohol Amnestic Disorder WM 274 Alcohol Consumption see Alcohol Drinking Alcohol Dehydrogenase QU 140 Alcohol Drinking WM 274 Adolescents and children Psychiatric problem WM 274 School problem WA 352 Sociological problem HV 5006-5722 Traffic accidents WA 275 Alcohol, Ethyl Organic chemistry QD 305.A4 Pharmacology QV 84 Alcohol, Methyl QV 83 Alcohol Oxidoreductases QU 140 Alcohol, Propyl Organic chemistry QD 305.A4 Pharmacology QV 82 Alcohol Withdrawal Delirium WM 274 Alcoholic Beverages As dietary supplement in health or disease WB 444 Chemical technology TP 500-617 See also Alcoholism WM 274; Alcohol, Ethyl QV 84, etc. Alcoholic Cardiomyopathy see Cardiomyopathy, Alcoholic Alcoholic Cirrhosis see Liver Cirrhosis, Alcoholic Alcoholic Fatty Liver see Fatty Liver, Alcoholic Alcoholic Hepatitis see Hepatitis, Alcoholic Alcoholic Intoxication QV 84 Associated with traffic accidents WA 275 In forensic medicine W 780 NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSIFIED 260 Allergy and Immunology Alcoholic Liver Diseases see Liver Diseases, Alcoholic Alcoholism WM 274 Classify like material on Alcohol drinking See also Fatty liver, Alcoholic WI 700; Hepatitis, Alcoholic WI 700; Liver Cirrhosis, Alcoholic WI 725; Psychoses, Alcoholic WM 274; Skid row alcoholics WM 274, etc. Alcohols QV 82-84 Organic chemistry Aliphatic compounds QD 305.A4 Aromatic compounds QD 341.A4 Alcohols, Sugar see Sugar Alcohols Aldehyde Dehydrogenase QU 140 Aldehyde Reductase QU 140 Aldehydes QU 99 In alcohol metabolism QV 84 Organic chemistry Aliphatic compounds QD 305.A6 Aromatic compounds QD 341.A6 Used for particular experiments, by main topic of die work, e.g. as a fixative in histological experiments QS 525-530 Aldicarb Agriculture SB 952.C3 Public health WA 240 Aldolase see Fructosediphosphate Aldolase Aldose Reductase see Aldehyde Reductase Aldosterone WK 755 Deficiency WK 760 As a cause of a particular disorder, with the disorder Aldosterone Antagonists WK 755 Aldosteronism see Hyperaldosteronism Aleutian Disease Virus see Aleutian Mink Disease Parvovirus Aleutian Mink Disease SF 997.5.M5 Aleutian Mink Disease Parvovirus QW 165.5.P3 Aleuts see Eskimos Alexia see Dyslexia, Acquired Alexin see Complement Alexithymia see Affective Symptoms Algae QK 564-580.5 Algae, Blue-Green see Cyanobacteria Alginates Biochemistry QU 83 Phytochemistry QK 898.A3 Used in dentistry WU 190 Used in surgical dressings WO 167 Algodystrophic Syndrome see Reflex Sympathetic Dystrophy Algolagnia see Paraphilias Algor Mortis see Postmortem Changes Algorithms For computers (General) QA 76.9.A43 In particular fields (Form number 26.5 in any NLM schedule where applicable) Applied to special topics, by subject Alienation, Social see Social Alienation Alienists see Biography WZ 112.5.P6, etc. under Psychiatry; Directories WM 22 under Psychiatry Alimentary Tract see Digestive System Alimentation (Therapeutics) see Diet Therapy Aliphatic Compounds see Anti-Infective Agents, Local; Formaldehyde; Nitrofurans; Hydrocarbons or Aliphatic compounds under Chemistry, Organic Alkalemia see Alkalosis Alkali Disease see Tularemia Alkalies Pharmacology QV 275 Tpxicology QV 612 Alkaline Earth Metals see Metals, Alkaline earth Alkaline Phosphatase QU 136 Alkaloids As a therapeutic system WB 890 Organic Chemistry QD 421.A1-421.7 Toxicology QV 628 Alkalosis WD 226 Alkalosis, Respiratory WF 140 Alkanes Microbial chemistry QW 52 Organic chemistry QD 305.H6 Alkanesulfonates QU 98 Organic chemistry QD 305.S3 Alkenes Microbial chemistry QW 52 Organic chemistry QD 305.H7 Alkyl Sulfonates see Alkanesulfonates Alkylating Agents QV 269 Alkylation QD 281.A5 Alkynes Organic chemistry QD 305.H8 ALL, Childhood see Leukemia, Lymphocytic, Acute, LI Allantiasis see Botulism Allantoin In amino acid metabolism QU 65 Allantois Embryology QS 645 Alleles QH 447 Allergen Bronchial Provocation Tests see Bronchial Provocation Tests Allergen Immunotherapy see Desensitization, Immunologic Allergens QW 900 Allergic Angiitis see Churg-Strauss Syndrome Allergic Conjunctivitis see Conjunctivitis, Allergic Allergic Cutaneous Angiitis see Vasculitis, Allergic Cutaneous Allergic Cutaneous Vasculitis see Vasculitis, Allergic Cutaneous Allergic Diseases see Hypersensitivity Allergic Granulomatous Angiitis see Churg-Strauss Syndrome Allergy see Hypersensitivity Allergy and Immunology QW 501-949 Animals SF 757.2 Individual, by animal in QL or SF Biography of immunologists Collective WZ 112.5.15 Individual WZ 100 Directories QW 522 Military bacteriology, etc. UH 450-455 Nursing texts QW 504, etc. ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 261 Allergy and Immunology Transplantation see Transplantation Immunology WO 680 Associated with a particular disease, with the disease Allergy (Specialty) see Allergy and Immunology Allied Health Occupations W 21.5 Allied Health Personnel W 21.5 Directories General W 22 Special types of personnel, in the directory number for the specialty involved Education W 18 Alligators and Crocodiles QL 666.C925 Diseases SF 997.5.R4 Allium As a medicinal plant QV 766 Botany QK 495.L72 As a dietary supplement in health and disease WB 430 Allium sativum see Garlic Alloantibodies see Isoantibodies Alloantigens see Isoantigens Allograft see Transplantation, Homologous Allograft Dressings see Biological Dressings Allosteric Regulation QU 34 Special topics, by subject Allosteric Site QU 34 Allotypes, Immunoglobulin see Immunoglobulin Allotypes Allotypic Antibodies see Immunoglobulin Allotypes Allowing to Die see Euthanasia, Passive Alloxan Diabetes see Diabetes Mellitus, Experimental Alloys Analysis QD 133-137 Dental applications WU 180 Particular applications, by subject, e.g. used in orthopedics, WE 26, WE 172, etc. Almanacs AY 30-1730 Aloe As a medicinal plant QV 766 As a cathartic QV 75 Alopecia WR 460 Alopecia, Androgenetic see Alopecia Alopecia, Male Pattern see Alopecia Alpacas see Camelids, New World Alpers Syndrome see Cerebral Sclerosis, Diffuse alpha-Adrenergic Blocking Agents see Adrenergic alpha-Antagonists alpha Adrenergic Receptor Agonists see Adrenergic alpha-Agonists alpha-Adrenergic Receptor Blockaders see Adrenergic alpha-Antagonists alpha-Adrenergic Receptors see Receptors, Adrenergic, alpha alpha-Aminotoluene see Benzylamines alpha-Blockers, Adrenergic see Adrenergic alpha-Antagonists alpha-Cell Tumor see Glucagonoma alpha Fetoproteins WQ 210.5 alpha-Glucosidases QU 136 alpha-Heparin see Heparin alpha-Hypophamine see Oxytocin ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHM alpha Immunoglobulins see Immunoglobulins, alpha-Chain Alpha Particles WN 110 In nuclear physics (General) QC 793.5.A22-793.5.A229 Specific topics, by subject, e.g., of radioisotopes WN 420 Alpha Rays see Alpha Particles Alpha Rhythm WL 150 alpha-Trichosanthin see Trichosanthin alpha 1-Acid Glycoprotein see Orosomucoid alpha 1-Acid Seromucoid see Orosomucoid alpha 1-Antitrypsin WH 400 As an enzyme inhibitor QU 143 alpha 1-Protease Inhibitor see alpha 1-Antitrypsin alpha 1-Proteinase Inhibitor see alpha 1-Antitrypsin Alphamethyldopa see Methyldopa Alport's Syndrome see Nephritis, Hereditary Alprenolol QV 132 Alprostadil QU 90 Alteplase QU 142 Alternative Medicine WB 890-962 Cupping WB 371 Directories WB 22 Alternatives to Animal Testing see Animal Testing Alternatives Altitude Physiological effects WD 710-715 Altitude Sickness WD 715 Altruism BJ 1474 Special topics, by subject Aluminosis see Pneumoconiosis Aluminum Inorganic chemistry QD 181.A4 Pharmacology QV 65 Aluminum Hydroxide As an antacid QV 69 Aluminum Hydroxide Gel see Aluminum Hydroxide Aluminum Silicates Inorganic chemistry QD 181.S6 Pharmacology QV 65 Aluminum Sucrose Sulfate see Sucralfate Alveolar Abscess, Apical see Periapical Abscess Alveolar Bone Loss WU 240 Alveolar Echinococcis, Hepatic see Echinococcosis, Hepatic Alveolar Lavage Fluid see Bronchoalveolar Lavage Fluid Alveolar Nerve, Inferior see Mandibular Nerve Alveolar Process WU 240 Alveolar Resorption see Alveolar Bone Loss Alveolar Ridge Augmentation WU 600 Alveolitis, Fibrosing see Pulmonary Fibrosis Alzheimer's Disease WT 155 Amalgam Filling see Dental Amalgam Amanita QW 180.5.B2 Amanitz see Agaricales Amaurosis see Blindness Amaurotic Familial Idiocy see Lipoidosis Ambidexterity see Laterality Amblyopia WW 276 Toxic WW 276 Amblystoma see Ambystoma USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 262 Ammonium Compounds Amboceptor see Bacteriolysis; Hemolysins Ambulances WX 215 Military UH 500-505 Ambulatory Care General WB 101 In hospitals WX 205 In infancy & childhood WS 200 Clinics WS 27-28 Nursing WY 150 Pediatric nursing WY 159 Of a patient with a particular disease, with the disease Ambulatory Care Facilities WX 205 Ambulatory Care Facilities, Hospital see Outpatient Clinics, Hospital Ambulatory Care Information Systems WX 26.5 Ambulatory Electrocardiography see Electrocardiography, Ambulatory Ambulatory Surgery WO 192 Of particular parts, by subject Ambystoma QL 668.C23 As laboratory animals QY 60.A6 Ambystoma mexicanum QL 668.C23 As laboratory animals QY 60.A6 Diseases SF 997.5.A45 Ameba see Amoeba Amebiasis WC 285 Amebiasis, Hepatic see Liver Abscess, Amebic Amebiasis, Intestinal see Dysentery, Amebic Amebic Dysentery see Dysentery, Amebic Amebicides QV 255 Ameboma see Amebiasis Ameloblastoma WU 280 Amenorrhea WP 552 Americana see Books Americium WN 420 Nuclear physics QC 796.A5 See also special topics under Radioisotopes Amerinds, Central American see Indians, Central American Amerinds, North American see Indians, North American Amerinds, South American see Indians, South American Amethocaine see Tetracaine Amethopterin see Methotrexate Ametropia see Refractive Errors Amidases see Amidohydrolases Amidazine see Ethionamide Amides QU 62 Organic chemistry Aliphatic compounds QD 305.A7 Aromatic compounds QD 341.A7 Amidines QU 61 Organic chemistry QD 305.A8 Amidohydrolases QU 136 Amidone see Methadone Amidophenazon see Aminopyrine Amidotrezoate see Diatrizoate Amifostine As a radiation-protective agent WN 650 Amiloride QV 160 Amine Oxidase (Copper-Containing) QU 140 Amines QU 61 Organic chemistry Aliphatic compounds QD 305.A8 Aromatic compounds QD 341.A8 Amines, Biogenic see Biogenic Amines Amines, Sympathomimetic see Sympathomimetics Amino Acid Decarboxylases, Aromatic see Aromatic Amino Acid Decarboxylases Amino Acid Metabolism, Inborn Errors WD 205.5.A5 Amino Acid Oxidoreductases QU 140 Amino Acid Sequence QU 60 Amino Acids QU 60 Amino Acids, Branched-Chain QU 60 Amino Acids, Essential QU 60 Amino Acids, Sulfur QU 60 Amino Acyl tRNA see RNA, Transfer, Amino Acyl Amino Alcohols Organic chemistry QD 305.A4 Pharmacology QV 82 Amino Sugars QU 75 Aminoaciduria, Renal WJ 343 Aminobenzoic Acids QU 195 Aminobutyrate Aminotransferase QU 141 Aminobutyric Acids QU 60 Aminocaproic Acids QU 60 Aminocaproic Lactam see Caprolactam Aminoethanols see Ethanolamines Aminoform see Methenamine Aminoglycoside Antibiotics see Antibiotics, Aminoglycoside Aminoglycosides QU 75 Aminohippuric Acids QU 62 Organic chemistry QD 341.A7 Aminohydrolases QU 136 Aminophenazone see Aminopyrine Aminophenurobutane see Carbutamide Aminopropanols see Propanolamines Aminopropionitrile Organic chemistry Aliphatic compounds QD 305.N7 In plant poisoning WD 500 Aminopyrine QV 95 Aminosalicylic Acids QV 268 Aminotransferases QU 141 Amiodarone QV 150 Ammoidin see Methoxsalen Ammonia Detergent use QV 233 In nitrogen fixation Biochemistry (General) QU 70 Phytochemistry QK 898.N6 Plant and soil QW 60 Inorganic chemistry QD 181.N1 Ammonia-Lyases QU 139 Ammonium Chloride Inorganic chemistry QD 181.N1 Pharmacology QV 280 Ammonium Compounds Chemical technology TP 223 Detergent use QV 233 Organic chemistry QD 305.A8 Quaternary see Tetraethylammonium Compounds ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFTED 263 Ammonium Compounds QV 132 See also names of specific compounds Ammotherapy WB 525 Amnesia WM 173.7 Amniocentesis WQ 209 Amnion Animal embryology QL 975 Human embryology QS 645 Obstetrics WQ 210.5 Amniotic Fluid Animal embryology QL 975 Human embryology QS 645 Obstetrics WQ 210.5 See also Embolism, Amniotic Fluid WQ 244 Amniotic Membrane Dressings see Biological Dressings Amoeba QX 55 Amoebiasis see Amebiasis Amoxapine QV 77.5 Amoxicillin QV 354 Amphetamines QV 102 Dependence WM 270 Amphibia QL 640-669.3 As laboratory animals QY 60.A6 Amphibian Venoms WD 400 Amphiuma see Urodela Ampholines see Ampholyte Mixtures Ampholyte Mixtures QV 786 Ampicillin QV 354 Ampicillin Pivaloyl Ester see Pivampicillin Ampulla of Vater see Vater's Ampulla Amputation WE 170 Amputation Stumps WE 172 Amputees WE 172 Psychology BF 727.P57 Child psychology WS 105.5.H2 Rehabilitation General and medical aspects WE 172 Of children WS 368 Of disabled soldiers UB 360-366 Sociological aspects Disabled workers HD 7255-7256 Vocational rehabilitation HV 3018-3019 Amygdala see Amygdaloid Body Amygdalin QV 269 Amygdaloid Body WL 314 Amygdaloside see Amygdalin Amyl Nitrate QV 156 Amylases QU 136 Pancreatic WI 802 Amyloid P Component WH 400 Amyloidosis WD 205.5.A6 Amyoplasia Congenita see Arthrogryposis Amyotonia Congenita WE 550 Amyotrophic Lateral Sclerosis WE 550 Anabolic Steroids WK 150 See also Metabolism QU 120, etc.; names of anabolic steroids that are also synthetic androgens, e.g. Methandrostenolone WJ 875 Anabolism see Metabolism Anaerobic Bacteria see Bacteria, Anaerobic Anaerobiosis QU 120 Anal Drug Administration see Administration, ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHX Rectal Anal Fissure see Fissure in Ano Anal Fistula see Rectal Fistula Anal Gland see Anus Anal Sphincter see Anus Anal Stage WS 105.5.P3 Anal Ulcer see Fissure in Ano Analeptics QV 101-107 Analgesia WO 200 In labor see Anesthesia Obstetrical WO 450 Muscle relaxants with WO 297 Preanesthetic medication WO 234 Veterinary SF 914 Analgesia, Epidural WO 305 Analgesia in Labor see Anesthesia, Obstetrical Analgesia Tests see Pain Measurement Analgesic Cutaneous Electrostimulation see Transcutaneous Electric Nerve Stimulation Analgesics QV 95 Analgesics, Addictive see Analgesics, Opioid Analgesics, Anti-Inflammatory see Anti-Inflammatory Agents, Non-Steroidal Analgesics, Narcotic see Analgesics, Opioid Analgesics, Non-Narcotic QV 95 Analgesics, Opioid QV 89-92 In preanesthetic medication WO 234 Analgin see Dipyrone Analogue Pain Scale see Pain Measurement Analysis see Chemistry, Analytical; names of substances being analyzed Analysis of Variance QA 279 Particular variables, by subject Analytical Psychology see Psychoanalysis Analyzers, Neural see Neural Analyzers Anankastic Personality see Compulsive Personality Disorder Anaphylatoxins QU 68 In complement activation QW 680 Anaphylaxis QW 900 Anaplasma QW 150 Anaplasmosis WC 600 Veterinary SF 967.A6 Anarthria see Speech Disorders Anastomosis, Arteriovenous see Arteriovenous Anastomosis Anastomosis, Surgical In surgery for a particular condition, with the condition Anatomic Models see Models, Anatomic Anatomists see Biography WZ 112, etc., and Directories QS 22 under Anatomy Anatomy QS Adrenal glands WK 701 Bacterial QW 51 Cardiovascular system WG 101 Directories QS 22 Domestic animals SF 761-767 Ear WV 201 Eye WW 101 Fetus WQ 210.5 Gastrointestinal system WI 101 Gynecology WP 101 Heart WG 201 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 264 Anesthesia, Extradural Islands of Langerhans WK 801 Kidney WI 301 Larynx WV 501 Male genitalia WJ 701 Musculoskeletal system WE 101 Nervous system WL 101 Nose WV 301 Nursing texts QS 4, etc. Otolaryngology WV 101 Pathological (General) QZ Pharyngeal region WV 401 Pituitary gland WK 501 Respiratory system WF 101 Skin WR 101 Stomach WI 301 Surgical WO 101 Tooth WU 101 Thyroid gland WK 201 Urogenital system WJ 101 Wild animals QL 801-950.9 See also names of specific animals Other organs or systems, in the general number for the organ or system Anatomy, Artistic NC 760-783.8 Anatomy, Comparative Animals only QL 801-950.9 Human and animals QS 124 Anatomy, Regional QS 4 For surgeons WO 101 Anatomy, Veterinary SF 761-767 See also Anatomy, Comparative QL 801-950.9, etc. Anatoxins see Toxoids Anavar see Oxandrolone Anchored PCR see Polymerase Chain Reaction Ancillary Information Systems see Information Systems Ancillary Services, Hospital WX 162 Specific topics, by subject Ancrod As an anticoagulant QV 193 Biochemistry QU 136 Ancylostoma QX 243 Ancylostoma caninum see Ancylostoma Ancylostoma duodenale see Ancylostoma Ancylostomatoidea QX 243 Ancylostomiasis WC 890 Andresen Appliance see Activator Appliances Androblastoma WP 322 Androgen Analogs see Androgens, Synthetic Androgen Antagonists WJ 875 Androgens WJ 875 Androgens, Synthetic WJ 875 Andrology see Urology Androstenedione WJ 875 Anecdotes PN 6259-6268 Medicine, medical specialties and related fields WZ 305-305.5 Anemia WH 155-175 Cooley's see Thalassemia WH 170 Erythroblastic see Thalassemia WH 170 In pregnancy WQ 252 Megaloblastic see Anemia, Macrocytic WH 165 Miners' see Hookworm Infections WC 890, etc. Osteosclerotic see Anemia, Myelophthisic WH 175 Tunnel see Ancylostomiasis WC 890 Specific named types not listed here, see for example: Hemoglobinuria WJ 344 Veterinary (General) SF 769.5 Anemia, Addison's see Anemia, Pernicious Anemia, Aplastic WH 175 Anemia, Diamond-Blackfan see Fanconi's Anemia Anemia, Fanconi see Fanconi's Anemia Anemia, Hemolytic WH 170 See also Favism WD 515; Hemoglobinuria WJ 344 and other special topics Anemia, Hemolytic, Acquired see Anemia, Hemolytic Anemia, Hemolytic, Autoimmune WH 170 Anemia, Hemolytic, Congenital WH 170 Anemia, Hemolytic, Idiopathic Acquired see Anemia, Hemolytic, Autoimmune Anemia, Hypochromic WH 160 Anemia, Hypoplastic see Anemia, Aplastic Anemia, Hypoplastic, Congenital see Fanconi's Anemia Anemia, Iron-Deficiency WH 160 Anemia, Leukoerythroblastic see Anemia, Myelophthisic Anemia, Macrocytic WH 165 Anemia, Megaloblastic WH 165 Anemia, Microangiopathic see Anemia, Hemolytic Anemia, Myelophthisic WH 175 Anemia, Neonatal WS 421 Anemia, Pernicious WH 165 Anemia, Sickle Cell WH 170 Anemia, Splenic see Hypersplenism Anencephaly QS 675 Anesthesia WO 200-460 Adverse effects WO 245 Cardiac problems WG 460 Written for the anesthesiologist WO 245 Choice of WO 235 Drugs producing see Anesthetics QV 81, etc.; Anesthetics, Local QV 110-115 In old age WO 445 In infancy & childhood WO 440 In pregnancy see Anesthesia, Obstetrical WO 450 Nurses administering see Nurse anesthetists WY 151 Of laboratory animals QY 58 Veterinary SF 914 See also the specialty Anesthesiology WO 200-222 Anesthesia Adjuvants QV 81 Anesthesia Assistants see Physician Assistants Anesthesia, Caudal WO 305 Anesthesia, Closed-Circuit WO 277 Anesthesia, Conduction WO 300-340 Anesthesia, Dental WO 460 Anesthesia Department, Hospital WO 27-28 Anesthesia, Electric see Electronarcosis Anesthesia, Epidural WO 305 Anesthesia, Extradural see Anesthesia, Epidural ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 265 Anesthesia, General Anesthesia, General WO 275 Anesthesia, Inhalation WO 277 Anesthesia, Intratracheal WO 280 Anesthesia, Intravenous WO 285 Anesthesia, Local WO 300 Infiltration anesthesia WO 340 Surface anesthesia WO 340 Topical anesthesia WO 340 Anesthesia, Obstetrical WO 450 Anesthesia, Peridural see Anesthesia, Epidural Anesthesia, Rebreathing see Anesthesia, Closed-Circuit Anesthesia Recovery Period WO 183 Anesthesia, Rectal WO 290 Anesthesia, Refrigeration see Hypothermia, Induced Anesthesia, Regional see Anesthesia, Conduction Anesthesia, Sacral Epidural see Anesthesia, Caudal Anesthesia, Spinal WO 305 Anesthesiology WO 200-460 Children and other special groups see In infancy & childhood, etc. under Anesthesia Anesthetics QV 81 Diagnostic use WO 375 Therapeutic use WO 375 Topical see Anesthetics, Local QV 115 See also Analgesics QV 95, etc. Anesthetics, Conduction Blocking see Anesthetics, Local Anesthetics, Local QV 110-115 Synthetic QV 115 Anestrus SF 105 Aneuploidy QH 461 Aneurin see Thiamine Aneurysm WG 580 Aortic see Aortic Aneurysm WG 410 Arteriovenous see Arteriovenous Fistula WG 590 Cardiac see Heart Aneurysm WG 300 Cerebral see Cerebral Aneurysm WL 354-355 See also Bone Cyst Aneurysm, Arteriovenous see Arteriovenous Fistula Aneurysm, Bacterial see Aneurysm, Infected Aneurysm, Infected WG 580 Aneurysm, Mycotic see Aneurysm, Infected ANF see Atrial Natriuretic Factor Angel Dust Abuse see Phencyclidine Abuse Anger BF 575.A5 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Angiitis see Vasculitis Angiitis, Allergic Cutaneous see Vasculitis, Allergic Cutaneous Angiitis, Allergic Granulomatous see Churg-Strauss Syndrome Angina Pectoris WG 298 Angina Pectoris, Variant WG 298 Angina, Preinfarction see Angina, Unstable Angina, Unstable WG 298 Angiocardiography WG 141.5. A3 Angioedema see Angioneurotic Edema Angiogenesis see Neovascularization Angiogenesis Factor As a growth substance QU 107 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHJ* In mitosis QH 605.2 Angiography WG 500 Cerebral WL 141 Veterinary SF 757.8 Other specific organ or system, by site Angiography, Cerebral see Cerebral Angiography Angiohemophilia see von Willebrand's Disease Angioid Streaks WW 270 As a manifestation of diseases WW 475 Angioimmunoblastic Lymphadenopathy see Immunoblastic Lymphadenopathy Angiokeratoma WR 500 Angioma see Hemangioma Angiomatosis QZ 340 Localized, by site, in the neoplasm number if available Angioneurotic Edema WR 170 Angioplasty, Balloon WG 166.5.B2 In the treatment of arterial occlusive diseases WG 510 Angioplasty, Balloon, Coronary see Angioplasty, Transluminal, Percutaneous Coronary Angioplasty, Coronary Balloon see Angioplasty, Transluminal, Percutaneous Coronary Angioplasty, Laser WG 166.5.A5 Angioplasty, Transluminal see Angioplasty, Balloon Angioplasty, Transluminal, Percutaneous Coronary WG 300 Angiotensin see Angiotensin II Angiotensin Binding Sites see Receptors, Angiotensin Angiotensin-Converting Enzyme Inhibitors As antihypertensive agents QV 150 As protease inhitors QU 136 Angiotensin-Forming Enzyme see Renin Angiotensin II QU 68 Angiotensin Receptors see Receptors, Angiotensin Angiotensinogen QU 68 Angiotensinogenase see Renin Angiotensins QU 68 Angor Pectoris see Angina Pectoris Anguilluliasis see Strongyloidiasis Anhidrosis see Hypohidrosis Anhidrotic Ectodermal Dysplasia see Ectodermal Dysplasia Anhydrides Organic chemistry Aliphatic compounds QD 305.A2 Aromatic compounds QD 341.A2 Used for special purposes, by subject, e.g., for radiolabeling of proteins QU 55 Aniline Compounds Organic chemistry QD 341.A8 Toxicology QV 632 Animal-Borne Diseases see Zoonoses Animal Care Committees see Animal Welfare Animal Communication General QL 776 Animal Culture see Animal Husbandry Animal Diseases SF 600-1100 See also Zoonoses WC 950 Animal Feed SF 95-99 Animal Hospitals see Hospitals, Animal USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 266 Ant Venoms Animal-Human Bonding see Bonding, Human-Pet Animal Husbandry SF 1-597 Waste disposal WA 778-785 Animal Identification Systems QL 60.5 Animal Magnetism see Hypnosis; Mental Healing Animal Nutrition SF 95-99 Animal Parasites see Parasites Animal Poisons see Animals, Poisonous; Fishes, Poisonous Animal Testing Alternatives W 20.55.A5 Special topics, by subject Animal Viruses see Viruses Animal Vocalization see Vocalization, Animal Animal Welfare Laboratory animals QY 54 Other Animals HV 4701-4959 Animals Bites see Bites and stings and entries under it WD 400-430, etc. Clinical use see Animals, Laboratory QY 50-60, etc. Inoculation see Veterinary SF 757.2 under Vaccination Laboratory see Animals, Laboratory QY 50-60, etc. Microbiology QW 70 Quarantine SF 740 General works SF 740 By country SF 621-723 Wounds by WO 700 Animals, Domestic SF Anatomy and physiology SF 761-768.2 Culture SF 1-597 Diseases SF 600-1100 Laboratory see Animals, Laboratory QY 50-60 See also Animals Animals, Infancy of see Animals, Newborn Animals, Laboratory QY 50-60 Domestic Anatomy and physiology SF 761-768.2 Care and breeding QY 54 Diseases SF 996.5 See also names of specific animals or groups of animals Wild Anatomy QL 801-950.9 Care and breeding QY 54 Diseases SF 996.5 Physiology QP See also names of specific animals or groups of animals Animals, Newborn Animal behavior QL 751 Developmental behavior QL 763-763.2 Popular works QL 50 Animals, Nondomestic see Animals, Wild Animals, Poisonous WD 400-430 Animals, Suckling As laboratory animals QY 60.M2 Diseases SF 600-1100 Domestic SF Wild QL 700-739.8 Animals, Transgenic As laboratory animals QY 50 Genetics QH 442.6 Animals, Wild Anatomy QL 801-950.9 Diseases SF 996.35-996.45 Laboratory see Animals, Laboratory Physiology QP Animals, Zoo QL 77.5 Diseases SF 996 See also names of individual animals Anion Gap see Acid-Base Equilibrium Anion Transport Protein, Erythrocyte see Band 3 Protein Anions QV 280-285 Aniseikonia WW 300 Anisoles Organic chemistry QD 341.E7 Toxicology QV 632 Anisometropia WW 300 Ankle WE 880-883 Ankle Injuries WE 880 Ankle Joint WE 880 Ankylosis WE 346 Veterinary SF 901 Localized, by site Annelida QX 451 Anniversaries and Special Events Medical, dental, pharmaceutical, etc. (General) WZ 332 Specific occasions, by subject Anniversary Reaction see Adjustment Disorders Annual Implementation Plans see Regional Health Planning Anoci-Association see Preanesthetic Medication Anode see Electrodes Anodontia WU 101.5 Anodynes see Analgesics Anomalies see Abnormalities Anomie HM 291 Anonyms and Pseudonyms Z 1041-1121 Anopheles QX 515 Anoplura QX 502 Anorectics see Appetite Depressants Anorexia WI 143 See also Anorexia Nervosa Anorexia Nervosa WM 175 Anosmia WV 301 ANOVA see Analysis of Variance Anovulation WP 540 Anoxemia WF 143 Associated with high altitude WD 715 Associated with high atmospheric pressure WD 655 Anoxia WF 143 Altitude see Altitude Sickness WD 715 Cerebral see Cerebral Anoxia WL 355 Fetal see Fetal Anoxia WQ 211 Submarine medicine WD 655 Anoxia, Cellular see Cell Hypoxia Anoxia, Fetal see Fetal Anoxia ANP see Atrial Natriuretic Factor Ant Venoms WD 430 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 267 Antacids Antacids QV 69 Antagonism of Drugs see Drug Antagonism Antagonists see Names of substances affected, e.g., Hormone Antagonists Anterior Chamber WW 210 Anterior Chamber Epithelium see Endothelium, Corneal Anterior Cruciate Ligament WE 870 Anterior Eye Segment WW 210 Anterior Lobe Hormones see Pituitary Hormones, Anterior Anterior Perforated Substance see Olfactory Pathways Anthelmintics QV 253 Anthemorrhagics see Hemostatics Anthocyanins QU 75 Anthracenediones see Anthraquinones Anthracenes As carcinogens QZ 202 As cathartics QV 75 Anthracosilicosis WF 654 Anthracosis see Anthracosilicosis; Pneumoconiosis Anthracycline Antibiotics see Antibiotics, Anthracycline Anthralin Pharmacology QV 60 Anthraquinones QV 240 Organic chemistry QD 393 Anthrax WC 305 Veterinary SF 787 Anthropoidea see Haplorhini Anthropology GN Criminal HV 6035-6197 Parapsychology BF 1045.A65 Psychological GN 502-517 Anthropology, Cultural GN 307-673 See also Ethnopsychology GN 270-279 Anthropology, Physical GN 50.2-298 Miscegenation GN 254 In marriage HQ 1031 Anthropometry GN 51-59 Criminal see Anthropology HV 6035-6197, etc. Anthroposophy Philosophy BP 595-597 Alternative medicine WB 903 Anti-Antibodies see Antibodies, Anti-Idiotypic Anti-Anxiety Agents QV 77.9 Anti-Anxiety Agents, Benzodiazepine QV 77.9 Anti-Arrhythmia Agents QV 150 Anti-DNA Antibodies see Antibodies, Antinuclear Anti-HIV Positive see HIV Seropositivity Anti-Human Globulin Complement-Dependent Cytotoxicity Tests see Cytotoxicity Tests, Immunologic Anti-Human Globulin Consumption Test see Coombs' Test Anti-Idiotype Antibodies see Antibodies, Anti-Idiotypic Anti-Infective Agents QV 250-268.5 Anti-Infective Agents, Local QV 220-239 Oxidizing antiseptics QV 229 Anti-Infective Agents, Quinolone QV 250 Anti-Infective Agents, Urinary QV 243 ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPHA Anti-Inflammatory Agents QV 247 Anti-Inflammatory Agents, Gold see Antirheumatic Agents, Gold Anti-Inflammatory Agents, Non-Steroidal QV 95 Anti-Inflammatory Agents, Steroidal QV 247 Anti-Inflammatory Agents, Topical QV 60 Anti-Rheumatic Agents, Non-Steroidal see Anti-Inflammatory Agents, Non-Steroidal Anti-Rheumatic Agents, Steroidal see Anti-Inflammatory Agents, Steroidal Anti-Ulcer Agents QV 69 Antiadrenergic Agents see Adrenergic Antagonists Antiaggregants, Platelet see Platelet Aggregation Inhibitors Antiandrogens see Androgen Antagonists Antibiotic Resistance see Drug Resistance, Microbial Antibiotics QV 350-360 See also specific types of antibiotics Antibiotics, Aminoglycoside QV 350 Antibiotics, Anthracycline QV 269 Antibiotics, Antifungal QV 252 Antibiotics, Antineoplastic Pharmacology QV 269 Therapeutic use QZ 267 Antibiotics, Antitubercular Pharmacology QV 268 Therapeutic use WF 360 Antibiotics, beta-Lactam see Antibiotics, Lactam Antibiotics, Glycoside see Antibiotics, Aminoglycoside Antibiotics, Lactam QV 350 Antibodies QW 575 See also Antigen-Antibody reactions QW 570 Antibodies, Allotypic see Immunoglobulin Allotypes Antibodies, Anti-DNA see Antibodies, Antinuclear Antibodies, Anti-Idiotypic QW 575 Antibodies, Antinuclear QW 575 Antibodies, Bacterial QW 575 Antibodies, Heterogenetic see Antibodies, Heterophile Antibodies, Heterophile QW 575 Antibodies, Heterotypic see Antibodies, Heterophile Antibodies, Monoclonal QW 575.5.A6 Antibodies, Neoplasm QW 575 Neoplastic pathogenesis QZ 202 Antibodies, Viral QW 575 Antibodies, Xenogeneic see Antibodies, Heterophile Antibody Affinity QW 570 Antibody Avidity see Antibody Affinity Antibody Binding Sites see Binding Sites, Antibody Antibody Deficiency Syndrome see Immunologic Deficiency Syndromes Antibody-Dependent Cell Cytotoxicity QW 568 Antibody Diversity QW 575 Immunogenetic aspects QW 541 Antibody Enzyme Technique, Unlabeled see Immunoenzyme Techniques Antibody Formation QW 575 Antibody-Producing Cells QW 575 Antibody-Secreting Cells see Antibody-Producing Cells Antibody Specificity QW 570 Antibody-Toxin Conjugates see Immunotoxins E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 268 Antiparkinson Agents Antibody-Toxin Hybrids see Immunotoxins Anticancer Drug Combinations see Antineoplastic Agents, Combined Anticancer Drug Sensitivity Tests see Drug Screening Assays, Antitumor Anticestodal Agents QV 253 Anticholesteremic Agents QU 95 Anticholinergic Agents see Cholinergic Antagonists Anticholinesterase Agents see Cholinesterase Inhibitors Anticoagulants QV 193 Anticonvulsants QV 85 Antidepressants see Antidepressive Agents Antidepressive Agents QV 77.5 Antidiabetics see Hypoglycemic Agents; Insulin Antidiarrheals QV 71 Antidiuretic Hormones see Vasopressins Antidiuretics see Vasopressins Antidotes QV 601 Lists QV 605 For a particular poison, with the poison Antidromic Potentials see Evoked Potentials Antiemetics QV 73 Antiepileptic Agents see Anticonvulsants Antiestrogens see Estrogen Antagonists Antifibrillatory Agents see Anti-Arrhythmia Agents Antifibrinolysins see Antifibrinolytic Agents Antifibrinolytic Agents QV 195 Antifungal Agents QV 252 See also Antibiotics, Antifungal QV 252; Fungicides, Industrial SB 951.3 Antigamma Globulin Antibodies see Antibodies, Anti-Idiotypic Antigen-Antibody Reactions QW 570 Antigen Bronchial Provocation Tests see Bronchial Provocation Tests Antigen-Presenting Cells QW 568 Antigen Receptors see Receptors, Antigen Antigen Receptors, T-Cell see Receptors, Antigen, T-Cell Antigenic Determinants QW 573 Special topics, by subject Antigenic Specificity see Antigenic Determinants Antigens QW 573 In histocompatibility WO 680 Antigens, Bacterial QW 573 Antigens, Carbohydrate, Tumor-Associated see Antigens, Tumor-Associated, Carbohydrate Antigens, CD QW 573 Antigens, CD25 see Receptors, Interleukin-2 Antigens, CD4 QW 573 Antigens, Differentiation QW 573 Antigens, Differentiation, B-Cell see Antigens, Differentiation, B-Lymphocyte Antigens, Differentiation, B-Lymphocyte QW 573 Antigens, Fungal QW 573 Antigens, Helminth QW 573 Antigens, HLA-D see HLA-D Antigens Antigens, Immune Response see Histocompatibility Antigens Class II Antigens, Neoplasm QW 573 Neoplasm etiology QZ 202 Neoplasm research QZ 206 Antigens, Neoplasm, Viral see Antigens, Viral, Tumor Antigens, Surface QW 573 Antigens, Synthetic see Vaccines, Synthetic Antigens, Tumor-Associated, Carbohydrate QW 573 Antigens, Viral QW 573 Antigens, Viral, Tumor QW 573 Neoplasm etiology QZ 202 Antiglobulin Consumption Test see Coombs' Test Antiglobulin Test see Coombs' Test Antiglobulins see Antibodies, Anti-Idiotypic Antigout Agents see Gout Suppressants Antihistamines, Classical see Histamine HI Antagonists Antihistaminics, Classical see Histamine HI Antagonists Antihistaminics, HI see Histamine HI Antagonists Antihistaminics, H2 see Histamine H2 Antagonists Antihypertensive Agents QV 150 Antileprotic Agents see Leprostatic Agents Antilipemic Agents QU 85 Antiluetics see Syphilis Antilymphoblast Globulins see Antilymphocyte Serum Antilymphocyte Antibodies see Antilymphocyte Serum Antilymphocyte Globulin see Antilymphocyte Serum Antilymphocyte Serum QW 815 Immunosuppressive agent QW 920 Antimalarials QV 256-258 Antimetabolites QV 38 See also names of specific antimetabolites Antimetabolites, Antineoplastic QV 269 Therapeutic use QZ 267 Antimitotic Agents see Antineoplastic Agents Antimony QV 295 Antimony Potassium Tartrate QV 253 As an emetic QV 73 Antimuscarinic Agents see Muscarinic Antagonists Antimycin A QV 252 Antineoplastic Agents QV 269 Therapeutic use QZ 267 See also Antibiotics, Antineoplastic QV 269 Antineoplastic Agents, Combined QV 269 Therapeutic use QZ 267 Antineoplastic Agents, Phytogenic QV 269 Therapeutic use QZ 267 Antineoplastic Drug Combinations see Antineoplastic Agents, Combined Antineoplastics, Botanical see Antineoplastic Agents, Phytogenic Antinociceptive Agents see Analgesics Antinuclear Antibodies see Antibodies, Antinuclear Antinuclear Antibody Test, Fluorescent see Fluorescent Antibody Technique Antinuclear Factors see Antibodies, Antinuclear Antioncogenes see Genes, Suppressor, Tumor Antioxidants As a pharmaceutic aid QV 800 In food preservation WA 710-712 Antiparkinson Agents QV 80 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 269 Antiparkinson Agents See also Levodopa WK 725 Antiperspirants see Astringents Antiplasmins see Antifibrinolytic Agents Antiplatelet Agents see Platelet Aggregation Inhibitors Antiprotozoal Agents QV 254-258 Antipruritics QV 60 Antipsychotic Agents QV 77.9 Antipsychotic Agents, Butyrophenone QV 77.9 Antipsychotic Agents, Phenothiazine QV 77.9 Antipyretics see Analgesics, Non-Narcotic Antirejection Therapy see Immunosuppression Antireticular Cytotoxic Serum QW 815 Antirheumatic Agents QV 247 Antirheumatic Agents, Gold QV 247 Antisense DNA see DNA, Antisense Antisense Elements (Genetics) QU 57 Antisense Oligodeoxyribonucleotides see Oligonucleotides, Antisense Antisense Oligonucleotides see Oligonucleotides, Antisense Antisense Oligoribonucleotides see Oligonucleotides, Antisense Antisense Probes see Antisense Elements (Genetics) Antisense RNA see RNA, Antisense Antisepsis Dental WU 300 In labor WQ 400 Public health aspects WA 240 Surgical WO 113 Antiseptics see Anti-infective Agents, Local Antiseptics, Urinary see Anti-Infective Agents, Urinary Antisera see Immune Sera Antiserotonergic Agents see Serotonin Antagonists Antisickling Agents QV 180 Antisocial Personality Disorder WM 190 In infancy & childhood WS 350.8.P3 Antispasmodics see Parasympatholytics Antisyphilitics see Syphilis Antithrombin II see Antithrombin III Antithrombin III QV 193 Antithrombins QV 193 Antithrombotic Agents see Fibrinolytic Agents Antithyroid Drugs see Thyroid Antagonists Antitoxins Immunology Immunizing agent QW 805 Pharmacology QW 630 Used for particular diseases, with the disease See also names of specific antitoxins Antitrichomonal Agents QV 254 Antitrust Laws (Form number 32-33 in any NLM schedule where applicable) Antitrust Liability see Antitrust Laws Antitubercular Agents Pharmacology QV 268 Therapeutic use WF 360 See also Antibiotics, Antitubercular QV 268 Antitumor Drug Screening Assays see Drug Screening Assays, Antitumor Antitussive Agents QV 76 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHy* Antivenins Immunology Immunizing agent QW 805 Pharmacology QW 630 Therapy WD 400-430 Antiviral Agents QV 268.5 Antivivisection see Vivisection Antrum of Highmore see Maxillary Sinus Antrum, Pyloric see Pyloric Antrum Ants QX 565 Anura QL 668.E2-668.E275 As laboratory animals QY 60.A6 Diseases SF 997.5.A45 Anuria WJ 303 Anus WI 600-650 Anus, Artificial see Colostomy Anus Diseases WI 600 Anus Neoplasms WI 610 Anus Prolapse see Rectal Prolapse Anxiety WM 172 In adolescence WS 463 In infancy & childhood WS 350.6 Neuroses see Neuroses, Anxiety WM 172 Anxiety Disorders WM 172 Anxiety Neuroses see Anxiety Disorders Anxiety States, Neurotic see Anxiety Disorders Anxiolytic Agents see Anti-Anxiety Agents Anxiolytics, Benzodiazepine see Anti-Anxiety Agents, Benzodiazepine Aorta WG 410 Aorta, Abdominal WG 410 Aorta, Ascending see Aorta Aorta, Descending see Aorta, Thoracic Aorta, Thoracic WG 410 Aortic Aneurysm WG 410 Aortic Arch see Aorta, Thoracic Aortic Arch Syndromes WG 410 Aortic Bodies WL 600 Aortic Coarctation WG 220 Aortic Incompetence see Aortic Valve Insufficiency Aortic Regurgitation see Aortic Valve Insufficiency Aortic Stenosis see Aortic Valve Stenosis Aortic Stenosis, Supravalvular see Aortic Valve Stenosis Aortic Valve WG 265 Aortic Valve Incompetence see Aortic Valve Insufficiency Aortic Valve Insufficiency WG 265 Aortic Valve Stenosis WG 265 Aorticopulmonary Septal Defect see Aortopulmonary Septal Defect Aortitis WG 410 Aortitis Syndrome see Aortic Arch Syndromes Aortitis, Syphilitic see Syphilis, Cardiovascular Aortocoronary Bypass see Coronary Artery Bypass Aortography WG 410 Aortopulmonary Septal Defect WG 220 Aotus trivirgatus QL 737.P925 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Apazone QV 95 Ape, Barbary see Macaca Ape, Black see Macaca E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 270 ARDS, Human Ape, Celebes see Macaca Apert Syndrome see Acrocephalosyndactylia Apes see Pongidae Apex Cardiography see Kinetocardiography Aphakia WW 260 Aphakia, Postcataract WW 260 Aphaniptera see Fleas Aphasia Neurologic WL 340.5 Psychogenic WM 475.5 Aphasia, Acquired WL 340.5 Psychogenic WM 475.5 Aphasia, Broca WL 340.5 Psychogenic WM 475.5 Aphasia, Childhood WL 340.5 Psychogenic WM 475.5 Aphasia, Expressive see Aphasia, Broca Aphasia, Motor see Aphasia, Broca Aphasia, Nonfluent see Aphasia, Broca Aphasia Tests see Neuropsychological Tests Aphemia see Aphasia Apheresis see Blood Component Removal Aphids QX 503 As vectors of plant virus diseases SB 736 Aphonia Neurologic origin WL 340.2 Psychogenic origin WM 475 Aphorisms and Proverbs PN 6269-6278 Medicine and related fields WZ 309 Aphrodisiacs QV 170 Aphthae see Stomatitis, Aphthous; Moniliasis, Oral Aphthovirus QW 168.5.P4 Apicoectomy WU 230 Apis see Bees Apis Venoms see Bee Venoms Aplastic Anemia see Anemia, Aplastic Aplysia QX 675 Apnea WF 143 Apnea, Central see Sleep Apnea Syndromes Apnea, Obstructive see Sleep Apnea Syndromes Apnea, Sleep see Sleep Apnea Syndromes Apocrine Glands WR 400 Apodemus see Muridae Apomorphine QV 73 Apoplexy see Cerebrovascular Disorders Apothecaries see Pharmacies Apparatus see Equipment and Supplies Apparatus and Instruments see Equipment and Supplies Appendectomy WI 535 Appendiceal Neoplasms WI 535 Appendicitis WI 535 Appendix WI 535 Appetite WI 102 Appetite Depressants QV 129 Appetite Disorders see Eating Disorders Appetite Regulation WI 102 Appetite Suppressants see Appetite Depressants Appetitive Behavior BF 685 Animal aspects QL 758-785 Sex psychology BF 692 Apple see Fruit Appointments and Schedules In hospitals WX 159 Practice management Dental WU 77 Medical W 80 Nursing, by type, e.g. Private duty nursing WY 127 Appropriateness Review see Regional Health Planning Apraxia WL 340 Apricot see Fruit Aprotinin QU 143 Aptitude Tests BF 431-433 In special fields, in the career number for the field, e.g., for dentistry WU 21 APUD Cells WL 102 Apudoma QZ 200-380 Localized, by site Aqueous Humor WW 210 Ara-A see Vidarabine Ara-C see Cytarabine Arabic Physicians see Physicians Arabinofuranosyladenine see Vidarabine Arabinofuranosylcytosine see Cytarabine Arabinofuranosylnucleotides see Arabinonucleotides Arabinonucleotides QU 57 Arabinosyladenine see Vidarabine Arabinosylcytosine see Cytarabine Arachis see Peanuts Arachnid Venoms see Spider Venoms Arachnida QX 467-483 Arachnidism WD 420 Arachnoid WL 200 Arachnoiditis WL 200 Araneid Venoms see Spider Venoms Arbovirus, Group B see Flavivirus Arbovirus Infections WC 524-532 General works WC 524 See also Encephalitis, Epidemic WC 542 Arboviruses QW 168.5.A7 Archaebacteria see Archaeobacteria Archaeobacteria QW 50 Archaeology General CC (entire schedule) Individual countries D-F Prehistoric GN 700-890 Architectural Accessibility In health facilities WX 140 Public health aspects WA 795-799 See also specific types of buildings, e.g., Drug Treatment Centers WM 29-29.1, etc. Architecture NA Public health aspects WA 795-799 See also Design and Construction, Hospital WX 140; Housing WA 795, etc; types of particular buildings, e.g., Laboratories, Dental WU 23-24 Archives CD 931-4280 Cataloging Z 695.2 Arctic Regions Physiological effects and adaptation QT 160 Arcus Senilis WW 220 ARDS, Human see Respiratory Distress Syndrome, ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 271 ARDS, Human Adult Area Health Education Centers W 19 Areawide Planning see Regional Health Planning Areca As medicinal plant QV 766 Botany QK 495.P17 Culture SB 317.P3 Arenaviridae QW 168.5.A8 Arenaviridae Infections WC 501 Arenavirus Infections see Arenaviridae Infections Argentaffin Cells see Enterochromaffin Cells Argentaffin System see Chromaffin System Argentaffinoma see Carcinoid Tumor Arginase QU 136 Arginine QU 60 Arginine Vasopressin see Argipressin Argipressin WK 520 As an antidiuretic QV 160 Argon Inorganic chemistry QD 181.A6 Pharmacology QV 310 Argyria WR 265 Arizona Bacteria see Salmonella arizonae Arm WE 805 Artificial see Artificial Limbs WE 172 Upper arm WE 810 See also Forearm WE 820 Arm Ergometry Test see Exercise Test Arm Injuries WE 805 See also Forearm Injuries WE 820 Armadillos QL 737.E23 As laboratory animals QY 60.M2 Armed Forces Personnel see Military Personnel Armpit see Axilla Arnold-Chiari Deformity WL 101 Aroclors As air pollutants WA 754, etc. As water pollutants WA 689 Organic chemistry QD 341.H9 Toxicology (General) QV 633 Aromatase QU 140 Aromatic Amino Acid Decarboxylases QU 139 Aromatic Compounds see Anti-Infective Agents, Local; Cresols; Phenols QV 223, etc. and other compounds by name; Hydrocarbons; Polycyclic Hydrocarbons; Aromatic Compounds QD 330-341 under Chemistry, Organic Arousal WL 103 Behaviorism BF 199 In infancy & childhood WS 105.5.C7 Arrhenoblastoma see Androblastoma Arrhythmia WG 330 Arrhythmia, Sinus WG 330 Arsenic QV 294 Arsenicals QU 143 As amebicides QV 255 As antisyphilitic agents QV 262 Arson see Firesetting Behavior Arsphenamine QV 262 Art N Accidents in professional work WA 487.5.A78 Anatomy see Anatomy, Artistic NC 760-783.8 By physicians WZ 350 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHX Child study WS 105.5.E8 In psychotherapy see Art Therapy WM 450.5.A8 Related to medicine see Medicine in Art WZ 330, etc. Related to psychiatry WM 49 See also Medical Illustration WZ 348 Art Therapy WM 450.5.A8 In adolescence WS 463 In infancy & childhood WS 350.2 Artemia QX 463 Arterenol see Norepinephrine Arterial Catheterization, Peripheral see Catheterization, Peripheral Arterial Lines see Catheters, Indwelling Arterial Obstructive Diseases see Arterial Occlusive Diseases Arterial Occlusive Diseases WG 510 Arteries WG 510-595 Coronary see Coronary Vessels WG 300 See also Aorta WG 410 Arteriography see Angiography Arteriosclerosis WG 550 Cerebral see Cerebral Arteriosclerosis WL 355 Veterinary SF 811 Arteriosclerosis, Coronary see Coronary Arteriosclerosis Arteriosclerosis Obliterans WG 550 Arteriosclerotic Dementia see Dementia, Vascular Arteriosclerotic Heart Disease see Coronary Disease Arteriovenous Anastomosis WG 590 Arteriovenous Aneurysm see Arteriovenous Fistula Arteriovenous Fistula WG 590 Congenital see Arteriovenous Malformations WG 500 Arteriovenous Hemofiltration see Hemofiltration Arteriovenous Malformations WG 500 Cerebral see Cerebral Arteriovenous malformations WL 355 Arteriovenous Malformations, Cerebral see Cerebral Arteriovenous Malformations Arteriovenous Shunt, Surgical WG 170 Arteritis WG 515 Coronary WG 300 See also Endarteritis WG 515; Periarteritis Nodossa WG 518; Temporal Arteritis WG 510 Arteritis, Temporal see Temporal Arteritis Arthritis WE 344-348 Arthritis, Bacterial see Arthritis, Infectious Arthritis, Degenerative see Osteoarthritis Arthritis, Infectious WE 344 Arthritis, Juvenile Chronic see Arthritis, Juvenile Rheumatoid Arthritis, Juvenile Rheumatoid WE 346 Arthritis, Rheumatic, Acute see Rheumatic Fever Arthritis, Rheumatoid WE 346 Arthritis, Septic see Arthritis, Infectious Arthritis, Viral see Arthritis, Infectious Arthroderma see Ascomycetes Arthrodesis WE 312 Localized, by site Arthrography WE 300 IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 272 Aspiration Pneumonia Arthrogryposis WE 300 Arthromyodysplasia, Congenital see Arthrogryposis Arthropathy, Neurogenic WE 344 Arthroplasty WE 312 Localized, by site Arthroplasty, Replacement see Joint Prosthesis Arthroplasty, Replacement, Hip see Hip Prosthesis Arthroplasty, Replacement, Knee see Knee Prostiiesis Arthropod-Borne Viruses see Arboviruses Arthropod Vectors QX 460 See also Insect vectors QX 650 Arthropod Venoms WD 400-430 Arthropods QX 460-570 Bites, stings and poisoning WD 400-430 Cause of skin diseases WR 360-375 Non-medical Paleozoology QE 815-832 Zoology QL 434-599.82 See also specific arthropods Arthroscopy WE 304 Arthus Phenomenon see Arthus Reaction Arthus Reaction QW 900 Artie Regions see Cold Climate Articulation see Speech Articulation Disorders Neurologic WL 340.2 Psychologic WM 475 Articulators see Dental Articulators Artificial Eye see Eye, Artificial Artificial Fever see Hyperthermia, Induced Artificial Heart see Heart, Artificial Artificial Hibernation see Hibernation, Artificial Artificial Insemination see Insemination, Artificial Artificial Intelligence Q 334-341 In medicine (General) W 26.55.A7 In other special fields (Form number 26.5 in any NLM schedule where applicable) Used for special purposes, by subject Artificial Kidney see Kidney, Artificial Artificial Limbs WE 172 Artificial Organs WO 176 Banks WO 23-24 See also names of specific artificial organs Artificial Pneumothorax see Pneumothorax, Artificial Artificial Respiration see Respiration, Artificial Artificial Sweeteners see Sweetening Agents Artificial Tears see Ophthalmic Solutions Artificial Teeth see Dental Prosthesis; Denture, Partial; Denture, Complete; Tooth, Artificial Artificial Ventricle see Heart-Assist Devices Artiodactyla Diseases SF 997.5.U5 Wild QL 737.U5-737.U595 Artistic Anatomy see Anatomy, Artistic Arvicolinae see Microtinae Arvicolines see Microtinae Arvin see Ancrod Arylsulfonates QU 98 Organic chemistry QD 341. S3 As If Personality see Personality Disorders Asbestos As a mineral TN 930 As air pollutant WA 754 In industry WA 450 Industrial wastes WA 788 Toxicology QV 610 Asbestosis WF 654 Ascariasis WC 870 Veterinary SF 810.A5 Ascaridiasis WC 870 Ascaridoidea QX 277 Ascaris QX 277 Ascaroidea see Ascaridoidea Aschelminthes see Helminths Ascites WI 575 Ascites Shunt, Peritoneovenous see Peritoneovenous Shunt Ascitic Fluid WI 575 Clinical analysis QY 210 Ascomycetes QW 180.5.A8 Ascorbic Acid QU 210 Ascorbic Acid Deficiency WD 140 Asepsis Dental WU 300 Surgical WO 113 Asialia see Xerostomia Asialoglycoproteins QU 55 Asian Americans E 184.06 Specific topics, by subject See also special topics under Ethnic Groups Asiatic Race see Mongoloid Race Asjike see Beriberi ASP A Cement see Glass Ionomer Cements Asparaginase QV 269 Enzymology QU 136 Asparagine QU 60 Aspartame WA 712 Peptides QU 68 Aspartate Aminotransferase QU 141 Aspartate Aminotransferase Isoenzymes see Aspartate Aminotransferase Aspartate Aminotransferase Isozymes see Aspartate Aminotransferase Aspartic Acid QU 60 Aspartic Proteinases QU 136 Aspartyl Proteinases see Aspartic Proteinases Aspartylphenylalanine Methyl Ester see Aspartame Aspergillosis WC 450 Veterinary SF 809.A86 Aspergillus QW 180.5.D38 Aspergillus flavus QW 180.5.D38 Asphyxia WO 250 First aid WA 292 Asphyxia Neonatorum WQ 450 Aspiculariasis see Oxyuriasis Aspidium QV 253 Aspiration Biopsy see Biopsy, Needle Aspiration Lipectomy see Lipectomy Aspiration, Mechanical see Suction Aspiration of Gastric Contents see Pneumonia, Aspiration Aspiration, Pneumatic see Suction Aspiration Pneumonia see Pneumonia, Aspiration ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 273 Aspirin Aspirin QV 95 Aspirin-Like Agents see Anti-Inflammatory Agents, Non-Steroidal Asporogenous Rods, Gram-Positive see Bacteria Assay see Biological Assay Assertiveness Psychology In adolescence WS 462 In adulthood BF 575.A85 In infancy & childhood WS 105.5.S6 Social behavior disorders In adolescence WS 463 In adulthood WM 600 In infancy & childhood WS 350.8.S6 Assessment, Educational see Educational Measurement Assessment of Health Care Needs see Health Services Needs and Demand Assimilation see Acculturation Assimilation of Food see Metabolism Assisted Circulation WG 168 Associateship Practice, Dental see Partnership Practice, Dental Association Free see Free Association WM 460.5.F8 Of ideas (psychology) BF 365-395 Word tests see Word Association Tests WM 145.5.W9, etc. Association, Free see Free Association Association Learning BF 319.5.P34 Astasia-Abasia see Conversion Disorder Asthenia WB 146 Neurocirculatory see Neurocirculatory Asthenia WG 320 See also Neurasthenia WM 174 Asthma Bronchial WF 553 Cardiac see Dyspnea, Paroxysmal WG 370 Asthma, Bronchial see Asthma Asthma, Cardiac see Dyspnea, Paroxysmal Asthma, Exercise-Induced WF 553 Asthmatic Crisis see Status Asthmaticus Asthmatic Shock see Status Asthmaticus Astigmatism WW 310 Astringents QV 65 Astrocytes WL 102.5 Astrocytoma QZ 380 Localized, by site Astrology BF 1651-1729 And birth control BF 1729.B4 And medicine BF 1718 And sex BF 1729.S4 Astronauts, Physical Standards see Standards WD 752 under Space flight Astronomy QB General works QB 42-43.2 Asylums, Insane see Hospitals, Psychiatric Asystole see Heart Arrest Atabrine see Quinacrine Ataractics see Tranquilizing Agents Ataxia WL 390 See also Cerebellar Ataxia WL 320 Ataxia, Cerebellar see Cerebellar Ataxia ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPHA Ataxia, Locomotor see Tables Dorsalis Atelectasis WF 645 Atelectasis, Congestive see Respiratory Distress Syndrome, Adult Ateles see Cebidae Atelinae see Cebidae Atenolol QV 132 Atheroma see Atherosclerosis Atherosclerosis WG 550 Atherosclerosis, Coronary see Coronary Arteriosclerosis Athetosis WL 390 Athlete Is Foot see Tinea Pedis Athletic Injuries QT 261 First aid WA 292 Athletics see Sports Athymic Mice see Mice, Nude Atlanto-Axial Joint WE 725 Atlanto-Occipital Joint WE 708 Atlas WE 725 Atlases G (Form number 17 in any NLM schedule where applicable) Embryology QS 617 Forensic medicine and dentistry W 617 Histology QS 517 Immunology QW 517 Operative dentistry WU 317 Oral surgery WU 600.7 Orthodontics WU 417 Pharmacy and pharmaceutics QV 717 Prosthodontics WU 507 Surgery WO 517 Atloido-Occipital Joint see Atlanto-Occipital Joint ATLV see HTLV-I Atmosphere QC 851-999 Control WA 750-776 In industry WA 450 See also Environment, Controlled WA 750, etc. Pollutants see Air pollutants WA 754, etc. Relation to disease see Climate WB 700 Atmospheric Pressure High altitude WD 710 In industry WA 450 Meteorology QC 885-896 Underwater WD 650 Atomic Absorption see Spectrophotometry, Atomic Absorption Atomic Energy see Nuclear Energy Atomic Medicine see Nuclear Medicine Atomic Warfare see Nuclear Warfare Atomizers see Nebulizers and Vaporizers- Atopic Hypersensitivity see Hypersensitivity, Immediate Atopy see Hypersensitivity, Immediate ATP see Adenosine Triphosphate ATP Receptors see Receptors, Purinergic P2 ATPase see Adenosinetriphosphatase ATPase, Calcium see Ca(2+)-Transporting ATPase ATPase, Calcium Magnesium see Ca(2+) Mg(2+)-ATPase ATPase, F0 see H(+)-Transporting ATP Synthase E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 274 Autoanalysis ATPase, Fl see H(+)-Transporting ATP Synthase ATPase, Magnesium see Ca(2+) Mg(2+)-ATPase ATPase, Sodium, Potassium see Na(+)-K(+)-Exchanging ATPase Atractylic Acid see Atractyloside Atractyloside QU 75 Atracurium QV 140 Atracurium Besylate see Atracurium Atracurium Dibesylate see Atracurium Atrial Fibrillation WG 330 Atrial Flutter WG 330 Atrial Natriuretic Factor QU 68 Atrial Natriuretic Peptides see Atrial Natriuretic Factor Atriopeptins see Atrial Natriuretic Factor Atrioventricular Block see Heart Block Atrioventricular Bundle see Bundle of His Atrioventricular Node WG 201-202 Atrocities see Violence Atropa Belladonna see Belladonna Atrophy Manifestation of disease QZ 180 Atropine QV 134 Atropine Derivatives QV 134 Attendants see Nurses' Aides; Psychiatric Aides; Allied Health Personnel Attention BF 321-323 Children WS 105.5.C7 Vigilance BF 323.V5 Attention Deficit Disorder with Hyperactivity WS 350.8.A8 In adulthood WL 354 Attention Deficit Hyperactivity Disorder see Attention Deficit Disorder with Hyperactivity Attitude BF 327 In adolescence WS 462 In infancy & childhood WS 105.5.A8 Of patients W 85 In hospitals WX 158.5 In mental hospitals WM 29.5 Toward health insurance W 275 To specific topics, by subject Attitude of Health Personnel Allied health personnel W 21.5 Dentists WU 61 Hospital staff WX 160 Nurses WY 87 Physicians W 62 Psychiatrists WM 62 Special areas, with the area Attitude to Computers QA 76.9.P75 Attitude to Death BF 789.D4 In infancy & childhood WS 105.5.A8 Pastoral care WM 61 Speculative philosophy BD 443.8-445 Attitude to Health W 85 Other specific subjects, by subject Audio-Visual Aids (Form number 18.2 in any NLM schedule where applicable) Special topics, by subject Audiology WV 270-280 See also Hearing WV 270-280 Audiometry WV 272 Audiometry, Electroencephalic Response see Audiometry, Evoked Response Audiometry, Evoked Response WV 272 Audiometry, Impedance see Acoustic Impedance Tests Audiometry, Speech WV 272 Audition, Limits of see Auditory Threshold Auditory Brain Stem Evoked Responses see Evoked Potentials, Auditory, Brain Stem Auditory Canal, External see Ear Canal Auditory Cortex WL 307 Auditory Diseases, Central WV 270 Auditory Evoked Potentials see Evoked Potentials, Auditory Auditory Evoked Response see Evoked Potentials, Auditory Auditory Fatigue WV 272 Auditory Localization see Sound Localization Auditory Nerve see Acoustic Nerve Auditory Ossicles see Ear Ossicles Auditory Pathways WV 272 Auditory Perception WV 272 In infancy & childhood and other groups WV 272 Paracusis WV 272 Auditory Perceptual Disorders WV 270 Auditory Prosthesis see Cochlear Implant Auditory Threshold WV 272 In infancy & childhood and other groups WV 272 Auditory Tube see Eustachian Tube Auerbach's Plexus see Myenteric Plexus Aujeszky's Disease see Pseudorabies Aujeszky's Disease Virus see Herpesvirus 1, Suid Aural Vertigo see Meniere's Disease Auramine O see Benzophenoneidum Auranofin QV 247 Aureolic Acid see Plicamycin Aureomycin see Chlortetracycline Auricle, Ear see Ear, External Auricular Fibrillation see Atrial Fibrillation Auricular Flutter see Atrial Flutter Auriculin see Atrial Natriuretic Factor Auriculo-Ventricular Dissociation see Heart Block Auriculoventricular Bundle see Heart Conduction System Aurothioglucose QV 247 Auscultation WB 278 Heart see Heart Auscultation WG 141.5.A9 Used for special purposes, by subject Australia Antigen see Hepatitis B Antigens Australoid Race Anthropology GN 662-671 See also applicable special topics under Ethnic groups Authoritarianism Psychology BF 698.35.A87 Social psychology HM 271 Autism WM 203.5 Autism, Infantile WM 203.5 Autoanalysis Q 183.9 Analysis in a special field, in the technique number ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 275 Autoanalysis for the field, e.g. QY 25 for clinical analysis Special topics, by subject Autoantibodies QW 575 As a cause of autoimmune diseases WD 305 Autobiography CT As a literary form CT 25 Of mentally ill WM 40 Of physicians WZ 100 Of specialists in dentistry, nursing, pharmacy, psychology, science, etc. WZ 100 Of patients with a particular disease, with the disease Autoeroticism see Paraphilias Autogenic Training Parapsychology BF 1156.S8 Psychiatry WM 415 Autograft see Transplantation, Autologous Autohemolysis see Hemolysis Autoimmune Diseases WD 305 Autoimmunity QW 545 Autolysis QZ 180 Automated Multiphasic Health Testing see Multiphasic Screening Automatic Data Processing In medicine (General) W 26.55.A9 In other special fields (Form number 26.5 in any NLM schedule where applicable) Used for special purposes, by subject Automation T 59.5 Used for special purposes, by subject, e.g., of clinical laboratory procedures QY 23 Automation, Office see Office Automation Automatism Parapsychology (General) BF 1321 Psychiatry WM 197 Other special topics by subject, e.g., Automatic writing BF 1343 Automobile Accidents see Accidents, Traffic Automobile Driver Examination WA 275 Automobile Driving Public health aspects WA 275 Automobile Exhaust WA 754 Automobiles TL 1-390 Human engineering in design TL 250 Noise hazard WA 776 Sanitary conditions of buses and other public carriers WA 810 Sanitary disposal WA 778 Autonomic Agents QV 120-137 Autonomic Denervation WL 600 Autonomic Ganglia see Ganglia, Autonomic Autonomic Nerve Block WO 375 Autonomic Nervous System WL 600-610 Autonomic Nervous System Diseases WL 600 Autonomous Replication see DNA Replication Autopsy QZ 35 Medicolegal W 825 Veterinary SF 769 See also names of particular conditions requiring autopsy, e.g., Substance Abuse WM 270-290 Autoradiography Biochemistry General QU 4 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH4 Techniques QU 25 Biology QH 324.9.A9 Cytological techniques QH 585-585.5 Clinical pathology QY 95 Diagnosis (General) WN 445 Histological technique QS 525 Used for special purposes, by subject Autoregulation see Homeostasis Autosexuality see Narcissism Autosome Abnormalities see Chromosome Abnormalities Autosuggestion Parapsychology BF 1156.S8 Psychiatry WM 415 Autotransplant see Transplantation, Autologous AV Node see Atrioventricular Node Availability Equivalency see Biological Availability Availability of Health Services see Health Services Accessibility Aversive Therapy WM 425.5.A9 Avertin see Alcohol, Ethyl Avian Hypersensitivity Pneumonitis see Bird Fancier's Lung Avian Infectious Bronchitis Virus see Infectious Bronchitis Virus, Avian Avian Leukosis SF 995.6.L4 Avian Orthomyxovirus Type A see Orthomyxovirus Type A, Avian Avian Sarcoma Virus B77 see Sarcoma Viruses, Avian Aviation TL Air defense UG 730, etc. Standards Physical WD 705 Psychological WD 730 See also Aircraft WD 700, etc.; Space Flight WD 750-758 Aviation Accidents see Accidents, Aviation Aviation Dentistry see Dentistry; Aerospace Medicine; Military Dentistry Aviation Medicine see Aerospace Medicine Aviation Nursing see Aviation WY 143 under Nursing Aviation, Physical Standards see Standards WD 705 under Aviation Avidin QU 55 Avidity, Antibody see Antibody Affinity Avitaminosis WD 105-155 Pathogenesis of disease in general QZ 109 Veterinary SF 855.V58 See also names of specific vitamin deficiencies Avoidance Learning BF 319.5.A9 Awareness BF 321 Axenic Animals see Germ-Free Life Axilla WE 812 Axillary Artery WG 595.A9 Axillary Vein WG 625.A9 Axis WE 725 Axolotl see Ambystoma Axolotl, Mexican see Ambystoma mexicanum Axons WL 102.5 Ayerza's Syndrome see Hypertension, Pulmonary Ayurvedic Medicine see Medicine, Ayurvedic E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 276 Bacteriologists, Directories Azacyclopropanes see Aziridines Azapropazone see Apazone Azaserine QU 60 As antifungal agent QV 252 Cancer chemotiierapy QZ 267 Immunosuppression QW 920 Azathioprine QV 269 Cancer chemotherapy QZ 267 Immunosuppression QW 920 Azeserine see Azaserine Azides QU 54 Organic chemistry Aliphatic compounds QD 305.N84 Azidothymidine see Zidovudine Aziridines Organic chemistry QD 401 As carcinogens QZ 202 Azirines Organic chemistry QD 401 Azo Compounds QV 235 Organic chemistry Aliphatic compounds QD 305.A9 Aromatic compounds QD 341.A9 Azoles Organic chemistry QD 401 Azotemia see Uremia Azotobacter QW 131 AZT (Antiviral) see Zidovudine Aztreonam QV 350 Azygos Vein WG 625.A99 B B-Cell Differentiation Antigens see Antigens, Differentiation, B-Lymphocyte B-Cells see B-Lymphocytes B-K Mole Syndrome see Dysplastic Nevus Syndrome B-Lymphocyte Differentiation Antigens see Antigens, Differentiation, B-Lymphocyte B-Lymphocytes WH 200 Babesiasis see Babesiosis Babesiosis SF 791 Baboon, Gelada see Theropithecus gelada Baboons see Papio Baboons, Savanna see Papio Bacillaceae QW 127 Bacillary Dysentery see Dysentery, Bacillary Bacillus QW 127.5.B2 Bacillus anthracis QW 127.5.B2 Bacillus megaterium QW 127.5.B2 Bacillus stearothermophilus QW 127.5.B2 Bacillus subtilis QW 127.5.B2 Bacillus thuringiensis QW 127.5.B2 Bacitracin QV 350 Back WE 720-755 Back Pain WE 720 See also Low back pain WE 755 Backache see Back Pain Background Radiation WN 105 Baclofen Biochemistry QU 60 As a central muscle relaxant QV 140 Baclophen see Baclofen Bacteremia see Septicemia WC 240 Bacteria QW Actinomycetes QW 115, etc. Anatomy and morphology QW 51 As cause of disease QZ 65 Budding and/or appendaged QW 153 General works QW 50 Gliding QW 128 Gram-negative facultatively anaerobic rods QW 137-141 Gram-positive bacteria QW 142-142.5 Asporogenous rods QW 142.5.A8 Cocci QW 142.5.C6 Invasiveness QW 730 Metabolism QW 52 Sheathed QW 153 Spiral and curved QW 154 Bacteria, Anaerobic QW 52 Bacterial Adhesion QW 52 Bacterial Antibodies see Antibodies, Bacterial Bacterial Antigens see Antigens, Bacterial Bacterial Conjugation see Conjugation, Genetic Bacterial DNA see DNA, Bacterial Bacterial Drug Resistance see Drug Resistance, Microbial Bacterial Gene Expression Regulation see Gene Expression Regulation, Bacterial Bacterial Gene Products see Bacterial Proteins Bacterial Gene Proteins see Bacterial Proteins Bacterial Genetics see Genetics, Microbial Bacterial Infections WC 200-425 Enteric WC 260-290 In infancy & childhood WC 200-425 In plants SB 734 Of the kidney WJ 351 Veterinary SF 780.3 Specific infection see name of infection Other particular organ affected, by organ or region Bacterial Outer Membrane Proteins QW 52 Bacterial Pili see Pili, Sex Bacterial Polysaccharides see Polysaccharides, Bacterial Bacterial Proteins QW 52 Therapeutic use, with the disease being treated Bacterial RNA see RNA, Bacterial Bacterial Sensitivity Tests see Microbial Sensitivity Tests Bacterial Spores see Spores, Bacterial Bacterial Toxins QW 630.5.B2 Bacterial Vaccines WC 200 Pyrogenic WB 469 or with disease being treated For specific diseases, with the diseases Bacterial Warfare see Biological Warfare Bactericidal Action of Antibodies see Bacteriolysis Bacteriocins QV 350 Bacteriodaceae QW 133 Bacteriological Techniques QW 25 Clinical pathology QY 100 Veterinary QW 70 Bacteriologists, Directories see Directories QW 22 under Bacteriology ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 277 Bacteriology Bacteriology QW 1-155 General works QW 50 Clinical see Bacteriological Techniques QY 100 Dental QW 65 Directories QW 22 Industrial QW 75 Nursing texts QW 50, etc. Of air see Air Microbiology QW 82 Of food see Food Microbiology QW 85 Of milk QW 85 Of plants QW 60 Of sewage QW 80 Of soil see Soil Microbiology QW 60 Of water see Water Microbiology QW 80 Veterinary science QW 70 Bacteriolysis QW 660 Bacteriophage lambda QW 161.5.C6 Bacteriophage Typing QW 25 Bacteriophages QW 161 Bacteriophages T see T-Phages Bacteriorhodopsin QW 52 Bacteriuria WJ 351 In urine analysis QY 185 Bacteroides QW 133 Bacteroides Infections WC 200 Bagassosis see Pneumoconiosis Balance see Equilibrium Balantidiasis WC 735 Balantidium QX 151 Baldness see Alopecia Balint Psychoanalytic Therapy see Psychoanalytic Therapy Ballistics, Wound see Wounds, Gunshot Ballistocardiography WG 141.5.B2 Balloon Angioplasty see Angioplasty, Balloon Balloon Catheterization see Balloon Dilatation Balloon Dilatation WB 365 In cardiovascular diseases WG 166.5.B2 In other diseases, with the disease Balloon Dilatation, Coronary Artery see Angioplasty, Transluminal, Percutaneous Coronary Balloon Tamponade see Balloon Dilatation Balloon Valvotomy see Balloon Dilatation Balloon Valvuloplasty see Balloon Dilatation Balneology WB 525 Balneotherapy see Balneology Balsams QV 241 Banana see Fruit Bancroftian Elephantiasis see Elephantiasis, Filarial Band 3 Protein WH 400 Bandages First aid WA 292 Surgical WO 167 See also Occlusive Dressings WO 167 Bandages, Occlusive see Occlusive Dressings Bandicoot Rats see Muridae Bandicota see Muridae Banding, Chromosome see Chromosome Banding Bang's Disease see Brucellosis, Bovine Banks see Blood Banks; Eye Banks; Tissue Banks (Form number 23-24 in any NLM schedule where applicable) ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Bar Codes see Automatic Data Processing Baranyls Test see Caloric Tests Barbary Ape see Macaca Barber Surgeons see Surgery Barbering Care of hair WR 465 Public health aspects of barber shops WA 744 Registration of barbers WA 32 Barbital QV 88 Barbitone see Barbital Barbiturates QV 88 Barbituric Acid Derivatives see Barbiturates Barefoot Doctors see Community Health Aides Barium QV 618 As a contrast medium in radiology WN 160 Barlow's Disease see Scurvy Barnacles QX 463 Baroreceptors see Pressoreceptors Barotrauma In high altitude WD 710 Underwater WD 650 See also Atmospheric Pressure Barr Bodies see Sex Chromatin Barrett Esophagus WI 250 Barriers, Architectural see Architectural Accessibility Bartholin Is Glands WP 200 Bartonella Infections WC 640 Bartonellaceae Infections WC 640 Bartonellosis see Bartonella Infections Bartter's Disease WK 770 Basal Anesthesia see Preanesthetic Medication Basal Ganglia WL 307 Basal Ganglia Diseases WL 307 See also names of specific disorders, e.g., Parkinson Disease WL 359 Basal Metabolism QU 125 Basal Nuclei see Basal Ganglia Basal Vein see Cerebral Veins Base Composition QU 58 Base Pairs see Base Composition Base Ratio see Base Composition Base Sequence QU 58 Base Sequence Homology see Sequence Homology, Nucleic Acid Baseball QT 260.5.B2 Basedow's Disease see Goiter, Exophthalmic Basic Life Support see Cardiopulmonary Resuscitation Basic Pancreatic Trypsin Inhibitor see Aprotinin Basidiomycetes QW 180.5.B2 Basilar Artery WG 595.B2 Basilar Artery Insufficiency see Vertebrobasilar Insufficiency Basilar Impression see Platybasia Basilar Membrane WV 250 Basketball QT 260.5.B3 Basophilism, Pituitary see Cushing's Syndrome Basophils WH 200 Basophils, Tissue see Mast Cells Bathing Beaches WA 820 Baths Hygiene QT 240 IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 278 Benzathine Penicillin Mud see Mud Therapy WB 525 Public WA 820 Sand see Ammotherapy WB 525 See also Balneology WB 525; Thalassotherapy WB 750 Baths, Finnish WB 525 Baths, Sand see Ammotiierapy Bats see Chiroptera Batten-Spielmeyer-Vogt Disease see Neuronal Ceroid-Lipofuscinosis Battered Child Syndrome WA 320 Battle Fatigue see Combat Disorders Baunscheidtism see Acupuncture Bayer 39 see Inproquone BCG see Mycobacterium bovis BCG Vaccine WF 250 Beaches, Bathing see Bathing Beaches Beans see Legumes Beard see Hair Beauty BH Women HQ 1219-1220 Plastic surgery WO 600 Beauty Culture Hygienic aspects QT 275 Public health aspects WA 744 Registration of beauticians and cosmeticians WA 32 Beauty Salons see Beauty Culture Beavers see Rodentia Bechterew's Disease see Spondylitis, Ankylosing Becker Muscular Dystrophy see Muscular Dystrophy Beclomethasone WK 757 Beclomethasone Dipropionate see Beclomethasone Bed Capacity, Hospital see Hospital Bed Capacity Bed Conversion WX 140 In special type of facilities, with the facility Bed Occupancy WX 16 Bed Size, Hospital see Hospital Bed Capacity Bedbugs QX 503 Bedding and Linens WX 165 Home Care of Sick W 26 Beds Home Care of Sick W 26 Hospitals WX 147 Beds, Swing see Bed Conversion Bedsore see Decubitus Ulcer Bedsores see Decubitus Ulcer Bee Venoms WD 430 Beer As a dietary supplement in health or disease WB 444 Chemical technology TP 577 Microorganisms of fermentation QW 85 See also Alcoholism WM 274; Alcohol, Ethyl QV 84, etc. Bees QX 565 Beetles QX 555 Beggiatoales see Cytophagales QW 128 Beginning of Life see Biogenesis Behavior Drug effects WM; QV In adolescence WS 462 In infancy & childhood WS 105 Psychology (General) BF 11-32 Sex see Sex behavior HQ 12-30.7, etc Special topics, by subject Behavior, Adaptive see Adaptation, Psychological Behavior, Addictive WM 176 Behavior, Adolescent see Adolescent Behavior Behavior, Animal QL 750-785.3 Behavior, Compulsive see Compulsive Behavior Behavior, Dangerous see Dangerous Behavior Behavior Disorders see Affective Symptoms; Child Behavior Disorders; Social Behavior Disorders; names of specific disorders Behavior, Exploratory see Exploratory Behavior Behavior Modification see Behavior Therapy Behavior Modifiers see Psychotropic Drugs Behavior Therapy WM 425 In adolescence WS 463 In infancy & childhood WS 350.6 Nursing texts WY 160 See also Counseling WY 87, etc.; Nurse-patient relations WY 87 Behavior Therapy, Cognitive see Cognitive Therapy Behavioral Medicine WB 103 Special topics, by subject Behavioral Sciences Animals see Ethology QL 750-785.3 Educational aspects LB-LC Psychiatric aspects WM Psychological aspects BF Sociological aspects HM Other special topics, by subject, e.g., statistics for the behavioral sciences HA 29 Behaviorism BF 199 Behcet's Syndrome WW 240 Bejel WC 422 Belching see Eructation Belgian Hare see Rabbits Belladonna As a medicinal plant QV 766 As a sympatholytic QV 134 Culture SB 295.B4 Poisoning WD 500 Bellas Palsy see Facial Paralysis Benactyzine QV 77.9 Bence Jones Protein WH 540 Bender-Gestalt Test WM 145.5.B4 Bends see Decompression Sickness Beneckea see Vibrio Benhydramin see Diphenhydramine Benign Intracranial Hypertension see Pseudotumor Cerebri Benign Monoclonal Gammopathies see Monoclonal Gammopathies, Benign Bensokain see Benzocaine Benzalacetophenone see Chalcone Benzalkonium see Benzalkonium Compounds Benzalkonium Compounds QV 233 Benzamides QU 62 Organic chemistry QD 341.A7 Benzanthracenes QZ 202 Benzathine Penicillin see Penicillin G, Benzathine ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 279 Benzene Organic chemistry QD 341.H9 Toxicology QV 633 Benzene Derivatives Organic chemistry QD 341.H9 Toxicology QV 633 Benzene Hexachloride As an insecticide WA 240 Toxicology QV 633 Benzimidazoles As anthelmintics QV 253 Organic chemistry QD 401 Veterinary pharmacology SF 918.A45 Benzo(a)pyrene QZ 202 Benzoates QU 98 Organic chemistry QD 341.A2 Benzocaine QV 115 Benzodiazepine Tranquilizers see Anti-Anxiety Agents, Benzodiazepine Benzoin QV 241 Benzol see Benzene Benzophenoneidum Toxicology QV 632 As a disinfectant QV 235 Benzopyrans Organic chemistry QD 405 Benzopyrenes As carcinogens QZ 202 Benzothiadiazines Organic chemistry QD 401 Benzoyl Peroxide As a dermatological agent QV 60 Benzoyl Superoxide see Benzoyl Peroxide Benzylamines Biochemistry QU 61 Benzylideneacetophenone see Chalcone Benzylpenicillin see Penicillin G Bereavement BF 575.G7 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Bereavement Care see Hospice Care Berger's Disease see Glomerulonephritis, IGA Beriberi WD 122 Berries see Fruit Berry Aneurysm see Cerebral Aneurysm Bertielliasis see Cestode Infections Berylliosis WF 654 Beryllium QV 275 Beryllium Disease see Berylliosis Besnier-Boeck Disease see Sarcoidosis Besnoitiasis see Protozoan Infections Bestiality see Paraphilias beta-Adrenergic Blocking Agents see Adrenergic beta-Antagonists beta-Adrenergic Receptor Agonists see Adrenergic beta-Agonists beta-Adrenergic Receptor Blockaders see Adrenergic beta-Antagonists beta-Adrenergic Receptors see Receptors, Adrenergic, beta beta-Alanine Ketoglutarate Aminotransferase see Aminobutyrate Aminotransferase beta,beta-Dimethylcysteine see Penicillamine beta-Blockers, Adrenergic see Adrenergic beta-Antagonists Beta Cell, Artificial see Insulin Infusion Systems beta-Cell Tumor see Insulinoma Beta Globulins WH 400 Clinical analysis QY 455 beta-Hydroxyphenethylamine see 2-Hydroxyphenethylamine beta-Hypophamine see Vasopressins beta-Lactam Antibiotics see Antibiotics, Lactam beta-Lactamase I see Penicillinase beta-Lactamases QU 136 Beta-naphthol see Naphthols Beta Particles see Beta Rays beta-Phenylethanolamine see 2-Hydroxyphenethylamine Beta Rays WN 105 beta 2-Microglobulin WH 400 Clinical analysis QY 455 Betadexamethasone see Betamethasone Betaine QV 87 Betamethasone WK 757 Betatrons see Particle Accelerators Betel see Areca Beverages As a dietary supplement in health or disease WB 433-444 Chemical technology TP 500-659 Microbiology QW 85 Public health (General) WA 695 Legislation (General) WA 697 See also names of specific beverages, e.g. Alcoholic beverages WB 444, etc. Bezoars WI 300 Of the intestines WI 400 Veterinary SF 851 Bhang see Cannabis Bible BS Medicine depicted in WZ 330 Special topics, by subject, e.g., medical properties of Biblical plants QV 766 Bibliography Of subjects represented in NLM's classification, appropriate classification number preceded by the letter Z Of other subjects, LC's Z schedule See bibliography section of Introduction for further instructions Bibliography, Descriptive Z 1001 Bibliography, National Z 1201-4980 Bibliography of Medicine General works including monographs and serials Issued as monograph ZWB 100 Issued as serial ZW 1 Of monographs ZWB 100 Issued serially ZW 1 Of serials ZW 1 On specific subject, NLM number for the subject preceded by Z Bibliography, Statistical see Bibliometrics Bibliometrics Z 669.8 Special topics, by subject Bibliotherapy WM 450.5.B5 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 280 Biography Bicarbonates Inorganic chemistry QD 181.CI Pharmacology QV 138.C1 Bicuculline QV 103 Bicycle Ergometry Test see Exercise Test Bicycling QT 260.5.B5 Bifidobacterium QW 125.5.A2 Bifocal Lenses see Eyeglasses Bifunctional Reagents see Cross-Linking Reagents Biguanides QU 61 Organic chemistry QD 305.A8 Bilayer Fluidity see Membrane Fluidity Bilayers, Lipid see Lipid Bilayers Bile WI 703 Bile Acids and Salts WI 703 Bile Duct Diseases WI 750 Bile Duct Neoplasms WI 765 Bile Duct Obstruction see Cholestasis Bile Duct Obstruction, Extrahepatic WI 750 Bile Ducts WI 750 See also Common Bile Duct WI 750; Cystic Duct WI 750; Hepatic Duct WI 750 Bile Ducts, Intrahepatic WI 750 Bile Pigments WI 703 Clinical pathology QY 143 Bile Reflux WI 703 Bile Salts see Bile Acids and Salts Bilharzia see Schistosoma Bilharziasis see Schistosomiasis Biliary Atresia WI 750 Biliary Calculi see Cholelithiasis Biliary Calculi, Common Bile Duct see Common Bile Duct Calculi Biliary Fistula WI 750 Biliary Stasis see Cholestasis Biliary Stasis, Extrahepatic see Bile Duct Obstruction, Extrahepatic Biliary Surgery see Biliary Tract Surgery Biliary Tract WI 700-770 Biliary Tract Diseases WI 700-770 General works WI 700 Biliary Tract Neoplasms WI 735 Biliary Tract Surgery WI 770 Bilirubin WI 703 Clinical pathology QY 143 Bilirubin Encephalopathy see Kernicterus Bilirubinemia see Hyperbilirubinemia Binding, Competitive Bacteriology QW 570 Biochemistry (General) QU 34 Pharmacology QV 38 Binding Proteins see Carrier Proteins Binding Sites Antigen-antibody reactions QW 570 Biochemistry (General) QU 34 Immunochemistry QW 504.5 Pharmacology QV 38 Binding Sites, Antibody QW 575 See also Agglutination QW 640 Binocular Vision see Depth Perception; Eye Movements; Accommodation, Ocular; Vision Bioassay see Biological assay Bioavailability see Biological Availability Biobibliography General Z 1010 Individual WZ 100 Of individuals in fields largely unrelated to the biological sciences, in the appropriate LC number Of groups of persons in special fields WZ 112-112.5 or in appropriate LC number Biochemic Medicine see Alternative Medicine Biochemical Genetics see Genetics, Biochemical Biochemical Markers see Biological Markers Biochemical Phenomena see Biochemistry Biochemistry QU Biochemical phenomena (General) QU 34 Biography Collective WZ 112 Individual WZ 100 Cryobiochemistry QU 25 Directories QU 22 Fetus WQ 210.5 Inorganic substances QU 130 Nursing texts QU 4, etc. Of respiration WF 110 Technique QU 25 See also names of specialties and systems Biochemists see Biography; Directories QU 22 under Biochemistry Biocompatible Materials QT 37 Used for special purposes, by subject, e.g., for artificial organs (General) WO 176 Biocompatible Materials Testing see Materials Testing Biodegradation WA 671 Waste disposal WA 778-788 Special topics, by subject Bioelectric Energy Sources QT 34 Used for special purposes, by subject, e.g. for pacemakers WG 26 Bioenergetics see Energy Metabolism Bioequivalence see Therapeutic Equivalency Bioethics QH 332 Special topics, by subject See also Ethics, Medical W 50 Biofeedback (Psychology) WL 103 Behavior therapy WM 425.5.B6 Bioflavonoids QU 220 Biogenesis QH 325 Legal establishment of beginning of life W 789 Biogenic Amines QU 61 Special topics, by subject Biographical Accounts of Disease see Name of diseases, e.g. Mental Retardation Biographical Clinics see Famous Persons; Psychoanalytic Interpretation; names of particular persons Biography CT As a form of literature CT 21 Of mentally ill WM 40 Of other persons with particular diseases, with the disease Physicians and specialists of medically related fields Collective WZ 112-150 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 281 Individual WZ 100 Scientists and behavioral scientists Collective in appropriate LC number Individual WZ 100 Other professions, in appropriate LC number See also names of other groups of persons, e.g., Pharmacists WZ 112.5.P4 Biohazards Containment see Containment of Biohazards Biological Assay QV 771 Of hormones QY 330 Of vitamins QY 350 Biological Availability QV 38 Special topics, by subject Biological Availability, Nutritional see Nutritive Value Biological Chemistry see Biochemistry Biological Clocks QT 167 See also special topics under Orcadian Rhythm Biological Dressings WO 167 Biological Energy Sources see Bioelectric Energy Sources Biological Markers Genetics QH 438.4.B55 In the diagnosis of a particular disease, with the disease Biological Monitoring see Environmental Monitoring Biological Oscillators see Biological Clocks Biological Pest Control see Pest Control, Biological Biological Products QW 800 Refrigeration WA 730 Tissue extracts QV 370 Veterinary SF 918.B5 See also Hormones, Synthetic WK 187 Biological Psychiatry WM 102 Special topics, by subject Biological Pump see Biological Transport, Active Biological Response Modifiers QW 800 Biological Transport QH 509 Cytology QH 601 Metabolism QU 120 See also Osmosis QH 615, etc. Biological Transport, Active QH 509 Cytology QH 601 Metabolism QU 120 Biological Warfare Bacteriological aspects QW 300 Military aspects UG 447.8 Biological Waste Disposal see Medical Waste Disposal Biologies see Biological Products Biology QH 301-705 General works QH 307-307.2 History QH 305-305.2 In art N 72.B5 Bioluminescence see Luminescence Bioluminescent Proteins see Luminescent Proteins Biomass see Ecology Biomaterials see Biocompatible Materials Biomathematics see Mathematics Biomechanics WE 103 Biomedical Engineering QT 36 Special topics, by subject Biomedical Research see Research Biomedical Technology see Technology, Medical Biometry QH 323.5 Medical WA 950 Biomodulators see Biological Response Modifiers Bionator see Activator Appliances Bionics Q 317-321 Used for special purposes, by subject, e.g. in biophysics QT 34 Bionomics see Ecology Bioperiodicity see Periodicity Biopharmaceutics QV 38 Biophysics QT 34 Radiation WN 110 Biopolymers Organic chemistry QD 380-388 Bioprobes see Biosensors Bioprosthesis For heart valve WG 169 See also Heart valve prosthesis Biopsy Clinical diagnosis WB 379 Surgical diagnosis WO 142 Veterinary SF 772 Specific area, by organ; in specific diseases, with the disease Biopsy, Chorionic Villi see Chorionic Villi Sampling Biopsy, Needle Clinical diagnosis WB 379 Surgical diagnosis WO 142 Specific area, by organ; in specific diseases, with the disease Biopterin As a pteridines QU 188 As a growth substance QU 107 Biorhythms see Biological Clocks; Orcadian Rhythm; Periodicity Biosensors QT 36 Biostatistics see Statistics Biosynthetic Proteins see Recombinant Proteins Biotechnology TP 248.13-248.65 Applied to specific topics, by subject Biotin QU 195 Biotransformation Metabolism QU 120 Pharmacology QV 38 Biphenyl Compounds As carcinogens QZ 202 As insecticides WA 240 Organic chemistry QD 341.H9 Toxicology QV 633 Bipolar Disorder WM 207 Bird Diseases SF 994-995.6 Bird Fancier's Lung WF 150 Birds As laboratory animals QY 60. B4 Domestic (Breeding) SF 460-473 Wild QL 671-699 Birth see Delivery; Biogenesis Birth Certificates HA 38-39 Birth Control see Contraception; Family Planning Birth Defects see Abnormalities ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 282 Blood Cell Count, White Birth Injuries WS 405 Birth, Multiple see Pregnancy Multiple; named groups, e.g., Twins Birth Order Psychological aspects in children WS 105.5.F2 Birth Rate HB 901-1108 Birth Registration see Birth Certificates Birth Statistics see Birth Rate; Vital Statistics Birth Weight Newborn WS 420 Premature infant WS 410 Tables WS 16 Birthmark see Hemangioma; Nevus; Nevus, Pigmented Bis(Chloromethyl) Ether As a carcinogen QZ 202 Bisexuality As a life style HQ 74 Psychiatric aspects WM 611 Bishydroxycoumarin QV 193 Bismuth QV 290 Bisnorephedrine see 2-Hydroxyphenethylamine Bite Force WU 440 Bites and Stings WD 400-430 Insects see Insect Bites and Stings WD 430 Snake see Snake Bites WD 410 Spider and scorpion see Arachnidism WD 420 Surgical treatment WO 700 Bitters see Flavoring Agents; Gastrointestinal Agents Biundulant Meningc—Encephalitis Virus see Encephalitis Viruses, Tick-Borne Biureas Organic chemistry QD 315 BK Virus see Polyomavirus hominis 1 Black Ape see Macaca Black Flies see Simuliidae Black Tongue see Tongue, Hairy Blacks American E 184.6-185.97 As physicians Collective biography WZ 150 History WZ 80.5.B5 Individual biography WZ 100 In other countries, see name of country in LC schedules D-F See also special topics under Ethnic groups Blackwater Fever WC 750-770 Bladder WJ 500-504 Bladder Calculi WJ 500 Bladder Diseases WJ 500-504 General WJ 500 See also Vesicovaginal Fistula WP 180 Bladder Drug Administration see Administration, Intravesical Bladder Exstrophy WJ 500 Bladder Fistula WJ 500 Bladder Neck Obstruction WJ 500 Bladder Neoplasms WJ 504 Bladder, Neurogenic WJ 500 Bladder Stones see Bladder Calculi Bladder Worm see Taenia Blast Injuries WO 820 Blast Transformation see Lymphocyte Transformation Blast-2 Antigen, B-Cell see Antigens, Differentiation, B-Lymphocyte Blastocladiella QW 180.5.P4 Blastocyst Transfer see Embryo Transfer Blastogenesis see Lymphocyte Transformation Blastomyces QW 180.5.A8 Blastomycosis WC 450 Blastomycosis, North American see Blastomycosis Blastomycosis, South American see Paracoccidioidomycosis Bleeding see Hemorrhage Blennorrhea, Inclusion see Conjunctivitis, Inclusion Bleomycins Pharmacology QV 269 Therapeutic use QZ 267 Blepharitis WW 205 Blepharoptosis WW 205 Blepharospasm WW 205 Blindness WW 276 Color see Color Blindness WW 150 Education of blind HV 1618-2349 Hysterical WM 173.5 In infancy & childhood WW 276 Libraries for the blind Z 675.B6 Library operations Z 729-871 Night see Night Blindness WD 110 Rehabilitation Physical & medical WW 276 Social HV 1573-2349 Veterinary SF 891 Blister WR 143 Localized, by site Block Anesthesia see Anesthesia, Conduction Blood WH Chemistry see Blood chemical analysis QY 450-490, etc. Children WS 300 Clinical examination QY 400-490 Corpuscles see Blood Cells WH 140, etc.; Erythocytes WH 150-180; Leukocytes WH 200 Derivatives WH 450 Fluid elements WH 400 Flukes see Schistosoma QX 355 Medicolegal examination W 750 Substitutes see Plasma Substitutes WH 450 Typing see Blood Grouping and Crossmatching QY 415 Velocity see Blood Flow Velocity WG 106 See also Anticoagulants QV 193; Lipids QU 85-95; Plasma WH 400, etc. Blood, Artificial see Blood Substitutes Blood Bactericidal Activity QW 541 Special topics, by subject Blood Banks WH 23-24 Procedures WH 460 Blood-Borne Pathogens WA 790 Blood-Brain Barrier WL 200 Blood Cell Count QY 402 Veterinary SF 772.67 Blood Cell Count, Red see Erythrocyte Count Blood Cell Count, White see Leukocyte Count ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 283 Blood Cell Number Blood Cell Number see Blood Cell Count Blood Cells WH 140 Clinical examination QY 402 Drugs affecting QV 180-185 Blood Cells, Red see Erythrocytes Blood Cells, White see Leukocytes Blood Chemical Analysis QY 450-490 In infancy & childhood QY 450-490 Medicolegal W 750 Veterinary SF 772.67 Blood Circulation WG 103 Disorders as a manifestation of disease QZ 170 In infancy & childhood WG 103 Tests WG 103 See also names of specific types of circulation, e.g., Pulmonary Circulation WF 600 Blood Circulation, Collateral see Collateral Circulation Blood Circulation Time WG 103 Blood Coagulation Clinical examination QY 410 Drugs affecting QV 190-195 Physiology WH 310 Blood Coagulation Disorders WH 322 Hemophilia WH 325 Veterinary SF 769.5 See also names of specific disorders Blood Coagulation Factors WH 310 Clinical examination QY 410 Pharmacology QV 195 Blood Coagulation Tests QY 410 Blood Component Removal WH 460 Blood Component Transfusion WB 356 Blood Count, Complete see Blood Cell Count Blood Diseases see Hematologic Diseases Blood Donors WH 460 Blood Doping see Doping in Sports Blood Expanders see Plasma Substitutes Blood Flow see Rheology Blood Flow Velocity WG 106 Blood Gas Analysis QY 450 Veterinary SF 774 Blood Gas Monitoring, Transcutaneous QY 450 Blood Glucose QU 75 Clinical analysis QY 470 Blood Glucose Self-Monitoring In diabetes WK 850 Blood Group Incompatibility WH 420 Blood Grouping and Crossmatching QY 415 Special topics, by subject Blood Groups WH 420-425 Medicolegal examination W 791 Typing see Blood Grouping and Crossmatching QY 415 Blood Loss, Surgical During surgery for a particular condition, with the condition Blood Plasma see Plasma Blood Plasma Volume see Plasma Volume Blood Platelet Disorders WH 300 See also Purpura, Thrombopenic WH 315 Blood Platelet Transfusion see Platelet Transfusion Blood Plateletpheresis see Plateletpheresis ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH^ Blood Platelets WH 300 Count QY 402 Blood Poisoning see Septicemia Blood Preservation WH 460 Blood Pressure WG 106 General physical examination WB 280 High see Hypertension WG 340 Low see Hypotension WG 340 Blood Pressure Determination WG 106 Physical examination WB 280 Blood Pressure, High see Hypertension Blood Pressure, Low see Hypotension Blood Pressure Monitors WG 26 Blood Pressure, Venous see Venous Pressure Blood Protein Disorders WH 400 Clinical pathology QY 455 Specific disorders involving various blood elements, with the element See other specific disorders under their names in the index Blood Protein Electrophoresis QY 455 Blood Proteins WH 400 Clinical analysis QY 455 Coagulation factors WH 310 Clinical pathology QY 410 Blood Sedimentation QY 408 Blood Serum see Blood Blood Specimen Collection QY 26 Blood Substitutes WH 450 Blood Sugar see Blood Glucose Blood Sugar Self-Monitoring see Blood Glucose Self-Monitoring Blood Tests see Hematologic Tests Blood Transfusion WB 356 Veterinary SF 919.5.B55 See also Blood Banks WH 23-24, etc.; Blood Donors WH 460 Blood Transfusion, Intrauterine WQ 210 Blood Typing see Blood Grouping and Crossmatching Blood Vessel Prosthesis WG 170 Blood Vessels Peripheral WG 500-700 Surgery WG 170 Of a particular region or organ, with the region or organ Blood Viscosity WG 106 Clinical analysis QY 408 Blood Volume WG 106 Volume index QY 408 Bloodletting WB 381 Blotting, Northern QH 441 Blotting, Southern QH 441 Blotting, Western QW 525.5.132 Proteins QU 55 Peptides QU 68 Blue-Green Bacteria see Cyanobacteria Blue Sclera see Abnormalities WW 230 under Sclera Bluetongue Virus QW 168.5.R15 BLV Infections see HTLV-BLV Infections Board, Governing see Governing Board Boats see Ships USE NUMBER ASSIGNED ONLY WHEN [S OF WORK BEING CLASSinED 284 Book Reviews Bodies, Dead see Cadaver Body Buffer Zone see Personal Space Body Build see Somatotypes Body Burden WN 660 Body Composition QU 100-110 Body Constitution Anthropology GN 62 As a cause of disease QZ 50 Body Fluid Compartments QU 105 Body Fluids QU 105 Body Height Adults GN 66 In infancy & childhood WS 103 Tables WS 16 Body Image BF 697.5.B63 In adolescence WS 462 In infancy & childhood WS 105.5.S3 Body Language see Kinesics Body Lice see Lice Body Rocking see Stereotyped Behavior Body Size see Body Constitution Body Snatching see Cadaver Body Surface Area GN 66 Veterinary Domestic animals SF 761 Wild animals QL 363 Body Temperature WB 270 High see Fever WB 152 In antibody production QW 570 In infancy & childhood WS 141 Newborn WS 420 In ovulation WP 540 In physical examination WB 270 Veterinary SF 772.5 See also Skin Temperature WR 102 Body Temperature Regulation QT 165 Skin as a factor WR 102 Body Types see Somatotypes Body vermin see Lice; Bedbugs Body Water QU 105 Body Weight In adulthood GN 66 In infancy & childhood WS 103 Tables WS 16 Infant, Premature see Birth Weight WS 410, etc. Newborn see Birth Weight WS 420, etc. Boeck's Sarcoid see Sarcoidosis Boils see Furunculosis Bombesin QU 68 Bombina see Anura Bond Issues, Construction see Financing, Construction Bonding, Dental see Dental Bonding Bonding, Human-Pet WM 460.5.B7 Bonding (Psychology) see Object Attachment Bonds, Emotional see Object Attachment Bone Age Measurement see Age Determination by Skeleton Bone and Bones WE 200-259 Physiology WE 200 Surgery WE 168-190 Transplantation WE 190 See also Skeleton WE 100-102 Bone Cements WE 190 Used for special purposes, by subject Bone Conduction WV 272 Bone Cysts WE 258 Localized, by site Bone Density WE 200 Bone-Derived Transforming Growth Factor see Transforming Growth Factor beta Bone Development WE 200 Bone Diseases WE 225-259 In infancy & childhood WS 270 Infectious WE 251 Veterinary SF 901 Bone Diseases, Developmental WE 250 Bone Diseases, Infectious see Infectious WE 251 under Bone Diseases Bone Diseases, Metabolic WE 250 Bone Dysplasias see Bone Diseases, Developmental Bone Lengthening WE 168 Localized, by site Bone Loss, Age-Related see Osteoporosis Bone Loss, Osteoclastic see Bone Resorption Bone Loss, Perimenopausal see Osteoporosis, Postmenopausal Bone Loss, Periodontal see Alveolar Bone Loss Bone Loss, Postmenopausal see Osteoporosis, Postmenopausal Bone Marrow WH 380 Bone Marrow Diseases WH 380 See also Anemia, Aplastic WH 175; Anemia, Myelophthisic WH 175; Leukemoid reaction WH 200; Polycythemia vera WH 180 Bone Marrow Examination WH 380 Bone Marrow Fibrosis see Myelofibrosis Bone Marrow Transplantation WH 380 Bone Mineral Content see Bone Density Bone Mineral Density see Bone Density Bone Mineralization see Calcification, Physiologic Bone Neoplasms WE 258 Veterinary SF 910.T8 Bone Plates WE 185 Bone Regeneration WE 200 Bone Resorption WE 200 See also Ainhum WE 835 Bone Screws WE 185 Bone Transplantation WE 190 Bone Tuberculosis see Tuberculosis, Osteoarticular Book Circulation see Library Services Book Classification Z 696-697 Medicine Z 697.M4 Book Collecting Z 987-997 See also Libraries Z 662-1000; names of specific types of libraries Book Illustration see Books, Illustrated Book Imprints Z 242.13 Book Industry Z 116.A2-656 Book Ornamentation Z 276 See also Medical Illustration WZ 348 Book Prices Z 1000 Book Reviews Z 1035.A1 Criticism of early works (pre-1801) WZ 294 Of books on specific subjects in the bibliography ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 285 Book Reviews number for the subject See also Bibliography Book Selection Z 689-689.8 Bookbinding Z 266-276 Booklets see Pamphlets Bookplates Z 993-996 Medical WZ 340 Books History Z 4-8 Medicine and related fields Americana WZ 270 Early imprints WZ 240-270 Criticism WZ 294 Modern editions WZ 290 Modern collections WZ 292 See also Incunabula WZ 230, etc. Books, Illustrated Bibliography Z 1023 Techniques NC Special types of books, by subject See also Medical Illustration WZ 348, etc. Booksellers' Catalogs see Catalogs, Booksellers' Bookselling Z 278-549 Boranes QD 181.B1 Pharmacology QV 239 Borates QD 181.B1 Pharmacology QV 239 Borderline Personality Disorder WM 190 Bordetella QW 131 Bordetella Infections WC 340 Bordetella pertussis QW 131 Bordetella Pertussis Toxins see Pertussis Toxins Boredom In adolescence WS 462 In infancy & childhood WS 105.5.E5 Psychology BF 575.B67 Boric Acids QV 239 Bornholm Disease see Pleurodynia, Epidemic Borohydrides QD 181.B1 Pharmacology QV 239 Boron QD 181.B1 Metabolism QU 130.5 Boron Compounds QD 181.B1 As antiseptics QV 239 Dental use WU 190 Borrelia QW 155 Borrelia Infections WC 406 Veterinary SF 809.B67 Botany QK Economic SB 107-109 Medical see Pharmacognosy QV 752; Plants, Medicinal QV 766, etc. Botrytis see Hyphomycetes Bottle Feeding WS 120 Botulism WC 268 Bouillaud's Disease see Rheumatic Heart Disease Bourneville's Disease see Tuberous Sclerosis Bovine Herpesvirus 1 see Herpesvirus 1, Bovine Bovine Kunitz Pancreatic Trypsin Inhibitor see Aprotinin Bovine Leukemia Virus see Leukemia Virus, Bovine Bovine Virus Diarrhea-Mucosal Disease SF 967.M78 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Boxing QT 260.5.B7 Braces WE 172 Catalogs W 26 Brachial Artery WG 595.B7 Brachial-Basilar Insufficiency Syndrome see Subclavian Steal Syndrome Brachial Neuralgia see Cervico-Brachial Neuralgia Brachial Plexus WL 400 Brachiocephalic Trunk WG 595.B72 Brachiocephalic Veins WG 625.B7 Brachytherapy WN 250.5.B7 Bracyteles see Cebidae Bradyarrhythmia see Bradycardia Bradycardia WG 330 Bradykinin QU 68 Brain WL 300-385 Blood supply WL 302 See also Cerebral arteries WG 595.C37 Cerebral hemispheres WL 307 Cerebrum WL 307 Embryology WL 300 Hemorrhage see Cerebral hemorrhage WL 355 Injury WL 354 Intracranial complications of ENT diseases WV 180 Radiography WL 141 Surgery WL 368 Brain Abscess WL 351 Brain Chemistry WL 300 Brain Concussion WL 354 Brain Damage, Chronic WL 354 In infancy & childhood WS 340 Brain Death W 820 Brain Diseases WL 348-362 In infancy & childhood WS 340 Veterinary SF 895 See also specific Brain Diseases Brain Dysfunction, Minimal see Attention Deficit Disorder with Hyperactivity Brain Edema WL 348 Brain Electrical Activity Mapping see Brain Mapping Brain Injuries WL 354 In infancy & childhood WS 340 Brain Mapping WL 335 Brain Neoplasms WL 358 Localized, by site Brain Revascularization see Cerebral Revascularization Brain Stem WL 310 Brain Stem Auditory Evoked Potentials see Evoked Potentials, Auditory, Brain Stem Brain Tissue Transplantation WL 368 Brainwashing see Persuasive Communication Branched-Chain Ketoaciduria see Maple Syrup Urine Disease Branchial Arches see Branchial Region Branchial Clefts see Branchial Region Branchial Cyst see Branchioma Branchial Region WE 101 Branchioma QZ 310 Brassica Botany QK 495.C9 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 286 Buddhism Culture SB 317.B65 As a dietary supplement in health and disease WB 430 Bread As a dietary supplement in health or disease WB 431 Baking TX 769 Breakbone Fever see Dengue Breast WP 800-910 Breast Cysts see Fibrocystic Disease of Breast Breast Diseases WP 840-910 Breast Dysplasia see Fibrocystic Disease of Breast Breast Feeding WS 125 See also Lactation Disorders WP 825 Breast Neoplasms WP 870 Male WP 870 Breast Xeroradiography see Xeromammography Breath Tests For alcoholic intoxication in traffic accidents WA 275 Forensic medicine W 780 In general physical examination WB 205 Manifestation of gastroenterological diseases WI 143 Breathalyzer Tests see Breath Tests Breathing see Respiration Breathing Exercises WB 541 Breech Presentation WQ 307 Breeding Animal SF 105-109 Of laboratory animals QY 54 Of plants SB 123-123.5 Of individual animals or plants, with animal or plant Brevibacterium QW 118 Bridged Compounds Organic chemistry QD 341.H9 Toxicity QV 633 Used for special purposes, by subject Bridges, Dental see Denture, Partial; Tooth, Artificial Brief Psychotherapy see Psychotherapy, Brief Bright Disease see Glomerulonephritis Bright's Disease see Nephritis Brill-Symmers Disease see Lymphoma, Follicular Brill-Zinsser Disease see Brill's Disease Brill's Disease WC 605 Epidemics WC 610 Brine Shrimp see Artemia Briquet Syndrome see Somatoform Disorders Bristle-Coated Pits see Coated Pits, Cell-Membrane BRL 2288 see Ticarcillin Broad Ligament WP 275 Broadsides Z 240.4 Broca Area see Frontal Lobe Brochures see Pamphlets Bromchlortrifluorethane see Halothane Bromhexine QV 76 Bromides QV 87 Bromine QV 231 Metabolism QU 130 Bromocriptine QV 174 Bromocryptin see Bromocriptine Bromosuccinimide QV 85 Bromsulphalein see Sulfobromophthalein Bronchi WF 500-553 Blood supply WF 500 Calculi WF 500 Children WS 280 Drugs affecting see names of specific agents Bronchial Arteries WG 595.B76 See also Blood supply WF 500 under Bronchi Bronchial Asthma see Asthma Bronchial Constriction see Bronchoconstriction Bronchial Diseases WF 500-553 In infancy & childhood WS 280 Veterinary SF 831 Bronchial Fistula WF 500 Bronchial Lavage Fluid see Bronchoalveolar Lavage Fluid Bronchial Neoplasms WF 500 See also Adenocarcinoma, Bronchiolo-Alveolar WF 658; Carcinoma, Bronchogenic WF 658 Bronchial Provocation Tests WF 141.5.B8 Bronchial Spasm WF 500 Bronchiectasis WF 544 Bronchiolar Carcinoma see Adenocarcinoma, Bronchiolo-Alveolar Bronchioles see Bronchi Bronchitis WF 546 Veterinary SF 831 Bronchoalveolar Lavage Fluid WF 600 Bronchoconstriction WF 102 Bronchodilator Agents QV 120 Bronchography WF 500 Broncholithiasis see Bronchial Diseases Bronchopneumonia WC 202 Veterinary SF 831 Bronchopulmonary Dysplasia WS 410 Bronchoscopy WF 500 Bronchospasm see Bronchial Spasm Bronchospasm, Exercise-Induced see Asthma, Exercise-Induced Bronchospirometry WB 284 Bronze Diabetes see Hemochromatosis Browning Reaction see Maillard Reaction Brucella abortus QW 131 Brucella Vaccine WC 310 Brucellosis WC 310 Veterinary SF 809.B8 Brucellosis, Bovine SF 967.B7 Brucine see Strychnine Brucite see Magnesium Hydroxide Brugia QX 301 Bruises see Contusions Brunhilde Virus see Polio viruses, Human 1-3 Brunnerfc Gland see Duodenum Brush Border see Microvilli Bubo, Climatic or Tropical see Lymphogranuloma Venereum Bubo, Venereal see Sexually Transmitted Diseases Bubonic Plague see Plague Bucca see Cheek Buckthorn see Rhamnus Buddhism BQ ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 287 Buddhism And medical philosophy W 61 And psychology BQ 4570.P76 See also Religion and Psychology WM 61, etc. And psychoanalysis WM 460.5.R3 Medicine in religious works WZ 330 Budding and/or Appendaged Bacteria see Bacteria Budgerigar Fanciers Lung see Bird Fanciers Lung Budgetary Control see Budgets Budgets Hospitals WX 157 General Public finance HJ 2005 + U.S. HJ 2050-2053 For other topics, class by subject if specific; if general, in economics number where available Buerger Is Disease see Thromboangiitis Obliterans Buffaloes QL 737.U5 Diseases SF 997.5.B8 European bison QL 737.U53 Buffers QV 786 In acid base equilibrium QU 105 See also Preservation, Biological QH 324 Bufo see Bufonidae Bufonidae QL 668.E227 As laboratory animals QY 60.A6 Bugs see Hemiptera Buildings, Public Health Aspects see Housing; Public Housing; Restaurants; and names of other types of buildings; also Architecture; Environment, Controlled; Sanitation Bulbar Palsy see Paralysis, Bulbar Bulbourethral Glands WJ 600 Bulimia WM 175 Bulla see Blister Bullous Skin Diseases see Skin Diseases, Vesiculobullous Bumetanide QV 160 Bundle-Branch Block WG 330 Bundle of His WG 201-202 Bundle of Kent see Heart Conduction System Bunion see Hallux Valgus Bunostomiasis see Hookworm Infections Bunostomum see Ancylostomatoidea Bunyaviridae QW 168.5.B9 Bunyaviridae Infections WC 501 Bunyavirus Infections see Bunyaviridae Infections Buphthalmos see Hydrophthalmos Bupivacaine QV 115 Bupranolol QV 132 Buprenorphine QV 92 Burial WA 846 Burial Grounds see Mortuary Practice Burkitt Herpesvirus see Herpesvirus 4, Human Burkitt s Lymphoma WH 525 Localized by site Veterinary in the appropriate LC SF number, by site Burkitt's Lymphoma Virus see Herpesvirus 4, Human Burkitt's Tumor see Burkitt's Lymphoma Burning Mouth Syndrome WU 140 Burnout, Professional WM 172 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH> Burns WO 704 Death from (medicolegal aspects) W 843 Localized, by site See also Sunburn WR 150 Burns, Chemical WO 704 Burns, Electric WO 704 Burns, Inhalation WO 704 Bursa-Dependent Lymphocytes see B-Lymphocytes Bursa, Synovial WE 400 Bursine see Choline Bursitis WE 400 Burst-Promoting Factor, Erythrocyte see Interleukin-3 Buserelin WK 515 Used for treatment of particular disorders, with the disorder Buses see Automobiles Bush Babies see Galago Business see Commerce Business Administration see Hospital Administration; Organization and Administration; Practice Management, Dental; Practice Management, Medical Business Coalitions (Health Care) see Health Care Coalitions Buspirone QV 77.9 Busulfan QV 269 Cancer chemotherapy QZ 267 Busulphan see Busulfan Butacaine QV 115 Butanoic Acids see Butyric Acids Butesin Picrate see Butylamines Butorphanol QV 92 Butter As a dietary supplement in health or disease WB 425 Biochemistry QU 86 Manufacture SF 263 Public health aspects WA 715 Butter Yellow see p-Dimethylaminoazobenzene Butterflies QX 560 Buttermilk see Milk Buttocks WE 750 Butylamines QU 61 As local anesthetics QV 115 Butylated Hydroxyanisole Toxicology QV 632 As a food preservative WA 712 Butylated Hydroxytoluene As a food preservative WA 712 Butylcarbamide see Carbutamide Butylhydroxyanisole see Butylated Hydroxyanisole Butylhydroxytoluene see Butylated Hydroxytoluene Butyn see Butacaine Butyribacterium see Eubacterium Butyric Acids QU 90 Butyrophenone Antipsychotic Agents see Antipsychotic Agents, Butyrophenone Butyrophenone Tranquilizers see Antipsychotic Agents, Butyrophenone Butyrophenones QV 77.9 By-Products, Industrial see Industrial Waste; names of specific products USE NUMBER ASSIGNED ONLY WHEN !IS OF WORK BEING CLASSIFIED 288 Calcium Transport Proteins Bylaws see Constitution and Bylaws Bypass, Coronary Artery see Coronary ArteYy Bypass Byssinosis WF 654 B16 Melanoma see Melanoma, Experimental C Fibers see Nerve Fibers c-Ha-ras Genes see Genes, ras c-Ki-ras Genes see Genes, ras c-N-ras Genes see Genes, ras C-Peptide WK 820 CA Antigens see Antigens, Tumor-Associated, Carbohydrate CA-125 Antigen see Antigens, Tumor-Associated, Carbohydrate CA-15-3 Antigen see Antigens, Tumor-Associated, Carbohydrate CA-19-9 Antigen see Antigens, Tumor-Associated, Carbohydrate Ca(2+) Mg(2+)-ATPase QU 136 Ca(2+^Transporting ATPase QU 136 CA-50 Antigen see Antigens, Tumor-Associated, Carbohydrate Cabbage see Brassica Cacajao see Cebidae Cacao As a dietary supplement in health or disease WB 438 Chemical technology TP 640 Cultivation SB 267 Diseases of SB 608.C17 Pharmacology QV 107 See also Beverages WB 438, etc.; Candy WU 113.7, etc. Cachectin see Tumor Necrosis Factor Cachexia WB 146 Associated with malnutrition WD 100 Pituitary see Hypopituitarism WK 550 Cacodylic Acid QU 143 As amebicides QV 255 As antisyphilitic agents QV 262 Cadaver WA 840-847 Body snatching WZ 320 Destruction of human body W 822 Identification W 800 Resurrectionists WZ 320 See also Autopsy QZ 35, etc.; Coroners and Medical Examiners W 800; Death Certificates WA 54; Dissection QS 130, etc.; Embalming WA 844; Mortuary Practice WA 840-847 Cadmium QV 290 Caduceus see Emblems and Insignia Caenorhabditis QX 203 Caerulein Receptors see Receptors, Cholecystokinin Caeruloplasmin see Ceruloplasmin Caesarean Section see Cesarean Section Cafeterias see Restaurants Caffea see Coffee Caffeine QV 107 Caffeine Receptors see Receptors, Purinergic Caimans see Alligators and Crocodiles Caisson Disease see Decompression Sickness Calcaneus WE 880 Calciferols see Ergocalciferols Calcification, Pathologic see Calcinosis Calcification, Physiologic WE 200 See also Ossification, Physiologic WE 200 Calcinosis WD 200.5.C2 Intervertebralis WE 740 See also Ossification, Pathologic QZ 180 Calciphylaxis WD 200.5.C2 Calcitonin WK 202 Calcium QV 276 Inorganic chemistry QD 181.C2 Calcium-Activated Neutral Protease see Calpain Calcium Adenosinetriphosphatase see Ca(2+)-Transporting ATPase Calcium Antagonists, Exogenous see Calcium Channel Blockers Calcium ATPase see Ca(2+^Transporting ATPase Calcium-Binding Proteins Calcium Blockaders, Exogenous see Calcium Channel Blockers Calcium Carbimide see Cyanamide Calcium Channel Blockers QV 150 Calcium Channels QH 603.154 Calcium Cyanamide see Cyanamide Calcium-Dependent Activator Protein see Calmodulin Calcium-Dependent Neutral Proteinase see Calpain Calcium-Dependent Regulator see Calmodulin Calcium, Dietary QU 130 As a supplement in health or disease WB 428 Calcium Diphosphate see Calcium Pyrophosphate Calcium Hydroxide Dentistry WU 190 Inorganic chemistry QD 181.C2 Pharmacology QV 276 Calcium Inhibitors, Exogenous see Calcium Channel Blockers Calcium Isotopes Inorganic chemistry QD 181.C2 Pharmacology QV 276 Calcium Leucovorin see Leucovorin Calcium Magnesium Adenosinetriphosphatase see Ca(2+) Mg(2+)-ATPase Calcium Magnesium ATPase see Ca(2+) Mg(2+)- ATPase Calcium Metabolism Disorders WD 200.5.C2 Decalcification, Pathologic WE 250 Calcium Oxalate Biochemistry QU 98 Calcium Phosphates Inorganic chemistry QD 181.C2 Of bone in general WE 200 Of teeth WU 101 Calcium Pyrophosphate QV 285 Calcium Sulfate In density WU 190 In casting models QY 35 In surgical casts WO 170 Calcium Transport Proteins see Calcium-Binding Proteins ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 289 Calculators, Programmable Calculators, Programmable see Computers Calculi QZ 180 Biliary see Cholelithiasis WI 755 Bladder see Bladder Calculi WJ 500 Common bile duct see Common Bile Duct Calculi WI 755 Kidney see Kidney Calculi WJ 356 Salivary duct see Salivary Duct Calculi WI 230 Ureteral see Ureteral Calculi WJ 400 Urinary see Urinary Calculi WJ 140 Caldesmon see Calmodulin-Binding Proteins Calibration Special topics, by subject California Encephalitis Virus see California Group Viruses California Group Viruses QW 168.5.B9 Californium WN 420 Nuclear physics QC 796.C45 For other specific aspects use numbers listed in this index under Radioisotopes Calisthenics see Gymnastics Callicebinae see Cebidae Callithricidae see Callitrichinae Callitrichinae QL 737.P92 As laboratory animals QY 60.P7 Diseases SF 997.5.P7 Callosities WR 500 Foot WE 880 Toes WE 835 Other locations, by site Calmette-Guerin Bacillus see Mycobacterium bovis Calmette-Guerin Immunization see BCG Vaccine Calmodulin QU 55 Calmodulin-Binding Proteins QU 55 Caloric Intake In normal diet QT 235 Nutritional requirements QU 145 Caloric Tests WV 255 Caloric Value of Foods see Nutrition Calorie Deficiency see Deficiency Diseases; Protein-Energy Malnutrition Calorimetry QU 125 Calpain QU 136 Calspectin see Calmodulin-Binding Proteins Camelids, New World QL 737.U54 Diseases SF 997.5.C3 Camellia see Tea Camels QL 737.U54 Diseases SF 997.5.C3 Camphor QV 65 Campimetry see Perimetry Camping QT 250 Special topics, by subject, e.g., discussion of camp safety act WA 33 Campylobacter fetus QW 154 Campylobacter pylori see Helicobacter pylori Cancer see Neoplasms Cancer-Associated Carbohydrate Antigens see Antigens, Tumor-Associated, Carbohydrate Cancer Care Facilities QZ 23-24 Cancer Chemotherapy see Drug therapy QZ 267 under Neoplasms or names of specific types of ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH/4 neoplasm Cancer Genes see Oncogenes Cancer Research see Neoplasms, Experimental QZ 206 or names of specific types of neoplasm Cancer Staging see Neoplasm Staging Candida QW 180.5.D38 Candidiasis WC 470 Candidiasis, Cutaneous WR 300 Candidiasis, Oral WC 470 Candy As a dietary supplement in health or disease WB 400 In dental health WU 113.7 Canine Tooth see Cuspid Canker Sore see Stomatitis, Aphthous Cannabidiol As an anticonvulsant QV 85 As a hallucinogen QV 77.7 Cannabinoids QV 77.7 Cannabis Abuse see Marijuana Abuse WM 276 Associated with hallucinogens QV 77.7 Cannabis Abuse see Marijuana Abuse Cannabis Smoking see Marijuana Smoking Canned Foods see Food Preservation; Food-Processing Industry Canned Milk see Milk Cannulation see Catheterization Cantharides see Cantharidin Cantharidin QV 65 Caoutchouc see Rubber CAPD see Peritoneal Dialysis, Continuous Ambulatory Capgras Syndrome WM 202 Capillaries WG 700 Capillaries, Lymphatic see Lymphatic System Capillarity QC 183 Capillary Endothelium see Endothelium, Vascular Capillary Fragility WG 700 Capillary Permeability WG 700 Capillary Resistance WG 106 Capillary Resistance, Hematologic see Capillary Fragility Capital Expenditures Medicine W 74 Other fields, by subject, in the number for economics when available Capital Financing Hospitals WX 157 For other specific subject, class in economics number where applicalble Capitalism see Political Systems Capitation Fee Dental WU 77 Hospital WX 157 Medical W 74 Nursing WY 77 With other specialties, class in economics number where applicable Caprines see Goats Caproates QU 90 Caprolactam As an industrial poison WA 465 IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 290 Cardiac Pacing, Artificial Special topics, by subject Capsaicin QU 90 Capsules QV 785 Captopril As an antihypertensive agent QV 150 As an enzyme inhibitor QU 143 Carassius auratus see Goldfish Carassius carassius see Carp Carbachol QV 122 Carbamates QU 98 As insecticides WA 240 Organic chemistry Aliphatic compounds QD 305.A2 Carbamazepine QV 85 Carbamylcholine see Carbachol Carbarsone see Arsenicals CarbenicUlin QV 354 Carbenicillin Phenyl Sodium see Carfecillin Carbenoxalone see Carbenoxolone Carbenoxolone QV 66 Carbocaine see Mepivacaine Carbocysteine Biochemistry QU 60 Pharmacology QV 76 Carbofuran Agriculture SB 952.C3 Public health WA 240 Carbohydrate Antigens, Tumor-Associated see Antigens, Tumor-Associated, Carbohydrate Carbohydrate Conformation QU 75 Carbohydrate Linkage see Carbohydrate Conformation Carbohydrate Metabolism, Inborn Errors WD 205.5.C2 Carbohydrates QU 75 Clinical analysis QY 470 See also Dietary Carbohydrates WB 427, etc. Carbolic Acid see Phenols Carbolines As tranquilizing agents QV 77.9 Organic chemistry QD 401 Carbon QD 181.CI Pharmacology QV 138.C1 Carbon Dioxide QV 314 Carbon Dioxide Partial Pressure Determination, Transcutaneous see Blood Gas Monitoring, Transcutaneous Carbon Disulfide QD 181.C1 Toxicological effects QV 633 Carbon Isotopes Inorganic chemistry QD 181.CI Pharmacology QV 138.C1 Carbon Monoxide QV 662 Carbon Monoxide Poisoning QV 662 Carbon Tetrachloride As an anthelmintic QV 253 Organic chemistry QD 305.H5 Carbon Tetrachloride Poisoning QV 633 Carbonate Dehydratase QU 139 Carbonate Dehydratase Inhibitors see Carbonic Anhydrase Inhibitors Carbonate Dehydratase Isoenzymes see Carbonate Dehydratase Carbonates Inorganic chemistry QD 181.CI Organic chemistry QD 305.A2 Pharmacology QV 138.C1 Carbonic Acid QV 138.C1 Carbonic Anhydrase see Carbonate Dehydratase Carbonic Anhydrase Inhibitors QV 160 Enzymology QU 143 Carbonic Anhydrase Isoenzymes see Carbonate Dehydratase Carbonic Anhydride see Carbon Dioxide Carbonization see Drug Compounding Carbonyl Chloride see Phosgene Carboxy-Lyases QU 139 Carboxybenzyl Penicillin see Carbenicillin Carboxyl (Acid) Proteinases see Aspartic Proteinases Carboxylic Acids QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Aromatic compounds QD 341.A2 Carboxymethylcysteine see Carbocysteine Carbuncle WR 235 Carbutamide WK 825 Carcinoembryonic Antigen QW 570 Neoplasm immunology QZ 310 Carcinogen Markers see Tumor Markers, Biological Carcinogenesis see Neoplasms Carcinogenicity Tests QZ 202 Carcinogens QZ 202 Carcinogens, Environmental QZ 202 Carcinoid Heart Disease WG 210 Carcinoid Tumor WI 435 Localized, by site Carcinoma QZ 365 Localized, by site Carcinoma, Adenoid Cystic QZ 365 Localized, by site Carcinoma, Alveolar see Adenocarcinoma, Bronchiolo-Alveolar Carcinoma, Bronchial see Carcinoma, Bronchogenic Carcinoma, Bronchiolo-Alveolar see Adenocarcinoma, Bronchiolo-Alveolar Carcinoma, Bronchogenic WF 658 Carcinoma, Hepatocellular WI 735 Carcinoma, Hypernephroid see Carcinoma, Renal Cell Carcinoma, Renal Cell WJ 358 Carcinosarcoma QZ 310 Cardia WI 300 Neoplasms WI 320 Cardiac Arrest see Heart Arrest Cardiac Depressants see Anti-Arrhythmia Agents Cardiac Electroversion see Electric Countershock Cardiac Emergencies WG 205 Cardiac Failure see Heart Failure, Congestive Cardiac Glycosides QV 153 Cardiac Hypertrophy see Heart Hypertrophy Cardiac Neurosis see Neurocirculatory Asthenia Cardiac Output WG 106 Cardiac Output, Low WG 210 Cardiac Pacemaker, Artificial see Pacemaker, Artificial Cardiac Pacing, Artificial WG 168 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 291 Cardiac Pacing, Artificial See also Pacemaker, Artificial WG 26 Cardiac Rupture, Traumatic see Heart Injuries Cardiac Stimulants see Cardiotonic Agents Cardiac Transplantation see Heart Transplantation Cardiac Volume WG 106 Cardiography, Impedance WG 141.5.C15 Special topics, by subject, e.g., in the diagnosis of Tachycardia WG 330 Cardiologists, Directories see Directories WG 22 under Cardiology Cardiology WG Directories WG 22 Experimental studies WG 110 General works WG 100 In infancy & childhood WS 290 Nursing WY 152.5 Cardiomyopathies see Myocardial Diseases Cardiomyopathy, Alcoholic WG 280 Cardiomyopathy, Chagas see Chagas Cardiomyopathy Cardiomyopathy, Congestive WG 280 Cardiomyopathy, Dilated see Cardiomyopathy, Congestive Cardiomyopathy, Restrictive WG 280 Cardiopulmonary Arrest see Heart Arrest Cardiopulmonary Resuscitation First Aid WA 292 Cardiospasm see Esophageal Achalasia Cardiotocography WQ 209 Cardiotonic Agents QV 150 Cardiotonic Steroids see Cardiac Glycosides Cardiovascular Agents QV 150-156 Cardiovascular Disease (Specialty) see Cardiology Cardiovascular Diseases WG General works WG 120 In infancy & childhood WS 290 In pregnancy see Pregnancy Complications, Cardiovascular WQ 244 Neoplasms (General) WG 120 See also Neoplasms, Vascular Tissue QZ 340 Nursing WY 152.5 Veterinary SF 811 Cardiovascular System WG Abnormalities WG 220 Children WS 290 Drugs affecting QV 150-156 Experimental studies WG 110 Radiography (General) WG 141.5.R2 Radionuclide imaging WG 141.5.R3 Surgery WG 168-169.5 Tomography WG 141.5.T6 Cardioversion see Electric Countershock Carditis, Bacterial see Endocarditis, Bacterial Care, Surgical see Postoperative Care; Preoperative Care; Surgical Nursing Career Choice Dentistry WU 21 Nursing WY 16 Ophthalmology WW 21 Pharmacy QV 21 Physicians W 21 Psychiatry WM 21 Surgery WO 21 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHj* In other fields, by subject Career Counseling see Vocational Guidance Career Ladders see Career Mobility Career Mobility Social conditions HN Vocational guidance HF 5381-5382.5 Specific careers, by subject, e.g. Nursing WY 16 Caregivers In particular fields, by subjects See also names of specific caregivers Carfecillin QV 354 Caricatures NC 1300-1763 Medical WZ 336 See also Medical Illustration WZ 348 Caries see Dental Caries Caries, Dental see Dental Caries Cariogenic Agents WU 270 See also Diet, Cariogenic WU 113.7 Carnitine QU 187 Carnitine Palmitoyltransferase QU 141 Carnivora QL 737.C2-737.C28 Diseases SF 600-1100 Specific carnivora or groups, by animal or group Carnosine QU 68 Carotene QU 110 Animal biochemistry wild QP 671.C3 Plants QK 898.C35 Vitamin A related QU 167 Carotenoids QU 110 Animal biochemistry wild QP 671.C35 Plants QK 898.C35 Vitamin A related QU 167 Carotid Arteries WG 595.C2 Carotid Artery Diseases WL 355 Carotid Artery, External WG 595.5.C2 Carotid Artery, Internal WG 595.5.C2 Carotid Artery Thrombosis WL 355 Carotid Body WL 102.9 Carotid Body Tumor WL 102.9 Carotid Sinus WG 595.5.C2 Carotid sinus syndrome WG 560 Carp QL 638.C94 Diseases SH 179.C3 As laboratory animals QY 60. F4 Carpal Bones WE 830 Carpal Tunnel Syndrome WL 500 Carphenazine see Phenothiazine Tranquilizers Carpus see Wrist Carrageenan QU 83 Carrier Ampholytes see Ampholyte Mixtures Carrier Proteins QU 55 In immunochemistry QW 504.5 Special topics, by subject See also names of specific proteins, e.g., Ferrodoxins QW 52, etc. Carrier State QW 700 Veterinary SF 757.2 Carriers, Genetic see Heterozygote Carriers, Genetic, Detection see Heterozygote Detection Carriers of Infection see Carrier State; Disease Vectors; Insect Vectors USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSD7IED 292 Carriers, Public see Railroads WA 810, etc. and names of other forms of transportation Carrions Disease see Bartonella Infections Carsickness see Motion Sickness Cartilage WE 300 Cartilage, Articular WE 300 Cartilage Diseases WE 300 In infancy & childhood WS 270 Cartilage, Epiphyseal see Growth Plate Cartoons WZ 336 Caryophanales see Bacteria Casanthranol see Cascara Cascara QV 75 Case-Base Studies see Case-Control Studies Case-Comparison Studies see Case-Control Studies Case-Control Studies WA 950 Of particular disorders, with the disorder Case Management, Insurance see Managed Care Programs Case Mix see Diagnosis-Related Groups Case-Referent Studies see Case-Control Studies Case reports see Case studies Case studies Medicine WB 293 Psychiatry WM 40-49 Surgery WO 16 Special topics, by subject Case Taking see Medical History Taking Caseins WA 716 Dairy science SF 253 Food and milk microbiology QW 85 Cassava As a dietary supplement in health or disease WB 431 Cultivation SB 211.C3 Poisoning WD 500 Caste see Social Class Castor see Rodentia Castor Bean Lectin see Ricin Castor Oil QV 75 Castration Female WP 660 Male WJ 868 Veterinary SF 889 Castration, Male see Orchiectomy Casts see Models, Structural; Dental Casting Investment Casts, Surgical WO 170 Cat Diseases SF 985-986 CAT Scan, Radionuclide see Tomography, Emission-Computed CAT Scan, X-Ray see Tomography, X-Ray Computed CAT Scanners, X-Ray see Tomography Scanners, X-Ray Computed Cat-Scratch Disease WC 593 Catabolism see Metabolism Catalase QU 140 Catalepsy WM 197 Catatonic WM 203 Hysterical neurosis WM 173 Neurologic manifestation WL 390 Cataloging Z 693-695.83 Catalogs see Types of catalogs or product being announced, e.g., Catalogs, Drug QV 772 Catalogs, Booksellers' Z 998-1000.5 General catalogs of modern books Z 1036 On particular subjects, in bibliography number for the subject Catalogs, Commercial HF 5861-5862 Embryology QS 626 Medical supplies W 26 Non-book materials (Form number 18.2 in any NLM schedule where applicable) Embryology QS 618.2 Histology QS 518.2 Specialty catalogs W 26 See also names of specific types of catalogs Catalogs, Drug QV 772 Catalogs, Library Z 881-980 Private libraries Z 997-997.2 Other particular classes of libraries (not LC practice) Z 675.A-Z Catalogs, Publishers' Z 1217-4980 Booksellers Z 998-1000.5 General catalogs of modern books Z 1036 On particular subjects, in bibliography number for the subject Catalogs, Union Books or general Z 695.83 Serials Z 6945 On particular subjects, in bibliography number for the subject Catalysis Enzymatic QU 135 Organic chemistry QD 281.C3 Pharmaceutical chemistry QV 25 Physical chemistry QD 505 Therapeutics see Alternative Medicine WB 890 Applications in other areas, by subject Cataphoresis see Electrophoresis Cataplexy WM 197 Associated with narcolepsy WM 188 Cataract WW 260 Cataract Extraction WW 260 Catarrhina see Cercopithecidae Catastrophic Health Insurance see Insurance, Major Medical Catastrophic Illness Special topics, by subject See also Disease Catatonia WM 197 Associated with schizophrenia WM 203 Catatonic Schizophrenia see Schizophrenia, Catatonic Catchment Area (Health) WA 541 Geriatrics WT 30 Catechin In dyeing and tanning TP 925.C38 Special topics by subject Catechinic Acid see Catechin Catechol Estrogens see Estrogens, Catechol Catecholamines WK 725 Catechols Organic chemistry QD 341.P5 Catechu see Catechin ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 293 Catechuic Acid Catechuic Acid see Catechin Caterpillars see Lepidoptera Catharsis WM 420.5.A2 Cathartics QV 75 Cathepsins QU 136 Catheterization General WB 365 Heart see Heart Catheterization WG 141.5.C2 Surgical technique WO 500 Urinary see Urinary Catheterization WJ 500 Catheterization, Balloon see Balloon Dilatation Catheterization, Bronchial see Catheterization, Peripheral Catheterization, Cardiac see Heart Catheterization Catheterization, Heart see Heart Catheterization Catheterization, Peripheral General WB 365 Catheterization, Peripheral Arterial see Catheterization, Peripheral Catheterization, Peripheral Venous see Catheterization, Peripheral Catheterization, Ureteral see Urinary Catheterization Catheterization, Urethral see Urinary Catheterization Catheterization, Urinary see Urinary Catheterization Catheters, Indwelling (Form number 26 in any NLM schedule where applicable) See also names of various types of catheterization Cathode see Electrodes Cathode Ray Tube Display see Data Display Cathode Rays see Beta Rays Catholicism BX 800-4795 And birth control HQ 766.3 And psychiatry WM 61 Medical ethics W 50 Other special topics, by subject, e.g., nursing ethics according to Catholic standards WY 85 See also Religion and Medicine WB 885, etc.; other headings beginning with Religion Cations QV 275-278 Cations, Divalent QV 275 Cations, Monovalent QV 275 Cats As laboratory animals QY 60. C2 Anatomy QL 813.C38 Culture SF 441-450 Diseases see Cat Diseases SF 985-986 Wild QL 737.C23 Cattell Personality Factor Questionnaire WM 145.5.C3 In psychology BF 698.8.S5 Cattle Anatomy SF 767.C3 Culture SF 191-219 Physiology SF 768.2.C3 Cattle Diseases SF 961-967 Cattle Leukemia Virus see Leukemia Virus, Bovine Cattle Plague see Rinderpest Caucasoid Race Anthropology GN 537 See also special topics under Ethnic Groups Caudal Anesthesia see Anesthesia, Epidural Caudata see Urodela Caudate Nucleus WL 307 Causalgia WL 544 Cause of Death WA 900 Special topics, by subject Causes of Disease see Pathogenesis QZ 40-109 under Disease Caustics QV 612 Cautery WO 198 Cavernous Sinus WG 625.C7 CAVH see Hemofiltration Cavia see Guinea Pigs Caviidae see Guinea Pigs Cavities, Dental see Dental Cavity Preparation Cavus Deformity see Foot Deformities Cazenave's Lupus see Lupus Erythematosus, Discoid CD-ROM Catalogs and works about (Form number 18.2 in any NLM schedules where applicable) Special topics, by subject CDP Choline see Cytidine Diphosphate Choline CD25 Antigens see Receptors, Interleukin-2 CD4 Antigens see Antigens, CD4 CD4 Molecule see Antigens, CD4 CD4 Receptors see Antigens, CD4 Cebidae QL 737.P925 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Cebuella see Callitrichinae Cebus QL 737.P925 Diseases SF 997.5.P7 As laboratory animals QY 60.P7 Cecal Diseases WI 530 Cecal Neoplasms WI 530 Cecum WI 530 Cefacler see Cephalexin Cefaclor QV 350.5.C3 Cefalotin see Cephalothin Cefamandole QV 350.5.C3 Cefotaxime QV 350.5.C3 Cefoxitin QV 350.5.C3 Ceftazidime QV 350.5.C3 Ceftriaxone QV 350.5.C3 Cefuroxime QV 350.5.C3 Celebes Ape see Macaca Celiac Artery WG 595.C3 Celiac Disease WD 175 Celiac Ganglia see Ganglia, Sympathetic Celioscopy see Laparoscopy Cell Adhesion Molecules Biochemistry QU 55 Cell Aggregation QH 604.2 Cell Anoxia see Cell Hypoxia Cell Communication QH 604.2 Nerve cells WL 102.8 Cell Compartmentation QH 604.3 Cell Count QH 585.5 Of neoplasms QZ 202 Of particular organs, with the organ Cell Cycle QH 605-605.3 Cell Degranulation QH 631 Cell Density see Cell Count ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 294 Centrally Acting Muscle Relaxants Cell Differentiation Animals Domestic SF 767.5 Wild QL 963.5 General and human QH 607 Cell Division QH 605-605.3 Plants QK 725 Cell Fractionation QH 585.5.C43 Special topics, by subject Cell-Free System QH 581-581.2 Cell Fusion QH 451 Cell Growth see Cell Division Cell Growth Inhibitors see Growth Inhibitors Cell Hypoxia QH 633 Cell Isolation see Cell Separation Cell Line QH 585.4-585.45 Cell Line, Tumor see Tumor Cells, Cultured Cell-Mediated Immunity see Immunity, Cellular Cell-Mediated Lympholytic Cells see T-Lymphocytes, Cytotoxic Cell Membrane QH 601-601.2 Bacterial QW 51-52 See also Nuclear Membrane QH 601.2 Cell-Membrane Coated Pits see Coated Pits, Cell-Membrane Cell Membrane Permeability Cytology QH 611 Metabolism QU 120 Cell Membrane Proteins see Membrane Proteins Cell Movement QH 647 Cell Nucleolus QH 596 Cell Nucleus QH 595 Cell Number see Cell Count Cell Organelles see Organelles Cell Segregation see Cell Separation Cell Separation QH 585.5.C44 Cell Surface Antigens see Antigens, Surface Cell Surface Glycoproteins see Membrane Glycoproteins Cell Surface Proteins see Membrane Proteins Cell Surface Receptors see Receptors, Cell Surface Cell Therapy see Tissue Therapy Cell Transformation, Neoplastic QZ 202 Cell Transformation, Viral QH 604 Of neoplasms QZ 202 Cell Wall Bacterial QW 51-52 Plant QK 725 Cellophane Plastics manufacture TP 1180.C4 Used for special purposes, by subject, e.g.; in hemodialysis WJ 378 Cells Aging Animal QH 608 Human WT 104 Plants QK 725 Chromosome abnormalities QS 675 Eukaryotic QH 603.E8 Histology QS 504-532 Normal morphology and physiology QH 573-659 Pathology Animal QH 671 Human QZ 4, etc. Radiation effects WN 620 Of a specific tissue, with the tissue, e. g. Muscle cells WE 500 Cells, Cultured QH 585.2-585.45 In histology QS 530 Techniques QS 525 Cellular Immunity see Immunity, Cellular Cellular Includions see Inclusion Bodies Cellular Neurobiology see Neurobiology Cellulitis WR 220 Phlegmon WD 375 Cellulitis, Pelvic see Parametritis Cellulose Biochemistry QU 83 Deficiency WD 105 Organic chemistry QD 323 Plastics manufacture TP 1180.C6 Therapeutic use by diet WB 427 Used for special purposes, by subject, e.g., in the treatment of kidney calculi WJ 356 CELSS see Ecological Systems, Closed Cement, Dental see Dental Cementum Cement Fillings see Dental Cements; Silicate Cement Cementation WU 300 Crowns WU 515 Inlays WU 360 See also Dental Cements WU 190 Cementoblasts see Dental Cementum Cementoma WU 280 Cementoperiostitis see Periodontitis Cementum see Dental Cementum Cemeteries see Mortuary Practice Census see Demography Centenarian see Aged, 80 and over Centers for Health Planning see Health Planning Organizations Centipedes see Arthropods Central Nervous System WL 300-405 Drugs affecting QV 76.5-115 Central Nervous System Agents QV 76.5 Analeptics QV 100-107 Psychotropic drugs QV 77.2-77.9 Central Nervous System Depressants QV 80-98 Local anesthetics QV 110-115 See also specific depressants and specific types of depressants Central Nervous System Diseases WL 300-405 Associated eye diseases WW 460 General works WL 300 In infancy & childhood WS 340-342 Nursing WY 160.5 Veterinary SF 895 Central Nervous System Neoplasms WL 358 Central Nervous System Stimulants see Analeptics Central Retinal Artery see Retinal Artery Central Retinal Vein see Retinal Vein Central Supply, Hospital WX 165 Central Venous Pressure WG 106 Centralized Hospital Services WX 150 Centrally Acting Muscle Relaxants see Muscle Relaxants, Central ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 295 Centrifugation Centrifugation Biological research QH 324.9.C4 Chemical engineering TP 159.C4 Chemical techniques QD 54.C4 Clinical chemistry QY 90 See also Ultracentrifugation QD 54.C4, etc. Centrifugation, Density Gradient Clinical chemistry QY 90 Histochemistry QS 531 Other special topics, by subject Centrioles QH 597 Centrophenoxine see Meclofenoxate Cenuriasis see Cestode Infections Cephaelis see Ipecac (Syrup) Cephalalgia see Headache Cephalexin QV 350.5.C3 Cephalins see Phosphatidylethanolamines Cephalometry Anthropology (medieval and modern) GN 71-131 General dental diagnosis WU 141.5.C3 Used for diagnosis of particular disorders, with the disorder Cephalopelvic Disproportion see Labor Complications Cephalopelvic Proportion see Pelvimetry Cephalopelvimetry see Pelvimetry Cephalosporins QV 350.5.C3 Cephalothin QV 350.5.C3 Cephamycins QV 350.5.C3 Cephradine QV 350.5.C3 Ceramics Chemical technology TP 785-842 Dentistry WU 190 Medicine QT 37.5.C4 Used for special purposes, by subject Ceratopogonidae QX 505 Cercopithecidae QL 737.P93 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Cercopithecus aethiops QL 737.P93 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Cercopithecus pygerythrus see Cercopithecus aethiops Cercopithecus sabeus see Cercopithecus aethiops Cercopithecus tantalus see Cercopithecus aethiops Cereals As a dietary supplement in health or disease WB 431 Cultivation SB 188-192 Processing TS 2120-2159 Cerebellar Ataxia WL 320 Cerebellar Cortex WL 320 Cerebellar Diseases WL 320 Cerebellar Neoplasms WL 320 Cerebellar Nuclei WL 320 Cerebellopontile Angle see Cerebellopontine Angle Cerebellopontine Angle WL 320 Cerebellum WL 320 Cerebral Aneurysm WL 355 Traumatic WL 354 Cerebral Angiography WL 141 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHyl Cerebral Anoxia WL 355 Cerebral Arteries WG 595.C37 See also Blood supply WL 302 under Brain Cerebral Arteriosclerosis WL 355 Cerebral Arteriovenous Malformations WL 355 Cerebral Artery Diseases WL 355 Cerebral Cortex WL 307 Cerebral Decortication WL 307 Cerebral Dominance see Dominance, Cerebral Cerebral Edema see Brain Edema Cerebral Embolism and Thrombosis WL 355 Cerebral Hemispheres see Brain Cerebral Hemorrhage WL 355 Localized, by site Cerebral Infarction WL 355 Cerebral Ischemia WL 355 Cerebral Ischemia, Transient WL 355 Cerebral Meningitis see Meningitis Cerebral Palsy WS 342 In adulthood WL 354 Cerebral Peduncle see Mesencephalon Cerebral Revascularization WL 355 Cerebral Sclerosis, Diffuse WL 348 Cerebral Thrombosis see Cerebral Embolism and Thrombosis Cerebral Vasospasm see Cerebral Ischemia, Transient Cerebral Veins WG 625.C3 Cerebral Ventricle Neoplasms WL 358 Cerebral Ventricles WL 307 Cerebral Ventriculography WL 141 In infancy & childhood WS 340 Cerebrospinal Fluid WL 203 Clinical analysis QY 220 General diagnosis WB 377 Cerebrospinal Fluid Pressure WL 203 Cerebrospinal Fluid Proteins WL 203 Clinical examination QY 220 Cerebrospinal Meningitis, Epidemic see Meningitis, Meningococcic Cerebrovascular Circulation WL 302 Disorders WL 355 Cerebrovascular Disorders WL 355 Cerebrum see Brain Ceremonial Coming of age (Primitive customs) GN 483.3 Religious (Primitive customs) GN 473-473.6 Royalty and nobility GT 5010-5090 Cerium Inorganic chemistry QD 181.C4 Pharmacology QV 290 Cerium Isotopes Inorganic chemistry QD 181.C4 Pharmacology QV 290 Ceroid-Lipofuscinosis, Neuronal see Neuronal Ceroid-Lipofuscinosis Certificate of Need Relating to health facilities WX 157 Relating to regional health planning WA 541 For other special purposes, by subject Certification (Form number 21 in any NLM schedule where applicable) IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 296 Chemistry, Organic Of paraprofessionals, with the general number for the type Certification of the Dead see Death Certificates Ceruloplasmin WH 400 Clinical examination QY 455 Cerumen WV 222 Impacted WV 222 Cervical Rib Syndrome WL 500 Cervical Smears see Vaginal Smears Cervical Vertebrae WE 725 Cervicitis WP 475 Cervico-Brachial Neuralgia WL 400 Cervix Diseases WP 470 Veterinary SF 871 Cervix Dysplasia WP 480 Cervix Erosion WP 470 Cervix Mucus WP 470 Cervix Neoplasms WP 480 Cervix Uteri WP 470-480 Dilatation (in labor) Obstetrical surgery WQ 400 Physiology WQ 305 Cesarean Section WQ 430 Veterinary SF 887 Cesium Inorganic chemistry QD 181.C8 Pharmacology QV 275 Cesium Isotopes Inorganic chemistry QD 181.C8 Pharmacology QV 275 Cesium Radioisotopes WN 420 Nuclear physics QC 796.C8 See also special topics under Radioisotopes Cestoda QX 400 Cestode Infections WC 830-840 Veterinary SF 810.C5 Cetacea QL 737.C4 Paleozoology QE 882.C5 Chagas Cardiomyopathy WC 705 Chagas' Disease see Trypanosomiasis, South American Chagas Disease WC 705 Chalazion see Eyelid Diseases WW 205 Chalcone Pharmacology QV 150 Chalicosis see Pneumoconiosis Chalones see Growth Inhibitors CHAMPUS see Health Benefit Plans, Employee Chancroid WC 155 Channel Blockers, Calcium see Calcium Channel Blockers Chaplaincy Service, Hospital WX 187 Character BF 818-839 Disorders see Antisocial Personality WM 190; Personality Disorders WM 190 Charbon see Anthrax Charcoal QV 601 Ch?rcot-Marie Disease WE 550 Charcot-Marie-Tooth Disease see Charcot-Marie Disease Charcot's Joint see Arthropathy, Neurogenic Charge Nurses see Nursing, Supervisory Charges see Fees and Charges Charlatanry see Quackery Charting, Clinical see Medical Records Charts Statistical (Form number 16 in any NLM schedule where applicable) Chaulmoogra Oil QV 259 Chediak-Higashi Syndrome WD 308 Cheek WE 705 Cheese As a dietary supplement in health or disease WB 428 Dairying SF 270-274 Home economics TX 382 Sanitary processing WA 715 Cheilitis WI 200 Cheilosis see Riboflavin Deficiency Chelating Agents QV 290 Chelidonium see Plants, Medicinal Chemexfoliation WO 600 Chemical Analysis see Chemistry, Analytical Chemical Elements see Elements; Isotopes; Radioisotopes Chemical- Engineering- TP 155-156 Chemical Face Peeling see Chemexfoliation Chemical Genetics see Genetics, Biochemical Chemical Industry HD 9650-9663 Occupational medicine WA 400, etc. Industrial waste WA 788 Chemical Models see Models, Chemical Chemical Technology see Technology Chemical Toxicology see Toxicology Chemical Vaccines see Vaccines, Synthetic Chemical Warfare Agents QV 663-667 Chemical Water Pollution see Water Pollution, Chemical Chemicals see Chemistry; Drugs; and names of particular chemicals and groups of chemicals, e.g. Poisons Chemistry QD Bacterial QW 52 Biological see Biochemistry QU Chemicals as a cause of disease QZ 59 Dental WU 170 Forensic W 750 Industrial TP Industrial protection WA 465 Milk, Public health aspects WA 716 Physiological QU Water analysis WA 686 See also Blood Chemical Analysis QY 450-490; Histocytochemistry QS 531 Chemistry, Agricultural S 583-587.7 Chemistry, Analytical Inorganic QD 71-142 Methods in clinical pathology QY 90 Of air WA 750 Of food see Food Analysis QU 50, etc. Of milk WA 716 Of water WA 686 Chemistry, Clinical QY 90 Animal SF 772.66 Chemistry, Inorganic QD 146-197 Chemistry, Organic QD 241-441 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 297 Chemistry, Organic Aliphatic compounds QD 300-315 Aromatic compounds QD 330-341 Physical QD 476 Chemistry, Pharmaceutical QV 744 Chemistry, Physical QD 450-731 Chemodectoma see Paraganglioma, Extra-Adrenal Chemolysis, Intervertebral Disk see Intervertebral Disk Chemolysis Chemonucleolysis see Intervertebral Disk Chemolysis Chemoreceptors WL 102.9 Chemosterilants WA 240 Chemotactic Factor, Macrophage-Derived see Interleukin-8 Chemotactic Factor, Neutrophil, Monocyte-Derived see Interleukin-8 Chemotactic Factors In immune reaction QW 700 In phagocytosis QW 690 Chemotaxins see Chemotactic Factors Chemotaxis Cells (General) QH 647 In phagocytosis QW 690 Special topics, by subject Chemotaxis, Leukocyte In phagocytosis QW 690 Chemotherapy see Drug Therapy Chenic Acid see Chenodeoxycholic Acid Chenodeoxycholate see Chenodeoxycholic Acid Chenodeoxycholic Acid WI 703 Chenodiol see Chenodeoxycholic Acid Chenopodium QV 766 As an anthelmintic QV 253 Chest see Thorax Chest Injuries see Thoracic Injuries Chest Pain WF 970 Chest X-Ray see Mass Chest X-Ray; Thoracic Radiography Chewing see Mastication Chewing Tobacco see Tobacco, Smokeless Chick Embryo General works QL 959 Chicken Sarcoma Virus B77 see Sarcoma Viruses, Avian Chicken Tumor 1 Virus see Sarcoma Viruses, Avian Chickenpox WC 572 Chickenpox Virus see Herpesvirus 3, Human Chickens Anatomy SF 767.P6 Culture SF 481-503.52 Diseases SF 995-995.6 Physiology SF 768.2.P6 Chiggers see Mites Chilblains WG 530 Child WS Abnormal see Child, Exceptional WS 105.5.C3, etc. Adopted see Adoption WS 105.5.F2, etc. Anesthesia WO 440 Care and training see Child Care WS 113 Dentistry see Pedodontics WU 480 Labor HD 6228-6250.5 Nursing see Pediatric Nursing WY 159 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHi* Radiography WN 240 School child see School Health Services WA 350-352 Surgery WO 925 Tuberculosis see Tuberculosis in Childhood WF 415 Child Abuse WA 320 Child Abuse, Sexual WA 320 Abuser's psychological aspect WM 610 Child Advocacy WA 320 Special topics, by subject Child Behavior WS 105 Child Behavior Disorders WS 350.6 Child Care WS 113 Child Custody Special topics, by subject Child Day Care Centers Public health WA 310-320 Sociology HV 851-861 Child Development WS 105 Educational measurement LB 3051-3060.87 Evaluation (General) WS 105.5.E8 External influences WS 105.5.E9 Intelligence tests BF 432.C48 Of the mentally retarded child WS 107.5.D3 Physical see Growth WS 103, etc. Child Development Deviations see Child Development Disorders Child Development Disorders WS 350.6 Child Development Disorders, Pervasive WS 350 Child Development Disorders, Specific see Child Development Disorders Child, Exceptional Education LC 3951-4000 Rearing (General) WS 105.5.C3 See also Child Gifted LC 3991-4000, etc.; Education of Mentally Retarded LC 4601-4640.4; Mental Retardation WS 107-107.5, etc. Child, Gifted Care WS 113 Education LC 3991-4000 Guidance WS 350 Mental development WS 105 Child Guidance WS 350-350.8 Child Guidance Clinics WS 27-28 Directories WS 22 Child Health see Child Welfare Child Health Services WA 320 Mother and child WA 310 In school WA 350 See also School Health WA 350 Child, Hospitalized WS 105.5.H7 Child, Institutionalized Public health aspects WA 310-320 Retarded child WS 107.5.14 Sociological aspects HV 959-1420.5 See also Child, Hospitalized WS 105.5.H7 Child Language WS 105.5.C8 Child Molestation, Sexual see Child Abuse, Sexual Child Neglect see Child Abuse Child Nutrition Feeding WS 130 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 298 Choking Requirements WS 115 Child Nutrition Disorders WS 115 Child of Impaired Parents WS 105.5.F2 Special topics, by subject Child, Preschool General works WS 440 Other topics, by subject within the WS or other schedules Child Psychiatry WS 350-350.8 As a career WS 350 Case studies in mental retardation WS 107.5.C2 Child Psychology WS 105 Child Reactive Disorders WS 350.6 Child Rearing WS 105.5.C3 Physiological needs see Child Care WS 113 Child, Unwanted HV 873 Effect on pregnancy WQ 240 Parent-child relations WS 105.5.F2 See also Child Welfare WA 310, etc. Child Welfare Public health aspects WA 310-320 Sociology HV 701-1420.5 Childbirth see Labor; Popular works WQ 150 under Pregnancy; Natural Childbirth Childbirth at Home see Home Childbirth Childbirth Injuries see Birth Injuries; Labor Complications Childhood Schizophrenia see Schizophrenia, Childhood Children of Impaired Parents see Child of Impaired Parents Chills see Shivering; Hypothermia; Freezing; Frostbite Chimera QH 445.7 Chimeric Toxins see Immunotoxins Chimpansee troglodytes QL 737.P9 As laboratory animals QY 60. P7 Diseases SF 997.5.P7 Chimpanzee see Chimpansee troglodytes Chimpanzee Coryza Agent see Respiratory Syncytial Viruses Chin WE 705 See also Mandible WU 101, etc. Chinacrin see Quinacrine Chinchilla QL 737.R636 Culture SF 405.C45 Diseases SF 997.5.C5 Chinese see Mongoloid Race Chinese Americans see Asian Americans Chinese Herbal Drugs see Drugs, Chinese Herbal Chinese Liver Fluke see Opisthorchis Chinese Medicine, Traditional see Medicine, Chinese Traditional Chiniofon see Hydroxyquinolines Chipmunks see Sciuridae Chironex Venoms see Coelenterate Venoms Chironomidae QX 505 Chironomus see Chironomidae Chiropody see Podiatry Chiropotes see Cebidae Chiropractic WB 905-905.9 Chiroptera QL 737.C5 Diseases SF 997.5.B38 Chitin QU 83 Chitinase QU 136 Chlamydia QW 152 Chlamydia Infections WC 600 Veterinary SF 809.C45 Specific infection, by type Chlamydiales QW 152 Chloral Hydrate QV 85 Chlorambucil QV 269 Chloramiphene see Oomiphene Chloramphenicol QV 350.5.C5 Chlorbutol see Chlorobutanol Chlordecone see Kepone Chlordiazepoxide QV 77.9 Chlorella QK 569.C49 Chlorethazine see Mechlorethamine Chlorhexidine QV 220 Chlorides Inorganic chemistry QD 181.C5 Pharmacology QV 280 Water purification WA 690 Chlorimipramine see Clomipramine Chlorinated Hydrocarbons see Hydrocarbons, Chlorinated Chlorine QV 231 Toxicology QV 663 Chlormequat As a plant growth regulator QK 745 Organic chemistry QD 305.A8 Chlormerodrin QV 160 Chlormeroprin see Chlormerodrin Chlormethine see Mechlorethamine Chlorobutanol QV 115 Chlorodinitrobenzene see Dinitrochlorobenzene Chloroethylene see Vinyl Chloride Chloroethylene Polymer see Polyvinyl Chloride Chloroform QV 81 Chloroiodoquine see Clioquinol Chloromethyl Ether see Bis(Chloromethyl) Ether Chlorophenols QV 223 Chlorophenyl GABA see Baclofen Chlorophyll QK 898.C5 Chloropicrin QV 664 Chloroplast Coupling Factor see H(-f ^Transporting ATP Synthase Chloroplasts QK 898.C5 Chloroprene As a carcinogen QZ 202 Toxicology QV 633 Chloroquine QV 256 Chlorosis see Anemia, Hypochromic Chlorosis, Egyptian see Hookworm Infections Chlorphenamine see Chlorpheniramine Chlorpheniramine QV 157 Chlorpromazine QV 77.9 Chlorprophenpyridamine see Chlorpheniramine Chlorprothixene QV 77.9 Chlortetracycline QV 360 Chocolate see Cacao Choice Behavior BF 608-618 Special topics, by subject Choked Disk see Papilledema Choking see Airway Obstruction ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 299 Cholagogues and Choleretics Cholagogues and Choleretics QV 66 Cholalic Acids see Cholic Acids Cholangiography WI 750 Cholangiopancreatography, Endoscopic Retrograde WI 750 Cholates see Cholic Acids Cholecalciferol QU 173 Cholecystectomy WI 750 Cholecystitis WI 755 Cholecystography WI 750 Cholecystokinin WK 170 Cholecystokinin Octapeptide Receptors see Receptors, Cholecystokinin Cholecystokinin-Pancreozymin Receptors see Receptors, Cholecystokinin Cholecystokinin Receptors see Receptors, Cholecystokinin Cholecystostomy WI 750 Choledocholithiasis see Common Bile Duct Calculi Choledochus see Common Bile Duct Cholelithiasis WI 755 Cholelithiasis, Common Bile Duct see Common Bile Duct Calculi Cholera WC 262-264 Cholera Toxin WC 262 Cholera Vaccine WC 262 Choleragen see Cholera Toxin Choleragenoid see Cholera Toxin Choleretics see Cholagogues and Choleretics Cholestasis WI 703 Cholestasis, Extrahepatic see Bile Duct Obstruction, Extrahepatic Cholesteatoma QZ 365 Localized, by site Cholesterol QU 95 Cholesterol, Dietary QU 95 Control in sickness or health WB 425 Cookbooks WB 425 Cholesterol HDL see Lipoproteins, HDL Cholesterol Cholesterol Inhibitors see Anticholesteremic Agents Cholesterol LDL see Lipoproteins, LDL Cholesterol Cholesterol-7-Hydroxylase QU 140 Cholic Acids WI 703 Choline QU 87 Esters QV 122 Choline Acetylase see Choline Acetyltransferase Choline Acetyltransferase QU 141 Choline Deficiency WD 120 Choline Phosphoglycerides see Phosphatidylcholines Cholinergic Agents QV 122 Cholinergic Antagonists QV 124 Cholinergic-Blocking Agents see Cholinergic Antagonists Cholinergic Receptors see Receptors, Cholinergic Cholinesterase Inhibitors QV 124 Cholinesterase Reactivators QV 124 Cholinesterases QU 136 Cholinoceptive Sites see Receptors, Cholinergic Cholinoceptors see Receptors, Cholinergic Cholinolytics see Cholinergic Antagonists Cholinomimetics see Cholinergic Agents Chondroblastoma QZ 340 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIM Chondrodysplasia, Hereditary Deforming see Exostoses, Multiple Hereditary Chondrodysplasia Punctata WE 250 Chondrodystrophia Calcificans Congenita see Chondrodysplasia Punctata Chondrodystrophia Fetalis see Achondroplasia Chondroitin QU 83 Chondroma QZ 340 Chorda Tympani Nerve WL 330 Chordata QL 605-739.8 See also special aspects, e.g., Embryology QL 958, etc. Chordoma QZ 310 Localized, by site Chorea WL 390 Associated with rheumatic fever WC 220 Chorea, Hereditary see Huntington Chorea Chorioadenoma see Hydatidiform Mole, Invasive Choriocarcinoma WP 465 Pathology QZ 310 Chorioepithelioma see Choriocarcinoma Chorion WQ 210 Animal QL 977 Embryology QS 645 Chorionic Somatomammotropin, Human see Placental Lactogen Chorionic Villi WQ 210 Animal QL 977 Embryology QS 645 Chorionic Villi Sampling WQ 209 Chorioretinitis WW 270 Choroid WW 245 Edema WW 245 Choroid Diseases WW 245 Choroid Neoplasms WW 245 Choroid Plexus WL 307 Choroiditis WW 245 Christ-Siemens-Touraine Syndrome see Ectodermal Dysplasia Christian Science BX 6903-6997 Healing WB 885 See also Mental Healing WB 885, etc. Christianity BR And medicine W 61 See also Religion and Medicine BL 65.M4, etc. And psychiatry WM 61 See also Religion and Psychology BL 53, etc And psychoanalysis WM 460.5.R3 General works BR 120-126 Medical ethics W 50 Other special topics, by subject Chromaffin System Endocrinology WK 102 Of particular glands or other organs, by gland or organ Chromatin QU 56 Cytology QH 599 Chromatin, Sex see Sex Chromatin Chromatium QW 145 Chromatography Analytical chemistry (General) QD 79.C4 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 300 Cineradiography Organic analysis (General) QD 272.C4 Qualitative analysis QD 98.C4 Quantitative analysis QD 117.C5 Used for special purposes, by subject, e.g., in Assay of Hormones QY 330 Chromatography, Affinity Biochemistry QU 25 Chromatography, Gas Analytical chemistry QD 79.C45 Organic analysis QD 272.C44 Chromatography, Gas-Liquid see Chromatography, Gas Chromatography, High Performance Liquid see Chromatography, High Pressure Liquid Chromatography, High Pressure Liquid Analytical chemistry QD 79.C454 Chromatography, High Speed Liquid see Chromatography, High Pressure Liquid Chromatography, Paper Analytical chemistry QD 79.C46 Chromatography, Thin Layer Analytical chemistry QD 79.C8 Organic analysis QD 272.C45 Chromatophores QS 532.5.E7 Chromium QV 290 Metabolism QU 130.5 Chromium Isotopes Inorganic chemistry QD 181.C7 Pharmacology QV 290 Chromogenic Compounds Analytical chemistry QD 77 Pharmaceutical chemistry QV 744 Used for special purposes, by subject Chromogenic Substrates see Chromogenic Compounds Chromomycins QV 269 Chromophobe Adenoma see Adenoma, Chromophobe Chromosomal Probes see DNA Probes Chromosomal Translocation see Translocation (Genetics) Chromosome Aberrations QH 462.A1 See also Chromosome Deletion QH 462.D4; Inversion (Genetics) QH 462.15; Translocation (Genetics) QH 462.T7 Chromosome Abnormalities QS 677 See also Trisomy QH 461, etc. Chromosome Banding QH 600 Chromosome Deletion QH 462.D4 Chromosome Fragile Sites QH 461.A1 Chromosome Mapping QH 445.2 Chromosome Markers see Genetic Markers Chromosome 21 see Chromosomes, Human, Pair 21 Chromosomes QH 600 See also Sex Chromosomes QH 600.5 Chromosomes A see Chromosomes, Human, 1-3 Chromosomes, Bacterial QW 51-52 Chromosomes D see Chromosomes, Human, 13-15 Chromosomes, Human QH 600 Chromosomes, Human, Pair 21 QH 600 Chromosomes, Human, 1-3 QH 600 Chromosomes, Human, 13-15 QH 600 Chronic Disease WT 500 In infancy & childhood WS 200 Nursing WY 152 Social problems WT 30 Chronic Fatigue Syndrome see Fatigue Syndrome, Chronic Chronic Illness see Chronic Disease Chronic Limitation of Activity see Activities of Daily Living Chronic Obstructive Pulmonary Disease see Lung Diseases, Obstructive Chronobiology QT 167 Chronologies, Medicine see Chronologies WZ 30 under Medicine; Chronology Chronology CE Historical D-F Medical WZ 30 Chronotropism, Cardiac see Heart Rate Chrysanthemum see Pyrethrum Chrysenes QV 138.C1 Organic chemistry QD 395 Chrysotherapeutic Agents see Antirheumatic Agents, Gold Church see Catholicism; Religion Churg-Strauss Syndrome WG 515 Chyle WI 402 Chylomicrons QU 85 Chylothorax WF 700 Chymopapain QU 136 Chymosin QU 136 In milk analysis WA 716 CI-581 see Ketamine Cicatrix WR 143 Wound healing WO 185 Localized, by site Ciguatera see Ciguatoxin Ciguatoxin QW 630 Cilastatin QU 90 As a protease inhibitor QU 136 Cilia QS 532.5.E7 In animals QP 310.C5 Specific to an organ, with the organ Ciliary Body WW 240 Ciliary Dyskinesia see Ciliary Motility Disorders Ciliary Motility Disorders WF 140 Cilia of specific organs, with the organ Ciliata see Oliophora Ciliate Infections see Balantidiasis WC 735 or names of other parasitic diseases caused by Ciliata Oliophora QX 151 Ometidine QV 157 As an anti-ulcer agent QV 69 Cimex see Bedbugs Cincain see Dibucaine Onchocain see Dibucaine Cinchona QV 257 Onchophen QV 95 Cine-CT see Tomography, X-Ray Computed Cineangiography WG 500 Cinefluorography see Cineradiography Cineradiography WN 220 Heart WG 141.5.R2 Diagnosis of specific disease with the disease or organ ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7TED 301 Ciprofloxacin Ciprofloxacin QV 250 Orcadian Rhythm QT 167 Animals QP 84.6 Biology (General) QH 527 Circular Dichroism QD 473 Circulation see Blood Circulation; Cerebrovascular Circulation; Collateral Circulation; Coronary Circulation; Liver Circulation; Microcirculation; Pulmonary Circulation Circulation of Books see Circulation Z 712-714 under Library Services Circulatory Disorders see Blood Circulation; Cerebrovascular Circulation; Disorders WI 720 under Liver Circulation Circulatory Function Tests see Blood Circulation Circulatory System see Cardiovascular System Circumcision Anthropology GN 484 Judaism BM 705 Medical procedure WJ 790 Cirrhosis see Liver Cirrhosis; Pulmonary Fibrosis Cirrhosis, Liver see Liver Cirrhosis cis-Diamminedichloroplatinum(II) see Cisplatin cis-Dichlorodiammineplatinum(II) see Cisplatin Cisplatin QV 269 Therapeutic use for neoplasms QZ 267 Osterna Chyli see Thoracic Duct Cisterna Magna WL 200 Cisternal Puncture see Punctures Cisternography, Myelographic see Myelography Cisternography, Pneumoencephalography see Pneumoencephalography Citellus see Sciuridae Citicoline see Cytidine Diphosphate Choline Citizen Participation see Consumer Participation Citrated Calcium Cyanamide see Cyanamide Citrates QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Citric Acid Cycle QU 98 Citrin see Bioflavonoids Citrovorum Factor see Leucovorin Citrus Fruits As a dietary supplement in health or disease WB 430 Sanitary control WA 703 City Planning HT 165.5-169.9 Architecture and engineering NA 9000-9428 Public health aspects in WA See also Urban Renewal HT 170-178, etc. Civil Defense UA 926-929 Psychological aspects UA 926.5 Civil Rights JC 571-628 Constitutional law (U.S.) KF 4741-4785 Control of individual rights KF 4791-4856 Mentally disabled WM 30-32 Political rights JF 800-1191 Other special topics, by subject, e.g., Medical records and privacy rights WX 173, etc. Civilian Protection see Civil Defense Civilization CB General works CB 23-161 Sociological aspects HM 101-121 ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Other special topics, by subject, e.g. civilization and disease WA 30 Claims Review see Insurance Claim Review Clairvoyance see Parapsychology Clams QX 675 Food poisoning WC 268 Food sanitation WA 703; WA 710 Clarification, Pharmaceutical see Drug Compounding Class I Genes see Genes, MHC Class I Class II Antigens see Histocompatibility Antigens Class II Class II Genes see Genes, MHC Class II Class II Human Antigens see HLA-D Antigens Classical Complement Pathway see Complement Pathway, Classical Classification (Form number 15 in any NLM schedule where applicable) See also Book Classification Z 696-697 and subjects or objects being classified Clastogens see Mutagens Claustrophobia see Phobic Disorders Claustrum see Basal Ganglia Clavicle WE 810 Clavulanic Acids QV 350 Claw see Hoof and Claw Cleanliness, Personal see Cleanliness QT 240 under Hygiene Cleansing Agents see Detergents Cleavage, Cell see Cell Division Cleft Lip WV 440 Cleft Palate WV 440 Cleft Palate Prosthesis see Palatal Obturators Clemastine QV 157 Clerambault Syndrome see Organic Mental Disorders, Psychotic Clergy BV 659-683 See also Psychology, Pastoral WM 61 Clerical Medicine see Pastoral Care Clethrionomys see Microtinae Client-Centered Therapy see Nondirective Therapy Climacteric Female WP 580 See also Menopause WP 580 Male WJ 702 Postmenopausal see Menopause WP 580 Climate Climatology (Physics) QC 980-999 Prescribed for health WB 750 Prescribed for tuberculosis WF 330 Relation to disease WB 700-710 See also Acclimatization QT 145, etc.; Cold Climate QT 160, etc.; Desert Climate QT 150, etc.; Environment QT 230, etc.; Meteorological Factors WA 30, etc.; Tropical Climate QT 150, etc.; Weather WB 700-710, etc. Climatology, Medical see Climate; Weather Climatotherapy see Climate; Health Resorts; Thalassotherapy Clinical Charting see Medical Records Clinical Chemistry see Chemistry, Clinical NUMBER ASSIGNED ONLY WHEN >F WORK BEING CLASSIFIED 302 Cobalt Radioisotopes Clinical Competence W 21 As an educational measurement Works about (Form number 18 in any NLM schedule where applicable) Actual tests (Form number 18.2 in any NLM schedule where applicable) Clinical Departments see Hospital Departments Clinical Engineering see Biomedical Engineering Clinical Equivalency see Therapeutic Equivalency Clinical Ethics see Ethics, Medical Clinical Informatics see Medical Informatics Clinical Investigators see Research Personnel Clinical Laboratory Information Systems QY 26.5 Clinical Ladders see Career Mobility Clinical Markers see Biological Markers Clinical Medicine WB 102 Clinical Nurse Specialists see Nurse Clinicians Clinical Nursing Research WY 20.5 Clinical Pathology see Pathology, Clinical Clinical Pharmacology see Pharmacology, Clinical Clinical Pharmacy Service see Pharmacy Service, Hospital Clinical Practice Nursing Research see Clinical Nursing Research Clinical Practice Patterns see Physician's Practice Patterns Clinical Practice Variations see Physician s Practice Patterns Clinical Protocols Used for special purposes, by subject Clinical Psychology see Psychology, Clinical Clinical Refraction see Refraction, Ocular Clinical Skills see Clinical Competence Clinical Trials Drugs QV 771 Vision research WW 20 For other purposes, by subject or specific drug or procedure Clinical Trials, Controlled see Controlled Clinical Trials Clinical Trials, Randomized see Randomized Controlled Trials Clinics, Dental see Dental Clinics Clinics, Free-Standing see Ambulatory Care Facilities Clinics, Outpatient see Outpatient Climes, Hospital Clioquinol QV 255 Clitoris WP 200 Cloaca WJ 101 Clofibric Acid As an anticholesteremic agent QU 95 Clofibrinic Acid see Clofibric Acid Clomifene see Clomiphene Clomiphene QV 170 Clomipramine QV 77.5 Clone Cells QH 585 Nuclear cloning QH 442.2 Cloning, Molecular QH 442.2 Cloning Vectors see Genetic Vectors Clonogenic Cell Assay see Colony-Forming Units Assay Clonogenic Cell Assay, Tumor see Tumor Stem Cell Assay Clonorchis sinensis QX 353 Cloranfenicol see Chloramphenicol Closed-Circuit Anesthesia see Anesthesia, Closed-Circuit Closed Cohort Studies see Cohort Studies Closed Ecologic Life Support Systems see Ecological Systems, Closed Clostridiopeptidase A see Microbial Collagenase Clostridium QW 127.5.C5 Clostridium botulinum QW 127.5.C5 Clostridium histolyticum Collagenase see Microbial Collagenase Clostridium Infections WC 368-375 See also Botulism WC 268; Hemoglobinuria, Bacillary WJ 344; Wound Infection WC 255 Clostridium perfringens QW 127.5.C5 Clostridium welchii see Clostridium perfringens Closure of Wounds see Wounds and Injuries Clothing QT 245 See also Protective Clothing WA 260, etc. Clouston's Syndrome see Ectodermal Dysplasia Clubfoot WE 883 Veterinary SF 901 Clumping see Agglutination Clumping, Erythrocytic see Hemagglutination Cluster Headache WL 344 Clysis see Enema Clyster see Enema CMHC see Community Mental Health Centers Cnidaria QX 195 CoA see Coenzyme A Coagulants QV 195 Coagulase WH 310 Special topics, by subject Coagulation see Blood Coagulation; Laser Coagulation; Light Coagulation Coagulation Factors see Blood Coagulation Factors Coal TP 325-326 Poisoning QV 633 See also Pneumoconiosis WF 654 and related disorders Coal Mining Occupational accidents WA 485 Occupational medicine WA 400-495 Industrial waste WA 788 Coal Tar QV 60 Anti-infective dyes derived from QV 235 Toxicology QV 633 See also Cresols QV 223, etc.; Phenols QV 223, etc. Coated Pits, Cell-Membrane QH 603.C63 Cobalamin see Vitamin B 12 Cobalt Inorganic chemistry QD 181.C6 Metabolism QU 130.5 Pharmacology QV 290 Cobalt Isotopes Inorganic chemistry QD 181.C6 Pharmacology QV 290 Cobalt Radioisotopes WN 420 Nuclear physics QC 796.C6 See also special topics under Radioisotopes ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSnTED 303 Coca QV 113 Cocaine QV 113 Dependence WM 280 Cocarboxylase see Thiamine Pyrophosphate Cocarcinogenesis QZ 202 Cocci, Gram-Positive see Gram-Positive Cocci Coccidia QX 123 Coccidioides QW 180.5.P4 Coccidioidomycosis WC 460 Coccidiosis WC 730 Veterinary SF 792 Avian diseases SF 995.6.C6 Coccygeal Region see Sacrococcygeal Region Coccyx WE 725 Cochlea WV 250 Cochlear Aqueduct WV 250 Cochlear Diseases WV 250 Cochlear Implant WV 274 Cochlear Microphonic Potentials WV 270 Cochlear Nerve WL 330 Physiology of hearing WV 272 Cochlear Prosthesis see Cochlear Implant Cochliobolus see Ascomycetes Cockroaches QX 570 Cocoa see Cacao Coconut Diets for control of fats WB 425 Diets for control of proteins WB 426 Plant culture SB 401.C6 Cocos see Coconut Cod Liver Oil QU 86 Codeine QV 92 Dependence WM 286 Codes of Ethics see Bioethics; Ethics; Ethics, Medical; ethics in other specialties Codes, Sanitary see Legislation WA 32-33 under Sanitation Codon QU 58.7 Coelenterata see Cnidaria Coelenterate Venoms WD 405 Coendou see Rodentia Coenuriasis see Cestode Infections Coenzyme A QU 135 Coenzyme I see NAD Coenzyme II see NADP Coenzyme M see Mesna Coenzyme Q see Ubiquinone Coenzymes QU 135 Coercion Special topics, by subject Coffea see Coffee Coffee As a dietary supplement in health or disease WB 438 Cultivation SB 269 See also Caffeine QV 107 Coformycin As an antineoplastic agent QV 269 As an immunosuppressant QW 920 Cognition BF 311-499 Cognition & age (adulthood) BF 724.55.C63 In adolescence WS 462 In infancy & childhood WS 105.5.C7 In old age WT 145 Cognition Disorders General and psychotic WM 204-205 Other special topics by subject, e.g., Amnesia WM 173.7 Cognitive Dissonance BF 337.C63 Cognitive Therapy WM 425.5.C6 In infancy & childhood WS 350.6 Cohort Analysis see Cohort Studies Cohort Studies In epidemiology WA 105 Special topics, by subject Coin Lesion, Pulmonary WF 658 Coins see Numismatics Coinsurance see Deductibles and Coinsurance Coitus Animal (General) see Copulation QL 761 Human HQ 19-30.7 Psychophysiologic problems WM 611 Female WP 610 Male WJ 709 Cola see Beverages Colchicine QV 98 Colchicum QV 98 Cold Adverse effects QZ 57 In anesthesia see Anesthesia, Refrigeration WO 350 Therapeutic use WB 473 Cold Agglutinin Disease see Anemia, Hemolytic, Autoimmune Cold Climate Physiological effects QT 160 Winter temperatures (meteorology) QC 905 Cold, Common see Common Cold Cold-Insoluble Globulins see Fibronectins Cold Therapy see Cryotherapy Colectomy WI 520 Coleonol see Forskolin Coleoptera QX 555 Colic WI 147 Colicines see Colicins Colicins QV 350 Coliform Bacilli see Enterobacteriaceae Coliphage lambda see Bacteriophage lambda Coliphages QW 161.5.C6 Coliphages T see T-Phages Colistin QV 350 Colitis WI 522 Amebic see Dysentery, Amebic WC 285 Colitis, Amebic see Dysentery, Amebic Colitis, Granulomatous see Crohn Disease Colitis, Mucous see Colonic Diseases, Functional Colitis, Ulcerative WI 522 Collagen QU 55 Collagen Diseases WD 375 See also names of specific diseases Collagen Type I see Collagen Collagen Type II see Collagen Collagen Type III see Collagen Collagen Type IV see Collagen Collagen Type IX see Collagen Collagen Type V see Collagen ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 304 Communicable Disease Contact Tracing Collagen Type VI see Collagen Collagen Type VII see Collagen Collagen Type VIII see Collagen Collagen Type X see Collagen Collagen Type XI see Collagen Collagen Type XII see Collagen Collagen Type XIII see Collagen Collagenase, Microbial see Microbial Collagenase Collapse Therapy WF 350 Collateral Circulation WG 103 Collected works By several authors (Form number 5 in any NLM schedule where applicable) By individual authors (Form number 7 in any NLM schedule where applicable) Collection of Fees see Fees and Charges; Fees, Dental; Fees, Medical; Fees, Pharmaceutical Collections see Form numbers 5-7 in any NLM schedule where applicable Collective Bargaining HD 6971.5-6971.6 Hospitals and hospital personnel WX 159.8 Industry and health services WA 412 Mental health services WA 495 Industry and health insurance W 125-270 Nurses WY 30 With hospital staff WX 159.8 Special topics, by subject College Admission Test LB 2353-2353.8 Works about (Form number 18 in any NLM schedule where applicable) Actual tests (Form number 18.2 in any NLM schedule where applicable) See also Educational Measurement LB 3051-3059, etc. College Students, Health see Student Health Services Colleges, Medical see Schools, Medical Collodion Pharmaceutic aids QV 800 Photographic processing TR 390 Colloids As dosage form QV 785 Biochemistry QU 133 Colobus QL 737.P93 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Colocynth QV 75 Colon WI 520-529 Colon and Rectal Surgery (Specialty) WI 650 Colon only WI 520 Colon, Irritable see Colonic Diseases, Functional Colonialism see Political Systems Colonic Diseases WI 520-529 Colonic Diseases, Functional WI 520 Colonic Neoplasms WI 529 Colonic Polyps WI 529 Colonoscopy WI 520 Colony-Forming Units see Stem Cells Colony-Forming Units Assay QH 585 Colony-Forming Units Assay, Tumor see Tumor Stem Cell Assay Colony-Forming Units, Hematopoietic see Hematopoietic Stem Cells Colony-Forming Units, Neoplastic see Tumor Stem Cells Colony-Stimulating Factor, Mast-Cell see Interleukin-3 Colony-Stimulating Factor, Multipotential see Interleukin-3 Colony-Stimulating Factor 2 Alpha see Interleukin-3 Colony-Stimulating Factors In hematopoiesis WH 140 Color QC 494-496.9 Psychology BF 789.C7 Therapeutics see Alternative Medicine WB 890, etc. See also Eye Color WW 101; Food Additives WA 712; Hair Color WR 450; Pigmentation WR 102, etc. Color Blindness see Color Vision Defects Color Perception WW 150 Color Vision see Color Perception Color Vision Defects WW 150 Colorectal Neoplasms WI 529 Colorectal Neoplasms, Hereditary Nonpolyposis WI 529 Colorimetry QD 113 Clinical pathology QY 90 Coloring Agents see Dyes Coloring Agents, Food see Food Coloring Agents Coloring Agents, Hair see Hair Dyes Colostomy WI 520 Colostrum WP 825 Colpohysterectomy see Hysterectomy, Vaginal Colposcopy WP 250 Coma WB 182 Diabetic see Diabetic Coma WK 830 Hepatic see Hepatic Encephalopathy WI 700 Coma, Hyperglycemic Hyperosmolar Nonketotic see Hyperglycemic Hyperosmolar Nonketotic Coma Combat Disorders WM 184 Combat Psychiatry see Psychiatry, Military Combination Chemotherapy see Drug Therapy, Combination Combined Modality Therapy General WB 300 For neoplasms QZ 266 Combining Site see Binding Sites Comfort Stations see Toilet Facilities Commerce HF General works HF 1003-1008 Commercial Oils see Industrial Oils Commercial Preparations see Drugs, Non-prescription Comminution, Pharmaceutical see Drug Compounding Commitment of Mentally 111 WM 32-33 Common Bile Duct WI 750 Common Bile Duct Calculi WI 755 Common Bile Duct Diseases WI 750 Common Bile Duct Neoplasms WI 765 Common Cold WC 510 Common Cold Virus see Rhinovirus Common Hepatic Duct see Hepatic Duct, Common Communicable Disease Contact Tracing see Contact ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 305 Communicable Disease Contact Tracing Tracing Communicable Disease Control WA 110-240 Disinfestation WA 240 Notifiable disease registration WA 55 See also Quarantine WA 230, etc.; names of various types of control, e.g., Pest control WA 240 Communicable Diseases WC Drugs used in QV 250-268.5 General works WC 100 In infancy & childhood WC In pregnancy see Pregnancy, Complications, Infectious WQ 256 Nursing WY 153 Prevention see Communicable Disease Control WA 110, etc.; Insect Control QX 600; Quarantine WA 230, etc. Transmission Epidemiological aspects WA 110 Insect vectors QX 650 Mechanisms QW 700 Veterinary SF 781-809 Communication In adolescence WS 462 In infancy & childhood WS 105.5.C8 In mentally retarded WM 307.C6 In infancy & childhood WS 107.5.C6 In psychoanalysis WM 460.5.C5 Information systems Z 699, etc. Manual HV 2474-2480 Medical writing and publishing WZ 345 Nonverbal see Nonverbal communication HM 258 Philosophy and linguistics P 87-96 Physicians interpersonal relations W 62 Psychology BF 637.C45 Social psychology HM 258 Telecommunication (General) TK 5101-5105.9 Communication Aids for Disabled For communicative disorders WL 340.2 See also specific types of aids Communication Aids for Handicapped see Communication Aids for Disabled Communication, Animal see Animal Communication Communication Barriers In adolescence WS 462 In infancy & childhood WS 105.5.C8 In mentally retarded WM 307.C6 Physician's interpersonal relations W 62 Psychological aspects BF 637.C45 Social psychology aspects HM 258 Communication Boards see Communication Aids for Disabled Communication Methods, Total HV 2497 Communicative Disorders General WL 340.2 Psychogenic WM 475 Neurologic WL 340.2 Communism HX 72-73, 626-780.7 As practiced in special countries in JN or in the history number for the country Special topics, by subject, e.g. State medicine in a Communist country W 275 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH^ Community Action see Consumer Participation Community Dentistry WU 113 Community Health Aides W 21.5 Community Health Care see Community Health Services Community Health Education see Health Education Community Health Nursing WY 106 Community Health Services WA 546 Community-Institutional Relations Hospital WX 160 Other types of institutions, by subject Community Medicine W 84.5 Community Mental Health Centers WM 29 Community Mental Health Services WM 30 In infancy & childhood and other age groups WM 30 Special population groups WA 305 See also Hospitals, Psychiatric WM 27-28, etc.; Social Work, Psychiatric WM 30.5 Community Pharmacies see Pharmacies Community Pharmacy Services QV 737 Community Psychiatry WM 30.6-31.5 Etiological factors in mental disorders WM 31 Preventive measures WM 31.5 Social psychiatry WM 30.6-31.5 Comorbidity Of particular disorders, with the disorder Compact Disk Read-Only Memory see CD-ROM Comparative Anatomy see Anatomy, Comparative Comparative Pathology see Pathology Comparative Physiology see Physiology, Comparative Comparative Psychology see Psychology, Comparative Compartment Syndromes WE 550 Compensation, Disability see Veterans Disability Claims; Disability Evaluation; Workers' Compensation Competence, Clinical see Clinical Competence Competence, Immunologic see Immunocompetence Competence, Professional see Professional Competence Competency-Based Education General works LC 1031-1034.5 In a particular field (Form number 18 in any NLM schedule where applicable) Competition, Economic see Economic Competition Competitive Behavior HM 136 Competitive Bidding Medical work W 74 Other fields, in economics number by subject Competitive Binding see Binding, Competitive Complement QW 680 Complement Activating Enzymes QW 680 Biochemistry QU 135 Complement Activation QW 680 Complement Fixation Tests QY 265 Complement Pathway, Classical QW 680 Complement Proteins see Complement Complement Receptors see Receptors, Complement Complement 1 QW 680 Complement 1 Esterase Inhibitors see Complement 1 Inactivators USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSinED 306 Concurrent Studies Complement 1 Inactivators QW 680 Biochemistry QU 136 Complement 1 Inhibitors see Complement 1 Inactivators Complement 3 QW 680 Complement 3 Convertase QW 680 Complement 5 Convertase see Complement 3 Convertase Complexons see Chelating Agents Compliant Behavior see Cooperative Behavior Composite Resins WU 190 Compound Fractures see Fractures, Open Compound Q see Trichosanthin Comprehensive Dental Care WU 29 Comprehensive Health Care W 84.5 Comprehensive Health Insurance see Insurance, Major Medical Comprehensive Health Planning see Regional Health Planning Comprehensive Health Planning Agencies see Health Systems Agencies Comprehensive Health Plans, Local see Health Systems Plans Comprehensive Health Plans, State see State Health Plans Compressed Air Disease see Decompression Sickness Compression of the Brain see Brain Injuries, Acute Compression of the Spinal Cord see Spinal Cord Compression Compulsive Behavior WM 176 See also Obsessive-Compulsive Disorder WM 176 Compulsive Personality see Compulsive Personality Disorder Compulsive Personality Disorder WM 190 Compulsory Health Insurance see Insurance, Health Computed Tomography Scanners, X-Ray see Tomography Scanners, X-Ray Computed Computer Architecture see Computer Systems Computer-Assisted Decision Making see Decision Making, Computer-Assisted Computer-Assisted Diagnosis see Diagnosis, Computer-Assisted Computer-Assisted Image Processing see Image Processing, Computer-Assisted Computer-Assisted Instruction (Form number 18.2 in any NLM schedule where applicable) Embryology QS 618.2 General works LB 1028.5 Histology QS 518.2 Computer-Assisted Radiotherapy see Radiotherapy, Computer-Assisted Computer-Assisted Radiotherapy Planning see Radiotherapy Planning, Computer-Assisted Computer-Assisted Therapy see Therapy, Computer-Assisted Computer Communication Networks TK 5105.5-5105.9 Computer Data Processing see Automatic Data Processing Computer Graphics T 385 Computer Hardware see Computers Computer Literacy QA 76.9.C64 Computer Models see Computer Simulation Computer Network Management see Computer Communication Networks Computer Programs see Software Computer Reasoning see Artificial Intelligence Computer Simulation QA 76.9.C65 Used for special purposes, by subject Computer Software see Software Computer Systems As equipment in special fields (Form number 26.5 in any NLM schedule where applicable) Used for particular fields, by subject Computer Systems Development see Computer Systems Computer Systems Evaluation see Computer Systems Computer Systems Organization see Computer Systems Computer Terminals TK 7887.8.T4 Computer User Training QA 76.27 In form number 26.5 in any NLM schedule where applicable Computer Vision Systems.see Artificial Intelligence Computerized Emission Tomography see Tomography, Emission-Computed Computerized Tomography, X-Ray see Tomography, X-Ray Computed Computers QA 75-76.95 As equipment in special fields In medicine (General) W 26.55.C7 (Form number 26.5 in any other NLM schedule where applicable) Computer engineering TK 7885-7895 Digital QA 76.5-76.73 Machine theory QA 267-268.5 See also Automatic Data Processing W 26.55.A9, etc.; Information Systems Z 699, etc. Computers, Analog QA 76.4 As equipment in special fields In medicine (General) W 26.55.C7 (Form number 26.5 in any other NLM schedule where applicable) Computer engineering TK 7885-7985 See also Automatic Data Processing W 26.55.A9, etc.; Information Systems Z 699, etc. Computers, Digital see Computers Computers, Personal see Microcomputers Concanavalin A As antibodies QW 575 Diagnostic use, with disease being diagnosed, e.g., in nephritis WJ 353 Other special topics, by subject Concentration see Attention Concentration Camps HV 8963-8964 Concept Formation BF 443 In infancy & childhood WS 105.5.D2 Conception see Fertilization Conchae Nasales see Turbinates Concurrent Review WX 153 Concurrent Studies see Cohort Studies ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 307 Concussion Concussion see Brain Concussion WL 354 and other localized injuries, e.g. of the spinal cord Condiments As a dietary supplement in health or disease WB 447 Cookery TX 819 Conditioned Reflexes see Conditioning, Classical Conditioning, Classical BF 319 Conditioning, Operant BF 319.5.06 Conditioning (Psychology) BF 319 Conditioning Therapy see Behavior Therapy Conduct Disorders, Child see Child Behavior Disorders Conduction Anesthesia see Anesthesia, Conduction Conduction Blocking Anesthetics see Anesthetics, Local Conduction of Nerve Impulses see Neural Conduction Conductometry QD 116.C65 Clinical chemistry QY 90 Condurango see Gastrointestinal Agents Conferences see Congresses Confidentiality Dentistry, Forensic W 705 United States KF 8958-8959.5 Medicolegal (General) W 700 Psychiatry, Forensic W 740 Conflict of Interest W 50 Economic aspects W 58 Conflict (Psychology) In infancy & childhood WS 105.5.M5 Interpersonal BF 637.148 Psychoanalysis WM 460.5.M6 Social psychology HM 136 Conformity, Social see Social Conformity Confusion In old age WT 150 Related to psychoses WM 204 Congenital Anomalies see Abnormalities Congenital Defects see Abnormalities Congestive Cardiomyopathy see Cardiomyopathy, Congestive Congestive Heart Failure see Heart Failure, Congestive Congo Red QV 240 Congo Virus Infection see Hemorrhagic Fever, Crimean Congresses W3 Directories W 3.5 See also NLM Classification Practices, preceding the Schedules Conjoined Twins see Twins, Conjoined Conjugation, Genetic QW 51 Conjugative Pili see Pili, Sex Conjunctiva WW 212-215 Conjunctival Diseases WW 212 Conjunctivitis WW 212 Contagious granular see Trachoma WW 215 Conjunctivitis, Acute Hemorrhagic WW 212 Conjunctivitis, Allergic WW 212 Conjunctivitis, Atopic see Conjunctivitis, Allergic Conjunctivitis, Giant Papillary see Conjunctivitis, Allergic ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Conjunctivitis, Inclusion WW 212 Conjunctivitis, Vernal see Conjunctivitis, Allergic Connecting Peptide see C-Peptide Connective Tissue QS 532.5.C7 Aging WT 104 Connective Tissue Disease, Mixed see Mixed Connective Tissue Disease Connective Tissue Diseases WD 375 See also names of specific diseases, e.g., Cellulitis WR 220 Conns Disease see Hyperaldosteronism Conradi-Hunermann Syndrome see Chondrodysplasia Punctata Consanguinity Forensic medicine W 791 Marriage HQ 1026 Primitive customs GN 480 See also Inbreeding SF 105, etc. Conscience BJ 1471 Psychoanalysis WM 460.5.R3 Conscious Sedation In dentistry WO 460 Consciousness General diagnosis WB 182 In infancy & childhood WS 105.5.C7 Neurologic manifestation of disease WL 341 Physiological aspects WL 705 Psychology BF 309-499 See also Unconsciousness WB 182 etc. Consciousness Disorders WL 341 Consensus Development Conferences On specific topics, by subject Consensus Development Conferences, NIH On specific topics, by subject Consensus Sequence QU 58 Consensus Workshops see Consensus Development Conferences Conservation of Energy Resources TJ 163.3-163.5 In hospitals WX 140 Other special topics, by subject Conservation of Natural Resources S 900-954 Forestry SD 411-428 Game and bird conservation and protection SK 351-579 Nature QH 75-77 Wildlife QL 81.5-84.77 See also Ecology QH 540-549, etc. Constipation WI 409 In pregnancy WQ 240 Constitution and Bylaws Special topics, by subject, e.g. in Hospital Administration WX 150 Constitution, Body see Body Constitution Constitutional Psychopathic Personality see Antisocial Personality Disorder Constriction, Pathologic Of blood vessels WG 560 Of duodenum WI 505 Special topics, by subject Constrictive Pericarditis see Pericarditis, Constrictive Construction Loans see Financing, Construction Construction Materials TA 401-492 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 308 Convalescence Industrial wastes WA 788 Consultants Medical W 64 Nursing WY 90 Psychiatric WM 64 Surgical WO 64 In other specific specialties in the number for interpersonal relationships or lacking that, in the general works number Consultation see Referral and Consultation Consumer Advocacy WA 288 Environmental control WA 670-847 General HC 79.C63 In special areas, by subject Consumer Involvement see Consumer Participation Consumer Organizations HC 79.C6-79.C63 By country HC 94-1085 (with topical breakdown as given in HC 79, etc.) Consumer protection HC 79.C63 By country (as above) For community health planning WA 546 For special purposes, by subject Consumer Participation In mental health planning WM 30 In special areas, in the administrative number for the area or lacking that, in the general number, e.g., in community health organizations WA 546 See also Patient Participation WX 158.5 Consumer Preference see Consumer Satisfaction Consumer Price Index see Economics Consumer Product Safety WA 288 Special topics, by subject Consumer Protection see Accident Prevention; Consumer Organizations Consumer Satisfaction General works HF 5415.3-5415.5 With hospitals WX 158.5 With health services, medical treatment, etc. W 85 With mental hospitals WM 29.5 With other services or products, by subject Consumption Coagulopathy see Disseminated Intravascular Coagulation Contact Dermatitis see Dermatitis, Contact Contact Lenses WW 355 Contact Lenses, Extended-Wear WW 355 Contact Lenses, Hydrophilic WW 355 Contact Prevention in Illness see Communicable Disease Control; Patient Isolation; Quarantine Contact Tracing Of particular disorders, with the disorder Contactants as Allergens see Allergens Contagious Diseases see Communicable Diseases Contagious Pustular Dermatitis see Ecthyma, Contagious Containment of Biohazards In the environment WA 671 In genetic engineering QH 442 In other areas, by subject Contingent Negative Variation WL 102 Continued Stay Review see Concurrent Review Continuing Care Retirement Centers see Housing for the Elderly Continuity of Patient Care W 84.6 Continuum of Care see Continuity of Patient Care Contour Perception see Form Perception Contraception WP 630 By prevention of ovulation WP 630 Male WJ 710 Religious aspects HQ 766.2 Catholicism HQ 766.3 Protestantism HQ 766.35 Islam HQ 766.374 Other HQ 766.4, A-Z Sociological aspects HQ 763-766 See also Abortion WQ 225, etc. Contraception, Immunologic WP 630 Contraceptive Agents QV 177 See also specific topics under Contraception Contraceptive Agents, Female QV 177 Contraceptive Agents, Male QV 177 Contraceptive Devices WP 640 Contraceptive Devices, Female WP 640 See also Intrauterine devices WP 640 Contraceptive Devices, Intrauterine see Intrauterine Devices Contraceptive Devices, Male WJ 710 Contraceptives, Oral QV 177 Contraceptives, Oral, Combined QV 177 Contraceptives, Oral, Hormonal QV 177 Contraceptives, Oral, Sequential QV 177 Contraceptives, Oral, Synthetic QV 177 Contraceptives, Postcoital QV 177 Contract Services Medical work W 74 Other topics, class by subject if specific; if general, in economics number where available Contracture Fingers, wrist see Volkmann 's Contracture WE 835 Hand see Dupuytren's Contracture WE 830 Hip see Hip Contracture WE 855 Joint WE 300 Muscle (General) WE 545 Contrast Media In radiology Supplies WN 150 Technique of use WN 160 Used for special purposes, by subject Contrast Sensitivity WW 105 As a measure of visual acuity WW 145 Controlled Clinical Trials Drugs QV 771 For other purposes, by subject or specific drug or procedure Controlled Clinical Trials, Randomized see Randomized Controlled Trials Controlled Hypotension see Hypotension, Controlled Contusions WO 192 First aid WA 292 Localized, by site Convalescence WB 545 After surgery WO 183 Convalescence from particular disorder, by the ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 309 disorder Particular forms of convalescence, by subject Convallaria QV 153 Convergence, Ocular WW 410 Convergent Strabismus see Esotropia Conversion Disorder WM 173.5 Convulsants QV 103 Convulsions WL 340 Drugs checking see Anticonvulsants QV 85 In epilepsy WL 385 In infancy & childhood WL 340 In pregnancy see Eclampsia WQ 215 Veterinary SF 895 Convulsions, Febrile WL 340 Convulsive Disorders see Chorea; Epilepsy Convulsive Therapy WM 410-412 With pentylenetetrazole WM 410 Convulsive Therapy, Electric see Electroconvulsive Therapy Cookery Army UC 720-735, UH 487 Diabetic diet WK 819 For hospitals WX 168 Institutional (General) TX 820 Navy VC 370-375 Obesity diet see Diet, Reducing WD 210, etc. Therapeutic diet (General) WB 405 See also names of specific diets and diseases for which diet is being administered Cooley's Anemia see Thalassemia Coombs' Test QY 265 Diagnosis of erythroblastosis fetalis WH 425 Used for other special purposes, by subject Coon's Technique see Fluorescent Antibody Technique Cooperative Behavior HM 131-134 COPD see Lung Diseases, Obstructive Coping Behavior see Adaptation, Psychological Copper QV 65 Metabolism QU 130.5 Copulation QL 761 Human see Coitus Particular animals, in QL or SF number for the animal Copying Processes Z 265-265.5 Copyright Z 551-656 Cor Pulmonale see Pulmonary Heart Disease Coramine see 1 Nikethamide Cord, Umbilical see Umbilical Cord Cordials see Alcoholic Beverages Corethamid see Nikethamide Corn As a dietary supplement in health or disease WB 430 Cultivation SB 191.M2, 351.C7 Cornea WW 220 Eye bank procedures WW 170 Transplantation WW 220 Corneal Arcus see Arcus Senilis Corneal Diseases WW 220 Corneal Endothelium see Endothelium, Corneal Corneal Opacity WW 220 Corneal Transplantation WW 220 Corneal Ulcer WW 220 Corns see Callosities Coronary Angioplasty, Transluminal Balloon see Angioplasty, Transluminal, Percutaneous Coronary Coronary Arteries see Coronary Vessels Coronary Arteriosclerosis WG 300 Coronary Arteritis see Coronary WG 300 under Arteritis Coronary Artery Bypass WG 169 Coronary Artery Disease see Coronary Disease Coronary Artery Vasospasm see Coronary Vasospasm Coronary Atherosclerosis see Coronary Arteriosclerosis Coronary Care Units WG 27-28 Coronary Circulation WG 300 Coronary Disease WG 300 Popular works WG 113 Coronary Embolism see Embolism Coronary Heart Disease see Coronary Disease Coronary Infarction see Myocardial Infarction Coronary-Prone Personality see Type A Personality Coronary Reperfusion see Myocardial Reperfusion Coronary Thrombosis WG 300 Coronary Vasospasm WG 300 Coronary Vessel Anomalies WG 220 Coronary Vessels WG 300 Coronaviridae QW 168.5.C8 Coroners and Medical Examiners W 800 Coronoid Fossa see Humerus Corpora Bigemina see Optic Lobe Corpora Quadrigemina WL 310 Corporate Practice see Professional Corporations Corpses see Cadaver Corpulence see Obesity Corpus Callosum WL 307 Corpus Cardiacum see Neurosecretory Systems Corpus Luteum WP 320 Endocrine functions WP 530 See also Corpus Luteum Hormones WP 530 Corpus Luteum Cyst see Ovarian Cysts Corpus Luteum Hormones WP 530 Corpus Pineale see Pineal Body Corpus Striatum WL 307 Corpuscles, Blood see Blood Cells; Erythrocytes; Leukocytes Correspondence Physicians and specialists of medically related fields Collective WZ 112-150 Individual WZ 100 Special topics, by subject Correspondence Courses see Education Corridor Disease see Theileriasis Corrosion TA 462 In dentistry WU 180 In orthopedics WE 26 In other areas, by subject Corrosion Casting QS 525 Corrosive Poisons see Poisons Corset see Braces; Clothing Cortex see Adrenal Cortex; Auditory Cortex; ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 310 Cerebellar Cortex; Cerebral Cortex; Kidney Cortex; Motor Cortex; Somatosensory Cortex; Visual Cortex Cortexone see Desoxycorticosterone Cortical Depression, Spreading see Spreading Cortical Depression Cortical Hormones see Adrenal Cortex Hormones Corticoids see Adrenal Cortex Hormones Corticospinal Tracts see Pyramidal Tracts Corticosteroid Receptors see Receptors, Glucocorticoid Corticosteroids see Adrenal Cortex Hormones Corticosterone WK 755 Corticotropin WK 515 Corticotropin-Releasing Factor see Corticotropin-Releasing Hormone Corticotropin-Releasing Hormone WK 515 Corticotropin-Releasing Hormone-41 see Corticotropin-Releasing Hormone Cortis Organ see Organ of Corti Cortisol see Hydrocortisone Cortisone WK 755 Corynebacteriaceae see Actinomycetales Corynebacterium QW 118 Corynebacterium diphtheriae QW 118 Corynebacterium Diphtheriae Toxin see Diphtheria Toxin Corynebacterium Infections WC 318-320 Coryneform Group QW 118 Coryza, Acute see Common Cold Coryza Viruses see Rhinovirus Cosmetic Surgery see Surgery, Plastic Cosmetics Chemical technology TP 983 Public health aspects WA 744 See also Beauty Culture QT 275, etc. Cosmetics, Hair see Hair Preparations Cosmetology see Beauty Culture Cosmic Radiation WN 415 Adverse effects WN 610-650 Biophysics QT 34 Cosmic physics QC 809.R3 Medical safety measures WN 650 Radiation physics QC 484.8-485.9 Cosmids QW 51 As genetic vectors QH 442.2 Cost Allocation Medicine W 74 Other topics, class by subject if specific; if general, in economics number where applicable Cost Apportionment see Cost Allocation Cost-Benefit Analysis HD 47.4 Of particular procedures, by subject if specific, e.g., value of a diagnostic test WB 141; if general, in economics number for the specialty, e.g., economics of medical practice W 74; lacking an economics number, in the general number Cost-Benefit Data see Cost-Benefit Analysis Cost Containment see Cost Control Cost Control General HD 47.3 Dentistry WU 77 ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Coupling Factor 1 Hospitals WX 157 Medicine W 74 Nursing WY 77; Pharmacy QV 736 Cost Effectiveness see Cost-Benefit Analysis Cost Shifting see Cost Allocation Costens Syndrome see Temporomandibular Joint Syndrome Costs and Cost Analysis Dentistry WU 77 Hospitals WX 157 Medicine W 74 Nursing WY 77 Pharmacy QV 736 Costs, Direct Service see Direct Service Costs Cot Death see Sudden Infant Death Cotton Agriculture SB 245-251.5 Diseases from dust WF 654 Industrial wastes WA 788 Control in work atmosphere WA 450 Used for special purposes, by subject Cottonseed see Cottonseed Oil Cottonseed Oil WB 431 As dietary protein In animal feed SF 99.C6 In human nutrition WB 426 Biochemistry QU 86 Cough WF 143 Coumaphos Agriculture SB 952.P5 Public health WA 240 Coumarins QV 193 Counseling WM 55 By nurses WY 87 Divorce WM 55 Genetic see Genetic Counseling QZ 50, etc.; In adolescence WS 462 In infancy & childhood WS 105.5.C3 Marriage WM 55 Pastoral care WM 61 Sex WM 55 Special population groups WA 305, etc. Students LB 1027.5-1027.9 Extension. Adult education LC 5225.C68 Secondary education LB 1620.4-1620.53 Higher education LB 2343 (Form number 18 or other appropriate education number in any NLM schedule where applicable) See also Mental Health Services WA 352-353, etc. Vocational HF 5381-5382.5 Workers HD 5549.5.C8 Mental health WA 495 Counseling, Sex see Sex Counseling Counterimmunoelectrophoresis QY 250-275 Used for diagnostic monitoring, or evaluation tests in special fields, with the field Counterirritants see Irritants Counterirritation see Therapeutic Use under Irritants Countertransference (Psychology) WM 62- Coupling Factor 1 see H(+)-Transporting ATP NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSIFIED 311 Coupling Factor 1 Synthase Court Plaster see Bandages Courtship HQ 801-801.5 Animal QL 761 Cowpers Glands see Bulbourethral Glands Coxa see Hip Coxa Plana see Legg-Perthes Disease Coxarthrosis see Osteoarthritis, Hip Coxiella QW 150 Coxsackievirus Infections WC 500 Coxsackieviruses QW 168.5.P4 CPR see Cardiopulmonary Resuscitation Crabs, Horseshoe see Horseshoe Crabs Crackles see Respiratory Sounds Cramp see Muscle Cramp Cranial Fossa, Posterior WE 705 Cranial Nerve Diseases WL 330 Cranial Nerve Neoplasms WL 330 Cranial Nerves WL 330 See individual nerves under name of nerve Cranial Sinus Thrombosis see Sinus Thrombosis Cranial Sinuses WG 625.C7 Cranial Sutures WE 705 Craniofacial Dysostosis WE 705 Craniology GN 71-131 Craniometry GN 71-131 Craniopharyngioma QZ 310 Craniosynostoses WE 705 Craniotomy WL 368 Cranium see Skull Crataegus QV 150 Crayfish QX 463 CRD-401 see Diltiazem Creatine QU 61 Creatine Kinase QU 141 Creatine Kinase Isoenzymes QU 141 Used for special purposes, by subject Creatine Kinase Isozymes see Creatine Kinase Isoenzymes Creatine Phosphate see Phosphocreatine Creatine Phosphokinase see Creatine Kinase Creatinine QU 65 Creativeness BF 408-426 In adolescence WS 462 In infancy & childhood WS 105.5.C7 In psychoanalysis WM 460.5.C7 Credentialing (Form number 21 in any NLM schedule where applicable) Nursing WY 16 See also specific methods, e.g., Licensure, Medical W 40 Credit and Collection, Patient see Patient Credit and Collection Cremation see Mortuary Practice Crenothrix see Bacteria Creosote As an anti-infective agent QV 223 Toxicology QV 627 Cresols As an anti-infective agent QV 223 Organic chemisty QD 341.P5 Cresylic Acid see Cresols ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHX Cretinism WK 252 CRF-41 see Corticotropin-Releasing Hormone Crib Death see Sudden Infant Death Cribriform Plate see Ethmoid Bone Cricetidae see Microtinae Cricetinae see Hamsters Cricetulus QL 737.R666 As laboratory animals QY 60. R6 As pets SF 459.H3 Cricetus see Hamsters Crigler-Najjar Syndrome WD 205.5.H9 Crime HV 6251-7220.5 Compensation to victims W 910 Therapy for victims WM 401 Specific types, by subject Criminal Justice see Criminal Law Criminal Law Psychiatric aspects W 740 Criminal Psychology HV 6080-6113 Criminal Violence Victims see Crime Criminology HV 6001-9960 Crippled see Disabled Crisis Intervention Community programs WM 30 General WM 401 In adolescence WS 463 In infancy & childhood WS 350.2 In preventing suicide HV 6545 See also Emergency Services, Psychiatric WM 401 Critical Care WX 218 In emergencies (not in hospital) WB 105 In infancy & childhood WS 366 Administration of hospital unit WS 27-28 Nursing WY 154 Pediatric WY 159 Of a particular disease or in a particular field General, with the disease or field Nursing, with the nursing specialty Criticism see Book Reviews Crocodiles see Alligators and Crocodiles Crohn Disease WI 512 Affecting the colon only WI 522 Cromolyn Sodium QV 120 Cronkhite-Canada Syndrome see Churg-Strauss Syndrome Cross-Cultural Comparison Comparative civilization CB 151 Ethnology GN 378 Ethnopsychology GN 270-279 Mental development WS 105 Special topics by subject, e.g., Cross-National MMPI Research WM 145 Cross-Eye see Strabismus Cross Infection WC 195 Prevention and control in hospitals WX 167 Cross-Linking Reagents Analytical chemistry QD 77 Pharmaceutical chemistry QV 744 Used for special purposes, by subject Cross-Sectional Studies WA 950 Special topics, by subject Crossing Over (Genetics) QH 445 IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSD7IED 312 Cutaneous Leishmaniasis Crossmatching, Blood see Blood Grouping and Crossmatching Crossmatching, Tissue see Histocompatibility Testing Crotalid Venoms WD 410 Croton Oil QV 75 Croup WV 510 Crouzons Disease see Oaniofacial Dysostosis Crowding Animal population QL 752 Housing WA 795 Human population HB 871 Crown Compounds see Ethers, Cyclic Crowns WU 515 Crude Oil see Petroleum Cruor see Postmortem Changes Crush Injuries see Wounds and Injuries Crush Syndrome WJ 342 Crustacea QX 463 Crutches WE 26 Crying Children WS 105.5.E5 Emotions BF 575.C88 Grief BF 575.G7 Neuroses WM 170-184, etc. Cryoanesthesia see Hypothermia, Induced Cryobiochemistry see Biochemistry; Freezing Cryobiology see Freezing Cryofixation see Cryopreservation Cryogenic Surgery WO 510 Localized, by site See also Freezing Cryoglobulinemia WH 400 Cryopreservation QH 324.9.C7 Cryoprotective Agents In blood preservation WH 460 In microbiology QW 25-26 See also Freezing Cryosurgery WB 473 Used for special purposes, by subject See also Freezing Cryotherapy WB 473 Used for special purposes, by subject Cryptococcosis WC 475 Cryptococcus QW 180.5.D3 Cryptorchidism WJ 840 Veterinary SF 871 Cryptorchism see Cryptorchidism Cryptosporidiosis WC 730 Veterinary SF 792 Cryptosporidium QX 123 Crystal Violet see Gentian Violet Crystalline Lens see Lens, Crystalline Crystallins WW 101 Crystallization Crystal structure and growth QD 921 Pharmaceutical chemistry QV 744 Physical and theoretical chemistry QD 548 Other special topics, by subject Crystallography QD 901-999 CTG, Antepartum see Cardiotocography Cu-Zn Superoxide Dismutase see Superoxide Dismutase Cuban Americans see Hispanic Americans Cubital Fossa see Elbow; Humerus Cues Conditioned response BF 319 Prediction (Logic) BC 181 Culdoscopy WP 141 Culex QX 530 Culicidae QX 510-530 See also Aedes QX 525; Anopheles QX 515; Culex QX 530 Culicoides see Ceratopogonidae Cults, Medical see Alternative Medicine Cultural Characteristics Special topics, by subject Cultural Deprivation Adolescents WS 462 Children WS 105.5.D3 Education LC 4051^*100.4 Cultural Disadvantagement see Cultural Deprivation Cultural Evolution HM 106+ Special topics, by subject Culture CB Anthropology GN 301-499 General works CB 23-113 Sociology HM 101-121 Culture Media QW 25-26 Cultured Cells see Cells, Cultured Cultured Tumor Cells see Tumor Cells, Cultured Cumulative Survival Rate see Survival Rate Cupping see Alternative Medicine Curare QV 140 Curare-Like Agents see Neuromuscular Nondepolarizing Agents Curariform Drugs see Neuromuscular Nondepolarizing Agents Cures, Special see Alternative Medicine Curettage WO 500 Localized, by site See also Dilatation and Curettage WP 470, etc. Curietherapy see Brachytherapy Curiosities, Medical see Folklore; Superstitions Curiosity see Exploratory Behavior Curium WN 420 Nuclear physics QC 796.C55 See also special topics under Radioisotopes Curriculum (Form number 18 in any NLM schedule where applicable) Education extension LC 5219 Elementary schools LB 1570-1571 Secondary schools LB 1628-1629.8 Universities and colleges LB 2361-2365 University extension LC 6223 Curvatures, Spinal see Kyphosis; Lordosis; Scoliosis Cushing's Syndrome WK 770 Cushion Liners see Denture Liners Cuspid WU 101 Custody, Child see Child Custody Customized Drugs see Designer Drugs Customs see Culture Cutaneous Drug Administration see Administration, Cutaneous Cutaneous Leishmaniasis see Leishmaniasis ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 313 Cutaneous Oximetry Cutaneous Oximetry see Blood Gas Monitoring, Transcutaneous Cutis Elastica see Ehlers-Danlos Syndrome Cutting Wounds see Wounds, Penetrating Cyanamide QV 610 Cyanates QV 280 Cyanidanol-3 see Catechin Cyanides QV 610 Cyanobacteria QW 131 Cyanocobalamin see Vitamin B 12 Cyanophyceae see Cyanobacteria Cyanosis WG 142 Cybernetics Q 300-390 Used for special purposes, by subject See also Information Theory Q 350-390 Cyclamates WA 712 Cyclandelate QV 243 Cyclic AMP QU 57 Pharmacology QV 185 Cyclic GMP QU 58 Pharmacology QV 185 Cyclic N-Oxides Organic chemistry QD 401 Cyclicity see Periodicity Cyclitis, Heterochromic see Iridocyclitis Cycloamylose see Cyclodextrins Cyclodextrins QU 83 Cycloheptaamylose see Cyclodextrins Cyclohexanes Organic chemistry QD 305.H9 Cyclohexanones As carcinogens QZ 202 Toxicology QV 633 Cycloheximide QV 252 Cyclopentanes Organic chemistry QD 305.H9 Cyclophosphamide QV 269 Cancer chemotherapy QZ 267 Immunosuppression QW 920 Cycloplegics see Mydriatics Cyclopropane* QV 81 Cycloserine QV 268 Cyclosporins QW 920 Cyclostomes QL 638.12-638.25 Cyclothymic Disorder WM 171 Cyclothymic Personality see Cyclothymic Disorder Cyclothymic Psychoses see Psychoses, Manic-Depressive Cylindroma see Carcinoma, Adenoid Cystic Cyprinidae SH 167.C3 Anatomy and physiology QL 638.C94 Diseases SH 179.C3 Cyprinus see Carp Cyproheptadine QV 157 Cyproterone WJ 875 Cyprus Fever see Brucellosis Cystadenocarcinoma QZ 365 Localized, by site Cystadenoma QZ 365 Localized, by site Cystadenoma Lymphomatosum, Papillary see Adenolymphoma Cysteamine QU 61 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPFL4 As a radiation-protective agent WN 650 Organic chemistry QD 305.A8 Cysteinamine see Cysteamine Cysteine QU 60 Cysteinyldopa WK 725 As a disease marker, class with the specific disease Cystic Disease of Breast see Fibrocystic Disease of Breast Cystic Duct WI 750 Cystic Fibrosis WI 820 Cysticercosis WC 838 Localized, by site Veterinary SF 810.C5 Cysticercus QX 400 Cystine QU 60 Cystinosis WJ 301 Cystitis WJ 500 Cystocele see Bladder Diseases Cystosarcoma Phyllodes see Phyllodes Tumor Cystoscopy WJ 500 Cysts QZ 200 Bone see Bone Cyst WE 258 Breast WP 840 Dermoid see Dermoid Cyst QZ 310 Kidney see Kidney, Cystic WJ 358 Mediastinum see Mediastinal Cyst WF 900 Mesentery see Mesenteric Cyst WI 500 Nonodontogenic see Nonodontogenic Cysts WU 280 Odontogenic see Odontogenic Cysts WU 280 Ovary see Ovarian Cysts WP 322 Pancreatic see Pancreatic Cyst WI 810 Periodontal see Periodontal Cyst WU 240 Pilonidal see Pilonidal Cyst WE 750 Radicular see Radicular Cyst WU 240 Sebaceous see Epidermal Cyst WR 420 Thyroglossal see Thyroglossal Cyst WK 270 Vaginal WP 250 Vulval WP 200 Other localities, by site Cysts, Hydatid see Echinococcosis Cytarabine QV 269 Cytidine Diphosphate Choline QU 87 Cytidine Phosphates see Cytosine Nucleotides Cytochemistry see Histocytochemistry Cytochrome aa3 see Cytochrome-c Oxidase Cytochrome-c Oxidase QU 140 Cytochrome Oxidase see Cytochrome-c Oxidase Cytochrome P-450(arom) see Aromatase Cytochromes WH 190 Clinical examination QY 455 Cytodiagnosis QY 95 Neoplasms QZ 241 Gynecology WP 141 Used for diagnosis of particular disorders, with the disorder or system Cytofluorometry, Flow see Flow Cytometry Cytogenetics QH 441.5 General QH 441.5 Human QH 431 Blood analysis QY 402 Predisposition to disease QZ 50 Cytokeratin see Keratin USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSIFTED 314 Day Care Cytokines QW 568 Cytokinesis see Cell Division Cytokinetics see Cell Cycle Cytological Techniques QH 585 Clinical pathology QY 95 Cytology QH 573-671 Cell pathology, with specific subject in NLM schedules See also Cells QH 573-659, etc. and related headings Cytolysins see Cytotoxins Cytomegalic Inclusion Disease see Cytomegalovirus Infections Cytomegalovirus QW 165.5.H3 Cytomegalovirus Infections WC 500 Cytometry, Flow see Flow Cytometry Cytopathic Effect, Viral see Cytopathogenic Effect, Viral Cytopathogenic Effect, Viral QW 160 Cytophagales QW 128 Cytophotometry QH 585.5.C984 Clinical pathology QY 95 Cytoplasm QH 591 Cytoplasmic Filaments see Cytoskeleton Cytoplasmic Granules QH 603.M35 Cytoplasmic Inclusions see Inclusion Bodies Cytosine In nucleic acids QU 58 Cytosine Arabinoside see Cytarabine Cytosine Nucleotides QU 57 Cytoskeletal Filaments see Cytoskeleton Cytoskeletal Proteins QU 55 Cytoskeleton QH 603.C96 Cytosol Aminopeptidase see Leucine Aminopeptidase Cytostatic Agents see Antineoplastic Agents Cytotaxinogens see Chemotactic Factors Cytotaxins see Chemotactic Factors Cytotoxic Antibiotics see Antibiotics, Antineoplastic Cytotoxic Drugs see Antineoplastic Agents Cytotoxic T-Lymphocytes see T-Lymphocytes, Cytotoxic Cytotoxicity, Antibody-Dependent Cell see Antibody-Dependent Cell Cytotoxicity Cytotoxicity, Immunologic QW 568 Cytotoxicity Tests, Immunologic QW 568 Used for special purposes, by subject Cytotoxin-Antibody Conjugates see Immunotoxins Cytotoxins QW 630.5.C9 See also Antibiotics, Antineoplastic QV 269; names of toxins specific to particular cells, e.g., Enterotoxins QW 630.5.E6 CI Esterase Inhibitors see Complement 1 Inactivators CI Inactivators see Complement 1 Inactivators C3 Activator see Complement 3 Convertase C3 Convertase see Complement 3 Convertase C5 Cleaving Enzyme see Complement 3 Convertase D D-Amino-Acid Oxidase QU 140 D-Glucuronolactone Dehydrogenase see Aldehyde Dehydrogenase D 600 see Gallopamil DAB see p-Dimethylaminoazobenzene Dacryocystitis WW 208 Dacryocystorhinostomy WW 208 Dacryocystostomy see Dacryocystorhinostomy Dactylolysis Spontanea see Ainhum Dairy Products SF 250.5-275 As dietary supplement in health or disease WB 428 Bacteriology QW 85 Home Economics TX 759-759.5 Sanitation WA 715 Dairying SF 221-250 Public health aspects WA 715-719 Pasteurization WA 719 Danazol WP 522 Dance Therapy WM 450.5.D2 Dancing Injuries WA 487.5.D4 Physiological aspects QT 255 Dandruff see Scalp Dermatoses Dandy-Walker Syndrome WL 350 Dane Particle see Hepatitis B Virus Dangerous Behavior As a social behavior disorder WM 600 In adolescence WS 463 In infancy & childhood WS 350.8.A4 Dantrolene QV 140 Dapsone QV 259 Dark Adaptation WW 109 Darkness Physiological effects QT 162.L5 See also Nyctalopia WD 110; Visual Perception WW 105 Data Analysis, Statistical see Data Interpretation, Statistical Data Collection WA 950 For particular purposes, by subject Data Display TK 7882.16 (Form number 26.5 in any NLM schedule where applicable) Special topics, by subject Data Interpretation, Statistical Special topics, by subject Data Processing, Automatic see Automatic Data Processing Data Systems see Information Systems Database Management Systems W 26.5 Used for special purposes, by subject Databases see Databases, Bibliographic Databases, Bibliographic Z 699-699.5 By subject Z 699.5.A-Z In medicine (General) W 26.55.14 In other special fields (Form number 26.5 in any NLM schedule where applicable) Databases, Distributed see Computer Communication Networks Datura see Stramonium Day Blindness see Vision Disorders Day Care In old age WT 29 Of the mentally ill WM 29 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 315 Day Care Of the physically ill and disabled WX 29 See also Child Day Care Centers WA 310-320, etc. Day Dreams see Fantasy DDAVP see Desmopressin DDD WA 240 DDE WA 240 DDT WA 240 DDX see DDE De Lange's Syndrome QS 675 Dead Bodies see Cadaver Deadly Nightshade see Belladonna DEAE-Dextran QU 83 Deaf-Mutism see Deafness; Mutism Deafness WV 270-280 In infancy & childhood WV 271 Education see Education, Special HV 2417-2990.5 Rehabilitation Physical and medical WV 270-280 Social HV 2353-2990.5 Deafness, Conductive see Hearing Loss, Conductive Deafness, Partial see Hearing Loss, Partial Deafness, Sensorineural see Deafness Deafness, Sudden WV 270 Deamination QD 281.A6 Biochemistry QU 25 Deamino Arginine Vasopressin see Desmopressin Death Attitude see Attitude to Death BF 789.D4 In infancy & childhood WS 200 Legal establishment of W 820 See also Death certificates WA 54 Medicolegal aspects W 800-867 In old age WT 116 Registration WA 54 Speculative philosophy BD 443.8-445 Statistics see Mortality HB 1321-1528, etc. See also Brain death W 820; Fetal death WQ 225 Death Certificates WA 54 Death Rate see Mortality Death, Sudden W 820 Special topics, by subject, e.g., when associated with coronary disease WG 300 See also Sudden Infant Death WS 430 Death with Dignity see Right to Die Debridement WO 700-820 Localized, by site Decalcification, Pathologic WE 250 Decalcification Technique QS 525 Decamethonium Compounds QV 140 Decarboxylases see Carboxy-Lyases Decay, Dental see Dental Caries Decayed, Missing, and Filled Teeth see DMF Index Deceleration WD 720 Deception see Lying Decerebrate State WL 340 Decidua WQ 210 Embryology QS 645 Decidual Cell Reaction see Ovum Implantation Decision Analysis see Decision Support Techniques Decision Making BF 448 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 In adolescence WS 462 In infancy & childhood WS 105.5.D2 Special topics, by subject, e.g., in local health administration WA 546 Decision Making, Computer-Assisted In medicine (General) W 26.55.D2 In other special fields (Form number 26.5 in any NLM schedule where applicable) Used for special purpose, by subject Decision Making, Organizational Management HD 30.23 Psychology BF 448 Special topics, by subject Decision Modeling see Decision Support Techniques Decision Support Systems, Management W 26.5 In other areas, by subject Decision Support Techniques Special topics, by subject, e.g., Diagnosis WB 141 Decision Theory In mathematical statistics QA 279.4-279.7 In special topics, by subject Decision Trees In mathematical statistics QA 279.4 In special topics, by subject Decoctions see Solutions Decoloration, Drug see Drug Compounding Decompression Aerospace medicine WD 710 Submarine medicine WD 650 Other special topics, by subject Decompression, Explosive see Atmospheric Pressure Decompression Sickness Altitude effects WD 712 Aviation medicine WD 712 Diving problem WD 650 Submarine medicine WD 650 Decontamination Chemical warfare agents QV 663 Radiation WN 650 Decortication, Cerebral Cortex see Cerebral Decortication Decubitus Ulcer WR 598 Decussation, Pyramidal see Pyramidal Tracts Dedications see Anniversaries and Special Events Deductibles and Coinsurance Medical insurance W 100-275 See also specific types of insurance, e.g. Insurance, Health W 100-275 Deer Fly Fever see Tularemia Defecation WI 600 See also Encopresis WI 600; Fecal incontinence WI 600 Defectives, Mental see Mental Retardation Defects, Equipment see Equipment Failure Defense Mechanisms WM 193-193.5 In infancy & childhood WS 350.8.D3 Defensive Medicine W 44 Dentistry WU 44 Nursing WY 44 (Form number 33 in any other NLM schedule where applicable) Defensive Practice see Defensive Medicine USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 316 Dental Cements Deferoxamine QV 183 Defibrillation, Electric see Electric Countershock Deficiency Diseases WD 105-155 Veterinary SF 854-855 Defoliants, Chemical Plant culture SB 951.4 Public health aspects WA 240 Deformities see Abnormalities Degeneration see Atrophy; Hepatolenticular Degeneration; Lipoidosis; Nerve Degeneration; Retinal Degeneration Degeneration, Social see Skid Row Alcoholics; Social Alienation; Social Behavior Disorders Degenerative Processes in Disease see Disease Deglutition WI 102 Deglutition Disorders WI 250 Degus see Rodentia Dehydration Diagnostic significance WB 158 In water-electrolyte imbalance WD 220 Dehydrocholesterol see Cholecalciferol Dehydrocortisone see Prednisone Dehydrogenases see Oxidoreductases Dehydromethyltestosterone see Methandrostenolone Deinstitutionalization W 84.7 See also Home Care Services WY 115, etc. Deja Vu WM 173.7 Delayed-Action Preparations QV 785 Delayed Effects, Prenatal Exposure see Prenatal Exposure Delayed Effects Deletion (Genetics) see Chromosome Deletion Delhi Sore see Leishmaniasis Delirium Neurologic manifestations WL 340 Psychotic WM 204 Specific disease associations, with the disease Delirium Tremens see Alcohol Withdrawal Delirium Delivery WQ 415 Drugs affecting see Oxytocics QV 173 Methods WQ 415-430 Forceps WQ 425 See also Cesarean section WQ 430 Version WQ 415 Veterinary SF 887 See also Natural Childbirth WQ 152; Home Childbirth WQ 155 Delivery, Abdominal see Cesarean Section Delivery, Home see Home Childbirth Delivery of Dental Care see Delivery of Health Care Delivery of Health Care W 84 In developing countries WA 395 In rural areas WA 390 Delphi Technique Research (Form number 20 or 20.5 in any NLM schedule where applicable) Used for particular purposes, by subject Delta Agent QW 170 Delta Hepatitis see Delta Infection Delta Infection WC 536 Delta Sleep-Inducing Peptide WL 104 Biochemistry QU 68 Delta Superinfection see Delta Infection delta(9)-THC see Tetrahydrocannabinol Delusions WM 204 Dementia WM 220 Dementia, Multi-Infarct WM 220 Dementia Paralytica see Paresis Dementia Praecox see Schizophrenia Dementia, Presenile WM 220 Dementia, Primary Degenerative, Presenile see Dementia, Presenile Dementia, Primary Degenerative, Senile see Dementia, Senile Dementia, Senile WT 155 Dementia, Vascular WM 220 Demethyl Epipodophyllotoxin Ethylidine Glucoside see Etoposide Demography HB 848-3697 Demulcents see Dermatologic Agents Demyelinating Diseases General works WL 140 Manifestation of disease, with the disease Demyelination see Demyelinating Diseases Dendrites WL 102.5 Dendritic Cells QW 568 Dendritic Cells, Follicular see Dendritic Cells Denervation WL 368 Denervation, Autonomic see Autonomic Denervation Denervation, Sympathetic see Sympathectomy Dengue WC 528 Denial (Psychology) WM 193.5.D3 In adolescence WS 463 In infancy & childhood WS 350.8.D3 Densitometry Photometry (Optics) QC 391 Radiography WN 160 Technique in radiography of special systems with the radiography number for the system or disease being diagnosed Dental Abrasion see Tooth Abrasion Dental Acid Etching see Acid Etching, Dental Dental Alloys WU 180 Dental Amalgam WU 180 Dental Anesthesia see Anesthesia, Dental Dental Arch WU 101 Dental Articulators WU 26 Dental Assistants WU 90 Dental Attrition see Tooth Abrasion Dental Auxiliaries WU 90 Dental Bonding WU 190 Dental Bridgework see Denture, Partial Dental Calculus WU 250 Dental Care WU 29 School clinics see School Dentistry WA 350-351, etc. Dental Care for Aged WU 490 Dental Care for Disabled WU 470 Dental Care for Handicapped see Dental Care for Disabled Dental Care Plans see Insurance, Dental Dental Caries WU 270 Dental Casting Investment WU 180 Dental Casting Technique WU 25 Dental Cavity Preparation WU 350 Dental Cements WU 190 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 317 Dental Cements See also Silicate Cement WU 190 Dental Cementum WU 230 Dental Chemistry see Chemistry Dental Clinics WU 27-28 School Dental Clinics WA 350-351 Dental Crowns see Crowns Dental Decay see Dental Caries Dental Deposits WU 250 Dental Economics see Economics, Dental Dental Education see Education, Dental Dental Education, Continuing see Education, Dental, Continuing Dental Education, Graduate see Education, Dental, Graduate Dental Enamel WU 220 See also Mottled Enamel WU 220 Dental Enamel Solubility WU 220 Dental Equipment WU 26 Dental Facilities WU 27-28 Dental Fillings, Permanent see Dental Restoration, Permanent Dental Fillings, Temporary see Dental Restoration, Temporary Dental Focal Infection see Focal Infection, Dental Dental Granuloma see Periapical Granuloma Dental Health Education see Health Education, Dental Dental Health Services WU 29 Dental Health Surveys WU 30 Dental High-Speed Equipment WU 26 Dental High-Speed Technique WU 25 Dental Hygiene see Oral Hygiene Dental Hygienists WU 90 Dental Implantation WU 640 Dental Implants WU 640 Dental Impression Materials WU 190 Dental Impression Technique WU 25 Dental Inlays see Inlays Dental Instruments WU 26 Dental Materials WU 190 See also Equipment and Supplies WU 26 under Dentistry. Dental Medicaid Program see Medicaid Dental Medicine see Dentistry; Jaw Diseases; Mouth Diseases; Tooth Diseases Dental microbiology see Microbiology QW 65 under Mouth or Tooth Dental Models WU 26 Dental Nurses see Dental Assistants Dental Occlusion WU 440 Dental Occlusion, Balanced WU 440 Dental Occlusion, Centric WU 440 Dental Occlusion, Traumatic WU 440 Dental Offices WU 77 Dental Onlays see Inlays Dental Pharmacology see Pharmacology Dental Pins WU 26 Dental Plaque WU 250 Dental Porcelain WU 190 Dental Prophylaxis WU 113 Dental Prosthesis WU 500-530 See also Prosthodontics WU 500 Dental Prosthesis Design WU 500 Dental Prosthesis, Surgical see Dental Implants Dental Pulp WU 230 Dental Pulp Calcification WU 230 Dental Pulp Capping WU 230 Dental Pulp Cavity WU 230 Dental Pulp Devitalization WU 230 Dental Pulp Diseases WU 230 Dental Pulp Stones see Dental Pulp Calcification Dental Radiography see Radiography, Dental Dental Receptionists see Dental Auxiliaries Dental Records WU 95 Dental Restoration, Permanent WU 300-360 Dental Restoration, Temporary WU 350 Dental Scaling WU 113 Dental Schools see Schools, Dental Dental Sealants see Pit and Fissure Sealants Dental Service, Hospital WU 27-28 Dental Staff, Hospital WU 27-28 Dental Stone, Artificial see Calcium Sulfate Dental Stress Analysis Dental materials WU 190 Occlusion etiology WU 150 Dental Technicians WU 150 Dental Veneers WU 515 Dental Waste WA 790 Dental White Spots see Dental Caries Dentate Nucleus see Cerebellar Nuclei Denticaid see Medicaid Denticle see Dental Pulp Calcification Dentifrices WU 113 Dentigerous Cyst WU 280 Dentin WU 220 Dentin Sensitivity WU 220 Dentist-Patient Relations WU 61 Children WU 480 Dentistry WU Anesthesia see Anesthesia, Dental WO 460 Army see Military Dentistry UH 430-435 Assistants see Dental Assistants WU 90 Aviation WD 745 Cardiac Problems WG 460 Equipment and supplies WU 26 Ethics see Ethics, Dental WU 50 Forensic see Forensic Dentistry W 705 Geriatric see Geriatric Dentistry WU 490 Hygienists see Dental Hygienists WU 90 In infancy & childhood see Pedodontics WU 480 Occupational see Occupational Dentistry WA 412 Insurance see Insurance, Dental W 260, etc. Manpower WU 77 See also supply & distribution WU 77 under Dentists Microbiology see Microbiology QW 65 under Mouth Navy VG 280-285 Pathology WU 140 Pharmacology QV 50 Roentgen diagnosis see Radiography, Dental WN 230 School clinics see School Dentistry WA 350, etc.; Dental clinics WU 27-28 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 318 Dermatoglyphics Social relations see Dentist-Patient Relations WU 61, etc.; Interprofessional Relations (with specialty emphasized); Public Relations WU 61 Technicians see Dental Technicians WU 90 Dentistry for Aged see Dental Care for Aged Dentistry for Disabled see Dental Care for Disabled Dentistry for Handicapped see Dental Care for Disabled Dentistry, Geriatric see Geriatric Dentistry Dentistry, Operative WU 300-360 In infancy & childhood WU 480 In old age WU 490 Dentistry, Pediatric see Pediatric Dentistry Dentists Attitudes see Attitude of Health Personnel WU 61, etc. Biography Collective WZ 112.5.D3 Individual WZ 100 Directories WU 22 Interprofessional and public relations WU 61 Licensure see Licensure, Dental WU 40 Supply & distribution WU 77 Dentists, Women WU 21 See also special topics under Dentistry where applicable Dentition WU 210 Dentoalveolar Abscess, Apical see Periapical Abscess Dentoalveolar Cyst see Periodontal Cyst Denture Bases WU 500 Denture, Complete WU 530 Denture, Complete, Immediate WU 530 Denture Liners WU 500 Denture, Overlay WU 515 Denture, Partial WU 515 Denture, Partial, Fixed WU 515 Denture, Partial, Immediate WU 515 Denture, Partial, Removable WU 515 Denture, Precision Attachment WU 515 Denture Retention WU 500 Denture Stability see Denture Retention Dentures see Dental Prosthesis WU 500-530; types of dentures Denturists WU 150 Deodorants WA 744 Deontological Ethics see Ethics Deoxycorticosterone see Desoxycorticosterone Deoxyephedrine see Methamphetamine Deoxyglucose QU 75 Deoxyribonucleases QU 136 Deoxyribonucleic Acid see DNA Deoxythymidine Kinase see Thymidine Kinase Deoxyursocholic Acid see Ursodeoxycholic Acid Dependency (Psychology) BF 575.D34 Dependent Personality Disorder WM 190 Depersonalization see Depersonalization Disorder Depersonalization Disorder WM 171 Depilation see Hair Removal Depolarizing Muscle Relaxants see Neuromuscular Depolarizing Agents Depot Preparations see Delayed-Action Preparations Depreciation Hospital administration WX 157 Other topics, class by subject if specific; if general, in economics number where available Deprenalin see Selegiline Deprenil see Selegiline Deprenyl see Selegiline Depressants see Alcohols; Analgesics; Anesthetics; Anticonvulsants; Hypnotics and Sedatives; names of specific depressants Depression WM 171 Bipolar see Psychoses, Manic Depressive WM 207 Neuroses see Depression, Reactive WM 171 Depression, Bipolar see Bipolar Disorder Depression, Chemical QV 38 Depression, Endogenous see Depressive Disorder Depression, Involutional WM 207 Depression, Neurotic see Depressive Disorder Depression, Reactive see Adjustment Disorders Depression, Unipolar see Depressive Disorder Depressive Disorder WM 171 Psychotic WM 207 Depressive Symptoms see Depression Depressive Syndrome see Depressive Disorder Deprivation see Names of types of deprivation, e.g., Maternal Deprivation, Psychosocial Deprivation, Sleep Deprivation, etc. Deprivation Diseases see Deficiency Diseases Depth Intoxication see Inert Gas Narcosis Depth Perception WW 105 Dercum's disease see Adiposis Dolorosa Dermabrasion WO 600 Dermal Drug Administration see Administration, Cutaneous Dermal Sinus see Spina Bifida Occulta Dermatalgia see Skin Diseases Dermatitis WR 160-190 General works WR 160 Occupational see Occupational Dermatitis WR 600 Dermatitis, Adverse Drug Reaction see Drug Eruptions Dermatitis, Atopic WR 160 Veterinary SF 901 Dermatitis, Contact WR 175 Dermatitis, Contagious Pustular see Ecthyma, Contagious Dermatitis, Eczematous see Eczema Dermatitis, Exfoliative WR 180 Dermatitis Herpetiformis WR 200 Dermatitis Medicamentosa see Drug Eruptions Dermatitis, Occupational WR 600 Dermatitis, Radiation-Induced see Radiodermatitis Dermatitis, Seborrheic WR 415 Dermatitis Seborrheica see Dermatitis, Seborrheic Dermatitis, Toxicodendron WR 175 Dermatitis Venenata see Dermatitis, Contact Dermato-neuroses see Neurodermatitis Dermatoglyphics Anatomical structure WR 101 Criminal anthropometry HV 6074-6078 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 319 Dermatoglyphics Physiological anthropology GN 191-192 Used for diagnosis of particular disorders, with the disorder, or system, e.g., of chromosome abnormalities QS 677 Dermatologic Agents QV 60-65 Adsorbents QV 63 Demulcents QV 63 Emollients QV 63 Protectives QV 63 See also Astringents QV 65; Irritants QV 65, etc.; Anti-Infective Agents, Local QV 220-239 Dermatologists, Directories see Directories WR 22 under Dermatology Dermatology WR Children WS 260 Directories WR 22 Nursing texts WY 154.5 Dermatomycoses WR 300-340 General works WR 300 Veterinary SF 901 Dermatomyositis WE 544 Dermatophytes QW 180.5.D3 Dermatophytoses see Dermatomycoses Dermatoplasty see Skin Transplantation Dermatosclerosis see Scleroderma, Circumscribed Dermatoses see Skin Diseases Dermatotoxins see Dermotoxins Dermatotropic Virus Infections see Skin Diseases, Infectious Dermoid see Dermoid Cyst Dermoid Cyst QZ 310 Dermotoxins QW 630 Desensitization, Immunologic QW 900 For particular diseases of hypersensitivity, with the disease Desensitization, Psychologic WM 425.5.D4 In adolescence WS 463 In infancy & childhood WS 350.6 Desert Climate QC 993.7 Diseases of geographic areas WB 710 Physiological effects QT 150 Desferrioxamine see Deferoxamine Desiccated Stomach see Tissue Extracts Desickling Agents see Antisickling Agents Design and Construction, Hospital see Hospital Design and Construction Design, Equipment see Equipment Design Designer Drugs Abuse WM 270 General works QV 55 Pharmacology QV 38 Desipramine QV 77.5 Desmethylimipramine see Desipramine Desmoid see Fibromatosis, Aggressive Desmolases see Lyases Desmopressin WK 520 Desoxycorticosterone WK 755 Desoxycortone see Desoxycorticosterone Desoxyribonucleases see Deoxyribonucleases Desoxyribonucleic Acid see DNA Detachment, Choroid see Choroid Detachment, Retinal see Retinal Detachment ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH* Detergents QV 233 Determination of Health Care Needs see Health Services Needs and Demand Detoxication, Drug, Metabolic see Metabolic Detoxication, Drug Deuterium QV 275 Inorganic chemistry QD 181.HI Deuteromycetes QW 180.5.D38 Deuterons see Deuterium Developing Countries Economics HC 59.69-59.72 Public health WA 395 Other special topics, by subject Development see Bone Development; Child Development; Growth; Language Development; Maxillofacial Development; Personality Development; Psychosexual Development Development, Urban see Urban Renewal Developmental Biology QH 491 Genetics QH 453 Developmental Bone Diseases see Bone Diseases, Developmental Developmental Conditions as a Cause of Disease see Pathogenesis QZ 45 under Growth Disorders Developmental Delay Disorders see Child Development Disorders Deviant Behavior, Social see Social Behavior Disorders Deviants, Sexual see Paraphilias Device Design see Equipment Design Device Failure see Equipment Failure Device Safety see Equipment Safety Devices see Equipment and Supplies Dexamethasone QV 60 Dexpropranolol see Propranolol Dextranase QU 136 Dextrans WH 450 Dextrins QU 83 dextro-Amino Acid Oxidase see D-Amino-Acid Oxidase Dextrose see Glucose Dextrosulfenidol see Thiamphenicol DFP see Isoflurophate Diabetes, Autoimmune see Diabetes Mellitus, Insulin-Dependent Diabetes, Bronze see Hemochromatosis Diabetes Insipidus WK 550 Diabetes Mellitus WK 810-850 See also Obesity in Diabetes WK 835; Pregnancy in Diabetes WQ 248; Prediabetic State WK 810 Diabetes Mellitus, Adult-Onset see Diabetes Mellitus, Non-Insulin-Dependent Diabetes Mellitus, Brittle see Diabetes Mellitus, Insulin-Dependent Diabetes Mellitus, Experimental WK 810 Diabetes Mellitus, Insulin-Dependent WK 810 Diabetes Mellitus, Juvenile-Onset see Diabetes Mellitus, Insulin-Dependent Diabetes Mellitus, Ketosis-Prone see Diabetes Mellitus, Insulin-Dependent Diabetes Mellitus, Ketosis-Resistant see Diabetes Mellitus, Non-Insulin-Dependent USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 320 Diatrizoate Diabetes Mellitus, Non-Insulin-Dependent WK 810 Diabetes Mellitus, Stable see Diabetes Mellitus, Non-Insulin-Dependent Diabetes Mellitus, Type 1 see Diabetes Mellitus, Insulin-Dependent Diabetes Mellitus, Type 2 see Diabetes Mellitus, Non-Insulin-Dependent Diabetic Acidosis see Acidosis, Diabetic Diabetic Angiopathies WK 835 Diabetic Coma WK 830 Diabetic Diet WK 818-819 Diabetic Foot WK 835 Diabetic Ketoacidosis WK 830 Diabetic Ketosis see Diabetic Ketoacidosis Diabetic Nephropathies WK 835 Diabetic Neuropathies WK 835 Diabetic Retinopathy WK 835 Diacetylmorphine QV 92 Dependence see Heroin Dependence WM 288 Diagnosis WB 141-293 Breast diseases WP 815 Cardiovascular diseases WG 141 Ear diseases WV 210 Eye diseases WW 141-145 Gastrointestinal diseases WI 141 Gynecologic diseases WP 141 In infancy & childhood WS 141 Mental disorders WM 141 Musculoskeletal system WE 141 Neoplasms QZ 241 Nervous system diseases WL 141 Otorhinolaryngologic diseases WV 150 Physical WB 200-288 See also Physical Examination WB 205, etc. Pregnancy WQ 202 See also Pregnancy Complications WQ 240; Pregnancy Tests QY 335; Sex Determination WQ 206, etc. Prenatal see Prenatal diagnosis WQ 209 Radioisotope WN 445 Radioscopic see Fluoroscopy WN 220 Skin diseases WR 141 Symptomatology WB 143 TTioracic diseases WF 975 Tooth diseases WU 141 Tuberculosis WF 220-225 Urologic WJ 141 For diagnosis of other diseases see specific headings below or general works number for disease, organ or system Diagnosis, Computer-Assisted General WB 141 Used for diagnosis of particular disorders, with the disorder or system Diagnosis, Differential WB 141.5 In infancy & childhood WS 141 Diagnosis, Immunological see Immunologic Tests Diagnosis, Laboratory QY In adolescence WS 141 In infancy & childhood WS 141 In old age WT 100 Of other age groups QY Veterinary SF 772.6-773 Diagnosis, Nursing see Nursing Diagnosis Diagnosis, Oral WU 141 Diagnosis, Prenatal see Prenatal Diagnosis Diagnosis-Related Groups WX 157.8 Diagnosis, Surgical WO 141 Diagnostic Errors WB 141 In special fields, in the diagnosis number for the field Diagnostic Imaging WN 180 Diagnostic Reagent Kits see Reagent Kits, Diagnostic Diagnostic Services WA 243 Diagnostic Skin Tests see Skin Tests Diagnostic Tests, Routine WB 200 Used for specific purposes, by subject Diagnosticians, Directories see Directories W 22 under Medicine Dialysis Biochemical technique QU 25 Organic chemistry (General) QD 281.D47 See also Hemodialysis WJ 378, etc. Dialysis, Extracorporeal see Hemodialysis Diamine Oxidase see Amine Oxidase (Copper-Containing) Diaminodiphenylsulfone see Dapsone Diammonium Chloroplatinum Compounds Inorganic chemistry QD 181.P8 Pharmacology QV 290 Diamond-Blackfan Anemia see Fanconi's Anemia Diamorphine see Diacetylmorphine Diaper Pins see Infant Care Diaper Rash WS 420-430 Diapers, Infant see Infant Care Diaphanography see Transillumination Diaphanoscopy see Transillumination Diaphorase see Lipoamide Dehydrogenase Diaphoretics see Drugs for QV 122 under Hypohidrosis Diaphragm WF 800-810 Diaphragmatic Eventration WF 800 Diaphragmatic Hernia see Hernia, Diaphragmatic Diaphragmatic Hernia, Traumatic see Hernia, Diaphragmatic, Traumatic Diaphragmatic Paralysis see Respiratory Paralysis Diaphyseal Aclasis see Exostoses, Multiple Hereditary Diarrhea WI 407 In infancy & childhood WS 312 Veterinary SF 851 Diarrhea, Infantile WS 312 Diarsenol see Arsphenamine Diastase see Amylase Diastematomyelia see Spina Bifida Occulta Diastole WG 280 Diathermy WB 510 Surgical see Electrocoagulation WO 198 Diathermy, Surgical see Electrocoagulation Diathesis see Disease Susceptibility Diathetic Disease see Disease Susceptibility Diatrizoate As contrast medium WN 160 Organic chemistry QD 341.A2 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 321 Diazepam Diazepam QV 77.9 Diazinon Public health WA 240 Diazonium Compounds QU 54 Organic chemistry Aliphatic compounds QD 305.A9 Aromatic compounds QD 341.A9 Diazoxide QV 150 Dibekacin QV 268 Dibenzazepines As antidepressive agents QV 77.5 Organic chemistry QD 401 Dibothriocephalus see Diphyllobothrium Dibucaine QV 115 Dichlorodiethyl Sulfide see Mustard Gas QV 666 under Mustard Compounds Dichlorodiphenyldichloroethane see DDD Dichloroethanes see Ethylene Dichlorides Dichloroethylenes Toxicology QV 633 Dichloromethane see Methylene Chloride Dichloromethyl Ether see Bis(Chloromethyl) Ether Dichotic Listening Tests WV 272 Diclofenac As an analgesic QV 95 Biochemistry QU 98 Diclophenac see Diclofenac Dicoumarin see Bishydroxycoumarin Dicrostonyx see Microtinae Dictionaries (Form number 13 in any NLM schedule where applicable) Others, in appropriate LC number Dictionaries, Chemical QD 5 Dictionaries, Classical DE 5 Dictionaries, Dental WU 13 Dictionaries, Medical W 13 Dictionaries, Pharmaceutic QV 13 Dictionaries, Polyglot P 361 Of a specific subject, with the subject Dictyocaulus QX 248 Dictyoptera see Orthoptera Dictyostelium QW 180.5.M9 Dictyostelium discoideum see Dictyostelium Dicumarol see Bishydroxycoumarin Didelphis see Opossums Dideoxykanamycin B see Dibekacin Dieldrin WA 240 Diemal see Barbital Diencephalon WL 312 Diet QT 235 And oral health WU 113.7 Diabetic see Diabetic Diet WK 818-819 In disease see Diet Therapy WB 400-449 In infancy & childhood WS 115-130 Low sodium see Diet, Salt-Free WB 424 Raw food WB 432 See also Nutrition QU 145; Vegetarianism WB 430; names of particular foods used in special diets; particular diseases for which diet is prescribed Diet, Atherogenic WG 550 Diet, Cariogenic WU 113.7 Diet, Chemically Defined see Food, Formulated Diet, Diabetic see Diabetic Diet Diet, Elemental see Food, Formulated Diet Fads WB 449 Diet, Formula see Food, Formulated Diet, Low-Salt see Diet, Sodium-Restricted Diet, Macrobiotic WB 422 Diet, Reducing WD 210-212 Popular works WD 212 Diet, Salt-Free see Diet, Sodium-Restricted Diet, Sodium-Restricted WB 424 Cookery WB 424 Diet Surveys QU 146 Diet, Synthetic see Food, Formulated Diet Therapy WB 400-449 In infancy & childhood WS 366 Dietary Calcium see Calcium, Dietary Dietary Carbohydrates QU 75 As a supplement in health or disease WB 427 Cookery for carbohydrate control WB 427 See also Diet, Reducing WD 210-212 Dietary Cholesterol see Cholesterol, Dietary Dietary Fats QU 86 As a supplement in health or disease WB 425 Cookery for fat control WB 425 See also Butter QU 86, etc.; Cholesterol, Dietary QU 95, etc.; Diet, Reducing WD 210-212; Margarine QU 86, etc. Dietary Fats, Unsaturated QU 86 As a supplement in health or disease WB 425 Cookery for fat control WB 425 Dietary Fiber QU 83 As a supplement in health or disease WB 427 Dietary Formulations see Food, Formulated Dietary Habits see Food Habits Dietary Modification see Food Habits Dietary Oils see Dietary Fats, Unsaturated Dietary Proteins QU 55 As a supplement in health or disease WB 426 Cookery for protein control WB 426 Dietary Services Hospitals WX 168 See also Food Service, Hospital WX 168 Public health aspects WA 695-722 See also Dietetics WB 400; Food Services WA 350, etc. Dietary Sodium see Sodium, Dietary Dietetic Departments in Hospitals see Dietary Services; Food Service, Hospital Dietetics WB 400 In infancy & childhood WS 115 Diethyl Ether see Ether, Ethyl Diethyldithiocarbamate see Ditiocarb Diethylmalonylurea see Barbital Diethylnicotinamid see Nikethamide Diethylnitrosamine As a carcinogen QZ 202 Diethylstilbestrol WP 522 Animal Feed SF 98.H67 Organic chemistry QD 341.H9 Dietotherapy see Diet Therapy Differential Diagnosis see Diagnosis, Differential Differential Leukocyte Count see Leukocyte Count ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 322 Diphosphates Differential Thermal Analysis QD 79.T38 Of a particular substance, with the substance Differentiation Antigens see Antigens, Differentiation Differentiation Antigens, B-Cell see Antigens, Differentiation, B-Lymphocyte Differentiation Antigens, B-Lymphocyte see Antigens, Differentiation, B-Lymphocyte Differentiation Antigens, Hairy Cell Leukemia see Antigens, Differentiation Differentiation Antigens, Leukocyte, Human see Antigens, CD Differentiation Markers see Antigens, Differentiation Difficult Labor see Dystocia Diffuse Lewy Body Disease see Parkinson Disease Diffusion Biochemistry QU 34 Biophysics QT 34 Solution chemistry QD 543 Diffusion of Innovation Special topics, by subject Diflucortolone As a dermatologic agent QV 60 Diflunisal QV 95 As a dermatological agent QV 60 Digenic Acid see Kainic Acid Digestants see Gastrointestinal Agents Digestion WI 102 Liver function in WJ 704 Digestive System WI Animal SF 851 Children WS 310 Digestive System Diseases WI 140 Diagnosis WI 141 Surgery WI 900 In infancy & childhood WS 310 Digestive System Neoplasms WI 149 Digital Radiography see Radiographic Image Enhancement Digital Signal Processing see Signal Processing, Computer-Assisted Digitalis QV 153 Dihydrodiethylstilbestrol see Hexestrol Dihydrofolate Dehydrogenase see Tetrahydrofolate Dehydrogenase Dihydrofolate Reductase see Tetrahydrofolate Dehydrogenase Dihydrolipoamide Dehydrogenase see Lipoamide Dehydrogenase Dihydrotachysterol QU 95 Dihydroxycholecalciferols QU 173 Dihydroxyphenylalanine see Dopa Dihydroxyvitamins D see Dihydroxycholecalciferols Diiodohydroxyquin see Iodoquinol Diiodotyrosine Receptors see Receptors, Thyroid Hormone Diisocyanatotoluene see Toluene 2,4-Diisocyanate Diisopropylfluorophosphate see Isoflurophate Dilatation Of the cervix Obstetrical surgery WQ 400 Physiology WQ 305 Of the pupil WW 240 Dilatation and Curettage WP 470 Used for special purposes, by subject Dilatation, Balloon see Balloon Dilatation Dilatation, Pathologic Of the blood vessels WG 578 Of the colon see Megacolon WI 528 Of the heart see Heart Hypertrophy WG 210 Of the pupil WW 240 Of the stomach see Stomach Dilatation WI 300 Of other specific parts, with the part Dilatation, Transluminal Arterial see Angioplasty, Balloon Dilated Cardiomyopathy see Cardiomyopathy, Congestive Diltiazem QV 150 Dilution Techniques see Indicator Dilution Techniques Dimenhydrinate QV 73 Dimethoxystrychnine see Brucine Dimethyl Sulfoxide QV 60 Dimethylaminoazobenzene see p-Dimethylaminoazobenzene Dimethylaminophenazone see Aminopyrine Dimethylcysteine see Penicillamine Dimethylguanylguanidine see Metformin Dimexide see Dimethyl Sulfoxide Dinitrochlorobenzene Toxicology QV 633 Dinitrophenols As fungicides WA 240, etc. Pharmaceutical indicators or reagents QV 744 Toxicology QV 632 Dinoflagellida QX 70 Dinoprost QU 90 As an abortifacient agent QV 175 Diodone see Iodopyracet Diodoquin see Diiodohydroxyquin Diodoxyquinoline see Iodoquinol Diosgenin Biochemistry QU 85 Diothane Hydrochloride see Anesthetics, Local Dioxanes WA 240 As a carcinogen QZ 202 Dioxins Organic chemistry QD 405 Dioxoles As pesticides WA 240 Organic chemistry QD 405 Dipeptidyl Aminopeptidases see Dipeptidyl Peptidases Dipeptidyl Peptidases QU 136 Diphasic Milk Fever Virus see Encephalitis Viruses, Tick-Borne Diphenhydramine QV 157 Diphenhydramine Theoclate see Dimenhydrinate Diphenyl Oxides see Phenyl Ethers Diphenylamine Toxicology QV 632 Diphenylbutazone see Phenylbutazone Diphenylhydantoin see Phenytoin Diphenylhydramin see Diphenhydramine Diphosgene see Phosgene Diphosphates QV 285 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 323 Diphosphopyridine Nucleotide Diphosphopyridine Nucleotide see NAD Diphtheria WC 320 Diphtheria Antitoxin WC 320 Diphtheria Toxin WC 320 Diphtheria Toxoid WC 320 Diphtheria Vaccine see Diphtheria Toxoid Diphyllobothrium QX 400 Diploidy QH 461 Diplopia WW 410 Dipropyl Acetate see Valproic Acid Diptera QX 505 Dipylidiasis see Cestode Infections Dipyridamole QV 150 Dipyrine see Aminopyrine Dipyrone QV 95 Direct Service Costs By subject, in economics number where applicable Directories (Form number 22 in any NLM schedule where applicable) Embryology QS 622 Forensic medicine W 622 Optometry WW 722 Toxicology QV 605 Dirofilaria immitis QX 301 Dirofilariasis WC 880 Disability Compensation see Veterans Disability Claims; Workers' Compensation Disability Evaluation Medicolegal aspects of insurance . W 900 Medicolegal aspects of occupational disease and injury W 925 Other special topics, by subject, e.g., in epilepsy WL 385; in ophthalmology WW 32; in otolaryngology WV 32 Disability Insurance see Medicare Disabled Consumer rights HD 7255-7256 Education LC 4001-4824 In adulthood LC 4815-4824 Mentally disabled LC 4815 Socially disabled LC 4822-4824 In infancy & childhood LC 4001-4806.5 Psychological problems Group psychotherapy WM 430.5.H2 In adulthood Counseling WM 55 Special problems, by subject, e.g., Neuroses WM 170 In infancy & childhood WS 105.5.H2 Readers for disabled children PE 1126.D4 Rehabilitation In adulthood WB 320 In infancy & childhood WS 368 Sociological aspects only HD 7255-7256 See also other entries under Rehabilitation; names of disabilities Sociological aspects HV 1551-3024 Transportation Mentally disabled HV 3005.5 Physically disabled HV 3022 Vocational guidance Mentally disabled HV 3005 Physically disabled HV 3018-3019 Disaccharides QU 83 Disaster Planning WX 185 See also special topics under Disasters Disasters HC 79.D45 First aid WA 292 Hospital emergency service WX 215 Hospital programs see Disaster Planning WX 185 Medical emergencies WB 105 Relief (General) HV 553-555 Nursing WY 154 Specific types of disaster, by subject See also Civil Defense UA 926-929, etc. Discharge Planning see Patient Discharge Disclosure, Truth see Truth Disclosure Discolysis see Intervertebral Disk Chemolysis Discrete Subaortic Stenosis see Aortic Valve Stenosis Discretionary Adjustment Factor see Prospective Payment System Discriminant Analysis QA 278.65 Special topics, by subject Discrimination Learning Animal QL 785 Educational psychology LB 1059 General psychology BF 318 Discrimination (Psychology) BF 697 Racial see Prejudice BF 575.P9 Sex see Women's Rights HQ 1154, etc. See also Race Relations HT 1503-1595, etc. Disease General manifestations QZ 140-190 Degenerative processes QZ 180 Pathogenesis QZ 40-109 Bacterial QZ 65 Special topics, by subject, e.g., endocrine aspects of disease processes WK 140 Disease Frequency Surveys see Cross-Sectional Studies Disease Models, Animal QY 58 Disease Outbreaks WA 105 Cholera WC 264 History WA 11 Plague WC 350-355 Smallpox WC 590 Statistics and surveys WA 900 Typhus WC 610 Veterinary SF 781 Yellow fever WC 532 Disease Reservoirs WA 106 Endemic to a particular locality WB 710 Pathogenesis QZ 40 Veterinary SF 780.9 See also names of particular diseases Disease Resistance see Immunity, Natural Disease Susceptibility QZ 50 Disease Vectors Bacteriology QW 700 Parasitology Arthropod Vectors QX 460, etc. Insect Vectors QX 650 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 324 DNA Nicking-Closing Protein Public health aspects WA 110 See also Insect Control QX 600 Diseases in Twins QZ 50 Particular deseases, with the disease Disgerminoma see Dysgerminoma Disinfectants QV 220-239 Disinfection In hospitals WX 165 In preventive medicine WA 240 In surgery WO 113 Disinfection, Hand see Handwashing Disinfestation see Communicable Disease Control; Ectoparasitic Infestations; Mite Infestations; Tick Infestations Disk, Herniated see Intervertebral Disk Displacement Disk, Intervertebral see Intervertebral Disk Dislocation, Tooth see Tooth Luxation Dislocations WE 175 Hip see Hip Dislocation WE 860 Jaw WU 610 Shoulder see Shoulder Dislocation WE 810 Tooth see Tooth Luxation WU 158 Of other specific bones or joints, with the bone or joint Disodium Cromoglycate see Cromolyn Sodium Disopyramide QV 150 Dispensaries, Outpatient see Outpatient Clinics, Hospital Dispensatories QV 740 Dispensing Fees see Prescription Fees Dispensing, Pharmaceutical see Drug Compounding; Pharmacy Service, Hospital; Pharmaceutical Services Displacement (Psychology) WM 193.5.D5 In adolescence WS 463 In infancy & childhood WS 350.8.D3 Disposable Equipment W 26 Disposal of the Dead see Cadaver; Mortuary Practice Dissection QS 130-132 Veterinary SF 762 Disseminated Intravascular Coagulation WH 322 Dissertations, Academic General Z 5053 Presented to medical, dental, pharmacy, nursing, public health and veterinary schools or departments. American schools W 4A Foreign schools W4 Dissociation see Dissociative Disorders Dissociative Disorders WM 173.6 Distance Perception WW 105 Distemper Virus, Canine QW 168.5.P2 Distributed Systems see Computer Communication Networks Disulfides QV 280 Disulfiram Organic chemistry QD 305. S3 Used in treatment of alcoholism WM 274 Used for other particular purposes, by subject. Dithranol see Anthralin ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Ditiocarb As a chelating agent QV 290 Diuresis WJ 303 Diuretics QV 160 Diuretics, Mercurial QV 160 Diuretics, Osmotic QV 160 Diuretics, Sulfamyl QV 160 Diurnal Rhythm see Orcadian Rhythm Divalproex see Valproic Acid Divers' Paralysis see Decompression Sickness Diverticulitis WI 425 Diverticulitis, Colonic WI 425 Diverticulosis see Diverticulum Diverticulosis, Colonic WI 425 Diverticulosis, Esophageal see Esophageal Diverticulum Diverticulum WI 425 Diving QT 260.5.D6 Accidents QT 260.5.D6 Anoxia associated with WD 650 Industrial accidents WA 485 Submarine and deep-water VM 975-989 Divorce HQ 811-960.7 Counseling WM 55 Effect on adolescents WS 462 Effect on children WS 105.5.F2 See also Maternal Deprivation WS 105.5.D3; Paternal Deprivation WS 105.5.D3 Dixamon Bromide see Methantheline Dizziness WL 340 DMF Index WU 30 DMSO see Dimethyl Sulfoxide DNA QU 58.5 DNA, Antisense QU 58.5 DNA, Bacterial QW 52 DNA-Binding Proteins QU 58.5 DNA Cytosine-5-Methylase see DNA (Cytosine-5-)-Methyltransferase DNA (Cytosine-5-)-Methyltransferase QU 141 DNA Damage QH 465 By specific agent, A-Z, e.g., Chemicals QH 465.C5 DNA-Dependent RNA Polymerases see RNA Polymerases DNA, Double-Stranded see DNA DNA Fingerprinting As a genetic technique QH 441 In forensic medicine W 700-791 DNA-Gyrase see DNA Topoisomerase (ATP-Hydrolysing) DNA Helix Destabilizing Proteins see DNA-Binding Proteins DNA Injury see DNA Damage DNA Insertion Elements QH 462.148 DNA Joinases see Polydeoxyribonucleotide Synthetases DNA Ligases see Polydeoxyribonucleotide Synthetases DNA Markers see Genetic Markers DNA Mutational Analysis QU 58.5 DNA, Neoplasm QZ 200 DNA Nicking-Closing Protein see DNA Topoisomerase USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSinED 325 DNA Nucleotidylexotransferase DNA Nucleotidylexotransferase QU 141 DNA Probes QU 58.5 DNA Rearrangement see Gene Rearrangement DNA, Recombinant QU 58.5 Genetic and ethical emphasis QH 438.7 DNA Recombinant Proteins see Recombinant Proteins DNA Relaxing Enzyme see DNA Topoisomerase DNA Repair QH 467 Biochemistry QU 58.5 DNA Repair Enzymes see Polydeoxyribonucleotide Synthetases DNA Replication QH 462.D8 Biochemistry QU 58.5 DNA Restriction Enzymes QU 136 DNA, Satellite QU 58.5 DNA Sequence see Base Sequence DNA Sequence Analysis see Sequence Analysis, DNA DNA, Single-Stranded QU 58.5 Phages QW 161 DNA Topoisomerase QU 58.5 DNA Topoisomerase (ATP-Hydrolysing) QU 137 DNA Topoisomerase I see DNA Topoisomerase DNA Topoisomerase II see DNA Topoisomerase (ATP-Hydrolysing) DNA Tumor Viruses QW 166 Directory of research QW 22 DNA Untwisting Enzyme see DNA Topoisomerase DNA Untwisting Protein see DNA Topoisomerase DNA, Viral QW 165 DNA Viruses General works QW 165 Specific viruses QW 165.5A-Z DNAase see Deoxyribonucleases DNase see Deoxyribonucleases DNCB see Dinitrochlorobenzene Do-Not-Resuscitate Orders see Resuscitation Orders Dobutamine DOCA see Desoxycorticosterone Docimasia, Pulmonary see Autopsy; Biogenesis Docosenoic Acids see Erucic Acids Doctor-Patient Relations see Physician-Patient Relations Doctors see Physicians Documentation Z 1001 Documents, Serial see Periodicals Dog Diseases SF 991-992 Dog Heartworm see Dirofilaria immitis Dogfish QL 638.95.S84 Dogs As laboratory animals QY 60.D6 Domestic SF 421-440.2 Anatomy SF 767.D6 Wild QL 737.C22 Dolphins QL 737.C432 Domestic Medicine see Popular works WB 120 under Medicine; Self-Medication Domestic Violence HQ 809-809.3 Criminal W 860 Domiciliary Care see Home Care Services Dominance, Cerebral WL 335 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Dominance, Social see Social Dominance Dominance-Subordination In animals QL 775 Sociology HM 132 Donovanosis see Granuloma Inguinale Dopa WK 725 Dopa Decarboxylase QU 139 Dopamine WK 725 Dopamine Agents QV 76.5 Dopamine Agonists QV 76.5 Dopamine Antagonists QV 76.5 Dopamine Receptor Agonists see Dopamine Agonists Dopamine Receptor Antagonists see Dopamine Antagonists Dopamine Receptors see Receptors, Dopamine Dopaminergic Agonists see Dopamine Agonists Dopaminergic Antagonists see Dopamine Antagonists Doping in Sports QT 261 Doppler Echocardiography see Echocardiography, Doppler Doppler Effect Biophysics QT 34 Health physics WN 110 Special topics, by subject Doppler Shift see Doppler Effect Doppler Ultrasound see Ultrasonics Dormice see Rodentia Dosage see Drug Administration Schedule; Drug Therapy; Prescriptions, Drug; Radiation Dosage; Radiotherapy Dosage Dosage Forms QV 785 See also names of specific forms Dose-Response Relationship, Drug QV 38 Dose-Response Relationship, Radiation Non-ionizing radiation WB 460 Radioisotopes WN 450 Radium WN 340 X-rays WN 250.5X7 Ultraviolet rays WB 480 Other specific types of radiation, by type Specific disease treated, with the disease Dosimetric System of Therapeutics see Alternative Medicine Dosimetry Calculations, Computer-Assisted see Radiotherapy Planning, Computer-Assisted Dot Immunoblotting see Immunoblotting Double Bind Theory In parent-child communication WS 105.5.F2 In psychotherapy WM 420 Other applications, by subject Double-Stranded RNA see RNA, Double-Stranded Double Vision see Diplopia Down Syndrome WS 107 Adult WM 300 Doxorubicin QV 269 Doxylamine QV 157 As enzyme inhibitors QU 143 Organic chemistry QD 401 As sedatives QV 85 DPN see NAD Dracunculus QX 203 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 326 Drug Insurance Dracunculus medinensis see Dracunculus Dragon Worm see Dracunculus Drainage WO 188 Localized, by site Drainage, Sanitary WA 670 Drainage, Suction see Suction Drama Related to medicine WZ 330 Related to psychiatry WM 49 Drama Therapy in Psychiatry see Psychodrama Drawings (Form number 17 in any NLM schedule where applicable) Dreams In infancy & childhood WS 105.5.D8 Parapsychology BF 1074-1099 Psychoanalysis WM 460.5.D8 Sleep, Normal WL 108 Dress see Clothing; Protective Clothing Dressings see Bandages Dressings, Biological see Biological Dressings Dressings, Occlusive see Occlusive Dressings Dressings, Surgical see Bandages; Occlusive Dressings DRG see Diagnosis-Related Groups Dried Milk see Dairy Products; Milk Drill see Papio Drinking WI 102 See also Alcohol Drinking WM 274, etc.; Water Supply WA 675-690 Drinking, Alcohol see Alcohol Drinking Drinking Behavior Customs GT 2850-2930 Drinks see Beverages Drip Infusions see Infusions, Intravenous Drive BF 501-505 In adolescence WS 462 In infancy & childhood WS 105.5.M5 Psychoanalysis WM 460.5.M6 Dromedary see Camels Dropsy see Edema Drosophila QX 505 Drought see Natural Disasters Drowning Resuscitation WA 292 Statistics HB 1323.D7 Swimming, accidents QT 260.5.S9 Drowsiness see Sleep Stages Drug Abuse see Substance Abuse Drug Abuse, Intravenous see Substance Abuse, Intravenous Drug Abuse, Parenteral see Substance Abuse, Intravenous Drug Abuse, Sports see Doping in Sports Drug Abuse Testing see Substance Abuse Detection Drug Action see Pharmacology; Drug interactions; Dose-response relationships, Drug QV 38 and other specific actions Drug Addiction see Substance Dependence Drug Administration, Bladder see Administration, Intravesical Drug Administration, Dermal see Administration, Cutaneous Drug Administration, Inhalation see Administration, Inhalation Drug Administration, Intranasal see Administration, Intranasal Drug Administration, Oral see Administration, Oral Drug Administration, Rectal see Administration, Rectal Drug Administration, Respiratory see Administration, Inhalation Drug Administration Routes WB 340-356 Drug Administration Schedule WB 340 Drug Administration, Topical see Administration, Topical Drug Adulteration see Drug Contamination Drug Aerosol Therapy see Administration, Inhalation Drug and Narcotic Control Laws (sales) QV 32-33 Laws (use) WM 32-33 Sociological aspects HV 5800-5840 Special topics, by subject Drug Antagonism QV 38 Drug Benefit Plans see Insurance, Pharmaceutical Services Drug Carriers QV 785 Drug Catalogs see Catalogs, Drug Drug Combinations QV 785 See also Drug Therapy, Combination WB 330 and names of specific drugs, or diseases for which the drug combinations are prescribed Drug Combinations, Antineoplastic see Antineoplastic Agents, Combined Drug Compounding QV 778 Drug Containers and Closures see Drug Packaging Drug Contamination Fraud QV 773 Legislation and jurisprudence QV 32-33 Public health aspects WA 730 Drug Counterfeiting see Drug Contamination Drug Delivery Systems, Implantable see Infusion Pumps, Implantable Drug Dependence see Substance Dependence Drug Design QV 744 Drug Detoxication, Metabolic see Metabolic Detoxication, Drug Drug Eruptions WR 165 Drug Evaluation QV 771 See also Drug Screening QV 771 Drug Evaluation, Preclinical see Drug Screening Drug Exanthems see Drug Eruptions Drug Habituation see Substance Dependence Drug Hypersensitivity WD 320 Drug Incompatibility QV 746 Drug Industry QV 736 Fraud QV 773 See also Ethics, Pharmacy QV 21 Occupational medicine WA 400-495 Industrial waste WA 788 Drug Information Services Computerized QV 26.5 Services in particular fields, by subject Drug Infusion Systems see Infusion Pumps Drug Insurance see Insurance, Pharmaceutical ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 327 Drug Insurance Services Drug Interactions QV 38 Drug Kinetics see Pharmacokinetics Drug Labeling QV 835 Drug Laws see Legislation, Drug Drug Modeling see Drug Design Drug Packaging QV 825 Drug Potentiation see Drug Synergism Drug Precursors see Prodrugs Drug Recall see Drug and Narcotic Control Drug Receptors see Receptors, Drug Drug Regulations see Drug and Narcotic Control Drug Residues Food contamination WA 701 Public health WA 730 Drug Resistance WB 330 In particular diseases, with the disease Drug Resistance, Microbial QW 52 In drug therapy WB 330 Of particular organisms, with the organism To particular drugs, with the drug Drug Screening QV 771 See also Drug Evaluation QV 771 Drug Screening Assays, Antitumor Used in testing antineoplastic agents QV 269 Drug Screening Tests, Tumor-Specific see Drug Screening Assays, Antitumor Drug Sensitivity Assay, Microbial see Microbial Sensitivity Tests Drug Stability QV 754 Drug Storage QV 754 Public health aspects WA 730 Drug Stores see Pharmacies Drug Surveillance, Postmarketing see Product Surveillance, Postmarketing Drug Synergism QV 38 Drug Therapy WB 330 Adverse effects QZ 42 In infancy & childhood WS 366 In old age WT 166 In pregnancy WQ 200 Mental Disorders WM 402 In infancy & childhood WS 350.2 Neoplasms QZ 267 Veterinary SF 915-919.5 For particular diseases, with the disease Drug Therapy, Combination WB 330 Anti-neoplastic QZ 267 For other particular diseases, with the disease See also Drug Combinations QV 785 Drug Tolerance QV 38 Drug Use Disorders see Substance Use Disorders Drug Utilization WB 330 Drug Withdrawal Symptoms see Substance Withdrawal Syndrome Drugs Administration & dosage QV 748 Administrative methods WB 340-356 See also Administration, Intranasal WB 342; Administration, Oral WB 350; Administration, Topical WB 340; Dosage Forms QV 785; Drug Administration Schedule WB 340; Injections WB 354; ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH^ Perfusion, Regional QZ 267; Respiratory Therapy WF 145, etc., and particular diseases being treated Adverse effects QZ 42 Analysis QV 25 Autonomic see Autonomic Agents QV 120 Catalogs see Catalogs, Drug QV 772 General works QV 55 Legislation see Legislation, Drug QV 32-33 Metabolism QV 38 Military supplies UH 420-425 Mucopolysaccharidosis IV WD 205.5.C2 Packaging QV 825 Patent medicines see Drugs, Non-Prescription QV 772 Preservation QV 754 Public health aspects WA 730 Proprietary QV 772 Public health aspects WA 730 Quack see Nostrums QV 722 Receptors see Receptors, Drug QV 38 Standards QV 771 See also Iatrogenic Disease QZ 42; names of specific drugs and types of drugs Drugs, Chinese Herbal QV 767 See also Medicine, Herbal WB 925 Drugs, Investigational QV 771 Drugs, Non-Prescription QV 772 Drugs of Abuse see Street Drugs Dry Eye Syndromes WW 208 DSIP see Delta Sleep-Inducing Peptide Dual Personality see Multiple-Personality Disorder Dubin-Johnson Syndrome see Jaundice, Chronic Idiopathic Duchenne Muscular Dystrophy see Muscular Dystrophy Ducks Anatomy SF 767.P6 Culture SF 504.7-505.63 Diseases Domestic and wild SF 995.2 Wild SF 510.D8 Ductless Glands see Endocrine Glands Ductus Arteriosus WQ 210.5 Ductus Arteriosus, Patent WG 220 Ductus Deferens see Vas Deferens Due Process see Jurisprudence Duffy Blood-Group System WH 420 Duhring's Disease see Dermatitis Herpetiformis Dumbness, Hysteric see Mutism Dumping Syndrome WI 380 Duncan's Syndrome see Lymphoproliferative Disorders Duodenal Contents see Analysis QY130 under Duodenum Duodenal Diseases WI 505 Duodenal Neoplasms WI 505 Duodenal Obstruction WI 505 Duodenal Papilla, Major see Vater's Ampulla Duodenal Papilla, Minor see Pancreatic Ducts Duodenal Ulcer WI 370 Duodenitis WI 505 Duodenogastric Reflux WI 302 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 328 Eccrine Glands Duodenoscopy WI 505 Duodenum WI 505 Analysis QY 130 Feeding by see Tube Feeding WB 410 Duplicating Processes see Copying Processes Dupuytren's Contracture WE 830 Dura Mater WL 200 Durable Power of Attorney see Living Wills Dwarfism WE 250 See also Cretinism WK 252 Dwarfism, Pituitary WK 550 Dwellings see Housing Dye Dilution Technique WG 141 In hemodynamics WG 106 Dye Exclusion Assays, Antitumor see Drug Screening Assays, Antitumor Dyes As anti-infective agents QV 235 As reagents, indicators, etc. QV 240 Used in particular procedures, with the procedure See also Stains and Staining QW 25, etc. Dyes, Hair see Hair Dyes Dynorphins QU 68 Dysarthria WL 340.2 Psychogenic WM 475 Dysautonomia see Autonomic Nervous System Diseases Dysautonomia, Familial WL 600 Dyschondroplasias see Osteochondrodysplasias Dysembryoma see Teratoma Dysentery WC 280-285 Veterinary SF 809.D87 Dysentery, Amebic WC 285 Dysentery, Bacillary WC 282 Dysgammaglobulinemia WD 308 Dysgerminoma QZ 310 Localized, by site Dyskinesia see Movement Disorders Dyskinesia, Drug-Induced WL 390 Dyskinesia, Tardive see Dyskinesia, Drug-Induced Dyslexia Neurologic WL 340.6 Psychogenic WM 475.6 Remedial teaching LB 1050.5 Dyslexia, Acquired Neurologic WL 340.6 Psychogenic WM 475.6 Remedial teaching LB 1050.5 Dyslexia, Congenital see Dyslexia Dyslexia, Developmental see Dyslexia Dysmenorrhea WP 560 Dysmyelopoietic Syndromes see Myelodysplastic Syndromes Dysostosis, Craniofacial see Craniofacial Dysostosis Dyspareunia WP 610 Dyspepsia WI 145 Dysphagia see Deglutition Disorders Dysphasia see Aphasia Dysphonia see Voice Disorders Dyspituitarism see Hyperpituitarism; Hypopituitarism Dysplasia Epiphysialis Punctata see Chondrodysplasia Punctata Dysplastic Nevus Syndrome WR 500 Pathology QZ 310 Dyspnea WF 143 Dyspnea, Paroxysmal WG 370 Dyssocial Behavior see Antisocial Personality Disorder Dysthymic Disorder see Depressive Disorder Dystocia WQ 310 Dystonia WL 390 Dystonia Musculorum Deformans WE 550 Dystrophic Skin Disorders see Skin Diseases WR 140, etc. or name of specific disorders, e.g., Scleroderma, Circumscribed Dystrophy, Progressive Muscular see Muscular Dystrophy E Antigens see Hepatitis B e Antigens E-B Virus see Herpesvirus 4, Human E. coli Infections see Escherichia coli Infections EAC142 see Complement 3 Convertase Ear WV 200-290 Surgery WV 200 Ear Canal WV 222 Ear Deformities, Acquired WV 220 Deformities of other than the external ear, by part Ear Diseases WV 200-290 General works WV 200 In infancy & childhood WV 200-290 Nursing WY 158.5 Ear Drum see Tympanic Membrane Ear, External WV 220-222 Ear, Inner see Labyrinth Ear, Internal see Labyrinth Ear, Middle WV 230-233 Ear Molds see Hearing Aids Ear Neoplasms WV 290 Localized, by site Ear Ossicles WV 230 Ear Protective Devices WV 26 Ear Trumpets see Hearing Aids Ear Wax see Cerumen Early Gene Transcription see Transcription, Genetic Earthquakes see Natural Disasters Earthworms see Oligochaeta East Coast Fever see Theileriasis Eating Behavior see Feeding Behavior Eating Disorders In infancy & childhood Children WS 130 Infants WS 120 Manifestation of disease WI 143 Psychophysiological WM 175 Ebstein's Anomaly WG 220 EBV see Herpesvirus 4, Human EC Cells see Tumor Stem Cells EC-IC Arterial Bypass see Cerebral Revascularization Eccentro-Osteochondrodysplasia see Mucopolysaccharidosis IV Eccrine Glands WR 400 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 329 Ecdysone Ecdysone SF 768.3 Zoology QL 868 ECG see Electrocardiography Echinococcosis WC 840 Veterinary SF 810.H8 Echinococcosis, Hepatic WI 700 Echinococcosis, Hepatic Alveolar see Echinococcosis, Hepatic Echinococcosis, Pulmonary WF 600 Echinococcus QX 442 Echinopanax see Ginseng Echo Viruses see Echoviruses Echocardiography WG 141.5.E2 Echocardiography, Continuous Doppler see Echocardiography, Doppler Echocardiography, Contrast see Echocardiography Echocardiography, Cross-Sectional see Echocardiography Echocardiography, Doppler WG 141.5.E2 Echocardiography, Doppler, Color WG 141.5.E2 Echocardiography, Doppler, Pulsed WG 141.5.E2 Echocardiography, M-Mode see Echocardiography Echocardiography, Two-Dimensional see Echocardiography Echocardiography, Two-Dimensional Doppler see Echocardiography, Doppler Echoencephalography WL 154 Echography see Ultrasonography Echolalia WM 475 Echolocation QL 782.5 Echothiophate Iodide QV 124 Echoviruses QW 168.5.P4 Eck Fistula see Portacaval Shunt, Surgical Eclampsia WQ 215 Eclecticism WB 920 Eco DNA Topoisomerase II see DNA Topoisomerase (ATP-Hydrolysing) Ecological Monitoring see Environmental Monitoring Ecological Systems, Closed WD 756 Ecology General and animal QH 540-549.5 Human GF General works GF 31-48 Plant QK 901-938 Economic Competition By subject, in economics number where applicable Economic Factors see Socioeconomic Factors Economic Inflation see Inflation, Economic Economics Land, agriculture, industry HD General works HD 31-37 National production HC General works HC 21 Pharmacy QV 736 Theory HB General works HB 151-181 Economics, Dental WU 77-79 Economics, Hospital WX 157 Economics, Medical W 74-80 Economics, Nursing WY 77 Ecosystem see Ecology ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPHA Ecothiopate Iodide see Echothiophate Iodide ECT (Psychotherapy) see Electroconvulsive Therapy Ectasia, Alveolar see Pulmonary Emphysema Ecthyma WR 225 Ecthyma, Contagious WC 584 Ectodermal Defect, Congenital see Ectodermal Dysplasia Ectodermal Dysplasia WR 218 Ectogenesis WQ 205 Ectohormones see Pheromones Ectoparasitic Infestations WC 900 Disinfestation WC 900 Veterinary SF 810 Ectopia Cordis see Heart Defects, Congenital Ectopic Hormone Syndromes see Neoplastic Endocrine-Like Syndromes Ectopic Pregnancy see Pregnancy, Ectopic Ectropion WW 205 Eczema WR 190 Veterinary SF 901 Eczema, Atopic see Dermatitis, Atopic Eczema, Contact see Dermatitis, Contact Eczema, Dyshidrotic WR 200 Eczema, Infantile see Dermatitis, Atopic Eczema, Vesicular Palmoplantar see Eczema, Dyshidrotic Edathamil see Edetic Acid Edema Angioneurotic see Angioneurotic Edema WR 170 Brain see Brain Edema WL 348 Bronchial WF 500 Diagnostic significance WB 158 Drugs affecting QV 160 Laryngeal see Laryngeal Edema WV 500 Lymph see Lymphedema WH 700, etc. Manifestation of Disease QZ 170 Optic papilla see Papilledema WW 280 Pulmonary see Pulmonary Edema WF 600 See also names of body parts with which the edema is associated Edema, Cardiac WG 370 Edema-Proteinuria-Hypertension Gestosis see Gestosis, EPH Edentata QL 737.E2 Edetates see Edetic Acid Edetic Acid QV 276 EDTA see Edetic Acid Education (Form number 18 in any NLM schedule where applicable) Elementary LB 1555-1602 Health see Health Education WA 590, etc.; Health Education, Dental WU 113 Higher LB 2300-2430 Physical see Physical Education and Training QT 255 Safety WA 250 Secondary LB 1603-1696.6 Sex see Sex Education QT 225, etc. Vocational see Vocational Education LC 1041-1048 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 330 Elbow Joint See also subheading Education under names of disabilities, specialties, etc. Education, Competency-Based see Competency-Based Education Education, Continuing LC 5201-6660.4 See also specific continuing education terms, e.g., Education, Dental, Continuing; Education, Medical, Continuing; Education, Pharmacy, Continuing; etc. Education, Dental WU 18 Education, Dental, Continuing WU 20 Education, Dental, Graduate WU 20 Education, Dental Health see Health Education, Dental Education, Graduate LB 2371-2372 Education, Health see Health Education Education, Medical W 18 Education, Medical, Continuing W 20 In psychiatry WM 19.5 Education, Medical, Graduate W 20 In psychiatry WM 19.5 Education, Medical, Undergraduate W 18 Education, Nursing WY 18 See also Education WY 18.8 under Nursing, Practical Education, Nursing, Associate WY 18 Education, Nursing, Baccalaureate WY 18 Education, Nursing, Continuing WY 18.5 Education, Nursing, Diploma Programs WY 18 Education, Nursing, Graduate WY 18.5 Education of Mentally Defective see Education of Mentally Retarded Education of Mentally Retarded LC 4601-4640.4 Sex education HQ 54.3 Health education LC 4613 Education of Patients see Patient Education Education, Pharmacy QV 18 Education, Pharmacy, Continuing QV 20 Education, Pharmacy, Graduate QV 20 Education, Predental WU 18 Education, Premedical W 18 Education Research, Nursing see Nursing Education Research Education, Sex see Sex Education Education, Special Blind children HV 1618-2349 Children with behavior disorders LC 4801-4803 Deaf children HV 2417-2990.5 Disabled adults LC 4812-4824 Disabled children LC 4001-4043 Mentally ill children LC 4165-4184 Mentally retarded children see Education of Mentally Retarded LC 4601-4640.4 Other ill children LC 4580-4599 Physically disabled children LC 4201-4243 Slow learning or under achieving children LC 4661-4700.4 Socially disabled children LC 4051-4100.4 See also subheading Education under names of disabilities, specialties, etc. Education, Veterinary SF 756.3-756.37 Educational Achievement see Educational Status Educational Measurement LB 3051-3060.87 In a particular field Works about (Form number 18 in any NLM schedule where applicable) Actual tests (Form number 18.2 in any NLM schedule where applicable) Other special topics, by subject Educational Status General official reports, by country L 111-791 School surveys LB 2823 Relation to special topics, by subject Special classes of people LC 1390-5160.3 Educational Therapy in Psychiatry see Occupational Therapy; Education of Mentally Retarded EEG see Electroencephalography Eel, Congo see Urodela Efficiency Industrial T 58.8 Use of time BF 637.T5 Effort see Exertion Effort Syndrome see Neurocirculatory Asthenia EGF-URO Receptors see Receptors, Epidermal Growth Factor-Urogastrone Egg see Ovum Egg Proteins QU 55 In diet therapy WB 426 Egg Shell Proteins see Egg Proteins Egg White Proteins see Egg Proteins Egg Yolk Proteins see Egg Proteins Eggs As a dietary supplement in health and disease Cholesterol content WB 425 Protein content WB 426 See also Egg Proteins QU 55 Sanitary handling WA 703 Ego Child psychology WS 105.5.S3 Psychoanalysis WM 460.5.E3 See also Self Concept BF 697, etc. Ehlers-Danlos Syndrome WR 218 Ehrlichia QW 150 Eicosanoids QU 90 Eidetic Imagery WL 705 Eigenmannia see Electric Fish Ejaculation Physiology WJ 750 Psychological disorders WM 611 Ejaculatory Ducts WJ 750 Ejection Seats WD 740 EKG see Electrocardiography Elaeophoriasis see Filariasis Elastic Stockings see Bandages Elastic Tissue QS 532.5.E5 Elastica see Rubber Elasticity QC 191 Of arteries, bones, etc. in general QT 34 Of specific organs or parts, by subject Of a particular material, with material Elastin QU 55 Elastomers see Rubber Elastomers, Silicone see Silicone Elastomers Elbow WE 820 Elbow Joint WE 820 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 331 Elder Abuse Elder Abuse HV 6626.3 For the aged being abused WT 30 For the abusers' aggressive behavior WM 600 Elderly see Aged Elderly, Frail see Frail Elderly Electric Anesthesia see Electronarcosis Electric Burns see Burns, Electric Electric Conductance, Skin see Galvanic Skin Response Electric Conductivity Human QT 34 Physics QC 610.3-612 Electric Countershock WG 330 Electric Fish QL 639.1 As laboratory animals QY 60.F4 Electric Injuries WD 602 Industrial WA 485 See also Burns, Electric WO 704 Electric Organ In fishes QL 639.1 Electric Power Plants see Power Plants Electric Shock see Electric Injuries; Electroconvulsive Therapy; Electroshock Electric Stimulation Neurophysiology WL 102 Therapeutic use see Electric Stimulation Therapy WB 495 Diagnostic use see Electrodiagnosis WB 141 Electric Stimulation Therapy WB 495 See also Electroconvulsive Therapy WM 412 Electric Stimulation, Transcutaneous see Transcutaneous Electric Nerve Stimulation Electricity Adverse effects WD 602 See also Electric Injuries WD 602 Atmospheric QC 960.5-969 See also Lightning WD 602, etc. Death by (Medicolegal aspects) W 843 Physics QC 501-718.8 Electric currents QC 601-625 Electroacoustic Impedance Tests see Acoustic Impedance Tests Electroacupuncture WB 369 Electroanalgesia see Transcutaneous Electric Nerve Stimulation Electroanesthesia see Electronarcosis Electrocardiography WG 140 In infancy & childhood WS 290 Veterinary SF 811 Electrocardiography, Ambulatory WG 140 Electrocardiography, Dynamic see Electrocardiography, Ambulatory Electrocardiography, Holter see Electrocardiography, Ambulatory Electrocautery see Electrocoagulation Electrochemistry QD 551-575 Electrochemical analysis QD 115 Industrial TP 250-261 Organic compounds QD 273 Electrocoagulation WO 198 Electrocochleography see Audiometry, Evoked Response Electroconvulsive Therapy WM 412 ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPH4 See also Electroshock WM 25 Electrocution, Accidental see Electric Injuries Electrodeposition see Electroplating Electrodermal Response see Galvanic Skin Response Electrodes QD 571 Biomedical engineering QT 36 In electric stimulation therapy WB 495 Used for special purposes, by subject, e.g., in Urinalysis QY 185 See also Microelectrodes QT 36, etc. Electrodes, Enzyme see Biosensors Electrodes, Miniaturized see Microelectrodes Electrodiagnosis WB 141 Used for diagnosis of particular disorders, with the disorder or system Electroencephalography WL 150 Electroencephalography, Alpha Rhythm see Alpha Rhythm Electrofocusing see Isoelectric Focusing Electrogalvanism, Intraoral WU 180 Electrohydraulic Shockwave Lithotripsy see Lithotripsy Electroimmunoblotting see Immunoblotting Electroimmunodiffusion Test see Immunodiffusion Electrokymography WN 100 Cardiovascular WG 141.5.K9 Used for diagnosis of particular disorders, with the disorder or system Electrolysis QD 551-575 In electrotherapy WB 495 In hair removal WR 450 Special topics, by subject Electrolytes QV 270 Analytical chemistry QD 139.E4 Bacteriology QW 52 Electrochemistry QD 565 Physiological effects (General) QT 162.E4 See also Water-Electrolyte Balance QU 105; Water-Electrolyte Imbalance WD 220 Electrolytic Depilation see Hair Removal Electromagnetic Energy see Radiation Electromagnetic Fields Biophysics QT 34 Physics QC 665.E4 Electromagnetic Radiation see Radiation Electromagnetic Radiation, Ionizing see Radiation, Ionizing Electromagnetic Radiation, Non-Ionizing see Radiation, Non-Ionizing Electromagnetic Waves see Radiation Electromagnetics Biophysics QT 34 Electromyography WE 500 Electromyography WE 500 Special topics, by subject Electron Microscope see Microscopy, Electron Electron Microscopy see Microscopy, Electron Electron Microscopy, Transmission see Microscopy, Electron Electron Nuclear Double Resonance see Electron Spin Resonance Spectroscopy Electron Paramagnetic Resonance see Electron Spin Resonance Spectroscopy E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 332 Embryologists, Directories Electron Probe Microanalysis Qualitative analysis QD 98.E4 Quantitative analysis QD 117.E42 Special topics, by subject Electron Spin Resonance Spectroscopy Biological research General QH 324.9.E36 Medically oriented QT 34 Chemistry QD 455.2 Used for special purposes, by subject Electron Theory, Roentgenographic see Health Physics Electron Transport QU 125 Electronarcosis Anesthesiology WO 275 Psychiatry WM 412 Electronic Data Processing see Automatic Data Processing Electronic Mail see Office Automation Electronics TK 7800-8360 Electronics, Medical QT 34 See also Biomedical Engineering QT 36 Electrons WN 415-450 In general nuclear physics QC 793.5.E62-793.5.E629 In health physics WN 110 Electronystagmography WW 410 Electrooculography WW 143 Electrophoresis Analytical chemistry (General) QD 79.E44 Biology QH 324.9.E4 Medically oriented QU 25 Microbiology QW 25 Organic chemistry (General) QD 272.E43 Quantitative analysis QD 117.E45 Used for other special purposes, by subject See also Blood Protein Electrophoresis QY 455; Isoelectric focusing QW 25, etc. Electrophoresis, Agar Gel QU 25 Special topics, by subject Electrophoresis, Agarose Gel see Electrophoresis, Agar Gel Electrophoresis, Gel, Two-Dimensional QU 25 Special topics, by subject Electrophysiology QT 34 Animals (General) QP 341 Domestic SF 768 Wild QP 341 Biology (General) QH 517 Nervous system WL 102 Plants QK 845 Other systems involved, in physiology number for the system or part Electroplating TS 670-693 Electroretinography WW 270 Electroshock WM 25 See also Electric injuries WD 602; Electroconvulsive therapy WM 412 Electroshock Therapy see Electroconvulsive Therapy Electrosleep see Electronarcosis Electrosurgery WO 198 Dental WU 600 Electrosyneresis see Counterimmunoelectrophoresis Electrotherapy see Electric Stimulation Therapy Electroversion, Cardiac see Electric Countershock Elements Biochemistry QU 130 Inorganic chemistry QD 181 Non-metallic (pharmacology) QV 138 Physical chemistry QD 466-469 See also Isotopes QD 181, etc.; Radioisotopes WN 420, etc. and specific chemical elements Elephantiasis WH 700 Elephantiasis, Bancroftian see Elephantiasis, Filarial Elephantiasis, Filarial WC 880 Elephants QL 737.P98 Diseases SF 997.5.E4 Eligibility Determination For Medicaid W 250 For Medicare WT 31 Medicolegal aspects Of insurance W 900 Of occupational disease & injury W 925 Eligibility for other benefits and services, by subject See also Disability Evaluation, W 900, etc. ELISA see Enzyme-Linked Immunosorbent Assay Elixirs, Pharmacy see Pharmaceutic Aids Emaciation WB 146 Malnutrition WD 100, etc. Metabolic diseases WD 200 Emasculation see Castration Embalming WA 844 Emblems and Insignia In medicine and related fields WZ 334 Seals CD 5005-6471 Embolic Tumor Cells see Neoplasm Circulating Cells Embolism QZ 170 Arterial WG 540 Cerebral see Cerebral Embolism and Thrombosis WL 355 Coronary WG 300 Pulmonary see Pulmonary Embolism WG 420 Venous WG 610 Embolism, Air QZ 170 As an effect of high altitude WD 710 In decompression sickness WD 712 In other disorders, with the disorder Embolism, Amniotic Fluid WQ 244 Embolism, Fat QZ 170 Embolism, Gas see Embolism, Air Embolism, Tumor see Neoplasm Circulating Cells Embolus see Embolism Embryo QS 604 Animals Domestic SF 767.5 Wild animals QL 971 Specific animals, with the animal Embryo, Chick see Chick Embryo Embryo Development see Fetal Development Embryo Transfer Human WQ 205 Embryologists, Directories see Directories QS 622 under Embryology ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 333 Embryology Embryology QS 604-681 Directories QS 622 Domestic animals SF 767.5 Experimental QS 604 Gynecology WP 150 Twinning QS 642 See also Twins WQ 235, etc.; Pregnancy, Multiple WQ 235 Zoology QL 951-991 See also special topics under Anatomy Localized, by site Embryonal Carcinoma Cells see Tumor Stem Cells Embryonic Induction QH 607 Embryopathies see Fetal Diseases Embryos, Plant see Seeds Embryotomy WQ 435 Embryotoxins see Teratogens Emergencies Cardiac WG 205 Dental (General) WU 105 First aid WA 292 General WB 105 In infancy & childhood WS 205 Medical see Emergency Medicine WB 105 Surgical WO 700-820 Veterinary (General) SF 778 Veterinary surgery SF 914.3-914.4 See also Crisis Intervention WM 401, etc. Emergency Care see Emergency Medical Services Emergency Care Information Systems see Information Systems Emergency Health Services see Emergency Medical Services Emergency Medical Service Communication Systems see Emergency Medical Services WX 215, etc. Emergency Medical Services WX 215 Occupational WA 412 See also Emergency Services, Psychiatric WM 401; Emergency Service, Hospital WX 215; names of particular types of service, e.g., Mobile Health Units WX 190 Emergency Medical Tags W 26 Emergency Medical Technicians W 21.5 Emergency Medicine WB 105 In infancy & childhood WS 205 Emergency Mobile Units see Ambulances Emergency Nursing WY 154 Emergency Outpatient Unit see Emergency Service, Hospital Emergency Service, Hospital WX 215 Emergency Services, Psychiatric WM 401 Emergency Surgery see Surgery Emergicenters see Emergency Medical Services Emerogenes see Genes, Suppressor, Tumor Emetics QV 73 Emetine QV 255 Emigration and Immigration JV 6008-6348 Emigration JV 6061-6149 General works JV 6008-6049 Immigration JV 6201-6348 Of health manpower W 76 See also Transients and Migrants WA 300, etc. Emmenagogues see Menstruation-Inducing Agents Emollients QV 63 Emotional Bonds see Object Attachment Emotional Disturbances see Affective Symptoms Emotional Maladjustment see Affective Symptoms Emotional Stress see Stress, Psychological Emotions BF 531-593 Disorders see Affective Symptoms WS 350.6, etc. In adolescence WS 462 In infancy & childhood WS 105.5.E5 Physiology WL 103 Empathy BF 575.E55 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Emphysema QZ 140 Mediastinal see Mediastinal Emphysema WF 900 Pulmonary see Pulmonary Emphysema WF 648 Emphysema, Mediastinal see Mediastinal Emphysema Emphysema, Pulmonary see Pulmonary Emphysema Employee Assistance Programs (Health Care) see Occupational Health Services Employee Discipline Hospital WX 159 Nursing WY 30 Psychiatry WM 30 In other areas, by subject Employee Grievances Hospital WX 159 Nursing WY 30 Psychiatry WM 30 In other areas, by subject Employee Health see Occupational Health Employee Health Benefit Plans see Health Benefit Plans, Employee Employee Health Services see Occupational Health Services Employee Orientation Programs see Inservice Training Employee Performance Appraisal Hospital Personnel WX 159 Nursing WY 30 Psychiatry WM 30 Employee Strikes see Strikes, Employee Employee Turnover see Personnel Turnover Employment Children HD 6228-6250.5 Employment agencies HD 5860-6000.7 Health problems see Occupational Medicine WA 400-495 Labor market HD 5701-5856 Migrants see Transients and Migrants WA 300, etc. Nurses WY 29 Women HD 6050-6223 See also Physicians, Women W 21, etc. Other special topics, by subject See also Rehabilitation, Vocational HD 7255-7256; Unemployment HD 5707.5-5851; Vocational Guidance HF 5381, etc. Employment Application see Job Application c,I;Wrt^CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 334 Endophthalmitis Employment Termination see Employment Emporiatrics see Travel Empyema WF 745 Empyema, Gallbladder see Cholecystitis Empyema, Tuberculous WF 745 EMS Communication Systems see Emergency Medical Service Communication Systems Emulsifying Agents see Excipients Emulsions QV 785 EN-1639A see Naltrexone Enalapril QV 150 Enalapril Maleate see Enalapril Enallynymalum see Methohexital Enamel see Dental Enamel Encephalitis WL 351 Equine see Encephalomyelitis, Equine SF 959.E5, etc. Meningeal see Meningoencephalitis WL 351, etc. Encephalitis, Central European see Encephalitis, Tick-Borne Encephalitis, Epidemic WC 542 Encephalitis, Equine see Encephalomyelitis, Equine Encephalitis, Japanese WC 542 Veterinary SF 809.E62 Encephalitis, Japanese B see Encephalitis, Japanese Encephalitis, Post-Vaccinal see Encephalomyelitis, Acute Disseminated Encephalitis, St. Louis WC 542 Encephalitis, Tick-Borne WC 542 Veterinary SF 809.E62 Encephalitis Virus, California see California Group Viruses Encephalitis Virus, Central European see Encephalitis Viruses, Tick-Borne Encephalitis Virus, St. Louis QW 168.5A7 As arthropod-borne virus QW 168.5.A7 Encephalitis Virus, Venezuelan Equine QW 168.5.A7 Encephalitis Viruses QW 168.5.A7 Encephalitis Viruses, Tick-Borne QW 168.5.A7 Encephalocele Congenital WL 350 Traumatic WL 354 Encephalography see Cerebral Angiography; Electroencephalography; Radiography WL 141 under Brain; Cerebral Ventriculography Encephalomalacia WL 348 Associated with cerebral infarction WL 355 Encephalomyelitis WL 351 Equine see Encephalomyelitis, Equine SF 959.E5 As a communicable disease SF 809.E7 Encephalomyelitis, Acute Disseminated WL 351 Encephalomyelitis, Allergic WL 351 Encephalomyelitis, Equine SF 959.E5 In humans WC 542 Encephalomyelitis, Experimental Allergic see Encephalomyelitis, Allergic Encephalomyelitis, Myalgic see Fatigue Syndrome, Chronic Encephalomyelitis Virus, Venezuelan Equine see Encephalitis Virus, Venezuelan Equine Enchondroma see Chondroma Enclomifene see Clomiphene Encopresis WI 600 Toilet training WS 113 See also Defecation WI 600; Fecal Incontinence WI 600 Encounter Groups In psychotherapy WM 430.5. S3 In sociology HM 134 Encyclopedias AE (Form number 13 in any NLM schedule where applicable) Science Q 121 On other topics, by subject End-Stage Renal Disease see Kidney Failure, Chronic Endamoeba see Entamoeba Endarterectomy WG 170 Endarteritis WG 515 Endbrain see Telencephalon Endemic Typhus see Typhus, Endemic Flea-Borne Endocardial Cushion Defects WG 220 Endocarditis WG 285 Endocarditis, Bacterial WG 285 Endocarditis Lenta see Endocarditis, Subacute Bacterial Endocarditis, Subacute Bacterial WG 285 Endocardium WG 285 Endocavitary Fulguration see Electrocoagulation Endocrine Diseases WK General works WK 140 In infancy & childhood WS 330 Nursing WY 155 Endocrine Drugs see Hormones; Hormones, Synthetic; Hypoglycemic Agents Endocrine Glands WK Of children WS 330 Of domestic animals SF 768.3 Of wild animals QP 187 See also Corpus Luteum WP 530, etc.; Ovary WP 520-530, etc.; Testis WJ 875, etc.; names of other specific glands Endocrinologists, Directories see Directories WK 22 under Endocrinology Endocrinology WK Directories WK 22 In infancy & childhood WS 330 Endocrinology and Metabolism (Specialty) see Endocrinology Endoderm WQ 205 Endodermal Sinus Tumor In the ovary WP 322 Endodontics WU 230 Endolymph WV 250 Endolymphatic Duct WV 255 Endolymphatic Sac WV 255 Endometrial Cycle see Menstrual Cycle Endometriosis WP 390 Endometritis WP 451 Endometrium WP 400 Endomycetales QW 180.5.A8 Endomycopsis see Endomycetales Endophthalmitis WW 212 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 335 Endoplasmic Reticulum Endoplasmic Reticulum QH 603.E6 ENDOR see Electron Spin Resonance Spectroscopy Endorphins QU 68 Neurochemistry WL 104 Other special topics, by subject Endoscopic Retrograde Cholangiopancreatography see Cholangiopancreatography, Endoscopic Retrograde Endoscopy WB 141 Used for diagnosis of particular disorders, with the disorder or system See also specific types of endoscopy Endoscopy, Digestive System WI 141 Endoscopy, Gastrointestinal WI 141 Endoscopy, Uterine see Hysteroscopy Endosomes QH 591 Endothelin-1 see Endothelins Endothelin-2 see Endothelins Endothelin-3 see Endothelins Endothelins As vasoconstrictors QV 150 Biochemistry QU 68 Endothelium Histology QS 532.5.E7 See also organ-specific terms, e.g., Endothelium, Corneal WW 220 Endothelium, Anterior Chamber see Endothelium, Corneal Endothelium, Corneal WW 220 Anterior chamber epithelium WW 210 Eyebank procedures WW 170 Endothelium-Derived Relaxing Factor QV 150 Endothelium-Derived Vasoconstrictor Factors see Endothelins Endothelium, Vascular WG 500-700 Histology QS 532.5.E7 Endotoxins QW 630.5.E5 Endotracheal Anesthesia see Anesthesia, Intratracheal Endowments see Financial Management Enema WB 344 Energy Expenditure see Energy Metabolism Energy-Generating Resources Special topics, by subject, e.g. Environmental Health WA 30 Energy Metabolism QU 125 Energy Resources Conservation see Conservation of Energy Resources Energy Transfer QU 34 Enflurane QV 81 Engineering TA Biomedical see Biomedical Engineering QT 36 General works TA 144-145 Hospital maintenance WX 165 Sanitary see Sanitary Engineering WA 671, etc. Engineering, Hospital see Maintenance and Engineering, Hospital Engineering Psychology see Human Engineering English Literature see Literature P, etc. and related headings Enhancer Elements (Genetics) QH 450.2 Enkephalins QU 68 Neurochemistry WL 104 ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPHA Other special topics, by subject Enoxacin QV 250 As an urinary anti-infective agent QV 243 Enoxaparin QV 193 Enoxolone see Glycyrrhetinic Acid Enriched Food see Food, Fortified Entamoeba QX 55 Entamoebiasis WC 285 Entamoebiasis, Hepatic see Liver Abscess, Amebic Entamoebiasis, Intestinal see Dysentery, Amebic Enteral Feeding see Enteral Nutrition Enteral Nutrition WB 410 Enteric Fever see Typhoid Enteric Hormones see Gastrointestinal Hormones Enteric Infections see Enterobacteriaceae Infections; Enterovirus Infections; Intestinal Diseases, Parasitic; names of specific infections Enterically-Transmitted Non-A, Non-B Hepatitis see Hepatitis E Enteritis WI 420 Enteritis, Granulomatous see Crohn Disease Enteritis, Regional see Crohn Disease Enterobacter QW 138.5.E5 Enterobacteriaceae QW 138 Enterobacteriaceae Infections WC 260-290 Veterinary SF 809. E63 Enterobiasis see Oxyuriasis Enterocele see Hernia Enterochromaffin Cells WI 400 Physiology WI 402 Enteroclysis see Enema Enterocolitis WI 420 Enterocolitis, Pseudomembranous WI 420 Enteropathy, Exudative see Protein-Losing Enteropathies Enterostomy WI 480 Enterotoxins QW 630.5.E6 Enterovirus QW 168.5.P4 Enterovirus Infections WC 500 Veterinary SF 809.E64 See also names of specific infections, e.g., Poliomyelitis WC 555-556 Enterovirus 70 see Enterovirus Entomology QL 461-599.82 Medical QX 500-650 See also Insects QX 500-650, etc. Entrapment Neuropathy see Nerve Compression Syndromes Entropion WW 205 Enuresis WJ 146 In infancy & childhood WS 322 Environment Living space QT 230 Physical Adaptation to QT 140-165 As a cause of disease (Pathology) QZ 57 See also Climate WB 750, etc. and related headings Relation to general public health see Environmental Health WA 30, etc. Relation to mental health see Environmental Health WM 31, etc. Social see Social Environment HM 206 USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSinED 336 Epilepsy, Partial See also Ecology QH 540-549.5 Environment, Controlled WA 670-847 General works WA 671 In hospitals General WX 165 Intensive care WX 218 In industry WA 440-491 Of laboratory animals QY 56 See also Extraterrestrial Environment WD 758; Germ-Free Life QY 56, etc.; Incubators QS 530, etc.; Ecological Systems, Closed WD 756, etc.; names of specific types of control, e.g., Ventilation WA 770, etc. Environment Design TA 170 Government policy General HC 79.E5 By country HC 94-1085 See also Oty Planning HT 165.5-169.9, etc.; Environment, Controlled WA 670-847, etc. Environmental Air Pollutants see Air Pollutants, Environmental Environmental Exposure QT 140-162 In workplace WA 400-495 To air pollution (General) WA 754 To radiation WN 415-650 To other specific conditions, by subject Environmental Factors see Environmental Exposure; Meteorological Factors; Socioeconomic Factors; names of physical agents, e.g., Heat Environmental Health WA 30 Diseases of geographic areas WB 710 Psychiatric aspects WM 31 See also Environment, Controlled WA 671, etc. Environmental Microbiology QW 55 Environmental Monitoring QH 541.15.M64 In occupational health WA 400-495 Of environmental pollutants WA 671 Of air pollutants WA 754 Of water pollutants WA 689 Of radioactive pollutants WN 615 Of other specific conditions, by subject Environmental Pollutants WA 671 Environmental Pollution WA 670 See also specific types of pollution; e.g., Water Pollution WA 689 Environmental Pollution, Tobacco Smoke see Tobacco Smoke Pollution Enzymatic Zonulolysis WW 260 Enzyme Activation QU 135 Enzyme Immunoassay see Immunoenzyme Techniques Enzyme Induction QU 135 Enzyme Inhibitors QU 143 Enzyme-Labeled Antibody Technique see Immunoenzyme Techniques Enzyme-Linked Immunosorbent Assay QW 525.5.E6 Used for diagnostic, monitoring, or evaluation tests in special fields, with the field Enzyme Precursors QU 142 Enzyme Reactivators QU 144 Enzyme Repression QU 135 Enzyme Tests QY 490 Enzymes QU 135-141 Blood chemistry QY 490 Enzymes, Immobilized QU 135-141 Enzymologic Gene Expression Regulation see Gene Expression Regulation, Enzymologic Enzymology see Enzymes EOG see Electrooculography Eosinophilia WH 200 Eosinophilic Granuloma WH 650 Localized, by site Eosinophils WH 200 Ependyma WL 307 EPH Gestosis see Gestosis, EPH Ephedrine QV 129 Ephemeral Fever SF 967.T47 Epidemic Non-A, Non-B Hepatitis see Hepatitis E Epidemics see Disease Outbreaks Epidemiologic Determinants see Epidemiologic Factors Epidemiologic Factors In a particular subject, with the subject Epidemiologic Methods WA 950 Epidemiological Monitoring see Environmental Monitoring Epidemiology WA 105-106 Statistics WA 900 See also Epidemiologic Methods WA 950 Of particular disorders with the disorder (Form number 16 in any NLM schedule where applicable) Epidermal Cyst WR 420 Epidermal Growth Factor see Epidermal Growth Factor-Urogastrone Epidermal Growth Factor Receptors see Receptors, Epidermal Growth Factor-Urogastrone Epidermal Growth Factor-Urogastrone WK 170 As a growth substance QU 107 As an antacid QV 69 Epidermal Necrolysis, Toxic WR 165 Epidermis WR 101 Epidermoid Cyst see Epidermal Cyst Epidermolysis Bullosa WR 200 Epidermophytosis see Tinea Epidermotoxins see Dermotoxins Epididymis WJ 800 Epidural Analgesia see Analgesia, Epidural Epidural Anesthesia see Anesthesia, Epidural Epidural Space WE 725 Epiglottis WV 500 Epilation see Hair Removal Epilepsy WL 385 Experimental see Convulsions WL 385, etc. Epilepsy, Abdominal see Epilepsy, Temporal Lobe Epilepsy, Absence WL 385 Epilepsy, Cryptogenic see Epilepsy Epilepsy, Focal see Epilepsy, Partial Epilepsy, Generalized Secondary see Epilepsy, Partial Epilepsy, Grand Mai see Epilepsy, Tonic-Clonic Epilepsy, Localization-Related see Epilepsy, Partial Epilepsy, Myoclonic WL 385 Epilepsy, Myoclonus see Epilepsy, Myoclonic Epilepsy, Partial WL 385 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFD2D 337 Epilepsy, Petit Mai Epilepsy, Petit Mai see Epilepsy, Absence Epilepsy, Post-Traumatic WL 385 Epilepsy, Simple Partial see Epilepsy, Partial Epilepsy, Temporal Lobe WL 385 Epilepsy, Tonic-Clonic WL 385 Epilepsy, Traumatic see Epilepsy, Post-Traumatic Epilepsy, Uncinate see Epilepsy, Temporal Lobe Epinephrine WK 725 Epiphyseal Cartilage see Growth Plate Epiphyseal Plate see Growth Plate Epiphyses WE 200 Epiphyses, Slipped WE 175 Epiphyses, Stippled see Chondrodysplasia Punctata Epiphysiolysis see Epiphyses, Slipped Epiphysis Cerebri see Pineal Body Episiotomy WQ 415 Episomes see Plasmids Epispadias WJ 600 Epistaxis WV 320 Epistropheus see Axis Epithalamus see Diencephalon Epithelial Attachment WU 240 Epithelioma see Carcinoma Epithelium Dermatology WR 101 Histology QS 532.5.E7 Neoplasms QZ 365 Epithelium, Anterior Chamber see Endothelium, Corneal Epithelium, Retinal Pigment see Pigment Epithelium of Eye Epitopes see Antigenic Determinants Eponyms Disease (General) WB 15 In specialties (Form number 15 in NLM schedule or in appropriate LC number) Epoprostenol QV 180 Biochemistry QU 90 Epoxides see Epoxy Compounds Epoxy Compounds Organic chemistry QD 305. E7 Epoxy Resins Chemical technology TP 1180.E6 Dentistry WU 190 Used for special purposes, by subject Epoxytrichothecenes see Trichothecenes Epsom Salts see Magnesium Sulphate Epstein-Barr Virus see Herpesvirus 4, Human Epstein-Barr Virus Syndrome, Chronic see Fatigue Syndrome, Chronic Epulis, Giant Cell see Granuloma, Giant Cell Equilibrium WV 255 See also Acid-Base Equilibrium QU 105; Water-Electrolyte Balance QU 105 Equine Infectious Anemia SF 959.A6 Equipment Alarm Systems see Equipment Failure Equipment and Supplies Anesthetic WO 240 Catalogs (medical and surgical) W 26 Dental see Dental Equipment WU 26; Dental High Speed Equipment WU 26; Dental Instruments WU 26 Disposable see Disposable Equipment W 26 ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPH* Immunology QW 526 Orthopedic see Orthopedic Equipment WE 26 Pharmaceutical QV 26; QV 785-835 Military UH 420-425 Radiological WN 150 Surgical see Surgical Equipment WO 162, etc. (Form number 26 in any NLM schedule where applicable) See also particular types of equipment or supplies Equipment and Supplies, Hospital WX 147 See also particular items, e.g., Beds WX 147, etc. Equipment Contamination Of particular equipment, with the equipment See also Equipment and Supplies Equipment Design Of a specific equipment, with the equipment Equipment Failure of a specific equipment, with the equipment Equipment Safety Of a specific equipment, with the equipment Equivalency, Therapeutic see Therapeutic Equivalency ERCP see Cholangiopancreatography, Endoscopic Retrograde Eremothecium see Endomycetales Ergastoplasm see Endoplasmic Reticulum Ergobasin see Ergonovine Ergocalciferols QU 173 Ergolines Pharmacology QV 174 Ergometrin see Ergonovine Ergometrine see Ergonovine Ergonomics see Human Engineering Ergonovine QV 173 Ergot Alkaloids QV 174 Ergot Poisoning see Ergotism Ergotamine QV 174 Ergotamine Derivatives QV 174 Ergotamine Tartrate see Ergotamine Ergotism WD 505 Ergotoxine QV 174 Erosion, Cervix see Cervix Erosion Erotica HQ 450-472 Erucic Acids QU 90 Eructation WI 143 Eruption, Skin see Exanthema; Exanthema Subitum Erysipelas WC 234 Erysipeloid WC 234 Erysipelothrix Infections Swine SF 977.E7 Erythema WR 150 Migrans see Glossitis, Benign Migratory WI 210 Erythema Multiforme WR 150 Erythema Nodosum WR 150 Erythermalgia see Erythromelalgia Erythremia see Polycythemia Vera Erythrina QV 140 Erythroblastic Anemia see Thalassemia Erythroblastosis, Fetal WH 425 Erythroblasts WH 150 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 338 Ethers, Cyclic Erythrocebus patas QL 737.P93 Diseases SF 997.5.P7 As laboratory animals QY 60.P7 Erythrocyte Aggregation, Intravascular WH 150 Erythrocyte Aging WH 150 Erythrocyte Anion Transport Protein see Band 3 Protein Erythrocyte Aplasia see Red-Cell Aplasia, Pure Erythrocyte Burst-Promoting Factor see Interleukin-3 Erythrocyte Count QY 402 Erythrocyte Ghost see Erythrocyte Membrane Erythrocyte Membrane WH 150 Erythrocyte Membrane Band 3 Protein see Band 3 Protein Erythrocyte Number see Erythrocyte Count Erythrocyte Sedimentation see Blood Sedimentation Erythrocyte Sialoglycoprotein see Glycophorin Erythrocyte Substitutes see Blood Substitutes Erythrocyte Survival see Erythrocyte Aging Erythrocyte Transfusion WB 356 Erythrocyte Volume WG 106 Erythrocyte Volume, Packed see Hematocrit Erythrocytes WH 150-180 Clinical examination QY 402 Erythrocytes, Abnormal WH 150 Erythrocythemia see Polycythemia; Polycythemia Vera Erythrocytosis see Polycythemia Erythroderma see Dermatitis, Exfoliative Erythroderma, Maculopapular see Parapsoriasis Erythromelalgia WG 578 Erythromycin QV 350.5.E7 Erythropoiesis WH 150 Erythropoietin WH 150 Special topics, by subject Erythroxylon see Coca Escape Reaction BF 319.5.A9 Escharotics see Caustics Escherichia coli QW 138.5.E8 Escherichia coli Infections WC 290 Veterinary SF 809.E82 In swine SF 977.E83 Escherichia coli Phages see Coliphages Eserine see Physostigmine Eskimos E99.E7 See also special topics under Ethnic Groups Esophageal Achalasia WI 250 Esophageal and Gastric Varices WI 720 Esophageal Atresia WI 250 Esophageal Diseases WI 250 Esophageal Diverticulum WI 250 Esophageal Dysmotility see Esophageal Motility Disorders Esophageal Fistula WI 250 Esophageal Motility Disorders WI 250 Esophageal Neoplasms WI 250 Esophageal Reflux see Gastroesophageal Reflux Esophageal Stenosis WI 250 Esophageal Stricture see Esophageal Stenosis Esophageal Varices see Esophageal and Gastric Varices Esophagitis WI 250 Esophagogastroduodenoscopy see Endoscopy, Digestive System Esophagoplasty WI 250 Esophagotracheal Fistula see Tracheoesophageal Fistula Esophagus WI 250 Esophagus, Barrett see Barrett Esophagus Esotropia WW 415 Esox see Salmonidae ESRD see Kidney Failure, Chronic Essays see Form number 9 in any NLM schedule where applicable Essences see Solutions Essential Amino Acids see Amino Acids, Essential Essential Oils see Oils, Volatile Essential Polyarteritis see Polyarteritis Nodosa Esterases QU 136 Esthetic Surgery see Surgery, Plastic Esthetics BH Plastic surgery WO 600 Transplantation WO 660 Women HQ 1219-1220 Esthetics, Dental WU 100 Special methods, by subject, e.g. Orthodontics WU 400-440 Estradiol WP 522 Estradiol-17 beta see Estradiol Estramustine QV 269 Estramustinphosphate see Estramustine Estriol WP 522 Estrogen Analogs see Estrogens, Synthetic Estrogen Antagonists WP 522 Estrogen Receptors see Receptors, Estrogen Estrogen Replacement Therapy WP 522 Estrogenic Substances, Conjugated see Estrogens, Conjugated Estrogens WP 522 Estrogens, Catechol WP 522 Estrogens, Conjugated WP 522 Estrogens, Synthetic WP 522 Used for special purposes, by subject Estrone WP 522 Estrous Cycle see Estrus Estrus SF 105 ESWL (Extracorporeal Shockwave Lithotripsy) see Lithotripsy Etching, Dental see Acid Etching, Dental Ethambutol QV 268 Ethanol see Alcohol, Ethyl Ethanolamine Phosphoglycerides see Phosphatidylethanolamines Ethanolamines QV 84 Organic chemistry QD 305.A4 Ether, Ethyl QV 81 Ethers As anesthetics QV 81 Organic chemistry Aliphatic compounds QD 305.E7 Aromatic compounds QD 341.E7 Spectra QC 463.E7 Used for special purposes, by subject Ethers, Cyclic Organic chemistry QD 305.E7 Used for special purposes, by subject ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 339 Ethics Ethics BJ General works BJ 991-1185 Special applications, by subject Ethics, Dental WU 50 Ethics in Publishing see Scientific Misconduct Ethics, Institutional Special topics, by subject, e.g., in hospitals WX 150 Ethics, Medical W 50 In psychiatry WM 62 Ethics, Nursing WY 85 Ethics, Pharmacy QV 21 Ethics, Professional BJ 1725 Of special groups, by name of group Ethinyl Estradiol WP 522 As a contraceptive QV 177 Ethinyl Estradiol 3-Methyl Ether see Mestranol Ethinyl Trichloride see Trichloroethylene Ethinylestrenol see Lynestrenol Ethinylnortestosterone see Norethindrone Ethiofos see Amifostine Ethionamide QV 268 Ethioniamide see Ethionamide Ethmoid Bone WE 705 Ethmoid Sinus WV 355 Ethnic Groups Anthropology GN 301-673 Diseases WB 720 Education LC 3701-3747 General works DA 125, E 184-185, F 1035, etc. Health surveys WA 300 Medical biography WZ 150 Medical history WZ 80 Mental ability assessment BF 432 Nutrition surveys QU 146 Psychology GN 270-279 Public health (including mental health) WA 300-305 Other special topics, by subject See also names of specific groups Ethnography see Anthropology, Cultural Ethnology GN 307-673 See also Anthropology, Cultural GN 307-673 Ethnomedicine see Medicine, Traditional Ethnopsychology GN 270-279 Ethoform see Benzocaine Ethology QL 750-785.3 Veterinary sciences SF 756.7 Ethoxy Compounds see Ethyl Ethers Ethyl Alcohol see Alcohol, Ethyl Ethyl Aminobenzoate see Benzocaine Ethyl Carbamate see Urethane Ethyl Chloride QV 81 Ethyl Ether see Ether, Ethyl Ethyl Ethers QV 81 Organic chemistry QD 305.E7 Ethyl Methanesulfonate As an antineoplastic agent QV 269 Ethylamines QU 61 Organic chemistry QD 305.A8 Ethylbarbital see Barbital Ethyldithiourame see Disulfiram ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPH^ Ethylene Chlorohydrin QV 82 Ethylene Dibromide QV 633 Public health aspects WA 240 Ethylene Dichlorides Toxicology QV 633 Ethylene Oxide As a fungicide SB 951.3 Organic chemistry QD 305.E7 Ethylene Polymers see Polyethylenes Ethylenediaminetetraacetic Acid see Edetic Acid Ethyleneimines see Aziridines Ethylenes QV 81 Organic chemistry QD 305.H7 Ethylenethiourea As a carcinogen QZ 202 Biochemistry QU 65 Ethylestrenolone see Norethandrolone Ethylnortestosterone see Norethandrolone Ethynyl Estradiol see Ethinyl Estradiol Etiology see Pathogenesis QZ 40-109 under Disease; names of particular diseases Etoposide QV 269 Etretinate QU 167 Used in treating a particular skin disease, with the disease Etryptamine see Indoles Etymology see Dictionaries; Nomenclature Eubacterium QW 120 Eugenics HQ 750-755.5 Euglena QX 50 Euglobulins see Serum Globulins Eukaryotic Cells QH 581-581.2 Eunuchism WJ 840 Euoticus see Galago Euphausia see Crustacea Euphoria BF 575.E5 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Europium Inorganic chemistry QD 181.E8 Pharmacology QV 290 Eustachian Tube WV 230 Eutamias see Sciuridae Eutelegenesis see Insemination, Artificial Euthanasia W 50 Euthanasia, Passive W 50 Evaluation, Program see Program Evaluation Evaluation Research, Nursing see Nursing Evaluation Research Evaluation Studies Health services W 84 Other special topics, by subject being evaluated Evaluation Studies, Drug see Drug Evaluation Evaluation Studies, Drug, Pre-Clinical sfee Drug Screening Evaluation Studies, Postmarketing see Product Surveillance, Postmarketing Evidential Material see Forensic Medicine Evoked Potentials WL 102 Evoked Potentials, Auditory WV 270 Evoked Potentials, Auditory, Brain Stem WV 270 Evoked Potentials, Somatosensory WL 102 Evoked Potentials, Visual WW 103 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 340 Extended Care Facilities Evoked Response Audiometry see Audiometry, Evoked Response Evoked Responses, Auditory, Brain Stem see Evoked Potentials, Auditory, Brain Stem Evolution QH 359-425 Darwin s works QH 365 General works QH 366-366.2 Periodicals, numbered congresses, serial collections, yearbooks, in appropriate NLM numbers Single organs with the organ See also Ontogeny QH 359-425, etc.; Phylogeny QH 367.5 Ewings Tumor see Sarcoma, Ewings Examination see Diagnosis; names of specific types of examination, e.g., Neurologic Examination Examination questions (Form number 18.2 in any NLM schedule where applicable) Exanthema WR 220 Veterinary SF 901 Exanthema Subitum WC 570 Exchange Transfusion, Whole Blood WB 356 RH factor WH 425 Excipients QV 800 Excitotoxins see Neurotoxins Excretion of Drugs see Metabolism QV 38 under Drugs Exercise Movement WE 103 Physical education QT 255 Sports QT 260 Exercise, Aerobic see Exercise Exercise-Induced Asthma see Asthma, Exercise-Induced Exercise-Induced Bronchospasm see Asthma, Exercise-Induced Exercise, Isometric see Exercise Exercise, Physical see Exercise Exercise Test WG 141.5.F9 Exercise Therapy WB 541 In water see Hydrotherapy WB 520 Exertion Movement WE 103 Physical education QT 255 Sports QT 260 Exfoliative dermatitis see Dermatitis Exfoliativa Exhaustion see Fatigue; Heat exhaustion; Neurasthenia Exhibitionism WM 610 Exhibits T 391-999 (Form numbers 27-28 in any NLM schedule where applicable) Existential Psychology see Existentialism Existentialism Philosophy General B 105.E8 Modern B 819 Psychoanalysis WM 460.5.E8 Psychology BF 204.5 Exocrine Glands QT 172 Skin glands WR 101 Specific glands, with system where located, e.g. Sebaceous glands WR 410 Exodontia see Tooth Extraction Exodontics see Tooth Extraction Exomphalos see Hernia, Umbilical Exophthalmic Goiter see Graves' Disease Exophthalmos WW 210 See also Goiter, Exophthalmic WK 265 Exostoses WE 250 Localized, by site Exostoses, Familial see Exostoses, Multiple Hereditary Exostoses, Hereditary Multiple see Exostoses, Multiple Hereditary Exostoses, Multiple see Exostoses, Multiple Hereditary Exostoses, Multiple Cartilaginous see Exostoses, Multiple Hereditary Exostoses, Multiple Hereditary WE 250 Exotoxins QW 630 Expectation (Psychology) BF 323.E8 Expectorants QV 76 Expeditions Medical W 10 Scientific expeditions Q 115-116 Expenditures, Health see Health Expenditures Experimental Design see Research Design Experimental Psychology see Psychology, Experimental Experimental works in specialties other than psychology see Under the specialty Expert Systems QA 76.76.E95 In medicine (General) W 26.55.A7 In other special fields (Form number 26.5 in any NLM schedule where applicable) Expert Testimony Chemistry W 750 Dentistry W 705 Medicine W 725 Psychiatry W 740 Special topics, by subject Expiratory Forced Flow Rates see Forced Expiratory Flow Rates Expiratory Peak Flow Rate see Peak Expiratory Flow Rate Exploratory Behavior BF 323.C8 Children WS 105.5.M5 Exploratory Surgery see Diagnosis, Surgical Explosions Hospital emergency service WX 215 In industry WA 485 Mining WA 485 Nuclear explosions WN 610 Nursing in emergency situations WY 154 Prevention & control WA 288 In industry WA 485 Thermochemistry QD 516 Explosive Decompression see Atmospheric Pressure Exposure (Radiology) see Environmental Exposure; conditions under which exposure takes place, e.g., Radiotherapy Expression, Pharmacy see Drug Compounding Extended Care Facilities see Skilled Nursing Facilities ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 341 Kxternal Degree Programs, Nursing External Degree Programs, Nursing see Education, Nursing, Baccalaureate External Ear see Ear, External External Influences on Child see Child Development; Television; related topics Extinction (Psychology) BF 319.5.E9 Extracellular Fluid see Extracellular Space Extracellular Matrix QH 603.E93 Body fluids QU 105 Extracellular Matrix Proteins QU 55 Extracellular Space QU 105 Extrachromosomal Inheritance QW 51 Extracorporeal Circulation WG 168 Extracorporeal Dialysis see Hemodialysis Extracorporeal Shockwave Lithotripsy see Lithotripsy Extracranial-Intracranial Arterial Bypass see Cerebral Revascularization Extraction, Obstetrical WQ 415 Extraction of Teeth see Tooth Extraction Extracts see Dosage Forms; Liver Extracts; Pancreatic Extracts; Placental Extracts; Thymus Extracts; Tissue Extracts Extramarital Relations HQ 806 Extraordinary Treatment see Life Support Care Extrapyramidal Disorders see Basal Ganglia Diseases Extrapyramidal Tracts WL 400 Extrasensory Perception see Parapsychology Extrasystole WG 330 Extraterrestrial Environment WD 758 Extraversion (Psychology) Personality BF 698.35.E98 Psychoanalysis WM 460.5.E9 Extremities WE 800-890 Blood supply WG 500-700 Specific extremities, with the part, e.g. Blood supply to the leg WE 850 Lower extremities WE 850-890 Upper extremities WE 805-835 Extremities, Artificial see Artificial Limbs Extremity, Lower see Leg Extremity, Upper see Arm Exudates and Transudates QU 105 Clinical examination QY 210 Eye WW Blood supply WW 101-103 See also names of particular arteries and veins, e.g., Ophthalmic Artery WG 595.07 Conservation WW 113 Innervation WW 101-103 See also Optic Nerves WW 280, etc. Pathology due to diseases of central nervous system WW 460 Pathological eye conditions in other diseases WW 475 Posterior chamber WW 210 Surgery WW 168 Eye Abnormalities WW 101 Eye, Artificial WW 358 Eye Banks WW 23-24 Procedures WW 170 Eye Burns WW 100 Eye Color WW 101 Eye Conservation see Eye Eye Diseases WW Disability evaluation WW 32 General works WW 140 In infancy & childhood WW 600 In old age WW 620 Neurologic manifestation WW 460 Nursing WY 158 Surgery WW 168 Therapy WW 166 Veterinary SF 891 Eye Diseases, Hereditary WW 140 Eye Enucleation WW 168 Eye Foreign Bodies WW 525 Eye Hemorrhage WW 140 Eye Infections, Parasitic WW 160 Eye Injuries WW 525 Disability evaluation WW 32 Eye Injuries, Penetrating WW 525 Eye Manifestations WW 475 Ocular disorders due to neurological disorders WW 460 Of particular diseases, with the disease Eye Motility Disorders see Ocular Motility Disorders Eye Movements WW 400-460 General works WW 400 Eye Neoplasms WW 149 Of parts of the eye, with the part Eye Protective Devices WW 113 Eye Proteins WW 101 Eyeball see Eye Eyebrows WW 205 Eyedrops see Ophthalmic Solutions Eyeglasses WW 350-354 Eyelashes WW 205 Eyelid Diseases WW 205 Eyelids WW 205 F Factor QW 51 F-2 Toxin see Zearalenone Face WE 705-707 Facial Bones WE 705 Maxillofacial injuries WU 610 Physiological works for the dentist WU 102 Facial Dermatoses WR 140 Facial Expression BF 592.F33 In infancy & childhood WS 105.5.C8 Physical examination WB 275 Physiology WE 705 See also Nonverbal Communication HM 258, etc.; Physiognomy BF 840-861 Facial Injuries WE 706 Facial Muscles WE 705 Facial Neoplasms WE 707 Facial Nerve WL 330 Facial Nerve Diseases WL 330 Facial Neuralgia WL 544 Facial Pain WE 705 In dentistry WU 140 Facial Paralysis WL 330 SUMF^ p?p^L!^ SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 342 Farsightedness Facility Access see Architectural Accessibility Facility Construction see Facility Design and Construction Facility Design and Construction Health facilities WX 140 For the specialties (Form number 27-29 in any NLM schedule where applicable) Hospital departments WX 200-225 Public health aspects of houses and public buildings WA 795-799 See also Design and Construction, Hospital WX 140, etc. Facility Regulation and Control WX 153 See also names of particular types of facility, e.g., Rehabilitation Centers WM 29, etc. Facteur Thymique Serique see Thymic Factor, Circulating Factor Analysis, Statistical QA 278.5 In psychology BF 39.2.F32 Used in diagnosis, in the diagnosis number for the disease or specialty or lacking that in the general works number Used in other studies, by subject Factor Construct Rating Scales (FCRS) see Psychiatric Status Rating Scales Factor I see Fibrinogen Factor II see Prothrombin Factor III see Thromboplastin Factor IV see Calcium Factor, RH see RH-HR Blood Group System Factor VII WH 310 Clinical examination QY 410 Factor VIII-Related Antigen see von Willebrand Factor Factor XIII, Activated see Protein-Glutamine gamma-Glutamyltransferase Factor XIII Transamidase see Protein-Glutamine gamma-Glutamyltransferase Factor XHIa see Protein-Glutamine gamma-Glutamyltransferase Faculty (Form number 19 in any NLM schedule where applicable) Superintendents and principals LB 2831.7-2831.99 Teaching personnel LB 2832-2844.47 Faculty, Medical General W 19 Graduate W 20 Undergraduate W 19 Faculty, Nursing General WY 19 Graduate WY 18.5 Undergraduate WY 19 Faculty, Pharmacy see Faculty FAD QU 135 Fads, Food see Diet Fads Fagine see Choline Failure, Equipment see Equipment Failure Failure to Thrive WS 104 Fainting see Syncope Faith Cures see Mental Healing Faith Healing see Mental Healing Fallopian Tube Diseases WP 300 Fallopian Tube Neoplasms WP 300 Fallopian Tubes WP 300 Neoplasms WP 300 Pregnancy see Pregnancy, Tubal WQ 220 Sterilization see Sterilization, Tubal WP 660 Fallot's Tetralogy see Tetralogy of Fallot Falls, Accidental see Accidental Falls Familial Atypical Multiple Mole-Melanoma see Dysplastic Nevus Syndrome Familial Erythroblastic Anemia see Thalassemia Familial Jaundice see Spherocytosis, Hereditary Familial Mediterranean Fever see Periodic Disease Family HQ 503-1057 Adjustment to mentally retarded child WS 107.5.R5 Health WA 308 Relations WS 105.5.F2 See also Father-Child Relations WS 105.5.F2; Mother-Child Relations WS 105.5.F2; Parent-Child Relations WS 105.5.F2; Sibling Relations WS 105.5.F2 Family Caregivers see Caregivers Family Characteristics HQ 503-743 Family Health WA 308 Family Leave General works HD 6065-6065.5 Family Life Cycles see Family Family-Patient Lodging see Housing Family Physicians see Physicians, Family Family Planning HQ 763.5-767.7 Family Practice As a profession W 89 Texts and treatises WB 110 Family Relationship see Family Family, Single-Parent see Single Parent Family Size see Family Characteristics Family Therapy WM 430.5.F2 Famotidine As an anti-ulcer agent QV 69 Famous Persons Biography Collective In the field of medicine and related sciences WZ 112-150 In other fields, by subject in LC schedules Individual WZ 100 Illnesses WZ 313 Fanconi's Anemia WH 175 Fangotherapy see Mud Therapy Fantasy BF 408-411 In adolescence WS 462 In infancy & childhood WS 105.5.C7 Psychiatry WM 193.5.S8 Far Eastern Russian Encephalitis see Encephalitis, Tick-Borne Faradic Currents see Electric Conductivity; Electric Stimulation Therapy; Electricity Farcy see Glanders Farm Animals see Animals, Domestic Farmer's Lung WF 652 Veterinary SF 831 Farsightedness see Hyperopia ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 343 Fascia Fascia WE 500 Localized, by site Fascicular Block see Bundle-Branch Block Fasciola QX 365 Fascioliasis WC 805 Veterinary SF 810.F3 Fasciolopsiasis see Trematode Infections Fast Electrons see Electrons Fast Neutrons Nuclear physics QC 793.5.F32-793.5.F329 In health physics WN 110 Fasting WB 420 Fat Emulsions, Intravenous QU 86 In parenteral feeding WB 410 Father-Child Relations WS 105.5.F2 Fathers Popular works HQ 756-756.7 Special topics, by subject Fatigue Aviation WD 735 Occupational General WA 475 Mental WA 495 Physical WA 475 Nervous see Fatigue, Mental WM 174, etc. Physical (General) WB 146 Fatigue Fractures see Fractures, Stress Fatigue, Mental see Mental Fatigue Fatigue Syndrome, Chronic As a virus disease WC 500 Etiology unknown WB 146 Fatigue Syndrome, Postviral see Fatigue Syndrome, Chronic Fats QU 86 Public health aspects WA 722 See also Dietary Fats WB 425, etc. Fats, Unsaturated QU 86 Fatty Acids QU 90 Fatty Acids, Essential QU 90 Fatty Acids, Free see Fatty Acids, Nonesterified Fatty Acids, Monounsaturated QU 90 Fatty Acids, Nonesterified QU 90 Fatty Acids, Omega-3 QU 90 As a supplement in health or disease WB 425 Fatty Acids, Polyunsaturated see Fatty Acids, Unsaturated Fatty Acids, Unsaturated QU 90 Fatty Acids, Volatile QU 90 Fatty Liver WI 700 In chickens SF 995.6.F3 Fatty Liver, Alcoholic WI 700 Fatty Streak, Arterial see Atherosclerosis Fatty Tissue see Adipose Tissue Fatty Tumor see Lipoma Favism WD 515 Favus see Tinea Favosa Fc Receptors see Receptors, Fc Fear WM 178 In adolescence WS 462 In aviation & space flight WD 730; WD 754 In infancy & childhood WS 105.5.E5 See also Phobic Disorders WM 178 Febrifuges see Anti-Inflammatory Agents, Non-Steroidal Fecal Incontinence WI 600 See also Defecation WI 600; Encopresis WI 600 Feces QY 160 Analysis QY 160 Veterinary diagnosis SF 772.7 Feces, Impacted WI 460 Fecundity see Fertility Federal Health Insurance Plans, United States see National Health Insurance, United States Federal Regulations see Names of Legislation; in products or specialties being regulated, e.g., Drug and Narcotic Control Fee, Capitation see Capitation Fee Fee for Service, Medical see Fees, Medical Fee Schedules Dental WU 77 Hospital WX 157 Medical W 74 Nursing WY 77 Pharmaceutical QV 736 For other services, by subject Fee-Splitting Dental WU 58 Medical W 58 See also Fees, Dental WU 77; Fees, Medical W 80; Fees and Charges W 74, etc. Feeble-Mindedness see Mental Retardation Feedback Electronics TK 7871.58.F4 Mechanical engineering TJ 216 Psychophysiology WL 103 See also Biofeedback (Psychology) WL 103, etc. Feedback, Psychophysiologic see Biofeedback (Psychology) Feeding see Child Nutrition; Food Supply; Infant Nutrition Feeding Behavior Customs GT 2850-2960 Disorders (Neurosis) WM 175 Feeding Methods (Non Mesh) see Bottle Feeding; Breast Feeding; Parenteral Feeding; Tube Feeding Feeding Patterns see Feeding Behavior Feelings see Emotions Fees and Charges W 74 Fee-splitting Dental WU 58 Medical W 58 Hospitals WX 157 Nursing WY 77 See also Economics, Medical W 74,and economics in other specialties Fees, Dental WU 77 Fee-splitting WU 58 Fees, Medical W 80 Fee-splitting W 58 Fees, Pharmaceutical QV 736 Fees, Prescription see Prescription Fees Feigned Diseases see Malingering Feldshers see Physician Assistants Feline Fibrosarcoma Virus see Sarcoma Virus, JS d^S^L™™ SCHEDULES- USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 344 Fiberglass Casts Feline Feline Sarcoma Virus see Sarcoma Virus, Feline Fellowships and Scholarships Dental WU 20 Medical W 20 Nursing WY 18.5 Pharmacy QV 20 Female Genitalia see Genitalia, Female Femoral Artery WG 595.F3 Femoral Fractures WE 865 Femoral Head Prosthesis see Hip Prosthesis Femoral Hernia see Hernia, Femoral Femoral Neck Fractures WE 865 Femoral Nerve WL 400 Femoral Vein WG 625.F3 Femur WE 865 Femur Head WE 865 Femur Neck WE 865 Fenazoxine see Nefopam Fendiline QV 150 Fenestration WV 265 See also Otosclerosis WV 265 Fenfluramine QV 129 Fenformin see Phenformin Fenilbutazon see Phenylbutazone Fenitoin see Phenytoin Fenoterol Fentanyl QV 89 Fermentation QU 34 Industrial QW 75 Of beverages QW 85 Ferments see Enzymes Ferredoxins In bacteriological chemistry QW 52 In photosynthesis QK 882 Other special topics, by subject Ferrets QL 737.C25 As laboratory animals QY 60.M2 As pets SF 459.F47 Diseases SF 997.3 Ferrihemoglobin see Methemoglobin Ferriprotoporphyrin see Hemin Ferritin QV 183 Ferrocyanides Inorganic chemistry QD 181.F4 Pharmacology QV 183 Ferroprotoporphyrin see Heme Ferrous Compounds QV 183 Ferroxidase see Ceruloplasmin Fertility WP 565 Animals Domestic SF 871 Wild QP 273 Drugs affecting QV 170 Drug effects WP 565 Male WJ 702 Radiation effects WN 620 Fertility Agents QV 170 Fertility Factor see F Factor Fertilization WQ 205 Animals Domestic SF 871 Wild QP 273 Biology (General) QH 485 Plants QK 828. Fertilization, Delayed see Fertilization Fertilization in Vitro WQ 205 Fertilization, Polyspermic see Fertilization Fertilized Ovum see Zygote Fertilizers S 631-667 Festivals see Holidays Fetal Alcohol Syndrome WQ 211 Fetal Anoxia WQ 211 Fetal Circulation, Persistent see Persistent Fetal Circulation Syndrome Fetal Death WQ 225 Veterinary SF 887 Fetal Development WQ 210.5 Fetal Diseases WQ 211 Fetal Distress WQ 211 Fetal Growth Retardation WQ 211 Fetal Heart WQ 210.5 Fetal Heart Rate see Heart Rate, Fetal Fetal Hemoglobin WQ 210.5 Fetal Maturity, Chronologic see Gestational Age Fetal Maturity, Functional see Fetal Organ Maturity Fetal Membranes Embryology QS 645 Neoplasms QZ 310 Obstetrics WQ 210 See also Chorion WQ 210 etc. Fetal Monitoring WQ 209 Fetal Organ Maturity WQ 210.5 Fetal Presentation see Labor Presentation Fetal Presentation, Breech see Breech Presentation Fetal Transfusion see Blood Transfusion, Intrauterine Fetal Ultrasonography see Ultrasonography, Prenatal Fetal Viability WQ 210.5 Fetishism (Psychiatric) WM 610 Fetoplacental Function Tests see Placental Function Tests Fetoscopy WQ 209 Fetotoxins see Teratogens Fetuins see alpha Fetoproteins Fetus WQ 210-211 Disproportion WQ 310 Effect of labor on WS 405 Embryology QS 645 Experimentation W 20.5 Manipulation WQ 415 Monitoring WQ 209 Presentation see Labor Presentation WQ 307, etc. Version see Delivery WQ 415, etc. Fever WB 152 Drugs relieving see Analgesics, Anti-Inflammatory QV 95 Therapeutic use see Hyperthermia, Induced WB 469, etc. Fever Blister Virus see Simplexvirus Fever Therapy see Hyperthermia, Induced Fiber Optics QC 447.9-448.2 In endoscopy WB 141 See also use in specific types of endoscopy Fiberglass Casts see Casts, Surgical ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 345 Fibrillation Fibrillation see Atrial Fibrillation; Ventricular Fibrillation Fibrin WH 310 Clinical examination QY 410 Fibrinogen WH 310 Clinical examination QY 410 Fibrinogen Deficiency see Afibrinogenemia Fibrinokinase see Streptodomase and Streptokinase Fibrinoligase see Protein-Glutamine gamma-Glutamyltransferase Fibrinolysis WH 310 Fibrinolytic Agents QV 190 Fibrinolytic Therapy see Thrombolytic Therapy Fibroblast Growth Factor QU 107 Fibrocystic Disease of Breast WP 840 Fibrocystic Disease of Pancreas see Cystic Fibrosis Fibrocystic Mastopathy see Fibrocystic Disease of Breast Fibroid see Fibroma; Leiomyoma Fibroid Tumor see Leiomyoma Fibroids, Uterine see Uterine Neoplasms Fibroma QZ 340 Fibroma, Shope see Tumor Virus Infections Fibromatosis, Aggressive QZ 340 Localized, by site Fibromyalgia WE 544 Fibronectins QU 55 Fibrosarcoma Virus, Feline see Sarcoma Virus, Feline Fibrosis QZ 150 Localized, by site Fibrosis, Bone Marrow see Myelofibrosis Fibrosis, Liver see Liver Cirrhosis Fibrositis see Fibromyalgia Fibrous Dysplasia of Bone WE 250 Fibula WE 870 Fiedlers Disease see Weil's Disease Field-Block Anesthesia see Anesthesia, Conduction Field Dependence-Independence BF 323.F45 Figural Aftereffect WW 105 Filaria see Filarioidea Filarial Elephantiasis see Elephantiasis, Filarial Filariasis WC 880 Filariasis, Lymphatic see Elephantiasis, Filarial Filarioidea QX 301 Filarioidea Infections see Filariasis Fillings, Dental see Inlays; Dental Materials; specific types of material used Film, Radiographic see X-Ray Film Film-Screen Systems, X-Ray see X-Ray Intensifying Screens Film, X-Ray see X-Ray Film Films see Motion Pictures Filth, Epidemic Factor see Communicable Disease Control; Environmental Health Filtration QD 63.F5 Finances see Economics; headings beginning with Fee or Fees, etc. Financial Audit Dental administration WU 77 Hospital administration WX 157 Medical administration W 80 Nursing administration WY 77 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Pharmacy administration QV 736 In other specific fields, by subject Financial Management Dentistry WU 77 Medicine W 80 Nursing WY 77 Pharmacy QV 736 Financial Management, Hospital WX 157 Financing, Capital see Capital Financing Financing, Construction WX 157 Financing, Government HJ Education (Form number 18 in any NLM schedule where applicable) Health insurance W 275, etc. Hospitals WX 157 Public health organizations WA 540 Other special topics, by subject Financing, Organized Fund raising HG 177 Hospitals WX 157 Medical research (Form number 20 in any schedule where applicable) Voluntary health agencies (Form number 1 in any NLM schedule where applicable) See also Insurance, Health W 100-275, etc. and names of other types of insurance Financing, Personal HG 179-195 Medical costs W 74 Physicians' income W 79 See also Fees and charges W 74, etc.; Insurance, Health W 100-275; names of other types of insurance Financing, Public see Financing, Government Finger Injuries WE 835 Finger Joint WE 835 Fingernails see Nails Fingerprints see Dermatoglyphics Fingerprints, DNA see DNA Fingerprinting Fingers WE 835 Abnormalities WE 835 Fingersucking WS 350.6 Malocclusion etiology WU 440 Fire Retardants see Flame Retardants Fireflies see Beetles Fireproofing Agents see Flame Retardants Fires Accidents in firefighting WA 487.5.F4 Prevention WA 250 In hospitals WX 185 Firesetting Behavior WM 190 First Aid WA 292 Military UH 396 Naval VG 466 Veterinary SF 778 Fischer Rats see Rats, Inbred F344 Fish Diseases SH 171-179 Aquarium fish diseases SF 458.5 Fish Liver Oils see Fish Oils Fish Oils QU 86 As a source of vitamins A and D QU 165 Fish Poisoning see Fishes, Poisonous Fish Products As a dietary supplement in health or disease USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 346 Fluorescent Antinuclear Antibody Test WB 426 Preservation WA 710 Sanitation WA 703 Supply WA 703 Fish Skin Disease see Ichthyosis Fish Venoms WD 405 Fisheries SH 201-399 Public health aspects WA 703 Fishes QL 614-639.8 Aquaculture SH As a dietary supplement see Fish Products WB 426, etc. As laboratory animals QY 60.F4 Fishes, Poisonous WD 405 Fission Yeast see Schizosaccharomyces Fissure in Ano WI 605 Fissure Sealants see Pit and Fissure Sealants Fistula Anal see Rectal Fistula WI 605 Arteriovenous see Arteriovenous Fistula WG 590 Biliary see Biliary Fistula WI 750 Bladder see Bladder Fistula WJ 500 Bronchial see Bronchial Fistula WF 500 Esophagotracheal see Tracheoesophageal Fistula WI 250 Esophagus see Esophageal Fistula WI 250 Gastric see Gastric Fistula WI 300 Genital see Rectovaginal Fistula WP 180; Vaginal Fistula WP 250; Vesicovaginal Fistula WP 180 Intestinal see Intestinal Fistula WI 400 Pancreatic see Pancreatic Fistula WI 800 Rectal see Rectal Fistula WI 605 Salivary see Salivary Gland Fistula WI 230 Tracheoesophageal see Tracheoesophageal Fistula WI 250 Urinary see Urinary Fistula WJ 140 Fixation, Ocular WW 400 Fixed Action Pattern see Instinct Fixed Bridge see Denture, Partial, Fixed Fixed Partial Denture see Denture, Partial, Fixed Flagella QW 51 Flagellata see Mastigophora Flame Retardants General WA 250 In hospitals WX 185 Flaps see Surgical Flaps Flatfoot WE 886 Flatulence WI 150 Flatus see Flatulence Flatworms see Platyhelminths Flavin-Adenine Dinucleotide see FAD Flavin Mononucleotide see FMN Flavins QU 110 Flavivirus QW 168.5.A7 Flavoring Agents WA 712 For drugs QV 810 See also Food Additives WA 712 Fleas QX 550 Fletcher Factor see Prekallikrein Flicker Fusion WW 105 Flies see Diptera Flies, True see Diptera Flight, Animal Birds QL 698.7 General QP 310.F5 Flight Reaction see Escape Reaction Flocculation Tests QY 265 Flood Fever see Scrub Typhus Flooding see Implosive Therapy Floods see Natural Disasters Floor of Mouth see Mouth Floor Floppy Mitral Valve see Mitral Valve Prolapse Florafur see Tegafur Flour As a dietary supplement in health or disease WB 431 Sanitary control WA 695-701 Flow Cytometry QH 585.5.F56 Clinical pathology QY 95 Flow Microfluorimetry see Flow Cytometry Flow, Pulsating see Pulsatile Flow Flowmeters Measuring blood flow velocity WG 106 Measuring fluids TJ 935 Measuring gases TJ 1025 Measuring water TC 177 Flowmetry see Rheology Floxuridine QV 268.5 Flubenisolone see Betamethasone Flufenazin see Fluphenazine Fluid Balance see Water-Electrolyte Balance Fluid Therapy WD 220 Flukes see Trematoda Flumazenil QV 77.9 Flumazepil see Flumazenil Flunarizine QV 150 Fluocortolone As dermatologic agent QV 60 Fluocortolone Caproate see Fluocortolone Fluocortolone Pivalate see Fluocortolone Fluoren-2-ylacetamide see 2-Acetylaminofluorene Fluorenes QZ 202 Fluorescein Angiography WG 500 Ocular diagnosis WW 141 Fluoresceins QV 240 Fluorescence Physics QC 477-477.4 Qualitative and quantitative analysis (Fluorimetry) QD 79.F4 Quantitative analysis QD 117.F5 Special topics, by subject, e.g., in urinalysis QY 185 Fluorescence-Activated Cell Sorting see Flow Cytometry Fluorescence Angiography see Fluorescein Angiography Fluorescence Microscopy see Microscopy, Fluorescence Fluorescent Antibody Technique QW 525.5.F6 In clinical pathology QY 250 Used for special purposes, by subject Fluorescent Antinuclear Antibodies see Antibodies, Antinuclear Fluorescent Antinuclear Antibody Test see ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 347 Fluorescent Antinuclear Antibody Test Fluorescent Antibody Technique Fluorescent Dyes QV 240 Fluorescent Probes see Fluorescent Dyes Fluorescent Protein Tracing see Fluorescent Antibody Technique Fluoridation WU 270 Fluoride Poisoning QV 282 Dentistry WU 270 Veterinary SF 757.5 Fluoride Varnishes see Fluorides, Topical Fluorides QV 282 Fluorides, Topical QV 282 Dental pharmacology QV 50 Fluorimetry see Fluorometry Fluorinated Hydrocarbons see Hydrocarbons, Fluorinated Fluorine QV 282 Metabolism QU 130.5 Toxicity in animals SF 757.5 Fluormethyldehydrocorticosterone see Fluocortolone Fluorochromes see Fluorescent Dyes Fluorodeoxyuridine see Floxuridine Fluorofur see Tegafur Fluoroimmunoassay QW 525.5.F6 In clinical pathology QY 250 Used for special purposes, by subject Fluorometry Analytical chemistry (General) QD 79.F4 Laboratory diagnosis QY 25 Quantitative analysis QD 117.F5 Used for particular purposes, by subject Fluorophotometry WW 143 Fluoroscopy WN 220 Used for diagnosis of particular disorders, with the disorder or system Fluorosis see Mottled Enamel Fluorosis, Dental see Mottled Enamel Fluorouracil QV 269 Fluostigmine see Isoflurophate Fluoxetine QV 126 Biochemistry QU 61 Fluphenazine QV 77.9 Flurazepam QV 77.9 Flurbiprofen QV 95 Biochemistry QU 98 Flutter, Auricular see Auricular Flutter FMN QU 135 Focal Epilepsy see Epilepsy, Focal Focal Infection WC 230 Focal Infection, Dental WU 290 Fogarty Balloon Catheterization see Balloon Dilatation Folate Polyglutamates see Pteroylpolyglutamic Acids Foley Balloon Catheterization see Balloon Dilatation Folic Acid QU 188 Folic Acid Deficiency WD 120 Folic Acid Reductase see Tetrahydrofolate Dehydrogenase Folie a Deux see Shared Paranoid Disorder Folinic Acid see Leucovorin Folk Medicine see Medicine, Traditional ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPHA Folklore GR Curiosities WZ 308 Medical WZ 309 General works GR 60-71 Follicle-Stimulating Hormone see FSH Follicular Lymphoma see Lymphoma, Follicular Folliculostatin see Inhibin Follow-Up Studies (Form number 20 in any NLM schedule where applicable) In a particular area, with the subject of the original study, e.g., Heart Diseases WG 210 Food Adulteration see Food Contamination WA 701 Allergy see Food Hypersensitivity WD 310 Assimilation QU 120 Chemical technology see Food Technology TP 368-465, etc. Chemistry QU 50 Deficiency diseases WD 105-155 Digestion WI 102 Fads see Diet Fads WB 449 For children WS 115-130 For infants see Infant Food WS 115-125 Fresh WA 703 Hospital service see Food Service, Hospital WX 168 Laws see Legislation, Food WA 697; subheading legislation under heading beginning with Food Nutritive value QU 145.5 Public health aspects WA 695-722 Therapeutic use see Diet Therapy WB 400-449; names of specific foods Food Additives WA 712 Food Adulteration see Food Contamination Food Allergy see Food Hypersensitivity Food Analysis Bacteriology QW 85 Biochemistry QU 50 Home Economics TX 501-597 Nutrition QU 145.5 Sanitation WA 695-722 Analysis for specific nutritive agents QU 50-98, etc. Food, Artificial see Food, Formulated Food-Borne Diseases see Communicable Diseases; Food Contamination; Food Poisoning Food Browning see Maillard Reaction Food, Canned see Food Preservation Food Coloring Agents WA 712 Food Contamination WA 701 Poisoning from see Food Poisoning WC 268, etc. Food Contamination, Radioactive WN 612 Food Deprivation Experimental biochemistry QU 34 Experimental pharmacology QV 34 See also Hunger QU 146, etc. Deficiency diseases WD 105-155, etc. Food, Dried see Food Preservation Food, Drug and Cosmetic Act see Legislation, Drug Food Fads see Diet Fads USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIRED 348 Forensic Medicine Food, Formulated WB 447 Special types or for special purposes, by subject Food, Fortified QU 145.5 Food processing (General) TP 370 Food, Frozen see Frozen Foods Food Habits GT 2850-2960 Food Handling Restaurant sanitation WA 799 Sanitation WA 695-722 Technology TP 368-684 Food Hypersensitivity WD 310 Food, Infant see Infant Food Food Inspection WA 695 Food Intake Regulation see Appetite Regulation Food, Irradiated see Food Irradiation Food Irradiation WA 710 Food Laws see Legislation, Food Food Microbiology QW 85 Food Parasitology WA 701 Food Plants see Plants, Edible Food Poisoning WC 268 Veterinary SF 757.5 See also Mushroom Poisoning WD 520; Plant Poisoning WD 500-530, etc.; Salmonella Food Poisoning WC 268; Staphylococcal Food Poisoning WC 268 and specific types of poisoning or poisoning agents Food Preferences Health aspects QT 235 Institutional cooking TX 820 Food Preservation WA 710 Food Preservatives WA 712 Food, Preserved see Food Preservation Food Processing see Food Handling Food-Processing Industry Chemical technology TP 368-684 Economic aspects HD 9000-9440 Occupational medicine WA 400-495 Industrial waste WA 788 Food Selection see Food Preferences Food Service, Hospital WX 168 Food Services Public health aspects WA 695-722 Schools Elementary and Secondary WA 350 University and College WA 351 See also Dietary services WX 168, etc.; Restaurants WA 799 Food, Supplemented see Food, Fortified Food Supply Home economics TX 351-354.5 Public health aspects WA 695-722 Food Technology Chemical technology TP 368-465 Public health aspects WA 695-722 See also Meat WA 707, etc.; names of other specific foods Food Values see Nutritive value Foot WE 880-886 Foot-and-Mouth Disease SF 793 Foot-and-Mouth Disease Virus see Aphthovirus Foot Deformities WE 883 Foot Deformities, Acquired WE 883 Foot Deformities, Congenital WE 883 Foot Dermatoses WR 140 See also Tinea pedis WR 310 Foot Diseases WE 880 Veterinary (General) SF .906 Foot Joint see Tarsal Joint Foot Ulcer, Diabetic see Diabetic Foot Football QT 260.5.F6 Foramen of Monro see Cerebral Ventricles Foramen Ovale, Patent see Heart Septal Defects, Atrial Forced Expiratory Flow Rates WF 102 As a diagnostic test WF 141 General physical examination WB 284 Forced Expiratory Flow 0.2-1.2 see Maximal Expiratory Flow Rate Forced Expiratory Flow 200-1200 see Maximal Expiratory Flow Rate Forceps Delivery see Methods WQ 425 under Delivery; Obstetrical Forceps Forearm WE 820 Forearm Injuries WE 820 Forebrain see Embryology WL 300 under Brain Forecasting CB 158 Agriculture HD 1401-2210 Business HB 3730 Civilization CB 428-430 Environment HC 79.E5 Health manpower W 76 Hospitals WX 140 Natural resources Conservation S 900-954 Economics HC 55 Land HD 1635-1741; S 950-954 Urban areas HT 165.5-178 Other special topics, by subject Forefoot, Human WE 880 Foreign Aid see International Cooperation Foreign Bodies As a cause of disease QZ 55 In the ear WV 222 Localization by radiography WN 210 Removal WO 700 Localized, by site See also Bezoars WI 300, etc.; Eye foreign bodies WW 525 Foreign Medical Graduates Education W 18-20 Supply & distribution W 76 Foreign Professional Personnel Health sciences (General) W 76 Science Q 147-149 See also Foreign Medical Graduates W 76, etc. Forelimb QL 950.7 Forensic Chemistry see Chemistry Forensic Dentistry W 601-925 General works W 705 Forensic Examination of Blood see Blood Chemical Analysis Forensic Medicine W 601-925 Directories W 622 Examination of evidential material W 750 Postmortem W 825 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 349 Forensic Medicine Medical evidence for establishing responsibility W 725 Medicolegal examination W 775-867 Nineteenth century works W 600 See also Jurisprudence W 32.5-32.6 Forensic Psychiatry W 740 As a career W 740 Foreskin see Penis Forestier-Certonciny Syndrome see Polymyalgia Rheumatica Forests see Trees Form Perception WW 105 Formaldehyde Organic chemistry QD 305.A6 Pharmacology QV 225 Formalin see Formaldehyde Formalin Test see Pain Measurement Formates QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Formicoidea Venoms see Ant Venoms Forms and Records Control W 80 Special field, by subject Formularies QV 740 Formularies, Dental QV 50 Formularies, Homeopathic WB 930 Formularies, Hospital QV 740 Forskolin Biochemistry QU 85 Toxicology QV 633 Fosfomycin QV 350 Fossils QE 701-996.5 Special topics, by subject Foster Home Care HV 875 Public health aspects WA 310-320 Of persons with various disabilities, with the disability, e.g., of mental patients WM 29; of the mentally retarded child WS 107.5.F6 Fourier Analysis QA 403.5-404.5 Biomedical mathematics QT 35 Fowl Paralysis see Marek's Disease Fowl Pest see Fowl Plague Fowl Plague SF 995.6.F59 Fowl Plague Virus see Orthomyxovirus Type A, Avian Fowls, Domestic see Poultry Foxes QL 737.C22 Foxglove see Digitalis Fractionation Of a particular substance, with the substance, e.g., Blood protein fractionation QY 455 See also Cell Fractionation QH 585.5.C43 Fracture Fixation WE 185 Veterinary SF 914.4 Fracture Fixation, Internal WE 185 Fracture Fixation, Intramedullary WE 185 Fractures WE 175-185 In infancy & childhood WE 175-180 See also types of fracture by site, e.g., Skull Fractures WL 354 Fractures, Compound see Fractures, Open Fractures, Fatigue see Fractures, Stress Fractures, March see Fractures, Stress ALWAYS CONSULT MAIN SCHEDULES SUBJECT REPRESENTS MAJOR EMPH^ Fractures, Open WE 182 Fractures, Pathological see Fractures, Spontaneous Fractures, Spontaneous WE 180 Fractures, Stress WE 180 Fractures, Ununited WE 180 Fragile Sites, Chromosome see Chromosome Fragile Sites Fragile X Syndrome QS 677 Fragilitas Ossium see Osteogenesis Imperfecta Frail Elderly WT See special topics under Aged Frail Older Adults see Frail Elderly Frambesia see Yaws Frames (Spectacles) see Eyeglasses Frangula see Rhamnus Fraternities see Societies; names of specialties Fraud HV 6691-6699 Special topics, by subject Fraud, Drug Manufacture and Sales see Drug Industry Fraud, Scientific see Scientific Misconduct Fraudulent Data see Scientific Misconduct Freckles see Lentigo Free Association WM 460.5.F8 Free Fatty Acids see Fatty Acids, Nonesterified Free Radicals QD 471 Freedom Political theory JC 585-599 Sociology HM 271 Special topics, by subject Freeze Drying Blood WH 460 Food WA 710 Research techniques QH 324.9.C7 Tissue QS 525 See also Tissue Preservation WO 665, etc. Freeze Fracturing QH 236.2 Freezing Anesthesia see Hypothermia, Induced WO 350 Biochemical technique QU 25 Blood WH 460 Food WA 710 Normal effects on cells QH 653 Research techniques QH 324.9.C7 Special aspects, by subject Tissue WO 665 Frei's Disease see Lymphogranuloma Venereum Frenum, Labial see Labial Frenum Fresh Foods see Food Fresh Frozen Plasma see Plasma Fresh Water WA 675-690 Freudian Theory WM 460 Friedlaender's Pneumonia see Pneumonia Friedreich's Ataxia WL 390 Friedreich's Disease see Paramyoclonus Multiplex Frigidity WP 610 Fringe Benefits see Salaries and Fringe Benefits Froehlich's Syndrome WK 550 Frog Venoms see Amphibian Venoms Frogs and Toads see Anura Frontal Bone WE 705 Frontal Lobe WL 307 Frontal Sinus WV 350 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 350 Gallium Frostbite WG 530 Frottage see Paraphilias Frozen Foods WA 710 Frozen Sections QH 233 Frozen Semen see Semen Preservation Fructose QU 75 Fructosediphosphate Aldolase QU 139 Fructosediphosphates QU 75 Fruit As a dietary supplement in health or disease WB 430 Plant culture SB 354-399 Sanitation and other public health aspects WA 703 Fruit Flies see Drosophila Frusemide see Furosemide Frustration BF 575.F7 In adolescence WS 462 In infancy & childhood WS 105.5.E5 FSH WK 515 FSH-Releasing Hormone see Gonadorelin Ftorafur see Tegafur Fuchsin Dyes see Rosaniline Dyes Fuchsins see Rosaniline Dyes Fucidin see Fusidic Acid Fucosyltransferases QU 141 FUdR see Floxuridine Fuel Oils Chemical technology TP 345-359 Toxicology QV 633 Fuels Chemical technology TP 315-360 Energy conservation TJ 163.3-163.5 Heating WA 770 Pollution WA 754 See also Gas Poisoning QV 662, etc. and names of other specific fuels Fugue see Dissociative Disorders Full Dentures see Denture, Complete Fumigation see Sterilization Function Tests see Heart Function Tests; Kidney Function Tests; Liver Function Tests; Ovarian Function Tests; Pituitary-Adrenal Function Tests; Pituitary Function Tests; Placental Function Tests; Respiratory Function Tests; Thyroid Function Tests; Vestibular Function Tests; See also names of specific tests Functional Heart Disease see Neurocirculatory Asthenia and names of other functional disorders Functional Psychoses see Psychotic Disorders Functionally-Impaired Elderly see Frail Elderly Fund Raising Hospitals WX 157 Other special topics, by subject Funding, Capital see Capital Financing Fundus Fluorescence Photography see Fluorescein Angiography Fundus Oculi WW 270 Funeral Directors see Mortuary Practice Funeral Rites Ethnology GN 486 Manners and customs GT 3150-3390.5 Psychology BF 789.F8 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHj* Fungal Antigens see Antigens, Fungal Fungal Spores see Spores, Fungal Fungal Toxins see Mycotoxins Fungal Vaccines WC 450 Fungi As a cause of disease QZ 65 Non-pathogenic QK 600-635 Pathogenic QW 180-180.5 Fungi imperfecti see Deuteromycetes Fungicides, Industrial Agriculture SB 951.3 Public health aspects WA 240 See also Antifungal Agents QV 252 Fungicides, Therapeutic see Antifungal Agents Fungus Diseases see Mycoses Fungus Poisoning see Mycotoxicosis Funnel Chest WE 715 Furans Organic chemistry QD 405 Furazosin see Prazosin Furniture see Interior Design and Furnishings Furocoumarins see Psoralens Furosemide QV 160 Furrow Keratitis see Keratitis, Dendritic Fursemide see Furosemide Furunculosis WR 235 Fusarium QW 180.5.D38 Fusidic Acid QV 350 Fusobacterium QW 133 Fusobacterium Infections WC 200 Veterinary SF 809.F87 Futurology see Forecasting Fl ATPase see H(+)-Transporting ATP Synthase FIFO ATPase Complex see H(-f )-Transporting ATP Synthase G G Force see Gravitation G Periods see Interphase G Phases see Interphase G-Proteins QU 55 GABA QU 60 GABA Receptors see Receptors, GABA GABA Transaminase see Aminobutyrate Aminotransferase Gagging WI 143 Gait WE 103 Galactokinase QU 141 Galactose QU 75 Galactosemia WD 205.5.C2 Galactosidases QU 136 Galago QL 737.P955 As laboratory animals QY 60. P7 Diseases SF 997.5.P7 Galantamin see Galanthamine Galanthamine QV 124 Gallbladder WI 750 Gallbladder Diseases WI 750 Gallbladder Neoplasms WI 765 Gallium Organic chemistry QD 181.G2 Pharmacology QV 290 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 351 Gallodesoxycholic Acid Gallodesoxycholic Acid see Chenodeoxycholic Acid Gallopamil QV 150 Gallstones see Cholelithiasis Gallstones, Common Bile Duct see Common Bile Duct Calculi Galvanic Skin Response Psychiatric test WM 145 Reflex test (general) WL 106 Galvanism, Oral see Electrogalvanism, Intraoral Galvanosurgery see Electrosurgery Galvanotherapy see Electric Stimulation Therapy Gamasoidiasis see Mite Infestations Gambling As an impulse control disorder WM 190 See also Risk-Taking BF 637.R57 Game Theory QA 269-272 In leadership development HM 141 Other uses with the area being studied, e.g., doctor/nurse relations WY 87 Games see Physical Education and Training; Play and Playthings; Sports; Recreation Games, Experimental QA 269 Gamete Intrafallopian Transfer Human WQ 205 Gametogenesis WQ 205 Gamma-Aminobutyric Acid see GABA gamma-Aminobutyric Acid Receptors see Receptors, GABA gamma-Benzene Hexachloride see Benzene Hexachloride Gamma Camera Imaging see Radionuclide Imaging Gamma Globulin, 7S see IgG Gamma Globulins WH 400 Clinical examination QY 455 Prophylactic QW 806 Used for treatment of particular disorder, with the disorder or system gamma-Interferon see Interferon Type II Gamma Rays WN 105 Gammaphos see Amifostine Ganciclovir QV 268.5 Ganglia WL 500 Ganglia, Autonomic WL 600 Ganglia, Basal see Basal Ganglia Ganglia, Parasympathetic WL 610 Ganglia, Sympathetic WL 610 Ganglion of Corti see Spiral Ganglion Ganglioneuroma QZ 380 Localized, by site Ganglionic Blockers QV 132 Ganglionic Blocking Agents see Ganglionic Blockers Ganglioplegic Agents see Ganglionic Blockers Gangliosides QU 85 Gangliosidoses WD 205.5.L5 Gangrene QZ 180 Gas see Gas Gangrene WC 375 Ganja see Cannabis Garbage Disposal see Refuse Disposal Gargoylism see Mucopolysaccharidosis I Garlic As a dietary supplement in health or disease WB 430 As a medicinal plant QV 766 Gas Gangrene WC 375 Gas Masks see Respiratory Protective Devices Gas Poisoning QV 662 In industry WA 465 Gases Analysis QD 121 As anesthetics QV 81 Asphyxiating see Lung irritants QV 664 under Irritants Chemical technology TP 242-244 Description and properties QC 161-168.86 In air pollution see Air Pollutants WA 754, etc. Inorganic chemistry QD 162 Irritant see Irritants QV 666, etc. Lacrimator see Tear Gases QV 665 Paralysants QV 667 Pharmacology QV 310-318 Poisonous see Gas Poisoning QV 662, etc. Vesicant see Irritants QV 666, etc. War see Chemical Warfare Agents QV 663-667 Gasoline Chemical technology TP 692.2 Handling and storage TP 692.5 Toxicology QV 633 Gastrectomy WI 380 In infancy & childhood WS 310 Gastric Acid WI 302 Gastric Acidity Determination QY 130 Gastric Antacid Drugs see Antacids Gastric Antrum see Pyloric Antrum Gastric Contents see Analysis QY 130 under Stomach Gastric Emptying WI 302 Gastric Fistula WI 300 Gastric Fundus WI 300 Gastric Hypothermia WI 380 Used for treatment of particular disorders, with the disorder Gastric Juice WI 302 Clinical pathology QY 130 Gastric Parietal Cells see Parietal Cells, Gastric Gastric Ulcer see Stomach Ulcer Gastric Varices see Esophageal and Gastric Varices Gastrin Receptors see Receptors, Cholecystokinin Gastrins WK 170 Gastritis WI 310 Gastroduodenal Ulcer see Peptic Ulcer Gastroenteritis WI 140 Gastroenteritis, Transmissible, of Swine SF 977T7 Gastroenterology WI In infancy & childhood WS 310-312 Gastroenterostomy WI 900 Gastroesophageal Reflux WI 250 Gastrointestinal Agents QV 66 Gastrointestinal Diseases WI 140 In infancy & childhood WS 310-312 Nursing WY 156.5 Veterinary SF 851 Gastrointestinal Hemorrhage WI 143 Particular types, by type Gastrointestinal Hormone Receptors see Receptors, Gastrointestinal Hormone ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 352 Genetic Engineering of Proteins Gastrointestinal Hormones WK 170 Gastrointestinal Motility WI 102 Gastrointestinal Neoplasms WI 149 Gastrointestinal System WI Children WS 310-312 Drugs acting on see Gastrointestinal Agents QV 66 Hormones see Gastrointestinal Hormones WK 170 Manifestations of Disease WI 143 Gastroscopy WI 300 Gatekeepers, Health Service see Referral and Consultation Gaucher s Disease WD 205.5.L5 Gays see Homosexuality, Male Geese QL 696.A52 Culture SF 505-505.63 Diseases SF 995.2 Gehrig s Disease see Amyotrophic Lateral Sclerosis Geiger-Mueller Counters see Radiometry Gel Diffusion Tests see Immunodiffusion Gel Electrophoresis, Two-Dimensional see Electrophoresis, Gel, Two-Dimensional Gel Precipitation Test see Immunodiffusion Gelada Baboon see Theropithecus gelada Gelatin QU 55 Gels QV 785 Gelsemium QV 766 Toxicology QV 628 Gender see Sex Gender Identity HQ 1075 In adolescence WS 462 In infancy & childhood WS 105.5.P3 Psychological aspects BF 692.2 In men BF 692.5 In women HQ 1206, etc. Gender Role see Gender Identity Gene Action Regulation see Gene Expression Regulation Gene Activation see Gene Expression Regulation Gene Amplification QH 450.3 Gene Bank see Gene Library Gene Clusters see Genes, Reiterated Gene Duplication see Genes, Reiterated Gene Expression QH 450 Gene Expression Regulation QH 450 Gene Expression Regulation, Bacterial QW 51 Gene Expression Regulation, Enzymologic QU 135 Gene Expression Regulation, Neoplastic QZ 202 Gene Expression Regulation, Viral QW 160 Gene Fusion see Cloning, Molecular Gene Library QH 442.4 Gene Mapping see Chromosome Mapping Gene Pool QH 455 Gene Probes, DNA see DNA Probes Gene Products see Proteins Gene Products, Bacterial see Bacterial Proteins Gene Products, Viral see Viral Proteins Gene Proteins see Proteins Gene Rearrangement QW 541 In antibodies QW 575 Gene Therapy QZ 50 Genetic engineering aspects QH 442 Of a specific disease, with the disease Gene Transfer see Transfection General Adaptation Syndrome QZ 160 General Paralysis see Paresis General Practice see Family Practice General Practice, Dental WU 21 Textbooks WU 100 General Practitioners see Physicians, Family General Systems Theory see Systems Theory Generalists see Physicians, Family Generalization (Psychology) BD 235 Stimulus BF 319.5.S7 Generalized Radiation Sickness see Radiation Injuries Generic Equivalency see Therapeutic Equivalency Genes QH 447-447.8 Genes, Bacterial QW 51 Genes, Class I see Genes, MHC Class I Genes, Class II see Genes, MHC Class II Genes, H-2 Class I see Genes, MHC Class I Genes, HLA Class I see Genes, MHC Class I Genes, HLA Class II see Genes, MHC Class II Genes, Ig see Genes, Immunoglobulin Genes, Immune Response see Genes, MHC Class II Genes, Immunoglobulin QW 601 Genes, Immunoglobulin Heavy Chain see Genes, Immunoglobulin Genes, Immunoglobulin Light Chain see Genes, Immunoglobulin Genes, Immunoglobulin VH Germ Line see Genes, Immunoglobulin Genes, MHC Class I In immunogenetics QW 541 Speical topics, by subject Genes, MHC Class II In immunogenetics QW 541 Special topics, by subject Genes, ras QZ 202 Genes, Regulator QH 450 Genetic regulation QH 450-450.6 Genes, Reiterated QH 447 Genes, Spliced see DNA, Recombinant Genes, Split see Genes Genes, Suppressor, Tumor Genes, Synthetic QH 447 Genes, Viral QW 160 Genetic... See also inverted headings, e.g., Transformation, Genetic QW 51 Genetic Carriers see Heterozygote Genetic Carriers, Detection see Heterozygote Detection Genetic Code QH 450.2 Genetic Counseling QZ 50 In family planning HQ 766 Other special topics, by subject Genetic Diversity see Variation (Genetics) Genetic Engineering QH 442-442.6 Chemical technology TP 248.6 Special topics, by subject Genetic Engineering of Proteins see Protein ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 353 Genetic Engineering of Proteins Engineering Genetic Induction see Gene Expression Regulation Genetic Intervention see Genetic Engineering Genetic Markers QZ 50 Genetic Recombination see Recombination, Genetic Genetic Screening QZ 50 Genetic Skin Diseases see Genetic WR 218 under Skin Diseases Genetic Techniques QH 441 Medical QZ 50 Social and moral aspects QH 438.7 Genetic Toxicity Tests see Mutagenicity Tests Genetic Translation see Translation, Genetic Genetic Vectors QH 442.2 Genetics QH 426-470 Animal (General) QH 432 Domestic animal breeding SF 105 Developmental QH 453 Plant QK 981-981.7 Veterinary genetics SF 756.5 See also Cytogenetics QH 605, etc.; Pharmacogenetics QV 38 Genetics, Bacterial see Genetics, Microbial Genetics, Behavioral QH 457 Genetics, Biochemical For the biochemist QU 4 Genetic regulation QH 450-450.6 General works QH 430 Human QH 431 Works on the retarded child WS 107.5.B4 Special topics, by subject Genetics, Human see Genetics; Genetics, Medical Genetics, Medical QZ 50 Genetics, Microbial QW 51 Genetics, Molecular see Genetics, Biochemical Genetics, Population QH 455 Physical anthropology GN 289 Genetics, Radiation see Radiation Genetics Geniculate Ganglion WL 330 Genital Diseases, Female WP General works WP 140 In infancy & childhood WS 360 Nursing WY 156.7 See also Obstetrical Nursing WY 157, etc. Surgery WP 660 Therapy WP 650 Urologic WJ 190 Veterinary SF 871 Genital Diseases, Male WJ 700 Veterinary SF 871 Genital Neoplasms, Female WP 145 Genital Neoplasms, Male WJ 706 Genitalia Animals, Domestic SF 871 Children WS 320 Drugs affecting QV 170-177 General works (male and female, combined) WJ 700 See also Gonads WK 900 Genitalia, Female WP Children WS 360 General works WP 100 See also specific organs ALWAYS CONSULT MAIN SCHEDULES USE SUBJECT REPRESENTS MAJOR EMPHASIS C Genitalia, Male WJ 700-875 Genitourinary Diseases see Urogenital Diseases Genitourinary Neoplasms see Urogenital Neoplasms Genitourinary System see Urogenital System Genius see Child, Gifted; Creativeness; Intelligence Genome, Human QH 447 Genomic Library QH 442.4 Genotype QH 447 Histocompatibility WO 680 Gentamicins QV 350.5.G3 Gentamycin see Gentamicins Gentian see Plants, Medicinal Gentian Violet As an anthelmintic QV 253 As an anti-infective agent QV 235 Geographic Tongue see Glossitis, Benign Migratory Geography Medical see Climate WB 700-710; Epidemiology WA 900, etc.; names of diseases in a particular area WB 700-710, etc. Geology QE General works QE 26-26.2 Geopathology see Climate; Disease Reservoirs; Environmental Health Gerbillinae QL 737.R666 As laboratory animals QY 60.R6 As pets SF 459.G4 Gerbils see Gerbillinae Geriatric Assessment WT 30 Geriatric Dentistry WU 490 Geriatric Health Services see Health Services for the Aged Geriatric Nursing WY 152 Geriatric Ophthalmology see In Old Age WW 620 under Ophthalmology Geriatric Psychiatry WT 150 As a career WT 150 Geriatrics WT See also Aged Germ Cells WQ 205 Animal QL 964-966 Germ-Free Life Experimentation QY 56 Particular experiments, by subject Laboratory animals QY 56 Germ-Line Cells see Germ Cells Germ Line Theory see Antibody Diversity Germ Theory of Disease see Pathogenesis QZ 65 under Disease German Measles see Rubella Germanium Inorganic chemistry QD 181.G5 Pharmacology QV 290 Germinoblastoma see Lymphoma Gerontology see Geriatrics Gestalt Theory BF 203 Gestalt Therapy WM 420.5.G3 Gestation see Pregnancy Gestational Age WQ 210.5 Gestosis, EPH WQ 215 Gestures In adolescence WS 462 In infancy & childhood WS 105.5.C8 NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSinED 354 Glucosephosphatase Deficiency Psychology BF 637.N66 Social psychology HM 258 Ghettos see Poverty Areas Giant Cell Arteritis see Temporal Arteritis Giant Cell Granuloma see Granuloma, Giant Cell Giant Cell Tumors QZ 340 Bone WE 258 Localized, by site Giardia QX 70 Giardiasis WC 700 Gibbons see Hylobates Gibraltar Fever see Brucellosis GIFT see Gamete Intrafallopian Transfer Gifted Child see Child, Gifted Gifts, Financial see Fund Raising Gigantism WK 550 Gilberts Disease WD 205.5.H9 Gilles de la Tourettes Disease see Tourette Syndrome Gingiva WU 240 Gingival Crevicular Fluid WU 240 Gingival Diseases WU 240 Gingival Exudate see Gingival Crevicular Fluid Gingival Index see Periodontal Index Gingivectomy WU 240 Gingivitis WU 240 Gingivitis, Necrotizing Ulcerative For the dentist WU 240 For the gastroenterologist WI 200 Gingivosis see Gingival Diseases Gingivostomatitis, Herpetic see Stomatitis, Herpetic Ginseng QV 766 Glanders WC 330 Veterinary SF 796 Glands see Endrocrine Glands; Exocrine Glands; names of specific glands Glandula Carotica see Carotid Body Glandular Fever see Infectious Mononucleosis Glass Occupational medicine WA 400-495 Materials of engineering and construction TA 450 Optical instruments QC 375 Glass Ionomer Cements WU 190 Glasses see Eyeglasses Glaucoma WW 290 Glaucoma, Angle-Closure WW 290 Glaucoma, Closed-Angle see Glaucoma, Angle-Closure Glaucoma, Open-Angle WW 290 Glaucoma, Pigmentary see Glaucoma, Open-Angle Glaucoma, Simple see Glaucoma, Open-Angle Glaucoma Simplex see Glaucoma, Open-Angle Glial Fibrillary Acidic Protein QU 55 Glial Intermediate Filament Protein see Glial Fibrillary Acidic Protein Gliclazide WK 825 Organic chemistry QD 305.S6 Gliding Bacteria (Non Mesh) see Bacteria Gliobastoma see Astrocytoma Glioblastoma QZ 380 Localized, by site Glioblastoma-Derived T-Cell Suppressor Factor see Transforming Growth Factor beta Glioblastoma Multiforme see Glioblastoma Gliocladium see Hyphomycetes Glioma QZ 380 Localized, by site Global Warming see Greenhouse Effect Globulins QU 55 Globus Hystericus see Conversion Disorder Globus Pallidus WL 307 Glomangioma see Glomus Tumor Glomerular Filtration Rate QY 175 Glomerulonephritis WJ 353 Glomerulonephritis, IGA WJ 353 Glomerulonephritis, Lupus see Lupus Nephritis Glomerulosclerosis, Diabetic see Diabetic Nephropathies Glomus Caroticum see Carotid Body Glomus Tumor QZ 340 Localized, by site Glossalgia WI 210 Glossectomy WI 210 Glossina see Tsetse Flies Glossitis WI 210 Glossitis Areata Exfoliativa see Glossitis, Benign Migratory Glossitis, Benign Migratory WI 210 Glossodynia see Glossalgia Glossopharyngeal Nerve WL 330 Gloves, Surgical WO 162 GLQ223 see Trichosanthin Glucagon WK 801 Associated with hypoglycemia WK 880 Glucagonoma WK 885 Glucan Phosphorylase see Glycogen Phosphorylase Glucans QU 83 Glucitol see Sorbitol Glucocorticoid Analogs see Glucocorticoids, Synthetic Glucocorticoid Receptors see Receptors, Glucocorticoid Glucocorticoids WK 755 Glucocorticoids, Synthetic WK 757 Glucocorticoids, Topical QV 60 Glucokinase QU 141 Gluconeogenesis QU 75 Glucosamine QU 75 Glucose QU 75 Dietary supplement WB 427 Infusion technique WB 354 Pharmacology QU 75 Glucose, Blood see Blood Glucose Glucose Infusion see Glucose; Infusions, Parenteral Glucose Oxidase QU 140 Glucose Solution, Hypertonic QU 75 Infusion WB 354 Glucose Tolerance Test QY 470 Glucose-6-Phosphatase QU 136 Glucose-6-Phosphatase Deficiency see Glycogen Storage Disease Type I Glucose-6-Phosphate Dehydrogenase see Glucosephosphate Dehydrogenase Glucosephosphatase see Glucose-6-Phosphatase Glucosephosphatase Deficiency see Glycogen ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 355 Glucosephosphatase Deficiency Storage Disease Type I Glucosephosphate Dehydrogenase QU 140 Glucosephosphate Dehydrogenase Deficiency WH 170 Glucosides QU 75 Glucosiduronates see Glucuronates Glucosyltransferases QU 141 Glucuronates QU 84 Organic chemistry QD 321 Glucuronidase QU 136 Glucuronides see Glucuronates Glue Sniffing see Substance Use Disorders Glues see Adhesives Glutamate-Ammonia Ligase QU 138 Glutamate Dehydrogenase QU 140 Glutamates QU 60 Glutamic-Oxaloacetic Transaminase see Aspartate Aminotransferase Glutamic-Pyruvic Transaminase see Alanine Aminotransferase Glutaminase QU 136 Glutamine QU 60 Glutamine Synthetase see Glutamate-Ammonia Ligase Glutaminyl-Peptide Gamma-Glutamyltransferase see Protein-Glutamine gamma-Glutamyltransferase Glutaraldehyde-Stabilized Grafts see Bioprosthesis Glutathione QU 68 Glutathione Peroxidase QU 140 Glutathione Reductase QU 140 Gluteal Region see Buttocks Gluten QK 898.G49 Gluten Enteropathy see Celiac Disease Glutethimide QV 85 Glybutamide see Carbutamide Glycans see Polysaccharides Glycerides QU 85 Glycerin Biochemistry QU 75 In blood preservation WH 460 In tissue culture QS 525 Organic chemistry QD 305.A4 Pharmacology QV 82 Glycerites see Solutions Glycerol see Glycerin Glycerophosphates QU 93 Glyceryl Trinitrate see Nitroglycerin Glycine Max see Soybeans Glycoconjugates QU 75 Glycogen QU 83 Glycogen Phosphorylase QU 141 Glycogen Storage Disease WD 205.5.C2 Glycogen Storage Disease Type I WD 205.5.C2 Glycogen Synthase QU 136 Glycogen Synthetase see Glycogen Synthase Glycogenosis see Glycogen Storage Disease Glycogenosis 1 see Glycogen Storage Disease Type Glycolates QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Glycolipids QU 85 Glycols Organic chemistry QD 305.A4 Pharmacology QV 82 Glycolysis QU 75 Glyconeogenesis see Gluconeogenesis Glycophorin Glycoprotein Sialyltransferases see Sialyltransferases Glycoproteins QU 55 Glycosidases see Glycoside Hydrolases Glycoside Antibiotics see Antibiotics, Aminoglycoside Glycoside Hydrolases QU 136 Glycosides QU 75 Cardiac see Cardiac Glycosides QV 153 Glycosuria WK 870 Glycosylation Of proteins QU 55 Glycyrrhetic Acid see Glycyrrhetinic Acid Glycyrrhetinic Acid As a dermatologic agent QV 60 As a gastrointestinal agent QV 66 Glycyrrhiza QV 766 Glyoxylates QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Gnathostoma QX 203 Gnotobiotics see Germ-Free Life GnRH see Gonadorelin Goals BF 505.G6 As a philosopical concept B 105.G63 Goat Diseases SF 968-969 Goat Fever see Brucellosis Goats Culture SF 380-388 Goggles see Eye Protective Devices Goiter WK 259 Veterinary SF 768.3 Goiter, Endemic WK 259 Goiter, Exophthalmic see Graves' Disease Goiter, Intrathoracic see Goiter, Substernal Goiter, Substernal WK 259 Goitrogens see Thyroid Antagonists Gold Dental application WU 180 In organic chemistry QD 181.A9 Pharmacology QV 296 Used for treatment of particular disorders, with the disorder or system Gold Alloys Analytical chemistry QD 137.G6 Dentistry WU 180 Gold Anti-Inflammatory Agents see Antirheumatic Agents, Gold Gold Antiarthritic Agents see Antirheumatic Agents, Gold Gold Colloid, Radioactive WN 420 Nuclear physics QC 796.A9 See also special topics under Radioisotopes Gold Isotopes Inorganic chemistry QD 181.A9 Pharmacology QV 296 Gold Salts, Anti-Rheumatic see Antirheumatic Agents, Gold ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 356 Granulocytes Gold Thioglucose see Aurothioglucose Goldfish SF 458.G6 As laboratory animals QY 60. F4 Golf QT 260.5.G6 Golgi Apparatus QH 603.G6 Gonadal Dysgenesis QS 677 Gonadal Dysgenesis, 45,X see Turner's Syndrome Gonadal Dysgenesis, 45,XO see Turner s Syndrome Gonadoliberin see Gonadorelin Gonadorelin WK 515 Gonadotropin-Releasing Hormone see Gonadorelin Gonadotropins WK 900 Gonadotropins, Chorionic WK 920 Gonadotropins, Chorionic, Human see Gonadotropins, Chorionic Gonadotropins, Human Menopausal see Menotropins Gonadotropins, Pituitary WK 515 Gonads WK 900 See also Ovary WP 320-322, etc. Testis WJ 830, etc.; Castration WJ 868, etc. Gonioscopy WW 210 Goniotomy see Trabeculectomy Gonococcus see Neisseria gonorrhoeae Gonorrhea WC 150 Female WP 157 Gonosomes see Sex Chromosomes Gonyaulax see Dinoflagellida Gordius see Helminths Gossypium see Cotton Gout WE 350 Drugs for see Gout Suppressants QV 98 Gout Suppressants QV 98 Governing Board Hospitals WX 150 Of other organizations and institutions, in the administration number for the agency or lacking that, in the general number, e.g., governing board of the American Medical Association WB 1 Government J Agencies (General), with the country in J schedule Medical practice W 94 See also Institutional Practice W 96, etc.; Veterinary Service, Military UH 650-655 Nursing service WY 130 See also Military Nursing WY 130; Public Health Nursing WY 108, etc.; Specialties, Nursing WY 130, etc. Government Agencies JF 1501-1525 Public health WA 540-546 See also Hospitals, Veterans UH 460-485; names of particular types of agencies Government Nursing Services see Military Nursing; Public Health Nursing Government Publications Administrative serials W2 Bibliography Z 7164.G7 Of individual countries Z 1201-4980 Statistical serials W2 Subject oriented publications Monographs, by subject Serials (Medicine and related fields) WI Government Regulations see Legislation; names of products or specialties being regulated, e.g. Drug and Narcotic Control Government, State see State Government Graafian Follicle WP 320 Graduate Education see Education, Medical, Graduate; names of other branches of graduate education Graduate Records Examination see Educational Measurement Graffi Virus see Leukemia Viruses, Murine Graffis Chloroleukemic Strain see Leukemia Viruses, Murine Graft Rejection WO 680 Graft-Versus-Host Disease see Graft vs Host Disease Graft vs Host Disease WD 300 Transplantation complication WO 680 Graft vs Host Reaction WO 680 Grafting, Bone see Bone Transplantation Grafting, Bone Marrow see Bone Marrow Transplantation Grafting, Brain Tissue see Brain Tissue Transplantation Grafting, Heart see Heart Transplantation Grafting, Heart-Lung see Heart-Lung Transplantation Grafting, Islets of Langerhans see Islets of Langerhans Transplantation Grafting, Kidney see Kidney Transplantation Grafting, Liver see Liver Transplantation Grafting, Lung see Lung Transplantation Grafting of Tissue see Transplantation Grafting, Organ see Organ Transplantation Grafting, Pancreas see Pancreas Transplantation Grafting, Skin see Skin Transplantation Grafting, Tissue see Tissue Transplantation Grain see Cereals Gram-Negative Aerobic Bacteria QW 131 Gram-Negative Anaerobic Bacteria QW 133 Gram-Negative Bacteria QW 131 Gram-Negative Chemolithotrophic Bacteria QW 135 Gram-Negative Facultatively Anaerobic Rods (Non Mesh) see Bacteria Gram-Positive Bacteria QW 142-142.5 Gram-Positive Cocci QW 142.5.C6 Gram-Positive Organisms see Bacteria Gramicidins QV 350 Graminea see Grasses Grammar see Philology; "phrase books" under specialties, e.g., Medicine Grana see Chloroplasts Grand Mai Attacks see Epilepsy, Tonic-Clonic Grants and Subsidies, Educational see Training Support Grants and Subsidies, Government see Financing, Government Grants and Subsidies, Health Planning see Health Planning Support Grants and Subsidies, Research see Research Support Granulocytes WH 200 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 357 Granulocytic Leukemia Granulocytic Leukemia see Leukemia, Myeloid Granulocytic Leukemia, Chronic see Leukemia, Myeloid, Chronic Granulocytopenia see Agranulocytosis Granuloma QZ 140 Eosinophilic see Eosinophilic Granuloma WH 650, etc. Fungoides see Mycosis Fungoides WR 500 Granuloma, Eosinophilic see Eosinophilic Granuloma Granuloma Gangraenescens see Granuloma, Lethal Midline Granuloma, Giant Cell Gingiva WU 240 Jaws WU 140.5 Granuloma, Giant Cell Reparative see Granuloma, Giant Cell Granuloma, Hodgkin s see Hodgkin's Disease Granuloma Inguinale WC 180 Granuloma, Lethal Midline WV 300 Granuloma, Malignant see Hodgkin's Disease Granuloma, Periapical see Periapical Granuloma Granuloma, Reparative Giant Cell see Granuloma, Giant Cell Granuloma Sarcomatodes see Mycosis Fungoides Granuloma Venereum see Granuloma Inguinale Granulomatosis, Wegener's see Wegeners Granulomatosis Granulomatous Disease, Chronic QW 690 Granulosa Cell Tumor WP 322 Grapes As a dietary supplement in health or disease WB 430 Cultivation SB 387-398 See also Wine WB 444, etc. Graphite Pharmacology QV 138.C1 Inorganic chemistry QD 181.CI Grasses As allergens QW 900 Cultivation SB 197-202 Graves' Disease WK 265 Grave's Disease see Goiter, Exophthalmic Gravitation QC 178 Aviation medicine WD 720 Physiological effects QT 162.G7 Space medicine WD 752 Gravity see Gravitation Grawitz Tumor see Carcinoma, Renal Cell Graylings see Salmonidae Green Monkey see Cercopithecus aethiops Greenhouse Effect On environmental health WA 30 Physics QC 912.3 Global warming QC 981.8.G56 Special topics, by subject Grenz Rays see X-Rays Grief BF 575.G7 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Grievances, Employee see Employee Grievances Grippe see Influenza Grivet Monkey see Cercopithecus aethiops ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Grommet Insertion see Middle Ear Ventilation Groundnuts see Peanuts Group Health Insurance see Insurance, Health Group Health Organizations, Prepaid see Health Maintenance Organizations Group Hospitalization see Insurance, Hospitalization Group Identification see Social Identification Group Practice W 92 Group Practice, Dental WU 79 Group Practice, Prepaid W 92 Group Processes HM 131-134 Psychotherapy WM 430 Small groups HM 133 Sensitivity training groups WM 430.5.S3 etc. Special topics, by subject Group Psychotherapy see Psychotherapy, Group Group Structure HM 131-134 Group Therapy see Psychotherapy, Group Growth General growth of child WS 103 Mental growth see Child Development WS 105, etc* Physical WS 103 Tables WS 16 Growth Disorders Congenital WE 250 Endocrine WK 550 In infancy & childhood WS 104 Manifestation of disease QZ 190 Pathogenesis QZ 45 Growth Factor, Mast-Cell see Interleukin-3 Growth Factors see Growth Substances Growth Hormone see Somatotropin Growth Hormone, Pituitary see Somatotropin Growth Hormone Receptors see Receptors, Somatotropin Growth Inhibitors QU 107 See also Growth Disorders WE 250, etc. Growth Plate WE 200 Growth Retardation, Intrauterine see Fetal Growth Retardation Growth Substances QU 107 Plant see Plant Growth Regulators QK 745 GTP-Binding Proteins see G-Proteins GTP-Regulatory Proteins see G-Proteins Guanacos see Camelids, New World Guanidines QU 61 Organic chemistry QD 305.A8 Guanine Nucleotide Regulatory Proteins see G-Proteins Guanosine Cyclic Monophosphate see Cyclic GMP Guanosine Cyclic 2',3-Monophosphate see Cyclic GMP Guanosine Cyclic 3',5-Monophosphate see Cyclic GMP Guanylyl Imidodiphosphate QU 57 Guerin-Stern Syndrome see Arthrogryposis Guest Relations see Hospital-Patient Relations Guidelines for Health Planning see Health Planning Guidelines Guillain-Barre Syndrome see Polyradiculoneuritis Guilt BF 575.G8 In adolescence WS 462 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 358 In infancy & childhood WS 105.5.E5 Guinea Pigs QL 737.R634 As laboratory animals QY 60. R6 Guinea Worm see Dracunculus Gums see Gingiva Gunshot Wounds see Wounds, Gunshot Gymnastics QT 255 Medical WB 541 Gymnodinium see Dinoflagellida Gymnotid see Electric Fish Gynecologic Diseases see Genital Diseases, Female Gynecologic Neoplasms see Genital Neoplasms, Female Gynecology WP Pediatrics WS 360 Physiology WP 505 Urology WJ 190 Gynecomastia WP 840 Gypsies see Transients and Migrants WA 300, etc. Gypsum see Calcium Sulfate Gypsum Dressings see Calcium Sulfate Gyrectomy see Psychosurgery H H(+) ATPase Complex see H(+)-Transporting ATP Synthase H-D Antibodies see Antibodies, Heterophile H(+^Transporting ATP Synthase QU 136 H(+)-Transporting ATPase see H(-(-^Transporting ATP Synthase H-Y Antigen WO 680 H-2 Antigens WO 680 See also Mice as laboratory animals QY 60.R6 H 93-26 see Metoprolol Ha-ras Genes see Genes, ras Habilitation see Rehabilitation Habit Disturbances see Habits Habitations see Housing Habits BF 335 Habituation (Psychophysiology) WL 103 Haem Oxygenase see Heme Oxygenase Haemophilus QW 139 Haemophilus ducreyi QW 139 Haemophilus Infections WC 200 See also Chancroid WC 155 Haemophilus influenzae QW 139 Haemophilus pertussis see Bordetella pertussis Hafnium Inorganic chemistry QD 181.H5 Pharmacology QV 290 Hair WR 450-465 Hair Balls see Bezoars Hair Cells WV 250 Hair Color WR 450 Hair Colorants see Hair Dyes Hair Diseases WR 450 Hair Dyes WR 465 Pharmacology QV 235 Hair Follicle Diseases see Hair Diseases Hair Preparations WR 465 See also Barbering WA 744, etc. Hair Removal WR 450 Hairy Cell Leukemia see Leukemia, Hairy Cell Halfway Houses For criminal offenders HV 9081-9920.5 For psychiatric patients WM 29 Halitosis WI 143 Hallucinations WM 204 Hallucinogens QV 77.7 Hallucinosis, Organic see Organic Mental Disorders, Psychotic Hallux WE 835 Hallux Abductovalgus see Hallux Valgus Hallux Valgus WE 883 Halogenated Hydrocarbons see Hydrocarbons, Halogenated Halogens QV 280 Antiseptics QV 231 Haloperidol QV 77.9 Halothane QV 81 Halsted Mastectomy see Mastectomy, Radical Hamadryas see Papio Hamman-Rich Syndrome see Pulmonary Fibrosis Hamsters As laboratory animals QY 60. R6 Hamsters, Armenian see Cricetulus Hamsters, Chinese see Cricetulus Hamsters, Golden see Mesocricetus Hamsters, Golden Syrian see Mesocricetus Hamsters, Grey see Cricetulus Hamsters, Syrian see Mesocricetus Hand WE 830 Infections WE 832 See also Hand Dermatoses WR 140 Hand Deformities WE 830 Hand Deformities, Acquired WE 830 Hand Deformities, Congenital WE 830 Hand Dermatoses WR 140 See also Infections WE 832 under Hand Hand Injuries WE 830 Hand-Schueller-Christian Syndrome WH 650 Hand-Shoulder Syndrome see Reflex Sympathetic Dystrophy Handbooks (Form number 39 in any NLM schedule where applicable) Anesthesiology WO 231 Animal poisoning WD 401 Aviation and space medicine WD 701 Dentistry WU 49 Diseases and injuries caused by physical agents WD 601 Embryology QS 629 Histology QS 529 History of medicine WZ 39 Immunologic diseases. Hypersensitivity. Collagen diseases WD 301 Medicine W 49 Metabolic diseases WD 201 Nursing WY 49 Nutrition disorders WD 101 Pharmacy QV 735 Physiology QT 29 Plant poisoning WD 501 Psychiatry WM 34 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 359 Toxicology QV 607 Handedness see Laterality Handicapped see Disabled Handwashing In hospitals WX 165 In preventive medicine WA 240 Handwriting Graphology BF 889-905 Paleography Z 105-115.5 Used for diagnostic purposes, with the disorder Hanganutziu-Deicher Antibodies see Antibodies, Heterophile Hansen s Disease see Leprosy Hantaan Virus QW 168.5.B9 Hantavirus QW 168.5.B9 Haplorhini QL 737.P925-737.P965 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Happiness BF 575.H27 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Haptoglobins WH 400 Clinical examination QY 455 Harassment, Non-Sexual see Social Behavior Hardware, Computer see Computers Harelip see Cleft Lip Harvest Mites see Mites Hashish see Cannabis Hashish Abuse see Marijuana Abuse Hashish Smoking see Marijuana Smoking Hate BF 575.H3 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Haverhill Fever see Rat-Bite Fever Hay Fever WV 335 Hazardous Chemicals see Hazardous Substances Hazardous Materials see Hazardous Substances Hazardous Substances Environment WA 670-788 Occupational WA 400-495 Radioactive WN 615 Other specific conditions, by subject Hazardous Waste WA 788 Hazardous Waste, Radioactive see Radioactive Waste Hazardous Waste Sites see Hazardous Waste Hazards, Equipment see Equipment Safety HBAg see Hepatitis B Antigens HBeAg see Hepatitis B e Antigens HBsAg see Hepatitis B Surface Antigens HCB see Hexachlorobenzene HCG see Gonadotropins, Chorionic HDL Cholesterol see Lipoproteins, HDL Cholesterol Head WE 705-707 See also Scalp WR 450 Head and Neck Neoplasms WE 707 Head Banging see Stereotyped Behavior Head Injuries WE 706 See also Skull Fractures WL 354 Head Nurses see Nursing, Supervisory Head Protective Devices In industry WA 485 Headache WL 342 See also Migraine WL 344 Healing, Mental see Mental Healing Healing of Wounds see Wound Healing Healing, Religious see Mental Healing Health Developing countries WA 395 Occupational see Occupational Health WA 400-495 Maintenance of personal health QT 255 Mental see Mental Health WM 105, etc. Oral see Oral Health WU 113 Public see Public Health WA, etc. Rural see Rural Health WA 390 Statistics WA 900 Students see School Health Services WA 350, etc.; Student Health Services WA 351, etc. Urban WA 380 See also Hygiene QT 180-275, etc.; Physical Fitness QT 255 Health Administration WA 525-546 Health and Welfare Planning see Health Planning Health Behavior W 85 Special topics, by subject Health Benefit Plans, Employee W 100-275 Health Benefits see Insurance Benefits Health Care Coalitions WA 525-546 In special fields by subject Health Care Costs General W 74 For providing particular types of care, by subject, if specific; if general, in economics number where applicable Health Care Delivery see Delivery of Health Care Health Care Rationing WA 525-546 Health Care Reform WA 525-546 Health Care Research see Health Services Research Health Care Seeking Behavior see Patient Acceptance of Health Care Health Care Systems see Delivery of Health Care Health Care Team see Patient Care Team Health Centers, Ambulatory see Ambulatory Care Facilities Health Centers, Ambulatory, Non-Hospital see Ambulatory Care Facilities Health Diaries see Medical Records Health Education Informal WA 590 Physical see Physical Education and Training QT 255 School texts QT 200-215 See also education under Patients Health Education, Dental WU 113 Health Expenditures W 74 Health Facilities WX General works WX 27 Special types of facilities, with the specialty for which designed See also names of types of facilities, e.g., Maternal-Child Health Centers WA 310; Rehabilitation Centers WM 29, etc. Health Facility Administrators WX 155 Directories WX 22 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 360 Health Systems Agencies Health Facility Conversion see Health Facility Planning Health Facility Planning WX 140 Facility planning in the specialties, with the specialty, e.g., Coronary Care Units WG 27-28 Health Facility Size WX 140 Special types of facility, with the specialty for which designed Health Fairs WA 590 Special topics, by subject Health Insurance see Insurance, Health Health Insurance for Aged and Disabled, Tide 18 see Medicare Health Insurance Reimbursement see Insurance, Health, Reimbursement Health Insurance, Voluntary see Insurance, Health Health Legislation see Legislation Health Maintenance Organizations W 132 Health Manpower W 76 Excluding physicians W 21.5 In specialties see Manpower in the economics number under the specialty, e.g., Dentistry WU 77, etc. or lacking that in the number for the career, e.g., manpower in otolaryngology WV 21 Health Occupations W 21 Specialties, with the field, e.g., Surgery WO 21 Types of medical practice W 87 See also names of particular occupations, e.g., Allied Health Occupations W 21.5, etc.; Mortuary Practice WA 840-847 Health Occupations Manpower see Health Manpower Health Occupations Schools see Schools, Health Occupations Health Physics WN 110 Health Plan Implementation WA 525-546 Special topics, by subject Health Planning Government WA 525-546 Of health services W 84 Of other special topics, by subject Health Planning Councils WA 525-546 With special topics, class by subject Health Planning Guidelines Government WA 525-546 Special topics, by subject Health Planning Organizations WA 23 In special fields, by subject, e.g., WW 23 for ophthalmology institutes Health Planning Support WA 540 Health Policy Government WA 525-546 Special topics, by subject Health Priorities WA 525-546 In special areas by subject Health Professions see Health Occupations Health Promotion Government WA 525-546 Through education WA 590 Special topics, by subject Health Records, Personal see Medical Records Health Resorts WB 760 History WB 760 Health Resources W 74 Hospital financial management WX 157 Specific purposes, by subject Health Risk Appraisal see Health Status Indicators Health Service Area see Catchment Area (Health) Health Services W 84-84.8 Community see Community Health Services WA 546 Emergency see Emergency Medical Services WX 215, etc. See also Emergency Service, Hospital WX 215 For children see Child Health Services WA 320, etc. For the aged WT 31 For the indigent W 250 See also Medical Indigency W 250, etc. Occupational see Occupational Health Services WA 412 Maternal see Maternal Health Services WA 310 Mental see Community "Mental Health Services WM 30; Mental Health Services WM 30, etc. Personal see Personal Health Services W 84 Private practice WB 50 Public see Preventive Health Services WA 108; Public Health Administration WA 525-590 School see School Health Services WA 350, etc.; Student Health Services WA 351, etc. Supply & distribution W 76 See also names of specific services, e.g., Home Care Services WY 115, etc. Health Services Accessibility W 76 Special population groups WA 300-395 Health Services for the Aged WT 31 Health Services, Indigenous W 250 Health Services Marketing see Marketing of Health Services Health Services Misuse W 84-84.8 Special topics, by subject Health Services Needs and Demand In a particular population or community, by subject Health Services Research W 84.3 In special areas, by subject Health Status WB 141.4 Health Status Index see Health Status Indicators Health Status Indicators WA 900 Special topics, by subject Health Surveys WA 900 Chronic disease WT 30 Dental see Dental Health Surveys WU 30 Diet see Nutrition Surveys QU 146 Geriatric WT 30 Hospital surveys WX 27 Nursing surveys WY 31 Public health WA 900 Sanitary WA 672 Of special population groups WA 300, etc. Health Systems Agencies WA 525-546 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 361 Health Systems Plans Health Systems Plans WA 540-546 Health Visitors see Community Health Nursing Hearing WV 270-280 Conservation WV 276 Hearing Aids WV 274 Hearing Disorders WV 270 In infancy & childhood WV 271 Hearing Loss, Bilateral WV 270 Hearing Loss, Conductive WV 270 Hearing Loss, Extreme see Deafness Hearing Loss, Functional WV 270 Hearing Loss, Noise-Induced WV 270 Industrial WA 470 Veterinary SF 891 Hearing Loss, Nonorganic see Hearing Loss, Functional Hearing Loss, Partial WV 270 Hearing Loss, Sensorineural WV 270-276 Hearing Protective Devices see Ear Protective Devices Hearing Tests WV 272 See also Acoustic Impedance Tests WV 272; Audiometry WV 272; names of other specific tests Heart WG Beat Disorders WG 330 Physiology WG 202 See also Heart Rate WG 106; Pulse WB 282, etc.; Tachycardia WG 330 Children WS 290 Drugs affecting QV 150 See also specific drugs Fetal see Fetal heart WQ 210.5 Radiography WG 141.5.R2 Radionuclide imaging WG 141.5.R3 Sounds see Heart Auscultation WG 141.5.A9; Phonocardiography WG 141.5.P4 Tomography WG 141.5.T6 Heart Abnormalities see Heart Defects, Congenital Heart Aneurysm WG 300 Heart Arrest WG 205 Heart, Artificial WG 169.5 Heart-Assist Devices WG 169.5 Heart Atrium WG 201-202 Heart Auscultation WG 141.5.A9 See also Phonocardiography WG 141.5.P4 Heart Block WG 330 Heart Catheterization WG 141.5.C2 Veterinary SF 811 Heart Conduction System WG 201-202 Heart Contractility see Myocardial Contraction Heart Defects, Congenital WG 220 Children WS 290 Heart Diseases WG 210 In infancy & childhood WS 290 Ischemic see Coronary Disease WG 300, etc. Pick s disease see Pericarditis, Constrictive WG 275 Pulmonary see Pulmonary Heart Disease WG 420 Rheumatic see Rheumatic Heart Disease WG 240 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Veterinary SF 811 Heart Enlargement see Heart Hypertrophy Heart Failure, Congestive WG 370 Popular works WG 113 See also Adverse effects WO 245 under Anesthesia Heart Function Tests WG 141.5.F9 See also names of specific tests Heart Hypertrophy WG 210 Heart Injuries WG 210 Surgery WG 169 Heart-Lung Machine see Heart, Mechanical Heart-Lung Transplantation WG 169 Heart Massage WG 205 Heart, Mechanical WG 169.5 Heart Rate WG 106 Heart Rate, Fetal WQ 210.5 Monitoring WQ 209 Heart Rupture, Traumatic see Heart Injuries Heart Septal Defects WG 220 Heart Septal Defects, Atrial WG 220 Heart Septal Defects, Ventricular WG 220 Heart Sounds Physiology WG 106 See also Heart Auscultation WG 141.5.A9; Phonocardiography WG 141.5.P4 Heart Surgery WG 169 In infancy & childhood WS 290 Heart Transplantation WG 169 Heart Valve Diseases WG 260-269 Heart Valve Prosthesis WG 169 Heart Valves WG 260-269 Heart Ventricle WG 201-202 Heart Ventricle, Artificial see Heart-Assist Devices Heart Volume see Cardiac Volume Heartburn WI 145 Heartworm Disease see Dirofilariasis Heat As a cause of disease QZ 57 Body see Body Temperature WB 270, etc.; Skin Temperature WR 102 Control in industry WA 450 Prostration see Heat Exhaustion WD 610 Therapeutic use WB 469 See also Desert Climate QT 150, etc.; Temperature WB 700, etc. Heat Exhaustion WD 610 See also Sunstroke WD 610 Heat Loss see Body Temperature Regulation Heat Production see Body Temperature Regulation Heat-Shock Protein 70 see Heat-Shock Proteins Heat-Shock Protein 90 see Heat-Shock Proteins Heat-Shock Proteins QU 55 Heat Waves see Infrared Rays Heating WA 770 In industry WA 450 Heatstroke see Heat Exhaustion Heavy Metals see Metals Hebephrenic Schizophrenia see Schizophrenia, Disorganized Hedgehogs QL 737.153 Hedonism see Philosophy Heel WE 880 USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSinED 362 Hemoglobins, Abnormal Height see Body Height Height-Weight-Growth Tables see Tables WS 16 under Birth Weight, Body Height, Body Weight, Growth Hela Cells QH 585 Helicobacter Infections WC 200 In specific diseases, with the disease Helicobacter pylori QW 154 Helicopters see Aircraft Heliotherapy General medical WB 480 For treating pulmonary tuberculosis WF 330 Heliotrope see Valerian Helium QV 318 Inorganic chemistry QD 181.H4 Hellebore see Veratrum Helmets see Head Protective Devices Helminth Antigens see Antigens, Helminth Helminthiasis WC 800-890 Veterinary SF 810.H44 Helminthiasis, Animal (Non Mesh) see Veterinary SF 810.H44 under Helminthiasis Helminths QX 200-442 See also Anthelmintics QV 253 Helping Behavior BF 637.H4 Helplessness, Learned WM 165 Hemadsorption Virus 2 see Parainfluenza Virus Type 1 Hemagglutinating Virus of Japan see Parainfluenza Virus Type 1 Hemagglutination QW 640 Hemagglutination Inhibition Tests QY 265 Used for special purposes by subject Hemagglutination Tests Used for special purposes, by subject Hemagglutinins, Plant see Lectins Hemangioma QZ 340 Localized, by site Hemangioma, Cavernous QZ 340 Localized, by site Hemangiopericytoma QZ 340 Localized, by site Hemarthrosis WH 325 Hematemesis WI 146 Related to a particular disease, with the disease Hematin see Heme Hematinics QV 181 Hemato-Encephalic Barrier see Blood-Brain Barrier Hematoblast see Blood Cells Hematochezia see Gastrointestinal Hemorrhage Hematocrit QY 408 Apparatus QY 26 Hematologic Diseases WH General works WH 120 In infancy & childhood WS 300 In pregnancy see Pregnancy Complications, Hematologic WQ 252, etc. Nursing WY 152.5 Veterinary SF 769.5 Hematologic Tests QY 400-415 See also names of specific tests Hematology WH Blood (Clinical analysis) QY 400-490 Children WS 300 In nursing WY 152.5 Hematoma WH 312 Hematoma, Epidural WL 355 Hematoma, Subdural WL 200 Hematopoiesis WH 140 Hematopoietic Agents see Hematinics Hematopoietic Cell Growth Factors WH 140 Hematopoietic Stem Cells WH 380 Hematopoietic System WH 140 Children WS 300 Drugs affecting QV 180 Hematopoietins see Hematopoietic Cell Growth Factors Hematoporphyria see Porphyria Hematoporphyrin Photoradiation WB 480 Hematuria WJ 344 Heme WH 190 Heme Oxygenase QU 140 Hemeproteins WH 190 Clinical examination QY 455 Hemeralopia see Vision Disorders Hemianopsia WW 276 Hemic System see Hematology Hemicrania see Migraine Hemin WH 190 Hemiparesis see Hemiplegia Hemiplegia WL 346 Specific etiological factors, by cause, e.g., Cerebrovascular Disorders WL 355 Hemiptera QX 503 Hemispheres, Cerebral see Brain Hemisporosis see Sporotrichosis Hemochromatosis WR 267 Hemocuprein see Superoxide Dismutase Hemocyanin WH 190 Clinical examination QY 455 Hemocytes WH 140 Hemodialysis WJ 378 Nursing WY 164 Hemodialysis, Home WJ 378 Hemodilution WG 166 In blood transfusion WB 356 In hypothermia WD 670 In microculation WG 104 For other purposes, by subject Hemodynamics WG 106 Hemoencephalic Barrier see Blood-Brain Barrier Hemofiltration Speicial topics, by subject Hemofiltration, Continuous Arteriovenous see Hemofiltration Hemoglobin A WH 190 Clinical examination QY 455 Hemoglobin A, Glycosylated WH 190 Hemoglobin C WH 190 Clinical examination QY 455 Hemoglobin F see Fetal Hemoglobin Hemoglobin Substitutes see Blood Substitutes Hemoglobinopathies WH 190 Hemoglobins WH 190 Clinical examination QY 455 Hemoglobins, Abnormal WH 190 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 363 Hemoglobinuria Hemoglobinuria WJ 344 Hemoglobinuria, Bacillary WJ 344 Hemoglobinuria, Paroxysmal WJ 344 Hemoglobin uric Fever see Malaria Hemolymph WH 400 Hemolysins QW 660 Hemolysis Erythrocyte destruction WH 150 Immunology QW 660 Hemolytic Anemias see Anemia, Hemolytic Hemolytic Disease of Newborn see Erythroblastosis, Fetal Hemoperfusion WG 168 Hemopericardium see Pericardial Effusion Hemoperitoneum WI 575 Hemophilia WH 325 Hemophilia A see Hemophilia Hemophilia, Vascular see von Willebrand's Disease Hemophilus see Haemophilus Hemophilus Infections see Haemophilus Infections Hemophthalmos see Eye Hemorrhage Hemopneumothorax WF 746 Hemoptysis QY 120 Associated with a particular disease, with the disease Hemorrhage WO 700 Cerebral see Cerebral Hemorrhage WL 355 Drugs checking QV 195 In labor WQ 330 Nasal see Epistaxis WV 320 Ovarian WP 320 Peptic ulcer see Peptic Ulcer Hemorrhage WI 350 Retinal see Retinal Hemorrhage WW 270 Subarachnoid see Subarachnoid Hemorrhage WL 200 Uterine see Uterine Hemorrhage WP 440 Veterinary SF 811 Vulva WP 200 See also Menorrhagia WP 555 Hemorrhage, Cerebral see Cerebral Hemorrhage Hemorrhage, Eye see Eye Hemorrhage Hemorrhage, Gastrointestinal see Gastrointestinal Hemorrhage Hemorrhage, Oral see Oral Hemorrhage Hemorrhage, Peptic Ulcer see Peptic Ulcer Hemorrhage Hemorrhage, Postpartum see Postpartum Hemorrhage Hemorrhage, Retinal see Retinal Hemorrhage Hemorrhage, Subarachnoid see Subarachnoid Hemorrhage Hemorrhage, Surgical see Blood Loss, Surgical Hemorrhage, Uterine see Uterine Hemorrhage Hemorrhagic Diathesis WH 312-325 See also names of specific disorders Hemorrhagic Disease of Newborn WS 421 Hemorrhagic Fever, American WC 534 Hemorrhagic Fever, Argentinian see Hemorrhagic Fever, American Hemorrhagic Fever, Bolivian see Hemorrhagic Fever, American Hemorrhagic Fever, Crimean WC 534 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH^ Hemorrhagic Fever, Dengue see Dengue Hemorrhagic Fever, Epidemic see Hemorrhagic Fever with Renal Syndrome Hemorrhagic Fever, Korean see Hemorrhagic Fever with Renal Syndrome Hemorrhagic Fever, Omsk WC 534 Hemorrhagic Fever Virus, Epidemic see Hantaan Virus Hemorrhagic Fever Virus, Korean see Hantaan Virus Hemorrhagic Fever Virus, Omsk see Encephalitis Viruses, Tick-Borne Hemorrhagic Fever with Renal Syndrome WC 534 Veterinary SF 809.H45 Hemorrhagic Fever with Renal Syndrome Virus see Hantaan Virus Hemorrhagic Fevers, Viral WC 534 Hemorrhagic Nephroso-Nephritis see Hemorrhagic Fever with Renal Syndrome Hemorrhagic Nephroso-Nephritis Virus see Hantaan Virus Hemorrhoids WI 605 Hemosiderin QV 183 Hemosiderosis QU 130.5 Localized, by site Hemosorption see Hemoperfusion Hemostasis WH 310 Hemostasis, Surgical WO 500 Complications WO 184 Hemostatics QV 195 Hemothorax WF 746 Hemotoxins see Hemolysins Hemp see Cannabis Heparin QV 193 Heparin-Clearing Factor see Lipoprotein Lipase Heparin Cofactor see Antithrombin III Heparin, Low-Molecular-Weight QV 193 Heparinic Acid see Heparin Heparinoid QV 193 Hepatectomy WI 770 Hepatic Amebiasis see Liver Abscess, Amebic Hepatic Artery WG 595.H3 See also Blood Supply WI 702 under Liver; Liver Circulation WI 702 Hepatic Cirrhosis see Liver Cirrhosis Hepatic Coma see Hepatic Encephalopathy Hepatic Duct, Common WI 750 Hepatic Encephalopathy WI 700 Hepatic Entamoebiasis see Liver Abscess, Amebic Hepatic Failure, Fulminant see Hepatic Encephalopathy Hepatic Transplantation see Liver Transplantation Hepatic Veins WG 625.H3 See also Blood Supply WI 702 under Liver; Liver Circulation WI 702 Hepatitis WI 700 Veterinary see Hepatitis, Animal SF 851 Hepatitis A WC 536 Hepatitis A Virus see Hepatovirus Hepatitis, Alcoholic WI 700 Hepatitis, Animal SF 851 Hepatitis B WC 536 Hepatitis B Antigens WC 536 USE NUMBER ASSIGNED ONLY WHEN [S OF WORK BEING CLASSinED 364 Heterosexuality Hepatitis B e Antigens WC 536 Hepatitis B Surface Antigens WC 536 Hepatitis B Virus QW 170 Hepatitis C WC 536 Hepatitis, Chronic Active WC 536 Hepatitis D see Delta Infection Hepatitis D Virus see Delta Agent Hepatitis, Delta see Delta Infection Hepatitis E WC 536 Hepatitis, Homologous Serum see Hepatitis B Hepatitis, Infectious see Hepatitis A Hepatitis, Toxic WI 700 Hepatitis, Viral, Human WC 536 Hepatitis, Viral, Non-A, Non-B, Enterically-Transmitted see Hepatitis E Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted see Hepatitis C Hepatitis, Viral, Vaccines see Viral Hepatitis Vaccines Hepatitis Virus, Homologous Serum see Hepatitis B Virus Hepatitis Virus, Infectious see Hepatovirus Hepatitis Virus, Marmoset see Hepatitis Viruses Hepatitis Viruses QW 170 Hepatitis, Water-Borne see Hepatitis E Hepatocellular Carcinoma see Carcinoma, Hepatocellular Hepatolenticular Degeneration WI 740 Hepatology see Gastroenterology Hepatoma see Carcinoma, Hepatocellular Hepatoma, Experimental see Liver Neoplasms, Experimental Hepatoma, Morris see Liver Neoplasms, Experimental Hepatoma, Novikoff see Liver Neoplasms, Experimental Hepatomegaly WI 700 Hepatorenal Glycogen Storage Disease see Glycogen Storage Disease Type I Hepatovirus QW 170 Herbal Teas see Beverages Herbalism see Medicine, Herbal Herbicides Plant culture SB 951.4 Public health aspects WA 240 Herbs QV 767 Herbs, Medicinal see Plants, Medicinal Hereditary Diseases QZ 50 In infancy & childhood WS 200 Prenatal diagnosis QZ 50 Veterinary genetics SF 756.5 See also names of specific diseases Hereditary Multiple Exostoses see Exostoses, Multiple Hereditary Hereditary Nonpolyposis Colorectal Neoplasms see Colorectal Neoplasms, Hereditary Nonpolyposis Hereditary Spinal Sclerosis see Friedreich's Ataxia Hereditary Type I Motor and Sensory Neuropathy see Charcot-Marie Disease Heredity see Genetics Hermaphroditism WJ 712 Hernia WI 950 Vaginal WP 250 See also names of specific hernias, e.g., Hernia, Diaphragmatic WF 810, etc. Hernia, Abdominal see Hernia, Ventral Hernia, Cerebral see Encephalocele Hernia, Diaphragmatic WF 810 Hernia, Diaphragmatic, Traumatic WF 810 Hernia, Femoral WI 965 Hernia, Hiatal WI 250 Hernia, Inguinal WI 960 Hernia, Umbilical WI 940 Hernia, Ventral WI 955 Heroin see Diacetylmorphine Heroin Dependence WM 288 Herpes Genitalis WC 578 Herpes labialis Virus see Simplexvirus Herpes Simplex WC 578 Veterinary SF 809.H47 Herpes Simplex, Genital see Herpes Genitalis Herpes Simplex, Oral see Stomatitis, Herpetic Herpes Simplex Virus see Simplexvirus Herpes Zoster WC 575 Herpes Zoster, Ocular see Herpes Zoster Ophthalmicus Herpes Zoster Ophthalmicus WW 160 Herpes zoster Virus see Herpesvirus 3, Human Herpesviridae QW 165.5.H3 Herpesviridae Infections WC 571 Veterinary SF 809.H47 Herpesvirus hominis see Simplexvirus Herpesvirus Infections see Herpesviridae Infections Herpesvirus platyrhinae see Simplexvirus Herpesvirus saimiri see Herpesvirus 2, Saimirine Herpesvirus varicellae see Herpesvirus 3, Human Herpesvirus 1, Bovine QW 165.5.H3 Herpesvirus 1, Saimirine see Simplexvirus Herpesvirus 1, Suid QW 165.5.H3 Herpesvirus 2, Saimirine QW 165.5.H3 Herpesvirus 3, Human QW 165.5.H3 Herpesvirus 4, Human QW 165.5.H3 Herpesvirus 5 O^eta), Human see Cytomegalovirus Herpesvirus 5, Human see Cytomegalovirus Hertzian Waves see Radio Waves HETE see Hydroxyeicosatetraenoic Acids Heteroantibodies see Antibodies, Heterophile Heterochromatin QU 56 Heterochromic Cyclitis see Iridocyclitis Heterocyclic Compounds Associated with amino acid biochemistry QU 65 Organic chemistry QD 399-406 Used for special purposes, by subject See also names of specific compounds Heterocyclic N-Oxides see Cyclic N-Oxides Heterograft see Transplantation, Heterologous Heterograft Bioprosthesis see Bioprosthesis Heterograft Dressings see Biological Dressings Heterologous Antibodies see Antibodies, Heterophile Heterophile Antibodies see Antibodies, Heterophile Heterophoria see Strabismus Heterophyes see Heterophyidae Heterophyidae QX 353 Heteroptera see Hemiptera Heterosexuality see Sex Behavior ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 365 Heterotopia Heterotropia see Strabismus Heterozygote QH 447 Histocompatibility WO 680 Heterozygote Detection Of a particular trait, with the trait Hexachlorobenzene Toxicology QV 633 Hexachlorocyclohexane see Benzene Hexachloride Hexachlorophene QV 233 Hexadecadrol see Dexamethasone Hexadecanoic Acid see Palmitic Acids Hexamethonium Compounds QV 140 Hexamethylenamine see Methenamine Hexamethylenetetramine see Methenamine Hexamine see Methenamine Hexanes Microbial chemistry QW 52 Toxicology QV 633 Hexanoates see Caproates Hexestrol WP 522 Hexobarbital QV 81 Hexokinase QU 141 Hexose Monophosphate Shunt see Pentosephosphate Pathway Hexosephosphates QU 75 Hexoses QU 75 Hexylresorcinol QV 253 Heymann Nephritis see Glomerulonephritis HFRS see Hemorrhagic Fever with Renal Syndrome HFRS Virus see Hantaan Virus Hiatal Hernia see Hernia, Hiatal Hibernation QL 755 Hibernation, Artificial see Hypothermia, Induced Hiccup WF 805 Hidradenoma see Adenoma, Sweat Gland Hidrotic Ectodermal Dysplasia see Ectodermal Dysplasia Hierarchy, Social HM 132 Special topics, by subject High-Cost Technology see Technology, High-Cost High-Frequency Currents see Electric Stimulation Therapy; Electricity High-Frequency Jet Ventilation WF 145 High Mobility Protein 20 see Ubiquitin Higher Nervous Activity WL 102 Highway Accidents see Accidents, Traffic Hill-Burton Act see Financing, Government Hindbrain see Cerebellum; Pons; Medulla Oblongata Hindlimb QL 950.7 Hip WE 855 Hip Contracture WE 855 Hip Dislocation WE 860 Hip Dislocation, Congenital WE 860 Hip Dysplasia, Canine SF 992.H56 Hip Dysplasia, Congenital see Hip Dislocation, Congenital Hip Fractures WE 855 Hip Joint WE 860 Hip Prosthesis WE 860 Hippocampus WL 314 Hippocratic Oath W 50 Hippurates QU 62 Organic chemistry QD 341.A7 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA In human urine WJ 303 In urinalysis QY 185 Hirschsprung Disease WI 528 Hirsutism WR 455 Hirudinea see Leeches His-Werner Disease see Trench Fever Hispanic Americans E 184.S75 Special topics, by subject See also special topics under Ethnic Groups Histaminase see Amine Oxidase (Copper-Containing) Histamine QV 157 Biochemistry QU 61 Histamine Antagonists QV 157 Histamine Binding Sites see Receptors, Histamine Histamine HI Antagonists QV 157 Histamine HI Receptor Antagonists see Histamine HI Antagonists Histamine HI Receptor Blockaders see Histamine HI Antagonists Histamine H2 Antagonists QV 157 Histamine H2 Receptor Antagonists see Histamine H2 Antagonists Histamine H2 Receptor Blockaders see Histamine H2 Antagonists Histamine H2 Receptors see Receptors, Histamine H2 Histamine Liberation In anaphylaxis and hypersensitivity QW 900 Special topics, by subject Histamine Receptors see Receptors, Histamine Histapyridamine see Pheniramine Histidine QU 60 Histiocytes WH 650 In phagocytosis QW 690 Histiocytic Lymphoma see Lymphoma, Large-Cell Histiocytosis, Langerhans-Cell WH 650 Histiocytosis, Lipid see Niemann-Pick Disease Histiocytosis X see Histiocytosis, Langerhans-Cell Histochemistry see Histocytochemistry Histocompatibility WO 680 Blood bank procedures WH 460 Histocompatibility Antigens QW 573.5.H6 Transplantation immunology WO 680 Histocompatibility Antigens Class II QW 573.5.H6 Transplantation immunology WO 680 Histocompatibility Complex see Major Histocompatibility Complex Histocompatibility Testing WO 680 Histocytochemistry Cytology QH 613 Histology QS 531 Histological Techniques QS 525 Histologists, Directories see Directories QS 22 under Histology Histology QS 504-539 Dental WU 101 Directories QS 22 Experimental QS 530 Pathological QZ 4 Veterinary medicine SF 757.3 See also special topics under Anatomy Histology, Comparative QS 504 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 366 Homosexuality, Female Animal only QL 807 Histomoniasis see Protozoan Infections Histones QU 56 Histopathology see Pathology QZ 4 under Histology Histoplasmosis WC 465 Historical Cohort Studies see Cohort Studies Historiography D 13-15 Medical WZ 345 History of Dentistry WU 11 History of Medicine WZ By locality WZ 70 For special groups WZ 80-80.5 General works WZ 40 Symbols see Emblems and insignia WZ 334 See also form number 11 in any NLM schedule where applicable History of Medicine, Ancient WZ 51 History of Medicine, Medieval WZ 54 History of Medicine, Modern WZ 55 History of Medicine, 15th Cent. WZ 56 History of Medicine, 16th Cent. WZ 56 History of Medicine, 17th Cent. WZ 56 History of Medicine, 18th Cent. WZ 56 History of Medicine, 19th Cent. WZ 60 History of Medicine, 20th Cent. WZ 64 History of Nursing WY 11 History Taking see Medical History Taking Histrionic Personality Disorder WM 173 HIV QW 168.5.H6 HIV Antibodies QW 575 HIV Antibody Positive see HIV Seropositivity HIV-Associated Antibodies see HIV Antibodies HIV-Associated Nephropathy see AIDS-Associated Nephropathy HIV Dementia see AIDS Dementia Complex HIV Encephalopathy see AIDS Dementia Complex HIV Infections WC 503-503.7 HIV Seroconversion see HIV Seropositivity HIV Serodiagnosis see AIDS Serodiagnosis HIV Seronegativity WC 503-503.7 HIV Seropositivity WC 503-503.7 HIV Seroprevalence WC 503.4 HIV-1 QW 168.5.H6 HIV-2 QW 168.5.H6 Hives see Urticaria HLA Antigens QW 573.5.H7 Transplantation immunology WO 680 HLA-D Antigens QW 573.5.H7 Transplantation immunology WO 680 HLA-Dw Antigens see HLA-D Antigens HMG CoA Reductases see Hydroxymethylglutaryl CoA Reductases HMG-20 see Ubiquitin HMN Distal Type I see Charcot-Marie Disease HMO see Health Maintenance Organizations HMSN Type I see Charcot-Marie Disease Hoarseness WV 510 Hobbies QT 250 Hockey QT 260.5.H6 Hodgkin's Disease WH 500 HOE 766 see Buserelin Hog Cholera SF 973 Holidays GT 3925-4995 Holistic Health W 61 Medical ethics W 50 Medical philosophy W 61 Holocaine Hydrochloride see Anesthetics, Local Holography Acoustic (Physics) QC 244.5 Applied TA 1540-1555 Physical optics QC 449-449.3 Holter Monitoring see Electrocardiography, Ambulatory Home Accidents see Accidents, Home Home Blood Glucose Monitoring see Blood Glucose Self-Monitoring Home Care Agencies WY 115 Home Care, Non-Professional see Home Nursing Home Care Services WY 115 Mental patients WM 35 Tuberculous patients WF 315 See also Popular works WB 120 under Medicine; Self Medication WB 120 Home Childbirth WQ 155 Home Health Agencies see Home Care Agencies Home Health Care Agencies see Home Care Agencies Home Hemodialysis see Hemodialysis, Home Home Medicine see Popular works WB 120 under Medicine; Self Medication Home Nursing WY 200 See also Nursing, Practical WY 195 Home care services WY 115, etc. Home Range Animal behaviour QL 751 See also Territoriality QL 756.2 Homeless Persons HV 4480-4630 Special topics, by subject, e.g., Health problems of homeless persons WA 300-305 Homeopathy WB 930 History WB 930 In infancy & childhood WS 366 In treatment of particular diseases or system with the disease or system Veterinary medicine SF 746 Homeostasis QT 120 Homes for the Aged WT 27-28 Homicide Criminology HV 6499-6535 Juvenile HV 9067.H6 Medicolegal aspects W 860 Hominidae GN 51-289 Hominids see Hominidae Homo sapiens see Hominidae Homocystinuria WD 205.5.A5 Homograft see Transplantation, Homologous Homograft Dressings see Biological Dressings Homologous Sequences, Nucleic Acid see Sequence Homology, Nucleic Acid Homologous Wasting Disease see Graft vs Host Disease Homosexuality HQ 75-76.8 Psychiatric aspects WM 611 Homosexuality, Ego-Dystonic WM 611 Homosexuality, Female HQ 75.3-75.6 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 367 Homosexuality, Female Psychiatric aspects WM 611 Homosexuality, Male HQ 75.7-76.2 Psychiatric aspects WM 611 Homozygote QH 447 Histocompatibility WO 680 Honey Dietary supplement in health or disease WB 447 Pharmaceutical preparation QV 785 Hoof and Claw QL 942 Domestic animals SF 761-768 Hookworm Infections WC 890 Veterinary SF 810.N4 Hookworm, New World see Necator Hookworm, Old World see Ancylostoma Hookworms see Ancylostomatoidea Hordeolum WW 205 Hormone Analogs see Hormones, Synthetic Hormone Antagonists WK 102 See also names of specific antagonists Hormone-Dependent Neoplasms see Neoplasms, Hormone-Dependent Hormone Replacement Therapy, Post-Menopausal see Estrogen Replacement Therapy Hormones WK Analysis QY 330-335 Female see Sex Hormones WP 520-530, etc.; and names of specific hormones General works WK 102 Male see Sex Hormones WJ 875, etc.; and names of specific hormones Renal WK 180 Secretion WK 102 Steroid WK 150 Therapeutic use WK 190 See also names of specific hormones Hormones, Ectopic WK 185 Neoplastic etiology QZ 202 Hormones, Invertebrate see Invertebrate Hormones Hormones, Synthetic WK 187 See also names of specific hormones Hornets see Wasps Horse Diseases SF 951-959 Horseradish Peroxidase QU 140 Horses SF 277-360.4 Anatomy SF 765 Horseshoeing SF 907 Military UC 600-695 Horseshoe Crabs QX 460 Hospice Care WB 310 Hospice Programs see Hospice Care Hospices WX 28.6-28.62 Hospital-Addiction Syndrome see Munchausen Syndrome Hospital Administration WX 150-190 As a career WX 155 Of specialty hospitals (Form number 27-28 in any NLM schedule where applicable) Of wards General hospitals WX 159 Psychiatric hospitals WM 30 Hospital Administrators WX 155 Hospital Admission Tests see Diagnostic Tests, ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIU Routine Hospital Admissions Office see Admitting Department, Hospital Hospital Admitting Department see Admitting Department, Hospital Hospital Ancillary Services see Ancillary Services, Hospital Hospital Anesthesia Department see Anesthesia Department, Hospital Hospital Anesthesia-Resuscitation Department see Anesthesia Department, Hospital Hospital Auxiliaries WX 159.5 Hospital Bed Capacity WX 140 Hospital Care see Hospitalization Hospital Central Supply see Central Supply, Hospital Hospital Chaplaincy Service see Chaplaincy Service, Hospital Hospital Communication Systems WX 150 In disaster WX 185 Hospital Dental Service see Dental Service, Hospital Hospital Dental Staff see Dental Staff, Hospital Hospital Departments WX 200-225 See also names of various hospital departments, e.g., Psychiatric Department, Hospital WM 27-28 Hospital Design and Construction WX 140 In specialty fields (Form number 27-28 in any NLM schedule where applicable) Hospital Distribution Systems WX 165 Hospital Diversification see Hospital Restructuring Hospital Drug Distribution Systems see Medication Systems, Hospital Hospital Economics see Economics, Hospital Hospital Emergency Service see Emergency Service, Hospital Hospital Engineering see Maintenance and Engineering, Hospital Hospital Equipment and Supplies see Equipment and Supplies, Hospital Hospital Financial Management see Financial Management, Hospital Hospital Food Service see Food Service, Hospital Hospital Gift Shops see Hospital Shops Hospital Groundskeeping see Maintenance and Engineering, Hospital Hospital Housekeeping see Housekeeping, Hospital Hospital Incident Reporting see Risk Management Hospital Infection see Cross Infection Hospital Infections see Cross Infection Hospital Information Systems WX 26.5 In particular fields (Form number 26.5 in any NLM schedule where applicable) Hospital Jurisprudence see Jurisprudence Hospital Laboratories see Laboratories, Hospital Hospital Laundry Service see Laundry Service, Hospital Hospital Licensure see Licensure, Hospital Hospital Maintenance see Maintenance and Engineering, Hospital Hospital Materials Management see Materials Management, Hospital Hospital Medical Records Department see Medical Records Department, Hospital USE NUMBER ASSIGNED ONLY WHEN ilS OF WORK BEING CLASSinED 368 Hospitals, Special Hospital Medical Staff see Medical Staff, Hospital Hospital Medication Systems see Medication Systems, Hospital Hospital Nuclear Medicine Department see Nuclear Medicine Department, Hospital Hospital Nurseries see Nurseries, Hospital Hospital Nursing Service see Nursing Service, Hospital Hospital Nursing Staff see Nursing Staff, Hospital Hospital Obstetrics and Gynecology Department see Obstetrics and Gynecology Department, Hospital Hospital Occupational Therapy Department see Occupational Therapy Department, Hospital Hospital Organization and Administration see Hospital Administration Hospital Outpatient Clinics see Outpatient Clinics, Hospital Hospital-Patient Relations WX 158.5 Hospital Personnel see Personnel, Hospital Hospital Personnel Administration see Personnel Administration, Hospital Hospital Pharmacy Service see Pharmacy Service, Hospital Hospital Physical Therapy Department see Physical Therapy Department, Hospital Hospital-Physician Joint Ventures WX 150 Hospital Planning WX 140 Mental hospitals WM 30 Other special hospitals (Form number 27-28 in any NLM schedule where applicable) Hospital Psychiatric Department see Psychiatric Department, Hospital Hospital Purchasing see Purchasing, Hospital Hospital Radiology Department see Radiology Department, Hospital Hospital Readmission see Patient Readmission Hospital Records WX 173 Hospital Recovery Room see Recovery Room Hospital Referral see Referral and Consultation Hospital Renovation see Hospital Design and Construction Hospital Reorganization see Hospital Restructuring Hospital Respiratory Therapy Department see Respiratory Therapy Department, Hospital Hospital Restructuring WX 150 Hospital Services, Centralized see Centralized Hospital Services Hospital Shared Services WX 150 Hospital Shops WX 161 Hospital Social Work Department see Social Work Department, Hospital Hospital Surgery Department see Surgery Department, Hospital Hospital Units WX 200-218 Self-care units WX 200 Wards WX 200 Hospital Urology Department see Urology Department, Hospital Hospital Volunteers WX 159.5 Mental hospitals WM 30.5 Nursing WY 193 Hospitalization WX 158-158.5 Anecdotes about WZ 305.5 Children see Child, Hospitalized WS 105.5.H7 Insurance see Insurance, Hospitalization W 160 Tuberculosis WF 330 Hospitalization Insurance see Insurance, Hospitalization Hospitalized Child see Child, Hospitalized Hospitals WX Administrative serial reports (all types of hospitals) WX 2 Directories (Form number 22 in any NLM schedule where applicable) Disasters WX 185 Food service see Food Service, Hospital WX 168 Libraries see Libraries, Hospital Z 675.H7 Medical record libraries see Medical Records, Medical Record Administrators WX 173, etc. Safety measures WX 185 Social service W 322 Standards WX 15 Surveys WX 27 Veterinary see Hospitals, Animal SF 604.4-604.7 See also Accreditation WX 15, etc.; Hospitals, Military UH 460-485; Utilization Review WX 153 Hospitals, Air Force see Hospitals, Military Hospitals, Animal SF 604.5 Hospitals, Army see Hospitals, Military Hospitals, Cancer see Cancer Care Facilities Hospitals, Community WX 27-28 Administration and organization WX 150-190 Architectural planning and construction WX 140 Hospitals, Convalescent WX 27-28 Administration and organization WX 150-190 Architectural planning and construction WX 140 Hospitals, General WX 27-28 Administration and organization WX 150-190 Architectural planning and construction WX 140 Hospitals, Maternity WQ 27-28 Hospitals, Military UH 460-485 Naval VG 410-450 Hospitals, Navy see Hospitals, Military Hospitals, Private, Not-for-Profit see Hospitals, Voluntary Hospitals, Psychiatric WM 27-28 Administration WM 30 Directories WM 22 For children only WS 27-28 Practices in care of mental patients WM 35 See also Psychiatric Department, Hospital WM 27-28, etc. Hospitals, Public WX 27-28 See also special topics under Hospitals Hospitals, Special (Form number 27-28 in any NLM schedule where applicable) Cancer QZ 23-24 Hospices WX 28.6-28.62 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSriTED 369 Hospitals, Special Isolation WC 27-28 Leprosaria WC 27-28 Maternity WQ 27-28 Quarantine WC 27-28 Tuberculosis WF 27-28 Hospitals, Teaching WX 27-28 For specific curriculum, in hospital number of appropriate schedule Hospitals, Veterans UH 460-485 Administration UH 460-465 Nursing WY 130 Special topics, by subject Hospitals, Veterinary see Hospitals, Animal Hospitals, Voluntary see Hospitals WX 27-28, etc. Host-Parasite Relations QX 45 Hostility BF 575.H6 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Hostility Catharsis see Abreaction Hot Climate Physiological effect QT 150 Hotlines Special topics, by subject, e.g., Emergency Services, Psychiatric WM 401 House Calls WB 50 House Staff see Internship and Residency Houseflies QX 505 Household Articles Accidents from WA 288 Safety control Home measures WA 288 Regulatory measures WA 288 Household Equipment see Household Articles Household Medicine see Popular works WB 120, etc. under Medicine Household Products As a cause of accidents WA 288 Ocular toxicity WW 100 Safety control Home measures WA 288 Regulatory measures WA 288 See also names of specific products Household Supplies see Household Products Housekeeping Building operations and housekeeping TX 955-985 Home economics TX 301-323 Plant housekeeping TS 193 See also Self Help Devices WB 320 Housekeeping, Hospital WX 165 Housing Design for the disabled WA 795 See also Architecture WA 795, etc. Architectural Accessibility WA 795-799 For the elderly WT 30 Real estate HD 251-1395 Repairs and maintenance TH 4817 Rural HD 7289 Sanitation WA 795 See also Public Housing HD 7288-7288.78 Housing, Animal SF 91 Laboratory animals QY 56 Of particular animals, by animal Housing for the Elderly WT 30 HPLC see Chromatography, High Pressure Liquid HSAN Type III see Dysautonomia, Familial HTLV-BLV Infections WC 502 HTLV-BLV Viruses QW 168.5.R18 HTLV-I QW 168.5.R18 HTLV-I Infections WC 502 HTLV-III see HIV HTLV-III Antibodies see HIV Antibodies HTLV-III Infections see HIV Infections HTLV-III-LAV Antibodies see HIV Antibodies HTLV-III-LAV Infections see HIV Infections HTLV-III Seroconversion see HIV Seropositivity HTLV-III Serodiagnosis see AIDS Serodiagnosis HTLV-III Serology see AIDS Serodiagnosis HTLV-III Seronegativity see HIV Seronegativity HTLV-III Seropositivity see HIV Seropositivity HTLV Infections see HTLV-BLV Infections HTLV-IV see HIV-2 HTLV Viruses see HTLV-BLV Viruses Human Anatomy see Anatomy Human Class II Antigens see HLA-D Antigens Human Development BF 713 Aging process WT 104 Physical development WS 103 Human Engineering TA 166-167 Special topics, by subject, e.g., Biomedical Engineering QT 36, etc.; Space Right WD 750-758 Human Experimentation W 20.55.H9 Special topics, by subject, e.g., in drug research QV 20.5 Human Figure in Art see Anatomy, Artistic Human Forefoot see Forefoot, Human Human Genome see Genome, Human Human Immunodeficiency Virus-Associated Nephropathy see AIDS-Associated Nephropathy Human Immunodeficiency Virus Type 1 see HIV-1 Human Immunodeficiency Virus Type 2 see HIV-2 Human Immunodeficiency Viruses see HIV Human-Pet Bonding see Bonding, Human-Pet Human Physiology see Physiology Human Reproduction see Reproduction Human Resources Development see Staff Development Human Rights Constitutional law (United States) KF 4741-4786 Right to education KF 4151-4155 Political theory JC 571-628 Special topic by subject, e.q., Advocacy of Child Health Services WA 320 See also Civil Rights WM 30-32, etc.; Wpmen 's Rights HQ 1236-1236.5 Human T-Cell Leukemia-Lymphoma Viruses see HTLV-BLV Viruses Human T-Cell Leukemia Virus I see HTLV-I Human T-Cell Leukemia Viruses see HTLV-BLV Viruses Human T-Cell Lymphotropic Virus Type III see HIV Human T-Lymphotropic Virus Type III see HIV Human T-Lymphotropic Virus Type IV see HIV-2 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 370 Hydrogen-Ion Concentration Humanism In medical etiiics W 50 In medical philosophy W 61 Modern B 821 Renaissance B 778 In other areas, by subject Humanities CB, AZ And religion BL 65.H8 And science AZ 361, etc. Education (Humanistic) LC 1001-1C24 Renaissance LA 106-108 Other special topics, by subject Humeral Fractures WE 810 Humeral Fractures, Proximal see Shoulder Fractures Humerus WE 810 Humic Acids Geochemistry QE 516-516.5 Soil acidity (agriculture) S 592.57-592.575 Humidity Control WA 774 In industry WA 450 Hygienic aspects QT 230 Hot climates QT 150 Meteorology QC 915-917 Physiological effects (General) QT 162.H8 Humor see Wit and Humor Hunger Malnutrition WD 100 Nutrition surveys QU 146 Physiology WI 102 Prevention WA 695 Huntington Chorea see Huntington's Disease Huntington s Disease WL 390 Hurler-Scheie Syndrome see Mucopolysaccharidosis I Hurler s Syndrome see Mucopolysaccharidosis I Hurricanes see Natural Disasters Hutchinson s Teeth see Syphilis, Congenital HY Antigen see H-Y Antigen Hyaline Membrane Disease WS 410 Hyaluronic Acid QU 83 Hybrid Cells QH 425 Hybridization QH 421-425 Animals QH 425 Plants QK 982 See also Animals SF 105-109 and Plants under Breeding SB 123-123.5 Hybridomas As fused cells QH 451 In the production of monoclonal antibodies QW 575.5.A6 Hydantoins QV 85 Hydatid see Echinococcus Hydatid Cyst see Echinococcosis Hydatid Cyst, Hepatic see Echinococcosis, Hepatic Hydatid Cyst, Pulmonary see Echinococcosis, Pulmonary Hydatidiform Mole WP 465 Malignant see Hydatidiform Mole, Invasive WP 465, etc. Pathology QZ 310 Hydatidiform Mole, Invasive WP 465 Pathology QZ 310 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Hydatidosis see Echinococcosis Hydatidosis, Hepatic .see Echinococcosis, Hepatic Hydatidosis, Pulmonary see Echinococcosis, Pulmonary Hydralazine QV 150 Hydrallazin see Hydralazine Hydrarthrosis WE 304 Hydrated Alumina see Aluminum Hydroxide Hydrazines As antiparkinson agents QV 80 Biochemistry QU 60 Organic chemistry Aliphatic compounds QD 305.A8 Neoplasm etiology QZ 202 See also Phenylhydrazines QD 341.A8, etc. Hydrocarbons Organic chemistry Aliphatic compounds QD 305.H5-H9 Aromatic compounds QD 341.H9 Toxicology QV 633 Hydrocarbons, Chlorinated As anesthetics QV 81 Organic chemistry QD 305.H5 Aliphatic QD 305.H5 Aromatic QD 341.H9 Toxicology QV 633 Hydrocarbons, Fluorinated Organic chemistry Aliphatic compounds QD 305.H5 Aromatic compounds QD 341.H9 Toxicology QV 633 Hydrocarbons, Halogenated As anesthetics QV 81 As carcinogens QZ 202 Organic chemistry Aliphatic QD 305.H5 Aromatic QD 341.H9 Toxicology QV 633 Hydrocarbons, Polycyclic see Polycyclic Hydrocarbons Hydrocele WJ 800 Hydrocephalus WL 350 Hydrochloric Acid QD 181.C5 Gastric see Gastric Juice WI 302, etc. Toxicology QV 612 Hydrochloric Acid, Gastric see Gastric Acid Hydrochlorothiazide QV 160 Hydrocortisone WK 755 Deficiency WK 760 As a cause of a particular disorder, with the disorder Hydrocortisone, Topical QV 60 Hydrocyanic Acid see Hydrogen Cyanide Hydroelectric Power Plants see Power Plants Hydrogen Inorganic chemistry QD 181.HI Pharmacology QV 275 Hydrogen Acceptors see Oxidation-Reduction Hydrogen Bonding QD 464.H1 Hydrogen Chloride see Hydrochloric Acid Hydrogen Cyanide QV 632 Hydrogen-Ion Concentration Electrochemistry QD 562.H93 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 371 Hydrogen-Ion Concentration Disorders of body fluids WD 220 In body fluids QU 105 Hydrogen Ions see Protons Hydrogen Peroxide QV 229 Hydrogen Sulfide Inorganic chemistry QD 181.S1 Toxicology QV 662 Hydrogenation QD 281.H8 Hydrogenomonas see Pseudomonas Hydrogymnastics see Hydrotherapy Hydrolases QU 136 Hydrolysis Organic chemistry QD 281.H83 Physical chemistry QD 501 Hydronephrosis WJ 300 Hydrophobia see Rabies Hydrophthalmos WW 290 Hydrops see Edema Hydroquinones As dermatologic agents QV 60 Organic chemistry QD 341.P5 Hydrostatic Pressure Physiological adaptation WD 650 Hydrotherapy WB 520-525 Hydroxamic Acids QU 61 Organic chemistry QD 305.A8 Hydroxides QV 280 Hydroxy Acids QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Aromatic compounds QD 341.A2 Hydroxyampicillin see Amoxicillin Hydroxyapatites Of bone in general WE 200 Of teeth WU 101 Hydroxybutyrates In diabetic acidosis WK 830 Organic chemistry QD 305.A2 Hydroxychlorobenzenes see Chlorophenols Hydroxychlorochin see Hydroxychloroquine Hydroxychloroquine QV 256 Hydroxycholecalciferols QU 173 Hydroxycorticosteroid Analogs see Hydroxycorticosteroids, Synthetic Hydroxycorticosteroids WK 755 Hydroxycorticosteroids, Synthetic WK 757 Hydroxyeicosatetraenoic Acids QU 90 Hydroxyethyl Starch Plasma Substitute WH 450 Biochemistry QU 83 Hydroxyethylrutoside QU 220 Hydroxyimino Compounds see Oximes Hydroxylamines QU 61 Inorganic chemistry QD 181.N1 Hydroxylases QU 140 Hydroxylation Organic chemistry QD 281.H85 Hydroxymethoxyphenylglycol see Methoxyhydroxyphenylglycol Hydroxy methylglutaryl CoA Reductases QU 140 Hydroxymethyltestosterone WJ 875 Hydroxynaphthalenes see Naphthols Hydroxyphenylbutazone see Oxyphenbutazone Hydroxyproline QU 60 Hydroxyquinolines As anti-infective agents QV 250 Organic chemistry QD 401 Hydroxysteroid Dehydrogenases QU 140 Hydroxytetracycline see Oxytetracycline Hydroxytyramine see Dopamine Hydroxyvitamins D see Hydroxycholecalciferols Hygiene QT 180-275 Cleanliness QT 240 Dental see Dental Prophylaxis WU 113 See also Preventive Dentistry WU 113 In adolescence WS 460 In cardiovascular diseases WG 113 In gastrointestinal diseases WI 113 In infancy & childhood WS 113 In old age WT 120 In pregnancy WQ 150 Prenatal care WQ 175 Industrial see Occupational Health WA 400-495 Mental see Mental Health WA 495, etc. Military see Military Hygiene UH 600-629.5 Naval VG 470-475 See also Naval Medicine VG 470-475 Of cold climates QT 160 Of eyes WW 113 Of hot climates QT 150 Of school children WA 350 Of students WA 350 Oral see Oral Hygiene WU 113, etc. Prisons HV 8833-8841 Public see Public Health WA, etc. Rural see Rural Health WA 390, etc. Surgery WO 113 Tropical QT 150 See also Tropical Medicine WC 680, etc. Hygienists, Dental see Dental Hygienists Hylobates QL 737.P96 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Hymen WP 250 Hymenolepis QX 400 Hymenoptera QX 565 Hyoid Bone WE 705 Hyoscine see Scopolamine Hyoscyamine see Atropine Hyoscyamus see Atropine Hyperactive Child see Hyperkinesis Hyperactivity, Motor see Hyperkinesis Hyperaldosteronism WK 770 Hyperalimentation, Parenteral see Parenteral Nutrition, Total Hyperbaric Oxygenation WF 145 Used in general therapeutics WB 342 For treatment of other special conditions, by subject Hyperbilirubinemia WI 703 Hyperbilirubinemia, Hereditary WD 205.5.H9 Hyperbilirubinemia, Neonatal see Jaundice, Neonatal Hypercalcemia WD 200.5.C2 Hypercapnia WF 140 Hypercholesteremia see Hypercholesterolemia ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 372 Hypertrophy Hypercholesterolemia WD 200.5.H8 Hypercorticism see Adrenal Gland Hyperfunction Hyperemesis Gravidarum WQ 215 Hyperemia QZ 170 Localized, by site Hyperesthesia WL 710 Of skin WR 280 Of the vagina WP 250 Other localities, by site Hyperglycemia WK 880 Hyperglycemic Hyperosmolar Nonketotic Coma WK 830 Hyperhidrosis WR 400 Hyperinsulinism WK 880 Hyperkeratosis Linguae see Tongue, Hairy Hyperkeratosis Palmaris et Plantaris see Keratoderma, Palmoplantar Hyperkinesis WM 197 In adolescence WS 463 In infancy & childhood WS 350.8.H9 Hyperkinetic Heart Syndrome see Neurocirculatory Asthenia Hyperkinetic Syndrome see Attention Deficit Disorder with Hyperactivity Hyperlipemia see Hyperlipidemia Hyperlipidemia WD 200.5.H8 Hyperlipidemia, Essential Familial see Hyperlipidemia Hyperlipoproteinemia WD 205.5.L5 Hyperlipoproteinemia Type IV WD 205.5.L5 Hypermenorrhea see Menorrhagia Hypermetropia see Hyperopia Hypermobility, Joint see Joint Instability Hypernatremia WD 220 Hypernephroma see Carcinoma, Renal Cell Hyperopia WW 300 Hyperostosis Corticalis Generalisata see Osteochondrodysplasias Hyperostosis Frontalis Interna WE 705 Hyperparathyroidism WK 300 Hyperphagia WM 175 Hyperpituitarism WK 550 Hyperplasia QZ 190 Hyperprebetalipoproteinemia see Hyperlipoproteinemia Type IV Hyperprolactinemia WD 200.5.H9 Hypersensitivity Allergenic substances see Allergens QW 900 Diseases (General) WD 300-330 Drug see Drug Hypersensitivity WD 320 Eye WW 160 Food see Food Hypersensitivity WD 310 Immunology QW 900 Light see Photosensitivity Disorders WR 160 Respiratory see Respiratory Hypersensitivity WF 150 Skin WR 160-190 Veterinary SF 757.2 See also other specific diseases or disease groups associated with hypersensitivity, e.g., Collagen Diseases WD 375 Hypersensitivity, Atopic see Hypersensitivity, Immediate Hypersensitivity, Contact see Dermatitis, Contact Hypersensitivity, Delayed WD 300-330 General works WD 300 Immunologic factors QW 900 Hypersensitivity, Drug see Drug Hypersensitivity Hypersensitivity, Food see Food Hypersensitivity Hypersensitivity, Immediate WD 300-305 General works WD 300 Immunological factors QW 900 Hypersensitivity Pneumonitis, Avian see Bird Fancier's Lung Hypersensitivity, Respiratory see Respiratory Hypersensitivity Hypersensitivity, Tuberculin-Type see Hypersensitivity, Delayed Hypersensitivity, Type I see Hypersensitivity, Immediate Hypersensitivity, Type III see Immune Complex Diseases Hypersensitivity, Type IV see Hypersensitivity, Delayed Hypersomnia WM 188 Hypersomnia with Periodic Respiration see Sleep Apnea Syndromes Hypersplenism WH 600 Hypertelorism WE 705 Hypertensinogen see Angiotensinogen Hypertension WG 340 Hypertension-Edema-Proteinuria Gestosis see Gestosis, EPH Hypertension, Goldblatt see Hypertension, Renovascular Hypertension, Malignant WG 340 Hypertension, Portal WI 720 Hypertension, Pulmonary WG 340 Hypertension, Pulmonary, of Newborn, Persistent see Persistent Fetal Circulation Syndrome Hypertension, Renal WG 340 Hypertension, Renovascular WG 340 Hyperthermia see Fever Hyperthermia, Induced WB 469 In mental disorders WM 405 Hyperthermia, Local see Hyperthermia, Induced Hyperthermia, Therapeutic see Hyperthermia, Induced Hyperthyroidism WK 265 Hypertonic Glucose Solution see Glucose Solution, Hypertonic Hypertonic Saline Solution see Saline Solution, Hypertonic Hypertonic Solution, Glucose see Glucose Solution, Hypertonic Hypertonic Solution, Saline see Saline Solution, Hypertonic Hypertonic Solutions QV 786 Hypertrichosis WR 455 Hypertriglyceridemia WD 200.5.H8 Hypertriglyceridemia, Familial see Hyperlipoproteinemia Type IV Hypertrophic Arthritis see Osteoarthritis Hypertrophy QZ 190 See also Cervix Hypertrophy WP 470; Gingival Hypertrophy WU 240; Heart Hypertrophy ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 373 WG 210; Myocardial Diseases, Primary WG 280; Prostatic Hypertrophy WJ 752 Hypertropia see Strabismus Hyperventilation WF 143 Hyphomycetes QW 180.5.D3 Hypnosis Parapsychology BF 1111-1156 Psychiatric therapy WM 415 Self Hypnosis WM 415 Surgery see Hypnosis, Anesthetic WO 200 Hypnosis, Anesthetic WO 200 Hypnosis, Dental WO 460 Hypnotics and Sedatives QV 85-88 Hypobaropathy see Altitude Sickness Hypocalcemia WD 200.5.C2 Veterinary SF 910.H86 Hypochlorhydria see Achlorhydria Hypocholesteremic Agents see Anticholesteremic Agents Hypochondriasis WM 178 Hypochromic Anemias see Anemia, Hypochromic Hypodermic Medication see Infusions, Parenteral; Injections, Subcutaneous Hypodermoclysis see Infusions, Parenteral; names of solutions or agents used, e.g., Sodium Chloride Hypodermyiasis WC 900 Hypodontia see Anodontia Hypogalactia see Lactation Disorders Hypogammaglobulinemia see Agammaglobulinemia Hypogastric Plexus WL 600 Hypoglossal Nerve WL 330 Hypoglycemia WK 880 Hypoglycemic Agents WK 825 Hypogonadism WK 900 Hypohidrosis WR 400 Drugs for QV 122 Hypokalemia WD 220 Hypokinesia see Immobilization Hypomenorrhea see Menstruation Disorders Hyponatremia WD 220 Hypoparathyroidism WK 300 Hypopharyngeal Neoplasms WV 410 Hypophysectomy WK 590 Hypophysectomy, Chemical WK 590 Hypophysis see Pituitary Gland Hypophysis Cerebri see Pituitary Gland Hypopituitarism WK 550 Hypopotassemia see Hypokalemia Hypoprothrombinemias WH 322 Hyposalivation see Xerostomia Hyposensitization Therapy see Desensitization, Immunologic Hyposomnia see Insomnia Hypospadias WJ 600 Hypotension WG 340 Hypotension, Controlled WO 350 Hypotension, Orthostatic WG 340 Hypotension, Postural see Hypotension, Orthostatic Hypothalamic Diseases WL 312 Hypothalamic Hormones WL 312 Hypothalamo-Hypophyseal System WK 501-502 Hypothalamus WL 312 Hypothalamus, Infundibular see Hypothalamus, Middle Hypothalamus, Medial see Hypothalamus, Middle Hypothalamus, Middle WL 312 Hypothermia WD 670 Pathogenesis QZ 57 Physiological adaptation QT 160 Hypothermia, Induced WO 350 For extending life for future therapy WO 350 Veterinary SF 914 See also Cryogenic Surgery WO 510; Gastric Hypothermia WI 380; Surgery of particular organs or systems, by part, e.g., Hypothermia in neurosurgery WL 368 Hypothyroidism WK 250 Hypoventilation, Central Alveolar see Sleep Apnea Syndromes Hypovolemic Shock see Shock Hypoxemia see Anoxemia Hypoxia see Anoxia Hypoxia, Cellular see Cell Hypoxia Hypsarrhythmia see Spasms, Infantile Hysterectomy, Vaginal WP 468 Hysteria WM 173-173.7 Hysteria, Conversion see Conversion Disorder Hysteria, Dissociative see Dissociative Disorders Hysterical Neuroses see Hysteria Hysterical Personality see Histrionic Personality Disorder Hysterosalpingography WP 141 Hysteroscopy WP 440 Used in surgical interventions WP 468 Hystrix see Rodentia la Antigens see Histocompatibility Antigens Class II la-Like Antigens see Histocompatibility Antigens Class II la-Like Antigens, Human see HLA-D Antigens IAP Pertussis Toxin see Pertussis Toxins Iatrogenic Disease QZ 42 IBR-IPV Virus see Herpesvirus 1, Bovine Ibuprofen QV 95 As an enzyme inhibitor QU 143 Ice Physical geography GB 2401-2598 Sanitation WA 675 Ice Cream As a dietary supplement in health or disease WB 428 Sanitary control WA 715 Ichthyosis WR 500 ICI-46474 see Tamoxifen ICI 66082 see Atenolol ICSH see LH Icterus see Jaundice Icterus Gravis Neonatorum see Erythroblastosis, Fetal Id WM 460.5.U6 IDDM see Diabetes Mellitus, Insulin-Dependent Identification of Persons see Forensic medicine W 786, etc. and names of special means of ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 374 Immune Body identification, e.g., Dermatoglyphics Identification (Psychology) In adolescence WS 462 In infancy & childhood WS 105.5.P3 Personality Development (General) BF 698 Psychoanalysis WM 460.5.14 Identification, Social see Social Identification Identity Crisis BF 697 In adolescence WS 463 In infancy & childhood WS 350.8.13 In psychoanalysis WM 460.5.P3 Idiocy see Mental Retardation Idiopathic Hypercatabolic Hypoproteinemia see Protein-Losing Enteropathies Idiosyncrasy, Drug see Pharmacology Idiotypes, Immunoglobulin see Immunoglobulin Idiotypes Iditol Dehydrogenase QU 140 Ifosfamide As an antineoplastic agent QV 269 As an immunosuppressive agent QW 920 IGA Glomerulonephritis see Glomerulonephritis, IGA IGA Nephropathy see Glomerulonephritis, IGA IgE QW 601 IGF-I see Insulin-Like Growth Factor I IGF-II see Insulin-Like Growth Factor II IgG QW 601 IL-1 see Interleukin-1 IL-2 see Interleukin-2 IL-2 Receptors see Receptors, Interleukin-2 IL-3 see Interleukin-3 IL-8 see Interleukin-8 Ileal Neoplasms WI 512 Ileitis WI 512 Ileitis, Regional see Crohn Disease Ileitis, Terminal see Crohn Disease Ileocecal Valve WI 512 Ileocolitis see Crohn Disease Ileostomy WI 512 Ileum WI 512 Ileus see Intestinal Obstruction Iliac Artery WG 595.15 Iliac Vein WG 625.15 Illegitimacy HQ 998-999 Adolescents WS 462, etc. Child psychology WS 105.5.A8 Maternal welfare WA 310 Paternity W 791 Unwed parents Relationship to children WS 105.5.F2 Illicit Drug Testing see Substance Abuse Detection Illicit Drugs see Street Drugs Illiteracy see Educational Status Illness Behavior see Sick Role Illuminating Gas Poisoning see Carbon Monoxide Poisoning Illumination see Lighting Illusions BF 491-493 Optical WW 105 Psychotic WM 204 Illustrated Books see Books, Illustrated Illustration, Medical see Medical Illustration Illustrations, Surgical see Medical Illustration Image Analysis, Computer-Assisted see Image Processing, Computer-Assisted Image Enhancement Photoelectronic devices TK 8316 Photography Treatment of negatives TR 299 Treatment of positives TR 335 Specific objects, by subject See also Radiographic Image Enhancement WN 160 Image Intensifies see Image Enhancement Image Interpretation, Computer-Assisted General WB 141 For particular disorders, with the disorder Image Processing, Computer-Assisted In particular fields (Form number 26.5 in any NLM schedule where applicable) Used for special purposes, by subject Image Reconstruction see Image Processing, Computer-Assisted Imagination In adolescence WS 462 In infancy & childhood WS 105.5.C7 Creative processes BF 408-426 Mental imagery (General) BF 367 See also Fantasy BF 408-411, etc. Imaging, Diagnostic see Diagnostic Imaging Imaging, Medical see Diagnostic Imaging Imaging Techniques see Diagnostic Imaging Imbecility see Mental Retardation Imidazoles QU 65 Organic chemistry QD 401 Imidazolidinethione see Ethylenethiourea Imidobenzyle see Imipramine Imines QU 54 Organic chemistry Aliphatic compounds QD 305.16 Aromatic compounds QD 341.16 Imipemide see Imipenem Imipenem QV 350 Imipramine QV 77.5 Imitative Behavior BF 357 In infancy & childhood WS 105.5.S6 Imizin see Imipramine Immaturity Syndromes see Personality Disorders Immediate Recall see Memory, Short-Term Immersion As a cause of accident or disease QZ 57 Special conditions resulting, with the condition, e.g., Hypothermia WD 670, etc. Immersion Foot WG 530 Immigration see Emigration and Immigration Immobilization WE 168 Used for special purposes, by subject Immobilized Enzymes see Enzymes, Immobilized Immotile Cilia Syndrome see Ciliary Motility Disorders Immune-Associated Antigens see Histocompatibility Antigens Class II Immune-Associated Antigens, Human see HLA-D Antigens Immune Body see Antibodies ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 375 Immune Complex Diseases Immune Complex Diseases WD 308 Immune Monitoring see Monitoring, Immunologic Immune Precipitates see Precipitins Immune Response Antigens see Histocompatibility Antigens Class II Immune-Response Antigens, Human see HLA-D Antigens Immune-Response-Associated Antigens see Histocompatibility Antigens Class II Immune Response-Associated Antigens, Human see HLA-D Antigens Immune Response Genes see Genes, MHC Class II Immune RNA Manipulation see Immunization, Passive Immune Sera QW 815 Immune System QW 504 Immune Tolerance QW 504 Transplantation immunology WO 680 Immunity QW 540-949 Acquired QW 551 Artificial QW 551 As affected by stress QZ 160 In infancy & childhood WS 135 Local QW 563 Preparations producing QW 800-815 Immunity, Active QW 552 Immunity, Cellular QW 568 Immunity, Humoral see Antibody Formation Immunity, Natural QW 541 Immunity, Non-Specific see Immunity, Natural Immunity, Passive QW 553 Immunization QW 800-815 In infancy & childhood WS 135 Public health aspects WA 110 Veterinary SF 757.2 For a particular disease, with the disease Immunization, Active see Vaccination Immunization, Booster see Immunization, Secondary Immunization, Passive QW 945 Of a particular disease, with the disease Immunization Programs WA 110 In infancy & childhood WS 135 For prevention of specific diseases, by disease Immunization Schedule QW 800-815 In infancy & childhood WS 135 Immunization, Secondary QW 800-815 In infancy & childhood WS 135 Immunoactivators see Adjuvants, Immunologic Immunoadjuvants see Adjuvants, Immunologic Immunoadsorbents see Immunosorbents Immunoassay General QW 525.5.13 Assay of hormones QY 330 Used for diagnostic, monitoring, or evaluation tests in special fields, with the field Immunoassay, Enzyme see Immunoenzyme Techniques Immunoblastic Lymphadenopathy WH 700 Immunoblotting QW 525.5.132 Used for diagnostic, monitoring, or evaluation tests in special fields, with the field Immunoblotting, Western see Blotting, Western Immunochemistry QW 504.5 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Immunocompetence QW 568 Immunocompromised Host QW 504 Immunocontraception see Contraception, Immunologic Immunocytochemistry see Immunohistochemistry Immunodeficiency Syndrome, Acquired see Acquired Immunodeficiency Syndrome Immunodiagnosis see Immunologic Tests Immunodiagnostic Tests see Immunologic Tests Immunodiffusion QY 265 Immunoelectroblotting see Immunoblotting Immunoelectroosmophoresis see Counterimmunoelectrophoresis Immunoelectrophoresis QY 250-275 Assay of hormones QY 330 Veterinary SF 774 Used for diagnostic monitoring, or evaluation tests in special fields, with the field Immunoelectrophoresis, Countercurrent see Counterimmunoelectrophoresis Immunoelectrophoresis, Crossover see Counterimmunoelectrophoresis Immunoenzyme Techniques QW 525.5.134 In immunodiagnostic tests QY 250 Immunofluorescence Microscopy see Microscopy, Fluorescence Immunofluorescence Technique see Fluorescent Antibody Technique Immunofluorometric Assay see Fluoroimmunoassay Immunogenetics QW 541 Immunogens, Synthetic see Vaccines, Synthetic Immunoglobulin Allotypes QW 575 Immunoglobulin Genes see Genes, Immunoglobulin Immunoglobulin Idiotypes QW 601 Immunoglobulin-Producing Cells see Antibody-Producing Cells Immunoglobulin-Secreting Cells see Antibody-Producing Cells Immunoglobulin Therapy see Immunization, Passive Immunoglobulins QW 601 Immunoglobulins, alpha-Chain QW 601 Immunoglobulins, mu-Chain QW 601 Immunogold-Silver Techniques see Immunohistochemistry Immunogold Techniques see Immunohistochemistry Immunohistochemistry QW 504.5 Immunohistocytochemistry see Immunohistochemistry Immunolabeling Techniques see Immunohistochemistry Immunologic Accessory Cells see Antigen-Presenting Cells Immunologic Competence see Immunocompetence Immunologic Deficiency Syndrome, Acquired see Acquired Immunodeficiency Syndrome Immunologic Deficiency Syndromes WD 308 Immunologic Diseases WD 300-330 Immunologic Markers see Biological Markers Immunologic Monitoring see Monitoring, Immunologic Immunologic Receptors see Receptors, Immunologic Immunologic Stimulation see Immunization Immunologic Surveillance QW 568 IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 376 Indexes Immunologic Techniques QW 525 Immunodiagnostic tests QY 250-275 See also names of particular tests and procedures, e.g., Immunoassay QW 525.5.13, etc. Immunologic Tests Used in diagnosis QY 250-275 Techniques QW 525 See also names of specific tests Immunologists see Biography WZ 112.5.15 and Directories QW 522 under Immunology Immunology see Allergy and Immunology Immunology, Transplantation see Transplantation Immunology Immunomodulators see Adjuvants, Immunologic Immunoperoxidase Techniques see Immunoenzyme Techniques Immunopotentiators see Adjuvants, Immunologic Immunoscintigraphy, Radiolabeled see Radioimmunodetection Immunosorbents In antigen-antibody complex QW 570 Immunostimulants see Adjuvants, Immunologic Immunostimulation see Immunization Immunosuppressed Host see Immunocompromised Host Immunosuppression QW 920 Immunosuppression (Physiology) see Immune Tolerance Immunosuppressive Agents QW 920 Immunosurveillance see Monitoring, Immunologic Immunotherapy QW 940-949 Of a particular disease, with the disease Immunotherapy, Active QW 949 Veterinary SF 919 Of a particular disease, with the disease Immunotherapy, Adoptive QW 940 Immunotherapy, Allergen see Desensitization, Immunologic Immunotherapy, Passive see Immunotherapy, Adoptive Immunotoxins QW 630.5.13 Impedance Tests, Acoustic see Acoustic Impedance Tests Impedance, Transthoracic see Cardiography, Impedance Impetigo WR 225 Impetigo Contagiosa see Impetigo Implant, Cochlear see Cochlear Implant Implant Radiotherapy see Brachytherapy Implantable Catheters see Catheters, Indwelling Implantable Infusion Pumps see Infusion Pumps, Implantable Implantation, Blastocyst see Ovum Implantation Implantation, Dental see Dental Implantation Implantation, Ovum see Nidation Implantation, Ovum, Delayed see Ovum Implantation, Delayed Implants, Artificial WE 172 See also Prosthesis See also names of specific artificial implants Implants, Dental see Dental Implants Implosive Therapy WM 425.5.D4 Impotence WJ 709 Impregnation, Artificial see Insemination, Artificial Impulse Control Disorders WM 190 Impulse-Ridden Personality see Personality Disorders Impulsive Behavior BF 575.146 Inadequate Personality see Personality Disorders Inanition see Deficiency Diseases Inborn Errors of Metabolism see Metabolism, Inborn Errors Inbreeding Animal SF 105 Physical anthropology GN 252 Social pathology HV 4981 Incentive Reimbursement see Reimbursement, Incentive Incentives see Motivation Incest WM 610 Incidence Studies see Cohort Studies Incident Reporting, Hospital see Risk Management Incipient Schizophrenia see Schizotypal Personality Disorder Incisor WU 101 Inclusion Bodies QH 603.149 Inclusion Disease see Cytomegalovirus Infections Income Economic theory HB 522-715 Labor HD 4906-5100.7 Of dentists WU 77 Of nurses WY 77 Of physicians W 79 Of other specialties, by type Income Tax HJ 4621-4824 Incompatibility of Drugs see Drug Incompatibility Incontinentia Pigmenti Achromians see Pigmentation Disorders Incubation Period see Time Factors; Carrier State Incubators (Form number 26 in any NLM schedule where applicable) Used in experimental histology QS 530; in microbiology QW 26 Incubators, Infant Catalogs W 26 Description WS 26 Usage WS 410-421 Incunabula Z 240-241 Medical WZ 230 Incus WV 230 Indans Organic chemistry QD 341.H9 Special topics, by subject Indapamide QV 160 Indazoles QV 95 Organic chemistry QD 401 Indenes As anti-arrhythmia agents QV 150 As anti-inflammatory analgesics QV 95 Organic chemistry QD 341.H9 Independent Living see Activities of Daily Living Independent Practice Associations W 130 Index Medicus see MEDLARS Indexes Of subjects represented in NLM's classification, ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 377 appropriate classification number preceded by the letter Z Of otiier subjects, LCs Z schedule Indexing see Abstracting and Indexing Indian Nursing Service see Public Health Nursing Indians, Central American F 1434-1435 See also special topics under Ethnic Groups Indians, North American E 75-99 As physicians Collective biography WZ 150 History WZ 80.5.13 Individual biography WZ 100 See also special topics under Ethnic Groups Mexico F 1219-1220 Indians, South American F 2229-2230.2 etc. As physicians Collective biography WZ 150 History WZ 80.5.13 Individual biography WZ 100 See also special topics under Ethnic Groups Indicator Dilution Techniques WG 141 Blood volume WG 106 See also Dye Dilution Technique WG 141, etc.; Radioisotope Dilution Technique WG 141, etc. Indicators and Reagents Analytical chemistry QD 77 Pharmaceutical chemistry QV 744 See also Dyes QV 240, etc. Indigency see Poverty Indigency, Medical see Medical Indigency Indigent Care see Medical Indigency Indigents, Medical Care see Medicaid; Medical Indigency Indigestion see Dyspepsia; Heartburn Indium Inorganic chemistry QD 181.15 Pharmacology QV 290 Indium Radioisotopes WN 415-450 Used for special purposes, by subject Individual Differences see Individuality Individual Practice Associations see Independent Practice Associations Individuality Psychology BF 697 Sociology HM 136 Individuation WM 460.5.15 In personality development BF 697 In adolescence WS 462 In infancy & childhood WS 105.5.P3 Indocyanine Green QV 240 Indoleacetic Acids QK 753.15 In amino acid metabolism QU 65 Indoleamine 2,3-Dioxygenase see Tryptophan Oxygenase Indoles As antidepressive agents QV 77.5 As hallucinogens QV 77.7 As tranquilizers QV 77.9 Organic chemistry QD 401 Indolylethylamines see Tryptamines Indomethacin QV 95 Indoor Air Pollution see Air Pollution, Indoor ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Indoor Air Quality see Air Pollution, Indoor Indoprofen QV 95 Indri see Strepsirhini Indriidae see Strepsirhini Induction of Labor see Labor, Induced Industrial Accidents see Accidents, Occupational Industrial Arts see Technology Industrial Bacteriology see Bacteriology Industrial By-Products in Air Pollution see Air Pollutants Industrial Chemistry see Chemistry Industrial Dentistry see Occupational Dentistry Industrial Dermatoses see Dermatitis, Occupational Industrial Diseases see Occupational Diseases Industrial Health see Occupational Health Industrial Hygiene see Occupational Health Industrial Medical Departments see Occupational Health Services Industrial Medicine see Occupational Medicine Industrial Mental Health see Mental Health Industrial Microbiology QW 75 Industrial Nursing see Occupational Health Nursing Industrial Oils Biochemistry QU 86 Chemical technology TP 670-699 Public health aspects WA 722 Industrial Ophthalmology see Ophthalmology Industrial Poisoning see Poisoning Industrial Surgery see Surgery Industrial Toxicology see Occupational Medicine; Poisons; Toxicology Industrial Waste WA 788 See also names of specific types of waste, e.g. Air Pollutants WA 450, etc. Industry HD 2321-4730.9 Inert Gas Narcosis Aviation and space medicine WD 715 Submarine medicine WD 650 Infant WS Anesthesia WO 440 General WS 430 Nursing see Pediatric Nursing WY 159 Radiography WN 240 Surgery WO 925 Welfare see Child Welfare WA 310-320 See also Birth Injuries WS 405, other headings beginning with Birth. Infant Care WS 113 Infant Food WS 115-125 Infant Health Services see Child Health Services Infant, Low Birth Weight WS 420 Infant Mortality HB 1323.14 Including causes of death WA 900 See also Fetal Death WQ 225, etc. Infant, Newborn WS 420 Legal establishment of life W 789 Resuscitation WQ 450 Infant, Newborn, Diseases WS 421 Infant, Newborn, Intensive Care see Intensive Care, Neonatal Infant, Newborn, Screening see Neonatal Screening Infant Nutrition Feeding WS 120-125 !E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 378 Infrared Rays Requirements WS 115 Infant Nutrition Disorders WS 120 Infant, Premature WS 410 Infant, Premature, Diseases WS 410 Infant Psychology see Child Psychology Infant Radiant Warmers see Incubators, Infant Infant, Small for Gestational Age WS 420 Infant Welfare Public health aspects WA 310-320 Social aspects HV 697-700 Infanticide Criminology HV 6537-6541 Medicolegal aspects W 867 Infantile Paralysis see Poliomyelitis Infantilism WK 900 See also Dwarfism WE 250 Infantilism, Genital see Hypogonadism Infantilism, Sexual see Hypogonadism Infanto Sexuality see Paraphilias Infarction QZ 170 Coronary see Coronary Disease WG 300, etc.; Myocardial Infarction WG 300 Pulmonary see Pulmonary Embolism WG 420 Infection Bacteriological aspects QW 700 Eye WW 160 Disease process WC 195 Surgical see Surgical Wound Infection WO 185 Veterinary SF 781 Wound see Wound infection WC 255 Localized, by site See also Cross Infection WC 195, Focal Infection WC 230, etc.; Laboratory Infection WC 195; names of other specifc types of infection Infection Control In hospitals WX 167 Infectious Bovine Rhinotracheitis Virus see Herpesvirus 1, Bovine Infectious Bronchitis Virus, Avian QW 168.5.C8 Infectious Bronchitis Virus of Birds see Avian Infectious Bronchitis Virus Infectious Disease Contact Tracing see Contact Tracing Infectious Diseases see Communicable Diseases; names of particular infectious diseases Infectious Human Wart Virus see Papillomavirus, Human Infectious Keratoconjunctivitis see Keratoconjunctivitis, Infectious Infectious Mononucleosis WC 522 Infectious Mononucleosis-Like Syndrome, Chronic see Fatigue Syndrome, Chronic Infectious Mononucleosis Virus see Herpesvirus 4, Human Infectious Pustular Vulvovaginitis Virus see Herpesvirus 1, Bovine Inferiority Complex see Personality Disorders Inferiority, Constitutional Psychopathic see Antisocial Personality Disorder Infertility WP 570 Veterinary SF 871 Infertility, Female WP 570 Infertility, Male WJ 709 Infiltration anesthesia see Anesthesia, Local Inflammation QZ 150 Immunological aspects QW 700 Localized, by site Inflammatory Bowel Diseases WI 420 Inflation, Economic By subject, in economics number where applicable Influenza WC 515 Influenza, Asian see Influenza Influenza D Virus see Parainfluenza Virus Type 1 Influenza Vaccine WC 515 Influenza Virus, Avian see Orthomyxovirus Type A, Avian Influenza Virus, Porcine see Orthomyxovirus Type A, Porcine Influenza Viruses see Orthomyxoviridae Information Display see Data Display Information Dissemination see Information Services Information Processing, Automatic see Automatic Data Processing Information Processing, Human see Mental Processes Information Retrieval see Information Storage and Retrieval Information Retrieval Systems see Information Systems Information Science Information theory Q 350-390 Special topics, by subject Information Services Z 674.2-674.5 Services in particular fields, by subject Information Storage and Retrieval Z 699 By subject Z 699.5.A-Z In medicine (General) W 26.55.14 In other special fields (Form number 26.5 in any NLM schedule where applicable) Information Systems Z 699 By subject Z 699.5.A-Z In medicine (General) W 26.55.14 In other special fields (Form number 26.5 in any NLM schedule where applicable) See also Automatic Data Processing W 26.55.A9, etc.; Computers W 26.55.C7, etc.; MEDLARS W 26.55.14 Information Theory Q 350-390 Special applications, by subject Informed Consent In human experimentation W 20.5 Legal aspects W 32-33 Other special topics, by subject, e.g., in drug research QV 20.5 Infrared Detectors see Instrumentation WB 26 under Infrared Rays Infrared Rays QC 457 Diagnostic use WB 288 General medical use WB 117 Instrumentation WB 26 Technology (Applied optics) TA 1570 Therapeutic use WB 480 See also Spectrophotometry, Infrared QC 457, etc. ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7TJED 379 Infrared Spectroscopy Infrared Spectroscopy see Spectrophotometry, Infrared Infusion see Drug Compounding Infusion Pumps WB 354 Infusion Pumps, External see Infusion Pumps Infusion Pumps, Implantable WB 354 Infusions, Intra-Arterial WB 354 Infusions, Intravenous WB 354 Infusions, Parenteral WB 354 Glucose WB 354 Saline WB 354 See also Sodium Chloride WB 354, etc. Infusions, Regional Arterial see Infusions, Intra-Arterial Infusors see Infusion Pumps Inguinal Hernia see Hernia, Inguinal Inhalation see Respiration Inhalation Anesthesia see Anesthesia, Inhalation Inhalation Burns see Burns, Inhalation Inhalation Devices see Nebulizers and Vaporizers Inhalation Drug Administration see Administration, Inhalation Inhalation Injury, Smoke see Smoke Inhalation Injury Inhalation of Drugs see Administration, Inhalation Inhalation Provocation Tests see Bronchial Provocation Tests Inhalation Therapy see Respiratory Therapy Inhalators see Nebulizers and Vaporizers Inhalers see Nebulizers and Vaporizers Inhibin WK 900 Female WP 520 Male WJ 875 Inhibition, Neural see Neural Inhibition Inhibition (Psychology) BF 335-337 In infancy & childhood WS 350.8.14 Injections WB 354 Hypodermic WB 354 Saline WB 354 See also Enema WB 344 Injections, Intra-Arterial WB 354 Injections, Intradermal WB 354 Injections, Intramuscular WB 354 Injections, Intravenous WB 354 Injections, Jet WB 354 Injections, Sclerosing see Sclerosing Solutions Injections, Subcutaneous WB 354 Injured, Transportation see Transportation of Patients Injuries see Wounds and Injuries Injuries, Multiple see Multiple Trauma Ink Paleography Z 112 Toxicology QV 627 Ink Blot Tests WM 145.5.15 Inlays WU 360 Innate Behavior see Instinct Innominate Artery see Brachiocephalic Trunk Innominate Veins see Brachiocephalic Veins Innovation Diffusion see Diffusion of Innovation Inoculation see Vaccination Inoculation Lymphoreticulosis see Cat-Scratch Disease ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Inorganic Chemistry see Chemistry, Inorganic Inorganic Ions see Ions Inorganic Poisons see Poisons Inorganic Substances, Biochemistry see Biochemistry Inosine Biochemistry QU 57 Pharmacology QV 185 Inosine Phosphorylase see Purine-Nucleoside Phosphorylase Inositol QU 87 Inositol Hexaphosphate see Phytic Acid Inositol Phosphates QU 75 Inositol Phosphoglycerides see Phosphatidylinositols Inotropic Agents, Positive Cardiac see Cardiotonic Agents Inotropism see Muscle Contraction Inotropism, Cardiac see Myocardial Contraction Inpatients WX 158.5 With specific disabilities, with the disability See also Patients Inproquone QV 269 Cancer chemotherapy QZ 267 Insanity see Mental Disorders Insanity Defense W 740 Legislation WM 32-33 Insect Bites and Stings WD 430 Insect Control QX 600 Insect Growth Regulators see Juvenile Hormones Insect Poisons see Insect Bites and Stings Insect Repellents Pest control in agriculture SB 951.5-951.54 Public health aspects WA 240 Insect Sterilization see Insect Control Insect Vectors QX 650 Preventive medicine WA 110 Insect Viruses QW 162 Insecticide Resistance Agriculture SB 957 Chemically induced mutations QH 465.C5 Insect control (Parasitology) QX 600 Public health aspects WA 240 Insecticides Agriculture SB 951.5-951.54 Public health WA 240 Insecticides, Carbamate Agriculture SB 952.C3 Public health WA 240 Insecticides, Organochlorine Agriculture SB 952.C44 Public health WA 240 Insecticides, Organophosphate Agriculture SB 952.P5 Public health WA 240 Insecticides, Organophosphate, Antagonists see Cholinesterase Reactivators Insecticides, Organothiophosphate, Antagonists see Cholinesterase Reactivators Insectivora QL 737.15-737.158 Insects Diseases SB 942 Parasitology QX 500-650 Poisoning WD 430 USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSIFIED 380 Intensive Care Insemination WQ 205 Insemination, Artificial WQ 208 Sociological aspects HQ 761 Veterinary SF 105.5 Insemination, Artificial, Heterologous WQ 208 Insemination, Artificial, Homologous WQ 208 Insemination, Artificial, Human Donor see Insemination, Artificial, Heterologous Insemination, Artificial, Husband see Insemination, Artificial, Homologous Insertion Elements, DNA see DNA Insertion Elements Insertion Sequence see DNA Insertion Elements Insertion Sequence Elements see DNA Insertion Elements Inservice Training HF 5549.5.T7 In hospitals WX 159 For particular jobs, by subject, e.g. as a nurses' aide WY 193 Insignia see Emblems and Insignia Insomnia WM 188 Inspection, Sanitary see Sanitation Inspiratory Positive-Pressure Ventilation see Intermittent Positive-Pressure Ventilation Instability, Joint see Joint Instability Instillation, Bladder see Administration, Intravesical Instillation, Rectal see Administration, Rectal Instinct Animal QL 781 Psychology BF 685 Social psychology HM 255 Institutes see Academies and institutes Institutional Liability see Liability, Legal Institutional Nursing see Nursing WY 125 under Institutional Practice; Specialties, Nursing Institutional Personnel Licensure see Licensure Institutional Practice W 96 Nursing WY 125 Institutional Review Board see Professional Staff Committees Institutional Tax see Taxes Institutionalization W 84.7 Geriatrics WT 31 See also Hospitals, Psychiatric WM 27-28, etc.; Hospitalization WX 158-158.5, etc. Institutionalized Child see Child, Institutionalized Institutions see Organizations Instrumental Learning see Conditioning, Operant Instruments see Equipment and Supplies; Surgical instruments; Catalogs, Commercial W 26, etc. and names of particular instruments Insufflation Anesthesia see Anesthesia, Inhalation Insufflation Radiography see Pneumoradiography Insula of Reil see Cerebral Cortex Insular Tissue, Pancreas see Islets of Langerhans Insulin WK 820 Shock see Hypoglycemia WK 880 Shock Therapy see Shock Therapy, Insulin WM 410 Insulin Antibodies QW 575 Insulin Coma Therapy see Convulsive Therapy Insulin Infusion Systems WK 820 Insulin, Lente WK 820 Insulin-Like Growth Factor I As a growth substance QU 107 Insulin-Like Growth Factor II As a growth substance QU 107 Insulinoma WK 885 Insuloma see Insulinoma Insurance HG 8016-9999 Insurance, Accident W 100-250 Medicolegal aspects W 900 Insurance Audit see Insurance Claim Review Insurance Benefits Life insurance rates HG 8751-9295 Medical, etc. service plans W 100-275 For particular disabilities, by subject Insurance Carriers Of health insurance W 100-275 Insurance Case Management see Managed Care Programs Insurance Claim Reporting Related to health insurance in gernal W 100-275 Special topics, by subject Insurance Claim Review W 100-275 For particular disorder, by subject Insurance Claims Processing see Insurance Claim Review Insurance, Dental W 260 Insurance, Disability see Medicare Insurance, Health W 100-275 Medicolegal aspects W 900 Surgical W 100-275 Insurance, Health, Catastrophic see Insurance, Major Medical Insurance, Health, for Aged and Disabled see Medicare Insurance, Health, Reimbursement W 100-275 Insurance, Hospitalization W 160 Insurance, Liability HG 9990 (Form number 33 or 33.1 in any NLM schedule where applicable and practical) Insurance, Life HG 8751-9271 Insurance, Long-Term Care W 160 For the aged WT 31 Insurance, Major Medical W 160 Insurance, Nursing Services W 255 Insurance, Old Age see Medicare; Social Security Insurance, Pharmaceutical Services W 265 Insurance, Physician Services W 100-275 Insurance, Psychiatric W 270-275 Insurance, Surgical W 100-275 Insurers see Insurance Carriers Integral Membrane Proteins see Membrane Proteins Integration, Prophage see Lysogeny Integumentary System see Skin Intelligence BF 431-433 Genius BF 412-426 In infancy & childhood WS 105 See also Educational Measurement LB 3051; Psychological Tests BF 176, etc. Intelligence Tests BF 431-433 In infancy & childhood BF 432.C48 Intensive Care WX 218 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 381 Intensive Care In infancy & childhood WS 366 Nursing WY 154 Pediatric WY 159 Of a particular disease or in a particular field General, with the disease or field Nursing, with the nursing specialty Intensive Care, Neonatal WS 421 Intensive Care Nursing see Nursing WY 154 under Intensive Care Intensive Care, Surgical see Intensive Care Intensive Care Units WX 218 Coronary see Coronary Care Units WG 27-28 Respiratory see Respiratory Care Units WF 27-28 Special fields, form numbers 27-28 where applicable See also Critical Care WX 218, etc. Interagency Relations see Interinstitutional Relations Interbrain see Diencephalon Intercalated Neurons see Interneurons Intercarotid Ganglion see Carotid Body Intercellular Junctions QH 603. C4 Intercellular Space see Extracellular Space Intercostal Muscles WE 715 Interdigitating Cells see Dendritic Cells Interdisciplinary Health Team see Patient Care Team Interface, User Computer see User-Computer Interface Interferometry, Microscopic see Microscopy, Interference Interferon Alfa, Recombinant Immunology QW 800 As an antiviral agent QV 268.5 As an antineoplastic agent QV 269 Interferon Alfa-2c see Interferon Alfa, Recombinant Interferon-gamma see Interferon Type II Interferon, Immune see Interferon Type II Interferon Inducers Immunology QW 800 Pharmacology QV 268.5 Interferon Type I Immunology QW 800 As an antiviral agent QV 268.5 As an antineoplastic agent QV 269 Interferon Type I, Recombinant see Interferon Alfa, Recombinant Interferon Type II Immunology QW 800 As an antiviral agent QV 268.5 As an antineoplastic agent QV 269 Interferons Immunology QW 800 Pharmacology QV 268.5 Interinstitutional Relations Hospitals WX 160 Other types of institutions, by subject Interior Design and Furnishings In health facilities WX 140 For the specialties (Form number 27-29 in any NLM schedule where applicable) Hospital departments WX 200-225 Public health aspects of houses and public buildings WA 795-799 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Interior Furnishings see Interior Design and Furnishings Interleukin-1 Cellular immunity QW 568 As a growth substance QU 107 Interleukin-2 Cellular immunity QW 568 As a growth substance QU 107 Interleukin-2 Receptors see Receptors, Interleukin-2 Interleukin-3 Cellular immunity QW 568 As a growth substance QU 107 Interleukin-8 Cellular immunity QW 568 As a growth substance QU 107 Interleukins Cellular immunity QW 568 As growth substances QU 107 Intermediary Body see Hemolysins Intermediate Filaments QH 603.C95 Intermedins see MSH Intermetatarsal Joint see Tarsal Joint Intermittent Claudication WG 550 Intermittent Fever see Malaria Intermittent Positive-Pressure Ventilation WF 145 Internal Ear see Labyrinth Internal-External Control Child development WS 105.5.S6 School management and discipline LB 3011 Training of will BF 632 Internal Mammary-Coronary Artery Anastomosis WG 169 Internal Medicine WB 115 Directories W 22 Internal Secretions see Body Fluids; Hormones; Intestinal Secretions WI 400 and names of specific secretions International Agencies JX 1995 International Cooperation General works JC 362 Special area of cooperation, by subject International Health Administration see World Health International Health Problems see World Health International System of Units QC 90.8-94 Pharmaceutical QV 16 Interneurons WL 102.5 Internists, Directories see Directories W 22 under Internal Medicine Internship and Residency Dental WU 20 Medical W 20 Hospital program WX 203 Nursing WY 18.5 Pharmacy QV 20 Internship, Dental see Internship and Residency Internship, Nonmedical Nursing WY 18.5 Pharmacy QV 20 Other fields, by subject Interpersonal Relations HM 132 In adolescence WS 462 In infancy & childhood WS 105.5.15 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 382 Intravenous Drug Abuse Of the retarded child WS 107.5.R4 In hospitals WX 160 Of surgeons WO 62 Specific relationships, by subject, e.g., Dentist-patient relations WU 61, etc.; Family WS 105.5.F2, etc. Interphase QH 605 Interprofessional Relations Dentists WU 61 In hospitals WX 160 Nurses WY 87 Physicians W 62 Surgeons WO 62 Others, with specialty primarily involved Intersexuality see Hermaphroditism Interstitial Cell-Stimulating Hormone see LH Interstitial Fluid see Extracellular Space Interstitial Lung Diseases see Lung Diseases, Interstitial Intertarsal Joint see Tarsal Joint Intertrochanteric Fractures see Hip Fractures Intervertebral Disk WE 740 Of the lumbosacral region WE 750 Intervertebral Disk Chemolysis WE 740 Intervertebral Disk Displacement WE 740 Veterinary SF 901 Interview, Psychological Applied psychology BF 637.15 In infancy & childhood WS 105 Psychiatry WM 141 Interviews For admission to schools (Form number 19 or 20 in any NLM schedule where applicable) For hospital jobs WX 159 For nurses WY 105 Of physicians and specialists of medically related fields Collective WZ 112-150 Individual WZ 100 Other special topics, by subject Intestinal Absorption WI 402 Intestinal Amebiasis see Dysentery, Amebic Intestinal Atresia WI 412 Intestinal Diseases WI 400-650 General works WI 400 In infancy & childhood WS 310-312 Veterinary SF 851 Intestinal Diseases, Parasitic WC 698 Veterinary SF 810.A3 Intestinal Fistula WI 400 Intestinal Hormone Receptors see Receptors, Gastrointestinal Hormone Intestinal Hormones see Gastrointestinal Hormones Intestinal Motility see Gastrointestinal Motility Intestinal Neoplasms WI 435 Localized, by site Intestinal Obstruction WI 460 Veterinary SF 851 Volvulus WI 450 See also Stomach Volvulus WI 300 Intestinal Perforation General WI 400 Localized, by site Intestinal Polyps WI 430 Localized, by site Intestinal Secretions WI 400 Intestine, Large WI 400 See-also names of specific organs, e.g., Colon WI 520-529 Intestine, Small WI 500-512 Intestines WI 400-650 See also specific organs, e.g., Rectum WI 600-650 Intoxication see Poisoning Intoxication, Alcoholic see Alcoholic Intoxication Intra-Abdominal Infusions see Infusions, Parenteral Intra-Aortic Balloon Pumping WG 168 Intra-Arterial Lines see Catheters, Indwelling Intracaine see Benzocaine Intracellular Adhesion Molecules see Cell Adhesion Molecules Intracellular Fluid QU 105 Intracellular Membranes QH 601 Intracellular Second Messengers see Second Messenger Systems Intracerebral Pressure see Intracranial Pressure Intracoronal Attachment see Denture, Precision Attachment Intracranial Aneurysm see Cerebral Aneurysm Intracranial Arteriovenous Malformations see Cerebral Arteriovenous Malformations Intracranial Hypertension, Benign see Pseudotumor Cerebri Intracranial Pressure WL 203 Intraligamentous Pregnancy see Preganancy, Ectopic Intramedullary Nailing see Fracture Fixation, Intramedullary Intraocular Pressure WW 103 In glaucoma WW 290 Measurement WW 143 Intraoperative Care WO 181 Geriatric surgery WO 950 Pediatric surgery WO 925 Intraoperative Complications WO 181 Special topics, by subject Intraoperative Monitoring WO 181 Intraoperative Period WO 181 Intraperitoneal Infusions see Infusions, Parenteral Intratracheal Anesthesia see Anesthesia, Intratracheal Intrauterine Devices WP 640 Intrauterine Devices, Medicated WP 640 Intrauterine Diagnosis see Prenatal Diagnosis Intrauterine Growth Retardation see Fetal Growth Retardation Intrauterine Transfusion see Blood Transfusion, Intrauterine Intravascular Agglutination see Erythrocyte Aggregation, Intravascular Intravascular Erythrocyte Aggregation see Erythrocyte Aggregation, Intravascular Intravenous Anesthesia see Anesthesia, Intravenous Intravenous Drip see Infusions, Intravenous Intravenous Drug Abuse see Substance Abuse, Intravenous ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7D2D 383 Intravenous Drug Delivery Systems Intravenous Drug Delivery Systems see Infusion Pumps Intravenous Feeding see Parenteral Nutrition Intravenous Hyperalimentation s~e Parenteral Nutrition, Total Intravenous Infusions see Infusions, Intravenous Intravesical Drug Administration see Administration, Intravesical Intrinsic Factor QU 195 Introversion (Psychology) Personality BF 698.35.159 Psychoanalysis WM 460.5.E9 Intubation WB 365 Feeding WB 410 Intubation, Endotracheal see Intubation, Intratracheal Intubation, Gastrointestinal WI 141 Used for special purposes, by subject Intubation, Intratracheal In anesthesia WO 280 Intubation, Nasogastric see Intubation, Gastrointestinal Intussusception WI 450 Inuits see Eskimos Inulin QU 83 Invasive Mole see Hydatidiform Mole, Invasive Invasiveness see Bacteria; Neoplasm Invasiveness Invasiveness, Neoplasm see Neoplasm Invasiveness Inventories, Hospital WX 147 Inverse PCR see Polymerase Chain Reaction Inversion (Genetics) QH 462.15 Inversion, Visceral see Situs Inversus Invertebrate Hormones QL 364 Investigational New Drugs see Drugs, Investigational Investments HG 4501-5993 Involuntary Commitment see Commitment of Mentally 111 Involution of the Uterus see Puerperium; Anatomy & histology under Uterus Iodamoebiasis see Amebiasis Iodide Peroxidase QU 140 Iodides QV 283 For syphilis QV 261 Iodinase see Iodide Peroxidase Iodine QV 283 As an antiseptic QV 231 Metabolism WK 202 Iodine Isotopes QV 231 Inorganic chemistry QD 181.11 Metabolism WK 202 Iodine Radioisotopes WN 420 Nuclear physics QC 796.11 See also special topics under Radioisotopes Iodobenzoylglycine see Iodohippuric Acid Iodochlorhydroxyquin see Clioquinol Iodochloroxyquinoline see Clioquinol Iodohippuric Acid WN 160 In kidney function tests QY 175 Organic chemistry QD 341.A7 Used for special purposes, by subject Iodopanoic Acid see Iopanoic Acid Iodopyracet WJ 141 Iodoquinol QV 255 lodothyronine Deiodinase see Iodide Peroxidase lodothyronine 5-Deiodinase see Iodide Peroxidase Iodotyrosine Deiodase see Iodide Peroxidase Ion Channels QH 603.154 Ion Channels, Calcium see Calcium Channels Ion Channels, Potassium see Potassium Channels Ion Channels, Sodium see Sodium Channels Ion Exchange QD 562.163 See also Iontophoresis WB 495 Ion Exchange Resins Anions QV 280 Cations QV 275 Ionic Strength see Osmolar Concentration Ionium see Thorium Ions Electrochemistry QD 561 Inorganic Biochemistry QU 130 Pharmacology QV 270 Physics QC 701.7-702.7 See also Anions QV 280-285; Cations QV 275-278 Iontophoresis WB 495 Iopanoic Acid WI 750 Iotalamic Acid see Iothalamic Acid Iothalamic Acid As contrast medium WN 160 Organic chemistry QD 341.A2 Biochemistry QU 98 IPA (Independent Practice Association) see Independent Practice Associations Ipecac (Syrup) QV 73 Ipecine see Emetine IPPV see Intermittent Positive-Pressure Ventilation Iproniazid QV 77.5 Iproveratril see Verapamil Ir Genes see Genes, MHC Class II Iridium Inorganic chemistry QD 181.17 Radioactive WN 420 Iridocyclitis WW 240 Iridodiagnosis see Eye Manifestations Iridoviridae QW 165.5.16 Iridoviruses see Iridoviridae Iris WW 240 Iris Diseases WW 240 Iritis WW 240 Iron Pharmacology QV 183 Iron Chelates Pharmacology QV 183 Physical chemistry QD 474 Iron-Deficiency Anemia see Anemia, Iron-Deficiency Iron Isotopes Inorganic chemistry QD 181.F4 Pharmacology QV 183 Iron Lung see Ventilators, Mechanical Iron Salts see Iron; names of specific salts Iron-Sulfur Proteins QU 55 Irritable Bowel Syndrome see Colonic Diseases, Functional ALWAYS CONSULT MAES SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFD2D 384 Jaw Diseases Irritable Heart see Neurocirculatory Asthenia Irritants QV 65 Gases QV 666 Lung irritants QV 664 Poisons other than gases QV 618 Therapeutic use WB 371 IS Elements see DNA Insertion Elements Ischemia QZ 170 Localized, by site Ischemia-Reperfusion Injury see Reperfusion Injury Islam BP 1-253 Birth control HQ 766.37 Psychological aspects BP 175 Special topics, by subject Islamic Physicians see Physicians Island Fever see Scrub Typhus Island Flaps see Surgical Flaps Islands of Langerhans see Islets of Langerhans Islet-Activating Protein see Pertussis Toxins Islet Cell Tumor see Adenoma, Islet Cell Islet Cell Tumor, Ulcerogenic see Zollinger-EUison Syndrome Islets of Langerhans WK 800-885 Neoplasms WK 885 Islets of Langerhans Transplantation WK 800 Isoantibodies QW 575 Isoantigens QW 573 Isoaspartic Acid see Aspartic Acid Isocyanates see Cyanates Isocyanides see Cyanides Isoelectric Focusing Analytical chemistry (General) QD 79.E44 Biochemistry QU 25 Clinical pathology QY 25 Microbiology QW 25 Parasitology QX 25 Used for special purposes, by subject Isoelectric Focusing Agents see Ampholyte Mixtures Isoenzymes QU 135-141 Isoephedrine see Ephedrine Isoflurane QV 81 Isoflurophate QV 124 Isofosfamide see Ifosfamide Isohexanes see Hexanes Isoimmunization, Rhesus see Rh Isoimmunization Isolation Hospitals see Hospitals, Special; Patient Isolation Isolation, Patient see Patient Isolation Isolation Perfusion see Perfusion, Regional Isolation Perfusion Therapy see Perfusion, Regional Isolation, Social see Social Isolation Isoleucine QU 60 Isoleucyl, Leucyl Vasopressin see Oxytocin Isomerases QU 137 Isomerism QD 471 Isometric Contraction WE 500 Isometric Exercise see Exercise Isoniazid QV 268 Isonicotinic Acid Hydrazide see Isoniazid Isonipecain see Meperidine Isophosphamide see Ifosfamide Isoprenaline see Isoproterenol Isoprenoid Phosphate Sugars see Polyisoprenyl Phosphate Sugars Isoprenoid Phosphates see Polyisoprenyl Phosphates Isopropanol see Alcohol, Propyl Isopropyl Alcohol see Alcohol, Propyl Isopropylarterenol see Isoproterenol Isoproterenol WK 725 Isoquinolines As antihypertensive agents QV 150 In opium alkaloids QV 90 Organic chemistry QD 401 Isotachophoresis see Electrophoresis Isotonic Solutions QV 786 Isotopes In organic chemistry QD 181 Physical chemistry QD 466.5 Radioactive see Radioisotopes WN 420, etc. Research in medicine, etc., by subject Isotretinoin QU 167 Isozymes see Isoenzymes Itch see Scabies Itch Mites see Sarcoptes scabiei Itching see Pruritus Ito Syndrome see Pigmentation Disorders IUGR see Fetal Growth Retardation Ivermectin SF 918.183 Ivy, Poison see Toxicodendron Ixodoidea see Ticks Jackknife Seizures see Spasms, Infantile Jacksonian Seizure see Epilepsy, Partial Jamestown Canyon Virus see California Group Viruses Jansky-Bielschowsky Disease see Neuronal Ceroid-Lipofuscinosis Japanese see Mongoloid Race Japanese Americans see Asian Americans Japanese Monkey see Macaca Japanese River Fever see Scrub Typhus Jaundice WI 703 Of the newborn see Jaundice, Neonatal WH 425 Spirochetal see Weil's Disease WC 420, etc. Jaundice, Cholestatic see Cholestasis Jaundice, Cholestatic, Extrahepatic see Bile Duct Obstruction, Extrahepatic Jaundice, Chronic Idiopathic WI 703 Jaundice, Hemolytic see Anemia, Hemolytic Jaundice, Mechanical see Cholestasis Jaundice, Neonatal WH 425 See also Erythroblastosis, Fetal WH 425 Jaundice, Obstructive see Cholestasis Jaundice, Obstructive, Extrahepatic see Bile Duct Obstruction, Extrahepatic Jaundice, Spirochetal see Weil's Disease Jaw Anatomy WU 101 Dislocation WU 610 Physiology WU 102 Jaw Abnormalities WU 101.5 Jaw Cysts WU 140.5 Jaw Diseases WU 140.5 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 385 Jaw, Edentulous, Partially Jaw, Edentulous, Partially WU 140.5 Jaw Fractures WU 610 Jaw Neoplasms WU 280 Jealousy BF 575.J4 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Jehovah s Witnesses see Christianity Jejunum WI 510 Jellyfish Venoms see Coelenterate Venoms Jervell-Lange Nielsen Syndrome see Long QT Syndrome Jews Cookery for the sick WB 405 Dietary laws BM 710 Diseases WB 720 General works DS 101-151 In medicine Collective biography WZ 150 History WZ 80.5.J3 Religion see Judaism BM See also special topics under Ethnic Groups Jimsonweed see Stramonium Jird see Gerbillinae Job Application Hospitals WX 159 Nursing WY 29 Medicine as a career W 21 Special fields, by subject Job Description Hospitals WX 159 Dentistry WU 21 Medicine W 21 Nursing WY 29 Special fields, by subject Job Ladders see Career Mobility Job Satisfaction HF 5549.5.J63 Jogging QT 260.5.J6 Johne's Disease see Paratuberculosis Joint Contracture see Contracture Joint Diseases WE 304-350 General works WE 304 In infancy & childhood WS 270 Veterinary SF 901 Joint Instability WE 304 Joint Prosthesis WE 312 Joint Tuberculosis see Tuberculosis, Osteoarticular Joint Ventures, Hospital-Physician see Hospital-Physician Joint Ventures Joints WE 300-350 Localized, by site Journals see Periodicals Judaism BM And medicine WZ 80.5.J3 See also Religion and Medicine W 50, etc. Medical ethics W 50 See also Jews WZ 150, etc. Judgment BF 447 In infancy & childhood WS 105.5.D2 Jugular Veins WG 625.J8 See also Blood Supply WE 708 under Neck Jungian Theory WM 460 Juniper QV 766 Jurisprudence Dental see Forensic Dentistry W 705 Hospital WX 33 Medical W 32.5-32.6 Nursing WY 33 Pharmaceutical QV 33 Psychiatric see Forensic Psychiatry W 740, etc. Veterinary K 3615-3617 See also Forensic Medicine W 601-925, etc. Jurisprudence, Psychiatric see Forensic Psychiatry Juvenile Delinquency Legal problem (non-medical) U.S. KF 184 Parent and physician WS 463, etc. Society HV 9051-9230.7 Juvenile Hormones SF 768.3 Zoology QL 868 Juxtaglomerular Apparatus WJ 301 K Cells see Killer Cells Kahn Test see Syphilis Serodiagnosis Kainic Acid QV 253 Kakke see Beriberi Kala-Azar see Leishmaniasis, Visceral Kallidin QU 68 Kallikrein QU 136 Kallikrein-Kinin System Enzymology QU 136 In regulating blood pressure WG 106 In water-electrolyte balance QU 105 Kallikrein-Trypsin Inactivator see Aprotinin Kanamycin QV 268 Kandinsky Syndrome see Organic Mental Disorders, Psychotic Kangaroos QL 737.M35 Kanner's Syndrome see Autism, Infantile Kaolin QV 71 Kaposi's Disease see Xeroderma Pigmentosum Kaposi's Sarcoma see Sarcoma, Kaposi's Kappa Allotypes see Immunoglobulin Allotypes Karwinskia see Rhamnus Karyokinesis see Mitosis Karyometry QH 595 Neoplasm diagnosis QZ 241 Kawasaki Disease see Mucocutaneous Lymph Node Syndrome Kedani Disease see Scrub Typhus Kell Blood-Group System WH 420 Keloid WR 143 Localized, by site Kepone Agriculture SB 952.C44 Public health WA 240 Keratan Sulfate QU 83 Keratin QU 55 Keratitis WW 220 Keratitis, Dendritic WW 220 Keratitis, Furrow see Keratitis, Dendritic Keratitis, Ulcerative see Corneal Ulcer Keratoconjunctivitis, Infectious Veterinary (General) SF 891 In cattle SF 967.K47 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7DSD 386 Knee Injuries In sheep and goats SF 969.K47 Keratoconjunctivitis, Vernal see Conjunctivitis, Allergic Keratoconus WW 220 Keratoderma, Palmoplantar WR 500 Keratoma see Keratosis Keratomalacia see Xerophthalmia Keratomycosis Linguae see Tongue, Hairy Keratosis WR 500 Keratosis Palmaris et Plantaris see Keratoderma, Palmoplantar Keratosis, Palmoplantar see Keratoderma, Palmoplantar Keratosulfate see Keratan Sulfate Keratotomy, Radial WW 220 Kernicterus WL 362 Kerosine Chemical technology TP 692.4.K4 Toxicology QV 633 Ketamine QV 81 Ketoacidosis, Diabetic see Diabetic Ketoacidosis Ketoconazole QV 252 Ketoglutaric Acids QU 98 Organic chemistry QD 305.A2 Ketone Bodies Organic chemistry Aliphatic compounds QD 305.K2 Aromatic compounds QD 341.K2 Liver metabolism and physiology WI 702 Ketones Organic chemistry Aliphatic compounds QD 305.K2 Aromatic compounds QD 341.K2 Used for special purposes, by subject Ketoquinolines see Quinolones Ketosis, Diabetic see Diabetic Ketoacidosis Ketotifen QV 157 Khellin QV 150 Ki-ras Genes see Genes, ras Kickbacks see Crime Kidd Blood-Group System WH 420 Kidnapping see Crime Kidney WJ 300-378 Blood supply WJ 301 See also Renal Artery WG 595.R3; Renal Veins WG 625.R3 Kidney, Artificial WJ 378 Kidney Bean Lectins see Phytohemagglutinins Kidney Calculi WJ 356 Kidney Calices WJ 301 Kidney Circulation see Renal Circulation Kidney Concentrating Ability WJ 303 Kidney Cortex WJ 301 Kidney, Cystic WJ 358 Kidney Diseases WJ 300-378 General works WJ 300 In infancy & childhood WS 320 Veterinary SF 871 Kidney Failure, Acute WJ 342 Kidney Failure, Chronic WJ 342 Kidney Function Tests QY 175 Kidney Glomerulus WJ 301 Kidney Insufficiency, Acute see Kidney Failure, Acute Kidney Insufficiency, Chronic see Kidney Failure, Chronic Kidney Medulla WJ 301 Kidney Neoplasms WJ 358 Kidney Papilla see Kidney Medulla Kidney Papillary Necrosis WJ 351 Kidney Pelvis WJ 301 Kidney, Polycystic WJ 358 Kidney Stones see Kidney Calculi Kidney Transplantation WJ 368 Kidney Tubular Transport, Inborn Errors see Renal Tubular Transport, Inborn Errors Kidney Tubules WJ 301 Kienboecks Disease see Osteochondritis Killer Cells WH 200 Cytotoxicity QW 568 Killer Cells, Lymphokine-Activated WH 200 In cellular immunity QW 568 Killer Cells, Natural WH 200 In cellular immunity QW 568 Killer Phenotype see Phenotype Kimmelstiel-Wilson Syndrome see Diabetic Nephropathies Kinases see Phosphotransferases Kindling (Neurology) WL 102 Kinesics In adolescence WS 462 In infancy & childhood WS 105.5.C8 Psychology BF 637. N66 Social psychology HM 258 Kinesiology see Movement Kinesitherapy see Exercise Therapy Kinesthesis WE 104 See also Motion Perception WW 105; Weight Perception WE 104 Kinetics Biochemical techniques QU 25 Enzymology QU 135 Pharmacology QV 38 Physical chemistry QD 502-502.2 Special topics, by subject, e.g.; mechanokinetics in the nervous system WL 102 Kinetics, Drug see Pharmacokinetics Kinetocardiography WG 141.5.K5 Kininase II Inhibitors see Angiotensin-Converting Enzyme Inhibitors Kininogenase see Kallikrein Kinins QU 68 Kinship see Consanguinity Kitchens, Hospital see Food Service, Hospital Klebsiella QW 138.5.K5 Klebsiella Infections WC 260 See also Pneumonia WC 209, etc. Rhinoscleroma WV 300 Kleptomania see Impulse Control Disorders Klinefelter s Syndrome QS 677 Kloramfenikol see Chloramphenicol Knee WE 870 Blood supply WE 870 See also Popliteal Artery WG 595.P6; Popliteal Vein WG 625.P6 Knee Injuries WE 870 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 387 Knee Prosthesis Knee Prosthesis WE 870 Knee Replacement, Total see Knee Prosthesis Knowledge Acquisition (Computer) see Artificial Intelligence Knowledge, Attitudes, Practice Related to specific topics, by subject See also Attitude to Health W 85 Knowledge Bases (Computer) see Artificial Intelligence Knowledge of Results (Psychology) Incentive (Educational psychology) LB 1065 See also Motivation BF 501-505, etc.; Feedback WL 102, etc. Knowledge Representation (Computer) see Artificial Intelligence KO 1173 see Mexiletine Koehlers Disease see Osteochondritis Korsakoff Psychosis see Alcohol Amnestic Disorder Korsakoff Syndrome see Alcohol Amnestic Disorder Korsakoff's Syndrome see Alcohol Amnestic Disorder Koumiss see Milk Kraurosis Vulvae WP 200 Krause's End Bulbs see Thermoreceptors Krebiozen see Quackery Krebs Cycle see Citric Acid Cycle Krill see Crustacea Krypton Inorganic chemistry QD 181.K6 Pharmacology QV 310 Radioactive WN 420 Kufs Disease see Neuronal Ceroid-Lipofuscinosis Kunitz Pancreatic Trypsin Inhibitor see Aprotinin Kupffer Cells WH 650 Localized, by site Kuru WC 540 Kwashiorkor WS 115 Kyasanur Forest Disease Virus see Encephalitis Viruses, Tick-Borne Kyasanur Forest Disease Virus see Flaviviruses Kymography In cardiology WG 141.5.K9 Radiographic see Electrokymography WN 100, etc. Used for diagnosis of particular disorders, with the disorder or system Kymography, Radiographic see Electrokymography Kynurenine QU 60 Kyphosis WE 735 L L Cells QS 532.5.C7 L-Dopa see Levodopa L Forms QW 51 La Crosse Virus see California Group Viruses Labeling, Drug see Drug Labeling Labeling, Product see Product Labeling Labels, Pharmaceutical see Drug Labeling Labetalol QV 150 Labia see Vulva Labial Frenum WI 200 Labor WQ 300-330 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Difficult see Dystocia WQ 310 General WQ 300 Labor Complications WQ 330 Lacerations WP 170 See also Injuries WP 170 under Perineum; other parts injured; names of other injuries Labor, Induced WQ 440 Drugs for see Oxytocics QV 173 Labor Migration see Transients and Migrants Labor Onset WQ 305 Labor, Premature WQ 330 See also Infant, Premature WS 410 Labor Presentation WQ 307 Animal SF 887 Labor Presentation, Breech see Breech Presentation Labor Unions HD 6350-6940.7 Hospitals and hospital personnel WX 159.8 Industry and health services WA 412 Mental health services WA 495 Industry and health insurance W 125-270 Nurses WY 30 Dealings with hospitals WX 159.8 Laboratories Form numbers 23-24 in any NLM schedule where applicable In military hospitals UH 470-475 Military research UH 399.5-399.7 Laboratories, Hospital WX 207 Laboratory Animal Science QY 50-60 Laboratory Animals see Animals, Laboratory Laboratory Diagnosis see Diagnosis, Laboratory Laboratory Infection WC 195 Infection in particular types of laboratory with the laboratory Prevention & control in laboratories QY 23 Special types of infection, with the infection Laboratory Information Systems see Clinical Laboratory Information Systems Laboratory Manuals (Form number 25 in any NLM schedule where applicable) Embryology QS 625 Forensic medicine W 625 Histology QS 525 Immunology QW 525 Toxicology QV 602 Laboratory Markers see Biological Markers Labyrinth WV 250-258 Labyrinth Diseases WV 250-258 General works WV 250 See also Motion Sickness WD 630 Labyrinthic Gases see Gases QV 664, etc. under Irritants Labyrinthine Fluids WV 250 Labyrinthitis WV 250 Lac Operon QH 450.2 Special topics, by subject Laceration Therapy see Surgery, Minor; Wounds and Injuries Lacerations see Wounds and Injuries; Labor Complications USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 388 Laryngeal Paralysis Lacquer Chemical technology TP 939 Industrial toxicology WA 465 Lacrimal Apparatus WW 208 Lacrimal Apparatus Diseases WW 208 Lacrimal Duct Obstruction WW 208 Lacrimal Gland see Lacrimal Apparatus Lacrimators see Tear Gases Lactams QU 62 Antibiotics QV 350 Other special topics, by subject Lactate Dehydrogenase QU 140 Lactate Dehydrogenase Isoenzymes QU 140 Lactate Dehydrogenase Isozymes see Lactate Dehydrogenase Isoenzymes Lactates QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Lactation WP 825 Animal Domestic SF 768 Wild QP 246 See also Mammae SF 890 Lactation Disorders WP 825 Veterinary SF 890 Lactic Cytochrome Reductase see Lactate Dehydrogenase Lactobacillus QW 142.5.A8 Lactoflavin see Riboflavin Lactogen Hormone, Placental see Placental Lactogen Lactogenic Hormone, Pituitary see Prolactin Lactoglobulins QU 55 Analysis Dairy science SF 251 Public health QW 601 Lactones Organic chemistry QD 305.A2 Lac toper oxidase QU 140 Lactose QU 83 Analysis Dairy science SF 251 Public health WA 716 Lactose Intolerance WD 200.5.M2 In infancy & childhood WD 200.5.M2 Lactulose QU 83 Lacunar Dementia see Dementia, Multi-Infarct LacZ Genes see Lac Operon Laetrile see Amygdalin Lafora Disease see Epilepsy, Myoclonic Lagomorpha QY 60.L3 Lagothrix see Cebidae LAK Cells see Killer Cells, Lymphokine-Activated lambda Phage see Bacteriophage lambda Lamblia see Giardia Lambliasis see Giardiasis Laminagraphy, X-Ray see Tomography, X-Ray Laminar Air-Flow Areas see Environment, Controlled Laminectomy WE 725 Lampreys QL 638.2-638.25 As laboratory animals QY 60.F4 LAN see Local Area Networks Landscaping, Hospital see Maintenance and Engineering, Hospital Langerhans-Cell Granulomatosis see Histiocytosis, Langerhans-Cell Langerhans' Islands see Islets of Langerhans Language P 1-410 Disorders WL 340.2 In psychoanalysis, psychoanalytic therapy, or psychoanalytic interpretation WM 460.5.L2 Psychology BF 455-463 Other special topics, by subject See also Communication WM 460.5.C5, etc. Language Comprehension Tests see Language Tests Language Delay see Language Development Disorders Language Development WS 105.5.C8 Formal education LB 1139.L3 Language Development Disorders Neurologic WL 340.2 Psychogenic WM 475 Language Disorders General WL 340.2 In infancy & childhood WL 340.2, etc. Neurologic WL 340.2 Psychogenic WM 475 See also Speech Disorders WM 475, etc. Language Pathology see Speech-Language Pathology Language Tests For aphasia of neurologic origin WL 340.5 For aphasia of psychogenic origin WM 475.5 For general and neurologic speech and language disorders WL 340.2 For psychogenic speech and language disorders WM 475 Language Therapy General WL 340.2 For disorders of neurologic origins WL 340.2 For disorders of psychogenic origins WM 475 Language Training see Language Therapy Langurs see Cercopithecidae Lansing Virus see Polio viruses, Human 1-3 Lanthanides see Metals, Rare Earth Lanthanum Inorganic chemistry QD 181.L2 Pharmacology QV 290 Lanugo see Hair Laparoscopy WI 575 Gynecologic WP 141 In infancy & childhood WS 310 Laparotomy WI 900 Laryngeal Cartilages WV 500-501 Laryngeal Diseases WV 500-540 General works WV 500 In infancy & childhood WV 500-540 Nursing WY 158.5 Veterinary SF 891 Laryngeal Edema WV 500 Laryngeal Muscles WV 500 Laryngeal Neoplasms WV 520 Laryngeal Nerves WL 330 See also Innervation WV 501 under Larynx Laryngeal Paralysis see Vocal Cord Paralysis ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSDTffiD 389 Laryngeal Prosthesis Laryngeal Prosthesis see Larynx, Artificial Laryngectomy WV 540 Laryngismus WV 500 See also Adverse effects WO 245 under Anesthesia Laryngitis WV 510 Laryngologists see Biography WZ 112.5.08, etc. and Directories WV 22 under Otolaryngology Laryngology see Laryngeal Diseases; Otolaryngology Laryngoscopy WV 505 Laryngospasm see Laryngismus Larynx WV 500-540 Innervation WV 501 Surgery WV 540 Larynx, Artificial WV 540 Laser Angioplasty see Angioplasty, Laser Laser Coagulation WO 198 In ophthalmology WW 168 Used for treatment of a particular disorder, with the disorder or system Laser Knife see Laser Surgery Laser Scalpel see Laser Surgery Laser Surgery WO 511 Lasers Applied optics TA 1671-1707 Biomedical application WB 117 Diagnostic use WB 288 In dentistry (General) WU 26 In surgery (General) WO 511 Physics QC 685-689.5 Therapeutic use WB 480 Used for other purposes, by subject See also special topics under Radiation, Non-ionizing Lassitude see Fatigue Late Gene Transcription see Transcription, Genetic Latency in Infection see Infection Latency Period (Psychology) WS 105.5.P3 Latent Schizophrenia see Schizotypal Personality Disorder Lateral Cyst see Periodontal Cyst Lateral Sclerosis see Amyotrophic Lateral Sclerosis Laterality WL 335 Physical anthropology GN 233 Latex Phytochemistry QK 898.L3 Used for special purposes, by subject, e.g., in scanning electron microscopy QH 212.S3 Latex Rubber see Rubber Lathyrism WD 500 Lathyrus see Legumes Latices see Latex Latinos see Hispanic Americans Latrines see Toilet Facilities LATS Receptors see Receptors, Thyroid Hormone Laughter BF 575.L3 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Laundering Hygiene QT 240-245 See also Laundry Service, Hospital WX 165 Laundries, Hospital see Laundering; Housekeeping, ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPItt Hospital Laundry Service, Hospital WX 165 Laurence-Moon-Biedl Syndrome QS 675 LAV Antibodies see HIV Antibodies LAV-HTLV-IH see HIV LAV-2 see HIV-2 Law and Psychiatry see Forensic Psychiatry; Legislation & Jurisprudence WM 32-33 under Psychiatry Laws see Legislation Laxatives see Cathartics Laxity, Joint see Joint Instability LDL Cholesterol see Lipoproteins, LDL Cholesterol LDL Receptors see Receptors, LDL LE Cells WH 200 In bone marrow WH 380 In lupus erythematosus WR 152 Lead QV 292 Lead Poisoning QV 292 Leader Signal Peptides see Signal Peptides Leadership BF 637.L4 Special topics, by subject See also Nursing, Supervisory WY 105 Learned Helplessness see Helplessness, Learned Learning In adolescence LB 1603-1632 In adulthood LB 2300-2397 In infancy & childhood Formal LB 1051-1091 Informal WS 105.5.D2 Kindergarten children LB 1141-1489 Informal WS 105.5.D2 Preschool children L Formal LB 1140-1140.5 Informal WS 105.5.D2 and WS 113 Psychology of LB 1051-1091 Special topics, by subject Learning Disorders Associated with poor vision WW 480 Educational aspects LC 4704, etc. Medical aspects WS 110 Lecithin Acyltransferase QU 141 Lecithin Cholesterol Acyltransferase see Lecithin Acyltransferase Lecithinase Al see Phospholipases A Lecithinase A2 see Phospholipases A Lecithinases see Phospholipases Lecithins see Phosphatidylcholines Lectin, Castor Bean see Ricin Lectin, Ricinus see Ricin Lectins QW 640 See also Phytohemagglutinins QW 640, etc. Lectins, Kidney Bean see Phytohemagglutinins Lectures see Form number 9 in any NLM schedule where applicable Leeches QX 451 Poisoning WD 420 Leeching see Bloodletting Leg WE 850 Artificial see Artificial Limbs WE 172 Blood supply WE 850 Lower WE 870 Upper WE 855 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 390 Leucokinin See also specific parts of the leg; Varicose Veins WG 620, etc. Leg Dermatoses WR 140 Leg Injuries WE 850 Lower leg WE 870 Upper leg WE 855 Leg Length Inequality WE 850 Leg Ulcer WE 850 Legal Guardians Special topics, by subject Legal Medicine see Forensic Medicine Legg-Perthes Disease WE 865 Legionella QW 131 Legionella pneumophila Infections see Legionnaires' Disease Legionellosis WC 200 Legionnaires' Disease WC 200 Legislation (Form number 32-33 in any NLM schedule where applicable) Non-medical subjects, in general works number for subject (avoiding K schedules when possible) See also specific legislation terms, i.e., Legislation, Dental; Legislation, Drug; Legislation, Food; etc. Legislation, Dental WU 32-44.1 Legislation, Drug QV 32-33 Food and drug laws WA 697 Legislation, Food WA 697 Legislation, Hospital WX 32-33 Legislation, Medical W 32-44 Legislation, Nursing WY 32-44 Legislation, Pharmacy QV 732-733 Legislation, Veterinary K 3615-3617 Legumes As dietary supplement in health and disease WB 430 As food plants SB 177.L45 As medicinal plants QV 766 Botany QK 495.L52 Poisoning WD 500 Leiomyoblastoma see Leiomyoma, Epithelioid Leiomyoma QZ 340 Localized, by site, e.g., of the uterus WP 459 Leiomyoma, Epithelioid QZ 340 Localized, by site, e.g., of the stomach WI 320 Leiomyosarcoma QZ 340 Localized, by site Leishmania QX 70 Leishmaniasis WR 350 Leishmaniasis, Mucocutaneous WR 350 Leishmaniasis, Visceral WC 715 Leisure Activities QT 250 Special topics, by subject Lemmings see Microtinae Lemmus see Microtinae Lemurifonnes see Strepsirhini Lemuroidea see Strepsirhini Length of Life see Longevity Length of Stay WX 158 At specialized hospitals (Form number 27-28 in any NLM schedule where applicable) Leninism see Communism Lens, Crystalline WW 260 Lens Diseases WW 260 Lens Implantation, Intraocular see Lenses, Intraocular Lens Opacities see Cataract Lens Proteins see Crystallins Lenses QC 385-385.2 Ophthalmic see Contact Lenses WW 355; Eyeglasses WW 350-354 Prosthesis (Intraocular) WW 358; For cataracts WW 260 Lenses, Contact see Contact Lenses Lenses, Contact, Hydrophilic see Contact Lenses, Hydrophilic Lenses, Intraocular WW 358 For cataracts WW 260 Lenticular Nucleus see Corpus Striatum Lentiform Nucleus see Corpus Striatum Lentiginosis see Lentigo Lentigo WR 265 Lentils see Legumes Lentinan QU 83 Leon Virus see Polioviruses, Human 1-3 Leontiasis Ossium see Hyperostosis Frontalis Interna Leontideus see Callitrichinae Leontopithecus see Callitrichinae Leper Colonies WC 27-28 See also Medical Missions, Official W 323 Leper Hospitals see Hospitals, Special Lepidoptera QX 560 Leprosaria see Hospitals, Special; Leper Colonies Leprostatic Agents QV 259 Leprosy WC 335 Drugs affecting see Leprostatic Agents QV 259 Hospitals see Hospitals, Special WC 27-28, etc.; Leper Colonies WC 27-28, etc. Leptazole see Pentylenetetrazole Leptoconops see Ceratopogonidae Leptomeninges see Arachnoid; Pia Mater Leptophos see Phosvel Leptospirosis WC 420 Icterohemorrhagic see Weil's Disease WC 420 Veterinary SF 809.L4 Leptospirosis, Icterohemorrhagic see Weil s Disease Leptothrix QW 153 Leriche's Syndrome WG 410 Lesbianism see Homosexuality, Female Lesbianism, Ego-Dystonic see Homosexuality, Ego-Dystonic Lesch-Nyhan Syndrome WD 205.5.P8 LET see Energy Transfer Lethal Midline Granuloma see Granuloma, Lethal Midline Lethargy see Sleep Stages LETS Proteins see Fibronectins Leu Antigens see Antigens, Differentiation Leu Antigens, B-Lymphocyte see Antigens, Differentiation, B-Lymphocyte Leucine QU 60 Leucine Aminopeptidase QU 136 Leucokinin see Tuftsin ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 391 Leucosarcoma see Leukosarcoma Leucotomy see Psychosurgery Leucovorin QU 195 Leukapheresis WH 460 Leukemia WH 250 Clinical pathology QZ 350 Veterinary SF 910.L4 Leukemia, Granulocytic see Leukemia, Myeloid Leukemia, Granulocytic, Chronic see Leukemia, Myeloid, Chronic Leukemia, Hairy Cell WH 250 Clinical pathology QZ 350 Leukemia, Lymphoblastic see Leukemia, Lymphocytic Leukemia, Lymphoblastic, Acute see Leukemia, Lymphocytic, Acute Leukemia, Lymphoblastic, Acute, LI see Leukemia, Lymphocytic, Acute, LI Leukemia, Lymphoblastic, Chronic see Leukemia, Lymphocytic, Chronic Leukemia, Lymphocytic WH 250 Clinical pathology QZ 350 Leukemia, Lymphocytic, Acute WH 250 Clinical pathology QZ 350 Leukemia, Lymphocytic, Acute, LI WH 250 Clinical pathology QZ 350 Leukemia, Lymphocytic, Chronic WH 250 Clinical Pathology QZ 350 Leukemia, Lymphoid see Leukemia, Lymphocytic Leukemia, Monoblastic WH 250 Clinical pathology QZ 350 Leukemia, Monocytic WH 250 Clinical pathology QZ 350 Leukemia, Monocytic, Chronic WH 250 Clinical pathology QZ 350 Leukemia, Myeloblasts WH 250 Clinical pathology QZ 350 Leukemia, Myelocytic see Leukemia, Myeloid Leukemia, Myelocytic, Chronic see Leukemia, Myeloid, Chronic Leukemia, Myelogenous see Leukemia, Myeloid Leukemia, Myelogenous, Chronic see Leukemia, Myeloid, Chronic Leukemia, Myeloid WH 250 Clinical pathology QZ 350 Leukemia, Myeloid, Chronic WH 250 Clinical Pathology QZ 350 Leukemia, Radiation-Induced WH 250 Clinical pathology QZ 350 Leukemia Virus, Avian see Avian Leukosis Viruses Leukemia Virus, Bovine QW 166 Leukemia Virus I, Human T-Cell see HTLV-I Leukemia Viruses, Human T-Cell see HTLV-BLV Viruses Leukemia Viruses, Murine QW 166 Leukemic Reticuloendotheliosis see Leukemia, Hairy Cell Leukemogenic Viruses see Leukoviruses Leukemoid Reaction WH 200 Leukocytapheresis see Leukapheresis Leukocyte Adherence Inhibition Test QW 525.5.L6 Leukocyte Adhesion Inhibitor see Interleukin-8 Leukocyte Antigens see HLA Antigens Leukocyte Count QY 402 Leukocyte Count, Differential see Leukocyte Count Leukocyte Differentiation Antigens, Human see Antigens, CD Leukocyte Number see Leukocyte Count Leukocyte Transfusion WB 356 Leukocytes WH 200 In inflammation QW 700 Leukocytes, Polymorphonuclear see Neutrophils Leukocytopenia see Leukopenia Leukocytosis WH 200 Veterinary SF 769.5 Leukoderma see Vitiligo Leukokeratosis see Leukoplakia Leukokinin see Tuftsin Leukokraurosis see Kraurosis Vulvae Leukoma see Corneal Opacity; Leukoplakia, Oral Leukopenia WH 200 Leukopheresis see Leukapheresis Leukoplakia QZ 204 Localized, by site, e.g., cervical WP 470 Leukoplakia, Oral WU 280 For the gastroenterologist WI 200 Leukorrhea WP 255 Leukosarcoma WH 525 Clinical pathology QZ 350 Leukosis, Avian see Avian Leukosis Leukosis Virus, Avian QW 166 Leukotaxis see Chemotaxis, Leukocyte Leukotomy see Psychosurgery Leukotriene B4 QU 90 Leukotrienes QU 90 Leukotrienes B see Leukotriene B4 Leukoviruses see Retroviridae Leurocristine see Vincristine Levarterenol see Norepinephrine LeVeen Shunt see Peritoneovenous Shunt Level of Health see Health Status Levodopa WK 725 Levomycetin see Chloramphenicol Levonorepinephrine see Norepinephrine Levulose see Fructose Lewisite QV 666 Lewy Body Disease see Parkinson Disease LH WK 515 LH-FSH Releasing Hormone see Gonadorelin LH-Releasing Hormone see Gonadorelin LHRH see Gonadorelin Liability see Insurance, Liability; Malpractice Liability, Legal W 44 General W 44 Dentistry WU 44 Nursing WY 44 (Form number 33 in any other NLM schedule where applicable) Libido Psychoanalysis WM 460.5.S3 Libman-Sacks Disease see Lupus Erythematosus, Systemic Librarianship see Library Science Libraries Z 665-997.2 Libraries, Dental Z 675.D3 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 392 Lignocaine Libraries, Health Science see Libraries, Medical Libraries, Hospital Z 675.H7 Patients' libraries Z 675.P27 Libraries, Medical Z 675.M4 Libraries, Medical Record see Medical Records Libraries, Nursing Z 675.N8 Nursing school Z 675.N8 Library Administration Z 678-678.88 Library Associations Z 673 Library Automation Z 678.9 Library Schools Z 668-669.5 Library Science Z 665-718.8 Library Services Z 665-997 Circulation Z 712-714 Extension Z 716 Reference Z 711-711.92 Reports Z 729-871 See also special types of service and specific types of libraries, e.g., Library technical services Z 688.5; Libraries, Medical Z 675.M4; also headings beginning with Book Library Surveys Z 721-871 Library Technical Services Z 688.5 Lice QX 501-502 Body lice QX 502 Disinfestation WA 240 Infestation see Pediculosis WR 375 Plant lice see Aphids QX 503, etc. Lice, Plant see Aphids Licenses see Licensure Licensure Barbers, beauticians, etc. WA 32 Dental hygienists WU 40 Midwives WQ 32 Other specialties, not listed here or below, by specialty Licensure, Dental WU 40 Licensure, Hospital WX 15 Licensure, Institutional, Personnel see Licensure Licensure, Medical W 40 Licensure, Nursing WY 21 Licensure, Pharmacy QV 29 Lichen Planus WR 215 Lichen Ruber Planus see Lichen Planus Lichen Simplex Chronicus see Neurodermatitis Lichens QK 580.7-597.7 Licorice see Glycyrrhiza Lidocaine QV 115 Lidoflazine QV 150 Lie Detection HV 8078 Life see Biogenesis; Biology; Philosophy Life Care Centers, Retirement see Housing for the Elderly Life Change Events In adolescence WS 462 In infancy & childhood WS 105 In old age WT 104 Special topics, by subject Life Expectancy WT 116 Actuarial science HG 8781-8793 Tables WT 16 Life Experiences see Life Change Events Life Insurance see Insurance, Life Life Islands see Patient Isolators Life, Legal Establishment see Biogenesis; Birth Certificates; Infant, Newborn; Physical Examination Life Style Adolescents WS 462 Aging WT 30 Other special topics, by subject, e.g., Anthropology, Cultural GN 315, etc.; conduct of life BJ 1545-1697 Life Support Care WX 162 Ethical questions W 50 In old age WT 31 Nursing WY 152 Life Support Systems WD 756 Life Support Systems, Regenerative see Ecological Systems, Closed Life Table Analysis see Life Tables Life Table Methods see Life Tables Life Table Models see Life Tables Life Tables Demography HB 1322 Specific topics, by subject See also Actuarial Analysis Ligament, Broad see Adnexa Uteri Ligaments WE 300 Localized, by site Ligaments, Articular WE 300 Localized, by site Ligases QU 138 Ligation, Tubal see Sterilization, Tubal Ligatures, Surgical see Sutures Light Adverse effects (General) WD 605 As cause of disease QZ 57 Diagnostic use (General) WB 288 General medical use WB 117 Hygiene see Lighting QT 230, etc.; Sunlight QT 230, etc. Perception WW 105 Photobiology QH 515 Phototherapy WB 480 Physics QC 350-467 Physiological effects (General) QT 162.L5 Light Coagulation WW 166 Used for specific disorders, by subject Light, Luminescent see Luminescence Light Metals see Metals QU 130, etc. and names of specific light metals; Aluminum; Magnesium Light, Visible see Light Lighting Industrial health WA 470 Private homes QT 230 School buildings WA 350 Vision conservation WW 113 Lightning Electric injuries WD 602 Meteorology QC 966-966.7 Lignin Animal feed SF 98.L54 Biochemistry QU 83 Phytochemistry QK 898.L5 Lignocaine see Lidocaine ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSfFTED 393 limbic System Limbic System WL 314 Limbs see Extremities Limbs, Artificial see Artificial Limbs Limitation of Activity, Chronic see Activities of Daily Living Limulus see Horseshoe Crabs Limulus Test QW 25 Special topics, by subject Lincolnensin see Lincomycin Lincomycin QV 350 Lindane see Benzene Hexachloride Linear Accelerators see Particle Accelerators Linear Energy Transfer see Energy Transfer Linear Regression see Regression Analysis Linens see Bedding and Linens Lingua Geographica see Glossitis, Benign Migratory Lingua Villosa Negra see Tongue, Hairy Lingual Bone see Hyoid Bone Linguistics P 121-149 Liniments QV 785 Linkage (Genetics) QH 445.2-445.5 Linkage Mapping see Chromosome Mapping Linseed Oil QV 785 Liothyronine see Triiodothyronine Lip WI 200 Cleft see Cleft Lip WV 440 For the dentist WU 140 Lip Diseases WI 200 For the dentist WU 140 Lip Neoplasms WU 280 For the gastroenterologist WI 200 Lip Reading see Lipreading Lipase QU 136 Lipectomy WO 600 Lipemia-Clearing Factor see Lipoprotein Lipase Lipid Bilayers QU 85 Lipid Emulsions, Intravenous see Fat Emulsions, Intravenous Lipid Metabolism, Inborn Errors WD 205.5.L5 See also Xanthomatosis WD 205.5.X2 Lipid Mobilization QU 85 Lipid Peroxidation QU 85 Lipid Peroxides Biochemistry QU 85 Lipidosis see Lipoidosis Lipids QU 85-95 Clinical analysis QY 465 Lipoamide Dehydrogenase QU 140 Lipocaic see Lipotropic Factors Lipochondrodystrophy see Mucopolysaccharidosis I Lipodystrophy Internal WD 214 Progressive WD 214 Lipofuscin QU 110 Lipoic Acid see Thioctic Acid Lipoidosis WD 205.5.L5 Lipoids QU 85 Lipolysis QU 85 Lipolysis, Suction see Lipectomy Lipoma QZ 340 Localized, by site Lipomatosis WD 214 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Lipopolysaccharides QU 83 Lipoprotein LDL Receptors see Receptors, LDL Lipoprotein Lipase QU 136 Lipoproteins QU 85 In blood chemistry QY 465 Lipoproteins, HDL Cholesterol QU 95 Lipoproteins, LDL Cholesterol QU 95 Liposarcoma QZ 345 Localized, by site Liposuction see Lipectomy Lipotropic Factors QU 87 Lipreading HV 2487 Liquid Paraffin see Mineral Oil Liquors see Alcoholic Beverages Listeria QW 142.5.A8 Listeria Infections WC 242 Veterinary SF 809.L5 Listeria monocytogenes QW 142.5.A8 Lisuride QV 174 Literacy Programs see Education Literature P By physicians WZ 350 Chinese PL 2250-3190 General works PN Influence on children WS 105.5.E9 Medicine in see Medicine in Literature WZ 330, etc. Physicians in WZ 330 Psychiatry and literature WM 49 Psychotherapeutic Use see Bibliotherapy WM 450.5.B5 Other languages, in appropriate LC schedule Other special topics, by subject See also Psychoanalytic Interpretation WM 460.7 Literature, Medieval History PN 661-694 Special topics, by subject, e.g., Dante e le scienze mediche WZ 330 Literature, Modern PN 695-779 Special topics, by subject Lithium QV 77.9 Litholapaxy see Lithotripsy Lithospermum QV 766 Lithotripsy For urinary calculi WJ 166 For special purposes, with subject Litomosoides see Filarioidea Little's Disease see Cerebral Palsy Liver WI 700-770 Blood supply WI 702 See also Hepatic Artery WG 595.H3; Hepatic Veins WG 625.H3; Liver Circulation WI 702 Tests QY 140-147 See also Liver Function Tests QY 147 Liver Abscess WI 730 Liver Abscess, Amebic WI 730 Liver Cell Adhesion Molecules see Cell Adhesion Molecules Liver Circulation WI 702 Disorders WI 720 Liver Cirrhosis WI 725 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 394 Luliberin Pigmentary WR 267 Veterinary SF 851 See also Hemochromatosis WR 267 Liver Cirrhosis, Alcoholic WI 725 Liver Diseases WI 700-770 General works WI 700 In infancy & childhood WS 310 Veterinary SF 851 Liver Diseases, Alcoholic WI 700 Liver Diseases, Parasitic WI 700 Veterinary SF 851 Liver Extracts Pharmacology QV 184 Therapeutic use (General) WB 391 Used for treatment of particular disorders, with the disorder or system Liver Failure, Fulminant see Hepatic Encephalopathy Liver Fibrosis see Liver Cirrhosis Liver Function Tests QY 147 Liver Glycogen WI 704 Liver Microsomes see Microsomes, Liver Liver Mitochondria see Mitochondria, Liver Liver Neoplasms WI 735 Liver Neoplasms, Experimental WI 735 Liver Regeneration WI 702 Liver Transplantation WI 770 Livestock see Animals, Domestic Living Space see Environment Living Wills W 85.5 Livor Mortis see Postmortem Changes Lizards QL 666.L2-666.L295 Diseases SF 997.5.R4 Llamas see Camelids, New World LMWH see Heparin, Low-Molecular-Weight Loa QX 301 Loa loa see Loa Lobbying Special topics, by subject Lobectomy see Pneumonectomy; Psychosurgery Lobotomy see Psychosurgery Lobstein's Disease see Osteogenesis Imperfecta Lobsters QX 463 Local Anesthesia see Anesthesia, Local Local Area Networks TK 5105.7-5105.8 Local Immunity see Immunity Localization of Function see Brain Mapping; Dominance, Cerebral Localization of Infection see Infection Location Directories and Signs In health facilities WX 140 For the specialties (form number 27-29 in any NLM schedule where applicable) In hospital departments WX 200-225 Public health aspects in public buildings WA 799 Lochia see Leukorrhea Locked-In Syndrome see Quadriplegia Lockjaw see Tetanus; Trismus Locomotion WE 103 Locomotion, Cell see Cell Movement Locomotor Ataxia see Tabes Dorsalis Locomotor System see Musculoskeletal System Locus Coeruleus WL 310 Locus of Control see Internal-External Control Lofepramine QV 77.5 Logic BC Adolescents WS 462 Children WS 105.5.D2 Medical W 61 Logotherapy WM 460.5.E8 Loneliness BF 575.L7 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Long QT Syndrome WG 330 Long-Term Care WX 162-162.5 In old age WT 31 Nursing WY 152 Of mentally ill WM 30 Long-Term Care Insurance see Insurance, Long-Term Care Longevity WT 116 See also Life Expectancy WT 116, etc. Longitudinal Studies WA 950 Special topics, by subject, e.g., of characteristics, etc. of medical school graduates W 76 Loop Ileostomy see Ileostomy Loperamide QV 71 Lopramine see Lofepramine Lordosis WE 735 Loris, Slow see Lorisidae Lorisidae QL 737.P955 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Lorr's Inpatient Multidimensional Psychiatric Rating Scale see Psychiatric Status Rating Scales Lotions see Cosmetics; Dermatologic Agents; Suspensions; Sunscreening Agents Lou Gehrig's Disease see Amyotrophic Lateral Sclerosis Loudness Perception WV 272 Louping 111 Virus see Encephalitis Viruses, Tick-Borne Love Adolescent psychology WS 462 Child psychology WS 105.5.E5 Family HQ 728-743 Marriage HQ 728-746 Psychology (General) BF 575.L8 Sex behavior HQ 19-25 Low Back Pain WE 755 Low Cardiac Output see Cardiac Output, Low Low-Income Population see Poverty Low-Molecular-Weight Heparin see Heparin, Low-Molecular-Weight Low Molecular Weight Nuclear RNA see RNA, Small Nuclear Low Sodium Diets see Diet, Sodium-Restricted Lower Extremities see Extremities; names of particular parts Lower Extremity see Leg LSD see Lysergic Acid Diethylamide LTB4 see Leukotriene B4 Luciferase QU 140 Ludwig's Angina WI 200 Luliberin see Gonadorelin ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 395 Lumbago Lumbago see Low Back Pain Lumbar Puncture see Spinal Puncture Lumbar Region see Lumbosacral Region Lumbar Vertebrae WE 750 Lumbosacral Plexus WL 400 Lumbosacral Region WE 750-755 Luminal see Phenobarbital Luminescence Bioluminescence QH 641 Radiation physics (General) QC 476.4-480.2 Used for particular purposes, by subject, in the techniques number 25 in any NLM schedule where applicable, or comparable LC number Luminescent Proteins QU 55 Lumpy Skin Disease WC 584 Lunar Cycle see Moon Lunar Phases see Moon Lundborg-Unverricht Syndrome see Epilepsy, Myoclonic Lung WF 600-668 Blood supply WF 600 Irritants QV 664 Radiography WF 600 Surgery WF 668 See also Mass Chest X-Ray WF 225 Lung Abscess WF 651 Lung Capacities see Lung Volume Measurements Lung Diseases WF 600-668 In infancy & childhood WS 280 Veterinary SF 831 Lung Diseases, Fungal WF 652 Lung Diseases, Interstitial WF 600 Lung Diseases, Obstructive WF 600 Lung Diseases, Parasitic WF 600 Lung Function Tests see Respiratory Function Tests Lung Irritants see Irritants Lung Lavage Fluid see Bronchoalveolar Lavage Fluid Lung Neoplasms WF 658 Lung Transplantation WF 668 Lung Volume Measurements General diagnosis WB 284 Respiratory diseases WF 141 Lupus WR 245 Lupus Erythematosus, Chronic Cutaneous see Lupus Erythematosus, Discoid Lupus Erythematosus, Cutaneous WR 152 Lupus Erythematosus, Cutaneous, Chronic see Lupus Erythematosus, Discoid Lupus Erythematosus, Cutaneous, Subacute see Lupus Erythematosus, Cutaneous Lupus Erythematosus, Discoid WR 152 Lupus Erythematosus Disseminatus see Lupus Erythematosus, Systemic Lupus Erythematosus, Subacute Cutaneous see Lupus Erythematosus, Cutaneous Lupus Erythematosus, Systemic WR 152 Lupus Glomerulonephritis see Lupus Nephritis Lupus Nephritis WJ 353 Lupus Vulgaris see Lupus Lurcher Mice see Mice, Neurologic Mutants Luteinizing Hormone see LH Luteinizing Hormone-Releasing Hormone see Gonadorelin Luteinoma see Luteoma Luteoma WP 322 Luteotropin see Prolactin Lutropin see LH Lyases QU 139 Lycine see Betaine Lycoremine see Galanthamine Lyell's Syndrome see Epidermal Necrolysis, Toxic Lying BJ 1420-1428 In adolescence WS 463 In infancy & childhood WS 350.8.L9 Lying-in Hospitals see Hospitals, Maternity Lyme Borreliosis see Lyme Disease Lyme Disease WC 406 Lymph WH 700 Lymph Node Excision WH 700 Localized, by site Lymph Node Syndrome, Mucocutaneous see Mucocutaneous Lymph Node Syndrome Lymph Nodes WH 700 Tuberculosis see Tuberculosis, Lymph node WF 290 Lymphadenectomy see Lymph Node Excision Lymphadenitis WH 700 Lymphadenitis, Tuberculous see Tuberculosis, Lymph Node Lymphadenopathy-Associated Antibodies see HIV Antibodies Lymphadenopathy-Associated Virus see HIV Lymphadenopathy, Immunoblastic see Immunoblastic Lymphadenopathy Lymphadenopathy Syndrome see AIDS-Related Complex Lymphangioendothelioma see Lymphangioma Lymphangiography see Lymphography Lymphangioma QZ 340 Localized, by site Lymphangitis WH 700 Lymphapheresis see Leukapheresis Lymphatic Capillaries see Lymphatic System Lymphatic Diseases WH 700 In infancy & childhood WS 300 Nursing WY 152.5 Veterinary SF 769.5 Localized, by site Lymphatic Filariasis see Elephantiasis, Filarial Lymphatic Metastasis WH 700 Of particular types of neoplasms, by site, e.g., of the stomach WI 320 Lymphatic Sarcoma see Lymphoma, Diffuse Lymphatic System WH 700 Children WS 300 Tuberculosis see Tuberculosis, Lymph Node WF 290 Lymphedema WH 700 Secondary to filariasis WC 880 Veterinary SF 769.5 Localized, by site Lymphoblast Transformation see Lymphocyte Transformation Lymphoblastic Leukemia see Leukemia, Lymphocytic ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7TED 396 Macromolecular Systems Lymphoblastic Leukemia, Acute see Leukemia, Lymphocytic, Acute Lymphoblastic Leukemia, Acute, Childhood see Leukemia, Lymphocytic, Acute, LI Lymphoblastic Leukemia, Acute, LI see Leukemia, Lymphocytic, Acute, LI Lymphoblastic Leukemia, Chronic see Leukemia, Lymphocytic, Chronic Lymphocytapheresis see Leukapheresis Lymphocyte-Activating Factor see Interleukin-1 Lymphocyte Activation see Lymphocyte Transformation Lymphocyte Cooperation Cellular immunity QW 568 Lymphocyte Mediators see Lymphokines Lymphocyte Mitogenic Factor see Interleukin-2 Lymphocyte Stimulation see Lymphocyte Transformation Lymphocyte Transformation Clinical pathology QY 402 Hematology WH 200 Transplantation immunology WO 680 Lymphocyte Transfusion WB 356 Lymphocytes WH 200 Cellular immunity QW 568 Lymphocytic Choriomeningitis WC 540 Lymphocytic Leukemia see Leukemia, Lymphocytic Lymphocytic Leukemia, Acute see Leukemia, Lymphocytic, Acute Lymphocytic Leukemia, Chronic see Leukemia, Lymphocytic, Chronic Lymphocytic Leukemia, LI see Leukemia, Lymphocytic, Acute, LI Lymphocytopenia see Lymphopenia Lymphocytosis WH 200 Lymphocytotoxic Antibodies see Antilymphocyte Serum Lymphogranuloma Inguinale see Lymphogranuloma Venereum Lymphogranuloma, Malignant see Hodgkin s Disease Lymphogranuloma Venereum WC 185 Lymphogranulomatosis Inguinalis see Lymphogranuloma Venereum Lymphography WH 700 Lymphoid Cells see Lymphocytes Lymphoid Leukemia see Leukemia, Lymphocytic Lymphoid Tissue WH 700 Lymphokine-Activated Killer Cells see Killer Cells, Lymphokine-Activated Lymphokines Cellular immunity QW 568 Other special topics, by subject Lymphoma WH 525 Clinical pathology QZ 350 See also Burkitt's Lymphoma WH 525 Lymphoma, Burkitt's see Burkitt's Lymphoma Lymphoma, Diffuse WH 525 Clinical pathology QZ 350 Lymphoma, Follicular WH 525 Clinical pathology QZ 350 Lymphoma, Giant Follicular see Lymphoma, Follicular Lymphoma, Histiocytic see Lymphoma, Large-Cell Lymphoma, Large-Cell WH 525 Clinical pathology QZ 350 Localized, by site Lymphoma, Malignant see Lymphoma Lymphoma, Nodular see Lymphoma, Follicular Lymphoma, Non-Hodgkin s WH 525 Clinical pathology QZ 350 Lymphomatosis Virus, Avian see Leukosis Virus, Avian Lymphopathia Venerea see Lymphogranuloma Venereum Lymphopenia WH 200 Lymphoproliferative Disorders General works WH 700 In infancy & childhood WS 300 Nursing WY 152.5 Veterinary SF 769.5 See also names of specific disorders, e.g., Lymphoma WH 525 Lymphosarcoma see Lymphoma, Diffuse Lynch Syndrome see Colorectal Neoplasms, Hereditary Nonpolyposis Lynestrenol WP 530 As a contraceptive QV 177 Lyophilization see Freeze Drying Lypressin WK 520 Lysergic Acid Diethylamide QV 77.7 Lysergide see Lysergic Acid Diethylamide Lysine QU 60 Lysine Vasopressin see Lypressin Lysis see Bacteriolysis; Hemolysis; Lysogeny Lysogeny QW 660 Lysol see Cresols Lysolecithins see Lysophosphatidylcholines Lysophosphatidylcholines QU 93 Lysosomes QH 603.L9 Lysozyme see Muramidase Lysuride Hydrogen Maleate see Lisuride Lysyl Bradykinin see Kallidin M m-Dihydroxybenzenes see Resorcinols M Phase see Mitosis Macaca QL 737.P93 As laboratory animals QY 60. P7 Diseases SF 997.5.P7 Macaca mulatta QL 737.P93 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Macaca nemestrina QL 737.P93 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Macaque see Macaca Mace see omega-Chloroacetophenone Maceration (Pharmacy) see Drug Compounding Machiavellianism BF 698.35.M34 Macrocytic Anemias see Anemia, Macrocytic Macroglobulinemia see Waldenstrom's Macroglobulinemia Macromolecular Systems Polymers (General) ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSnTED 397 Macromolecular Systems Inorganic QD 196 Organic QD 380-QD 388 Polysaccharides QU 83 Proteins QU 55 Special topics, by subject Macrophage Activation QW 690 Macrophage-Granulocyte Inducer see Colony-Stimulating Factors Macrophages WH 650 In phagocytosis QW 690 Macula Lutea WW 270 Macular Degeneration WW 270 Madura Foot see Maduromycosis Madurella see Hyphomycetes Maduromycosis WR 340 Maedi Virus see Visna-Maedi Virus Maedi-Visna Virus see Visna-Maedi Virus Magentas see Rosaniline Dyes Maggot Infestations see Myiasis Magic Medical WZ 309 Occult sciences BF 1585-1628 Magnesium Metabolism QU 130 Pharmacology QV 278 Toxicology QV 278 Magnesium Adenosinetriphosphatase see Ca(2+) Mg(2+)-ATPase Magnesium ADP see Adenosine Diphosphate Magnesium ATP see Adenosine Triphosphate Magnesium ATPase see Ca(2+) Mg(2+)-ATPase Magnesium Deficiency WD 105 Veterinary SF 855.M34 Magnesium Hydroxide As an antacid QV 69 Magnesium Sulfate QV 75 Magnetic Fields see Magnetics Magnetic Resonance see Nuclear Magnetic Resonance Magnetic Resonance Imaging WN 185 Magnetic Resonance Spectroscopy see Nuclear Magnetic Resonance Magnetics And electricity collectively QC 501-718.8 Biophysics QT 34 Effect on cells QH 656 Physics QC 750-766 Physiological effects QT 162.M3 Magnetism see Magnetics Magnetism, Animal see Mental Healing Magnetoencephalography WL 141 Magnetometry see Magnetics Maillard Reaction As pathogenesis of disease (General) QZ 40 Food processing technology TP 372.55.M35 Mainstreaming (Education) General LC 4015, LC 4031, etc. Of children with specific disabilities, with the disability Maintenance Housing WA 795-799 Of special equipment, by subject Maintenance and Engineering, Hospital WX 165 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIM Maize see Corn Major Histocompatibility Complex WO 680 Mai de Pinto see Pinta Malabsorption Syndromes WD 200.5.M2 For the gastroenterologist WI 500 See also Celiac Disease WD 175; Sprue WD 175 Malacosteon see Osteomalacia Maladjustment see Personality Disorders Malaria WC 750-770 Drugs for see Antimalarials QV 256-258 Prevention and control WC 765 Veterinary SF 791 Malaria, Avian SF 995.6.M3 Malaria, Hemolytic see Blackwater Fever Malathion Carcinogenicity research QZ 202 Public health WA 240 Male Fern see Plants, Medicinal Male Genitalia see Genitalia, Male Male Nurses see Nurses, Male Male Pattern Baldness see Alopecia Maleates QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Malformations, Congenital see Abnormalities; Arteriovenous Malformations; names of other specific malformations Malfunction, Equipment see Equipment Failure Malignant Carcinoid Syndrome WI 435 Malignant Hypertension see Hypertension, Malignant Malingering W 783 Malleus WV 230 Malnutrition see Nutrition Disorders Malocclusion WU 440 Malpractice W 44 General W 44 Dentistry WU 44 Gynecology WP 34 Nursing WY 44 Obstetrics WQ 34 (Form number 33 or 33.1 in any other NLM schedule where applicable and practical) Malt As a dietary supplement in health or disease WB 431 For alcoholic beverages TP 587 Malta Fever see Brucellosis Maltases see alpha-Glucosidases Malthusianism see Population Dynamics Maltose QU 75 Mammae General SF 890 Wild animals QP 188.M3 Mammals As laboratory animals QY 60.M2 Diseases SF 600-1100 Domestic SF Wild QL 700-739.3 Mammary Arteries WG 595.T4 Mammary Dysplasia see Fibrocystic Disease of Breast USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSDTTED 398 Markers, Biological Mammary Glands see Breast; Mammae; Udder Mammary Glands, Animal see Mammae Mammary Neoplasms, Experimental WP 870 Mammography WP 815 Mammotropic Hormone, Pituitary see Prolactin Mammotropic Hormone, Placental see Placental Lactogen Mammotropin see Prolactin Man-Machine Systems TA 167 Biomedical engineering QT 36 Special topics, by subject Managed Care Programs W 130 Managed Health Care Insurance Plans see Managed Care Programs Management Information Systems W 26.5 Ambulatory Care Information Systems WX 26.5 Clinical Laboratory Information Systems QY 26.5 Database Management Systems W 26.5 Decision Support Systems, Management W 26.5 Hospital Information Systems WX 26.5 Office Automation W 26.5 Radiology Information Systems WN 26.5 In other areas, by subject Management Quality Circles Hospitals WX 159 Nursing WY 30 Mandelic Acids QV 243 Mandelonitrile beta Gentiobioside see Amygdalin Mandible WU 101 See also special topics under Jaw Mandibular Condyle WU 101 See also special topics under Jaw Mandibular Diseases WU 140.5 Mandibular Fractures WU 610 Mandibular Injuries WU 610 Mandibular Neoplasms WU 280 Mandibular Nerve WL 330 Mandibular Prosthesis WU 600 Mandibular Ridge Augmentation see Alveolar Ridge Augmentation Mandibulofacial Dysostosis WU 101.5 Mandragora QV 85 Mandrake, American see Podophyllum Mandrake, European see Mandragora Mandrake Root see Podophyllum Mandrill see Papio Manganese QV 290 Metabolism QU 130.5 Mange see Mite Infestations Mange, Sarcoptic see Scabies Mania see Manic Disorder Manic-Depressive Psychoses see Psychoses, Manic-Depressive Manic-Depressive Psychosis see Bipolar Disorder Manic Disorder WM 207 Manic State see Manic Disorder Manifestations of Disease see Disease; Eye Manifestations; Gastrointestinal System; Neurologic Manifestations; Oral Manifestations; Skin Manifestations Manihot see Cassava Manikins QY 35 Manioc see Cassava Manipulation, Chiropractic see Chiropractic Manipulation, Orthopedic WB 535 Used for treatment of particular disorders, with the disorder Manipulation, Psychological see Machiavellianism Mannequins see Manikins Mannitol QV 160 Manpower see Health Manpower Manslaughter see Homicide Mantids see Orthoptera Manual Communication HV 2477-2480 See also Sign Language HV 2474-2476 Manuals Hospital staff Non-professional WX 159 Nursing WY 105 Pediatric WS 29 Ward manual WX 203 Other professional WX 203 Psychiatric WM 30 Others, by subject Manuscripts Z 6601-6625 Manuscripts, Medical Bibliography Z 6611.M5 Early western WZ 220 Other early WZ 225 Others, by subject Mapharsen see Oxophenarsine Maple Syrup Urine Disease WD 205.5.A5 Maprotiline QV 77.5 Maps G Of diseases WA 900 See also Atlases G Marasmus see Protein-Energy Malnutrition Marble Bone Disease see Osteopetrosis Marchiafava-Micheli Syndrome see Hemoglobinuria, Paroxysmal Marek's Disease SF 995.6.M33 Margarine As a dietary supplement in health or disease WB 425 Biochemistry QU 86 Public health aspects WA 722 Marguerite see Pyrethrum Marie-Struempell Disease see Spondylitis, Ankylosing Marihuana see Cannabis Marijuana see Cannabis Marijuana Abuse WM 276 Marijuana Smoking Dependence WM 276 Pharmacological effect QV 77.7 Social pathology HV 5822.M3 Marine Biology QH 91-95.9 Marine Toxins QW 630.5.M3 See also Fish Venoms WD 405 Marital Relationship see Marriage Marital Therapy WM 430.5.M3 Maritime Quarantine see Quarantine Marker Antigens see Antigens, Differentiation Markers, Biological see Biological Markers ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSOTED 399 Markers, DNA Markers, DNA see Genetic Markers Markers, Genetic see Genetic Markers Markers, Laboratory see Biological Markers Markers, Serum see Biological Markers Markers, Surrogate see Biological Markers Markers, Tumor see Tumor Markers, Biological Marketing of Health Services W 74 Special topics, by subject Marmoset Virus see Simplexvirus Marriage HQ 503-1058 Counseling WM 55 Miscegenation GN 254 Statistics HB 1111-1317 See also Marital Therapy WM 430.5.M3 Marriage Therapy see Marital Therapy Marrow see Bone Marrow Marsh Gas see Methane Marsupialia QL 737.M3-737.M39 Martial Arts QT 260.5.M3 Marxism see Communism Masks WA 260 In industry WA 485 In surgery WO 162 Masochism WM 610 Mass Behavior HM 281-291 Mass Chest X-Ray WF 225 Mass Media P 87-96 Special topics, by subject Mass Screening WA 245 In infancy & childhood WS 141 Mass Spectrometry see Spectrum Analysis, Mass Mass Spectroscopy see Spectrum Analysis, Mass Massage WB 537 Mast-Cell Colony-Stimulating Factor see Interleukin-3 Mast Cells QS 532.5.C7 Mastectomy WP 910 Mastectomy, Modified Radical WP 910 Mastectomy, Radical WP 910 Mastication WU 102 Masticatory Force see Bite Force Masticatory Muscles Anatomy WU 101 Physiology WU 102 Mastigophora QX 70 Mastitis WP 840 Mastitis, Cystic see Fibrocystic Disease of Breast Mastocytosis, Bullous see Urticaria Pigmentosa Mastocytosis, Diffuse Cutaneous see Urticaria Pigmentosa Mastoid WE 705 Region of the middle ear WV 233 Mastoiditis WV 233 Mastomys see Muridae Masturbation HQ 447 Psychiatric aspects WM 611 Matched Case-Control Studies see Case-Control Studies Materia Alba see Dental Deposits Materia Medica QV 760 Materials Management, Hospital WX 147 Materials Testing General and mechanical TA 410, etc. In special fields, with the field, i.e. in Dentistry WU 190 Of biocompatible materials QT 37 Of specific materials, with the material Of specific property, with the property (e.g., testing of impact strength TA 418.34) Maternal Age 35 and over Normal pregnancy WQ 200 Pregnancy complications WQ 240-260 Maternal and Child Welfare see Child Welfare; Maternal Welfare Maternal Behavior WS 105.5.F2 Maternal-Child Health Centers see Health Facilities WA 310 Maternal-Child Nursing WY 157.3 Maternal Deprivation WS 105.5.D3 Maternal-Fetal Exchange WQ 210.5 Immunological factor QW 553 Maternal Health see Maternal Welfare Maternal Health Services WA 310 See also Prenatal Care WQ 175; Postnatal Care WQ 500 Maternal Mortality HB 1322.5 Including causes of death WA 900 Maternal Patterns of Care see Maternal Behavior Maternal Welfare WA 310 Maternity see Illegitimacy; Mothers; Parents; Pregnancy Maternity Leave see Parental Leave Maternity Nursing see Obstetrical Nursing Mathematical Computing Special topics, by subject, e.g. Biological Models QH 324.8 Mathematics QA Biomathematics In general biological sciences QH 323.5 In medicine and related fields QT 35 In public health statistics WA 950 Concept formation in children WS 105.5.D2 Statistical methods (General) QA 276-280 Used in various specialties (Form number 25 in any NLM schedule where applicable) Mating Behavior, Animal see Sex Behavior, Animal Matrix, Extracellular see Extracellular Matrix Mattresses see Beds Maxilla WU Maxillary Antrum see Maxillary Sinus Maxillary Artery WG 595.M2 Maxillary Diseases WU 140.5 Maxillary Fractures WU 610 Maxillary Neoplasms WU 280 Maxillary Prosthesis see Maxillofacial Prosthesis Maxillary Ridge Augmentation see Alveolar Ridge Augmentation Maxillary Sinus WV 345 Maxillary Sinus Neoplasms WV 345 Maxillary Sinusitis WV 345 Maxillofacial Development WE 705 Dental aspects WU 101 Maxillofacial Injuries WU 610 Maxillofacial Prosthesis WU 600 Maximal Expiratory Flow Rate WF 102 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7IED 400 As a diagnostic test WF 141 General physical examination WB 284 Maximal Expiratory Flow-Volume Curves WF 102 Maximum Allowable Concentration see Maximum Permissible Exposure Level Maximum Permissible Exposure Level To industrial pollutants WA 400-495 To other specific conditions, by subject May Apple see Podophyllum McGill Pain Questionnaire see Pain Measurement McNaughton Rule see Insanity Defense MDA see 3,4-Methylenedioxyamphetamine Meals on Wheels see Food Services Measles WC 580 Measles, German see Rubella Measles Vaccine WC 580 Measles Virus QW 168.5.P2 Measles Virus, German see Rubella Virus Meat As a dietary supplement in health or disease WB 426 Butchering, packaging, etc. TS 1960-1981 Sanitation WA 707 Inspection WA 707 Meat-Packing Industry TS 1970-1973 Occupational medicine WA 400-495 Industrial waste WA 788 Meat inspection WA 707 Meat Products As dietary supplement in health or disease WB 426 Contamination WA 701 Preserved WA 710 Sanitation WA 707 Meatus, External Auditory see Ear Canal Meatus, Internal Auditory see Petrous Bone Meballymal see Secobarbital Mebubarbital see Pentobarbital Mebumal see Pentobarbital Mechanoreceptors WL 102.9 Mechanotherapy see WB 535 for works including Exercise Therapy; Gymnastics; Manipulation, Orthopedic; Massage and/or other similar procedures treated together. Mechlorethamine QV 269 Mechlorethamine Oxide see Mechlorethamine Meckel's Diverticulum WI 412 Meclastine see Clemastine Meclofenoxate Biochemistry QU 98 As an analeptic QV 101 As a plant growth regulator QK 745 Mecloprodin see Clemastine Meconium WQ 210.5 Medex see Physician Assistants Median Bar see Prostatic Diseases Median Nerve WL 400 See also names of organs affected, e.g., Hand WE 830 Mediastinal Cyst WF 900 Mediastinal Diseases WF 900 Mediastinal Emphysema WF 900 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIU Medical Informatics Applications Mediastinal Neoplasms WF 900 Mediastinitis WF 900 Mediastinoscopy WF 900 Mediastinum WF 900 Medicaid W 250 Medical Assistance W 100-275 Medical Assistance, Title 19 see Medicaid Medical Audit W 84 Of a hospital WX 153 Medical Botany see Plants, Medicinal Medical Care see Health Services Medical Care Costs see Health Care Costs Medical Care Research see Health Services Research Medical Care Team see Patient Care Team Medical Centers see Health Facilities WX and names of specific types of facilities Medical Climatology see Climate; Weather Medical Computer Science see Medical Informatics Medical Curiosities see Abnormalities; Medicine Medical Decision Making, Computer-Assisted see Decision Making, Computer-Assisted Medical Device Design see Equipment Design Medical Device Failure see Equipment Failure Medical Device Safety see Equipment Safety Medical Devices see Equipment and Supplies Medical Dissertations see Dissertations, Academic Medical Economics see Economics, Medical Medical Education see Education, Medical Medical Education, Continuing see Education, Medical, Continuing Medical Education, Graduate see Education, Medical, Graduate Medical Education, Undergraduate see Education, Medical, Undergraduate Medical Emergencies see Emergencies; Emergency Medicine Medical Ethics see Ethics, Medical Medical Evidence see Forensic Medicine Medical Examiners see Coroners and Medical Examiners Medical Geography see Climate; Epidemiology; Weather; names of diseases involved Medical Gymnastics see Exercise Therapy Medical History Taking WB 290 See also Medical Records WX 173 Medical Illustration WZ 348 (Form number 17 in any NLM schedule where applicable) Surgery WO 517 See also Anatomy, Artistic NC 760-783.8; Medicine in Art WZ 330; Photography TR 708, etc. Medical Imaging see Diagnostic Imaging Medical Indigency W 250 See also Medicaid W 250 Medical Informatics In particular fields (Form number 26.5 in any NLM schedules where applicable) Space medicine WD 751.6 Used for special purpose, by subject Medical Informatics Applications In particular fields (Form number 26.5 in any E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 401 Medical Informatics Applications NLM schedules where applicables) Used for special purpose, by subject Medical Informatics Computing W 26.5 Medical Information Science see Medical Informatics Medical Insurance see Insurance, Health Medical Jurisprudence see Jurisprudence Medical Literature Analysis and Retrieval System see MEDLARS Medical Logic see Logic Medical Missions, Official W 323 See also Missions and Missionaries W 323, etc. Medical Museums see Museums Medical Oncology QZ 200 Medical Philosophy see Philosophy, Medical Medical Profession see Medicine Medical Psychology see Psychology, Medical Medical Publishing see Publishing Medical Record Administrators WX 173 Medical Record Linkage WX 173 Medical Records Medical record libraries WX 173 See also Hospital Records WX 173; Medical History Taking WB 290 Medical Records Department, Hospital WX 173 Medical Records Librarians see Medical Record Administrators Medical Records, Problem-Oriented WX 173 Hospital records WX 173 Specific topics, by subject Medical Research see Research Medical Schools see Schools, Medical Medical Secretaries W 80 Medical Service Plans see Insurance, Health Medical Sociology see Sociology, Medical Medical Staff W 84 Of industry Medical and dental WA 412 Mental health services WA 495 Of schools, colleges, universities Medical and dental WA 350 Elementary and secondary WA 350 University and college WA 351 Mental health services WA 352 Elementary and secondary WA 352 University and college WA 353 See also Medical Staff, Hospital WX 203; names of specific types of hospitals See also Nursing Staff, Hospital WY 125, etc. and other medical personnel See also Personnel, Hospital WX 159; names of specific types of hospitals Medical Staff Privileges WX 203 Medical Staff Privileges, Nonphysician see Medical Staff Privileges Medical Symbols see Emblems and Insignia Medical Technology see Technology, Medical Medical Terminology see Nomenclature Medical Waste WA 790 Medical Waste Disposal WA 790 Medical Writing see Writing Medically Underserved Area W 76 Developing countries WA 395 Rural areas WA 390 Urban areas WA 380 Medicare WT 31 Medicare Assignment WT 31 Medication see Drug Therapy; Preanesthetic Medication; Premedication; Self Medication Medication Errors As a cause of disease QZ 42 Drug action QV 38 Medication Systems, Hospital WX 179 Medicinal Herbs see Plants, Medicinal Medicine As a profession W 21 As practiced in given localities WB 50 Bibliography see Bibliography of Medicine ZWB 100, etc. Case studies WB 293 Chronologies WZ 30 Curiosities WZ 308 Directories W 22 History see History of Medicine WZ, etc. Military see Military Medicine UH 201-630 Phrase books W 15 Popular works WB 120-130 Home medicine WB 120 See also Self Medication WB 120 Veterinary see Veterinary Medicine SF 600-1100 See also Clinical Medicine WB 102 Medicine, Alternative see Alternative Medicine Medicine, Arabic WZ 80.5.A8 Currently practiced WB 50 Pharmacology WZ 80.5.A8 Currently practiced QV 4 Medicine, Ayurvedic WZ 80.5.H6 Current practices by country WB 50 Medicine, Chinese Traditional WZ 80.5.O6 Currently practiced WB 50 History by country WZ 70 Medicine, Emporiatric see Travel Medicine, Folk see Medicine, Traditional Medicine, Herbal WB 925 Medicine, Hindu see Medicine, Ayurvedic Medicine in Art WZ 330 Related to psychiatry WM 49 Medicine in Literature WZ 330 Psychiatric aspects WM 49 See also Psychoanalytic Interpretation WM 460.7, etc. Medicine, Indigenous see Medicine, Traditional Medicine, Oriental Traditional WZ 80.5.O6 Currently practiced WB 50 History by country WZ 70 Medicine, Primitive see Medicine, Traditional Medicine, Traditional Current practices by country WB 50 History WZ 309 Medicine, Veterinary see Veterinary Medicine Medicolegal Chemistry see Chemistry Medicolegal Dentistry see Forensic Dentistry Medicolegal Examination see Autopsy; Forensic Medicine Medicolegal Psychiatry see Forensic Psychiatry ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7DED 402 Menstruation Medicolegal Specialists, Directories see Directories W 622 under Forensic Medicine Medina Worm see Dracunculus Mediterranean Disease see Thalassemia Mediterranean Fever, Familial see Periodic Disease MEDLARS W 26.55.14 Medroxyprogesterone WP 530 As a contraceptive QV 177 Medulla Oblongata WL 310 Medulloblastoma WL 358 Mefenamic Acid QV 95 Megacolon WI 528 Megacolon, Toxic WI 522 Megaesophagus see Esophageal Achalasia Megakaryocytes WH 380 Megaloblastic Anemia see Anemia, Macrocytic Megavitamin Therapy see Orthomolecular Therapy Megavolt Radiotherapy see Radiotherapy, High-Energy Meibomian Cyst see Chalazion Meiosis QH 605.3 Melancholia see Depressive Disorder Melancholia, Involutional see Depression, Involutional Melanins QU 110 Melanocyte-Stimulating Hormones see MSH Melanocytes QS 532.5.E7 Melanoma QZ 200 Melanoma, B16 see Melanoma, Experimental Melanoma, Cloudman S91 see Melanoma, Experimental Melanoma, Experimental QZ 206 Melanoma, Harding-Passey see Melanoma, Experimental Melanophores QS 532.5.E7 Melanosomes see Melanocytes Melanotrichia Linguae see Tongue, Hairy Melanotropin see MSH Meleda Disease see Keratoderma, Palmoplantar Melena QY 160 Related to a particular disease, with the disease Melioidosis WC 330 Melitococcosis see Brucellosis Melnick-Needles Syndrome see Osteochondrodysplasias Membrane Channels see Ion Channels Membrane Fluidity QU 34 Membrane Fusion QH 601 Membrane Glycoproteins QU 55 Membrane Potentials Biophysics QT 34 Cytology QH 601 Metabolism QU 120 Physiology QS 532.5.M3 Membrane Proteins QU 55 Membrane Tympani see Tympanic Membrane Membranes Cell see Cell Membrane QH 601, etc. Fetal see Fetal Membranes QS 645, etc. Histology QS 532.5.M3 Mucous see Mucous Membrane QS 532.5.M8 Periodontal WU 240 Synaptic see Synaptic Membranes WL 102.8 Synovial see Synovial Membrane WE 300 Membranes, Artificial Chemical technology TP 159.M4 In dialysis (chemical engineering) TP 156.D45 In hemodialysis WJ 378 Saline water conversion WA 687 Used for other special purposes, by subject Membranes, Intracellular see Intracellular Membranes Memory BF 370-387 In infancy & childhood WS 105.5.M2 Physiology WL 102 In psychoanalysis, psychoanalytic therapy, or psychoanalytic interpretation WM 460.5.M5 Memory Disorders WM 173.7 Memory for Designs Test see Neuropsychological Tests Memory, Immediate see Memory, Short-Term Memory, Photographic see Eidetic Imagery Memory, Short-Term BF 378.S54 Men Sexual life HQ 36 Other special topics, by subject Menadione see Vitamin K Menaquinone see Vitamin K Menarche WP 540 Mendel's Law see Genetics; Hybridization Meniere's Disease WV 258 Meniere's Syndrome see Meniere's Disease Meningeal Arteries WG 595.M3 Meningeal Neoplasms WL 200 Clinical pathology QZ 380 Meninges WL 200 Meningioma QZ 380 Localized, by site Meningism WL 340 Meningitis WL 200 Cerebral WL 200 Epidemic cerebrospinal see Meningitis, Meningococcal WC 245 Tuberculous see Tuberculosis, Meningeal WL 200 Meningitis, Listeria WC 242 Meningitis, Meningococcal WC 245 Meningitis, Tuberculous see Tuberculosis, Meningeal Meningitis, Viral WC 540 Meningocele WL 200 Meningococcal Infections WC 245 Meningococcal Meningitis see Meningitis, Meningococcal Meningoencephalitis WL 351 Epidemic WC 542 Syphilitic see Paresis WC 165, etc. Meningomyelitis WL 400 Meningomyelocele WE 730 Menisci, Tibial WE 870 Menopause WP 580 Menorrhagia WP 555 Menotropins WK 515 Menstrual Cycle WP 540 Menstrual Proliferative Phase see Menstrual Cycle Menstrual Secretory Phase see Menstrual Cycle Menstruation WP 550-560 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 403 Menstruation Disorders Menstruation Disorders WP 550-560 Hypomenorrhea WP 552 Oligomenorrhea WP 552 See also names of other specific disorders Menstruation-Inducing Agents QV 170 Menstruation, Retrograde see Menstruation Disorders Mental Deficiency see Mental Retardation Mental Disorders WM Case studies WM 40 Diagnosis WM 141 Drug therapy WM 402 Environmental factors WM 31 General works WM 140 In adolescence WS 463 In infancy & childhood WS 350-350.8 In mental retardation WM 307.M5 In old age WT 150 In pregnancy WQ 240 Jurisprudence see Forensic Psychiatry W 740, etc. Nursing see Psychiatric Nursing WY 160 Rehabilitation WM 29 Socioeconomic factors WM 31 Therapy WM 400, etc. See also names of specific disorders Mental Disorders, Organic see Organic Mental Disorders Mental Disorders, Organic, Psychotic see Organic Mental Disorders, Psychotic Mental Fatigue WM 174 Industrial WA 495 Mental Healing WB 880-885 Faith cure WB 885 See also Christian Science WB 885, etc. Mental Health WM 105 Environmental factors WM 31 In adolescence WS 462 In infancy & childhood WS 105.5.M3 In old age WT 145 Occupational WA 495 Military UH 629-629.5 Popular works WM 75 Rural WA 390 School WA 352 Socioeconomic factors WM 31 Special population groups WA 305 Women WA 309 Mental Health Services WM 30 In industry WA 495 In infancy & childhood WM 30 Military UH 629-629.5 School programs Elementary and secondary WA 352 University and college WA 353 Special population groups WA 305 Mental Health Services, Community see Community Mental Health Services Mental Hospitals see Hospitals, Psychiatric Mental Hygiene see Mental Health Mental Hygiene Services see Mental Health Services Mental Processes BF 441-449 In infancy & childhood WS 105.5.D2 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPJL4 Mental Retardation WM 300-308 Complications WM 300 In infancy & childhood WS 107 In adolescence WS 463 In infancy & childhood WS 107-107.5 Biographical accounts WS 107.5.C2 Mental disorders WM 307.M5 Vocational guidance HV 3005 See also Child, Exceptional WS 105.5.C3, etc.; Education of the Mentally Retarded LC 4601-4640.4 Mental Retardation, Psychosocial WM 300 In adolescence WS 463 In infancy & childhood WS 107.5.P8 Mental Status Schedule WM 141 Mental Tests see Intelligence Tests Mentally Handicapped see Mental Retardation Menthol Organic chemistry QD 416 Pharmacology QV 60 Menthyl Mercury Compounds QV 293 As fungicides WA 240, etc. Mentors In nursing education WY 18-18.8 Special topics, by subject Mentorships see Mentors Menu Planning In hospitals WX 168 In schools Elementary and secondary WA 350 Universities and colleges WA 351 Public health aspects in restaurants WA 799 Mepacrine see Quinacrine Meperidine QV 89 Mepivacaine QV 115 Meprobamate QV 77.9 MER-29 see Triparanol Mercaptamine see Cysteamine Mercapto Compounds see Sulfhydryl Compounds Mercaptoethanol QV 84 Organic chemistry QD 305.A4 Pharmacology QV 84 Mercaptoethylamines QU 61 Organic chemistry QD 305.A8 Mercaptovaline see Penicillamine Mercurial Diuretics see Diuretics, Mercurial Mercuric Chloride As an anti-infective agent QV 231 Mercury QV 293 For syphilis QV 261 Mercury Dichloride see Mercuric Chloride Mercury Isotopes Inorganic chemistry QD 181.H6 Pharmacology QV 293 Mercury Poisoning QV 293 Mercy Death see Euthanasia Mercy Killing see Euthanasia Meriones see Gerbillinae Mescaline QV 77.7 Used in North American Indian religion E 98.R3 Mesencephalic Central Gray see Periaqueductal Gray USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSDTTED 404 Methanesulfonates Mesencephalon WL 310 Mesenchyma see Connective Tissue Mesenchyme see Mesoderm Mesenchymoma QZ 310 Localized, by site Mesenteric Arteries WG 595.M38 See also Blood supply WI 500 under Mesentery Mesenteric Circulation see Splanchnic Circulation Mesenteric Cyst WI 500 Mesenteric Lymphadenitis WI 500 Mesenteric Vascular Occlusion WI 500 Mesenteric Veins WI 720 Mesentery WI 500 Blood supply WI 500 Neoplasms WI 500 Pathology QZ 340 Mesmerism see Hypnosis Mesna QV 76 Mesocolon WI 500 Mesocricetus QL 737.R666 As laboratory animals QY 60. R6 As pets SF 459.H3 Mesoderm WQ 205 Mesonephroma WP 322 Mesosigmoid see Mesocolon Mesothelioma QZ 340 Mesothelium see Epithelium Messenger RNA see RNA, Messenger Mestranol WP 522 As a contraceptive QV 177 Mesylates QU 98 Organic chemistry QD 305.S3 meta-Dihydroxybenzenes see Resorcinols Metabolic Activation see Biotransformation Metabolic Clearance Rate QY 450 Rate of particular substance, with the substance Metabolic Detoxication, Drug QV 38 Metabolic Diseases WD 200-226 General WD 200 Veterinary SF 910.M48 See also Calcium Metabolism Disorders WD 200.5.C2; Metabolism, Inborn errors WD 205 and other specific diseases Metabolic Pump see Biological Transport, Active Metabolism QU Bacterial see Bacteria QW 52 Disorders as a manifestation of disease QZ 180 General works QU 120 In infancy & childhood QU Radiation effects WN 610 Skin WR 102 Metabolism and Endocrinology (Specialty) see Endocrinology Metabolism, Basal see Basal Metabolism Metabolism, Inborn Errors WD 205-205.5 See also names of specific disorders Metabolite Markers, Neoplasm see Tumor Markers, Biological Metaethics see Ethics Metagonimiasis see Trematode Infections Metagonimus see Heterophyidae Metal Metabolism, Inborn Errors WD 205.5.M3 Metal Plating see Electroplating Metallo-Organic Compounds see Organometallic Compounds Metalloproteases see Metalloproteinases Metalloproteinases QU 136 Metalloproteins QU 55 Metallotherapy see Alternative Medicine Metallothionein QU 55 Metallurgy TN 600-799 Dental WU 180 Occupational medicine WA 400-495 Industrial waste WA 788 Metals In dentistry WU 180 Inorganic chemistry QD 171-172 Metabolism QU 130 See also Metal Metabolism, Inborn Errors WD 205.5.M3 Pharmacology and toxicology Alkaline earth metals QV 275-278 Heavy metals QV 290-298 See also names of specific metals Metals, Actinide see Metals, Actinoid Metals, Actinoid WN 420 Metals, Alkaline Earth Inorganic chemistry QD 172.A42 Pharmacology QV 275 Salts QV 275 Metals, Rare Earth Inorganic chemistry QD 172.R2 Pharmacology QV 290 Metamizole see Dipyrone Metamorphosis, Biological QL 981 Insects QL 494.5 Metaphysical Healing see Mental Healing Metaphysics BD 100-131 Metaplasia QZ 190 Metaproterenol see Orciprenaline Metasqualene see Triparanol Metastasis see Neoplasm Metastasis Metatarsal Deformity see Foot Deformities Metatarsus WE 880 Metencephalon see Cerebellum Meteorological Factors Climate and disease WB 700-710 Mental health WM 31 Public health WA 30 Other topics, by subject Meteorology see Meteorological Factors; Weather Metformin WK 825 Methacholine Compounds QV 122 Methadone QV 89 Dependence WM 270 Methalamic Acid see Iothalamic Acid Methaminodiazepoxide see Chlordiazepoxide Methamphetamine QV 102 Dependence WM 270 Methampyrone see Dipyrone Methandienone see Methandrostenolone Methandrostenolone WJ 875 Methane Microbial chemistry QW 52 Toxicology QV 662 Methanesulfonates see Mesylates ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 405 Methanobacteria Methanobacteria see Methanogens Methanogens QW 50 Methanol see Alcohol, Methyl Methantheline QV 132 Methaqualone QV 85 Methemoglobin WH 190 Methemoglobinemia WH 190 Methenamine QV 243 Methicillin Resistance Bacteriology QW 51 Drug therapy WB 330 Pharmacology QV 354 Methionine QU 87 Methodology Research, Nursing see Nursing Methodology Research Methods Q 180.55.M4 In particular areas, by subject Methofluranum see Methoxyflurane Methohexital QV 88 Methohexitone see Methohexital Methotrexate Folic acid antagonist QU 188 In therapy of neoplasms QZ 267 Other special topics, by subject Methoxsalen QV 63 Cosmetics WA 744 Methoxyflurane QV 81 Methoxyhydroxyphenylglycol QV 82 Methoxyverapamil see Gallopamil Methyl Alcohol see Alcohol, Methyl Methyl Chloride As an anesthetic QV 115 Organic chemistry Aliphatic compounds QD 305.H5 Toxicology QV 633 Methyl Ethers QV 81 Organic chemistry QD 305.E7 Methyl Violet see Gentian Violet Methyl Viologen see Paraquat Methyladenine Receptors see Receptors, Purinergic Methylamines QU 61 Organic chemistry QD 305.A8 Methylation QD 281.M48 Methylcellulose Cathartic QV 75 Suspension agent QV 787 Methylcephaeline see Emetine Methylcholanthrene QZ 202 Methyldopa QV 150 Methyldopate see Methyldopa Methylene Bichloride see Methylene Chloride Methylene Bis(chloroaniline) see Methylenebis(chloroaniline) Methylene Chloride Toxicology QV 633 Methylene Dichloride see Methylene Chloride Methylenebis(chloroaniline) As a carcinogen QZ 202 Toxicology QV 633 Methylenesulfonates see Mesylates Methylergol Carbamide see Lisuride Methylglyoxal see Pyruvaldehyde Methylhistamines QV 157 Methylhydrazines Biochemistry QU 60 Neoplasm etiology QZ 202 Methylhydroxyprogesterone see Medroxyprogesterone Methylphenyl Ethers see Anisoles Methylprednisolone WK 757 Methylprednisolone Hemisuccinate WK 757 Methylprednisolone Succinate see Methylprednisolone Hemisuccinate Methylrosaniline Chloride see Gentian Violet Methylxanthine Receptors see Receptors, Purinergic Methypregnone see Medroxyprogesterone Metindamide see Indapamide Metipranolol see Trimepranol Metolquizolone see Methaqualone Metoprolol QV 132 Metrazol see Pentylenetetrazole Metric System QC 90.8-94 Used for special purposes, by subject Metritis see Endometritis Metrizamide As a contrast medium WN 160 Used for special purposes, by subject Metronidazole QV 254 Metrorrhagia WP 555 Mevalonic Acid QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Mexiletine QV 150 Mezcalin see Mescaline MgADP see Adenosine Diphosphate MgATP see Adenosine Triphosphate MGI-1 see Colony-Stimulating Factors MHC Class I Genes see Genes, MHC Class I MHC Class II Genes see Genes, MHC Class II MHPG see Methoxyhydroxyphenylglycol Mianserin As an antidepressant QV 77.5 Mice As laboratory animals QY 60.R6 Diseases SF 997.5.M4 Mice, Athymic see Mice, Nude Mice, House see Mice Mice, Inbred Strains As laboratory animals QY 60.R6 Mice, Laboratory see Mice Mice, Mutant Strains As laboratory animals QY 60. R6 Mice, Neurologic Mutants As laboratory animals QY 60. R6 Mice, Nude As laboratory animals QY 60.R6 Mice, Red-Backed see Microtinae Mice, Transgenic As laboratory animals QY 60.R6 Genetic aspects QH 442.6 Micelles Biochemistry QU 133 Miconazole QV 252 Micro-Organisms see Bacteria, Fungi, Rickettsia, Viruses Microangiopathy, Diabetic see Diabetic ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSOTED 406 Midges, Nonbiting Angiopathies Microbial Collagenase QU 136 Microbial Sensitivity Tests QW 25.5.M6 Microbiological Techniques QW 25 See also names of specific techniques and tests Microbiology QW Air see Air Microbiology QW 82 Food see Food Microbiology QW 85 Industrial QW 75 Plant QW 60 Soil see Soil microbiology QW 60 Veterinary medicine QW 70 Water see Water Microbiology QW 80 See also Microbiology under names of animals, organs, plants, diseases, etc., e.g., under Mouth QW 65; Bacteriology QW; Virology QW 160, etc. Microbodies QH 603.M35 Microcapsules see Capsules Microcephaly QS 675 Microchemistry Analytical chemistry (General) QD 79.M5 Organic analysis (General) QD 272.M5 Qualitative analysis QD 98.M5 Quantitative analysis QD 117.M5 Microcirculation WG 104 Microclimate Of a particular area, with the area See also Climate Microcomputers QA 75.5-76.95 As equipment in special fields In medicine (General) W 26.55.C7 (Form number 26.5 in any other NLM schedule where applicable) Computer engineering TK 7885-7895 See also Computers Microcytotoxicity Tests see Cytotoxicity Tests, Immunologic Microelectrodes QD 571 Biomedical engineering QT 36 In electrotherapy WB 495 In electrosurgery WO 198 Microencapsulation see Drug Compounding Microfilament Proteins QU 55 Microfilaria QX 301 Microfilming TR 835 In library science Z 681 In printing Z 265 Microfluorometry see Cytophotometry Microfluorometry, Flow see Flow Cytometry Micrographic Surgery, Mohs see Mohs Surgery Microinjections WB 354 Special topics, by subject Microinterferometry see Microscopy, Interference Micrometry see Weights and Measures Microprocessors see Microcomputers Micropunctures see Punctures Microradiography WN 100 Microscopy QH 201-278.5 Histology QS 525 Micrometry QC 101-114 Pathology QZ 25 Slit-lamp WW 143 Used for other special purposes, by subject Microscopy, Electron QH 212.E4 In cytodiagnosis QY 95 Used for other special purposes, by subject Microscopy, Electron, Scanning QH 212.S3 Used for special purposes, by subject, e.g., for examining dental pulp WU 230 Microscopy, Electron, Transmission see Microscopy, Electron Microscopy, Electron, X-Ray Microanalysis see Electron Probe Microanalysis Microscopy, Fluorescence QH 212.F55 Used in diagnosis of pulmonary tuberculosis WF 300 Used for other special purposes, by subject Microscopy, Immunofluorescence see Microscopy, Fluorescence Microscopy, Interference QH 212.15 Experimental histology QS 530 Used for other special purposes, by subject Microscopy, Phase-Contrast QH 212.P5 Used for special purposes, by subject, e.g., in cytoscopic examination of urine QY 185 Microscopy, Polarization QH 212.P6 Used for special purposes, by subject, e.g. in clinical pathology QY 95 Microscopy, Polarized Light see Microscopy, Polarization Microscopy, Ultraviolet QH 212.U48 Microsomes QH 603.M4 Microsomes, Liver WI 700 Microsurgery WO 512 Localized, by site Microsurgery, Laser see Laser Surgery Microsurgical Revascularization, Cerebral see Cerebral Revascularization Microtinae QL 737.R666 Diseases SF 997.5.R3 As laboratory animals QY 60. R6 Microtines see Microtinae Microtomy QH 233 Microtrabecular Lattice see Cytoskeleton Microtubule-Associated Proteins QU 55 Microtubule Proteins QU 55 Microtubules QH 603.M44 Microtus see Microtinae Microvascular Permeability see Capillary Permeability Microvilli QH 601 Microwaves TK 7876 Diagnostic use WB 141 Therapeutic use WB 510 Midazolam QV 85 Midbrain see Mesencephalon Midbrain Central Gray see Periaqueductal Gray Middle Age Developmental psychology BF 724.6 Medical treatment WT 100 Special topics, by subject Middle Ear see Ear, Middle Middle Ear Ventilation WV 232 Midges, Biting see Ceratopogonidae Midges, Nonbiting see Chironomidae ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSinED 407 Midwifery Midwifery WQ 160-165 See also Nurse Mid wives WY 157 Mifepristone As an abortifacient agent QV 175 As a contraceptive agent QV 177 Special topics, by subject Migraine WL 344 Migrants see Transients and Migrants Migration, Cell see Cell Movement Migration, Internal see Transients and Migrants Miliaria WR 400 Miliaria Rubra see Miliaria Miliary Tuberculosis see Tuberculosis, Miliary Milieu Therapy WM 440 In adolescence WS 463 In infancy & childhood WS 350.2 Military Dentistry UH 430-435 Aviation WD 745 Naval VG 280-285 Military Hygiene UH 600-629.5 Military Medicine UH 201-570 Biography Collective WZ 112.5.M4 Individual WZ 100 History UH 215-324 Surgery WO 800 History WO 11 Special topics, by subject Military Nursing WY 130 Education WY 18-18.5 Veterans hospitals WY 130 Military Personnel General topics U 1-145 Military life U 750-773 Veterans UB 356-405 See also special aspects of military life, e.g. Disabled Veterans UB 360-366 under Rehabilitation Military Physicians see Military Medicine; Physicians Military Psychiatry UH 629-629.5 See also Combat Disorders WM 184 Military Psychology see Psychology, Military Military Science U Air defense UG 730 Civil UA 926-929 Military Anti-aircraft guns UF 625 Military aeronautics UG 623-1435 Military Surgeons see Military Medicine; Biography WZ 112.5.M4, etc. under Surgery Military Surgery see Military Medicine; Military WO 800 under Surgery Military Veterinary Service see Veterinary Service, Mihtary Milk Analysis Dairying SF 251-262.5 Public health WA 716 Bacteriology QW 85 Dairying (General) SF 221-275 Public health aspects WA 715-719 Diet (General) WB 428 In infancy & childhood WS 120; WS 130 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Preparation for use SF 259 Public health aspects WA 715-719 Pasteurization WA 719 Milk-Alkali Syndrome see Hypercalcemia Milk Fever, Animal see Parturient Paresis Milk, Human Infant feeding WS 125 Secretion WP 825 Milk Of Magnesia see Magnesium Hydroxide Milk Proteins WA 716 Dairy science SF 251 Milk Sickness WD 530 Millipedes see Arthropods Milroys Disease see Lymphedema Miltown see Meprobamate Milzbrand see Anthrax Mimetic Muscles see Facial Muscles Minamata Disease see Mercury Poisoning Mineral Content of Food see Minerals Mineral Oil QV 75 Mineral Waters WB 442 Mineralocorticoids WK 755 Minerals Biochemistry QU 130 Mineralogy QE 351-399.2 Of bone WE 200 Miner's Anemia see Hookworm Infections Minimal Brain Dysfunction see Attention Deficit Disorder with Hyperactivity Mining TN Occupational accidents WA 485 Occupational medicine WA 400-495 See also Pneumoconiosis WF 654 and other related disorders Mink QL 737.C25 Culture SF 405.M6 Diseases SF 997.5.M5 Mink Encephalopathy Virus see Prions Minnesota Multiphasic Personality Inventory see MMPI Minnows see Cyprinidae Minocycline QV 360 Minor Injuries see Wounds and Injuries Minor Surgery see Surgery, Minor Minority Groups Adolescents WS 462 Representation JF 1061-1063 Suffrage JF 879 Special topics, by subject See also Ethnic Groups GN 301-673, etc. and specific ethnic groups Minoxidil QV 150 Miopithecus talapoin see Cercopithecidae Miotics QV 120 Mirex Agriculture SB 952.C44 Public health WA 240 Mirror Writing see Dominance, Cerebral Misarticulation see Articulation Disorders Miscarriage see Abortion Miscegenation see Anthropology, Physical; Marriage; Racial Stocks Missions and Missionaries W 323 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 408 Molecular Radiobiology Biography (if medically related) Collective WZ 112-150 Individual WZ 100 See also Medical missions, Official W 323 Missions, Official Medical see Medical Missions, Official Misuse, Equipment see Equipment Failure Misuse of Health Services see Health Services Misuse Mite-Borne Rickettsial Fevers see Rickettsia Infections; names of specific infections Mite Control see Tick Control Mite Infestations Disinfestation WC 900 General WC 900 Veterinary SF 810.M5 See also Scabies WR 365, etc. Mites General QX 473 Sarcoptoidea QX 475 See also names of specific mites, e.g., Sarcoptes Scabiei QX 475 Mithramycin see Plicamycin Mitochondria QH 603.M5 Mitochondria, Liver WI 700 Mitochondria, Muscle WE 500 Mitogenic Factors, Lymphocyte see Interleukin-2 Mitogens QH 605.2 Mitogens, Endogenous see Growth Substances Mitomycins QV 269 Mitosis QH 605.2 Mitoxantrone QV 269 Mitozantrone see Mitoxantrone Mitral Click-Murmur Syndrome see Mitral Valve Prolapse Mitral Incompetence see Mitral Valve Insufficiency Mitral Regurgitation see Mitral Valve Insufficiency Mitral Valve Incompetence see Mitral Valve Insufficiency Mitral Valve Insufficiency WG 262 Mitral Valve Prolapse WG 262 Mitral Valve Stenosis WG 262 Mixed Connective Tissue Disease WD 375 Mixed Function Oxidases QU 140 Mixed Function Oxygenases see Mixed Function Oxidases Mixtures see Dosage Forms MK-421 see Enalapril MMPI WM 145.5.M6 MN Sialoglycoprotein see Glycophorin Mobile Emergency Units see Ambulances Mobile Genetic Elements see DNA Insertion Elements Mobile Health Units WX 190 In specialty fields (Form number 27-28 in any NLM schedule where applicable) Models, Anatomic QY 35 Models, Biological QH 324.8 Of a particular subject, by subject, e.g. of human gait WE 103 Models, Cardiovascular WG 20 Of a particular subject, by subject Models, Chemical QD 480 Biochemistry QU 25 or in number for the item represented Models, Computer see Computer Simulation Models, Decision Support see Decision Support Techniques Models, Dental see Dental Models Models, Genetic Medical QZ 50 Special topics, by subject Models, Molecular QD 480 Used for special purposes, by subject Models, Neurological Research WL 20 Study and teaching WL 18.2 Models, Nursing WY 20.5 Specific topics, by subject Models, Obstetrical see Models, Structural Models, Psychological Experimental psychology BF 181-188 Psychiatric Used in research WM 20 Used in teaching WM 18.2 Of specific subjects, by subject Models, Statistical Used for special purposes, by subject Models, Structural Construction QY 35 Obstetrical WQ 26 Other specific types, with the subject being illustrated Used in teaching (Form number 18.2 in any NLM schedule where applicable) Models, Theoretical As an educational tool (Form number 18.2 in any NLM schedule where applicable) Model theory QA 9.7 Used for special purposes, by subject Mohammedanism see Islam Mohs Surgery WR 500 Moire Topography TR 708 Used for specific subjects, by subject Molar WU 101 Molar, Third WU 101 Abnormalities WU 101.5 Extraction WU 605 Molasses As a dietary supplement in health or disease WB 447 Molds see Fungi Molds (Casts) see Dental Models; Models, Structural Molecular Biology QH 506 Molecular Cloning see Cloning, Molecular Molecular Configuration see Molecular Conformation Molecular Conformation QC 179 Molecular Genetics see Genetics, Biochemical Molecular Models see Models, Molecular Molecular Neurobiology see Neurobiology Molecular Probes QY 95 Used for diagnosis of particular disorders, with the disorder or system Molecular Radiobiology see Radiobiology ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 409 Molecular Sequence Data Molecular Sequence Data Of a specific substance, with the substance Molecular Stereochemistry see Molecular Conformation Molecular Structure QD 461 Molecular Vaccines see Vaccines, Synthetic Molecular Weight QD 463-464 Biochemistry QU 25 Molestation, Sexual, Child see Child Abuse, Sexual Mollities Ossium see Osteomalacia Mollusca QX 675 Molluscacides Agriculture SB 951.65 Public health WA 240 Molluscum Contagiosum WC 584 Molsidomine QV 150 Molting Hormone see Ecdysone Molybdenum Inorganic chemistry QD 181.M7 Metabolism QU 130.5 Pharmacology QV 290 Mongolism see Down Syndrome Mongoloid Race Anthropology GN 548 See also specific topics under Ethnic Groups Monieziasis SF 810.C5 Monilia see Candida Moniliales see Hyphomycetes Moniliasis see Candidiasis Moniliasis, Cutaneous see Candidiasis, Cutaneous Moniliasis, Oral see Candidiasis, Oral Monitoring, Ambulatory Electrocardiographic see Electrocardiography, Ambulatory Monitoring, Environmental see Environmental Monitoring Monitoring, Fetal see Fetal Monitoring Monitoring, Holter see Electrocardiography, Ambulatory Monitoring, Home Blood Glucose see Blood Glucose Self-Monitoring Monitoring, Immune see Monitoring, Immunologic Monitoring, Immunologic QW 525 Monitoring, Intraoperative see Intraoperative Monitoring Monitoring, Physiologic WB 142 Cardiovascular system WG 140 Drug utilization WB 330 In intensive care WX 218, etc. Of particular function, by subject Of other systems, in the examination number, usually 141, in the schedule for the system See also Radiation Monitoring WN 650 Monitoring, Radioimmunologic see Monitoring, Immunologic Monitors, Blood Pressure see Blood Pressure Monitors Monkey, African Green see Cercopithecus aethiops Monkey, Capuchin see Cebus Monkey, Colobus see Colobus Monkey Diseases SF 997.5.P7 Monkey, Green see Cercopithecus aethiops Monkey, Grivet see Cercopithecus aethiops Monkey, Japanese see Macaca ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Monkey, Northern Night see Aotus trivirgatus Monkey, Patas see Erythrocebus patas Monkey, Pig-Tailed see Macaca nemestrina Monkey, Red see Erythrocebus patas Monkey, Rhesus see Macaca mulatta Monkey, Ring-Tail see Cebus Monkey, Spider see Cebidae Monkey, Squirrel see Saimiri Monkey, Talapoin see Cercopithecidae Monkey, Vervet see Cercopithecus aethiops Monkey, Woolly see Cebidae Monkeypoxvirus QW 165.5.P6 Monkeys see Haplorhini Monkeys, New World see Cebidae Monkeys, Old World see Cercopithecidae Monoacylglycerols see Glycerides Monoamine Oxidase QU 140 Monoamine Oxidase Inhibitors QV 77.5 Monoblastic Leukemia see Leukemia, Monoblastic Monoclonal Antibodies see Antibodies, Monoclonal Monoclonal Gammopathies see Paraproteinemias Monoclonal Gammopathies, Benign WH 400 Monocytes WH 200 In phagocytosis QW 690 Monocytic Angina see Infectious Mononucleosis Monocytic Leukemia see Leukemia, Monocytic Monocytic Leukemia, Chronic see Leukemia, Monocytic, Chronic Mononucleosis, Infectious see Infectious Mononucleosis Monorchidism see Abnormalities WJ 840 under Testis Monosaccharides QU 75 Monosodium Glutamate see Sodium Glutamate Monosomy, Partial see Chromosome Deletion Monounsaturated Fatty Acids see Fatty Acids, Monounsaturated Monsters QS 675 Monte Carlo Method QA 298 Special topics, by subject Mood see Affect Moon MOPEG see Methoxyhydroxyphenylglycol Morale BJ 45 War U 22 Morals In adolescence WS 462 In infancy & childhood WS 105.5.M4 Ethics BJ 11-18 Psychoanalysis WM 460.5.R3 Sex HQ 32 Sociology HM 216 Moraxella QW 131 Morbid Obesity see Obesity, Morbid Morbidity WA 900 Morbillivirus QW 168.5.P2 Morgagni-Stewart-Morel Syndrome see Hyperostosis Frontalis Interna Mormyrid see Electric Fish Morning-After Pill see Contraceptives, Postcoital Moronity see Mental Retardation Morphea see Scleroderma, Circumscribed Morphine QV 92 IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 410 Moyamoya Disease Morphine Dependence WM 286 Morphine Derivatives QV 92 Morphogenesis General biology QH 491 Human embryology QS 604 Localized, by site Morphology see Anatomy Morquio s Disease see Mucopolysaccharidosis IV Morsydomine see Molsidomine Mortality HB 1321-1528 Children HB 1323.C5 Including causes of death WA 900 See also Fetal Death WQ 225; Infant Mortality HB 1323.14, etc.; Maternal Mortality HB 1322.5, etc. Mortuary Customs see Funeral Rites Mortuary Practice WA 840-847 Burial WA 846 Cemeteries WA 846 Cremation WA 847 General works WA 840 Mosaicism QH 445.7 Mosquito Control QX 600 Malaria control WC 765 Mosquitoes see Culicidae Mother Cells see Stem Cells Mother-Child Relations WS 105.5.F2 Mothers HQ 759-759.5 Special topics, by subject Mothers, Surrogate see Surrogate Mothers Moths QX 560 Moulin WK 170 Motility, Cell see Cell Movement Motion Aviation medicine WD 720 Special effects, by subject See also Movement WE 103 Motion Perception Visual WW 105 See also Kinesthesis WE 104 Motion Pictures Catalogs and works about (Form number 18.2 in any NLM schedule where applicable) Influence on children WS 105.5.E9 Reels, etc., by subject Motion Sickness WD 630 Motivation BF 501-504 In adolescence WS 462 In infancy & childhood WS 105.5.M5 Psychoanalysis WM 460.5.M6 Motor Activity WE 103 In infancy & childhood WE 103 Perceptual motor learning LB 1067 Motor Cortex WL 307 Motor Endplate WL 102.9 Motor Epilepsy see Epilepsy Motor Neurons WL 102.7 Motor Neurons, Gamma WL 102.7 Motor Skills WE 103 In infancy & childhood WE 103 Psychological aspects WE 104 Motor Vehicle Accidents see Accidents, Traffic Mottled Enamel WU 220 Moulages see Models, Anatomic Mountain Sickness see Altitude Sickness Mountaineering Accidents and illness QT 260.5.M9 Altitude sickness WD 715 First aid WA 292 Sports QT 260.5.M9 Mourning see Grief Mouse Leukemia Viruses see Leukemia Viruses, Murine Mouse Thymic Virus see Herpesviridae Mouse Tumor Viruses see Tumor Viruses, Murine Mouth WU General works for the dentist WU 140 General works for the gastroenterologist WI 200 Injuries WU 158 Microbiology QW 65 Pathology WU 140 Surgery WU 600 See also Administration, Oral WB 350 Mouth Abnormalities WU 101.5 Mouth Breathing WF 143 Special topics, by subject Mouth Diseases General works for the dentist WU 140 Therapy WU 166 General works for the gastroenterologist WI 200 Therapy WI 200 Mouth Dryness see Xerostomia Mouth, Edentulous WU 140 Dentures for WU 530 Mouth Floor Dentistry WU 140 Gastroenterology WI 200 Mouth Mucosa For the dentist WU 101 For the gastroenterologist WI 200 Mouth Neoplasms WU 280 Works for the gastroenterologist WI 200 Mouth Rehabilitation WU 140 Jaw injuries WU 610 Oral and dental injuries WU 158 Surgery WU 600-640 Mouth-to-Mouth Resuscitation see Cardiopulmonary Resuscitation Mouthwashes WU 113 Pharmacology QV 50 Movement WE 103 Movement, Cell see Cell Movement Movement Disorders WL 390 In infancy & childhood WS 340 Neuromuscular see Neuromuscular Diseases WE 550-559 Psychomotor see Psychomotor Disorders WM 197 Veterinary SF 901 Localized, by site or disease involved Moxalactam QV 350 Moxibustion WB 369 Moyamoya Disease WL 355 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 411 MR Spectroscopy MR Spectroscopy see Nuclear Magnetic Resonance MR Tomography see Magnetic Resonance Imaging MRI Scans see Magnetic Resonance Imaging mRNA see RNA, Messenger MSG see Sodium Glutamate MSH WK 515 mu Immunoglobulins see Immunoglobulins, mu-Chain Mucins QU 55 Mucociliary Clearance WF 102 Mucociliary Transport see Mucociliary Clearance Mucocutaneous Lymph Node Syndrome WH 700 Mucolytic Agents see Expectorants Mucopolysaccharidosis I WD 205.5.C2 Mucopolysaccharidosis IV WD 205.5.C2 Mucopolysaccharidosis V see Mucopolysaccharidosis I Mucoproteins QU 55 In blood chemistry QY 455 Mucorales QW 180.5.P4 Mucous Membrane QS 532.5.M8 Drugs affecting QV 60-65 Mucoviscidosis see Cystic Fibrosis Mucus QS 532.5.M8 Mud Baths see Mud Therapy Mud Therapy WB 525 Mudminnows see Salmonidae Multi-Hospital Information Systems see Hospital Information Systems Multi-Hospital Systems see Multi-Institutional Systems Multi-Infarct Dementia see Dementia, Multi-Infarct Multi-Institutional Systems Hospitals (General) WX 157.4 In specific fields, by subject Multigene Family see Genes, Reiterated Multimodal Treatment see Combined Modality Therapy Multiphasic Screening WA 245 Multiple Epiphyseal Dysplasia see Osteochondrodysplasias Multiple Myeloma WH 540 Multiple Organ Failure QZ 140 In specific diseases, with the disease Multiple-Personality Disorder WM 173.6 Multiple Pregnancy see Pregnancy, Multiple Multiple Sclerosis WL 360 Multiple Trauma V'O 700 Multiplication-Stimulating Activity see Insulin-Like Growth Factor II Multipotential Colony-Stimulating Factor see Interleukin-3 Multivariate Analysis QA 278 Special topics, by subject Mumps WC 520 Mumps Vaccine WC 520 Munchausen Syndrome WM 178 Mur-NAc-L-Ala-D-isoGln see Acetylmuramyl-Alanyl-Isoglutamine Muramidase QU 136 Muramyl Dipeptide see Acetylmuramyl-Alanyl-Isoglutamine Murder see Homicide ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIU Muridae QL 737.R666 Diseases SF 997.5.R64 As laboratory animals QY 60. R6 Murids see Muridae Murine Leukemia Viruses see Leukemia Viruses, Murine Murine Tumor Viruses see Tumor Viruses, Murine Murine Typhus see Typhus, Endemic Flea-Borne Murray Valley Encephalitis Virus see Flaviviruses Mus see Muridae Mus musculus see Mice Musca domestica see Houseflies Muscarinic Agents see Cholinergic Agents Muscarinic Antagonists QV 132 Muscarinic Receptors see Receptors, Muscarinic Muscle Contraction WE 500 Muscle Contracture see Contracture Muscle Cramp WE 550 Muscle Denervation WE 500 Muscle Dystonia see Dystonia Muscle Proteins WE 500 Muscle Relaxants, Central QV 140 In anesthesia WO 297 Muscle Relaxants, Depolarizing see Neuromuscular Depolarizing Agents Muscle Relaxants, Non-Depolarizing see Neuromuscular Nondepolarizing Agents Muscle Relaxants, Polarizing see Neuromuscular Nondepolarizing Agents Muscle Relaxation WE 500 Muscle Rigidity WE 550 Muscle, Smooth WE 500 Localized, by site Muscle, Smooth, Vascular WE 500 Muscle Spasticity WE 550 In infancy & childhood WS 270 Muscle Spindles WL 102.9 Muscle Tonus WE 500 Muscles WE 500-559 Anatomy WE 500 Physiology WE 500 Localized, by site Muscular Atrophy WE 550 Veterinary SF 901 Muscular Atrophy, Spinal WE 550 Muscular Diseases WE 544-559 General works WE 550 In infancy & childhood WS 270 Muscular Dystrophy WE 559 Musculocutaneous Nerve WL 400 See also names of organs innervated, e.g. Forearm WE 820 Musculoskeletal Diseases WE 140 In infancy & childhood WS 270 Nursing WY 157.6 Musculoskeletal System WE Children WS 270 Neoplasms (General) WE 140 See also Neoplasms, Muscle tissue QZ 340 Nursing care WY 157.6 Trunk WE 700 Museums (Form numbers 27-28 in QS-QT, QV-QZ, W, USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSD7D2D 412 WA and WZ schedules) Art N 405-3990 General AM Scientific Q 105 Mushroom Poisoning WD 520 Mushrooms Edible QK 617 Poisonous QW 180.5.B2 Music M Special topics, by subject, e.g., mouth instruments as a cause of malocclusion WU 440 Music Therapy General WB 550 In psychiatry WM 450.5.M8 Muskrats see Microtinae Muslims see Islam Mussels QX 675 Mustard As a condiment plant SB 307.M87 As a skin irritant QV 65 Botany QK 495.C9 Mustard Compounds As antineoplastics QV 269 Chemical warfare agent QV 666 Organic chemistry Aliphatic compounds QD 305.H5 Mustard Gas As a carcinogen QZ 202 As a chemical warfare agent QV 666 Mustard Plasters see Therapeutic use WB 371 under Irritants Mustine see Mechlorethamine Mutagen Screening see Mutagenicity Tests Mutagenesis QH 460-468 Mutagenesis, Oligonucleotide-Directed see Mutagenesis, Site-Directed Mutagenesis, Site-Directed QH 465.S5 Mutagenesis, Site-Specific see Mutagenesis, Site-Directed Mutagenicity Tests QH 465 Mutagens As a cause of congenital abnormalities QS 679 As air pollutants WA 754 General works on chemical mutagens QH 460 Industrial waste WA 788 Virology QW 160 Mutases see Oxidoreductases Mutation Evolution QH 390 Genetics QH 460-468 In specific organisms, with the organism Mutational Analysis, DNA see DNA Mutational Analysis Mutism Associated with deafness WV 280 Psychogenic WM 475 Hysterical WM 173.5 Other specific associations, by subject See also Akinetic Mutism WL 348; Deaf-Mutism WV 280 Mutism, Akinetic see Akinetic Mutism Myalgia, Epidemic see Pleurodynia, Epidemic Myasthenia Gravis WE 555 ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Myeloid Tissue Myatonia Congenita see Amyotonia Congenita myb Genes see Oncogenes Mycetoma see Maduromycosis Mycetozoa see Myxomycota Mycobacteriaceae QW 125.5.M9 Mycobacteriophages QW 161.5.M9 Mycobacterium QW 125.5.M9 Mycobacterium bovis QW 125.5.M9 Mycobacterium Infections WC 302 See also Leprosy WC 335; Paratuberculosis SF 809.J6; Tuberculosis WF, etc. Mycobacterium Infections, Atypical WC 302 Mycobacterium leprae QW 125.5.M9 Mycobacterium tuberculosis QW 125.5.M9 Mycology Botany QK 600-635 Fungus diseases see Mycoses WC 450-475 Medical (General) QW 180 Dictionaries QW 13 Laboratory manuals QW 25 Methods in medical mycology QY 110 See also Fungi QW 180, etc. Mycoplasma QW 143 Mycoplasma Infections WC 246 Veterinary SF 809.M9 Mycoplasma Pneumonia see Pneumonia, Mycoplasma Mycoplasma tales QW 143 Mycoplasmatales Infections WC 246 Mycoses WC 450-475 Veterinary SF 780.7 See also Dermatomycosis WR 300-340, etc.; Lung Diseases, Fungal WF 652; and names of specific fungal diseases Mycosis Fungoides WR 500 Mycotic Aneurysm see Aneurysm, Infected Mycotic Lung Infections see Lung Diseases, Fungal Mycotic Skin Infections see Dermatomycosis Mycotoxicosis WD 520 Mycotoxins QW 630.5.M9 Mydriasis see Pupil WW 240; Dilatation, Pathologic WW 240, etc. Mydriatics QV 134 Myelencephalon see Embryology WL 300 under Brain Myelin Sheath WL 102.5 Myelitis WL 400 Myeloblastic Leukemia see Leukemia, Myeloblastic Myelocele see Meningomyelocele Myelocytic Leukemia see Leukemia, Myelocytic Myelocytic Leukemia, Chronic see Leukemia, Myeloid, Chronic Myelodysplasia see Neural Tube Defects Myelodysplastic Syndromes WH 380 Myelofibrosis WH 380 Myelogenous Leukemia see Leukemia, Myeloid Myelogenous Leukemia, Chronic see Leukemia, Myeloid, Chronic Myelography WL 405 Myeloid Leukemia see Leukemia, Myeloid Myeloid Leukemia, Chronic see Leukemia, Myeloid, Chronic Myeloid Tissue see Bone Marrow NUMBER ASSIGNED ONLY WHEN iF WORK BEING CLASSIFIED 413 Myeloma, Plasma Cell Myeloma, Plasma Cell see Multiple Myeloma Myeloma Proteins WH 540 Myelomeningocele see Meningomyelocele Myelopathic Muscular Atrophy see Muscular Atrophy, Spinal Myelophthisic Anemia see Anemia, Myelophthisic Myeloproliferative Disorders WH 380 See also Anemia, Myelophthisic WH 175; Leukemoid Reaction WH 200; Polycythemia Vera WH 180 Myelosclerosis see Myelofibrosis Myenteric Plexus WL 600 Myers-Briggs Type Indicator see Personality Inventory Myiasis WC 900 Veterinary SF 810.F5 Myoblastoma see Neoplasms, Muscle Tissue Myocardial Contraction WG 280 Myocardial Depressants see Anti-Arrhythmia Agents Myocardial Diseases WG 280 Veterinary SF 811 Myocardial Diseases, Primary see Myocardial Diseases Myocardial Diseases, Secondary see Myocardial Diseases Myocardial Infarction WG 300 Myocardial Preinfarction Syndrome see Angina, Unstable Myocardial Reperfusion WG 280 Myocardial Reperfusion Injury WG 280 Myocardial Revascularization WG 169 Myocardial Stimulants see Cardiotonic Agents Myocardiopathies see Myocardial Diseases Myocarditis WG 280 Myocardium WG 280 See also Myocardial Revascularization WG 169 Myoclonia Epileptica see Epilepsy, Myoclonus Myoclonic Epilepsy, Progressive see Epilepsy, Myoclonic Myoclonic Jerking see Epilepsy, Myoclonic Myoclonic Jerking, Massive see Spasms, Infantile Myoclonus WE 550 Myodystrophia Fetalis Deformans see Arthrogryposis Myoepithelial Tumor see Myoepithelioma Myoepithelioma QZ 310 Localized, by site Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint see Temporomandibular Joint Syndrome Myofascial Pain Syndromes WE 550 Myofibrils WE 500 Myoglobin WH 190 Clinical analysis QY 455 Myoglobinuria WJ 344 Myoinositol see Inositol Myoma QZ 340 Uterine see Leiomyoma WP 459; Uterine Neoplasms WP 459, etc. Myometrium WP 400-460, 468 Myoneural Junction see Neuromuscular Junction Myopathies see Muscular Diseases ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Myopia WW 320 Myositis WE 544 Myotonia WE 550 Myoxidae see Rodentia Myringoplasty WV 225 Mysticism BV 5070-5095 And alchemy QD 23.3-26.5 And hallucinogens QV 77.7 Mythology BL 300-325 In medicine and related fields WZ 309 Mytilus see Mussels Myxedema WK 252 Myxobacterales see Myxococcales Myxococcales QW 128 Myxoma QZ 340 Localized, by site Myxoma Virus QW 165.5.P6 Myxomatosis, Infectious SF 997.5.R2 Myxomatosis Virus see Myxoma Virus Myxomycetes see Myxomycota Myxomycota QW 180.5.M9 Myxovirus Infections see Orthomyxoviridae Infections Myxovirus influenzae-A suis see Orthomyxovirus Type A, Porcine Myxovirus pestis galli see Orthomyxovirus Type A, Avian Myxoviruses see Orthomyxoviridae N N-Formimidoylthienamycin see Imipenem N-Methyl-D-Aspartate Receptors see Receptors, N-Methyl-D-Aspartate N-ras Genes see Genes, ras n-3 Fatty Acids see Fatty Acids, Omega-3 N(5)-Formyltetrahydrofolate see Leucovorin Na(+)-K(+)-Exchanging ATPase QU 136 Na(+)-K(+)-Transporting ATPase see NA(+)-K(+)-Exchanging ATPase NAD QU 135 NAD+ ADP-Ribosyltransferase QU 141 NAD Diaphorase see Lipoamide Dehydrogenase NADH Diaphorase see Lipoamide Dehydrogenase Nadide see NAD NADP QU 135 Nail Biting WM 172 In adolescence WS 463 In infancy & childhood WS 350.6 Nailing, Intramedullary see Fracture Fixation, Intramedullary Nails WR 475 Nails, Ingrown WR 475 Nalbuphine QV 92 Nalidixic Acid QV 243 Nalidixin see Nalidixic Acid Naltrexone QV 89 Names Corporate names (cataloging) Z 695.8 Geographic names (General) G 104-108 Special country, in appropriate LC number Subject cataloging Personal names Z 695.1.P4 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 414 Negative Reinforcement Nanism see Dwarfism Naphthalenediones see Naphthoquinones Naphthalenes Organic chemistry QD 391 Pharmacology QV 241 Naphthols QV 241 Naphthoquinones As antiviral agents QV 268.5 Organic chemistry QD 341.H9 Naproxen QV 95 Narceine see Noscapine Narcissism WM 460.5.E3 Narcolepsy WM 188 Narcosis, Therapeutic Use see Narcotherapy Narcosynthesis see Narcotherapy Narcotherapy WM 402 Narcotic Addiction see Narcotic Dependence Narcotic Analgesics see Analgesics, Opioid Narcotic Antagonists QV 89 Narcotic Control see Drug and Narcotic Control Narcotic Dependence WM 284 See also names of specific narcotics Narcotic Laws see Legislation, Drug Narcotics QV 89 Control see Drug and Narcotic Control QV 32, etc. Legislation see Legislation, Drug QV 32-33 Public health aspects WA 730 See also Analgesics, Opioid QV 89-92, etc. Narcotine see Noscapine Nasal Accessory Sinuses see Paranasal Sinuses Nasal Bone WV 301 Nasal Cavity WV 301 Nasal Decongestants see Vasoconstrictor Agents, Nasal Nasal Fossae see Nasal Cavity Nasal Polyps WV 300 Nasal Provocation Tests Used in the diagnosis of nasal hypersensitivity WV 335 Nasal Septum WV 320 Nasal Sinuses see Paranasal Sinuses Nasopharyngeal Diseases WV 410 Nasopharyngeal Neoplasms WV 410 Nasopharynx WV 410 In respiration WF 490 National Council on Health Planning and Development see Health Planning Councils National Health Insurance, Non-U.S. see National Health Programs National Health Insurance, United States W 275 National Health Policy see Health Policy National Health Programs WA 540 Programs in particular areas, by subject, e.g., Maternal Welfare WA 310 National Health Service, British see State Medicine National Health Service Corps see Medically Underserved Area Nationality see Ethnic Groups Native Americans see Indians, North American Natriuresis WJ 303 Natriuretic Factor see Natriuretic Hormone Natriuretic Hormone WK 185 Natriuretic Peptides, Atrial see Atrial Natriuretic Factor Natural Childbirth WQ 152 Natural Disasters Communicable disease control WA 110 Hospital emergency service WX 215 Medical emergencies WB 105 See also special topics under Disasters Natural History of Drugs see Pharmacognosy Natural Immunity see Immunity, Natural Natural Killer Cells see Killer Cells, Natural Natural Radiation see Background Radiation Natural Resources see Conservation of Natural Resources S 900-954, etc., and names of specific resources Natural Selection QH 375 Naturopathy WB 935 Nausea WI 146 Nautical Medicine see Naval Medicine Naval Hygiene see Naval Medicine Naval Medicine VG 100-475 Biography Collective WZ 112.5.M4 Individual WZ 100 Hygiene VG 470-475 Surgery WO 800 Naval Nursing see Military Nursing Naval Science V General works V 101-109 Naval Surgery see Naval Medicine; Naval WO 800 under Surgery Nazism see Political Systems Neamin see Neomycin Neapolitan Fever see Brucellosis Nearsightedness see Myopia Nebramycin Factor 6 see Tobramycin Nebulizers and Vaporizers WB 342 Necator QX 243 Necatoriasis WC 890 Neck WE 708 Blood supply WE 708 Neoplasms see Head and Neck Neoplasms WE 707 Neck Muscles WE 708 Neck Neoplasms see Head and Neck Neoplasms Necrobacillosis see Fusobacterium Infections Necrophilia see Paraphilias Necrosis QZ 180 Veterinary SF 769 Localized, by site Necrotizing Arteritis see Polyarteritis Nodosa Necrotizing Pyelonephritis see Kidney Papillary Necrosis Need Certification, Health Care see Certificate of Need Needle Biopsy see Biopsy, Needle Needle Sharing Special topics, by subject NEFA see Fatty Acids, Nonesterified Nefopam QV 95 Negative Contrast Radiography see Pneumoradiography Negative Reinforcement see Reinforcement ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 415 Negative Reinforcement (Psychology) Negatrons see Electrons Negligence, Professional see Malpractice Negroes see Blacks Negroid Race Anthropology GN 645 See also specific topics under Ethnic groups Neisseria QW 131 Neisseria gonorrhoeae QW 131 Neisseriaceae QW 131 Nelavane see Trypanosomiasis, African Nemathelminthes see Acanthocephala; Nematoda Nematoda QX 203-301 Nematode Infections WC 850-890 Veterinary SF 810.N4 Nematomorpha see Helminths Nematomorpha Infections see Helminthiasis Neoarsphenamine QV 262 Neocaine see Procaine Neomalthusianism see Population Dynamics Neomycin QV 350 Neomycin A see Neomycin Neon Inorganic chemistry QD 181.N5 Pharmacology QV 310 Neonatal Abstinence Syndrome WS 421 Neonatal Intensive Care see Intensive Care, Neonatal Neonatal Mortality see Infant Mortality Neonatal Nursing WY 157.3 Neonatal Screening For specific diseases, with the disease Neonate see Infant, Newborn Neonatology WS 420 See also Infant, Newborn WS 420, etc.; Perinatology WQ 210 Neoplasm Antibodies see Antibodies, Neoplasm Neoplasm Antigens see Antigens, Neoplasm Neoplasm Antigens, Viral see Antigens, Viral, Tumor Neoplasm Circulating Cells QZ 202 Neoplasm DNA see DNA, Neoplasm Neoplasm Invasiveness QZ 202 Neoplasm Metastasis QZ 202 Neoplasm Metastasis, Unknown Primary see Neoplasms, Unknown Primary Neoplasm Proteins QZ 200 Neoplasm Recurrence, Local QZ 202 Neoplasm Regression, Spontaneous QZ 202 Neoplasm Remission, Spontaneous see Neoplasm Regression, Spontaneous Neoplasm RNA see RNA, Neoplasm Neoplasm Staging QZ 241 Neoplasm Stem Cell Assay see Tumor Stem Cell Assay Neoplasm Transplantation QZ 206 Neoplasms QZ 200-380 Drug therapy QZ 267 See also Antineoplastic Agents QV 269 In adolescence (General) QZ 275 In infancy & childhood (General) QZ 275 Nursing WY 156 Oncolysis QZ 266 Special topics, by subject Radiotherapy QZ 269 Veterinary SF 910.T8 Localized, by site Neoplasms, Connective Tissue QZ 340 Neoplasms, Dental Tissue see Odontogenic Tumors Neoplasms, Embryonal and Mixed see Neoplasms, Germ Cell and Embryonal Neoplasms, Experimental QZ 206 Neoplasms, Germ Cell and Embryonal QZ 310 Neoplasms, Glandular and Epithelial QZ 365 Neoplasms, Hormone-Dependent QZ 200 Localized, by site Neoplasms, Mesenchymal see Neoplasms, Connective Tissue Neoplasms, Multiple Primary QZ 200 Neoplasms, Muscle Tissue QZ 340 Localized, by site Neoplasms, Nerve Tissue QZ 380 Neoplasms, Occult Primary see Neoplasms, Unknown Primary Neoplasms, Radiation-Induced QZ 200 Neoplasms, Unknown Primary QZ 202 Neoplasms, Vascular Tissue QZ 340 Neoplastic Cells, Cultured see Tumor Cells, Cultured Neoplastic Endocrine-Like Syndromes QZ 200 See also Hormones, Ectopic QZ 202, etc. Neoplastic Gene Expression Regulation see Gene Expression Regulation, Neoplastic Neoplastic Transformation, Cell see Cell Transformation, Neoplastic Neorickettsia see Rickettsiaceae Neostigmine QV 124 Neovascularization WG 500 Nephelometry and Turbidimetry Analytical chemistry QD 79.P46 Used for the diagnosis of particular disorder, with the disorder Nephrectomy WJ 368 Veterinary SF 871 Nephritis WJ 353 Veterinary SF 871 Nephritis, Familial see Nephritis, Hereditary Nephritis, Hereditary WJ 353 As a cause of deafness WV 270 Nephritis, Lupus see Lupus Nephritis Nephroblastoma WJ 358 Nephrocalcinosis WJ 356 Nephrolithiasis see Kidney Calculi Nephrolithotomy, Percutaneous see Nephrostomy, Percutaneous Nephrology WJ 300-378 Nursing WY 164 Nephrons WJ 301 Nephropathy, IGA see Glomerulonephritis, IGA Nephrosis WJ 340 Nephrostomy, Percutaneous WJ 368 Nephrotic Syndrome WJ 340 Neptunium WN 420 Nuclear physics QC 796.N7 See also special topics under Radioisotopes Nerve Block Anesthetic uses WO 300 Diagnostic and therapeutic uses WO 375 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7D2D 416 See also Autonomic Nerve Block WO 375 Nerve Block anesthesia see Anesthesia, Conduction Nerve Cells see Neurons Nerve Centers see Neurons Nerve Compression Syndromes WL 500 Nerve Conduction see Neural Conduction Nerve Degeneration WL 102.5 Of a particular part, by subject, e.g., in the cerebellum WL 320 Nerve Endings WL 102.9 Nerve Endings, Sensory see Receptors, Sensory Nerve Fibers WL 102.5 Nerve Fibers, Myelinated WL 102.5 Nerve Growth Factors WL 104 Nerve Impulses see Physiology WL 102 under Nervous System Nerve Net WL 102 Nerve Regeneration WL 102 Nerve Roots see Spinal Nerve Roots Nerve Tissue WL 101-102 Analysis WL 104 Anatomy WL 101 Histology QS 532.5.N3 Neoplasms QZ 380 Physiology WL 102 Nerve Tissue Proteins WL 104 Nerve Transmission see Synaptic Transmission Nerve Transmitter Substances see Neurotransmitters Nerves see Autonomic Nervous System; Nervous System; Peripheral Nervous System; Sympathetic Nervous System; names of specific nerves Nervous Exhaustion see Neurasthenia Nervous Mice see Mice, Neurologic Mutants Nervous System Anatomy WL 101 Autonomic see Autonomic Nervous System WL 600-610 Children WS 340-342 Drugs affecting QV 76.5 See also Analeptics QV 101-107; Analgesics, Anti-Inflammatory QV 95-98; Anesthetics QV 81, etc.; Anticonvulsants QV 85; Autonomic Drugs QV 120; Hypnotics and Sedatives QV 85-88; Narcotics QV 89; Neuromuscular Blocking Agents QV 140; Neuromuscular Depolarizing Agents QV 140 Neoplasms (General) WL 160 Parasympathetic see Parasympathetic Nervous System WL 610 Pathology WL 140 Physiology WL 102 Surgery WL 368 Sympathetic see Sympathetic Nervous System WL 610 See also Neoplasms, Nervous Tissue QZ 380; Neuroanatomy (specialty only) WL 101; Neurophysiology (specialty only) WL 102; Neurosurgery (specialty only) WL 368; names of specific nerves Nervous System Diseases WL 140-710 ENT complications WV 180 In infancy & childhood WS 340 ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Neurochemistry Nursing WY 160.5 Veterinary SF 895 Nervous System Neoplasms WL 160 Nesidioblastoma see Adenoma, Islet Cell Nesidioblastosis see Pancreatic Diseases Nesidioblasts see Islets of Langerhans Nested Case-Control Studies see Case-Control Studies Nesting Behavior QL 756 Bird QL 675 Netilmicin QV 350 Nettle Rash see Urticaria Network Communication Protocols see Computer Communication Networks Neural Analyzers WL 101-102 Neural Conduction WL 102.7-102.8 Neural Crest WL 101 Animal QL 938.N48 Neural Inhibition WL 102.7-102.8 Neural Interconnections see Neural Pathways Neural Networks (Anatomic) see Nerve Net Neural Pathways WL 102 See also Pyramidal Tracts WL 400; names of specific pathways Neural Transmission see Synaptic Transmission Neural Tube Defects WL 101 See also names of specific defects, e.g., Spinal Dysraphism WE 730 Neuralgia WL 544 Cervico-brachial see Cervico-Brachial Neuralgia WL 400 Facial see Facial Neuralgia WL 544 Trigeminal see Trigeminal Neuralgia WL 544 Neuralgic Amyotrophy see Cervico-Brachial Neuralgia Neuraminic Acids QU 84 Organic chemistry QD 321 Neuraminidase QU 136 Neurasthenia WM 174 Neurasthenic Neuroses see Neurasthenia Neurenteric Cyst see Spina Bifida Occulta Neurilemmoma QZ 380 Localized, by site Neurilemmoma, Acoustic see Neuroma, Acoustic Neurinoma see Neurilemmoma Neurinoma, Acoustic see Neuroma, Acoustic Neurite Outgrowth Factor see Nerve Growth Factors Neuritis WL 544 Endemic multiple see Beriberi WD 122 Optic see Optic Neuritis WW 280 Neuritis, Experimental Allergic WL 544 Neuro-Ophthalmology see Innervation WW 101-103 under Eye; Eye Movements; Oculomotor Muscles; Oculomotor Nerve; Optic Nerve Neuroanatomy WL 101 See also Anatomy WL 101 under Nervous System Neurobiology WL 100-102 Neuroblastoma QZ 380 Localized, by site Neurochemistry WL 104 See also Analysis WL 104 under Nerve Tissue NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSfFDZD 417 Neurocirculatory Asthenia Neurocirculatory Asthenia WG 320 Neurodermatitis WR 280 Neurodermatitis, Atopic see Dermatitis, Atopic Neurodermatitis, Circumscribed see Neurodermatitis Neurodermatitis, Disseminated see Dermatitis, Atopic Neurodermatitis, Localized see Neurodermatitis Neuroeffector Junction WL 102.9 Neuroendocrine System see Neurosecretory Systems Neuroendocrinology WL 105 Neurofibrils WL 102.5 Neurofibroma QZ 380 Localized, by site Neurofibromatosis QZ 380 Neurofilaments see Intermediate Filaments Neuroglia Anatomy WL 101 Histology QS 532.5.N3 Physiology WL 102 Neurohemal Organ see Neurosecretory Systems Neurohumor Receptors see Receptors, Neurotransmitter Neurohumors see Neurotransmitters Neurohypophysis see Pituitary Gland, Posterior Neuroimmune Processes see Neuroimmunomodulation Neuroimmunomodulation WL 102 Emphasis on immune system QW 504 Neuroleptanalgesia WO 297 Neuroleptic Malignant Syndrome WL 307 Neuroleptics see Antipsychotic Agents Neurologic Examination WL 141 In infancy & childhood WS 340 Neurologic Manifestations WL 340 Of eye diseases WW 460 Of particular diseases, with the disease See also Movement Disorders WL 390; Neuromuscular Diseases WE 550-559, etc.; Psychomotor Disorders WM 197; names of specific disorders Neurologic Models see Models, Neurological Neurology WL In infancy & childhood WS 340 Neurolymphomatosis see Marek's Disease Neuroma QZ 380 Localized, by site Neuroma, Acoustic WV 250 Neuroma, Acoustic, Unilateral see Neuroma, Acoustic Neuromediator Receptors see Receptors, Neurotransmitter Neuromodulator Receptors see Receptors, Neurotransmitter Neuromodulators see Neurotransmitters Neuromuscular Agents QV 140 Neuromuscular Blocking Agents QV 140 Neuromuscular Blocking Agents, Competitive see Neuromuscular Nondepolarizing Agents Neuromuscular Depolarizing Agents QV 140 Neuromuscular Diseases WE 550-559 In infancy & childhood WS 340 Ophthalmologic^ WW 400-475 Neuromuscular Junction WL 102.9 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Neuromuscular Mechanisms of the Eye see Eye Movements Neuromuscular Nondepolarizing Agents QV 140 Neuromuscular Spindles see Muscle Spindles Neuron Degeneration see Nerve Degeneration Neuronal Ceroid-Lipofuscinosis WD 205.5.L5 Neuronal Plasticity WL 102 Neurons WL 102.5 Neurons, Fusimotor see Motor Neurons, Gamma Neurons, Gamma Motor see Motor Neurons, Gamma Neuropathology see Pathology WL 140 under Nervous System Neuropathy, Type I Hereditary Motor and Sensory see Charcot-Marie Disease Neuropeptide Y WL 104 Neuropeptide Y-Like Immunoreactive Peptide see Neuropeptide Y Neuropeptides WL 104 Neuropharmacology QV 76.5 Neurophysins QU 55 Endocrinology WK 520 Neurochemistry WL 104 Neurophysiology WL 102 See also Physiology WL 102 under Nervous System Neuropsychological Tests In psychiatry WM 145.5.N4 In neurology WL 141 In infancy & childhood WS 340 Neuropsychology WL 103.5 Neuroradiography WL 141 In infancy & childhood WS 340 Neuroreceptors see Receptors, Sensory Neuroregulator Receptors see Receptors, Neurotransmitter Neuroregulators see Neurotransmitters Neurosciences WL 100 Neurosecretion WL 102 Neurosecretory Systems WL 102 Neuroses see Neurotic Disorders Neuroses, Anxiety see Anxiety Disorders Neuroses, Neurasthenic see Neurasthenia Neuroses, Phobic see Phobic Disorders Neuroses, Post-Traumatic see Stress Disorders, Post-Traumatic Neuroses, War see Combat Disorders Neurosis, Depressive see Depressive Disorder Neurosis, Hypochondriacal see Hypochondriasis Neurosis, Obsessive-Compulsive see Obsessive-Compulsive Disorder Neurospora QW 180.5.A8 Neurosurgery WL 368 See also Surgery WL 368 under Nervous System Neurosyphilis WC 165 Neurotensin WL 104 Neurotic Disorders WM 170-184 In adolescence WS 463 In infancy & childhood WS 350.6 In old age WT 150 Neurotoxins QW 630.5.N4 Of insecticides WA 240 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSffTED 418 Nitrosamines Neurotransmitter Uptake Inhibitors QV 129 Neurotransmitters QV 126 See also names of specific neurotransmitters Neurotropic Virus Infections see Virus Diseases Neutron Activation Analysis QD 606 Of a particular substance, with the substance Neutrons WN 415-420 In general nuclear physics QC 793.5.N462-793.5.N4629 In health physics WN 110 Neutropenia WH 200 Neutrophil-Activating Peptide, Lymphocyte-Derived see Interleukin-8 Neutrophil-Activating Peptide, Monocyte-Derived see Interleukin-8 Neutrophil-Activating Peptides, Fibroblast-Derived see Interleukin-8 Neutrophil-Derived Relaxant Factor see Endothelium-Derived Relaxing Factor Neutrophils WH 200 In phagocytosis QW 690 Nevus WR 500 Pathology QZ 310 Nevus, Pigmented WR 265 Pathology QZ 310 Nevus Syndrome, Dysplastic see Dysplastic Nevus Syndrome Newborn see Infant, Newborn Newborn Infant Screening see Neonatal Screening Newcastle Disease SF 995.6.N4 Newcastle Disease Virus QW 168.5.P2 News Media Relations see Public Relations Newsletters see Periodicals Newspapers General bibliography Z 6940-6967 Medical and related areas WI Bibliography ZW 1 Niacin see Nicotinic Acids QU 193 Niacinamide QU 193 Nialamide QV 77.5 Nicardipine QV 150 Nickel Inorganic chemistry QD 181.N6 Pharmacology QV 290 Nicolas-Favre Disease see Lymphogranuloma Venereum Nicotiana see Tobacco Nicotinamide see Niacinamide Nicotinamide-Adenine Dinucleotide see NAD Nicotinamide-Adenine Dinucleotide Phosphate see NADP Nicotine QV 137 Dependence WM 290 Nicotinic Acid see Niacin Nicotinic Acids QU 193 Nicotinic Agents see Cholinergic Agents Nicotinic Receptors see Receptors, Nicotinic Nidation see Ovum Implantation Nidation, Delayed see Ovum Implantation, Delayed NIDDM see Diabetes Mellitus, Non-Insulin-Dependent Niemann-Pick Disease WD 205.5.L5 Nifedipine QV 150 Night Blindness WD 110 Night Monkey, Northern see Aotus trivirgatus Night Terrors see Sleep Disorders Night Vision see Dark Adaptation Nightmares see Dreams NIH Consensus Development Conferences see Consensus Development Conferences, NIH Nikethamide QV 103 Nimodipine QV 150 Niobium Inorganic chemistry QD 181.N3 Radioactive WN 420 Nisoldipine QV 150 Nitrates QV 156 As caustics (e.g. when nitrates are used for nitric acid) QV 612 Nitric Acid see Nitrates Nitric Oxide As an air pollutant WA 754 Inorganic chemistry QD 181.N1 Nitriles As antineoplastic agents QV 269 Organic chemistry Aliphatic compounds QD 305.N7 Aromatic compounds QD 341.N7 Nitrites QV 156 Nitrobacter QW 135 Nitrobacteraceae QW 135 Nitrobenzenes Organic chemistry QD 341.H9 Toxicology QV 632 Nitrocellulose see Collodion Nitroferricyanide see Nitroprusside Nitrofural see Nitrofurazone Nitrofurans QV 243 Nitrofurazone QV 243 As a local anti-infective agent QV 225 Nitrogen QU 54 Blood chemistry QY 455 Nitrogen Dioxide As an air pollutant WA 754 Inorganic chemistry QD 181.N1 Nitrogen Fixation QU 70 Chemical technology TP 245.N8 In plants QK 898.N6 In soil QW 60 Nitrogen Isotopes QU 54 Inorganic chemistry QD 181.N1 Nitrogen Mustard see Mechlorethamine; Mustard Compounds; Thio-Tepa; Triethylene Melamine Nitrogen Mustard Compounds QV 269 As war gases QV 666 Nitrogen Mustard N-Oxide see Mechlorethamine Nitrogen Narcosis see Inert Gas Narcosis Nitrogen Oxides As air pollutants WA 754 Inorganic chemistry QD 181.N1 Mineralogy QE 389.5 Nitroglycerin QV 156 Toxicology QV 632 Nitroprusside As a vasodilator agent QV 156 Nitrosamines QZ 202 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSrFTED 419 Nitrosation Nitrosation As a metabolic phenomenon QU 120 Organic chemistry QD 281.N5 Nitroso Compounds As carcinogens QZ 202 Organic chemistry Aliphatic compounds QD 305.N8 Aromatic compounds QD 341.N8 Nitrosodiethylamine see Diethylnitrosamine Nitrosomonas QW 135 Nitrous Oxide QV 81 Nizethamid see Nikethamide NK Cells see Killer Cells, Natural NMDA Receptor-Ionophore Complex see Receptors, N-Methyl-D-Aspartate NMR Imaging see Magnetic Resonance Imaging NMR Tomography see Magnetic Resonance Imaging No-Fault Insurance see Insurance, Liability Nobel Prize AS 911 Collective biography of winners Chemists QD 21 General AS 911 Physicians WZ 112 Physicists QC 15 Physiologists WZ 112.5.P5 Nocardia Infections WC 302 Veterinary SF 809.N63 See also Maduromycosis WR 340 Nociception Tests see Pain Measurement Nociceptors WL 102.9 Nodding Spasm see Spasms, Infantile Nodulus Intercaroticus see Carotid Body Noise WA 776 Abatement WA 776 In industry WA 470 Adverse effects WV 270 In aviation WD 735 Prevention & control General public health WA 776 In industry WA 470 Noise-Induced Hearing Loss see Hearing Loss, Noise-Induced Noise, Occupational see Noise WA 470, etc. Noise, Transportation see Noise WA 776, etc. Nomascus see Hylobates Nomenclature (Form number 15 in any NLM schedule where applicable) Nomifensine As an antidepressant QV 77.5 As an antiparkinson agent QV 80 Non-Hodgkin's Lymphoma see Lymphoma, Non-Hodgkin 's Non-Steroidal Anti-Inflammatory Agents see Anti-Inflammatory Agents, Non-Steroidal Nonagenarian see Aged, 80 and over Nondirective Therapy WM 420.5.N8 Nondisjunction, Genetic QH 462.N65 Noninvasive Litholapaxy see Lithotripsy Nonodontogenic Cysts WU 280 Nonopioid Analgesics see Analgesics, Non-Narcotic Nonprofit Organizations see Organizations, Nonprofit Nonverbal Communication HM 258 In adolescence WS 462 In infancy & childhood WS 105.5.C8 In speech disorders WM 475 Psychology BF 637.N66 See also Kinesics WS 462, etc.; Manual Communication HV 2477, etc. Nootropic Drugs see Psychotropic Drugs Noradrenaline see Norepinephrine Noramidopyrine Methanesulfonate see Dipyrone Norepinephrine WK 725 Norethandrolone WJ 875 Norethindrone WP 530 As a contraceptive QV 177 Norethisterone see Norethindrone Norethynodrel WP 530 As a contraceptive QV 177 Norfloxacin QV 250 Norgestrel WP 530 As a contraceptive QV 177 Normal Range see Reference Values Normal Serum Globulin Therapy see Immunization, Passive Normal Values see Reference Values Normethandrolone WP 530 Normoblasts see Erythroblasts Norpregneninolone see Norethindrone Northern Blotting see Blotting, Northern Nortropanes Organic chemistry QD 401 Noscapine QV 76 Nose WV 300-335 Innervation WV 301 Surgery WV 300 Plastic WV 312 Nose Bleed see Epistaxis Nose Diseases WV 300-335 General works WV 300 In infancy & childhood WV 300-335 Nursing WY 158.5 Veterinary SF 891 Nose Neoplasms WV 300 Nosebleed see Epistaxis Nosocomial Infections see Cross Infection Nosology see Classification Nostrums QV 772 Notifiable Diseases, Registration see Communicable Disease Control; Registries Novelty-Seeking Behavior see Exploratory Behavior Novocaine see Procaine Nuclear Energy WN 415 Meteorology QC 913.2.A8 Nuclear physics QC 770-798 Nuclear Envelope see Nuclear Membrane Nuclear Magnetic Resonance QC 762 In biochemistry QU 25 Spectroscopy QD 96.N8 Other special topics, by subject See also Magnetic Resonance Imaging WN 185 Nuclear Medicine WN 440-450 Nuclear Medicine Department, Hospital WN ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSrPIED 420 Nursing 27-28 Nuclear Membrane QH 601.2 See also Cell Membrane QH 601, etc. Nuclear Physics Biological sciences WN 415 Physical sciences QC 770-798 Nuclear Pore see Nuclear Membrane Nuclear Proteins QU 55 Nuclear Radiology see Nuclear Medicine Nuclear Reactors QC 786.4-786.8 Industrial hazard WA 470 Nuclear reactor engineering TK 9202-9230 Radioactive waste hazard WA 788 Special uses, by subject Nuclear Warfare WN 610 Nuclear Waste see Radioactive Waste Nucleases see Phosphoric Diester Hydrolases; names of other specific nucleases, e.g., Deoxyribonucleases Nucleases, DNA see Deoxyribonucleases Nucleases, RNA see Ribonucleases Nucleic Acid Conformation QU 58 Nucleic Acid Hybridization QU 58 Nucleic Acid Probes QU 58 Nucleic Acids QU 58 Derivatives Biochemistry QU 58 Pharmacology QV 185 Nucleolar Organizer see Nucleolus Organizer Region Nucleolar Proteins see Nuclear Proteins Nucleolus Organizer Region QH 600 Nucleolysis, Intervertebral Disk see Intervertebral Disk Chemolysis Nucleoproteins QU 56 Nucleoside Diphosphate Sugars Biochemistry QU 57 Pharmacology QV 185 Nucleosides Biochemistry QU 57 Pharmacology QV 185 See also Hematopoiesis WH 140 See also names of specific nucleosides Nucleosomes QU 56 Cytology QH 599 Nucleotide Sequence see Base Sequence Nucleotides Biochemistry QU 57 Pharmacology QV 185 See also Hematopoiesis WH 140 See also names of specific nucleotides Nucleotides, Cyclic QU 57 Pharmacology QV 185 Nucleus Accumbens WL 314 Nucleus Dentatus see Cerebellar Nuclei Nude Mice see Mice, Nude Nudism QT 245 Nuisances (Air Pollution) see Air Pollutants Numerical Analysis, Computer-Assisted Special topics, by subject, e.g. Biological Models QH 324.8 Numismatics CJ 1-6661 Medical WZ 340 Nupercaine see Dibucaine Nurse Administrators WY 105 Nurse Anesthetists WY 151 Nurse Clinicians WY 128 Nurse Midwives WY 157 Directories WY 22 See also Obstetrical Nursing WY 157, etc.; Midwifery WQ 160-165 Nurse-Patient Relations WY 87 Children WY 159 Counseling WY 87 Education of patient WY 87 Nurse Practitioners WY 128 Nurseries WA 320 Nurseries, Hospital WX 200 Nursery Schools see Schools, Nursery Nurses Biography Collective WZ 112.5.N8 Individual WZ 100 Directories WY 22 Employment WY 29, etc. Liability WY 44 See also Insurance, Liability WY 44, etc. Nurses' Aides WY 193 Psychiatric see Psychiatric Aides WY 160 Nurses, Head see Nursing, Supervisory Nurses, Male WY 191 Nurses Performance Evaluation see Employee Performance Appraisal Nursing WY Administration WY 105 AIDS/HIV WY 153.5 As a profession WY 16 Aviation WY 143 By country WY 300 Community health see Community Health Nursing WY 106 Geriatric see Geriatric Nursing WY 152 History see History of Nursing WY 11 Home see Home Nursing WY 200 In adolescence WY 159 Industrial see Occupational Health Nursing WY 141 Military see Military Nursing WY 130 Naval see Military Nursing WY 130 Neurological WY 160.5 Obstetrical see Obstetrical Nursing WY 157 Office see Office Nursing WY 109 Operating room see Operating Room Nursing WY 162 Otolaryngologic^ WY 158.5 Pediatric see Pediatric Nursing WY 159 Psychiatric see Psychiatric Nursing WY 160 Religious orders WY 145 School see School Nursing WY 113 Specialties see Specialties, Nursing WY 101-164 Standards WY 16 Statistics WY 31 Surgical see Surgical Nursing WY 161-162 Surveys WY 31 Transcultural see Transcultural Nursing WY 107 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 421 Nursing Transportation nursing WY 143 Veterinary SF 774.5 See also names of diseases being treated or the specialty involved Nursing Administration Research WY 105 Nursing Assessment WY 100.4 Nursing Audit WY 100.5 Nursing Care General WY 100 In special field WY 150-164 Nursing Care Plans see Patient Care Planning Nursing Diagnosis WY 100.4 Nursing Economics see Economics, Nursing Nursing Education see Education, Nursing Nursing Education, Associate see Education, Nursing, Associate Nursing Education, Baccalaureate see Education, Nursing, Baccalaureate Nursing Education, Continuing see Education, Nursing, Continuing Nursing Education, Diploma Programs see Education, Nursing, Diploma Programs Nursing Education, Graduate see Education, Nursing, Graduate Nursing Education Research WY 18 Nursing Ethics see Ethics, Nursing Nursing Evaluation Research WY 20.5 Nursing Faculty see Faculty, Nursing Nursing, Home see Home Nursing Nursing Homes WX 27-28 Administration WX 150 Directories WX 22 For the aged WT 27-28 Directories WT 22 For other purposes, by specialty Nursing Libraries see Libraries, Nursing Nursing, Maternal-Child see Maternal-Child Nursing Nursing Methodology Research WY 20.5 Nursing, Military and Naval see Military Nursing Nursing Models see Models, Nursing Nursing, Oncologic see Oncologic Nursing Nursing Philosophy see Philosophy, Nursing Nursing Pools see Employment; Nurses Nursing, Practical WY 195 Education WY 18.8 Nursing, Private Duty WY 127 Education WY 18 Nursing Process WY 100 Specific activities, by subject Nursing Program Evaluation see Nursing Evaluation Research Nursing Protocols see Nursing Assessment Nursing Records WY 100.5 See also Medical Records WX 173, etc. Nursing Research WY 20.5 Nursing Research, Administrative see Nursing Administration Research Nursing Research, Clinical see Clinical Nursing Research Nursing Research, Educational see Nursing Education Research Nursing Schools see Schools, Nursing ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Nursing Service, Hospital WY 125 Administration WY 105 Nursing Services WY 100 Nursing Staff Of industry WY 141 Of schools WY 113 Nursing Staff, Hospital WY 125 Administration WY 105 Nursing, Supervisory WY 105 Of wards WY 105 Nursing, Team WY 125 See also Patient Care Team W 84.8, etc. Nursing Theory WY 86 Nursing, Transcultural see Transcultural Nursing Nutcracker Esophagus see Esophageal Motility Disorders Nutrition And oral health WU 113.7 General QU 145 In animals see Animal Nutrition SF 95-99 In children see Child Nutrition WS 115, etc. In infants see Infant Nutrition WS 115-125 In old age WT 115 In pregnancy WQ 175 In sickness (General) WB 400 Tables QU 145 For children WS 16 See also Diet QT 235; Parenteral Feeding WB 410; other particular topics Nutrition Assessment QU 146 Nutrition Disorders WD 100-175 As a cause of disease QZ 105 In infancy & childhood WS 115 Children WS 115; WS 130 In old age WT 115 Infant see Infant Nutrition Disorders WS 120, etc. Veterinary SF 851 See also Obesity WD 210-212 Nutrition Disorders, Child see Child Nutrition Disorders Nutrition Disorders, Infant see Infant Nutrition Disorders Nutrition, Enteral see Enteral Nutrition Nutrition, Parenteral see Parenteral Nutrition Nutrition Surveys QU 146 Nutrition, Total Parenteral see Parenteral Nutrition, Total Nutritional Availability see Nutritive Value Nutritional Requirements QU 145 In old age WT 115 Nutritional Status QU 145 Nutritive Value QU 145.5 Tables QU 145.5 Nuts Diets for control of fats WB 425 Diets for control of protein WB 426 Nux Vomica see Strychnine Nyctalopia see Night Blindness Nycticebus see Lorisidae Nyctiphanes see Crustacea Nyctohemeral Rhythm see Orcadian Rhythm USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSD7TED 422 Nylons Chemical technology TP 1180.P55 Used for special purposes, by subject, e.g., in plastic surgery WO 640 Nymphae see Vulva Nymphomania see Paraphilias Nystagmus WW 410 Nystagmus, Baranys see Nystagmus, Physiologic Nystagmus, Caloric see Nystagmus, Physiologic Nystagmus, Physiologic WW 410 Nystagmus, Thermal see Nystagmus, Physiologic O o-Dihydroxybenzenes see Catechols Oath, Hippocratic see Hippocratic Oath Oats As a dietary supplement in health or disease WB 431 Cultivation SB 191.02 Obesity WD 210-212 Obesity in Diabetes WK 835 Obesity, Morbid WD 210-212 Object Attachment WM 460.5.02 Object Relations see Object Attachment Object Relationship see Object Attachment Obligation, Social see Social Responsibility Obsessive Behavior WM 176 Obsessive-Compulsive Disorder WM 176 Obsessive-Compulsive Personality see Compulsive Personality Disorder Obstetrical Forceps WQ 425 Obstetrical Nursing WY 157 Education WY 18-18.5 See also Postnatal Nursing WY 157.3 Obstetricians, Directories see Directories WQ 22 under Obstetrics Obstetrics WQ Anesthesia see Anesthesia, Obstetrical WO 450 Cardiac problems WQ 244 Directories WQ 22 Nursing see Obstetrical Nursing WY 157, etc. Urology WJ 190 Complications WQ 260. Obstetrics and Gynecology Department, Hospital WQ 27-28 Obstruction, Intestinal see Intestinal Obstruction Obturators, Palatal see Palatal Obturators Occipital Lobe WL 307 Occlusal Equilibration see Dental Occlusion, Balanced Occlusal Force see Bite Force Occlusion see Dental Occlusion Occlusive Dressings WO 167 Occult Blood QY 160 Occult Primary Neoplasms see Neoplasms, Unknown Primary Occult Spina Bifida see Spina Bifida Occulta Occult Spinal Dysraphism see Spina Bifida Occulta Occultism Medical superstitions WZ 309 Occupational Accidents see Accidents, Occupational Occupational Air Pollutants see Air Pollutants, ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Ocular Fixation Occupational Occupational Dentistry WA 412 Occupational Dermatitis see Dermatitis, Occupational Occupational Diseases WA 400-495 Medicolegal aspects W 925 Mental disorders (General) WA 495 Nursing see Occupational Health Nursing WY 141 Ophthalmological WW 505 Prevention & control WA 412-495 See also Disability Evaluation W 925, etc.; Workers'Compensation HD 7103.6-7103.65, etc. Occupational Exposure WA 400-495 See also Environmental Exposure Occupational Health WA 400-495 Special topics, by subject Occupational Health Nursing WY 141 Education WY 18-18.5 Occupational Health Services WA 412 Mental health WA 495 See also Mental Health Services WM 30, etc. Occupational Hygiene see Occupational Health Occupational Medicine WA 400-495 Occupational Mobility see Career Mobility Occupational Neuroses see Occupational Diseases; Mental Health Occupational Noise see Noise, Occupational Occupational Nursing see Occupational Health Nursing Occupational Safety see Occupational Health Occupational Therapy WB 555 Hospital department WX 225 In adolescence WS 463 In infancy & childhood For mentally disabled WS 350.2 For physically disabled WS 368 In psychiatry WM 450.5.O2 See also Rehabilitation, Vocational HD 7255-7256 Occupational Therapy Department, Hospital WX 225 Occupational Toxicology see Poisons; Toxicology Occupations Statistics and demographic discussions HB 2581-2787 Specific occupations, by type, e.g., Surgery WO 21 See also Vocational Guidance HF 5381-5382.67, etc. Oceanography GC General works GC 10.9-11.2 Ochronosis WR 267 Octadecenoic Acids see Oleic Acids Octodon see Rodentia Octogenarian see Aged, 80 and over Ocular Accommodation see Accommodation, Ocular Ocular Adaptation see Adaptation, Ocular Ocular Dominance see Vision Ocular Fixation see Fixation, Ocular NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSD7IJED 423 Ocular Fluorophotometry Ocular Fluorophotometry see Fluorophotometry Ocular Herpes zoster Virus see Herpesvirus 3, Human Ocular Infections, Parasitic see Eye Infections, Parasitic Ocular Motility see Eye Movements Ocular Motility Disorders WW 410 Ocular Prosthesis see Eye, Artificial Ocular Refraction see Refraction, Ocular Ocular Tension see Intraocular Pressure Ocular Torticollis see Ocular Motility Disorders Ocular Toxoplasmosis see Toxoplasmosis, Ocular Ocular Tuberculosis see Tuberculosis, Ocular Oculomotor Muscles WW 400-460 See also Eye Movements WW 400-460 Oculomotor Nerve WL 330 Oculomotor Paralysis see Ophthalmoplegia Ocytocin see Oxytocin Oddi's Sphincter WI 750 Odontoblasts WU 230 Odontogenic Cysts WU 280 Odontogenic Tumors WU 280 Pathology of dental tissue QZ 200 Odontometry WU 141.5.02 Odontostomatology see Mouth WU, Tooth WU and related headings Odors Industrial control WA 450 Otolaryngology WV 301 Pollution WA 754 Oedipus Complex WM 460 Oesophagus see Esophagus Offenses, Sexual see Sex Offenses Office Automation W 26.5 In special areas, by subject Office Management W 80 Dental WU 77 See also Dental Offices WU 77 and names of specialties involved, e.g., Psychiatry WM 30 Office Nursing WY 109 Office Surgery see Ambulatory Surgery Office Visits Made for special purpose, by subject Offspring of Impaired Parents see Child of Impaired Parents Ofloxacin QV 250 Oils QV 785 Biochemistry QU 86 Public health aspects WA 722 See also names of specific oils Oils, Essential see Oils, Volatile Oils, Plant see Plant Oils Oils, Unsaturated see Fats, Unsaturated Oils, Vegetable see Plant Oils Oils, Volatile QV 785 Biochemistry QU 86 Chemical technology TP 958-959 Ointments QV 785 OK-432 see Picibanil Old Age see Aged WT Old Age Assistance WT 30 Social Security HD 7090-7250 Old Age Homes see Homes for the Aged ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHU Old Age Insurance see Medicare; Social Security Oldest Old see Aged, 80 and over Oleates see Oleic Acids Olefins see Alkenes Oleic Acids QU 90 Pharmaceutical agents QV 785 Oleomargarine see Margarine Oleoresins see Resins; specific resins or plants from which derived, e.g., Aspidium Olfaction see Smell Olfactory Cortex see Olfactory Pathways Olfactory Mucosa WV 301 Olfactory Nerve WL 330 See also Smell WV 301 Olfactory Pathways WL 314 Olfactory Sense see Smell Olfactory Tract see Olfactory Pathways Olfactory Tubercle see Olfactory Pathways Oligemia see Anemia Oligochaeta QX 451 Oligochromemia see Anemia Oligodeoxyribonucleotides, Antisense see Oligonucleotides, Antisense Oligomenorrhea WP 522 Oligonucleotide-Directed Mutagenesis see Mutagenesis, Site-Directed Oligonucleotides QU 57 Oligonucleotides, Antisense QU 57 Oligoribonucleotides QU 57 Oligoribonucleotides, Antisense see Oligonucleotides, Antisense Oligosaccharides QU 83 omega-Chloroacetophenone QV 665 Omega Protein see DNA Topoisomerase Omega-3 Fatty Acids see Fatty Acids, Omega-3 Omentum WI 575 Omeprazole QV 69 OMP Proteins see Bacterial Outer Membrane Proteins Omphalocele see Hernia, Umbilical On-Line Systems see Online Systems Onchocerca QX 301 Onchocerciasis WC 885 Oncogenes QZ 202 Oncogenic Viruses QW 166 Oncogens see Carcinogens Oncologic Nursing WY 156 Oncology, Medical see Medical Oncology Oncolysis see Neoplasms Ondatra see Microtinae Ondine's Curse see Sleep Apnea Syndromes Onions see Allium Onlays see Inlays Online Systems Z 699 By subject Z 699.5.A-Z In medicine (General) W 26.55.14 In other special fields (Form number 26.5 in any NLM schedule where applicable) Only Child WS 105.5.F2 Ontogeny QH 491 Specific animal QL Specific plant QK See also names of organ or organism involved USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSIFTED 424 Onychophagia see Nail Biting Oocytes WQ 205 Oophoritis WP 320 Opacity, Vitreous see Vitreous Body Opaque Media see Contrast Media Open-Angle Glaucoma see Glaucoma, Open-Angle Open Fractures see Fractures, Open Operating Room Nursing WY 162 Education WY 18-18.5 Operating Room Technicians WY 162 Operating Rooms WX 200 Architectural planning and construction WX 140 Operations Research Industrial engineering T 57.6-57.97 Special topics, by subject Operative Dentistry see Dentistry, Operative Operative Obstetrics see Abortion, Induced; Cesarean Section; Delivery; Embryotomy; and other specific subjects Operative Surgery see Surgery, Operative Operon QH 450.2 Ophthalmia see Endophthalmitis Ophthalmia, Sympathetic WW 525 Ophthalmic Artery WG 595.07 See also Blood supply WW 101-103 under Eye Ophthalmic Assistants WW 21.5 Ophthalmic Nerve WL 330 Ophthalmic Solutions WW 166 Ophthalmologists see Biography WZ 100, etc, and Directories WW 22 under Ophthalmology Ophthalmology WW Biography Collective WZ 112.5.07 Individual WZ 100 Directories WW 22 In infancy & childhood WW 600 In old age WW 620 Occupational WW 505 Instrumentation WW 26 Traumatic see Eye Injuries WW 525 See also Eye Diseases WW 140, etc. Ophthalmoplegia WW 410 Ophthalmoscopy WW 143 Veterinary SF 891 Opiate Dependence see Narcotic Dependence Opiates see Narcotics Opiates, Endogenous see Opioid Peptides Opioid Analgesics see Analgesics, Opioid Opioid Peptides QU 68 Opioids see Narcotics Opisthorchiasis WC 805 Opisthorchis QX 353 Opisthorchis felineus see Opisthorchis Opisthorchis sinensis see Clonorchis sinensis Opisthorchis viverrini see Opisthorchis Opium Dependence WM 286 See also Heroin Dependence WM 288; Morphine Dependence WM 286 Alkaloids QV 90 Opossums QL 737.M34 Oppenheim-Ziehen Disease see Dystonia ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Oral Tobacco Musculorum Deformans Oppenheims Disease see Amyotonia Congenita Opportunistic Infections General WC 195 Parasitic WC 695 Viral WC 500 Opportunistic Infections, AIDS-Related see AIDS-Related Opportunistic Infections Opsonins Antibodies QW 601 Clinical analysis QY 455 Derived from complement QW 680 See also Phagocytosis QW 690 Optic Atrophy WW 280 Optic Chiasm WW 280 For the neurologist WL 330 Optic Lobe WL 310 Optic Nerve WW 280 For the neurologist WL 330 See also Innervation WW 101-103 under Eye; Vision WW 103, etc. Optic Nerve Diseases WW 280 Optic Neuritis WW 280 Optical Dispensing see Optometry Optical Illusions WW 105 Optical Instruments see Instrumentation WW 26 under Ophthalmology or Optometry; Instrumentation QC 370.5-379 under Optics; names of particular instruments or procedures Optical Readers see Automatic Data Processing Optical Rotatory Dispersion Physical chemistry QD 473 Opticians see Optometry Optics QC 350-467 Instrumentation QC 370.5-379 Physiological see Optometry WW 704, etc.; Vision WW, etc. Stereoscopy WN 100 Optometrists see Biography WZ 112.5.07, etc., and Directories WW 722 under Optometry Optometry WW 704-722 Biography Collective WZ 122.5.07 Individual WZ 100 Directories WW 722 Instrumentation WW 26 Optical dispensing WW 350-355 Opticianry WW 350-358 Opticians WW 704-722 See also names of functions of the optometrist, e.g., Orthoptics WW 405 Oral Health WU 113 Children WU 113.6 Oral Hemorrhage WU 140 Oral Hygiene WU 113 Children WU 113.6 Oral Hygiene Index WU 30 Oral Manifestations WU 290 Of particular diseases, with the disease Oral Medicine see Dentistry Oral Rehydration Therapy see Fluid Therapy Oral Surgery see Surgery, Oral Oral Tobacco see Tobacco, Smokeless NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSIFIED 425 Orangutan see Pongo pygmaeus Orbit WW 202 Orbital Diseases WW 202 Orbital Neoplasms WW 202 Orchidectomy see Orchiectomy Orchiectomy WJ 868 Orchitis WJ 830 Orciprenaline QV 129 Orderlies see Personnel, Hospital Ordiflazine see Lidoflazine Orf see Ecthyma, Contagious Organ Banks see Tissue Banks Organ Donors see Tissue Donors Organ Failure, Multiple see Multiple Organ Failure Organ of Corti WV 250 Organ Preservation WO 665 Of specific organs, with the organ Organ regeneration see Regeneration Organ Specificity QW 700 Special topics, by subject Organ Temperature see Body Temperature Organ Transplantation WO 660-690 Organ Transplants see Organ Transplantation Organelles QH 591 Organic Brain Syndrome, Nonpsychotic see Organic Mental Disorders Organic Brain Syndrome, Psychotic see Organic Mental Disorders, Psychotic Organic Hallucinosis see Organic Mental Disorders, Psychotic Organic Mental Disorders WM 140 Organic Mental Disorders, Psychotic WM 220 Organic Poisons see Poisons Organic Psychoses see Psychoses, Organic Organization and Administration Hospital see Hospital Administration WX 150-190 Hospital Personnel see Personnel Administration, Hospital WX 159-159.5 Library see Library Administration Z 678-678.88 Medicine W 88 Neurology WL 30 Nursing WY 105 Nursing schools WY 20 Pharmacy see Pharmacy Administration QV 737 Psychiatry WM 30 Public health see Public Health Administration WA 525-590 Organization and Administration, Hospital see Hospital Administration Organizational Change see Organizational Innovation Organizational Decision Making see Decision Making, Organizational Organizational Innovation Hospital Administration WX 150-190 Nursing Service WY 105 Public Health Administration WA 525-590 Specific types of organization, by organization Organizations HM 131 See also names of specific types of organizations, e.g. Voluntary Health Agencies WA 1, etc.; names of specialties Organizations, Nonprofit WA 1, ETC. (Form number 1 in any NLM schedule where applicable) Non-medical HD 2769.15-2769.2 Organochlorine Insecticides see Insecticides, Organochlorine Organoids QH 581-581.2 Organometallic Compounds Biochemistry QU 131 Organic chemistry QD 410-412.5 Pharmacology QV 290 Organophosphorous Compounds Biochemistry QU 131 Organic chemistry QD 305.P6; QD 406 Toxicology QV 627 See also Insecticides, Organophosphate WA 240, etc. Organoplatinum Compounds Biochemistry QU 131 Pharmacology QV 290 Organotherapy WB 391 Organothiophosphorus Compounds Biochemistry QU 131 Organic chemistry QD 412.P1 Toxicology QV 627 See also Insecticides, Organothiophosphate WA 240, etc. Orgasm HQ 19-25 Oriental Medicine, Traditional see Medicine, Oriental Traditional Orientation Animal QL 782.5 Aviation WD 730 Bird navigation and migration QL 698.8-698.9 Outer space WD 754 Psychophysiology WL 103 Reflex WL 106 Spatial WV 255 Visual see Adaptation, Ocular WW 109 See also Adaption, Psychological WD 730, etc. Orientation Programs, Employee see Inservice Training Origin of Life see Biogenesis Ormond's Disease see Retroperitoneal Fibrosis Ornithine QU 60 Ornithine Carboxy-lyase see Ornithine Decarboxylase Ornithine Decarboxylase QU 139 Ornithosis WC 660 Orosomucoid WH 400 Clinical examination QY 455 Orotic Acid In nucleic acid biosynthesis and metabolism QU 58 Organic chemistry QD 401 Oroya Fever see Bartonella Infections Orphan Drug Production QV 736 ortho-Dihydroxybenzenes see Catechols Orthodontia see Orthodontics Orthodontic Appliances WU 426 Orthodontic Appliances, Activator see Activator ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 426 Osteosynthesis, Fracture Appliances Orthodontic Wires WU 426 Orthodontics WU 400-440 See also Dental Occlusion WU 440; Malocclusion WU 440 Orthodontics, Corrective WU 400-440 Orthodontics, Preventive WU 400 Orthomolecular Therapy WB 330 In psychiatry WM 402 Orthomyxoviridae QW 168.5.07 Orthomyxoviridae Infections WC 512 Orthomyxovirus Infections see Orthomyxoviridae Infections Orthomyxovirus Type A, Avian QW 168.5.07 Orthomyxovirus Type A, Porcine QW 168.5.07 Orthopantomography see Radiography, Panoramic Orthopedic Equipment WE 26 See also Prosthesis WE 172, etc.; Specific types of equipment, e.g., Bone Plates WE 185 Orthopedic Fixation Devices WE 185 Orthopedic Nursing WY 157.6 Orthopedic Surgery see Orthopedics Orthopedics WE 168-190 Animals SF 910.5 General works WE 168 In infancy & childhood WS 270 Nursing WY 157.6 Reconstructive orthopedics WE 190 See also names of particular bones, joints, or procedures Orthopsychiatry In adolescence WS 463 In infancy & childhood WS 350.6 Social Behavior Disorders WM 600 In infancy & childhood WS 350.8.S6 Orthoptera QX 570 Orthoptics WW 405 Orthoses see Orthotic Devices Orthotic Devices WE 26 Ortonal see Methaqualone Oryza see Rice Oscillators, Endogenous see Biological Clocks Oscillometry Biophysics QT 34 Circulation studies WG 106 Osgood-Schlatter Disease see Osteochondritis OSHA see Legislation WA 32-33 under Accidents, Occupational, Occupational Medicine, or Occupational Diseases Osler-Rendu Disease see Telangiectasia, Hereditary Hemorrhagic Osier-Vaquez Disease see Polycythemia Vera Osier's Disease see Polycythemia Vera; Telangiectasia, Hereditary Hemorrhagic Osmium Inorganic chemistry QD 181.07 Pharmacology QV 290 Osmolality see Osmolar Concentration Osmolar Concentration QD 541 Pharmaceutical chemistry QV 744 Osmolality see Osmolar Concentration Osmoregulation see Water-Electrolyte Balance Osmosis Biochemical phenomena QU 34 Cytology QH 615 Inorganic chemistry QD 543 Plant physiology QK 871 Osmotic Diuretics see Diuretics, Osmotic Osmotic Pressure QD 543 Osseointegration WE 200 Ossification, Heterotopic QZ 180 Ossification, Pathologic see Ossification, Heterotopic Ossification, Physiologic see Osteogenesis Osteitis WE 251 Osteitis Deformans WE 250 Osteitis Fibrosa Cystica WK 300 Osteitis Fibrosa Disseminata see Fibrous Dysplasia of Bone Osteoarthritis WE 348 Localized, by site Veterinary SF 901 Osteoarthritis, Hip WE 860 Osteoarthrosis see Osteoarthritis Osteoarthrosis Deformans see Osteoarthritis Osteoblastoma WE 258 Localized, by site Osteochondritis WE 259 Localized, by site Osteochondrodysplasias WE 250 Osteochondromas, Multiple see Exostoses, Multiple Hereditary Osteochondromatosis WE 250 Osteochondrosis see Osteochondritis Osteoclastic Bone Loss see Bone Resorption Osteocytes WE 200 Osteogenesis WE 200 Osteogenesis Imperfecta WE 250 Osteology see Bone and Bones Osteolysis WE 200 Osteoma QZ 340 Localized, by site Osteoma, Giant Osteoid see Osteoblastoma Osteoma, Osteoid WE 258 Localized, by site Osteomalacia WD 145 Osteomyelitis WE 251 Osteopathic Manipulation see Manipulation, Orthopedic Osteopathic Medicine WB 940 Osteopathy see Osteopathic Medicine Osteopenia see Bone Diseases, Metabolic Osteopetrosis WE 250 Osteophytosis, Spinal see Spinal Osteophytosis Osteoporosis WE 250 Osteoporosis, Age-Related see Osteoporosis Osteoporosis, Post-Traumatic see Sudeck 's Atrophy Osteoporosis, Postmenopausal WE 250 Osteoporosis, Senile see Osteoporosis Osteoradionecrosis WE 250 Osteosarcoma WE 258 Localized, by site Osteosclerosis WE 250 Osteosclerosis Fragilis see Osteopetrosis Osteosclerotic Anemia see Anemia, Myelophthisic Osteosynthesis, Fracture see Fracture Fixation, Internal ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7TED 427 Osteosynthesis, Fracture Osteosynthesis, Fracture, Intramedullary see Fracture Fixation, Intramedullary Osteotomy WE 168 Ostomy General works WI 900 See also specific kind of ostomy, e.g., Enterostomy, Gastrostomy, etc. Otalgia see Ear Diseases OTC Drugs see Drugs, Non-Prescription Otitic Barotrauma see Otitis Media Otitis WV 200 Otitis Externa WV 220 Otitis Interna see Labyrinthitis Otitis Media WV 232 Otitis Media, Purulent see Otitis Media, Suppurative Otitis Media, Secretory see Otitis Media with Effusion Otitis Media, Serous see Otitis Media Otitis Media, Suppurative WV 232 Otitis Media with Effusion WV 232 Otolaryngologists see Biography WZ 112.5.08, etc., and Directories WV 22 under Otolaryngology Otolaryngology WV Biography Collective WZ 112.5.08 Individual WZ 100 Directories WV 22 In infancy & childhood WV Otology see Otolaryngology Otorhinolaryngologic Diseases WV 140 Disability evaluation WV 32 In various age groups WV 140 Intracranial complications WV 180 Nursing WY 158.5 Surgery WV 168 Otorhinolaryngologic Neoplasms WV 190 Otorhinolaryngology see Otolaryngology Otosclerosis WV 265 Otospongiosis see Otosclerosis Outbreaks see Disease Outbreaks Outcome and Process Assessment (Health Care) W 84 Of particular treatments, by subject, e.g., Psychotherapy WM 420 Outdoor Games see Recreation; Sports Outer Membrane Proteins, Bacterial see Bacterial Outer Membrane Proteins Outlines (Form number 18.2 in any NLM schedule where applicable) Outpatient Care see Ambulatory Care Outpatient Clinics see Ambulatory Care Facilities Outpatient Clinics, Hospital WX 205 Specialty hospitals (Form numbers 27-28 in any NLM schedule where applicable) Outpatient Health Services see Ambulatory Care Outpatient Surgery see Ambulatory Surgery Outpatients WX 205 Patient with a particular disease, with the disease See also Ambulatory Care Ovarian Cycle see Menstrual Cycle ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Ovarian Cysts WP 322 Ovarian Diseases WP 320-322 Ovarian Function Tests WP 520 Ovarian Neoplasms WP 322 Ovary WP 320-322 Endocrine function WP 520-530 General works WP 520 See also Corpus Lateum WP 320, etc.; Graafian Follicle WP 320; names of hormones produced Ovarian function WP 540 Pregnancy in see Pregnancy, Ectopic WQ 220 Over-the-Counter Drugs see Drugs, Non-Prescription Overdenture see Denture, Overlay Overdose Adverse effects QZ 42 Drug action QV 38 Medication errors QZ 42 Particular drug, with the drug Overeating see Hyperphagia Overpopulation see Population Density Overutilization of Health Services see Health Services Misuse Oviducts Domestic animals SF 871 Human see Fallopian Tubes WP 300, etc. Wild animals QL 881 Oviducts, Mammalian see Fallopian Tubes Ovine Catarrhal Fever Virus see Bluetongue Virus Ovocytes see Oocytes Ovulation WP 540 Animal SF 871 See also Contraception WP 630, etc. Ovulation Induction WP 540 Ovum Animal QL 965 Development WQ 205 Ovum Implantation QS 645 Ovum Implantation, Delayed WQ 205 Ovum Proteins see Egg Proteins Ovum-Sperm Interactions see Sperm-Ovum Interactions Oxalates As disinfectants QV 220 Biochemistry QU 98 Toxicology QV 632 Oxandrolone WJ 875 Oxazoles QV 95 Oxidants, Photochemical WA 754 Oxidases see Oxidoreductases Oxidation see Metabolism Oxidation-Reduction Organic chemistry QD 281.09 Metabolism QU 125 Oxidative Phosphorylation QU 125 Oxides QV 312 Oxidizing Antiseptics see Anti-Infective Agents, Local; Hydrogen Peroxide; Potassium Permanganate Oxidoreductases QU 140 Oximes QV 124 Oximetry QY 480 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSOTED 428 Oximetry, Transcutaneous see Blood Gas Monitoring, Transcutaneous Oxine see Oxyquinoline Oxoglutarates see Ketoglutaric Acids Oxophenarsine QV 254 Oxopropanal see Pyruvaldehyde Oxoquinolines see Quinolones Oxycephaly see Craniosynostoses Oxychlorochin see Hydroxychloroquine Oxychloroquine see Hydroxychloroquine Oxygen QV 312 Deficiency see Anoxia WD 715, etc. Oxygen Consumption WF 110 Oxygen Deficiency see Anoxia Oxygen Inhalation Therapy WF 145 Oxygen Partial Pressure Determination, Transcutaneous see Blood Gas Monitoring, Transcutaneous Oxygenases QU 140 Oxygenation, Hyperbaric see Hyperbaric Oxygenation Oxygenators WO 162 Used for special purposes, by subject, e.g., during open heart surgery WG 168 Oxygenators, Membrane WO 162 Used for special purposes, by subject, e.g., during postoperative care WO 184, etc. Oxyneurine see Betaine Oxyntic Cells see Parietal Cells, Gastric Oxyphenbutazone QV 95 Oxyproline see Hydroxyproline Oxyquinol see Oxyquinoline Oxyquinoline As an anti-infective agent QV 250 Oxytetracycline QV 360 Oxytocics QV 173-174 Oxytocin QV 173 Oxyuriasis WC 860 Oxyuroidea QX 271 Oysters QX 675 Ozena see Rhinitis, Atrophic Ozone QV 312 P p-Aminohippuric Acid QU 62 P-B Antibodies see Antibodies, Heterophile P-Cell Stimulating Factor see Interleukin-3 p-Dihydroxybenzenes see Hydroquinones p-Dimethylaminoazobenzene QZ 202 P. P. Factor see Nicotinic Acids Pacemaker, Artificial WG 26 See also Cardiac Pacing, Artificial WG 168 Pacemakers, Biological see Biological Clocks Pachymeninges see Dura Mater Pacifiers see Infant Care Pacing, Cardiac, Artificial see Cardiac Pacing, Artificial Package Inserts see Product Labeling Package Inserts, Drug see Drug Labeling Packaging, Drug see Drug Packaging Packaging of Drugs see Drug Packaging; Drug Labeling ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Paludism Packed Red-Cell Volume see Hematocrit PACS (Radiology) see Radiology Information Systems Padutin see Kallikrein PAF-Acether see Platelet Activating Factor Paget s Disease of Bone see Osteitis Deformans PAH see p-Aminohippuric Acid PAI-3 see Protein C Inhibitor Pain WL 704 Symptomatology WB 176 Localized, by site See also Abdominal Pain WI 147 Pain Assessment see Pain Measurement Pain, Facial see Facial Pain Pain, Intractable WL 704 Pain Measurement WL 704 In specific diseases, with the disease Pain, Postoperative WO 184 Pain Receptors see Nociceptors Paint Chemical technology TP 934-944 Occupational health hazards, etc. WA 400-495 Lead poisoning QV 292 Paintings Related to medicine WZ 330 Related to psychiatry WM 49 Paired-Associate Learning LB 1064 Palatal Neoplasms WU 280 For the otolaryngologist WV 410 Palatal Obturators WV 440 Palate WV 410 Cleft see Cleft Palate WV 440 Dentistry WU 140 Gastroenterology WI 200 Neoplasms see Palatal Neoplasms WU 280, etc. Palatine Tonsil see Tonsil Palatopharyngeal Incompetence see Velopharyngeal Insufficiency Paleodontology GN 209 Paleography Z 105-115.5 Paleontology Animal and plant QE 701-996.5 Human GN 282-286.7 Paleopathology QZ 11.5 In veterinary medicine SF 758 Paleostriatum see Globus Pallidus Palladium Dental chemistry and metallurgy WU 180 Inorganic chemistry QD 181.P4 Pharmacology QV 290 Palliative Treatment WB 310 Palm of Hand see Hand Palmitic Acids QU 90 Organic chemistry QD 305.A2 Palmoplantar Keratoderma see Keratoderma, Palmoplantar Palmoplantaris Pustulosis see Psoriasis Palpation WB 275 Palsy see Cerebral Palsy; Facial Paralysis; Paralysis Palsy, Progressive Supranuclear see Supranuclear Palsy, Progressive Paludism see Malaria NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSIFIED 429 Pamphlets Pamphlets Collections W6 P3 Works about Z 691 Others, by subject Pan see Chimpansee troglodytes Panax see Ginseng Pancoast's Syndrome WF 658 Pancreas WI 800-830 Surgery (General) WI 830 See also Cystic Fibrosis WI 820; Islets of Langerhans WK 800-885 Pancreas, Artificial Endocrine see Insulin Infusion Systems Pancreas, Endocrine see Islets of Langerhans Pancreas Transplantation WI 830 Pancreatectomy WI 830 Pancreatic Alpha Cells see Islets of Langerhans Pancreatic Beta Cells see Islets of Langerhans Pancreatic Cyst WI 810 Pancreatic Cystic Fibrosis see Cystic Fibrosis Pancreatic Delta Cells see Islets of Langerhans Pancreatic Diseases WI 800-830 General works WI 800 Pancreatic Ducts WI 802 Pancreatic Extracts Pharmacology QV 370 Therapeutic use (General) WB 391 Used for treatment of particular disorders, with the disorder or system Pancreatic Fistula WI 800 Pancreatic Function Tests WI 802 Pancreatic Hormones WK 801 See also Glucagon WK 801; Insulin WK 820 Pancreatic Islets Transplantation see Islets of Langerhans Transplantation Pancreatic Juice WI 802 Pancreatic Neoplasms WI 810 Pancreatitis WI 805 Pancreozymin see Cholecystokinin Pancreozymin Receptors see Receptors, Cholecystokinin Panic WM 172 Panic Attacks see Panic Disorder Panic Disorder WM 172 Panniculitis, Nodular Nonsuppurative WR 140 Panophthalmitis WW 140 Panoramic Radiography see Radiography, Panoramic Panotitis see Otitis Pantomography see Radiography, Panoramic Pantothenic Acid QU 195 Papain QU 136 Papanicolaou Smear see Vaginal Smears Papaver QV 90 As a medicinal plant QV 766 See also Opium QV 90, etc. Papaveretum see Opium Paper Industrial waste WA 778 Printing Z 237, Z 247 Papillary Muscles WG 201-202 Papilledema WW 280 Papilloma QZ 365 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Localized, by site Papilloma, Shope see Tumor Virus Infections Papillomavirus QW 165.5.P2 Papillomavirus, Human QW 165.5.P2 Papio QL 737.P93 As laboratory animals QY 60.P7 Diseases SF 997.5.P7 Papovaviridae QW 165.5.P2 PAPP-D see Placental Lactogen Pappataci Fever see Phlebotomus Fever Papulosquamous Dermatoses see Skin Diseases para-Aminohippuric Acid see p-Aminohippuric Acid para-Dihydroxybenzenes see Hydroquinones Parabiosis Immunology QW 504 Twins, Conjoined QS 675 Other special topics, by subject Paracentesis see Punctures Parachuting WD 700 Accidents WD 740 Paracoccidioidomycosis WC 460 Paracusis see Auditory Perception Paradentium see Periodontium Paradoxical Sleep see Sleep, REM Paraffin QV 800 Plastic surgery WO 640 Paraganglia, Chromaffin In sympathetic ganglia WL 610 In other organs, with the organ Paraganglia, Nonchromaffin WL 600 Paraganglioma QZ 380 Localized, by site Paraganglioma, Extra-Adrenal QZ 380 Localized, by site Paraganglioma, Nonchromaffin see Paraganglioma, Extra-Adrenal Paragonimiasis WC 805 Paragonimus QX 353 Paraimmunoglobulinemias see Paraproteinemias Parainfluenza WC 518 Parainfluenza Virus Type 1 QW 168.5.P2 Parainfluenza Virus Type 4 see Parainfluenza Viruses Parainfluenza Viruses QW 168.5.P2 Parakeratosis Variegata see Parapsoriasis Paralysants see Chemical Warfare Agents Paralysins see Agglutinins Paralysis WL 346 Agitans see Parkinsonism WL 359 Cervical sympathetic WL 610 Divers' WD 712 Facial see Facial paralysis WL 330 General see Paresis WC 165, etc. Infantile see Poliomyelitis WC 555, etc. Ocular muscles see Oculomotor paralysis WW 410 Respiratory see Respiratory Paralysis WF 140 Vocal cord see Vocal Cord Paralysis WV 535 See also Hemiplegia WL 346; Paraplegia WL 346; Quadriplegia WL 346 Paralysis Agitans see Parkinson Disease Paralysis, Bulbar WL 310 Paralysis, Familial Periodic WD 205.5.P2 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 430 Partial Denture Paralysis, General see Paresis Paralysis, Obstetric WS 405 Paralysis, Pseudobulbar see Paralysis Paralysis, Spastic see Muscle Spasticity Paramagnetic Resonance see Electron Spin Resonance Spectroscopy Paramecium QX 151 Paramedical Personnel see Allied Health Personnel Paramedics see Allied Health Personnel Paramedics, Emergency see Emergency Medical Technicians Parametritis WP 275 Paramyoclonus Multiplex WE 550 Paramyxoviridae QW 168.5.P2 Paramyxovirus Infections WC 518-520 Veterinary SF 809.P37 See also Measles WC 580 Paranasal Sinuses WV 340-358 See also Ethmoid Sinus WV 355; Frontal Sinus WV 350; Maxillary Sinus WV 345; Sphenoid Sinus WV 358 Paranoia see Paranoid Disorders Paranoid Behavior WM 205 Paranoid Disorder, Shared see Shared Paranoid Disorder Paranoid Disorders WM 205 Paranoid Psychoses see Paranoid Disorders Paranoid Schizophrenia see Schizophrenia, Paranoid Paraphilias WM 610 Paraphimosis WJ 790 Paraphrenia, Involutional see Depression, Involutional Paraplegia WL 346 Paraplegia, Spastic see Paraplegia Paraproteinemias WH 400 See also Amyloidosis WD 205.5.A6; Multiple Myeloma WH 540 Paraproteins QW 601 See also Bence Jones Protein WH 540; Myeloma Proteins WH 540 Parapsoriasis WR 204 Parapsoriasis en Plaques see Parapsoriasis Parapsychology BF 1009-1389 Occult sciences BF 1405-1999 Paraquat Public health aspects WA 240 Parasite-Host Relations see Host-Parasite Relations Parasites QX Animal parasites As a cause of disease QZ 85 Zoology QL 757 Communicable disease control WA 240 Parasitic Diseases WC 695-900 Veterinary SF 810.A3 Parasitic Eye Infections see Eye Infections, Parasitic Parasitic Skin Diseases see Skin Diseases, Parasitic Parasitology QX Nursing texts QX 4 Veterinary Medicine SF 810.A3 Parasympathetic-Blocking Agents see Parasympatholytics Parasympathetic Ganglia see Ganglia, Parasympathetic Parasympathetic Nervous System WL 610 Children WS 340 Parasympatholytics QV 132 Parasympathomimetics QV 122 Parathion Agriculture SB 952.P3 Public health WA 240 Parathyroid Diseases WK 300 Parathyroid Glands WK 300 Parathyroid Hormones WK 300 Parathyroid Neoplasms WK 300 Paratopes see Binding Sites, Antibody Paratuberculosis SF 809.J6 Paratyphoid Fever WC 266 Veterinary SF 809.S24 Paratyphoid Vaccine see Typhoid-Paratyphoid Vaccines Paravertebral Anesthesia see Anesthesia, Conduction; Nerve Block Parent-Child Relations WS 105.5.F2 Parent, Single see Single Parent Parental Leave General works HD 6065-6065.5 Parenteral Feeding see Parenteral Nutrition Parenteral Hyperalimentation see Parenteral Nutrition, Total Parenteral Infusions see Infusions, Parenteral Parenteral Nutrition WB 410 Parenteral Nutrition, Total WB 410 Parenterally-Transmitted Non-A, Non-B Hepatitis see Hepatitis C Parents HQ 755.7-759.92 And illegitimacy HQ 998-999 Special topics, by subject Paresis WC 165 Veterinary (Milk fever) see Parturient Paresis SF 967.M5 Paresthesia WR 280 Parietal Cells, Gastric Cytology WI 301 Physiology WI 302 Parietal Lobe WL 307 Parkinson Disease WL 359 Drugs for see Antiparkinson agents QV 80 Parodontitis see Periodontitis Parodontosis see Periodontal Diseases Paronychia WR 475 Parotid Gland WI 230 Parotid Neoplasms WI 230 Parotitis WI 230 See also Mumps WC 520 Parovarian Cyst WP 275 Paroxysmal Dyspnea see Dyspnea, Paroxysmal Paroxysmal Tachycardia see Tachycardia, Paroxysmal Parrot Fever see Ornithosis Parrots QL 696.P7 Diseases SF 994.2.P37 As laboratory animals QY 60.B4 Parsonage-Turner Syndrome see Cervico-Brachial Neuralgia Parthenogenesis QH 487 Partial Denture see Denture, Partial ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 431 Partial Monosomy Partial Monosomy see Chromosome Deletion Particle Accelerators QC 787.P3 In neoplasm radiotherapy QZ 269 Nuclear engineering TK 9340 Particle-Induced X-Ray Emission Spectrometry see Spectrometry, X-Ray Emission Particle Size Air pollutants WA 754, etc. Determination TA 418.8, etc. Dosage form QV 785 Particle technology (Chemical engineering) TP 156.P3 Partner Notification see Contact Tracing Partnership Practice W 92 Partnership Practice, Dental WU 79 Parturient Paresis SF 967.M5 Parturition see Labor Parvoviridae QW 165.5.P3 Parvoviridae Infections WC 500 Parvovirus QW 165.5.P3 Parvovirus Infections see Parvoviridae Infections Passive Addiction, Neonatal see Neonatal Abstinence Syndrome Passive-Aggressive Personality Disorder WM 190 Passive Antibody Transfer see Immunization, Passive Passive-Dependent Personality see Dependent Personality Disorder Passive Immunity see Immunity, Passive Passive Transfer of Immunity see Immunization, Passive Pastes see Ointments Pasteurella QW 140 PaSteurella Infections WC 200 Veterinary SF 809.P37 Pasteurellosis see Pasteurella Infections Pastoral Care WM 61 See also Religion and Medicine W 50, etc.; Religion and Psychology WM 61, etc.; Chaplaincy Service, Hospital WX 187 Pastoral Psychiatry see Pastoral Care Pastoral Psychology see Pastoral Care Patas Monkey see Erythrocebus patas Patch Tests QY 260 Patella WE 870 Patent Medicines see Drugs, Non-prescription Patents T 201-342 Chemicals TP 210 Drugs QV 736 Medical instruments (Form number 26 in any NLM schedule where applicable) Paternal Behavior WS 105.5.F2 Paternal Deprivation WS 105.5.D3 Paternity Medicolegal aspects W 791 See also headings beginning with Father and Paternal Paternity Leave see Parental Leave Pathogenesis of Disease see Disease Pathogenic Fungi see Fungi Pathogens, Blood-Borne see Blood-Borne Pathogens Pathological Waste see Medical Waste Pathologists see Biography WZ 112.5.P2, etc., and Directories QZ 22 under Pathology Pathology QZ Biography Collective WZ 112.5.P2 Individual WZ 100 Cardiovascular system WG 142 Clinical QY Comparative QZ 33 Dental see Pathology, Oral WU 140 and subheading Pathology WU 140 under Tooth Dermatology WR 105 Directories QZ 22 In infancy & childhood WS 200 Nursing texts QZ 4, etc. Clinical pathology QY 4, etc. Physiological QZ 140 See also the general works numbers for parts of the body, diseases, or systems Pathology, Clinical QY Pathology, Oral WU 140 See also Pathology under Mouth WU 140 and Tooth WU 140 Pathology, Surgical WO 142 Pathology, Veterinary SF 769 Pathomimesis see Malingering Patient Acceptance of Health Care W 85 In the hospital WX 158.5 Special areas of health care, by area Patient Admission WX 158 Patient Advocacy W 85 Special topics, by subject Patient Appointments see Appointments and Schedules Patient Care Planning W 84.7 In nursing WY 100 Of hospital patients WX 162-162.5 Patient Care Team W 84.8 Hospital team WX 162.5 See also Nursing, Team WY 125 Patient Compliance W 85 In hospitals WX 158.5 In mental hospitals WM 29.5 Special areas of compliance, by subject Patient Cooperation see Patient Compliance Patient Credit and Collection Dental administration WU 77 Hospital administration WX 157 Medical administration W 80 Nursing administration WY 77 Pharmacy administration QV 736 In other specific fields, by subject Patient Data Privacy see Confidentiality Patient Discharge WX 158 Patient Education General W 85 See also Health Education WA 590, etc. In hospitals WX 158.5 In mental institutions WM 29.5 For specific conditions, with the condition Patient-Family Lodging see Housing Patient Isolation WX 167 Patient Isolators WX 147 Patient Monitoring see Monitoring, Physiologic ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7TED 432 Patient Ombudsmen see Patient Advocacy Patient Participation WX 158.5 Patient Readmission WX 158 Patient Representatives see Patient Advocacy Patient Schedules see Appointments and Schedules Patients W 85 In hospitals WX 158.5 In mental institutions WM 29.5 With specific disabilities, with the disability Patients' Libraries see Libraries, Hospital Patients' Rights see Patient Advocacy Pattern Recognition Computer engineering TK 7882.P3 (Form number 26.5 in any NLM schedule where applicable) Pattern Recognition, Visual WW 105 Paul-Bunnell Antibodies see Antibodies, Heterophile Pavor Nocturnus see Sleep Disorders PCBs see Polychlorinated Biphenyls PCP see Phencyclidine PCP Abuse see Phencyclidine Abuse PCR see Polymerase Chain Reaction Peak Expiratory Flow Rate WF 102 As a diagnostic test WF 141 General physical examination WB 284 Peanuts Diets for control of fats WB 425 Diets for control of protein WB 426 Peas As dietary supplement in health and disease WB 430 Cultivation SB 343 Peat S 592.85 Soils S 592.85 See also Mud Therapy WB 525; Soil Microbiology QW 60 Peat Therapy see Mud Therapy Pecten Oculi see Retinal Vessels Pectins QV 71 Pectoral Nerves see Thoracic Nerves Pectoralis Muscles WE 715 Pectus Excavatum see Funnel Chest Pederasty see Paraphilias Pediatric Dentistry WU 480 See also special topics, e.g., Children WU 113.6 under Oral hygiene Pediatric Nursing WY 159 Education WY 18-18.5 Pediatric Ophthalmology see In infancy & childhood WW 600 under Ophthalmology Pediatric Psychology see Child Psychology Pediatricians, Directories see Directories WS 22 under Pediatrics Pediatrics WS Anesthesia WO 440 Dentistry see Pediatric Dentistry WU 480 Directories WS 22 Nursing see Pediatric Nursing WY 159 Ophthalmology WW 600 Otolaryngology WV Radiology WN 240 Surgery WO 925 Pediculosis WR 375 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHiH Pediculus QX 502 Pedodontics see Pediatric Dentistry Pedophilia WM 610 PEEP see Positive-Pressure Respiration Peer Group In adolescence WS 462 In infancy & childhood WS 105.5.15 See also names of particular groups, e.g. Physicians W 21; persons with diabetes under Diabetes mellitus WK 810 Peer Review (Form number 21 in any NLM schedule where applicable, except Nursing WY 16) Peer Review Organizations see Professional Review Organizations Pelizaeus-Merzbacher Disease see Cerebral Sclerosis, Diffuse Pellagra WD 126 Pelvic Bones WE 750 Pelvic Exenteration WE 750 Pelvic Infection see Adnexitis Pelvic Inflammations see Adnexitis Pelvic Inflammatory Disease see Adnexitis Pelvic Neoplasms WE 750 Pelvimetry WQ 320 Pelvis Obstetrics WQ 320 Pemphigus WR 200 Neonatorum see Impetigo WR 225 Pemphigus Vulgaris see Pemphigus Penicillamine QV 354 Penicillanic Acid QV 354 Penicillin, Aminobenzyl see Ampicillin Penicillin G QV 354 Penicillin G, Benzathine QV 354 Penicillin Resistance Bacteriology QW 51 Drug therapy WB 330 Pharmacology QV 354 Penicillinase QU 136 Penicillins QV 354 Penicillium QW 180.5.D38 Penile Erection WJ 790 Penile Neoplasms WJ 790 Penis WJ 790 Pensions HD 7105-7105.45 For particular groups of people, by group, e.g., for occupational health nurses WY 141; for nurses in general WY 77 Pentachlorophenol As an anti-infective agent QV 223 Pentamethylenetetrazole see Pentylenetetrazole Pentanoates see Valerates Pentazocine QV 89 Pentetrazole see Pentylenetetrazole Penthiobarbital see Thiopental Pentobarbital QV 88 Pentose Phosphate Shunt see Pentosephosphate Pathway Pentose Shunt see Pentosephosphate Pathway Pentosephosphate Pathway QU 75 Pentoses QU 75 Pentothal see Thiopental IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 433 Pentoxifylline Pentoxifylline QV 107 Pentylenetetrazole QV 103 In shock therapy WM 410 Pepsin see Pepsin A Pepsin A Enzymology QU 136 Gastric physiology WI 302 Pepsinogen Enzymology QU 142 Gastric physiology WI 302 Peptic Ulcer WI 350-370 Peptic Ulcer Hemorrhage WI 350 Peptic Ulcer Perforation WI 350 Peptidase Inhibitors see Protease Inhibitors Peptide Hormones see Hormones Peptide Hydrolase Inhibitors see Protease Inhibitors Peptide Hydrolases QU 136 Peptide Peptidohydrolase Inhibitors see Protease Inhibitors Peptides QU 68 Peptide hormones WK 185 See also Oxytocin QV 173 Peptococcus QW 142.5.C6 Perception Auditory see Auditory Perception WV 272 Color see Color Perception WW 150 Depth see Depth Perception WW 105 Distance see Distance Perception WW 105 Form see Form Perception WW 105 In infancy & childhood WS 105.5.D2 Motion see Kinesthesis WE 104; Motion Perception WW 105 Neurophysiology WL 705 Psychology BF 311, etc. Self see Self Concept BF 697, etc. Size see Size Perception WW 105 Social see Social Perception HM 132 Space see Space Perception WW 105, etc. Speech see Speech Perception WV 272 Time see Time Perception BF 468, etc. Visual see Visual Perception WW 105 Weight see Weight Perception WE 104 Perception, Social see Social Perception Perceptual Defense WM 193.5.P3 In adolescence WS 463 In infancy & childhood WS 350.8.D3 Perceptual Disorders General and psychotic WM 204 Neurologic manifestation WL 340 Specific sensory disorder, with the organ involved Perceptual Distortion WL 705 Perceptual Motor Performance see Psychomotor Performance Perchloroethylene see Tetrachloroethylene Percussion WB 278 Percutaneous Administration see Administration, Cutaneous Percutaneous Electric Nerve Stimulation see Transcutaneous Electric Nerve Stimulation Percutaneous Nephrolithotomy see Nephrostomy, Percutaneous Percutaneous Nephrostomy see Nephrostomy, ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIM Percutaneous Percutaneous Transluminal Angioplasty see Angioplasty, Balloon Percutaneous Transluminal Coronary Angioplasty see Angioplasty, Transluminal, Percutaneous Coronary Percutaneous Ultrasonic Lithotripsy see Lithotripsy Performance Appraisal, Employee see Employee Performance Appraisal Perfume WA 744 Chemical technology TP 983.A1-983.Z5 Perfusion Organ preservation WO 665 Specific organs, with the organ Perfusion, Pulsatile see Pulsatile Flow Perfusion Pumps see Infusion Pumps Perfusion Pumps, Implantable see Infusion Pumps, Implantable Perfusion, Regional QZ 267 Localized, by site Perhexiline QV 150 Periadenitis Mucosa Necrotica Recurrens see Stomatitis, Aphthous Perianeurysmal Fibrosis, Inflammatory see Retroperitoneal Fibrosis Periaortitis, Chronic see Retroperitoneal Fibrosis Periapical Abscess WU 230 Periapical Cyst see Radicular Cyst Periapical Diseases WU 230 Periapical Granuloma WU 240 Periapical Periodontitis, Chronic Nonsuppurative see Periapical Granuloma Periapical Periodontitis, Suppurative see Periapical Abscess Periaqueductal Gray WL 310 Periarteritis Nodosa see Polyarteritis Nodosa Periarthritis WE 344 Pericardial Cyst see Mediastinal Cyst Pericardial Effusion WG 275 Clinical examination QY 210 Pericardial Fluid see Secretion under Pericardium Pericarditis WG 275 Pericarditis, Constrictive WG 275 Pericardium WG 275 Secretion Clinical examination QY 210 General WG 275 In general diagnosis WB 373 Pericementitis see Periodontitis Peridinium see Dinoflagellida Perilymph WV 250 Perilymphatic Duct see Cochlear Aqueduct Perimenopausal Bone Loss see Osteoporosis, Postmenopausal Perimetry WW 145 Perinatal Medicine see Perinatology Perinatal Mortality see Infant Mortality Perinatal Nursing see Neonatal Nursing Perinatology WQ 210-211 See also Neonatology WS 420 Perineum WE 750 Injuries General WE 750 USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSOTED 434 In the female WP 170 Periodic Acid QV 180 Inorganic chemistry QD 181.11 Periodic Disease WB 720 Periodic Health Examination see Physical Examination Periodicals WI Bibliography of medical and medically related ZW 1 Government administrative reports and statistics W2 Hospital administrative reports and statitics WX 2 See also Newspapers WI, etc. Periodicity Animal behavior QL 753-755.5 Animal physiology QP 84.6 General biology QH 527 Human physiology QT 167 Menstrual cycle WP 540 Plants QK 761 Periodontal Bone Loss see Alveolar Bone Loss Periodontal Cyst WU 240 Periodontal Cyst, Apical see Radicular Cyst Periodontal Diseases WU 240-242 Periodontoclasia WU 242 Periodontosis WU 242 Pyorrhea alveolaris WU 242 Periodontal Index WU 240 Periodontal Pocket WU 242 Periodontal Prosthesis WU 240 Periodontal Resorption see Alveolar Bone Loss Periodontal Splints WU 240 Periodontics WU 240-242 Periodontitis WU 242 Periodontitis, Apical, Chronic Nonsuppurative see Periapical Granuloma Periodontitis, Apical, Suppurative see Periapical Abscess Periodontium WU 240-242 Perioperative Nursing see Operating Room Nursing Peripheral Angiopathies see Peripheral Vascular Diseases Peripheral Catheterization see Catheterization, Peripheral Peripheral Nerve Diseases see Peripheral Nervous System Diseases Peripheral Nerve Neoplasms WL 500 Localized, by site Peripheral Nerves WL 500-544 See also Cranial Nerves WL 330; Spinal Nerves WL 400 Peripheral Nervous System WL 500-544 Peripheral Nervous System Diseases WL 500-544 In infancy & childhood WS 340 Localized, by site Veterinary SF 895 Peripheral Resistance see Vascular Resistance Peripheral Vascular Diseases WG 500-700 General works WG 500 In infancy & childhood WS 290 Veterinary SF 811 Periphlebitis see Phlebitis ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Personal Hygiene Perissodactyla QL 737.U6 Peristalsis WI 102 Intestinal WI 402 Peristaltic Pumps, Implantable see Infusion Pumps, Implantable Peritoneal Cavity WI 575 Peritoneal Dialysis WJ 378 As treatment for diseases other than those of the kidney, by site or disease Peritoneal Dialysis, Continuous Ambulatory WJ 378 Peritoneal Diseases WI 575 Peritoneal Effusion see Ascitic Fluid Peritoneal Fluid see Ascitic Fluid Peritoneal Infusions see Infusions, Parenteral Peritoneal Neoplasms WI 575 Peritoneoscopy see Laparoscopy Peritoneovenous Shunt In the treatment of intractable ascites WI 575 Peritoneum WI 575 Peritonitis WI 575 Peritonitis, Tuberculous see Tuberculosis, Peritoneal Perkinism see Alternative Medicine Permeability Capillary see Capillary Permeability WG 700 Cells see Cell Membrane Permeability QH 601, etc. Magnetic induction QC 754.2.P4 Other special topics, by subject Permeability, Capillary see Capillary Permeability Permeability, Cell Membrane see Cell Membrane Permeability Permeability, Microvascular see Capillary Permeability Pernicious Anemia see Anemia, Pernicious Pernio see Frostbite Perodicticus potto see Lorisidae Peroperative Care see Intraoperative Care Peroperative Complications see Intraoperative Complications Peroperative Period see Intraoperative Period Peroxidase-Antiperoxidase Complex Technique see Immunoenzyme Techniques Peroxidase-Labeled Antibody Technique see Immunoenzyme Techniques Peroxidases QU 140 Peroxide, Hydrogen see Hydrogen Peroxide Peroxides Inorganic chemistry QD 181.01 Organic chemistry QD 305.E7 Pharmacology QV 60 Peroxisomes see Microbodies Persistent Common Atrioventricular Canal see Endocardial Cushion Defects Persistent Fetal Circulation Syndrome WS 421 Persistent Ostium Primum see Endocardial Cushion Defects Persistent Pulmonary Hypertension of Newborn see Persistent Fetal Circulation Syndrome Persistent Vegetative State WB 182 Personal Expenditures see Financing, Personal Personal Health Services W 84 Personal Hygiene see Hygiene NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSinED 435 Personal Liability Personal Liability see Liability, Legal Personal narratives Physicians and specialists of medically related fields Collective WZ 112-150 Individual WZ 100 Special topics, by subject Personal Satisfaction Job satisfaction HF 5549.5.J63 Success (General) BJ 1611-1618 Special topics, by subject Personal Space Anthropogeography GF 51 Psychology BF 469 Personality BF 698-698.9 Dependency BF 575.D34 In psychoanalysis WM 460.5.P3 See also Antisocial Personality Disorder WM 190; Dual Personality WM 173.6; Hysterical Personality WM 173; Schizoid Personality WM 203 Personality Assessment Psychiatric interview WM 141 Psychiatric testing WM 145 Psychological BF 698.4-698.8 Personality Development BF 698 In adolescence WS 462 In infancy & childhood WS 105.5.P3 Personality Disorder, Antisocial see Antisocial Personality Disorder Personality Disorder, Borderline see Borderline Personality Disorder Personality Disorder, Compulsive see Compulsive Personality Disorder Personality Disorder, Dependent see Dependent Personality Disorder Personality Disorder, Histrionic see Histrionic Personality Disorder Personality Disorder, Passive-Aggressive see Passive-Aggressive Personality Disorder Personality Disorder, Schizoid see Schizoid Personality Disorder Personality Disorder, Schizotypal see Schizotypal Personality Disorder Personality Disorders General WM 190 In adolescence WS 463 In infancy & childhood WS 350.8.P3 Personality, Hysterical see Histrionic Personality Disorder Personality Inventory Psychology BF 698.5-698.8 Psychiatry WM 145 Personality Tests Psychology BF 698.5-698.8 Psychiatry WM 145 Personality Type A see Type A Personality Personnel Administration, Hospital WX 159-159.8 In psychiatric hospitals WM 30 In special hospitals, with the hospital Personnel Discipline see Employee Discipline Personnel, Hospital WX 159-159.8 See also names of specific types of personnel, ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 e.g., Operating Room Technicians WY 162 Personnel, Hospital, Organization and Administration see Personnel Administration, Hospital Personnel Management HF 5549.A2-5549.5 Hospitals WX 159 Nursing WY 30 Special fields, by subject, e.g., Nursing, Supervisory WY 105 Personnel Recruitment see Personnel Selection Personnel Selection HF 5549.5.S38 Special fields, by subject Personnel Staffing and Scheduling Hospitals WX 159 Nursing WY 30 Psychiatry WM 30 Personnel Turnover Hospitals WX 159 Nursing WY 30 Psychiatry WM 30 Specific profession, by subject Personnel Work see Personnel Management Perspiration see Sweat Perspiratory Glands see Sweat Glands Persuasion see Persuasive Communication Persuasive Communication BF 637.P4 Perthes Disease see Legg-Perthes Disease Pertussigen see Pertussis Toxins Pertussis see Whooping Cough Pertussis Toxins WC 340 Pertussis Vaccine WC 340 Pervasive Child Development Disorders see Child Development Disorders, Pervasive Perversion, Sex see Paraphilias Pes Cavus see Foot Deformities Pes Planus see Flatfoot Pessaries, Intracervical see Intrauterine Devices Pessaries, Intrauterine see Intrauterine Devices Pest Control WA 240 Agriculture SB 950-990.5 See also Insect Control QX 600 Pest Control, Biological Agriculture SB 975-978 General public health WA 240 See also Insect Control QX 600; names of other specific types of pest control Pesticide Residues WA 240 Pesticides Agriculture SB 951-970.4 Industrial poisoning WA 465 Public health WA 240 Toxicology WA 240 Pet-Human Bonding see Bonding, Human-Pet PET Scan see Tomography, Emission-Computed Petechiae see Purpura Pethidine see Meperidine Petit Mai Epilepsy see Epilepsy, Absence Petrolatum, Liquid see Mineral Oil Petroleum Chemical technology TP 690-699 Toxicology QV 633 Petrous Bone WV 230 Petrous Pyramid see Petrous Bone E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 436 Phenothiazines Pets see Animals, Domestic Peyote see Mescaline Pfaundler-Hurler Syndrome see Mucopolysaccharidosis I PGE1 see Alprostadil PGF2 see Dinoprost PGF2alpha see Dinoprost pH see Hydrogen-Ion Concentration Phage lambda see Bacteriophage lambda Phage Receptors see Receptors, Virus Phage Typing see Bacteriophage Typing Phages see Bacteriophages Phages T see T-Phages Phagocyte Bactericidal Dysfunction QW 690 Phagocytes QW 690 See also Histiocytes WH 650, etc.; Macrophages WH 650, etc.; Monocytes WH 200, etc.; Neutrophils WH 200, etc. Phagocytosis QW 690 Phantom Limb WE 170 Pharmaceutic Aids QV 800 Pharmaceutical Chemistry see Chemistry, Pharmaceutical Pharmaceutical Ethics see Ethics, Pharmacy Pharmaceutical Services QV 737 Hospital see Pharmacy Service, Hospital WX 179 Insurance see Insurance, Pharmaceutical Services W 265, etc. Military General UH 420-425 Navy VG 270-275 Pharmaceutics see Drugs Pharmacies QV 737 Directories QV 722 Public health aspects WA 730 See also Pharmacy Service, Hospital WX 179 Pharmacists Biography Collective WZ 112.5.P4 Individual WZ 100 Career books QV 21 Directories QV 22 Interprofessional and public relations QV 21 Registration QV 29 Pharmacists1 Aides QV 21.5 Pharmacogenetics QV 38 Pharmacognosy QV 752 Pharmacokinetics QV 38 Pharmacology QV Dental QV 50 Drug action QV 38 Experimental QV 34 In veterinary medicine SF 915 Nursing texts QV 4, etc. See also Psychopharmacology QV 77, etc. Pharmacology, Arabic see Medicine, Arabic; Pharmacology Pharmacology, Clinical QV 38 See also Drug Therapy WB 330, etc. Pharmacopoeias QV 738 Pharmacopoeias, Homeopathic WB 930 Pharmacotherapy see Drug Therapy ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Pharmacy QV 701-835 Instrumentation QV 26 Military UH 420-425 Naval VG 270-275 Nursing texts QV 704, etc. Public health aspects WA 730 Veterinary SF 915 Pharmacy Administration QV 737 Veterinary medicine SF 915 See also Pharmacy Service, Hospital WX 179 Pharmacy Education see Education, Pharmacy Pharmacy Education, Continuing see Education, Pharmacy, Continuing Pharmacy Education, Graduate see Education, Pharmacy, Graduate Pharmacy Schools see Schools, Pharmacy Pharmacy Service, Clinical see Pharmacy Service, Hospital Pharmacy Service, Hospital WX 179 Pharyngeal Arches see Branchial Region Pharyngeal Diseases WV 400-440 General works WV 400 In infancy & childhood WV 400-440 Nursing WY 158.5 Pharyngeal Region see Names of organs located in the region: Adenoids; Nasopharynx; Palate; Pharynx; Tonsil; Uvula Pharyngitis WV 410 Pharynx WV 410 In respiration WF 490 Phase-Contrast Microscopy see Microscopy, Phase-Contrast Phaseolus see Legumes Phaseolus vulgaris Lectins see Phytohemagglutinins Phenacaine see Anesthetics, Local Phenacetin QV 95 Phenadone see Methadone Phenanthrenes QV 138.C1 Organic chemistry QD 395 Phenanthridines As antineoplastic agents QV 269 Organic chemistry QD 401 Phenantoin see Phenytoin Phencyclidine QV 77.7 Phencyclidine Abuse WM 270 Phenemal see Phenobarbital Phenethylamines QU 61 Organic chemistry QD 341.A8 Phenformin WK 825 Pheniramine QV 157 Phenobarbital QV 88 Phenobarbitone see Phenobarbital Phenolphthaleins QV 75 Phenols As anti-infective agents QV 223 Organic chemistry QD 341.P5 Phenomenon see Anaphylaxis; Arthus Reaction; Shwartzman Phenomenon Phenothiazine Antipsychotic Agents see Antipsychotic Agents, Phenothiazine Phenothiazine Tranquilizers see Antipsychotic Agents, Phenothiazine Phenothiazines QV 253 NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 437 Phenothiazines In veterinary pharmacology SF 918.P5 Organic chemistry QD 401 Phenotype Human genetics QH 431 Human variation GN 62.8-263 Hereditary aspects GN 247 See also Somatotypes GN 66.5 Phenoxybenzamine QV 132 Phentanyl see Fentanyl Phenyl Ethers Organic chemistry QD 341.E7 Used for special purposes, by subject Phenylacetates QU 98 Organic chemistry QD 341.A2 Phenylalanine QU 60 Phenylamines see Aniline Compounds Phenylbarbital see Phenobarbital Phenylbutazone QV 95 Phenylenediamines QU 61 Carcinogenicity research QZ 202 Phenylethylamines see Phenethylamines Phenylglycolic Acid see Mandelic Acids Phenylhydrazines QV 180 Organic chemistry QD 341.A8 Phenylketonuria WD 205.5.A5 Phenylmethylamine see Benzylamines Phenylthiocarbamide see Phenylthiourea Phenylthiourea In goiter experiments WK 259 In taste experiments WI 210 Organic chemistry QD 305.T45 Phenytoin QV 85 Pheochromocytoma QZ 380 Localized, by site Pheresis see Blood Component Removal Pheromones Communication QL 776 Secretion QP 190 Phialophora QW 180.5.D38 Philanthropic Funds see Fund Raising Philately HE 6187-6228 Medical WZ 340 Philocytase see Bacteriolysis; Hemolysins Philology P Chinese PL 1001-2245 General works P English PE Modern grammar PE 1097-1400 French PC 2011-3761 Latin PA 2011-2915 Modern (General) PB 6-431 Other languages in appropriate P schedule Special topics, by subject See also "phrase books" under specialty headings, e.g., Medicine, and names of language groups below Philology, Classical PA 1-2915 Grammars for physicians and pharmacists PA 2092 See also subheading, e.g., Latin PA 2011-2915 under Philology Philology, Oriental PJ-PL General works PJ 10-187 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 See also names of specific oriental languages under Philology, e.g., Chinese PL 1001-2245 Philology, Romance PC General works PC 6-400 See also language subheadings, e.g., French PC 2011-3761 under Philology Philosophy B-BD General works B 69-5739 Life (Biology) QH 501 Of science Q 174-175.3 Scientology BP 605.S2 See also names of specific philsophies, e.g., Existentialism B 105.E8 etc.; Humanism B 821 Philosophy, Medical W 61 Philosophy, Nursing WY 86 Phimosis WJ 790 Phlebitis WG 610 Pyelophlebitis WJ 351 Other localities, by site Phlebography WG 600 Localized, by site or disease Phlebonarcosis see Anesthesia, Intravenous Phlebothrombosis see Thrombophlebitis Phlebotomus Fever WC 526 Phlebotomy see Bloodletting Phlegmasia Alba Dolens see Thrombophlebitis Phlegmon see Cellulitis Phobia, School see Phobic Disorders Phobia, Social see Phobic Disorders Phobias see Phobic Disorders Phobic Disorders WM 178 Phobic Neuroses see Phobic Disorders Phonation WV 501 Phonation Disorders see Voice Disorders Phonetics P 215-240 General P 221 Physiological aspects WV 501 Phonocardiography WG 141.5.P4 Phorbol Esters As carcinogens QZ 202 Phorbol Myristate Acetate see Tetradecanoylphorbol Acetate Phorias see Strabismus Phosgene QV 664 Phosphamidon Agriculture SB 952.P5 Public health WA 240 Phosphatases see Phosphoric Monoester Hydrolases Phosphates QV 285 Phosphates, Inorganic see Phosphates Phosphates, Organic see Organophosphorus Compounds Phosphatidal Compounds see Plasmalogens Phosphatidate Phosphatase QU 136 Phosphatidate Phosphohydrolase see Phosphatidate Phosphatase Phosphatides see Phospholipids Phosphatidylcholines QU 93 Phosphatidylethanolamines QU 93 Phosphatidylinositols QU 93 Phosphines As pesticides WA 240 IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 438 Physical Agents Inorganic chemistry QD 181.PI Phosphocreatine WE 500 Phosphodiesterases see Phosphoric Diester Hydrolases Phosphoglycerides see Glycerophosphates Phosphohydrolases see Phosphoric Monoester Hydrolases Phosphoinositides see Phosphatidylinositols Phospholipase Al see Phospholipases A Phospholipase A2 see Phospholipases A Phospholipases QU 136 Phospholipases A QU 136 Phospholipids QU 93 Phosphomonoesterases see Phosphoric Monoester Hydrolases Phosphonic Acids Inorganic chemistry QD 181.PI Pharmacology QV 138.P4 Phosphonomycin see Fosfomycin Phosphopeptides QU 68 Phosphoprotein Phosphatase QU 136 Phosphoprotein Phosphohydrolase see Phosphoprotein Phosphatase Phosphoranes Inorganic chemistry QD 181.PI Pharmacology QV 138.P4 Phosphorescence see Luminescence Phosphoric Acids QD 181.PI Pharmacology QV 138.P4 Phosphoric Diester Hydrolases QU 136 Phosphoric Monoester Hydrolases QU 136 Phosphorus Inorganic chemistry QD 181.PI Metabolism QU 130 Of bone WE 200 Pharmacology QV 138.P4 Toxicology As an irritant poison QV 618 Organic poison QV 627 Phosphorus Isotopes Inorganic chemistry QD 181.PI Metabolism QU 130 Micro-organism metabolism QW 52 Of bone WE 200 Pharmacology QV 138.P4 Phosphorus Metabolism Disorders WD 200.5.P4 Phosphorus Poisons, Organic see Toxicology QV 627 under Organophosphorus Compounds Phosphorus Radioisotopes WN 420 Nuclear physics QC 796.P1 See also special topics under Radioisotopes Phosphorylation QD 281.P46 Phosphorylcholine, Acetyl Glyceryl Ether see Platelet Activating Factor Phosphotransferases QU 141 Phosphotransferases, ATP see Phosphotransferases Phosvel Agriculture SB 952. P5 Public health WA 240 Photoaging of Skin see Skin Aging Photobacterium QW 141 Photobiology see Light Photochemistry QD 701-731 Industrial TP 249.5 Other special topics, by subject Photochemotherapy WB 480 Photochemotherapy, Hematoporphyrin see Hematoporphyrin Photoradiation Photocoagulation see Light Coagulation Photodermatitis see Photosensitivity Disorders Photodynamic Therapy see Photochemotherapy Photofluorography WN 220 Used for diagnosis of particular disorders, with Uie disorder Photogrammetry TR 693-696 For specific subjects, by subject Photography TR Dental TR 708 Fluorescent screen see Fluoroscopy WN 220 In psychotherapy WM 450.5.P5 Instrumentation TR 570 Medical TR 708 Roentgen-ray see Radiography WN 200, etc. Used for specific subjects, by subject Photokymography see Electrokymography Photometry Analytical chemistry (General) QD 79.P46 Optics QC 391 Quantitative analysis QD 117.P5 Used for diagnosis of particular disorders, with the disorder or system Photomicrography QH 251 Photons see Radiation Photoproteins see Luminescent Proteins Photoradiation see Light Photoradiation, Hematoporphyrin see Hematoporphyrin Photoradiation Photoradiation Therapy see Phototherapy Photoreceptors WL 102.9 Photosensitivity Disorders WR 160 Photosynthesis QK 882 Phototherapy WB 480 Phototrophic Bacteria QW 145 Phrase Books see Medicine Phrenic Nerve WL 400 Phrenology BF 866-885 As a diagnostic technique WB 365 Phthalein Dyes QV 240 Phthalic Acids QU 98 Organic chemistry QD 341.A2 Toxicology QV 612 Phthalic Anhydrides QU 98 Toxicology QV 612 Phthalidyl Ampicillin see Talampicillin Phthiraptera see Lice Phthiriasis see Pediculosis Phthiroptera QX 501 Phthisis see Tuberculosis, Pulmonary Phycomycetes QW 180.5.P4 Phyllodes Tumor WP 870 Phylloquinone see Phytonadione Phylogeny QH 367.5 Physarum QW 180.5.M9 Physiatry see Physical Medicine Physical Agents see Meteorological Factors; names of specific agents, e.g., Heat ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7IED 439 Physical Conditioning, Human Physical Conditioning, Human see Exercise Therapy Physical Disability see Disabled Physical Education and Training QT 255 Physical Effort see Exertion Physical Endurance QT 255 Special topics, by subject Physical Examination WB 200-288 For legal establishment of life W 789 In infancy & childhood WS 141 In old age WT 141 Physical Examination, Preadmission see Diagnostic Tests, Routine Physical Fitness QT 255 For automobile driving WA 275 In aviation medicine WD 705 In space medicine WD 752 Physical Medicine WB 460-545 Physical Optics see Optics Physical Therapy WB 460-545 General works WB 460 Hospital departments WX 223 In psychiatry WM 405-412 Veterinary SF 925 Physical Therapy Department, Hospital WX 223 Physically Challenged see Disabled Physically Handicapped see Disabled Physician Assignment Acceptance see Medicare Assignment Physician Assistants W 21.5 Physician Impairment Medicine W 21 For general impairment of physicians in various specialties, class in the number for the profession where applicable Physician-Patient Relations W 62 In adolescence WS 462 In infancy & childhood WS 105.5.15 In psychiatry WM 62 In surgery WO 62 Physician Shortage Area see Medically Underserved Area Physicians Arabic WZ 80.5.A8 Biography Collective WZ 112-150 Individual WZ 100 Directories W 22 Islamic WZ 80.5.A8 Liability W 44 See also Insurance, Liability W 44, etc. Literary & artistic works WZ 350 Military WZ 112.5.M4 Social relations W 62 See also names of ethnic groups, e.g., Blacks WZ 80.5.B5, etc.; other special topics Physicians' Assistants see Physician Assistants Physicians' Extenders see Physician Assistants Physicians, Family W 89 See also Family Practice WB 110, etc. Physicians Practice Patterns W 87 Physicians Role W 62 Physicians, Women W 21 Biography ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH> Collective WZ 150 Individual WZ 100 History of their place in medicine WZ 80.5.W5 See also special topics under Physicians Physics QC Biological see Biophysics QT 34, etc. Radiologic see Health Physics WN 110 Physiognomy BF 840-861 See also Facial Expression WB 275, etc. Physiologic Availability see Biological Availability Physiological Adaptation see Adaptation, Physiological Physiological Chemistry see Biochemistry Physiological Optics see Optometry; Vision Physiological Psychology see Psychophysiology Physiologists see Biography WZ 112.5.P5, etc., and Directories QT 22 under Physiology Physiology QT Bacterial QW 52 Biography Collective WZ 112.5.P5 Individual WZ 100 Cold climate QT 160 Desert climate QT 150 Directories QT 22 Domestic animals SF 768-768.2 Experimental QT 25 Fetus WQ 210.5 Hot climate QT 150 Human (General) QT 104 Labor WQ 305 Neurological see Neurophysiology WL 102 Nursing texts QT 104 Psychological see Psychophysiology WL 103 Surgical WO 102 Wild animals QP, etc. Particular systems, organism or parts, by subject See also Anthropology, Physical GN 50.2-298 Physiology, Comparative QT 4 Domestic animals only SF 768-768.2 Wild animals only QP 33 Physiopathology see Pathology Physiotherapy see Physical Therapy Physostigmine QV 124 Phytagglutinins see Lectins Phytic Acid QU 75 Phytin see Phytic Acid Phytochrome QK 898.P67 Phytohaemagglutinins see Plant Agglutinins Phytohemagglutinins QK 898.P8 Hemagglutination QW 640 Phytohormones see Plant Growth Regulators Phytomenadione see Phytonadione Phytomitogens see Lectins Phytonadione QV 195 Phytophagineae see Plant Viruses Pia Mater WL 200 Pial Vein see Cerebral Veins Pica WM 175 Picibanil As antineoplastic agents QV 269 Pick's Disease of Brain see Dementia, Presenile Pick's Disease of Heart see Pericarditis, Constrictive USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 440 Planigraphy, X-Ray Picloram Public health WA 240 Picodnaviruses see Parvoviridae Picornaviridae QW 168.5.P4 Picornaviridae Infections WC 501 Picornavirus Infections see Picornaviridae Infections Picrates QV 223 Picric Acid see Picrates Picrotoxin QV 103 Pictorial Works see Form number 17 in any NLM schedule where applicable or appropriate LC number Picture Archiving and Communication Systems see Radiology Information Systems Picture Archiving, Radiologic see Radiology Information Systems Picture Frustration Study see Rosenzweig Picture-Frustration Study Piebald Skin see Albinism; Pigmentation Disorders; Vitiligo Pig Skin Dressings see Biological Dressings Pig-Tailed Monkey see Macaca nemestrina Pigeon Breeders Lung see Bird Fanciers Lung Pigeons QL 696.C63 Diseases SF 994.6 Pigment Epithelium of Eye WW 103 Of particular parts of the eye, with the part, e.g., Retinal Pigment Epithelium WW 270 Pigmentary Retinopathy see Retinitis Pigmentosa Pigmentation Anthropology GN 197 Manifestations of disease WR 143 Physiology WR 102 Pigmentation Disorders WR 265-267 Manifestations of disease WR 143 Pigments QU 110 Animals Domestic SF 768-768.2 Wild QP 670-671 Plants Biochemistry QD 441 Botany QK 898.P7 See also Porphyrins QU 110, etc.; names of other specific pigments Pigs see Swine Pike see Salmonidae Pilar Cyst see Epidermal Cyst Piles see Hemorrhoids Pili, Bacterial see Pili, Sex Pili, Sex QW 51 Pills see Nostrums; Tablets Pilocarpine QV 122 Pilonidal Cyst WE 750 Pilonidal Sinus see Pilonidal Cyst Pineal Body WK 350 Pinealoma WK 350 Pinna see Ear, External Pinnipedia QL 737.P64 Pinta WC 422 Pinworm see Oxyuroidea Piperacillin QV 354 Pipradol see Pipradrol Pirenzepine As an anti-ulcer agent QV 69 Piroplasmosis see Babesiosis Piroxicam QV 95 Pit and Fissure Sealants WU 190 Pit Viper Venoms see Crotalid Venoms Pitch Discrimination WV 272 Pitch Perception WV 272 Pithecinae see Cebidae Pituitary Adenoma, Prolactin-Secreting see Prolactinoma Pituitary-Adrenal Function Tests WK 510 Pituitary-Adrenal System WK 510 Pituitary Diseases WK 500-590 Pituitary Dwarfism see Dwarfism, Pituitary Pituitary Function Tests WK 502 See also Pituitary-Adrenal Function Tests WK 510 Pituitary Gland WK 500-590 Pituitary Gland, Anterior WK 510 Pituitary Gland, Posterior WK 520 Pituitary Growth Hormone see Somatotropin Pituitary Hormone Release Inhibiting Hormones WK 515 Pituitary Hormone-Releasing Hormones WK 515 Pituitary Hormones WK 502 Pituitary Hormones, Anterior WK 515 Pituitary Hormones, Posterior WK 520 Pituitary Neoplasms WK 585 Pityriasis WR 204 Linguae see Glossitis, Benign Migratory WI 210 Pivampicillin QV 354 PIXE see Spectrometry, X-Ray Emission Pizotifen see Pizotyline Pizotyline As a serotonin antagonist QV 126 Placebos WB 330 Placement Agencies, Nursing see Employment Placenta WQ 212 Growth and Development see Placentation QS 645 Placenta Diseases WQ 212 Placental Extracts Pharmacology QV 370 Therapeutic use (General) WB 391 Used for treatment of particular disorders, with the disorder or system Placental Function Tests WQ 212 Placental Hormones WK 920 Placental Insufficiency WQ 212 Placental Lactogen WK 920 Placental Proteins see Pregnancy Proteins Placental Villi see Chorionic Villi Placentation QS 645 Placentoma, Normal see Placenta Placentome see Placenta Plague WC 350-355 Cattle see Rinderpest SF 966 Fowl see Fowl Plague SF 995.6.F59 Plague Vaccine WC 350 Planigraphy, X-Ray see Tomography, X-Ray ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSrFTED 441 Plankton Aquatic biology (General) QH 90.8.P5 Freshwater biology QH 96.8.P5 Marine biology QH 91.8.P5 Plant ecology QK 933-935 Zoology Freshwater QL 143 Ocean QL 123 Planned Parenthood see Family Planning Planning, Health and Welfare see Health Planning Planning, Health Facility see Health Facility Planning Planning Techniques Health administration WA 525-546 Health services W 84-84.8 Hospital administration WX 150 Hospital facility WX 140 In other particular areas, by subject Planning Theories see Planning Techniques Plant Agglutinins see Lectins Plant Diseases SB 599-795 Biological control SB 975-978 General works SB 731 Trees SB 761-767 Plant Extracts, Chinese see Drugs, Chinese Herbal Plant Growth Regulators QK 745 Plant Hormones see Plant Growth Regulators Plant Lice see Aphids Plant Microbiology see Microbiology; Plant Viruses Plant Oils Biochemistry QU 86 Chemical technology TP 680-684 Public health aspects WA 722 Plant Poisoning WD 500-530 Veterinary SF 757.5 See also Milk Sickness WD 530 Plant Proteins QK 898.P8 In nutrition QU 55 Plant Tumors SB 741.5 Of specific plants with the plant, e.g., tree galls in SB 767 Plant Viruses QW 163 Plantar Prints see Dermatoglyphics Plants QK Chemistry QK 861-899 Cytology QK 725 Histology QK 671 Lice see Aphids QX 503, etc. Microbiology QW 60 Poisons see Plants, Toxic WD 500-530 Plants, Edible QK 98.5 As a dietary supplement in health or disease WB 430-432 Plants, Medicinal QV 766-770 Atlases QV 717 Culture SB 293-295 See also specific names of medicinal plants Plants, Toxic WD 500-530 Plaque Therapy, Radioisotope see Brachytherapy Plasma WH 400 Blood transfusion WB 356 Plasma Cell Antigens PC-1 see Antigens, Differentiation, B-Lymphocyte Plasma Cell Dyscrasias see Paraproteinemias Plasma Cells WH 400 Plasma Exchange WB 356 Plasma Expanders see Plasma Substitutes Plasma Membrane see Cell Membrane Plasma Prokallikrein see Prekallikrein Plasma Proteins see Blood Proteins Plasma Substitutes WH 450 Plasma Transglutaminase see Protein-Glutamine gamma-Glutamyltransferase Plasma Volume WG 106 Plasma Volume Expanders see Plasma Substitutes Plasmacytes see Plasma Cells Plasmalogens QU 93 Plasmapheresis WH 460 Plasmids QW 51 Plasminogen Enzymology QU 142 Blood coagulation WH 310 Plasminogen Activator Inhibitor 3 see Protein C Inhibitor Plasminogen Activator Inhibitors see Plasminogen Inactivators Plasminogen Activator, Tissue-Type see Alteplase Plasminogen Activator, Urokinase-Type see Urokinase Plasminogen Activators Biochemistry QU 142 Blood coagulation WH 310 Plasminogen Inactivators QU 136 Plasminokinase see Streptodomase and Streptokinase Plasmodium QX 135 Plasmodium Infections see Malaria Plasmosome see Cell Nucleolus Plaster, Adhesive see Bandages Plaster Casts see Casts, Surgical Plaster of Paris see Calcium Sulfate Plasters see Dermatologic Agents; Irritants Plastic Casts see Casts, Surgical Plastic Surgery see Surgery, Plastic Plasticity, Neuronal see Neuronal Plasticity Plastics Chemical technology TP 1101-1185 Used for special purposes by subject, e.g., in plastic surgery WO 640 Platelet Activating Factor QU 93 In blood coagulation WH 310 Platelet Adhesiveness WH 310 Platelet Aggregation WH 310 Platelet Aggregation Inhibitors QV 180 Platelet Antagonists see Platelet Aggregation Inhibitors Platelet Antiaggregants see Platelet Aggregation Inhibitors Platelet-Derived Growth Factor QU 107 Platelet Function Tests QY 410 Platelet Transforming Growth Factor see Transforming Growth Factor beta Platelet Transfusion WB 356 Plateletpheresis WH 460 Platelets see Blood Platelets Platelets, Blood see Blood Platelets ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7TED 442 Poisoning Platinum Inorganic chemistry QD 181.P8 Pharmacology QV 290 Platinum Black see Platinum Platinum Diamminodichloride see Cisplatin Platybasia WE 730 Platyhelminths QX 350-422 Platyrrhina see Cebidae Play and Playthings Child psychology WS 105.5.P5 Physical education QT 255 Projective techniques WM 145.5.P8 Preschool children LB 1140.35.P55 Psychology (General) BF 717 Recreation QT 250 School children LB 1177; LB 3031 Play Therapy WS 350.2 Activity therapy WM 450 Special topics by subject, e.g., Hospitalized Child WS 105.5.H7 Pleasure-Pain Principle Psychoanalysis WM 460.5.P5 Psychology BF 515 Plethysmography WG 141.5.P7 Special topics, by subject, e.g., in the diagnosis of Thrombosis WG 610 Plethysmography, Impedance WG 141.5.P7 Special topics, by subject, e.g., diagnosis of Arteriosclerosis WG 550 Plethysmography, Impedance, Transthoracic see Cardiography, Impedance Plethysmography, Whole Body WF 141.5.P7 Special topics, by subject, e.g., in Tracheal Stenosis WF 490 Pleura WF 700-746 Secretion QY 210 Tuberculosis see Tuberculosis, Pleural WF 390 See also Pleuropneumonia WC 202 Pleural Cavity see Pleura Pleural Effusion WF 700 Clinical analysis QY 210 Pleural Fluid see Secretion QY 210 under Pleura Pleural Neoplasms WF 700 Pleural Rub see Respiratory Sounds Pleurisy WF 744 Pleurisy, Tuberculous see Tuberculosis, Pleural Pleuritis see Pleurisy Pleurodynia, Epidemic WC 500 Pleuropneumonia WC 202 Veterinary SF 831 In cattle SF 964 Pleuropneumonia-Like Organisms see Mycoplasma Plicamycin QV 269 Plumbing see Sanitary Engineering Plumbism see Lead Poisoning Plummer-Vinson Syndrome WI 250 Plutonium WN 420 Nuclear physics QC 796. P9 See also special topics under Radioisotopes Pneumatosis Cystoides Intestinalis WI 400 Pneumococcal Infections WC 217 See also Pneumonia, Lobar WC 204 Pneumoconiosis WF 654 Pneumoencephalography WL 141 Pneumogastric Nerve see Vagus Nerve Pneumology see Pulmonary Disease (Specialty) Pneumomediastinum see Mediastinal Emphysema Pneumomediastinum, Diagnostic WF 975 Pneumonectomy WF 668 Pneumonia WC 202-209 Friedlaender's pneumonia WC 209 Veterinary SF 831 Pneumonia, Aspiration WC 209 Pneumonia, Interstitial see Lung Diseases, Interstitial Pneumonia, Lipid WC 209 Pneumonia, Lobar WC 204 Pneumonia, Mycoplasma WC 209 Pneumonia, Pneumococcal see Pneumonia, Lobar Pneumonia, Staphylococcal WC 204 Pneumonia, Viral WC 207 Veterinary SF 831 Pneumonitis, Hypersensitivity, Avian see Bird Fanciers Lung Pneumonitis, Interstitial see Lung Diseases, Interstitial Pneumonology see Pulmonary Disease (Specialty) Pneumonolysis WF 668 Pneumoperitoneum WI 575 Pneumoperitoneum, Artificial WI 141 Used for diagnosis of particular disorders, with the disorder or system Pneumoradiography WN 200 Pneumoretroperitoneum see Retropneumoperitoneum Pneumothorax WF 746 Pneumothorax, Artificial WF 768 Pocket, Periodontal see Periodontal Pocket Podiatry WE 890 Podophyllum As an antineoplastic agent QV 269 As a cathartic QV 75 As a medicinal plant QV 767 Poisoning WD 500 Poetry PN 6099-6110 About medicine WZ 330 By physicians WZ 350 Light verse in medicine and related fields WZ 305-305.5 Poison Control Centers QV 600 Directories QV 605 In hospitals WX 215 Poison Ivy see Toxicodendron Poison Ivy Dermatitis see Dermatitis, Toxicodendron Poisoning QV 600-667 Animal see Animals, Poisonous WD 400-430; Fishes, Poisonous WD 405; Bites and Stings WD 400-430 Carbon monoxide see Carbon Monoxide Poisoning QV 662 Fluoride see Fluoride Poisoning QV 282, etc. Food see Food Poisoning WC 268 Gas see Gas Poisoning QV 662, etc. Industrial WA 465 Medicolegal Aspects W 925 Lead see Lead Poisoning QV 292 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSD7TJED 443 Poisoning Mercury see Mercury Poisoning QV 293 Mushroom see Mushroom Poisoning WD 520 Plant see Plant Poisoning WD 500-530 Salmonella food see Salmonella Food Poisoning WC 268 Staphylococcal food see Staphylococcal Food Poisoning WC 268 Veterinary SF 757.5 See also names of particular poisonous animals, bacteria, chemicals, insects, plants, viruses, etc., and the field Toxicology Poisonous Animals see Animals, Poisonous Poisonous Fishes see Fishes, Poisonous Poisonous Gases see Gases Poisonous Plants see Plants, Toxic Poisons QV 600-667 Corrosive QV 612 Detection see Laboratory manuals QV 602 and Methods QV 602 under Toxicology Industrial protection WA 465 Inorganic QV 610-618 Organic QV 627-633 Public health aspects WA 730 Volatile QV 633 See also names of specific poisons Polar Regions see Cold Climate Polarization Microscopy see Microscopy, Polarization Polarography Organic analysis QD 272.E4 Quantitative analysis QD 116.P64 Policy Making General H 97 In special topics, by subject Poliodystrophia Cerebri see Cerebral Sclerosis, Diffuse Poliomyelitis WC 555 Prevention and control WC 556 Poliomyelitis Immunization see Prevention and Control WC 556 under Poliomyelitis Poliosis see Hair Color Poliovirus Vaccine WC 556 Poliovirus Vaccine, Oral WC 556 Polioviruses QW 168.5.P4 Polioviruses, Human 1-3 QW 168.5.P4 Polishes see Industrial Oils Polishes, Dental see Dentifrices Political Activity see Politics Political Systems JC In psychoanalysis, psychoanalytic therapy, or psychoanalytic interpretation WM 460.5.P7 Related to special topics, by subject See also names of specific systems, e.g., Communism HX 72-73; 626-780.7, etc. Politics J (rarely used) Special topics, by subject Pollen QK 658 As an allergen QW 900 As a food preparation WB 447 Pollinosis see Hay Fever Pollution see Names of specific kinds of pollution, e.g., Air Pollution Polonium WN 420 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Nuclear physics QC 796. P6 See also special topics under Radioisotopes Poly Adenosine Diphosphate Ribose QU 57 Poly ADP Ribose see Poly Adenosine Diphosphate Ribose Poly ADP Ribose Polymerase see NAD+ ADP-Ribosyltransferase Poly ADP Ribose Synthetase see NAD+ ADP-Ribosyltransferase Poly I-C Immunology QW 800 Pharmacology QV 268.5 Polyacrylamide Gel Electrophoresis, Two-Dimensional see Electrophoresis, Gel, Two-Dimensional Polyamides see Nylons Polyamines QU 61 Organic chemistry Aliphatic QD 305.A8 Aromatic QD 341.A8 Polyangiaceae see Myxococcales Polyangium see Myxococcales Polyarteritis Nodosa WG 518 Polyarthritis see Arthritis Polyarthritis Rheumatica see Rheumatic Fever Polybrominated Biphenyls As carcinogens QZ 202 Toxicology QV 633 Polybromobiphenyl Compounds see Polybrominated Biphenyls Polychemotherapy see Drug Therapy, Combination Polychlorinated Biphenyls As air pollutants WA 754, etc. As water pollutants WA 689 Organic chemistry QD 341.H9 Toxicology (General) QV 633 Polychlorobiphenyl Compounds see Polychlorinated Biphenyls Polychloroethylene see Polyvinyl Chloride Polycyclic Compounds Organic chemistry QD 341.H9 Toxicology QV 633 Polycyclic Hydrocarbons Organic chemistry Aliphatic QD 305.H9 Aromatic QD 341.H9 Toxicology QV 633 Polycystic Kidney see Kidney, Polycystic Polycystic Ovary Syndrome WP 320 Polycythemia WH 180 Polycythemia V jra WH 180 Polydeoxyribonucleotide Ligases see Polydeoxyribonucleotide Synthetases Polydeoxyribonucleotide Synthetases QU 138 Polyergin see Transforming Growth Factor beta Polyethylene Terephthalates Inguinal hernia repair WI 960 Production TP 1180.P65 Used for other special purposes, by subject Polyethylenes Chemical technology TP 1180.P65 Used for special purposes, by subject, e.g., in drainage for middle ear surgery WV 230 IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 444 Port Quarantine Polyglucoses see Glucans Polyglutamate Folates see Pteroylpolyglutamic Acids Polygonum see Plants, Medicinal Polyhedrosis Viruses QW 162 Polyisocyanates see Polyurethanes Polyisoprenyl Phosphate Sugars QU 75 As glycolipids QU 85 Polyisoprenyl Phosphates Biochemistry QU 85 Toxicology QV 633 Polymenorrhea see Menstruation Disorders Polymerase Chain Reaction QH 450.3 Polymers QD 380-388 Classify by use where possible, e.g., in dentistry WU 190; in medicine QT 37.5.P7 Polymorphism (Genetics) QH 455 Polymorphonuclear Leukocytes see Neutrophils Polymyalgia Rheumatica WE 550 Polymyxin E see Colistin Polyneuritis WL 544 Polyneuritis Endemica see Beriberi Polynuclear Aromatic Hydrocarbons see Polycyclic Hydrocarbons Polynucleotides QU 57 Polyomavirus QW 165.5.P2 Polyomavirus hominis 1 QW 165.5.P2 Polyomavirus macacae QW 165.5.P2 Polypeptides see Peptides Polyphosphates QV 285 Polyploidy QH 461 Plant breeding SB 123 Polyposis see Polyps Polyposis Coli, Familial see Adenomatous Polyposis Coli Polyposis Syndrome, Familial see Adenomatous Polyposis Coli Polyproteins see Proteins Polyps QZ 200 Localized, by site See also Colonic Polyps WI 529; Intestinal Polyps WI 430; Nasal Polyps WV 300 Polyradiculitis WL 400 Polyradiculoneuritis WL 544 Polysaccharides QU 83 Polysaccharides, Bacterial QW 52 Polyurethanes Chemical technology TP 1180.P8 Used for special purposes, by subject, e.g., in tubing for tracheal prosthesis WF 490 Polyvidon see Povidone Polyvinyl Chloride Chemical technology TP 1180.V48 Polyvinylpyrrolidone see Povidone Polyvinylpyrrolidone Iodine see Povidone-Iodine Polyvinyls Chemical technology TP 1180.V48 Used for particular purposes, by subject, e.g., in Blood Bags WH 460 Pompholyx see Eczema, Dyshidrotic Pongidae QL 737.P96 As laboratory animals QY 60.P7 Diseases SF 997.5.P7 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Pongo pygmaeus QL 737.P96 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Pons WL 310 Pontocaine see Tetracaine Poor, Medical Care see Medical Indigency Popliteal Artery WG 595.P6 See also Blood Supply WE 870 under Knee Popliteal Space see Knee Popliteal Vein WG 625.P6 See also Blood Supply WE 870 under Knee Poppy see Papaver Popular works Cardiovascular system WG 113 Dentistry WU 80 Digestive system WI 113 Geriatrics WT 120 Gynecology WP 120 Medicine (General) WB 120-130 Neoplasms QZ 201 Obesity WD 212 Obstetrics WQ 150 Ophthalmology WW 80 Psychiatry WM 75 Surgery WO 75 Special topics, by subject Population HB 848-3697 Genetics see Genetics, Population QH 455, etc. Health problems of special groups WA 300-395 Movement HB 1951-2577 See also Demography HB 848-3697 Population Control HB 848-871 Population policy HB 883.5 See also Family Planning HQ 763.5-767.7 Population Density HB 1953 Population Distribution see Demography Population Dynamics QH 352 Special topics, by subject Population Explosion see Population Growth Population Growth HB 848-871 Population Size see Population Density Population Surveillance Epidemiological studies WA 105 See also names of specific types of surveys, e.g., Health Surveys WA 900, etc. Poradenitis Nostras see Lymphogranuloma Venereum Porcelain see Dental Porcelain Porcine Influenza Virus Type A see Orthomyxovirus Type A, Porcine Porcine Xenograft Bioprosthesis see Bioprosthesis Porcine Xenograft Dressings see Biological Dressings Porcupines see Rodentia Porifera QL 370.7-374.2 Pornography see Erotica Porphyria WD 205.5.P6 Special types, by system in which produced Porphyrins QU 110 Special types, by system in which produced, e.g., those related to hemorlobin WH 190 Porpoises see Dolphins Port Quarantine see Quarantine IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 445 Portacaval Shunt, Surgical Portacaval Shunt, Surgical WI 720 Portal Hypertension see Hypertension, Portal Portal System WI 720 Portal Vein WI 720 Portasystemic Shunt, Surgical WI 720 Portography WI 720 Portosystemic Encephalopathy see Hepatic Encephalopathy Portosystemic Shunt, Surgical see Portasystemic Shunt, Surgical Portraits N 7575-7624.5 Of physicians and other specialists in medically related fields in the appropriate biography number in WZ Position Description see Job Description Position, Sense of see Orientation Positioning, Radiography see Technology, Radiologic Positive End-Expiratory Pressure see Positive-Pressure Respiration Positive-Pressure Respiration WF 145 In first aid WA 292 Positive Reinforcement see Reinforcement (Psychology) Positron-Emission Tomography see Tomography, Emission-Computed Positrons see Electrons Posology see Administration & dosage QV 748 under Drugs; Prescriptions, Drug Post and Core Technique WU 515 Post-Surgical Nursing see Postanesthesia Nursing Post-Transcriptional RNA Modification see RNA Processing, Post-Transcriptional Post-Translational Protein Modification see Protein Processing, Post-Translational Post-Traumatic Stress Disorders see Stress Disorders, Post-Traumatic Postage Stamps see Philately Postanesthesia Nursing WY 154 Postcoital Contraceptives see Contraceptives, Postcoital Posterior Chamber see Eye Posterior Lobe Hormones see Pituitary Hormones, Posterior Postgastrectomy Syndromes WI 380 Postgraduate Education see Education, Graduate; names of specific types of graduate education, e.g., Education, Pharmacy, Graduate Postimplantation Phase WQ 205 Postmarketing Product Surveillance see Product Surveillance, Postmarketing Postmenopausal Bone Loss see Osteoporosis, Postmenopausal Postmenopausal Hormone Replacement Therapy see Estrogen Replacement Therapy Postmenopausal Osteoporosis see Osteoporosis, Postmenopausal Postmortem Changes QZ 35 Postmortem Examination see Autopsy Postnatal Care WQ 500 See also Postnatal Nursing WY 157.3 under Obstetrical Nursing Postnidation Phase see Postimplantation Phase ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Postoperative Care WO 183 Geriatric surgery WO 950 Pediatric surgery WO 925 See also Surgical Nursing WY 161 Postoperative Complications WO 184-185 Specific complications, by site Postoperative Period WO 183 Postoperative Wound Infection see Surgical Wound Infection Postpartum Hemorrhage WQ 330 Postpartum Period see Puerperium Postphlebitic Disease see Postphlebitic Syndrome Postphlebitic Syndrome WG 610 Postphlebitic Ulcer see Postphlebitic Syndrome Posture WE 103 Postviral Fatigue Syndrome see Fatigue Syndrome, Chronic Potassium QV 277 Inorganic chemistry QD 181.K1 Metabolism QU 130 Toxicology QV 277 Potassium Antimonyltartrate see Antimony Potassium Tartrate Potassium Canrenoate see Canrenoate Potassium Potassium Channels QH 603.154 Potassium Chloride Inorganic chemistry QD 181.K1 Pharmacology QV 280 Potassium Deficiency WD 105 Veterinary SF 855.P67 Potassium Isotopes Inorganic chemistry QD 181.K1 Pharmacology QV 277 Potassium Permanganate QV 229 Potassium Pump see Na(+)-K(+)-Exchanging ATPase Pottos see Lorisidae Pott's Disease see Tuberculosis, Spinal Poultry Anatomy SF 767.P6 Culture SF 481-507 Physiology SF 768.2.P6 Poultry Diseases SF 995-995.6 Poultry Products As a dietary supplement in health or disease WB 426 Public health aspects WA 707 See also Eggs WA 703, etc. Poverty Economic conditions HC 79.P6 By country HC 94-1085 Welfare HV 40-4630 Poverty Areas Health problems (General) WA 30 Special topics, by subject Povidone WH 450 Povidone-Iodine As an anti-infective agent QV 231 Powders QV 785 As adsorbent dermatological agents QV 63 As adsorbent gastrointestinal agents QV 66 Power, Personal see Power (Psychology) Power Plants TJ 164 USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSinED 446 Prevention and control of accidents and diseases WA 440-495 Power, Professional see Power (Psychology) Power (Psychology) As an expression of will BF 608-618, etc. Manipulation or control by others BF 632.5 Self control, willpower, etc BF 632 Other aspects, by subject Power, Social see Power (Psychology) Power Sources, Bioelectric see Bioelectric Energy Sources Poxviridae QW 165.5.P6 Poxviridae Infections WC 584-590 Poxvirus Infections see Poxviridae Infections Poxvirus myxomatis see Myxoma Virus Poxvirus officinale see Vaccinia Virus Poxvirus variolae see Variola Virus PPLO see Mycoplasma Practical Nurses see Nurses; Nursing, Practical Practice see Family Practice; General Practice, Dental; Group Practice; Group Practice, Dental; Group Practice, Prepaid; Institutional Practice; Mortuary Practice; Partnership Practice; Private Practice; Professional Practice; See also Medicine (as practiced in particular countries) Practice Management, Dental WU 77-79 Practice Management, Medical W 80 Practice Patterns, Professional see Physicians Practice Patterns Practice (Psychology) Educational psychology Habit LB 1061 Memory LB 1063 Philosophy B 831.3 Practolol QV 132 Prairie Dogs see Sciuridae Praomys see Muridae Praying Mantis see Orthoptera Praziquantel QV 253 Prazosin QV 150 Pre-Eclampsia WQ 215 Pre-Excitation Syndromes WG 330 Preanesthetic Medication WO 234 Precancerous Conditions QZ 204 Precautions, Universal see Universal Precautions Preceptorship Dentistry WU 20 Medicine W 20 Nursing WY 18.5 Pharmacy QV 20 Veterinary medicine SF 756.3-756.37 In other fields, by subject Precipitation QD 547 Antigens QW 640 Tests QY 265 Precipitins QW 640 Diagnostic reactions QY 265 Precocity see Child Development Predatory Behavior QL 758 Predental Education see Education, Predental Prediabetic State WK 810 Predictive Value of Tests Of a specific test, with the test ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Premature infants Prednisolone WK 757 Prednisolone, Topical QV 60 Prednisone WK 757 Preferred Provider Organizations W 130 Prefrontal Cortex WL 307 Pregnadienes WP 530 Pregnancy WQ 200-260 Breast in WP 825 General works WQ 200 Legal aspects W 791 Nursing WY 157 Popular works WQ 150 Pregnancy, Abdominal WQ 220 Pregnancy, Adolescent see Pregnancy in Adolescence Pregnancy, Animal SF 887 Pregnancy Complications WQ 240-260 General works WQ 240 Veterinary SF 887 See also Pregnancy, Animal SF 887 See also names of specific complications Pregnancy Complications, Cardiovascular WQ 244 Pregnancy Complications, Hematologic WQ 252 Veterinary SF 887 See also Pregnancy, Animal SF 887 Pregnancy Complications, Infectious WQ 256 See also Puerperal Infection WQ 505 Pregnancy Complications, Neoplastic WQ 240 Pregnancy, Ectopic WQ 220 Pregnancy in Adolescence Illegitimacy WS 462 Medical problems WQ Psychological problems WS 462 Welfare WA 310-352 Pregnancy in Diabetes WQ 248 Pregnancy, Multiple WQ 235 Pregnancy Outcome WQ 240 Pregnancy, Prolonged WQ 240 Pregnancy Proteins WK 920 Pregnancy, Teenage see Pregnancy in Adolescence Pregnancy Tests QY 335 Pregnancy Toxemias WQ 215 Pregnancy, Tubal WQ 220 Pregnancy, Unwanted WQ 200 Pregnandiol WP 530 Pregnanediones QV 81 Pregnanes WP 530 Pregnanetriol WP 530 Prehospital Emergency Care see Emergency Medical Services Preimplantation Phase WQ 205 Prejudice BF 575.P9 In adolescence WS 462 In infancy & childhood WS 105.5.S6 Specific prejudice, by subject Prekallikrein QU 136 Premarin see Estrogens, Conjugated Premarital Examinations General WB 200 Female WP 141 Male WJ 700 Premature Beat see Extrasystole Premature infants see Infant, Premature IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 447 Premedical Education Premedical Education see Education, Premedical Premedication In anesthesia see Preanesthetic Medication WO 234 In surgery WO 179 Used for special purposes, by subject Premenstrual Syndrome WP 560 Premenstrual Tension see Premenstrual Syndrome Prenatal Care WQ 175 Prenatal Diagnosis WQ 209 For hereditary diseases specifically QZ 50 Prenatal Diagnosis, Ultrasonic see Ultrasonography, Prenatal Prenatal Exposure Delayed Effects WQ 210 Prenidation Phase see Preimplantation Phase Preoperative Care WO 179 Geriatric surgery WO 950 Pediatric surgery WO 925 Preparation of patient for anesthesia WO 234 Prepaid Dental Care see Insurance, Dental Prepaid Group Health Organizations see Health Maintenance Organizations Prepaid Group Practice see Group Practice, Prepaid Preparatory Manipulation, Obstetric see Methods WQ 415-430 under Delivery Prepayment Medical Plans see Insurance, Health Preprosthetic Oral Surgery see Surgery, Oral, Preprosthetic Prepuce see Penis Presbyopia WW 300 Presbytis see Cercopithecidae Prescription Fees QV 736 Prescription Insurance see Insurance, Pharmaceutical Services Prescriptions, Drug Dental WU 166 Formularies QV 740 Pharmacopoeias QV 738 Veterinary SF 916.5 Writing QV 748 Prescriptions, Non-Drug For specific subjects, with the subject, e.g., Hearing aids WV 274 Presentation, Breech see Breech Presentation Presentation, Fetal see Labor Presentation Presentation (Obstetrics) see Labor Presentation Preservation, Biological QH 324 Blood see Blood Preservation WH 460, etc. Dead bodies see Embalming WA 844 Drugs see Drug Storage QV 754, etc. Food see Food Preservation WA 710 Organs see Tissue Preservation WO 665, etc. Preservation, Food see Food Preservation Preservatives, Pharmaceutical QV 820 Pressoreceptors WL 102.9 Pressure Therapeutic use WB 890 See also Atmospheric pressure WD 710, etc.; Blood Pressure WG 106, etc.; Intracranial Pressure WL 102, etc.; Intraocular Pressure WW 103, etc. Pressure Sore see Decubitus Ulcer Pressure Ulcer see Decubitus Ulcer ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHX Prevalence Studies see Cross-Sectional Studies Prevention of accidents see Accident Prevention Prevention of Infectious Diseases see Communicable Disease Control; names of specific diseases Prevention, Primary see Primary Prevention Preventive Dentistry WU 113-113.7 Preventive Health Services WA 108 See also Immunization QW 800-815, etc. Preventive Inoculation see Immunization Preventive Medicine WA 108-245 Preventive Psychiatry WM 31.5 Priapism WJ 790 Primaquine QV 258 Primary Care Physicians see Physicians, Family Primary Health Care W 84.6 Primary Nursing Care WY 101 Primary Prevention WA 108-245 Of particular conditions, by subject Primates QL 737.P9-737.P968 As laboratory animals QY 60. P7 Diseases SF 997.5.P7 Human emphasis, in NLM schedules, by subject Printers' Marks Z 235-236 Printing Z 116-264.5 Prinzmetal's Angina see Angina Pectoris, Variant Prion Diseases WL 300 Prion Proteins see Prions Prions QU 55 Priorities, Health see Health Priorities Prisoners Human experimentation QV 20.5 In special areas, by subject Psychology of prisoners of war BF 727.P7 Reform of HV 9261-9430.7 Special topics, by subject, e.g., Psychotherapy of Prisoners WM 420 Prisoner's Dilemma see Game Theory Prisons HV 8301-9025 Hygiene and medical service HV 8833-8844 Psychiatric services HV 8841 Sex in prisons HV 8836 Privacy Act see Civil Rights Privacy of Space see Personal Space Private Nursing see Nursing, Private Duty Private Practice W 89 By country WB 50 Nursing see Nursing, Private Duty WY 127 Textbooks for WB 100 Privatization In special fields, by subject, e.g. Mental Health Services WM 30, etc. Privileged Communication see Confidentiality PRL-Secreting Pituitary Adenoma see Prolactinoma PRO Professional Review Organizations see Professional Review Organizations Probabilistic Models see Models, Statistical Probability QA 273-274.8 Probability Learning QA 273.2 Educational psychology LB 1051 Probability Theory QA 273-274.8 Special topics, by subject Problem-Oriented Medical Records see Medical Records, Problem-Oriented USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 448 Problem Solving BF 449 In infancy & childhood WS 105.5.D2 Problems (Form number 18.2 in any NLM schedule where applicable) Probucol QU 95 Organic chemistry QD 341.P5 Procaine QV 115 In veterinary pharmacology SF 918.P75 In veterinary anestilesiology SF 914 Procarbazine Antineoplastic agent QV 269 Therapeutic use QZ 267 Other special topics, by subject Procolobus see Colobus Proconvertin see Factor VII Proctitis WI 600 Proctocolitis, Hemorrhagic see Colitis, Ulcerative Proctocolitis, Ulcerative see Colitis, Ulcerative Proctological Surgery see Surgery WI 650 under Rectum Proctology see Colon and Rectal Surgery (Specialty) Proctoscopy WI 620 Proctosigmoidoscopy see Sigmoidoscopy Prodrugs QV 785 Product Labeling WA 250 Of specific products, by subject See also Drug Labeling QV 835 Product Labeling, Drug see Drug Labeling Product Surveillance, Postmarketing Of specific product, with the product Productivity see Efficiency Proenzymes see Enzyme Precursors Proerythroblasts see Erythroblasts Professional Competence W 21 Dentists WU 21 Nurses WY 16 Pharmacists QV 21 As an educational measurement Works about (Form number 18 in any NLM schedule where applicable) Actual tests (Form number 18.2 in any NLM schedule where applicable) Professional Corporations W 87 Professional Impairment Medicine W 21 For general impairment in other specialties, class in the number for the profession where applicable Professional Liability see Liability, Legal Professional-Patient Relations Allied health personnel W 21.5 Hospital personnel WX 159 Particular specialty, with the specialty See also specific professional relationships with the patient, e.g. Physician-Patient Relations W 62, etc. Professional Practice Medicine as a career W 21 Types of professional practice W 87 See also names of specialties in medicine and allied fields, e.g., Nursing WY 16; form number 21 in any other NLM schedule where ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Projective Techniques applicable Professional Review Organizations W 84 By specialty, in the number for the profession, e.g., QV 21 Professional Staff Committees In schools (Form number 19-20 in any NLM schedule where applicable) In hospitals WX 159 Professional Standards Review Organizations see Professional Review Organizations Professions see Names of Professions, e.g., Nursing Profibrinolysin see Plasminogen Proflavine As a local anti-infective agent QV 220 Progenitor Cells see Stem Cells Progenitor Cells, Hematopoietic see Hematopoietic Stem Cells Progestational Hormones WP 530 Progesterone WP 530 Progesterone Receptors see Receptors, Progesterone Progestin Receptors see Receptors, Progesterone Progestins see Progestational Hormones Progestogens see Progestational Hormones Proglumide Receptors see Receptors, Cholecystokinin Prognathism WU 440 Prognosis WB 142 See also names of particular diseases Prognostic Nutritional Index (PNI) see Nutrition Assessment Program Evaluation Health Services W 84 Other special topics, by subject being evaluated Program Evaluation, Nursing see Nursing Evaluation Research Programmable Implantable Insulin Pump see Insulin Infusion Systems Programmable Implantable Medication Systems see Infusion Pumps, Implantable Programmed Instruction LB 1028.5-1028.7 (Form number 18.2 in any NLM schedule where applicable) Programmed Instruction, Computerized see Computer-Assisted Instruction Programmed Learning see Programmed Instruction Programming, Linear T 57.74-57.79 Special topics, by subject Progressive Lenticular Degeneration see Hepatolenticular Degeneration Progressive Lipodystrophy see Lipodystrophy Progressive Muscular Atrophy see Muscular Atrophy, Spinal Progressive Muscular Dystrophy see Muscular Dystrophy Progressive Patient Care W 84.7-84.8 Of hospital patients WX 162-162.5 Proinsulin WK 820 Projection WM 193.5.P7 In adolescence WS 463 In infancy & childhood WS 350.8.D3 Projections and Predictions see Forecasting Projective Techniques WM 145.5.P8 NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSIFIED 449 Projective Techniques In adolescence WS 462 In infancy & childhood WS 105.5.E8 See also Psychological Tests BF 176 Prokaryotic Cells QW 51 Prolactin WK 515 Veterinary medicine SF 768.3 Prolactin-Producing Pituitary Adenoma see Prolactinoma Prolactinoma WK 585 Prolapsed Disk see Intervertebral Disk Displacement Proliferative Phase see Menstrual Cycle Proline QU 60 Prolongation of life see Longevity; Rejuvenation Prolonged-Action Preparations see Delayed-Action Preparations Promethium WN 420 Nuclear physics QC 796.P5 See also special topics under Radioisotopes Promoter (Genetics) see Promoter Regions (Genetics) Promoter Regions (Genetics) QH 450.2 Promotion of Health see Health Promotion Promyelocytes see Granulocytes Pronormoblasts see Erythroblasts PROPAC see Prospective Payment Assessment Commission Propafenone QV 150 Propaganda HM 263 Propamidine see Antiprotozoal Agents Propanidid QV 81 Propanol see Alcohol, Propyl Propanolamines Organic chemistry QD 305.A4 Pharmacology QV 82 Used for specific purposes, by subject, e.g., as a betablocker QV 132 Properdin WH 400 Clinical analysis QY 455 Complement action QW 680 In other biological processes, by subject Prophage Integration see Lysogeny Propheniramine see Pheniramine Prophenpyridamine see Pheniramine Prophylactic Immunization see Vaccination Prophylaxis see Dental Prophylaxis; diseases for which prevention and control measures are prescribed Propionates QU 98 Propionibacteriaceae QW 120 Propionibacterium QW 120 Propionic Acids QU 98 Propiophenones Organic chemistry QD 341.K2 Pharmacology QV 150 Propolis Used for special purposes, by subject Propranolol QV 132 Proprioception WE 103 Proptosis see Exophthalmos Propyl Gallate As a carcinogen QZ 202 Prosencephalon see Embryology WL 300 under Brain ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIH Prosimii see Strepsirhini Prospective Payment Assessment Commission Prospective Payment System Hospitals WX 157 Prospective Pricing see Prospective Payment System Prospective Reimbursement see Prospective Payment System Prospective Studies In epidemiology WA 105 Special topics, by subject Prostacyclins see Epoprostenol Prostaglandin Antagonists QU 90 Prostaglandin-Endoperoxide Synthase QU 140 Prostaglandin Endoperoxides QU 90 Prostaglandin El see Alprostadil Prostaglandin F2 see Dinoprost Prostaglandin F2alpha see Dinoprost Prostaglandin Inhibitors see Prostaglandin Antagonists Prostaglandin Receptors see Receptors, Prostaglandin Prostaglandin Synthesis Antagonists see Anti-Inflammatory Agents, Non-Steroidal Prostaglandins QU 90 Prostaglandins A QU 90 Prostaglandins E QU 90 Prostaglandins F QU 90 Prostaglandins I see Epoprostenol Prostaglandins 12 see Epoprostenol Prostaglandins X see Epoprostenol Prostanoic Acids QU 90 Prostate WJ 750 Prostatectomy WJ 768 Prostatectomy, Transurethral see Prostatectomy Prostatic Diseases WJ 752 Prostatic Hyperplasia see Prostatic Hypertrophy Prostatic Hypertrophy WJ 752 Prostatic Hypertrophy, Benign see Prostatic Hypertrophy Prostatic Neoplasms WJ 752 Prostatitis WJ 752 Prosthesis WE 172 Blood vessels see Blood Vessel Prosthesis WG 170 Cleft palate see Palatal Obturators WV 440 Dental see Dental Prosthesis WU 500-530 Heart valve see Heart Valve Prosthesis WG 169 Joint see Joint Prosthesis WE 312 Mandibular see Mandibular Prosthesis WU 600 Maxillofacial see Maxillofacial Prosthesis WU 600 Ocular see Eye, Artificial WW 358; Lenses, Intraocular WW 358 Periodontal see Periodontal Prosthesis WU 240 Plastic surgery WO 640 Veterinary SF 901 Prosthesis, Dental see Dental Prosthesis Prosthesis Design WE 172 Localized, by site Prosthesis Failure Equipment failure (General) W 26 Of particular prosthesis, with the prosthesis E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 450 Pseudoglobulins Prosthesis Loosening see Prosthesis Failure prosthodontics WU 500 See also Dental Prosthesis WU 500-530 Prostitution HQ 101-440.7 Protactinium WN 420 Nuclear physics QC 796.P2 See also special topics under Radioisotopes Protease Antagonists see Protease Inhibitors Protease Inhibitors QU 136 Proteases see Peptide Hydrolases Protective Clothing WA 260 In industry WA 485 Protective Devices WA 260 In hospitals WX 185 In industry WA 485 Aviation WD 740 Ophthalmology WW 505 Professions WA 487 In ophthalmology (General) WW 113 Respiratory WF 26 For particular parts of the body (when not covered by above) use form number 26 in any schedule where applicable Protectives see Dermatologic Agents; Radiation-Protective Agents Protein A see Staphylococcal Protein A Protein Binding QU 55 Protein-Bound Iodine Test WK 202 Protein C As an anticoagulant QV 193 Protein C Inhibitor QU 136 Protein-Calorie Malnutrition see Protein-Energy Malnutrition Protein Conformation QU 55 Protein Deficiency WD 105 Veterinary SF 855.P76 Protein Denaturation QU 55 Protein-Energy Malnutrition WD 105 Protein Engineering TP 248.65.P76 Protein-Glutamine gamma-Glutamyltransferase WH 310 Clinical examination QY 410 Pharmacology QV 195 Protein Hydrolysates QU 55 Protein-Losing Enteropathies WI 400 Protein Methylases see Protein Methyltransferases Protein Methyltransferases QU 141 Protein Phosphatase see Phosphoprotein Phosphatase Protein Processing, Post-Translational QH 450.6 Protein Sensitization see Hypersensitivity Protein Structure, Primary see Amino Acid Sequence Protein Structure, Quaternary see Protein Conformation Proteinase Inhibitors see Protease Inhibitors Proteins QU 55 Antigens and antibodies QW 570-680 Bacterial see Bacterial Proteins QW 52 Blood see Blood Proteins QY 455, etc. Carrier see Carrier Proteins QU 55 Cerebrospinal fluid see Cerebrospinal Fluid Proteins WL 203, etc. Dietary see Dietary Proteins QU 55, etc. Eye see Eye Proteins WW 101 Milk see Milk Proteins WA 716, etc. Muscle see Muscle Proteins WE 500 Myeloma see Myeloma Proteins WH 540 Neoplasm see Neoplasm Proteins QZ 200 Nerve tissue see Nerve Tissue Proteins WL 104 Plant see Plant Proteins QK 898.P8 Viral see Viral Proteins QW 160 With drug action on a particular system in QV Localized elsewhere, by site See also names of other specific proteins Proteins, Acute Phase see Acute Phase Proteins Proteinuria WJ 343 Proteinuria-Edema-Hypertension Gestosis see Gestosis, EPH Proteoglycans QU 55 Proteolytic Enzymes see Peptide Hydrolases Protestantism see Christianity Proteus QW 138.5.P7 Prothrombin WH 310 Clinical analysis QY 410 Prothrombin Time QY 410 Protirelin WK 515 Proto-Oncogenes QZ 202 Protocol-Directed Therapy, Computer-Assisted see Therapy, Computer-Assisted Protocols, Clinical see Clinical Protocols Protoheme see Heme Proton-Induced X-Ray Emission Spectrometry see Spectrometry, X-Ray Emission Proton-Translocating ATPase Complex see H(+)-Transporting ATP Synthase Protons WN 415-420 In health physics WN 110 In nuclear physics (General) QC 793.5.P72-793.5.P729 Protoplasts Bacteria QW 51 Plants QK 725 Protoporphyrins General QU 110 Special types, by system in which produced Protozoa QX 50-151 Protozoan Infections WC 700-770 Veterinary SF 780.6 Protracted Pregnancy see Pregnancy, Prolonged Proverbs see Aphorisms and Proverbs Proverbs, Medical see Aphorisms and Proverbs Provocation Tests, Bronchial see Bronchial Provocation Tests Provocation Tests, Nasal see Nasal Provocation Tests Prurigo WR 282 Pruritus WR 282 Pruritus Ani WI 600 Pruritus Vulvae WP 200 Psammomys see Gerbillinae Pseudarthrosis WE 180 Pseudobulbar Paralysis see Paralysis Pseudoephedrine see Ephedrine Pseudoglobulins see Serum Globulins ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 451 Pseudohypoparathyroidism Pseudohypoparathyroidism WD 200.5.C2 Inborn error WD 205.5.M3 Pseudomonadaceae QW 131 Pseudomonas QW 131 Pseudomonas aeruginosa QW 131 Pseudomonas fluorescens QW 131 Pseudomonas Infections WC 330 Pseudoneurotic Schizophrenia see Schizotypal Personality Disorder Pseudonyms see Anonyms and Pseudonyms Pseudopelade see Alopecia Pseudopolyarthritis, Rhizomelic see Polymyalgia Rheumatica Pseudopsychopathic Schizophrenia see Schizotypal Personality Disorder Pseudorabies SF 809.A94 Pseudorabies Virus see Herpesvirus 1, Suid Pseudosclerosis see Hepatolenticular Degeneration Pseudotuberculosis Infections, Yersinia see Yersinia pseudotuberculosis Infections Pseudotuberculosis, Pasteurella see Yersinia pseudotuberculosis Infections Pseudotumor Cerebri WL 348 Psilocybine QV 77.7 Indian ritual use E 98.R3 Psilosis see Celiac Disease Psittacosis see Ornithosis Psittacosis-Lymphogranuloma Group see Chlamydia Psoralen Ultraviolet A Therapy see PUVA Therapy Psoralens QV 60 As sunscreens QV 63 Psoriasis WR 205 PSRO see Professional Review Organizations Psychasthenia see Neurasthenia Psychedelic Agents see Hallucinogens Psychiatric Aides WY 160 Psychiatric Aspects of Aerospace Medicine see Aerospace Medicine Psychiatric Department, Hospital WM 27-28 In a children's hospital WS 27-28 Psychiatric Nursing WY 160 Education WY 18-18.5 Psychiatric Social Work see Social Work, Psychiatric Psychiatric Status Rating Scales WM 141 Psychiatrist-Patient Relations see Physician-Patient Relations Psychiatrists see Biography WZ 112.5.P6, etc., and Directories WM 22 under Psychiatry Psychiatry WM Adolescents see Adolescent Psychiatry WS 463 Biography Collective WZ 112.5.P6 Individual WZ 100 Case studies WM 40-49 In mental retardation WM 302 Children see Child Psychiatry WS 350-350.8 Counseling WM 55, etc. Directories WM 22 Experimental WM 20 Techniques WM 25 Geriatric see Geriatric Psychiatry WT 150 Insurance see Insurance, Psychiatric W 270, ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHX etc. Legislation & jurisprudence WM 32-33 Medicolegal see Forensic Psychiatry W 740 Nursing see Psychiatric Nursing WY 160 Office management WM 30 Old age WT 150 Preventive see Community Psychiatry WM 31.5, etc. Social see Psychiatry, Community WM 30.6-31.5; Socioenvironmental Therapy WM 428 See also Forensic Psychiatry W 740 Psychiatry, Biological see Biological Psychiatry Psychiatry, Community see Community Psychiatry Psychiatry, Geriatric see Geriatric Psychiatry Psychiatry, Military see Military Psychiatry Psychic Energizers see Antidepressive Agents Psychic Maladjustment see Personality Disorders Psychical Research see Parapsychology Psychoacoustics WV 270 Psychoactive Agents see Psychotropic Drugs Psychoanalysis WM 460-460.5 In adolescence WS 463 In infancy & childhood WS 350.5 In old age WT 150 Psychoanalytic Interpretation WM 460.7 In adolescence WS 463 In infancy & childhood WS 350.5 In old age WT 150 Of art and literature WM 49 Of famous people from their works WZ 313 Psychoanalytic Theory WM 460 Psychoanalytic Therapy WM 460.6 In adolescence WS 463 In infancy & childhood WS 350.2 Psychodrama WM 430.5.P8 In infancy & childhood WS 350.2 Psychogenetics see Genetics, Behavioral Psychogeriatrics see Geriatric Psychiatry Psychoimmunology see Psychoneuroimmunology Psycholinguistics BF 455-463 In infancy & childhood WS 105.5.C8 Language development LB 1139.L3 Psychological aspects of Aerospace Medicine see Aerospace Medicine Psychological Tests BF 176 In infancy & childhood WS 105.5.E8 In psychiatry WM 145 Projective Techniques WM 145.5.P8 Intelligence Tests BF 431-433 Psychological Theory BF 38-64 Psychological Warfare UB 275-277 Psychology BF Abnormal WM Adolescent see Adolescent Psychology WS 462 As a career BF 75-76 Biography WZ 100 Biography, Collective BF 109 Child see Child Psychology WS 105 Counseling WM 55 Criminal see Criminal Psychology HV 6080-6113 Crowd HM 281-283 USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSIFIED 452 Puberty, Precocious Directories BF 30 Geriatric WT 145 In aviation medicine WD 730 In space medicine WD 754 Mass HM 281-283 Nursing WY 87 Pathological see Psychopathology WM, etc. Phenomenological BF 204.5 Physiological see Psychophysiology WL 103 Sex BF 692 War see Psychology, Military U 22.3; Psychological Warfare UB 275-277 Psychology, Applied BF 636-637 Psychology, Clinical WM 105 In infancy & childhood WS 105 Psychology, Comparative Animals (primarily) QL 751 Human BF 660-685 Psychology, Criminal see Criminal Psychology Psychology, Educational LB 1051-1091 Psychology, Experimental BF 181-198.7 In infancy & childhood WS 105 Laboratory manuals BF 79 Works about research BF 76.5 Psychology, Industrial HF 5548.8 Mental health of working people WA 495 Psychology, Medical WB 104 Special topics, by subject Psychology, Military U 22.3 Psychology, Pastoral see Pastoral Care Psychology, Physiological see Psychophysiology Psychology, Schizophrenic see Schizophrenic Psychology Psychology, Social HM 251-291 In adolescence WS 462 In infancy & childhood WS 105 Psychometrics BF 39 Psychomotor Disorders WM 197 Of the retarded child WS 107.5.P7 See also names of specific disorders Psychomotor Performance WE 104 Psychoneuroimmunology WL 103.7 Psychoneuroses see Neuroses Psychopathic Personality see Antisocial Personality Disorder Psychopathology WM In infancy & childhood WS 350 Psychopharmaceuticals see Psychotropic Drugs Psychopharmacology QV 77 Drug therapy of mental disorders WM 402 Psychophysics WL 702 Psychophysiologic Disorders WM 90 In infancy & childhood WM 90 Sex disorders WM 611 Psychophysiology WL 103 Psychoses see Psychotic Disorders Psychoses, Alcoholic WM 274 Psychoses, Drug see Psychoses, Substance-Induced Psychoses, Manic Depressive see Bipolar Disorder Psychoses, Organic see Organic Mental Disorders, Psychotic Psychoses, Paranoid see Paranoid Disorders Psychoses, Presenile see Dementia, Presenile ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Psychoses, Senile see Dementia, Senile Psychoses, Substance-Induced WM 220 Psychoses, Toxic see Psychoses, Substance-Induced Psychoses, Traumatic see Psychoses, Organic Psychosexual Development BF 692 In adolescence WS 462 In infancy & childhood WS 105.5.P3 Psychosexual Disorders WM 611 Psychosexual Dysfunctions WM 611 Psychosis, Brief Reactive see Psychotic Disorders Psychosis, Involutional see Depression, Involutional Psychosis, Manic-Depressive see Bipolar Disorder Psychosocial Deprivation HM 291 Adolescents WS 462 Children WS 105.5.D3 Psychological aspects WS 105.5.D3 Welfare WA 320 Psychosocial Support Systems see Social Support Psychosomatic Disorders see Psychophysiologic Disorders Psychosomatic Medicine WM 90 Diseases see Psychophysiologic Disorders WM 90, etc. Psychosurgery WL 370 Psychotherapy WM 420 In adolescence WS 463 In infancy & childhood WS 350.2 In old age WT 150 Psychotherapy, Brief WM 420.5.P5 Psychotherapy, Cognitive see Cognitive Therapy Psychotherapy, Group WM 430-430.5 In infancy & childhood WS 350.2 See also names of specific types of group therapy, e.g., Sensitivity Training Groups WM 430.5.S3, etc. Psychotherapy, Multiple WM 420.5.P7 Psychotherapy, Rational see Psychotherapy, Rational-Emotive Psychotherapy, Rational-Emotive WM 420.5.P8 Psychotic Disorders WM 200-220 Functional WM 202 In adolescence WS 463 In infancy & childhood WS 350-350.8 Presenile see Dementia, Presenile WM 220 Psychotomimetic Agents see Hallucinogens Psychotomimetic Drugs see Hallucinogens Psychotropic Drugs QV 77.2-77.9 PTCA see Angioplasty, Transluminal, Percutaneous Coronary Ptdlns see Phosphatidylinositols Pteridines In folic acid QU 188 Organic chemistry QD 401 Pterins QU 110 Pteroylglutamic Acid see Folic Acid Pteroylpolyglutamic Acids QU 188 Pterygium WW 212 Ptomaine Poisoning see Food Poisoining Ptosis, Eyelid see Blepharoptosis PTSD see Stress Disorders, Post-Traumatic Puberty WS 450 Puberty, Delayed WS 450 Puberty, Precocious WS 450 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSOTED 453 Pubic Bone Pubic Bone WE 750 Surgery to facilitate delivery WQ 430 Pubic Symphysis WE 750 Surgery WE 750 To facilitate delivery WQ 430 See also Symphysiotomy WQ 430 Pubiotomy see Surgery WQ 430 under Pubic Bone Public Advocacy see Consumer Advocacy Public Assistance HV 687-4630 For maternal and child welfare (Public health aspects) WA 310-320 For medicosocial problems of the aged WT 30 See also more specific headings, e.g., Medicaid W 250 Public Baths see Baths Public Carriers see Transportation Public Health WA As a profession WA 21 Statistics WA 900 See also Morbidity WA 900; Vital statistics HB, etc. Workers see Allied Health Personnel W 21.5, etc.; Health Manpower W 76 Public Health Administration WA 525-590 Public Health Dentistry WU 113 Public Health Nursing WY 108 Education WY 18 Government (General) WY 130 Indian services WY 130 See also Military Nursing WY 130 Public Health Schools see Schools, Public Health Public Health Surveillance see Population Surveillance Public Housing Hotels WA 799, etc. Low cost housing HD 7288.77-7288.78 Rural HD 7289 Sanitary control WA 795-799 Public Opinion HM 261 Specific topics, by subject Public Policy Abortion HQ 767 Laetrile QZ 267 Other areas, by subject Public Relations HM 263 Specific relations by subject, professions, or named group of persons involved Publishers' Catalogs see Catalogs, Publishers' Publishing Z 278-544 Medical WZ 345 Puericulture see Child Care Puerperal Disorders WQ 500-505 Puerperal Infection WQ 505 Puerperium WQ 500-505 Puerto Ricans see Hispanic Americans Pulex see Fleas Pulmonary Alveolar Proteinosis WF 600 Pulmonary Alveoli WF 600 Pulmonary Artery WG 595.P8 See also Blood Supply WF 600 under Lungs; Pulmonary Circulation WF 600 Pulmonary Circulation WF 600 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Pulmonary Coin Lesion see Coin Lesion, Pulmonary Pulmonary Diffusing Capacity WF 141 Pulmonary Disease, Chronic Obstructive see Lung Diseases, Obstructive Pulmonary Disease (Specialty) WF 100 Pulmonary Diseases see Lung Diseases Pulmonary Edema WF 600 Pulmonary Embolism WG 420 Pulmonary Emphysema WF 648 Pulmonary Fibrosis WF 600 Pulmonary Function Tests see Respiratory Function Tests Pulmonary Gas Exchange WF 102 Used for diagnostic aspects WF 141 Pulmonary Heart Disease WG 420 Pulmonary Incompetence see Pulmonary Valve Insufficiency Pulmonary Medicine see Pulmonary Disease (Specialty) Pulmonary Neoplasms see Lung Neoplasms Pulmonary Nodule, Solitary see Coin Lesion, Pulmonary Pulmonary Regurgitation see Pulmonary Valve Insufficiency Pulmonary Stenosis see Pulmonary Valve Stenosis Pulmonary Surfactants WF 600 Pulmonary Tuberculosis see Tuberculosis, Pulmonary Pulmonary Valve WG 269 Pulmonary Valve Incompetence see Pulmonary Valve Insufficiency Pulmonary Valve Insufficiency WG 269 Pulmonary Valve Stenosis WG 269 Pulmonary Veins WG 625.P8 See also Blood Supply WF 600 under Lungs; Pulmonary Circulation WF 600 Pulmonology see Pulmonary Disease (Specialty) Pulp see Dental Pulp Pulp Canal see Dental Pulp Cavity Pulp Capping see Dental Pulp Capping Pulp Chamber see Dental Pulp Cavity Pulpitis WU 230 Pulpotomy WU 230 Pulsatile Flow WG 106 Pulse Cardiovascular diagnosis WG 141 General diagnosis WB 282 Hemodynamics WG 106 Pulse Oximetry see Oximetry Pulse Radiolysis QD 643.P84 Pulsus Alternans see Arrhythmia Pulverization see Drug Compounding; Powders Pumping, Intra-Aortic Balloon see Intra-Aortic Balloon Pumping Pumps, Heart-Assist see Heart-Assist Devices Pumps, Infusion see Infusion Pumps Punched-Card Systems Z 695.92 Special topics, by subject Puncture Biopsy see Biopsy, Needle Puncture Fluids see Body Fluids; Diagnosis, Laboratory; Exudates and Transudates Punctures WB 373-377 Cisternal WB 377 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSD7IED 454 Sternal WH 380 Ventricular WB 377 See also Amniocentesis WQ 209; Biopsy, Needle WB 379, etc.; Spinal Puncture WB 377, etc. Punishment In adolescence WS 462-463 In infancy & childhood WS 105.5.C3 Conditioned response BF 319.5.P8 Theory of (Penology) K 5103 Pupil WW 240 Dilatation WW 240 See also Dilatation, Pathologic WW 240, etc. Dilators QV 134 Pupillary Reflex see Reflex, Pupillary Puppets see Play and Playthings Purchasing, Hospital WX 157 Pure Food Laws see Food and drug laws WA 697 under Legislation, Drug Pure Red-Cell Aplasia see Red-Cell Aplasia, Pure Purgatives see Cathartics Purification see Environment, Controlled; Sterilization Purine-Nucleoside Phosphorylase QU 141 Purine Nucleosides QU 57 Pharmacology QV 185 Purine-Pyrimidine Metabolism, Inborn Errors WD 205.5.P8 See also Gout WE 350 Purine Receptors see Receptors, Purinergic Purinergic Receptors see Receptors, Purinergic Purines Constituents of nucleic acids QU 58 Organic chemistry QD 401 Stimulants QV 107 Purkinje Cells WL 320 Purple Membrane see Bacteriorhodopsin Purpura WH 314-320 Purpura, Thrombocytopenic WH 315 Purpura, Thrombopenic see Purpura, Thrombocytopenic Pursuit, Saccadic see Saccades Pus see Suppuration Pustulants see Irritants Pustular Dermatosis, Subcorneal see Skin Diseases, Vesiculobullous Pustular Psoriasis of Palms and Soles see Psoriasis Pustulosis of Palms and Soles see Psoriasis Pustulosis Palmaris et Plantaris see Psoriasis PUVA Therapy WB 480 PVP-Iodine see Povidone-Iodine Pyelitis WJ 351 Pyelography see Urography Pyelonephritis WJ 351 Pyelonephritis, Acute Necrotizing see Kidney Papillary Necrosis Pyelophlebitis see Phlebitis Pyemia see Septicemia Pygathrix see Cercopithecidae Pyknolepsy see Epilepsy, Absence Pyloric Antrum WI 387 Pyloric Stenosis WI 387 Pylorospasm see Spasm Pylorus WI 387 Pyoctanium aureum see Benzophenoneidum Pyoderma WR 220 Pyonephrosis see Pyelonephritis Pyopneumothorax see Pneumothorax Pyorrhea Alveolaris see Periodontal Diseases Pyothorax see Empyema Pyramidal Tracts WL 400 Pyrans QV 138.C1 Organic chemistry QD 405 Pyrazinopyrimidines see Pteridines Pyrazoles Organic chemistry QD 401 Pharmacology QV 95 Pyrethrum As an insecticidal plant SB 292. P8 Public health aspects WA 240 Pyretotherapy see Hyperthermia, Induced Pyrexia see Fever Pyridazines QV 150 As antirheumatoid agents QV 95 Organic chemistry QD 401 Pyridines Enzyme inhibitors QU 143 Organic chemistry QD 401 Pyridinium Compounds Enzymology QU 135 Organic chemistry QD 401 Pyridinones see Pyridones Pyridones As anti-arteriosclerosis agents QV 150 Organic chemistry QD 401 Pyridoxal QU 195 Pyridoxine QU 195 Pyridoxine Deficiency WD 120 Pyrimethamine QV 256 Pyrimidines Constituents of nucleic acids QU 58 Organic chemistry QD 401 Pyrocatechols see Catechols Pyrogallol QV 223 Pyrogens As substances causing fever WB 152 Special topics, by subject Pyromania see Firesetting Behavior Pyrophosphatases QU 136 Pyrophosphates see Diphosphates Pyrosis see Heartburn Pyrroles As antirheumatoid agents QV 95 In heme and porphyrin chemistry WH 190 Organic chemistry QD 401 Pyrrolidines As antineoplastic agents QV 269 Organic chemistry QD 401 Pyruvaldehyde QU 98 Pyruvate Oxidase QU 140 Pyruvates QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Pyuria WJ 151 In urine analysis QY 185 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 455 Pyuria Q Q Fever WC 625 Quackery WZ 310 Supposed antineoplastic agents QV 269 Quadrigeminal Plate see Corpora Quadrigemina Quadriplegia WL 346 Veterinary SF 895 Quality Assessment, Health Care see Quality Assurance, Health Care Quality Assurance, Health Care W 84 Special topics, by subject Quality Circles see Management Quality Circles Quality Control Drugs QV 771 Public health aspects WA 730 Food (Flavor, texture, appearance) TP 372.5 Public health aspects WA 695-722 Health services W 84 Hospitals WX 153 See also Facility Regulation and Control WX 153 Nursing WY 16 Psychiatry WM 30 Sanitation WA 672 Other particular products or procedures, by subject Of other specialty fields, in the number for the profession, e.g. Dentistry WU 21 Quality of Health Care General W 84 Hospitals WX 153 Private practice WB 50 Public health WA 525-546 Quality of Life WA 30 Specific topics, by subject Quantum Theory QC 173.96-174.52 Quarantine WA 230 Law WA 32-33 Port and maritime WA 234 Veterinary medicine SF 740 By locality SF 621-723 Quarantine Hospitals see Hospitals, Special Quartz Toxicology QV 610 Questionnaires Research (Form number 20 or 20.5 in any NLM schedule where applicable) Statistical methods in psychology BF 39 Surveys Health WA 900 Nutrition QU 146 Special topics, by subject Queuing Theory see Systems Theory Quick Test see Prothrombin Time Quinacrine QV 258 Quinalbarbitone see Secobarbital Quinazolines As antihypertensive agents QV 150 Organic chemistry QD 401 Quincke's Edema see Angioneurotic Edema Quinidine QV 155 Quinine QV 257 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHX Quinolines As anti-infective agents QV 250 Organic chemistry QD 401 Quinolinic Acids Biochemistry QU 65 Organic chemistry QD 401 Quinolinium Compounds As anti-infective agents QV 250 Organic chemitry QD 401 Quinolinols see Hydroxyquinolines Quinolinones see Quinolones Quinolone Anti-Infective Agents see Anti-Infective Agents, Quinolone Quinolones QV 250 Quinones Organic chemitry QD 341.Q4 Quinoxalines As anti-infective agents QV 250 Organic chemistry QD 401 Quintan Fever see Trench Fever Quinuclidines As autonomic drugs (general) QV 120 Organic chemistry QD 401 Quokkas see Kangaroos R R Factors QW 51 R Plasmids see R Factors Rabbit Aorta Contracting Substance see Thromboxane A2 Rabbit Fever see Tularemia Rabbits As laboratory animals QY 60.L3 Culture SF 451-455 Diseases (Domestic and Wild) SF 997.5.R2 Wild QL 737.L32 Rabies WC 550 Veterinary SF 797 Rabies Vaccine WC 550 Rabies Virus QW 168.5.R2 Raccoon Dogs see Carnivora Race see Racial Stocks Race Psychology see Ethnopsychology Race Relations HT 1503-1595 Adolescent WS 462 Children WS 105.5.S6 Discrimination (non-MeSH usage) In education LC 212-212.73 In employment HD 4903-4903.5 In housing HD 7288.75-7288.76 In particular countries (General) by country D, E, or F schedules Races, Diseases of see Diseases WB 720 under Ethnic Groups Rachitis see Rickets Racial Stocks GN 537-673 Miscegenation GN 254 See also special topics under Ethnic Groups Radar TK 6573-6595 Special topics, by subject Rademacherism see Alternative Medicine Radial Keratotomy see Keratotomy, Radial IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 456 Radiant Warmers, Infant see Incubators, Infant Radiation WN As a cause of disease (Pathology) QZ 57 Physics (General) QC 474-496.9 Radiation Biology see Radiobiology Radiation Counters see Instrumentation WN 150 under Technology, Radiologic; Scintillation Counting; Whole-Body Counting Radiation Dosage Measurement, tolerance, safety measures WN 665 See also Radiotherapy Dosage WN 250, etc. Radiation Effects WN 610-630 See also names of organs, organisms, chemicals, drugs, or processes affected Radiation Genetics WN Animal WN 620 General works WN 610 Human WN 620 Plant WN 630 Radiation-Induced Dermatitis see Radiodermatitis Radiation Injuries WN 610-650 In industry WA 470 Prevention & control WN 650 Veterinary SF 757.8 See also Adverse effects WN 200 under Radiography; Adverse effects WN 250 under Radiotherapy; Adverse Effects WN 300 under Radium Radiation Injuries, Experimental WN 620 Radiation, Ionizing General works WN 105 Radiation Monitoring WN 650 Radiation, Non-Ionizing Diseases caused by WD 605 Diagnostic use WB 288 General medical use WB 117 General physiological effects QT 162.U4 Therapeutic use WB 480 Used for special purposes, by subject See also names of specific forms of non-ionizing radiation, e.g., Light WB 117, etc. Radiation Protection WN 650 In industry WA 470 See also Radioactive Waste WA 788 Radiation-Protective Agents WN 650 Radiation Sensitivity see Radiation Tolerance Radiation-Sensitizing Agents WN 610 Radiation Sickness see Radiation Injuries Radiation Syndrome see Radiation Injuries Radiation Therapy, Computer-Assisted see Radiotherapy, Computer-Assisted Radiation Tolerance WN 650 In treating particular conditions, with the condition, e.g., in the radiotherapy of neoplasms QZ 269 Radiation, Visible see Light Radiation, Whole-Body see Whole-Body Irradiation Radicular Cyst WU 240 Radiculitis WL 400 Radiesthesia WB 960 Radio In general education LB 1044.5-1044.6 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIU Radiography, Interventional In special fields of education (Form number 18.2 in any NLM schedule where applicable) Influence on adolescent WS 462 Influence on child WS 105.5.E9 Special topics, by subject Radio-Hippuran see Iodohippuric Acid Radio Waves QC 676-678.6 Adverse effects (General) WD 605 General physiological effects QT 162.U4 Radioactive Air Pollutants see Air Pollutants, Radioactive Radioactive Fallout WN 610-650 Radioactive Pollutants WN 615 Environmental Industrial WA 788 Atomic bomb WN 610-650 In industry WA 470 See also Radioactive Waste WA 788; names of other types of pollutants Radioactive Pollution see Air Pollution, Radioactive; Food Contamination, Radioactive; Water Pollution, Radioactive; also various types of pollutants, e.g., Radioactive Fallout Radioactive Substances see Radium; Radioisotopes; Radioactive Pollutants; Air Pollutants, Radioactive; Radiation, Ionizing WN 100, etc. and names of specific substances, e.g., Gold Colloid, Radioactive Radioactive Tracers WN 415-450 Radioactive Waste WA 788 Radioactivity WN 415-450 Safety measures WN 650 In industry Waste material WA 788 Workers WA 470 Radioallergosorbent Test QW 525.5.R15 Radioautography see Autoradiography Radiobiology WN 600 Radiochemistry QD 601-655 Radiocinematography see Cineradiography Radiodermatitis WR 160 Radiographic Film see X-Ray Film Radiographic Image Enhancement WN 160 Localized, by site Radiographic Intensifying Screens see X-Ray Intensifying Screens Radiographic Magnification WN 160 Localized, by site Radiography WN 180-240 Adverse effects WN 200 In infancy & childhood WN 240 Instrumentation WN 150 Veterinary SF 757.8 See also Diagnostic use WN 445 under Radioisotopes; names of specific radiographic techniques; names of organs, regions, and diseases being diagnosed Radiography, Body-Section see Tomography, X-Ray Radiography, Dental WN 230 Radiography, Insufflation see Pneumoradiography Radiography, Interventional WN 200 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 457 Radiography, Panoramic Radiography, Panoramic WN 230 Radioimmunoassay QW 525.5.R2 Assay of hormones QY 330 Used for diagnostic, monitoring or evaluation tests in special fields, with the field Radioimmunodetection WN 203 Radioimmunoimaging see Radioimmunodetection Radioimmunoscintigraphy see Radioimmunodetection Radioimmunosorbent Assay of Allergens see Radioallergosorbent Test Radioisotope Brachytherapy see Brachytherapy Radioisotope Dilution Technique WG 141 Blood volume WG 106 Radioisotope Generators see Radionuclide Generators Radioisotope Renography WJ 302 Radioisotope Scanning see Radionuclide Imaging Radioisotope Teletherapy WN 450 Radioisotopes WN 415-450 Adverse effects WN 610-650 Diagnostic use WN 445 General works slanted toward the biological sciences WN 420 Nuclear engineering TK 9400-9401 Nuclear medicine (General) WN 440 Nuclear physics General QC 795.6-795.8 Specific, A-Z (tike QD 181) QC 796 Therapeutic use WN 450 Used for special purposes, by subject See also Radioactive Waste WA 788; Radionuclide Imaging WN 203 Radiologic Physics see Health Physics Radiologic Services in Hospitals see Hospital Departments; Mass Chest X-Ray Radiology WN Veterinary medicine SF 757.8 Radiology Department, Hospital WN 27-28 Radiology, Diagnostic X-Ray see Radiography Radiology Information Systems WN 26.5 Radiology, Interventional As a profession WN 21 Radiometry WN 660 Equipment WN 150 Radionuclide Generators WN 150 Radionuclide Imaging WN 203 Cardiovascular diseases (General) WG 141.5.R3 Localized, by site Radionuclide Tomography, Computed see Tomography, Emission-Computed Radionuclide Tomography, Single-Photon Emission-Computed see Tomography, Emission-Computed, Single-Photon Radionuclides see Radioisotopes Radiopaque Media see Contrast Media Radiopharmaceuticals see Nuclear Medicine; Radioisotopes; Radionuclide Imaging; names of drugs or chemicals to which the radioactive substance is attached Radioscopy see Fluoroscopy Radiosensitivity see Radiation Tolerance Radiotherapy Adverse effects WN 250 Anti-neoplastic see Radiotherapy QZ 269 under Neoplasms Dermatology WR 660 General works WN 250 Radioisotopes see Therapeutic use WN 450 under Radioisotopes Radium see Therapeutic use WN 340 under Radium Veterinary SF 757.8 X-ray therapy WN 250.5.X7 See also names of diseases for which therapy is used Radiotherapy, Computer-Assisted WN 250.5.R2 Radiotherapy Dosage Radioisotopes WN 450 Radium WN 340 X-rays WN 250.5.X7 See also Radiation Dosage WN 665 Radiotherapy, High-Energy WN 250.5.R3 See also special topics under Radiotherapy Radiotherapy, Interstitial see Brachytherapy Radiotherapy, Intracavity see Brachytherapy Radiotherapy Planning, Computer-Assisted WN 250.5.R2 Radiotherapy, Surface see Brachytherapy Radium WN 300-340 Adverse effects WN 300 Inorganic chemistry QD 181.R1 Therapeutic use WN 340 Radius WE 820 Radius Fractures WE 820 Radon WN 300-340 General works WN 300 Therapeutic use WN 340 Rage BF 575.A5 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Raillietina see Cestoda Raillietiniasis see Cestode Infections Railroads Accidents WA 275 Occupational medicine WA 400-495 Nursing service WY 143 Sanitary control of public carriers WA 810 Rain Meteorology QC 924.5-926.2 Special topics, by subject, e.g., Air Pollution WA 754 Rales see Respiratory Sounds Raman Spectroscopy see Spectrum Analysis, Raman Ramps see Architectural Accessibility Ramsay Hunt Paralysis Syndrome see Parkinson Disease Random Allocation (Form number 20 or 20.5 in any NLM schedule where applicable) Randomization see Random Allocation Randomized Controlled Trials Special topics, by subject See also Clinical Trials ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 458 Receptors, Estrogen Ranitidine As an anti-ulcer agent QV 69 Rape Criminology HV 6558-6569 Medicolegal aspects W 795 Therapy for victims WM 401 Rapeseed see Brassica Raphe Nuclei WL 310 Rapid Eye Movements see Sleep, REM Rare Books Works about Z 688.R3 Medical books by period (if old) WZ 220-270 By subject, if post 1801 or post-Americana ras Genes see Genes, ras Rat-Bite Fever WC 390 Rat Virus see Parvovirus Rate Setting and Review General W 74 Hospitals WX 157 Rational-Emotive Psychotherapy see Psychotherapy, Rational-Emotive Rationalization WM 193.5.R1 Rationing, Health Care see Health Care Rationing Rats Diseases SF 997.5.R3 As laboratory animals QY 60. R6 Public health aspects see Rodent Control WA 240 Rats, Bandicoot see Muridae Rats, Brattleboro As laboratory animals QY 60.R6 Rats, Inbred CDF see Rats, Inbred F344 Rats, Inbred Fischer 344 see Rats, Inbred F344 Rats, Inbred F344 As laboratory animals QY 60. R6 Rats, Inbred SHR As laboratory animals QY 60. R6 Rats, Inbred Strains As laboratory animals QY 60. R6 Rats, Laboratory see Rats Rats, Mutant Strains As laboratory animals QY 60. R6 Rats, Norway see Rats Rats, Sand see Gerbillinae Rats, Spontaneously Hypertensive see Rats, Inbred SHR Rattlesnake Venoms see Crotalid Venoms Rattus see Muridae Rattus norvegicus see Rats Rauwolfia QV 150 Rauwolfia Alkaloids QV 150 Rauwolscine see Yohimbine Raw Food Diet see Diet Raynaud's Disease WG 570 Reactants, Acute Phase see Acute Phase Proteins Reaction, Acute-Phase see Acute-Phase Reaction Reaction Time BF 317 Reactive Disorders see Adjustment Disorders Reactive Site see Binding Sites Readiness Potential see Contingent Negative Variation Reading Education (General) LB 1050-1050.75 Children with learning disabilities LC 4704-4803 Mentally disabled children LC 4620 Medical aspects of problems associated with poor vision WW 480 Psychology BF 456.R2 See also Dyslexia WL 340.6; Dyslexia, Acquired WL 340.6 Reading Disability, Acquired see Dyslexia, Acquired Reading Disability, Developmental see Dyslexia Reading, Therapeutic see Bibliotherapy Reagent Kits, Diagnostic QY 26 Used for particular tests, by subject, e.g., for hemoglobin examination QY 455 Reagents see Indicators and Reagents Reagins QW 575 Associated with hypersensitivity QW 900 Real-Time Systems see Computer Systems Reality Testing Child psychology WS 105.5.S3 Psychoanalysis WM 460.5.E3 Recall BF 370-385 In infancy & childhood WS 105.5.M2 Receptor-Mediated Signal Transduction see Signal Transduction Receptors, Acetylcholine see Receptors, Cholinergic Receptors, Adenosine see Receptors, Purinergic PI Receptors, ADP see Receptors, Purinergic P2 Receptors, Adrenergic WL 102.8 Receptors, Adrenergic, alpha WL 102.8 Receptors, Adrenergic, beta WL 102.8 Receptors, alpha-Adrenergic see Receptors, Adrenergic, alpha Receptors, Angiotensin QU 68 Receptors, Antigen QW 573 Receptors, Antigen, T-Cell QW 573 Receptors, ATP see Receptors, Purinergic P2 Receptors, Benzodiazepine see Receptors, GAB A-A Receptors, Benzodiazepine-GABA see Receptors, GABA-A Receptors, beta-Adrenergic see Receptors, Adrenergic, beta Receptors, Caerulein see Receptors, Cholecystokinin Receptors, Caffeine see Receptors, Purinergic Receptors, Cell Surface Biochemistry QU 55 Immunochemistry QW 504.5 Pharmacology QV 38 Receptors, Cholecystokinin WK 170 Receptors, Cholinergic WL 102.8 Receptors, Complement QW 680 Receptors, Corticosteroid see Receptors, Glucocorticoid Receptors, Diazepam see Receptors, GABA-A Receptors, Diiodotyrosine see Receptors, Thyroid Hormone Receptors, Dopamine WL 102.8 Receptors, Drug QV 38 Receptors, Endogenous Substances see Receptors, Cell Surface Receptors, Epidermal Growth Factor-Urogastrone WK 170 Receptors, Estrogen WP 522 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 459 Receptors, Fc Receptors, Fc QW 601 Receptors, GABA-A QU 60 Receptors, GABA-Benzodiazepine see Receptors, GABA-A Receptors, gamma-Aminobutyric Acid see Receptors, GABA Receptors, Gastrin see Receptors, Cholecystokinin Receptors, Gastrointestinal Hormone WK 170 Receptors, Glucocorticoid WK 150 Receptors, Growth Hormone see Receptors, Somatotropin Receptors, Histamine QV 157 See also Histamine HI Receptor Blockaders QV 157 Receptors, Histamine H2 QV 157 Receptors, Hormone WK 102 Localized, by site See also names of specific hormone receptors Receptors, IL-2 see Receptors, Interleukin-2 Receptors, Immunologic QW 570 Immunochemistry QW 504.5 Receptors, Interleukin-2 QW 568 Receptors, LDL QU 95 Receptors, Low Density Lipoprotein see Receptors, LDL Receptors, Muscarinic WL 102.8 Receptors, Muscimol see Receptors, GABA-A Receptors, N-Methyl-D-Aspartate QU 60 As neurotransmitter QV 126 In synaptic transmission WL 102.8 Receptors, Neural see Receptors, Sensory Receptors, Neurohumor see Receptors, Neurotransmitter Receptors, Neurotransmitter WL 102.8 Receptors, Nicotinic WL 102.8 Receptors, Pancreozymin see Receptors, Cholecystokinin Receptors, Pheromone see Chemoreceptors Receptors, Progesterone WP 530 Receptors, Progestin see Receptors, Progesterone Receptors, Proglumide see Receptors, Cholecystokinin Receptors, Prostaglandin QU 90 Receptors, Purinergic QU 58 Receptors, Purinergic PI QU 58 Receptors, Purinergic P2 QU 58 Receptors, Sensory WL 102.9 Receptors, Sincalide see Receptors, Cholecystokinin Receptors, Somatotropin WK 515 Receptors, Steroid WK 150 Receptors, Stretch see Mechanoreceptors Receptors, Synaptic see Receptors, Neurotransmitter Receptors, T-Cell Growth Factor see Receptors, Interleukin-2 Receptors, Tetragastrin see Receptors, Cholecystokinin Receptors, Theophylline see Receptors, Purinergic Receptors, Thyroid Hormone WK 202 Receptors, Thyroxine see Receptors, Thyroid Hormone Receptors, Transforming Growth Factor Alpha see Receptors, Epidermal Growth Factor-Urogastrone Receptors, Triiodothyronine see Receptors, Thyroid Hormone Receptors, Urogastrone see Receptors, Epidermal Growth Factor-Urogastrone Receptors, Virus QW 160 Receptosomes see Endosomes Recklinghausen's Disease of Bone see Osteitis Fibrosa Cystica Recklinghausen's Disease of Nerve see Neurofibromatosis Recombinant DNA see DNA, Recombinant Recombinant Interferon Alfa-2c see Interferon Alfa, Recombinant Recombinant Proteins QU 55 Biotechnology TP 248.65.P76 Recombination, Genetic QH 443-450.6 Record Linkage, Medical see Medical Record Linkage Records Bibliographical on magnetic tape Z 699-699.5 Government administration JF 1521 Hospital see Hospital Records WX 173 Public records and privacy JC 596-596.2 Statistical HA 38-39 See also Dental Records WU 95; Medical Records WX 173, etc.; Nursing Records WY 100.5 Records Control see Forms and Records Control Recovery Period, Anesthesia see Anesthesia Recovery Period Recovery Room WX 218 Recovery Room Nursing see Postanesthesia Nursing Recreation QT 250 Centers (General works) GV 182 For physical education and outdoor games QT 250 Recrudescence see Recurrence Rectal Diseases WI 600 Rectal Drug Administration see Administration, Rectal Rectal Fistula WI 605 See also Rectovaginal Fistula WP 180 Rectal Neoplasms WI 610 Rectal Prolapse WI 600 Rectal Surgery (Specialty) see Colon and Rectal Surgery (Specialty) Rectocolitis, Hemorrhagic see Colitis, Ulcerative Rectocolitis, Ulcerative see Colitis, Ulcerative Rectovaginal Fistula WP 180 Rectum WI 600-650 Anesthesia by see Anesthesia, Rectal WO 290 Feeding by see Tube feeding WB 410 Medication by see Enema WB 344; Suppositories QV 785 Surgery WI 650 Recurrence QZ 140 Of specific diseases, with the disease Red Blood Cell Count see Erythrocyte Count Red Blood Cell Membrane Sialoglycoprotein see Glycophorin Red Blood Cell Transfusion see Erythrocyte Transfusion Red Blood Cells see Erythrocytes ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 460 Regression (Psychology) Red Bugs see Trombiculid Mites Red-Cell Aplasia, Pure WH 155 Red Cell Ghost see Erythrocyte Membrane Red Cell Mass see Erythrocyte Volume Red Cell Substitutes see Blood Substitutes Red Cross Army services UH 535-537 Disasters HV 560-583 Navy services VG 457 Nursing WY 137 Red Marrow see Bone Marrow Red Mites see Trombiculid Mites Red Monkey see Erythrocebus patas Red Nucleus WL 310 Red Tide see Dinoflagellida Redox see Oxidation-Reduction Reductases see Oxidoreductases Reductive Enzymes see Oxidoreductases Reeler Mice see Mice, Neurologic Mutants Reference Books General Z 711 On special topics, by subject Reference Books, Medical Bibliography ZWB 100 On special topics, by subject, e.g., Dictionary of Nutrition QU 13 Reference Ranges see Reference Values Reference Standards Drugs QV 771 Of other products, by subject Reference Values (Form number 16 in any NLM schedule where applicable) Referral and Consultation Initiated by the nurse practitioner WY 90 Initiated by the physician W 64 Initiated by the psychiatrist WM 64 Initiated by the surgeon WO 64 In other specific specialties, in the number for interpersonal relationships or lacking that, in the general works number Specific conditions discussed, by subject Reflex WL 106 Psychogalvanic see Galvanic Skin Response WM 145, etc. See also Conditioning, Classical BF 319 and other types of conditioning Reflex, Abnormal WL 340 Reflex, Acoustic In hearing assessment WV 274 Reflex, Conditioned see Conditioning, Classical Reflex Epilepsy see Epilepsy Reflex, Pharyngeal see Gagging Reflex, Psychogalvanic see Galvanic Skin Response Reflex, Pupillary WW 240 Reflex, Stretch WL 106 Reflex Sympathetic Dystrophy WL 600 Reflex, Tendon see Reflex, Stretch Reflex, Vestibulo-Ocular WV 255 Reflexology see Massage Reflexotherapy WB 962 Refraction, Ocular WW 300-320 Refractive Disorders see Refractive Errors Refractive Errors WW 300-320 Diagnosis WW 300 Refractive Index see Refractometry Refractometry QC 387 Refrigeration Biological products WA 730 Blood WH 460 Chemical technology TP 490-497 Drugs WA 730; QV 754 Food WA 710 Organs WO 665 Specimen handling QY 25, etc. Refrigeration Anesthesia see Anesthesia, Refrigeration Refugees Health problems WA 300 Mental health problems WA 305 Relief HV 640-640.5 Refuse Disposal Industrial bacteriology QW 75 Public health aspects General WA 780 Industrial WA 788 Solid and fluid waste combined (General) WA 778 See also names of specific types of waste and waste disposal, e.g., Industrial Waste, Radioactive Waste, Medical Waste, Medical Waste Disposal, etc. Regeneration Biology QH 499 Bone see Bone Regeneration WE 200 Liver see Liver Regeneration WI 702 Local reaction to injury (Pathology) QZ 150 Nerve see Nerve Regeneration WL 102 Other specific areas, with the area affected See also Wound Healing WO 185, etc. Regional Anatomy see Anatomy, Regional Regional Anesthesia see Anesthesia, Conduction Regional Blood Flow WG 106 Regional Health Planning WA 541 Regional Hospital Planning see Hospital Planning Regional Medical Programs WA 541 Regional Perfusion see Perfusion, Regional Regional Surgery see Surgery; names of organs or regions treated Registration see Birth Certificates; Death Certificates; Licensure; Notifiable disease registration WA 55 under Communicable Disease Control Registries Of mental diseases Administration of registries WM 30 Statistics themselves WM 16 Of neoplastic diseases QZ 200 Of notifiable diseases WA 55, etc. Of other diseases or types of data (Form number 16 in any NLM schedule where applicable) Regression Analysis QA 278.2 Special topics, by subject Regression Diagnostics see Regression Analysis Regression (Psychology) WM 193.5.R2 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 461 Regression (Psychology) In adolescence WS 463 In infancy & childhood WS 350.8.D3 Regulation of Gene Expression see Gene Expression Regulation Regulation of Gene Expression, Bacterial see Gene Expression Regulation, Bacterial Regulation of Gene Expression, Enzymologic see Gene Expression Regulation, Enzymologic Regulation of Gene Expression, Neoplastic see Gene Expression Regulation, Neoplastic Regulation of Gene Expression, Viral see Gene Expression Regulation, Viral Regurgitation, Gastric see Gastroesophageal Reflux Rehabilitation WB 320 Disabled veterans UB 360-366 Educational LC 4001-4824 General works on physically disabled WB 320 Of the blind HV 1573-2349 Medical WW 276 Of the deaf, etc. HV 2353-2990.5 etc. Medical rehabilitation WV 270-280 Orthopedic devices for see Orthopedic Equipment WE 172 Physical therapy WB 460 Physically disabled child WS 368 Psychological problems WS 105.5.H2 Retarded child see Mental Retardation WS 107.5.R3 Sociological aspects HD 7255-7256 Videotherapy in psychiatry WM 450.5.V5 See also names of particular disabilities or diseases being treated Rehabilitation Centers For the mentally disabled; alcoholics and drug addicts WM 29 For the physically disabled WB 29 See also Halfway houses WM 29, etc.; Sheltered workshops WB 29, etc. Rehabilitation, Vocational HD 7255-7256 See also Occupational Therapy WB 555, etc. Rehydration see Fluid Therapy Rehydration, Oral see Fluid Therapy Rehydration Solutions QV 786 Used for special purposes, by subject Reimbursement, Health Insurance see Insurance, Health, Reimbursement Reimbursement, Incentive Hospitals WX 157 Reimbursement Mechanisms Dentistry WU 77 Hospitals WX 157 Medicine W 80 Nursing WY 77 Pharmacy QV 736 In other specific fields, by subject Reimbursement, Prospective see Prospective Payment System Reimplantation see Replantation Reimplantation, Tooth see Tooth Replantation Reindeer QL 737.U55 Diseases SF 997.5.D4 Reinforcement (Psychology) BF 319.5.R4 Associated with psychoanalysis WM 460.5.R2 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Reinforcement Schedule BF 319.5.R4 Reinforcement, Social HM 291 Reinforcement, Verbal LB 1065 Rejuvenation WJ 875 rel Genes see Oncogenes Relapse see Recurrence Relapsing Fever WC 410 Relationship, Blood see Consanguinity; Family; Paternity; Twins Relative Risk see Risk Relative Value Scales Dental WU 77 Hospital WX 157 Medical W 74 Nursing WY 77 Pharmaceutical QV 736 For other services, by subject Relative-Value Schedules see Relative Value Scales Relaxation Hygiene QT 265 Mental health WM 75, etc. Physical therapy WB 545 Relaxation Techniques Behavior therapy WM 425.5.R3 Hygiene QT 265 Mental health WM 75 Physical therapy WB 545 Relaxation Therapy see Relaxation Techniques Reliability and Validity see Reproducibility of Results N Relief Work HV 553-555 i Hospital emergency service WX 215 See also special topics under Disasters Religion BL-BX In psychoanalysis WM 460.5.R3 See also Religion and Psychology BL 53, etc. Religion and Medicine Ethical considerations Church's BL 65.M4 Doctor's W 50 In literature WZ 330 Mental healing aspects WB 885 Mental health aspects WM 61 Other aspects, by subject See also specific religions, e.g., Christian Science BX 6903-6997, etc. Religion and Psychology Psychology of religion BL 53 Therapeutic aspects WM 61 See also Mental Healing WB 880-885; Pastoral Care WM 61 Religion and Science BL 239-265 Religion and Sex HQ 63 In psychoanalysis WM 460.5.R3 Religious Beliefs see Religion REM WL 108 Remedial Teaching LB 1029.R4 Special students, by type, e.g., the deaf HV 2417-2990.5 Remedies see Therapeutics Remission Induction WB 300 Special topics, by subject USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 462 Research Protocols, Clinical Remission, Spontaneous QZ 140 In specific diseases, with the disease Remission, Spontaneous Neoplasm see Neoplasm Regression, Spontaneous Renal Aminoaciduria see Aminoaciduria, Renal Renal Artery WG 595.R3 See also Blood Supply WJ 301 under kidney Renal Artery Obstruction WJ 300 Renal Artery Stenosis see Renal Artery Obstruction Renal Calculi see Kidney Calculi Renal Circulation WJ 301 Renal Dialysis, Home see Hemodialysis, Home Renal Disease, End-Stage see Kidney Failure, Chronic Renal Failure, Acute see Kidney Failure, Acute Renal Failure, Chronic see Kidney Failure, Chronic Renal Failure, End-Stage see Kidney Failure, Chronic Renal Function Tests see Kidney Function Tests Renal Hormones see Hormones Renal Hypertension see Hypertension, Renal Renal Insufficiency see Kidney Failure, Acute; Kidney Failure, Chronic Renal Insufficiency, Acute see Kidney Failure, Acute Renal Insufficiency, Chronic see Kidney Failure, Chronic Renal Osteodystrophy WD 200.5.C2 Renal Papillitis, Necrotizing see Kidney Papillary Necrosis Renal Transplantation see Kidney Transplantation Renal Tubular Transport WJ 301 Renal Tubular Transport, Inborn Errors WJ 301 Renal Veins WG 625.R3 See also Blood Supply WJ 301 under kidney Renin WK 180 Enzymology QU 136 Renin-Angiotensin-Aldosterone System see Renin-Angiotensin System Renin-Angiotensin System Enzymology QU 136 In hemodynamics WG 106 Renin-Substrate see Angiotensinogen Rennin see Chymosin Renography see Radioisotope Renography Reoperation WO 500 For specific condition, with the condition Reoviridae QW 168.5.R15 Reoviruses see Reoviridae Reperfusion Injury QZ 170 Localized, by site As a postoperative complication WO 184 Reperfusion Injury, Myocardial see Myocardial Reperfusion Injury Reperfusion, Myocardial see Myocardial Reperfusion Repetition Strain Injury WE 175 Replacement Therapy, Estrogen see Estrogen Replacement Therapy Replantation WO 700 Localized, by specific organ or tissue Replantation, Tooth see Tooth Replantation Repression WM 193.5.R4 In adolescence WS 463 In infancy & childhood WS 350.8.D3 Reproducibility of Results Used for special purposes, by subject Reproduction Animals, Domestic General SF 887 Specific SF 768.2.A^Z Animals, Wild General QP 251-285 Specific QL 364-739.2 Bacteria QW 52 Drugs affecting QV 170-177 Fishes SH 165 General biology QH 471-489 Human WQ 205-208 Plant ecology QK 925-929 Plant physiology QK 825-830 See also Genitalia WJ 100, etc.; Urogenital System WJ, etc. Reproductive System see Genitalia; Reproduction; Urogenital System Reptile Poisons see Snake Venoms Reptiles QL 665-666 As poisonous animals WD 410 Diseases SF 997.5.R4 Research (Form number 20 or 20.5 in any NLM schedule where applicable) Anesthesia WO 220 Genetics QH 440 For the biochemist QU 20 Internal medicine WB 25 Neoplasms QZ 206 Radiology WN 20 Scientific Q 179.9-180.6 Other fields outside the NLM area, in appropriate LC number Research, Clinical Nursing see Clinical Nursing Research Research Design (Form number 20-20.5 in any NLM schedule where applicable) Science Q 180.Al, etc. Research, Health Services see Health Services Research Research Institutes see Academies and Institutes Research, Nursing see Nursing Research Research, Nursing Administration see Nursing Administration Research Research, Nursing Education see Nursing Education Research Research, Nursing Evaluation see Nursing Evaluation Research Research, Nursing Methodology see Nursing Methodology Research Research Personnel Medical W 20.5 Scientific (General) Q 180.A5-Z [by country] Directories Q 145 See also names of fields in which research is done Research Protocols, Clinical see Clinical Protocols ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 463 Research Support Research Support (Form number 20-20.5 in any NLM schedule where applicable) Science Q 180-180.5 Reserpine QV 150 Residence Characteristics Demography HB 1951-2577 Housing HD 7285-7391 Public health aspects WA 795 Public housing HD 7288.77-7288.78 Residencies see Internship and Residency Residency, Dental see Internship and Residency Residency, Medical see Internship and Residency Residency, Nonmedical see Internship, Nonmedical Residential Facilities For children WS 27-28 For the mentally ill WM 29 For the physically ill WB 29 See also Foster home care HV 875, etc. Residential Mobility HB 1954 Of health manpower W 76 Of other special groups, by subject Residential Treatment Institutions General WM 29 In adolescence WS 27-28 In infancy & childhood WS 27-28 Programs General WM 445 In adolescence WS 463 In infancy & childhood WS 350.2 Resins Chemical technology TP 978-979.5 In dentistry WU 190 Pharmaceutical preparation QV 785 Used for special purposes, by subject, e.g., in the treatment of mandibular fractures WU 610 Resins, Synthetic Chemical technology TP 978-979.5 Dentistry WU 190 Pharmaceutic preparation QV 785 Used for special purposes, by subject See also Acrylic Resins WU 190, etc; Composite Resins WU 190; Epoxy Resins WU 190, etc. Resistance Factors see R Factors Resistance, Natural see Immunity, Natural Resistance to Infection see Infection Resistance Transfer Factor see F Factor Resorcinols QV 223 Resorts see Health Resorts Resorts, Health see Health Resorts Resource Allocation see Health Care Rationing Resource-Based Relative Value Scale see Relative Value Scales Respiration WF 102 Anesthesia see Anesthesia, Inhalation WO 277 Biochemistry WF 110 In physical examination WB 284 Skin WR 102 Respiration, Artificial Anesthesia complications WO 250 First Aid WA 292 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHJl Respirators see Ventilators, Mechanical Respirators, Air-Purifying see Respiratory Protective Devices Respirators, Industrial see Respiratory Protective Devices Respiratory Acidosis see Acidosis, Respiratory Respiratory Airflow WF 102 Respiratory Alkalosis see Alkalosis, Respiratory Respiratory Care Units WF 27-28 Respiratory Center WL 310 Respiratory Chain see Electron Transport Respiratory Diseases see Respiratory Tract Diseases Respiratory Distress Syndrome WS 410 Respiratory Distress Syndrome, Adult WF 140 Respiratory Drug Administration see Administration, Inhalation Respiratory Exchange see Respiration Respiratory Failure see Respiratory Insufficiency Respiratory Function Tests General physical examination WB 284 Respiratory diagnosis WF 141 Respiratory Hypersensitivity WF 150 See also Asthma WF 553; Farmers Lung WF 652; Hay Fever WV 335 Respiratory Insufficiency WF 140 Respiratory Mechanics WF 102 Respiratory Muscles WF 101-102 Respiratory Paralysis WF 140 Respiratory Protective Devices WF 26 Respiratory Sounds WF 102 Respiratory Syncytial Viruses QW 168.5.P2 Respiratory System WF Children WS 280 Drugs affecting see names of particular agents or groups of agents, e.g., Antibiotics QV 350 Respiratory Therapy WB 342 For disease of the respiratory system WF 145 For disease of the respiratory system in animals SF 831 Respiratory Therapy Department, Hospital WF 27-28 Respiratory Tract Diseases WF 140-900 In infancy & childhood WS 280 Nursing WY 163 Veterinary SF 831 See also names of specific diseases Respiratory Tract Infections General WF 140 In infancy & childhood WS 280 Veterinary SF 831 Viral WC 505-510 General works WC 505 See also name of specific infections Respiratory Tract Neoplasms WF 450 Response, Acute-Phase see Acute-Phase Reaction Response Latency see Reaction Time Response Time see Reaction Time Responsibility for Injuries see Forensic Medicine Responsibility, Social see Social Responsibility Rest Hygienic QT 265 Therapeutic WB 545 Restaurants WA 799 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 464 Rheumatology Resting Phase see Interphase Resting Potentials see Membrane Potentials Restraint, Physical Of mental patients WM 33 Veterinary (Surgery) SF 911 See also Immobilization WE 168; Protective Devices WX 185, etc. Restriction Endonucleases see DNA Restriction Enzymes Resume, Job see Job Application Resurrectionists see Cadaver Resuscitation Accidents in anesthesia WO 250 First aid WA 292 In infancy & childhood WS 100 Of the newborn WQ 450 Resuscitation Decisions see Resuscitation Orders Resuscitation Orders General works W 84.7 In hospitals WX 162 Ethical aspects W 50 See also Right to Die Retarded Child see Mental Retardation Retention (Psychology) BF 370-385 Physiology WL 102 In infancy & childhood WS 105.5.M2 Reticular Formation WL 310 Reticulocytes WH 150 Reticuloendothelial Cytomycosis see Histoplasmosis Reticuloendothelial System WH 650 Reticuloendotheliosis WH 650 Reticuloendotheliosis, Leukemic see Leukemia, Hairy Cell Reticulolymphosarcoma see Lymphoma Reticulosis see Reticuloendotheliosis Reticulum-Cell Sarcoma see Lymphoma, Large-Cell Retina WW 270 Retinal Artery WG 595.R38 Retinal Degeneration WW 270 Retinal Detachment WW 270 Retinal Diseases WW 270 Retinal Ganglion Cells WW 270 Retinal Hemorrhage WW 270 Retinal Pigment Epithelium see Pigment Epithelium of Eye Retinal Pigments WW 270 Retinal Vein WG 625.R38 Retinal Vessels WW 270 See also Retinal artery WG 595.R38; Retinal Vein WG 625.R38 Retinitis WW 270 Retinitis Pigmentosa WW 270 Retinoblastoma WW 270 Retinoic Acid see Tretinoin Retinoids QU 167 Retinol see Vitamin A Retinopathy of Prematurity WW 270 Retinoscopy see Diagnosis WW 300 under Refractive Errors Retirement HQ 1062-1063.2 As a problem of aging WT 30 Housing for HD 7287.9-7287.92 Pensions, etc. HD 7105-7105.45 Retirement Benefits see Pensions Retrognathism WU 440 Retrolental Fibroplasia see Retinopathy of Prematurity Retroperitoneal Fibrosis WI 575 Retroperitoneal Neoplasms WI 575 Retroperitoneal Space WI 575 Retropneumoperitoneum WI 575 Retrospective Studies Epidemiology WA 105 Other special topics, by subject Retroviridae QW 168.5.R18 Retroviridae Infections WC 502 Retrovirus Infections see Retroviridae Infections Retroviruses see Retroviridae Reuptake Inhibitors, Neurotransmitter see Neurotransmitter Uptake Inhibitors Reverse Immunoblotting see Immunoblotting Reverse Transcription see Transcription, Genetic Review Literature On special topics, by subject Revision, Joint see Reoperation Revision, Surgical see Reoperation Reward Conditioned response BF 319 School management LB 3025 Reyes Syndrome WS 340 Rh Factors see Rh-Hr Blood-Group System Rh-Hr Blood-Group System WH 425 Rh Isoimmunization WH 425 Rhabdomyolysis WE 550 Rhabdomyosarcoma QZ 345 Localized, by site Rhabdoviridae QW 168.5.R2 Rhamnus As a medicinal plant QV 766 Poisoning WD 500 Rhenium Inorganic chemistry QD 181.R4 Pharmacology QV 290 Rheography see Plethysmography, Impedance Rheology QC 189.5 Blood WG 106 Rhesus Blood-Group System see Rh-Hr Blood-Group System Rhesus Monkey see Macaca mulatta Rhetinic Acid see Glycyrrhetinic Acid Rheum see Rhubarb Rheumatic Diseases WE 544 Acute articular see Rheumatic Fever WC 220 Rheumatic Fever WC 220 Rheumatic Heart Disease WG 240 Rheumatism see Rheumatic Diseases Rheumatism, Articular, Acute see Rheumatic Fever Rheumatism, Muscular see Fibromyalgia Rheumatism, Peri-Extra-Articular see Polymyalgia Rheumatica Rheumatoid Arthritis see Arthritis, Rheumatoid Rheumatoid Factor WE 346 Rheumatoid Spondylitis see Spondylitis, Ankylosing Rheumatology WE 140 See also names of specific musculoskeletal disease ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 465 Rheumatology Rhinencephalon see Limbic System Rhinitis WV 335 Veterinary SF 891 Rhinitis, Allergic, Nonseasonal see Rhinitis, Allergic, Perennial Rhinitis, Allergic, Perennial WV 335 Rhinitis, Allergic, Seasonal see Hay Fever Rhinitis, Atrophic WV 335 Veterinary SF 891 Rhinitis, Vasomotor WV 335 Rhinology see Otolaryngology Rhinopharynx see Nasopharynx Rhinoplasty WV 312 Rhinoscleroma WV 300 Rhinosporidiosis WC 450 Rhinovirus QW 168.5.P4 Rhizanesthesia see Anesthesia, Conduction Rbizobium QW 131 Rhodanates see Thiocyanates Rhodopsin WW 270 Rhombencephalic Sleep see Sleep, REM Rhonchi see Respiratory Sounds Rhubarb As a medicinal plant QV 766 As a cathartic QV 75 Rhus see Toxicodendron Rhus Dermatitis see Dermatitis, Toxicodendron Rhythm Method WP 630 Rhythmicity see Periodicity Ribavirin As an antiviral agent QV 268.5 Riboflavin QU 191 Riboflavin Deficiency WD 124 Ribonucleases QU 136 Ribonucleic Acid see RNA Ribonucleoproteins QU 56 Ribonucleoside Diphosphate Reductase QU 140 Ribosomal RNA see RNA, Ribosomal Ribosomes QH 603.R5 Ribovirin see Ribavirin Ribozymes see RNA, Catalytic Ribs WE 715 Rice As a dietary supplement in health or disease WB 431 Cultivation SB 191.R5 Ricin As a toxin QW 630.5.R5 Ricinus QV 75 Rickets WD 145 Rickets, Renal see Renal Osteodystrophy Rickettsia QW 150 As a cause of disease QZ 65 Rickettsia Infections WC 600-660 General works WC 600 Mite-borne WC 630-635 Tick-borne WC 620-625 Veterinary SF 809.R52 Rickettsiaceae QW 150 Rickettsiaceae Infections WC 600-635 Rickettsial Vaccines WC 600 Rickettsiales QW 150 Rickettsialpox WC 635 Rickettsias see QW 149 for works including Rickettsias and Chlamydias treated together Rifampicin see Rifampin Rifampin QV 268 Rifamycins QV 350 Rifomycins see Rifamycins Rift Valley Fever WC 524 Rift Valley Fever Virus QW 168.5.B9 Right to Die W 85.5 Right to Treatment see Patient Advocacy Rigidity, Decerebrate see Decerebrate State Riley-Day Syndrome see Dysautonomia, Familial Rinderpest SF 966 Ringworm see Tinea Risk In specific topics, by subject Risk Behavior see Risk-Taking Risk Factors In a particular subject, with the subject Risk Management Hospitals WX 157 For other topics, class by subject if specific; if general, in economics number where available Risk-Taking Psychology BF 637.R57 Ritodrine Used in controlling premature labor WQ 330 RNA QU 58.7 RNA, Antisense QU 58.7 RNA, Bacterial QW 52 RNA Caps QU 58.7 RNA, Catalytic QU 58.7 RNA-Dependent RNA Polymerase see RNA Replicase RNA, Double-Stranded QU 58.7 RNA, Messenger QU 58.7 RNA, Messenger, Splicing see RNA Splicing RNA, Neoplasm In cancer research QZ 206 RNA Nucleotidyltransferases QU 141 RNA Polymerases QU 141 RNA Processing, Post-Transcriptional QH 450.2 RNA Replicase QU 141 RNA, Ribosomal QU 58.7 RNA, Ribosomal, Self-Splicing see RNA, Catalytic RNA Rodent Viruses see RNA Viruses RNA Sequence see Base Sequence RNA Sequence Analysis see Sequence Analysis, RNA RNA, Small Nuclear QU 58.7 RNA Splicing QH 450.2 RNA, Transfer QU 58.7 RNA, Transfer, Amino Acyl QU 58.7 RNA, Viral QW 168 RNA Viruses General works QW 168 Specific viruses QW 168.5.A-Z RNase see Ribonucleases Ro 10-9359 see Etretinate Ro 15-1788 see Flumazenil Robotics TJ 210.2-211.47 Biomedical engineering QT 36 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 466 Saccharides Used for special purposes, by subject, e.g., in clinical laboratory procedures QY 23 Rock Fever see Brucellosis Rocky Mountain Spotted Fever WC 620 Rod-Cone Dystrophy see Retinitis Pigmentosa Rodent Control WA 240 Rodent Diseases SF 997.5.R64 Rodentia QL 737.R6-737.R688 As laboratory animals QY 60. R6 Rodenticides Agriculture SB 951.8 Public health aspects WA 240 Rods and Cones WW 270 Roentgen Radiation see Radiation, Ionizing Roentgen Rays see X-Rays Roentgenkymography see Electrokymography Roentgenograms see Radiography Roentgenography see Radiography Roentgenography, Dental see Radiography, Dental Roentgenology see Radiation, Ionizing Roentgenotherapy see X-Ray Therapy Roeteln see Rubella Rogerian Therapy see Nondirective Therapy Role Parents WS 105.5.F2 Physician W 62 Sexual psychology BF 692-692.5 Social HM 131 See also Self Concept BF 697, etc. Role Concept see Role Role Playing WM 430.5.P8 In infancy & childhood WS 350.2 In adolescence WS 463 Romano-Ward Syndrome see Long QT Syndrome Root Canal see Dental Pulp Cavity Root Canal Filling Materials WU 190 Root Canal Therapy WU 230 Root Resection see Apicoectomy Root Resorption WU 230 Root Scaling see Dental Scaling Rorschach Test WM 145.5.R7 Rosa see Plants, Medicinal Rosacea see Acne Rosacea Rosaniline Dyes QV 240 Rose Bengal QV 240 Rosenzweig Picture-Frustration Study WM 145.5.R8 In adolescence WS 462 In infancy & childhood WS 105.5.E8 In psychology BF 698.8.R6 Roseola, Epidemic see Measles Roseola Infantum see Exanthema Subitum Rotation Aviation medicine WD 720 Motion sickness WD 630 Of the eye WW 103 Special topics, by subject Rotavirus Infections WC 501 Roughage see Dietary Fiber Round Window WV 250 Roundworms see Nematoda Rous-Associated Virus see Leukosis Virus, Avian Rous Sarcoma see Sarcoma, Avian Rous Sarcoma Virus see Sarcoma Viruses, Avian Roussy-Levy Syndrome see Charcot-Marie Disease Routine Diagnostic Tests see Diagnostic Tests, Routine Roxithromycin QV 350.5.E7 Royal Free Disease see Fatigue Syndrome, Chronic RU-486 see Mifepristone Rubber Agriculture SB 289-291 Industry TS 1870-1935 Used in artificial parts, with specific part Rubber Silicone see Silicone Elastomers Rubefacients see Irritants Rubella WC 582 Rubella Vaccine WC 582 Rubella Virus QW 168.5.R8 Rubeola see Measles Rubidium Inorganic chemistry QD 181.R3 Metabolism QU 130 Pharmacology QV 275 Rubinstein-Taybi Syndrome QS 675 Rubivirus QW 168.5.R8 Ruffini's Corpuscles see Thermoreceptors Rumen QL 862 Domestic animals SF 851 Ruminantia see Ruminants Ruminants QL 737.U5 Diseases SF 997.5.U5 Physiology SF 768.2.R8 Rumination, Obsessive see Compulsive Behavior Runaway Reaction Adolescents WS 463 Children WS 350.8.R9 Running QT 260.5.R9 Runt Disease see Graft vs Host Disease Rupture QZ 55 Localized, by site Rural Health WA 390 Rural Population Demography HB 2371-2577 Health problems see Rural Health WA 390 Other aspects, by subject See also Housing HD 7289, etc.; Public Housing HD 7288.77-7288.78 Russell's Viper Venom Time see Prothrombin Time Russian Baths see Baths Ruthenium Inorganic chemistry QD 181.R9 Pharmacology QV 290 Rutin QU 220 S-Adenosylhomocysteine QU 60 S-Adenosylmethionine QU 57 Sabin Vaccine see Poliovirus Vaccine, Oral Saccades WW 400 Saccadic Eye Movements see Saccades Saccharide-Mediated Cell Adhesion Molecules see Cell Adhesion Molecules Saccharides see Carbohydrates; Disaccharides; Monosaccharides; Oligosaccharides; Polysaccharides ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 467 Saccharides Saccharin WA 712 Saccharomyces QW 180.5.A8 Sacral Plexus see Lumbosacral Plexus Sacral Region see Sacrococcygeal Region Sacrococcygeal Region WE 750 Sacroiliac Joint WE 750 Sadism WM 610 Sadomasochism see Sadism; Masochism Safety WA 250-288 Safety, Consumer Product see Consumer Product Safety Safety Devices see Protective Devices Safety Equipment see Protective Devices Safety, Equipment see Equipment Safety Safety Glasses see Eye Protective Devices Safety Lenses see Eye Protective Devices Saimiri QL 737.P925 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Saimirine Herpesvirus 2 see Herpesvirus 2, Saimirine Salaam Seizures see Spasms, Infantile Salamanders see Urodela Salaries and Fringe Benefits Economic theory HD 4909-4912 Fringe benefits (General) HD 4928.N6 In hospitals WX 157 Of dentists WU 77 Of nurses WY 77 Of physicians W 79 Of other specialties, by type, e.g., of psychiatric nurses WY 160 Salicylates QV 95 Salicylic Acids QV 60 Salientia see Anura Saline see Sodium Chloride Saline Infusion see Infusions, Parenteral; Sodium Chloride Saline Solution, Hypertonic WB 354 Saliva QY 125 Salivary Duct Calculi WI 230 Salivary Duct Stones see Salivary Duct Calculi Salivary Gland Diseases WI 230 Salivary Gland Fistula WI 230 Salivary Gland Neoplasms WI 230 Salivary Gland Virus Disease see Cytomegalovirus Infections Salivary Gland Viruses see Cytomegalovirus Salivary Glands WI 230 Salk Vaccine see Poliovirus Vaccine Salmonella QW 138.5.S2 Salmonella arizonae QW 138.5.S2 Salmonella Food Poisoning WC 268 Salmonella Infections WC 269 Salmonella Infections, Animal SF 809.S24 Salmonella paratyphi B see Salmonella schottmuelleri Salmonella schottmuelleri QW 138.5.S2 Salmonella typhi QW 138.5.S2 Salmonella typhosa see Salmonella typhi Salmonellosis see Salmonella Infections Salmonidae Anatomy and physiology QL 638.S2 Diseases SH 179.S3 Salpingography see Hysterosalpingography Salt-Free Diet see Diet, Sodium-Restricted Salts Inorganic chemistry QD 189-193 Microorganism metabolism QW 52 See also names of specific salts, e.g. Sodium Chloride QV 273, etc. Sampling Studies Epidemiology WA 105-106, etc. Psychology BF 39 Research (Form number 20 or 20.5 in any NLM schedule where applicable) Surveys Health WA 900 Nutrition QU 146 Special topics, by subject Sanatorium Regimen in Tuberculosis see Rehabilitation WF 330, etc. under Tuberculosis, Pulmonary Sand Baths see Ammotherapy Sand-Dollar see Sea Urchins Sandfly Fever see Pappataci Fever Sanitary Codes see Legislation WA 32 under Sanitation Sanitary Conditions, Epidemic Factor see Communicable Disease Control; Public health WA 30 under Socioeconomic Factors Sanitary Control see Environment, Controlled Sanitary Engineering WA 671 See also specific topics, e.g. Refuse Disposal WA 780, etc. Sanitation WA 670-847 Housing WA 795 Occupational WA 440 Inspection WA 672 See also Food Inspection WA 695; Quality Control WA 672, etc. Legislation WA 32-33 Rural WA 390 School WA 350-351 Surveys WA 672 Santonin QV 253 Sao Paulo Typhus see Rocky Mountain Spotted Fever Saphenous Vein WG 625.S2 Sapogenins Biochemistry QU 85 Saponins QU 75 Saralasin QU 68 Sarcodina QX 55 Sarcoidosis QZ 140 Localized, by site Sarcolemma WE 500 Sarcoma QZ 345 Localized, by site Sarcoma, Avian Experimental in the interest of humans QZ 345 Sarcoma, Ewing's WE 258 Localized, by site Sarcoma, Germinoblastic see Lymphoma Sarcoma, Kaposi's QZ 345 Localized, by site ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 468 Sarcoma, Lymphatic see Lymphoma, Diffuse Sarcoma, Osteogenic see Osteosarcoma Sarcoma, Reticulum-Cell see Lymphoma, Large-Cell Sarcoma, Rous see Sarcoma, Avian Sarcoma, Synovial WE 300 Localized, by site Sarcoma Virus, Feline QW 166 Sarcoma Viruses, Avian QW 166 Sarcoptes scabiei QX 475 Sarcoptidae see Mites; Sarcoptes scabiei Sarcosomes see Mitochondria, Muscle Satellite DNA see DNA, Satellite Satire see Wit and Humor Sauna see Baths, Finnish Savanna Baboons see Papio Scabies WR 365 Veterinary SF 810.S26 Scalded Skin Syndrome, Nonstaphylococcal see Epidermal Necrolysis, Toxic Scalds see Burns Scalenus Anticus Syndrome see Thoracic Outlet Syndrome Scaling, Dental see Dental Scaling Scaling, Root see Dental Scaling Scaling, Subgingival see Dental Scaling Scaling, Supragingival see Dental Scaling Scalp WR 450 Scalp Dermatoses WR 450 Scanning Electron Microscopy see Microscopy, Electron, Scanning Scanning, Radioisotope see Radionuclide Imaging Scapula WE 810 Scarlatina see Scarlet Fever Scarlet Fever WC 214 Scarpa s Ganglion see Vestibular Nerve Scars see Cicatrix Scattering, Radiation Biomedical uses WB 117 Physical optics QC 427.4 Schamberg's Disease see Pigmentation Disorders Schaumann's Disease see Sarcoidosis Schedules, Patient see Appointments and Schedules Scheie's Syndrome see Mucopolysaccharidosis I Scheuermann's Disease WE 725 Schistosoma QX 355 Schistosomiasis WC 810 Schistosomiasis, Intestinal see Schistosomiasis mansoni Schistosomiasis japonica WC 810 Schistosomiasis mansoni WC 810 Schizoaffective Disorder see Psychotic Disorders Schizoid Personality Disorder WM 203 Schizomycetes see Bacteria Schizophrenia WM 203 Schizophrenia, Borderline see Schizotypal Personality Disorder Schizophrenia, Catatonic WM 203 Schizophrenia, Childhood WM 203 Schizophrenia, Disorganized WM 203 Schizophrenia, Hebephrenic see Schizophrenia, Disorganized ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Scintigraphy, Computed Tomographic Schizophrenia, Latent see Schizotypal Personality Disorder Schizophrenia, Paranoid WM 203 Schizophrenia, Pseudoneurotic see Schizotypal Personality Disorder Schizophrenic Disorders see Schizophrenia Schizophrenic Language WM 203 Schizophrenic Psychology WM 203 Schizophreniform Disorders see Psychotic Disorders Schizosaccharomyces QW 180.5.A8 Schizotypal Personality Disorder WM 203 Scholarships see Fellowships and Scholarships School Admission Criteria LB 2351-2351.6 (Form number 18 in any NLM schedule where applicable) School Dentistry Services offered WA 350-351 Specific dental problems WU School Dropouts see Student Dropouts School Health Services WA 350 Mental health WA 352 See also Student Health Services WA 350-353 School Nursing WY 113 Education WY 18-18.5 Schools L (Form number 19 in any NLM schedule where applicable) For exceptional children LC 3951-4801 For the blind HV 1618-2349 For the deaf HV 2417-2990.5 For the deaf-mute HV 2417-2990.5 Schools, Dental WU 19 Schools, Health Occupations W 19 Schools, Library see Library Schools Schools, Medical W 19 Schools, Nursery LB 1140-1140.5 Public health aspects WA 350-352 Schools, Nursing WY 19 Schools, Pharmacy QV 19 Schools, Public Health WA 19 Schools, Veterinary SF 756.3-756.37 Schueller-Christian Disease see Hand-Schueller-Christian Syndrome Schwalbe's Nucleus see Vestibular Nuclei Schwannoma see Neurilemmoma Schwannoma, Acoustic see Neuroma, Acoustic Schwartz-Jampel Syndrome see Osteochondrodysplasias Sciatic Nerve WL 400 Sciatica WE 755 Science Q Biography Collective Q 141 Individual WZ 100 Directories Q 145 General works Q 158-158.5 History (General) Q 125 Scientific Misconduct Q175.37 Special topics, by subject Scientific Societies see Societies, Scientific Scientology see Alternative Medicine; Philosophy Scintigraphy see Radionuclide Imaging Scintigraphy, Computed Tomographic see Tomography, Emission-Computed NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSIFIED 469 Scintigraphy, Computed Tomographic Scintillation Counting WN 660 Scintiphotography see Radionuclide Imaging Sciuridae QL 737.R68 As laboratory animals QY 60. R6 Sclera WW 230 Abnormalities WW 230 Scleritis WW 230 Scleral Buckling WW 230 Scleroderma, Circumscribed WR 260 Scleroderma, Diffuse see Scleroderma, Systemic Scleroderma, Localized see Scleroderma, Circumscribed Scleroderma, Systemic WR 260 Scleroma, Nasal see Rhinoscleroma Scleroproteins (Non MeSH) QU 55 Sclerosing Solutions QV 786 Sclerosis QZ 190 Disseminated see Multiple Sclerosis WL 360 Hereditary spinal see Friedreich s Ataxia WL 390 Presenile see Dementia, Presenile WM 220 Progressive systemic see Scleroderma, Systemic WR 260 Sclerosis, Disseminated see Multiple Sclerosis Sclerosis, Hereditary Spinal see Friedreich's Ataxia Sclerosis, Presenile see Dementia, Presenile Sclerosis, Progressive Systemic see Scleroderma, Systemic Sclerostomy For glaucoma WW 290 Sclerotherapy WB 354 Special topics, by subject Sclerotinia see Ascomycetes Scoliosis WE 735 Scopolamine QV 134 Scopolamine Derivatives QV 134 Scopolamine-Morphine Anesthesia see Anesthesia, Obstetrical; Preanesthetic Medication Scorbutus see Scurvy Scorpion Venoms WD 420 Scorpions QX 469 Sting see Arachnidism WD 420 Scrapie Agent see Prions Scrapie-Associated Fibrils see Prions Scrapie Virus see Prions Screen-Film Systems, X-Ray see X-Ray Intensifying Screens Screens, Radiographic see Instrumentation WN 150 under Radiography Scrofula see Tuberculosis, Lymph Node Scrofuloderma see Tuberculosis, Cutaneous Scrotum WJ 800 Scrub Typhus WC 630 Sculpture Related to medicine WZ 330 Related to psychiatry WM 49 Scurvy WD 140 Sea Anemone Venoms see Coelenterate Venoms Sea Bathing see Balneology; Swimming; Thalassotherapy Sea Pollution see Seawater; Water Pollution Sea Urchins QL 384.E2 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Sealants, Tooth see Pit and Fissure Sealants Sealed Cabin Ecology see Ecological Systems, Closed Seasickness see Motion Sickness Seasons Astronomical geography QB 637.2-637.8 Atmospheric temperature QC 903-906 Folklore GR 930 Medical climatology WB 700 Seawater Balneology WB 525 Ecology QH 541.5.S3 Marine biology QH 91-95.9 Microbiology see Plankton QH 90.8.P5, etc.; Water Microbiology QW 80 Oceanography GC 100-181 Pollution Bathing beaches WA 820 Industrial waste WA 788 See also Water Pollution WA 689 Seaweed QK 564-580 Sebaceous Cyst see Epidermal Cyst Sebaceous Gland Neoplasms WR 410 Sebaceous Glands WR 410 Seborrhea see Dermatitis, Seborrheic Secobarbital QV 88 Second-Look Surgery see Reoperation Second Messenger Systems QU 120 Second Opinion see Referral and Consultation Secretaries, Medical see Medical Secretaries Secretin WK 170 Secretory Granules see Cytoplasmic Granules Secretory Phase see Menstrual Cycle Secretory Rate QU 120 Security Measures Hospitals WX 185 Libraries Z 679.6 Sedation, Conscious see Conscious Sedation Sedatives see Hypnotics and Sedatives Sedimentation of Blood see Blood Sedimentation Seeds As a dietary supplement in health and disease WB 431 Botany QK 661 Plant culture SB 113.2-118.46 Toxic WD 500 Seizures WL 340 Seizures, Febrile see Convulsions, Febrile Selection (Genetics) QH 455 See also Natural Selection QH 375 Selegiline As an antiparkinson agent QV 80 Selenium Inorganic chemistry QD 181.S5 Metabolism QU 130.5 Pharmacology QV 138.S5 Self see Ego Self Assessment (Psychology) BF 697 In infancy & childhood WS 105.5.S3 Self Care WB 327 For particular conditions, with the condition Self Care (Rehabilitation) see Activities of Daily Living USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 470 Seroepidemiologic Methods Self-Care Units WX 200 Self Concept BF 697 In infancy & childhood WS 105.5.S3 Self Determination see Freedom Self Disclosure BF 697.5.S427 In infancy & childhood WS 105.5.S3 Self Esteem see Self Concept Self-Evaluation Programs In a particular field (Form number 18-18.2 in any NLM schedule where applicable) Other special topics, by subject Self-Examination WB 120 For specific conditions, with the condition Self-Help Devices WB 320 Catalogs W 26 For particular disability, by the disability See also specific types of devices Self-Help Groups In mental disorders WM 426 In other areas, by subject Self-Instruction Programs see Programmed Instruction Self-Instruction Programs, Computerized see Computer-Assisted Instruction Self Medication WB 120 Popular works WB 120 Self-Monitoring, Blood Glucose see Blood Glucose Self-Monitoring Self Mutilation WM 100 Special topics, by subject Self Perception see Self Concept Self Realization see Achievement Sella Turcica WE 705 Selye Syndrome see General systemic reaction QZ 160 under Wounds and Injuries; Stress Semantic Differential Used in psycholinguistics BF 463 As a personality test BF 698.5 Semantics P 325 Semen Analysis QY 190 Medicolegal W 750 Secretion Genital physiology WJ 702 Spermatozoa WJ 834 Semen Preservation WJ 834 Artificial insemination WQ 208 Semicircular Canals WV 255 Semiconductors Electronics TK 7871.85-7871.99 Medical engineering QT 36 Photoelectronics TK 8320-8334 Physics QC 610.9-611.8 Semilunar Bone WE 830 Semilunar Cartilages see Menisci, Tibial Seminal Vesicles WJ 750 Seminiferous Tubules WJ 830 Seminoma see Dysgerminoma Semiochemicals see Pheromones Semiology see Symptomatology WB 143 under Diagnosis Semisynthetic Vaccines see Vaccines, Synthetic Semliki Forest Virus QW 168.5.A7 Sendai Virus see Parainfluenza Virus Type 1 Senescence see Aging Senile Osteoporosis see Osteoporosis Senility see Aged; Psychoses, Senile Sensation WL 702 Disorders Dermatological WR 280 General WL 710 See also Touch WR 102; Smell WV 301 and other sensations Sense see Hearing; Orientation; Pain; Proprioception; Smell; Taste; Temperature Sense; Touch; Vision Sense Organs WL 700-710 Sensibilisinogens see Anaphylaxis Sensitinogens see Allergens; Anaphylaxis Sensitivity, Contact see Dermatitis, Contact Sensitivity Training Groups Psychiatry WM 430.5.S3 Social psychology HM 134 Sensitization see Anaphylaxis; Hypersensitivity Sensitization, Immunologic see Immunization Sensitizer see Antibodies Sensory Aids Catalogs W 26 General WL 26 See also Eyeglasses WW 350-354; Hearing Aids WV 274; other specific types in the equipment number, usually 26, for the field Sensory Deprivation WL 710 Sensory Motor Performance see Psychomotor Performance Sensory Thresholds WL 705 See also names of specific thresholds, e.g., Auditory Threshold WV 272, etc. Seoul Virus see Hantavirus Separation, Drugs see Drug Compounding Septal Nuclei WL 314 Septic Sore Throat see Streptococcal Infections Septicemia WC 240 Puerperal see Puerperal Infection WQ 505 Veterinary SF 802 Septum, Nasal see Nasal Septum Septum Pellucidum WL 314 Sequence Analysis As a genetic technique (General) QH 441 Special topics, by subject Sequence Analysis, DNA As a genetic technique (General) QH 441 Special topics, by subject Sequence Analysis, RNA As a genetic technique (General) QH 441 Special topics, by subject Sequence Data, Molecular see Molecular Sequence Data Sequence Homology, Nucleic Acid QU 58 Serial Learning LB 1059 Serial Publications (Non Mesh) see Periodicals Serine QU 60 Serine Proteases see Serine Proteinases Serine Proteinases QU 136 Serodiagnosis QY 265-275 Seroepidemiologic Methods Used for the detection of a specific disease, with the disease ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 471 Seroepidemiologic Methods Serology QW 570 Seromucoid see Orosomucoid Serotherapy see Immunization, Passive Serotonin QV 126 Serotonin Antagonists QV 126 Serotonin Blockaders see Serotonin Antagonists Serpin Superfamily see Serpins Serpins QU 136 Serratia QW 138.5.S3 Sertoli Cell Tumor WJ 858 Serum see Blood; Immune Sera; Serum Albumin; Serum Globulins Serum Albumin WH 400 Clinical analysis QY 455 Serum Globulins WH 400 Immunoglobulins QW 601 Serum Markers see Biological Markers Serum Proteins see Blood Proteins Serum Sialomucin see Orosomucoid Serum Sickness WD 330 Serum Thymic Factor see Thymic Factor, Circulating Servicemen see Military Personnel Set (Psychology) BF 321 Sewage Bacteriology QW 80 Disposal WA 785 General waste disposal WA 778 Water pollution WA 689 Sex Counseling WM 55 General HQ 12-25 Hygiene Female WP 120 Male WJ 700 In mental retardation WM 307.S3 Medicolegal aspects W 795 Organs see Genitalia WJ 700, etc. Psychoanalysis WM 460.5.S3 Psychology BF 692 Research HQ 60 Sex Behavior Human HQ 12-472 In adolescence WS 462 In infancy & childhood WS 105.5.S4 Psychology BF 692 Sex Behavior, Animal QL 761 Domestic animals SF 195-518 Wild animals QL 364-739.3 Sex Characteristics Physical QS, QT Female WP 101 Male WJ 101-102 Psychological BF 692 Sex Chromatin QH 599 Sex Chromosome Abnormalities QS 677 Sex Chromosomes QH 600.5 Sex Counseling WM 55 Sex Determination Diagnostic WQ 206 Embryogenic QS 638 Sex Deviations see Paraphilias ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Sex Differences see Sex Characteristics Sex Differentiation Embryogenic QS 640 Sex Differentiation Disorders WJ 712 Veterinary SF 871 Sex Dimorphism see Sex Characteristics Sex Disorders Female WP 610 Male WJ 709 Problems of mentally retarded WM 307.S3 Psychophysiologic (General) WM 611 Sex Education HQ 34-59 Of the mentally retarded LC 4601-4640.4 oi HQ 54.3 Sex problems WM 307.S3 School texts QT 225 Sex Factor, Bacterial see F Factor Sex Factor F see F Factor Sex Factors As a cause of disease QZ 53 See also Sex Ratio QH 455, etc. Demography HB 1741-1947 Other special topics, by subject Sex Hormones WK 900 Female WP 520-530 Male WJ 875 See also names of specific hormones Sex Manuals HQ 31 Sex Offenses Criminology HV 6556-6593 Medicolegal aspects W 795 Sex Pili see Pili, Sex Sex Predetermination see Sex Preselection Sex Preselection WQ 205 Using genetic engineering techniques QH 44: Sex Ratio Animals Domestic (Breeding) SF 105 Wild QH 352 Population genetics QH 455 Population statistics At birth by country HB 911-1107 General HB 1741-1947 Other special topics, by subject, e.g., Sex Rati< of children born with Huntington Chorea WI 390 Sex Reversal, Gonadal WK 900 Sex Role see Gender Identity Sex Selection see Sex Preselection Sexology see Sex Sexual Abuse, Child see Child Abuse, Sexual Sexual Adjustment see Sex Disorders; Sex Manual Sexual Dysfunctions, Psychological see Psychosexual Dysfunctions Sexual Harassment HD 6060.3 Sexual Intercourse see Coitus Sexual Partners Special topics, by subject Sexually Transmitted Diseases WC 140-185 General works WC 140 Gonorrhea WC 150 In the female WP 157 SGOT see Aspartate Aininotransferase USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSIFIED 472 Signs and Location Directorie SGPT see Alanine Aminotransferase Shadow Test see Refraction, Ocular Shame BF 575.S45 In adolescence WS 462 In infancy & childhood WS 105.5.E5 Shared Paranoid Disorder WM 205 Sharks QL 638.9-638.95 Sharp Syndrome see Mixed Connective Tissue Disease Sheathed Bacteria (Non Mesh) see Bacteria Sheehans Syndrome see Hypopituitarism Sheep Domestic SF 371-379 Anatomy SF 767.S5 Physiology SF 768.2.S5 Wild QL 737.U53 Sheep Diseases SF 968-969 Shellfish As a dietary supplement in health or disease WB 426 Culture SH 365-380.92 Diseases SH 179.S5 Poisoning WD 405 See also Crustacea QX 463; Mollusca QX 675 Sheltered Workshops For the mentally disabled WM 29 For the physically disabled WB 29 Sherman Antitrust Act see Antitrust Laws Shigella QW 138.5.S4 Shigella Infections see Dysentery, Bacillary Shingles see Herpes Zoster Ships Naval science V Nursing service WY 143 Public health aspects WA 810 Quarantine WA 234 Shivering WB 152 Shock QZ 140 Anaphylactic see Anaphylaxis QW 900 Electric see Electric Injuries WD 602, etc. Shock, Anaphylactic see Anaphylaxis Shock, Cardiogenic WG 300 Shock, Endotoxic see Shock, Septic Shock, Hemorrhagic Surgical complications WO 149 Injury WO 700 Shock Lung see Respiratory Distress Syndrome, Adult Shock, Septic QZ 140 In pregnancy WQ 240 In septicemia WC 240 Other special topics, by subject Shock, Surgical WO 149 Shock Therapy see Convulsive Therapy Shock Therapy, Electric see Electroconvulsive Therapy Shock Therapy, Insulin see Convulsive Therapy Shock, Toxic see Shock, Septic Shock, Traumatic WO 700-820 Shockwaves, Ultrasonic see Ultrasonics Shoes QT 245 Orthopedic WE 880-890 Protective In sports QT 260 In industry WA 485 Short-Term Psychotherapy see Psychotherapy, Brief Short Waves see Radio Waves Shorthand Z 53-102 Medical W 80 Dictionaries W 13 Shoulder WE 810 Shoulder Dislocation WE 810 Shoulder Fractures WE 810 Shoulder-Girdle Neuropathy see Cervico-Brachia Neuralgia Shoulder-Hand Syndrome WE 810 Shoulder Joint WE 810 Shrimp QX 463 Shwartzman Phenomenon QW 900 Shyness BF 575.B3 SI Units see International System of Units Sialadenitis WI 230 Sialidase see Neuraminidase Sialography WI 230 Sialolithiasis, Ductal see Salivary Duct Calculi Sialyltransferases QU 141 Siamang see Hylobates Siamese Twins see Twins, Conjoined Sibling Relations WS 105.5.F2 Sicca Syndrome see Sjogren's Syndrome Sick Building Syndrome see Air Pollution, Indooi Sick Role WM 178 Special topics, by subject Sick Sinus Syndrome WG 330 Sickle Cell Anemia see Anemia, Sickle Cell Sickle Cell Trait WH 170 Sickness Insurance see Insurance, Health SID see Sudden Infant Death Siderophilin see Transferrin Siderosis WF 654 Localized, by site, e.g., of the cornea, WW 22C Sight see Vision Sigma Element see Sigma Factor Sigma Factor QU 141 Sigma Initiation Factor see Sigma Factor Sigma Subunit see Sigma Factor Sigmoid WI 560 Sigmoid Neoplasms WI 560 Sigmoidoscopy WI 620 Sign Language HV 2474-2476 Signal Interpretation, Computer-Assisted see Signal Processing, Computer-Assisted Signal Pathways see Signal Transduction Signal Peptides QU 68 Signal Processing, Computer-Assisted As equipment in special fields (Form number 26.5 in any NLM schedule where applicable; e.g. Nursing WY 26.5) Signal Processing, Digital see Signal Processing, Computer-Assisted Signal Sequences, Peptides see Signal Peptides Signal Transduction Cytology QH 601 Signs and Location Directories see Location Directories and signs ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 473 Signs and Location Directories Silastics see Silicone Elastomers Silica see Silicon Dioxide Silicate Cement WU 190 Used for special purposes, by subject, e.g., in dental cavity treatment WU 350 Silicate Fillings see Silicate Cement Silicic Acid Toxicology QV 610 Silicon Inorganic chemistry QD 181.S6 Metabolism QU 130.5 Toxicology QV 618 Silicon Dioxide Inorganic chemistry QD 181.S6 Toxicology QV 610 Silicone Elastomers Artificial organ construction (General) WO 176 Chemical technology TP 248.S5 Dental materials WU 190 Plastic surgery WO 600-640 Used in other particular procedures, with the procedure Silicone Oils Chemical technology TP 685 Public health aspects WA 722 In the treatment of retinal detachment WW 270 Silicones Analytical chemistry QD 139.S5 Chemical technology TP 248.S5 Plastic Surgery WO 600-640 Used in other particular procedures, with the procedure Silicopolyacrylate Cement see Glass Ionomer Cements Silicosis WF 654 Silicotuberculosis WF 654 Silver QV 297 Metabolism QU 130 Silver Nitrate Inorganic chemistry QD 181.A3 Pharmacology QV 297 Simian Immunodeficiency Viruses see SIV Simian T-Lymphotropic Virus Type III see SIV Simian Virus 40 see Polyomavirus macacae Simmonds1 Disease see Hypopituitarism Simplexvirus QW 165.5.H3 Simuliidae QX 505 Simulium see Simuliidae SIN-10 see Molsidomine Sinapis see Mustard Sincalide Receptors see Receptors, Cholecystokinin Single Parent HQ 759.915 Special topics, by subject Single-Parent Family see Single Parent Single Person HQ 800-800.4 Widows and widowers HQ 1058-1058.5 Relations to adolescents WS 462 Relations to children WS 105.5.F2 Single-Photon Emission-Computed Tomography see Tomography, Emission-Computed, Single-Photon Single-Stranded DNA see DNA, Single-Stranded ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH/* Single-Stranded DNA Binding Proteins see DNA-Binding Proteins Sinoatrial Node WG 201-202 Sinus Arrhythmia see Arrhythmia, Sinus Sinus Arrythmia see Arrythmia, Sinus Sinus Thrombosis WL 355 Sinuses, Cranial see Cranial Sinuses Sinuses, Paranasal see Paranasal Sinuses Sinusitis WV 340 Sinusitis, Maxillary see Maxillary Sinusitis Siphonaptera see Fleas Sipunculida see Nematoda sis Genes see Oncogenes Sisomicin QV 350.5.G3 Sisomycin see Sisomicin Sissomicin see Sisomicin Sister Chromatid Exchange QH 445 Site-Directed Mutagenesis see Mutagenesis, Site-Directed Site-Specific Mutagenesis see Mutagenesis, Site-Directed Situational Ethics see Ethics Situational Therapy see Milieu Therapy Situs Inversus QS 675 Situs Transversus see Situs Inversus SIV QW 166 SIV-1 see SIV SIV-2 see SIV Sixth Disease see Exanthema Subitum Size Perception WW 105 Sjogren's Syndrome WE 346 Skeletal Age Measurement see Age Determination by Skeleton Skeletal Fixation see Fracture Fixation Skeletal Muscle Relaxants see Neuromuscular Agents Skeletal System see Musculoskeletal System Skeleton WE 100-102 Skiascopy see Diagnosis WW 300 under Refractive Errors; Fluroscopy Skid Row Alcoholics Medical aspects WM 274 Sociological problems HV 5050 Skiing QT 260.5.S6 Skilled Nursing Facilities WX 27-28 Skin WR Drugs affecting see Dermatologic Agents QV 60-65 Epidermis WR 101 Skin Absorption WR 102 Skin Aging WR 102 Skin Appendage Diseases WR 390-475 Skin Diseases WR General WR 140 Diagnosis WR 141 Genetic (General) WR 218 In infancy & childhood WS 260 Nursing WY 154.5 Papulosquamous WR 204 Radiotherapy WR 660 Veterinary SF 901 Skin Diseases, Bullous see Skin Diseases, Vesiculobullous USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 474 Social Behavior Skin Diseases, Fungal see Dermatomycoses Skin Diseases, Infectious WR 220-245 Bacterial WR 220-245 Fungal see Dermatomycosis WR 300-340 General works WR 220 Veterinary SF 901 Viral WC 570-590, etc. General works WC 570 Skin Diseases, Parasitic WR 345 Veterinary SF 901 Skin Diseases, Vesicular see Skin Diseases, Vesiculobullous Skin Diseases, Vesiculobullous WR 200 Skin Drug Administration see Administration, Cutaneous Skin Electric Conductance see Galvanic Skin Response Skin Glands see Exocrine Glands Skin Grafts see Skin Transplantation Skin Manifestations WR 143 Skin Neoplasms WR 500 Veterinary SF 901 See also Sebaceous Gland Neoplasms WR 410; Sweat Gland Neoplasms WR 400 Skin Pigmentation WR 102 Disorders WR 265 Skin Syphilis see Syphilis, Cutaneous Skin Temperature WR 102 Skin Tests QY 260 Skin Transplantation WO 610 Skin Tuberculosis see Tuberculosis, Cutaneous Skin Ulcer WR 598 Skin Wrinkling see Skin Aging Skinfold Thickness Malnutrition WD 105 Obesity diagnosis WD 210 Skull WE 705 Animal QL Domestic SF 901 Wild QL 822 Anthropology GN 71-131 Skull Fractures WL 354 Skull Neoplasms WE 707 Slang see Language; Philology; Vocabulary Slaughter Houses see Abattoirs Slaughterhouses see Abattoirs Sleep WL 108 Drugs promoting QV 85 In personal hygiene QT 265 Physiology WL 108 Sleep Apnea Syndromes WF 143 Sleep Deprivation Experimental WL 108 In personal hygiene QT 265 Sleep Disorders WM 188 See also names of specific disorders Sleep, REM WL 108 Sleep Stages WL 108 Sleep Talking see Sleep Disorders Sleep Terror Disorder see Sleep Disorders Sleep Therapy see Rest; specific conditions for which therapy is used Sleep Walking see Somnambulism Sleeping Sickness see Encephalitis, Epidemic; Trypanosomiasis, African Slime Bacteria see Myxococcales Slime Molds see Myxomycota Slipped Disk see Intervertebral Disk Displacement Slit-Lamp Microscopy see Microscopy Slotted Attachment, Dental see Denture, Precision Attachment Slow Virus Diseases WC 500 See also names of specific diseases, e.g., Kuru WC 540 Slums see Poverty Areas Small Nuclear RNA see RNA, Small Nuclear Smallpox WC 585-590 Prevention & control WC 588 Smallpox Vaccine WC 588 Used in the treatment of other diseases, with the disease Smallpox Virus see Variola Virus Smell WV 301 Smith, Theobald, Phenomenon see Anaphylaxis Smittia see Chironomidae Smoke Air pollution WA 754 Tobacco QV 137 Public health aspects WA 754 Toxicology QV 665 Smoke Inhalation Injury WO 704 Smokeless Tobacco see Tobacco, Smokeless Smokers' Patches see Leukoplakia, Oral Smoking Dependence WM 290 Effects QV 137 General HV 5725-5770 Smoking, Passive see Tobacco Smoke Pollution Snails QX 675 Snake Bites WD 410 Snake Poisons see Snake Venoms Snake Venoms WD 410 Snakeroot Poisoning see Milk Sickness Snakes QL 666.06-666.0694 Diseases SF 997.5.R4 Sneddon-Wilkinson Disease see Skin Diseases, Vesiculobullous Sneezing Gas see Toxicology QV 665 under Smoke Snoring WF 143 Snuff see Tobacco, Smokeless Soaps QV 233 Soccer QT 260.5.S7 Social Accountability see Social Responsibility Social Adjustment HM 291 In adolescence WS 462 In infancy & childhood WS 105.5.A8 Social Alienation In adolescence WS 463 In infancy & childhood WS 350.8.S6 Psychiatry WM 600 Sociology HM 291 Social Behavior HM 251 Animals QL 775 In adolescence WS 462 In infancy & childhood WS 105.5.S6 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 475 Social Behavior Disorders Social Behavior Disorders In adolescence WS 463 In infancy & childhood WS 350.8.S6 See also Child Behavior Disorders WS 350.6 Psychiatry (General) WM 600 Sociology HM 291 Television influence HE 8700.6 Social Breakdown Syndrome WM 600 In adolescence WS 463 In infancy & childhood WS 350.8.S6 Sociology HM 291 Social Change Progress HM 101 Reform HN Social Class HT 603-1445 Adolescents WS 462 Children WS 105.5.S6 Social Clubs, Therapeutic see Self-Help Groups Social Conditions HN Social Conformity HM 291 Social Control, Formal Penology HV 7240-9960 Social elements, forces, laws HM 201-221 Special topics, by subject Social Control, Informal HM 291 Primitive customs, e.g., Taboo GN 493-495.2 Special topics, by subject Social Desirability HM 132 Social Discrimination see Prejudice Social Disorganization see Anomie Social Distance HM 132 In adolescence WM 462 In infancy & childhood WS 105.5.S6 Social Dominance Anthropology Matriarchy GN 479.5 Patriarchy GN 479.6 In animals QL 775 Sociology HM 132 Leadership BF 637.L4 Social Environment HM 206 Mental Health WM 31 Social Facilitation BF 774 Social Identification In adolescence WS 462 In infancy & childhood WS 105.5.S6 Social Insurance see Social Security Social Interaction see Interpersonal Relations Social Isolation In infancy & childhood WS 105.5.D3 Psychology BF 575.L7 Social psychology HM 291 Social Justice Special topics, by subject Social Medicine WA 31 Social Perception HM 132 Social Planning HN Social Policy see Public Policy Social Problems HN In old age WT 30 Of the mentally retarded WM 307.S6 Of children WS 107.5.P8 Of the normal child WS 105.5.S6 Social Psychiatry see Community Psychiatry Social Psychology see Psychology, Social Social Reinforcement see Reinforcement, Social Social Responsibility Medical ethics W 50 Medical research W 20.5 Specific topics, by subject Social Sciences H Social Security HD 7090-7250.7 Medical benefits W 225-275 See also Medicare WT 31 Social Service see Social Work Social Service, Psychiatric see Social Work, Psychiatric Social Support Special topics, by subject Social Values HM 73 Social Welfare HV 1-4959 General works HV 30-31 By country HV 85-525 Social Work As a preventive health measure WA 108 Children WA 310-320 General works HV 6-696 Hospitals W 322 Maternity WA 310 Medical W 322 Periodicals WI Social Work Department, Hospital W 322 Social Work, Psychiatric WM 30.5 Social Workers see Social Work Socialization HM 131 Adolescents WS 462 Children WS 105.5.S6 Socialized Dentistry see State Dentistry Socialized Medicine see State Medicine Societies (Form number 1 in any NLM schedule where applicable. Include history) Fraternities in medicine and allied fields W 20.S Other societies in appropriate LC number Societies, Dental WU 1 Societies, Hospital WX 1 Societies, Medical WB 1 Fraternities W 20.9 Specialties (Form number 1 in any NLM schedule where applicable) Societies, Nursing WY 1 Societies, Pharmaceutical QV 701 Societies, Scientific Q 10-99 See also types of societies above or subheading societies under specialty headings, e.g., Zoolog> QL 1 Sociocultural Change see Acculturation Socioeconomic Factors Mental health WM 31 Public health WA 30 Other topics, by subject Socioeconomic Status see Social Class Socioenvironmental Therapy WM 428-445 Sociology HM-HX See also Social Medicine WA 31; Social Wort W 322, etc.; Social Work, Psychiatric WM30.5 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 476 Sound Spectrography Sociology, Medical WA 31 Sociometric Techniques HM 48 Sociopathic Personality see Antisocial Personality Disorder Sodium Inorganic chemistry QD 181.N2 Pharmacology QV 275 Sodium Bicarbonate see Bicarbonates Sodium Cephalothin see Cephalothin Sodium Channels QH 603.154 Sodium Chloride Metabolism QU 130 Water-electrolyte balance QU 105 Water-electrolyte imbalance WD 220 Pharmacology QV 273 Solution QV 786 Infusion WB 354 Sodium Chloride Solution, Hypertonic see Saline Solution, Hypertonic Sodium Cromoglycate see Cromolyn Sodium Sodium, Dietary Metabolism QU 130 Pharmacology QV 273 Relation to a particular disorder, with the disorder Sodium Glutamate Biochemistry QU 60 As a food additive WA 712 Sodium Iodohippurate see Iodohippuric Acid Sodium Isotopes Inorganic chemistry QD 181.N2 Pharmacology QV 275 Sodium Nitroprusside see Nitroprusside Sodium, Potassium Adenosinetriphosphatase see Na(+)-K(+)-Exchanging ATPase Sodium, Potassium ATPase see Na(+)-K(+)-Exchanging ATPase Sodium-Potassium Pump see Na(+)-K(+)-Exchanging ATPase Sodium Pump see Na(+)-K(+)-Exchanging ATPase Sodium Valproate see Valproic Acid Sodoku see Rat-Bite Fever Soft Contact Lenses see Contact Lenses, Hydrophilic Soft Tissue Neoplasms WD 375 Localized, by site Soft Tissue Radiography see Technology, Radiologic Softball see Baseball Softening, Brain see Encephalomalacia; Paresis Software QA 76.75-76.765 In medicine (General) W 26.55.S6 In other special fields (Form number 26.5 in any NLM schedule where applicable) Software Engineering see Software Software Tools see Software Soil S 590-599.9 Soil Microbiology QW 60 Soil Pollutants General public health aspects WA 785 Radioactive WN 615 Soil Pollutants, Radioactive WN 615 Solar Aging of Skin see Skin Aging Solar Fever see Dengue Solcoseryl see Actihaemyl Soldiers see Military Personnel Soldier's Heart see Neurocirculatory Asthenia Sole, Foot see Foot Solo Practice see Private Practice Solubility QD 543 Pharmaceutical chemistry QV 744 Solutions QV 786 Used for special purposes, by subject Solvents Pharmaceutical chemistry QV 744 Solution chemistry QD 544-544.5 Toxicology QV 633 Soman Biochemistry QU 131 Toxicology QV 627 Somatic Cell Hybrids see Hybrid Cells Somatic Gene Therapy see Gene Therapy Somatization Disorder see Somatoform Disorders Somatization Syndromes see Psychophysiologic Disorders Somatoform Disorders WM 170 Somatomammotropin, Chorionic see Placental Lactogen Somatomammotropin Receptors see Receptors, Somatotropin Somatomedin C see Insulin-Like Growth Factor I Somatomedin MSA see Insulin-Like Growth Factor II Somatosensory Cortex WL 307 Somatosensory Evoked Potentials see Evoked Potentials, Somatosensory Somatostatin WK 515 Somatostatin-14 see Somatostatin Somatotropin WK 515 Deficiency WK 550 As a cause of a particular disorder, with the disorder Somatotropin Receptors see Receptors, Somatotropin Somatotropin Release Inhibiting Hormone see Somatostatin Somatotypes GN 66.5 Somnambulism WM 188 Somniloquism see Sleep Disorders Sonography, Speech see Sound Spectrography Soporifics see Hypnotics and Sedatives; names of specific drugs Sorbitol QV 160 Sorbitol Dehydrogenase see Iditol Dehydrogenase Sore Throat see Pharyngitis Sore Throat, Septic see Streptococcal Infections Sotalol QV 132 Sound QC 221-246 Animal QL 765 Insect QL 496.5 See also Acoustics WA 776, etc.; Hearing WV 270; Noise WA 776, etc.; Ultrasonics WN 208, etc.; other particular topics associated with sound Sound Localization WV 272 Sound Spectrography QC 246 In a specific field, by subject ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 477 Sound Spectrography Southern Blotting see Blotting, Southern Soy Beans see Soybeans Soybeans As a dietary supplement in health or disease WB 430 Cultivation SB 205.S7 Sanitary control WA 703 Space Biology see Extraterrestrial Environment Space Flight WD 750-758 Standards Physical WD 752 Psychological WD 754 Space Medicine see Space Flight Space Perception WW 105 Concept formation in children WS 105.5.D2 Psychological aspects BF 469 Spanish Americans see Hispanic Americans Spasm WL 340 Bronchial see Bronchial Spasm WF 500 Drugs affecting QV 85 Pyloric WI 150 Affecting other parts of the body, with the part Spasmolytics see Parasympatholytics Spasmophilia see Tetany Spasms, Infantile WS 340 Spasmus Nutans see Spasms, Infantile Spastic Paralysis see Muscle Spasticity Spastic Paraplegia see Paraplegia Spasticity, Muscle see Muscle Spasticity Spatial Behavior Anthropogeography GF 51 Psychology BF 469 Spatial Orientation see Orientation Spatial Vectorcardiography see Vectorcardiography Specialism W 90 Specialization see Specialism; Specialties, Dental; Specialties, Medical; Specialties, Nursing Specialties, Dental WU 21 Specialties, Medical W 90 See also names of particular specialties Specialties, Nursing WY 101-164 Government WY 130 Indian service WY 130 Institutional WY 125 See also specific types of nursing, e.g., Occupational Health Nursing WY 141 Specialty Boards (Form number 21 in any NLM schedule where applicable) Species Specificity Bacteriology QW 700 Special topics, with the affecting organism or the organism affected Specimen Handling QY 25 In field other than clinical pathology, with the field SPECT see Tomography, Emission-Computed, Single-Photon Spectacles see Eyeglasses Spectrin WH 400 Spectrometry, Mass see Spectrum Analysis, Mass Spectrometry, Particle-Induced X-Ray Emission see ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Spectrometry, X-Ray Emission Spectrometry, Proton-Induced X-Ray Emission see Spectrometry, X-Ray Emission Spectrometry, X-Ray Emission Analysis of drinking water WA 686 Analytical chemistry QD 96.X2 Radiation physics QC 482.S6 Used for other purposes, by subject Spectrometry, X-Ray Emission, Electron Microscopic see Electron Probe Microanalysis Spectrometry, X-Ray Emission, Electron Probe see Electron Probe Microanalysis Spectrometry, X-Ray Fluorescence see Spectrometry, X-Ray Emission Spectrophotometry Analytical chemistry (General) QD 95 Quantitative analysis QD 117.S64 Used for special purposes, by subject, e.g., Analysis of hormones QY 330 Spectrophotometry, Atomic Absorption QC 454.A2 Used for special purposes, by subject, e.g., for blood chemical analysis QY 450-490, etc. Spectrophotometry, Infrared Organic chemistry QD 272. S57 Physics QC 457 Used for special purposes, by subject, e.g., for measuring impurities in the air WA 754 Spectroscopy see Spectrum Analysis Spectroscopy, Magnetic Resonance see Nuclear Magnetic Resonance Spectroscopy, Mass see Spectrum Analysis, Mass Spectroscopy, Nuclear Magnetic Resonance see Nuclear Magnetic Resonance Spectrum Analysis Analytical chemistry QD 95 Organic analysis QD 272.S6 Spectrum Analysis, Mass QC 454.M3 Spectrum Analysis, Raman QC 454.R36 Speech WV 501 Development see Language Development WS 105.5.C8, etc. Speech Acoustics WV 501 Speech, Alaryngeal WV 540 Speech Articulation Tests WV 501 In disorders of psychogenic origins WM 475 In disorders of neurologic origins WL 340.2 Speech Discrimination see Speech Perception Speech Discrimination Tests WV 272 Speech Disorders Associated with the larynx and other organs involved with speech WV 500 Neurologic WL 340.2 Psychogenic WM 475 Therapy WL 340.2; WM 475; WV 500 See also Speech Therapy WM 475, etc. See also Deaf-Mutism WV 280 Speech, Esophageal WV 540 Speech Intelligibility In adolescence WS 462 In infancy & childhood WS 105.5.C8 Physiological aspects WV 501 Speech disorders WM 475, etc. USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSIFIED 478 Splanchnoptosis Speech-Language Pathology Neurologic WL 340.2 Psychogenic WM 475 Speech Pathology see Speech-Language Pathology Speech Perception WV 272 Speech Production Measurement WV 501 In disorders of psychogenic origins WM 475 In disorders of neurologic origins WL 340.2 Speech Reception Threshold Test WV 272 Speech Sounds see Phonetics Speech Synthesizers see Communication Aids for Disabled Speech Therapy General WL 340.2 For disorders of neurologic origins WL 340.2 For disorders of psychogenic origins WM 475 See also Therapy WL 340.2, etc., under Speech Disorders Speechreading see Lipreading Speed see Accidents, Traffic; Aircraft Sperm see Spermatozoa Sperm Immobilizing Agents QV 177 Sperm-Ovum Interactions WQ 205 Sperm Penetration see Sperm-Ovum Interactions Spermatic Cord WJ 780 Spermatic Cord Torsion WJ 780 Spermatocidal Agents QV 177 Spermatocytes WJ 834 Spermatogenesis WJ 834 Spermatogonia WJ 834 Spermatophores see Spermatogonia Spermatozoa WJ 834 Drugs destroying see Spermatocidal Agents QV 177 Drugs immobilizing see Sperm-Immobilizing Agents QV 177 Spermicidal Agents see Spermatocidal Agents Spermiocytes see Spermatocytes Spermophilus see Sciuridae Sphaerophorus see Fusobacterium Sphaerophorus Infections see Fusobacterium Infections Sphagnum see Plants Sphenoid Bone WE 705 Sphenoid Sinus WV 358 Spherocytosis, Hereditary WH 170 Spheroplasts QW 51 Sphingolipidoses WD 205.5.L5 See also names of specific forms, e.g., Niemann-Pick Disease WD 205.5.L5 Sphingolipids QU 85 Sphingomyelins QU 93 Sphygmography see Blood Pressure Determination Sphygmomanometers, Continuous see Blood Pressure Monitors Spider Bite see Arachnidism Spider Monkey see Cebidae Spider Venoms WD 420 Spiders QX 471 Bites see Arachnidism WD 420 Spin Labels Biological research QH 324.9.S62 Spina Bifida see Spinal Dysraphism Spina Bifida Aperta see Spina Bifida Cystica Spina Bifida Cystica WE 730 Spina Bifida Manifesta see Spina Bifida Cystica Spina Bifida Occulta WE 730 Spina Bifida, Open see Spina Bifida Cystica Spinal Accessory Nerve see Accessory Nerve Spinal Anesthesia see Anesthesia, Spinal Spinal Bifida, Closed see Spina Bifida Occulta Spinal Canal WE 725 Spinal Cord WL 400 Spinal Cord Compression WL 400 Spinal Cord Diseases WL 400 Spinal Cord Injuries WL 400 Spinal Cord Neoplasms WL 400 Spinal Cord Syphilis see Tabes Dorsalis Spinal Diseases WE 725 Veterinary SF 901 Spinal Dysraphism WE 730 Spinal Fluid Pressure see Cerebrospinal Fluid Pressure Spinal Fractures WE 725 Spinal Fusion WE 725 Spinal Injuries WE 725 Spinal Muscular Atrophy see Muscular Atrophy, Spinal Spinal Neoplasms WE 725 Spinal Nerve Roots WL 400 Spinal Nerves WL 400 Spinal Osteophytosis WE 725 Veterinary SF 901 Spinal Puncture Anesthesia see Anesthesia, Spinal WO 305 Clinical pathology Cerebrospinal fluid QY 220, etc. General diagnosis WB 377 In neurology Cerebrospinal WL 203, etc. Spinal Stenosis WE 725 Spine WE 725-740 Spiral and Curved Bacteria (Non Mesh) see Bacteria Spiral Ganglion WV 250 Spiral Organ see Organ of Corti Spirillum QW 154 Spiritual Healing see Mental Healing Spiritualism BF 1228-1389 Spiro Compounds As tranquilizing agents QV 77.9 Organic chemistry QD 341.H9 Spirochaeta QW 155 Spirochaetales QW 155 Spirochaetales Infections WC 400-425 General works WC 400 Veterinary SF 809.S6 Spirochete Infections see Spirochaetales Infections Spirochetosis see Spirochaetales Infections Spirolactone see Spironolactone Spirometry General physical examination WB 284 Respiratory diagnosis WF 141 Spironolactone QV 160 Splanchnic Circulation WI 900 Splanchnic Nerves WL 610 Splanchnoptosis see Visceroptosis ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 479 Spleen Spleen WH 600 Blood supply WH 600 Splenectomy WH 600 Splenic Anemia see Hypersplenism Splenic Artery WG 595.S7 See also Blood supply WH 600 under Spleen Splenic Diseases WH 600 Splenic Neoplasms WH 600 Splenic Rupture WH 600 Splenic Vein WI 720 Splenomegaly WH 600 Febrile tropical see Leishmaniasis, Visceral WC 715 Splenoportography see Portography Spliced Leader Peptides see Signal Peptides Splicing, RNA see RNA Splicing Splints WE 26 Splints, Periodontal see Periodontal Splints Split Genes see Genes Spondylarthritis Ankylopoietica see Spondylitis, Ankylosing Spondylitis WE 725 Spondylitis, Ankylosing WE 725 Spondyloepiphyseal Dysplasia see Osteochondrodysplasias Spondylolisthesis WE 730 Spondylosis see Spinal Osteophytosis Spondylosis Deformans see Spinal Osteophytosis Spontaneous Generation see Biogenesis Spores QW 190 Of bacteria only in QW 51 Of cryptogams (other than fungi) in QK 506 Of fungi in QW 180 Spores, Bacterial QW 51 Spores, Fungal QW 180 Sporotrichosis WC 475 Sporozoa see Sporozoea Sporozoea QX 123-140 Sports QT 260 Sports Medicine QT 261 First aid WA 292 Spotted Fever, Rocky Mountain see Rocky Mountain Spotted Fever Spouse Abuse Counseling WM 55 Crime against the person HV 6626 Effect on family HQ 809-809.3 Spouse Caregivers see Caregivers Sprains and Strains WE 175 Spreading Cortical Depression WL 307 Sprue see Celiac Disease Sprue, Tropical WD 175 Sputum QY 120 SQ 14225 see Captopril Squalene QU 85 Organic chemistry QD 416 Squint see Strabismus Squirrel Monkey see Saimiri Squirrels see Sciuridae St. Anthony's Fire see Ergotism St. Vitus' Dance see Chorea STA-MCA Bypass see Cerebral Revascularization Stabilizing Agents see Excipients ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH^ Stable Factor see Factor VII Staff Development Job enrichment HF 5549.5.J616 Training of employees HF 5549.5.T7 In special fields, by subject See also Personnel Management Staffing and Scheduling see Personnel Staffing and Scheduling Staggerer Mice see Mice, Neurologic Mutants Staging, Neoplasm see Neoplasm Staging Stains and Staining Bacteriology QW 25 Microscopy (General) QH 237 In medicolegal examination W 750 Stammering see Stuttering Standard Preparations see Reference Standards Standardization, Drugs see Standards QV 771 under Drugs Standards see Name of specialties with subheading standards or, lacking that, the number for the specialty as a profession, e.g., in psychiatry; Hospitals; Professional standards review organizations; Quality control Standards, Reference see Reference Standards Stannum see Tin Stapedectomy see Stapes Surgery Stapedius WV 230 Stapes WV 230 Stapes Surgery WV 230 Treatment of otosclerosis WV 265 Staphylocoagulase see Coagulase Staphylococcal Clumping Factor see Coagulase Staphylococcal Food Poisoning WC 268 Staphylococcal Infections WC 250 Veterinary SF 809.S72 Staphylococcal Phages see Staphylococcus Phages Staphylococcal Pneumonia see Pneumonia, Staphylococcal Staphylococcal Protein A QW 52 Staphylococcal Toxoid WC 250 Staphylococcal Vaccines WC 250 Staphylococcus QW 142.5.C6 Staphylococcus Phages QW 161.5.S8 Starch QU 83 Starvation WD 100 Stasis Ulcer see Varicose Ulcer State Dentistry W 260 By political jurisdiction W 275 State Government Special topics, by subject State Health Planning and Development Agencies WA 540 State Health Planning, United States see Health Planning State Health Plans WA 540 State Medicine W 225 By political jurisdiction W 275 State-of-the-Art Review see Review Literature Statewide Health Coordinating Councils see Health Planning Councils Statistical Computing see Mathematical Computing Statistical Models see Models, Statistical Statistical Regression see Regression Analysis E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 480 Stomatitis Statistics HA Biometry (General) QH 323.5 Mathematical methods (General) QA 276-280 Medical WA 900 By specialty or particular disease (Form number 16 in any NLM schedule where applicable) Theory and methods WA 950 By specialty (Form number 25 in any NLM schedule where applicable) Nursing WY 31 Periodical government documents W2 Vital see Vital statistics, HB, etc. Special topics, by subject Status Asthmaticus WF 553 Status Dysraphicus see Spinal Dysraphism Status Lymphaticus see Lymphatic Diseases Stealing see Theft Steam TJ 268-280.7 See also Baths, Finnish WB 525; Sterilization WX 165, etc. Steatorrhea see Celiac Disease Steatorrhea, Idiopathic see Celiac Disease Steele-Richardson-Olszewski Syndrome see Supranuclear Palsy, Progressive Stegomyia see Aedes Stein-Leventhal Syndrome see Polycystic Ovary Syndrome Stellate Ganglion WL 600 Stem Cell Assay see Colony-Forming Units Assay Stem Cell Assay, Tumor see Tumor Stem Cell Assay Stem Cells QH 581.2 Stem Cells, Hematopoietic see Hematopoietic Stem Cells Stem Cells, Neoplastic see Tumor Stem Cells Stenocardia see Angina Pectoris Stenosis see Constriction, Pathologic; names of various types of stenosis, e.g., Pulmonary Valve Stenosis Step Test see Exercise Test Stereognosis WR 102 Stereophotogrammetry see Photogrammetry Stereopsis see Depth Perception Stereoscopic Vision see Depth Perception Stereoscopy see Optics Stereotyped Behavior WM 165 In a particular situation, with the situation Stereotyping BF 323.S63 Sterility see Infertility Sterility, Female see Infertility, Female Sterility, Male see Infertility, Male Sterilization In dentistry WU 300 In hospitals WX 165 In mortuary practice WA 840 In organ transplantation WO 665 In preventive medicine WA 240 In surgery WO 113 Sterilization, Involuntary Social aspects HV 4989 Sterilization, Sexual Family planning HQ 767.7 Female WP 660 See also Castration WP 660; Sterilization, Tubal WP 660 Insect QX 600 Male WJ 868 See also Castration WJ 868; Vasectomy WJ 780 Sterilization, Tubal WP 660 Sternum WE 715 Steroid Receptors see Receptors, Steroid Steroidal Anti-Inflammatory Agents see Anti-Inflammatory Agents, Steroidal Steroids Biochemistry QU 85 Organic chemistry QD 426-426.7 Hormones WK 150 See also names of specific steroids, e.g., Anabolic Steroids WK 150, etc. Steroids, Anabolic see Anabolic Steroids Sterols QU 95 Stethoscopy see Auscultation Stevens-Johnson Syndrome WR 150 Sticklebacks see Fishes Stigmatization BV 5091.S7 Stilbenes As contraceptives QV 177 Organic chemistry QD 341.H9 Stilbestrol see Diethylstilbestrol Stillbirth see Fetal Death Still s Disease, Juvenile-Onset see Arthritis, Juvenile Rheumatoid Stimulants see Analeptics; Convulsants; Parasympathomimetics; Sympathomimetics; Xanthines; names of specific stimulants Stimulation, Chemical QV 38 Stimulation, Electric see Electric Stimulation Stings see Bites and Stings Stippled Epiphyses see Chondrodysplasia Punctata STLV-III see SIV Stochastic Processes QA 274-274.76 Special topics, by subject Stockings, Compression see Bandages Stockings, Elastic see Bandages Stoicism see Philosophy Stokes-Adams Attacks see Adams-Stokes Syndrome Stomach WI 300-387 Acidity see Gastric Acidity Determination QY 130; Gastric Juice WI 302, etc.; Antacids QV 69 Analysis QY 130 Desiccated see Tissue Extracts QV 370, etc. Stomach Dilatation WI 300 Veterinary SF 851 Stomach Diseases WI 300-387 General works WI 300 Veterinary SF 851 Stomach Neoplasms WI 320 Stomach, Ruminant QL 862 Domestic animals SF 851 Stomach Rupture WI 300 Stomach Ulcer WI 360 Stomach Volvulus WI 300 Stomatitis General works for the dentist WU 140 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 481 Stomatitis General works for the gastroenterologist WI 200 Veterinary SF 852 Stomatitis, Aphthous General works for the dentist WU 140 General works for the gastroenterologist WI 200 Stomatitis, Herpetic WC 578 Stomatitis, Ulcerative see Gingivitis, Necrotizing Ulcerative Stomatology see Mouth; Mouth Diseases Storerooms see Materials Management, Hospital Strabismus WW 415 Strabismus, Convergent see Esotropia Strains see Sprains and Strains Stramonium QV 134 Strapping, Wounds see Bandages Stratigraphy, X-Ray see Tomography, X-Ray Stream Pollution see Water Pollution Street Drug Testing see Substance Abuse Detection Street Drugs Abuse WM 270 General works QV 55 Pharmacology QV 38 Street People see Homeless Persons Streetcars, Public Health Aspects see Public Health Aspects WA 810 under Transportation Strepsirhini QL 737.P95 Diseases SF 997.5.P7 Streptococcal Infections WC 210 Food poisoning WC 268 Streptococcal OK-432 see Picibanil Streptococcal Preparation OK-432 see Picibanil Streptococcus QW 142.5.C6 Streptococcus mutans QW 142.5.C6 Streptococcus pneumoniae Infections see Pneumococcal Infections Streptodomase see Deoxyribonucleases Streptodomase and Streptokinase QU 136 Streptomyces QW 125.5.S8 Streptomycetaceae QW 125.5.S8 Streptomycin QV 356 Streptozocin Diabetes see Diabetes Mellitus, Experimental Streptozotocin Diabetes see Diabetes Mellitus, Experimental Stress QZ 160 Physiology QT 162.S8 Special topics, by subject Stress Disorders, Post-Traumatic WM 170 Stress Fractures see Fractures, Stress Stress, Mechanical Biophysics QT 34 Bone WE 140 Other special topics, by subject Stress Proteins see Heat-Shock Proteins Stress, Psychological WM 172 In aviation medicine WD 730 In infancy & childhood WS 350 In space medicine WD 754 Stress Test see Exercise Test Stressful Events see Life Change Events Striate Cortex see Visual Cortex ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Striated Border see Microvilli Stridor see Respiratory Sounds Strikes, Employee HD 5306-5450.7 Hospital personnel WX 159.8 Occupational health services WA 412 Mental health services WA 495 Nurses WY 30 Dealings with hospitals WX 159.8 Special fields, by profession, industry, or specialty See also Labor Unions Stroke see Cerebrovascular Disorders; Heat Exhaustion; Lightning; Sunstroke Stroke Volume WG 106 Strongyloidea QX 243 Strongyloidiasis WC 865 Strontium Inorganic chemistry QD 181.S8 Metabolism QU 130 Pharmacology QV 275 Strontium Isotopes Inorganic chemistry QD 181.S8 Pharmacology QV 275 Strontium Radioisotopes WN 420 Nuclear physics QC 796.S8 See also special topics under Radioisotopes Strophanthins QV 153 Structure-Activity Relationship Biochemistry QU 34 Pharmaceutical chemistry QV 744 Structure, Molecular see Molecular Structure Struma see Goiter Struma Ovarii WP 322 Strychnine QV 103 Toxicology QV 628 Student Dropouts LC 142-145 Adolescent psychology and psychiatry WS 462-463 Student Health Services WA 350-353 Universities and colleges WA 351 Mental health WA 353 See also Mental Health Services WM 30, etc.; School Health Services WA 350, etc. Student Loans see Training Support Student Selection see School Admission Criteria Students Substance abuse WM 270, etc. School mental health services WA 352-353 School public health services WA 350-351 Sexual behavior HQ 27-29 See also Adolescence WS 460, etc.; Child WS, etc. Students, Dental WU 18 Students, Health Occupations W 18 Students, Medical W 18 Supervision of student assistants in a mental hospital WM 30 Other special topics, by subject Students, Nursing WY 18 Supervision in hospitals WY 105 In mental hospitals WM 30 Students, Premedical W 18 Stuttering WM 475 Stye see Hordeolum USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 482 Styrenes Organic chemistry QD 341.H9 Toxicology QV 633 Subarachnoid Hemorrhage WL 200 Subarachnoid Pressure see Intracranial Pressure Subarachnoid Space WL 200 Subcellular Fractions QH 581-581.2 Subchondral Cysts see Bone Cysts Subclavian Artery WG 595.S8 Subclavian Steal Syndrome WL 355 Subclavian Vein WG 625.S8 Subconscious see Unconscious (Psychology) Subcorneal Pustular Dermatosis see Skin Diseases, Vesiculobullous Subcutaneous Tissue, Medication by see Injections, Subcutaneous Subdiaphragmatic Abscess see Subphrenic Abscess Subject Headings Z 695-695.1 Medicine Z 695.1.M48 Sublimation WM 193.5.S8 In adolescence WS 463 In infancy & childhood WS 350.8.D3 Sublimation, Drugs see Drug Compounding Subliminal Perception see Subliminal Stimulation Subliminal Projection see Subliminal Stimulation Subliminal Stimulation BF 323.S8 In psychoanalysis WM 460 Perception WL 705 Suggestion BF 1156.S8 Sublingual Gland WI 230 Sublingual Region see Mouth Floor Submandibular Gland WI 230 Submarine Medicine WD 650 Submaxillary Gland see Submandibular Gland Submersion see Immersion Subphrenic Abscess WI 575 Subsidies, Educational see Training Support Subsidies, Government see Financing, Government Subsidies, Health Planning see Health Planning Support Subsidies, Research see Research Support Substance Abuse WM 270-290 Autopsy to determine WM 270-290 Social aspects HV 5800-5840 See also Doping in Sports QT 261 Substance Abuse Detection HV 5823-5823.5 Of specific substance, with the substance Through urine screening QY 185 Substance Abuse, Intravenous WM 270 Special topics, by subject Substance Abuse Testing see Substance Abuse Detection Substance Dependence WM 270-290 Cannabis WM 276 Cocaine WM 280 Narcotics WM 284 Nicotine WM 290 Opium alkaloids WM 286 See also Heroin Dependence WM 288; Morphine Dependence WM 286 Substance Use Disorders WM 270-290 Substance Withdrawal, Neonatal see Neonatal Abstinence Syndrome ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Sulfates, Organic Substance Withdrawal Syndrome WM 270-290 Substactia Nigra WL 310 Substrate Specificity QU 135 Subtrochanteric Fractures see Hip Fractures Success see Achievement Succinate Dehydrogenase QU 140 Succinates QU 98 Organic chemistry Aliphatic compounds QD 305.A2 Succinbromimide see Bromosuccinimide Succinic Oxidase see Succinate Dehydrogenase Succinimides QV 85 Succinylcholine QV 140 Succinyldicholine see Succinylcholine Sucralfate QV 66 Sucrase QU 136 Sucrose QU 83 Suction Drainage in surgery WO 188 Puncture technique in diagnosis WB 373 Suction Curettage see Vacuum Curettage Suction Lipectomy see Lipectomy Sudden Deafness see Deafness, Sudden Sudden Infant Death WS 430 Sudeck's Atrophy WE 250 Sudorifics see Sweating Suffocating Gases see Phosgene; names of other specific gases Suffocation see Asphyxia Sugar Acids QU 84 Sugar Alcohol Dehydrogenases QU 140 Sugar Alcohol Oxidoreductases see Sugar Alcohol Dehydrogenases Sugar Alcohols Biochemistry QU 75 Organic chemistry QD 305.A4 Pharmacology QV 82 Sugar Phosphates QU 75 See also Glycerophosphates QU 93 Sugar Substitutes see Sweetening Agents Sugars see Carbohydrates Suggestion WM 415 See also Counseling WM 55, etc.; Mental Healing WB 880-885; related special topics Suicide HV 6543-6548 Medicolegal aspects W 864 Specific mental disorders associated with suicide, with the disorder See also Crisis Intervention WM 401 Suicide, Assisted W 50 Suipoxvirus QW 165.5.P6 Sulbactam QV 350 Sulfadiazine QV 265 Sulfadoxine QV 265 Sulfamethoxazole QV 265 Sulfamethoxypyridazine QV 265 Sulfamethylisoxazole see Sulfamethoxazole Sulfamyl Diuretics see Diuretics, Sulfamyl Sulfanilamides QV 265 Sulfaninylbutylurea see Carbutamide Sulfates QV 280 Sulfates, Inorganic see Sulfates Sulfates, Organic see Sulfuric Acids NUMBER ASSIGNED ONLY WHEN F WORK BEING CLASSIFIED 483 Sulfathiazoles Sulfathiazoles QV 265 Sulfhydryl Compounds Biochemistry QU 130 Organic chemistry Aliphatic compounds QD 305.S3 Aromatic compounds QD 341. S3 Sulfhydryl Compounds Antagonists see Sulfhydryl Reagents Sulfhydryl Compounds Inhibitors see Sulfhydryl Reagents Sulfhydryl Reagents QU 143 Sulfides QV 280 Inorganic chemistry QD 18 LSI Sulfobromophthalein QV 240 Sulfonamides QV 265 Sulfones Biochemistry QU 130 Organic chemistry Aliphatic compounds QD 305.S6 Aromatic compounds QD 341.S6 Pharmacology QV 265 Sulfonethylmethane see Hypnotics and Sedatives Sulfonic Acids QU 98 Inorganic chemistry QD 18 LSI Organic chemistry Aliphatic QD 305.S3 Aromatic QD 341.S3 Sulfonmethane see Hypnotics and Sedatives Sulfonyldianiline see Dapsone Sulfonylurea Compounds As hypoglycemic agents WK 825 Organic chemistry Aliphatic compounds QD 305.S6 Sulformethoxine see Sulfadoxine Sulforthomidine see Sulfadoxine Sulfoxides Organic chemistry Aliphatic compounds QD 305. S3 Aromatic compounds QD 341.S6 Pharmacology QV 265 Sulfur Inorganic chemistry QD 18 LSI Pharmacology QV 265 Mineral waters WB 442 Sulfur Amino Acids see Amino Acids, Sulfur Sulfur Dioxide Inorganic chemistry QD 18 LSI Toxicology QV 618 Sulfur Isotopes Inorganic chemistry QD 18 LSI Pharmacology QV 265 Sulfur Mustard see Mustard Gas Sulfur Oxides As air pollutants WA 754 Inorganic chemistry QD 18 LSI Sulfuric Acids QD 18LSI Toxicology QV 612 Sulindac As an anti-inflammatory analgesic QV 95 Sulph- For words beginning thus, see those beginning with Sulf- Sulpiride QV 77.5 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH4 Sumac see Toxicodendron Sun Baths see Sunlight; Heliotherapy Sun Fever see Dengue Sunbathing see Heliotherapy Sunburn WR 160 Sunlight As an aid to health QT 230 Therapeutic use see Heliotherapy WB 480, etc. Sunscreening Agents QV 63 Sunstroke WD 610 See also Heat Exhaustion WD 610 Superego WM 460.5.R3 In adolescence WS 463 In infancy & childhood WS 350.5 Superfecundation see Pregnancy, Multiple Superfetation WQ 235 Superior Vena Cava Obstruction see Superior Vena Cava Syndrome Superior Vena Cava Syndrome WG 625.V3 Superior Vena Cava Thrombosis see Superior Vena Cava Syndrome Superiority Complex see Personality Disorders Supernumerary Organs see Abnormalities Superoxide Dismutase QU 140 Superoxides QV 312 Superpalite see Phosgene Supersonic Waves see Ultrasonic Therapy; Ultrasonics Superstitions Curiosities WZ 308 Medical WZ 309 Occult sciences BF 1405-1999 Popular delusions AZ 999 Religion BL 490 Supplies, Pharmaceutical see Equipment and Supplies; Pharmacy; Catalogs, Drug; specific types of pharmaceutical supplies, e.g., Drug packaging Supply Catalogs see Catalogs, Commercial; names of other specific types of catalogs Suppositories Administration of medicines WB 344 Drug forms QV 785 Suppressor Cells see T-Lymphocytes, Suppressor-Effector Suppressor-Effector T-Lymphocytes see T-Lymphocytes, Suppressor-Effector Suppressor Factor, T-Cell, Glioblastoma-Derived see Transforming Growth Factor beta Suppressor Transfer RNA see RNA, Transfer Suppuration QZ 150 Clinical examination QY 210 See also Infection WC 195, etc. Supranuclear Palsy, Progressive WL 359 Suprarenal Glands see Adrenal Glands Suprarenalin see Epinephrine Suprasellar Cyst see Craniopharyngioma Supratentorial Neoplasms WL 358 Suprofen QV 95 Surface-Active Agents QV 233 See also Pulmonary Surfactant WF 600; Surface Tension QC 183 Surface Anesthesia see Anesthesia, Local IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 484 Surrogate Mothers Surface Antigens see Antigens, Surface Surface Glycoproteins see Membrane Glycoproteins Surface Markers, Immunological see Antigens, Surface Surface Properties QD 506.A1A-508 Dental chemistry WU 170 In other areas, by subject Surface Proteins see Membrane Proteins Surface Tension QC 183 See also Pulmonary Surfactant WF 600; Surface Active Agents QV 233 Surfactants see Surface-Active Agents Surfactants, Pulmonary see Pulmonary Surfactants Surgeon-Patient Relations see Physician-Patient Relations Surgeons see Biography WZ 112.5.S8, etc., and Directories WO 22 under Surgery Surgeons, Oral, Directories see Directories WU 22 under Surgery, Oral Surgery WO Abdominal see Surgery WI 900-970 under Abdomen Animal see Surgery SF 911 under Veterinary Medicine Atlases see Surgery, Operative WO 517, etc. Barber surgeons WO 11 Biography Collective WZ 112.5.S8 Military WZ 112.5.M4 Individual WZ 100 Cardiac problems WG 460 Cardiovascular see Surgery WG 168, etc., under Cardiovascular System Care plans see Insurance, Health W 100-275 Case Studies WO 16 Cryogenic see Cryogenic Surgery WO 510, etc. Dental see Dentistry, Operative WU 300-360, etc.; Surgery, Oral WU 600-640, etc. Directories WO 22 Diseases WO 140 Emergency WO 700-820 Experimental WO 50 Exploratory WO 141 Humor about WZ 305.5 In adolescence WO 925 In infancy & childhood WO 925 In old age WO 950 Industrial WO 700-820 Infection WO 184-185 Insurance see Insurance, Health W 100-275 Military WO 800 Naval WO 800 Obstetrical WQ 400-450 Ophthalmological see Surgery WW 168 under Eye Orthopedic see Orthopedics WE 168-190, etc. Otorhinolaryngologic see Surgery WV 168 under Otorhinolaryngologic Diseases; or Surgery WV 200 under Ear; Surgery WV 300 under Nose; Surgery WV 540 under Larynx Proctological see Surgery WI 650 under Rectum Thoracic see Thoracic Surgery WF 980 Traumatic WO 700-820 Urologic see Urinary Tract WJ 168, etc.; or Urogenital System WJ 168, etc. Veterinary see Surgery SF 911 under Veterinary Medicine See also Electrosurgery WO 198, etc.; Neurosurgery WL 368; names of other diseases, organs or systems; names of other types of surgery Surgery, Cosmetic see Surgery, Plastic Surgery Department, Hospital WO 27-28 Surgery, Esthetic see Surgery, Plastic Surgery, Laparoscopic General works WO 500 For specific diseases, with the disease Surgery, Laser see Laser Surgery Surgery, Minor WO 192 Surgery, Office see Ambulatory Surgery Surgery, Operative WO 500-517 Atlases WO 517 Obstetrical WQ 400 Veterinary SF 911 Localized, by site Surgery, Oral WU 600-640 Directories of oral surgeons WU 22 In infancy & childhood WU 480 Surgery, Oral, Preprosthetic WU 500 Surgery, Orthopedic see Orthopedics Surgery, Outpatient see Ambulatory Surgery Surgery, Plastic WO 600-640 Nose WV 312 Other locations, by site Surgery, Repeat see Reoperation Surgery, Veterinary SF 911-914.4 Surgical Anastomosis see Anastomosis, Surgical Surgical Atlases see Surgery, Operative Surgical Blood Loss see Blood Loss, Surgical Surgical Care Plans see Insurance, Health Surgical Diathermy see Electrocoagulation Surgical Diseases see Surgery Surgical Equipment WO 162-170 Catalogs W 26 Surgical Flaps WO 610 Used in surgery for a particular condition, with the condition Surgical Infection see Surgical Wound Infection Surgical Instruments WO 162 Catalogs W 26 Surgical Mesh WO 162 Surgical Nursing WY 161-162 Education WY 18-18.5 See also Operating Room Nursing WY 162; Nursing WY 154, etc. under Critical Care Surgical Pathology see Pathology, Surgical Surgical Replantation see Replantation Surgical Revision see Reoperation Surgical Scrub see Handwashing Surgical Staplers WO 162 Surgical Wound Dehiscence WO 185 Surgical Wound Infection WO 185 Surrogate Markers see Biological Markers Surrogate Mothers HQ 759.5 Special topics, by subject ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 485 Surrogate Mothers Surveillance, Immunologic see Immunologic Surveillance Survey Methods see Data Collection Surveys see Dental Health Surveys; Health Surveys; Library Surveys; Nutrition Surveys; subject of other specific surveys, e.g., Nursing Survival Arctic and antarctic QT 160 Atomic warfare WN 650 Aviation accidents WD 740 Civil defense UA 926-929 First aid WA 292 Shipwrecks Navies and merchant marines VK 1250-1299 Private ships G 525-530 Space flight WD 740 Wilderness WA 250 From other accidents and disasters, by subject Survival Analysis WA 950 Special topics, by subject Survival Rate WA 900 Special topics, by subject Survivorship see Survival Rate Suspending Agents see Excipients Suspensions QV 785 Sustained-Release Preparations see Delayed-Action Preparations Suture Techniques WO 166 Sutures WO 166 Suxamethonium see Succinylcholine SV40 Virus see Polyomavirus macacae Swallowing see Deglutition Swamp Fever see Equine Infectious Anemia Sweat WR 400 Sweat Gland Diseases WR 400 Sweat Gland Neoplasms WR 400 Sweat Glands WR 400 Sweating WR 102 Drugs inducing QV 122 Swedish Gymnastics see Gymnastics; Exercise Therapy Sweetening Agents WA 712 Swimbladder see Air Sacs Swimming QT 260.5.S9 Accidents QT 260.5.S9 Swimming Pools WA 820 Swine Anatomy SF 767.S95 Culture SF 391-397.83 As laboratory animals QY 60. S 8 Physiology SF 768.2.S95 Swine Diseases SF 971-977 Swine Herpesvirus 1 see Herpesvirus 1, Suid Swine Influenza Virus see Orthomyxovirus Type A, Porcine Swinepox Virus see Suipoxvirus Swing Beds see Bed Conversion Swiss Mice see Mice Sydnones Organic chemistry QD 401 Used for particular diseases, with the disease Sylvian Vein see Cerebral Veins ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Symbiosis Ecology and general QH 548 Microbial QW 52 Plant QK 918 Symbiotes see Rickettsiaceae Symbiotic Relations (Psychology) see Object Attachment Symbolism (Psychology) BF 458 Psychoanalysis WM 460.5.D8 See also Emblems and Insignia WZ 334, etc. Sympathectomy WL 610 Sympathetic-Blocking Agents see Sympatholytics Sympathetic Ganglia see Ganglia, Sympathetic Sympathetic Nerve Block see Autonomic Nerve Block Sympathetic Nervous System WL 610 Children WS 340 Sympathetic Transmitter Releasers see Sympathomimetics Sympathins see Catecholamines Sympatholytics QV 132 Sympathomimetics QV 129 Symphalangus see Hylobates Symphysiotomy WQ 430 Symptomatology see Diagnosis Synapses WL 102.8 Synaptic Membranes WL 102.8 Synaptic Potentials see Synaptic Transmission Synaptic Receptors see Receptors, Neurotransmitter Synaptic Transmission WL 102.7-102.8 Synaptosomes WL 102.8 Syncope WB 182 Syndactyly WE 835 Syndrome QZ 140 Of specific disorders, with the disorder Synergism see Drug Synergism Synostosis WE 250 Synovia see Synovial Fluid Synovial Fluid WE 300 Synovial Membrane WE 300 Synovioma see Sarcoma, Synovial Synovitis WE 300 Synovitis, Pigmented Villonodular WE 300 Synstigmin see Neostigmine Synthetases see Ligases Synthetic Vaccines see Vaccines, Synthetic Syphacia see Oxyuroidea Syphilids see Syphilis, Cutaneous Syphilis WC 160-170 Antisyphilitics QV 261-262 Cerebrospinal see Neurosyphilis WC 165 Drug therapy WC 170 In pregnancy WQ 256 Syphilis, Cardiovascular WC 168 Syphilis, Congenital WC 161 Syphilis, Cutaneous WC 160 Syphilis, Latent WC 160-164 Syphilis Serodiagnosis QY 275 Syphilis, Spinal Cord see Tabes Dorsalis Syringadenoma see Adenoma, Sweat Gland Syringe Sharing see Needle Sharing Syringes W 26 Syringomyelia WL 400 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 486 Tc-99m MDP Systematics see Classification Systeme International d Unites see International System of Units Systemic Poisons see Poisons Systems Analysis Analytical methods connected with physical problems QA 402-402.37 Industrial engineering T 57.6-57.97 Systems Theory QA 402-402.37 Of other special topics, by subject Systole WG 280 Systolic Click-Murmur Syndrome see Mitral Valve Prolapse Systolic Time Interval see Systole Szondi Test WM 145.5.S9 In adolescence WS 462 In infancy & childhood WS 105.5.E8 In psychology BF 698.8.S85 T T Antigens see Antigens, Viral, Tumor T-Cell Growth Factor see Interleukin-2 T-Cell Growth Factor Receptors see Receptors, Interleukin-2 T-Cell Leukemia Vims I, Human see HTLV-I T-Cell Leukemia Viruses, Human see HTLV-BLV Viruses T-Cell Receptors see Receptors, Antigen, T-Cell T-Cells see T-Lymphocytes T-Cells, Suppressor-Effector see T-Lymphocytes, Suppressor-Effector T-Groups see Sensitivity Training Groups T-Lymphocytes WH 200 Cellular immunity QW 568 T-Lymphocytes, Cytotoxic WH 200 In cellular immunity QW 568 T-Lymphocytes, Suppressor-Effector WH 200 In cellular immunity QW 568 T-Lymphotropic Vims Type III Antibodies, Human see HIV Antibodies T-Lymphotropic Virus Type III Infections, Human see HIV Infections T-Lymphotropic Vims, Type HI, Simian see SIV T-Phages QW 161.5.C6 Tabacosis see Pneumoconiosis Tabes Dorsalis WC 165 Tables (Form number 16 in any NLM schedule where applicable or appropriate LC number, e.g., tables illustrating general science Q 199) See also name of specific subject of the table Tablets QV 787 As medication for particular diseases, with the disease Tablets, Enteric-Coated QV 787 Taboo GN 471.4 Tac Peptide see Receptors, Interleukin-2 Tac P55 Peptide see Receptors, Interleukin-2 Tachyarrhythmia see Tachycardia Tachycardia WG 330 Tachycardia, Paroxysmal WG 330 Tachypleus see Horseshoe Crabs ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Taenia QX 400 Taenia Infections see Taeniasis Taeniacides see Anticestodal Agents Taeniarhynchus see Taenia Taeniasis WC 838 Veterinary SF 810.C5 Tahyna Vims see California Group Vimses Talampicillin QV 354 Talc Adverse effects WF 654 Dosage form QV 785 Talipes Cavus see Foot Deformities Talipes Equinovams see Clubfoot Tamarin, Golden see Callitrichinae Tamias see Sciuridae Tamoxifen As an estrogen antagonist WP 522 Used in the treatment and prevention of breast neoplasms WP 870 Tampons In surgery WO 162 Tanning Occupational medicine WA 400-495 Tannins QV 65 Tantalum Inorganic chemistry QD 181.T2 Pharmacology QV 290 Tape Recording Catalogs and works about (Form number 18.2 in any NLM schedule where applicable) Recordings, by subject Tape Recording, Video see Videotape Recording Tapetoretinal Degeneration see Retinitis Pigmentosa Tapeworm Infection see Cestode Infections Tapeworms see Cestoda Tapioca see Cassava Tapping see Punctures Tarantulas see Spiders Targeted Toxins see Immunotoxins Tars QV 241 As dermatologic agents QV 60 See also Coal Tar QV 60, etc. Tarsal Joint WE 880 Tartar see Dental Calculus Tartar Emetic see Antimony Taste WI 210 Taste Buds WI 210 TAT see Thematic Apperception Test Tattooing GN 419.3 Taurine QU 60 Organic chemistry QD 305.A8 Taxes General HJ 2240-7390 Dentistry WU 77 Hospitals WX 157 Medicine W 74 Nursing WY 77 Pharmacy QV 736 Tax aspects of legislation, in number for discussion of legislation, e.g., of black lung legislation WF 33 Taxonomy see Classification Tc-99m MDP see Technetium Tc 99m Medronate E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 487 TCGF see Interleukin-2 TDE see DDD Tea As a beverage used as a dietary supplement in health or disease WB 438 As a medicinal plant QV 766 Chemical technology TP 650 Cultivation of plant SB 271-272 See also Theophylline QV 107 Teachers' Manuals see Teaching Materials Teaching (Form number 18 in any NLM schedule where applicable) As a medical profession W 88 Nursing WY 105 Of the blind HU 1618-2349 Of the deaf HV 2417-2990.5 Of the deaf-mute HV 2417-2990.5 Of other groups in education, number for the group Teaching Materials LB 1027 (Form number 18.2 in any NLM schedule where applicable) Physiology QT 200 Special topics, by subject Team Nursing see Nursing, Team Tear Gases QV 665 Tears WW 208 Secretion WW 208 See also Crying WS 105.5.E5, etc. Tears, Artificial see Ophthalmic Solutions Teas, Herbal see Beverages Teas, Medicinal see Beverages Technetium WN 420 Nuclear physics QC 796.T35 See also special topics under radioisotopes Technetium Methylene Diphosphonate see Technetium Tc 99m Medronate Technetium Tc 99m Medronate WN 420 Diagnostic use WN 445 Technical Services, Library see Library Technical Services Technology T-TX Chemical (General) TP 144-145 General works T 44-51 Special topics, by subject Technology Assessment, Biomedical General W 74 Special topics, by subject Technology, Dental WU 150 Technology, Food see Food Technology Technology, High-Cost Medicine W 74 Other topics, class by subject if specific; if general, in economics number where available Technology, Medical As a profession QY 21 Clinical pathology QY Diagnostic and therapeutic techniques WB 365 Technology, Pharmaceutical QV 778 Technology, Radiologic WN 160 Instrumentation WN 150 Veterinary SF 757.8 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIM Tectum Mesencephali see Corpora Quadrigemina Tedelparin QV 193 Teenage Pregnancy see Pregnancy in Adolescence Teeth see Tooth Teeth-Straightening see Orthodontics Teething see Tooth Emption Tegafur QV 269 Telangiectasia, Hereditary Hemorrhagic WG 700 Telangiectasis WG 700 Telecommunication Networks see Computer Communication Networks Telecommunications TK 5101-5105.9 Teleconference see Telecommunications Telemetry Biomedical (General) QT 34 General TK 399 Space flight WD 750 Monitoring special systems, in the diagnosis number for the system Telencephalon WL 307 Teleological Ethics see Ethics Telepathy BF 1161-1171 Telephone Hotlines see Hotlines Teleradioisotope Therapy see Radioisotope Teletherapy Teletherapy, Radioisotope see Radioisotope Teletherapy Television Educational (General) LB 1044.7-1044.8 Effect on adolescents WS 462 Effect on children WS 105.5.E9 In special fields of education (Form number 18.2 in any NLM schedule where applicable) Special topics, by subject Tellurium Inorganic chemistry QD 181.T4 Metabolism QU 130 Temperament BF 795-811 Temperance HV 5701-5722 Temperature Medical climatology WB 700 Meteorology QC 901-913.2 Physiological effects on animals QP 82.2.T4 Physiological effects on humans QT 145-160 See also Body Temperature WB 270, etc.; Cold Climate QT 160, etc.; Desert Climate QT 150, etc.; Heat QZ 57, etc. Temperature Sense WL 103 Templates Biochemistry QU 58 Dental see Dental Materials WU 190 Genetics QH 450.2 Temporal Arteries WG 595.T3 Temporal Arteritis WG 595.T3 Temporal Bone WE 705 For the otolaryngologist WV 201 Temporal Lobe WL 307 Temporary Threshold Shift, Auditory see Auditory Fatigue Temporomandibular Joint WU 101-102 Temporomandibular Joint Diseases WU 140.5 Temporomandibular Joint Syndrome WU 140.5 IE NUMBER ASSIGNED ONLY WHEN OP WORK BEING CLASSIFIED 488 Thalamencephalon Tendinitis WE 600 Tendon Injuries WE 600 Veterinary SF 901 Tendon Reflex see Reflex, Tendon Tendon Sheaths see Tendons Tendon Transfer WE 600 Tendons WE 600 Achilles see Achilles Tendon WE 880 Teniasis see Taeniasis Tenicides see Anticestodal Agents Tennis QT 260.5.T3 Tenosynovitis WE 600 Veterinary SF 901 TENS see Transcutaneous Electric Nerve Stimulation Tensile Strength Biophysics QT 34 Bone WE 103 Tension-Discharge Disorders see Personality Disorders Tension, Intraocular see Intraocular Pressure Tensor Tympani WV 230 Teratogenesis see Etiology QS 675 under Abnormalities; Abnormalities, Dmg-Induced; Chromosome Abnormalities Teratogens QS 675-679 Teratoid Tumor see Teratoma Teratology see Abnormalities Teratoma QZ 310 Localized, by site Teratoma, Cystic see Dermoid Cyst Teratoma, Mature see Dermoid Cyst Terminal Addition Enzyme see DNA Nucleotidylexotransferase Terminal Care In infancy & childhood WS 200 Medical aspects WB 310 Nursing WY 152 Of patients with particular disease, with the disease See also Attitude to Death BF 789.D4; Hospices WX 28.6-28.62 Terminal Deoxyribonucleotidyltransferase see DNA Nucleotidylexotransferase Terminals, Computer see Computer Terminals Terminology 0?onn number 15 in any NLM schedule where applicable) Terpene Phosphates see Polyisoprenyl Phosphates Terpenes Biochemistry QU 85 Toxicology QV 633 Territoriality Animal QL 756.2 Human HM 132 Terrorism see Violence Test-Tube Fertilization see Fertilization in Vitro Testicular Diseases WJ 800-875 General Works WJ 830 Monorchidism WJ 840 Testicular Feminization WJ 712 Testicular Hormones WJ 875 Testicular Neoplasms WJ 858 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Testicular Torsion see Spermatic Cord Torsion Testing, Biocompatible Materials see Materials Testing Testis WJ 830 Abnormalities WJ 840 Diseases see Testicular Diseases WJ 830, etc. Feminization see Testicular Feminization WJ 712 Hormones see Testicular Hormones WJ 875 Neoplasms see Testicular Neoplasms WJ 858 Surgery WJ 868 Tunica Vaginalis WJ 800 See also Castration WJ 868, etc.; Epididymis WJ 800 Testis, Undescended see Cryptorchidism Testosterone WJ 875 Testosterone Propionate see Testosterone Tests see Diagnosis Laboratory; Psychological Tests WM 145, etc; Serodiagnosis; names of other specific tests Tetanus WC 370 Veterinary SF 804 Tetanus Antitoxin WC 370 Tetanus Toxoid WC 370 Tetanus Vaccine see Tetanus Toxoid Tetany WD 200.5.C2 Veterinary SF 910.T47 Tethered Cord Syndrome see Spina Bifida Occulta Tetracaine QV 115 Tetracemate see Edetic Acid Tetrachlorodibenzodioxin As an herbicide WA 240 Tetrachloroethylene QV 253 Tetracycline QV 360 Tetradecanoylphorbol Acetate As a carcinogen QZ 202 Tetraethylammonium Compounds QV 132 Tetraethylthiuram Disulfide see Disulfiram Tetragastrin Receptors see Receptors, Cholecystokinin Tetrahydrocannabinol QV 77.7 Tetrahydrofolate Dehydrogenase QU 140 Tetrahydronaphthalenes Organic chemistry QD 391 Pharmacology QV 241 Tetrahymena QX 151 Tetrakain see Tetracaine Tetralins see Tetrahydronaphthalenes Tetralogy of Fallot WG 220 Tetramon see Tetraethylammonium Compounds Tetraplegia see Quadriplegia Tetrylammonium see Tetraethylammonium Compounds Textbooks, Programmed see Programmed Instruction Textile Industry Occupational accidents WA 485 Occupational medicine WA 400-495 Industrial waste WA 788 Textiles Fire prevention WA 250 TGF-beta see Transforming Growth Factor beta Thalamencephalon see Diencephalon E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 489 Thalamic Nuclei Thalamic Nuclei WL 312 Thalamostriate Vein see Cerebral Veins Thalamus WL 312 Thalassemia WH 170 Thalassotherapy WB 750 Thalidomide QV 85 Adverse effects QS 679 Thalidomide Children see Abnormalities, Dmg-Induced Thallium Toxicology QV 618 Thallium Radioisotopes WN 415-450 Thanatology HQ 1073-1073.5 THC see Tetrahydrocannabinol Thea see Tea Thebaine QV 92 Theca Cell Tumor see Thecoma Thecoma WP 322 Theft Special topics, by subject Theileriasis SF 809.T5 Thematic Apperception Test WM 145.5.T3 Theobroma see Cacao Theobromine QV 107 Theology see Religion Theophylline QV 107 Theophylline Receptors see Receptors, Purinergic Therapeutic Abortion see Abortion, Therapeutic Therapeutic Community WM 440 Therapeutic Cults see Alternative Medicine Therapeutic Equivalency QV 38 Therapeutics WB 300-962 Animals (General works) SF 743-745 See also Dmg Therapy SF 915-919.5 Anesthetics WO 375 Cardiovascular diseases WG 166 Eye diseases WW 166 Gynecologic diseases WP 650 Home remedies WB 120 Hormones WK 190 In infancy & childhood WS 366 In old age WT 166 Mental disorders WM 400-460.7 In infancy & childhood WS 350.2 Mouth diseases WU 166 Neoplasms QZ 266-269 Physical see Physical Therapy WB 460-545, etc. Radioisotopes WN 450 Radium WN 340 Roentgen ray see X-Ray Therapy WN 250.5.X7 Skin diseases WR 650-660 Special systems see Alternative Medicine WB 890-962, etc.; other specific types of therapy, by name Tooth diseases WU 166 Urologic diseases WJ 166 For therapy of other diseases see general works number for disease, organ, or system Therapy, Combined Modality see Combined Modality Therapy Therapy, Computer-Assisted WB 365 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPILA Special topics, by subject Thermocoagulation see Electrocoagulation Thermodynamics Biochemistry QU 34 Physical and theoretical chemistry QD 504 Physics QC 310.15-319 Thermoelectric Power Plants see Power Plants Thermography WN 205 Used for diagnosis of specific diseases, with the disease Thermogravimetry QD 79.T4 In clinical pathology QY 90 Thermoluminescent Dosimetry WN 660 Thermometers As equipment WB 26 In physical examination WB 270 Thermopenetration see Diathermy Thermoreceptors WL 102.9 Thermoregulation see Body Temperature Regulation QT 165, etc Thermotherapy see Hyperthermia, Induced; Therapeutic use WB 469 under Heat Theropithecus gelada QL 737. P93 Diseases SF 997.5.P7 As laboratory animals QY 60. P7 Theses see Dissertations, Academic Thiabendazole QV 253 Thiamine QU 189 Thiamine Deficiency WD 122 Veterinary SF 855.V58 Thiamine Diphosphate see Thiamine Pyrophosphate Thiamine Pyrophosphate QU 135 Thiamphenicol QV 350.5.C5 Thiazines Dyes QV 240 Chemical technology TP 918 Chemistry QD 441 Organic chemistry QD 403 Thienamycins QV 350 Thigh WE 865 Thin Sectioning see Microtomy Thinking BF 441^*49.5 In adolescence WS 462 In infancy & childhood WS 105.5.D2 Thinness Anthropology GN 66-67.5 Nutrition disorders WD 100 Symptomatology WB 146 Thio-Tepa see Thiotepa Thiobacillus QW 135 Thiobacteriaceae see Gram-Negative Chemolithotrophic Bacteria Thioctic Acid QU 135 Thiocyanates WK 202 Thioethers see Sulfides Thiols see Sulfhydryl Compounds Thiomebumal see Thiopental Thiopental QV 88 Thiopentobarbital see Thiopental Thiophenes Acting on the nervous system QV 76.5 As anthelmintics QV 253 Organic chemistry QD 403 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 490 Thymus Extracts Thiophenicol see Thiamphenicol Thiophosphamide see Thiotepa Thioredoxin QU 55 Thiosemicarbazones QV 268 Thiosulfates Inorganic chemistry QD 18 LSI Pharmacology QV 280 Thiotepa QV 269 Thiothixene QV 77.9 Thiourea WK 202 Third-Party Payments see Insurance, Health, Reimbursement Thirst Neurophysiology WI 102 Thomsonian Medicine see Alternative Medicine Thoracentesis see Punctures Thoracic Arteries WG 595.T4 Thoracic Cyst see Mediastinal Cyst Thoracic Diseases WF 970-985 In infancy & childhood WS 280 See also Empyema WF 745 Thoracic Duct WH 700 Thoracic Injuries WF 985 Thoracic Neoplasms WF 970 Thoracic Nerves WL 400 Thoracic Outlet Syndrome WL 500 Thoracic Radiography WF 975 In infancy & childhood WS 280 See also Mass Chest X-Ray WF 225 Thoracic Surgery WF 980 Thoracic Vertebrae WE 725 Thoracoplasty WF 980 Thoracotomy WF 980 Thorax Anatomy and physiology WE 715 Bone stmcture and abnormalities WE 715 Diseases of the organs within (General) WF 970-975 Funnel see Funnel Chest WE 715 Mass X-ray see Mass Chest X-Ray WF 225 Surgery see Thoracic Surgery WF 980 Wounds see Thoracic Injuries WF 985 Thorium WN 420 Nuclear physics QC 796.T5 See also special topics under Radioisotopes Thornapple see Stramonium Thorny-Headed Worms see Acanthocephala Threadworms see Nematoda Three-Day Fever see Phlebotomus Fever Three-Day Sickness see Ephemeral Fever Threshold Limit Values see Maximum Permissible Exposure Level Throat see Pharynx Thrombase see Thrombin Thrombelastography QY 410 Thrombin QV 195 In the mechanism of blood coagulation WH 310 Thromboangiitis Obliterans WG 520 Thrombocytapheresis see Plateletpheresis Thrombocytes see Blood Platelets Thrombocytopathy see Blood Platelet Disorders Thrombocytopenia WH 300 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Thromboelastography see Thrombelastography Thromboembolism QZ 170 Venous WG 610 Thromboendarterectomy see Endarterectomy Thrombolysis, Therapeutic see Thrombolytic Therapy Thrombolytic Agents see Fibrinolytic Agents Thrombolytic Therapy QZ 170 See also Fibrinolytic Agents QV 190 Thrombopenia see Thrombocytopenia Thrombopenic Purpura see Purpura, Thrombopenic Thrombophlebitis WG 610 Thromboplastin WH 310 Clinical analysis QY 410 Thrombosis QZ 170 Arterial WG 540 Cerebral see Cerebral Embolism and Thrombosis WL 355 Carotid artery see Carotid Artery Thrombosis WL 355 Coronary see Coronary Disease WG 300 Meningeal vessels WL 200 Pulmonary see Pulmonary Embolism WG 420 Sinus see Sinus Thrombosis WL 355 Venous see Thrombophlebitis WG 610 Thrombosis, Coronary see Coronary Thrombosis Thrombosis, Venous see Thrombophlebitis Thrombotest see Prothrombin Time Thromboxane A Synthase see Thromboxane Synthetase Thromboxane A2 QU 90 Thromboxane Synthetase QU 137 Thromboxanes QU 90 Perinatology WQ 210-211 Thrombus see Thrombosis Thrush see Moniliasis, Oral Thulium Inorganic Chemistry QD 181.T8 Pharmacology QV 290 Thumb WE 835 Thumbsucking see Fingersucking Thyme see Herbs Thymectomy WK 400 Thymic Cyst see Mediastinal Cyst Thymic Factor, Circulating WK 400 Thymic Group Viruses see Herpesviridae Thymidine QU 57 Pharmacology QV 185 Thymidine Kinase QU 141 Thymine QU 58 Thymins see Thymopoietins Thymoanaleptics see Antidepressive Agents Thymol QV 250 Thymoleptics see Antidepressive Agents Thymoma WK 400 Veterinary SF 910.T8 Thymopoietins WK 400 Thymosin WK 400 Thymotaxin see beta 2-Microglobulin Thymus-Dependent Lymphocytes see T-Lymphocytes Thymus Extracts Pharmacology QV 370 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 491 Thymus Extracts Therapeutic use (General) WB 391 Used for treatment of particular disorders, with the disorder or system Thymus Gland WK 400 Thymus Hyperplasia WK 400 Thymus Neoplasms WK 400 Thyrocalcitonin see Calcitonin Thyroglobulin WK 202 Thyroglossal Cyst WK 270 Thyroid Antagonists WK 202 Thyroid Diseases WK 200-280 Thyroid Function Tests WK 202 Thyroid Gland WK 200-280 Thyroid Hormone Receptors see Receptors, Thyroid Hormone Thyroid Hormones WK 202 Deficiency WK 250 As a cause of particular disorders, with the disorder See also Hypothyroidism WK 250 Thyroid Neoplasms WK 270 Thyroid Peroxidase see Iodide Peroxidase Thyroid-Stimulating Hormone see Thyrotropin Thyroidectomy WK 280 Thyroiditis WK 200 Thyroliberin see Protirelin Thyrotoxicosis see Hyperthyroidism WK 265 Thyrotropin WK 515 Thyrotropin-Releasing Hormone see Protirelin Thyroxine WK 202 Thyroxine-Binding Globulin see Thyroxine-Binding Proteins Thyroxine-Binding Prealbumin see Thyroxine-Binding Proteins Thyroxine-Binding Proteins WK 202 Thyroxine Receptors see Receptors, Thyroid Hormone Thyroxine 5-Deiodinase see Iodide Peroxidase Thyroxine 5 -Monodeiodinase see Iodide Peroxidase Tiabendazol see Thiabendazole Tibia WE 870 Tibial Fractures WE 870 Tibial Menisci see Menisci, Tibial Tic WM 197 Neurologic manifestation WL 340 Tic Douloureux see Trigeminal Neuralgia Ticarcillin QV 354 Tick-Borne Diseases WC 600 Tick-Borne Rickettsial Fevers see Rickettsia Infections Tick Control QX 600 Animal culture SF 810.T5 Tick Infestations WC 900 Disinfestation WC 900 Veterinary SF 810.T5 Ticks QX 479 Time QB 209-224 Factor in ability to infect QW 700 In relation to particular topics, by subject Time and Motion Studies Special topics, by subject Time Factors Factor in ability to infect QW 700 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 In relation to particular topics, by subject Time Perception BF 468 In infancy & childhood WS 105.5.D2 Time-Resolved Immunofluorometric Assay see Fluoroimmunoassay Timed-Release Preparations see Delayed-Action Preparations Timidity see Shyness Timolol QV 132 Tin As a trace element QU 130.5 Dental use WU 180 Toxicology QV 618 Used in particular procedures, with the procedure Tinctures, Pharmacy see Solutions Tinea WR 310 Veterinary SF 809.R55 Tinea Capitis WR 330 Tinea Favosa WR 330 Tinea Pedis WR 310 Tinidazole QV 254 Tinnitus WV 272 Tiotixene see Thiothixene Tissue Aging WT 104 Composition QU 100 Specific types QS 532-532.5 Susceptibility to infection QW 700 Transplantation WO 660-690 See also Histology QS 504-539, etc. Tissue Adhesives WO 166 Tissue Banks QS 523-524 Organ banks WO 23-24 Tooth banks WU 24.5 See also Eye Banks WW 23-24 Tissue Compatibility see Histocompatibility Tissue Culture General works QS 530 Plant QK 725 Technique QS 525 Tissue Distribution QV 38 Tissue Donors QS 523-524 Tissue Extracts Pharmacology QV 370 Therapeutic use (General) WB 391 Used for the treatment of particular disorders, with the disorder or system Tissue Factor see Thromboplastin Tissue Preservation Histology QS 525 Transplantation WO 665 Tissue Therapy WB 391 Tissue Thromboplastin see Thromboplastin Tissue Transplantation WO 660-690 Tissue-Type Plasminogen Activator see Alteplase Tissue Typing see Histocompatibility Testing Titanium Inorganic chemistry QD 181.T6 Dentistry WU 180 Titration, Conductometric see Conductometry TLV see Maximum Permissible Exposure Level TMJ Syndrome see Temporomandibular Joint Syndrome IE NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 492 Tn Elements see DNA Insertion Elements TNF-alpha see Tumor Necrosis Factor Toad, Fire-Bellied see Anura Toad Venoms see Amphibian Venoms Toads and Frogs see Anura Toads, True see Bufonidae Tobacco Cultivation SB 273-278 Dependence WM 290 See also Smoking WM 290 Pharmacology QV 137 See also Nicotine QV 137; Smoking WM 290, etc. Tobacco Dependence see Tobacco Use Disorder Tobacco Mosaic Vims QW 163 Tobacco Smoke see Smoke; Tobacco Tobacco Smoke Pollution WA 754 Tobacco, Smokeless Dependence WM 290 Pharmacology QV 137 Tobacco Use Disorder WM 290 Tobramycin QV 350 Tocodynamometry see Uterine Monitoring Tocography see Uterine Monitoring Tocolysis WQ 330 Tocolytic Agents Pharmacology WK 102 Tocolytic Therapy see Tocolysis Tocopherol see Vitamin E Tocopherols see Vitamin E Toenails see Nails Toes WE 835 Abnormalities WE 835 Togaviridae QW 168.5.A7 Togaviridae Infections WC 501 Togavirus Infections see Togaviridae Infections Toilet Facilities WA 830 Toilet Training WS 113 Token Economy BF 319.5.R48 In behavior therapy WM 425 Token Reinforcement see Token Economy Tolbutamide WK 825 Tolerance of Dmgs see Dmg Tolerance Tolmetin QV 95 Tolonium Chloride QV 195 Tolosa-Hunt Syndrome see Ophthalmoplegia Toluene As indicators and reagents QV 240 Organic chemistry QD 341.H9 Toxicology QV 633 Toluene 2,4-Diisocyanate QV 280 Toluidine Blue O see Tolonium Chloride Tolylene Diisocyanate see Toluene 2,4-Diisocyanate Tombs, Public Health Aspects see Burial Tomodensitometry see Tomography, X-Ray Computed Tomography WN 206 Cardiovascular diseases (General) WG 141.5.T6 Used in the examination of particular organs, with the organ or region Tomography, Computed, Scanners see Tomography Scanners, X-Ray Computed Tomography, Emission-Computed WN 206 ALWAYS CONSULT MAIN SCHEDULES. USE SUBJECT REPRESENTS MAJOR EMPHASIS C Tooth Crowding Tomography, Emission-Computed, Single-Photon WN 206 Localized by site Tomography, NMR see Magnetic Resonance Imaging Tomography, Positron-Emission see Tomography, Emission-Computed Tomography, Proton Spin see Magnetic Resonance Imaging Tomography, Radionuclide-Computed see Tomography, Emission-Computed Tomography Scanners, X-Ray Computed WN 150 Used in the examination of particular organs, with the organ or region Tomography, Single-Photon, Emission-Computed see Tomography, Emission-Computed, Single-Photon Tomography, Transmission see Tomography, X-Ray Tomography, Transmission Computed see Tomography, X-Ray Computed Tomography, X-Ray WN 206 Used in the examination of particular organs, by organ or region Tomography, X-Ray Computed WN 206 Used in the examination of particular organs, with the organ or region Tomography, X-Ray Computed, Scanners see Tomography Scanners, X-Ray Computed Tongue WI 210 Tongue Diseases WI 210 Tongue, Geographic see Glossitis, Benign Migratory Tongue Habits In adolescence WS 463 In adulthood WM 172 In infancy & childhood WS 350.6 Malocclusion etiology WU 440 Tongue, Hairy WI 210 Tongue Neoplasms WI 210 Tonofilaments see Intermediate Filaments Tonometry WW 143 Tonsil WV 430 Tonsil, Palatine see Tonsil Tonsillar Neoplasms WV 430 Tonsillectomy WV 430 Tonsillitis WV 430 Tonsils see Tonsil Tooth WU Banks WU 24.5 Canine see Cuspid WU 101 Devitalized see Dental Pulp Devitalization WU 230 Injuries WU 158 Medicolegal aspects W 705 Microbiology QW 65 Pathology WU 140 Transplantation WU 640 Tooth Abnormalities WU 101.5 Tooth Abrasion WU 140 Tooth Apex see Tooth Root Tooth, Artificial WU 515 Tooth Avulsion see Tooth Luxation Tooth Cleaning see Toothbrushing Tooth Crowding see Malocclusion NUMBER ASSIGNED ONLY WHEN IF WORK BEING CLASSIFTED 493 Tooth, Deciduous Tooth, Deciduous WU 480 Tooth Diseases WU 140 Tooth Erosion WU 140 Tooth Eruption WU 102 Teething WU 480 Tooth Extraction WU 605 Tooth Fractures WU 158 Tooth Germ WU 101 Tooth, Impacted WU 101.5 Tooth Luxation WU 158 Tooth Mobility WU 102 Orthodontics WU 400 Periodontics WU 240 Tooth Movement, Minor WU 400 Tooth Reimplantation see Tooth Replantation Tooth Remineralization WU 166 Tooth Replantation WU 640 Tooth Root WU 230 Tooth Supporting Structures see Periodontium Tooth, Wisdom see Molar, Third Toothache WU 140 Toothbrushing WU 113 Topectomy see Psychosurgery Topical Infiltration see Topical Anesthesia WO 340 under Anesthesia, Local Topographic Brain Mapping see Brain Mapping Topography, Moire see Moire Topography Tornadoes see Natural Disasters Torsion QZ 150 Ovarian WP 320 Testicular see Spermatic Cord Torsion WJ 780 Torsion Dystonia see Dystonia Musculorum Deformans Torticollis WE 708 Torture As a form of punishment HV 8593-8599 Torula see Cryptococcus Torulopsis see Candida Tomlosis see Cryptococcosis Total Body Clearance Rate see Metabolic Clearance Rate Total Body Irradiation see Whole-Body Irradiation Total Communication Methods see Communication Methods, Total Total Parenteral Nutrition see Parenteral Nutrition, Total Total Quality Management HD 62.15 In special fields by subject, in number for professions where available Touch WR 102 Tourette Syndrome WM 197 Tourette's Disorder see Tourette Syndrome Tourniquet Pain Test see Pain Measurement Town Planning see City Planning Toxaphene Agriculture SB 952.C44 Public health WA 240 Toxemia WC 240 In pregnancy see Pregnancy Toxemias WQ 215 Intestinal WI 405 Toxic Shock Syndrome see Shock, Septic Toxic Substances, Environmental see Hazardous Substances ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPIL4 Toxicodendron WD 500 See also Dermatitis, Toxicodendron Toxicodendron Dermatitis see Dermatitis, Toxicodendron Toxicology QV 600-667 Industrial WA 465 Laboratory manual QV 602 Medicolegal aspects W 750 Methods QV 602 Nursing texts QV 600 Public health aspects WA 730 Veterinary SF 757.5 See also Poisoning QV 600-667, etc.; names of types of poisoning, e.g. Plant poisoning WD 500-530; names of particular poisons Toxin-Antibody Conjugates see Immunotoxins Toxin-Antibody Hybrids see Immunotoxins Toxin-Antitoxin Reaction see Antitoxins; Toxins Toxin Carriers see Immunotoxins Toxin Conjugates see Immunotoxins Toxins QW 630 See also names of specific toxins Toxins, Chimeric see Immunotoxins Toxins, Deactivated see Toxoids Toxins, Targeted see Immunotoxins Toxoids QW 805 Used for particular diseases, with the disease See also names of specific toxoids Toxoplasma QX 140 Toxoplasma gondii see Toxoplasma Toxoplasma gondii Infection see Toxoplasmosis Toxoplasmosis WC 725 Toxoplasmosis, Animal SF 809.T6 Toxoplasmosis, Congenital WC 725 Toxoplasmosis, Ocular WW 140 Toys see Play and Playthings Trabeculectomy For glaucoma WW 290 Trabeculoplasty see Trabeculectomy Trace Elements Biochemistry QU 130.5 Analytical chemistry QD 139.T7 Tracers, Radioactive see Radioisotopes Trachea WF 490 Tracheal Cyst see Mediastinal Cyst Tracheal Diseases WF 490 Tracheal Neoplasms WF 490 Tracheal Stenosis WF 490 Tracheitis WF 546 Tracheoesophageal Fistula WI 250 Tracheotomy WF 490 Trachoma WW 215 Track and Field QT 260.5.T7 Traction WE 190 Trade Unions see Labor Unions Trades, Diseases see Occupational Diseases Traditional Birth Attendant see Midwifery Traditional Medicine, Chinese see Medicine, Chinese Traditional Traditional Medicine, Oriental see Medicine, Oriental Traditional Traffic Accidents see Accidents, Traffic Training, Athletic see Sports USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 494 Transplantation Training of Children see Child Care; Child Rearing Training Programs see Education Training Support (Form number 18 in any NLM schedule where applicable) Directories (Form number 22 in any NLM schedule where applicable) Science Q 181-183.4 Tranquilizing Agents QV 77.9 In anesthesia WO 297 Tranquilizing Agents, Major see Antipsychotic Agents Tranquilizing Agents, Minor see Anti-Anxiety Agents Transactional Analysis WM 460.6 Special topics, by subject Transaminases see Aminotransferases Transcendental Meditation see Relaxation Techniques Transcriptases see RNA Polymerases Transcription, Genetic QH 450.2 Transcriptional Regulatory Elements see Genes, Regulator Transcultural Nursing WY 107 Transcultural Studies see Cross-Cultural Comparison Transcutaneous Administration see Administration, Cutaneous Transcutaneous Blood Gas Monitoring see Blood Gas Monitoring, Transcutaneous Transcutaneous Capnometry see Blood Gas Monitoring, Transcutaneous Transcutaneous Electric Nerve Stimulation WB 495 Transcutaneous Oximetry see Blood Gas Monitoring, Transcutaneous Transdermal Administration see Administration, Cutaneous Transdermal Electrostimulation see Transcutaneous Electric Nerve Stimulation Transducers, Pressure QT 26 Transduction, Genetic QW 51 Transfection QW 51 Transfer Factor In cellular immunity QW 568 Other special topics, by subject Transfer (Psychology) LB 1059 Transfer RNA see RNA, Transfer Transfer RNA, Amino Acyl see RNA, Transfer, Amino Acyl Transferases QU 141 Transference (Psychology) WM 62 Transferrin WH 400 Clinical analysis QY 455 Transformation, Bacterial QH 448.4 Transformation, Genetic QW 51 Transforming Genes see Oncogenes Transforming Growth Factor Alpha Receptors see Receptors, Epidermal Growth Factor-Urogastrone Transforming Growth Factor beta QU 107 Transforming Growth Factors QU 107 Transforming Region see Base Sequence Transfusion see Blood Transfusion Transgenic Animals see Animals, Transgenic Transgenic Mice see Mice, Transgenic Transglutaminase see Protein-Glutamine gamma-Glutamyltransferase Transient Ischemic Attack see Cerebral Ischemia, Transient Transient Situational Disturbance see Adjustment Disorders Transients and Migrants Demography HB 1951-2577 Labor HD 5855-5856 Health problems WA 300, etc. See also Emigration and immigration JV 6008-6348 Transillumination WW 143 Used for other special purposes, by subject Transketolase QU 141 Translating PN 241-245 Directories of translators PN 241 Machine translating P 307-310 Science Q 124 Technology T 11.5 See also Automatic Data Processing W 26.55.A9, etc. Translation, Genetic QH 450.5 Translations Bibliography Z 6514.T7 Classical Z 7018.T7 Medical NLM subject number preceded by Z National Great Britain and Ireland Z 2014.T7 Latin and South America Z 1609.T7 United States Z 1231.T7 Individual works, with the original work, by subject Translocation, Chromosomal see Translocation (Genetics) Translocation (Genetics) QH 462.T7 Transluminal Coronary Balloon Dilatation see Angioplasty, Transluminal, Percutaneous Coronary Transmembrane Potentials see Membrane Potentials Transmissible Gastroenteritis of Swine see Gastroenteritis, Transmissible, of Swine Transmission Electron Microscopy see Microscopy, Electron Transmission of Infectious Diseases see Carrier State; Disease Outbreaks; Epidemiology; Infection; specific types of vectors, e.g., Insect Vectors; names of particular diseases Transmitter Uptake Inhibitors, Neuronal see Neurotransmitter Uptake Inhibitors Transphosphorylases see Phosphotransferases Transplacental Exposure see Maternal-Fetal Exchange Transplantation WO 660-690 Legal, ethical, or religious aspects WO 690 (Laws W0 32) Skin W0 610 Tube grafts W0 610 Specific organs, with the organ See also Tissue preservation WO 665 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 495 Transplantation Transplantation, Allogeneic see Transplantation, Homologous Transplantation, Autologous WO 660 Transplantation, Bone see Bone Transplantation Transplantation, Bone Marrow see Bone Marrow Transplantation Transplantation, Brain Tissue see Brain Tissue Transplantation Transplantation, Cardiac see Heart Transplantation Transplantation, Heart see Heart Transplantation Transplantation, Heart-Lung see Heart-Lung Transplantation Transplantation, Hepatic see Liver Transplantation Transplantation, Heterologous WO 660 Transplantation, Homologous WO 660 Veterinary SF 911 Transplantation Immunology WO 680 Transplantation, Islets of Langerhans see Islets of Langerhans Transplantation Transplantation, Kidney see Kidney Transplantation Transplantation, Liver see Liver Transplantation Transplantation, Lung see Lung Transplantation Transplantation, Organ see Organ Transplantation Transplantation, Pancreas see Pancreas Transplantation Transplantation, Pancreatic Islets see Islets of Langerhans Transplantation Transplantation, Renal see Kidney Transplantation Transplantation, Skin see Skin Transplantation Transplantation, Tissue see Tissue Transplantation Transport, Biological see Biological Transport Transport of Wounded and Sick see Transportation of Patients Transport Proteins see Carrier Proteins Transportation Hazardous materials WA 810 Mentally disabled HV 3005.5 Nursing services WY 143 Of elderly WT 30 Physically disabled HV 3022 Public Health aspects WA 810 See also Automobiles TL 1-390, etc.; Wheelchairs WB 320, etc.; names of other modes of transportation Transportation of Patients Ambulance service (general or hospital) WX 215 War UH 500-505 See also Ambulances WX 215 etc. Transposable Elements see DNA Insertion Elements Transposition of Great Vessels WG 220 Transposons see DNA Insertion Elements Transsexualism WM 611 Transudates see Exudates and Transudates Transvestism WM 610 Tranylcypromine QV 77.5 Trauma see Wounds and Injuries Trauma, Multiple see Multiple Trauma Trauma Severity Indices Traumatology WO 700 Travel QT 250 First aid WA 292 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Medical W 10 See also Expeditions W 10, etc. Trazodone As an antidepressant QV 77.5 Treacher-Collins Syndrome see Mandibulofacial Dysostosis Treadmill Test see Exercise Test Treatment Costs see Health Care Costs Treatment Protocols see Clinical Protocols Trees Botany QK 475-493.5 Conservation SD 411-428 Damage from natural elements SB 781-795 Diseases SB 761-767 Forestry SD Toxic WD 500 Trematoda QX 353 Trematode Infections WC 805-810 Veterinary SF 810.F3 Tremor WL 340 Veterinary SF 895 Trench Fever WC 602 Trench Foot see Immersion Foot Trench Mouth see Gingivitis, Necrotizing Ulcerative Trephining WE 705 Treponema QW 155 Treponemal Infections WC 422 Tretamine see Triethylenemelamine Tretinoin QU 167 Used in treating a particular skin disease, with the disease Triacylglycerol Lipase see Lipase Triacylglycerols see Triglycerides Trials, Medicolegal see Forensic Medicine Triamcinolone WK 757 Triamcinolone Acetonide WK 757 Triamterene QV 160 Triazines As analgesics QV 95 As herbicides WA 240, etc. Organic chemistry QD 401 Triazoles Organic chemistry QD 401 Tribavirin see Ribavirin Tributyrinase see Lipase Tricarboxylic Acid Cycle see Citric Acid Cycle Trichina see Trichinella Trichinella QX 207 Trichinelliasis see Trichinosis Trichinelloidea see Trichuroidea Trichinosis WC 855 Veterinary SF 810.T7 Trichlorbutanol see Chlorobutanol Trichlormethane see Chloroform Trichloroacetic Acid QU 98 Organic chemistry QD 305.A2 Trichloroethanes Toxicology QV 633 Trichloroethylene QV 81 Trichloromethylchloroformate see Phosgene Trichobezoars see Bezoars Trichocephaliasis see Trichuriasis Trichocephalus see Trichuris USE NUMBER ASSIGNED ONLY WHEN IIS OF WORK BEING CLASSIFIED 496 Trypanosomiasis, South American Trichomonas QX 70 Trichomonas Infections WC 700 Veterinary SF 810.T73 Localized, by site Trichomonas vaginalis QX 70 Trichomonas Vaginitis WP 258 Trichomoniasis see Trichomonas Infections Trichophytosis see Tinea Trichosanthin As an abortifacient agent QV 175 Trichostrongyloidea QX 248 Trichothecene Epoxides see Trichothecenes Trichothecenes As mycotoxins QW 630.5.M9 Trichuriasis WC 860 Trichuris QX 207 Trichuris trichiura see Trichuris Trichuroidea QX 207 Tricuspid Incompetence see Tricuspid Valve Insufficiency Tricuspid Regurgitation see Tricuspid Valve Insufficiency Tricuspid Valve WG 268 Tricuspid Valve Incompetence see Tricuspid Valve Insufficiency Tricuspid Valve Insufficiency WG 268 Tricuspid Valve Stenosis WG 268 Triethylenemelamine QV 269 Triethylenethiophosphoramide see Thiotepa Trifluoperazine QV 77.9 Trifluoroperazine see Trifluoperazine Trifluperidol QV 77.9 Trifluralin Public health aspects WA 240 Toxicology QV 633 Triftazin see Trifluoperazine Trigeminal Nerve WL 330 Trigeminal Neuralgia WL 544 Trigeminal Nuclei WL 310 Trigger Points, Myofascial see Myofascial Pain Syndromes Triglyceride Lipase see Lipase Triglycerides QU 85 Triiodobenzoic Acids Biochemistry QU 98 As plant growth regulators QK 745 Triiodothyronine WK 202 Triiodothyronine Receptors see Receptors, Thyroid Hormone Trimepranol QV 132 Trimeprimine see Trimipramine Trimethoprim QV 256 Trimethoxyphenethylamine see Mescaline Trimipramine QV 77.5 Triolein QU 85 Trional see Ethyl Methanesulfonate Triparanol QU 95 Triphosphopyridine Nucleotide see NADP Triple-Symptom Complex see Behcet's Syndrome Triplets WQ 235 Embryology QS 642 Psychology WS 105.5.F2 Tris Buffer see Tromethamine Trisaccharides QU 83 Trisamine see Tromethamine Trismus WC 370 Trisomy QH 461 Associated with abnormalities, with the abnormality, e.g., Chromosome Abnormalities QS 677 Trisomy 21 see Down Syndrome Triterpenes Organic chemistry QD 416 Pharmacognosy QV 752 Pharmacology QV 66 Triticum see Wheat Tritium WN 420 Inorganic chemistry QD 181.HI See also special topics under Radioisotopes Trituration see Drug Compounding tRNA see RNA, Transfer tRNA-Amino Acyl see RNA, Transfer, Amino Acyl Trochanter see Femur Trochanteric Fractures see Hip Fractures Trombicula see Trombiculid Mites Trombiculiasis WC 900 Trombiculid Mites QX 483 Trombididae see Mites Trometamol see Tromethamine Tromethamine In acid-base equilibrium QU 105 Trophoblast QS 645 Trophoblastic Neoplasms WP 465 Pathology QZ 310 Trophoblastic Tumor see Trophoblastic Neoplasms Tropical Climate Hygiene QT 150 Meteorology QC 993.5 Physiological effects QT 150 Tropical Hygiene see Tropical Climate Tropical Medicine WC 680 In infancy & childhood WC 680 Of the skin WR 350 See also names of particular diseases Trunk see Musculoskeletal System Tmsses WO 162 Trustees Hospitals WX 150 Of other organizations and institutions, in the administration number for the agency or lacking that, in the general number, e.g., Trustees of the American Medical Association WB 1. Tmth Disclosure In drug research QV 20.5 In medical research W 20.5 In other fields, in research number if applicable and available; elsewhere, by subject Trypanosoma QX 70 Trypanosomiasis WC 705 Veterinary SF 807 Trypanosomiasis, African WC 705 Veterinary SF 807 Trypanosomiasis, Bovine SF 967.T78 Trypanosomiasis, Cardiovascular see Chagas Cardiomyopathy Trypanosomiasis, South American see Chagas Disease ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 497 Trypanosomiasis, South American Tryparsamide QV 254 Trypsin WI 802 Trypsin Inhibitor, alpha 1-Antitrypsin see alpha 1-Antitrypsin Trypsin Inhibitor, Kunitz, Pancreatic see Aprotinin Trypsin Inhibitors WI 802 Tryptamines Biochemistry QU 61 Organic chemistry QD 401 Serotonin antagonists QV 126 Tryptophan QU 60 Tryptophan Oxygenase QU 140 Tryptophan Pyrrolase see Tryptophan Oxygenase Tsetse Flies QX 505 Tsetse Fly Disease see Trypanosomiasis, African TSH see Thyrotropin Tsutsugamushi Disease see Scrub Typhus Tsutsugamushi Fever see Scrub Typhus Tuba Uterina see Fallopian Tubes Tubal Embryo Transfer see Embryo Transfer Tubal Ligation see Sterilization, Tubal Tubal Pregnancy see Pregnancy, Tubal Tube Feeding see Tube Feeding see Enteral Feeding Tube Grafts see Transplantation Tube Ileostomy see Ileostomy Tubercle Bacillus see Mycobacterium tuberculosis Tuberculin WF 250 Tuberculin Test WF 220 Veterinary SF 808 Tuberculin-Type Hypersensitivity see Hypersensitivity, Delayed Tuberculoid Infections see Mycobacterium Infections, Atypical Tuberculoma WF 200 Localized (other than the lungs), by site or associated disease Tuberculosis WF 200-415 Drugs for see Antitubercular Agents QV 268, etc. Genital see Tuberculosis, Female Genital WP 160, etc.; Tuberculosis, Male Genital WJ 700, etc. In pregnancy WQ 256 Industrial WF 405 Laws WF 200 Nursing WY 163 Oral see Tuberculosis, Oral WI 200, etc. Skin see Tuberculosis, Cutaneous WR 245 Veterinary SF 808 See also Paratuberculosis SF 809.J6 Other localities, by site See also Silicotuberculosis WF 654 Tuberculosis, Avian SF 995.6.T8 Tuberculosis, Bovine SF 967.T8 Tuberculosis, Cardiovascular WG 100 Localized, by site Tuberculosis, Cutaneous WR 245 Tuberculosis, Endocrine WK 140 Localized, by site Tuberculosis, Female Genital WP 160 Localized, by site Tuberculosis, Gastrointestinal WI 140 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Localized, by site Tuberculosis, Hepatic WI 700 Tuberculosis in Childhood WF 415 Tuberculosis, Laryngeal WV 500 Tuberculosis, Lymph Node WF 290 Tuberculosis, Male Genital WJ 700 Localized, by site Tuberculosis, Meningeal WL 200 Tuberculosis, Miliary WF 380 Tuberculosis, Ocular WW 160 Localized, by site Tuberculosis, Oral WI 200 For the dentist WU 140 Tuberculosis, Osteoarticular WE 253 Localized, by site Tuberculosis, Peritoneal WI 575 Tuberculosis, Pleural WF 390 Tuberculosis, Pulmonary WF 300-360 Rehabilitation At home WF 315 At hospital WF 330 Tuberculosis, Renal WJ 351 Tuberculosis Societies WF 1 Tuberculosis, Spinal WE 253 Tuberculosis, Splenic WH 600 Tuberculosis, Urogenital WJ 140 Localized, by site Tuberculostatic Agents see Antitubercular Agents Tuberous Sclerosis QS 675 Tubocurarine QV 140 Tubulin QU 55 Tuftsin QW 806 As Immunologic Factors WH 400 Tularemia WC 380 Tullidora see Rhamnus Tumescence, Penile see Penile Erection Tumor Antibodies see Antibodies, Neoplasm Tumor Antigens see Antigens, Neoplasm Tumor Antigens, Viral see Antigens, Viral, Tumor Tumor-Associated Carbohydrate Antigens see Antigens, Tumor-Associated, Carbohydrate Tumor Cells, Cultured Special topics, by subject Tumor Cells, Embolic see Neoplasm Circulating Cells Tumor Initiators see Carcinogens Tumor Markers, Biochemical see Tumor Markers, Biological Tumor Markers, Biological In the diagnosis of neoplasms QZ 241 Tumor Metabolite Markers see Tumor Markers, Biological Tumor Necrosis Factor QW 630 See also Antibiotics, Antineoplastic QV 269; names of toxins specific to particular cells, e.g. Enterotoxins QW 630 (jcn added) Tumor Necrosis Factor-alpha see Tumor Necrosis Factor Tumor Promoters see Carcinogens Tumor Staging see Neoplasm Staging Tumor Stem Cell Assay Used in testing antineoplastic agents QV 269 Tumor Stem Cells QZ 202 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 498 Tumor Suppressor Genes see Genes, Suppressor, Tumor Tumor Virus Infections QZ 200 Tumor Viruses see Oncogenic Viruses Tumor Viruses, Murine QW 166 Tumoricidal Activity, Immunologic see Cytotoxicity, Immunologic Tumorigenicity Tests see Carcinogenicity Tests Tumors see Neoplasms Tungsten Inorganic chemistry QD 181.W1 Metabolism QU 130 Pharmacology QV 290 Tunica Vaginalis see Testis Tunnel Anemia see Ancyclostomiasis Turbellaria QX 352 Turbidimetry see Nephelometry and Turbidimetry Turbinates WV 301 Turkeys Culture SF 507 Diseases SF 995.4 Turkish Baths see Baths Turner's Syndrome QS 677 Turpentine QV 65 Turtles QL 666.C5-666.C587 Diseases SF 997.5.T87 Twenty-Four Hour Rhythm see Circadian Rhythm Twilight Sleep see Anesthesia, Obstetrical Twinning see Embryology Twins WQ 235 Embryology QS 642 Psychology WS 105.5.F2 Twins, Conjoined QS 675 Twins, Dizygotic WQ 235 Special topics, by subject See also Twins Twins, Fraternal see Twins, Dizygotic Twins, Identical see Twins, Monozygotic Twins, Monozygotic WQ 235 Special topics, by subject See also Twins Two-Parameter Models see Models, Statistical Tympanic Cavity see Ear, Middle Tympanic Membrane WV 225 Tympanometry see Acoustic Impedance Tests Tympanoplasty WV 225 Tympanostomy Tube Insertion see Middle Ear Ventilation Tympanum see Ear, Middle Type A Personality BF 698.3 Medical aspects, with the disease Type I Hypersensitivity see Hypersensitivity, Immediate Type III Hypersensitivity see Immune Complex Diseases Type IV Hypersensitivity see Hypersensitivity, Delayed Typhoid WC 270 Typhoid Bacillus see Salmonella typhi Typhoid-Paratyphoid Vaccines For paratyphoid WC 266 General and for typhoid WC 270 Typhus see Typhus, Epidemic Louse-Borne ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH* Typhus, Abdominal see Typhoid Typhus, Endemic Flea-Borne WC 615 Typhus, Epidemic Louse-Borne WC 605-610 Typhus, Murine see Typhus, Endemic Flea-Borne Typhus, Sao Paulo see Rocky Mountain Spotted Fever Typhus, Scrub see Scrub Typhus Typing, Bacteriophage see Bacteriophage Typing Typology see Somatotypes Tyramine QV 174 Tyrocidine QV 220 Tyrosine QU 60 Tyrosine Aminotransferase see Tyrosine Transaminase Tyrosine Transaminase QU 141 Tyrothricin QV 350 Tyl Transposon see DNA Insertion Elements T3 Receptors see Receptors, Thyroid Hormone T4 Antigens, T-Cell see Antigens, CD4 T4 Receptors see Receptors, Thyroid Hormone U Ubiquinone QU 135 Ubiquitin QU 56 Udder see Mammae UDP Glucose see Uridine Diphosphate Glucose UDP Sugars see Uridine Diphosphate Sugars UDPG see Uridine Diphosphate Glucose Ulcer Corneal see Corneal Ulcer WW 220 Decubitus see Decubitus Ulcer WR 598 Duodenal see Duodenal Ulcer WI 370 Gastric see Stomach Ulcer WI 360 Leg see Leg Ulcer WE 850 Pathology QZ 150 Peptic see Peptic Ulcer WI 350-370 Skin see Skin Ulcer WR 598 Varicose see Varicose Ulcer WG 620 Ulcer, Aphthous see Stomatitis, Aphthous Ulna WE 820 Ulnar Nerve WL 400 See also names of organs innervated, e.g., Forearm WE 820 Ultracentrifugation Biological research QH 324.9.C4 Chemical engineering TP 159.C4 Chemical techniques QD 54.C4 Clinical chemistry QY 90 See also Centrifugation QD 54.C4, etc. Ultradian Cycles see Activity Cycles Ultramicrotomy see Microtomy Ultrasonic Diagnosis see Ultrasonography Ultrasonic Imaging see Ultrasonography Ultrasonic Lithotripsy see Lithotripsy Ultrasonic Therapy WB 515 Ultrasonics Biophysics QT 34 Diagnostic use (General) see Ultrasonography WN 208 Physics QC 244 Used for other special purposes, by subject Ultrasonography WN 208 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 499 Ultrasonography Used for special purposes, by subject Ultrasonography, Fetal see Ultrasonography, Prenatal Ultrasonography, Prenatal WQ 209 Ultraviolet Microscopy see Microscopy, Ultraviolet Ultraviolet Rays Adverse effects (General) WD 605 Diagnostic use WB 288 General physiological effects QT 162.U4 Medical use (General) WB 117 Meteorology QC 976. U4 Therapeutic use see Ultraviolet Therapy WB 480 Ultraviolet Therapy WB 480 Umbilical Arteries WG 595.U6 Umbilical Cord WQ 210 Umbilical Hernia see Hernia, Umbilical Umbilical Veins WI 720 Embryology QS 604 Obstetrics WQ 210 Umbilicus WI 940 See also Umbilical Cord WQ 210 Umbra see Salmonidae Uncinaria see Hookworms Uncinaria stenocephala see Ancylostomatoidea Uncinariasis, Human see Necatoriasis Unconscious (Psychology) BF 315 In adolescence WS 462 In infancy & childhood WS 105 Psychoanalysis WM 460.5.U6 Unconsciousness General diagnosis WB 182 Neurological manifestation WL 341 Underachievement BF 637.U53 Academic LC 4661 Relation to personality BF 698.9.A3 Underpopulation see Population Density Undertaking see Mortuary Practice Undulant Fever see Brucellosis Unemployment HD 5707.5-5710.2 Unipolar Depression see Depressive Disorder United States National Health Insurance see National Health Insurance, United States Universal Precautions Precaution against a specific communicable disease, by disease Universities LB 2301-2430 University Health Services see Student Health Services Unknown Primary Tumors see Neoplasms, Unknown Primary Unsaturated Dietary Fats see Dietary Fats, Unsaturated Unsaturated Fats see Fats, Unsaturated Unsaturated Oils see Fats, Unsaturated Unwed Fathers see Illegitimacy Unwed Mothers see Illegitimacy Uphill Transport see Biological Transport, Active Upper Extremities see Extremities; names of particular parts Upper Extremity see Arm Upper Respiratory Infections see Respiratory Tract Infections ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH/4 Urachus WQ 210.5 Uracil In nucleic acids QU 58 Uragoga see Ipecac (Syrup) Uralenic Acid see Glycyrrhetinic Acid Uranium WN 420 Nuclear physics QC 796.U7 See also special topics under Radioisotopes Urban Development see Urban Renewal Urban Health WA 380 Urban Planning see City Planning Urban Population Demography HB 2161-2367 Health Problems WA 380 Other aspects, by subject See also Housing HD 257, etc.; Public Housing HD 7288.77-7288.78 Urban Renewal HT 170-178 Architecture and engineering NA 9000-9428 Public health aspects in WA Urea In animal nutrition SF 98.U7 In blood QY 455 In protein metabolism QU 55 In urine QY 185 Organic chemistry QD 315 Urease QU 136 Uremia WJ 348 Ureter WJ 400 Ureteral Calculi WJ 400 Ureteral Diseases WJ 400 Ureteral Neoplasms WJ 400 Ureteral Obstruction WJ 400 Ureteritis see Ureteral Diseases Ureterolithiasis see Ureteral Calculi Urethane QV 269 Urethra WJ 600 Surgery WJ 600 Urethral Diseases WJ 600 Urethral Stenosis see Urethral Stricture Urethral Stricture WJ 600 In infancy & childhood WS 320 Urethritis WJ 600 Urethrotomy see Surgery WJ 600 under Urethra Uric Acid WJ 303 In urine QY 185 Organic chemistry QD 401 Uricosuric Agents QV 98 Uridine QU 57 Uridine Diphosphate Glucose Biochemistry QU 57 Pharmacology QV 185 Uridine Diphosphate Sugars Biochemistry QU 57 Pharmacology QV 185 Uridine Diphosphoglucose see Uridine Diphosphate Glucose Urinalysis QY 185 Urinary Calculi WJ 140 See also Bladder Calculi WJ 500; Kidney Calculi WJ 356; Ureteral Calculi WJ 400 Urinary Catheterization WJ 141 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 500 Vaccination Urinary Diversion Surgery of the kidney WJ 368 Surgery of the penis WJ 790 Surgery of the ureter WJ 400 Surgery of the urethra WJ 600 By organ used as conduit if more appropriate for the work Urinary Fistula WJ 140 See also Bladder Fistula WJ 500; Vesicovaginal Fistula WP 180 Urinary Incontinence WJ 146 Urinary Incontinence, Stress WJ 146 Urinary Tract WJ Animals, Domestic SF 871 Antiseptics see Anti-Infective Agents, Urinary QV 243 Children WS 320-322 Drugs affecting see Diuretics QV 160; Vasopressin QV 160, etc. Surgery WJ 168 Urinary Tract Diseases see Urologic Diseases Urinary Tract Infections WJ 151 In infancy & childhood WS 320 Veterinary SF 871 Urination WJ 146 Urination Disorders WJ 146 Veterinary SF 871 Urine Analysis See Urinalysis QY 185 Secretion WJ 303 Sugars see Diabetes Mellitus WK 810-850; Glycosuria WK 870 Urine therapy see Alternative Medicine WB 890, etc. Urine Concentrating Ability see Kidney Concentrating Ability Urodela QL 668.C2-668.C285 As laboratory animals QY 60.A6 Urodynamics WJ 102 Urogastrone see Epidermal Growth Factor-Urogastrone Urogastrone Receptors see Receptors, Epidermal Growth Factor-Urogastrone Urogenital Diseases General WJ 140 Urogenital Neoplasms WJ 160 Localized, by site See also names of specific urogenital neoplasms Urogenital System WJ Animals, Domestic SF 871 Children WS 320-322 Surgery WJ 168 Urography WJ 141 In infancy & childhood WS 320 Pyelography WJ 302 Urokinase QU 142 Urokinase-Type Plasminogen Activator see Urokinase Urolithiasis see Urinary Calculi Urologic Diseases WJ Diagnosis WJ 141 General WJ 140 Gynecology WJ 190 In infancy & childhood WS 320-322 In pregnancy WQ 260 Nursing WY 164 Therapy WJ 166 Veterinary SF 871 Urologic Neoplasms WJ 160 Localized, by site Urology WJ Pediatric WS 320-322 Urology Department, Hospital WJ 27-28 Uropepsin QU 136 Urotropin see Methenamine Ursodeoxycholic Acid Bile acid WI 703 As a Cholagogue and choleretic QV 66 Urticaria WR 170 Urticaria, Giant see Angioneurotic Edema Urticaria Pigmentosa WR 267 User-Computer Interface QA 76.9.U83 Uterine Contraction WQ 305 Uterine Diseases WP 440-480 General works WP 440 Uterine Endoscopy see Hysteroscopy Uterine Hemorrhage WP 440 Uterine Inertia WQ 330 Uterine Inversion see Uterine Diseases Uterine Monitoring WQ 209 Uterine Muscle see Myometrium Uterine Neoplasms WP 458-465 Leiomyoma WP 459 Uterine Prolapse WP 454 Uterus WP 400-480 Anatomy & histology WP 400 During puerperium WQ 500 Drugs affecting QV 170-174 See also Oxytocics QV 173-174 Utilitarianism see Ethics Utilization and Quality Control Peer Review Organizations see Professional Review Organizations Utilization Review WX 153 Of special hospitals, by type Utopias HX 806-811 Uvea WW 240-245 Uveal Diseases WW 240 Uveal Neoplasms WW 240 Uveitis WW 240 Uveitis, Sympathetic see Ophthalmia, Sympathetic Uvula WV 410 Ul Small Nuclear RNA see RNA, Small Nuclear U2 Small Nuclear RNA see RNA, Small Nuclear U3 Small Nuclear RNA see RNA, Small Nuclear U4 Small Nuclear RNA see RNA, Small Nuclear U5 Small Nuclear RNA see RNA, Small Nuclear U6 Small Nuclear RNA see RNA, Small Nuclear U7 Small Nuclear RNA see RNA, Small Nuclear v-Ha-ras Genes see Genes, ras v-Ki-ras Genes see Genes, ras Vaccination QW 806 BCG see BCG Vaccine WF 250 ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 501 Vaccination In infancy & childhood WS 135 Poliomyelitis see Prevention & control WC 556 under Poliomyelitis Smallpox see Prevention & control WC 588 under Smallpox Veterinary medicine SF 757.2 Other diseases, with the disease See also Vaccines and particular types of vaccines Vaccination Encephalitis see Encephalomyelitis, Acute Disseminated Vaccine Therapy see Immunotherapy, Active Vaccines QW 805 Bacterial see Bacterial Vaccines WC 200 BCG see BCG Vaccine WF 250 Brucella see Brucella Vaccine WC 310 Cholera see Cholera Vaccine WC 262 Fungal see Fungal Vaccines WC 450 Influenza see Influenza Vaccine WC 515 Measles see Measles Vaccine WC 580 Mumps see Mumps Vaccine WC 520 Pertussis see Pertussis Vaccine WC 340 Plague see Plague Vaccine WC 350 Poliovirus see Poliovirus Vaccine WC 556 Rabies see Rabies Vaccine WC 550 Rickettsial see Rickettsial Vaccines WC 600 Rubella see Rubella Vaccine WC 582 Smallpox see Smallpox Vaccine WC 588 Staphylococcal see Staphylococcal Vaccines WC 250 Tuberculosis see BCG Vaccine WF 250 Typhoid-Paratyphoid see Typhoid-Paratyphoid Vaccines WC 270, etc. Viral see Viral Vaccines WC 500 Vaccines, Recombinant see Vaccines, Synthetic Vaccines, Synthetic As a vaccine QW 805 As an antigen QW 573 Vaccinia WC 584 Vaccinia Virus QW 165.5.P6 Vacuolating Agent see Polyomavirus macacae Vacuoles QH 591 In plant cells QK 725 Vacuum Curettage WP 470 Used for special purposes, by subject Vagina WP 250-258 Vaginal Birth after Cesarean WQ 415 Vaginal Diseases WP 250-258 General works WP 250 Vaginal Fistula WP 250 See also Rectovaginal Fistula WP 180; Vesicovaginal Fistula WP 180 Vaginal Neoplasms WP 250 Vaginal Prolapse see Uterine Prolapse Vaginal Smears WP 141 Vaginismus see Dyspareunia; Hyperesthesia; Vaginal Diseases Vaginitis WP 255 See also Trichomonas Vaginitis WP 258; Vulvovaginitis WP 200 Vagotomy WL 330 Vagotomy, Parietal Cell see Vagotomy, Proximal Gastric Vagotomy, Proximal Gastric WL 330 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA Vagotomy, Selective Proximal see Vagotomy, Proximal Gastric Vagus Nerve WL 330 Vagotonia WL 330 Valerates QU 90 Valerian QV 767 As sedative QV 85 Validity of Results see Reproducibility of Results Valine QU 60 Valproic Acid QV 85 Vanadium Inorganic chemistry QD 181.V2 Metabolism QU 130.5 Pharmacology QV 290 Vanillin QV 810 Vanylglycol see Methoxyhydroxyphenylglycol Vapor Baths see Baths Vaporization, Laser see Laser Surgery Vaporizers see Nebulizers and Vaporizers Vaquez's Disease see Polycythemia Vera Variation (Genetics) QH 401-411 Animal QH 408 Microbial genetics Bacteria QW 51 Fungi QW 180 Viruses QW 160 Plants QK 983 Varicella see Chickenpox Varicella-Zoster Virus see Herpesvirus 3, Human Varices see Varicose Veins Varicocele WJ 780 Varicose Ulcer WG 620 Varicose Veins WG 620 In pregnancy WQ 244 Variola see Smallpox Variola Virus QW 165.5.P6 Varnish see Paint Vas Deferens WJ 780 Vascular Access Ports see Catheters, Indwelling Vascular-Assist Devices see Heart-Assist Devices Vascular Dementia see Dementia, Vascular Vascular Diseases WG 500-700 General works WG 500 In infancy & childhood WS 290 Varices WG 620 Veterinary SF 811 See also Cardiovascular Diseases WG, etc.; names of specific organs or systems (for their blood supply) or specific vascular diseases Vascular Diseases, Peripheral see Peripheral Vascular Diseases Vascular Endothelium see Endothelium, Vascular Vascular Headache WL 344 See also specifics, e.g., Migraine WL 344y Vascular Permeability see Capillary Permeability Vascular Prosthesis see Blood Vessel Prosthesis Vascular Resistance WG 106 Vascular Surgery WG 170 Children WS 290 Vasculitis WG 515 Of the veins only WG 610 Vasculitis, Allergic Cutaneous WG 515 Emphasis on skin hypersensitivity WR 160 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 502 Veratrum Alkaloids Vasculitis, Churg-Strauss see Churg-Strauss Syndrome Vasectomy WJ 780 Vasoactive Agonists see Vasoconstrictor Agents Vasoactive Antagonists see Vasodilator Agents Vasoactive Intestinal Peptide WK 170 As a Peptide QU 68 As a Vasopressin WK 520 Vasoconstriction WG 106 See also Constriction, Pathologic WG 560, etc. Vasoconstrictor Agents QV 150 Vasoconstrictor Agents, Nasal QV 150 Vasodilation WG 106 See also Dilatation, Pathologic WG 578, etc. Vasodilator Agents QV 150-156 Vasodilator Disorders see Dilatation, Pathologic Vasomotor Disorders see Vasomotor System; names of specific disorders Vasomotor Regulation see Vasomotor System Vasomotor Rhinitis see Rhinitis, Vasomotor Vasomotor System WL 610 Disorders WG 560 Spastic see Raynaud s Disease WG 570 Vasodilator WG 578 See also Constriction, Pathologic WG 560, etc. Regulation WG 560 Vasopressin, Arginine see Argipressin Vasopressin, Deamino Arginine see Desmopressin Vasopressin, Isoleucyl-Leucyl see Oxytocin Vasopressin, Lysine see Lypressin Vasopressins WK 520 Diuretic QV 160 Vasopressor Agents see Vasoconstrictor Agents Vasospastic Disorders see Raynaud's Disease Vasotocin, Leucyl see Oxytocin Vater's Ampulla WI 750 Vectorcardiography WG 140 Vectors see Disease Vectors Vectors, Genetic see Genetic Vectors Vecuronium see Vecuronium Bromide Vecuronium Bromide QV 140 Vegetable Oils see Plant Oils Vegetables As a dietary supplement in health and disease WB 430 Cultivation SB 320-353.5 Drugs see Plants, Medicinal QV 766, etc. Poisonous see Plants, Toxic WD 500-530 Processing TX 801-807 Purgatives see Cathartics QV 75 Sanitation and other public health aspects WA 703 See also names of specific vegetables Vegetarianism WB 430 Vegetative Nervous System see Autonomic Nervous System Vegetative State, Persistent see Persistent Vegetative State Vehicles QV 800 Veiled Cells see Dendritic Cells Vein Anesthesia see Anesthesia, Local Vein of Galen see Cerebral Veins ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHd Veins WG 600-625 Coronary see Coronary Vessels WG 300 Medication by see Injections, Intravenous WB 354 Portal see Portal Vein WI 720 Velocimetry see Rheology Velopharyngeal Insufficiency WV 410 Vena Cava, Inferior WG 625.V3 Vena Cava, Superior WG 625.V3 Venae Cavae WG 625.V3 Venereal Diseases see Sexually Transmitted Diseases Venereology WC 140-185 Venesection see Bloodletting Venipuncture see Bloodletting Venoclysis, Medication see Injections, Intravenous Venography see Phlebography Venoms Poisoning WD 400-430 Therapeutic use see name of disease being treated; Alternative Medicine WB 890, etc. See also specific venoms, e.g., Bee Venoms WD 430 Venous Catheterization, Peripheral see Catheterization, Peripheral Venous Insufficiency WG 600 Venous Pressure WG 106 Venous Pressure, Central see Central Venous Pressure Venous Thrombosis see Thrombophlebitis Venous Ulcer see Varicose Ulcer Venovenous Hemofiltration see Hemofiltration Ventilation WA 770 Hospitals WX 165 Industrial WA 450 Ventilation, High Frequency Jet see High-Frequency Jet Ventilation Ventilation, Intermittent Positive-Pressure see Intermittent Positive-Pressure Ventilation Ventilation, Maximal Voluntary see Respiratory Airflow Ventilation, Mechanical see Respiration, Artificial Ventilation, Middle Ear see Middle Ear Ventilation Ventilation-Perfusion Ratio WF 141 Ventilation Tests see Respiratory Function Tests Ventilators, Mechanical WF 26 Ventilators, Pulmonary see Ventilators, Mechanical Ventilatory Muscles see Respiratory Muscles Ventral Hernia see Hernia, Ventral Ventricle-Assist Device see Heart-Assist Devices Ventricular Ejection Fraction see Stroke Volume Ventricular End-Diastolic Volume see Stroke Volume Ventricular End-Systolic Volume see Stroke Volume Ventricular Fibrillation WG 330 Ventricular Puncture see Punctures Ventricular System see Cerebral Ventricles Ventriculography, Cerebral see Cerebral Ventriculography Verapamil QV 150 Veratrum QV 150 Veratrum Alkaloids QV 150 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 503 Verbal Behavior Verbal Behavior In adolescence WS 462 In infancy & childhood WS 105.5.C8 General psychology BF 455 Physiological aspects WV 501 Social psychology HM 258 Verbal ability BF 463.V45 Verbal self-defense BF 637.V47 Speech disorders WM 475, etc. Verbal Learning LB 1139.L3 Vermifuges see Anthelmintics Vermin, Public Health Aspects see Parasites Veronal see Barbiturates Verruga Peruana see Bartonella Infections Verse's Disease see Calcinosis; Intervertebral Disk Version, Fetal WQ 415 Vertebrae see Spine Vertebral Artery WG 595.V3 Vertebral Artery Insufficiency see Vertebrobasilar Insufficiency Vertebrate Viruses General works QW 164 DNA see DNA Viruses QW 165 RNA see RNA Viruses QW 168 See also names of other specific vertebrate viruses Vertebrate Viruses, Unclassified QW 169 Vertebrates Anatomy Domestic animals SF 761-767 Fishes QL 639 Wild animals QL 801-950.9 Specific animals or groups of animals, with animal or group Diseases SF 600-997.5, etc. Human see specific topics Physiology QP Domestic animals SF 768-768.2 Fishes QL 639.1 Wild animals QP See also other specific topics relating to vertebrates, e.g., Embryology QL 959, etc. Vertebrobasilar Insufficiency WL 355 Verticillium see Hyphomycetes Vertigo WV 255 Aural see Menire's Disease WV 258 Manifestation of disease QZ 140 Vertigo, Aural see Meniere's Disease Vervet Monkey see Cercopithecus aethiops Vesical Calculi see Bladder Calculi Vesical Fistula see Bladder Fistula Vesicants see Irritants Vesication see Blister Vesico-Ureteral Reflux WJ 500 In infancy & childhood WJ 500 Vesicovaginal Fistula WP 180 Vesicular Exanthema of Swine SF 977.V3 Vesicular Palmoplantar Eczema see Eczema, Dyshidrotic Vesicular Skin Diseases see Skin Diseases, Vesiculobullous Vesiculitis, Seminal see Seminal Vesicles Vesiculobullous Skin Diseases see Skin Diseases, Vesiculobullous ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH4 Vespid Venoms see Wasp Venoms Vestibular Apparatus see Vestibule Vestibular Aqueduct WV 255 Vestibular Diseases WV 255 Vestibular Function Tests WV 255 Vestibular Nerve WL 330 Physiology of hearing WV 272 Vestibular Nuclei WV 255 Vestibule WV 255 Vestibulo-Ocular Reflex see Reflex, Vestibulo-Ocular Veterans UB 356-405 Hospitalization UH 460-485 Lists of veterans UA 37-39 Provision for vetrans UB 356-405, etc. Veterans Disability Claims UB 368-369.5 Veterans Hospitals see Hospitals, Veterans Veterans Nursing see Hospitals, Veterans; Military Nursing Veterinary Anatomy see Anatomy, Veterinary Veterinary Bacteriology see Veterinary Science QW 70 under Bacteriology Veterinary Clinics see Hospitals, Animal Veterinary Education see Education, Veterinary Veterinary Histology see Histology Veterinary Hospitals see Hospitals, Animal Veterinary Medicine SF 600-1100 Education SF 756.3-756.37 Immunology SF 757.2 Military see Veterinary Service, Military UH 650-655 Surgery SF 911-914.4 See also Veterinary under particular topics and specific animals being treated Veterinary Microbiology see Microbiology Veterinary Pathology see Pathology, Veterinary Veterinary Schools see Schools, Veterinary Veterinary Service, Military UH 650-655 Veterinary Toxicology see Toxicology Vibration Adverse effects (General) WD 640 As a cause of disease QZ 57 In aviation WD 735 In industry Diseases WA 400 Prevention & control WA 470 Therapeutic use WB 535 Vibrio QW 141 Vibrio fetus see Campylobacter fetus Vibrio Infections WC 200 Veterinary SF 809.V52 See also Cholera WC 262-264 Vibrio parahaemolyticus QW 141 Vibrionaceae QW 141 Vibrocardiography see Kinetocardiography Vicarious Menstruation see Menstmation Disorders Vichy Water see Mineral Waters Vidarabine QU 57 As an antiviral agent QV 268.5 Video Display Terminals see Computer Terminals Video Games see Play and Playthings Video Recording TK 6655.V5 Recording by subject USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 504 Videodisc Recording TK 6685 Catalogs and works about (Form number 18.2 in any NLM schedules where applicable) Actual recordings, by subject Videotape Recording Catalogs and works about (Form number 18.2 in any NLM schedule where applicable) Actual recordings, by subject Videotherapy In psychiatry WM 450.5.V5 Vidine see Choline Vigilance see Attention Vigilance, Cortical see Arousal Village Health Worker see Community Health Aides Vinblastine QV 269 Vinca Alkaloids QV 269 Vincaleukoblastine see Vinblastine Vincent's Angina see Gingivitis, Necrotizing Ulcerative Vincent's Infection see Gingivitis, Necrotizing Ulcerative Vincristine QV 269 Vinyl Chloride As carcinogen QZ 202 Vinyl Chloride Polymer see Polyvinyl Chloride Vinyl Compounds Organic chemistry QD 305.H7 Toxicology QV 633 Vinyl Ether QV 81 Vinylidene Chlorides see Dichloroethylenes Violence In adolescence WS 463 In infancy & childhood WS 350.8.A4 Influence of television WS 105.5.E9 Criminal (Medicolegal aspects) W 860 Political theory JC 328.6 Psychology (General) BF 575.A3 Sociology HM 281-283 Viper Venoms WD 410 Viral Antibodies see Antibodies, Viral Viral Antigens see Antigens, Viral Viral DNA see DNA, Viral Viral Gene Expression Regulation see Gene Expression Regulation, Viral Viral Gene Products see Viral Proteins Viral Gene Proteins see Viral Proteins Viral Genes see Genes, Viral Viral Hepatitis Vaccines WC 536 Viral Interference QW 160 Viral Markers see Biological Markers Viral Proteins QW 160 Viral RNA see RNA, Viral Viral Tumor Antigens see Antigens, Viral, Tumor Viral Vaccines WC 500 Used for particular disease, with the disease See also names of specific vaccines Virales see Viruses Viremia WC 500 Virilism WK 770 Virilizing Adenoma see Adenoma, Virilizing Viroids QW 160 Virology QW 160 See also numbers QW 1-85 (except 5, 7, 9, 20.5, ALWAYS CONSULT MAIN SCHEDULES. UJ SUBJECT REPRESENTS MAJOR EMPHASIS Vision Disorders 50, 51 and 52) Veterinary medicine QW 70 Specific viruses, in number for the group QW Virus diseases of animals (General) SF 780.4 Virulence QW 730 Virus Cultivation QW 25.5.V7 Virus Diseases WC 500-593 Affecting the nerve tissues WC 540-556 Affecting the skin see Skin Diseases, Infectious WC 570-590 In infancy & childhood WC 500-593, etc. In plants SB 736 Veterinary (individual virus diseases) SF 781-809 Virus Inhibitors QW 160 Virus Pneumonia see Pneumonia, Viral Virus Receptors see Receptors, Virus Virus Replication QW 160 Virus Transforming Antigens see Antigens, Viral, Tumor Viruses QW 160-170 As a cause of disease QZ 65 Bacteria see Bacteriophages QW 161 Insect see Insect Viruses QW 162 Of animals QW 70 Plant see Plant Viruses QW 163 Vertebrate see Vertebrate Viruses QW 164, etc. See also names of other specific viruses Visammin see Khellin Viscera In the abdomen WI 900 In the thorax WF 970 In the pelvis WE 750 Gynecological WP 155 Visceral Arches see Branchial Region Visceroptosis WI 900 Of the intestines WI 450 Other localities, by site Viscosity Of blood WH 400 Clinical analysis QY 408 Of gases QC 167 Of liquids QC 145.4.V5 Vision WW 103 Acuity see Visual Acuity WW 145 Binocular see Eye Movements WW 400-460; Accommodation, Ocular WW 109 Conservation WW 113 Fields see Visual Fields WW 145 Measurement see Vision Tests WW 145; Optometry WW 704, etc. Night see Dark Adaptation WW 109 Perception see Visual Perception WW 105 Physiology WW 103 See also Perimetry WW 145 Vision, Binocular WW 400 Vision Disorders WW 140 Corrective devices WW 350-358 In infancy & childhood WW 600 Neuromuscular WW 410-460 Orthoptics WW 405 Refractive errors WW 300-320 E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSIFIED 505 Vision Disorders See also Blindness WW 276; Color Blindness WW 150 Vision, Low see Vision, Subnormal Vision, Subnormal WW 140 Vision Tests WW 145 Visiting Nurse Associations see Home Care Services Visiting Nurses see Community Health Nursing Visna-Maedi Virus QW 166 As pathogen, with the specific disease Visna Virus see Visna-Maedi Virus Visual Acuity WW 145 Visual Aids see Audio-Visual Aids Visual Analogue Pain Scale see Pain Measurement Visual Contrast Sensitivity see Contrast Sensitivity Visual Cortex WL 307 Visual Evoked Response see Evoked Potentials, Visual Visual Fields WW 145 Visual Motor Coordination see Psychomotor Performance Visual Pathways WW 103 Visual Perception WW 105 Visual Purple see Rhodopsin Vital Statistics HB 848-3697 Deaths, by disease WA 900 See also Birth Rate HB 901-1108; Divorce HQ 811-960.7; Marriage HB 1111-1317; Morbidity WA 900; Mortality HB 1321-1528, etc. Vitamin A QU 167 Vitamin A Acid see Tretinoin Vitamin A Deficiency WD 110 Veterinary SF 855.V58 Vitamin B Complex QU 187-195 See also names of specific vitamins Vitamin B Deficiency WD 120-126 Vitamin B T see Carnitine Vitamin B 1 see Thiamine Vitamin B 12 QU 194 Vitamin B 12 Deficiency WD 120 Vitamin B 2 see Riboflavin Vitamin B 6 see Pyridoxine Vitamin C see Ascorbic Acid Vitamin Content of Food see Analysis QU 160 under Vitamins; Nutrition Vitamin D QU 173 Vitamin D Deficiency WD 145 Vitamin D 2 see Ergocalciferols Vitamin D 3 see Cholecalciferol Vitamin Deficiency see Avitaminosis Vitamin E QU 179 Vitamin E Deficiency WD 150 Vitamin G see Riboflavin Vitamin H see Biotin Vitamin K QU 181 Vitamin K Deficiency WD 155 Vitamin K 1 see Phytonadione Vitamin M see Folic Acid Vitamin P Complex see Bioflavonoids Vitamin PP see Niacinamide Vitamins QU 160-220 Analysis QU 160 Clinical assay QY 350 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH4 Animal nutrition SF 98.V5 Animal physiology Domestic SF 768-768.2 Wild QP 771-772 Fat soluble QU 165-181 Plant constituents QK 898.V5 Water soluble QU 185-210 See also names of specific vitamins Vitiligo WR 265 Vitrectomy WW 250 Vitreous Body WW 250 Opacity WW 250 Vitreous Fluorophotometry see Fluorophotometry Vivisection Experimental surgery WO 50 Sociological aspects HV 4915 Vocabulary P 305 Special topics, by subject Vocabulary Tests see Language Tests Vocal Cord Paralysis WV 535 Vocal Cords WV 530-535 Vocal Fold see Vocal Cords Vocalization, Animal QL 765 Vocational Education LC 1041-1048 Exceptional children LC 3976 Vocational Guidance HF 5381-5382.5 Dentistry WU 21 Dietetics WB 400 For the blind HV 1652-1658 For the deaf HV 2452-2458 For the mentally disabled HV 3005 For the physically disabled HD 7255-7256; HV 3018-3019 Hospital administration WX 155 Hospital work (General) WX 159 Nurses' aides WY 193 Nursing WY 16 See also special types of nursing Ophthalmology WW 21 Opticianry WW 721 Optometry WW 721 Physicians W 21 Psychiatry WM 21 Surgery WO 21 In other areas, with the number for the profession or lacking that, in a general works number Vocational Rehabilitation see Rehabilitation, Vocational Vocations see Occupations Voice Care WV 500 Physiology WV 501 Voice Disorders WV 500 Psychogenic WM 475 Voice Production, Alaryngeal see Speech, Alaryngeal Voice Prosthesis see Larynx, Artificial Voice Quality WV 501 Voice Training WV 500 Volatile Oils see Oils, Volatile Volatile Poisons see Poisons Volcanic Ash see Volcanic Emption USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSinED 506 Water Volcanic Eruption First aid WA 292 Hospital emergency service WX 215 Medical emergencies WB 105 Volcanic Gases see Volcanic Eruption Voles see Microtinae Volhynia Fever see Trench Fever Volition BF 608-635 Volkmann Contracture see Compartment Syndromes Volkmanns Contracture see Compartment Syndromes Volume Index see Blood Volume Voluntary Health Agencies WA 1 (Form number 1 in any NLM schedule where applicable) See also Red Cross HV 560-583, etc.; names of specialties Voluntary Health Insurance see Insurance, Health Voluntary Sterilization see Sterilization, Sexual Voluntary Workers In hospitals see Hospital Volunteers WX 159.5, etc. In psychiatry WM 30.5 In social service HV 41 In other areas, by subject Volunteers see Voluntary Workers Volvulus see Intestinal Obstruction Volvulus, Stomach see Stomach Volvulus Vomer see Nasal Septum Vomiting WI 146 Drugs promoting see Emetics QV 73 In pregnancy WQ 215 See also Adverse effects WO 245 under Anesthesia Von Gierke's Disease see Glycogen Storage Disease Type I von Willebrand Factor WH 310 von Willebrand's Disease WH 312 Voyages see Expeditions; Travel VP 16-213 see Etoposide Vulva WP 200 Vulvar Neoplasms WP 200 Vulvitis WP 200 Vulvovaginal Glands see Bartholin's Glands Vulvovaginitis WP 200 VZ Virus see Heepesvirus 3, Human W Wages see Salaries and Fringe Benefits Waiting Lists In hospitals WX 159 Practice management Dental WU 77 Medical W 80 Wakefulness WL 108 In personal hygiene QT 265 Waldenstrom's Macroglobulinemia WH 400 Clinical pathology QY 455 Walking As locomotion WE 103 As a sport QT 260.5.W2 Wallabies see Kangaroos ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPH/ War U; V Adolescent psychology WS 462 Atomic warfare U 263 Bacterial warfare UG 447.8 For the bacteriologists QW 300 Biological warfare UG 447.8 For the bacteriologists QW 300 Chemical warfare UG 447-447.65 Child psychology WS 105.5.E9 Civil defense UA 926-929 Combat psychiatry UH 629-629.5 Military dentistry UH 430-435 Naval VG 280-285 Military medical services UH 201-630 Morale U 22 Naval medical services VG 100-475 Psychiatry see Military Psychiatry UH 629-629.5 Psychological warfare UB 275-277 Psychology see Psychology, Military U 22.3 Rehabilitation UB 360-366 Surgery WO 800 Veterinary services UH 650-655 War crimes JX 5419.5 Wounded, Transportation UH 500-505 See also Military Hygiene UH 600-627; Military Medicine UH 201-515, etc. War Gases see Chemical Warfare Agents War Neuroses see Combat Disorders Ward Administration see Hospital Administration Ward Attendants see Nurses Aides; Personnel, Hospital; Psychiatric Aides Ward Secretaries see Personnel, Hospital Wards, Hospital see Hospital Units; also special topics under Manuals and Nursing, Supervisory Warfare, Biological see Biological Warfare Warfarin QV 193 Wart-Hog Disease Virus see African Swine Fever Virus Warthin Tumor see Adenolymphoma Wasp Venoms WD 430 Wasps QX 565 Waste Disposal, Fluid WA 785 Waste Disposal, Industrial see Industrial Waste Waste Disposal, Solid see Refuse Disposal Waste Products WA 670 Utilization TP 995-996 Special topics, by subject See also names of particular products, e.g., Radioactive Pollutants WN 615, etc. Water Analysis WA 686-689 Bacteriological see Water Microbiology QW 80 Pharmacology QV 270-273 As a beverage WB 442 See also Drinking WI 102; Water Supply WA 675-690 Bacteriology see Water Microbiology QW 80 Balance see Water-Electrolyte Balance QU 105 Imbalance see Water-Electrolyte Imbalance WD 220 Metabolism QU 120 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 507 Mineral see Mineral Waters WB 442 Officinal QV 785 Pharmacology QV 270-273 Therapeutic use see Hydrotherapy WB 520; Balneology WB 525 See also Seawater WB 525, etc. Water Buffaloes see Buffaloes Water Consumption see Drinking Water Deprivation Experimental biochemistry QU 34 Experimental pharmacology QV 34 Experimental physiology QT 25 See also Dehydration WD 220, etc.; Thirst WI 102 Water-Electrolyte Balance QU 105 Water-Electrolyte Imbalance WD 220 Water Intake see Drinking Water Microbiology QW 80 Water Pollutants WA 689 See also names of specific pollutants Water Pollutants, Chemical WA 689 Water Pollutants, Radioactive WN 615 Water Pollution WA 689 See also Sewage WA 785, etc. Water Pollution, Chemical WA 689 Water Pollution, Radioactive WN 615 Water Softening TP 263 Public health aspects WA 675-689 Water Supply WA 675-690 Analysis Bacteriological see Water Microbiology QW 80 General works WA 686 Purification WA 690 Sanitation WA 675 Waterborne Diseases see Communicable Diseases; Water Pollution Waterhouse-Friderichsen Syndrome WC 245 Waxes QU 85 Weaning WS 125 Weather Meteorology (Physics) QC 980-999 Relation to disease WB 700-710 Of animals SF 760.C55 See also Acclimatization QT 145-160 Weaver Mice see Mice, Neurologic Mutants Webbed Fingers and Toes see Abnormalities WE 835. under Fingers and under Toes Weber-Christian Disease see Panniculitis, Nodular Nonsuppurative Wechsler Scales For adults BF 432.5.W4 For children BF 432.5.W42 Wegener's Granulomatosis WF 600 Weight Gain In infancy & childhood WS 103 Weight Lifting QT 260.5.W4 Weight Loss In infancy & childhood WS 103 Weight Perception WE 104 Weight Reduction see Weight Loss Weight Tables for Children see Tables WS 16 under Body Weight ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHy* Weightlessness WD 752 Weights and Measures QC 81-114 Pharmaceutical QV 16 See also Metric System QC 90.8-94 Weil's Disease WC 420 Veterinary SF 809.L4 Welding Occupational accidents WA 485 Occupational medicine WA 400-495 Welfare Work see Social Work; Social Welfare Wellness Programs see Health Promotion Wens, Sebaceous see Epidermal Cyst Wernicke Area see Temporal Lobe Wernicke's Encephalopathy WD 122 West Syndrome see Spasms, Infantile Western Blotting see Blotting, Western Western Immunoblotting see Blotting, Western Wet Lung see Pulmonary Edema Whales QL 737.C4 Diseases SF 997.5.M35 Wheat As a dietary supplement in health or disease WB 431 Cultivation SB 191.W5 See also Bread WB 431, etc. Wheelchairs WB 320 Catalogs W 26 For particular disability, by the disability Wheezing see Respiratory Sounds Whiplash Injuries WE 725 Whirlpool Baths see Hydrotherapy White Blood Cell Count see Leukocyte Count White Blood Cell Transfusion see Leukocyte Transfusion White Blood Cells see Leukocytes White Spots see Dental Caries Whitefish see Salmonidae Whites Anthropology GN 537 Other special topics, by subject, e.g., Alcohol problem WM 274 Whitmore's Disease see Melioidosis Whole-Body Counting WN 660 Whole-Body Irradiation Adverse effects WN 620 Therapeutic use WN 450 Other aspects, by subject Whooping Cough WC 340 Widowers see Widowhood Widowhood HQ 1058-1058.5 Special topics, by subject Widows see Widowhood Widows and Widowers see Widowhood Wife Abuse see Spouse Abuse Wild Animals see Animals, Wild Will see Volition Wilms' Tumor see Nephroblastoma Wilson's Disease see Hepatolenticular Degeneration Wind QC 930.5-959 Wine As a dietary supplement in health or disease WB 444 Chemical technology TP 544-561 See also Grapes WB 430, etc. USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 508 Wing QL 950.7 Birds QL 697-698.9 Insects QX 500 Wirsungs Duct see Pancreatic Ducts Wit and Humor PN 6147-6231 Medicine and related subjects WZ 305-305.5 Satire on medicine WZ 305-305.5 Withdrawal Symptoms see Substance Withdrawal Syndrome Wittenborn Scales see Psychiatric Status Rating Scales Wolff-Parkinson-White Syndrome WG 330 Wolfram see Tungsten Women As physicians see Physicians, Women W 21; WZ 80.5.W5 As dentists see Dentists, Women WU 21 In industry HD 6050-6220.7 In history of medicine WZ 80.5.W5 Protection WA 491 In marriage HQ In medicine see Physicians, Women W 21, etc. Psychoanalysis WM 460.5.W6 See also Gynecology WP, etc.; Obstetrics WQ, etc.; other specific subjects Women Physicians see Physicians, Women Women, Working Special topics, by subject Women's Health WA 309 Women's Liberation see Women's Rights Women's Rights HQ 1236-1236.5 As executives HD 6054.3-6054.4 As educators LB 2837 In industry HD 6050-6220.7 U.S. HQ 1236.5.U6 See also Physicians, Women W 21, etc. Wood Industrial accidents among wood workers WA 485 Occupational disease of wood workers WA 400-495 Wool SF 377 Animal anatomy QL 942 Domestic animals SF 761-767 Textile fibers TS 1547 Woolly Monkey see Cebidae Woolsorters' Disease see Anthrax Word Association Tests Psychiatry WM 145.5.W9 Psychology BF 698.8.A8 Word Processing In particular fields (Form number 26.5 in any NLM schedule where applicable) Used for special purposes, by subject Work Health see Occupational Health WA 400-495, etc. Physical effects WE 103 Psychology BF 481 Work Capacity Evaluation Medicolegal aspects W 925 Special topics, by subject ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHi* X-Ray Emission Spectrometry Work of Breathing WF 102 Work Satisfaction see Job Satisfaction Work Schedule Tolerance Occupational health aspects WA 400-495 Physiological effects WE 103 Psychological aspects BF 481 Workers' Compensation HD 7103.6-7103.65 Medicolegal aspects W 925 Working Women see Women, Working Workmen's Compensation see Workers' Compensation World Health WA 530 Worms see Helminths Wound Healing WO 185 Pathology QZ 150 Surgical wounds WO 185 Wound Infection WC 255 See also Surgical Wound Infection WO 185 Wounded, Transportation see Transportation of Patients Wounds and Injuries WO 700-820 As a cause of disease QZ 55 Closure WO 188 General systemic reaction QZ 160 Local reaction QZ 150 Medicolegal aspects in death W 843 Minor injuries WA 292 Minor surgery WO 192 Veterinary SF 914.3-914.4 See also Surgical Wound Dehiscence WO 185; Surgical Wound Infections WO 185; Wound Infection WC 255; names of various types of injury, by cause or site, e.g., Blast Injuries WO 820; Facial Injuries WE 706 Wounds, Gunshot WO 807 Wounds, Multiple see Multiple Trauma Wounds, Penetrating WO 700-820 WPW Syndrome see Wolff-Parkinson-White Syndrome WR-2721 see Amifostine Wrestling QT 260.5.W9 Wrist WE 830 Wrist Injuries WE 830 Wrist Joint WE 830 Writing English (General) PE 1402-1497 In psychotherapy WM 450.5.W9 Medical WZ 345 Rules (English) PE 1411 See also Handwriting Z 105-115.5, etc. Wryneck see Torticollis Wuchereria QX 301 X X Chromosome QH 600.5 X-Linked Lymphoproliferative Syndrome see Lymphoproliferative Disorders X-Ray Departments see Radiology Department, Hospital X-Ray Diagnosis see Radiography X-Ray, Diagnostic see Radiography X-Ray Emission Spectrometry see Spectrometry, X-Ray Emission E NUMBER ASSIGNED ONLY WHEN OF WORK BEING CLASSinED 509 X-Ray Emission Spectrometry X-Ray Emission Spectrometry, Electron Microscopic see Electron Probe Microanalysis X-Ray Emission Spectrometry, Electron Probe see Electron Probe Microanalysis X-Ray Film WN 150 Used for specific purpose, by subject X-Ray Film-Screen Systems see X-Ray Intensifying Screens X-Ray Fluorescence Spectrometry see Spectrometry, X-Ray Emission X-ray Information Systems see Radiology Information Systems X-Ray Intensifying Screens WN 150 Used for specific purpose, by subject X-Ray Measurement in Obstetrics see Pelvimetry X-Ray Microanalysis, Electron Microscopic see Electron Probe Microanalysis X-Ray Microanalysis, Electron Probe see Electron Probe Microanalysis X-Ray Service, Hospital see Radiology Department, Hospital X-Ray Therapy WN 250.5.X7 X-Ray Tomography see Tomography, X-Ray X-Ray Tomography, Computed see Tomography, X-Ray Computed X-Rays General works WN 105 Diagnostic use (General) WN 200 Therapeutic use WN 250.5.X7 Physics QC 480.8-482.3 Xanthines QV 107 Xanthinol Niacinate QV 150 Xanthinol Nicotinate see Xanthinol Niacinate Xanthomatosis WD 205.5.X2 Xanthotoxin see Methoxsalen Xantinol Nicotinate see Xanthinol Niacinate Xenoantibodies see Antibodies, Heterophile Xenobiotics As carcinogens QZ 202 Metabolism QU 120 Xenograft see Transplantation, Heterologous Xenograft Bioprosthesis see Bioprosthesis Xenograft Dressings see Biological Dressings Xenon Inorganic chemistry QD 181.X4 Pharmacology QV 310 Xenopus QL 668.E265 As laboratory animals QY 60.A6 Xeroderma see Ichthyosis Xeroderma Pigmentosum WR 265 Xeromammography WP 815 Xerophthalmia WW 208 Xeroradiography, Breast see Xeromammography Xerostomia WI 230 Xiphosura see Horseshoe Crabs Xylenes As antiseptics QV 223 Organic chemistry QD 341.H9 Xylitol Organic chemistry QD 305.A4 Pharmacology QV 82 Xylose QU 75 ALWAYS CONSULT MAIN SCHEDULES. SUBJECT REPRESENTS MAJOR EMPHA XYY Karyotype QS 677 Y Y Chromosome QH 600.5 Yaws WC 425 Yeast, Dried WB 447 Yeast, Fission see Schizosaccharomyces Yeasts As a dietary supplement in health or disease WB 447 Microbiology QW 180.5.Y3 Processing TP 433 Yellow Fever WC 530-532 Yellow Jackets see Wasps Yellow Marrow see Bone Marrow Yersinia QW 138.5.Y3 Yersinia enterocolitica QW 138.5.Y3 Yersinia Infections WC 350-355 Yersinia pseudotuberculosis QW 138.5.Y3 Yersinia pseudotuberculosis Infections WC 350-355 Yoga QT 255 Philosophy B 132.Y6 Therapeutics see Alternative Medicine WB 890, etc. Yogurt SF 275.Y6 As a dietary supplement in health or disease WB 428 Bacteriology QW 85 Sanitation WA 715 Yohimbans As cardiovascular agents QV 150 Organic chemistry QD 421 Yohimbine QV 132 Yolk Proteins see Egg Proteins Yolk Sac Tumor see Endodermal Sinus Tumor Youth see Adolescence Yttrium Isotopes Inorganic chemistry QD 181.Y1 Pharmacology QV 290 Z Z-DNA see DNA Zea see Corn Zearalenone As a mycotoxin QW 630.5.M9 As an estrogen WP 522 Special topics, by subject Zidovudine QV 185 Special topics, by subject Zimeldine As an antidepressant QV 77.5 Zimelidine see Zimeldine Zimmermann's Corpuscles see Blood Platelets Zinc Inorganic chemistry QD 181.Z6 Pharmacology QV 298 Zinc Isotopes Inorganic chemistry QD 181.Z6 Pharmacology QV 298 Ziram As an industrial fungicide WA 240 Toxicology QV 298 USE NUMBER ASSIGNED ONLY WHEN IS OF WORK BEING CLASSIFIED 510 8-Quinolinol Zirconium Inorganic chemistry QD 181.Z7 Pharmacology QV 290 Zollinger-Ellison Syndrome WK 885 Of the duodenum WI 505 Zona see Herpes Zoster Zona Pellucida WQ 205 Animal QL 965 Zone Therapy see Massage Zonography see Tomography, X-Ray Zoology QL Biography Collective QL 26 Individual WZ 100 Societies QL 1 Zoonoses WC 950 Prevention & control WA 110 See also names of specific diseases Zoophaginae see Viruses Zoster see Herpes Zoster Zuclomifene see Clomiphene Zygote WQ 205 Zymogens see Enzyme Precursors Zymosan QU 83 1 1-Oxacephalosporin see Moxalactam l-Sar-8-Ala Angiotensin II see Saralasin l-Sarcosine-8-Alanine Angiotensin II see Saralasin 1,2-Benzopyrones see Coumarins 1,2-Dibromoethane see Ethylene Dibromide l,8-Dihydroxy-9-anthrone see Anthralin 13-cis-Retinoic Acid see Isotretinoin 17 beta-Estradiol see Estradiol 17-Ketosteroids WK 755 Synthetic WK 757 17-Oxosteroids see 17-Ketosteroids 2 2-Acetamidofluorene see 2-Acetylaminofluorene 2-Acetylaminofluorene QZ 202 2-Aminoethylisothiuronium Bromide see AET 2-Bromoergocryptine see Bromocriptine 2-Chlorethanol see Ethylene Chlorohydrin 2-Chloroacetophenone see omega-Chloroacetophenone 2-Chloroethyl Alcohol see Ethylene Chlorohydrin 2-Hydroxyphenethylamine QU 61 2-Mercaptoethanesulfonate see Mesna 2-Phenylethanolamine see 2-Hydroxyphenethylamine 2 ',3 -Cyclic-Nucleotide Phosphodiesterases QU 136 2,4-D see 2,4-Dichlorophenoxyacetic Acid 2,4-Dichlorophenoxyacetic Acid As a herbicide Agriculture SB 951.4 Public health WA 240 Organic chemistry QD 341.A2 2',5-Oligoadenylate Polymerase see 2 ',5 -Oligoadenylate Synthetase ALWAYS CONSULT MAIN SCHEDULES. USE NUMBER ASSIGNED ONLY WHEN SUBJECT REPRESENTS MAJOR EMPHASIS OF WORK BEING CLASSIFIED 2 ,5-Oligoadenylate Synthetase QU 141 2-5A Synthetase see 2',5'-Oligoadenylate Synthetase 21-Hydroxyprogesterone see Desoxycorticosterone 3 3-Isoleucine,8-Leucine Vasopressin see Oxytocin 3,4-Benzopyrene see Benzo(a)pyrene 3,4-Methylenedioxyamphetamine QV 102 4 4-Aminobutyric Acid see GABA 4-Aminohippuric Acid see p-Aminohippuric Acid 5 5-HT see Serotonin 5-HT Antagonists see Serotonin Antagonists 5-Hydroxytryptamine see Serotonin 5-Hydroxytryptamine Antagonists see Serotonin Antagonists 5,12-diHETE see Leukotriene B4 5,12-HETE see Leukotriene B4 6 6-Mercaptopurine QV 269 7 7S RNA see RNA, Small Nuclear 8 8-Hydroxyquinoline see Oxyquinoline 8-Methoxypsoralen see Methoxsalen 8-Quinolinol see Oxyquinoline 511 BANDI A-Z ACEffiWffl (ACE Inhibitors) ItT >¥*T > y >«lfcW m&m*%x Achilles)^ (Achilles Tendon) WE 880 Achromobacteriaceae (Achromobacteriaceae) It 7 7 J* ptr|4irfll4S£Jl£ Ach^Wft(Receptors. Acetylcholine) Ii 3 ij V-gWf^* Mi Acostaf! (Acosta's Disease) (itijUJi^^E J: ACTH (ACTH) lia^fa h n b°> £1,X ACTH & ft Hi1 (Corticotropin-Releasing Factor) Ii CRH£J1£ A-C'M'*X (Aortocoronary Bypass) iiniftciM''^-"? X^JU Adams-Stokes^l^^ (Adams-Stokes Syndrome) WG 330 ADCC (Antibody-Dependent Cell Cytotoxicity) QW 568 Addison-Biermer^JflL (Anemia, Addison's) (ilS'ttH'jfo. Addison^ (Addison's Disease) WK 765 Addison^JfiL (Addison's Anemia) (i3§ttSMfn.£ J1L X ADL (ADD liBftiiSiMt^JiJ: ADP (Adenosine Diphosphate) QU 57 mm¥ qv 185 ADP^fc (Receptors, ADP) Ii7°>) >P2^s£f££ ££ ADPi)*y;H<7>X7i7-^ (t&it) (ADP- Ribosyltransferase (Polymerizing)) (iNAD + ADP 'J ,-K->;u h 7 > X 7 x 7 —fcT^l. J: ADP 'J -K-X (Adenosine Diphosphate Ribose) QU 57 AET (AET) WN 650 AFP (AFP) liT^777xF7°of^>^lJ: AGEPC (AGEPC) liJfiL'MgfegftHi^ j?. £ Agkistrodon rhodostomaH"7°nf7—b' (Agkistrodon rhodostoma) Ii 7 > ? o -y K £ £ £ AH5158 (AH 5158) Ii7^^n-;^1J: AHG-CDCrX h (AHG-CDC Tests) Itftf&^tfifflW ttrxh£jl,i AIDS (AIDS) lii-fX*£ji,£ AIDS? 4 /UXft#:(AIDS Antibodies) (iHIVftf££ JI i AITP (Purpura, Thrombopenic) (iJfiL'MS«4>tt^S£*pf £JEi Albers-Schoenberg^(Albers-Schoenberg Disease) li^: «£#>??£££ Albright^ (Albright's Disease) liS!jliMittfH0SJIft£JI '<& &M.m*%X Alpers^f£Sf: (Alpers Syndrome) ltV\.%ffltia&1ffl.£% X Alportffijilf (Alport's Syndrome) [?&&&'&&&M.X Alzheimer^ (Alzheimer's Disease) WT 155 AmblystomaM (Amblystoma) Ii Ambystoma Mfr^LX Ambystoma mexicanum (Ambystoma mexicanum) QL 668.C23 £3£®Jt/i LT QY 60.A6 #c*N SF 997.5.A45 AmbystomalU (Ambystoma) QL 668. C23 'HftSltot IX QY 60.A6 AnaplasmaM (Anaplasma) QW 150 anf (anf) it'bm&i- h 'i 7i>mmm?£%X ANOVA (ANOVA) lifttoftftifLX anp (anp) u&mfti-Y >)y^vmmT£%£ Apert-fnif&fflp (Apert Syndrome) li&m&ffimt: % X APUDWUfc (APUD Cells) WL 102 Ara-A (Ara-A) lit 7" 7 h*> £££ Ara-C (Ara-C) \ty 9 7 SJ >£ £ £ Archaebacteria (Archaebacteria) li^Hffi^ JE i ARDS (Adult Respiratory Distress Syndrome) (iritA mnmm&mm*fLx Arnold - Chiari ^-^ (Arnold-Chiari Deformity) WL 101 ArtemiaH (Artemia) QX 463 Arthus*.g.|i (Arthus Phenomenon) (iArthusSj£<£££ ArthusSS (Arthus Reactina) QW 900 ASPA-b/> h- (ASPA Cement) Ii7*7 ^7 A */•?-* ;<>[-£££ Aspergillus^ (Aspergillus) QW 180.5.D38 ATLV (ATLV) (iHTLVl £IE£ ATP (Adenosine Triphosphate) QU 57 ftat—jfel-fctt* QU 120 mm¥ QV 185 ATP7--fcf (Adenosinetriphosphatase) QU 136 ATP7--te*Fl (Adenosinetriphosphatase Fl) l±H( + )- ATP7 —V£%X ATPS^f* (ATP Receptors) iff V >P2%m*£%X ATP*X*h7>X7x7--te* (Phosphotransferases, ATP) li*X* h7>X7x7—V&M.X AuerbachttHfl (Auerbach's Plexus) (£J&fffflttiEI££ ££ Aujeszky-lpi (Aujeszky's Disease) ItiKfeB.ttfi&M.X Aujeszky^?^ )VX (Aujeszky's Disease Virus) Ii7*^ ^.jv^xyAiVT, 1 £JE,£ AV/-F (AV Node) {tmmm^^lX Ayerza-GEJl£t£ (Ayerza's Syndrome) !iBiliifjlfoJ±;fiE£ JILi AzotobacterM (Azotobacter) QW 131 AZT(i5i'7^;uX'|i) (AZT (Antiviral)) liyh*ry>* ££ AWn'A (Hepatitis A) WC 536 ASfF&'M^X (Hepatitis A Virus) (i-^° h 7 4 )\>X £%X ASAt& (Type A Personality) BF 698.3 mmtft^mu, *U-t 7$e££ £ BaranyBRttH Nystagmus. Barany's) (i£H&'>jMtisJi£ Baranytfcft (Barany's Test) (ii£r£!Slgf£^£JE.£ Barlowfa" (Barlow's Disease) liJUifo.*?! £ £ £ Barrett&it (Barrett Esophagus) WI 250 Bartholin** (Bartholin's Glands) WP 200 BartterJpf (Bartter's Disease) WK 770 Basedow^ (Basedow's Disease) lil8J$£ajte¥#ll*II WK 265$- £ £ Batten-Spielmeyer-Vogt^ (Batten-Spielmeyer-Vogt Disease) littS-ta'f K'j t>7Xf/-->X Jli Bayer 39 (Bayer 39) li>f V7°n 7 * >£££ BCG (BCG) lir7^>SS^®^££ BCG<7?^> (BCG Vaccine) WF 250 Bechterew^ (Bechterew's Disease) (i&B/ffiWtf i££ JE X Becker®; :xX h o y i — (Becker Muscular Dystrophy) (iSSvX h o 7 >f -£££ BehcetJEfl^^ (Behcet's Syndrome) WW 240 BellM (Bell's Palsy) itWMWWk% WL 330 £££ Bence-Jones3r&JC (Bence-Jones Protein) WH 540 Bender Gestalt^ (Bender-Gestalt Test) WM 145. 5.B4 BeneckeaH (Beneckea) (iVibrio£££ Berger^ (Berger's Disease) li^/o7 "J > A&J£f£ t&£££ Besnier-Boeck^(Besnier-Boeck Disease) lit;i/3 4 K —>X£££ BK'M/UX (BK Virus) (i b h # U ^-^"7 >f ;ux 1 £ ££ B-K§3*f^f£f¥ (B-K Mole Syndrome) (iHffM«ffi f&$£££ Blastocladiellag (Blastocladiella) QW 180.5.P4 Blastomyces^ (Blastomyces) QW 180.5.A8 BLS (Basic Life Support) (£l>SifiI?4rS£££ BLV$*te£(BLV Infections) iiHTLV-BLVI*ifeE££ X Boeck^rvm-1" K (Boeck's Sarcoid) !i+r;un^ K-->x £££ Bordetella^ (Bordetella) QW 131 Bornholm#| (Bornholm Disease) itMW^k^^X BorreliaS (Borrelia) QW 155 Bouillaud^ (Bouillaud's Disease) it') ^-vf-'ffi'W^.f.^ ££ Bourneville^ (Bourneville's Disease) it&W't^it&Z ££ BrevibacteriumH (Brevibacterium) QW 118 Bright^ (Bright Disease) li*W^&£££ Bright-^ (Bright's Disease) {*¥?&£.!,£ Brill-Symmers^(Brill-Symmers Disease) Iiitl&tt U > 'm&M.X Brill-Zinsser^ (Brill-Zinsser Disease) (iBrill^£££ Brill^ (Brill's Disease) WC 605 #c*R<7)itfr WC 610 Briquetffif£# (Briquet Syndrome) (iJH£^JfEt4PfW£ ££ BRL2288 (BRL 2288) it + ivvy \) > £££ Broca&l&fe (Aphasia, Broca) WL 340.5 •fcBtt WM 475.5 Brocaff (Broca Area) itma&.'l^HX Brunhilde^^^X (Brunhilde Virus) lit h.fUt^-f ^Xl-3£££ Brunner^ (Brunner's Gland) (i f-rtaSf £M £ BSSBfeffi (Blood Sugar Self-Monitoring) liifilft^e, &*!£££ Buerger^ (Buerger's Disease) (ifS^ttJfiL&£ JH i BurkittlffiiK (Burkitt's Tumor) Ii Burkitt »j ^^M^HJ; Burkitt^A^X'M^x (Burkitt Herpesvirus) Ii t h -v;^X7^f;^ 4 £££ BurkittU W?1I (Burkitt's Lymphoma) WH 525 ummftmrnmiiizucti-mmnsFttiz Burkitt1) >^H*7-Oux (Burkitt's Lymphoma Virus) lih h'VU^X'M ;ux4£jfl£ B^flf^ (Hepatitis B) WC 536 BOT&EftiJIl (HBeAg) (iHBett)g££ i BSItfF&'M^X (Hepatitis B Virus) QW 170 BSflf^StlS (Hepatitis B Antigens) WC 536 BSHB^flSlfc (Encephalitis, Japanese B) WC 542 UkUmftK SF809.E5 mm& (B-Cells) liBiJ^^Ii BWfi&3ffi.2*nM (Blast-2 Antigen, B-Cell) liB ■; >>< &ft{mM*JLX B%m&ftitVti% (Antigens, Differentiation, B-Cell) Ii b'j >'mft^°J$[ (B-Lymphocytes) WH 200 B 'J >'*^Le\MM (Leu Antigens, B-Lymphocyte) Ii W>'*mft\mM*fLX B i) >'<&J5HVRM (Antigens, Differentiation, B- Lymphocyte) QW 573 CI (Complement 1) QW 680 ClxXT7-^WI*SC (Complement 1 Esterase Inhibitors ) itaTtmmtmttJLi Cl^iSttftH^- (Complement 1 Inactivators) QW 680 *£it¥ QU 136 Cl^rSte&K (CI Inactivators) (iCl^ffittHi^M£ C1»J^5C (Complement 1 Inhibitors) liCl^ffittttH i^£££ C3 (Complement 3) QW 680 C3m&W&M. (C3 Activator) itC3=i >*-<^7—If (Complement 3 Convertase) QW 680 C5n >-;/!✓;?—-tf (Complement 5 Convertase) (iC33 > C5WSIS (C5 Cleaving Enzyme) l±C3=J >^i/?~tf £££ Ca(2 + ) Mg(2 + )-ATPT—tr (Ca(2 + ) Mg(2 + )- ATPase) QU 136 Ca (2 +) -|fc£ATP7 - -tf (Ca (2 +) -Transporting ATPase) QU 136 CA-125M (CA-125 Antigen) (i*Sgll#IHI&lJiJii£S, £ CA-15-WLm (CA-15-3 Antigen) imiiMmM&Vifci: ££ CA-19-9ClH (CA-19-9 Antigen) tttgSMM&ftlS* ££ CA50#lJS (CA-50 Antigen) (2«KH*M£#L!Si£JU Caenorhabditis (Caenorhabditis) QX 203 CAI (Computer-Assisted Instruction) 514 CRONK (NLM^SH^-C(iff^f^-18.2) %£¥ QS 618.2 »£!£ LB 1028.5 M& QS 518.2 Callitrichinae (Callitrichinae) QL 737. P92 HBIMfcfcLT QY 60.P7 &^ SF 997.5.P7 Calmette-Guerinff-lS (Calmette-Guerin Bacillus) it 7 ymzmtzx Calmette-GuerinftStS (Calmette-Guerin Immunization) IJ BCG 7 7*>*&X CAM (Cell Adhesion Molecules) £fk^ QU 55 CaMgATPT —-tf (Calcium Magnesium ATPase) (i Ca(2 + ) Mg(2 + )-ATPT—tf£££ cAMP (Cyclic AMP) QU 57 mm.¥ QV 185 Campylobacter fetus (Campylobacter fetus) QW 154 Campylobacter pylori (Campylobacter pylori) Ii Helicobacter pylori £££ Candidal (Candida) QW 180.5.D38 CAPD (Peritoneal Dialysis, Continuous Ambulatory) WJ 378 CapgrasSEl^SE (Capgras Syndrome) WM 202 Carrion^ (Carrion's Disease) li-'^hf-7i^g WC 640 £££ Caryophanales (Caryophanales) li$HI§*£i CattellH^S'JAt&ttS7>y-h (Cattell Personality Factor Questionnaire) WM 145.5.C3 kwmziitfh BF 698.8.S5 CAVH (CAVH) lilfiL$j$®*££ Cavus^ (Cavus Deformity) liJ£^2 % Wf* £££ CDPn ij > (CDP Choline) l±->*--> >r n X,&3 ij >£ ££ CD-ROM (CD-ROM) 2) CDftIK (Antigens, CD) QW 573 CEA (Carcinoembryonic Antigen) QW 570 mm%.m¥ qz 310 CELSS (CELSS) liffliI^*J*^£X cGMP (Cyclic GMP) QU 58 %W% QV 185 Chagas'DfS-GE (Chagas Cardiomyopathy) WC 705 Chagasi^ (Chagas Disease) WC 705 CHAMPUS (CHAMPUS) li^«ffl^f*PM&#ftlii*£ X c-Ha-rasjtfSi1 (c-Ha-ras Genes) IirasjifS-?-£££ Charcot-Marie-Tooth-)^ (Charcot-Marie-Tooth Disease) liCharcot-Marie!^ £ £ £ Charcot-Marie^l (Charcot-Marie Disease) WE 550 Charcot^® (Charcot's Joint) mmn'MmMWMZtt X Chediak-Higashiffill^ff- (Chediak-Higashi Syndrome) WD 308 ChironomusM (Chironomus) (i^-X ij ij^£•££ Christ-Siemens-TouraineiEfliKiSt- (Christ-Siemens- Touraine Syndrome) [inK;il»Mi£££ ChromatiumH (Chromatium) QW 145 Churg-Strauss-fiHfl^ftf- (Churg-Strauss Syndrome) WG 515 Churg-StraussIH?•£ (Vasculitis, Churg-Strauss) (i Churg-Strauss^|5sfflf■* £ £ CI-581 (CI-581) (iT?;>£££ c-Ki-rasjfif^-f (c-Ki-ras Genes) lirasjftfz; f-£££ Clerambault«i,T- (Clerambault Syndrome) (ifriW^14 »ftti'?WfW£££ CLL (Lymphocytic Leukemia, Chronic) litt 14 U ~s> ^14 Clostridium histolyticum=» 7 f-f — -tf (Clostridium histolyticum Collagenase) itWW) ? 7 ^7—tf £ £ £ Clostridium^ (Clostridium) QW 127.5. C5 CloustonJgtJetf (Clouston's Syndrome) it^M^M^Bfk }££££ CMHC (CMHC) li«$*l«tHfe^>?£££ c-N-rasiftfS^- (c-N-ras Genes) lirasjafSzF-£'££ CoA (CoA) lifflgt*A*££ CoccidioidesS (Coccidioides) QW 180.5.P4 Cochliobolus (Cochliobolus) li-?ftM*I£££ Connf! (Conn's Disease) itMT^ Y'Xf o >;££•££ Conradi-HunermannSgfl^lf (Conradi-Hunermann Syndrome) ii.£W£#ffMJtS?E£££ Cooley^ifiL (Cooley's Anemia) it7y-t i T £££ Coombsr X h (Coombs' Test) QY 265 ^jt^wmm^mm wh 425 Coon£S (Coon's Technique) ItlkJtfJLifcHfc & X COPD (COPD) (iffl*l4fl^B£££ Corti^'g- (Organ of Corti) WV 250 Corynebacterium^ (Corynebacterium) QW 118 Costen^fltSf (Costen's Syndrome) i±mW&5&&&& JL X Cowperifc (Cowper's Glands) immW WJ 600 ££ £ CoxiellaS (Coxiella) QW 150 CPR (CPR) it'bWBWZ%X CRD-401 (CRD-401) (ii^f-7-tfA£££ Crenothrix (Crenothrix) li*H0£££ CRF-41 (CRF-41) (iCRH£££ CRH (Corticotropin-Releasing Hormone) WK 515 Cricetidae^f (Cricetidae) li'>?*X* = £!£££ CricetulusS (Cricetulus) QL 737.R666 %mfflfot LT QY 60.R6 ^■y YtLX SF 459.H3 CricetusM (Cricetus) li^AX *-£££ Crigler-Najjarffifltlf (Crigler-Najjar Syndrome) WD 205.5.H9 Crohn^ (Crohn Disease) WI 512 ISfliW*2'-^ WI 522 Cronkhite-Canada^fl^ (Cronkhite-Canada 515 CROUZ Syndrome) (iChurg-StraussSEli£g££££ Crouzon?jN (Crouzon's Disease) liSlIESil5^#^£££ CRTr'-f X-Zu-f (Cathode Ray Tube Display) 1*7*4 x7M^i CryptococcusJg (Cryptococcus) QW 180.5.D3 CTX^r-rT- (Tomography, Computed, Scanners) liX ^3>h°J--^Kfllft^xJf^7-*££ Cushing-£1&g£ (Cushing's Syndrome) WK 770 CVP (Venous Pressure, Central) lifp'l>Hmi±£££ Cytophagales (Cytophagales) QW 128 CSffHfc (Hepatitis C) WC 536 CSJfiLfe^ (Hemoglobin C) WH 190 &mfli£. QY 455 Cmm (C Fibers) (i^^^*l$-££ C*?* K (C-Peptide) WK 820 D600 (D 600) (i#u'<~;u£££ DAB (DAB) (ip-^yf-^TS y^>-tf>£££ Dandy-Walker^EfSl^ (Dandy-Walker Syndrome) WL 350 DCM (Dilated Cardiomyopathy) {±-5 ojfo.14'l>S5ffi££ £ DDAVP (DDAVP) {ifX*7V-> > £££ DDD (DDD) WA 240 DDE (DDE) WA 240 DDT (DDT) WA 240 DDX (DDX) liDDE£££ De lange£EfSg£ (De Lange's Syndrome) QS 675 DEAE-f* X h 7 > (DEAE-Dextran) QU 83 Denticaid (Denticaid) (iMedicaid£££ Dercum^ (Dercum's Disease) (iWfSBIKffi WD 214$: ££ DFP (DFP) HA V7W7i- h£££ Diamond-Blackfan®Ml (Diamond-Blackfan Anemia) liFanconi®JfiL$'££ Diarsenol (Diarsenol) liT/U7xt; >£££ DIC (Disseminated Intravascular Coagulation) WH 322 DictyocaulusH (Dictyocaulus) QX 248 Dictyostelium^ (Dictyostelium) QW 180.5.M9 DMFfglfc (DMF Index) WU 30 DMSO (DMSO) ity/"r)^7,)Vf!s^y K£££ DNA (DNA) QU 58.5 DNA7 —tef (DNAase) liDNT—tf£££ DNA7>f--te>X (Antisense DNA) li7>f--te>X DNA£££ DNA1£#14*°U/7—tr (DNA-Dependent RNA Polymerases) liRNAd? ij / 7 --tf ££ £ DNA-*ij{ (Single-Stranded DNA) li-*MDNA££ £ DNAjfifE^yo-r (Gane Probes, DNA) liDNA7°n -"7*£££ DNA 7 4IVX (DNA Viruses) mt QW 165 ¥f%7A)V7, QW 165.5A-Z DNAW* (DNA Injury) (iDNAJ11i£££ DNA*I&^£JC(DNA Recombinant Proteins) Iill&g &W£££ DNA&^SSfC (DNA-Binding Proteins) QU 58.5 DNA&g£8£|| (DNA Restriction Enzymes) QU 136 DNA£-$g^ (DNA Joinases) lid? \) r**ytfZ 7 V *+ V'y>T?—tf£££ DNASge^iJ (DNA Rearrangement) liitfiiT-tfKfilfcJi £ DNA&l&mm (DNA Relaxing Enzyme) liDNA r *'f y/7—tf£££ DNA-> h v>-5-^f-7--fe* (DNA Cytosine-5- Methylase) liDNA (-> h y>-5-) vf;^7>X7i 7--tf£££ DNA (vhv>-5-) -/f;H-7>X7x7-tf (DNA (Cytosine-5-)-Methyltransferase) QU 141 DNAS>W 7~feT (DNA-Gyrase) liDNA h #>f V/ 7 —bTDNA (ATP*n*#JWL) £££ DNAji^fl (DNA Repair) QH 467 &itm QU 58.5 DNAfi^l^^ (DNA Repair Enzymes) (i#i;f**y ')^^wtfKy>T7-tf£££ DNAJil^'M^X (DNA Tumor Viruses) QW 166 m?if y y 7—if (ATP-iP7K^-»fb) (dna Topoisomeiase (ATP-Hydrolysing)) QU 137 DNA h #4 y y 7—feTl (DNA Topoisomerase I) Ii DNAb*V yy 7-tf^££ DNA h #4 y y 7~fcT2 (DNA Topoisomerase II) Ii dna h #4 y y 7—if (ATP-*n*#A?{b) £££ DNA-^3->7*-7n->?>7*SeJC (DNA Nicking- Closing Protein) liDNA h #>f V y 7—tf £££ DNAyyu-T-^f (Nucleases, DNA) (iDN7--tf£JE £ DNA^^l/tf^i^V h 7>X7i7--b* (DNA Nucleotidylexotransferase) QU 141 DNAK^J (DNA Sequence) li* ? Wtff-KSBfllfcJU DNAg^iJ^/f (Sequence Analysis, DNA) JtfE^fttTT (-jfe) J: LT QH 441 WWY tVyxfi, itlWc DNA7 4 >tf—y°\) y r- (DNA Fingerprinting) itlK^-ttffrfcL-C QH 441 j£[l^:-C- W 700-791 DNAHSli (DNA Replication) QH 462.D8 §i\m QU 58.5 DNA7°n-7* (DNA Probes) QU 58.5 DNA^H^Jff (Mutational Analysis, DNA) liDNA^ **$H3«££ DNA-V-X7- (DNA Markers) lijffSi^-^-^i DNA£ 9 ii t' L&M (DNA Untwisting Enzyme) Ii DNAhrK-fyy 7—tf£££ DNA£ 9 i> £ LS&K (DNA Untwisting Protein) Ii DNAhd-^yy 7—tf£££ DNA^SE^t ii t' L^SK (DNA Helix Destabilizing Proteins) (iDNA*££-Se«££ £ DNA U if—tf(DNA Ligases) lid? 'J f * * -> 'J ** ? u ^-7cK->>r^-tf^£i DNCB (DNCB) ity=- h n 7 n o~;>-tf > £££ 516 FMG DN7~-tf (Deoxyribonucleases) QU 136 DOCA (DOCA) UfV^fy^^f^Xf n y£££ Donovanosis^ (Donovanosis) li$.MS|5ft#:II£££ Doppler^* (Doppler Effect) tmmwz QT 34 m.w% WN 110 ftfth t°-y?x(i±HJ3i]l;: Doppler'C'i^—El?S (Echocardiography, Doppler) WG 141.5.E2 Doppler£l^i& (Doppler Ultrasound) (£&#}&£££ DownSEJI£l!¥ (Down Syndrome) WS 107 ISA WM 300 DPN (DPN) (iNAD£££ DRG (DRG) (it^££gij£$g^^7y*££££ DSIP (DSIP) (irVu?BilJ^H^70^ K£££ Dubin-JohnsonSEfl£l$ (Dubin-Johnson Syndrome) litl imw&Mm.z&x Duchennei5 '>' X h o 7 -f (Duchenne Muscular Dystrophy) li!5>!Xho7^—$•££ DuffyS;jfiLH5S (Duffy Blood-Group System) WH 420 Duhringfif (Duhrings Disease) (i^tt &)*&£££ DuncanSE^Sf (Duncan's Syndrome) (i ') >',f*#fiI14#|.Si £££ Dupuytren#J#t (Dupuytren's Contracture) WE 830 D-7 ^ / & * * y 7—>d (dextro-Amino Acid Oxidase) QU 140 DS1FF& (Hepatitis D) HfVi^lS&fcJi J: X)^W&7 4 ivx (Hepatitis D Virus) lirVwy Hi1^ £ DSfifcfefo: (Chromosomes D) lit h ^13-15ifcfef£££ £ EAC142 (EAC142) (iC33 >"<>1>?—V&JIX Ebstein^ (Ebstein's Anomaly) WG 220 EBV (EBV) lit h^u^X7^UX4 £££ EB"7-Ol'X (Epstein-Barr Virus) lit Y~.)Vbmmimm£%x Echinococcusjg (Echinococcus) QX 442 Echinopanax (Echinopanax) !ililfflA#£££ ECT mffltm (ECT (Psychotherapy)) ti*fl-> s -v ?«?££££ EC-ICgjM^M ' £££ EGF^n^X ho> (Epidermal Growth Factor- Urogastrone) WK 170 fiScft^gt LT QU 107 ffitmtLX QV 69 EGF-7n^xM>^fls: (Receptors, Epidermal Growth Factor-Urogastrone) WK 170 Ehlers-DanlosS£f£|$ (Ehlers-Danlos Syndrome) WR 218 Eigenmannia (Eigenmannia) it%%fa%bLX ekg (eko it'bmmmz*%x Elaeophoriasis-EE (Elaeophoriasis) li*#i;&-ffi£££ ELISA (Enzyme-Linked Immunosorbent Assay) QW 525.5.E6 wmnmrnu t - y u > y, ifii r x h izmm ■§■ n S±£&(i*eo^fftc EMSf£ii->XrA(EMS Communication Systems) lift &&*-* -1* X fsit *> X r A £ £ £ EN-1639A (EN-1639A) (iT^U h * y > £££ Endomycopsis^ (Endomycopsis) lii> pi^Xg^l £ ENDOR (ENDOR) litfXf>*i**IJ: Entamoeba^ (Entamoeba) QX 55 eog (eog) itmnmmmmmuz % x EPH&*gfp#^(EPH Gestosis) (iBfc»l&*g4>S^££i Epstein-Barr-7^ 1VX (E-B Virus) lihK^^X1)^ ^X4 £££ ercp (ercp) it\HmfimimmMBigm&ti;£%x EremotheciumIS (Eremothecium) li^>Ki'7"X@§:£ £ ErythrinaM (Erythrina) QV 140 ESRD (ESRD) Ii1tt4^^^r*£i ESR^ftiit&S'/S (Electron Spin Resonance Spectroscopy) (if;-?-X t>4tp.|£££ ESWL (Extracorporeal Shockwave Lithotripsy) IiW^i ffi£££ EubacteriumIS (Eubacterium) QW 120 Eustachi^ (Eustachian Tube) li^^§££ EwingfflM! (Ewing's Tumor) liEwingl*)Sll:£i EwinglSlSE (Sarcoma, Ewing's) WE 258 EJ^tt«9*>«OliSlH£J3'J£ ESffFifc (Hepatitis E) WC 536 EltJg (E Antigens) (iHBe£iJl!££i F0ATP7—tf (ATPase, F0) liH-ATPv >? —tf ££ £ F1-ATP7—tf (Fl ATPase) liH-ATPv>y —tf££ £ F1ATP7—tf (ATPase, Fl) (iH-ATPv >? —tf ££ £ F1-F0 ATP7--tf ^ V7V -y y X (FIFO ATPase Complex) (iH-ATP->>y—tf£££ FAD (FAD) QU 135 FallotHfilfcffi (Tetralogy of Fallot) WG 220 FanconiS^JfiL (Fanconi's Anemia) WH 175 FasciolaH (Fasciola) QX 365 FCRS (Factor Construct Rating Scales (FCRS)) (iffl Fc^#f£ (Receptors, Fc) QW 601 FGF (Fibroblast Growth Factor) QU 107 Fiedler^ (Fiedler's Disease) Ii Weil*?! £ £ £ Fischer?-y r- (Fischer Rats) l±aE£*7-y r F 344$ ££ FletcherH^- (Fletcher Factor) ity'Vt \) y W >££ X FMG (Foreign Medical Graduates) ffcW W 18-20 517 FMN mtttftte W 76 FMN (FMN) QU 135 Fogarty's'>^— > # f — T>^ (Fogarty Balloon Catheterization) it'O^— >J£:JSJ££££ Fo\e\'<)V—>i)T — TH' (Foley Balloon Catheterization) [t'OV—>U.WA£ £ £ Forestier-Certoncinyffifl^ (Forestier-Certonciny Syndrome) (i') r7^^'t4^%'l4®5ffi^££ FourierAWff (Fourier Analysis) QA 403.5-404.5 &tommtt&m qt 35 Frei^" (Frei's Disease) Iit4^14') >^°l*I1Ht£££ FreudM (Freudian Theory) WM 460 Friedlaenderlifi^ (Friedlaender's Pneumonia) (ilifr^^ ££ FriedreichiiiJJ^I^ffi (Friedreich's Ataxia) WL 390 Friedreich^ (Friedreich's Disease) li£%tt'*7 5^y o-y x£££ Froehlich«3¥ (Froehlich's Syndrome) WK 550 FSH (FSH) WK 515 FSHStftdwi^v (FSH-Releasing Hormone) lttf-f-Y W'J >£££ FUdR (FUdR) (i 7 o * y 7 U :J > £ £ £ FusariumS (Fusarium) QW 180.5.D38 FH-7- (F Factor) QW 51 GABA (GABA) QU 60 GABA-A-g^ff (Receptors, GABA-A) QU 60 GABA-f nft (GABA Receptors) QU 60 GABA h7>X7^7---tf (GABA Transaminase) Ii7 ismmrs. y ^>x7i7-^ii GABA^>y*^7-tft°>^f£ (Receptors, GABA- Benzodiazepine) liGABA-Ay.'^H^ £ £ GalenSi* (Vein of Galen) li*ISit§*£££ Ganja (Ganja) li^ >7" tXJl£££ Gaucher^ (Gaucher's Disease) WD 205.5.L5 Gehrig^(Gehrig's Disease) li$#Sfrf4ffiiJij^{b££££ GH-g§f£ (Growth Hormone Receptors) tiJ&ftdwi-^ >S^f££££ GIFT (Gamete Intrafallopian Transfer Human) WQ 205 Gilberts (Gilbert's Disease) WD 205.5.H9 Gilles de la Tourette #! (Gilles De La Tourette's Disease) WM 197 GliocladiumH (Gliocladium) li^&^*;tfc®IK£££ GLQ223 (GLQ223) (ih 'J nf>f >^Si GnRH (GnRH) (i h't" V V \) > ££ £ Goldblattit5ME (Hypertension, Goldblatt) (i'fi-lfo/g'ffi ^J(iir±^^££ Golgi^S (Golgi Apparatus) li3'Vl^f££££ GOP (Aspartate Aminotransferase) QU 141 GraafW^ (Graafian Follicle) WP 320 Graffi7 A )VX (Graffi Virus) Ii V7 X &faffi7 A 1^X £ ££ Grafting,SlfiLfift (Graffi's Chloroleukemic Strain) (i v7X&tt7^^X^i Gravest (Graves' Disease) WK 265 Grommetff A (Grommet Insertion) licr1¥^f\^££ GTPIS^^SK (GTP-Binding Proteins) IiGMf3R£ ££ GTPUgS^&K (GTP-Regulatory Proteins) liG^SK £££ Guerin-Sternifcfl^ttf: (Guerin-Stern Syndrome) (ifSDEfiflj *fe'£££ Guillain-Barre^iMII^Sf (Guillain-Barre Syndrome) (i £ %+B**il&&£££ GVHR (Graft vs Host Reaction) itm^HIn \:Kf&$ ££ GymnodiniumH (Gymnodinium) (ii^¥S"Eih.!EH-S- W. £ Gymnotid^f (Gymnotid) (i€*\,%£££ GW (G Periods) itmmftmfflW£%X GSfjJC (G-Proteins) QU 55 H( + )ffy&ATP7--tf (H( + )-Transporting ATPase) liH-ATP^ > 9 --tf£££ H2y 7X lilfg-f- (Genes, H-2 Class I) (iMHC?7X ljtf£^£££ H-2M (H-2 Antigens) WO 680 %mm^}h Lt«v7X QY60.R6£k££ H93-26 (H 93-26) it/ h7°nn-^£££ Haemophilus)!! (Haemophilus) QW 139 HalstedlUI^^ff (Halsted Mastectomy) li?Uf ffife^ ^At£££ Hamman-Richffifli^ (Hamman-Rich Syndrome) lilt mmzzx Hand-Schueller-Christian-GEfl&gf (Hand-Schueller- Christian Syndrome) WH 650 Hanganutziu-Deicherf;tf£ (Hanganutziu-Deicher Antibodies) (iff UStn.fc& £ £ Haplorhini (Haplorhini) QL 737.P925-737.P965 mm SF 997.5.P7 mmmtix qy 60.P7 Ha-rasiftfS^- (Ha-ras Genes) liras3ftfSi1$'£i Harding-PasseyMfeSl (Melanoma, Harding- Passey) !i3a^MfellI£££ H-ATP->>y--tf (H( + )-Transportng ATP Synthase) QU 136 HBAg (HBAg) liB§yJrT&tt)Il£££ HBetfClK (Hepatitis B e Antigens) WC 536 HBsAg (HBsAg) (iHBefi:JIi£££ HBsitHl (Hepatitis B Surface Antigens) WC 536 HBmmttlW-. (Hepatitis B Surface Antigen) [iHBsffiJI £££ HCB (HCB) (i^+ry Dn^>-b*>^££ HCG (HCG) !ifct€t414ll&$iJi§^^>£££ HCL (Hairy Cell Leukemia) li^7 'J —t/^jfil#l£M £ HDLni/XfD-;i/i)t°fSI (Lipoproteins, HDL Cholesterol) QU 95 H-Dftf£ (H-D Antibodies) li£rHMf££££ HelaSfflflS (Hela Cells) QH 585 Helicobacter pylori (Helicobacter pylori) QW 154 HETE (HETE) Ii t K ° *y^4 ?7t Y 7^/ >S£* ££ Heymann^-i^ (Heymann Nephritis) (i&i-fif^n ££11 £ HFRS (HFRS) lilf^fim4a}JME^£££ HFRS 7 4 )VX (HFRS Virus) \i.">9->7 4 )\r*Z% X Highmoreilsl (Antrum of Highmore) (i±?li|5]£££ Hill-Burtonj£ (Hill-Burton Act) (iS^Jf#i6<$IflJj££ £ Hirschsprung^ (Hirschsprung Disease) WI 528 518 IL1 His* (Bundle of His) WG 201-202 HIV (HIV) QW 168.5.116 HIV 1 (HIV-1) QW 168.5.H6 HIV-2 (HIV-2) QW 168.5.H6 HlVfgifeffi (HIV Infections) WC 503-503.7 HIYHJiitfr (HIV-Associated Antibodies) (iHlVli'if^ £JU HIYIH&^EE UUY-Associated Nephropathy) lix>fX wm&z%x HI\'JfiLif^'l4 (HIV Seronegativity) WC 503-503.7 HIVJft.it^Wffc ft (HIV Serodiagnosis) QY 265 HIYjfo/if RlSUIIY Seroconversion) lilllYjfiLifHMifcH, £ HIYjfitffPi'14 (HIV Seropositivity) WC 503-503.7 HIVjfllTtS.ft* (HIV Seroprevalence) WC 503.4 HIVttfr (HIV Antibodies) QW 575 HIVIen* (HIV Dementia) li^^f X«riV:$-£i HIVlfifE (HIV Encephalopathy) J±x>f X#p*£££ HLA-Dwttlg (HLA-Dw Antigens) (iHLA-Dtt!Si££ £ HLA-D4tl§ (HLA-D Antigens) QW 573.5.H7 fltSft^ WO 680 HLA?7X litiil-(Genes, HLA Class I)(iMHC?7 Xlillsi^£i HLA^7X2jtf5iL (Genes, HLA Class II) I1MHC7 7X2JtfeiL?r£i HLAJtlfl (HLA Antigens) QW 573.5.H7 &&%.&¥ WO 680 HMG-CoAw^y ?--tf (Hydroxymethylglutaryl CoA Reductases) QU 140 HMG^&g20(High Mobility Protein 20)li-^t^> £££ HMN*1S 1 M (HMN Distal Type I) (iCharcot- Marief!£££ HMO (HMO) (ifit**lft*i$f*£i HMP->-\-> h (Hexose Monophosphate Shunt) (i^> h-xn/li£igi&£££ HMSN1S (HMSN Type I) (iCharcot-Marie#!££i HodgkinlSl^tt (Granuloma, Hodgkin's) Ii Hodgkin^ £££ Hodgkin^ (Hodgkin's Disease) WH 500 HOE766 (HOE 766) Ii7'-tu^>^££ Holter<;El (Electrocardiography, Holter) li^lfP$'t> «0£££ Holter^-y ij >y* (Monitoring, Holter) (i^ffflfct'fE 0£££ HPLC (Chromatography, High Performance Liquid) itnJ±.m¥7w?h77y 4-£%X HSAN3S (HSAN Type III) lil£^4g|£*M&£P*E£ ££ HTLV-1 (HTLV-I) QW 168.5.R18 HTLV-ISI (Leukemia Virus I, Human T-Cell) Ii HTLV-I £ ££ HTLV-l^ife^ (HTLV-I Infections) WC 502 HTLV3SLAV^ifeS! (HTLV-III-LAV Infections) Ii HIVftf££££ HTLV3SLAVftif£ (HTLV-III-LAV Antibodies) Ii HIV£££ HTLV3S!Sjfe£ (HTLV-III Infections) (JHIV$iM=* ££ HTLV3^-!JfiLo'i'7- (HTLV-III Serology) (ilHVlto'ii'i W>J «fc££H.J: HTLV3^jfiU#t£lff (HTLV-III Serodiagnosis) (iHIVjfo. HTLV3^JflliVi7jcliS (HTLV-III Seroconversion) Ii HIVl(lLifiiii14^££ HTLV3S!!UTl-itMSPt1t. (HTLV-III Seronegativity) it IIIVJlilVi,i-K14^£i HTLVWM'iW&Vm. (HTLV-III Seropositivity) Ii HIVJto.'ii!i^'l4*££ HTLV3$!fiif* (HTLV-III Antibodies) (iHIVW;f£££ £ HTLV4S (HTLV-IV) (iHIV-2£££ HTLV-BLV7^^X(HTLV-BLV Viruses) QW 168. 5.R18 HTLV-BLVJS&SK (HTLV-BLV Infections) WC 502 HTLVM^X (HTLV Viruses) (iHTLV-BLVM IV X£££ HTLV!:£vfc:iii:: (HTLV Infections) liHTLV-BLV!gife£ £££ Huntington-!?! (Huntington's Disease) WL 390 Hurler-Scheieffifl^lff (Hurler-Scheie Syndrome) liAn m-&imz%x HurlertElj*^ (Hurler's Syndrome) liA o £*|ffi 1 S£ ££ Hutchinson^ (Hutchinson's Teeth) ti5t.7cl4ffe#£££ HVJ (Hemagglutinating Virus of Japan) lt'*7 A >y )\,z->*Y7A)\>X 1S£££ HydrogenomonasS (Hydrogenomonas) Ii Pseudomonas/K £ £ £ H-Y#tft: (H-Y Antigen) WO 680 HM^.!syD7"lJ >itf5^- (Genes, Immunoglobulin Heavy Chain) liftSyo7*>) >»1e^F-£££ IAPWBBI#^(IAP Pertussis Toxin) liWB^S*S:£ £ Ia*t)^ (la Antigens) \tm&M&&$LW.? 7 X 2 £££ Ia^flilg (la-Like Antigens) itm^M^\^nM-9 7X 2 £££ IBR-IPV'M A-X (IBR-IPV Virus) it 7 ->^;i^X 7 A )VX 1 £££ ICI-46474 (ICI-46474) (iy**->7:r.>££i ICI-66082 (ICI 66082) li7f/D-;^Ii icsh (icsh) itmmi&K^^yz&x ICU (Intensive Care Units) WX 218 'siiOliCCU WG 27-28* ££ nm^immm^^m^ wf 27-28$•££ t»^ffli)F^&^27-28 m^HMm WX 218^ £ ii £ £ IDDM (IDDM) HA >X'J >i£#S*Jtm^£££ IgAl-ffi(Nephropathy, IGA) lift^y n 7*') >A*Sfcf* W&£££ IgE (IgE) QW 601 IgG (IgG) QW 601 IGF 1 (Insulin-Like Growth Factor I) iSIftltU QU 107 IGF 2 (Insulin-Like Growth Factor II) (tS^M^LT QU 107 Igjifci1 (Immunoglobulin Genes) li&lsy'ny'1) >m.U ^-£££ IL-1 (IL-1) UA >?-aA*> 1 £££ 519 IL2 IL-2 (IL-2) it A >?-nA *>2£££ IL-2^^f* (Receptors, IL-2) it A > 9-v A * >2££ ft>£££ IL-3 (IL-3) UA >9-vA*>Z*5LX IL-8 (IL-8) UA >9-vA*> 8 £££ IND (Investigational New Drugs) tiVp5$H£££ Index Medicus (Index Medicus) (iMEDLARS£££ IPA (IPA (Independent Practice Association)) liliA mm&%*%x IPPV (IPPV) li^7v^PIE^$1.$-££ Intfsi1 (Ir Genes) liMHCy 7X 2 £££ ISWi1 (IS Elements) liDNA#A^£££ Ito^1£S¥ (Ito Syndrome) (i£^JI;tffi£££ IUGR (IUGR) liB^^fiSt^S^^££ Ixodoidea (Ixodoidea) U~?7— £££ Jacksonfef^(Jacksonian Seizure) U$bttXA,frA,%&X Jamestown Canyon7^^X (Jamestown Canyon Virus) li^7'j7+^-7flia^7-f;ux$-££ Jansky-Bielschowsky ^ (Jansky-Bielschowsky Disease) (i*«&14-fevA K 'J *° 7 X ^- y - ~> X £ £ £ Jervell-Lange Nielsen &MWE (Jervell-Lange Nielsen Syndrome) (iQmftffil'gS^ £ £ Jird (Jird) U7 ui-^X I M*4£££ Johne^ (Johne's Disease) (i^°7l§f£??!£££ Jung^lA (Jungian Theory) WM 460 KahnrX h (Kahn Test) (itg#Jfir7#TX h £££ Kakke (Kakke) liP^^££ Kandinsky^1£!¥ (Kandinsky Syndrome) liffiW^'ffil? SttffiWfS:^££ Kanner^A^ (Kanner's Syndrome) (i?l!£gffl^£££ Kaposi^;*^ (Kaposi's Disease) Ii£lt14ii£&^£££ Kaposi 1*1 HE (Sarcoma, Kaposi's) QZ 345 vm&nii^umiwz Karwinskia (Karwinskia) Ii7 o 7/ t Y*M,%5LX Kell^JfiuftS (Kell Blood-Group System) WH 420 Kent£ (Bundle of Kent) (i4>!I$lJW£#^£££ Kidd^Jfir^S (Kidd Blood-Group System) WH 420 Kienboeck^ (Kienboeck's Disease) {£##;#•&£■££ Kimmelstiel-Wilson^lSSf (Kimmelstiel-Wilson Syndrome) (iffljl^tt* 7 o^->-£££ KI-rasji:f5^- (Ki-ras Genes) lirasii;f:K-:P£"££ Klinefelter-ffiH^ (Klinefelter's Syndrome) QS 677 KO 1173 (KO 1173) liy *y Uf- >£££ Koehler^ (Koehler's Disease) li#f£#&£££ Korsakoffffil^S^ (Korsakoff's Syndrome) UT)Va— ;u 14flt£-^£££ Krause**-5fc'hf£ (Krause's End Bulbs) lii£ltS^i?££ £ Krebiozen (Krebiozen) (if&?lft££-££ KrebsHK- (Krebs Cycle) Ii < LMfc*rA y^£££ Kufs^ (Kufs Disease) liWi&tt-tn ^f K >) d"°7X^-y- ->X£££ KunitzPH h x)y°yymm*fa% (Kunitz Pancreatic Trypsin Inhibitor) Ii77°nf-—>£££ Kupffer*ffl!& (Kupffer Cells) WH 650 mW)&<7) ii<7)UU®.mz KttBUS (K Cells) li*7-«£££ Limii'J >^i*14£|jfn.^ (Leukemia, Lymphoblastic, Acute, Ll) (iLlfett '1 w'ftSM £££ Ll.%14'1 W?t£fijfa.;l?i (Leukemia, Lymphocytic, Acute, Ll) WH 250 $&mmm¥ qz 350 La Crossed A ^X (La Crosse Virus) li^ 'J 7 + ^-7 Ja<&7A*xU£%X lacZJtfS^- (LacZ Genes) Ii Lac*^o>£££ Lac^ny (Lac Operon) QH 450.2 *m&h t'yyxii±MS"jic Lafora^ (Lafora Disease) li;;t^D--t^KJ•I £ LAKfflBS (Killer Cells, Lymphokine-Activated) WH 200 &S*M&K<6 QW 568 LAN (Local Area Networks) TK 5105.7-5105.8 Langerhans$fflfl£$Jl$jl$fc5E (Histiocytosis, Langerhans- Cell) WH 650 Langerhans^ (Islets of Langerhans) WK 800-885 Mm WK 885 Langerhans Jb^+it (Islets of Langerhans Transplantation) WK 800 LATS^f* (LATS Receptors) li¥ttll&dWU* >££ 1*£££ Laurence-Moon-Biedl£Elj£lr£ (Laurence-Moon-Biedl Syndrome) QS 675 LAV-2 m (LAV-2) liHIV-2£££ LAV-HTLV-35!! (LAV-HTLV-III) Ii HIV££i LAV tfifc (LAV Antibodies) Ii HIVtttt:£££ LDHA Vf-A (Lactate Dehydrogenase Isozymes) Ii ?L$tT*t I'nyf-VTA y+>M A£££ LDL^J WXfn-;ui) *'ISf (Lipoproteins, LDL Cholesterol) QU 95 LDL^f£ (Receptors, LDL) QU 95 LDLU-fe7°y ') d"°SfiK (Lipoprotein LDL Receptors) (iLDLS#f££££ L-Dopa (L-Dopa) liUd^K-^°^£i Legg-Perthes^ (Legg-Perthes Disease) WE 865 Legionella^ (Legionella) QW 131 Leontideus (Leontideus) Ii Callitrichinae£££ Leontopithecus (Leontopithecus) Ii Callitrichinae££ £ LeptothrixE (Leptothrix) QW 153 LericheSEll^Sf (Leriche's Syndrome) WG 410 Lesch-NyhanSEfl^lJ^ (Lesch-Nyhan Syndrome) WD 205.5. P8 LET (LET) !ix;fwu3r-^gj£££ LETSg&M (LETS Proteins) Ii7 4 7*o* 9* >££ X LeuiXW. (Leu Antigens) li#(fc#iJli £ £ £ LeVeen->-\* > h (LeVeen Shunt) liKie«HR->+ > r * ££ Lewyhffc-lN (Lewy Body Disease) liParkinson*?i££i LEIH8& (LE Cells) WH 200 #16Visits WH 380 UM^m^^Hiih WR 152 LH-FSHSfciUdwi^y (LH-FSH Releasing Hormone) Ii rf-j- Y u ') > £ £ £ LHRH (LHRH) ito'-f- Y v 'J > £££ LHJ&aidvl^V (LH-Releasing Hormone) li^'-fK^ 'J>£££ Libman-Sacks^ (Libman-Sacks Disease) (i£IH4-X "J 520 MYERS f? h-r*x£££ LimulusM (Limulus) li*7 7*h#-£££ Limulusr X h (Limulus Test) QW 25 Lingua Villosa Negra (Lingua Villosa Negra) li^fj £££ Listeria^ (Listeria) QW 142.5.A8^ Litomosoides (Litomosoides) Ii7 -f 7 'J 7fcl£££ Little*?! (Little's Disease) liBw'14lft*$r££ LMWH (LMWH) lite^*'^'J > £££ Lobstein^ (Lobstein's Disease) (i#0)& t>£S££££ LoTT^mitM^itmn^mm^MmRfS. (Lorr's Inpatient Multidimensional Psychiatric Rating Scale) liWttE^WfFffiKKfcJii Lou Gehrig^ (Lou Gehrig's Disease) li^^*fe''l4fi^Cl ft££££ LSD (LSD) li'J-b.^y^^x^-^7i K£££ LTB4 (LTB4) (in A a h 'J x>B4£££ Ludwig7 > ^ (Ludwig's Angina) WI 200 Lundborg-Unverrichtffil^H (Lundborg-Unverricht Syndrome) Ii 5 *9 n-* X-t^*>A,£££ Lurcher^7X (Lurcher Mice) liW*i^*$$l|-^7X £££ LyellS1£S£ (Lyell's Syndrome) U^fc^fcWXMWct ££ Lyme*?! (Lyme Disease) WC 406 Lymejtfl'') 7$E (Lyme Borreliosis) liLyme#!££i Lynchfi*18e# (Lynch Syndrome) lijtfEl4#d"°') #--> LS(L Forms) QW 51 LfflBfe (L Cells) QS 532.5.C7 L IMS y D 7' 'J > itfr■? (Genes, Immunoglobulin Light Chain) Iift*g7*a7*') >£££ MacacaM (Macaca) QL 737.P93 mmnfytLX QY 60.P7 &*?! SF 997.5.P7 MaillardMS (Maillard Reaction) mw& (-&) qz 40 ftSJuXttlfi TP 372.55.M35 MandraketS (Mandrake Root) Ii ^ -\»* V 7Jg£££ Mansoni ftjfo. "ft 4.SE (Schistosomiasis mansoni) WC 810 Mapharsen (Mapharsen) (i** V 7 if"^->>£££ Marchiafava-Micheli^l^^ (Marchiafava-Micheli Syndrome) IiISfftt^t/ot^S^Ii Marek^ (Marek's Disease) SF 995.6.M33 Marie-Struempell^ (Marie-Struempell Disease) li^Ht 14l?tt&£££ MBD (Minimal Brain Dysfunction) li?SiMfiJ14&s.^ +PfW£££ McGillffi«^7>y-h (McGill Pain Questionnaire) (i *£ffi«i|££££ MCLS (Lymph Node Syndrome, Mucocutaneous) li& j*temi)>'<®fcmmz%x McNaughtonWj£giJ (McNaughton Rule) littttUffi^ ftft£££ MCTD (Connecive Tissue Disease, Mixed) livI^SIS £*fl$s??i£££ MDA (MDA) Ii3,4-y f i^^^Jf'/T^i; ^ >£ ££ Meckeli!^ (Meckel's Diverticulum) WI 412 Medicaid (Medicaid) W 250 MEDLARS (MEDLARS) W 26.55.14 MeibomHSfe (Meibomian Cyst) li£/Uiflt£££ Meleda^ (Meleda Disease) lif-*J£l£^Ji^*££ Melitococcosis (Melitococcosis) li7Vw-fe 7$e£££ Melnick-NeedlesiSM&lft (Melnick-Needles Syndrome) li#&fr)FMfl$;4iE££i Meniere^ (Meniere's Disease) WV 258 MER-29 (MER-29) Ii h ') '*y 9 -^£££ MESNA (Mesna) QV 76 MgADP (MgADP) fiADP£££ MgATP (MgATP) liATP£££ Mg-ATP7--tf (Magnesium ATPase) Ii Ca.Mg- ATP7-*'£££ MGI-1 (MGI-1) liaD--*iJi|tHi1?:££ MHC^7X litfg-f- (Genes, MHC Class I) fc«ciU£¥ QW 541 m*\- t'yyxliiMSiJl^ MHCy 7X2Jtfg^- (Genes, MHC Class II) fe^itfe^ QW 541 EM*h t'y yxlii^SiJtc MHPG(MHPG) (i v h*->t Kn *->7 x-^y'J 3- ;u£££ Microtines (Microtines) li^y ;f-X* ^ H£|-£££ Milroy#5 (Milroy's Disease) (i U >^7K1I£££ Milzbrand (Milzbrand) li^S:^^££ MK-421 (MK-421) liX7-77°U ^£££ MMPI (MMPI) WM 145.5.M6 MNi£iffi*!5&K (MN Sialoglycoprotein) liHS&K* ££ MOF (Organ Failure, Multiple) li^l«S?PfS:$'££ Mohsffif (Mohs Surgery) WR 500 Moire ^^777^- (Topography, Moire) (i^ 7 V r *777^-*Si MOPEG (MOPEG) Ii * r- * x t K o * y 7 x -;u 7') a -;u£££ MoraxellaJg (Moraxella) QW 131 MormyridJS (Mormyrid) liflSfl,%£££ Morquio^ (Morquio's Disease) Ii A a £«Sffi 4 S £ £ £ Morrisffflfi (Hepatoma, Morris) li^Sfc6W8I)!*££ £ MRIXdf^-^ (MRI Scans) WN 185 mRNA (RNA, Messenger) QU 58.7 MRS (Spectroscopy, Magnetic Resonance) QC 762 MRX^y h nX3 t°— (MR Spectroscopy) QC 762 MSG (MSG) li/^y 5 >&i- h U 7A££i MSH (MSH) WK 515 Munchausen£E|gf¥ (Munchausen Syndrome) WM 178 Mur-NAc-L-Ala-D-isoGln (Mur-NAc-L-Ala-D- isoGin)ii7-fe^-^A7 =.>v-T7-^-A yy^y S > £££ mybitfii1 (myb Genes) (i^Jtfe^€-££ Mycobacteriaceae (Mycobacteriaceae) QW 125.5. M9 Mycobacterium^ (Mycobacterium) QW 125.5.M9 Mycoplasmal (Mycoplasma) QW 143 Myers-BriggsStHH (Myers-Briggs Type Indicator) Ii 521 MYXOC Myxococcales (Myxococcales) QW 128 Mffl (M Phase) li#*#«!£M.J: M't— F't'i3-Edi£ (Echocardiopgraphy, M- Mode) 'C.>xd-^}££££ n-3B&Wfi£ (n-3 Fatty Acids) Ii* J if-Zmm*fLX Na. K-ATP7--tf (Na( + )-K( + )-Exchanging ATPase) QU 136 Na, Ktf&ATPT—fcr (Na( + )-K( + )-Transporting ATPase) QU 136 NAD (NAD) QU135 NAD + ADP')d?-> h7>X7x7-** (NAD +ADP- Ribosyltransferase) QU 141 NADHft h'Drt-fe' (NADH Diaphorase) Ii U #7 > K-ft Foyt-^IJ: NADIDE (Nadide) (iMAD£££ NADP (NADP) QU135 NADv>7'*7—tf (NAD Diaphorase) (i U #7 5 Kft Kort-tf£££ NDRF (Neutrophil-Derived Relaxant Factor) Ii EDRF£££ Necator/1 (Necator) QX 243 NEFA (NEFA) (i#xXr;HigKB&£££ Neisseria^ (Neisseria) QW 131 Nelavane(Nelavane)li77'J# h U '*/ V—?&£5LX Nemathelminthes (Nemathelminthes) lii^Sf&IB ', i&& *g£££ NeurosporaE (Neurospora) QW 180.5.A8 Nicolas-Favre*?1 (Nicolas-Favre Disease) Ii14*?i'l4 ') > Niemann-Pick*^ (Niemann-Pick Disease) WD 205.5.L5 NIH 3 >-t >-7X^-||| (Consensus Development Conferences, NIH) W£\> \i-v 9 xizMLXU^MMiz Nitrobacteraceae (Nitrobacteraceae) QW 135 Nitrobacteria (Nitrobacter) QW 135 NitrosomonasH (Nitrosomonas) QW 135 NKttWS (Natural Killer Cells) IH- + *. y)V* y-%Mk £££ NMDAgWA * / *Tm&fc (NMDA Receptor- Ionophore Complex) liN-y f-^-D-7X^^°7:if>^S #f££££ NMRHm (NMR Imaging) (i5&xY4tn.|B*f$l&£££ NMRKff lil^i (Tomography, NMR) WN 185 NovikoffflflS (Hepatoma, Novikoff) limfcftjJrFRM £££ N-rasJlfg^- (N-ras Genes) (irasiifSi1 £ £ £ Nycticebus (Nycticebus) lin']X£|-£££ OA (Office Automation) W 26.5 Oddites (Oddi's Sphincter) WI 750 OK-432 (OK-432) Iit°->'<-^£££ Oleates (Oleates) (i:tM>$c£££ OMPgSK (OMP Proteins) (i*HlWiJ|g&«£££ Onchocerca® (Onchocerca) QX 301 Opisthorchis® (Opisthorchis) QX 353 Ormonde (Ormond's Disease) limiHHiM^£££ Osgood-Schlatter*?! (Osgood-Schlatter Disease) l±## #££££ osha (osha) mmm; mmrnm; mmmnmrn W WA 32-33*££ Osier-Rendu*?! (Osier-Rendu Disease) (iitfe'ltff.JfiLti £ mik^fo'fefcZfLX Osier-Vaquez*?!(Osier-Vaquez Disease) li&E£tfn.£££ ££ Osiers (Osier's Disease) (i*IE£illL*£ ; ilfKttrh" Jfiitt^ msk'Wi&Mm^^X OTCM (OTC Drugs) (iM7j-£/ll||£££ PACS (mm) (PACS (Radiology)) litt#fi»E^W^ vXrA*££ PAFT-br^ (PAF-Acether) (iJfc'H£rSt4(LKl ¥£££ PAH (PAH) l&P-T $.;&%■&£%£ PAI-3 (PAI-3) Ii7°nr-f >CP1W#J£££ Pancoast-fiEf^Uf (Pancoast's Syndrome) WF 658 PAPP-D (PAPP-D) (iflSSgyy b-r>£££ Parkinson*?^ (Parkinson Disease) WL 359 ~tz#>*-*>v>U QV 80£££ Parsonage-Turner-GEfSSf (Parsonage-Turner Syndrome) UWmmm £ £ £ Pasteurella® (Pasteurella) QW 140 Paul-Bunnell#if£ (Paul-Bunnell Antibodies) QW 575 P-Bftf£ (P-B Antibodies) li*?JI*!#Lft:£££ PCBS (PCBs) li*°'JiM:t7x-;u£££ PCP (PCP) Ii7x>->y U y>£££ PCPSlffl (PCP Abuse) Ii 7 * > y 9 U y > SLffl £ £ £ PCRjS (Polymerase Chain Reaction) QH 450.3 PDGF (Platelet-Derived Growth Factor) QU 107 PEEP (PEEP) liPH±«£££ PEG (Pneumoencephalography) (iyUlilJai2-/£££i Pelizaeus-Merzbacher*?! (Pelizaeus-Merzbacher Disease) IiW&'&S&Wklfc.£ £ £ PenicillumH (Penicillum) QW 180.5.D38 Peptococcus® (Peptococcus) QW 142.5.C6 Perodicticus potto (Perodicticus potto) (in ij X£f£H £ Perthes*?! (Perthes Disease) liLegg-Perthes*?!£££ PETX^f^> (PET Scan) fix ~ .y -> 3 >CT£££ Pfaundler-Hurlerffijl^S^ (Pfaundler-Hurler Syndrome) Ii A a £feM 1 S £ £ £ PFCS (Persistent Fetal Circulation Syndrome) WS 421 PGE1 (PGE1) (i7^7°oxy v;u£££ PGF2 (PGF2) Ii y y 7° n X h £ £ £ PGF27/W77 (PGF2alpha) liy/7°nxh£££ pH (PH) uymAt>mm£M.x Phaseolus vulgaris V 9 f- > (Phaseolus vulgaris Lectins) (iffiW4JM*£*^ £ £ £ Phialophora (Phialophora) QW 180.5.D38 PhlebotomusJS (Phlebotomus Fever) WC 526 Phthiraptera @ (Phthiraptera) (i->7i£££ Physarum® (Physarum) QW 180.5.M9 Picodna7 A )VX (Picodnaviruses) li^VUd<7 A ;ux£l£ ££ PIXE (PIXE) liX^H7t^7t5rt/f?:££ PlasmodiumMii^-E (Plasmodium Infections) ii~?7 U 7£££ Plummer-Vinson-Efl^Sf (Plummer-Vinson Syndrome) WI 250 PNS (Percutaneous Nephrostomy) lill&tfJff£9Fffi£ ££ POMR (Problem-Oriented Medical Records) (iPolM^ 522 RINSH fa $&«!£»& a £ Pott*?.J (Pott's Disease) liffmfe:t^££ PPHN (Persistent Pulmonary Hypertension of Newborn) liPFCS£££ PPLO (PPLO) (iMycoplasma£££ PPH^ (P. P. Factor) li-n f->/$£££ Prinzmetal$'l>*£ (Prinzmetal's Angina) (i$*t^C>*E£ ££ PRL#i#T"ill*WMI (PRL-Secreting Pituitary Adenoma) li7°o y 9 + / —^>£££ PRO (PRO Professional Review Organization) lilXfS* ffcft$tS£££ Propionibacteriaceae (Propionibacteriaceae) QW 120 PropionibacteriumS (Propionibacterium) QW 120 Psammomys (Psammomys) Ii 7 U -f % X l jffif 1 £ £ £ Pseudomonadaceae (Pseudomonadaceae) QW 131 Pseudomonas^ (Pseudomonas) QW 131 Psilosis (Psilosis) li-tr >J 7 -v ?*?!£££ PSRO (PSRO) !i[S«f£ftt£ti!££i PTCA (PTCA) U&&fo&mmtkJkmi'm$:%X Ptdlns (Ptdlns) Ii * X 7 r f- v: ;w 4 y -> h - ;w £ £ £ PTGF (Platelet Transforming Growth Factor) Ii TGF-<-:?*££ PTSD (PTSD) IJH-1iaxH/X»i*IJ: PT#A#Blffi£ (Parenterally-Transmitted Non-A, Non-B Hepatitis) (iCSffi^^££ Purkinje*fflS& (Purkinje Cells) WL 320 PUVASRS (PUVA Therapy) WB 480 PVD (Vascular Diseases, Peripheral) (i^tffJfo.§*£.&* ££ PVP 3 - K (PVP-Iodine) Ii # t K > 3 - K * £ £ PVS(Vegetative State, Persistent) UM&WE.UW-\k?MZ ££ Pygathrix (Pygathrix) (i:*7-#-?Vuf4£££ p-7 i 9,%%.& (p-Aminohippuric Acid) QU 62 PfflH&i|njittHjyL(P-Cell Stimulating Factor) UA >9- vA*>Z*%X QT5ift*£fS^ (Long QT Syndrome) WG 330 Quincke}?!! (Quincke's Edema) fiJliL^*M&1£*K* J!, £ Qfft (Q Fever) WC 625 RamanX-^y hH"fr%x (Spectrum Analysis, Raman) QC 454.R36 Ramsay HuntlW^SEfi^ff (Ramsay Hunt Paralysis Syndrome) Ii Parkinson*?? ££ £ rasitfg^- (Genes, ras) QZ 202 Raynaud*?! (Raynaud's Disease) WG 570 Recklinghausen*?!c7)#*?f5; (Recklinghusen's Disease of Bone) (i«I£f4M14#& WK300£££ Recklinghausen's7)}^*?!^: (Recklinghusen's Diasease of Nerve) li*M£|fUf)!f*E QZ 380H£££ Reeler^7X (Reeler Mice) litti^*fIv7X^M £ Reilfi) (Insula of Reil) UMmfeM£%X REM (REM) WL 108 Reye*£ll?¥ (Reye's Syndrome) WS 340 Rhesus^jfiL^S (Rhesus Blood-Group System) liRh- Hn£jfir$S£££ Rh-Hr^Jt-^S (Rh-Hr Blood-Group System) WH 425 RhW {- (Rh Factors) liRh-Hrj£jlitffcS£ M£ RhlalUfcffi (Rh Isoimmunization) WH 425 Riley-Day*ElS^(Riley-Day Syndrome) (i^M4g#W &ikm&*%x R\:Jx.^U-9 (Radionuclide Generators) WN 150 RWM^.^y>i-9y y 4— (Immunoscintigraphy, Radiolabeled) liMtft*£ffcttij£-£££ RNA (RNA) QU 58.7 RNA7>-f--b>X (Antisense RNA) li7>ft>X RNA£££ RNAift#14DNA*°'jy 7--tf (RNA-Dependent RNA Polymerase) liRNAU7°U ;?--tf£££ RNA7-f;uX (RNA Viruses) m?. QW 168 Wx.7A>^X QW 168.5. A-Z RNA3-7y7°fHi£ (RNA Caps) QU 58.7 RNAIfoiir*I7-f^X (RNA Rodent Viruses) Ii RNA7^X£££ RNAX7°7^ y>9 (RNA Splicing) QH 450.2 RNA-^m. (Double-Stranded RNA) (iH*0RNA££ £ RNAy 9 U7-b" (Nucleases, RNA) Ii V d^7 9VT- -tf£££ RNA7 9 U-ff-yjU h 7>X7x7--fe' (RNA Nucleotidyltransferases) QU 141 RNAIfi^l (RNA Sequence) U9 9 V** K8e#J£££ RNA|£#J5M7f (Sequeace Analysis, RNA) ikumtm (-m ttx qh 441 ^F?*h t-yyxii, ±m%uz RNAdC'jy 7--tf (RNA Polymerases) QU 141 RNAU7°iJ*—bT (RNA Replicase) QU 141 RN7—tf (RNase) Ii ') #* 9 VT—V£££ Ro 10-9359 (Ro 10-9359) lix h i/ff- h £££ Ro 15-1788 (Ro 15-1788) li7/W-v-tf-;u£££ Rogers^fittSRS (Rogerian Therapy) li*Ut^f8ft££ ££ Romano-Ward*Efl^S^ (Romano-Ward Syndrome) Ii QT^&-mnm£M,x RorschachrX h (Rorschach Test) WM 145.5.R7 Rosenzweig££jIi7 7Xh^-x3>xyf^ (Rosenzweig Picture-Frustration Study) WM145.5.R8 W^W WS 462 %VJimt£££ Rubinstein-Taybi-Ef^ (Rubinstein-Taybi Syndrome) QS 675 Rufini'hft (Rufini's Corpuscles) (ii&K^§2*£££ RBf (R Factors) QW 51 523 RPURA RyyXiY (R Plasmids) !iRB-?££i S1021 (Actihaemyl) QV 370 Saimirine'^/l'^X 7 A >VX (Herpesvirus 1, Saimirine) U%-f&7 A ^X£££ Salmonella arizonae (Salmonella arizonae) QW i::,s.5.S2 Salmonella schottmuelleri (Salmonella schottmuelleri) QW 138.5.S2 Scarpatti£3ii (Scarpa's Ganglion) (iHU^#ig^££ Schamberg*?! (Schamberg's Disease) (ife^^?££E£-£ £ Schaumann*?! (Schaumann's Disease) U+fi^^A Y — y x£££ Scheie^M^ (Scheie's Syndrome) liAn^i^iS^^ £ Scheuermann' (Scheuermann's Disease) WE 725 SchizosaccharomycesSI (Schizosaccharomyces) QW 180.5.A8 Schueller-Christian' (Schueller-Christian Disease) it Hand-Schueller-ChristianliEfl£lj££- £ £ Schwalbel^ (Schwalbe's Nucleus) UmM.WW&£ *JLX Schwartz-Jampel*£1Si^ (Schwartz-Jampel Syndrome) (i#ft#^$;J|£**£££ Selye Syndrome (Selye Syndrome) ti|iJfl§i:tIf|§Ti9 h y >X7 x 7—tf££ £ Sharp^f£S£ (Sharp Syndrome) li^S*£^l&*&*?!££ £ Sheehan*mf£?£ (Sheehan's Syndrome) liT^ft=f$ii£1g;T *££££ Sherman h y X h- M±W: (Sherman Antitrust Act) Ufa &m±m£%x Shope?LslM (Papilloma, Shope) UMM7 A ^X^ifelE £££ Shwartzmanil^ (Shwartzman Phenomenon) QW 900 SWUM (Sulfhydryl Reagents) QU 143 Sicca^M^ (Sicca Syndrome) (iSjogren^f£?££££ Sick Building^f^|$ (Sick Building Syndrome) UMft £§Vfti££££ SID (SID) (i?L#J^**?E£££ Simmonds*?! (Simmonds' Disease) liTSf^^HglgT*^ WK 550£££ SIN-10 (SIN-10) U*)vy Y i >£££ SIU(Systeme International d'Unites) (iSl^^tivXT A£££ SIV (SIV) QW 166 SIV-1 (SIV-1) (iSIV£££ SIV-2 (SIV-2) (iSIV£££ SI^---y h (SI Units) Iill^^fi->XTA^££ Sjogren-^?? (Sjogren's Syndrome) WE 346 Smith, Theobald*!!! (Smith, Theobald, Phenomenon) UT-fy^y^y — -^^^ Sneddon-Wilkinson*?! (Sneddon-Wilkinson Disease) Ii 'l^*mftfcftm&£%X snRNA (RNA, Small Nuclear) QU 58.7 Southern 7" □ ••/t 1 >9 (Southern Blotting) U7V- > 7'D-yr^ >y"£££ SPECT (Tomography, Emission-Computed, Single- Photon) WN 206 mm&<7)i><7)ummiz SQ 14225 (SQ 14225) itijy° h 7°') ;u£££ St. Anthony^ (St. Anthony's Fire) U^Pi^M^^X St. Vitus'Hifg (St. Vitus' Dance) liftJ&*?!£££ Staggerers7X (Staggerer Mice) li*M£^*£$gv 7x£££ Steele-Richardson-01szewski*El1£g£ (Steele- Richardson-Olszewski Syndrome) Iiitft'l4^±^*$ £££ Stein-Leventhalffil^lf (Stein-Leventhal Syndrome) Ii zmm^mmmzzx Stevens-Johnson*EJI^^ (Stevens-Johnson Syndrome) WR 150 STLV-3 (STLV-III) (iSIV£££ Stokes-Adams^efN (Stokes-Adams Attacks) Ii Adams-Stokes-Kfl^ £ £ £ Strepsirhini (Strepsirhini) QL 737.P95 *£*?! SF 997.5.P7 Streptococcus mutans (Streptococcus mutans) QW 142.5.C6 StreptomycesM (Streptomyces) QW 125.5.S8 Streptomycetaceae (Streptomycetaceae) QW 125.5.S8 Sudeck#|ig (Sudeck's Atrophy) WE 250 SV407 A )VX (SV40 Virus) UT ij Y*Y)V tf \) * - v 7 A ^X£££ Swiss-v7X (Swiss Mice) (i"v7x£££ SzondirX h (Szondi Test) WM 145.5.S9 &*%] WS 462 ?v&mtth>jim WS 105.5.E8 &mmz & It h BF 698.8. S85 SfttJK (Surface Antigens) (ig®#lJ£££i S^clgfli (Sigmoid) WI 560 sttfemmm (Mesosigmoid) u&mmm£%x S#^S§ftl&g*£ (Sigmoidoscopy) WI 620 S^k&WiWM (Sigmoid Neoplasms) WI 560 T3^f£(T3 Receptors) li¥#c!l£*/Hi >££#£££ T4»f£(T4 Receptors) (i*TO!*;tvHE >^£f£££i Tac P55^7> Y (Tac P55 Peptide) it A >9-vA* >2^f££££ Tachypleus)! (Tachypleus) fi;>7 7" h #-£££ Tac^7°f- Y (Tac Peptide) UA >9-vA *>2%®W £££ TaeniarhynchusH (Taeniarhynchus) (i^A^$-£i Tahyna7^X (Tahyna Virus) li^ >J 7 *)V-T%k'$. 7-f;ux^£££ TAT (TAT) (i^iD^t:TXh^££ TCBD (Transluminal Coronary Balloon Dilatation) Ii TPCA£££ TCGF (TCGF) li-f >y-n A *>2£££ TCGFu-fe7°y (Receptors, T-Cell Growth Factor) Ii ^f>y-o.f 3r>2££f££££ TDE (TDE) (iDDD£££ TEM (Electron Microscopy, Transmission) IiMTWffi. §If£^'££££ 524 WECHS TENS (TENS) li&&ttifi*tt&*iJ»fcSc£ J1J: TGF (Transforming Growth Factors) QU 107 TGF7^7 7"S§f£ (Transforming Growth Factor Alpha Receptors) liEGF-7)^ifX h n >£§f££££ TGF^<— 9 (Transforming Growth Factor beta) QU 107 THC (THC) lir b7t Kn^>f-tV-;b$-££ TLV (TLV) UWt-kffW^^'O^Z&X TMJS^S* (TMJ Syndrome) li1^Bi5«{tf-£££ TNF (Tumor Necrosis Factor) QW 630 tmm$i$Lmm qv 269;w^.mmzn^^mm<^t ft, mLlf*->Tvl*y>l* QW 630 ((jcn added)) TNF7.^7r (Tumor Necrosis Factor-alpha) Ii TNF£££ TnSi1 (Tn Elements) liDNA}? AWH?£££ Tolosa-Hunt*£1£8£ (Tolosa-Hunt Syndrome) ttRRftlft *£££ TourettePf W (Tourette's Disorder) liTouretteffi^Sf^ ££ Tourette*£1£8f (Tourette Syndrome) WM 197 Toxicodendron^ (Toxicodendron) WD 500 7n->£l*&£&££ tPA (Tissue-Type Plasminogen Activator) (£7^77° y—tf£££ TPCA (Angioplasty, Transluminal, Percutaneous Coronary) WG 300 TQM (Total Quality Management) HD 62.15 ±mizxMm^ft¥f'mmx'$&^rm£££ Turner-EH^ (Turner's Syndrome) QS 677 Ty;u-7° (T-Groups) (i^-|4fl|ii*y^-7°££i T*7r-y (Phages T) (iT7r-v>£££ TttM (T Antigens) U7 A /UXffiS*»*£l§£££ TfflHfc (T-Cells) (iT')>'>!££££ T»W&T4!Jl1I (T4 Antigens, T-Cell) (iCD4itJI£££ Tfflll&g£1* (Receptors, Antigen, T-Cell) QW 573 Tffll&JtMH^ (T-Cell Growth Factor) UA >9-vA *>2£££ Tmimmm=r^fo (T-Cell Growth Factor Receptors) Ii-* >y-n A * >2^f££££ T'<9T])-tyT-y (Bacteriophages T) liT 7 7 - v5 £££ Ty r-y (T-Phages) QW 161.5.C6 T ') >'!Ui7^3-X^li UDPyyua-x (UDP Glucose) Ii7') S^rn/^y/u 3-x£££ UDP*$ (UDP Sugars) Ii7 U v >H 9 /.$?$?£££ UmbraM (Umbra) (i+T7-£f£££ Vaquez*?! (Vaquez's Disease) (ilCIE£jfo.*iE£££ Vateri0^S|5 (Vater's Ampulla) WI 750 Verse*?! (Verse's Disease) (i£M>t#*£ ; tttm*£££ £ VerticilliumM (Verticillium) (i^1t£*:ttlS3S££i v-Ha-rasjftfg^- (v-Ha-ras Genes) lirasjtf£-f-?*£i VH'fem^iI^*ftyo7U yikUT- (Genes, Immunoglobulin VH Germ Line) li&Syc^*1.) >£ ££ VibrioM (Vibrio) QW 141 Vincent7 >*i- (Vincent's Angina) lii|£?E'f£fi*Ml*] &£££ Vincent^ &*E (Vincent's Infection) li^^Ett^il'tt'iri*! &£££ VIP (Vasoactive Intestinal Peptide) WK 170 ^7f- Yt IX QU 68 'tLX WK 520 Virales (Virales) li7^/UX£££ v-Ki-rasjftf£-f (v-Ki-ras Genes) (irasii:fE-f-$'££ Volhyniafft (Volhynia Fever) (££*#*£££ Volkmann 41U&5 (Volkmann's Contracture) lin>y<— M >h*Ef£3¥£££ von Gierke*?! (von Gierke's Disease) (isH?)§*?| 1 S$:£ £ von WillebrandH^f- (von Willebrand Factor) WH 310 von Willebrand*?! (von Willebrand's Disease) WH 312 VP16-213 (VP 16-213) IJx h #y K£££ VTR (Videotape Recording) ~izffit&i}9v rwrn^(NLM^H«Tli^^:#^- 18.2) mmmuiMmz VZ7A^X (Varicella-Zoster Virus) lit h^/l" jft.SE (Waldenstrom's Macroglobulinemia) WH 400 fammm QY 455 Warthin®* (Warthin Tumor) (lift ') >'*&%%£ Waterhouse-FriderichsenSEJl^Sf (Waterhouse- Friderichsen Syndrome) WC 245 Weaver~v7X (Weaver Mice) li^^*^f*$^^7X £££ Weber-Christian *?! (Weber-Christian Disease) (i|£iii5 mmm£fcTMm% £ £ £ WechslerfcJfigtfcS (Wechsler Scales) &.h<7)tzib >X"1£^14£££ WirsungW (Wirsung's Duct) (iP^^££ WittenbornfFfBKS (Wittenborn Scales) lifSttH^tfj mmRmzzx Wolff-Parkinson-Whitest* (Wolff-Parkinson- White Syndrome) WG 330 Wool sorters*?! (Woolsorters'Disease) (i/?t*JL*?!£*££ WR2721 (WR-2721) Ii7 i *Xf > £££ Xenopusfll (Xenopus) QL 668.E265 %HkWmt IX QY 60.A6 XLP*iii1j£I£ (X-Linked Lymphoproliferative Syndrome) Ii ') > ' (CAT Scan, X-Ray) (iX^CT££ £ X^CT (Tomography, X-Ray Computed) WN 206 nz^-g^tkffAzj&mzti&m&u, znWr-Bxumn X" X^CTXJf7 7- (Tomography, X-Ray Computed, Scanners) (iXij&n > t°x-yHlfJf}j|fM* tt^fij: X£M|IjJtf^£ (Cineradiography) WN 220 'll«H WG 141.5. R2 :f#£*££.<7)t£Blf(i, fwfelXliSti: XM (X-Ray Departments) (i*?1K»|^S|3P^££ X%&*"E 9'y y j — (Kymography, Radiographic) (ifl; tlifJEy*77-< -£££ X^^ftl&fJS (Photofluorography) WN 220 #^PfWW#tSf^llffl§^L^i#^li, -e^Pf^tc X*fc3t##jfc##f& (X-Ray Fluorescence Spectrometry) X m%±frltfttJf £ £ £ X|gn>h0^-yifl^|^xif^7- (Tomography Scanners, X-Ray Computed) WN 150 ic X^ttt^ (Radiography) WN 180-240 ^Wftffl WN 200 nmmtw&m wn 240 *££l£ffl WN 150 Wtmm SF 757.8 »*Ht|5lfil*i7)TW^»fWf'Jffl WN 445;#£<7>X|& mmvzftzhftx Xmmtft (Roentgenography) (iX^ft|££££ X S£¥H?) X y ij - > (Screens, Radiographic) it X &$ i^TO$f| WN 150 £ ££ Xm^fJUy 4 ;UA (Radiographic Film) liX|87 4>UA £££ X^ifftyXrA (X ray Information Systems) Ufo^ %&mmffittz%x Xifeftf* (X Chromosome) QH 600.5 X&tiitmmmmff (Fragile X Syndrome) QS 677 X»»f (X-Ray Diagnosis) (iXMI;£££ Xl^xy U->7^f^A->X7A (Screen-Film Systems, X-Ray) UXmt%®M£%X Xmfo. (Roentgenograms) (iX*&4fi;£££ X^ffei£± (Radiographic Magnification) WN 160 X^if^lft (X-Ray Intensifying Screens) WN 150 &%.Bmzfem2tL&m&i£, ±nsijti Xf&i%5£ik (Radiographic Image Enhancement) WN 160 mW)'&V>ii##f WA 686 ftffiitm QD 96. X2 mmwnwm qc 482.S6 ^ft!l^gWtcf£ffl;?;ft§J#^(i, ifijgijfc; XH^V 7-vitU (Panoramic Radiography) (i'V 77 X$Htf££££ X^a^^/fli^-II^I (Microscopy, Electron, X- Ray Microanalysis) li€i17°u-7X^^-t/f^££ XHv^A (X-Ray Film) WN 150 ^umiizfemzti&m&u, 3Mmz Xl7^^AX^ij->yXfA (X-Ray Film-Screen Systems) (iXij&if$*££££ X^7°7-y'7 7^ (Planigraphy, X-Ray) (iXiMJf !£ffi£££ X«gft#t (Roentgen Radiation) UAtyltMmZM.X XB.mm (X-Ray Therapy) WN 250.5.X7 Yersinia enterocolitica (Yersinia enterocolitica) QW 138.5.Y3 Yersinia pseudotuberculosis (Yersinia pseudotuberculosis) QW 138.5. Y3 Y&fef£ (Y Chromosome) QH 600.5 Z-DNA (Z-DNA) (iDNA£££ Zimmermann 'hffc (Zimmermann's Corpuscles) liJlil/h f5£££ Zollinger-Ellisonffifl^^ (Zollinger-Ellison Syndrome) WK 885 -bizmmn WI 505 526 T9l)t\>*s 7 f (Love) £11*31 £& J T'fX?1)— A (Ice Cream) 11J*l$£fc(i^l$WWi£fcL.-e WB 428 jSr^J! WA 715 7>fy-tf>f A (Isoenzymes) QU 135-141 T-fVh-70 (Isotopes) li[§]Rf^£££ TA V ^ h 'J ■/ y Mill (Isometric Exercise) U^-9 77 A X*££ TA'<>9 (Eye Banks) WW 23-24 Jtil WW 170 TA ^"/ Vifr&lkMtiW (Islet-Activating Protein) lift' n®mm£%x TAyy-l* (Ainhum) WE 835 T7 h YT (Outdoor Games) liu 9 'J ^—i a > ; Xd< -■y£££ 777/7 4 > (Auranofin) Q\" 247 *i& (Zinc) SMftffc^ QD 181.Z6 ^S^ QV 298 SiSlslfttt (Zinc Isotopes) iRfltft^ QD 181.Z6 Ha^& QV 298 TiJt^XS. (Mice, Red-Backed) li'^y * X ~ ^f4£ T-hf+f)^ (Macaca mulatta) QL 737.P93 mm SF 997.5.P7 HfciMfcfcLT QY 60.P7 T ij Y^f^MW.1t& (Isoimmunization, Rhesus) tiRhfs] fi&*5£££ 7^y-*fVUrH ij y — V7^f ^X (Polyomavirus macacae) QW 165.5. P2 7ii*T (Chenopodium) QV 766 IB&^i: IX QV 253 %m (Red Tide) (iifttt€lWB* ££ 7^7 7'Z-tffiUMkM (Academies and Institutes) AS (NLM3HISTIil£5£#^-23-24) Z<7>fa(7)WZBtf)iZft IXU^mftllz Ti}*Xi (Apodemus) U*XzM&M.X 7iiJ*y (Red Bugs) Ii7 7#A v£££ Til^ym (Akamushi Disease) (iiig &*?!£££ 7#n —xy;u^E3Vl4fflJll4'L.>l*ll]I& (Endocarditis, Subacute Bacterial) WG 285 3L%14&!ix ') 7-v h —TX (Lupus Erythematosus, Cutaneous, Subacute) (i&Jfi ') 7~v h -fX^Ii 7* WXil (Achilles Tendon) WE 880 Wi&S: (Cachexia) WB 146 i&m&mmizfti wd 100 Tmmtrmfemzi&T wk sso£££ WLij^ + S A Y&i&U (Malignant Carcinoid Syndrome) WI 435 S&teigJfiUEffi (Hypertension, Malignant) WG 340 ltt«Wl&^Hte* (Cell Transformation, Neoplastic) QZ 202 :S14*iEll£&p- (Neuroleptic Malignant Syndrome) WL 307 JSttjIi'l'ffl^lft (Granuloma, Lethal Midline) WV 300 ,fVl4l*)#:li (Granuloma, Malignant) (iHodgkin*?!££ I .'HJtt.ftlfo. (Anemia, Pernicious) WH 165 .#14 U >'<& (Lymphoma, Malignant) li'J>^!l££ £ fli^^^fl (Lymphogranuloma, Malignant) Ii Hodgkin*?! £ ££ 1IW?|- (Crackles) li«^£££ T7-fen777-f- (Accelography) it^^Yil^v*9 77^-£££ 7n-7A (Actinium) WN 420 mWt QC 796.A2 T9T-Y (Actinides) UT 9 *r 9 A YM^^X T9Jr~Y$M (Metals, Actinide) UT 9 i~ 9 A Y'kW, £££ T9 + 9 A Y (Actinoids) UT 9 (Actinomycin) QV 269 7 9 f- / 5 -fe X (Actinomyces) QW 125.5. A2 T 9 1- 9 ;-feX|4 (Actinomycetaceae) QW 125.5.A2 7 y f- / 5 -feXjjgi&fiE (Actinomyces Infections) (iJ&l§ M*S£££ 7^f/i-tXg (Actinomycetales) QW 125-125.5 7 y f- y HX| i§ife*£ (Actinomycetales Infections) WC 302 T9"r9v (Actinon) (i7K>£££ 7y f"<—yiS^iE^S (Activator Appliances) WU 426 T9 f-~£— 9 — liifcHwIESil (Orthodontic Appliances, Activator) UT9i-<-9mmS.^U£^X 7yf->lB^HfiK (Actin-Binding Proteins) Ii < y o 7^7/ >hHfifl£££ 7?* (Acne) WR 430 iyp (Nightmares) (i^£££ T9yy9-^Ay>A (Aclacinomycin A) UT 9 y )^\Z ->>£££ 7 y 7 fr t -> > (Aclarubicin) QV 269 7 y 'J y y (Acridines) %m mmmt LX QV 235 m&W&tLX QV 240 Ti9miLltmzt5i7& QU 65 *f«{t¥ QD 401 7 y ') 7 — h (Acrylates) It^ftWi TP 1180.A35 mtft-nm WE 190 ^JI^: QV 50 wzmzxmmz ti&m&uzn&mz 7y !J^7; K (Acrylamides) QU 62 W^Sib^ QD 305.A7 T 9 U ^HHb (Acrylic Resins) ffr^ftffi TP 1180.A35 m^z&ith wu 190 iaf QV 50 m*Bmzim$ti&m&u±mmz, mx.im&ft® 527 7^1/7^ f-WtlZtiifi, W 190 #-b> > h WE 190£&££ T^f^f-yj/1 (Accreditation) r;D->y (Acrosin) QU 136 T 9 uv — A7°07-f7 — -f (Acrosomal Proteinase) Ii 7?o->>£££ ryo^->> (Acronycine) UT9v — >£%X T 9 v — A. (Acronyms) mm W 13 ^nizmixu (NLM^n«T-ii^s:#^-i3) T9a-> (Acronine) QV 269 7 9 v^y<9 9 —M, (Achromobacter) (iAlcaligenesM£ ££ T9uvA ~y (Acrolein) Mmm QV 627 T^-fy (Aconitine) nmm qv 628 73-7 h (Aconite) £ft3* QV 628 *? (Birthmark) IiJfll^M ; ^r^ ; •fe^|4^Sl^££ 7fy7o7'n^'y (Azacyclopropanes) UTy^)y>£ ££ 7-+f-fe "J > (Azaserine) QU 60 Jfi*®3££ LT QV 252 l&itmffift QZ 267 ftScffllSiJ QW 920 77^*7° >J > (Azathioprine) QV 269 ffiitm^m QZ 267 &*£TOJ QW 920 7-f7°n/N°y> (Azapropazone) Ii7^'fy*>$'£i £$Kfc^ (Nitrous Oxide) QV 81 & (Foot) WE 880-886 n* (Taste) WI 210 TyTmA yy)V^y*f (Influenza, Asian) UAyy>V i>^f^££ T-yTlkT / Vi] A (Asian Americans) E 184.06 Wx. h \Z-;9XU, ±HWc 7x7 AS (Asiatic Race) (i^XD'o^ KAH£££ 7y7o7ij37"Dr^>(Asialoglycoproteins) QU 55 TyftM (Azides) QU 54 Mmtm mumt&m qd 305.N84 St" (Ankle) WE 880-883 aiTtSfll (Ankle Injuries) WE 880 T :s 9 u ?T 9 y y (Acycloguanosine) it 7 x y o t/U £ ££ 7 x y n tVU (Acyclovir) QV 268.5 7'>lf-^ (Acidosis) WD 222 WM.m SF 910.W38 7 y Y f- ~ x > (Azidothymidine) (i x K 7* -x > £ £ £ £<7)^ffiH£ (Foot Deformities) WE 883 7->7iyJfy'J7A (Aciphenochinolium) Ii x > 3 7 *>£££ T5;a/<>,f (Adjuvants, Immunologic) QW 800 &5Hg$l (Nitrites) QV 156 7 x 'J y y (Aziridines) ^wtm QD 401 BffifcHfcLT QZ 202 7 x ij > (Azirines) ^mtm QD 401 7>/^7>X7x7--tf (Acyltransferases) QU 141 X£*£ WD 105 7X77 'J x"7*£ (Ascaridiasis) WC 870 7Xr?^h*>^ (Ascorbic Acid) QU 210 7X3;uh'/'^2i (Ascorbic Acid Deficiency) WD 140 TX h- 'J x-t> (Astringents) QV 65 7X'hUpj-^-A (Aztreonam) QV350 7X^°7^ft—f (Asparaginase) QV 269 mmm qu 136 TX^y^'y (Asparagine) QU 60 TX'i7;/ h7>X7x7—tf (Aspartate Aminotransferase) QU 141 7X^,7^*>^7; y h7>X7i7--t*7-i' yx>-if^ A (Aspartate Aminotransferase Isoenzymes) Ii7x ^7^>WtTi y r-7>X7i7--t££i 7X^N°7df*>^7°0 7^7---t (Aspartic Proteinases) QU 136 7X/^f^7i-^77-^/f^xxf;p (Aspartylphenylalanine Methyl Ester) li7X'N°/U7 -A£££ 7X^f-A (Aspartame) WA 712 ^•y°i- Y QU 68 7X t^f ^ 7 U 7*£ (Aspiculariasis) (i£*j: 7 &£e£££ 7 X t U > (Aspirin) QV 95 TX t ij xltftj (Aspirin-Like Agents) li#X7 o A Y% ix%mm$:%x 7X^Xh (Asbestos) S.*yJl WA 450 mmmm^i wa 788 %mm QV 610 7X~cx r-)'£#*£ (Asbestosis) WF 654 7X^;udf';uxffi (Aspergillosis) WC 450 ElS^-ff SF 809.A86 rT (Sweat) WR 400 SiE^l^ (Vision, Subnormal) WW 140 7-t-fe U y (Azeserine) Ii7-f-fe 'J >£££ 7-fey/uyx (Acetarsone) (ir/^£££ 7-fef7U;7;u-f-x (Acetylcarnitine) QU 187 7-fe^^yj-b'J;Ui-7^d^Xd-siJ;U3 ij > (Acetyl Glyceryl Ether Phosphorylcholine) (iJflL^J^tSiS'l^'fbH i=-£££ 7-fef7U 3 ij > (Acetylcholine) QV 122 7-fe771-3 ij >xx-7 7—tf (Acetylcholinesterase) QU 136 T*iT)Va ij >xxt7—b'Pl^^iJ (Acetylcholinesterase Inhibitors) Ii 3 ij >xX7 7- -fe*HM£££ 7-fef-^n ij >Jg45t^ (Acetylcholine Antagonists) lis U>^«:^^££ 7-tf-;ur? ij >^f£ (Acetylcholine Receptors) lis 'J >££#£££ 7-fc^7U+r ij f-;Hg (Acetylsalicylic Acid) UTX\Z°\) y £££ T-tf-^^'i'7v't K (Acetylformaldehyde) (i tVu 77 'i 71 K £ £ £ 7-fe^;wA7 ;*-77-'^-'f V 9°)V9 \ y (Acetylmuramyl-Alanyl-Isoglutamine) QW 800 7-t-f- W > (Acetylene) Wttffc^ QD 305. H8 tfcfofc±*ft£1*9* QW 60 $ft¥ QV 633 7-fcr-r- (Acetates) QU 90 mum QD 305.A2 7-feh7-feT-h (Acetoacetates) QU 90 mitm QD 305.A2 7-feh7—'J K (Acetanilides) QV 95 7-fe h7^7't K (Acetaldehyde) QU 99 Trt'a-MtatfcfcltS QV 84 *f«Hfc¥ QD 305.A6 m*ht>yyx(i±gpijic, 15IRIfKjR«6U|«^4^tt fcfclt* WE 500 TJzY><9 9-W, (Acetobacter) QW 131 7-feh7x*f-x> (Acetophenetidin) Ii7it-tfyj ££ 7-t h x (Acetone) im^fc'Jt* QY 185 *fttft¥ QD 305.K2 7-fer-xynndwuA (Acetonchlorof orm) Ii y o a 7* y /-^££i 7-fe h >f£ (Acetone Bodies) (iyh>f£££i 7-fe7x> (Acephen) U9 9 uy jl 9 *7-\-£%X 7*/{£&fa (Azo Compounds) QV 235 Wttft¥ Uglttf8Efl:£4* QD 305.A9 jsmmt&m qd 341. A9 TV\-><9 9- (Azotobacter) QW 131 ilU^a (Play Therapy) (iJg)KS?8i££i 7/-^ (Azoles) Wttffc^ QD 401 797*) > (Atabrine) (i*7-y'J >£££ ®Sll9£kfr (Capitation Fee) ftf* WU 77 *?!Rfc WX 157 EH W 74 mm. WY 77 *f/-7 (Adamantinoma) lixf/^±Stt^ ££ 7fAX • X Y-9xm$m (Adams-Stokes Syndrome) WG 330 E*fe££t¥ (Crush Syndrome) WJ 342 EfttfltT (Stockings, Compression) Iil2w££i ES^S (Pressoreceptors) WL 102.9 T-y-tA (Assay) (i^M *7 -y -M £££ E&14rS* (Pressure Ulcer) lifl?*f 14rt*£££ E£*l (Pressure Sore) Ii«?*f14rft*§££i E7J (Pressure) fe^^fijffl WB 890 7\J± WD 710# ; Jfo. EE WG106^;liaE WL 102^;ISE WW103^£&££ E^^l^H (Transducers, Pressure) QT 26 77h-xX (Athetosis) WL 390 7r"-^Sfcxy 7 --tf (Adenylate Cyclase) l±7f—^x 9 7--te'£££ 7f-;^/?7--t' (Adenyl Cyclase) QU 139 7f ^yuto »)/Jfc (Adenylpyrophosphate) (iATP££ £ T-f—y (Adenine) im^toll I QU 58 fc'fllft^ QD 401 7 7'— > 7 7 t* y x Y (Adenine Arabinoside) Ii t* 9 7 tx£££ T7'—y 9 9 Wti- Y (Adenine Nucleotides) ffcft'r- QU 57 mmm qv iss Tt'9 A Y (Adenoids) WV 430 77V A KW& (Adenoidectomy) WV 430 Tt'9 7A^*W (Adenoviridae) QW 165.5.A3 TT9 7 A HsXtyW 7*7 S 7 - -tf £ £ i Tt'9 y y7A 9 'J -y y — 9 A,$£ (Adenosine Cyclic Monophosphate) licAMP £ £ £ 77V x>-*M y ij ■y92',3'-'0A,m (Adenosine Cyclic 2',3'-Monophosphate) licAMP£££ Tt'9 yy7A 9 'J >y y3',5'— •)/,& (Adenosine Cyclic 3',5'-Monophosphate) (icAMP£££ 7f/y>y*Xd; 'J d?— X (Adenosine Diphosphoribose) liADP U d*- X £ £ £ 77V yy^^Vf (Receptors, Adenosine) Ii7°i) xPl^ Wf*£££ 77V x X-77 ^ 7" —-t (Adenosine Deaminase) QU 136 7f/y>-U» (ADP) (iADP£££ 7fV x >- " A,Wt 'J d*- X (ADP Ribose) liADP 'J X -X£££ Tf9 y y to ij /v|& (Adenosine Pyrophosphate) Ii ADP£££ 77'y x x 9 L'Wl (Adenosine Phosphates) UTT—y 9 9v*tK£££ 7f/y>HHi (Adenosine Triphospate) QU 58 Hftttftittfcfclt* QU 120 H*^ QV 185 77'y-^ (Adenoma) QZ 365 7ryp-;u (Atenolol) QV 132 770-A (Atheroma) li77D-A'|4DjM5Mfb*E£££ Trv-MiMWMttM (Atherosclerosis) WG 550 770-Alf^^ (Diet, Atherogenic) WG 550 && (Afterbirth) {JIBES ; )I63££££ 7h-t- (Atopy) (Jffll#SM*££££ 7 r- t:-tt««Sfl£ (Atopic Hypersensitivity) liBPi^S^i Sfcffi£££ 7 h t0-'|4#£SI& (Conjunctivitis, Atopic) IJ7Wl^'- 'f4*£)ilS&£££ 7 h t-ffil*^ (Eczema, Atopic) UT r- tf-te&Jtifc* 529 T r b.±A ££ 7 h t-ttM&£J#& (Neurodermatitis, Atopic) Ii7 h t-14 &!*&£££ vht-ftJ£#& (Dermatitis, Atopic) WR 160 m%m SF 901 7l-7>ff (Atomizers) (ititfftgfc^ft??£££ 7h7y^'J>^ (Atractylic Acid) UT Yy9J-vyY *•££ 7h7y^-DvK (Atractyloside) QU 75 T h 7 y 'J 7 A (Atracurium) QV 140 7hyy'J 7A->'J7A£££ 7 h 7 X (Atlases) G (NLMfrmmxuifm&^n) ft^m QS 617 mmmtmny: w 617 *mm qs 517 %.mm qw 517 ^■mrnnrn wu 317 ni&tmm WU 600.7 (ftfl^Sil- WU 417 mmmt mmm qv 717 mmm. wu 507 rw^ WO 517 7 K 'J 7 -7 A x x (Adriamycin) Ii K Jf V ^ t x X £ £ £ 7 h 'J +-^7°f-x (Atriopeptins) li-L>M7 h 'J 7AfiJJ^El i^£££ 7Kwtl)> (Adrenaline) lix t* 7 0 > £££ 7 K U-f- 'J >7 3"-X h (Adrenergic Agonists) QV 129 7 K y 7 ') >7^7 r 7 3-x h (Adrenergic alpha- Agonists) QV 129 7 Kl^7-iJ yT^yy^mm (Adrenergic alpha- Antagonists) QV 132 7F>tl)>7^777'n7*- (alpha-Blockers, Adrenergic) UT Ku7'J >7;U7tJ£M£££ 7 K Wf 'J x}£l£$ij (Adrenergic Antagonists) QV 132 7 K y-T 'J y{m&7;U7 r^tmimm (Adrenergic alpha-Receptor Agonists) Ii7 K 1^7 !J >7/U7 r 7 3* -Xh£££ 7 K U7 'J yimi£T^yr%m*mmm (Adrenergic alpha Receptor Blockaders) UT Y uf U X7;i^7 T £ifi3ij£££ 7 K 1^7 f^ffl14^-y 5§^ffll (Adrenergic beta-Receptor Agonists) Ii7 Kl^7'J y-<—9T^— x^li 7 K Wt 'J y\m&-<-9%®ftmmm (Adrenergic beta-Receptor Blockaders) Ii7 K V-f ij y^-9^tK #J£££ ^l-'^iJ X^ffl^g (Adrenergic Agents) QV 129-132 7 KU7-'J y-gm* (Receptors, Adrenergic) WL 102.8 TY'y-r*) y^imT 3'^-X h (Adrenergic Receptor Agonists) (i 7 K y 7 ij x 7 zf- x h £ £ £ 7 K u7 'J >^-y 7 n-x h (Adrenergic beta- Agonists) QV 129 TYyi-') >~i-?ftmi (Adrenergic beta- Antagonists) QV 132 T Y y-r 'J y~z.-97u •/ ti— (beta-Blockers, Adrenergic) UTY' U 7 'J >*<- 9 mm £ £ £ 7 Y y 9 9 o A (Adrenochrome) QV 77.7 TYy9rs)v^-a hotx (Adrenocorticotropin) it ? )l f-3 r-nt>£££ 7 K y 9 -b7°y - (Adrenoceptors) Ii7 Y V-f- 'J >'2-ftf£ £££ 7 h d^°^7 K>7 (Atropa Belladonna) it^y Y'yf £££ 7 r- n t°x (Atropine) QV 134 7 r- n txffzgf£ (Atropine Derivatives) QV 134 77h^fx> (Anatoxins) lih^fy^K^££ T-r-'VU (Anavar) itt*7y Y o o x£££ 777^7^x- (Anaphylaxis) QW 900 77-7-f7Jfx-x a-y? (Shock, Anaphylactic) Ii7 77^ 7*x-£££ 777^ 7 h^xx (Anaphylatoxins) QU 68 ffifrr&ttffcKfcltS QW 680 7t7"7X"vS (Anaplasmosis) WC 600 IKE^) SF 967.A6 7t7'7X'vl (Anaplasma) QW 150 77-dT'J v 9 XtvA Y (Anabolic Steroids) WK 150 iXm QU 120 m ; tefcTy For>fU§|5iftxj vA Y%,miit9 9 > Knx-fy o> WJ 875£££ Ti-Jl>yy (Analgin) Uy\iu>$;%X Ti-v9*='y\i^-9 (Computers, Analog) QA 76.4 itmfrWizau&m&t lx Um (—fe) Q 26.55.C7 (NLM^IgTiiff^#^-26.5) ^fa-i-If TK 7885-7985 SIJj7'-y^H W 26.55.A9^ ; fiffgxX7A Z 699 ^£*>££ 7to/^iX7--^ (Analogue Pain Scale) im% )HI5e£££ T-iry (Anions) QV 280-285 7-*x*>.y7° (Anion Gap) imt&m¥ffi£%X T—v-)V (Anisoles) GWMtm QD 341. E7 mWim QV 632 7-^'-t-iJMfii (Anniversary Reaction) liil£#* £££ 7-U >it&V>J (Aniline Compounds) ^mitm QD 341.A8 ny»m qv 632 7/>f ij X (Aneurin) lif-7^>£££ T9 I- (Anomie) HM 291 7'*Vx (Apazone) QV 95 7txX (Avidin) QU 55 7t;u (Ducks) mW SF 767.P6 IbIW SF 504.7-505.63 mm M^tff^ SF 995.2 ?f£ SF 510.D8 7 7 4 — T J — y n-v h y 7 7 ^f - (Chromatography, Affinity) 4{C^ QU 25 77xU-xX (Apheresis) lilflL^fiSc^^i^£i 7 7 9 (Aphthae) li7 7yt4PI*]& : nJg*-'J7>**£ ££ 530 7;/7i 77 9tT (Aftercare) ?l!OJ>*fc£»l WS 366 m*m% WB 325 $zmm^A#?-ffii (Stapes Surgery) WV 230 %mitnfem W\' 265 |>^A#^[^ (Stapedectomy) (i#>^A-it-f-ffif££i ii (Oils) QV 785 Siltm QU 86 &*»£W#!£ WA 722 1frZ (Plant Lice) Ii7 'J -v**•££ 77 ij ii&.T * 'J # A (African Americans) fiMA££ £ 77 ij # b7'*X'~ (Acomys) li^X-H^Ii 77*) tl Y ') yV V—-7& (Trypanosomiasis, African) WC 705 Bt|S¥ SF 807 77*)tl79 iyy (African Swine Fever) SF 977.A4 77')*773W7'7'f^X (African Swine Fever Virus) QW 165.5.16 77 U i] i Y iJ -f ^ (African Green Monkey) (i 5 K U 7'^£££ 77 U ^7 ij W?@l (African Lymphoma) (iBurkitt1) >"< K£££ 77°nf-^> (Aprotinin) QU 143 7-7"> (Arvin) (i7>ynK£££ 7^<^t> (Avertin) U^-t^T^?-;u£ %X WX (Opium) 1£# WM 286 ^o^ v$M WM 288 ; t/i-h^ffiff WM 2865- fc ££ 7fl"#n>f K QV 90 7^>1ft#£E (Opiate Dependence) liI#M&#£££ 7-df7^UX (Arboviruses) QW 168.5.A7 7-X7A^XBU(Arbovirus, Group B)(i77t7^ ^X£££ 7 —d? 7 4 ;WX !!§&•!£ (Arbovirus Infections) WC 524-532 mi WC 524 ilfi-ttflialfc WC542£&££ 7*V ') yMl (Apocrine Glands) WR 400 7-t°-:t^7^x (Apomorphine) QV 73 7*n- h;u (Axolotl) (iAmbystoma£££ *>£Kil& (Linseed Oil) QV 785 7v;u#A£Jg: (Amalgam Filling) liitf4ffl7-w^*A £££ 7;tfn/ (Amiodarone) QV 150 7 ^ yy'J > (Amygdalin) QV 269 Ti99ayY (Amygdaloside) (i7$yyiJ>£££ 7 ~yy (Amidines) QU 61 iiWtit-7- QD 305.A8 Tl9yy (Amidazine) liif*t;K*Si Tl9-*£ (Amidases) Ii7 i KtKny—tf£££ 7U' (Amides) QU 62 Mmtm mimtt&fa QD 305.A7 JtmMt&yn QD 341. A7 75KF W/x- r- (Amidotrezoate) ityT Y 'J 77- h£££ 7; Kt K07—-tf (Amidohydrolases) QU 136 7 5 Y 7 x 7 7 > (Amidophenazon) (i 7 5 y t 'J x £ £ £ 7 5 K> (Amidone) li/yK>£££ T i 9T x^RNA h 7 > X 7 r - (Amino Acyl tRNA) UT i y7^x^tRNA$-££ 7 = /7->MRNA (RNA, Transfer, Amino Acyl) QU 58.7 7;/7^3-^ (Amino Alcohols) ^mtm QD 305.A4 mmm qv 82 7 5 9 $,|,#IS (Aminobenzoic Acids) QU 195 7;/f£,lfixf^ (Ethyl Aminobenzoate) li^xV iiA y*%X 7 s y xy 9—)V (Aminoethanols) Iixyy-;W75/ £££ 7^y^7°n>@g (Aminocaproic Acids) QU 60 7a y^7°o>^7yyA (Aminocaproic Lactam) Uti 7°nyy yA$-££ 7 ~ y y* ij 3 x K (Aminoglycosides) QU 75 7 = //i)3y K*#t£&H (Antibiotics, Aminoglycoside) QV 350 7 5/-f "Jf-n^ (Aminosalicylic Acids) QV 268 T $. 9 m (Amino Acids) QU 60 D-7 ^ /MX*yf--tf (D-Amino-Acid Oxidase) QU 140 7>y $3- =* x K U y y y --tf (Amino Acid Oxidoreductases) QU 140 7; /Itie^Dil^ (Amino Acid Sequence) QU 60 75/11 (Amino Sugars) QU 75 T S. 9 Y y >X7x 7—-t(Aminotransferases) QU 141 T $. 9 gcDtfafil^^K (Aminoglycoside Antibiotics) Ii T19 9*) n->K*St4!t*M*££ Ti/,^Ri (Aminohippuric Acids) QU 62 ^mtm QD 341. A7 7 = ytKo7—-tf (Aminohydrolases) QU 136 7 5 y t 'J y (Aminopyrine) QV 95 7 s 77 if/y (Aminophenazone) (i75yt1Jx£ ££ 7~/7xyn7*y> (Aminophenurobutane) li^UT" y5 H£££ 531 7;/7P r 5 9y°v<9 — )V (Aminopropanols) li7°o>"f/ — )VT 5 >£££ 7 5 / 7' □ t-t — h 'J )*y (Aminopropionitrile) umtm ^mmit^m QD 305.N7 Hi^l^MlztH-fi WD 500 7 5 /'Ox'/W^—x 'J > (Penicillin, Aminobenzyl) (i 7vutx'J >£££ 75/dwUA (Aminoform) (i/77-5x£££ 7 5 y B&$t (Aminobutyric Acids) QU 60 7 5/ B&$7 5y h 7 x X 7 i 7 —-bT (Aminobutyrate Aminotransferase) QU 141 7;*Xf y (Amifostine) mmmmmmtLx wn 650 7 5 7--tf (Amylases) QU 136 PM?) WI 802 7 5 vA Y& (Amyloidosis) WD 205.5.A6 7 5 xdA YPl&ft (Amyloid P Component) WH 400 7 5 d ij Y (Amiloride) QV 160 7 5 y (Amines) QU 61 %mtm mumt&m QD 305.A8 7f#^lb^^ QD 341.A8 7 5 >:t*xy--tf (JB^f) (Amine Oxidase (Copper-Containing)) QU 140 ffi (Rain) nfUm QC 924.5-926.2 •ftftY ¥-y yxli, ±fiJgiJ{C, fyUli'AtVfSife WA 754 7/YilAy (Amethocaine) (i7r-77-1'x£££ 7 9 Y7t 'J y (Amethopterin) it 9 Y r-l^-t:-r££ X 7 /->< (Amoeba) QX 55 79-' (Amoxapine) QV 77.5 7**xxijx (Amoxicillin) QV 354 T^-iv^-r- (Medicine, Ayurvedic) WZ 80.5. H6 m&'ttbtix^httiummiz wb 50 TyA7~? (Raccoon Dogs) (i&|*im£££ 77->75yh7>X7x7--tf (Alanine Aminotransferase) QU 141 7 7h7gf (Medicine, Arabic) WZ 80.5.A8 m&ftbtlX^Z WB50 mmrr- wz so.5.as m&irbtiX^Z QV4 77 tV y;i-7f-y (Arabinosyladenine) U\^7y\^y £££ 7 7 t y x/W x h x x (Arabinosylcytosine) (i x y 7 t >£££ 77b7 7^ytf F (Arabinonucleotides) QU 57 77 tv 77 y yivTT— y (Arabinofuranosyladenine) (i t* y 7 t* x <£• £ £ 77 tv 77 y yivy y y > (Arabinofuranosylcytosine) Iixy7t*x£££ 77tV77y x;uy y u^f- k (Arabinofuranosylnucleotides) li77tVyyu:tf K£££ Tyy Y A y (Allantoin) Tl9M?miz&UZ, QU 65 7 'J (Ants) QX 565 7U±.f4# (Formicoidea Venoms) Ii7ij#$£££ 7 'J 7*7"i§ (Arizona Bacteria) liSalmonella arizonae £££ 7 'J #tf£ (Ant Venoms) WD 430 T'JvJf (Aphids) QX 503 ffi^7 4^X*^.Sc7)^yy-(>: LT SB 736 ^MWiT 5 ^ (Amyl Nitrate) QV 156 iffii^X (Sulfur Dioxide) t&mtm qd i8i.si SW QV 618 7'J i-yt>S7^W (Aleutian Disease Virus) Ii 5 xy7'J ^-x^x*?!^VWd*7^;UX£££ 7'J-^X;u,77- r (Arylsulfonates) QU 98 ^mtm QD 341. S3 TiVii ij (Alkalies) HH^ QV 275 «^ QV 612 7^7iJjflL*£ (Alkalemia) (£7^7 n-->x££i 7^^7iJ±^#M (Metals, Alkaline Earth) %mtm QD 172. A42 mmm qv 275 i&H QV 275 7^7 ij*?! (Alkali Disease) liim*?!£££ TiyiJ ij -7X7 7 y—tf (Alkaline Phosphatase) QU 136 T)yt n 4 K (Alkaloids) te*JTi£A^LT WB 890 W$Hfc¥ QD 421.A1-421.7 mmm qv 628 7^7 o-vX (Alkalosis) WD 226 Tail's (Alkanes) w^mtm qw 52 ^mitrn QD 305.H6 7^7xX;u,7t--h (Alkanesulfonates) QU 98 %mtm QD 305.S3 T^*'t—t* (Arginase) QU 136 7;u3f^.X (Arginine) QU 60 7;i^3f-*^.x^->°y7Vx> (Arginine Vasopressin) UT ^ =?7Vxx£££ 7^=5f7Vxx (Argipressin) WK 520 mmmtLx qv 160 532 7^777 7'HfMfc (Alkylation) QD 281. A5 TH*>iit#\ (Alkylating Agents) QV 269 7;U*;UXA<*7-- h (Alkyl Sulfonates) liT/u7xx ,u;*7—h££i Til*y (Alkynes) mitm QD 305.H8 TtU^'yWU. (Alginates) ^itm QU 83 mmtm qk 898.A3 m)izi5^xfem$tiz>t$i& wu 190 M*&%ftitmmztii>®& wo 167 7>iry (Alkenes) WiQimtm QW 52 Mmtm QD 305.H7 7;W3''JX*A (Algorithms) 3 >ti-y (-fe) QA 76.9.A43 ft£#lfKfclt6 (NLM#MT"(i)f^#^-26.5) #5*h t-y 9 xizmmztiht%&U3Lm%*\\z T>va-)V (Alcohols) UT>^zi-;ym^^X T)Vo— ;uffc£l- (Alcoholic Beverages) fl|)«m^^li*^*?1^<7)ffi^^ LT WB 444 {tm%M TP 500-617 7;U3-^41# WM274 ; x^;ur;wn-;u QV84#£ &££ 7;U3— )VX*y Y'y79 9— -tf (Alcohol Oxidoreductases) QU 140 7;U3-;uBI!5fF (Fatty Liver, Alcoholic) WI 700 7/1 a— M'HW (Alcohol Consumption) IJ$;?g£££ 7)Vzi-)V&M$. (Hepatitis, Alcoholic) WI 700 7)Vn— )V&M^%. (Liver Cirrhosis, Alcoholic) WI 725 7/U3— ^ttfF^.t- (Liver Diseases, Alcoholic) WI 700 7;U3-;U'(4®^^ (Alcohol Amnestic Disorder) WM 274 Tilzt— ;M4'£>$&£E (Cardiomyopathy, Alcoholic) WG 280 Tllzj-iv^Wm (Psychoses, Alcoholic) WM 274 7)Vz\—)\y^% (Intoxication, Alcoholic) UT^zi— )V 8&8T£££ T)Va-)V$% (Alcoholism) WM 274 tkmi.nmttLxftm.-th 7^3-;ufl||5fF WI 700 ; 7^^-;H4fF^ WI 700 ; T)Vzi-)VWmM WI 725 ; T)\szi->lffiftm WM 274 ; %KT>Vzi-)V^m^ WM 274l££££ Tih-)Vt"c h'nrt-tf (Alcohol Dehydrogenase) QU 140 7/Hj—;wggBT (Alcoholic Intoxication) QV 84 %mm&tM&t&m& wa 275 £H¥l;<6 W 780 T>n-J*s%im (Alcohol Abuse) UT>va-)V^%^^ X T)va->vmW±k,^ (Alcohol Withdrawal Delirium) WM 274 7JUa-;\sm (Alcohols) QV 82-84 mwrnitfrVv QD 305.A4 Jimmt&W) QD 341. A4 7)\ (Argon) Wfaitm QD 181. A6 mmm qv 310 7)vyi]ivy' (Aldicarb) 9k% SB 952.C3 5>*m* WA 240 7/UX7x75> (Arsphenamine) QV 262 7^xnf7l/v (Arthroderma) li^P!i#]3i£££ 7/U-tf xf- > ttjJflL*ft (Hemorrhagic Fever, Argentinian) (i7/'J tftfiJliUtt* JE.J: 7^ ft K (Aldehydes) QU 99 T)Vz2-)\y^M\zHUh QV 84 HHW&ftfi-^ QD 305.A6 ttmitfr® QD 341.A6 mx ii'*fl»&ms*ca u z> m£#J t l x qs 525- 530 T>Vt*t Kf t Knrf--tf (Aldehyde Dehydrogenase) QU 140 7;uf'h Kwyyy—tf(Aldehyde Reductase) QU 140 7^77°7--t (Alteplase) QU 142 T>Vry9—)V (Arterenol) (i/n^x t* 7 U x£££ 7^FXfa> (Aldosterone) WK 755 'K.ZM WK 760 wzmnwtmt LTii^wpf*^ T^YXr^yiaiKm (Aldosterone Antagonists) WK 755 T)V Y X 7 n X*£ (Aldosteronism) lii^7^ K X X f n > *££££ Ttv Y — XV79 y--tr" (Aldose Reductase) (J7^f t H^yyy—tf£££ 7^K7—tf (Aldolase) Ii7^y F-X1H^7^F 7—1£££ 7^ h*7— -tf (Fructosediphosphate Aldolase) QU 139 T)V>VtlJy^fr (Receptors, Adrenergic, alpha) WL 102.8 7/1^7 7 7 Kwf'J >^f£ff-fflH! (alpha Adrenergic Receptor Agonists) Ii7 K ^7 U >7^7t7^-X h £££ 7^7r7FVfiJ yg^feMffim (alpha-Adrenergic Receptor Blockaders) UT Y yf "J >7^7r JS#l#J£ ££ 7/U7 r 7 5 y r- ^x v (alpha-Aminotoluene) U^vy t7 Ki^t-'J >-g^f*£££ 7^7tI (Alpha Rays) Ii7^7 rfef £££ 7;i/7 7 F ij Dfyf > (alpha-Trichosanthin) (i r- ') ^ 7>7>£££ 7)vy y '^Afty 7 5 x (alpha-Hypophamine) li^t^x rxx£££ T>yy r y 3. Y o7°o TV x (alpha Fetoproteins) 533 7^77^ WQ 210.5 7'1-7t^''!IJ/' (alpha-Heparin) li^'*') x £££ T 'i 77 / -f-zu K — /N° (Alphamethyldopa) (i/^-/l/K — '<£££ 7^7 7 &*5l: 7 ° 7*'J x (alpha Immunoglobulins) Ii7 /i/7rill&*$yo7ij x£££ 7 l 7 T ') X'A (Alpha Rhythm) WL 150 7/1/7 7 'J X'ASgjjfclrlii'S (Electroencephalography, Alpha Rhythm) UT>vy y \) X'A £££ 7^7rM (Alpha Particles) WN 110 te'^S''^ (-US) iZHiyh QC 793.5.A22-793.5. A229 t#£ h t-y y Xlii^iJtC, lriJxli'^tl4[5]fiff^li WN 420 7/1/77 1 fit F- 'JTxX (alpha 1-Antitrypsin) WH 400 mmmmtLx qu 143 7/1/7 r 1 fit h ') 7°x x h 'J 7°x XPIW^K (Trypsin Inhibitor, alpha 1-Antitrypsin) Ii7^7 7 1 fit h 'J 7° xx£££ 7/1-77 1 SCtt-fen A n >f K (alpha 1-Acid Seromucoid) litoyAn^f K£££ 7/1/7 7 lgJtt*S®&H (alpha 1-Acid Glycoprotein) Ii *nVA3>f K£££ 7/1/7 7 17°D7 7--b'PlW^J (alpha 1-Protease Inhibitor) (£7/1/7 y 1 fit h 'J 7°x X £££ 7/1/7*5 x (Albumins) QU 55 Jfiu#(ijfinff7/U7 5 X WH400#£££ 7/l/7'5>)^*£ (Albuminuria) WJ 343 7/l/7Vyn-;i^ (Alprenolol) QV 132 7/1/7 nxy x/l/ (Alprostadil) QU 90 7't--K7-f/l/X (Arboviruses) QW 168.5.A7 7/^7'7/f /l/X^ife*E (Arbovirus Infections) WC 524 -532 &lr2 WC 524 iftffttlB& WC 542 7/l/-vxn (Armadillos) QL 737.E23 3U*IM*fc LT QY 60.M2 T/l/5f7k^l^ (Hydrated Alumina) Ii7kltft:7/l/ 5 - 7A£££ 7 /l/ 5 — 7 A (Aluminum) fefifcft^ QD 181. A4 mmm qv 65 7/l/5-7Afi£ (Aluminosis) (iffi!r|iS£££ 7/I//-7^Axy- (Hamsters, Armenian) Ii Cricetulus® £ £ £ 71/7F (Aleuts) (ixx*^-£££ 7i/7 (Areca) Hffltfi&fc LT QV 766 m»m QK 495.P17 ft*g SB 317. P3 7y*yy (Alexin) liffif££££ 7Uf-*X» (Gerbils) Ii7 Uf-^X 5 S£f£££ 7Uf *X'5 3if4 (Gerbillinae) QL 737.R666 £I*IM*J: LT QY 60.R6 ^y h fc LT SF 459.G4 7l/77/f/bXf;f (Arenaviridae) QW 168.5.A8 7u77/f^xf4^**£ (Arenaviridae Infections) WC 501 7U/1/*-- (Allergy) (£«££££ 7u/l/3f-(#H) (Allergy (Specialty)) (i7 U/b^'-t &«*££ 7U/l/Jf-14ifc.if & (Allergic Angiitis) (iChurg- Strauss*£1l£g££££ 7Wl^HiiBHSifc (Conjunctivitis, Allergic) WW 212 TV)\,%—|4*£& (Allergic Diseases) (£$«£££ 7Wl/^'-14l*l3Flit14lfo.l:'& (Allergic Granulomatous Angiitis) (iChurg-Strauss*m1^^^££ 7W^-ttffl#:!EttlKS"ifc (Angiitis, Allergic Granulomatous) (iChurg-Strauss-fiEfi££¥ 5" £ £ 7^^-'I4CTM& (Encephalomyelitis, Allergic) WL 351 7Wl/Jf*-14&JtJftLii:& (Vasculitis, Allergic Cutaneous) WG 515 fo^'Mkmzi]* WR 160 7Wl/df-'|4£J*J!lRig:£ (Angiitis, Allergic Cutaneous) IJ7 v)),*?— |4£Ji]fi]/f &£££ 71^/1/^*— fcft*£^ (Allergy and Immunology) QW 501-949 %m SF 757.2 {S^iOlilJj^iJlcQLXIiSFlc Ttmm^^mi %& WZ 112.5.15 m\cr> WZ 100 A£ • mmm qw 522 ¥*fS:^^/^^ UH 450-455 mmmmm qw 504^ mmmm^mm wo680£££ ■ftx.m.% t ffl&t h m&U * )|!gm*?1 (Alloxan Diabetes) li^WJff J/R*?;* ££ 7oyo—;u (Aroclors) JzJaft&tylWt LT WA 754^ 7kWr§}SSt LT WA 689 Gtikitm QD 341. H9 mmm (-*w qv 633 7 o x 7 ij -y y fW£|l (Allosteric Regulation) QU 34 WkY\i:7-PCR (Anchored PCR) (iPCR}££££ 7 x^rXy-yy 9 Yt — -tf (Angiotensinogenase) fil/ — >£££ 7>;)r^7>y7-7"y (Angiotensinogen) QU 68 7 x Jf*^ f x x x (Angiotensin) (i 7 x ^'^ f x x x 2 * ££ 534 'f*7*X 7 > * 7 7 x x Xfl^ >&/$■£ (Angiotensin-Forming Enzyme) liW — x£££ 7>^f'tf yy X^-f^fi (Angiotensin Binding Sites) li7X-r-t7XxX-g^£££ 7y3ftf X x X-§§f£ (Receptors, Angiotensin) QU 68 7 X df** 7 X x X $&g?£Pl¥$J (Angiotensin- Converting Enzyme Inhibitors) fititiJfiUBi^LT QV 150 70747—tPJT#$iJi LT QU 136 7X^77X->x5Ji (Angiotensins) QU 68 7X^7X>/X2 (Angiotensin II) QU 68 7y^7t (Anguilluliasis) l£^^4.i£$-££ 7 > 9 n K (Ancrod) fit«Hl^t LT QV 193 $L\tm QU 136 7X7- Y& (Questionnaires) (£KIU]iKyc£££ S£tk (Suggestion) WM 415 77 7X* 'J X7 WM 551? i «tt*& WB 880-885 ; \% V££lc (Dark Adaptation) WW 109 mtfa (Denture Bases) WU 500 R±»l& (Suprasellar Cyst) (£s!MP09l!f £££ rxX (Apricot) lim^^££ £#i$ftl&i (Metabolism, Basal) (i«ftltt£££ Z^m (Occupational Safety) (£«m*£££ ££14 (Safety) WA 250-288 $£gg (Safety Devices) (if*Hgg£££ ^Z'kttM (Security Measures) m?A WX 185 glStf Z 679.6 ££IBft (Safety Glasses) (£f£H^M;i£££ £.!.# (Benzoin) QV 241 %MM\W&. (Benzoates) QU 98 %®1tm QD 341. A2 7>7-bxx^'J 77pj-Jf->iJd x^s mum) £££ 7yf-byxfl (jafs^) (Antisense Elements (Genetics)) QU 57 7x7-feXXDNA (DNA Antisense) QU 58.5 7xf-tXXRNA (RNA, Antisense) QU 58.7 7yfv^fyyA (Antimycin A) QV 252 Txf-^EX (Antimony) QV 295 S^Hi1 (Stable Factor) (i^7H^-£££ %&tM (Stabilizing Agents) (ifKJP3iJ£££ 'Zx.m.mW.m (Diabetes Mellitus, Stable) it A XX ij X mmmmmmzzx TyY:yT-y (Anthocyanins) QU 75 T X h 7 * 9 X (Anthraquinones) QV 240 %mtm QD 393 7 X h 7+M y 'J X^fit^K (Antibiotics, Anthracycline) QV 269 7 X h 7 -fe * xTf x (Anthracenediones) (£7 X Y y* 9 >£££ 7 X h y -fe X (Anthracenes) *c»HtLT QZ 202 YMt LT QV 75 7X h y-;um (Anthranilic Acids) QU 98 7 X h 7 i) X (Anthralin) mmm qv 60 T'y Yy •'/ -fe >Sei (Andresen Appliance) Ii7 y 7-<- ^"^^i].^;K^££ T>Kd7"X (Androgens) WJ 875 7 X K P 7 X MfUf^N (Androgen Analogs) li£-J&7 X K n 7"x£££ 7X Knrxttfit^ (Androgen Antagonists) WJ 875 7 X Y o X 7 X x 7 x (Androstenedione) WJ 875 7Xt7v (Amphiuma) lifr)£*I££i 7Xtx'JX (Ampicillin) QV 354 TX tx ') X t°'J<7)%ft$:ii%X ^7vS*£ (Achylia Gastrica) life@£*££££ ^Hj (Runaway Reaction) W^ WS 463 'Wfi WS 350.8.R9 'fx/U (Houseflies) QX 505 B& (Gastritis) WI 310 &M (Sulfur) $**${[:¥ QD 181. SI mmm qv 265 te* WB 442 UtMftm (Thiobacillus) QW 135 535 (Thiobacteriaceae) Iiy7 A|^14*t«l* *«£££ ftfc«[slftf* (Sulfur Isotopes) %$. WZ 225 -e-Offel£, ±«JgiJ|c [S^ffcW (Education, Medical) W 18 H^ffcf^Stf^i (Medical Education, Undergraduate) (£^«*g[S^ffcW * £ £ E§¥tm?fcW (Education, Medical, Continuing) W 20 tnwmm wm 19.5 Umm% (Medical Research) I£flf3££££ mm^m^ (Reference Books, Medical) #!£ ZWB 100 &KY t-yyxi;|l|1-£*rL(i±fiJ3iJ(i, mtimmm ##Mi QU 13 \5Lm%. (History of Medicine) WZ &&M WZ 70 ^F^maiiWLT WZ 80-80.5 *£!r2 WZ 40 xxdOUiL6L WZ 334£££ NLMftmnnB3.$!$ll £ £ £ [S^^jJtL (Dictionaries, Medical) W 13 Um&Wi (Medical Publishing) liUiJ&3l£££ mm±.^^ (Medical Curiosities) li^ ; K'^££i [S^UIS (Bibliography of Medicine) ^9 7yy JkV&k&Mzti?>m& zw i St^fiHf*^ zw 1 w^i.mizmLxu, indite, zt#;££nlm# ^-t Wim'MmMWfril (Premedical Education) UmmW&m m.?m^z%x g^ y x dT/l/ (Medical Symbols) (£ L 6 L £ £ £ *Mm^mm (Psychology, Medical) WB 104 #?*h t-yyxii, ±mmz mm& (Students, Medical) W 18 mwmmz&rtzm^Bh^n&'g wm 30 Zcr>m<7lW%kY \i-y9XU, iH^td 1 &?g (Stomach Dilatation) WI 300 mUm SF 851 mmmft (Medical Writing) !£»< .!££££ mmt&mm (Medical Geography) itf\m \ &m \ 7c*l; M&tzmmn%fo£%x [SWiiftiE (Medical Evidence) I£}£[1^£££ mmfo$S& (Medical Emergencies) (£&,%*£.$. ; ftftg *££££ g^fti £b? (Proverbs, Medical) it&n t Z tbZi ££ IS^WJ6« (Medical Care) lifS«|S*-»r-t*X$-££ [S^Mtf (Libraries, Medical) Z 675.M4 H^¥ft^ (Chronologies, Medicine) liH^OT^ft 12 WZ 30;¥ft¥£££ [l^tf^lt (Medical Museums) (£lf!t*fil^££ [S¥M^t£*I$W (Education, Premedical) W 18 UmfftA yXYy — y a x (Medical Illustration) WZ 348 (NLM^^^TI£^^#^- 17) fl^r WO 517 mmmmrn NC 760-783.8 ; Iftfc It SEf WZ 330 ;¥* TR 708#£^££ g^/flfg^ (Medical Terminology) liifr£j££££ mmimmm (Medical Ethics) (ig<7)fi|Jl£££ mmmm (Medical Logic) l£M^£££ ^frZtfem (Charlatanry) l£f&*jj?a;£££ [SfWl^ff (Specialties, Medical) W 90 ft^WntTZfinZfoZ &££ mm (casts) um^^r^-.mmmmm^mi^x mm±m (Schools, Medical) W 19 WM9\m\}WC% (Education, Medical, Graduate) W 20 mnmm wm 19.5 mm®.m& (Corrosion Casting) QS 525 UWSm (Medical Philosophy) li[SW£££ &*) (Anger) BF 575.A5 W¥$ WS 462 zvjmtwjm WS 105.5.E5 536 A yzL-y i gfJ|-w-x7'X HSJH£#J (Residency, Medical) itA >9 — ytyyry Ymmzftx ^!&&14?i± (Immunocompromised Host) QW 504 ft (Breathing) (£!«£££ KTft'E (Subliminal Perception) (±#1ilT*ljafc*' £ £ affiTWlIk (Subliminal Stimulation) BF 323.S8 ffttt#*jffcfc«t4 WM 460 <®% WL 705 ll&JF BF 1156.S8 »ttTWfl:|^ (Subliminal Projection) l£MT*lJi§fc££ £ m% (Medical Profession) (£[S^-*-££ fliHtSS (Gastroscopy) WI 300 ffi£ (Child Rearing) WS 105.5.C3 4a^W--xii^s*n WS 113£££ fiBfc (Food, Infant) (i?l!£fe£££ ^S (Breeding) mV» SF 105-109 **|JM**> QY 54 ttftW SB 123-123.5 gSJifE^fitfc (Antibodies, Heterogenetic) litf HHtii tt££i gJP&jfef} (Heterophyidae) QX 353 fUP&ifcJS (Heterophyes) li^JP&&f4£££ HSife'bSE (Angina Pectoris, Variant) WG 298 IIPl£##E*JElS5£ (Dysplastic Nevus Syndrome) WR 500 mmm qz 310 H5$£f£ (Heterozygote) QH 447 *&tttil&14 WO 680 *S#HHWfc{ll (Heterozygote Detection) ¥fK%M (Physician's Practice Patterns) W 87 Hffi*)&ffl (Physician's Role) W 62 mmT^i&i& (Physician Shortage Area) JiflSESBlMft £££ mmm (Feldshers) {£(SMDjm£££ m^&ffl (Legislation, Medical) W 32-44 EfrMflM (Physician Assistants) W 21.5 m% (Doctors) li|£&i|i£££ m%-fc%ffli& (Doctor-Patient Relations) liEfrP-.t ^A^Plf^££ mt&U (Transplantation, Heterologous) WO 660 mmmW-^^imm (Xenograft Bioprosthesis) UQEMmU £££ H«#fit Yy-yyy7 (Xenograft Dressings) li£&*f£|- izXh&W&Z&X mM.fcW.ft (Heterograft) UmmUZtLX mUfcUft^i^mm. (Heterograft Bioprosthesis) li£1* *§&!£££ mm.Wft'iLft (Heterograft Dressings) Ii3£#rfffi-tc£ h&Wfc*&X &&% (Migrants) liMW^ft^t*$£#£££ B+ "*§««* (Gastroduodenal Ulcer) (iMfL14fi*S£ ££ I +Zl*ill6«*aiJfll (Hemorrhage, Peptic Ulcer) itmit '|4?t*aiJfil^££ B+—*fll&tm§£?L (Peptic Ulcer Perforation) WI 350 Hlfg*lE (Atrophy) mmft& (Caduceus) (£L6L£££ fclti&t&AB: (Emigration and Immigration) JV 6008-6348 #&£ JV 6061-6149 537 /fxJ-37 ..ii! JV 6008-6049 IUK JV 6201-6348 ^X7y^*7- W 76 Ml»££ Vflffi*ft (Stomach Neoplasms) WI 320 l*ffi*fc'7: (Oncology, Medical) (iH*§^£££ ti% (Dress) li&H ; Kf£llli£££ K-# (Anomalies) li^-^$*££ %% K^f4c(Dyspituitarism)(iTMf^^7LJl*£ : TUft mfilEt£F^^££ Hft"SHf (Tobacco Use Disorder) WM 290 HftWtt (Heterotropia) lii^Jl$-££ H^BfP&BilKSE (Hypersomnia with Periodic Respiration) (iBi^BWf MiH^S: £ £ fl?£*Jfo.ifc (Erythtrocytes, Abnormal) WH 150 ^l&S&ME (Paraproteinemias) WH 400 7;nO'iWD 205.5.A6 ; ^5l'l4#Mit WH 540 £*,££ Hfim#t (Reflex, Abnormal) WL 340 Hi^BDp^*'xi)^«4 (Generic Equivalency) (itef§?yJj3M| liBit4£££ HJ-.SB**tt^«JJlffi (Vagotomy, Proximal Gastric) WL 330 g#/^7nt*X (Hemoglobins, Abnormal) WH 190 g$/^yot*X*£ (Hemoglobinopathies) WH 190 !$«*g (Gastric Varices) Ii t it t R i**S £ £ £ £Wl (Transplantation) WO 660-690 \mm, fiaw. tmm^w. wo 690 «£# WO 32) SI* WO 610 ffttfcffifr WO 610 W£<9>%r-&UZ££ ^fil^-sW^S (Implant, Cochlear) l£APfiIf£££ H&*£ (Pica) WM 175 &mm& (Organ Transplants) (illIS?#fit££i Hfcitffiijfc (Gastroesophageal Reflux) WI 250 &Wfttem (Graft Rejection) WO 680 &Wfrm:MVim (Graft vs Host Disease) WD 300 f&tfi&flrffi WO 680 $ttK-*t?B±5tS (Graft vs Host Reaction) WO 680 &Wmm%t'<£ (Implant Radiotherapy) (iiEffiUMte «&£££ $ffift*£^ (Transplantation Immunology) WO 680 &WMMffi.#>7° (Perfusion Pumps, Implantable) (£# tfiffli±A*°X7°£££ $mmt&W]tf>y (Peristaltic Pumps, Implantable) (£ $tIffl£A*°X7°£££ f£fitfl4<£A--Kx7° (Infusion Pumps, Implantable) WB 354 #tfifflDDS(Drug Delivery Systems, Implantable) (£# fitffliiAdmi%U (Ectopic Hormone Syndromes) im?ffifrK* >m&W.1&ffim*££ K-ffllH (Heteroptera) liT-8!S(£ MJ: IM^fll^T^' (Physician Assignment Acceptance) li£ a£*hh$£££ l^ii^fEV-'l-: (Students, Premedical) W 18 Utttt (Aneuploidy) QH 461 /f X7A?fc (Islam) BP 1-253 Jt!fi»JIIS HQ 766.37 •L»Jl¥ft#l? BP 175 »h t>yyxl£, ±fiJSiJ|c: A XyA$(.<9>mm (Islamic Physicians) (i[S&ip*-££ Uttft (Heterosexuality) I£t4fr&£££ JH4ffc#* (Isomerases) QU 137 Hffiff (Isomerism) QD 471 US (Bezoars) (£^7*7-/u£££ StJJf^ (Gastrectomy) WI 380 ?L!£ffit#>!£W WS 310 B$J&1&8£lJefflM Postgastrectomy Syndromes) WI 380 A / 7X^N°7drX^(Isoaspartic Acid) UTX^y ^'y^ £££ fiffl^UfSffffc^S (Microscopy, Phase-Contrast) QH 212.P5 &ftnmzmm2tih%&i*±&fti£, mumwmb &Mlzt3ttZ>m&l£ QY 185 A y x 7 x K 'J x (Isoephedrine) Ii x 7 x K ') X £ £ £ /f y ^r / 'J X (Isoquinolines) fiti^JflLE^ QV 1501 LT WiftTiiiivA YizHiih QV 90 W«ft¥ QD 401 A y =3f* y 7 7 y # (Sea Anemone Venoms) (*JgJI&iJlft9 £££ A9yTy\YM (Isocyanides) li->7>ftft^lJ: Avy7 y\W& (Isocyanates) I£x77-h£££ /f7 7-A (Isozymes) Ii7>f V7M A£££ /fyhX7/^X (Isotretinoin) QU 167 /f V -7 -xK (Isoniazid) QV 268 /f y^nf y|h K 7 -x" K (Isonicotinic Acid Hydrazide) l£ A 7 - 7 x K * £ £ /f y— /^7/fx (Isonipecain) Ii/ ^ 'J x*x£££ /fy 7tX7r; K (Isofosfamide) IH*X7r; K £ ££ -1" 7 7/1/7 X (Isoflurane) QV 81 /fy7/l/07x-h (Isoflurophate) QV 124 A Vy'y-f-*) X (Isoprenaline) (i>f V 7°n7 W/ -/l/££ X A 9y°y 9 A Y fcX y x — r- (Isoprenoid Phosphates) Ii *°>J/f 77V-/u^S££££ /f y7°Xy /f K*X7x-hi (Isoprenoid Phosphate Sugars) Ii fc 'J A V 7 x -)V ') X^^*^ * £ £ A V7°0 7 X/-/1/ (Isoproterenol) WK 725 -f vyw-tS—jv (Isopropanol) Ii7°n MivTlVO-fri ££ /f V7°o t/U7/l/^—/!/ (Isopropyl Alcohol) Ii7°n t'/U 7/U3-/u££££ /f 77°d t/l/7/1/7 X/ —/l/ (Isopropylarterenol) li'f V 7°n7 xy — /u£££ /fy^*+rx (Isohexanes) (£-\3"7x£££ ^/*X7r; K (Isophosphamide) li-f*X7r: K* ££ /f 7 / 7—tf (Isomerases) QU 137 -f 7 d A x/i/, o-f x/i/p A yjw- 538 Ay->yv (Isoleucyl. Leucyl \rasopressin) lid"^ x h x x ££ £ /f y o /f -> x (Isoleucine) QU 60 #c# (fi¥) (Dependency (Psychology)) BF 575.D34 tfcfrfrf)] (Behavior, Addictive) WM 176 $c#t4Af&P*'# (Dependent Personality Disorder) WM 190 ffiA (Pain) WL 704 mmm wb 176 im&u$iiimz Btffi WI 147£&££ ffiA£§& (Pain Receptors) (iffW£§§*£££ fiS^Wtlf^ (Location Directories and Signs) mmmmzmfh wx ho #H#!f (NLM^S&feTli^l^ 27-29) JFfBfc&aJH WX 200-225 £*w«!ft[::*il-r4£*«£Hj#f& WA 799 ftlffilfc (Position, Sense of) (££^s1&*;££ gK (Yaws) WC 425 -^tfLfflfrfil (Persistent Ostium Primum) Ji-DrtlSElcX 91££i -*«*» (Striate Cortex) liM&H£££ —#f- K (Primary Prevention) WA 108-245 IIsj1D] (Gastrointestinal Motility) WI 102 BSfifc (Gastroenteritis) WI 140 BH^ (Gastrointestinal System) WI 'Jim. WS 310-312 -izimt&mufimm qv 66 £££ ^/l/^EX^mfb^d-x/w^X WK 170 £££ mmmf\ (Feigned Diseases) li{K*?|££i PE (Gastric Fundus) WI 300 flf£l&& (Gastric Hypothermia) WI 380 ¥ffflm<7)femizfem$ti&m&uz>3x££ £ j&U-T-mfo-^-i}- (Markers, Genetic) liitlS^-* -£££ 'MUT-m (Genotype) QH 447 &&&&£. WO 680 JtfSi^Sttft(Gene Activation) l£JtfEi=-%l£figii^££ itfc^alff (Gene Bank) ir&itt 7 A 7 7 *) - £ % £ itl£-?-*&* (Recombination, Genetic) QH 443-450.6 SfE-T-y o-^y/ (Cloning, Molecular) QH 442.2 jtlS-^X^ (Genetic Engineering) QH 442-442.6 itmXM TP 248.6 m*Y\i'y9xu±mfrttz JtfS^-M^iJ (Gene Rearrangement) QW 541 fittt QW 575 539 A y-sy*t AiK i^.'l.Vn (Gene Products) Ii^r3®£££ itd;/"-£& (Genetic Intervention) Ui&.iH-JLm£%X ftfi f-Uil-ti (Gene Clusters) UKWAU'f-^^X itfii-ftft (Gene Duplication) (i£f£dF-7 4 7*7 ') -* ££ Afc^*! (Gene Amplification) QH 450.3 Atef^SS (Gene Proteins) li§S§C£££ Aiif-ttW (Gene Mapping) (£ifefef£ifcg]£££ ikiiHhm (Gene Therapy) QZ 50 Aiif-Xmm^m QH 442 #£*£.& K o v> T (£* W£& K JtfST # A-v 7 X (Transgenic Mice) l£ r 7 X X -x x - ■y y-v7X^££ iIfE^-%3! (Gene Expression) QH 450 'AU^W^Mffi (Gene Expression Regulation) QH 450 ifefAxF-r-/!/ (Gene Pool) QH 455 SfSi^yy- (Vectors, Genetic) U^<9 9$:%X itfg^-^-7- (Genetic Markers) QZ 50 itfEi"-^ (Gene Fusion) lt^.Usf-9 n-^xy£££ itfg^-^le (Genetic Induction) (£JtfSi'-?e*J!Pgii£££ j&fSlt$Sfc¥ (Transcription, Genetic) QH 450.2 itfs^-7 /f 7 7 ij - (Gene Library) QH 442.4 'AUTiHWlMBv (Gene Action Regulation) teatfS^JJ! iEiin£££ itfSl4«DJ®^:14-^-D^°x- 1 S (Hereditary Type I Motor and Sensory Neuropathy) (i Charcot-Marie*?! £ £ £ itf£l4HB*£.£. (Eye Diseases, Hereditary) WW 140 &f£l4^K*Jfo.Sfcffi (Spherocytosis, Hereditary) WH 170 JSfSitifj t ij /U t X jfo.SE (Hyperbilirubinemia, Hereditary) WD 205.5.H9 JtfS'l4#M^1l:*£ (Hereditary Spinal Sclerosis) Ii Friedreich»ilj£i^ £ £ £ itfgtt&.'B (Hereditary Diseases) QZ 50 ivjtmtih'jim ws 200 fc'umtm qz so mmmw&um sf 756.5 #£*£*?I^£«;£&££ SfSttftlfilt^MTOM (Telangiectasia, Hereditary Hemorrhagic) WG 700 itfKl4^i£ (Nephritis, Hereditary) WJ 353 mm^umt lt wv 270 '&U&MiT\inmm (Huntington Chorea) (i Huntington*?! £• £ £ gfEteWH^lt^E (Sclerosis Hereditary Spinal) Ii FriedreichJIiJj£iffi£ £ £ JtfSl4^^14#^#)l (Hereditary Multiple Exostoses) Ii£fe14jtf£l4##-#]S£££ £fEl4#^d<'J*°-xX7dJ§IS*f (Colorectal Neoplasms, Hereditary Nonpolyposis) WI 529 '&i£fe&¥&m (Chorea, Hereditary) (£Huntington*?! £ £ £ £f£l4$^t£ft#^&#l;f*£ (Chondrodysplasia, Hereditary Deforming) I££%14&f£l4##-#!ffi£££ j&fi;ffll^ (Ganetic Counseling) QZ 50 %mnmiz£>uz> hq 766 ArnmnftKY t y yxii, iHSijc: jifEftll&X. (Genetic Recombination) liitfSi1!!^^ ££ iIf.S&^fCfc& (Transformation. Genetic) QW 51 «f£^14-*^$W (Sex Preselection) WQ 205 ikii^xmitm^mmth^^ qh 44 Jtfg^ttil^ (Sex Selection) li*f£W14*^SiJif[i^££ itf£(frl££- (Conjugation, Genetic) QW 51 i&UMZmii (Genetic Diversity) t£$H(»fi"^) £££ >tfSftJkJ**£& (Genetic Skin Diseases) li£j»*£*<7)T <0*fSft WR 218 £££ JtfSe^f*H^^ai (Genetic Carriers, Detection) U%*1 &£fctf>&£%X iifSftSHIK (Translation, Genetic) QH 450.5 *fE#14M (Genetic Toxicity Tests) li$HJ)il14sU* £££ iftfg^TVl/ (Models, Genetic) mm QZ 50 iftgfch t-yyxl£, 3£SD3ijK /f Y (Id) WM 460.5.U6 $iJj (Locomotion) WE 103 &W]%tMMM (Mobile Emergency Units) li&,%i»S££ £ ®W]BffiMm (Mobile Health Units) WX 190 mftmz & It ■■*> *§£• (NLM3-$|*Tliff^#^27-28) BftMft (Gastric Emptying) WI 302 fll*!^^I (Aspiration of Gastric Contents) Ii"ft3114 Ai|i&£££ ^AH-7- (Transfer Factor) «ft*$t3&tt& QW 568 ^Wffec7)#?*h t-y yxii, ±M«"Jt^ itm*£ (Enuresis) WJ 146 fVJtmt^'Jtm WS 322 /fy (Dogs) %m.my»t lt qy 60.D6 ^g SF 421-440.2 J$£l]^ SF 767.D6 ff£<7) QL 737.C22 -< ^ -f h (Inuits) lixx**-£££ A 9&>)& (Ancylostoma caninum) l£$jj£!jl£££ A 9%mmtfcg% (Hip Dysplasia, Canine) SF 992.H56 A 9 &#c& (Dirofilaria immitis) QX 301 A 9 &tk!km (Dirofilariasis) WC 880 A 9~yxfy<—7 A )*"X (Distemper Virus, Canine) QW 168.5. P2 A 9 m^. (Dog Diseases) SF 991-992 A 9 'J X (Inulin) QU 83 4* (Oryza) (£*£££ A *W (Graminea) l£5££££ 1 WM (Regurgitation, Gastric) l£l &iti£iJit^£ £ i /f y x h -/l/ (Inositol) QU 87 A 9 y Y-^^*7fcXy 3.— Y (Inositol Hexaphosphate) (£7xf-x^£££ A 9 yY -/!/ fc X fc y 'J -b "J K (Inositol Phosphoglycerides) li*X7 7 7 7'^A 9 x h-/i/^l £ -T y x h -/l/ *J A,^ (Inositol Phosphates) QU 75 A 9 yy (Inosine) ^itm QU 57 mmm qv 185 A 9 x X *X fc 'J 7 --tf (Inosine Phosphorylase) Ii7* "J 540 A l)37U >??yfcy F*x*'J y--fe*£££ p??)f*]^ (Gastric Contents) (iB^T^'Mf QY 130 £££ g<7)fm8t (Ethics, Medical) W 50 mnmmiziUTZ, wm 62 fl$S (Stomach Rupture) WI 300 ^t7£ (Snoring) WF 143 g7-fX7/l/ (Gastric Fistula) Ii!*(£££ £HK (Clothing) QT 245 Mmm WA 260#£*>££ Wfa (Foreign Bodies) 3M?3I£££ /f7*7°D7xX (Ibuprofen) QV 95 mmrnmt ix qu 143 ^70-7-xK (Iproniazid) QV 77.5 /f 7°n/<7 h'J/l/ (Iproveratril) (£^7'^ /!/£££ ill (Encopresis) WI 600 ^RfI\>X (Wart-Hog Disease Virus) (i 77'J^77*y 31/7 £££ SiS^itlSlpap (Illicit Drugs) lix r- 'J - h Yy -y 7£££ &mmikmS,(&&l (Illicit Drug Testing) li^SCSLffllta} £££ it2£ftEi£ (Abortion, Illegal) (iBHS^i /f-7+T/l/ (Colobus) QL 737.P93 mm SF 997.5.P7 UWmmt LT QY 60.P7 •Y*X77^K (Ifosfamide) ixmmmtix qv 269 ft*BWft;K£ LT QW 920 !i*^#iJE'JJ£ (Semantic Differential) 'bmmmmiztsa&mm bf 463 At&^gt LT BF 698.5 -f^xX (Imizin) UA S. 7° 7 ^ X £££ /f ^ 77 ij yyfty (Imidazolidinethione) I£x7xx 7d-m*^££ 4 ^ 77-/U (Imidazoles) QU 65 %mtm qd 401 /f ^ K^Xx/U (Imidobenzyle) l£/f i7°7 5 x£££ /f j77 S X (Imipramine) QV 77.5 /f~-<*A (Imipenem) QV 350 A l^-l Y (Imipemide) it A i^*A£££ 11*11 (Semantics) P 325 A I X (Imines) QU 54 -%mtm MhMc&to qd 305.i6 Jimmit&m QD 341.16 U777-fe^f (Immunoassay) Iift*£^ft1$;£j££££ /f Ay ^-;u KiS (Immunogold Techniques) U%M1&$k \tm*%x A±9*W, (Manihot) (£7>y+r'<£££ Wm™a (Remedies) f£teSft££££ mSSBJK (Drug Recall) l£[S*paD t^*^^^*) ^££ EHp?,7yny (Drug Catalogs) (£[SI|papg#£££ [£$£&A (Dictionaries, Pharmaceutic) QV 13 l^iatiMS-fr-fc:* (Drug Information Services) ^y\f.=u-9 QV 26.5 ^xE^ff'<7)7- t'X IliHSiJfc r^pn'tfsfdx'* (Package Inserts, Drug) \t%&7~<;HS /fi££i K*iSfcJ|**<7>W) (Drug and Narcotic Control) ffi$ (VSLft) QV 32-33 Sf£ (Ifcffl) WM 32-33 tt^'m^m HV 5800-5840 «M*r- t>yyxl£, iHJ5iJ{; [S^ppO^S (Administration of Medicine) (iH^T <7)^S77-a WB 340-3565- ££ (§0lpapg& (Catalogs, Drug) QV 772 EiHtf.mS (Drug Modeling) (i F77^7f^ x£££ mm"u7-££ %& (Volition) BF 608-635 4 ij Vs 7 A (Iridium) ftlflllffc^ QD 181.17 mm WN 420 /f ij K7/f/ux (Iridoviruses) (i-f 'J K7/f/i/X£f£££ 4 iJ K7/f/UX# (Iridoviridae) QW 165.5.16 [SS^M (Malpractice) W 44 —fe W 44 ftf4 WU 44 mhwm wp 34 mm wy 44 i£f4 WQ 34 (NLM3HB^-Clil£5$#^33fc L < Ii33.1) [S*Je®!^R[§^ (Defensive Medicine) W 44 ftft^ WU 44 mm WY 44 (NLM^SSTii)B^#^-33) E*«»^l»WiMfc (Defensive Practice) liElRfi*Vf R H^£££ |S!RI»«#WffiS (Attitude of Health Personnel) mtiUS2L&&% W 21.5 $tf4IS WU 61 mfnXfvy WX 160 #!!*§ WY 87 mm W62 «tttf41S WM 62 M#f?li, **>#»£ IS8SE3E (Medical Audit) W 84 mWzmiX WX 153 [S*le^:SI7°oy7 A (Managed Care Programs) W 130 541 A 9 3 7 * IXfftlW.i!tXift (Allied Health Occupations) W 21.5 IVv^HJJgHaiW (Institutional Personnel Licensure) (i B.M£££ l*afc&U*£ (Medical Device Failure) lig5*^££ W. *■ l**KJ4tfr (Medical Technology) (ifcV*f&:££££ IX#*&tt (Health Benefits) (£fWk&£££ |^*#t?£4j|J£ (Business Coalitions (Health Care)) li[S *£*>tflS££i [*£«geflk*lBjf'Jffl (Medical Record Linkage) WX 173 W&W&m (Economics, Medical) W 74-80 ISS&tt (Medical Care Costs) lif£fltE*l?ii&S£££ H*Bf5£ (Medical Care Research) lif*fi|[S*l?7-tx ffi3t£££ feWrfciifflktifr (Professional Review Organizations) W 84 IHCi'), A:Bmizmm*ti&m&u, ±mmi~ mmtfim. n x t ^ - y *£JI (Medical Informatics Computing) W 26.5 mm^m (Quality of Health Care) -«! W 84 mix. WX 153 mk&m wb so £&'&£ WA 525-546 mM*m%M. (Quality Assurance, Health Care) W 84 W%Y Vy9 7.lt, ±HSiJ(I mmx9-y 7 (Medical Staff) W 84 m.mtmnm wa 412 *itWi$jt:7--tx WA 495 m 'i'^Av. S&ftA^KfHILT |7?££ m\%mmx9-yy wy m^tz9— (Medical Centers) itmmi&Wc WX fc#& <7>?Ay°m;&%t:%.£ mmm,%.<9>&t}Kffi (Professional Impairment) mm w 21 Ar&-}izfrmt& m&WTim (Health Professions) (if*HK*£ll$£££ HfSfg£tf9$£14 (Medical Device Safety) litSrJS'&r^tt £££ E*fMa (Medical Gymnastics) ttilifrlg?&£££ [S*i7-A (Medical Care Team) Ii|.f77f-A^M £ HfSettfl* (Health Care Coalitions) WA 525-546 wm>f?it±mmiz. mm\Z (Curiosities, Medical) UKWifrfr \ &{f£ ££ WSfM%M (Medical Waste) WA 790 UWMM^afSM (Medical Waste Disposal) WA 790 US?* (Fee for Service, Medical) (£[SS?f|-ft*££ mmUW (Secretaries, Medical) it 9 fy ti )V■£ 9 \s 9 V -£££ mmmmmmm (Professional Standards Review Organizations) (£HS?ltt41$fif£££ HS?S:W (Medical Indigency) W 250 Medicaid W 250 £ fc £ £ [S^KJMffi (Quality Assessment, Health Care) (if* M[S«7K38f*fiE£££ mtitikBh (Medical Assistance) W 100-275 mmmh%19mB (Medical Assistance, Title 19) Ii Medicaid £ ££ mmmk (Medical Insurance) l£®Jtf*Pk£££ mmmk^mzm (Managed Health Care Insurance Plans) (i|Ifl7D77A^Mi EfKlfclfcWM (Insurance Case Management) itmM M7°o77A£££ mmi^m.(Health Occupations Manpower) li^i'X?/ ^°7-£££ mmmm% (Imaging, Medical) !£@»»f£££ ESffflflr (Medical Devices) (ilMfflflUS t 'gttfflpan£££ mmmMcmt (Medical Device Design) Ii!8:fi!i9:tt*£ £ ES?£r£ (Fees, Medical) W 80 H£fiJ 9 M L W 58 542 A>9>Y m (Clothing) QT 245 livti (Dolphins) QL 737. C 432 iv7x (iieus) imm§m.*&x t>ilfA (Tattooing) GN 419.3 fe (Color) QC 494-496.9 frmm BF 789.C7 fc£tfjfllffllifttllgffi WB 89(Cy£££ IRWfe WW 101 ; ££1^*11* WA 712 ; %W(.%\&W\iiLfc (Indium Radioisotopes) WN 415-450 tmBfoizmmztizm&u, £.mmz Hi^flf (Factor Analysis, Statistical) QA 278.5 ■kmmiziiiih BF 39.2.F32 mm izmm ? tn> m&umm t tz ii#n izn-t & wm^.iJ 9—7 (Insulinoma) WK 885 A X y a. U X (Insulin) WK 820 x a 7 y lifgjfitff^ WK 880 £ £ £ xa 7 7fiili^yyai)yy37?Sffi WM 410££ £ A yy^- ij x#tf£ (Insulin Antibodies) QW 575 -f X y -l ij X'|4§BiSeffi (Insulin Coma Therapy) li« mmzFtx A yy^-i) Xi±AxX7A (Insulin Infusion Systems) WK 820 A yy*. ij x^^ftH^l (IGF-I) l£IGFl£££ ^y-/aijyitft8^2 (IGF-II) (£IGF2£££ A XX 'J Xf£#SffJ3i*?t (Diabetes Mellitus, Insulin- Dependent) WK 810 A X X ij X x a y y$ft£ (Shock Therapy, Insulin) (i*I *Wft££££ /f XX ij y4mtf*MW£m (Diabetes Mellitus, Non- Insulin-Dependent) WK 810 mm&it (Negative Reinforcement) l£^fb (<1>S^) £ ££ F#14'&.&7 y't/7 7^ (Negative Contrast Radiography) Ii fAftlil^i £ £ £ /f >yy*-/l/ (Indazoles) QV 95 umitm qd 401 4*xy-7^ x7°iJ7i)-f*flt[£*£7-A (Interdisciplinary Health Team) (i&^777-A£ ££ 4 x*v<= K (Indapamide) QV 160 A y 9 — 7 i o X (Interferons) &,*£'?- QW 800 USt-'r': QV 268.5 A xy-7xnX7/l/7r2C (Interferon Alfa-2c) (ill &fMxy-7xox7^7r£££ 4* X^ — 7xnx7'xv (Interferon-gamma) Ii /f X y — 7xnx2S£££ /f X y — 7 x o Xff HH-p (Interferon Inducers) ?mm qw 8oo mmm qv 268.5 /f xy-7x.nXlS! (Interferon Type I) ft&m QW 800 ^7A >vxmt LT QV 268.5 mmrnm t lt qv 269 /fxy-7xnx2S (Interferon Type II) &*£¥ QW 800 tf[7A ^xmtLX QV 268.5 mmrnmt lt qv 269 A x y —A*y8 (Interleukin-8) «&*£ QW 568 Sft^Sft LT QU 107 A X 7 X (Indans) W»k# QD 341. H9 »h t°.yyxi£, ±MSiJl3 /f X y - X i: X x 7 X h fflfi^W (Internship and Residency) m:\ WU 20 mn w 20 *?*Pft7°ny7A WX 203 mm WY 18.5 543 A >tA 7 mm qv 20 A xf-f Ty fiof1£$ (Indian Nursing Service) it£M &£#§**•££ A X7 9 7'*^ (Interior Furnishings) (±4 xt 9 7ff A xifi|pan£££ A x7 9 Tff'f X fcfSoD (Interior Design and Furnishings) fit/tSfetS: WX 140 WHtffrdttLT (NLM ^mmXitM^.^^27-29) mtz&un WX 200-225 f4^^£^S4t^^^(lM-r-5»S**4W#^ WA 795 -799 Ayy^9yy (Intermedins) (£MSH£££ A >f> (Indenes) iKT^mmttx QV 150 tt£*£14ifl*S0!£LT QV 95 %mitm QD 341. H9 mm? (Negatrons) li*i1^££ msS. (Pharynx) WV 410 fVJklz is Hi WF 490 PBIlife (Pharyngitis) WV 410 PBsl^ (Epiglottis) WV 500 msm (Pharyngeal Arches) fiftgSl3ft££i PBslPl^^rSE (Palatopharyngeal Incompetence) l£P mmm^z&x PH»S#i& (Pharyngeal Diseases) WV 400-440 mi WV 400 •tl'JtWtty'Jim WV 400-440 mm WY 158.5 uSslffi (Sore Throat) (£PHsM&£££ "HSSRW (Reflex, Pharyngeal) (ij£4>£££ PBsI&SB (Nasopharynx) WV 410 "fH&fcfcltS WF 490 PBsISG (Pharyngeal Region) (£^035 file fig LT^3 Stf K ; #PH5f ; pi ; pbs! ; if % ; ^£££ /f X K x 7 - X 7* 9 - X (Indocyanine Green) QV 240 A X Yy*fc9m (Rauwolfia) QV 150 /f x Kx>rKyiS7^7n/f p (Rauwolfia Alkaloids) QV 150 A X K7o 7 x X (Indoprofen) QV 95 /f X K y 9 x X (Indomethacin) QV 95 Ay Yy tl Ay (Intracaine) l£^xy*7 A V £££ 4 X K 9 (Indri) l£Sterpsirhini£££ ^>K 9*4 (Indriidae) liSterpsirhini £ £ £ ^ x K 9 /Ux7;u7 ^ x (Indolylethylamines) (£ h- 9 7°y i>£££ A y Y—)*y (Indoles) tKl^mt LT QV 77.5 £)%mtLX QV 77.7 r-7x>7>f-f-i: LT QV 77.9 %mitm qd 401 A X K-/l/7i x2,3-y^=*rx77—t (Indoleamine 2, 3-Dioxygenase) (£ r 9 7° h 7 7 >**yYi—t£££ /f x K-/uB£& dndoleacetic Acids) QK 753.15 Tz9mtm QU 65 PxfiSife (Hospital Infection) l±£2tS5*fc£&«fc ft* (Scrotum) WJ 800 mm*m (Hydrocele) WJ 800 A x h: - 7 X X -L>^0i£ (Cardiography, Impedance) WG 141.3.C15 WftY t°y yxi£±)gsijic, 1W£Jjr«fiifc*)i*»fKfcit4 *^li WG 330 A x b"-7yxi|Jjig (Audiometry, Impedance) lif WA xt-7xx7x h£££ A Xt-7xX7°X7X*y7 7 4 - (Plethysmography, Impedance WG 141.5.P7 *my\i-v9xu±mwz, mummmimnmu WG 550 A y 11 x (Inhibin) WK 900 £14 WP 520 ^14 WJ 875 /fX7*— A K d x-fe X I- (Informed Consent) kft-JkmztiifZ W 20.5 m^m W 32-33 ^-com^^^h t-yyxii, insijn, mutm^i\za iihit QV 20.5 ^SP^M^/U-^X (Herpes Simplex, Genital) liP£S|W /U^X£££ ^g|Wi/-7 (Herpes Genitalis) WC 578 /fX7°7Xh (Implants, Dental) l£/f X7°7 X h tt£jj" £ /f X7°7 x hM (Dental Implants) WU 640 ^ X 7/1/x-X-7 (Influenza) WC 515 A X7/l/XX-77/f /UX (Influenza Viruses) litf/UV ~ *y7/f/UX£££ /f y7^xyf| (Haemophilus influenzae) QW 139 ^X7/l/XX7f7y7> (Influenza Vaccine) WC 515 A X7/l/XX-7DS7^/l/X (Influenza D Virus) li^°7 A X7/l/XX+T7/f/UX 1S£££ /fX7X —xsX (Inflation, Economic) ±hk£9, immxvm^tc&^zm^z Ayy°u99[y (Inproquone) QV 269 ffiitmmm qz 267 A X-S7 7 (Impetigo) WR 225 Ayfcy-yx (Impotence) WJ 709 tfcffl (Drinking) WI 102 IXm WM 274^ ; I&7K WA 675-690£ &££ tm (Liquors) l£7/l/^ -/l/fifr^ £ £ £ £fc$4 (Beverages) vmmzi £££ /f XX- (Inlays) WU 360 7 7yh^i-^7 (Wit and Humor) PN 6147-6231 mmRvmmm&^M wz 305-305.5 mmizmt&®.m wz 305-305.5 7-f/i/X (Viruses) QW 160-170 mm^mmt LT QZ 65 ifflffi(£'WZ7A >\sX<7)£fo£ &££ 7-f/i/XJtfg^- (Genes, Viral) QW 160 7/f/uXJtf5i=-Mt)(Viral Gene Products) Ii7 A ^*% &»£££ 7 4 /1/XJtfS^geK (Viral Gene Proteins) U7A^* SfiK£££ 7/f/l/X^ (Virology) QW 160 &^§-QW 1-85(5, 7, 9, 20.5, 50, 51, 52£&<) *i 544 773.7A gfcg^ QW 70 #£7>f;wXtt«A, (-«!) SF 780.4 7 4 /wXJSifeftffi^^lS*^ (Postviral Fatigue Syndrome) Ii1f14$l#ffi^£££ 74/wXjfc£ (Viremia) WC 500 7^/wX-x^f^ (Receptors, Virus) QW 160 •M/UXttjtlX^ISJ&WBiS (Gene Expression Regulation, Viral) QW 160 74 /uxi4ff^7y 7X (Viral Hepatitis Vaccines) WC 536 74/l/Xl4;F^ (Viral Interference) QW 160 ^/f/wxtt^ln^ (Arthritis, Viral) (i®*14llSgn&££ £ 7/f/l/Xl4ttJI (Viral Antigens) QW 573 7/f/l/Xl41/lf£ (Viral Antibodies) QW 575 ■7/f/UXt4iffllMi*t*£& (Cell Transformation, Viral) QH 604 R*D QZ 202 7/f/i/Xi4*HB&$14v)j'4l (Cytopathogenic Effect, Viral) QW 160 74/t/Xl4*££, (Virus Diseases) WC 500-593 WmmZWtiiV WC 540-556 S**f ttW(i»ifett&Sr«ft WC 570-590£££ ?L^«t^^W WC 500-593^ ffillKn SB 736 gtgf (ffl^«7^UXEI) SF 781-809 7A /l/Xl4tiiJfiLS (Hemorrhagic Fevers, Viral) WC 534 7/f/l/Xl4Jl*SDtJ§C (Antigens, Viral, Tumor) QW 573 mmmmm qz 202 7 4/I/X14S&IH& (Meningitis, Viral) WC 540 7 4 /l/Xt4$sl&#Ll£ (Virus Transforming Antigens) (i 74/i/Xl4H*l/lJI£££ ^-f/l/Xttflife^ (Pneumonia, Viral) WC 207 »|S¥ SF 831 7^1^X161 (Viral Proteins) QW 160 7A)VXt%W(k (Virus Cultivation) QW 25.5.V7 7A)V7.mk (Virus Replication) QW 160 7/f/UX-v-7-(Viral Markers) Ii£&¥tfi}-?-7-£ ££ 7 4 ;uxfflMH^ (Virus Inhibitors) QW 160 74/i/X7y7x (Viral Vaccines) WC 500 ^^7y7xc7)^«;^t££ ^4/uxDNA (DNA, Viral) QW 165 74^XRNA (RNA, Viral) QW 168 74 n4 Y (Viroids) QW 160 73- — Y-f — $\7%-m& (Granulomatosis, Wegener's) Ii Wegener 1*3 IF Bl-Ee ££ £ ffii>iS77-7/1/ (Implantable Catheters) WgW7T- 7/H:££ 7xxyx7*oy7^f y 9 (Blotting, Western) QW 525.5.132 wum QU 55 ^77 Y QU 68 7iX;yM7*D7 Y;&(Western Immunoblotting) Ii 7xxyx7*P'y74 X7£££ 7 x )\> x j. i*i (Clostridium welchii) (iWelchS £ £ £ 7x;u^.y7ff- (Wernicke Area) l£flHJs!H£££ 7*>\<7-'-!-*y9y-fc7A Y'&mU (WPW Syndrome) liWolff-Parkinson-White*£1^^* £ £ 7*/l/7 7A (Wolfram) li^y/Xf ^Jli n£&<6 (Swimbladder) liflfc£££ IftfiMffi (Contraet Services) Uti&M W 74 *wffc<7) h t-y y xii p.ii^ijic ; t L-te&W£3-(ii& <•#&*£ (Passive Immunity) !i£DJ&*g£££ 77*-* (Rabbits) SUMMfcfc LT QY 60.L3 figlW SF 451-455 mm m^tff^mm SF997.5.R2 »£IM* QL 737. L32 7-7**AfMWfB!Mt (Rabbit Aorta Contracting Substance) Ii h n yfc**t XA2£££ 77^*g (Lagomorpha) QY 60.L3 Kft (Caries, Dental) lifi?lfeil£££ 7x (Cattle) Mmm SF 767.C3 HH SF 191-219 £.mm SF 768.2.C3 7x7 4/l/X'|4T*?I'l4lil5Bt*?1 (Bovine Virus Diarrhea- Mucosal Disease) SF 967.M78 7xS*£$ffi (Mycobacterium bovis) QW 125.5.M9 7x*£l£ (Tuberculosis, Bovine) SF 967.T8 7xfK&14#fvS:i£7 4/UX (Infectious Bovine Rhinotracheitis Virus) (i7x^/1/^X7 4 )VX 1 ££ £ 7x h 'J^V V — "^*JE (Trypanosomiasis, Bovine) SF 967.T78 7y<9>m*\ (Cattle Diseases) SF 961-967 yyW&MWt&Wl (Pleuropneumonia-Like Organisms) liMycoplasmaJH £ £ £ ^y^'xS (Hypodermyiasis) WC 900 7xfijfiL*?^7 4/i/X (Leukemia Virus, Bovine) QW 166 7x7*/l/-b7*£ (Brucellosis, Bovine) SF 967.B7 7y/\;i/^X7/f/l'Xl (Herpesvirus 1, Bovine) QW 165.5.H3 7xKunitzPh 9 7°x XPIW^J (Bovine Kunitz Pancreatic Trypsin Inhibitor) Ii77°n7^x££i 7-x$& (Maggot Infestations) (i'>x#;&£E£££ Kf& (Dental Caries) WU 270 Silfife^ (Cavities, Dental) UffimBfc£%X •Sf*Jg14Jt (Diet, Cariogenic) WU 113.7 MftlSliftK (Cariogenic Agents) WU 270 SiliJ^'14^ WU113.7£&££ IMiifcifcit/^E** (Decayed, Missing, and Filled Teeth) (£DMF^fe£££ 7y\H&M (Brucella abortus) QW 131 \&&m (Turbellaria) QX 352 m. (Lying) BJ 1420-1428 W^»j WS 463 ZVJtmtWJiKl WS 350.8.L9 ^ile£ (Lie Detection) HV 8078 P^m (Shyness) BF 575.B3 ^mm (Space Medicine) (i^&fFHf £££ 545 71-3.7-t r&V.Wim (Space Biology) (iit&J$yW&£££ "y'\U$U. (Cosmic Radiation) WN 415 ^&-JI*££ 'f-ilifftlf (Space Flight) WD 750-758 fymmm WD 752 •C'S^p'J WD 754 7olflll4lt*« (Stasis Ulcer) (£$**g'l4fi*S£££ 1 oJfiLtt'll'i&SE (Cardiomyopathy, Congestive) WG 280 7 ^Jfo.14'04^ (Heart Failure, Congestive) WG 370 iIfS#ff-!f% WG 113 mwrw^mm wo 245^ &££ 7 olfiL'|4te^,||i (Atelectasis, Congestive) (iJ£A5LJPfP& m&mmmz%x 7oJi?Lsl (Choked Disk) (i?Lsl7KJS£££ 7 r>m (Depression) WM 171 r.&mmi^m wm 207£££ 9 Au —VUlxBfti^m WM 171 £££ m (Arm) WE 805 KXWUkXmB. WE 172£££ ±l!£ WE 810 mm WE 820£ &££ S^cofflfl (Arm Injuries) WE 805 fjWitft WE 820£&££ itittkm (Drowsiness) (£RiagcO!£|Sg£££ 7- (Sea Urchins) QL 384.E2 ?.;;€ (Lanugo) (£€£££ 7-v (Horses) SF 277-360.4 mmm sf 765 gftfr SF 907 WW. UC 600-695 7-vfiifcti^-jfiL (Equine Infectious Anemia) SF 959.A6 7^3w& (Eacephalitis, Equine) !i7-^l*iWti&££i 7-vfli^fl^ (Encephalomyelitis, Equine) SF 959.E5 Afplll^lt^ WC 542 7-?m%. (Horse Diseases) SF 951-959 7—?> "J 7" (Women's Liberation) Ii£'f4y>f|lfij£££ &^f&*£ (Maritime Quarantine) li l/f X$t£££ 7 7 x (Uranium) WN 420 mtvmm qc 796.U7 m^mm^r^m r t -y y x £ & £ £ &%%&& (Dipylidiasis) Ii3:£ti>i&*££££ 7 9 xx (Uridine) QU 57 7 9 -x x ~ ij ^@£7;^ a -x (Uridine Diphosphate Glucose) £fb¥- QU 57 mmm qv iss 7 9 xx;2 9/^$i (Uridine Diphosphate Sugars) £S'# QU 57 mmm qv iss 7-9-^x*- (Monkey, Woolly) (£7 7 7+r7M4£ ££ 7/UxM (Rhus) (i ToxicodendronM£££ 7ivy7^'^ (Dermatitis, Toxicodendron) WR 175 7/1/7 r-K * y ? -ivftt (Ursodeoxycholic Acid) mam WI 703 fjm* t mitftwm > l t qy 66 7X7--t (Urease) QU 136 7 X y X (Urethane) QV 269 7o7*X h DX (Urogastrone) (iEGF7D7'X hDy^ £ 7n7*X hox^f£ (Urogastrone Receptors) Ii EGF-7n^rx hnyf^ii 7u^-f — Af (Urokinase) QU 142 7 n *7--te-§!]7°7 X s 9-y>T9A--<-9 (Urokinase-Type Plasminogen Activator) (i7D* -f—1£££ 7ohot°X (Urotropin) iiy77$x£££ 7n^7°xX (Uropepsin) QU 136 7Xx7 9 7X7/-b7r7 (Uncinaria stenocephala) l££6}iLhf4£££ 7Xx797^ (Uncinaria) (£$)&£££ MW) (Motion) mm^iztix JSIUj (Movement) WE 103 M§m^-& (Dyskinesia) liiIDj|SfW£££ iilJj^ (Kinesiology) lijiijj££i JSIfri: (Motion Perception) Wt WW 105 Sift®* WW 104£^££ iiiJJig'14 (Motor Activity) WE 103 fl'Jtmtifi'JIW WE 103 to-simmmm lb 1067 ill7J?SIJj14^^ (Hyperactivity, Motor) (iJIDj7tJi££ £ illJj^OS (Athlete's Foot) (££SBfifJ£££ JlIM^: (Kinesthesis) WE 104 mm ww 105; mm.n we n>4£ &££ mmiiZ (Motor Skills) WE 103 fi'jtmtib'jtm we 103 ^mmw^m we 104 JIlAMft (Athletics) (ix*°--y£££ SIM (Locomotor System) (i$#f&^£££ SlJJTtJi (Hyperkinesis) WM 197 #*NW WS 463 i-vjtmtwjm WS 350.8.H9 mil&m (Ataxia) WL 390 'hflS14iIfjj&il| WL320 £ ii £ £ MW&U (Motor Endplate) WL 102.9 illJjPf ^ (Movement Disorders) WL 390 ¥l^»^#/!Ol WS 340 M^I^^Pf* WE 550-559£££ mnmrnummmrg wm 197*££ mmm sf 901 ES^tto&oii, SIHiX(£Pilt&*&f?1lc mm^mm (Aphasia, Motor) (£Broca£I&ffi£££ £ifttt-CX,*\C (Motor Epilepsy) UXLfrLk^lX «IWST*E (Hypokinesia) (£[51^^££ M-i-nx (Motor Neurons) WL 102.7 if f)j£K (Motor Cortex) WL 307 M§hM.$j (Exercise Test) WG 141.5.F9 MW)mftfl^mm (Exercise-Induced Bronchospasm) UmM'i&m& £ £ £ M%hW&*mM, (Asthma, Exercise-Induced) WF 553 546 14 37t g|W8£ (Exercise Therapy) WB 541 #**> !**&*& WB 5205-££ x77—/i/ (Aerosols) ?Hf$£ QV 220 ykH-mi QV 785 ii/^foHllAcftr^M WA 450 : WA754$££ ttAflRSKfcltSISiffl WB 342 i7nt7Xf£li (Aerobic Exercise) U3-977A X% ££ Bjfcjlj (Motion Pictures) (NLM^HSST(iffi^#vl8.2) >VJL\z5-Lhim WS 105.5.E9 TkXHM (Dental Fillings, Permanent) l±*X£tS£M £ 7kXJ£ft (Dental Restoration, Permanent) WU 300 -360 ^SHSfS^VH (National Health Service, British) li&Stl«SiJ^*-££ 5.A?79AY (Eicosanoids) QU 90 SJeaL (Infanticide) 3E.JP^ HV 6537-6541 mmm&%m w 867 x4X (Acquired Immunodeficiency Syndrome) WC 503-503.7 mi WC 503 £« WC 503.5 mm wc 503.1 mm WC 503.4 ftHH. &ife WC 503.3 mm WY 153.5 RftJfcSiJE WC 503.6 ■l>JItt£^tt#& WC 503.7 \m WC 503.2 x^X74/i/X (AIDS Virus) liHIV-l$££ *AXM&&i%U (AIDS-Related Complex) WC 503 -503.7 x-A XM&nfc (AIDS-Associated Nephropathy) WC 503.5 x4Xffl3lBffi£®^*£ (AIDS-Related Opportunistic Infections) -fe WC 503.5 %fZ®&%Zii&X x4Xjfiuff£g (AIDS Serodiagnosis) QY 265 ^A XskWKiB (AIDS Seroconversion) JiHIVJfitftHM* $££ x4XJfiijfP#'|4(AIDS Seropositivity) !£HIVlfiLYfPf14$ ££ x4X$d* (AIDS Dementia Complex) WC 503.5 *4 Xmm (AIDS Encephalopathy) (£x4 X«$££ *4 (Sanitation) WA 670-847 £1S^I $££ ffi£¥ (Hygiene) QT 180-275 8?a? QT 240 *f*li#*4TO* WU 113$££ ^K#*4¥ WU 113$ &££ #¥W WS 460 'l>HjfiL§aM£.fi WG 113 P?)i§*£,t.diseases WI 113 ?L!OHh#j!OH WS 113 %*tm WT 120 &mm wq 150 ,,i*|jij7 7 WQ 175 i*:3lo(«t-?*j£ WA 400-495$- ££ hmnwmm'Y wa 495^$ ££ ^¥<7)li¥*m* UH 600-629.5$££ mW VG 470-475 ■J&IPIX'T' VG 470-475$ t££ ^JD-'4fl^<7) QT 160 tltt<7) WW 113 Mti.jl£o QT 150 7^'AllW WA 350 ■r':'fe<7) WA 350 P^linJEHr'l-: WU 113l£$££ Mftflr HV 8833-8841 &*Oli&*»* WAI?$££ ^Ht%& WP 170 ^BffllBBfB (Episiotomy) WQ 415 x^tvX&fnttllSlffi (Adenoma, Eosinophilic) (i#f$J£ 14l!*lt$££ Hfcig (Axilla) WE 812 &m (Epidemiology) WA 105-106 mf WA 900 &mbW% WA 950$ &££ (NLM^|^TIiJF^#^-16) *£¥#J$:£^ (Epidemiologic Determinants) fi-JS^&tl ^H$££ &^6W3K£ (Epidemiologic Methods) WA 950 Jgr^lft^e —y 'J x7 (Epidemiological Monitoring) !£H t^^e-y ij xy$££ ^^(ftHH (Epidemiologic Factors) m&&m. (Axillary Vein) WG 625.A9 &£i8?IM (Axillary Artery) WG 595.A9 HfcKlliai (Collodion) mmmshm qv soo ffM&m TR 390 x^fx>>^—h xX7A (Expert Systems) QA 76.76.E95 LI^& (-fe) W 26.55.A7 fte<7)#Sfc&#ff (NLM^Uf^#^-26.5) x3f-x*9 77x£Jt& (Exfoliative dermatitis) ttftJIK 14&*&$££ JfcttJS'gftfeJI (Waste Disposal, Fluid) WA 785 :Mk (Vacuoles) QH 591 myimmz ts iy& qk 725 xy-tr74X (Exercise) mm^mm we 103 f£W QT 255 X,f—y QT 260 x y i/ y x (Ecdysone) SF 768.3 W)%»m QL 868 ^9 Yfc)V^y (Ectohormones) (£7^n^x$££ xy ij >U (Eccrine Glands) WR 400 xn-74/WX (Echoviruses) QW 168.5.P4 &JE (Necrosis) QZ 180 ifcg^ SF 769 mm^iiuum*\iz x->x ij if 7 (Escherichia) QW 138.5.E8 mK&ffifc (Necrobacillosis) Ii7 Vi *X$££ xx h n x (Estrone) WP 522 x-t9x (Eserine) Ii7 4 /Xf/5 X$£i m& (Gangrene) QZ 180 ifXitifxm.^ WC 375$££ ^*Ji'l41*1 3F11 (Granuloma Gangraenecens) I£^'14jE,+,I*I «$££ x77-i/i/ (Edathamil) I£x7*h^$££ ^9 9-)V (Ethanol) I£x7;u7;ua-;u$ ££ ^-9 9 -)VT 5. X (Ethanolamines) QV 84 ^mtm QD 305.A4 x y y —)VT I y *X fc 7 9 -fe K (Ethanolamine Phosphoglycerides) Ii fc X 7 r 7 x JV $ £ £ xyx7h-/l/ (Ethambutol) QV 268 xftt; K (Ethionamide) QV 268 xft-T; K (Ethioniamide) Iix7*7i K$££ xft*X (Ethiofos) l£7^*X7x$££ xf^-;nx h 7 x^-zu (Ethinyl Estradiol) WP 522 W&mt LT QV 177 if^-;ux h 7 x^" —/U3-y 7/l/X-7;w (Ethinyl Estradiol 3-Methyl Ether) U9 7, Yy 9->v£flX x7^.-/uxx h xy-/l/ (Ethinylestrenol) liU*X h l/-y-/u$££ xf^-/H< ijyo74 K (Ethinyl Trichloride) (i h U yonx7xx$££ xf^-/l/y/l/7XhX7DX (Ethinylnortesto- sterone) lixf-- tv 9 )Vy-X Y Xfn X$££ x7;i^7 = x (Ethylamines) QU 61 W$HL^ QD 305.A8 x7;u7;U3-/u (Alcohol, Ethyl) ^mitrn QD 305.A4 ^S^ QV 84 x7;wxxhxynx (Ethylestrenolone) U9 )Vx.9~yY' do X$££ x7/l/x-7;u (Ether, Ethyl) QV 81 xf/px-j/H (Ethyl Ethers) QV 81 tl®itm QD 305.E7 xf;i^i/ft77;y (Ethyldithiourame) \tyxJV7 A 7A$££ x.=j-)V9)Vy-X Y Xy-vy (Ethylnortestosterone) it/ >v 548 I^SIf i?xKonX$££ x + !i'<>v¥9->v (Ethylbarbital) (£'< 9 y Xivfcs-F— Y (Ethyl Methanesulfonate) ttH**iCT QV 269 xf l/X (Ethylenes) QV 81 mitm QD 305.H7 xf v y A S. y (Ethyleneimines) Ii7 x' 9 x X $ £ £ x+vyt^y Y (Ethylene Oxide) SBtffillfcLT SB 951.3 mitm QD 305.E7 xfXX^ont K 9 x (Ethylene Chlorohydrin) QV 82 xf x > ->*7 i x WS^S^ (Ethylenediaminetetraacetic Acid) lix7HS£$££ if u x 1£4£ (Ethylene Polymers) Ii # 9 x 7 X x $ £ £ ifuyftKt (Ethylenethiourea) £*ffi^K£LT QZ 202 <£itm QU 65 xy-txx (Essences) lii'§$$££ x-yfe>X7 4/i/ (Essential Oils) lilf %14'ift$££ if^f-F (Edetates) lixf*rS£$££ x7^7x^x7°Xy yx (Oedipus Complex) WM 460 xf H* (Edetic Acid) QV 276 x-7/i/ (Ethers) K»*fc LT QV 81 M®\tm mumtt&fa QD 305.E7 ^mm\\L^m qd 341. E7 X^y YJV QC 463.E7 xh^fyft^ft (Ethoxy Compounds) lixfyn-f^ 3i$££ xh7^-/UA (Ethoform) li-j7°y^X (Etryptamine) it A X K-/l/$££ xhxff-h (Etretinate) QU 167 ¥fZ%&ftmn-&mizm^ &m&uA:<9>m&iz 3-y-9)V% (Dental Enamel) WU 220 mm WU 220$ &££ ^7y/HfigJ»«(Dental Enamel Solubility) WU 220 xfy^LSl (Ameloblastoma) WU 280 xf 77°9/i/ (Enalapril) QV 150 xf iJ-v;uA (Enallynymalum) U9 Y^*y9>v%% X x*ju%-&$) (Energy Transfer) QU 34 x*/V%-%Mi%m (Conservation of Energy Resources) TJ 163.3-163.5 *?Wlfcl*l WX 140 f^ffeoh t.y7X|£, ±MN 3-%,)V%—i£WA%fe (Energy Resources Conservation) (£x^;u^-^i^|^^$££ x-*JV*?-m% (Energy Expenditure) (£x^;i/^-ftlH $££ x^.;udf—^jUjjfjJg (Energy-Generating Resources) ^*h t^yyxii±M^Jl3, miummm^it WA 30 ^*JV¥-{\:m (Energy Metabolism) QU 125 x/df 7-> x (Enoxacin) QV 250 W.foi)Xm&mt LT QV 243 x/3--f?9 x (Enoxaparin) QV 193 x/af-yox (Enoxolone) U7 9 y JV Xf x(®$££ x t V - A (Episomes) Ii7°7 X S K $ £ £ x t^/l/^e h 3- x X (Epidermotoxins) lif/t^ h * x X $££ xth-7° (Epitopes) UWtkfc&ZRX xt*7 9x (Epinephrine) WK 725 X7x K9 x (Ephedrine) QV 129 x7°yAi& (Epsom Salts) (i6fc$-77* x7 A $££ x ,7 % x {t n^ (Epoxy Compounds) WflMfc* QD 305. E7 x,7Jrxt£tJi& (Epoxy Resins) itmtm TP 1180. E6 m'Am wu 190 m*[]Wlcffiffl?a^^^li±M«iJlc x,t^xK (Epoxides) lix.-jC*x4fc£-t/$£i x ,K Jf -> h 9 d f -fe X (Epoxytrichothecenes) (i h 9 =» 7 fex$££ x.fc'«7)t£kift. (Jehovah's Witnesses) (i^ 9 X hffc$£ £ x.fc7°aXr9-JV (Epoprostenol) QV 180 ^itm QU 90 x-v- y-t x y - (Emergicenters) l£|St.%[Slle7- t'X $ ££ x ~ ••/ y 3 xCT (Tomography, Emission- Computed) WN 206 x / f x (Emetine) QV 255 x7xf x (Elastin) QU 55 x 7 x h -v — (Elastomers) Ii 7 A $ £ £ x ij *y-jvM(Elixirs, Pharmacy) [i§^JtiflJj3iJ$££ x ij ^ox') 7^ XjjglfefiE (Erysipelothrix Infections) 7"y SF 977.E7 x ij x n * x n x (Erythroxylon) (i 3 7 $ £ £ x ij x o -v 4 x X (Erythromycin) QV 350.5. E7 xiJXo,t°4xfx (Erythropoietin) WH 150 ErBfcr- t-yyxl£±a^iJ(Z x;u7^-K3-fex^ (Erucic Acids) QU 90 x;u77/l/x7xo—;i/ (Ergocalciferols) QU 173 x.jva'9 S. X (Ergotamine) QV 174 x;u7y = yW^Vf (Ergotamine Derivatives) QV 174 xyu^VtX (Ergonovine) QV 173 x.jva'9 i. -y 9 X (Ergonomics) (£AfyiI^$££ x.jvd'/tyy (Ergobasin) I£x;u7ytx$££ x^37 h 9 X (Ergometrin) lix;nry tX$£i x/urfij x (Ergolines) %mm QV 174 xjvy-T (Yersimia) QW 138.5.Y3 x;i^>-7i&ifeffi (Yersinia Infections) WC 350-355 x.jvy — T\M£1&MWiJk& (Pseudotuberculosis Infections, Yersinia) l£f&*S&M$*fe!E$££ x-^U .y tM (Ehrlichia) QW 150 xxy h o x A- y y X (Electrosyneresis) l£ 7 7 X y — 4 Ay xxy h n7xXxX$££ xxy h p 7 * — 7 x X 7 (Electrofocusing) U#9.g,ft iS$££ %LikT X ^E — 7 A (Ammonium Chloride) ^Wt\tm QD 181. Nl mmm qv 280 &ftxf ;i/ (Ethyl Chloride) QV 81 549 iy^A'J J&fL7 i) 7 A (Potassium Chloride) fcSt*ft''£ QD 181.Kl %mm qv 280 l)L\Wvfc-)V (Carbonyl Chloride) (i-7X7x$££ SHRUNK (Telemetry) *mm (-fe) QT 34 -fe TK 399 ■?-&mft WD 750 ttR^&nm QV 633 i^fe'l4Af§PfW (Histrionic Personality Disorder) WM 173 m&Vmm.Y 9 7°xX|51W^fC (Basic Pancreatic Trypsin Inhibitor) (£77°of-X$££ im^lllic (Base Composition) QU 58 &SM (Base Pairs) (£Mlll&$££ il^Sc5'J (Base Sequence) QU 58 ^^S^ilffl|5]f4 (Base Sequence Homology) UW&Wi^ ffi[5l14$££ &^J± (Base Ratio) (£i£XIM:$££ xxyo~7xX (Enclomifene) (£yn/i7iX$££ %X (Deglutition) WI 102 ifl$J (Drama) mmrnm wz 330 mmmmg. wm 49 (STWti (Dysphagia) (£€TP*t:$££ €TPfW (Deglutition Disorders) WI 250 #? K14Iiti& (Aspiration Pneumonia) (iH)4'JI'14lfi^$ILi P1M1M (Alopecia) l£H^*S$££ xx77r9> (Enkephalins) QU 68 w&im- WL 104 fa%fW^%&UYmzX% WPS (Cyclostomes) QL 638.12-638.25 i&M (Hydrochloric Acid) QD 181.C5 !<7)l£ir$ WI 302^$££ %^ QV 612 t&t}&yfc9y (Diothane Hydrochloride) Jil-'jSjJJftfiHJa £ m*l (Hyperopia) WW 300 &*JE (Inflammation) QZ 150 &*£«#!£ QW 700 mmiiumzNiz ^*£'l4^fflUjH*S^t*^ (Perianeurysmal Fibrosis, Inflammntory) tt&flglgg&iMt*E$ £ £ &S14)li*£& (Inflammatory Bowel Diseases) WI 420 mmiW) (Helping Behavior) BF 637.H4 i£'llv/5r$l (Centrifugation) ^mbW& QH 324.9.C4 itmxm TP 159.C4 it«fti£ QD 54.C4 ®,mitm qy 90 m&>b QD 54.C4^-$^££ &Ef£ (Medulla Oblongata) WL 310 nmnm (Keratoconus) WW 220 J£HJfr*£ (Bulbar Palsy) (£i^l#*¥$££ x x -fe/l/ 7X h iim (Angel Dust Abuse) l£ 7 x X x y U xSLffl$££ i&m (Chlorine) QV 231 mmm qv 663 mMWTkiVk^ (Chlorinated Hydrocarbons) iifaitlkit 7K^$££ SftMcfl:*^ (Hydrocarbons, Chlorinated) mmmttx qv si Mmm QD 305.H5 mtm QD 305.H5 TfM QD 341. H9 g!^=£: QV 633 SII;fiAI (Insecticides, Organochlorine) jtH SB 952. C44 &^ffi£ WA 240 WttJit (Cylindroma) l£)j*^*)l&*g$££ JifiMSflitS: (Extended Care Facilities) (iB^#^l« $££ xxfo74/l/X (Enterovirus) QW 168.5.P4 x x 7 d 7 4 /l/ X ;§i£*jE (Enterovirus Infections) WC 500 mmm sf 809.E64 ^S®^iO^^$ (;££, tfiJxii'*° 'J * WC 555-556^ xxfn74/i/X70 (Enterovirus 70) fix >y-v7A >V9 $££ xx7nh*xX (Enterotoxins) QW 630.5.E6 xxfD^Ft9>-l (Endothelin-1) (ixxK-fe9x$££ x>F-t9X-2 (Endothelin-2) l£x y K-t U x $££ x>Kfe'J>-3 (Endothelin-3) lixx K-fe 9 V $ ££ x>KV-A (Endosomes) QH 591 x y Y I 7 X g (Endomycetales) QW 180.5. A8 xxhVl/7-fX (Endorphins) QU 68 WSlftf WL 104 ^fte^** r- t°-y 9 X(£ HSISiJt:: xx^^>7pS^ (ififAvO (Enhancer Elements (Genetics)) QH 450.2 pq$t$x ') 7"^ h —7'X (Lupus Erythematosus, Discoid) WK 152 P3t57>f!* (Discolysis) (i^:PB1t' WP 530$ &££ tWbt/i/^x (Luteinizing Hormone) UKfoMfofcJV €X$££ Hl$ft*/i/J&Xfetlj'7/i/^E X (Luteinizing Hormone- Releasing Hormone) Ii 7f K x U X $ £ £ tMM*/l/€X (LH) WK 515 tftK (Luteoma) WP 322 Mitmtk (Corpus Luteum Cyst) (iM*flS$££ Hf^-tv/i/^ X (Corpus Luteum Hormones) WP 530 Hi! (Jaundice) WI 703 WjmttiUmfJtMlM. WH 425$££ Xto/N-y(iWeil*?1 WC 420#$££ H*iftjfiLl4 X7° h X 17Se (Leptospirosis, Icterohemorrhagic) l£Weil*?j $ £ £ If Bffffi4>x 3 — gjjj (Echocardiography, Cross- Sectional) li'll>xr?-g|^$^£ »in± (Vomiting) WI 146 -zt&mt&minmm qv 73$££ <&mm wq 215 IfWiW RHl'WfF-Jll WO 245$ &££ #** (Yellow Fever) WC 530-532 ft'flE (Macula Lutea) WW 270 li'iW:^14 (Macular Degeneration) WW 270 fc7A (Parrots) QL 696.P7 **i*?j SF 994.2.P37 "HffllMt LT QY 60.B4 t7Ai (Parrot Fever) li*/U- h - xX $ £ £ t7A*j*j (Psittacosis) UfcJV- Y -xX $££ t7A*«iJ X^I^-flfiEfl^ (Psittacosis- Lymphogranuloma Group) (iChlamydia$££ HM&IS5l*lMi (Rhabdomyosarcoma) QZ 345 vmn-.tnhnuMomz mU%mm& (Rhabdomyolysis) WE 550 liDJU'L'fl^ (Psychology, Applied) BF 636-637 i#Jj7Xr- (Stress Test) liil|Jjflli.!r$££ + *7*?'<7# (Vespid Venoms) (£XXV'<7#$££ Ac$3*>$SrS£ (Size Perception) WW 105 fc 7 >i Y (Occultism) Ii WW? $ £ £ ;$« (Chiiis) u.i.&z.; turnip ; ffi& ; ;^^$££ t^f7; (Euphausia) (i'f'w«H$££ 7*7 7fl (Nyctiphanes) (£9^1$ ££ fc^-yV'-JV (Oxazoles) QV 95 t^-7xKooX (Oxandrolone) WJ 875 fc^y^9*)y (Oxyquinoline) tfc&'&mt LT QV 250 fc*y9na*c> (Oxychloroquine) Ii t Y n * x y a n *X$££ t^y^nofy (Oxychlorochin) (£ t KnJf-/y*DDJf X$££ t^fyrt-t" (Oxygenases) QU 140 **->?—fcT (Oxidases) Ii** x K x ^y y -fe*$££ ^^x7h774y9x (Oxytetracycline) QV 360 Tf * -> h x X (Oxytocin) QV 173 **y Yv 99 y--fe (Oxidoreductases) QU 140 7f^r->y4'Jx (Oxyneurine) I£^y4x$££ fc*y9-JV (Oxyquinol) li**x*y 9 X $££ 7 * x 7 x x 7' y 7* X (Oxyphenbutazone) QV 95 :t * x7o U x (Oxyproline) l£ t K n * ->7°n 9 X $£ £ **xA (Oximes) QV 124 * * x x (Oxine) (£* * x * 9 U X $ £ £ ^^•y^-yijx (Oxoquinolines) li*y'nx$£i * * 7 y/l/ y X - h (Oxoglutarates) l£ 7 h 9)V9 X ^ $ ££ * * 7 7xf/UxX (Oxophenarsine) QV 254 yJ-^V7°D/^f—/U (Oxopropanal) Ii t/l/7*7/l/7"t h $££ fc9 97'iiy^ (Octadecenoic Acids) itfc y A xl&$£ £ fc9 Y Y'y (Octodon) lilfo &$!$££ is < X7 (Eructation) WI 143 HfrflSH: (Distance Perception) WW 105 WM (Cloaca) WJ 101 fc y 9Wk (Aspidium) QV 253 *xhxX (Ocytocin) Ii** x h-> X $££ isl*y;>) (Pacifiers) li?L^*ff$££ jfrt» (Nausea) WI 146 txTT^-7 (Osteopenia) (£ftit14#*^f.$££ fc-X Y 7 9 TtiiM (Australia Antigen) liBSflf&i/L^ 551 *X 17D $££ t - * Y 7 o 4 K AM (Australoid Race) A5T£ GN 662-671 tX;7A (Osmium) *«<£■*• QD 181.07 Ha^ QV 290 W& (Pollution) itftyk* (Chin) WE 705 T?x# wu ior#$ ii%x %*?ii&> (Widowers) (£*£A$££ %(?>x.tt. (Sound Localization) WV 272 fc-Y 9-y ay (Automation) T 59.5 ^m\t*79xizmmztiz>m&u±mmiz, mum. *tS«i|^li QY 23 fc—Yyyfc7yy4— (Autoradiography) mm -fe QU 4 ^ft QU 25 ^mm QH 324.9.A9 «^jf-ft QH 585-585.5 &mmmm qy 95 mm (-fe) wn 445 *l$e^&W* QU 525 &mnwizmmzti2>m&u, ±mm^ fcy-if^fJV (Monkey, Vervet) Ji 5 K9 77l/$££ fc-fii'7'jvn (Cercopithecidae) QL 737.P93 mm SF 997.5.P7 tl»t Lt QY 60.P7 fc-fcXS. (Bandicoot Rats) l£4-X'^3I$££ t-^'-fyft- (Overdenture) !£*—' WO 234 fc\zfcA H7f K (Opioid Peptides) QU 68 *t°X h/l/*X*£ (Opisthorchiasis) WC 805 fc-y y y Y 7 -y 7SSia (Orphan Drug Production) QV 736 77 4X^14 (Surgery, Office) I£^*m4$££ 7 7 v — x (Opsonins) tttt QW 601 &f*^#f QY 455 %ifcfrtim^$tiZ>~ QW 680 &im QW 690$ &££ *7o*7-xX (Ofloxacin) QV 250 *^7 x h^fcfto'lt (Conditioning, Operant) BF 319.5.06 fc~ (Operon) QH 450.2 * fc-y -7 A (Opossums) QL 737. M34 fcfc-y7^m (Didelphis) (£*-7°-y7A$££ *-^3-771/ (Cebus) QL 737.P925 m% SF 997.5.P7 %msmtLX QY 60.P7 *Axytfiifll*i(Hemorrhagic Fever, Omsk) WC 534 *Axyji}lfa.*fc7 4/l/X (Hemorrhagic Fever Virus, Omsk) l£7-S0Hla&7 4^X$££ istf^>frMtl (Diaper Rash) WS 420-430 fcfro^jt^tr (Diaper Pins) l£j£af*^$££ *y 7*y o 07-fe h 7xy X (omega- Chloroacetophenone) QV 665 * y 7*g&K (Omega Protein) l£DNA h fcA 9 9 y —fe $££ fc9m-mmm (Fatty Acids, Omega-3) QU 90 mm\?$xummtfF/7 x 9 4- 4 7A$! £ *7X7-yx (Pongo pygmaeus) QL 737.P96 mm SF 997.5.F7 %m%mt LT QY 60.P7 *- 9 ^ ^ 9 X (Auriculin) (£4»5lf h 9 7AfijmH4-$ ££ 7 9 7y y X*f K (Oligonucleotides) QU 57 * ij 77 y X*f Y^mmmmft (Oligonucleotide- Directed Mutagenesis) l£#£M3!?*^fite$££ * ij 7 9 ^7 y X*f K (Oligoribonucleotides) QU 57 Wfa (Textile) W'k WA 250 fcJVifXA (Orgasm) HQ 19-25 fcjvyyyyy (Ordiflazine) l£ 9 K77v7X$££ fcjvyy'yy-*) X (Orciprenaline) QV 129 */l/7 ^°X r-^7774— (Orthopantomography) it'* 9y-?xmmk£%x fcJVV 5. 9 97 A JVXty (Orthomyxoviridae) QW 168.5.07 fcJVV i 9 97 A JVXm&i£.& (Orthomyxoviridae Infections) WC 512 fcjv Y -x t Kn^f x/ (Ondine's Curse) l£Bf§gBWfP&*E 1£S¥$££ lmf£i (Temperature) f\2M*7- WB 700 %.%'¥ QC 901-913.2 m^m-mmrnm qp 82.2.T4 km^n^mmmm qt 145-160 ttia WB 270^ ; *tf*mi£ QT 160^ ; ffl'iim^ QT 1503 \m QZ 573$ &££ iaJtlSH: (Temperature Sense) WL 103 i£)tlSig (Nystagmus, Caloric) (i£Jlft«igii$££ i£j£IRJg5tf* (Caloric Tests) WV 255 im.fx.it (Thermometers) Mt LT WB 26 Vnmm<f&izisiyh WB 270 i&KSffS (Thermoreceptors) WL 102.9 SfftRRlg (Nystagmus, Thermal) (££S&T 7 A f 7 x 4- /l/7*n -y 7 $ £ £ y^H'l47/i/x7A^B(f^ (Calcium Blockaders, Exogenous) (£7/l/x7 Af 7 x4-7U7*o -y 7$££ ytH'l47/i/x7APP|iJ^ (Calcium Inhibitors, Exogenous) l£ 7 JV x 7 A f 7 x 4- /I/7* o -y 7 $ £ £ tt&fH&K (Pruritus Vulvae) WP 200 W£gB (Vulva) WP 200 W£S$Kifc (Vulvovaginitis) WP 200 553 ■hA A >7 5WS&13H* (Vulvovaginal Glands) (iBartholin8fc$££ &l*j (Paintings) mmw& wz 330 ffitt|£3*M£ WM 49 telfh'tftUfcT X h (Thematic Apperception Test) WM 145.5.T3 1eS7 7X Yy — y 3 >tXY (Picture Frustration Study) liRosenzweig^®7 7Xhl/-X3X7y7/f $££ tTAif-l^-y -ftSSc^ (Geiger-Mueller Counters) lift ^ifc§Uii]£$££ ikVO. (Congresses) W 3 A£ • ttF/rii W 3.5 NLM^Hl^lcftAto rNLM^HH^J $*>££ m>)%%7tm&MUmm%. (Periadenitis Mucosa Necrotica Recurrens) (£77yi4ni*l&$££ WMmmm (Regression Diagnostics) ^HJ'Jf^Jf$££ ^Ir^&flA (Ectoparasitic Infestations) WC 900 mw. WC 900 mmm<9> sf sio @'Jf|^ (Relapsing Fever) WC 410 H'Jf-frtff (Regression Analysis) QA 278.2 ftWY t-yyxl£, ±MSijK fflmWi (Thoracotomy) WF 980 mW-mm (Naval Medicine) VG 100-475 mi mt¥ WZ 112.5. M4 10 A WZ 100 »£ VG 470-475 m^m WO 800 &¥fij£ (Naval Hygiene) (iiS¥[S^$££ :MWWm (Naval Science) V mi V 101-109 UWmm (Naval Nursing) l£|iE¥#^$££ UWtYW (Naval Surgery) liilfg? ; 5||#WT^i W WO 800$££ UWmU (Hospitals, Navy) (£|S£¥*?il%$££ a^ft" (Accounting) %mm\*ii^x MZIt (Contour Perception) l£ffiMfcji:$££ KMWiM. (Carotid Artery, External) WG 595.5.C2 ®&m%. (Ileocolitis) l£Crohn*?!$££ t£tfn.m (Scurvy) WD 140 H(a] (A^mm) (Extraversion (Psychology)) Ate BF 698.35.E98 *ffa##f WM 460.5.E9 Mmtklg. (Port Quarantine) (£*£*£$££ fflllBm (Lockjaw) (£^mm; MPPfW$££ WPPfS (Trismus) WC 370 ft-mmm (Foreign Aid) (£Mm;rj $££ y*HlA#H^ (Foreign Professional Personnel) imwm (-fe) W 76 &m Q 147-149 FMG W 763$ fc££ frm^k (Caregivers) ^^.^■ffu^mmz WZvlrm%<7)Zft£ii%x ^#£e (Exostoses) WTE 250 mmnnhou^iimiz ^4-i_CI> (Interneurons) WL 102.5 KM (Ear, External) WV 220-222 :M¥mm (Nautical Medicine) (£&¥I77$££ 5^& (Otitis Externa) WV 220 ftM (Ear Canal) WV 222 ftfc (Trauma) liiUfSHil1£$££ ft-Mm (Traumatology) WO 700 ?14If£#*& LnS (Osteoporosis, Post-Traumatic) Ii Sudeck#ftg$££ KWikW^.&(Neuroses, Post-Traumatic) Uftfa'&x Y xXPf*$££ PrWikX Y XXPft (Stress Disiorders, Post- Traumatic) WM 170 7\^\kXLfrh, (Epilepsy, Post-Traumatic) WL 385 >A%WfeMimW; (Trauma Severity Indices) fY%^MW^^)V-T (Hernia, Diaphragmatic, Traumatic) WF 810 ^#14^^ (Dental Occlusion, Traumatic) WU 440 WI14x a *y9 (Shock, Traumatic) WO 700-820 ?14I14'l>M§J (Cardiac Rupture, Traumatic) U>\imi ^$££ ft-^mnm (Psychoses, Traumatic) (£§sSC'l4*jfW?i$l £ K%WMm (Ballistics, Wound) l£££|iJ$££ K^XLfrL (Epilepsy, Traumatic) WA'fe'ikXLfrL $££ WifflSw (Dressings, Surgical) l££^ ; %&&%%£ ££ 1tBh&$St (Suicide, Assisted) W 50 »iR£ (Abreaction) WM 420.5.A2 J&7JC (Seawater) 3tM!l$££ jfc*f5!fe (Sea Pollution) i£i&7j< ; 7Kgf^iS$££ }fc*i£ (Sea Bathing) U'&^m ', *$* ', }£#«&*£ J i^7Ki§iI (Beaches, Bathing) (£jgi7t.*i$££ Jft*fKS (Thalassotherapy) WB 750 tffM (Scabies) WR 365 mmm sf 810.S26 S)8g*#&E (Onchocerciasis) WC 885 HISI*ttAJS (Onchocerca) QX 301 MM (Seaweed) QK 564-580 m&ffi (Fenestration) WV 265 5M*m$&££ &%.& (Keloid) WR 143 ftmmifc (Lateral Cyst) (£ftlftlfe$££ J$f£S#S*?5 (Schizophrenia, Disorganized) WM 203 @A (Roundworms) f£|£jklS$££ SATO (Pest Control) WA 240 &M SB 950-989 m&mm qx 6oo$££ MA& (Ascariasis) WC 870 mmm sf sio.as SJ&_L£r (Ascaridoidea) QX 277 M&m (Ascaris) QX 277 t*M±AtKx7° (Infusion Pumps, External) lii±A7x7 $££ @1§ (Ileum) WI 512 @B§& (Ileitis) WI 512 mmmm (Ileal Neoplasms) WI 512 Mffi&fclft (Ileostomy) WI 512 mmWiVk (Iliac Artery) WG 595.15 554 *j437-t* [nlfc; (Rotation) %i%mm wn 720 *%$ WD 630 agco ww 103 ftKlcrt-yyxli, iSSiJU frMSttll (Abducens Nerve) WL 330 Dftg (Glycolysis) QU 75 ffiMfff (Craniotomy) WL 368 ft#$ (Exotoxins) QW 630 frAl4iiffc^®f^ (Radiology, Interventional) #n«i:LT WN 21 tt& (Ectopic Pregnancy) l£4L^^4£(!B$££ ^4-xtt (Kainic Acid) QV 253 WL&1&& (Concept Formation) BF 443 ll'JIMtWJLW WS 105.5. D2 Jg.S (Hippocampus) WL 314 WTfl^ffMfiE (Ectodermal Dysplasia) WR 218 ftJX (Ectropion) WW 205 ftlxftfih (Hallux Valgus) WE 883 EljS^fi (Avoidance Learning) BF 319.5.A9 ft-felh (Integumentary System) (£&!#$££ ik&m (Lumpy Skin Disease) WC 584 ftftfflftj (Dermatologic Agents) QV 60-65 *mm QV 63 ttltai QV 63 ikftmnm qv 63 ftHits QV 63 WtiA,m QV 65 ; mmm QV 653 : ^PWJlt&ife^ QV 220-239$ £>££ ft^ttJSI'J (Pleasure-Pain Principle) fifttTrtff WM 460.5.P5 •t>3¥ BF 515 HHIJW (Convalescence) WB 545 1fi?£ WO 183 Wimmi'lt (Hospitals, Convalescent) WX 27-28 WSfcffl^ WX 150-190 mmm t mm. wx 140 B£S (Recovery Room) WX 218 Hft^flU (Recovery Room Nursing) (il#BH£fHS$£ £ WfeMi (Laparotomy) WI 900 tt4MG?» (Exocrine Glands) QT 172 SJ»» WR 101 #£^»(i-eH WG 201 IffA WK 801 ffl* WI 301 Hgpfi WV 501 ^tt't-ms wj 701 85fl-trr* WE 101 MS* WL 101 © WV 301 fra-m* qs 4^ fl"#PHPgSfKr': WV 101 *?W£o (-fe) QZ 0SMSI5 WV 401 T§ff£ WK 501 »¥«# WF 101 SI* WR 101 1 WI 301 frrfrtfJ WO 101 & WU 101 ¥ttl» WK 201 ^m*«ii* WJ 101 U£#M*<7> QL 801-950.9 #^<7)|J]^^$^££ H¥Sil^# (Anatomists) lifeifi WZ U2^tmmcoT<7) A£ -ftffifi QS 22$££ MJ&ftfcOTf (Glaucoma, Open-Angle) WW 290 ffl#Cl»a**fll¥ (Open-Angle Glaucoma) liBfl»ft»rt» $££ H^-i-flf (Fractures, Open) WE 182 Wilk-Zftn (Spina Bifida Aperta) (£ftS&'l47^Wtt$ ££ ^SiJtlS (Models, Anatomic) QY 35 7 4-^x (Caimans) l£7-1)1$££ IPffiifittS"J (Surface-Active Agents) QV 233 Ifc^ffiStt^K WF 600 ; SdB3I*l QC 183$ k££ iS^^TvlfiL^il (Hemangioma, Cavernous) QZ 340 mmtmmiz M\hmMWL (Ambulatory Care Facilities) WX 205 74-*f£t|-fe y 9 - (Health Centers, Ambulatory) I£t1-* te*JOfet£$££ ft-%MWi (Dispensaries, Outpatient) itmf%K^:B^r^H $££ tt*±* (Hedonism) l£?^$££ tfftt (Dissociation) (iftOTfW$££ AMIWW (Dissociative Disorders) WM 173.6 mm t X 7 9 - (Hysteria, Dissociative) l£f)¥fllPf W $ £ £ yVJ X'* (Perilymph) WV 250 ?4 9 x'*tf (Cochlear Aqueduct) WV 250 H«l (Shellfish) mm^xumm^^m-kt lt wb 426 fiiOW SH 365-380.92 *£*?t SH 179.S5 ^H WD 405 ¥t££I QX 463 ; ^ttgrffc QX 675$ &££ ilA v7y9T 4 >y9 (Chiropractic) WB 905-905.9 £!S (Speech) WV 501 ?§iil£W!S?§ii WS 105.5.C83$££ TWMmm (Hypopharyngeal Neoplasms) WV 410 7 7-f/i/*'- (Causalgia) WL 544 7 77o.-y (Caoutchouc) linA^lJ; 7 7^-||& (Cowper's Glands) (£mifM$££ 7 7 X-fe 9 x y (Counseling) WM 55 mmth WY 87 mm wm 55 ilf£(i*fsf@§£ QZ 503$££ n%-mizisit& ws 462 fVJimtwjimiztsiiz ws 105.5x3 *S4g WM 55 tt&p7 7 WM 61 14 WM 55 £r£¥*&1*H WA 3053 m^ LB 1027.5-1027.9 &ffl&Af*& LC 5225.C68 4^3^^ LB 1620.4 1620.53 rii3^W LB 2343 (NLM^gT4ii^#^18£S^liiI^ &#£?)$ *S#1?j£II WA 352-3533 $ & £ £ ^H HF 5381-5382.5 fF-H# HD 5549.5.C8 mnm^ wa 495 7 7 X 9 — y 3 7^ (Cardiac Electroversion) (iH:^7 */- xy-x3yy$££ #>xTxn -y7°*R (Maple Syrup Urine Disease) WD 205.5.A5 ii^)V% (Frog Venoms) l£Po £$?#$$££ ijx-JVthZ-if^jV (Frogs and Toads) (£&^fl$££ J]3U)vyA X-g^f£ (Caerulein Receptors) li^ x->x Y *-x££ft:$££ M (Face) WE 705-707 M<9>m^n (Facial Expression) BF 592. F33 fl'JLWtty'Jim WS 105.5. C8 mmwtk^ WB 275 41^ WE 705 #af£3 ^ j--T-y 3 X HM 2583 \ Affi BF 840 -861$ &££ 7 fc 9 X (Kaolin) QV 71 #14 (Culicidae) QX 510-530 ^y'ij-m QX 525:^-^777 QX 515; 4x7® QX 530$ &££ 7 7^" (Cacao) @WX(£*£*fi^i§&£: LT WB 438 itmftffi TP 640 $c*S SB 267 ~(n^,m SB 608.C17 mmm qv 107 Jfr*4 WB 4383 ; *7 xf'- WU 113.73$ *>££ ^4^ (Science) Q mi %&9ayT§lPkft%ft<7jmi&££ t£i 556 ■ht-h>-* ft^g^ttH (Chemodectoma) \t9ftW\-'*y*f> 9 9 fc -v$££ T?6iiIli!#JI:M4;:£*jE (Mandibulofacial Dysostosis) WU 101.5 ft^ftffi (Chemical Technology) Ii7 7 y o x-$££ itm^f^mtm^T'JV (Chemical Models) !ift^7*/U$ ££ itmjt^ (Chemical Elements) I£tC^ ; MRf* ; tt#H4 |s]fift$££ {tmxm (Chemical Engineering) TP 155-156 ffc¥I* (Chemical Industry) HD 9650-9663 &Mmm WA 4003 HkMmm^l WA 788 T*# (Mandible) WU 101 S#*>T<7>«r* r- t y 7 X $ fc £ £ TH#Man«l (Mandibular Condyle) WU 101 TP###f (Mandibular Fractures) WU 610 TS#fI1§ (Mandibular Injuries) WU 610 itmMM (Stimulation, Chemical) QV 38 TS*£& (Mandibular Diseases) WU 140.5 itm$& (Dictionaries, Chemical) QD 5 THIS*! (Mandibular Neoplasms) WU 280 itm^fc (Chemoreceptors) WL 102.9 T^tt£ (Mandibular Nerve) WL 330 ffc^ttrtKft-ifettK (Water Pollutants, Chemical) WA 689 ft^lUiS (Chemicals) mm: mm; &x.T-]E^& (Fraud, Scientific) !£4M)xi7&$££ fL^SC&JWfW (Substance Use Disorders) WM 270 -290 ttm^&m (Chemosterilants) WA 240 itmfttf (Chemical Analysis) (£^f)f«$££ T^ffiffl. (Mandibular Prosthesis) WU 600 itm^TJV (Models, Chemical) QD 480 £1* QU25XI£/?-c7)gJ£$ixTt^*!t*W#^-i: TH^|e{£Ji (Mandibular Ridge Augmentation) l£HH &*$££ \mmm (chemotherapy) ummmmz&x itm7 9j-y (Chemical Vaccines) liM7^f X$£ £ *»*»*: (Heel) WE 880 *»?*'< a (Snuff) im&9'<=i£%X i*£M& WV 272 tfl^fctf (Perilymphatic Duct) I£tVJX^$££ %Lmftitf&&m7-'<-9 (TGF-beta) l£TGF^-y$£ £ #ifc$&(Blast Transformtion) l£ 9 x^Jfc#j£4k$££ i&fc-ffiffl. (Cochlear Prosthesis) l&AXfiZ&JLX 4^4^ v 4 y n 7 r Xfl4i (Cochlear Microphonic Potentials) WV 270 7*m (Oysters) QX 675 *ft (Poultry) mmm sf 767.P6 fislW SF 481-507 £.mm SF 768.2.P6 %M&.tyl (Poultry Products) Mm&fXummti?coffi'kt lt wb 426 £$tffi£.m%m wa 707 m WA 7033$ fc££ %^fa£um^ &lc#^- iz W.mm (Nuclear Medicine) WN 440-450 mamX (Theses) (£^fffHX$££ iRx^yuir*- (Nuclear Energy) WN 415 %M.m QC 913.2.A8 mkmm QC 770-798 t£i£14*llis&«1£fflJ|± (Spreading Cortical Depression) WL 307 ^ly^n-y (Nuclear Envelope) (£$ffg$££ mm& (Kernicterus) WL 362 ftffcjfilM (Angiokeratoma) WR 500 n\tm (Keratoma) l£^IL"*£$££ ftitfc (Keratosis) WR 500 'mfflffi (Temporomandibular Joint) WU 101-102 lifmfp^.f'. (Temporomandibular Joint Diseases) WU 140.5 ?MPSn*£1i^f¥ (Temporomandibular Joint Syndrome) WU 140.5 mmWftWi (Maxillofacial Injuries) WU 610 %IMM^M (Maxillofacial Development) WE 705 ttftft#£ WU 101 557 ■h9f)>9 tflflfjl/ritfity (Maxillofacial Prosthesis) WU 600 ■7 4.4^ (Underachievement) BF 637.U53 K7X- LC 4661 k\\y--.m\& BF 698.9.A3 Ht-fl (Nuclear Pore) l£t£Il$££ ti"HI*SflH (Nuclear Proteins) QU 55 W&M (Retrognathism) WU 440 3PAIR (Gnathostoma) QX 203 S# (Jaw) mmm wu 101 VLB WU 610 %.mm wu 102 H#^f^ (Jaw Abnormalities) WU 101.5 S###f (Jaw Fractures) WU 610 m&m& (Jaw Disease) WU 140 «#K* (Jaw Neoplasms) WU 280 P#^tli (Prognathism) WU 440 ft-pj-ftflfc (Jaw Cysts) WU 140.5 ^#gic h \i-y 9 xi£, ±mmz MRI WN 185$ &££ W^*n,|X^y'foX3b0- (Spectroscopy, Nuclear Magnetic Resonance) QC 762 S#l.& (Jaw Diseases) WU 140.5 m^ (Learning) W¥#l LB 1603-1632 bVf (Cell Nucleolus) QH 596 tPhfcBBfeisS (Nucleolus Organizer Region) QH 600 f£7fMMf* (Nucleolar Organizer) lif£7f£ffMW<*-1 £ {£7f*gr3K (Nucleolar Proteins) lil£$f$3cfif?$l £ gg (Arousal) WL 103 If IJJiii BF 199 ?L]fc»i *:*&£»! WS 105.5. C7 m^E (Students) mmim WM 2703 ftitti4t-h*X WA 352-353 ^Sfcffi^-e* WA 350-351 mm HQ 27-29 #¥« WS 4603 ; 'W£ ws3$ &££ ^SlttfJ (Wakefulness) WL 108 IBAffi^Kfclta QT 265 m^Mik (Student Selection) (£A^rJU£$££ m£i%&M% (Student Health Services) WA 350-353 m^±mtw-m±m wa 351 mm^ wa 353 mnm^-vx wm 303; ^ci*H7-tx WA 3503$ &££ m^mv-y (Student Loans) li|ScWtiD]$££ M^ (Nuclear Warfare) WN 610 "Mm3Z& (Prognathism) WU 440 ^lTIi*Sffi (Subcorneal Pustular Dermatosis) li'MS 7K*§14&J**££.$££ m%ft%& (Karyometry) QH 595 mmrnm qz 241 JfiT^itffl ny9 9 hXXX" (Contact Lenses, Extended-Wear) WW 355 &SB1S. (Nucleoproteins) QU 56 «5M>8$*£ (Cardiomyopathy, Dilated) (£7 oiLl4-C« ®5*m$££ tifim (Diastole) WG 280 tiSmm (Dilatation and Curettage) WP 470 $mm'wtzsbizmm2tiz>t%&u, i.mmz WWfc (Dilatation) fen^-ffi WQ 400 %.mm wq 305 H?L^ WW 240 558 ■hxA9A W&$uk (Alveolar Ridge Augmentation) WU 600 $£JMK (Maxalary Artery) WG 595. M2 Htf§fe*£ (Acquired Immunity) QW 551 tf&Uft (Nuclear Waste) (ilA#M4^^^$££ ^g|5it^[S-?^W (Education, Medical, Undergraduate) W 18 Wimm (Nuclear Physics) £ftfSr# WN 415 fymftm QC 770-798 $1&ttt&mm (Nuclear Radiology) (it£|77-$££ Hifw (Maxillary Prosthesis) l£?Ii^ffiMM$££ ftflt (Nuclear Membrane) QH 601.2 «?t QH 601$ t££ ftm (Cornea) WW 220 7A'<>?X.m WW 170 #ttt WW 220 ft8£#tii (Corneal Transplantation) WW 220 ftH& (Keratitis) WW 220 nmtkm (Corneal Ulcer) WW 220 ft&8i (Corneal Arcus) l££Ai!$££ ftRlSS (Corneal Opacity) WW 220 ft8£#c£< (Corneal Diseases) WW 220 ftmXfo (Corneal Endothelium) tifclRl*]/Ji$££ ftHft& (Endothelium, Corneal) WW 220 WlW^A WW 210 TA'Q9to.MT& WW 170 ftmkim (Keratomalacia) l£iSl^^«*iE$££ nm%km (Arcus Senilis) li£A^$££ PKtt.£3 (Isolation, Patient) (£.t.#P>$££ Pggt*^ (Hypertelorism) WE 705 Sf$ (Probability) QA 273-274.8 m^m^ (Probability Learning) QA 273.2 »JSK'& LB 1051 5f$iig (Stochastic Processes) QA 274-274.76 ®%Y\z-y9XU, ±fiJSiJ(; ff$€7/l/ (Probabilistic Models) t£^clttiS$££ $t$H (Probability Theory) QA 273-274.8 %f%Y\z-/9XU, ±fi«ijn Hltt£i$ (Isolation Hospitals) li#H^K : .ft#RSH* ££ =F7jfSPfifcW (Education, Competency-Based) lit&TjC: *7<#*W$££ ¥H£ (Educational Status) S^£&-feft&ftfg^ L 111-791 ¥Kf3£ LB 2823 VfWsY \z-y 9 xizm^fc i>W}^u^.mmz #J5'J^« LC 1390-5160.3 JftHM (Hyperplasia) QZ 190 7>7y7x (Cachectin) liTNF$£i itltV (Gambling) mumm^ttx wm 190 feBfcH& BF 637.R57$t££ if- 7/f ij XA (Gargoylism) (£ A 3 %%$&. 1 SLJ $£ £ 37LHft (Dental Bridgework) lia^^fta$££ fP*f (Thrush) (iP^^E-0 7*£$££ Tff^gjM (Aorta, Descending) l£B^AIM$££ 7 ^ yjvm (Cacodylic Acid) QU 143 til79-'7A >V (Benzoyl Peroxide) n-fcmmt LT QV 60 ij^y Y 7 9-JV (Casanthranol) li7X77$££ AOjM (Volcanic Ash) (£p£A$££ YB. (Lower Extremities) liEK ; ^;£g|3^)£ft;$££ TK (Lower Extremity) l£i|l$££ Mi (Fires) l£A&$££ KKrftflS (Leg Ulcer) WE 850 4*1*^ (Radiation, Visible) l£7t$££ 'rr*Hrr*i& (Alveolar Nerve, Inferior) (iT!I;fM&$£ £ Xmm (Leg Injuries) WE 850 TH WE 870 ±ffi WE 855 *->^7- (Sand-Dollar) l£7-$££ TR& )*#!.* (Leg Dermatoses) WR 140 SSHS (Superfetation) WQ 235 'M'Pft& (Hypomenorrhea) (i)!*£Prt$£i fflfiJKII (Supernumerary Organs) li:&^$££ $&*£ (Hyperphagia) WM 175 7X (Gases) ^M^^l$££ Xmt (Pituitary Gland) WK 500-590 TSft=fiHffi1tSi£ (Pituitary Function Tests) WK 502 T^ttim &««&&£ WK510$&££ T^f*^Bg7L3l*£ (Hyperpituitarism) WK 550 TMffcfefcfiglSTffi (Hypopituitarism) WK 550 TUffcfi^ (Pituitary Gland, Posterior) WK 520 Y^W-WMfc-JV^y (Pituitary Hormones, Posterior) WK 520 Titf*#l.£ (Pituitary Diseases) WK 500-590 X^kftmm (Pituitary Neoplasms) WK 585 Tmmtmmmnm (Basophilism, Pituitary) t£ Cushing#:fl££f$££ T^ft447A*£ (Dwarfism, Pituitary) WK 550 Titft:14ttMlifiiJ8fr 7JV^y (Gonadotropins, Pituitary) WK 515 Tl£fef&%:fcJV*:y (Pituitary Growth Hormone) UJk fi*/l/^ex$££ XMiPMLUMftXfcJV^y (Lactogenic Hormone, Pituitary) !£7°U7y7x$££ T^fc'lii&yiMffllfcJV^y (Mammotropic Hormone, Pituitary) l£7°oyy7x$££ ym^WB (Hypophysectomy) WK 590 X^i^mM (Pituitary Gland, Anterior) WK 510 Xi&ifcMMfcJV^. X (Pituitary Hormones, Anterior) WK 515 "TMttliJtf&Rtfcfiglfclt (Pituitary-Adrenal Function Tests) WK 510 559 ■h*A9A K •£ 7 Sim & ft & (Pituitary-Adrenal System) WK 510 Y'i'iYfc'i'ty (Pituitary Hormones) WK 502 K$ ft-,7 'U € Xj&ft.-fwi/^ x (Pituitary Hormone- Releasing Hormones) WK 515 Y&fcfc'V^yfothWfflfcJV^y (Pituitary Hormone Release Inhibiting Hormones) WK 515 Mftm (Hydrolysis) Mmm QD 281. H83 mmitm qd 501 1)U*ftmmm (Hydrolases) QU 136 tfxmW-9 v-?Y 777 4— (Chromatography, Gas- Liquid) (i77Xyo-7hy77 4-$£i ifX®.1& (Gas Gangrene) WC 375 7X7 7 (Cascara) QV 75 77Xynv77774— (Cyromatography, Gas) fttirim QD 79.C45 ^mftffi QD 272.C44 ifXM&fc (Embolism, Gas) (i£fl^t£*£$££ ffX^% (Gas Poisoning) QV 662 fcmzisUh WA 465 ifX'&.XXftffii.te (Radiography, Insufflation) l£flf£lig &#£$££ 7-Xh (Caste) liti^l^l$££ 77 X h 9 X (Gastrins) WK 170 7X h 9 X-g^ft: (Gastrin Receptors) (i^ XxX h ^r- x£^f*:$££ ifX-77.9 (Gas Masks) l^ft^ff ffiJI$££ % (Wind) QC 930.5-959 *»■£ (Common Cold) WC 510 ft* (Metaplasia) QZ 190 (S14ffi7*w (Pseudorabies) SF 809.A94 f£14SA^7 4/i/X (Pseudorabies Virus) U7 9 ^JV^ X74/i/Xl$££ f£14M>il&^(ft#g!*?1 (Pseudoneurotic Schizophrenia) (i #S!*?iS!!AfeP$W$£i 7-fe*4 X (Caseins) WA 716 8&M SF 253 &&tfc-?L?)®e£mm QW 85 #>-t£7 A JVX (Common Cold Virus) l£74y74/UX$ ££ fUS (Fossils) QE 701-996.5 wky t-yyxi£, ±miiz &m. (Underpopulation) (iAP&^$££ k& (Cremation) [mWm»m*JLl *M\%^M (Image Enhancement) Ttm^gg TK 8316 ^iftn^m TR 299 *y^l TR 335 #£<0*mi£±SiJ3iJi:: XHJ#Srtfc WN 160$ &££ HJffcSiSftffi (Imaging Techniques) (£®ft^»f$££ l*lff^#f (Diagnostic Imaging) WN 180 mfcmtkgW. (Image Intensifiers) l£Hiftl$ilP$££ pjffcilTC (Image Reconstruction) l£^ x t a — y djffc&l: S$££ liif^f*^:fEj£xX7A (Picture Archiving and Communication Systems) (iS^I;t^lS^'tW^xX7A$ ££ mm (Family) HQ 503-1057 tfit*S»!e*'^>ilJ& WS 107.5. R5 fi|JK WA 308 Mi& WS 105.5. F2 St-^Mffi WS 105.5.F2 ; ft^FMffi WS 105.5.F2 ; * :m% WS 105.5.F2 ; $ J: nti\.W& WS 105.5. F2$*>£i mmMffi, (Family Relationship) W$.Bi£5LX tam&^mfcWL (Family-Patient Lodging) (ift=£, ^ 7xx7$££ mmiktfx. (Family Leave) mtl HD 6065-6065.5 W.mnm (Family Planning) HQ 763.5-767.7 SSfcttJHa (Familial Jaundice) (££fEl4£fctt*]foIfc&$ ££ »l4*£Bf # 9 *'-yX (Polyposis Coli, Familial) Ii* S£147d##9tf-xX$££ *^'l4i^ r- 9 7 9 -fe 7 4 Kjfo.SE (Hypertriglyceridemia, Familial) UM 9 *°g&lfo*£ 4 S$££ *»El4#tfc#K (Exostoses, Familial) liJUSttitfigftt &«$££ *^'l4^^'l4raKl#*^ (Paralysis, Familial Periodic) WD 205.5.P2 Mma.§W-W%££:Wl&. (Dysautonomia, Familial) WL 600 i£j£14'Pr& (Nephritis, Familial) I£*f£'l4^^$££ ^KttWJfcttM (Familial Erythroblastic Anemia) l£77-fe^7$££ ^J£147vS§7° 9 fc— yx (Adenomatous Polyposis Coli) WI 520 mm^^k^MB (Familial Mediterranean Fever) l£JI]#] 14*£&$££ W.mmtx.m£^m&M (Familial Atypical Multiple Mole-Melanoma) (£HJlM^«1l^$££ *t£14*°iJ fc-yx-m^U (Polyposis Syndrome, Familial) (£l£S£14?VJ!§*° 9 ,7-xX $££ *PJtS (Acceleration) WD 720 Um<7)±$$ (Family Size) l£*/j£<7)#®[$££ mmcoMm (Family Health) WA 308 W.WkCD'gffflL (Family Chiaracteristics) HQ 503-743 %m#$£ (Bursa, Synovial) WE 400 rt$£ifc (Bursitis) WE 400 ^Tflfc (Submandibular Gland) WI 230 BPfl (Beriberi) WD 122 »£jfiL (Hemoptysis) QY 120 ftzmmizM&ztziiCDu, ztzlbii<7)it, ^mmz $>&KK5 (Browning Reaction) liMaillardJEx.Ji£$££ SJiS-fi! (Diastematomyelia) I£^£'l4-#lft£ $ £ £ )S'f4lb^l3H-? (Factor XIII, Activated) l£S&«-7*/i/ y ~ yffy-?—9'JV9 S.JVY 7XX7i7--fe$££ if£ (Talc) %mim WF 654 ik^-nm QV 785 Jt^^gjfflffi (Gliding Bacteria) QW 128 MM (frmm) (Conflict (Psychology)) ?L!£Mfc#j!OU WS 105.5.M5 lHAIUlfiO BF 637.148 tdtt##f WM 460.5.M6 ti^S^ HM 136 iSf^fltt&^^Pf'.1;' (Attention Deficit Disorder with Hyperactivity) WS 350.8. A8 efeAW WL 354 X&WMZ'Jin. (Hyperactive Child) liJlUJ7ut$££ )SD)'l474y/i/ (Activity Cycles) QT 167 i'£lfrl4t£14ffF& (Hepatitis, Chronic Active) WC 536 SDJlli (Action Potentials) WL 102 85 WE 102 Arnmt$Lmmv>&^iz, ttz w£mm<7j&^fr'ii:^®&u-tikv>&i%izftm-£X ffilljSRfi (Active Site) li*S^S|3fi$££ iSDj^ft (Activity Therapy) mwmmzisi7& wm 450 %mim& £ £ mmftWitl (Domestic Violence) HQ 809-809.3 Vin W 860 mmftVk. (Home Childbirth) WQ 155 mm\m7k (Family Caregivers) li^>^^$££ mmm&M; (Household Equipment) li^Mffl*$££ mmKM (Household Articles) -izxmtk WA 288 mmft&w. wa 288 %Lx.%±m WA 288 ^cEfflJfoJfSs41 (Home Blood Glucose Monitoring) Ii MgSi£*l$££ mmmum°a (Household Products) W^Umt LT WA 288 mcoma ww 100 561 •hy*i. *B£ft*iE WA 288 W-fctiK WA 288 l.VVEl!l£.fc*:fcJi£ ?7*x- (Catechu) ,'i77*X$££ *f*a-«H (Catechuic Acid) (£77*>$££ *f ^y (Catechin) vftfefctrtLKfclt* TP 925.C38 ftSfch \Zy9X*JLX 7 7*X$ (Catechinic Acid) (£77dfX$££ tiya—jv (Catechols) %mm QD 341. P5 $fa-jvTiy (Catecholamines) WK 725 7 7^-/i/lB8&7/i/;&X(Estrogens, Catechol) WP 522 bIIS^pC^^T (Denture, Partial, Removable) WU 515 7 7 — 7 JV (Catheterization) -ft WB 365 ■t>HWIi, 'C>7 7-7/U}£ WG 141.5.C2$££ tt*Srtti£ WO 500 SiO(£SUS&7 7-7^ WJ 500$££ 7 77°xX (Cathepsins) QU 136 i&mmm (Electrocochleography) lffi&Kl&&1]tit:§.& ££ ffi*ft*I!lieXlSfi*####f (Particle-Induced X- Ray Emission Spectrometry) (iX^^Tt^Tfe^lTr$£ £ ^TDj^fE-T-a^ (Mobile Genetic Elements) (£DNA4f A g£'$££ &M&1& (Dental Cavity Preparation) WU 350 JfiilMl»SEli£t£ (Hyperkinetic Heart Syndrome) WG 320 i&i&tfJlJciftPfW (Transient Situational Disturbance) Ii iISPf*$££ 7 K ^ 7 A (Cadmium) QV 290 7 h- 9 v 7A (Catholicism) BX 800-4795 fc^iESilliS HQ 766.3 tmnmm wm 6i mmmm w 50 ^^ftfe^5*h t-yyx(£, ±«»ij{;, mtUijY*)-y9 nmmizxzmmimmu wy 85 £#£[S^ WB 88511 ; *<7>ffe9£ffrT-ji&£M*££*, ££ 7 7-^4 xX (Kanamycin) QV 268 7-^--X#A (Cannulation) l£77-7/U$££ $&4S (Superfecundation) (££)!6&$I$££ ftli (Suppuration) QZ 150 BSI5K*fc£ QY 210 && WC 195^$ t££ ft8Rl4fg££&li]& (Periapical Periodontitis, Suppurative) (ifI£J§]HIIt*«$££ ftl&tt^ifc (Otitis Media, Suppurative) WV 232 ftlUE (Pustulants) (£j|!iJM$££ 7 y n y 7 (Valerian) Q\r 767 «»Ht LT QV 85 ^0£-9^At§ (As If Personality) (£AfePrS$££ frVfeSKW. (Fungal Antigens) (£M®4filIl$££ Site (Hypersensitivity) ^1§9^^I$££ &t&&.im (Type I Hypersensitivity) l±BPI#S}&$r-E£ ££ ai^3S (Type III Hypersensitivity) I£&*£*§£4£*?1 $££ iajfcffi4fft'! (Type IV Hypersensitivity) itMH^T V/v *-$££ ifi&'t'K (Irritable Heart) liW&HSIH*S/j*F:*JlJ: &8d4*S)I§ (Colon, Irritable) (i«M&14*£MMSE.ft$J£J: iatett»ffil5l» (Irritable Bowel Syndrome) littftg&ti B§*£&$££ 7 7 x 4 x (Caffeine) QV 107 77x4x-g'#f£ (Caffeine Receptors) (£7 9 X-g'^f* $££ 7 7 x x 9 X (Carfecillin) QV 354 77x7 9 7 (Cafeterias) (£XXhyx$££ TUttM (Hypogastric Plexus) WL 600 77°-74xx (Capsaicin) QU 90 77°-fe/l/ (Capsules) QV 785 77b 7*- (Horseshoe Crabs) QX 460 7 7° h 7 9/1/ (Captopril) ijXM&LJE-mt LT QV 150 mmrnmttx qu 143 77 9 x (Caprines) l£-r-df$££ 7 7° n 7 y y A (Caprolactam) rl^StLT WA 465 »h t-yyxl£, ±HJ5iJtC 77°nxS& (Caproates) QU 90 W® (Pollen) QK 658 71/^rvt LT QW 900 -ktynmmm wb 447 W?tf& (Hay Fever) WV 335 KflMXft (Numismatics) CJ 1-6661 mmfo WZ 340 iftfS^AS (Dinoflagellida) QX 70 7/7x1*]® (Kaposi's Sarcoma) IiKaposi 1*1 It$££ ii. (^mm) (Set (Psychology)) BF 321 7-7*i) (Praying Mantis) !£i£M$££ 7-7*9f4 (Mantids) (£S:M$££ m^kskm^sk (Sickle Cell Anemia) (£tfc;bc*Jfo.ifc14S:ifo. $££ IfctKMS&tSlSl (Sickle Cell Trait) WH 170 §t#*lfoifc14f:ifo. (Anemia, Sickle Cell) WH 170 Mtk^Skfemm (Desickling Agents) (£4t«*tt»Jfo*$£ £ 7-v# (Toad Venoms) l£j3fl£3IS$$££ j&"7X7*X@£7 9 7 A (Potassium Permanganate) QV 229 ft (Paper) mtm%M> wa 778 EPJBU Z 237, Z 247 ni^yy<3 (Chewing Tobacco) l£*&^y ,o $££ 7y (Turtles) QL 666.C5-666.C587 mm SF 997.5.T87 1R£ (Pseudonyms) (£g£ h^x4>-A$££ 7-T4x*i (Muskrats) (£^y 7X* = *4$££ fr^A (Itch) l£*?F*ip$££ *»«9>A (Itching) (££!** 7 *£*£$££ *»t9>Ajhy> (Antipruritics) QV 60 ifi£7^B£ (Periodic Acid) QV 180 *&mm QD 181.11 7 7 — Dopplerx u —121'<£ (Echocardiography, Doppler, Color) WG 141.5.E2 7 7 77'-/u (Kala-Azar) l£f*U« 9 -xxvx.7*£$£ 562 ■h)vy Y - ^7^7^h'S (Crotalid Venoms) WD 410 jfy 7 Y^-j—\f (Galactokinase) QU 141 7*7 9\y 9—fe (Galactosidases) QU 136 if 7 9 Y-X (Galactose) QU 75 7*7 9 f-XME (Galactosemia) WI) 205.5.C2 jfy-J (Galago) QL 737.P955 %mm>z\zx QY 60.P7 mm SF 997.5.P7 frhL (Mustard) mvtmW.Vltl'C SB 307.M87 $.$mmv»tix qv 65 fflfa¥ QK 495.C9 frfcLiJS (Mustard Plasters) l£#$*^T^te«*i|ffl WB 371$ ££ 7 7--x'7x (Carrier Ampholytes) liPitemWEigftft $££ 77 X (Glass) MMmm WA 400-495 xmtm.fkmMizis\jh WG 106 *-*#«¥*££It* QU 105 7 'J y x 4 X- h 9 7x x^?g-t4%M (Kallikrein- Trypsin Inactivator) (£77 nf- x$££ 7 'J -x X (Kallidin) QU 68 7ij7^-/U-7flua^7 4/l/X^ (California Group Viruses) QW 168.5. B9 7 ij 7/1/-7 A (Californium) WN 420 im QC 796.C45 znmwK^miz-mxit, mmmmT iJ X r- $ftT^I>#^-$f£fflt6 Ifife^ (Granulocytes) WH 200 mMMftBlkm (Leukemia, Granulocytic) l£#Mf4&Jfo *?]$££ RH;>''J.RfHfo*?1 (Granulocytic Leukemia) li#Mt4filfo*?l $££ Wl^lIlM: (Granulosa Cell Tumor) WP 322 ifiiJttilr (Whirlpool Baths) li*?fc,Bft££ Ji J: iifit (Overdose) WV^ffl QZ 42 $#) QV 38 «:*«» QZ 42 w%.ntinztt+&*tiu, z^mm 7 /!/ n X (Chalcone) *J17- QV 150 7/Ux7A (Calcium) QV 276 ftflfcft^ QD 181.C2 7/Ux7 A 4 fc x7-\* X4-/1/ (Ion Channels, Calcium) l£7/l/x7 A77 x4/l/$££ 7 ;u x 7 A # #j£14{fcg & K (Calcium-Dependent Activator Protein) (£7/1/*-xx 9 X$££ 7/i/x7AlS#4,'|47n7-f 7 —-fe (Calcium- Dependent Neutral Proteinase) l£7/i/-"f4 X$££ 7/l/x7Al£#|TOriJ (Calcium-Dependent Regulator) !£ 7 JV * x x U x $ £ £ 7/l/x7Aig'f4{b4''f470n77--fe (Calcium-Activated Neutral Protease) Ui]JV'77 5 K (Calcium Cyanamide) I£x77^ K$££ 7/i/x7AftitPf'i: (Calcium Metabolism Disorders) WD 200.5.C2 mmmim we 250 7 /U x 7 A 7 7 X 4- JV (Calcium Channels) QH 603.154 7 JV y 7 A 7 7 X 4- /U7*n -y 7 (Calcium Channel Blockers) QV 150 7ivy7AloMtrffc (Calcium Isotopes) M$Hb¥ QD 181. C2 ^S^ QV 276 7/l/x7A-^74-x7AATP7--fe (Calcium Magnesium Adenosinetriphosphatase) tiCa(27) Mg(2 + )-ATP7-^'$££ 7/l/x7A$fgjtJi3rfi3C (Calcium Transport Proteins) Ii 7^x7A|£^®&K$££ 7/Ux7Ao4 ^ 79 X (Calcium Leucovorin) I£n4 n 79X$££ 7/l/x7AATP7--b' (Calcium Adenosinetriphosphatase) (£Ca (2 7) H5&ATP7 —fe$ ££ 7>vyfc'<—y 3 y (Electroversion, Cardiac) (£1tf\7 7xy-xs yy$££ tjjvyY-y (Calcitonin) WK 202 563 ■h iv y 7 4 7>vyy < y*yx (Calciphylaxis) WD 200.5.C2 7 >vyy 3.U-IV (Calciferols) lix/u 77/i/x7 x n- /u$££ 7>vx~i.9A-y (Calspectin)l£7/U^xx 9 x*££-MSK $££ 7/U7/4 Ymm (Carcinoid Tumor) WI 435 muftniinummiz tj>VA-9 A K'll'*£.ft (Carcinoid Heart Disease) WG 210 7/i/7X^&x (Caldesmon) U7JV* y *. 9 y&fcMBK $££ tuv-^j-y (Carnitine) QU 187 ijjU—A-ytJVS. Y A JV Y 7 XX7 x 7— -fe* (Carnitine Palmitoyltransferase) QU 141 7 /!/ y x X (Carnosine) QU 68 7/U'M X (Calpain) QU 136 7)V'v (Carbachol) QV 122 7;U/<-v-tt°X (Carbamazepine) QV 85 ilfW 9 X (Carbenicillin) QV 354 7 )V^<- y*)yy x -/l/ y x 7 A (Carbenicillin Phenyl Sodium) l£7/l/7xx9 X$££ 7/1/^*7 * 9 o x (Carbenoxolone) QV 66 7/u~*.yy-7nx (Carbenoxalone) li*/l"/< x yjv^i— y 9 x (Carboxybenzyl Penicillin) l£ 7 /I/-*- x 9 X $ £ £ 7/t/7drxX 7/l/xX74 X (Carboxymethylcysteine) (£ 7 /U 7 x X 7 4 X$££ 7/u7Jfx'J7-7* (Carboxy-Lyases) QU 139 7)VX*yiv m.) 7*or 4 7—If (Carboxyl (Acid) Proteinases) li7X^*7 =? >^7°n7 4 7 — -fe$££ 7 /U 7 x X 7 4 x (Carbocysteine) £ft¥ QU 60 mmm qv 76 7 /I/ 77 - h 71 K 7 y - -fe (Carbonate Dehydratase) l£K^llft7K^^ $ £ £ 7/1/77 7 X (Carbofuran) gH SB 952.C3 £%:'$!£ WA 240 7/U79 X (Carbolines) h7X#74-7i: LT QV 77.9 %mm qd 401 7/i/<7xg£ (Carboxylic Acids) QU 98 ^mtm KkWim*g^Sf3R (Calmodulin-Binding Proteins) QU 55 mm (Aging) WT 104 •bm.ftWt WT 145 7o7y4 Y (Carotenoids) QU 110 mtxMmtx\m qp 67i.c35 m® QK 898.C35 \±9 \ XAP^ QU 167 7o7> (Carotene) QU 110 ff^m^l^im QP 671. C3 mm QK 898.C35 \Z~9 a xAHIg QU 167 7*o7"X^^ y^-Jvm. (Gallodesoxycholic Acid) U7 Arfc*y3-jvM£%x 7*o^°~/u (Gallopamil) QV 150 7 o 9 -K2M (Calorie Deficiency) l£yV.£*£ ; S&H- x4/u3r*-^#PfW$££ 7 o 9 -fSJfri: (Caloric Intake) #il£ QT 235 **^^ft QU 145 7 77-^X^4 (Pike) (£77*4$££ m$ (Thirst) w&^mm wi 102 Jlliiif*^ (Kawasaki Disease) it&mm 9 xv*8&£lBS#* ££ *7btvxi (Graylings) (£+r7*4$££ 7 7-vX (Esox) l£77^4$££ *S (Cancer) (£St!li$££ IREE (Intraocular Pressure) WW 103 fcOTflc<l, WW 290 911%. WW 143 lRf±$i]£j£ (Tonometry) WW 143 lfrT9-'<& (Hepatic Amebiasis) li7/-'*ttlff** $££ UfM (Transplantation, Hepatic) fifrrJi$tiI$££ *Sjff£^- (Oncogenes) QZ 202 iSmmMWC (Cancer Care Facilities) QZ 23-24 flfifc (Hepatitis) WI 700 mmm<7)uw)Wimi wz 100 m>zh& • mm ww 22$££ VfryfcmmMm (Bile Duct Obstruction, Extrahepatic) WI 750 ffrTHJB rH 08P (Cholestasis, Extrahepatic) litfJTHfif P^K*S$££ BT7l-IB?t7o^'l4Mli: (Jaundice, Cholestatic, Extrahepatic) imftm^fflimt:£ £ ffFttHlfilteJttH: (Jaundice, Obstructive, Extrahepatic) lifff^rlfi'ff WIH^ $ £ J: %.mm%. (Remission Induction) WB 300 m*Y t.yyxl£, ±fl)3ijll 564 ■h>%ft£ii%x,mtimitimu wv 2723 ®1£g% (Paresthesia) WR 280 gSJtSKliifcff (Sensory Motor Performance) JifSWJHll ^7J$££ &%%■ (Sense Organs) WL 700-710 SJifciSBf (Sensory Deprivation) WL 710 JgHS^fc (Receptors, Sensory) WL 102.9 SULMME; (Sensory Aids) 7 * d 7 W 26 -fe WL 26 *>j&*h WW 350-354 ; 1fR& WV 274 ; -e^f&ft^y 4 7cOiWl£jiS^SI#^-26lc flRffi£.£ (Orbital Diseases) WW 202 mMmm (Orbital Neoplasms) WW 202 IS*4Ifc¥- (Ophthalmic Assistants) WW 21.5 mtmm (Optical Instruments) (£85*4^ fclitfc|R«OT Wl£& WW26 ; Tt^OT^ltis- QC 370.5-379 ; Wk *>»£****>« ft ££ J: 7x7'/!/- (Kangaroos) QL 737.M35 JiSHjff (Oncologic Nursing) WY 156 SfSE (Eunuchism) WJ 840 ffifflMtiii^ffiiW-. (Cancer-Associated Carbohydrate Antigens) ttfgfftt&M&ffilg $ £ £ &M (Ventilation) WA 770 mm wx 165 £H WA 450 ft^JBS (Ventilatory Muscles) (£iJ?-n&^$££ 15^ (Eye Abnormalities) WW 101 SSM-iLJtJt (Ventilation-Perfusion Ratio) WF 141 &50&S (Ventilation Tests) (i^n&^fl^g$££ ffftflgftlt (Liver Function Tests) QY 147 mi (Eyeball) l£IS$££ BSlfciiDj (Eye Movements) WW 400-460 mi WW 400 BS#uIgj& (Oculomotor Muscles) W 400-460 flft&Iib WW 400-460$ t££ IS^JlDjPf ¥ (Ocular Motility Disorders) WW 410 m&m& (Xerophthalmia) WW 208 IBSfc*£$ (Tuberculosis, Ocular) WW 160 m%i£<7)ii co uummz m&MXfc (Pigment Epithelium of Eye) WW 103 mXfoU WW 270 ISi^aiJflL (Hemophthalmos) (£|gaiifo.$££ BSJfcASS (Ocular Adaptation) l£IB<7)JS/£$££ W$M.& (Nystagmus) WW 410 lEjciJijSB (Anterior Eye Segment) WW 210 RRSfrBMWl^X (Herpes Zoster, Ocular) l£HSS(5^«^ /l/^X$££ W&^tk^JV^xy 4 JVX (Ocular Herpes zoster Virus) (£t h^»/U^X7^/l/X3$££ UlSfcgfiSC (Eye Proteins) WW 101 ltf»)i& (Clonorchis sinensis) QX 353 \Wmm (Ocular Accommodation) i£|gWf^$££ UTOSftffif (Eye Enucleation) WW 168 TO^tf} (Proptosis) (£«':£&*£$££ IMI*£&& (Exophthalmos) WW 210 BS^ttVl49J;tUMl WK 265$ i £ £ IH£l^avl49M;yftflI (Goiter, Exophthalmic) l£Graves*?1 $££ IR«r*9H1* (Eye Foreign Bodies) WW 525 IS^I^XXX* (Lenses, Intraocular) WW 358 BlHWm WW 260 S$i£f*l X x X^tit (Lens Implantation, Intraocular) Ii HBfcf*lXXX$££ Sti^l (Environment) »§^l$££ mm (Spectacles) I£a67>7a$££ mi%Wl3L (Environmental Health) WA 30 m&comm wb 710 mnmmfo^m wm 31 kXW% WA 671^$ &££ TOffilfe (Environmental Pollution) WA 670 #£ 9 A 7 (-fe) WA 754 mW^ 7 9 *> Y (Gangliosides) QU 85 7,x7 9 4x KtfWM- (Gangliosidoses) WD 205.5.L5 W7ifc}t)t!£o>flf (Ocular Fluorophotometry) (£M?fclg yt'i$£i mi$m (Annelida) QX 451 HYM (Laxatives) (£T'£iJ$££ ScflfiL^ (Coronary Vessels) WG 300 Stilt fKii (Thrombosis, Coronary) (i;a#ciMJfaftffi$£ £ tulX&'-jF|7klfc''4, (Intermittent Positive-Pressure Ventilation) WF 145 P^TC** (Intermittent Fever) li"V7 9 7$££ liUT^t (Intermittent Claudication) WG 550 HSI& (Eyelids) W 205 !&!&& (Blepharitis) WW 205 SfiB&T^ (Blepharoptosis) WW 205 mm% (Cancer Research) U%%ktf)mm QZ 206X.I£^£ y4 7°c7)H*<7)^ft$££ tBBj«« (Blepharospasm) WW 205 mjtmm (Reductases) (£7* x K V 79 y—fe$££ IBH&l£.t. (Eyelid Diseases) WW 205 mm (Nursing) WY fl WY 105 AIDS/HIV WY 153.5 7°n t LT WY 16 «l£ WY 143 MM WY 300 tmmmuwmmmm wy io6$££ ZkUZkmm WY 152$££ B££(i#igK£ WY n$£i mmu&^mm wy 2oo$££ ff^JW WY 159 mmimm\mnm wy hi$££ ^^|£f^¥#|f WY 130$££ mwimwmm wy i3o$££ W&m<9> WY 160.5 itf4(i)t*4#lf WY 157$ ££ mmrnmkmrnftmrn wy 109$££ xmmuxmmmm wy i62$££ 3"#ngp£f4<0 WY 158.5 7!£f4(i7^4#l WY 159$££ mnnumtmmm wy i6o$££ fi£it£ WY 145 ■'mummmfc wy ii3$££ #H(£#^#P^ WY 101-164$££ mm WY 16 #cft^ WY 31 mumnmm wy i6i-i62$££ m^s. WY 31 HXltliU*^^ WY 107$££ tmxifc'CDmn wy 143 tfclS^ SF 774.5 femZtihm&ttzimHZWi Zfc* ii%X flT-bX^y h (Nursing Assesment) WY 100.4 ff@'3! (Liver Cirrhosis) WI 725 fe^tt WR 267 mmm sf 85i il&^-ffi WR 267$ &££ S'lf^W-?^!^ (External Degree Programs, Nursing) <77±a£?S#iI^|^$££ fi-ai^-Uctt (Nursing Education) l£f,,i#^^$££ mmmft&mii&ft. (Nursing Education, Baccalaureate) (£'?:!;,,'IUV ■fiU'r-ftfr $ £ £ rrffW^fr'TC^fl (Nursing Education, Associate) (i fakwiMmmmmiz&x mmm$t.1$y'<(y°v-?„,m (Nursing Education, Diplo- ma Programs) (£ 7V 7° d -v ,1 f,!■ f;-„/£ -yrffef? $ £ £ HH^ffcil (Faculty, Nursing) -fe WY 19 km?* WY 18.5 m^ WY 19 Sli^lliiltl^W (Education, Nursing, Continuing) WY 18.5 mmm^ (Students, Nursing) WY 18 mmzisli&M WY 105 mwrnrnzisaz wm 30 mmmkmflt^k^ (Education, Nursing, Graduate) WY 18.5 mmm WY 141 m&co WY 113 #l#H^ff (Specialties, Nursing) WY 101-164 iftJfr WY 130 4x7^7>7--t*X WY 130 MWCCD WY 125 !fr£y 4 7V)5ffI$*,££, mumMimmm WY 141 H# (Coxa) l£flJPgli$££ £#0 (Acetabulum) WE 750 566 ■hyy-^z ftHf-HM (Nursing Process) WV 100 fllff^ (Philosophy. Nursing) WV 86 #10*tt (Libraries, Nursing) Z 675.N8 mmmft z 675. ns #II^)S£ (History of Nursing) WV 11 f MIPlffiW^ (Nursing Evaluation Research) WV 20.5 #!$(# (Nurses) (£12 ^f>CO WZ 112.5.N8 mkco WZ 100 A£ • tfeRfr^ WY 22 mm WY 29^ Kff WY 44 *fffSPfc WV 44^$ t££ fl4t-.t.#APB1^H (Nurse-Patient Relations) WY 87 7£ WV 159 77X7 0 X7 WV 87 i.^ffc^ WV 87 #14§^S# (Nurse Administrators) WV 105 mm%6$hXlzXZ>mm (Nursing, Practical) WV 195 m WV 18.8 #lii§ISBl (Licensure, Nursing) WY 21 #^7d M/l, (Nursing Protocols) (£#ff 7-feX / X h $££ mtWfe (Nursing Care) -fe WY 100 #P1#fr WY 150-164 mWAU (Legislation, Nursing) WY 32-44 #l?7ji£finffi3E (Nursing Methodology Research) WY 20.5 mm^7/1/ (Models, Nursing) WY 20.5 #il-h'7?Xl£ fc\mmz mmxmw (Nursing Pools) uttm; mmm$££ HSfi (Nursing Theory) WY 86 mm$MW$L (Nursing Research, Clinical) UWMmm W^$££ mmimm (Ethics, Nursing) WY 85 «{£ (Sensitization) Ji 77747* x-; $it*£ $ £ £ ffS4 (Liver Regeneration) WI 702 (Stem Cells) QH 581.2 •y-b4 (Stem Cell Assay) linn^-J^l&WS i*$££ *fi (Carcinoma, Hepatocellular) WI 735 lf#H7- (Liver Cell Adhesion Molecules) (£ CAM$££ BiW (Sensitinogens) l£7X/l/7x ; 777 4 7*x- $££ *L%m (Medical Examiners) Umt^t&WM*%X m&mmmm (cyclic N-oxides) %mm qd 401 ^ttUDgn (Atlanto-Axial Joint) WE 725 7xi/yot7l/ (Ganciclovir) QV 268.5 UT-xXh-v (Opisthorchis sinensis) (iJrT»JA&$££ 7 X x 7*£ (Candidiasis) WC 470 7xv7JI (Candida) QW 180.5.D38 B8RS5 (Interstitial Fluid) liaMSttSIH* JI.J: IS*££. (Eye Diseases) WW WmWttfc WW 32 J&lii WW 140 w&mtw&m WW 600 £<|-»j WW 620 m$mk ww 460 mm. wy 158 $714 WW 168 m WW 166 'W77- SF 891 |UlH*WHfa*'iJi8itrt>l';e>' (Interstitial Cell-Stimulating Hormone) l£ i'i'ii$&l& fc >v € X $ £ £ ISlKftllili* (Pneumonia, Interstitial) l£Pd!K14Ii|5*£&$ ££ PNl11S14irili*^.f. (Lung Diseases, Interstitial) WF 600 m-HHfe(Forceps Delivery) li#tft«OT*> WQ 425 ; )1 fH114-$££ .«■# (Patients) W 85 mfeiztilfl WX 158.5 KmmVjtiz$siT& WM 29.5 «f£lllFi:ttt4*lili, *<7>RrV,'K fcfimmmtmm (Patient Care Planning) W 84.7 mmizisui, wy ioo J?iFx.&#<7> WX 162-162.5 ,|ft>7"X7y (Patient Ombudsmen) U.%^m^lWm $££ •g^frmmm. (Continuity of Patient Care) W 84.6 ,ft#RIPSI (Patient Isolation) WX 167 B^mm^}&MWt (Patient-Family Lodging) l£ft^$£ £ .£.«*& (Patient Monitoring) (i£f£l$H£&*l$££ .&#ffcW (Patient Education) -fe W 85 flIJtffeW WA 590#$&££ m^miZisUh WX 158.5 «W^K(=iJttS WM 29.5 ftztkmizttfc&ztut, zcotkmiz ,*#7 7tfia (Patient Care Planning) W 84.7 mmizisUh WY 100 JSK.ft#W WX 162-162.5 ,lfyTf-A (Patient Care Team) W 84.8 *?tP*7-A WX 162.5 7-A7-xX7 WY125$&££ #HAPft (Patient Readmission) WX 158 #£&ft@i (Patient Schedules) t£7-^Ji:4i^$££ #ilK (Patient Discharge) WX 158 #ft^ (Patient Representatives) (£&H-<7)tftfi]#Ill$ ££ #*'L>&ffi (Client-Centered Therapy) li*S*i^8ft££ ££ #7-yf*ll (Patient Data Privacy) !£*£•£;$££ %MW (Patients' Libraries) (£*?H%K]»if $££ #AK (Patient Admission) WX 158 ^CommMil) (Patient Participation) WX 158.5 %C0&m (Education of Patients) l£f.#ffcW$££ ■gcoffi,!] (Patient Cooperation) l£f.^<7)[5]£$££ #t#fll^lgl$££ %co\mWkm (Patient Advocacy) W 85 ftSfcr- \z-y9XU, ifiS'lK #<7)il*R (Advance Directives) W 85.5 %cdW\M (Patient Compliance) W 85 567 *>>*>*/ mraztn-fz wx 158.;, tAWmfitlztsUZ WM 29.5 lul.&yUV^^Ii. mmz &%co'ft*\l (Sick Role) WM 178 777 \z-y 9XU, ^mWz .&^<7){ffflH L tMiLX (Patient Credit and Collection) £|S9^I$££ &-%co&i&mm<7)-%:& (Patient Acceptance of Health Care) W 83 mmzisiiZ, WX 158.5 vmmmvj&mmu, mmmiz .§.#$«i£ (Transportation of Patients) &m$7-tx (-Wittzumm wx 215 W.& UH 500-505 &,%¥ WX 215^$()££ ,f,ffflT7/l/-^- (Patient Isolators) WX 147 &%X-m (Schedules, Patient) l£7-#Jfc7-£$££ *S)ffi (Carcinoma) QZ 365 mmH.<7)iiCr>U%tfZ.mz Ifg (Customs) l£XfL$££ ®S14Dll^y/l/-7 (Sensitivity Training Groups) ffiWmm WM 430.5.S3 tt&bmm HM 134 &£147X h (Microbial Sensitivity Tests) QW 25 fffJ!7v (Hepatomegaly) WI 700 IBtfiJfo. (Eye Hemorrhage) WW 140 mmm (Eye Neoplasms) WW 149 m$>ftcoA:tiU, ArCDfilftiz %fmm (Liver Neoplasms) WI 735 Sfi^ (Coronary Circulation) WG 300 ®lf (Affect) BF 511-568 #¥»j WS 462 ?VJtmt&)]'Jim WS 105.5. E5 gftTfo-Aftfti (Atherosclerosis, Coronary) l£*f tt®JMfl:*S$££ i^^titfr (Tube Grafts) l£#M$££ &tf#A (Empathy) BF 575.E55 ft*?-]® WS 462 ivjfmtwjm WS 105.5.E5 m*k3--T>V (Ethers, Cyclic) WtSHtl^ QD 305. E7 tmBmz'mmzti&m&u, x\mmz Mikity (Crown Compounds) l£il^i-7/i/$££ SgflclfrM^ (Coronary Vasospasm) WG 300 MVLJk!g±7Xm% (Coronary Vessel Anomalies) WG 220 ^^Sfcia^SS (Microscopy, Interference) QH 212.15 nmmm qs 530 &mm (Buffers) QV 786 m^rnw-m qu 105 ^mmnVkft QH324$&££ BB$E#: (Eye Manifestations) WW 475 wgpfwiz x * mcomm ww 460 ftZnm&cDZtiU, zcom&iz tf#-mtk#$:mfc (Rod-Cone Dystrophy) U&m&m &§&$££ Sttt^Bflffi (Crcumcision) A» GN 484 J- 9^XM BM 705 mmwum wj 790 fftttttffittf* (Rods and Cones) WW 270 ®ffiM$-r% (Emotional Bonds) (£W**#14$££ ®1ffe^ ('Omm) (Transference (Psychology)) WM 62 g^DjSK^ (Coronary Arteritis) l£IM&<7)T<053# WG 300$££ W^)MMi\L& (Coronary Arteriosclerosis) WG 300 Mtk$))Mm& (Coronary Disease) WG 300 Ji^fiM* WG 113 53#cIMS&*S (Coronary Embolism) (£Sr£«K$££ T&kWM'iiCDimmniz Mffi&m (Laxity, Joint) l£Pgp *££*£$£X mffim.% (Joint Diseases) WE 304-350 mm WE 304 fvjmtwjm ws 270 mmm sf 901 MgnSBifc (Periarthritis) WE 344 mm&JE^-ffi (Revision, Joint) (£4WtfJ$££ 568 ij>7-A y |flHJJ|i£ (Hepatectomy) WI 770 BDgfiW^ (Ligaments, Articular) WE 300 mfi&u^miUz ffUmm (Sweat Gland Neoplasms) WR 400 !§&*IE (Infectious Diseases) lifE&*?i ; ^^M* j£*ie£ $ ££ li^lElf teBfilSft (Infectious Disease Contact Tracing) li£.^04£«!gi^$£i t§ytk1iE.aWi (Transmission of Infectious Diseases) (£f$ m#m; mm^t; mm; i^;M«^^7^ 99m, ^jxiim^m*;#^^.t.^«^$££ W$mm% (Carriers of Infection) Ufcffi^ttm \ *mZJV9 (Dried Milk) I£?IUIbdb ; ?Lit$££ -kArim (Mouthwashes) WU 113 mmm QV 50 PB1ft'l4&« (Myoclonus) WE 550 ff^'el&SE (Alveolar Echinococcis, Hepatic) {£JJfl2& *£$££ 7 X y 9 x X (Cantharidin) QV 65 \%m (Enema) WB 344 i£J!§3iJ (Clyster) !£}£)]#$££ m.m (Atlas) WE 725 Htftf£sf Win (Atlanto-Occipital Joint) WE 708 Ril'ffilKHIi (Eye Injuries, Penetrating) WW 525 MMPI (Wounds, Penetrating) WO 700-820 mtk (Food, Canned) l£&nM*#$££ felg^4^?L (Canned Milk) li?Ut$££ m$sht.& (Canned Foods) l£&nanf*# ; ^paDJjPX^$£ £ ISS (Fundus Oculi) WW 270 Hil/EtiEa (Expert Testimony) itm W 750 M W 705 mm W 725 mnmm w 740 m*Y \z-y9xu±mM 569 tj>y-y tfiS (Chinese Liver Fluke) (£OpisthorchisM$££ HftetE (Fascioliasis) WC 805 mmm SF810.F3 *A (Agar) QU 83 T#J Q\' 75 tSJtfc QY 26 %k7/1/$5fM^$££ fefJMUJljft (Coronary Reperfusion) l£'l>&5M?jfL$ £ £ agjM*£.£. (Coronary Artery Disease) (i53tt®J)ilR*££. $££ x£§j)m'bm& (Coronary Heart Disease) UMftWlMmB $££ *i&W)U'm% (Eye Burns) WW 100 7X7/1/ (Camphor) QV 65 SSiJ^Bf (Diagnosis, Differential) WB 141 5 IVJLMtWJim WS 141 rT*S (Pompholyx) r?*§;(*jl4£ $ £ £ SW (Common Cold) WC 510 rTJSttlia? (Eczema. Dyshidrotic) WR 200 M1jhm$im (Drugs, Chinese Herbal) QV 767 HMK3* WB 925$ &££ mm* (Aqueous Humor) WW 210 Vfcil&fiE (Echinococcosis, Hepatic) WI 700 7*X-v7 5 yg&^ (Gamma-Aminobutyric Acid) Ii GABA$££ 7'y-?T i 9mm-%m¥ (Receptors, gamma- Aminobutyric Acid) f£GABA^'#f£$££ 7'X-v4xy — 7xox (gamma-Interferon) it A >9- 7xoX2^$££ 7'y-?MWl—x- — vy (Motor Neurons, Gamma) WL 102.7 7*X-v7^ 74 y-xxy (Gamma Camera Imaging) f£Jft#M4M4^-xX7$££ 7*X-v7o7 9x (Gamma Globulins) WH 400 BS#:*fcSt QY 455 7K<7) QW 806 iz 7S7'X'vyn7iJ X (Gamma Globulin, 7S) iift*57o 7'9XG$££ 7*X-77d7"iJ xH&JfiL*2 (Dysgammaglobulinemia) WD 308 7"X-vyo7'J X?v2JftL*i (Agammaglobulinemia) WH 400 7*X-v|g (Gamma Rays) WN 105 7*x-7-7*X (Gammaphos) li7^7X7x$££ 7'X-v-/s;x7'X/\Jf7-y U74 K (gamma-Benzene Hexachloride) li>xmm)S3i$££ ^^11 (Mesenchymoma) QZ 310 mm^cohcoimm^z WIHH^tff (Transactional Analysis) WM 460.6 ft^Y \z~v >y 9XUXMWz 570 + 2JX7-4 *gOTJ*f£4- (Emerogenes) teJSfllWitiiJifcfti^ ££ fS (Administration) l£*I*$i !=*!$££ ^Mmm (Nursing, Supervisory) WY 105 #Hf<7> WY 105 ^S#Ilfflf^S (Nursing Research, Administrative) l£S f£§JIf3f3£$££ fSUffc (Administrative Work) U&UtM$££ ifSH (Administrative Personnel) 3£I!^'jl$££ }git (Perfusion) mmm wo 665 ^817 S/Si (Amino Acids, Sulfur) QU 60 1)1*°>7° (Perfusion Pumps) l£i4A7°X7°$££ ■m (Cold) WWflsffl QZ 57 ft8Mc*slt4*ftliffr}*lftStt£ WO 350$££ mmum wb 473 Wtiltm (Cryobiochemistry) it^im '. ;4Un';$££ *Jt^.1S (Cold Climate) £«W12# QT 160 £wftia (^*¥) QC 905 ^^«*^*?t (Cold Agglutinin Disease) l£ g r2ft*£14i§ jfiLl4tlfo.$££ m'fc-Vvm (Cryobiology) (£<&£$££ *ft4^147n79 X (Cold-Insoluble Globulins) l£7 4 7d4/7x$££ *<7tt§£ (Cryoanesthesia) (£1gf£i£i£$££ *tt«8£ (Cold Therapy) (£<$*£«&$££ ffXXX4£S!t4 (Hepatolenticular Degeneration) WI 740 mmm (Emollients) im&mM QV 63 $££ «WS8£ (Palliative Treatment) WB 310 flEE (Atmospheric Pressure) WH WD 710 ^Mizisiih WA 450 %%m QC 885-896 *4" WD 650 jXELWHf (Barotrauma) ia^fT-O WD 710 ** WD 650 ^J±$6££ ^7/w-x7*?1 (Giardiasis) WC 700 ICtt (Memory) BF 370-387 *LJOBfc#7iE»I WS 105.5. M2 'XM.m WL 102 m^yjm, mwTjtfxmmii l< (iww^wiw^t-*stt* WM 460.5.M5 letfPfW (Memory Disorders) WM 173.7 tlfi (Temperature) ^lf^?|$££ Ultt (Starvation) WD 100 *J*M5U6 (Extrasystole) WG 330 ttM*£§£ (Mechanoreceptors) WL 102.9 $§«TO& (Jaundice, Mechanical) (£ISrH r>m$££ ttMffi*^, (Ventilation, Mechanical) teAInf >>&$££ $ttftn&3l (Aspiration, Mechanical) l£»&^C^$££ 8M*ffiX h XX (Stress, Mechanical) >mfy)mm qt 34 # WE 140 *faS«*>£ffc*.a«l: flfcSS'tfjUe (Equipment Contamination) ftSfcflK&li-twttSK [Mffl«£«ttfflnnp$&££ *ij*^ (Handedness) !£{iJJ14$££ faf^^ilj^lt (Crisis Intervention) HM^^I$££ fU & g (Ocular Dominance) (£^1^$££ &KPSB (Pinnipedia) QL 737.P64 iklR&mfafe (Paralysis, Pseudobulbar) l£Jfr*£t4*£.£.$ ££ %M (Pneumothorax) WF 746 ^tM (Abnormalities) ^lg^?3l$££ ^l&m (Teratology) (£^$££ WJ& (Monsters) QS 675 mtm (Teratoma) QZ 310 vm&niiCoumtftHz =StMmifo (Teratoma, Cystic) i£3S&i£l&$££ f&l£$3i (Pseudotuberculosis, Pasteurella) I£f&ln1£l§ &&*£$££ \h^m^MW^k&. (Yersinia pseudotuberculosis Infections) WC 350-355 %M (Atmosphere) QC 851-999 %m WA 750-776 &MizisUh WA 450 mmrnm wa 750^$ &££ ^&^3f(£*mfSife^K WA 754^$££ m&tcom&uf\m wb7oo$££ foVkmX (Risk Factors) &Zi.Mizis if & A: tzit, %co±Miz fa$fc'i7$ti (Dangerous Behavior) tt^rimm^t lt wm 600 n^m ws 463 U'JLIRRViAim WS 350.8.A4 ffikfkfe (Risk-Taking) >bmm BF 637. R57 fam® (Hazardous Materials) l£WW^K$££ M1£ (Climate) iys^i$££ f&Sffcffi (Pseudosclerosis) (£tfFx >X*^'|4$££ WfeMfa (Acclimatization) QT 145 m<%7Xn QT 160 ##mi£ QT 150 wxim qt 150 ^; m%$\m qt 150^$^££ M1S14XI£^^i4£C:^ (Bubo, Climatic or Tropical) l£14*?TI4 9 X^°|*|^®$££ fXnmii (Climatotherapy) lifMg ; f»#jJiE ; fli*flR£ $££ $*47 y n 7 (Supply Catalogs) (£j3jH7 9 n y ; *<7)ffc *££y 4 7°ct)7 y d y<7)^^$£ £ £*&& (Formates) QU 98 fliW&ft^ QD 305.A2 *-TX7y-/i/-7x7-r (Xanthinol Niacinate) QV 150 *7x7y-/l/-n74--r (Xanthinol Nicotinate) (£ *-f x7y-/u-7x7- h$££ ^f-TX7x (Xanthines) QV 107 *-TXh*xX (Xanthotoxin) l£'r*7XX$££ jg& (Tooth, Artificial) WU 515 £ft (Artificial Teeth) (£*M» ; SB^Uft ; «££ *;«^6$££ H& (Extremities, Artificial) (£AXEgi&$££ mm^Z (Denture Stability) !£ilMft$££ &ft&& (Denture Retention) WU 500 Wt£. (Ceremonial) #A UgC*&Wg«) GN 483.3 mffk (JSC*&Krg«) GN 473-473.6 EEJ£t*;S£ GT 5010-5090 ^Mfc (Denture Bases) WU 500 ^MlSitt (Dental Prosthesis Design) WU 500 mm%k (Deja Vu) WM 173.7 MiC (Temperament) BF 795-811 SKttSJJfcffi (Hallucinosis, Organic) li«tt*lttSKtt ffiWfW$££ S?3Ct4*S«f W (Organic Mental Disorders) WM 140 SKItStt^ (Psychoses, Organic) li«*HStt£Ktt« WPfW$££ ^Ht#JI14 (Substrate Specificity) QU 135 #fft£ (Dilution Techniques) (£Hli£##ft£$££ %M (Emphysema) QZ 140 ifciPIO Initial WF 900$££ mcDUBfim WF648$££ flMPi'S (Pneumomediastinum, Diagnostic) itmmtflfX «&$££ ftffiT¥ffy)f*l# (Diffusion of Innovation) #Sfcfc Y t°7 y Xl£iM^iJl-Special topics, by subject Ifij^SlS (Bibliography, Descriptive) Z 1001 %% (Weather) %M.m evamm) qc 980-999 mmtcoMifc WB 700-710 Dj^ SF 760 fmmit QT 145-160 $ ii £ £ fXMmm (Medical Climatology) (£MfS ; A*\$££ %%m (Meteorology) U%MM^ \ ^M$££ f&ii&'hfWt^blST^fi! (Pseudohypoparathyroidism) WD 200.5.C2 £X14H$ WD 205.5.M3 %mm. (Azygos Vein) WG 625.A99 M^^H (Meteorological Factors) *\mtmm wb 700-710 mw&£ WM 31 &Mffi£ WA 30 A:§t£* ££ 572 + -T-& |ffr (bmm) (Bonding (Psychology)) li*t*«#tt $££ %?* (Animal Vocalization) lii)M*«0&J**&J: $£$£&# (Pseudobulbar Paralysis) (£I*£&$£ £ f&tttStt*??"^^*?? (Pseudopsychopathic Schizophrenia) li5rf!!*?iSAfeP$*$££ U^ftftifflSI^ (Parasite-Host Relations) l£'if ±3r £tt*BlM$££ 3F4& (Parasites) QX «^«0lgHfc LT QZ 85 gftft^ QL 757 mm?H» WA 240 U**.^ (Parasitology) QX €»¥»**» QX 4 IRE^ SF 810.A3 ^AIBSIfeSE (Parasitic Eye Infections) l£3r£444tB &&*£$££ $£&#tl£ (Helminth Antigens) l£tf AltlS $ £ £ $£&*£.£ (Parasitic Diseases) WC 695-900 mmm sf 810.A3 3F£&14tB!i&SE (Eye Infections, Parasitic) WW 160 *4AttfRK.ft (Liver Diseases, Parasitic) WI 700 mmm sf ssi 3r£&14ll§*&$« (Intestinal Diseases, Parasitic) WC 698 mmm sf 810.A3 $4&tttt8i.ft (Lung Diseases, Parasitic) WF 600 $£&tt£l»#E.ft (Skin Diseases, Parasitic) WR 345 mmm sf 901 *4&tt&J»#i (Parasitic Skin Diseases) li^Att* »*££.$££ *4IM*&**£W#£ (Vermin, Public Health Aspects) (£1r£&$££ SSiJ^^ (Locus of Control) I£l*l74-to)a$ij$££ ?SS (Seasons) kxmtfit&mm qb 637.2-637.8 SUB. QC 903-906 EWIk* GR 930 f&mm wb 700 SUfi (Fainting) (£&#$££ ?HnW7x/U^-'(4^^ (Rhinitis, Allergic, Seasonal) [tWSt&ZJLi. *-fe/x (Xenon) *»ffc^ QD 181. X4 mmm qv 310 £fcftftf (Basal Metabolism) QU 125 %mmmm (Basal Anesthesia) (£JftBfriu&m$££ ^t7y 9 77y 9 74 X7-T 7> (Amerinds, North American) I£4txfc7y 9 7 4 X7^ 7 x $££ ZT 9 9 777X h ~-feX*£ (Blastomycosis, North American) li7vX h ^-feX*£$££ tlf£ (Gases) £tTOI$££ fflft ('1>9Pf0 (Expectation (Psychology)) BF 323.E8 inSfcffl&£ (Pneumoradiography) WN 200 *77--t (Chitinase) QU 136 ££,'! (Rare Books) ~izmfci>m\^ Z688.R3 ^ftS'l^^* (#ltfltf) WZ 220-270 1801^1UP%Xli7^ 9#XjttlU»frfe±liJSi|i:: *A-y (Chitin) QU 83 «« (Smoking) tft# WM 290 I£* QV 137 -» HV 5725-5770 "*«-£«£ (Smokers' Patches) liPKfiift$££ ■£# (Stammering) l£«WP#'#$££ ^7^a'7 7 (Kickbacks) l£?BP$££ tel/lfr-ffl (Drug Antagonism) QV 38 JSJftf* (Anti-Antibodies) I£#t4 7^ 7 y 4 7°#if£ $ £ £ JSffiftK (Antagonists) liftffl$£tt£^S£o£|fc, f#Jx l£7/u^x^4t^iJ$t££ £&7 y 9 7 A (Native Americans) l£^t^7 y 9 7 4 X 7^7X$££ W&i& (Valerates) QU 90 WXWM (Philately) HE 6187-6228 mm WZ 340 *«y* (Foxes) QL 737. C22 3f 7 4- "7/l/H (Lemuriformes) l£ Strepsirhini $ £ £ Jf74y77*yo (Foxglove) (£x*=>f 7 9 X $££ SfiflB&ft (Basal Ganglia Diseases) WL 307 #£*£ A£, MLIS'*-*>V>1H WL359$££ m&& (Ergastoplasm) !i7J&f£$££ SJStM&fn (Ganglia, Basal) l£)ia^$££ £&eHJE (Basilar Membrane) WV 250 #Sf3S (Perissodactyla) QL 737.U6 Hmm (Pneumonology) filing. (#H) $££ SUtlSSfc (Respiratory Tract Infections) !£"¥%MitiS*ife *£$££ §UlH&ft (Respiratory Tract Diseases) Ii"?n&fui*£.t. $££ Hilfli*! (Respiratory Tract Neoplasms) (i"?H&^.itll *!$££ ^itffitii (Airway Resistance) WF 102 7X h WF 141 xumH (Burns, Inhalation) WO 704 9\m£i&U^9 9 7 7 XX (Mucociliary Clearance) WF 102 %j&W& (Airway Obstruction) WF 140 mmzisuh WO 250 WiWRS (Cults, Medical) lift^EH;t$£i #±H#)S (Metals, Rare Earth) Mflfcft^ QD 172.R2 mmm qv 290 *7-?9x- (Quinacrine) QV 258 %-f—V (Kinases) |J*X*l?yX7i7-tf*lJ: *i-m (Cinchona) QV 257 ^ft/ij X (Quinazolines) #Lit5lfiLeM££ LT QV 150 Mm\m QD 401 *-T-)V<)V\Z Y x (Quinalbarbitone) (£7 3/<;uty-/l/ $££ *-tfcy (Chiniofon) l£ t Kn *x*y 9 X$££ ^^x (Quinidine) QV 155 3r^7--t*2PIW^J(Kininase II Inhibitors) (£7 >=?77 Xxx^^^^PlW^J$££ 573 *-* *--* (Quinine) QV 257 * —/77--t (Kininogenase) I£7 9y*x4x$££ if-X (Kinins) QU 68 % i 9 x) yy (Quinuclidines) g ****£"* (-fe) tLX QY 120 fttifcft-/- QD 401 *9Y-*fJV?\ (Callithricidae) (£Callitrichinae$££ * * 7 * X $ jgf4 (Cricetinae) (£^Axy-$££ if*74X~f4 (Ondatra) (£^y 4X ~ M$££ §Afc# (Incus) WV 230 if 7 X — X (Kynurenine) QU 60 if 47 A (Guinea Worm) (£ Kyyxy/l/XJi$££ if4 F7/l/-x77774— (Kinetocardiography) WG 141.5. K5 Ifi^H t^M'tt^- (Anniversaries and Special Events) [g^r, #jdj&, ^^ (-fe) WZ 332 m*l7i%&U, ±H55'J(3 ^H (Air Sacs) QL 855 tttb^ft (Localization of Function) I£1S"V y t°xy* ; k Hi27Mfi14$££ ffl&fc& (Function Tests) &&&,&&£. : *&&&$& \ TSfW*fi&tfc£Sc; ^«*mm$fc^m; "f «tbi£^; ¥ ttMUan&tfc-fc : i!uBl«M$££ ; *fcEtfc3E<7)«*fc* t££ f&fliaffll (Pseudotumor Cerebri) WL 348 l*flEP$^*A (Functionally-Impaired Elderly) !£jti|:g 3Mf$££ Mt\£%&Bm& (Colonic Diseases, Functional) WI 520 m&l£%tl&%: (Hearing Loss, Functional) WV 270 SUlwiai^iS (Pneumoencephalography) WL 141 m&fo^mm (Functional Heart Disease) litt&ifSilB timtA:mmmm<7)%fo£%x ffimimWm (Functional Psychoses) (i»W^1±P$W* ££ mZX'k'fl (Desiccated Stomach) !£fflMa^$££ ^r y ^r7 9 X (Quinoxalines) m&&mt LT QV 250 W*£ft^ QD 401 % 9 ? (Mushrooms) &ffl QK 617 WS QW 180.5.B2 5 9?^% (Mushroom Poisoning) WD 520 if/ 9—7A{[:£■!$/ (Quinolinium Compounds) #LJ8&Iii LT QV 250 *f8Sffc¥ QD 401 */i)9-)U (Quinolinols) (£ t K o if -> if y 9 x $ £ £ *9 U y x (Quinolinones) 11*/ 9 >$££ if y U X (Quinolines) It^^^t LT QV 250 Mmm QD 401 ^f/'oy (Quinolones) QV 250 * 9 □ X$$ji (Quinolinic Acids) £ft^ QU 65 Mmm QD 401 ^ y X (Quinones) Wttffc^ QD 341.Q4 #5eHH (Oligomenorrhea) WP 522 J¥*£t£Jlftli/;itt (Fatty Acids, Volatile) QU 90 W%,&%V* (\rolatile Poisons) Ii >%\Vn$ £ £ »IS14il& (Oils, Volatile) QV 785 Xim QU 86 ffcMfff TP 958-959 H1M*jE (Pneumoperitoneum) WI 575 **7°X (Plaster of Paris) (£M7/l/x7 A $££ **7°X&<{£ (Plaster Casts) (£m4=sf7°X^^$££ if7°nx*; (Cyprus Fever) U7 JVAz 7*£$££ flft (Mood) (£ii'lt$££ fW^ffffiPfW (Dysthymic Disorder) liffll-j of4P# W$ ££ =>f'7x (Gibbons) l£777*77l/$££ £#Wi£ (Endowments) (£M$M$££ &#fa£^ (Diet, Elemental) (£ 7 r 7* 9 7 - h &,£ $ £ £ f&IH14£■(!§•& (Enterocolitis, Pseudomembranous) WI 420 Ztttlft (Fads, Food) l£74x.y h&$££ mmmi&mm (Deontological Ethics) (£M$££ *9 y (Chimera) QH 445.7 =r^7h^xX (Toxins, Chimeric) (£ft*&#^$££ %*z7yy 4 — (Kymography) ^mmizisUh WG 141.5.K9 XBWimm^A:tlU,mfX^^7yy4- WN 100^$ ££ mx.m&<7)mwizi$Lm£tiz>m&u, tnm&ximt ic if^xX (Chymosin) QU 136 ¥LH-##fKfclt£ WA 716 mt» (Clothing) QT 245 if ^y-i^A y (Chymopapain) QU 136 M (Leg) WE 850 AXI£^K WE 172$££ lkmm£ WE 850 Tffil WE 870 AH WE 855 mcomzmt; mmm wg 620^$ &££ mm (Placebos) WB 330 &PCR (Inverse PCR) !£PCR?£$££ m®. (Situs Transversus) (£l*]l!IM-!£$££ ffiti (i&Um) (Inversion (Genetics)) QH 462.15 MBiHS (Paradoxical Sleep) l£xAliflg$££ M&X^ (Leg Length Inequality) WE 850 $15^ 0l>II¥) (Countertransference (Psychology)) WM 62 mi,^ (Reverse Transcription) (£a4£4Hf &&¥$££ i7'n -y 9 (Bundle-Branch Block) WG 330 j£#L*S:7*n -y Y'H, (Reverse Immunoblotting) l£ft*£7'n •yT4 x7$££ %\79 — )VfaWm7 A >VX (Kyasanur Forest Disease Virus) (£7-g0Mla&7 4 /l/X$££ j£*ftt M& (Menstruation, Retrograde) l£E*£P£f$£ £ j£fftt«f£ (Antidromic Potentials) (i.lf5etfi$££ ^rfyt^' (Manioc) (£7 7 7^*$££ ^rt<7 (Cabbage) l£77'77$££ ^7 9 7ffi14^f#K (Carrageenan) QU 83 3- 7 9 7* X — x a X (Calibration) #5*h t-yyx|£, ±fil!ill3 574 *^.7-fe4 if-r X77 — (Candy) «!|tP#X.I£*^*?1Bf^MtiLT WH 400 &f4JSj£K&ttS WU 113.7 if-rX7° (Camping) QT 250 #!* h ¥-y 7 xu^mftiizmiu* * yy^zm^mm it WA 33 $& (Courtship) HQ 807801.5 pft QL 761 (S5I ®) (Suction) ^■mzisitimmm wo iss mmizisi7h%mtt.ffi wb 373 *3U&!IS*I*K0l!fe (Suction Lipectomy) l£OMilWJI& #r$££ PS?IBilWfl'W (Lipolysis, Suction) l£fltW*l*Stf>JP&ffir$£ £ J&3l£f&£ (Aspiration Biopsy) (££r£f&$££ nft^lttHiifc (Pneumonia, Aspiration) WC 209 ^IIIJIWt (Vacuum Curettage) WP 470 wmumzi&m$tiz>t%&u, ±m»uz n&?IFl/7-x (Drainage, Suction) (£»/4ii.A$££ 7*5 (Rinderpest) SF 966 ft* (Smell) W\" 301 "fcjS&Ifr (Olfactory Pathways) WL 314 ftHftHf* (Anosmia) WV 301 ft^&K (Olfactory Cortex) liftH:ig»*£J: 7iS (Buphthalmos) l£7kHS$££ P&t\14P^r±^fl (Inspiratory Positive-Pressure Ventilation) l£P(HAftlf§EE&M$££ fe.%H# (Emergency Medicine) WB 105 *LJE»ifc*&J£*i WS 205 tttf£fij$ (Emergency Mobile Units) !£&.%$$££ tttlSSK (Emergency Care) l£ME«7 -1X $ £ £ fe.llISfJ^filTii' (Emergency Medical Technicians) W 21.5 $.MMm7— tx (Emergency Medical Services) WX 215 ^HJ:<50 WA 412 ^tt[l^^.miS«7-tX WM 401 ; «K*cl.IS*^ - tx wx 215; mmmwmv>%$%9 a y X 7 A (Ambulatory Care Information Systems) WX 26.5 ftllfffl^7/ (Emergency Medical Tags) W 26 fe&ttfcSBH (Emergency Outpatient Unit) UmWfc% E*f7-tX$££ ft.%#li (Emergency Nursing) WY 154 $cH.*£.£ (Emergencies) ^M^l$££ fefe* (Ambulances) WX 215 ¥Bto UH 500-505 fei.*2:M (First Aid) WA 292 WW-I1i.1&Jft$££ *%m (Olfactory Tract) l£Pj|1i:*£i&$££ ,%5E (Death, Sudden) !£3c**?E$££ f4)44}?*# (Fingersucking) WS 350.6 XX»%&££ 9071'£±c7)A (Nonagenarian) (£807747^)A$££ IpJt (Food Services) ftM£6'-J#m WA 695-722 'hm^lt^m^C WA 350 l££A^t^fl-A^ WA 351 fefg&7-tX WX 168# ; XXh7X WA 799$ i> ££ *&£H (Meals on Wheels) !£*£&$££ £***£ (Olfactory Nerve) WL 330 £* WV 301$ &££ -fx^SfrtJc&JFt*?! (Papulosquamous Dermatoses) (£&Jjt*£ .£.$££ *£7k (Water Supply) WA 675-690 ftHrS^WI£«£^ QW 80$££ l&sfi WA 686 jfKt WA 690 %>X WA 675 M^MVc^^n'S. (Pyelonephritis, Acute Necrotizing) (£»¥LsI«$££ f44HSn'J 7-v7 (Rheumatism, Articular, Acute) l£'J 7v7#ft$££ i44W&*£RS (Acute-Phase Reaction) QZ 150 &14»J:RJ8 (Acute-Phase State) l£,%14»l&ffiJ5tS$£ £ f.MS&K (Acute Phase Proteins) WH 400 1.14SHMS (Response, Acute-Phase) l£.%14»&ffiMS $££ mi4WKS^® (Acute Phase Reactants) li&teffige «$££ &14=»9—9* (Coryza, Acute) l£AMf$££ :i44*£,£ (Acute Disease) WB 105 WJmtWJlM WS 200 SttaiilfiLttfell^ (Conjunctivitis, Acute Hemorrhagic) WW 212 &\£Xm&Mj'£. (Enterocolitis, Acute) WI 420 M,'\i.nX± (Kidney Failure, Acute) WJ 342 i44M'l4Mli& (Encephalomyelitis, Acute Disseminated) WL 351 %\XM&. (Abdomen, Acute) WI 900 tvjimtwjm WI 900 575 *:i7-tr4 &tt. 9 7 v7**(Arthritis, Rheumatic, Acute) (£97^ 7**$££ .244 9 y><%W&.B'k.m (Leukemia,Rheumatic, Acute) liS.1t 9 x^44r3iftL*?i$££ lf.141) y*QBfam (Leukemia, Lymphocytic, Acute) WH 250 &mmmm qz 350 IHHtffffjA (Hookworm, Old World) l£i*)di.^$££ \\\\<&:<$.*r>v (Monkeys, Old World) (£ fc 7 ifT'JV $ £ £ IB^^f^ (Paleostriatum) (£^1:^$££ SitlBifcilDj(Rapid Eye Movements) (£X ABilg$££ P&flf (Adsorption) ^M^l$££ mmm (Adsorbents) l£y4*ffl^J ; SB#^ ; ifc#J$££ n&A (Flukes) l£n&AIH$££ P&&-E (Trematode Infections) WC 805-810 mmm sf 8io.F3 P&&3I (Trematoda) QX 353 ®i!km (Coccidia) QX 123 P&A (Inhalation) (£nfP&$££ n&AH (Inhalators) (£(tHH^^.lbS$££ P&A14S1S (Burns, Inhalation) WO 704 P&Agil (Inhalation Devices) (iMStia4fci?$££ P&A&4 (Administration, Inhalation) WB 342 T-?L*?i (Milk Sickness) WD 530 P&Afl*6£ (Anesthesia, Inhalation) WO 277 vJkkmtk^ (Inhalation Drug Administration) l£n&At£ 4$££ P&Atf?li£SI (Inhalation Provocation Tests) l£^,^5 !fm*l*$££ mkm& (Inhalation Therapy) (£««'<£$££ ftffilR (Olfactory Mucosa) WV 301 Plflia (Rhinencephalon) (£AM*i^$££ »*£ (Paralysis, Bulbar) WL 310 *c3r#C,%iMB (Critical Care) WX 218 £IS^I$££ ft* (Rest) »£¥#» QT 265 %*W WB 545 *&*4t#*Pl&# (Salaries and Fringe Benefits) 3tM3l$££ 3tS?& (Moxibustion) WB 369 if i-^'17/ 9 7 A (Cuban Americans) !£X^4 x^ T997A$££ if a. 'J 7 A (Curium) WN 420 mvmm qc 796x55 Scl^lHjfif^^To^^ r t -y y X $ ii £ £ ifo.9 34 7xm (Culicoides) l£!0f!&*4$££ ?fcW (Education) (NLM^TOT(£ff^#^-18) 30^1 $££ ffcT=fMI)j (Training Support) (NLM^^^T(£ff^^#^-18) A£ • mam. (NLM^mmxitm^.^^22) mm q 181-183.4 ffcWMMl (Curriculum) (£7 9 * * 7 A$££ &W#^ffl3S (Nursing Research, Educational) l£#^ ffcWffl£$££ ftWmitt (Training Programs) (£3&W$££ $W&?4 (Dental Education) li&*4ffcW$££ ffcfMl'Jl^ (Psychology, Educational) LB 1051-1091 ffc^S'l/E (Educational Measurement) LB 3051-3060.87 -i:-5i>T«f^ (NLM^H^TIi^^#^-18) 7Xh (NLM#«^T-«iE2j$«18.2) *<7>flll«0#B|cr- t^yxli, ifiJSiJC $W*?!P£ (Hospitals, Teaching) WX 27-28 #£7 9 *^7A(cMLTIi^^^O*?1PA#^(c ^Wfflffi (Assessment, Educational) (i#cWiii|£$££ ffcW*fil)j& (Subsidies, Educational) (£#ti£flfj$££ &MRW®fikWl& (Grants and Subsidies, Educational) (£tfcWMfflj$££ $km. (Faculty) (NLM^H*TI£f2:rX#^-19) Rfifc^fi LB 2831.7-2831.99 &R LB 2832-2844.47 SBft#£ (Mirror Writing) (£*Bi*i¥Mfi'l4$££ Sift (<1>S^) (Reinforcement (Psychology)) BF 319.5.R4 ffiW^flftM^L*:*#£• WM 460.5.R2 #£■ (Church) (£7 h- 9 xXA ; £$$££ ftlPAt&WW (Borderline Personality Disorder) WM 190 J8IM£At&Hffi (Personality Disorder, Borderline) tt# #AfePfW$££ ifLRftgim (Schizophrenia, Borderline) Uftmm^k® PfW$££ W?W£l*ffi (Thoracoplasty) WF 980 M%m& (Thoracic Diseases) l£Wa3*£.£.$££ m%&U&®m (Thoracic Outlet Syndrome) WL 500 mnmm (Thoracic Neoplasms) l£Sfe|g|3)l*#$££ WlBfflflS (Thoracic Injuries) (£ Willi $ £ £ WJBFWttJfttt (Goiter, Intrathoracic) (iW#T¥tttt ®$££ mt&m, (Food, Fortified) QU 145.5 &&MX (-US) TP 370 ffiitXY y jl—JV (Reinforcement Schedule) BF 319.5.R4 XB (14) (Empathy) (£$Hf*£A$££ m^ (Thoracic Duct) WH 700 ffifl (Insanity) l£*itt#$W$££ mmm (Bridges, Dental) tt&^Efc&ft ; H*$££ mWi (Pectoralis Muscles) WE 715 WJfcttg (Pectoral Nerves) l£)^Wig$££ WK (Pleural Cavity) l£W^$££ WK^IiJ (Thoracentesis) l£^iU$££ tftjfiL* (Blood Donors) WH 460 fckm (Rabies) WC 550 mmm sf 797 ft.km7A)VX (Rabies Virus) QW 168.5.R2 ffiA*H7y 7 x (Rabies Vaccine) WC 550 ijgm (Coagulation) ttjfiU&ggl ; x-7iS@l ; #«[S$£ £ illUHi1 (Coagulation Factors) l£lfiL$;&[I!ia?$££ &&£ (Catalepsy) l£7y u7°->-$££ SHJUtWW (Panic Disorder) WM 172 ffi.&tf)ifc& (Binding, Competitive) mmm qw 570 ^m (-fe) qu 34 576 *37/^x %mm qv 38 ~m&% (Coagulase) WH 310 Wft (Sternum) WE 715 M#T^ttMUt (Goiter, Substernal) WK 259 Uctt (Teaching Materials) LB 1027 (NLMtfSKTIilBjS*^ 18.2) £Bt^ QT 200 ^^htyy'Xli, Z&ftllZ $3g (Stenosis) (i*?ift^ : ««&*>»* 9 A 7V)£ft, ^Jxl£!ilii*M#^^-ffi$££ ^^14'C'^^ (Constrictive Pericarditis) (i4Xi&Bl4l$£ $££ &Hki.m (Communism) HX 72-73, 626-780.7 #£S(cT£Ste;?tt!) h<9)t LXCoArtlit, JNX(i*<7) mizmM^m$.mx<7j^^x w£Y£y9x&±mwz, mux&mzmm'&iztoit SftHESWKti W 225 i£tt (Ocular Fixation) liLSim$££ ;£££ (Flocculation Tests) QY 265 iSSt&g (Agglutination Tests) QY 265 %££ (Agglutinins) QW 640 ffift QW 640 SiJ (Cardiac Stimulants) JJ3£«I>H$ ££ ft-bffi (Angina Pectoris) WG 298 5M.>X7n4 K (Cardiotonic Steroids) I£&'l>geii1£$£ £ a-t'EISI* (Cardiac Glycosides) QV 153 foOm (Cardiotonic Agents) QV 150 W# (Pleural Effusion) WF 700 B&*#*f QY 210 i&*£ (Hydrophobia) l£ffiA*?t$££ £4 (Symbiosis) 4»& £ rjf-ft QH 548 W&fa QW 52 t&lfc QK 918 3£f|jiJ (Coercion) &mY tyyxi£, jimmiz ftili ('!>*£) (Symbiotic Relations (Psychology)) (£*m®#14$££ fofflmmWlk (Compulsory Health Insurance) (ifit/f f* ^$££ &ftjft)3 (Involuntary Commitment) li«W$$#3SSiJ AK$££ *ifIEft*4¥ (Orthodontics, Corrective) WU 400-440 &$iJj|X^0f (Concentration Camps) HV 8963-8964 ^XmWmm (Orthopsychiatry) t¥#3 WS 463 UULWtWAm WS 350.6 tt^ftfrDlPf W WM 600 ?Li&»lfc#j!fc»l WS 350.8. S6 JtZ/m (Symbiotes) l£ 9 7-y 77ff$££ 3i 144^43:f-ff (Sterilization, Involuntary) t!.£KJ#8 HV 4989 (MIA (Thymus Gland) WK 400 yfaMikftt) >^^(Thymus-Dependent Lymphocytes) it T9X^J£$££ mW&fcifc (Thymus Hyperplasia) WK 400 mU9lV-7°7A >VX (Thymic Group Viruses) U^JV ^X74^X|4$££ Hfi)liajfiLvSH4-(Facteur Thymique Serique)lilS8iJWMlH ^T-$££ mmi. (Thymoma) WK 400 mmm sf 910.ts mWmm (Thymus Neoplasms) WK 400 WUlWjail* (Thymus Extracts) mmm qv 370 femmm i-m wb 391 «p^»W»Wt> l < l£ WMUlSaiffi (Thymectomy) WK 400 mmmm (Thymic Cyst) li*»IiiJl&$££ ^#4tI)J (Competitive Behavior) HM 136 tt^-AJL (Competitive Bidding) mmm% w 74 £ t 1 fi\>m% (Sibling Relations) WS 105.5.F2 mkmW. (Aorta, Thoracic) WG 410 m& (Pinworm) (£JiA±^4$££ 1&!km (Oxyuriasis) WC 860 m&Xn (Oxyuroidea) QX 271 MffiRT£XA,i)^ (Epilepsy, Tonic-Clonic) WL 385 &)&& (Ankylosis) WE 346 Sfiffiteffltifc (Spondylitis, Ankylosing) WE 725 Mtt^tttMBKifc (Spondylarthritis Ankylopoietica) Ii $$ii:i41f4#&$££ mm (Thoracic Vertebrae) WE 725 m^k (Chest Pain) WF 970 *iiS.ft (Comorbidity) #£»£*><£ fili, zcovmiz $#S.& (-US) WF 970-975 H4liJi+W WE 715$££ ^[-i-lX^tt^li^a3X^mSItt^$££ WF 225 y4*4l£WSBy4*4$££ WF 980 m%ummm*%x wf 985 W8BM5 (Chest Injuries) (£WmiH$££ WSB^H (Angor Pectoris) (£#H>*£$££ Wgi5y4*4 (Thoracic Surgery) WF 980 m$Vm& (Thoracic Diseases) WF 970-985 IVJtWtWJLW WS 280 £Mt WF 745$ &££ m^mm (Thoracic Neoplasms) WF 970 SI*PfW (Phobic Disorders) WM 178 S1W*£*£ (Phobic Neuroses) l£S'lfPf*$££ WSBftfiJ (Thoracic Injuries) WF 985 WSflftflS (Thoracic Cyst) (£ii&PMftJ&$££ W8BX*S»f&a (Thoracic Radiography) WF 975 ?L^«£«J!£W WS 280 m^xmmmmz wf225$&££ WSBXiir£& (Chest X-Ray) l£PlSPX&&Stti& \ mU XfflSN&m*JLZ. m^>XU%mm^ (Mass Chest X-Ray) WF 225 mm (Pleura) WF 700-746 ftW QY 210 &mmmm& wf 39o$££ mmmfc wc202$t££ mm (Sclera) WW 230 ^ WW 230 im% WW 230 mM (Pleurisy) WF 744 mmfeW. (Tuberculosis, Pleural) WF 390 ^mmnb^Um (Scleral Buckling) WW 230 14Bgl£$ (Pleural Neoplasms) WF 700 mWM&m (Pleural Fluid) li»MJ|<7>T<7>#*i? QY 210$ ££ ailRWffifS (Sclerostomy) »flW<7>fctf>0) WW 290 WBIWlfc (Pleuropneumonia) WC 202 mmm sf 83i 7 x SF 964 »!!£*&# (Pleural Rub) l£»fn&i1$££ H^^S (Business Administration) itmVx.'Wm ; &j$£ ^3 ; flmn*W&M ; E*f *^t:S$££ ft&Hi1! (Coupling Factor 1) l£H-ATPx X y--t$ ££ *WSffiltWW (Shared Paranoid Disorder) WM 205 t&7JfrilJ (Cooperative Behavior) HM 131-134 \&-hi¥m (Synergism) (£*%to/jf1;lll$ ££ fj.M (Megakaryocytes) WH 380 STO14S:jfiL (Megaloblastic Anemia) l£A*lfll^14KJta $££ )1£; (Fisheries) SH 201-399 &*!*T£W#g WA 703 W]?ammm (Anatomy, Regional) QS 4 fl.f4-E<7> £*>t&M (Dispensatories) QV 740 ^m^m^m (Parapsoriasis en Plaques) l£H^«$£ £ £jfiL (Ischemia) QZ 170 vmii.coiiTOl*]3« $££ gA&it (Megaesophagus) (£&ii7 7 y x7$££ gA LA tm (Urticaria, Giant) liJfiLfftt&liTKIl* JE. £ gA?L2lttl£!l^ (Conjunctivitis, Giant Papillary) (£7 x/^'-14ig!ll&$££ gA«##)S (Osteoma, Giant Osteoid) (£#^BlSSt$ ££ gAitl&tt'J y*m(Lymphoma, Giant Follicular) (iit I£t4')X^lg$££ 8SLW& (Collapse Therapy) WF 350 £;%M (Expectorants) QV 76 &# (Fish Venoms) WD 405 glfcffi (Splenomegaly) WH 600 fftfirtt^fftlirtR'J-'Xi-v-Txffi WC 715$££ &jf& (Fish Oils) QU 86 ¥9 iyA,Dcom&MtLX QU 165 ffiKS!: (Depth Perception) WW 105 &mm (Ichthyosis) WR 500 fSuM (Fishes) QL 614-639.8 mm sh ffi-kt lXU%Mn& WB 426#$££ %WLW}fy)tLX QY 60.F4 ISffito (Fish Liver Oils) li,#Jft$££ faM^S, (Fish Products) mmm & tz ummmcoffi-k ttx wb 426 f*# WA 710 *4 WA 703 ffe£ WA 703 feHO*£*?I (Fish Diseases) SH 177179 m&comm SF 458.5 * y-mm (Killer Cells) WH 200 »#14 QW 568 *7-7xyy4 7 (Killer Phenotype) l£^£S$££ * 'J X h #C (Christianity) BR ~i[S^ W 61 £ffch[S# BL 65.M4#$t££ -tittle WM 61 £Uc t -DS^ BL 53^ $ <> £ £ ~fc*fW7f)r WM 460.5. R3 mi BR 120-126 mmwimm w so Arcot&coWkY t-yyx(£, ±gJ3iJ£ * U X h OflM- i£iUhZ.t (Stigmatization) BV 5091.S7 & 7|41&JfilJ± (Hypotension, Orthostatic) WG 340 m QD 181.A9 *S^ QV 296 ft^mcofemizttt&mmuArcDvmttzu&iz m (Silver) QV 297 ftllt QU 130 &^5&*-ffi (Muscular Dystrophy) WE 559 &5#&S*£ (Muscular Atrophy) WE 550 mmm sf 901 S5#S14fIiJ^^'fL*£ (Amyotrophic Lateral Sclerosis) WE 550 3£{ii:)te###f (Humeral Fractures, Proximal) liW# #f$££ B'-k (Myositis) WE 544 \$m (Mycology) ffiW QK 600-635 nnnmfcunm& wc 450-475$££ m~ (-fe) qw 180 ft* QW 13 Mv-i7^ QW 25 mmrnmm qy 110 mm QW 180 ^$fc££ ffiSHS (Sclerotinia) l£7ftlH$££ ®Wm (Myoblastoma) I£®*1IS£)1*»$££ JSIS (Nearsightedness) l£M$££ £M%v$.m (Gold Antiarthritic Agents) (£fit') 7^7# t^'J$££ ^1.7-fff (Emergency Surgery) l£/144¥$££ m^itiS (Telephone Hotlines) lirt-y h?4 X$£ £ *y%3 (Goldfish) SF 458.G6 ^IfcDl^fcLT QY 60.F4 ®jte\K& (Myotonia) WE 550 mm?Mtfem (Curietherapy) I£i£j?6».t7te«i?i£$£ £ m£$&mf<&m& (Brachytherapy) WN 250.5.B7 ®^3S (Muscle Tonus) WE 500 ffil&mmm-mZffi- (Myofascial Pain Syndromes) WE 550 579 *x*xv M$5?**£**£ (Trigger Points. Myofascial) lt%jBH$1% Vfi*,V.te&$££ iR y o - 7 X (Myoclonus) WE 550 MWM (Muscle Spasticity) WE 550 wmtwitm ws 270 %,&& (Spasticity, Muscle) (£M#B$££ famM (Muscle Cramp) WE 550 glfo.*£ (Bacteremia) l£Bfclfo.*£ WC 240$££ ®1%M& (Myofibrils) WE 500 £a tZthg (Aphorisms and Proverbs) PN 6269- 6278 mmm&yrff wz 309 Bft (Banks) (£ifir$^T \TA'itix qy 60.R6 i£££8£ (Inbreeding) QH 431 iftft SF 105 f£KASl# GN 252 tt^*^S^ HV 4981 85#Jl?S (Muscle Contracture) l£#j|g$££ tt&fc (Muscle Rigidity) WE 550 IB#t&* (Musculoskeletal System) WE /•J^!^, WS 270 S£ (-fe) WE 140 mmrnm qz 340$ &££ mmm wy 157.6 i*# WE 700 ffi#ft**l.ff. (Musculoskeletal Diseases) WE 140 ?L!OHfcMlW WS 270 #H WY157.6 &*& (Myopia) WW 320 &?&*! (Muscle Relaxation) WE 500 fayxY-- (Muscle Dystonia) l£-7Xh-7$££ &yxYa74- (Muscular Dystrophy) WE 559 &*£.£. (Muscular Diseases) WE 544-559 mm WE 550 ?l'Jtmt®ftW WS 270 aS5Ett&3J»f (Muscle Denervation) WE 500 BW. (Mycetoma) (£-vX*7 $ a-yy. $££ &!S (Myoma) QZ 340 X%Wfe%,m WP 459 ; J-'gMm WP 459^ $£ £ &J|Xai (Muscle Contraction) WE 500 ®#.&I*]£e (Mycosis Fungoides) WR 500 faX&M (Myoepithelioma) QZ 3l0EgJf)14<7) k<7)(£Sfl IB**&«£■« (Myoneural Junction) liW^*S^lSJ$££ J£#ttB& (Incest) WM 610 mmm (Argentaffin System) li^PAMSJli £B«ifll*ffl8& (Argentaffin Cells) UB9 nAliflittttil)fc$ ££ ftffiM&ft (Sarcolemma) WE 500 iK!Ifilttll!! (Myenteric Plexus) WL 600 &H (Metals) mmmiztsifz wu iso *HJM:¥ QD 171-172 ftftt QU 130 ftA14&Sfti!iJI& WD 205.5.M3$t££ mmmtm^m T>V7 '1±S&JS QV 275-278 *#M QV 290-298 Wx.CD&mco%fo£ii%X MM (Crowns) WU 515 £MS6fC (Metalloproteins) QU 55 £mMmt&V>} (Metallo-Organic Compounds) (££$t ^t^^$££ Mmm (Metallotherapy) l£ft*^IS^$££ MWsM.m (Neoplasms, Muscle Tissue) QZ 340 mm&nii<7)umiLftttz j&.RMm&. (History of Medicine, Modern) WZ 55 ifxiXXm (Literature, Modern) PN 695-779 #ftr- \z-y9XU, ±m»Uz mffi&lk (Withdrawal Symptoms) (£BgMtli&£tt$J! X m*n (Argyria) WR 265 mmmfrmm (Catatonic Schizophrenia) li*3ftfitt#8! *?!$££ 9§§i3tfe^iS (Relaxation Techniques) mmm wm 425.5.R3 f$i£ QT 265 mnm^ wm 75 Vvmrnm wb 545 H§!jS'I4:&I£ (Urinary Incontinence, Stress) WJ 146 §?3S1£i$}$H£Pf t (Tension-Discharge Disorders) liAlfc H&$££ mMcDZ^Zt (Stressful Events) (£^ffilt^$M#JS$ ££ mm (Catatonia) (£7yh--$££ m^m'&frmm (Schizophrenia, Catatonic) WM 203 &femm (Chrysotherapeutic Agents) I£4t')7v7#l^ #J$££ «&*£ (Argyria) WR 265 (KffittlBffteifc (Encephalomyelitis, Myalgic) (iti14*I #*£1£1¥$££ ffimmim (Electromyography) WE 500 m^Y t-yyxi£, ±mmz ±Wliii¥ (Gold Isotopes) 4&mm QD 181. A9 mmm qv 296 m Y -9 X (Muscle Tonus) WE 500 ffiftmB (Muscular Diseases) WE 544-559 mm WE 550 fVJtmt'^jtm ws 270 JKffitt&^E&i (Muscle Denervation) WE 500 &l*l3f&K (Muscle Proteins) WE 500 &5l*]l*]i4.lri (Injections, Intramuscular) WB 354 580 9V ®ft i) 7v7 (Rheumatism, Muscular) liS*£85l*l*&$ ££ g£l£ (Argyria) WR 265 S/SftiS (Musculocutaneous Nerve) WL 400 M&iKSilk's $*>££. fflxli'lf'Mli WE 820 falffim (Muscle Spindles) WL 102.9 %y-? (Betel) liAreca$£i %m (Fascia) WE 500 im'&.<7)ii ®,i)7-?A- (Fibromyalgia) WE 544 £5&fr (Sarcosomes) (iS5 ^ h3xK'J7$££ SS (Fungi) mm^^mtix qz 65 %mWM QK 600-635 *7fS14 QW 180-180.5 SUltS (Antigens, Fungal) QW 573 S«14*££. (Fungus Diseases) l£Hffi*£$££ SS+# (Fungus Poisoning) l£ ^ ^ h^rxX*E$££ $%%% (Fungal Toxins) l£^='hJr^X$££ nmt&X (Spores, Fungal) QW 180 g^7y7x (Fungal Vaccines) WC 450 9T->77y\L (Quokkas) (£7 x7*/i/-$££ 777^ (Guanacos) t£#f1it# * * 9 "J -y K $ £ £ 9T- yy (Guanidines) QU 61 Mmm QD 305.A8 /7- ij,uA ; K—v/l& (Guanylyl Imidodiphosphate) QU 57 9T-y9 9yfc3- YMBSB'S. (Guanine Nucleotide Regulatory Proteins) (£GSfiK$££ 77 / y >I- 9 /l^c (Guanosine Cyclic Monophosphate) l£cGMP $ £ £ y7/xXS2',3'— 9A,$t (Guanosine Cyclic 2',3'- Monophosphate) l£cGMP $ £ £ /7/->>l3',5' — ') Al£ (Guanosine Cyclic 3', 5'- Monophosphate) l£cGMP $ £ £ /4-yyrXr (Quick Test) (£7°n hnxt*XB^ra$£ £ Mfimtk£.m (Gonioscopy) WW 210 mnwm (Goniotomy) l£ffl#cl&^l&ffiT$££ ^fBlftg) (Spatial Behavior) kx&mm GF 51 •bmm BF 469 £RfJ*fl:t (Space Perception) WW 105 'WJtiZiSlT&mitMfo WS 105.5. D2 'bmmtfi^m bf 469 SRU^ti (Spatial Orientation) l££^t&$££ £mco7yA'yTi-5. Y (Citrated Calcium Cyanamide) l£x775K$££ < tA,m.7A 9)V (Citric Acid Cycle) QU 98 ^ (Grasses) 7x/l/7Xfc LT QW 900 &Jg SB 197-202 581 9n Jfc7 7 7/ t7l» (Chelidonium) IJ*BlWiflj£H. <3- (Fruit Flies) l£x a 7 x a 7'<^$££ P (Mouth) WU ^1§^I$££ P - P AX»f »&'<£ (Mouth-to-Mouth Resuscitation) l£4.> lti.^^?S$££ pPfPft (Mouth Breathing) WF 143 m*Y t-yyxl£, 4HISIJIC # (Labia) l£/4PtSl3$££ IgA^ (Anthelmintics) QV 253 Ilk (Shoes) QT 245 g)fmf4#J WE 880-890 7-KM Xfc-7izisiTZ> QT 260 i£iflt;fcft& WA 485 7-y->3X747- (Cushion Liners) (£^ftS^4$£ £ mtamftfe (Refractive Errors) WW 300-320 mm WW 300 m$Tm& (Refractive Disorders) !£JS#f^SS$££ SWl^an (Clinical Refraction) (£IBJS#f$££ mam (Refrative Index) (£)S4*f*!i|£$££ lg,ianx. (Refractometry) QC 387 H^fitHMc (National Health Policy) l£«Jti&pg$£ £ mmm (Antiluetics) (£*&#$££ t (Neck) I£S1£|$$££ 9 i) 7° h n .y y x m (Cryptococcus) QW 180.5. D3 9-^7'JV (Monkey, Spider) (£7 7 7 77xf4$££ ^?U';I (Rattus) l£4X~SI$££ y -^ 7 x (Coumaphos) It31 SB 952.P5 &&&£ WA 240 y v ij x (Coumarins) QV 193 y-vx/<7 (Hornets) l£XX"/ '<7H$£ £ ffi&DNA (DNA, Recombinant) QU 58.5 JtfE^J • fiSft»|4 QH 438.7 ffl&4xy-7iDX15!| (Interferon Type I, Recombinant) U&&1*A xy-7xoX7/l/7r$£ £ *JHft4 xy-7x □ X7/i/7r2c (Recombinant Interferon Alfa-2c) l£#IHfcf£4 xy-7xDX7/U7r $££ MSDNA (Recombinant DNA) (£*IH*DNA$££ ffll^f4;4 xy-7xnx7/l/7r (Interferon Alfa, Recombinant) 9L&m QW 800 #t74 Jvxmt LT QV 268.5 ffiffi#£fcLT QV 269 I&&S&SI (Recombinant Proteins) QU 55 £.ty!Xm TP 248.65.P76 *JH&7y7x (Vaccines, Recombinant) Ufetii7 9 + y $££ 9-5.X (Koumiss) l£?Lft$££ 9^m (Arachnida) QX 467-483 9W*M (Spider Bite) l£# <• i 4>#$££ 9^7'JV (Ateles) (£7 7 y 77uf4$££ 9*i% (Spider Venoms) WD 420 < &H$ (Arachnoid) WL 200 < iiM (Arachnoiditis) WL 200 < &BITK (Subarachnoid Space) WL 200 < £))HT4± (Subarachnoid Pressure) l£ISEE$££ < £Jg~FftJfo. (Subarachnoid Hemorrhage) WL 200 9tm (Spiders) QX 471 ^flli^y^fpS WD 420$££ 9y7 4 "y'/mm (Grawitz Tumor) l£^ffl)ife*S$££ 9y7 K^xa^)jiS91 (Melanoma, Cloudman S91) it £S^sfe)if$££ 9y7y (Dental Crowns) (£&)S7a$££ 9 7Y% (Jellyfish Venoms) l£KIi®j!f*S$££ Bf? (Darkness) >Xmmh% QT 162. L5 fc n *^ WD 110 ; m^fl't WW105$&££ y y X 1 Jtf57 (Class I Genes) l£MHCy y X 1 jff£4 $££ y y X 2 mi,X (Class II Genes) l£MHCy y X 2 $f£4 $££ 9yX2$jXW- (Class II Antigens) lidfiffia&ttffiJS? 7 X2 $££ 77 XT A fc9~? — 7/ X h (Glass Ionomer Cements) WU 190 y 7 X y -slffi (Cluster Headeche) WL 344 yyxhrx (Clastogens) l£^#DIC$££ /7 X 7 r 4 '<-3r7'X'&# (Fiberglass Casts) liW4* 7'X-a^$££ 777 (Grana) (£3tfcl4*$££ ^rT^t (Clavulanic Acids) QV 350 77-7M& (Graafian Follicle) WP 320 9*JV?-X%MU$k (Glucose Tolerance Test) QY 470 9yl -xTJS&Se (Chlamydia Infections) WC 600 Dcg^ SF 809.C45 WZ^ykmt, 9A7WZ 9 7 7/7S (Chlamydial) QW 152 yy ^ x7-XX (Chlamydia) QW 152 77 $ xi^x (Gramicidins) QV 350 7y^m'\tM (Gram-Negative Bacteria) QW 131 77APij4£|?Vl4! (Gram-Negative Anaerobic Bacteria) QW 133 77AP#141(TfVl4® (Gram-Negative Aerobic 582 9JVH7, Bacteria) QW 131 /y A|£14fttfVI4rTW*i (Gram-Negative Facultatively Anaerobic Rods) QW 137 ?y AfettftM*'*-*!*' (Gram-Negative Chemolithotrophic Bacteria) QW 135 yyAP§'|4M8&4-ff^lW (Asporogenous Rods, Gram- Positive) l£*HI|V-i$££ /7AFI'|4^1 (Gram-Positive Cocci) QW 142.5.C6 /yAPIH4$ (Gram-Positive Bacteria) QW 142-142.5 77AP§14Wfllf£ (Gram-Positive Organisms) !i*fflM'$ ££ ?y-V (Curare) QV 140 9 7-vmV>i% (Curare-Like Agents) litt&ftJIWtf&i ^$££ ?yy\zs9 (Clumping) liillRft^Si 7iJ7^tSt't4HeW (Glial Fibrillary Acidic Protein) QU 55 71) 7^17 4 y / x h SBM (Glial Intermediate Filament Protein) (£ 7') 7«S£14Sf3fC$£ £ /i)-t*i//l/$tia (Glyoxylates) QL 98 M®itm mwmit&yv QD 305.A2 9 ') fc *9-)V (Clioquinol) QV 255 9 iJ77n7') xitfig (Cryoglobulinemia) WH 400 7i)7'y>9-Af (Glycogen Synthase) QU 136 7 0 a - Y x y x 7 9 - -t (Glycogen Synthetase) (£ 7 U 3-rx-xxy--t'$££ y ij u - r x 7 X 7 'J 7 —tf (Glycogen Phosphorylase) QU 141 y ij n y y—tf (Glycosidases) Ii 7 'J 3 x K t Y o y —tf $££ y 'J ^ x K (Glycosides) QU 75 •t«*>(ia«'Dfir:*tf£ QV 153$££ 7]J =» x Ytt.'XWA (Antibiotics, Glycoside) UT I 9 9 ^yKM4ftI^ll yj^xKt Kny—fe'(Glycoside Hydrolases) QU 136 7'J 3 x ML (Glycosylation) g&W^ QU 55 yij ^Wt/flT^yntxA (Hemoglobin A, Glycosylated) WH 190 y ij a $ 7 74 x X (Glyconeogenesis) i£*tff * $ £ £ y U 3 7 'J x (Glycophorin) 7 'J 3 y - h (Glycolates) QU 98 Mmm MTjMt&VJ} QD 305.A2 yij a-j\, (Glycols) Mmm QD 305.A4 mmm qv 82 7ijn-,!^i& (Glycolates) I£7'j3y-h$££ ^'J7X7-VA (Chrysanthemum) I£p&&^$££ yj->h-/l/ (Alcohols, Sugar) l£lt7/l/3 -/U$££ 7lJx/l/X7x$? (Glycyrrhetinic Acid) tt^ffl^fc LT QV 60 nmmt LT QV 66 7 7/l/f/i (Glycyrrhetic Acid) (£ 9 ') x/l/ X 7 x|& $££ ? U X ? ij x (Crystallins) WW 101 9 'J X?/l/'<4 7X-y h (Crystal Violet) I£7x777'< AfcV-y h$££ 9\)XA-*?y7Az-yX (Christian Science) BX 6903 -6997 •;i/r-yxX7x7 — 7" (Glucosyltransferases) QU 141 yVun-X (Glucose) QU 75 583 pjvztx* Mi ft WB 427 il:.Att*r WB 354 €mm QU 75 9>v?-Xfc*y9-JV (Glucose Oxidase) QU 140 9/V a - ?. ,\:,v 3 - x 7 X 7 r y —-tf (Glucosephosphatase) (£ 7>V 3-X-6-7X7r y--t:'$££ 7;u 3 - x 7 X 7 r y — -tf ft£S£ (Glucosephosphatase Deficiency) tiilgfilS^lJ: 7;u => -X 'J ^fhFn 77-7' (Glucosephosphate Dehydrogenase) QU 140 (Glucosephosphate Dehydrogenase Deficiency) WH 170 7/i^-X-6-7X7t y-7* (Glucose-6- Phosphatase) QU 136 9-JVa -X -6-7X 7 r y --tf A£*£ (Glucose-6- Phosphatase Deficiency) (£#£!&*i*! 1 S$££ y/^-x-e-'^g^t Fnrt-b' (Glucose- 6- Phosphate Dehydrogenase) l£ 'J ^§£7* t K c 77 —-tf $££ 9>vyY->v (Glucitol) l£7/i/t h-/!/$££ 9)V9A-fcy (Glutathione) QU 68 7^y77X~;/U7 3-x7--tf (Glutathione Peroxidase) QU 140 9JV 9 7 fc X X 7 y y - -tf (Glutathione Reductase) QU 140 7/uy i 7-7' (Glutaminase) QU 136 9-,i9 =-;\,^yj- Yify-?7iv9 iJVfc&BM (Glutaminyl-Peptide Gamma- Glutamyltransferase) (£lr&jft-7>v9 i. yyy-7-9 JV9 ^/H-7XX7xy—b'$££ 9)V9 ly (Glutamine) QU 60 9JV9 I ymT^E-T ij 7-7' (Glutamate- Ammonia Ligase) QU 138 7/1/ 9 = X®?1£ (Glutamates) QU 60 9>v9 I ym-fc*7vmm Yy XX7^7—tf (Glutamic-Oxaloacetic Transaminase) l£GOT$£ £ 9JV9 =L ymrh Ku77-7' (Glutamate Dehydrogenase) QU 140 9JV9 z X^7 h 'J 7 A (Sodium Glutamate) £ft¥ QU 60 &n^/jn^fc LT WA 712 9JV9 i >#- t/l/tx^ h 7 XX7 ~ 7-7' (Glutamic- Pyruvic Transaminase) (iGPT$££ 7/1/y ~ ym*9i-Y iJ 7A (Monosodium Glutamate) (£7/l/y ~ xg?7 h U 7A$££ 9>V9 = yyyr9-V (Glutamine Synthetase) (£7/1/ y i ym.Ty^-T 'J 7'--tr'$££ /;^;^;^t P$£fcffi (Glutaraldehyde- Stabilized Grafts) (££^1iSg$££ 7/U77^ Y (Glutethimide) QV 85 9'V7 X (Gluten) QK 898.G49 y/7x14)li^ (Gluten Enteropathy) (£7 0 7 .y y ***. ££ M'Nat- (Culdoscopy) WP 141 < i>m (Rickets) WI) 145 7/I/-7 (Croup) WV 510 <£^*L (Ankle) WE 880 883 7/l/-74i'j4>ii*Je*£ (Group Psychotherapy) Ii tiJ-tlMtt^ }£$££ ~<¥ffiX (Wheelchairs) WB 320 7yoy W 26 W^$^cr>fz^^ArtLit, A:W-HX ♦Sfcn (Carsickness) (£fiW$££ < h ^flj >) mit&M. (Nutcracker Esophagus) li&iiu'f fjj Pfl:$££ yx77-X (Creatinine) QU 65 y X77x (Creatine) QU 61 yx77x^7-7' (Creatine Kinase) QU 141 y X77xdr7-7'74y7'4A (Creatine Kinase Isoenzymes) QU 141 mmfoizmz tiz>m&u±mmiz ?X77x*7-7'4y7-A (Creatine Kinase Isozymes) l£y X77 X3- 7--tf74 77*4 A$££ y X77x7X7^f7-7' (Creatine Phosphokinase) Ii y X77x*7-7'$££ y v 77 X n ^g£ (Phosphocreatine) WE 500 y X 7 7 - h (Creosote) ft^iMfc LT QV 223 ny»m qv 627 yx7y-A (Nucleosomes) QU 56 mfikm QH 599 y I//-/L- (Cresols) ftlSifelifc LT QV 223 Mmm QD 341. P5 ^V'-/^ (Cresylic Acid) (£yxy'-;u$££ y X7X*^ (Cretinism) WK 252 y iJ7xx7 (Klebsiella) QW 138.5.K5 ^1/7'yxTi^g (Klebsiella Infections) WC 260 B% WC 209^$ &££ ^mt& WV 300 y X7X0J& (Krebs Cycle) QU 98 yx-^X7x (Clemastine) QV 157 y*l^>7^ (Grenz Rays) (iX*£$££ y o7y^& Y*i% (Rhamnus) mmmvnt lt qv 766 7 $££ 9v — —y?y<7 y- (Cloning Vectors) (£^y> 9 n 7 4 7 'J y tit (Clofibrinic Acid) it 9 n 7 4 7"/ufi$ $ ££ 7 vy 4 7'>vt\£ (Clofibric Acid) 4t3l/X7n-;x«fcLT QU 95 /o7*'JX (Globulins) QU 55 ^ovf y (Chromatin) QU 56 mum qh 599 ?v?Y 9yy 1 — (Chromatography) ##fft? (-^) QD 79.C4 MMYtt (^fe) QD 272.C4 £14##f QD 98.C4 SStftff QD 117.C5 ^?* 0 ft I- flSffl 3 ft 4 *l & (i ."US B"J iz, fflj x (£ 7 >v ± x SH^Ii QY 330 ? n a 7 x X (Clomiphene) QY 170 ?viy°yz.y (Clomipramine) QV 77.5 7oA (Chromium) QV 290 m QU 130.5 ?dA1IDS (Chromaffin System) rW»¥ WK 102 smmxim-gcoArtiumxim-gftuz 7nA$fl]14*fflJ]&ll (Pheochromocytoma) QZ 380 7oA$fl]14'*7 7*X 7 (Chlorimipramine) liyni7y^X $££ 9u>vyTJ£fc*yY (Chlordiazepoxide) QV 77.9 9v/vfa> (Kepone) SH SB 952.C44 S*ffi£ WA 240 ^d;u73X (Chlordecone) (£77°X$££ ^n^7hx74y'Jx (Chlortetracycline) QV 360 ?o/l/7x7i x (Chlorpheanmine) l£ y n ;i/ 7 x — 7 ^ >$££ 9&JV7iL — y ~y (Chlorpheniramine) QV 157 9vjvy'Y-JV (Chlorbutol) it 9 o o7*y 9 -/!/$££ ^n;P/nfH> (Chlorprothixene) QV 77.9 y D;u7'n7x X tU f; X (Chlorprophenpyridamine) l£y n;u7 x — 7 i X$£ £ 9zuvy°a-?y> (Chlorpromazine) QV 77.9 9njV<^*yyy (Chlorhexidine) QV 220 9 o JV 9 7 y h (Chlormequat) wmftttmwiwn fc l t qk 745 1)4*ft7 QD 305.A8 9v)VJ + y (Chlormethine) t£yyoxy~X$££ 9 o )V 9 d Y >J > (Chlormerodrin) QV 160 ^ d /u y n 7° 'J X (Chlormeroprin) Ii y o JV 9 n K 'J x $ ££ 7Dl/?vX (Chlorethazine) (£yynxy~X$££ zn xy (Chlorella) QK 569.C49 70D77h7x/X (Chloroacetophenone) QV 665 7oox7l/X (Chloroethylene) l£l&{l:t-/l/$££ 7 d Dif x yfc 'J ■v— (Chloroethylene Polymer) (£i& fL7'J t-/l/$££ 7 n o ^ x (Chloroquine) QV 256 7 n n y — h p /< x -tf x (Chlorodinitrobenzene) (i x — h D7on/<9 v 7xX$££ 7nn7x/-/l/ (Chlorophenols) QV 223 9uu-/9 /—)\, (Chlorobutanol) QV 115 ? on7°XX (Chloroprene) %mmt LT QZ 202 'MWm QV 633 ^oo7/l/A (Chloroform) QV 81 7nn77/l/i-7/l/ (Chloromethyl Ether) (£t'X (y pn/f*) x — 7/i/$££ 7003— K Jf x (Chloroiodoquine) l£ y 'J 7 ^f y —/l/ $ ££ y n - x Jg14*HJI&##f$£ (Clonogenic Cell Assay) l£ 3 n --JFM ¥{£*&£$££ yn-x*HSfe (Clone Cells) QH 585 f^yn-^-xy QH 442.2 9 a —ym (Crohn Disease) I £ Crohn*?! $£ £ 9 7yfcJV3JV (Kwashiorkor) WS115 Wm (Military Physicians) UW^mm ', tS6iF$££ W^mm (Military Medicine) UH 201-570 mi %&cr> WZ 112.5.M4 iMkCO WZ 100 BSSt UH 215-324 y%m WO 800 lf££ WO 11 V-mY \z-y9Xit, ±H«iJi: WWfaX (Military Hygiene) UH 600-629.5 WYXY?- (Military Science) U KS UG 730 &m UA 926-929 wm mm uf 625 Wtfi£¥ UG 623-1435 WtoWf- (Military Dentistry) UH 430-435 ■^M WD 745 :MW VG 280-285 W^nWmm (Military Psychiatry) UH 629-629.5 ymw-M- wm 184$ ii%x < A.M (Fumigation) (£MffiJ£$££ Wk (Military Personnel) -wnt°7^x u 1-145 ¥P££i£ U 750-773 585 9 x y x *r mtl'l'-A L'B 356-405 '•HK'tffiUoi't^^i-IS* ii%X, fflxli'J'-t 0 7--> -i xWT*>J#**iiBf5tfPA UB 360-366 VWH-fHS (Military Surgeons) (£W[§¥ ; y4*4^y>T cof^fi WZ 112.5.M4^$££ 'QWrtfW (Militaty Surgery) UWWm \ W)T^ ipftftf} WO 800$££ W-Omm (Psychology, Military) U 22.3 Wmmmtfi (Veterinary Service, Military) UH 650 -655 Wffckmm (Military Psychology) l£¥P$-ll>S^$££ WWtnWmm(Psychiatry, Military) liTO«ttIS¥£ Ji £ ^ (Hair) WR 450-465 gftI.^JS->Xfi (Decision Support Systems, Management) W 26.5 ArCDHicomt&U, ±M)5'llz fcl'gHf IS x X 7 A (Management Information Systems) W 26.5 ^ISItniyXfA WX 26.5 £r7fctt^1tfBxX7A QY 26.5 DBMS W 26.5 gf*S.ftl"i«"/Xfi W 26.5 *^P^tffSxX7A WX 26.5 OA W 26.5 MmmmmuyxrA wn 26.5 Zcoi&coftTf-izisi^XU, ±MSiJtz ItPjUffit (Planning Techniques) mmi%Mft$k WA 525-546 \mmm7-vx w 84-84.8 m^rn wx 150 muuwc WX 140 Z<9>m<7)W£yYfflzisiyZ,iiCDU, A:CO±mt\iz ttHitfJii (Planned Parenthood) (iMftiii$££ tMBiailft (Planning Theories) l£ffiIiJlf|ir$££ mM (Corns) i£^/l£>$££ *£!?'£* (Tube Feeding) l£*£!it'£* WB 410$££ Illr^tfllS (Tube Feeding) (£gS§^#$££ H^JFM (Angioplasty, Transluminal) (£' it [*]<£$££ %m&A xt-yxx7°x7x^yy7^f- (Plethysmography, Impedance, Transthoracic) (£ 4xt-7xx-L-mHii$££ H£5 (Neck Muscles) WE 708 ^^W, (Light Metals) it±m QU130 #&m#g|<&&& ^<7)£fa ; 7/1/i ^7 a ; v77>/7A$££ gft (Moronity) (£«*♦£}£££ J: IIIEftllS&^ttJfot^ltJlT (Angioplasty, Transluminal, Percutaneous Coronary) WG 300 H5\ (Acupuncture Points) WB 369 1J£1t (Fluorescence) {I| QD 117. F5 ft** r- t -y y X (t felBSiJ I-. ffl X. imtftt■ IZ £ It & *7l l£ QY 185 it^tJStt'ft^/l/y — 7-f xy (Fluorescence-Activated Cell Sorting) (£7o—7 4 h ^ h 'J-$££ akytmi&Wc&'m (Fundus Fluorescence Photography) Ii yjvfcy-tA xifii^ £!#£$££ IgJtW (Pseudomonas fluorescens) QW 131 ^^fclfo/iSJsl^S (Fluorescence Angiography) l£7/1/41/ -fe4>lflLt:iti^$££ ^IMf&faft^S (Microscopy, Fluorescence) QH 212.F55 mzmmizmmzti&m&u wf 3001Z Arcoi&^micBfoiz'mmzh&m&u, x\mmz ^JttKMfcKW (Fluorescent Antinuclear Antibodies) Ii ttTOf*$££ iKitW&fcjlWy&k (Fluorescent Antinuclear Antibody Test) t£&7tltf£-;£$££ i&itiJLifc'm (Fluorescent Antibody Technique) QW 525.5.F6 smmmmizisu & qy 250 smBwntzsbiz'mmzti&mfru, ±nsijtz ^itjt^.6f^ (Fluorophotometry) WW 143 Mit&m (Fluorimetry) (£Maij£$££ %£±&M (Fluorochromes) (£S:*ifel4$££ ■gyt&W- (Fluorescent Dyes) QV 240 :s:3fc$i]/E (Fluorometry) %mm (-fe) QD 79.F4 tk^mmm qy 25 £iifc#0f QD 117. F5 wfcBfonrziibco'mmu, ±mmiz J&yt-gkBIS. Y y — y y 9* (Fluorescent Protein Tracing) (£^*ltft:JS$££ •Mit'Mmii (Fluoroscopy) WN 220 tmmmvjmwizmmzti&m&u, zcovmitzim IZ i&P454 (Administration, Oral) WB 350 &nm&m (Contraceptives, Oral) QV 177 ^*7°o-7* (Fluorescent Probes) li^^"^4$££ HP 7 'J fc 7 A JVX 7 y 7 X (Poliovirus Vaccine, Oral) WC 556 HPM&4 (Drug Administration, Oral) I^Pft^ $££ &:>fcX»®lti^£ (Cinefluorography) l£XHM« &$££ ff^Jx)£ (Alarm Reaction) l£Xhxx$££ d# (Tibia) WE 870 HS##tJf (Tibial Fractures) WE 870 Wm (Economics) ^lg^?l$££ H'i£»t#- (Economic Competition) ±MIZ£ 'm«±.ff{#.$££ iMM&l (Silicic Acid) % wz 350 !£m¥W WS 105.5. E8 %mmmzisitz>A:izumffimm wm 450.5.as$£ £ mmM&umwiizisitzmm wz 330 #$££ mnmmm& wm 49 mmmAyX \v-y* x WZ348$&££ sffilz£(t£[l^ (Medicine in Art) WZ 330 mnmmizM&itz wm 49 sJffi(zfc(t£Af£ (Human Figure in Art) UM'M-mm $££ SlfiSfffi (Art Therapy) WM 450.5.A8 W^m WS 463 ?LJe«fc*&£»J WS 350.2 J^tt^ (Form Perception) WW 105 W&m (Jugular Veins) WG 625.J8 m^coxiz^^kmm^ we 7os$^££ HHM3t#;& (Intravenous Hyrperalimentation) I£#jH P£**$££ YitiLyXm (Surgery, Plastic) WO 600-640 * WV 312 zcomomiu, anisijtz ffitt^Jft* (Spastic Paraplegia) !£j^A**¥$££ ¥f&X&1£%:\k (Anemia, Hypoplastic) (£|?£4^14S: JflL$££ SttJft* (Spastic Paralysis) (£Mlig$££ St (Silicon) fSHHt^ QD 181.S6 ftUt QU 130.5 ifcflr? QV 618 WiMfrm (Continuum of Care) l£.f.?f^lliPJ£$££ MfciLfimmft^ (Nursing Education, Continuing) l£fi $7«:#w$££ H&titftfi (Education, Continuing) LC 52076660.4 VfZ<7>®mftfimm£%x, miitmmmmfi; mm ftfmn; m-mmm^ mmmmmm (Saccadic Eye Movements) liJtffJJJIUj $££ »£AP£'#fi (Continued Stay Review) li#:P*H#'#ft$ ££ mW\-n (Menisci, Tibial) WE 870 7 4 V X*w (Caisson Disease) li«H-*fi WD 712$££ ff^ig'7 (Morphology) (ifW#lj^$££ 0S3J1:M (Morphogenesis) -^Hk^Mm QH 491 ABB $843* QS 604 mmi.coiiCoum.miz m£*&mm (Transplacental Exposure) liftf#16iBIS£ &$££ &ll§*# (Enteral Nutrition) WB 410 &.Wj%7 n ij -^mm (Nutrition, Enteral) l£^lt**$ ££ SItt (Cervical Vertebrae) WE 725 **£H£ (Phylogeny) QH 367.5 SiftlK (Carotid Arteries) WG 595.C2 mmmmWi (Intercarotid Ganglion) !£?IiJjM7f*$ ££ SliJJJKJfiLte^ (Carotid Artery Thrombosis) WL 355 3K$mmfc (Carotid Artery Diseases) WL 355 SgUM'M* (Carotid Body) WL 102.9 MihMXifcmm (Carotid Body Tumor) WL 102.9 WWUBkfo (Glandula Carotica) li?IiM7f£$££ WMlWM (Carotid Sinus) WG 595.5.C2 mmmmmm wg 560 ^^.iM.miLUW^ (Prostatectomy, Transurethral) Urn £)!&«$££ fiifeS (Silicotuberculosis) WF 654 Slifrffi (Silicosis) WF 654 &#HII§l*tf¥W (Intubation, Nasogastric) (£HJI§l*]4fW $££ jf&Jkn&JlX (Skin Absorption) WR 102 g/iJB^'jgttJflLW^lKffi (Percutaneous Transluminal Coronary Angioplasty) U&mfo&ikWnittskWhm $££ &£f£l£l?Jl^h£ (Percutaneous Transluminal Angioplasty) li^'/l/-Xjfi.t:J^*fff$££ I^JlcS^^rEEiMSE (Oxygen Partial Pressure Determination, Transcutaneous) liH&ffalfo.JifcT'X^ -y 'J xy$££ &&m (Erythroderma) (£i»14£lf &$££ SJ^6tl77°y y r 'J (Transcutaneous Capnometry) (£H AtftfoM**.*-? ') >7$££ l££^JJfnJ#7'X^ —y ij X7 (Blood Gas Monitoring, Tianscutaneous) QY 450 H&tfJ&SfcSiJS (Transcutaneous Oximetry) !£|&&6/llz&(t6 WL 385 H'jtmtwjim wl 340 <&mmUXfr/o WQ 215$££ ifcg^ SF 895 mm (Cramp) (£&*!*$££ &W*F (Convulsive Disorders) UU&m \ TA,7^$ ££ &*1if£K (Spasmophilia) l£7y~-$££ mmm (Convulsants) QV 103 mmmm (Convulsive Therapy) WM 410-412 -^X7xx7 Yy7-)Vt fc Mz WM 410 Wfo&MU (Cervical Rib Syndrome) WL 500 74 nx (Chalones) YiZhi>ijiMl WZ 112.5. S8^&U'k% • tmU WO 22$££ mm-&%ffik®\Ml& (Surgeon-Patient Relations) (J 'A-mA y X Y y-y 3 X (Illustrations, Surgical) (i[7? mAyXYy-y3x$££ mm (Surgery) WO mswim^coxizb&mrr wi 9oo-97o$££ mmtmmmcoxizhhmvm sf9h$££ TYyXUXmm WO 517^$££ fcmmm wo n %&<7j WZ 112.5.S8 W^co WZ 112.5.M4 Mkco WZ 100 &m<7>f$m wg 460 4:>jfiL^(£4:>]lljf[Lf:^7)Tlz&&74*4^ WG 168^$ ££ imtmumm&m wo 100-275$££ 7-XXy77 WO 16 'foftcoimmm* wo 5io^$££ *f4(£^l«fi^m^ WU 300-360^ ; PJ£y4*4 WU 600 -640^$ ££ A£ • mam wo 22 mm wo 140 ISC.% WO 700-820 ■Mm wo 50 ffl&tf) WO 141 3--^7lzoi^T WZ 305.5 #¥»! WO 925 fVJtmt^itm wo 925 £¥W WO 950 71; WO 700-820 W& WO 184-185 mmmmim w 100-275$££ W WO 800 mw wo 800 &m WQ 400-450 IS^4l£BS(7)Tlz*§y4l4^ WW 168$££ mmmumtmm WE 168-190#$££ n&mmmu^^mmm&coxizhh mm wv 168 ; ttzU^coXizb&mm wv 200; #<7)TC hhy\mm WV 300 ; «^Ttz£6 74fr¥ WV 540$££ W-mKLHimmcoxizhzm-m wi 65o$££ mmtm^^m wf 98o$££ /4fi(£ WO 700-820 MBcSliBtK- WJ 168^ ; ^^(£^^4^2?^ WJ 168 !?$££ DcE^o(£|^[S^^Tiz*^^4^ SF 911$££ ■-li/i^fl WO 198^ ; tt&*r*4 WL 368 ; *WfiM&«, 31W, ^>7>£ fa ; m^% ft $ 11 £ SW^EIfi (Surgical Atlases) UXWimtRX m*mm (Surgical Nursing) WY 167162 $m WY 18-18.5 %.$>3kM,Bm3-mMm wy 162; nn wy 154^$ &££ 588 T-'yi + a W&W (Surgical Instruments) WO 162 7 9 o 7 W 26 iY^yxWft (Casts, Surgical) WO 170 ftff&lfo. (Blood Loss, Surgical) f-ftj^^^lftlzo^TIi, ZntkUT ftft^fem (Intensive Care, Surgical) ti1£'I1 tfi*f[$£ £ ^^fp^ (Operative Surgery) (£7ffirr;$££ ^47ffif*Pt (Insurance, Surgical) W 100-275 5144!Mlf (Diagnosis, Surgical) WO 141 ft£l#*ftii (Surgical Care Plans) (£fi|/if£Pfc$££ ttfSrtfJf*ti&# (Surgical Flaps) WO 610 ^■ffiXfemZii&WZcomRiz^^Xit, A:^:\k?lX mW1®~&lX (Surgical Infection) (£f-!lf^Jl^7L$££ ^4W*£^ (Ligatures, Surgical) (i^lfr*$££ $144ftl?$fl (Surgical Replantation) l£##tfl$££ STftft+Wffi (Surgical Revision) Ii4*lf-ftf$££ ^46^x77/1/ i - (Diathermy, Surgical) l£fltfv)i[S|}£ $££ ^Wft^Hf^ (Dental Prosthesis, Surgical) (£4x7 yx b nmmrnaxry x h m$ £ £ 7Kf46t(-ltJfiL (Hemostasis, Surgical) WO 500 £4#*£ WO 184 mWm& (Surgical Diseases) (i?4*4^$£i 'JYmtfJfejE.Xffi (Revision, Surgical) liS7fff$££ ^4^ailfll (Hemorrhage, Surgical) (i/4f4^Jfil$£i mmtiififfi (Surgical Diathermy) limfvl[I]i£$£i mmiHtW: (Care, Surgical) Uffiimm ; flnnM ; H mmmzzx W-mtfJih&W.tfV&ffi (Arteriovenous Shunt, Surgical) WG 170 ^4f4Wi^//nffT (Anastomosis, Surgical) ftZiktMlznfcIXWiizisUZArtiU, ZcotkMiz m^nWdzmm.W^ (Portacaval Shunt, Surgical) WI 720 5144ft HHM& (Portasystemic Shunt, Surgical) WI 720 77 tg (Mucorales) QW 180.5.P4 mmmm (Pathology, Surgical) WO 142 WJflSsJI: (Surgical Equipment) WO 162-170 7 y n y W 26 mmxr-yjv (Surgical Staplers) WO 162 ^4Jfly-yx^ (Surgical Mesh) WO 162 %\m%fX± (Liver Failure, Fulminant) (£Hf14JJua*E$£ £ 8fc& (Rage) BF 575.A5 1r¥W WS 462 fl'JIWtty'Jtm WS 105.5. E5 TJfi. (Melena) QY 160 ftzmmizM&t&m&u, Azv Ymm (Gestalt Therapy) WM 420.5.G3 ftffipn (Cosmetics) itmitm TP 983 %Mmw%m wa 744 mm QT 275-^$ t££ 7"/k (Sewage) wmm qw so Jlffll WA 785 -W^M'^^m. WA 778 *Kffi83 WA 689 7 — X?yYv—)VX9yJ4 (Nested Case-Control Studies) (i*iiif?iJMffiii-$££ 7-X-<-XX9y'4 (Case-Base Studies) U&W\ftMm $££ 7-Xi-y9X (Case Mix) l£^rr^SiJ^lll^fc4j^$£ £ 7 - X X 7' - r- (Case reports) U&MW& $ £ £ 7 9 iy (Ketamine) QV 81 iflLffi (Blood Pressure) WG 106 -toWm#.£L WB 280 ,',',',^{iiUJfllE WG 340 $££ ffi^lij&lME WG 340 $££ JfiUEElfttK (Monitors, Blood Pressure) (iJfo.J±^-y$ ££ M±P$T3£ (Antihypertensive Agents) QV 150 ifiLEifliJSE (Blood Pressure Determination) WG 106 mm#)$£M: WB 280 jfiLEE^E-y (Blood Pressure Monitors) WG 26 JfiLft? (Red Cell Ghost) (i*Jfn.^Hi$£i jfiLftg (Blood) WH imitSkmim^k^. QY 450-490#$££ X'Jl WS 300 ffiflctfclE QY 400-490 'ht£U\kmm'A& WH 1403 ; *M WH 150-180 ; B jflLS^ WH 200$££ mmfe wh 450 imfcft WH 400 WkiiUiftjMfcitiJS QX 355$££ mmmtfitii&. w 750 ftrnmuskmitmrn wh 450$££ W%.li.]kmmW%.t#£tMlk QY 415$££ iDtliirffiitlt WG 106$££ tji&mn QV 193 ; M QU 85-95 ;if WH 400^ $&££ ifiLtfHb^fJT (Blood Chemical Analysis) QY 450-490 ?VJLfflt$]'Jim QY 450-490 f£g^ W 750 mmm sf 772.67 MMm (Hematology) WH M.m (ffitfc^lff) QY 400-490 'W/E WS 300 mmiZi3iT& WY 152.5 lft.i#'7ftf&^ (Hematologic Tests) QY 400-415 #£ffcS^£fa$&££ itmm&l^ffltfa.'giWii&m (Capillary Resistance, Hematologic) l£^ffl^Bfail14$££ $n.m$.'P& (Oligemia) (£S:ifiL$££ SkmifX^ff (Blood Gas Analysis) QY 450 mmm sf 774 tfa.mm (Blood Groups) WH 420-425 mmmmt. w 791 nmatmrnt^xmrnm qy 4is$££ foM^iWsL (Blood Typing) liJfiL»ES!PJ£fc£lisU*£Jt1 589 7 7X^-/3 £ \lll.m*fiW££$.%Myk (Blood Grouping and Crossmatching) QY 415 ft7bt-y7X(i. Kglgijiz rttjft^iift (Blood Group Incompatibility) WH 420 lfiL$'fr*ffll]& (Hematopoietic Stem Cells) WH 380 tiBiWMtii (Hemoperfusion) WG 168 tfammi (Hemodilution) WG 166 m&LizisitZ WB 356 i£i£fillZ^lt-i> WD 670 f»7MgilZfclt6 WG 104 ^WffecOgftlzWLTIi, ±MSiJlz tf&.ifev)k% (Hemosorption) (ilfiL^ii!!it$££ ifiLifoSlI] (Blood Coagulation) Kiftffc^ QY 410 -izimt&m QV 190-195 tmm WH 310 iMBiiaBT- (Blood Coagulation Factors) WH 310 BSJ*tfc£ QY 410 mmm qv 195 \km'&®tkfi (Blood Coagulation Tests) QY 410 JfiLtf&llSIP?-',1;' (Blood Coagulation Disorders) WH 322 tfiLJxm WH 325 mmm sf 769.5 ^£Pr»$*>££ ifiLiftgmH (Coagulants) QV 195 Skmma (Blood Banks) WH 23-24 54*17*1 WH 460 jfiU#& (Hemic System) l£jflLH?-^$££ jfiLlftftft (Blood Cell Count) QY 402 mmm sf 772.67 jfiUf^ttfti&lft-SE (Pregnancy Complications, Hematologic) WQ 252 mmm sf 887 §moo&m SF887$t££ lkm%?&&&t£&k (Crossmatching, Blood) UM.mmWx. fc£Htft§§i$££ tfa.mmH& (Blood Cells) WH 140 E*l*^ QY 402 -izimfc&mu QY 180-185 lfiL$&l)fi14 (Blood Bactericidal Activity) QW 541 #5*h \z-y9Xit, ±£IWz jfiL-ffi^lt (Blood Tests) I£jfiu^76-Jf&^$££ MMm& (Hematologic Diseases) WH mm WH 120 ?L!£»lfc#J!£W WS 300 i&i&izis^xuihm&m&im wq 2523$££ mm WY 152.5 tfcg^c7) SF 769.5 ifiriftfliU (Blood Circulation) WG 103 mmmM.tLxcom^ qz 170 ?l!£»3t#J!/E&3 WG 103 tfffi. WG 103 #* y 4 y&#l&± (Blood Component Removal) WH 460 jfiLflfc^ (Hemotoxins) (£i'&Jfo.^$££ faWWOiM (Blood Expanders) (£jfo.$ftffi$$££ ifil^ftffltfS (Plasma Substitutes) WH 450 fiL&MB'S. (Blood Proteins) WH 400 &M.##f QY 455 iHlSlHT- WH 310 f&ftilH&m QY 410 jfiL^^l'lP^W (Blood Protein Disorders) WH 400 mMmmm qy 455 ftff^jfiu^'7$£trf$£Pr#li, *££ jfiLlfH^ (Relationship, Blood) l£lfiL*f ; mm \ SC1S '. « £!£$££ *§tt (Tuberculosis) WF 200-415 ~<7)/ZRai QV 2683$££ £«&W|±*tt£JKII*g« WP 1603 ; fm£«£*S =R WJ 7003$££ ffiEW WQ 256 iHH WF 405 ?£# WF 200 mm WY 163 PElinmgjR WI 2003$££ JfcJ* (£&**£$ WR 245$££ g)c[S¥ SF 808 '££ ^c7)ffec7)gpfll£, SMiWz SJffi*£f£ WF654$&££ WF 654 |pf£t&"£ (Tuberculosis Societies) WF 1 !ol£ll] (Mycobacterium tuberculosis) QW 125.5.M9 $m®y£m$.±ty}K (Tuberculostatic Agents) liffitStt 3I$££ ISM (Tuberculoma) WF 200 ffiHj14 UffilUtt*)) iiltAitM&mmiz &&&mm'& (Pleurisy, Tuberculous) itmm&m%X ^14f&Hgik (Meningitis, Tuberculous) li«il|gt£#*S £ !&mi.mm (Empyema, Tuberculous) WF 745 &mmm$i (Peritonitis, Tuberculous) f£HM*£$$l £ ISfJC'ffi 'J x^°gfi& (Lymphadenitis, Tuberculous) Ii 'J > %afkm%Pa; U " t* 'J 7- x a > 590 y--y=i7 7 WF 3303$££ £%&*ffi£ (Reproducibility of Results) ^5*7 I Id'jU ffiljjSrlS *#&!£. feUSiJlz $%:tMv.fc^ (\%M££ Sk^MBW&MB (Vasomotor Regulation) l£jflLWSIJj^ $££ lfo.1rJIIM4#& (Rhinitis, \'asomotor) WY 335 jftf^Bjai^i (Cineangiography) WG 500 tfSL^fc (Vasculitis) WG 515 &m<7)fr<7)A:tlU WG 610 jfilt&SS (Vasodilation) WG 106 mbmmm wg 5783 $ fc £ £ jft-^tS^itt^Pf W (Vasodilator Disorders) Um#)tiM& $££ jfiLtte^fi^ (Vasodilator Agents) QY 150-156 ifctffM (Angiogenesis) (£jfiL^f/f^$££ jfo/HfJiMHi1 (Angiogenesis Factor) ^ft^SfcLT QU 107 M&ftmzisiyh QH 605.2 jfilf ^f4¥ (Vascular Surgery) WG 170 XI WS 290 Jdlf f^UJ^fil^ (Vasoactive Antagonists) li.fa.!g&m& $££ ASftWim (Vasoactive Agonists) (£ifo/g:iRI?segi$£ £ Jfti^f. (Vascular Diseases) WG 500-700 mi WG 500 fl'JIWtib'Jim WS 290 H»g WG 620 mmm sf sn 'H>JliiifiLf£*£f. WG3 ItfrfcSlTXli* (JfiLSJEfSteJz Wt5), XimZo(i3lH!£iJ(z Jfo.iir4XI?g (Vasoconstriction) WG 106 mW&m WG 5603$ fc££ JfiLiWfii (Vasoconstrictor Agents) QV 150 JdW^ffi (Vascular Surgery) WG 170 'W6 WS 290 JflLWMffi (Angiomatosis) QZ 340 P5H14^fcw(£SlHiSiJlz, ^ff£^#^-tz lflL'Tviiti^.14yKir« (Angioneurotic Edema) WR 170 ifiL'TFDf'l- (Neovascularization) WG 500 rfltW'H*^IJ (Angiocardiography) WG 141.5.A3 lfo.T?'l4lto./k*i'-j (Hemophilia, Vascular) (£von Willebland*W$££ jflt^ttyMfi (Vascular Headache) WL 344 vr^mm $ h £ £, mi ui\-mmu wl 344y iflL-Wig^ (Angiography) WG 500 !iii<7) WL 141 mmm sf 757.8 A:W£nt;ttzit&U, ,W7;'Jiz lfiL]yft'p'!+!. (Dementia, Vascular) WM 220 ifiL-Wtitl/L (Vascular Resistance) WG 106 JflLWiSS14 (Vascular Permeability) li^*HllfiLlr;£®14$ ££ JlM£M£ife (Intravascular Agglutination) (iJfiL^fi^lfo. *!%$££ W\\AHfc}faS$&% (Erythrocyte Aggregation, Intravascular) WH 150 faWfi-m (Angioedema) liJflLt:W^14i?)l$££ ifo-f^'if^ (Muscle, Smooth, Vascular) WE 500 ifillj^I (Vascular-Assist Devices) l£'l>MIJJ*$il $££ JfiL§tiB*S (Blood Vessel Prosthesis) WG 170 jfiL^ftS^iM&tt'J x^°gp*£ (Angioimmunoblastic Lymphadenopathy) l£ft*£3R£14 'J X^°gi5*£$ £ £ ifo-f^^Pf* (Vasospastic Disorders) (£Raynaud*S$£ £ jflfT.)3fiJ (Hemopneumothorax) WF 746 MM (Corpuscles, Blood) l£lfiu$*ffl)]& ; *lfiL^ ; 6lfo.J£$ ££ jfiLEfc (teWfilJj^) (Hemocytes) WH 140 jfo.Mli (Hemagglutination) QW 640 xfiLJfcftJi: (Blood Cell Count) QY 402 mmm^-n sf sn HtM^i (Blood Cell Number) QY 402 jfo.«« (Hematoblast) l£jfir$*fflJ&$££ jfiLSftJ (Hemothorax) WF 746 R& (Menstruation) WP 550-560 HS&igi^ (Menorrhagia) WP 555 J32£BIt*iE (Dysmenorrhea) WP 560 W&mffl (Menstrual Cycle) WP 540 Hi&P¥'# (Menstruation Disorders) WP 550-560 S'>flg WP 552 mn®. wp 552 ^•wftfec7)^^coPfW^>^^$ fc££ RgkmfflfcJV'Ey (Progestational Hormones) WP 530 Egkm^'M (Premenstrual Tension) !£J!l*£ftiI*iEil£££$£ £ HI£lft*iEli£!$ (Premenstrual Syndrome) WP 560 Yl&^Mffl (Menstrual Proliferative Phase) UB&.m%l $££ W&ftWffl (Menstrual Secretory Phase) l£J43£JS]»l$ ££ ILSfflih (Menopause) WP 580 IH&ff^E^K (Menstruation-Inducing Agents) QV 170 !££•!&!& (Connective Tissue) QS 532.5. C7 JJP^- WT 104 IS^lim^ (Fibrositis) l£^'J7^7$££ 591 y-'ya-zv tfifttlUSftMftfS (Neoplasms. Connective Tissue) QZ 340 tfi Otll*3j*iN (Connective Tissue Diseases) WD 375 *.rma\^fcfr${>££fflxl£**£&(i WR 220 Vifr£UV. (Binding Proteins) H^xi'MB^*:%X *.',rVSP (Combining Site) (i*£&SfHi$£i te-rVSPtt (Binding Sites) tmmms QW 570 £ft? (-^) QU 34 9i&im QW 504.5 &S1& QV 38 *S£"<7°7 K (Connecting Peptide) l£C^77K$££ *g#Hfti£-(Marriage Therapy) li3c»|SIIMfrl>3lSft££JE, £ Itfe* (Homoglobins) WH 190 te)4ffe^ QY 455 ]fo.fe^*JE (Hemochromatosis) WR 267 'K'kC&im) (Deletion (Genetics)) (£ikfef*ftH$££ jfoH (Hematoma) WH 312 Jfo^ (Plasma) WH 400 ftufo WB 356 &&m (Crystallography) QD 907999 JfilSJtX* (Plasma Exchange) WB 356 )3#c# (Semilunar Bone) WE 830 foL^*ift^iJ (Plasma Volume Expanders) (£jfoJ#ftffl$ $££ ia8Mf4 (Crystallization) feil^JStlSS QD 921 Mim QV 744 tyjm&wmmim qd 548 tcoikcom* Y \z-y 9 X(£±MSiJlz JWJIgeSC (Plasma Proteins) (£jfo.$gf4SC$££ ifo/MS (Blood Platelets) WH 300 Wat QY 402 jfiL/M8f|& (Blood Platelet Disorders) WH 300 M*i*I WH 315$ t££ jfo.'M5ifrl4fl:HX (Platelet Activating Factor) QU 93 M.WSm¥\z}Hyb WH 310 Jfo/MSteffiftK (Platelet Antagonists) liJftL'M&g&ISW !£$££ tiLXUmt^m (Platelet Function Tests) QY 410 jftL'MfiJgS (Platelet Aggregation) WH 310 lkXU<%$k$R'gm (Platelet Aggregation Inhibitors) QV 180 lkXWP& (Thrombocytopenia) WH 300 Jfo/MSi$444^J&*?! (Purpura, Thrombocytopenic) WH 315 SkXUtJi<^MM (Platelet Antiaggregants) UskXW^M Plf^$££ JllL'MSliE (Thrombocytopathy) (£jfo/J7^?£$££ jfiL'htSteff (Platelet Adhesiveness) WH 310 Mft7xl/--/X (Plateletpheresis) WH 460 JliL'M5#*£ (Blood Plateletpheresis) (£jfo/M&7 x X- y X$££ jfo/MS$nJfo. (Platelet Transfusion) WB 356 jfo^7o7 'J y X4 x (Plasma ProkalHkrein) (£7X7 'jyi/4x$££ Jfo-^M: (Plasma Volume) WG 106 If o(ftSI (Rodentia) QL 737.R6-737.R688 UlSiMfci: LT QY 60.R6 Ifo&St^*^' (Rodent Diseases) SF 997.5.R64 KttT/,0^ (Epilepsy. Absence) WL 385 XWfgft5 (Absence Seizures) tiXWC/,**/, «• H, £ llinf (Serum) (£lfo.$ ; fLlSttititi : Jfitfft7/U7*$ x ; rful,', yo7'J X$££ ifovf7/1/7= x (Serum Albumin) WH 400 Bil*##f QY 455 JfoffS^W^Tfi (Seroepidemiologic Methods) ^me.^f£;hizf£ffl?rl.|>it£-|£, ^-J X (Serum Globulins) WII 400 ftg7*D/iJ X QW 601 jfitff v 7 o A 7 X (Serum Sialomucin) Ii fc n y A 3 /f (>• $££ foUffSSK (Serum Proteins) (iJfo/$g&K$£ t \Sl^m (Serum Sickness) WD 330 JfiUfpfI!& (Serum Markers) li£^&^-7-$££ Mmmm (Serotherapy) l£SDj&*£$££ IS4J (Calculi) QZ 180 SH^(£!fi44 WI 755$££ mwtnimm&ft wj 500$££ mm^coumm^^^m wi 755$££ nmcoum&fc wj 356$££ iSJBEff^liiSJa^eS WI 230$££ mwcoiim^ee wj 400$££ Bl<7)l±Bc*gE WJ 140$ ££ f£gn14^1t*£ (Tuberous Sclerosis) QS 675 *£bp'I4*D£ (Erythema Nodosum) WR 150 *SIS14£?e!M& (Polyarteritis Nodosa) WG 518 &ffimmmm$. (Periarteritis Nodosa) !i*£gfi14£^D] Hlil&$££ iggn14#Mt!i14&Tltlft*&£ (Panniculitis, Nodular Nonsuppurative) WR 140 I5gn14'j >'<&. (Lymphoma, Nodular) IJilll&te'J >'* St$££ jfo{£ (Thrombus) I£lfo4£*£$££ ifoteffi (Thrombosis) QZ 170 mMco WG 540 mcoiXMfefctmskfefc WL 355$££ ^iM(££IiMlfc47*£$££ WL 355 Mtkcoim#iW)Wim.% WG300$££ @8f M WL 200 m^immwrx WG 420$££ Mli»Wkmfo&fc WL 355$££ 3WKl±J{iLt£#lllfc& WG 610$££ &Lfe&m$. (Thrombophlebitis) WG 610 Jfote^teffi (Thromboembolism) QZ 170 &mco WG 610 M&Wmi&m (Thrombelastography) QY 410 JfiLfe^BHftmffi (Thromboendarterectomy) liSDRrtlR^ P34fT$££ St^mmm (Thrombolytic Agents) li7^7'J>i§^^ IC$££ 592 Y>7V m^mm (Thrombolytic Therapy) QZ 170 7<7r'J>iS»'foK QY 190$&££ ^9>va-X (Glucose, Blood) (i ifuft'r $ £ £ jfotji 9iv 3 - X n Biafli (Self-Monitoring, Blood Glucose) lillttfldElMSii &H (Colon) WI 520-529 ffl$ (Colitis) WI 522 7 t -'<14(£7 A -><$m WC 285* £ £ tgReH9Rl (Mesocolon) WI 500 IglHli^^ (Diverticulitis, Colonic) WI 425 igllffii&E (Diverticulossis, Colonic) WI 425 t£H£.ft (Colonic Diseases) WI 520-529 fc^MM (Colonic Neoplasms) WI 529 |£!§^P&ftf (Colectomy) WI 520 *£Hi£*ftf (Colostomy) WI 520 *glfciiL,l§ttf4 (#H) (Colon and Rectal Surgery (Specialty)) WI 650 «WA WI 520 fflknWtifcM. (Colonoscopy) WI 520 *g».K'J-7* (Colonic Polyps) WI 529 jfilit (Blood Sedimentation) QY 408 &5l*1H (Decision Theory) a^Wttti- QA 279.4-279.7 m^Y\L-y9Xit, XMKMz Jtifcg (Hemosiderosis) QU 130.5 Pf^14^<7)(ig|H£SiJ(c Y-yY- (Ghettos) !iS:5W$££ MM (Blood Glucose) QU 75 ffi*##f QY 470 MtP^TII (Hypoglycemic Agents) WK 825 jfiLfif§r2&*l (Blood Glucose Self-Monitoring) URSSlzisttS WK 850 MM. (Hematuria) WJ 344 tm (Cruor) umkmt^^x X^M (Deficiency Diseases) WD 105-155 mmm sf 854-855 £111 (Conjunctiva) WW 212-215 £HE& (Conjunctivitis) WW 212 $ttl4f[*i(i h y 3 —^ WW 215$ £ £ eiBUK.* (Conjunctival Diseases) WW 212 Skfcm (Hemophilia) WH 325 AMmA (Hemophilia A) fiJfo£*?i$£i JfoS (Blood Flow) (iX7n->'-$££ JfiLiSJSS (Blood Flow Velocity) WG 106 JfoJJx^ (Hemolymph) WH 400 yh^yijx (Ketoquinolines) (i*ynx$££ &Um (Antidotes) QV601 'J X p- QV 605 ^^.m^coArtLit, Arcomyniz 7Y9JV9Jvm (Ketoglutaric Acids) QU 98 Mmm QD 305.A2 7 Y 3 7/-/1, (Ketoconazole) QV 252 7 h - y x&mtklfefiLffi (Diabetes Mellitus, Ketosis- Prone) (£4 XX 0 xfS#5LJltm*R$££ 7Y-yxfemm^m (Diabetes Mellitus, Ketosis- Resistant) it A xx 0 x#fS#ff;JltJ7*W$££ 17-7hX7n4K (17-Ketosteroids) WK 755 &1&CO WK 757 7 Y 7 7 x X (Ketotifen) QV 157 7 h x (Ketones) fl$ft£ HBIWflUL^I* QD 305.K2 Yjfim 3 -yn^$££ 7 7 77 *x 3 —jvWl (Chenodeoxycholic Acid) WI 703 7 9 y'fc *yay—Y (Chenodeoxycholate) (£74 * x 3-/H»&$££ 7VA (Human Genome) lithryA$££ 7V A 7 A 7"7 'J - (Genomic Library) QH 442.4 \Km (Malingering) W 783 77 r 'J X (Cephalins) QU 93 7-A (Games) (£f4Wfc h x--xy ; jS^fciTcJI ; x 7-7 ; v9 i)x.-y 3 x$££ €& (Caterpillars) (i!»LSI$£i IS (Smoke) AfV<7ife WA 754 9'7: 7 7t t $££ 7 7 y ytfm. (Keratan Sulfate) QU 83 777X (Keratin) QU 55 77 hM (Keratosulfate) (i7yyxM$££ XW\ (Diarrhea) WI 407 IVJimt'Mm WS 312 mmm sf ssi XfflXfom (Antidiarrheals) QV 71 7 U X (Khellin) QV 150 YJV (Gels) QV 785 7/l/t ~ 7A^ (Gelsemium) QV 766 m^m qv 628 YJVitM (Gal Precipitation Test) (£%«3Sj£$££ 7/H*)4£3S7X h (Gel Diffusion Tests) (£%*£«?£$ ££ y/l'V-^A (Germanium) *Mk\m QD 181. G5 ^Jl^ QV 290 YJV = /7'7Xl--v (Germinoblastoma) Ii 'J >'7yy ^SOffcCOf; A. :• t / 9XU, YMftliZ Ml|-*iif. (Decompression Sickness) «««»'i: WD 712 Vi'7:[^'7- WD 712 itt**>|«H§ WD 650 j»*l^'? WD 650 ttltffi (Bends) l£$r±-ffi$££ fcfcfrfti (Tendon Transfer) WE 600 tlt$ YM (Authoritarianism) •Omm BF 698.35.A87 tt&t>mm HM 271 ^31 (Traction) WE 190 l$WA^!W7£&mm&& (Neoplasm Metastasis, Unknown Primary) l£HC?e4^Jif*I$££ l£M4W-JL QZ 140 DIM (Phantom Limb) WE 170 \kUm (Retinoscopy) {iJBflfUffiffi^TWtfrBf WW300$££ m*W (Shadow Test) (£IB/SUf $££ *&*£ (Quarantine) WA 230 mW WA 32-33 'nmtmm wa 234 fttg^ SF 740 JfttsKSiJ SF 621-723 f£*£*i*jp5fc (Quarantine Hospitals) (£#H*?!P£$££ H£ (Tendinitis) WE 600 jft£ft (Diet, Sodium-Restricted) WB 424 US WB 424 IgJISf (Prosimii) l£Strepsirhini$££ 4tS4^ii- (Aversive Therapy) WM 425.5.A9 mWU (Threshold Limit Values) UWckit^-famy^JV $££ mmm (Cost Control) -ft HD 47.3 mmm wu 77 *??P£ WX 157 mm w 74 mm wy 77 ** QY 736 £7* (Hallucinations) WM 204 SJitM (Hallucinogens) QV 77.7 WMmik (Prokaryotic Cells) QW 51 £7H:?£DJ^ (Psychedelic Agents) f££71i:$7>7a$£4j WW 350-355 tbfrimit WW 350-358 thtfteM WW 704-722 tf-mXnmWnZfot £>££, miltmmwmt WW 405 ftlSitf&^ffi (Ophthalmoscopy) WW 143 mmm sf 89i mfflffi (Shoulder Joint) WE 810 Sf3£ (Research) 3tM3l$££ MHU&] (Research Support) (NLM^S?^T(£JFi^||-§- 20-20.5) mm Q 180-180.5 m%mm (Institutes) f£777i-fcffl'£W$££ Sr^EftPi (Research Design) (NLM^S|gT(£Jf^#^-20-20.5) mm q iso.ai^ ffi^H" (Research Personnel) mmto W 20.5 mmoo (-m q iso.as-z A£ • ttP/rii [HS'J] Q 145 m%mab ti h ^wbmm BF 455-463 A;Comcom*Y\z-y9XU, iHWz 3 5J.^^_->3> WM 460.5.C5 =!$&££ nm (Speech) WV 501 5eJil£HlS?£ii WS 105.5.C8^$££ mm (Health) »9£3I$££ MMWftflk^ (Health Maintenance Organizations) W 132 mmmm^km (Health Status) WB 141.4 HJiM (Health Administration) WA 525-546 mm^mmmtm (Health Care Rationing) WA 525- 546 mm^mfr^- (Health Care Reform) WA 525-546 fillflyXfA (Health Care Systems) l£|S^7-t x*im$££ mm^m&Jfr'im (Health Care Seeking Behavior) (if. Hf*fit[S«^£$££ 594 Y>1 v>> (lH^ffllM (Health Records, Personal) l£*fi"H#$££ lit$1? (Health Education) #&* WA 590 #W7if*W fc hi/ -- X 7 QT 255$ £ £ *H*#f4S QT 200-215 ,f1^<7)T'7)^W$ t££ dliffg (Health Planning) ffclflf WA 525-546 f*ffi[S«7-tXlz|?5LT W 84 fnfanftlk* Y \z*y9xiz\%fchZ:tiU, ±^«ij(z HH ftiirt$1# (Health planning Organizations) WA 23 #s*#ffiz:m>Tli±tiSiJlz, f?iU(£IM;Ki WW 23 DSftg^Ji (Health Planning Support) WA 525-546 EtJlftH^tlW (Subsidies, Health Planning) IJfltJSft @^tS$££ S^ItiiwWfSfclillJ (Grants and Subsidies, Health Planning) lifi|)*ftSi"i« $ £ £ )fftp# (Scapula) WE 810 fitltfli^fMI (Health Risk Appraisal) (itt/fEttJSJtffi $££ OJtttlSfflS (Health Status Indicators) WA 900 #5*ht-y?X(i, XMWz HJiftfl (Health Policy) &M WA 525-546 %m\- \z-y9Xit, iMJtZ lltlfii (Promotion of Health) liflt/itf£il$££ UfiEJi (Health Promotion) &)& WA 525-546 !fcf$iILT WA 590 ftgfch tyyx(£, XMftliZ «*P3S (Health Surveys) WA 900 1i'l4*£.t WT 30 mx^:mmmmm& wu 3o$££ //fx.y H7£#P12 QU 146$££ Zkjtm ws 105.5.cs ^wmtft^m wv 501 sMPfW WM 475^ tf§¥ (Linguistics) P 121-149 fM¥H (Verbal Learning) LB 1139.L3 &s$M^TX Y (Speech Articulation Tests) WV 501 'l>H14PfWlZ;Fott6 WM 475 W&PflVflzfcltS WL 340.2 .i.'i/Hflll (Verbal Behavior) i'j^DI WS 462 ?L^fflfc#Jl£ffl WS 105.5.C8 -ft'DJI'? BF 455 x.mmb^m wv 501 tt&'L»81'? HM 258 FJISH^J BF 463. V45 iWlLiWffi BF 637.V47 .i,'i.W,y WM 475^ r-Ji'inpl&>JiJ (Speech Discrimination) (ili'ii,'f'/;ll'i,£$££ B'loPfVr (Language Disorders) --fe WL340.2 ?LieWfci&!fllW WL 340.2^ MM'') WL 340.2 •L»BKj WM 475 ntm^ WM 475^$ t££ SilnPfW (Speech Disorders) msM.Rtf&t&fc fc i^TT ^Wftll^^'B-(Z|||iit-Si#^ WV 500 #*££ WL 340.2 H14 WM 475 femm WL 340.2 ; WM 475 ; WV 500 mmm WM 475^$ ^££ hnh% WV 280$ &££ alfxX-b74 7- (Speech Synthesizers) (iKtW^£ffl=> al^M (Speech Perception) WV 272 mWHft)gH$&o£ti*£tz*tLT WM 475.5 -miRvw&fonmvmiztttx wl 340.2 4>BWmgP$W(z*tLT WM 475 miaY X —— xy (Language Training) !£1ttgVn*jS$£ £ alo^lji (Language Development) WS 105.5.C8 JEJStfeiif LB 1139. L3 alnMiiPfW (Language Development Disorders) tt&W WL 340.2 WM 475 Slg^iiS^ (Language Delay) (£HIgHiiP*W$££ aloStHlbi'JSJi (Speech Production Measurement) WV 501 'H>H14PfWlz£o'lt-i> WM 475 »l4Pr»(zfc(£!> WL 340.2 tl§*^a^ (Language Pathology) Uffi^m%mmm££ £ mWimMtltfk^t (Language Comprehension Tests) its ifXh$££ sWmm (Speech Therapy) -fe WL 340.2 W&mn^^tzihoo WL 340.2. •bm&W£tz#>^cowxrxh^>^ft;$££ ft£ (Examination) IJtfrKli7 ttfc? A 7V>ft£Wfcft* ££. mumtetiLftm \\$WiB (Acromioclavicular Joint) WE 810 ItfY'i? (Hospital Laboratories) (£*?!P£lt^i?$£X7A$££ Ifk-ft^mWr (Diagnosis,Laboratory) QY %%.1H WS 141 zvmtwJiM ws 141 %Sf.W WT 100 ArCOikcoiY-^mm^ QY mmmn sf 772.6-773 ftfEM^ — j-7/l/ (Laboratory Manuals) (NLM 3-«T(£JF^#^ 25) %>¥% QS 625 i£E'# W 625 tmm QS 525 ?m.m qw 525 *&¥ QV 602 ft^ffl^-7- (Markers, Laboratory) (££^W-^ -7-$££ \fc£.W\Wfc*'y Y (Diagnostic Reagent Kits) li^BfffllS l**-y h$££ 74H (Cuspid) WU 101 Wl (Autopsy) QZ 35 mWm W 825 mmmftff sf 769 WM 270$££ £JK (Phantom Limb) WE 170 W-Xmm (Atomic Medicine) l£M¥$££ IgfetSfff (Medicine, Primitive) l£fS#c[S^$££ Wl^t^Mm (Coroners and Medical Examiners) W 800 W.X^Jkit (Atomic Absorption) l±Jg?ift#:##:ffll*i££ ££ UXWk±5r%Mit:m (Spectrophotometry, Atomic Absorption) QC 454.A2 tmicBmzmmzti&m&uxmmiz, mtusumit mtft^U QY 450-490# m.%&ft (Reality Testing) x'&kmm WS 105.5.S3 *Stt##f WM 460.5.E3 flfTOIS (Residencies) (£4 X y - X fc X x7'X h fflf&$] $££ l^ffiS (Aborigines) 4X74 7X E 51-99 xx^^e- E 99.E7 ft«*r- t'y^Xli, ±M«iJIZ 7-X hyo4 KAJ8 GN 662-671$ &££ W^tJsi* (Shoulder-Hand Syndrome) WE 810 mm (Tendon Sheaths) l£SI$££ *SW»W (Inservice Training) HF 5549.5.T7 mrnzmyi wx 159 ^^w^7JZ^LT(£±M«iJlz, f£iJx(£'#HIJj¥-li WY 193 iz ^Xil^fc'V^c- (Atomic Energy) (i$i4/l/;J?-$£ £ l&XtlWY (Atomic Warfare) UmVi>£H.i \P,X^ (Nuclear Reactors) QC 786.4 786.8 ;S£&W WA 470 W.XfrX.m TK 9202-9230 mm&Mty!} WA 788 ^i7\mmu, ±fi*ijiz i^&^-gi (Meiosis) QH 605.3 Jg£gj!|* (Protozoa) QX 50-151 aUt—fl-Wtfl (Spina Bifida Manifesta) (i||ll&ttr_#ft tt$££ gfSifll&ff (Bond Issues, Construction) (i^i«:JSB!«$H, £ ^»i*¥f (Financing, Construction) WX 157 ^IxfflfflX (Construction Loans) (£^nx6&}£$££ jtM. (Elements) ttitm QU 130 %mm qd i8i #&s mmm qv 138 IfcSffr^ QD 466-469 Islfif* QD 181^ ; mmmiLVf WN 420^ ; #«Mt ^tc^$(>££ OTK (Phantom Limb) WE 170 t£& (Deceleration) WD 720 Bllfl (Tendon Injuries) WE 600 mmm sf 901 tfcfaflfc 9 «>->$£ (Specimen Handling) QY 25 %?MmmmYmco'7rmizisiihA:Mt, *9~?Ay~y (Gentamicins) QV 350.5.G3 7X777 (Gentian) (£^ffltil^$££ 7x777'<4 7X ••/ Y (Gentian Violet) m&mt LT QV 253 It&'i&^fcLT QV 235 ^fg (Architecture) NA £*ffi£KJ#« WA 795-799 mvft££ ^Htt*4 (Constructioa Materials) TA 401-492 ri3IJfSJt% WA 788 imw7^-tX(7)L^4? (Architectural Accessibility) mmmwcizisi7z> wx 140 &*ffi£ftj#8 WA 795-799 ^£^y4 7V)M$k££, f?iJxl£^%fS#ffifa-t xy-!£ WM 29-29.1# l^itJiifeffi (Protozoan Infections) WC 700-770 mmm- sf 780.6 £^l^ (Orientation) ^M^^l$££ 1&m (Urinalysis) QY 185 jttffl (Dedications) UtlltU fc*#S"lir*$£i )K?e14'l>&*££. (Myocardial Diseases, Primary) li't'SS *££.$££ Ig?§14*fc€l*fig*£i£1&# (Immotile Cilia Syndrome) !£*§^IiJjPf*$££ lg&>r^flffi*& (Neoplasms, Unknown Primary) QZ 202 ftMfrt (Reflex, Tendon) l£#SS#t$£i 596 n^rty* Sifft ivYik (Interferometry, Microscopic) it YWAffi$% $£$$££ gSfftit^^'A (Microscopy) QH 207278.5 |&tt'7: QS 525 |Mlft& QC 107114 fcmm qz 25 mmi ww 143 ftzcomtyzmmzti&tft&u, xmmz gI©§i¥Wti^£ (Photomicrography) QH 251 Mt^Mf-tfcii (Microtomy) QH 233 %i\%.ffl (Xiphosura) (£ 7 7* h 7 — $ £ £ HfSf-ft (Microsurgery) WO 512 gftX&ftl*<£ (Microradiography) WN 100 ttS (Amnesia) WM 173.7 Hg|*g (Bunion) (±y4eC«$££ f4£H§ (Subject Headings) Z 695-695.1 E¥ Z 695.1.M48 (gftb (Crude Oil) (i£il&$£i $1 (Weight Reduction) (£f4SM^$££ 3 7 77—t (Coagulase) WH 310 Sftlb'^xli. 7MSIJIZ ■3 A (Carp) QL 638.C94 *££. SH 179. C3 HSfciJ^/fcLT QY 60.F4 Wk (Vocabulary) P 305 #5*ht-y^xi£, xmmz n/fff (Cyprinidae) SH 167. C3 mmmt^mm ql 638.C94 mm SH 179.C3 ?A9X (Coitus) U* (-fe) li£JI QL 761$££ kf$ HQ 19-30 *iW£JI^W1II WM611SA £14 WP 610 ^14 WJ 709 ?Ay¥mm (Coin Lesion, Pulmonary) WF 658 %XJM~¥9 v?Y 9yy 4 — (Chromatography, High Pressure Liquid) ##fft7 QD 79.C454 MELlkMmm (Hyperbaric Oxygenation) WF 145 -m)\m\zfem$ixi>m& wb 342 Arcofccommm^&mcotMfru, ±mmz iXTY'yX 'J x$ K<^iV* |- t -y y X $ {, £ £ »iiH (Lectures) (£ NLM'7*ri£T(£JFi^#-/9 $££ WMifc (Basophils) WH 200 lt&*ii-.14ffi*i'fi#< (Analgesics, Anti-Inflammatory) (£X 7o4 K*lt:Mi«$£i #t'-fcSi-->& (Anti-Inflammatory Agents) QV 247 Hit (Articulation) li^(i,<;$££ til#nBn*W'Il'7: (Speech-Language Pathology) W*£W WL 340.2 [*l(ft WM 475 W PFP$W (Stuttering) WM 475 WSBW? (Articulation Disorders) mW) WL 340.2 LWj WM 475 86ft (Coins) l£ft$MXm$££ tii$ (Voyages) (£«;Jfc7r$££ 577- (Environmental Pollution) WA 670 #£ y 4 -TV^lfc, fl&] x li/kfji'; '^ WA 689$ t £ £ US (Palate) WV 410 SKiP&gl WV 440$££ ftf43& WU 140 ffHi*i^ WI 200 K#(£P3tt*g WU 280^$££ um.mm (Palatal Neoplasms) WU 280 M^m^m<7>MMtLXC0 WV 410 Pli (Uvula) WV 410 HS&tP (Palatal Obturators) WV 440 nUipJlDEsS4>^ (Velopharyngeal Insufficiency) WV 410 PSMffc (Palatine Tonsil) !£ii#fc$££ Vlimmm (Anti-Ulcer Agents) QV 69 Pig (Cleft Palate) WV 440 nmmmm (Cleft Palate Prosthesis) iiP*1£4-$£i fi!lt/$$ij (Sclerosing Solutions) QV 786 Itim (Photochemistry) QD 701-731 itlg TP 249.5 mcom* Y\z-y9X it, XMM tz jtitmfc^y9'y Y (Oxidants, Photochemical) WA 754 jtitmmm (Photochemotherapy) WB 480 ±m (Optics) QC 350-467 « QC 370.5-379 >xmmmmm ww 704^; tm ww#$££ S44Mttg WN 100 Xm (Engineering) TA xmmmuxw-mmxm qt 36$££ mm TA 144-145 mmmmmuf^ wx 165 WjXcoitmXlXm WA 671l£$££ Mtimm (Insurance, Health, Catastrophic) lill*Flf*P& $££ mt%mmHiMik (Catastrophic Health Insurance) l£S*^ f*P£$££ ijX&mX (Antinuclear Factors) (£ttMf*$££ itjUftfiffif (Technology, High-Cost) mm W 74 ZCOitiLCOY \z-y9Xit, m^iiCOX'hUUXMMiZft mt& \-%mt£i> "f^f£$££ 3t®n&.Vkm (Denervation, Sympathetic) U$L&m&W P£ffiT$££ ^C^W^In (Ganglia, Sympathetic) WL 610 £Mi&«ffiT (Sympathectomy) WL 610 Z&W&Um'MK&ffitylW (Sympathetic Transmitter Releasers) l£^li#g^ffl^$££ ^*7k*g (Hydrocele) WJ 800 3c!g14li3& (Ophthalmia Sympathetic) WW 525 ^^L'l4£'l4fl: (Testicular Feminization) WJ712 £^147K7li3li& (Uveitis, Sympathetic) (£»I4IE& $££ f/L.ri'^-li (Anti-Infective Agents) QV 250-268.5 lt*gft£"M3iJ (Anticancer Drug Combinations) (£1*F-ffl!A ltm:«$££ mmm (Posterior Chamber) (£B£$££ ^AfcJV^y (Testicular Hormones) WJ 875 #L7'X-^7rJ7''J Xl£f£ (Antigamma Globulin Antibodies) lift 4 7 4 fc 9 A 74/tf+:$ W, £ tflffim (Antineoplastic Agents) (iltRTi*&*$££ f^Witf£4-fe¥(Late Gene Transcription)li^fAtiiftifc; ''/$££ #fL^P (Aerobacter) (£EnterobacterM$£ £ $t^4x (Curiosity) (£&'44fiJj$££ *ffl£i§ (Aerobiosis) QU 120 H£ltj£ (Industrial Hygiene) (il®!£i$7'4:$££ ^^ItM^K^ (Interinstitutional Relations) mvjt wx i6o &*^Py>fraS (Ethics, Institutional) #&& Y\z-y9xUXMiz £ 4, f0Uumt%<7)t%& WX 150 ifrg|II3£ (Anticoagulants) QV 193 XMBWm (Industrial Bacteriology) (£SBl'^$££ &**Hfflf44ft (Institutional Tax) !£&$££ £4t-jg# (Financing, Public) (£Hl£&WiftigilJJ$££ &*ft^ (Public Housing) 77/1/ WA 7991? f&ffifefi^ HD 7288.77-7288.78 14t HD 7289 ffiX^m WA 795-799 S*jfr3£ (Public Policy) flit ii HQ 767 X h ij /!/ QZ 267 ArComco9rffU, XMftliz XMWXWJSm (Industrial Microbiology) QW 75 ^^mmmm (Public Carriers) li£il*t[li]$££ S*lf}&l$M (Carriers, Public) l£i*il WA 810^&t/ ArCO{&com&mMt>*^$££ flftS (Aviation) TL ^1^31 $££ HaS, Jf4££ftW (Aviation, Physical Standards) lift ^OT^W WD 705$££ PJ&IS^ (Oral Medicine) (£*W$££ Ml^mm (Aviation Medicine) t£«C^^^[S'7$££ ffii^X'&mm (Aerospace Medicine) WD 700-758 Hs&mm WD 700-745 Asmmmm wd 730 -fe WD 700-745 Xftmm WD 750-758 >bmm&)%m wd 754 ffii^.X:'&mmmmtft%% (Psychological aspects of Aerospace Medicine) WHaU^.X'&m.m* £ £ tf[^1=OT^<7)^i|j[§^#|? (Psychiatric Aspects of Aerospace Medicine) U%V£7F'&mm%5LX HEftt (Oral Hygiene) WU 113 'WE WU 113.6 PJ£7*/l"<-X'A (Galvanism, Oral) (£PJ£l*]7'/l/'<-=- X'A$££ 598 3«/=19 fi£#;$(Aviation Nursing)(iffiil^ r'^>#L'7 WV 143 $E£ U&ijyy9& (Candidiasis, Oral) WC 470 U$fy&*LK (Xerostomia) Wl 230 PK^ (Mouth Abnormalities) WU 101.5 tfC^tt^iS (Accidents, Aviation) WD 740 ^$.0OYTlz h h A £ • H7">r£* WU 22 $££ PK^tS (Tuberculosis, Oral) WI 200 i%mm (Mouth Diseases) ftfUSW^^W^ie WU 140 m WU 166 fimnmntzthcomm wi 200 te*f wi 200 PJgJtiiL (Oral Hemorrhage) WU 140 PEIS*S (Mouth Neoplasms) WU 280 "nmrnrnGotzthco^ft wi 200 PKfettli*! (Oral Manifestations) WU 290 ftum&izttfchA-iiu. Arcomm n&&m (Diagnosis, Oral) WU 141 PJg'ift§lg}£& (Oral Hygiene Index) WU 30 te^tt^ifc (Otitic Barotrauma) l£4^£$££ Pl&ft^JI& (Mouth Abnormalities) WU 101.5 PE¥*4px/l/^X (Herpes Simplex, Oral) Ii^/1/^X14 Pl*l&$£i PK1S (Floor of Mouth) (iPl£$££ PEF*il7*/l/^<—XA (Electrogalvanism, Intraoral) WU 180 nWn^yYitmm (Oral Rehydraion Therapy) tttftijgffi &$££ P/g^ttlM*^ (Burning Mouth Syndrome) WU 140 PM^Sf (Mouth Mucosa) mmcotmtixco wu 101 SHf4HOWIifc LXco WI 200 PK&Jft (Leukoplakia, Oral) WU 280 mmmmmmtLxco wi 200 PKf&ft^ (Dental Microbiology) QW 65 iM (Airsickness) (if^g£$££ □ K*^^ (Stomatology) (£P ; PJ£*£/f.$££ PifilS^ (Dental Focal Infection) (£#14*?* J£!gi&$ ££ Qj&mmm (Pathology, Oral) WU 140 acoxcommm wu 140 tm wu 140 $ t££ nm%m (Oral Health) WU 113 'W£ WU 113.6 □ Sxli^ltijf-ffi (Surgery, Oral, Preprosthetic) WU 500 PK^e- ij T& (Moniliasis, Oral) l£PJ£7 X x7*m$£ £ P)l$'J^t'iJ7-X3 X (Mouth Rehabilitation) WU 140 mum WU 610 UJE&yWiWHl* WU 158 ftfr WU 600-640 ft 7 o 7 'J X (Antiglobulins) lift 4 77 7 9 A 7°ftf£$ ££ ft 7 n 7" U X ill ® 7 X h (Antiglobulin Consumption Test) (£Coombs7 X r $ £ £ ftyo7iJ X7X h (Antiglobulin Test) (iCoombs7X h$££ if'ijWr (Fractures. March) l£*I^#?Jf$££ l.7: (Industrial Arts) li7yyo-y-$££ tammm (Anticonvulsants) QV 85 #*14 (Aggression) im ql 758.5 ^mm W¥W WS 462 i£A BF 575.A3 IL^fflfc^W WS 105.5.S6 frXW WS 463 ISA WM 600 Zl'JIWtiti'JtW WS 350.8.A4 mf]'U^, HM 281-283$ & £ £ rtjjfoJBS (Hypertension) WG 340 iiilfiLffi}¥ffilc&/4y yxi£, XMS'Jlz WW.m (Collagen Diseases) WD 375 #£*£•££$&££ fiHff (Plasters) i£74&ffl$iJ ; S»H$££ p££- (Occlusion) itmW^^^^X 599 373^/f "x.:fr£# (Malocclusion) WU 440 »$&& (Dental Articulators) WU 26 ftitiML^ (Antihypertensive Agents) QV 150 ftrSifllME* (Antilipemic Agents) QU 85 tfL^ttUHS (Antithyroid Drugs) (£¥^S*^ftH$££ #£■)£ (Photosynthesis) QK 882 yt&i&MM (Phototrophic Bacteria) QW 145 ftftf* (Anti-Antibodies) QW 575 «$^ii (Occlusal Equilibration) (£W££$££ "2&7J (Bite Force) WU 440 ^~&m (Archaeology) -fe CC (£#«) g-musij d-f M%M GN 700-890 ££ (Advertising) 3£M3I$££ MPfW (Dysarthria) WL 340.2 <1>IS'I4<7) WM 475 tfEM (Pulsus Alternans) !£4^K$££ ftn ij xxx7 7— -t'^SC(Anticholinesterase Agnts) it a ij XXX7 7—tGF7»#J$££ ft3ijxf^|jj^ (Parasympatholytics) QV 132 ftn ij xf^ffl^g (Anticholinergic Agents) (£3 ij x}£ft ^J$££ ^ a l/Xfn — /1/jfoJg (Hypercholesterolemia) WD 200.5.H8 ftn xxro— /l/^(Anticholesteremic Agents) QU 95 £^ (JtfE^) (Crossing Over (Genetics)) QH 445 KLI2 (Iris) WW 240 £•81 (Mixtures) l£^JJ^$££ £!?£& (Iritis) WW 240 £L?i*£& (Iris Diseases) WW 240 tSMWSi (Iridodiagnosis) !£»#$££ tjXmffl&.M&%!kW (Antireticular Cytotoxic Serum) QW 815 ttf^&Brffrifc (Iridocyclitis) WW 240 XHlgSSfc (Cross Infection) WC 195 mmzisiihxmt%m wx 167 £H (Hybridization) QH 421-425 fjj^ QH 425 fflb QK 982 SlWTOltt SF 105-109 fc til 1* SB 123-123.5$ *>££ ft^lbH (Antioxidants) I^J-tfMJfc LT QV 800 ^nDnf*#(zfcltl, WA 710-712 $r&ifc (Eosinophils) WH 200 Hm$tf5.&m (Adenoma, Acidophil) WK 585 *Fi*3$ttffi3NI (Eosinophilic Granuloma) WH 650 mfi&niicoumzmiz H&&P£1m& (Eosinophilia) WH 200 ftfSrttWffi (Adenoma, Eosinophilic) WK 585 mihm (Altitude Sickness) WD 715 kx (Photons) ummzzx &ft (Hindlimb) QL 950.7 1 -5 t frt/Wk (Aspergillus) QW 180.5.D38 mm®? (Lipocaic) (£J!iW£tfni4H-4-$££ &jKmmi&nv® (Medical Missions, Official) W 323 fcmt^ftffi W 323 ^$fc££ itSJJlJfiLffi (Hyperlipemia) (£Ui)jJjlfiL*S$££ ftHtJfillSi (Antilipemic Agents) QU 85 iHiSE (Syndactyly) WE 835 ifi&WlifiSUJ (Higher Nervous Activity) WL 102 &3£n/l/7 3 4 Y (Mineralocorticoids) WK 755 P# (Halitosis) WI 143 &*»£ (Public Health) WA #PWfc LT WA 21 mt WA 900 m&m wa 900; kammmt hb^$ t££ f^n^i£[s^jiiafj£*^ w 21.53; ^xv^<7- W 76$££ &^Jtr£^S|5 (Public Health Schools) (i£#llr*A~^$ ££ &#fi&£M (Public Health Nursing) WY 108 #W WY 18 M (-fe) WY 130 4x7V7x-7-tx WY 130 feWmm WY 130$fc££ S^fU^frift (Public Health Administration) WA 525-590 &*»£•?—:4 7 XX (Public Health Surveillance) Ii AP7—^47>X$££ S^MftW (Public Health Dentistry) WU 113 £$t'&£9\m (Schools, Public Health) WA 19 RMffi^foMWl (Buildings, Public Health Aspects) it ttig ; &*ft^ ; xx h y x ; A:comco9 Ay°&WlM (Cranial Sinuses) WG 625.C7 ILferT* (Miliaria Rubra) (iH4£$££ fffe* (Erotica) HQ 450-472 giS&£f4f4£f*P£fc*|5]f*P& (Deductibles and Coinsurance) mmutk W 100-275 ft£oy4 7V)f*P&$&££, fflxli'MWPfc W 100- 275 Wam (Altitude Sickness) WD 715 P# (Lip) WI 200 S^liPSg! WV 440$££ mmntmtLxco WU 140 P#& (Cheilitis) WI 200 P#jft*i (Canker Sore) Ii77yi4PI*I&$£i JOIt14ft£tlR (Antibiotics, Antifungal) QV 252 fannm (Antifungal Agents) QV 252 ft*si4ft£^K qv 252; mmrnm^vm sb 951.3 $£>££ P#*££. (Lip Diseases) WI 200 mmcoMMLtLXco WU 140 P#M*» (Lip Neoplasms) WU 280 fimmmcotmt ixco wi 200 P#-S (Cheilosis) (i 'J 77 7 txft£*£$££ ft4>Hlfflg]m (Antifibrillatory Agents) l£ft4^M^$ ££ P#/N.;i/-s%&uA:coxMmz fH& 7/1/ 3 a >VA- 3 4 K (Glucocorticoids, Synthetic) WK 757 {H£*lPiI!41e& (Contraceptives, Oral, Synthetic) QV 177 ftmm (Antigens, Synthetic) it^^.7 9 7 X $££ "pHSttjjtflH (Resins, Synthetic) ffr74fcffi TP 978-979.5 fiWr- WU 190 8J>ftiJ QV 785 7 y 'J /M!t>l& WU 190^ ; 3 x 7 x -y r X x* X WU 190 ; x 7 * i/tftfl§ WU 190^ $ t £ £ &lftftffit (Diet, Synthetic) l£7 r 7 ij 7- h &p°p$££ tamnmm (Antipsychotic Agents) QV 77.9 famWm (Psychotropic Drugs) QV 77.2-77.9 ftl& t K d ^r x 3 ;b7 3 x 7 n 4 Y (Hydroxycorticosteroids, Synthetic) WK 757 ft£MI (Antibiotics) QV 350-360 mH £ £ ft£^»iM4 (Antibiotic Resistance) (ift£1*l!1*ifl* $££ ^|*;Ky (Hormones, Synthetic) WK 187 £-fi£ft*£JK (Immunogens, Synthetic) liM7?f^* ££ ^IM^A^X (Estrogens, Synthetic) WP 522 tmBmzmm$nz>t%&u, insijiz /&WL7 9Xy (Vaccines, Synthetic) 7 9A-yt LT QW 805 ftl^fc LT QW 573 ft 7 nF->l (Antiserotonergic Agents) li-tr n h — X l£ftil$££ ££&*£3Si£ft?3l (Antifibrinolysins) l£^S^i§^PlJhtl® $££ 3feii&j&ifc£E (Photosensitivity Disorders) WR 160 #l£j£Jt& (Photodermatitis) l£*^i@iiSc*£$££ *8Hfci£ (Phototherapy) WB 480 m% (Enzymes) QU 135-141 jfiLtfHt^ QY 490 HHtiSlifflM (Structure-Activity Relationship) tim QU 34 m\m QV 744 WM^fJV (Models, Structural) &Z.X QY 35 ,lf4 WQ 26 A:Commi\<7>9A7ii, l*JM$riT^I>±itlT BMlztefflSfi*^ (NLM^$I^TI£ff^#^-18.2) g££3& (Enzymology) l£^^$££ ^^^W*fS4-leiIPIn (Gene Expression Regulation, Enzymologic) QU 135 S^JSttft (Enzyme Activation) QU 135 mM (Infarction) QZ 170 ^co%t\UMm& WG 300^ ; bfaWM WG 300 $£ £ BcoA:tiimmfe& WG 420$££ iftiit'ffiffcy 07^/77^- (Chromatography, High Speed Liquid) liiHEJRffy n-v h 77 y 4 -$££ itS&ft^UPJ^E (Dental High Speed Equipment) 601 u 7 V 9 -fe WU 26 iflJiftfflfiiJB (Dental High-Speed Equipment) WU 26 SSa+tt-f- (Fast Neutrons) tmmm qc 793.5x72-793.5.F329 \m?m??-'jm wn 110 £,j&mf (Fast Electrons) l£€4-$££ ■foiiitlfr*** (Highway Accidents) (i£il*&$££ BMJtfcft (Enzyme Tests) QY 490 B££ftf4i£ (Immunoenzyme Techniques) QW 525.5.134 J (Enzyme Inhibitors) QU 143 8¥S&VW»fWffiT (Enzymatic Zonulolysis) WW 260 &*€£i (Electrodes, Enzyme) (i^<4 77 X7$££ S^tff&ftttS (Enzyme-Labeled Antibody Technique) (£^^ftf*ffi$££ S^&^fi'I/E (Immunoassay, Enzyme) (£S£;|jftf4:i£$ ££ W&W& (Enzyme Induction) QU 135 m%n%<\ (Enzyme Repression) QU 135 &W8ffi$i (Enzyme Inhibitors) QU 143 ftf* (Antibodies) QW 575 ftlgftf£/xj£ QW 570 $ t> £ £ tn.t¥Ty 4 -T4 (Antibody Affinity) QW 570 ftf4fft#14*ffl!&^14 (Cytotoxicity, Antibody- Dependent Cell) l£ADDC$££ ififttJi (Hyperthermia) !£%#*$££ H51*iai£ (Hyperthermia, Induced) WB 469 «!ttPr#l# WM 405 ftftJFM (Antibody Formation) QW 575 ftf^g^'14 (Antibody Avidity) I£ftf*iifn14$££ tsim^U\t (Binding Sites, Antibody) QW 575 '&MKm QW 640$(>££ tJli^XW^MW^ (Antibody Deficiency Syndrome) (£& iscx^mmz^x ftf^lxllf^ffl (Bactericidal Action of Antibodies) l£i§ S$££ ftf£/g£*BJ& (Antibody-Producing Cells) QW 575 ftf43IW14 (Affinity, Antibody) (£ftf£77^-7 4$ ££ ftf££t*14 (Antibody Diversity) QW 575 ftfiEiH£¥fa#g QW 541 ftf44#H14 (Antibody Specificity) QW 570 ftf£#3l*££4£ (Antibody-Toxin Conjugates) (£&*£# S$££ ftf£M^4 7'J y Y (Antibody-Toxin Hybrids) l£& *£«$££ ftH<'774M& (Antibody-Secreting Cells) l£ftf£il£*ffl !]&$££ ftf£*a&7J (Avidity, Antibody) iiftfWii]'l4$££ ftKHI* (Antivenins) y\^.m %L&m QW 805 mmm qw 63o {&* WD 400-430 UJ&S&E (Hypercapnia) WF 140 fi^SK (Scleroproteins (Non MeSH)) QU 55 rt5^Jfo.*lE (Azotemia) (i^#*£$££ ft#a*H (Nootropic Drugs) (ifp])&tW*$ ££ §6|A (Hookworms) liftASflfc MJ: itjA^'ifeffi (Hookworm Infections) WC 890 mmm{tl> QW 690 W+^JS^ffi (Neutropenia) WH 200 ifij&SE (Ancylostomiasis) WC 890 PJ&X*4 (Ancylostomatoidea) QX 243 ifcj&'ffiM (Tunnel Anemia) lipj&*£$££ §fcj&/S (Ancylostoma) QX 243 ¥Ai (Beetles) QX 555 mWifc (Hypertonic Solutions) QV 786 &ffl&.fcf Y 'J 7MWM (Sodium Chloride Solution, Hypertonic) (ii!53i£&igifc£aA,^ (Antiepileptic Agents) (£ft*l^$£B£<7> WM 475-6 jfjfj^ff LB 1050.5 $5ct4if<7)Jf2Klil& (Hand Deformities, Acquired) WE 830 H^ttSMFW* (Reading Disability, Acquired) (ift^j 14*I^$££ $^14^*5: (Acquired Immunity) life§:$£i ^X1i^.*5X^ffi1^f¥ (Immunologic Deficiency Syndrome, Acquired) Ii x 4 X $ £ £ f^^c74lJ#jfn-1^S:JfiL(Anemia, Hemolytic, Acquired) li)§ jfii14tJfiL$££ jgg; (Altitude) %.mmm^ wd 710-715 «gg (Larynx) W\r 500-540 ttig^Sc WV 501 ftft^ WV 540 fffij (Behavior) £tg§^l$££ fyfjjg^ (Behavioral Medicine) WB 103 77 b t-yyX(i, XHSiJtz ffihikam (Genetics, Behavioral) QH 457 msM (Laryngitis) WV 510 ffiWL (Acting Out) WM 193.5.A2 t^ffl WS 463 fLlSMttblSM WS 350.8.D3 mmm (Epiglottis) WV 500 «Slf^(Laryngology) (ingsS*^* ; :?#Pp£f4¥$£ £ 'iT^mm (Behavioral Sciences) £fg^l$££ mmm% (Laryngoiogists) un &mmmm £ £ mimfe (Laryngeal Nerves) WL 330 mmcoxcowmai wv 501$ &££ mmjm (Laryngeal Edema) WV 500 \l^\'Xmm (Ethology) QL 750-785.3 mmrnm sf 756.7 PJSfA (Thorny-Headed Worms) (£i4jSlAffl$££ frm&m (Acanthocephala) QX 200 'YrWim&m (Behavior Modifiers) l£ffe]fflW^$££ mmiM&ffi (Laryngectomy) WV 540 tsl#:# (Laryngeal Cartilages) WV 500-501 mmmm (Antidiabetics) l£lfil*iP$ K* ; 4 xx^ U X $££ mmWm (Laryngeal Edema) WV 500 l)IJj$IJj (Behavior Modification) l£trlJ]*M£$££ mM\m% (Laryngeal Prosthesis) (£ AX^fift $ £ £ mffitim (Laryngeal Paralysis) (£J*^J^*^$££ fcffiM (Occipital Lobe) WL 307 ififtfSftS (Behavior Therapy) WM 425 n%-W WS 463 IVJIMtib'JIW WS 350.6 mmmm\m wy 160 77x7 ij xy wy 87^; mmm-&%wikmm& WY 87$t££ ft#^ (Antitoxins) ft&m %L&m QW 805 mmm qw 63o ¥fx.m&izmmztit>m&u, Arcom&iz ^£ft#^£$£>££ §&)^ (Coronoid Fossa) (i±!Jfc#£Ji«J: rfi h 'J 7'J 7 KifiL*E (Hypertriglyceridemia) WD 200.5.H8 ftr-'j3^7x|g (Antitrichomonal Agents) QV 254 ft h- n X t X (Antithrombins) QV 193 ft h n x t X 2 (Antithrombin II) i£ft h n x t X 3 $£ £ ft h n x t X 3 (Antithrombin III) QV 193 Pf*l& (Stomatitis) mmmntz&bcomm wu 140 ^mmmcotzubcomm wi 200 tKE^ SF 852 P !*!$£*£*£ (Xerostomia) WI 230 Pffitffc^J (Mouthwashes) WU 113 mmm qv 50 MX Y 'J 7Ajfa.ffi (Hypernatremia) WD 220 H^Wi (Climacteric) £14 WP 580 fl&fflih WP 580$ &££ I!'I4 WJ 702 mmkunmnx wp sso$££ li^$H off (Melancholia, Involutional) i£j!fr$B o *^$££ Mm (Hindbrain) UXWi \ ffi ; &!£$££ 3cl2 (Breeding) fj]^ SF 105-109 ^ltUj^<7) QY 54 W^CO SB 123-123.5 lB*Wgj&£fclitI8j^*flli, *W iJJ^ £/,:[£» tz ffl$k%m (Antisyphilitics) litfe#$££ ijl'^—^yvym (Antiparkinsion Agents) QV 80 yfcY-^° WK 725$ &££ W£ (Erythema) WR 150 31^140{£^14#UJ14^^ WI 210$££ JAJJlttlBSMItlm (Cerebral Sclerosis, Diffuse) WL 348 £1514 £14414iMffi (Hyperostosis Corticalis Generalisata) (£##;#JFMJI&*£$££ /£# (Platyrrhina) I£7 7y7*/U$££ %m (Copulation) QL 761 AflS!li14£$££ 'W^.m^lUArCoWl^izm^^QLXUSFco^^iz 603 37 fcix i£#xxM^/l/'^7 4/l/X (Herpesvirus platyrhinae) it^M7 A JVX $££ 6jg£*E (Scleroderma, Systemic) WR 260 fttxy>x$iJHl (Antihistaminics, HI) (itxy~X Hmft&$££ fttxy ~ x#JH2 (Antihistaminics, H2) !£txy ~ x H2t75ft^$££ ft t h 7n7"iJ xmtrX h (Anti-Human Globulin Consumption Test) (iCoombs7X h $££ ft t h 7o7'J yffittmtfmmBWTX Y (Anti- Human Globulin Complement-Dependent Cytotoxicity Tests) I£^*5^^*HS“X h $££ i^t iJ/l/t*XjfiL*£ (Hyperbilirubinemia) WI 703 IISyi7 hJfefl (High-Frequency Jet Ventilation) WF 145 MffifeMim. (High-Frequency Currents) Ut,f\MMm m', €t4$££ iKX'gmmm (Anxiolytic Agents) I£ft4^^$££ iJlX^m (Anti-Anxiety Agents) QV 77.9 ft 7 4 7'iJ yiZm^JJ'S. (Antifibrinolytic Agents) QV 195 3?*I (Happiness) BF 575.H27 ItX-m WS 462 zvjtmtwjtm WS 105.5.E5 ?&IEJl£fUJt$E (Retropneumoperitoneum) WI 575 M%mi& (Retroperitoneal Space) WI 575 Mtmmm (Retroperitoneal Neoplasms) WI 575 'ikM.mW&& (Retroperitoneal Fibrosis) WI 575 tVfWikm (Anti-Arrhythmia Agents) QV 150 &?<%!& (Miner's Anemia) (£§fcjfiU§jfe*iE$££ ft7°yx5x (Antiplasmins) (£|&ffi^jg1$Plih«$£ £ my°y-<-9 *)fcmBM& (Hyperprebetalipoproteinemia) l£i^ ij 7°lf SM-feE 4S$££ ^7°ny y 7xjfiL?£ (Hyperprolactinemia) WD 200.5.H9 ft* (Mm) (Kindling (Neurology)) WL 102 8t$Cf4 (Ceratopogonidae) QX 505 HS#J (Stimulants) UMXim ; mmm \ 3 ij ymm ; ^.B^m^mm; =r7x7x ;#£ji«$ijw £*£$££ M^rX^h (Macromolecular Systems) fi£4£ (-fe) fStH QD 196 MWl QD 380-QD 388 $-mm QU 83 SBW QU 55 tmY tyyx(£, ±H£iJ(i »£#F7Jllk (Midges, Biting) !£«|!l>^4$££ mm (Cirrhosis) (£JrF« ; «*£$££ m® (Yeasts) mmmt tzummmcom-ktix wb 447 WXTkm QW 180.5.Y3 taX TP 433 )A$fi (Public Relations) HM 263 mvsfflmt, xmmm*> & ^ umM%mmizx &mfr)kXtimtpl& (Abortion, Legal) WQ 440 mmtm HQ 763.5-767.7$ &££ S?^['^^ (Torulosis) liy ij 7° h 3 .y y x££ WC 475$ ££ S^UM (Saccharomyces) QW 180.5.A8 tjifcJV^y (Hormone Antagonists) WK 102 Wx.cottVim%t:ii%X mm (Dura Mater) WL 200 mm^Ylkm (Hematoma, Epidural) WL 355 mmftmim (Epidural Analgesia) UmmtW&ffimtfL £ ^If^I^S^ (Anesthesia, Epidural) WO 305 mm^mm (Analgesia, Epidural) WO 305 MTlfo-K (Hematoma, Subdural) WL 200 mm±& (Epidural Space) WE 725 MUM (Cranial Sinuses) WG 625.C7 5®JHMJ|5lJfil&*£ (Cranial Sinus Thrombosis) it mm lfilt£*E$££ mmW)Nk (Meningeal Arteries) WG 595.M3 ft-^7 U Tm (Antimalarials) QV 256-258 S^^J (Flavoring Agents) QV 810 ^£;JtU7^f3iC3XX7 3-,u (HDL Cholesterol) Ii HDL3XX7n-;Hj,7^eW$££ ftAX7 'J X^(Antimuscarinic Agents) l£AX 7 0 Xft ft*$££ Wl^WMXU (Bristle-Coated Pits) fifflJMg$M7&$ ££ 3 7^'J (Bats) (iSf-g$££ CF1 (Anus) WI 600-650 mffl (Torture) mcoamt lt hv 8593-8599 HIFIffHS (Anal Ulcer) littP1SHS$££ ttHff^J^ (Anal Sphincter) I£1LH$££ KHM (Anal Stage) WS 105.5. P3 ttPl^.f. (Anus Diseases) WI 600 KT^mm (Anus Neoplasms) WI 610 mm (Anal Gland) l£JTLH$££ Cntl*$*3E (Pruritus Ani) WI 600 Kf^mm^iH- (Anal Drug Administration) U^MMn^H- $££ SIH^fl (Fissure in Ano) WI 605 Kfm (Anal Fistula) (£iU#*i$££ *%ffi.'\£nm%* (Entrapment Neuropathy) li^tftttfc&E i&*£ftf4$££ &C^ < JxS (Gagging) WI 143 l£?ft (Mineral Oil) QV 75 &MfcJV*:y (Posterior Lobe Hormones) UX^fc'ikM 7/W^EX$££ fflffil-om (Antidepressive Agents) QV 77.5 ttmnm (Antileprotic Agents) (£jf£0SB|$££ ft'J 7~?T&S&m (Gold Salts, Anti-Rheumatic) lift'J 7-^7#§^iJ$££ ftU7-v7#M^iJ (Antirheumatic Agents, Gold) QV 247 ft'J 7-^7^ (Antirheumatic Agents) QV 247 &mit (Rationalization) WM 193.5. Rl yttimmm (Photodynamic Therapy) liftltj^jM! £ tymXm (Utilitarianism) (£ffcJI$££ &MP£ (Hospitals, Public) WX 27-28 mUcoX<7>m% r t ^y y X $ t £ £ tiimW.fcJV^y (Antidiuretic Hormones) (i'<77Vx >$££ ftf'JSllg (Antidiuretics) (£'<7 7VxX$££ 604 =J+a? 'J H 'J 4°3rr3lflfo.*jE (Hyperlipoproteinemia) WD 205.5.L5 jtjU ft°lrfifClfo.*jE4 S (Hyperlipoproteinemia Type IV) WD 205.5.L5 £ll##r (Transactional Analysis) WM 460.6 #g|crt-y?X(i, 7MSIJIZ fci]lliL$6.*$^^.'i^cfJ (Counterimmunoelectrophoresis) QY 250-275 m%^-?-izmmi-z>, b&^mmitfrffxcon fffirx Hzf£ffl-4&*§£-lzli, Arcoftftiz f 14 (Perfume) WA 744 ftF4*ifT TP 983.AT983.Z5 jftij yfoH H$£i Wm% (Hip Joint) WE 860 SSUgjftlt (Hip Contracture) WE 855 IxWgnl&B (Hip Dislocation) WE 860 SxMlnlftfff (Arthroplasty, Replacement, Hip) UltkM !5ffilS$££ ®Mffi% (Hip) WE 855 KHHjSB'tflf (Hip Fractures) WE 855 fc?M%¥&M%n& (Osteoarthritis, Hip) WE 860 SSWInM^ (Hip Prosthesis) WE 860 7*70 (Cockroaches) QX 570 f % (Respiration) WF 102 %mumkmn wo 277$££ ±itm wf no mm^^k&iziiith wb 284 &Jt WR 102 fv&MW) (Breathing Exercises) WB 541 fs&m (Respiratory Sounds) WF 102 Wh&¥ (Pneumology) liJJifi*£& (#H) $££ iWk»& (Respiratory System) WF 'WE WS 280 ~lzfl5ffltl>*^li^^*onp^*p0By/U-7c7)^^$£ £, fflxlift^Hli QV 350 if "&SJ&i&$rjE (Respiratory Hypersensitivity) WF 150 «£.& WF 553 ; RitW WF 652 ; WStfc WV 335$ i ££ "f WS^-ft (Respiratory Diseases) li"f »&'4jl*£.$. $ £ £ "f-UKfUtlBifeffi (Respiratory Tract Infections) -«k WF 140 ?l!E#lfc«J!E#l WS 280 BK|£¥ SF 831 7 4/l/X'|4<7) WC 505-510 tile WC 505 #£®ife*£o£ffc$i££ fnJiflii*%.$, (Respiratory Tract Diseases) WF 140-900 ZVJtWtih'JlW WS 280 mm WY 163 !K[S^ SF 831 %f*.m&R&my>lt&X (Respiratory Drug Administration) (i»& A&^-$££ if n&HJ&fiE^Sf (Respiratory Distress Syndrome) WS 410 »f H&^flS (Respiratory Airflow) WF 102 f "&& (Respiratory Muscles) WF 101-102 if n&SHM (Breathing Exercises) WB 541 if n&M (Breath Tests) %mmmzis n ztjv ?-jvmxzMtz wa 275 jig^ W 780 -fe#f4tt^lz£ol£S WB 205 nmm&cow% wi 143 f»7i3c& (Respiratory Exchange) l£fn&$££ ^"STtit (Hyperventilation) WF 143 "fUSfflU (Dyspnea) WF 143 if "MI (Respiratory Chain) l£144sji$££ if Hft-fi:** (Work of Breathing) WF 102 W&'Ft&flMfl (Respiratory Care Units) WF 27-28 f»&147x K-xX (Acidosis, Respiratory) WF 140 if 0&147/1/7 n — yx (Alkalosis, Respiratory) WF 140 ifn&fftR (Respiratory Center) WL 310 f "S^^r (Respiratory Insufficiency) WF 140 "ft^f X 1 (Breathalyzer Tests) (£if&M$££ if »,&f:&ff fflft (Respiratory Protective Devices) WF 26 vfBfcMW (Respiratory Paralysis) WF 140 vfajkfsm (Respiratory Mechanics) WF 102 if Vkmm (Respiratory Therapy) WB 342 fn&H&*£/E(z*t1-6 WF 145 gj^tzioltSf HSS*«.ftt3*l1-4 SF 831 «f«Rmm^H (Hospital Respiratory Therapy 605 3 yxx Department) Itmf&fMifrUWl $ £ £ ««S (Graphite) V.il^ QY 138. CI !Rl»1fi*(£, ±!I(Z £ & Hf^fitt^S (International Health Administration) (i A^Wflt/i$££ HRMi*Mfi (International Health Problems) UkM?) flt*$££ SfWfixXrA (International System of Units) QC 90.8-94 mm QV 16 3y-7'y*-74/i/X (Coxsackieviruses) QW 168.5. P4 3 n? * — 7A)VXWi&& (Coxsackievirus Infections) WC 500 3 y -> -y 7 A^ (Coccidiosis) WC 730 mmm sf 792 Mmcomm sf 995.6.C6 i9yyfcA K*E (Coccidioidomycosis) WC 460 mnm (Plague) wc 350-355 mmmftm sf soo mW (Substantia Nigra) WL 310 Mfe® (Melanoma) QZ 200 *fefllB16 (B16 Melanoma) (£3?Mi1lIS$££ HfeS (Melanotrichia Linguae) l£€^"$££ Mfe^IS (Melanophores) QS 532.5.E7 MfeS^if (Acanthosis Nigricans) WR 265 mk (Blacks) *I*1A E 184.6-185.97 mmt lxco m&mi WZ 150 m$. WZ 80.5.B5 fHAfsie wz 108 Z-comcomizisli&ArtiU, LC5r«D-F4"0[II£$£ £ S7k*V (Blackwater Fever) WC 750-770 M 1*1 $ffi#!¥ (Migration, Internal) (£*5«Mfc#ft #$££ HftPf (Amaurosis) (££BJI$££ Ml*)P$14l£M4&#n (Amaurotic Familial Idiocy) l£ "J 7 4 K-xX$££ » (Flour) mmmt fzummm^mt.ttx wb 431 ffiXMM WA 695-701 m&mm7-^xmm (National Health Service corps) immmmmz^x H&I4 (Nationality) l£g}£$££ SSfisttHiflt® (National Health Programs) WA 540 W£9j?fxcostmux.mmz, mium^mmt WA 310 ISftfflttft (Grain) (£SH$££ H£fS1ilS*fWIW?gSfa£ (National Council on Health Planning and Development) Ui%Wmm$tm ^Ii^$££ KM (Cereals) flt'tl#X(£*£»c7)M&fcLT WB 431 Ifctf- SB 188-192 *4S TS 2120-2159 Elff^r^^S(Waste Disposal, Solid) I£PH^«1H$££ WiMm (Etymology) lt&& ; ^£j£$££ 337 (Cocoa) Ii777$£i £*fflS (Archaeobacteria) QW 50 ffi^ttHi (Chorda Tympani Nerve) WL 330 EltE (Fixation, Ocular) WW 400 &mmm (Paleodontology) GN 209 -Lit (Leukorrhea) WP 255 ^clE (Tympanum) l£cp?$££ ^c^fiScffT (Tympanoplasty) WV 225 W*m (Diagnostic Errors) WB 141 #Sfc9-ff(zfc^T(£, 6r¥fcomffiflbc?) 9Ay°coimco%fc£ii%X fSA&triiJS. (Personal Satisfaction) ffl&m& HF 5549.5.J63 65c#J (-fe) BJ 1611-1618 WWY t-yyx|£, ±MSiJ(Z 111 AO 7] (Power, Personal) (£|^7J («t»B|^) $££ \nk%mmmmm% (Personal Health Services) W 84 mmmm. (Vocabulary Tests) (£stgrXr$££ ?XY-££ ##tS (Bone Transplantation) WE 190 fife (Osteitis) WE 251 f^ (Osteology) (£#$££ ft& (Skeleton) WE 100-102 ft&S5?4*S^ (Skeletal Muscle Relaxants) (itt&ffi** ££ fft* (Skeletal System) ii&#f&*$££ #fc@£ (Skeletal Fixation) !£-fl4Jf@l£f£$££ ff&f~£6^iptf£ (Age Determination by Skeleton) GN 70 f WM&m (Osteoblastoma) WE 258 mwi&? (Leukemia, Myeloblastic) WH 250 im QZ 350 (Bone Marrow Examination) WH 380 frMftiE (Myelosclerosis) l£#MM*£$££ #$&*£& (Bone Marrow Diseases) WH 380 &JfMS:JfiL WH 175 ; #tfi-5 -5 ttRjfo. WH 175 ; ifc*fi 14/xS WH 200 ; *JE^JfiLffi WH 180$ fc££ #MHS&K (Myeloma Proteins) WH 540 fHUPf Wttftjfo. (Myelophthisic Anemia) (£#M^> 7 14» JfiL$££ #f&14l4jfo.*F! (Leukemia, Myeloid) WH 250 §mmmm qz 350 #tfili8tft-£ (Myelofibrosis) WH 380 #ffi£jfilJtft&t£S¥ (Dysmyelopoietic Syndromes) (i# MJIJFM*£M$££ #H*gfii14*£.i. (Myeloproliferative Disorders) WH 380 #$&^>7l4f:ifiL WH 175 ; mBshmiXB WH 200 ; M J££M WH 180$ {,££ #figitBJ& (Myeloid Tissue) li#fS$££ #M6 7l4S:!fo. (Anemia, Myelophthisic) WH 175 #145»4-ffi*E (Leontiasis Ossium) I £ 1*1 i!ijsil# $#*£$£ £ #lltii*i (Fragilitas Ossium) l£#J£)£4^*E$££ #$:& (Osseointegration) WE 200 -B4JT (Fractures) WE 175-185 zvjtmtwjtm we 175-180 gBf£<7)##f O y 4 7$ fc £ £, m x lisfiM-PHJf WL 354 itffi4t#Mf*J#t££4l!T (Osteosynthesis, Fracture, Intramedullary) l£til*][3S£$££ #ffi4£#}££* (Osteosynthesis, Fracture) l£l*J[51£*£$ ££ ##flH£S (Fracture Fixation) WE 185 mmm sf 914.4 f-t/ X r- (Bone Cements) WE 190 mmfoizmmzti&tij&u, xmmz #« (Phrenology) BF 866-885 mmxmttx wb 365 flLnS (Osteoporosis) WE 250 #C (Epiphyses) WE 200 #Ct:y*E (Epiphyses, Slipped) WE 175 &mmmm (Epiphysiolysis) (£#*£&;')*£$££ #Jg*fc# (Epiphyseal Cartilage) li«fttS$££ #fi5£ftj£ (Bone Lengthening) WE 168 #fg# (Bone Conduction) WV 272 mkitfc (Osteomalacia) WD 145 -g-M-x coy y-y pa 2011-2915$ &£ x ?£slMi§? (Cranial Fossa, Posterior) WE 705 BL& (Loneliness) BF 575.L7 WX-rn WS 462 fVJtmtwjtm WS 105.5.E5 X&. (Child) WS ^sg^|$t££ ^■fS^triWgW (Conduct Disorders, Child) li'Mfcffft Prt$££ Ztbg (Proverbs) li&H i - fc .r??$£i 3 Kx (Codon) QU 58.7 77 K r- o t° X (Gonadotropins) WK 900 3*7 K 'J ^ 'J x (Gonadoliberin) (i 77 K X ij x $ j£ £ 77 K x 'J x (Gonadorelin) WK515 7-7X3t- (Gonioscopy) WW 210 ?°-fcy-y9X (Gonyaulax) (i«fS€iWS$£i i l£ < W0&. (Succinates) QU 98 Mmim ^ffimit&Vi) QD 305.A2 Z\ Ii < mrt Y o 77-7* (Succinate Dehydrogenase) QU 140 >! Ii < W.9 7/1/7*X K-/o X (Methylprednisolone Succinate) liy 7/1/7° x p-/nys; xy yf- h$ ££ 3/<7 ^ x (Cobalamin) lity 5 XB 12$££ i'<)VY (Cobalt) %mm qd i8i.C6 ftUt QU 130.5 mmm qv 290 ■=!->%x 3-t- (Coffee) M/iB#X(£*£*fiP#Wffi:£fc LT WB 438 %tg SB 269 77x4 X QV 107$ &££ 7A*E (Dwarfism) WE 250 y X7x*^ WK 252$ &££ &mmm (Paleopathology) QZ 11.5 mrnrnizisu & sf 758 *®1 (Rumen) QL 862 mM SF 851 3*-hi^ (Cohort Studies) ?$^c7) WA 105 W%Y t-yyx|£, ±HJ?iJlZ 3*-l-^tff (Cohort Analysis) (£ => fc - Ym % $ £ £ 3 7>/U,v4 x X (Coformycin) tjxmmmtix qv 269 &*sWtiiJ^fcLT QW 920 ri*»L (Deception) («$££ gcBI (Tympanic Membrane) WV 225 HcIf4xt-yxXii7Jtt^ (Tympanometry) Ug&A y\z-7yXTX h$££ HfcSlJFMffi (Myringoplasty) WV 225 akmmm (Tensor Tympani) WV 230 Z^|)i<> (Crowding) UJ^AP QL 752 ftsg WA 795 AP HB 871 o x i- — Y — y 3 y (Communication) £1^1 $££ ? I 3, — Y — y 3 yW^ (Communicative Disorders) -fe WL 340.2 608 3 U^* Y .|>HW WM 475 mw WL 340-2 -jij.^y — y 3 xP#H (Communication Barriers) ^#j WS 462 wmtwm WS 105.5.C8 titttS^iZ^ttl. WM 307.C6 ma^W#£ BF 637.C45 tt£4>«¥W#S HM 258 3* A (Rubber) feU SB 289-291 £H 1870-1935 AXWSB^I-^ffl^^^ii^lzli^^^^gB^lz 3 A 3* (Wheat) «HiBfXli*^*SB*^M^fcLT WB 431 fctg SB 191. W5 *££ 3A**JS (Triticum) l£3A^f*$££ 3A?L$ (Latices) (£77-yyx$££ # (Rice) «*P#(i*^*^^<7)M^fc LT WB 431 fcig SB 191. R5 ££» (Archives) CD 9374280 gflftlt Z 695.2 ££» (Paleography) Z 105-115.5 SHaSH: (Proprioception) WE 103 8fflS&£ (Employment Termination) l£M^$££ 3—7 (Cola) l£tm$££ 37-y/ (Collagen) QU 55 3 y-7X IS (Collagen Type I)l£3y-7x$££ 3 7-7X 2 S(Collagen Type II) (£3 y-Y'y $££ 3 7-7X 3 5»(Collagen Type III) (£3 y-7x$££ 3 7-7X 4 S(Collagen Type IV) (£3 y-Yy $££ 3 7-7X 5 S(Collagen Type V)I£3 7-7X$££ 3 7-7X 6 S(Collagen Type VI) (£3 y-7X$££ 3 7-7X 7 S (Collagen Type VII) (£3 y-7x$££ 3y-7'X 8 S (Collagen Type VIII) Ii 3 7-7x$££ 3 7-7x 9 m(Collagen Type IX) (£3 y-7X$££ 3 7-7xl0S(Collagen Type X)l£37-7x$££ 3 7-7 x US (Collagen Type XI) (£3 y-7X$££ 3 7-7xi2S(Collagen Type XII) (£3 y-7x$££ 3 7-7xl3S(Collagen Type XIII) Ii3 y-7x$££ 37 ^X (Coramine) it—79 1 K$££ 3 7/H (Cholalic Acids) (£3-;i^$££ 3>J-7'74/i/X (Coryza Viruses) U7 A 97 Aivx^t ££ 3 'J x x (Colicins) QV 350 3IJX7X (Colistin) QV 350 3 'J 9-m (Corridor Disease) U9Ayi) 7*£$££ lA&M'b&ffi(Pulmonary Nodule, Solitary) (£1*3 4 > tt*S*$££ 3iJ4SB^ (Coryneform Group) QW 118 3 ij fc'<9 7 iJ 7 A£l (Corynebacteriaceae) l£7 y 7 y $7Xg$££ 3 ij fc'<9 7 'J 7 A^ifesg (Corynebacterium Infections) WC 318-320 3 ij 7 r - -x (Coliphages) QW 161.5. C6 3 'J X (Choline) QU 87 z-Xyjv QV 122 3 0x7-1:77-7' (Choline Acetylase) (£3 ij x7-t7 jv Y y xX7x7--t$££ 3 ij x77 7/1/ h 7 XX7x 7-7* (Choline Acetyltransferase) QU 141 3ijxxx77--t (Cholinesterases) QU 136 3IJXXX77--t'ifRiS^ (Cholinesterase Reactivators) QV 124 3 ij Xxx7 7--t|51',l,:ftiJ (Cholinesterase Inhibitors) QV 124 3 ij y^tfim (Cholinergic Antagonists) QV 124 3 ij >fr-2M (Choline Deficiency) WD 120 3 U Xf^jUj^ (Parasympathomimetics) QV 122 3 ij Xft-ffl^K (Cholinergic Agents) QV 122 3 U yMWm (Cholinergic-Blocking Agents) Ii3 ij xt£ 1/L$ij$££ 3 'J X"Z'niY (Receptors, Cholinergic) WL 102.8 3 ij y^'^m^OMVr. (Cholinoceptive Sites) (£3 ij xg £f£$££ 3 ij x 7 X 7 y* ij 7 ij Y (Choline Phosphoglycerides) Ii 7X7r7x/U3 ij x$££ 3 jvT- 3 y%m%m (Korsakoff Psychosis) itTJV 3 -;x|4 fit£*£$££ 3-;u^ (Cholic Acids) WI 703 3-/HHS (Cholates) !£3-/^$££ 3*;i^f£ (Golgi Apparatus) QH 603.G6 ajv-tyY (Corset) (£g* ; #H$££ 3-JV9-JV (Coal Tar) QV 60 ~frt36mztifci)X&ysyk&% qv 235 ^W QV 633 9yY-JV QV 223# ; y ^9-JV QV 223^$ ^££ 3;p7|g:'g (Corti's Organ) liCortiS?'i"$£i 3^734 K (Corticoids) UMn&Mfc'V^ X$££ 3;u73X7d4 K (Corticosteroids) UWl^BC&fcJV^: X$££ 3;u73X7d4 KS^fa (Corticosteroid Receptors) (i 7;i,Da;i,f3^ KSWf4:$££ 3;u73X7dx (Corticosterone) WK 755 3;w73hotX (Corticotropin) WK 515 3;w73 h a t'XJAdi^/i/^ X41 (Corticotropin- Releasing Hormone-41) l£CRH$££ 3;w7#^Sn (Ganglion of Corti) (£A>SIW^8n$££ 3/U7 7/1/ (Cortisol) l£ t Kn 3;u7 7x $££ 3^77x (Cortisone) WK 755 o'jvy'4 7XJS (Gordius) l£4fiil$££ 3 ;u7 y y x (Cortexone) (£7*7 * x^-/u7 3 x 7 n x $ ££ 3*—jvfyy 'J 7 X'^AX y — (Hamsters, Golden Syrian) liMesocricetusH$££ 3'—/l/7xy-v ij x (Tamarin, Golden) Ii Callitrichinae $ £ £ 3'—;i/7*X/>AX y — (Hamsters, Golden) (£ Mesocricetus^ $ £ £ 3-/1/ Kit&*£$ij (Gold Anti-Inflammatory Agents) Ii i/L'J7-v7#l!J£ (Colchicine) QV 98 7/U7 (Golf) QT 260.5.G6 3X4y-/i/ (Coleonol) l£7/ux 3 ij x $££ 3 x7/l/x7iD—/I/ (Cholecalciferol) QU 173 3xy-xaX (Collections) l£NLM5r«T(£ff;^#^-5 -7$££ 3XxXh^f-X (Cholecystokinin) WK 170 609 3l/y^ ^ ayyx Y*-yfc9 9^7t K-g??f£ (Cholecystokinin Octapeptide Receptors) (£3 XxX hJf-x^'>,if^$£i 3X->X h Jf-X^ft: (Receptors, Cholecystokinin) WK 170 3 xxX h-Jf-x^xy X47^ xS^f4 (Cholecystokinin-Pancreozymin Receptors) (£3 Xx X r-*-xS#f£$££ 3 xx7 'J X81 (Cholesteatoma) QZ 365 &gfJrt£<7)k<7)li^fi#Jlz 3 x X7 xo-jv (Cholesterol) QU 95 3 x X r n —/1/-7-1 K n Jf x 7 —-f (Cholesterol-7- Hydraoxylase) QU 140 3 xxr 3-/l/HDL (Cholesterol HDL) liHDL3 XX7 d-/HJ7°S&K$££ 3XX7o-;i/LDL (Cholesterol LDL) (£LDL3XX7 □ -/1/|J7S&K$££ 3 xX7o— /l/jafiJjflL*S (Hypercholesteremia) (£iij3 x Xtd— /l/jfo.*iE$££ 3 x X 7 c — /1/fST^K (Hypocholesteremic Agents) (i i£3XX7D-;i^$££ 3 xX7o-/l/Pp$iJ!(^K (Cholesterol Inhibitors) I£#l3 XX7n-/l/^$££ 3 x X 7° X 7 X X (Correspondence) nem fc m^p^fr^rii* m^- WZ 112-150 ISA WZ 100 ftKY\z"y9xu, xmmiz ?y9 z Y (Corethamid) (£-7 y ^ K$££ 3X7 (Cholera) WC 262-264 3X7$#I? (Cholera Toxin) WC 262 ayyY9AY (Choleragenoid) (£3X7ffl#^$££ 3X77X (Choleragen) l£3xyffi#^$££ 3 x 7 7 y 7 X (Cholera Vaccine) WC 262 3 o A Y (Colloids) ST^fiJff^fc LT QV 785 £tm QU 133 3 n y x h (Colocynth) QV 75 3D77 4/1/X (Coronaviridae) QW 168.5.C8 3 of ij —7°o — >;<— 9X]) T 4 (Coronary-Prone Personality) i£ASAt&$££ 3 o^-f^ft^fi (Colony-Forming Units) f£$frffll&$£ £ 3a^.-^eS<:liifi^^ (Colony-Forming Units Assay) QH 585 3o^.-$iJ^g^- (Colony-Stimulating Factors) iilfiLtzfcltS WH 140 3 xj--mmmX 2T)Vyy (Colony-Stimulating Factor 2 Alpha) (£4 x y-o 4 * X 3 $££ 3o^>/7 i (Body Lice) I£x7~$££ 3DX7XM (Monkey, Colobus) (£4 777HJS$££ 4g*B (Marriage) HQ 503-1058 7 7X7 i> X7 WM 55 Htli&g^ GN 254 m\ HB 1111-1317 9\mmm%^.m^mmm wm 430.5. M3 $ t £ £ 4§t4143c (Extramarital Relations) HQ 806 3X77'-*'J XA (Concanavalin A) 15tf£fcLT QW 575 mmmmmm\%tihmmiz,mz-im%.u wj 353 ArComcoftWY \z-y 9XU, XMYAiz fEW (Root Canal) (ift«gE$££ tB-WfttiStt (Root Canal Filling Materials) WU 190 t&Wihm (Root Canal Therapy) WU 230 3 X3*7 4/UXJgi&'E (Congo Virus Infection) Ii? ij ; 7tfiM$££ &&m!fe&ffl.m.m (Mixed Connective Tissue Disease) WD 375 )g£4$llbfc*y?*—A? (Mixed Function Oxidases) QU 140 '&^V\M.mM (Drug Combinations, Antineoplastic) Ii wmmmmmiRx 3 x 7- x -y K (Congo Red) QV 240 3 x-7/l/y X h (Consultants) IfW W 64 #a WY 90 mnmmw wm 64 mwi wo 64 ^ommiJ^A^Mi¥^#^lz, ^ft^ttftlilSie^ #^(z #Si (Coma) WB 182 mmm&umw.m'\i.j&m wk 83o$££ fF14l£fF14ia*S WI 700$££ 3 x X* 7 X 3* (Condurango) ii 1 B§^ $ £ £ fI14£?e14miWgimi4£?g14i&*i« (Pseudopolyarthritis, Rhizomelic) l£ 'J 7-7714£?§14$*S$££ £§HiIH/t^l$f (Premarital Examinations) -fe WB 200 £14 WP 141 f§14 WJ 700 3X7 x+rx-£|j| (Consensus Development Conferences) &ZY tv yxizwLTi£, xmmz 3 x-fe X+rXflr'^ (Consensus Workshops) Ii3 x-teX 7X^fi$££ 3X7x7Xge^iJ (Consensus Sequence) QU 58 tS^fttfSIil (Dentoalveolar Abscess, Apical) litfi£JS] HH*I$££ W&mmmfc (Periapical Diseases) WU 230 t-R&mmmwm (Periapical Granuloma) WU 240 m&mmWkm (Periapical Abscess) WU 230 m&&mmmfo (Periodontal Cyst, Apical) ttftfBftlfc $££ fS^I&ffir (Apicoectomy) WU 230 ny99YyyX (Contact Lenses) WW 355 ^5:14® (Menu Planning) mmzisuz wx 168 mmzisaz, ij)Zft$m WA 350 ^A^fcMA-^ WA 351 xx h 7 y\zis\7h£%LffiX.tf)%m WA 799 MA (Insects) mm SB 942 %i£!km QX 500-650 rp# WD 430 &&7A >VX (Insect Viruses) QW 162 &!km (Entomology) QL 461-599.82 mm QX 500-650 HA QX 500-650^$ &££ &&&Mm (Insect Repellents) 610 3X77U &HlZfc!+&WW£!tf9» SB 951.5-951.54 &*«r*Wi;'« WA 240 !&$& (Insect Control) QX 600 &&%W% (Insect Bites and Stings) Wl) 430 M&fjfcgpl^fC (Insect Growth Regulators) UHjftfc /l/*X$££ l&tf (Insect Poisons) (ijiijlj?*l$£i I&^ffii (Insect Sterilization) (£Mifei<^$££ 3>h7^hX3 —^m (Echocardiography, Contrast) I£4>x3-S|;r£$££ 3>h7Xhii'g14 (Contrast Sensitivity) WW 105 tlJjUltfcLT WW 145 a > K 3 4 7 X (Chondroitin) QU 83 3>^°7XKQ (Compound Q) I£HJ37X7X$££ j^a'- Y A y YliEMffi (Compartment Syndromes) WE 550 3X^*7'J 7 (Convallaria) Q\' 153 ny}i3--9 (Computers) QA 75-76.95 ftft#f?lz4>lt&t£3s-fcLT mm (-fe) W 26.55.C7 (NLM^&ST(iff^f^26.5) ?y}i3--9Xm TK 7885-7895 y'4 y9)V QA 76.5-76.73 mmm qa 267-268.5 *-Y-?A-y9y'-9l!±m W 26.55.A9^ : 1lf|gxX7 A Z 699# (> £ £ 3Xh°j. — ? 7 — ^f ^f-v (Computer Architecture) l23Xt^-yxX7A$££ 3 X t jl — y t x' 3 yyXy-2* (Computer Vision Systems) liAI*flff£$££ 3X t°i — ^©f^JlS (Image Processing, Computer- Assisted) #£#» (NLM^«*T-(i^^#^-26.5) *m£gfa izf£ffl£rl£i#£-(i±giWz 3Xt^-yjlilf^4iJl5E (Image Interpretation, Computer-Assisted) -fe WB 141 ft£&ITOzJ4LT(i, A:comm\z ?y ti-yjaft^-^f (Image Analysis, Computer- Assisted) Ii 3 x t7=. - y Hf!-M $ £ £ 3>trL-yy77^f '^X (Computer Graphics) T 385 3Xt°i-y u $ i^y--> 3 x4 -y Y7 — 9 (Computer Communication Networks) TK 5105. 5-5105.9 3y\z^-93LMM.W¥*-?%.&&&.fflr (Numerical Analysis, Computer-Assisted) ttWY t.yyxiiig^ijiz, mtux:V>i*rjvu qh 324.8 ^y\z^-97.W.izXi>\&m (Protocol-Directed Therapy, Computer-Assisted) l£3 x ti — yfijfflte «*£$££ 3Xt^-y^4Jo[g'^W4'Jif (Medical Decision Making, Computer-Assisted) it^y\z^--9 £.$.M^ *£$££ 3 x t°i - 9 I'l^itL*! (Self-Instruction Programs, Computerized) liCAI$££ 3Xt°j- — y->XrA (Computer Systems) t.m^fflz£o(tl>tJlSfcLT(NLM^^^T(£J^^#,4 26.5) 'ti£ft¥fxAm$nzmfrit, lwjiz 3 x t j. — y x X 7 /> i'tuiiA. (Computer Systems Organization) l£3 x fi -y ->X7A$ !-i £ 3Xti — y->^j.X — xaX (Computer Simulation) QA 76.9.C65 V\^Hfi'>J(zf!tiffl£ ft&%Lft(i, 7JiWz 3 x t°j. —y f.i'.j-J'tJf. (Signal Processing, Computer- Assisted) ^^yffco^mt LT (NLM5>Hily\zj--9 MlBfem^f H $ £ £ 3Xt°i — yy7h7x7 (Camputer Software) (£ V 7 h7x7$££ 3 X t^-yHf/itx>7777'f (Scintigraphy, Computed Tomographic) I£x ~ -y y 3 xCT$££ 3 xt^-yC* (Terminals, Computer) l£C*^$£ £ 3 x t jl — y 7*— y %hm (Computer Data Processing) (i igj7-y*2:St$£i 3Xt°i — y/N— K7x7 (Computer Hardware) Ii 3 x \z^-9ik^X 3Xti — y7nyyA (Computer Programs) l£ 9 7 h 7x7$££ 3 x t^ — y 7°oy7 A^r^ (Programmed Instruction, Computerized) (iCAI$££ 3>h\-^WM (Attitude to Computers) QA 76.9.P75 3 x t -x - y WMMtm (Radiation Therapy, Computer-Assisted) (£3 x t^-yfijffl^^|^a$£ £ 3 x ti-yJAI^^ftH (Radiotherapy Planning, Computer-Assisted) WN 250.5. R2 3 x t i — y ^E 7*/l/ (Computer Models) l£ 3 x t a. — 9 xi^X-->3X$££ 3yt'a-^ IJ77X— (Computer Literacy) QA 76.9.C64 3Xto.-yfiJJl^|kW (Computer User Training) QA 76.27 NLM^-^gT(£Jf^^#^26.5 3X \zp--9mm\&mm (Therapy, Computer- Assisted) WB 365 WWY \z-y9XU, xmwiz 3 x t°j.-yfiJmJAI^^£(Radiotherapy, Computer- Assisted) WN 250.5.R2 3 x 7 r x X X (Conferences) t£-£ff|$ £ £ 611 nx7i^y 3X7U- 9 9 x (Complexons) Ii* x-h flj$££ 3 x 7 ->' y h XxX (Composite Resins) WU 190 #j£ (Consciousness Disorders) WL 341 fSf.''[J5ft (Rhizobium) QW 131 ■v- IPJElS (Guilt) BF 575.G8 nXm WS 462 ?U/E#!fc #>!£»! WS 105.5.E5 7ATly (Thiamine) QU 189 7 AT i >X2M (Thiamine Deficiency) WD 122 mmm^fy sf 780.5 S^tit (Replantation) WO 700 ®.m& ii coimz^-gxiummz &EcB£#£ (Concurrent Review) WX 153 mmm (Aphrodisiacs) QV 170 74 xx h u y- (Scientology) teftHISffiT ; t§^$££ &W (Disasters) HC 79.D45 *Ct.«!:ffi WA 292 m?*%.MMm7-VX WX 215 mmmwjimm wx iss$££ ft.mis« WB 105 feil (-fe) HV 553-555 mm wy 154 !ft£y4 70^Jk'i:(£±J!PiJtZ SPalKm UA 926-929^$ ^££ '&m$kmim (Relief Work) HV 553-555 mfo$i;MMm7-\z'x wx 215 &¥^T<7)£m Y\z-y9XZii%X 'A^ftM (Disaster Planning) WX 185 'JimcOXcom*:* Y \z~y9X$:%X &14*P£ (Accident Insurance) (£PfWf*P£$££ HiH^Hf! (Reperfusion Injury) QZ 170 mmi£<7>iiCoumtmz W&£A%fct LT WO 184 mWg^z. (Bronchioles) lit\t:^$££ ffltvg^® (Bronchiolar Carcinoma) (2*fflfl^8lSlffi£ ££ fcffl*\'l:;£ll&*g (Adenocarcinoma, Bronchiolo- Alveolar) WF 658 mfx^^Mfk^ (Carcinoma, Bronchiolo-Alveolar) (£ffl mt:5)l§*S$££ ftSSt^M (Branchial Clefts) f£igg|Hl$££ fi^JB (Teratogenesis) UMZcoXcommfc QS 675 ; mmm^^rM ; &&f£Jt?fi;*£,i$££ mmmS. (Teratogens) QS 675-679 mm (Bacteria) QW T^f/v^Xi QW 115^ mftimtMmm qw 51 mmt LT QZ 65 x^^-m QW 153 -fefa« QW 50 rt£jg&J QW 128 77^m&&&Mf\MJZftM QW 137-141 77APH4*ffll QW 142-142.5 &mmiM QW 142.5. A8 M QW 142.5.C6 ftH14 QW 730 ftm QW 52 Hi QW 153 $>-tiX QW 154 tiaffiikixm (Genetics, Bacterial) itWYWAiiimZtLX IfflW&izX (Genes, Bacterial) QW 51 MW&teXm (Bacterial Genetics) UWY.W&Hm'kK.l MM'ikUXm^l (Bacterial Gene Products) Itmtii&fW $££ mW&UXSBW (Bacterial Gene Proteins) Umffi'Mte H$££ *mM%SBW (Bacterial Outer Membrane Proteins) QW 52 mmm (Bacteriology) QW 1-155 mm qw so ffi,mummmmffi qy ioo$££ mmco qw 65 A£ • mam qw 22 r£H<0 QW 75 M^tm* QW 50^ ky\^cou^.mktxmm qws2$££ mm^ixk^mxmmi qw 85$££ ?LH-<7) QW 85 ti^(7) QW 60 T7K<7) QW 80 ±y>(£±«f!J$:£« QW 60$££ JkcoUym^Vim QW 80$££ ifcdW QW 70 ilffcOA^ • H7Jf£fs (Bacteriologists, Direc- tories) ummmcoxcokz • mam qw 22$££ ffll^txIS (Bacteriological Technigues) QW 25 K^M^ QY 100 mmm qw 70 fflffi^US (Bacterial Spores) (£*fflffil!&4-$££ *fflSii^147X h (Bacterial Sensitivity Tests) (i»4ft mm$ykfc (Bacterial Infections) WC 200-425 mco WC 260-290 fl'JlM tWXM WC 200-425 fflfaPi SB 734 nmco WJ 351 mmmoo sf 780.3 ttzimmtmykmnzfoz &££ ftufl* gits #&&§(*, &&itzimmiiiz mmMmife (Transformation, Bacterial) QH 448.4 IfflffiiTiJI (Antigens, Bacterial) QW 573 ifflrll/Lf* (Antibodies, Bacterial) QW 575 *ffll14JtfE4-|gi£Pln (Gene Expression Regulation, Bacterial) QW 51 mmiiyXmSBK (Outer Membrane Proteins, Bacterial) li*HHy4If^r3K$££ ttHttMSIifc (Arthritis, Bacterial) (£$ifc14fltjgn&$£ £ tHBttlSIS (Bacterial Antigens) l£fflllA^$£i: mffl&fcfc (Bacterial Antibodies) (£*B!15Lf*$££ mm&'bfc (Carditis, Bacterial) l*llI'$$! £ TOtt-L^liM (Endocarditis, Bacterial) WG 285 ifflif 1414-*£Hif (Sex Factor, Bacterial) liFH-f^l £ ffl®14**U (Dysentery, Bacillary) WC 282 612 VA Y-hA W'lItt£tffS (Bacterial Polysaccharides) l£*IU$ £f$ffl $££ IHf14I»*S (Aneurysm, Bacterial) I£!^*I4Uj)1)^$ &£ ^ll^/v^yn tX^l*£ (Hemoglobinuria, Bacillary) WJ 344 IH0147/4X (Bacterial Vaccines) WC 200 ||$y|4 WB 469XI£-££ ft^ffigtJf (Renal Dialysis, Home) (£^^^|/fvS$££ It^'Mffim (Hemodialysis, Home) WJ 378 ft'SffllMt* — y 'J X7 (Monitoring, Home Blood Glucose) lijfitffg£M$££ t£K (Coal Mining) M^ift WA 485 ^Hg^ WA 400-495 mmmmw wa 788 \Um.m (Cholagogues and Choleretics) QV 66 *HfJj (Fibrillation) (£Jf mW) \ 4>^ffliJj$££ mW)B (Umbilical Arteries) WG 595.U6 74 Y7A y (Cytokines) QW 568 613 VA YY"7 7-AY77A-y (Cytokeratin) (£777x$££ 7A Y9*y9-Yy (Cytotaxinogens) f££lLvl4H4-$ ££ «rAY9*yy (Cytotaxins) li*fL*14H^$££ *t~A\9ifx37A)VX (Cytomegalovirus) QW 165.5. H3 74 r- 9 7*o7 4/l/X^^*£ (Cytomegalovirus Infections) WC 500 74 h A 7'zi£ikW-m (Cytomegalic Inclusion Disease) WC 500 IIn±l6 (Emetics) QV 73 UMk. (Hospital Readmission) (£&ffiAP£$££ imifcJV^y (Prolactin) WK 515 mmm sf 768.3 nm (Recrudescence) (£#?§$££ WA (Recurrence) QZ 140 Wx.m&coA:tlU, Arcomfciz VA^fcT 4 y9X (Cybernetics) Q 300-390 tmm<)izmm$ti&m&it, xm^nz itMit q 350-390$ &££ 74 7rx7M (Syphacia) (£llA7^4$££ S8£|3fi (Branchial Region) WE 101 ISSP^ (Branchial Arches) (£il£g|Hi$££ ^/\;Uj=.7 (Umbilical Hernia) itmff^JV-T £ %X mm (Cells) ^1Ss5?<3I$££ miki&Um (Cytogenetics) QH 441.5 -fe QH 441.5 k^ QH 431 jfiLi^tJf QY 402 mmm% qz 50 fcBMUj (Cell Movement) QH 647 m%kfcJV7'fcy (Cell Organelles) UfcJViffc y $££ m^tYM (Extracellular Fluid) (£*B)&74£|1U$££ fcfflfl&^iC (Extracellular Matrix) QH 603.E93 f4i$ QU 105 *M&t4£&!J (Extracellular Space) QU 105 ffll&H^ h iJ y9X^BW (Extracellular Matrix Proteins) QU 55 mMm (Cytochemistry) (£MSB!£ltV^$££ m^kYk (Cell Nucleus) QH 595 mmm (Cytology) QH 573-671 immmmuNLM5rmM<7)Wz±Miz mm QH 573-659^ fc Mil L tzifc% $ (, £ £ fflBfet$)HI^ (Karyometry) QH 595 mmrnm qz 241 mn&mtfiiXm (Cytological Techniques) QH 585 s&mmmm qy 95 *fflflfefal3 S. j.~Y — y 3 y (Cell Communication) QH 604.2 w&mm WL 102.8 mi&mi$&$& (Intercellular Junctions) QH 603.C4 MK&&M (Cell Aggregation) QH 604.2 mm& (Cell Line) QH 585.4-585.45 mmt& (Cell Count) QH 585.5 mmco qz 202 #££tCO A: flit, Arco^-gx mmyt&mx.m (Cytophotometry) QH 585.5.C984 WMmmm qy 95 *ffll&#fe (Cytoskeleton) QH 603.C96 mfoitfamBn (Cytoskeletal Proteins) QU 55 *(flfl&#{k7 4 y ' y Y (Cytoskeletal Filaments) UUWd #{&$££ fcfflS&SC (Cytoplasm) QH 591 mm'M.WM (Cytoplasmic Granules) QH 603.M35 mftklg.7 4 7 A > Y (Cytoplasmic Filaments) liiMJ-frlft $££ mmWtikW- (Cytoplasmic Inclusions) littAf^$££ mffcMftm (Cytokinesis) l£*ffl)fe#gi$££ mmmm (Cell Cycle) QH 605-605.3 mm%W&T >J X^ifc (T-Lymphocytes, Cytotoxic) WH 200 mmftmzisiyz, qw 568 mmX^-g (Organelles) QH 591 «tf IRfSjt (Signal Transduction) mmm qh 601 mmm (Cytodiagnosis) QY 95 mm qz 241 »Afl7' WP 141 ¥Fx.m-gcomMizmmzti&t%frit, *nmi-x.it%iz mm^WX^nm (Cellular Neurobiology) UW1&X.Wm£ ££ mm$k (Cell Number) li$»N&$£i mm'm&mm& (Anoxia, Cellular) (£f£I£5|«$££ mmffcirfrm (Subcellular Fractions) QH 581-581.2 «14&*£ (Immunity, Cellular) QW 568 mmimXftlScmm (Adoptive Cellular Immunotherapy) (£S|jJ^Sf^?S $ £ £ mmmm (Cell Growth) l£«#U!$££ mm^mnUmX (Cell Growth Inhibitors) l£Ji^ffl$iJ^] $££ ifflJfctfMftiiJIg (Cytostatic Agents) l£KS*I*$££ mmmm>) ymmm (Cell-Mediated Lympholytic Cells) t£*«fW14T 'J X^°i£$££ mmi&MM (Cell Anoxia) UimmmmZRX mmW)M (Cytokinetics) (£«)!]»]$££ mmm (Cytotoxins) QW 630.5.C9 ftM*S14#L4^K QV 269 ; ¥fZcommizft%?M%, mt I£xx7 3 Y*yy QW 630.5. E6$&££ «#14T U X^°E)< (Cytotoxic T-Lymphocytes) (iffllft 1»f44T'JX^$££ mmmiiiXX^lM (Cytotoxic Antibiotics) (£#1)1*11514- t/K$££ mmMM-tjXmS^- (Cytotoxin-Antibody Conjugates) it &«!?$££ mmmm (Cytotoxic Drugs) (£47l)!*S^$££ SBJ&I*]$ (Intracellular Fluid) QU 105 fcfflJ&f*!^ (Intercellular Space) Ummft^ZfLX OTfeftEllHI: (Cell Compartmentation) QH 604.3 mmn&mmX (Intracellular Adhesion Molecules) Ii CAM$££ WSrtl-^ -yXyy-Y- (Intracellular Second Messengers) (£ 7 7 x Y 9 -y -fe X -x -r — 3k $ £ £ mmnm^k (Intracellular Membranes) QH 601 mmmifftfe (Cell-Mediated Immunity) (£*«4ft*&$ ££ mmmmiKm (Cell Surface Antigens) (£^ffil/i!J> $££ mmMm^it (Receptors, Cell Surface) Xim QU 55 yl&im QW 504.5 614 v-9y>A *m.m qv 38 ttH&^SiSeK (Cell Surface Proteins) liHISl4fi$£ £ (Bl&*iii«ISrJH(Cell Surface Glycoproteins) lilKWiK ee$£i Ml^ffll^^79 (Cell Surface Receptors) li*BB&^|fii £'£f*$££ fflli&ttAtt (Cellular Includions) (£14Af£$££ ffllfe^Ml: (Cell Differentiation) m% SF 767.5 ff£iM* QL 963.5 -ft&VAIBI QH 607 IfflS&^iiJS (Cell Fractionation) QH 585.5.C43 WkY ¥"/ 9 Xl£iMSiJlz fflia^St (Cell Separation) QH 585.5.C44 fflflfc^S (Cell Division) QH 605-605.3 tgft QK 725 ttlte#8HH*l (Interphase) QH 605 Ifflifc-frSfflilii]^ (Antimitotic Agents) (£lt®*I^$££ «BI&«S (Cell Wall) fflSD QW 51-52 fflfo QK 725 IfflS&SI (Cell Membrane) QH 601-601.2 $mn QW 51-52 tm QH 601.2$ &££ m^mSBK(Cell Membrane Proteins) (iBfg&W$£ £ fflflSHOilrtt (Cell Membrane Permeability) mmm QH 611 fttt QU 120 ffll&lfl&ftS'hSl (Coated Pits, Cell-Membrane) QH 603. C63 m%&%& (Cell Density) (£«f42£$££ «&*£ (Cellular Immunity) l£*fflll&14ft*£$££ IfflSai!^ (Cell Fusion) QH 451 fflA&i&£ (Migration, Cell) (i*ffll&ilgj$££ Hfll&igfW^ (Cytolysins) (iffl8Si!$££ mmmm (Cell Therapy) (i*fH&ff?j£$£i ffiiE (Hypnosis) 6'l>3¥ BF 1111-1156 mwmmfem wm 415 HBffilg WM 415 mmmmmm wo 2oo$£i {«KlwBft£ (Hypnosis, Anesthetic) WO 200 mmm (Soporifics) immrnt&»n; &%.mtotX (Psilocybine) QV 77.7 4 > K^fl^T^JJJ E 98.R3 7 4 Xfc'£|*)tft (Signs and Location Directories) l£1J fi'£l*]fclf(7r<$££ 77 7^ (Sauna) Ii7 4 x 7 x K^4ift$££ tiMFMHH&ffllS (Sarcoma, Reticulum-Cell) Ii±mm U X ^11$ ££ 77 X YX^<9 Y uYyy 4 - (Sound Spectrography) QC 246 mmffuxmmiz 7-77*^7xUXA (Circadian Rhythm) QT 167 $m QP84.6 X%»m (-fe) QH 527 tilt/ QK 761 lt» (Fraud) HV 66976699 &mY t>y yxl£, ±g|Wz i^Mmm (Occupational Therapy) WB 555 m^n WX 225 mXM WS 463 ?i'jtmt@'jim h'mW^ntzisbco WS 350.2 %\fcW^%mv)i£ft$m^x ArCOfacoXmtLCmmnZX 3f3lfftfc (Indexing) li#iifW fc^t3lf^ft£$££ mm (Acetic Acids) QU 90 Mmm QD 305.A2 m$t& (Acetates) QU 90 Mmm QD 305.A2 mmmM, (Acetobacter) QW 131 §g*Jl (Optical Illusions) WW 105 +j-y^^;U3Ux (Succinylcholine) QV 140 7-9 yfc-Y (Succinates) QU 98 Mmm mtmit&W) QD 305.A2 tM*»MffT (Trabeculoplasty) UmMmWM$££ tWcMl&ffir (Trabeculectomy) Hl*lP|i(ZJ4LT WW 290 7-9 yy A i Y (Succinimides) QV 85 615 if^fa') Mitt (Paracusis) li&tolti: fl £ HiJ&ffi (Dermabrasion) WO 600 $bSL (Confusion) £¥*! WT 150 «tt#5Ma WM 204 77^4 (Salmonidae) m%\mtx.mm ql 638.S2 mm SH 179.S3 SH# (Clavicle) WE 810 m^X&Wi (Subclavian Vein) WG 625.S8 m-^X&Wi (Subclavian Artery) WG 595.S8 a#T8JlKfeJfili£18!if (Subclavian Steal Syndrome) WL 355 lfe#**l£ (Sciatic Nerve) WL 400 «k#W£*6 (Sciatica) WE 755 &M (Adjuvants, Pharmaceutic) QV 38 ife^J (Suppositories) 3$ WB 344 mmm qv 785 77*- X7*o -yf4 x 7 (Blotting, Southern) QH 441 £ L*£ (Book Illustration) (£0Ji£A 0 M$££ »« (Strains) (££34£fcM WE 175$££ t*H (Contusions) WO 192 SfefeftiS WA 292 PS^'l4W^Ol£|fCfi5iJlz SH (Crush Injuries) liiUftfctaftWO 700-820$££ nl>S (Hoarseness) WV 510 &* (Acne) li#-f14M$£i ffitttSfX (Acneform lesions) (£^*t$££ 7 V 'J (Scorpions) QX 469 tWHi^y^^ WD 420$££ 7 7 ij $ (Scorpion Venoms) WD 420 7-y 7- (Soccer) QT 260.5.S7 &JI: (Illusions) BF 491-493 W.C0 WW 105 tfW*S'(4 WM 204 7 -y 7 iJ X (Saccharin) WA 712 Wm (Sterilization) mmizisith WU 300 mmzism wx 165 mmmmzisijh wa 840 R»#4£l::fc(t£ WO 665 xmmmizisiiz, wa 240 y4f4lz£o(tl) WO 113 mm (Miscegenation) UWMkmm ; *§iH ; AH$££ mt. (Journals) (£^WfiJ1f^$££ mxm (Brush Border) Ufflit«>-)€$££ *ia^fS (Hybridization) (£^4 7>J >y KJtM$££ WW.mm (Hybrid Cells) QH 425 &3k&M (Tenicides) l£it^iiL^$££ %kk (Homicide) mmm HV 6499-6535 'PX-CO HV 9067. H6 mmmfi^m w 860 WtnX'fy'iS. (Spermatocidal Agents) QV 177 iktfim (Spermicidal Agents) lilSffii^JC$££ IJUaSJ (Rodenticides) HH SB 951.8 £%:'&£&)%% WA 240 &lJl£iJ (Insecticides) AH SB 951.5-951.54 &&ffi£ WA 240 ^x&^Jlfil/llS (Insecticide Resistance) AH SB 957 imm^it^mmm qh 465.cs m&m®; m&skm qx 600 &&'&£&)%% WA 240 77*4 X'A (Sadism) WM 610 77 7 4 hDNA (DNA, Satellite) QU 58.5 fMGZtfB (Bagassosis) (iSJIilj^$££ fcHtftH^ (Sugar Substitutes) {£11^*4$ ££ QU^m (Foster Home Care) HV 875 &*ffi£Kj#8 WA 310-320 &8#f«**£ftokcOA:tliiA:^#WfWlz, tfiRli ffitt*i#<7)*fU;J: WM 29 ; mWMWJtcoAztiu WS 107.5.F6 WMfXWi (Desert Climate) QC 993.7 &±m WB 710 M«12W QT 150 7'm&u, tcom&x ttftlBWkt&tfL%. (Bronchospirometry) ti^vtSHigl fiiJ £*£$££ W<$mm (Ammotherapy) WB 525 f^ffll^Fia (Reaction Time) BF 317 7 7 -fe a 7 (Thalassemia) WH 170 7 7 7 x X (Saralasin) QU 68 7* iJ if- (Crayfish) QX 463 7'J 7/1/^ (Salicylic Acids) QV 60 7 ij t>V&& (Salicylates) QV 95 +MJ Y-?A Y (Thalidomide) QV 85 MWim QS 679 7"'J K-v4 K!€ (Thalidomide Children) UmWimft^M $££ 7-JV (Macaque) l£Macaca^$££ 7-JV (Monkeys) l£Haplorhini$££ 7-JVzjA Y-yx (Sarcoidosis) QZ 140 mwi&coiicoimmmz 7-)vm.7AiVX (Monkeypoxvirus) QW 165.5.P6 T-JVeomm (Monkey Diseases) SF 997.5.P7 7-)Vyr-7X9-Y (Sulfur Mustard) U^X9-Y7X $££ 616 "•fx+39 *f)\,^)V''<7)}j& WQ 415-430$££ iT4;IX^SiJ'^$££ mMfyMm (Industrial Toxicology) li/UHE^ ; #^ ; S«$££ mWMWfa (Industrial Waste) WA 788 m*9A7°commy>)) QD 341. A9 yTTJVi- (Diathermy) WB 510 m:mum*v&mm wo 198 $££ x7 h 'J 77— h (Diatrizoate) itf^Jfc LT WN 160 Mmtm QD 341. A2 x77- h (Cyanates) QV 280 y7t; K (Cyanamide) QV 610 x7-7X-/U3 (Cyanidanol-3) (£77:Jrx$££ yT-Y (Cyanides) QV 610 y7/^<7> (Cyanocobalamin) l£ty ^ XB12$1 £ x'7 7 7-7* (Diaphorase) l£ 'J fcT 5 KftKort- *$££ x7 ^ y x7x— JVXJVfcy (Diaminodiphenylsulfone) (£ 77 9 X $ £ £ ■TTi X7^x7-7* (Diamine Oxidase) (£7$ xt* 618 y-hA y a ur-Af (PlaW) $££ y7^/U7>fX (Diamorphine) (ix T-b7/l/:E/l/7 4 X $££ 5/7U/—tf (Sialidase) (£/ 4 7 5 - 7-7*$ ££ y7'J/l/h 7 xX7x7—7*(Sialyltransferases) QU 141 yTJVyT (Giardia) QX 70 >s7>it*% (Hydrogen Cyanide) QV 632 x7xfb/k^^ (Hydrocyanic Acid) IJ •>7 x {£**££ £ isT'silti! (Cyanides) Q\' 610 yTytm (Cyanates) QV 280 yTyt-^A^onQift^itl (Diammonium Chloroplatinum Compounds) %mtm QD 181.P8 mmm qv 290 a St (Masturbation) HQ 447 mwmmm wm 611 y4y->77— h h/l/xx (Diisocyanatotoluene) (£ YJV xx2,4-x4 V x77- h $££ ■jA V7°n t/U7/l'43 7X7x— h (Diisopropylfluorophosphate) IJ4V7/l/07x— h $ Mi ?EH (Cause of Death) WA 900 #£*rt'yyx(i, ±HSiJlz ?EH^ (Thanatology) HQ 1073-1073.5 v'x7;ux —r/i/ (Diethyl Ether) (ixf/px-f/^l, £ yx7;uv74 7/i''tm SF 98.H67 Mmtm QD 341. H9 •/if;^3f>7 ; K(Diethylnicotinamid)(i'-7i/t*y -/!/$££ xx7/l/— h n y 7 ~ x (Diethylnitrosamine) ^*g^lRfcLT QZ 202 /xf^vn^HI (Diethylmalonylurea) (i'J 7A$££ x4*7x (Dioxanes) WA 240 ^mmwtLx QZ 202 x4^fxX (Dioxins) Mmm QD 405 xt^V-;!/ (Dioxoles) tUfcLT WA 240 Mmm QD 405 yiTXY—y (Diosgenin) Xitm QU 85 :J fc Y * y * 9 "J X (Diodoxyquinoline) Ii 3 — K ^r 9 — /!/$££ x4Kx (Diodone) (i 3 - K^°7-fe h $££ x7 (Deer) QL 737.U55 mm SF 997.5.D4 if 4 (Tooth) WU 3yg^ !${>££ §a (Ego) !£SM>« WS 105.5.S3 *fftt##f WM 460.5.E3 StilUS: BF 697^$ &££ ftftX *&»#&- (Radiography, Dental) WN 230 mm (Dentists) ^t§?£3l$££ nit- (Pinna) l£n?$££ ftfrlXK (Dental Offices) WU 77 *44I77 (Dental Medicine) itmmm ; 5HK.fl ; Pfi£*K * ;if^*K.f.$££ tMYimm^imm (Ethics, Dental) WU 50 nm%moo®,T?>Sjftffi£¥KJ#& WA 810 $££ mmmm (Dental Care) WU 29 •^Rf**li^8c#*43* WA 350-351^$££ mmmmftfi (Education, Dental Health) itmmmxn W$££ mmmmttm (Dental Care Plans) (iftf41*Pt$££ MEfi?M (Dental Facilities) WU 27-28 mmmm^ffi^m (Practice Management, Dental) WU 77-79 mrmmtt^imUIS. (Socialized Dentistry) l£&SM SiJS$££ mmmmcomfe (Delivery of Dental Care) f£E«7-1 X^f4t$££ mmmmUWfa (Dental Waste) WA 790 mmmm^ (Fees, Dental) WU 77 m&mrn l wu 58 619 y-hA l) a mVmmmS))^ (Dental Auxiliaries) WU 90 <*rfr£PJk!£flStf£ (Dental Impression Technique) WU 25 4ffW y 9 - X fflf&XH (Internship, Dental) l£ 4 > 9 - X fcXx*7X rfflM$££ &fM x7°7x h (Dental Implanation) WU 640 mm%tt% (Dental Receptionists) (£i£*4EMfl^$£ £ f^^Tky^iyl (Dental Restoration, Permanent) WU 300-360 mXfaX (Dental Hygiene) (£PJ£M$££ mW&X$i.1l (Health Education, Dental) WU 113 ft4Htr£7--t*X (Dental Health Services) WU 29 mW&£± (Dental Hygienists) WU 90 mm'&Xm^. (Dental Health Surveys) WU 30 ft4x -y 7 x 7 (Etching, Dental) (£ft^S^x -y 7 x 7$ ££ mmfctlfttif (Dental Stress Analysis) mmmnm wu 190 «%&m® wu 150 mmfc yy- (Dental Onlays) (£4 X !/*-$££ mmm (Dental Chemistry) (£1L*^$££ ^Tfjf^fe (Dentistry) WU mmituswtm wo 46o$££ w.muwmmmm uh 43o-435$££ IJ]7-l£^4to^ WU 90$££ tt3! WD 745 -DIH^FpIM WG 460 mmm&tmAm& wu 26 tasmummitsm wu 50$££ SE^(£*f4JiE*^ W 705$££ %kcou%xmmm wu 490$££ Hi£±(£lif4itr4£± WU 90$££ %vjmtwjmuxxJimm wu 48o$££ ^^l£^H^4^ WA 412$££ \mummim W 260^$££ kbXM;M WU 77 mmmcox&£t*iIE (Orthodontics) WU 400-440 *I4^^ WU 440 ; XJE»£& WU 440$ 6££ ft*4*tiE^ (Teeth-Straightening) li*^4^iE$£i mffl$X& (Orthodontic Wires) WU 426 mfA^JEUU (Orthodontic Appliances) WU 426 mm&Wl&m (Partnership Practice, Dental) WU 79 mmim (Dental Records) WU 95 tft* (Vision) WW 103 mmmU^tl WW 145$££ mmcoim&MW) ww 400-460; m££ KOT^ (Eligibility Determination) Medicaidlz^LT W 250 9y*4 7TiZttlX WT 31 mmmmm mkco W 900 mmmtmrnxcom^co w 925 A:Com>+v WU 25 $7«£>Ri*iE (Dental Attrition) lif^ftBlVi $££ $:5f||#ti£ftj (Tooth Remineralization) WU 166 t^Htfi (Replantation, Tooth) l£i*(W?tHi$$££ ff;HiBS?i (Hypnosis, Dental) WO 460 &3-$x-y7x7 (Acid Etching. Dental) WU 190 §34££. (Tooth Diseases) WU 140 ^jf^-ft (Dictionaries, Dental) WU 13 tftgHE^ (Group Practice, Dental) WU 79 ltl4£W (Fillings, Dental) Ii4 x X- ; #flfflMW : #£?4 7V)f£)fl4l74$££ jfcftUjf- (Dental Assistants) WU 90 $$%±~JjWi (Formularies, Dental) QV 50 #ftjl¥Wfltfcft (Education, Predental) WU 18 #3*JifcE (Tooth Erosion) WU 140 ftJftSU (Esthetics, Dental) WU 100 ft-*7j-<£(i±tISiJtz, f*Jx(£#*4*itIE WU 400-440 m^mmta (Dental Clinics) WU 27-28 m&mn»mpa wa 350-351 mXmm& (Dental Records) WU 95 ^X 3 -y Y T 9 ••/ 7 9 X h (Slotted Attachment, Dental) Itm^mT 9 -y 7 A x r-H#$££ ft*ftifi£ (Dental Bonding) WU 190 ?Tlft (Parotid Gland) WI 230 ?T»& (Parotitis) WI 230 iftffttSTMtifc C 520 $^££ STUB* (Parotid Neoplasms) WI 230 f^HH^If (Specialties, Dental) WU 21 t**I^ffi*I (Neoplasms, Dental Tissue) I£#I£141I*S $££ m*km (Schools, Dental) WU 19 ffifcfc^KffcW (Education, Dental, Graduate) WU 20 ft^Siia (Dislocation, Tooth) itmnftLB $££ ft?4HJta (Dental Casting Technique) WU 25 Ig^feRIWQtft (Dental Casting Investment) WU 180 Si'S (Independent Living) it B S4?SiJ]f^$££ i»PI-ttWfe« (Identity Crisis) BF 697 t¥W WS 463 fl'JLWtty'JLm WS 350.8.13 lStt^*ft=*Jlt4 WM 460.5.P3 #*«U& (Dentigerous Cyst) WU 280 £34£4/f (Tooth Fractures) WU 158 mX'&'mm (Dental microbiology) Ii P * tlif«T« »4to3* QW65 $££ #3\J.o3?i£ (Fluorosis, Dental) (£&##$££ &mmmm (Forensic Dentistry) W 607925 mi W 705 t^Hai (Tooth Eruption) WU 102 Xm WU 480 m:mm (Legislation, Dental) WU 32-44.1 ftW*P£ (Insurance, Dental) W 260 t*4f£®E£?7-tX (Dental Health Services) WU 29 tf4f*MffcW (Dental Health Education) Ji#fHti£ffe t$££ ftf4f*#¥ (Dentistry, Operative) WU 300-360 K'Jtmtx'jtm wu 480 £^#! WU 490 #44t§*8 (Prosthodontics) WU 500 ftfHimft WU 500-530$ i> £ £ AftMtHI* (Dental Prosthesis) WU 500-530 mmrnm wu 500$&££ #f'Uftl$ (Anesthesia, Dental) WO 460 #J>f £?*&)£ (Tooth Abrasion) WU 140 #fM7v4 7 4 Kit® (Dental Medicaid Program) Ii Medicaid$££ #f4**t'r- (Dental Pharmacology) itmmmZflX mmmT-7)Vtr^ (Dental Amalgam) WU 180 ftf4Hl£PftW (Dental Impression Materials) WU 190 #44ffl^ (Dental Instruments) WU 26 #14111*+ X r-JiifcM (Dental Casting Investment) WU 180 #f4fflflrJ8M (Polishes, Dental) Ii#fg3ij$££ #ffBJ'&& (Dental Alloys) WU 180 #f'lfflttf4 (Dental Materials) WU 190 mmmcoxmmm&t:&ttm& wu26$*>££ #fHH-fe^xh (Dental Cements) WU 190 HmXA > Y WU 190$ &££ #fHll t°X (Dental Pins) WU 26 mmmfc--tyy (Dental Porcelain) WU 190 #f4fflH£! (Dental Models) WU 26 mmimm (Ethics, Dental) WU 50 #*4 y x 7* X h ffii\gm (Residency, Dental) l£ 4 X 9 - X fcxx7*x hWfi^W$££ 4-*ffi (Eclampsia) WQ 215 ftlUI (Time) QB 209-224 m&mti iz is u&mrmx qw 700 *££ h \z~y9xizM&fcZ>m&U, iHJSiJf*: ^tf??$mX QW 700 ^h K-yyx izm&r hm&u, xmwz mfflXVvm (Chronobiology) QT 167 XffimfiE. (Pre-Eclampsia) WQ 215 #1111391 It (Time Perception) BF 468 fi'jtmt&h'jim ws 105.5.D2 B#fHl fc ift-f^W^t (Time and Motion Studies) <&mY \z-y9Xit, iHSiJtz mm& wp 468 X^m (Uterine Muscle) (£4^851 $££ X^WiM (Myometrium) WP 400-460, 468 X'&W (Cervix Uteri) WP 470-480 fomm (frmzisiyz) mmxwt wq 400 &mm wq 305 X'&M^'fc (Cervicitis) WP 475 X'&m^'MX I T (Cervical Smears) lilPgX i 7$ Wi i^H-Wrt-^yT-iJ- (Pessaries, Intracervical) lift f*ll?^$££ X'&m'W^tft (Cervix Mucus) WP 470 X"&W.^mZf& (Cervix Dysplasia) WP 480 X~&mUm& (Cervix Diseases) WP 470 mmm sf 87i X'sM^mm (Cervix Neoplasms) WP 480 X'&M^rf ^^ (Cervix Erosion) WP 470 X"&fc.T$m (Broad Ligament) WP 275 X'sJKfSm\Hi&M (Intraligamentous Pregnancy) li-ft mimzftx X'slXU^ (Ligament, Broad) l£4-*s 14111?$££ X'&mfc (Uterine Diseases) WP 440-480 mm wp 440 X"S>GLB (Uterine Contraction) WQ 305 X&WlfeM (Oxytocics) QV 173-174 X's'limmmm (Tocolytic Therapy) (£P$ffiWffiiJ$£ £ 4-*saiJriL (Uterine Hemorrhage) WP 440 X'&mm (Uterine Neoplasms) WP 458-465 xmmm wp 459 ffllifa (Corpora Quadrigemina) WL 310 *J$44^& (Glomerulonephritis) WJ 353 &m*\M.W (Glomerular Filtration Rate) QY 175 4-S1& (Uterine Prolapse) WP 454 T-'sfifUr (Intrauterine Devices) WP 640 X'&nmm^. (Uterine Endoscopy) li^ifttfcftfcJE £ X'&ft&W (Intrauterine Diagnosis) l£ft£fjij !£#$££ X"&YX&.&'Mffi (Intrauterine Growth Retardation) (iSp !£l£:SM$£i X"&mH°Mffi'Jt (Infant, Small for Gestational Age) WS 420 X"UP\J9M (Uterine Inversion) (£4"'a*^.f.$££ f^^iSSI (Contraceptive Devices, Intrauterine) (£4L'sF*Ii5-;flr$££ X"S \H^< -y 7 'J — (Pessaries, Intrauterine) UX'&ft&M: $££ X"S 1*111 (Endometrium) WP 400 X"gftm% (Endometritis) WP 451 X's^mmm (Endometrial Cycle) l£J4igllW$££ X"S\Hm& (Endometriosis) WP 390 X-gttmfrWm (Secretory Phase) (£J!*I^#]$££ X"S\HW\M- (Blood Transfusion, Intrauterine) WQ 210 IP'S comU (Involution of the Uterus) itm% \ XtX comzmtimmzfix X'siim^- (Adnexa Uteri) WP 275-322 X-gim&fc (Adnexitis) WP 275 #*ll*l&m WP 155-157 X'sttm&m& (Adnexal Diseases) WP 275-322 X-£i%m&tm%. (Parametritis) WP 275 X^teJim (Uterine Inertia) WQ 330 =£.-£^=.9 \)y7 (Uterine Monitoring) WQ 209 X'&WW&zZ (Hysterosalpingography) WP 141 X'gmmm (Fibroids, Uterine) l£^*sH*$£i 622 Hlr-$£ £ y7v881Rffl#iia4- (Sigma Initiation Factor) (£x7^ H4-$££ y/?^| (Sigma Element) l£i/X'-^H f $££ y/vij x (Dicoumarin) (i tX t K 3 ^ ^ y-v ij x $M £ y?-vn-/MDicumarol)l£tX t K'3 ^ri/7-7"J x$£ £ v97A-Y (Cyclamates) WA 712 y^7X7*7-h (Cyclandelate) QV 243 y9uT lv — X (Cycloamylose) !iy?of4x h 0 x $££ x^ o X - -y 7 X (Dicrostonyx) U"9 fcXl Sf4 $ £ £ -> 9 3 X 7 "J x (Cyclosporins) QW 920 i/ 9 3 -fe ij x (Cycloserine) QV 268 v 9 uY*X Y 'J X (Cyclodextrins) QU 83 yyn7x7y (Diclofenac) il*S^fcLT QV 95 Xitm QU 98 yyo7°3^°x (Cyclopropanes) QV 81 x 7 3 /^ ^ +r / y (Cyclohexanones) »f&lSCfcLT QZ 202 %tyim QV 633 /^n^Jf-ify (Cyclohexanes) Mmm QD 305.H9 x7 3/NJf-xi K (Cycloheximide) QV 252 i/ ? n /\7° y 7 ^ 3 — X (Cycloheptaamylose) l£ x y 3 7*Xh ijx$££ y^o^y^y (Cyclopentanes) £t£lt*# QD 305.H9 y7n*X7rU' (Cyclophosphamide) QV 269 i&itmmm qz 267 ftmm qw 920 y 9 3 n x y > (Dichloroethanes) (£—J<x 7 X x $ £ £ yynnx7xx (Dichloroethylenes) ##^ QV 633 i* y d u -x 7 x — /I/ x y 3 n x y x (Dichlorodiphenyldichloroethane) (£DDD $ £ £ y 9 3 o 9 9 X (Dichloromethane) (£±^4"ll7 7 X X $ £ £ xynoy7^x-7;u (Dichloromethyl Ether) l£t*X (9wa9A-)V) x-x;u$££ sfc'Ji!J(#^ (Excitotoxins) ii*W£$$££ *iJ»B§*J?-<£ (Implosive Therapy) WM 425.5.D4 mtfcm (Irritants) QV 65 VUf QV 666 ffitidJlJi^ QV 664 'Am^com*® qv 6is \hmmm\ wb 371 il.jflL (Hemostasis) WH 310 H&Mi-iltif H4- (Lipemia-Clearing Factor) (i 'J 77°3 7 4X0^—fe*$££ ihtflL-lif^ttlrt^ (Tourniquet Pain Test) (i^*iiSiia$£ £ lklfo.31 (Hemostatics) QV 195 x7"7 (Shigella) QW 138.5.S4 yY-®. (Digenic Acid) l£74-x^$££ Eita^-gfjf (Test-Tube Fertilization) I£^y4'<4,'i$££ lit$$5fe t£ !*]'#:£ #ii"£ (Institutional Review Board) it #n^M£$£i 1*fJ§14»§ (Odontogenic Tumors) WU 280 mcoi$mJ1^) (Self Assessment (Psychology)) BF 697 fl'Jtmtib'Jtm WS 105.5. S3 §£!if'ffi7°n77A (Self-Evaluation Programs) Wx.ftff (NLM^HI^T(£JF^#^- 18-18.2) A:COt&com*Y \z-y9Xit, XWAiz g£#f$ (Autolysis) QZ 180 Jt'&^it (Postmortem Changes) QZ 35 ♦fficKlh (Accident Prevention) WA 250-288 mmzisiyt, WX 185 WfiiziSiyZUftWAW WA485-491 $££ mmmm wn 650 ^^y4 7°<7)*S'$t££, mtimmmikooxnxm fcSOE WA 275 ; im%W WA 260^ §£&*& (Autoimmunity) QW 545 g £&*£'l41iK*?? (Diabetes, Autoimmune) Ii4xx'j >1K#S*im*^$£i g B*5fe*ft'l4)§JfiL'l41:Jfil (Anemia, Hemolytic, Autoimmune) WH 170 §£%*&*N (Autoimmune Diseases) WD 305 SSiSlflL (Autohemolysis) (£i'§Jlil$££ #ffi (Tooth Root) WU 230 #tB£ (Pulp Canal) l£#MS^$££ fttfin&W (Root Resorption) WU 230 #$B#E&* (Scaling, Root) l£#S^*$££ mmwmm (Root Resection) (£#tS^«^lt$££ #tB£ (Tooth Apex) l£#IS$££ #tfa.m%l& WE 850 TK WE 850-890 ±K WE 805-835 3C&MJL (Second Opinion) ti&Sfr fcfflf£$£i BISC (Lipids) QU 85-95 B^ffi QY 465 SMt£?cJItfcg (Colposcopy) WP 250 BIKifilftft (Lipid Peroxidation) QU 85 SI®bjIML (Lipid Mobilization) QU 85 ?*%£. (Ear Diseases) WV 200-290 mm wv 200 ¥L!fc»l £*&!£»! WV 200-290 mm wy 158.5 fllfC14iffif&Ifc!E (Histiocytosis, Lipid) (iNiemann- Pick*^$££ SlfC-Sl (Lipid Bilayers) QU 85 HKfi**¥ (Quadriplegia) WL 346 mmm sf 895 0#*M (Cartoons) WZ 336 $&^3H#flft£ (Indicator Dilution Technics) WG 141 itmstmrn. wg 106 &m%mm wg 141^; mt\miiL7tm%mm wg 141^fc££ iaX^m fc ^H (Indicators and Reagents) frmm QD 77 mim qv 744 fe* QV 240^$fc££ mm%. (Periodontitis) WU 242 *ifib€£- (Syndactylia) WE 835 #JH#M& (Periodontal Bone Loss) li#lf #il$g$£i #JHei£i£ (Periodontal Splints) WU 240 #J§l#flf#i»JK (Periodontal Resorption) (£#£#&£ $££ m%\m& (Periodontal Diseases) WU 240-242 mmmm&m. wu 242 #J1*£ WU 242 mwrnm-m wu 242 mmmi&j%$k (Periodontal Index) WU 240 #JH*E (Parodontosis) li#JSj*££.$££ mmm.U. (Periodontium) WU 240-242 #mftl& (Periodontal Cyst) WU 240 g^7°377A (Self-Instruction Programs) (£73 77 A^g$££ #J^7°7'yh (Periodontal Pocket) WU 242 mmmm. (Periodontal Prosthesis) WU 240 mmmm (Periodontics) WU 240-242 M* (Ear Neoplasms) WV 290 RB^t4^()^(£Sf*fiSiJ|z ,@.#$J (Puberty) WS 450 .S#)W?g*£ (Pubeity, Precocious) WS 450 ®mMM%m (Puberty, Delayed) WS 450 S^mt&m (Pregnancy, Adolescent) U^X-M&mtfL X m\% (Stings) l£»$1lfc$yil$££ WM (Thalamus) WL 312 tmm (Thalamic Nuclei) WL 312 mtXYk (Nucleus Dentatus) l£'J^t^$£cfc 624 y-bv9-t SJfcTSB (Hypothalamus) WL 312 tli^TSBTi^f^ (Hypothalamo-Hypophyseal System) WK 501-502 $j5tcT!H$*£& (Hypothalamic Diseases) WL 312 ftflcTSBflffllSB (Hypothalamus, Medial) WL 312 SJ^TSB^U^x (Hypothalamic Hormones) WL 312 fcfti (Molds) li$3I$£i #7# (Ear Ossicles) WV 230 tB.)5K_hSP (Epithalamus) (£PaWi$££ &W.B£iYMi (Thalamostriate Vein) (£AiK$*$£ £ fctt&Kfc (Filariasis) WC 880 &:tfclk142l&*F? (Filarial Elephantiasis) (£7 4 7 'J 714 gi&*i»i$££ &#AH (Wuchereria) QX 301 &ttrfa*I744!S&*£ (Filarioidea Infections) li&ifcifcfiE $££ t£tt*£*e*ffllfe (Interdigitating Cells) (iHt1£#c*fflll& $ £ £ tEJ^IJis (Thalamencephalon) (£PalBS$££ gSJjA (Self-Help Devices) WB 320 79 f 9 W 26 ^F^y4 77)gS$C)££ gUjy/l/-7° (Self-Help Groups) mWmizis it I WM 426 tfeR (Earthquakes) (iS?*$.W$££ *Et*£ (Optic Nerve) WW 280 tt&ftH*>*tft WL 330 HR*>T*>tt&£K ww 101-103; w% ww 1033 $*>££ tltt&^Ss (Optic Atrophy) WW 280 tttt&lfc (Optic Neuritis) WW 280 &tt*££^ (Optic Chiasm) WW 280 wmmmmt txco wl 330 &W&m& (Optic Nerve Diseases) WW 280 %mm (Acupuncture) WB 369 imm (Dental Pulp) WU 230 #tti& (Pulpitis) WU 230 #tt£ (Dental Pulp Cavity) WU 230 ftMS^ (Dental Pulp Stones) l£#MSl?c1L$££ mfa&Wm (Dental Pulp Devitalization) WU 230 mmm.% (Dental Pulp Diseases) WU 230 ftHSKft (Dental Pulp Calcification) WU 230 mmwmm (Pulpotomy) WU 230 yX'AUX (sis Genes) UW&iiXZflX mmm.Wm (Dental Pulp Capping) WU 230 fe&X&m (Hypodontia) (£$&#*£$££ yXYJV J/-7 (Disgerminoma) (i4c1trafflM$££ yX-yT iyy9waBik(2) (cis- Diamminedichloroplatinum (II)) l£ x X 7 7 7 X $ £ £ xX7x (Cystine) QU 60 xX7xft-fc-E (Cysticercosis) WC 838 mJ?}&cohv?-)vtYmcofemiz®.mztiht%& wm 274 ^ffc^^gftlzteffl^rLSii^li, xm^liz 6&14 (Magnetism) Ii58fl$£i m% (Posture) WE 103 ftMJft&ife (Focal Infection, Dental) WU 290 514*^>^^ (Aural Vertigo) l£Meniere*S$££ #£ (Deatal Calculus) WU 250 *}4|S&± (Dental Scaling) WU 113 tftfjf (Tooth Fractures) WU 158 Sfetx (Institutions) l£ffij&$££ 561x7477 (Deinstitutionalization) W 84.7 4^flt-t'X WY115^$fc££ MWO&.WL (Facility Construction) l£JH£<7)l£ftfc^tS:$ ££ SIIxJIx^I/l. (Child, Institutionalized) &WfaX$)%% WA 310-320 M^'Jt WS 107.5.14 tt^mfo^M HV 959-1420.5 kWJtm. WS 105.5.H7 $&££ MmW^mX (Adolescent, Institutionalized) WS 460 -463 mWcmm (Facility Access) Um.W$!\^mm BF 727.P57 'Jtm.-t'-mm WS 105.5. H2 0 At 'J 7 — X 3 X -feWfc£r/[l^^#^ WE 172 'JIM.C0 WS 368 ft*^4£y> UB 360-366 n^m^m Pf * $ fc r>mWl% HD 7255-7256 WlgWM£*i# HV 3018-3019 MWL x Y mmrnm wx uo •WllzJ4LT(i (NLM34IagT(}JE^#^27-29) mf%&&n WX 200-225 trt;fc&*&^&*l$j£® WA 795-799 muco mi- fc m.m wx 140^ $ fc £ £ 7-ty x M£ (Dental Cementum) WU 230 Ij&flfc (Sebaceous Glands) WR 410 UySWfc (Remission, Spontaneous) QZ 140 ft£o*£&lz&(£•£>•£ftl£, Ar^mBiz g*$##f (Fractures, Spontaneous) WE 180 g^i&f (Natural Disasters) ux (Self Esteem) l£gSffi^$££ Kit (Cadaver) WA 840-847 KW*&% WZ 320 Af£M W 822 [5]-fb W 800 W.W%M% WZ 320 sj& qz 35#; mttt&mm w soo; jtt&mm WA 54; m&\ QS 130^ ; KfethW^W. WA 844 ; yEf£»|| WA 840-847 $ fc £ £ ^Ef^Wp'J (Postmortem Examination) (i£lJtfc$££ ylWco^m (Disposal of the Dead) li*fcf^ : ftftifjsjt $££ Kfc%M^i (Resurrectionists) (£$tf£$££ Hxf*^*^ (Crippled) (£#fWr#$££ KWffim'Ukm (Embalming) WA 844 ^EffcSPH (Mortuary Practice) WA 840-847 mm WA 846 Mm WA 846 km WA 847 mm wa 840 KW*&% (Body Snatching) l££Ef£$££ KW{% (Algor Mortis) UmmitZflX S^Mffim (Hemodialysis, Home) (£&'€S|ffJi$££ .S^Jrfc (Childbirth at Home) (££-^Hfc$££ y9 7}dy (Cytarabine) QV 269 KC&Iffi^ (Erythromelalgia) WG 578 -7 77 7/1/7" (Ditiocarb) *X- hftjfc LT QV 290 Wm% (Visual Perception) WW 105 x7 3ijx (Citicoline) liCDP3)Jx$££ x7x*X~ n ^^3 ij x (Cytidine Diphosphate Choline) QU 87 x7 y x 9 ^g£ (Cytidine Phosphates) It x h x x 9 9 V 77K$££ x7X >7 a 7 (Turkeys) islW SF 507 mm SF 995.4 W&Htfttt (Audio-Visual Aids) (NLM5t$mTI£JF^#^T8.2) m*Y \z-y9Xit, XMMz m (Knee) WE 870 skmmz we 870 m&wiffi. wg 595.P6; ®ix»m wg 625.P6$ t £i #ffi (Toothache) WU 140 %m (Otalgia) l£^*^f.$££ B& (Popliteal Space) (£)&$££ mm.% (Patella) WE 870 %kW>BW. (Popliteal Vein) WG 625.P6 mcoxnjkmmz wE87o$fc££ mmm (Popliteal Artery) WG 595.P6 mc0X<7>JkmiM% WE870$fc££ »lfffi (Alexithymia) i£lftJj*Ett $ £ £ H£PfpMM (Arthroplasty, Replacement, Knee) Ii8$ PtSMM$£i liMMil (Knee Prosthesis) WE 870 &H (Unemployment) HD 5707.5-5710.2 %%kT x/l^'-14JliifFi!& (Encephalomyelitis, Experimental Allergic) l£7 X/^*-14J3B^flii&$£i %m\Wm (Experimental Design) (£if^ftiii$£i ^i&iE (Laboratories) NLM^£^T(£JI^#^- 23-24 WmmVltlzisU& UH 470-475 W^mft UH 399.5-399.7 HSfcM-v-7- (Laboratory Markers) (t^T^- 7-$££ %$fcW.PX§iJi± (Laboratory Infection) WC 195 ^%co9 Ay°%mMnxcomku, Azco-m>'£i- %m^.\zisuhxmtmv\ qy 23 626 <>.yx>f/\ ftJ*£M7V>8BU!s(i, Arcoi'&^iz ^H"7— j-TJV (Laboratory Manuals) (NLM tttmxUW£&^ 25) %Xm QS 625 %mm W 625 mm qs 525 %$& QW 525 $ft$ QV 602 %1kAjmm (Psychology, Experimental) BF 181-198.7 fVJLWtWJtm WS 105 %&■£■?-^T)V BF 79 0f-£lz[it&#f^ BF 76.5 'il^&\j7X/l/4:'-14W^'^ (Neuritis, Experimental Allergic) WL 544 HSfc&WKIt*^ (Liver Neoplasms, Experimental) WI 735 %1k$)Y-l* (Games, Experimental) QA 269 HSfcWMfe® (Melanoma, Experimental) QZ 206 %tk$)MM (Neoplasms, Experimental) QZ 206 %W$)¥\Mmm (Mammary Neoplasms, Experimental) WP 870 %&&)%lW.m (Diabetes Mellitus, Experimental) WK 810 WkftiHUmm (Mammary Neoplasms, Experimental) WP 870 %Wl$}WLWiUW^ (Radiation Injuries, Experimental) WN 620 WkWfa (Animals, Laboratory) QY 50-60 m^ mumtxmm sf 761-768.2 77fcWS QY 54 mm SF 996.5 «p^iJ)^xiiiJ]^^y/i/-7o«^$ fc££ mUm QL 801-950.9 77fcWH QY 54 mm SF 996.5 xmm qp wzm^xum^x (Mice, Laboratory) (i-^7X$££ Mffl7 7l> (Rats, Laboratory) l£7-yh$££ &f§*JE (Aphasia) tt^14 WL 340.5 <1>H14 WM 475.5 Mm (Apraxia) WL 340 fcfgtfcS (Aphasia Tests) l£t*^i:>a^Wtt^$££ %fcbmm (Existential Psychology) ifMfcXBZ fl X ^B#Fb14j^ (Real-Time Systems) (£3Xti-yxX7 A$££ &#*£ (Agraphia) WL 340 fctt (Syncope) WB 182 £& (Eczema) WR 190 mrnmvj sf 901 Vm&m (Geniculate Ganglion) WL 330 WBfe&fcfc (Dermatitis, Eczematous) [£}I*£$££ &/£££ (Aphonia) tm%M'\& WL 340.2 ■kWKiifclt: WM 475 !$£K& (Knee Replacement, Total) (£AT.I$$££ 4ifr 1:.^ (Existentialism) t'l-'r- -Hft<7> B 105. E8 JUAftw B 819 ffltt^Mff WM 460.5.E8 ■H'Wr' BF 204.5 mUWVj (Knee Injuries) WE 870 "JiJlfcfiH (Practical Nurses) l£-n^ i 7°7 y 7 ^f 7/1/7 -xX7$££ "£JtilG.$M (Nurse Practitioners) WY 128 *P'l4*^*iH (Aphemia) l£*|g*E$££ iil£ (Humidity) 8HWi WA 774 rt^tz<S WA 450 ffiX.tfs QT 230 £B£fl11£ QT 150 ti.%7- QC 915-917 xmmmm (-») qt 162.H8 ft£46 (Jealousy) BF 575.J4 W^ffl WS 462 ?L!£»lfc*&!£W WS 105.5.E5 £M*E (Alexia) lif£?cl4&g5t*E$£i ^n5t*£ (Dyslexia) ^^^^^ WL 340.6 -C>g14<7) WM 475.6 te^ffcW LB 1050.5 ^1*1 Stir? & (Air Pollution, Indoor) WA 754 ^I*]*£#i4#14 (Indoor Air Quality) (iMl*]:£f\fljife$£ £ &fg (Agnosia) WL 340 9c3t£fcGE (Agrammatism) l£Broca^|f*£$££ mm&^H (Disease Susceptibility) QZ 50 mmmmamm^ (Pathological waste) ummmmty}* ££ mm*&1i.ik (Manifestations of Disease) I£*^ta ; $&& tt ; m§* ; W&&K ; PEttt ; &)i-ffi4ic$££ *£*filTfJj (Illness Behavior) lif.#Wf£ilJ$£i mmVfW (Diathetic Disease) (i*£*??;S^14$££ mmSWi. (Disease Resistance) !£§?*&*£$££ mmizisit i>^'\i^x. (Degenerative Processes in Disease) (£*^?4$££ mm!<7)3l£$££ mm^At-X^l (Disease Vectors) wxmm QW 700 627 •>7M7 tix&m t&jrB£&)V>l QX 460^ i&frliJii QX 650 &*»r*i&" WA 110 liitiig^ QX 600$fc££ mmftmm (\osoiogy) uftmzfix mm\m (Health Insurance) (£tttf*P&$££ mm&M% (Disease Reservoirs) WA 106 m-zmm.com.xm wb 710 mmm qz 40 mmm sf 780.9 ft £*£*?! <7)£«->$fc££ mm^T'JVWfa (Disease Models, Animal) QY 58 &BJI (Blindness) WW 276 fel£feW WW 150$££ MkcOfiM HV 1618-2349 tX7'J-14 WM 173.5 fVJIWtiti'JLm WW 276 WAfflgl#fit Z 675.B6 m^nmn z 729-871 &I£#W*£ WD 110$££ iJ^t*iJ7-x3 x ^sw^lte^ WW 276 ti^W HV 1573-2349 ifcd^ SF 891 HfnTOJi (Questionnaires) flf£ (NLM^Sf£T(£Ji^#^-20^20.5) bmmtzisuzmtf(bum bf 39 mm wa 900 '£** QU 146 m*Y t-yyxit, iH^iJlZ KlX^y YJVfrffi (Spectrum Analysis, Mass) QC 454.M3 Kl:^#f (Spectrometry, Mass) (£ X ^ 9 Y JVfrffi $ £ £ ^7*7^x77-^4 xXB (Dideoxykanamycin B) i£x" ^7xX$££ yTuy 4 'J y (Siderophilin) l£ h y xX7x U X$££ #& (Dictionaries) (NLM^^STI£^^#^-13) ^<7)ftkliii«J^LC#^-|Z Sf5 (Autobiography) CT X^OJF^fc LXco CT 25 tSW*^.t.#C0 WM 40 mffico WZ 100 #f4, mm, m^, ^mm, w^iztoitx^Hi^ WZ 100 ¥fZm&cofc%coA:ixU, Arcom&iz 'JLm. (Child) WS mfttcUWWJtm WC 105.5.C3#$££ mxcoumxm& ws ios.5.F2^$££ «*5£ WO 440 mmtmmwjtmmm ws 113$ ££ #f4l£4^#f4 WU 480$££ #*fc HD 6228-6250.5 mmux'jimm wy 159$££ xm&& WN 240 ^!£m(£'74£f*fit-7--tX WA 350-352$££ mm WO 925 -oo^mt WF 415$££ SUrttlffSM (Information Processing, Automatic) Ii SUJ7- 9 $451$ ££ !£af#i# (Child Abuse) WA 320 !/EsIM«J#r (Cephalopelvic Proportion) lifHSItHU; $££ IfiSl#^ft?liJ (Cephalopelvimetry) (ifr»)liia$ j££ ^jfM^WX^^a (Cephalopelvic Disproportion) li->>4fcft #*£$££ *f #^& (Mentors) S^ffc^tzioltx WY 18-18.8 «£ h t-y y Xl£, /?-y)i^SiJlz g|Jj$ (Automobiles) TL 1-390 3£M3I$££ SSJ^JIIe (Automobile Driving) ftiitffiXfl^m WA 275 StJj$Ji$si&g& (Automobile Driver Examination) WA 275 ggj^^K (Automobile Accidents) Ii^ii*4i5'$£i StJjWf\7*X (Automobile Exhaust) WA 754 SUJ*JE (Automatism) S'll'II:^ (-15) BF 1321 mmm wm 197 -ey>ft!i<7)» Y t>y y xi£±^ijiz, fyiRli'gfjjtlrlli BF 1343 'JLM^mm (Child Psychology) WS 105 'Jtm.m*5rmm (Childhood Schizophrenia) UX'Jtmttft mmzfix !£affll& (Child Guidance) WS 350-350.8 !£S7*4 7 7-fexy (Child Day Care Centers) %%tffiX WA 310-320 tt^m HV 851-861 &W)T-9%±m (Automatic Data Processing) mm (-fe) W 26.55.A9 *WfiM*m#IJ (NLM^H^I£Jl^^#^-26.5) m*.mizfemztihm&u, ±m«ijiz 'JtA^yfcmm(External Influences on Child) li!El?g ii ; 7xt*>>3 x ; mfct h t^yx$££ >JtmcO%\\m (Training of Children) U'Jtm^m ; t!£$ ££ 'Jtm-^mmm (Child Advocacy) WA 320 WMY t-yyxl£, ±M^iJlz JJEaHWP^W (Child Development Disorders, Specific) imWJtmMWPfW$££ l/SaHit (Child Development) WS 105 IfcitiiJ^ LB 3051-3060.87 mm (-fe) WS 105.5.E8 ?Ymm WS 105.5.E9 fcnfl&ifc£ BF 432.C48 mWMffi'&co WS 107.5. D3 #f*W^I£fiScft WS 103^$££ 'Jtm.m± (Child Welfare) &$tffi±tf)%m WA 310-320 4t^ HV 701-1420.5 'JLmlk^mtikfkty} (Aid to Families with Dependent Children) HV 697-700 ^m^xm^m. wa 320 gUj##f (Autoanalysis) Q 183.9 ft'ft^T^tff^, *<7)#??W¥4*#^iZ, fflxli'Bi fi^Ttffli QY 25(z ftf*h t.yyxii, i^iJlz 628 y t u 9 * ftlftlt (Child Health) li!^*^lk$££ £tf%117-tX (Child Health Services) WA 320 ffT- WA 310 ^\t\ziSith WA 350 ^tSffcfil WA 350$fc££ IfilfSfl (Child Custody) #^ht-yyxl£, ±MSiJlz !£l#^ (Child Care) WS 113 yfyn-A (Cytochromes) I£7hy3 —A$££ yY~yy (Cytosine) f£g£tzt;it!> QU 58 y Y x X 7 7 t / x K (Cytosine Arabinoside) l£ x y 7 tx$££ x h x X 7 7 X 4 7 K (Cytosine Nucleotides) QU 57 y h 9-JVT i / -<7°7 7-fe" (Cytosol Aminopeptidase) Ii 3 A x X 7 ^ 9 *77°X (Synapses) WL 102.8 yy-yx^mfe (Synaptic Receptors) ItWi&fEii^/KS £(£$££ yy-YxW.it (Synaptic Potentials) (£x77°xfgji$£ £ •/77xfEit (Synaptic Transmission) WL102.7-102.8 x77°XUI (Synaptic Membranes) WL 102.8 x77°hy-A (Synaptosomes) WL 102.8 ft ft (Gingiva) WU 240 ftfti% (Gingivitis) WU 240 mfaXmxmm (Scaling, Subgingival) (£#£!&*$£ £ ftft'^f flV$ (Gingival Crevicular Fluid) WU 240 ftft*££. (Gingival Diseases) WU 240 ftftS (Gingivosis) (£#!*]*£&$££ ltft±#5l&± (Scaling, Supragingival) (£#44|S&±$ ££ ftftiifrVift (Gingival Exudate) (i#l*lif ?!*$$££ ftft^Bfcffj (Gingivectomy) WU 240 x— hoyDo/£jA^^^ (Prospective Payment System) mr*. WX 157 KM. (Livor Mortis) UKMitZflX Btii (Cribriform Plate) l£IS#$££ ftm&mm£u%s.& (Product Surveillance, Postmarketing) WZmffaCOArilit, ArCO$L£,iz 4iHW£i,l4iW# (Evaluation Studies, Postmarketing) (i mmrnm &&&£ fix mtm (Purpura) WH 314-320 milk* (Commercial Preparations) (i#$2:47£/l*$£ £ 3"&pgp!£fUM (otolaryngologists) un&mmmmcoxco mi WZ 112.5.08^t;£t/'A^-f4FJrl* WV 22$£ £ %&mvfeWr- (Otolaryngology) WV am tfk&co WZ 112.5.08 Mkco WZ 100 k% • mam wv 22 fi'jtmtyj'jtm wv %&mvfem!g> (Otorhinolaryngologic Diseases) WV 140 %mm&nz wv 32 m« %x^-w=mizis it & wv ho mm. ft &im wv iso mm WY 158.5 X% WV 168 M^W$M.m (Otorhinolaryngologic Neoplasms) WV 190 gJ£Mk (Mercy Killing) l£*£^?E$££ MfiXt (Mercy Death) li$^?E$££ P — i^t K o 7 ^ x^ X -fe* X (p-Dihydroxybenzenes) Ii t Yv*9X$££ x t Y a 3- x 3 x 7 jv y 7 x o — jv (Dihydroxycholecalciferols) QU 173 y t K 3 Jf x t* y ^ X D (Dihydroxyvitamins D) l£ y t K 3 ^f x 3 x 7 /l/ x 7 x 3 -;i/ $ £ £ -x t K 3 =Sf -> 7 x -/1/7 7 - X (Dihydroxyphenyblanine) (£ K— •/N°$££ M--x t Y d Jf >//?tr-*3 7X-hxyyy--fe* (Dihydrofolate Reductase) (£7 h 7 t Kolifh K3 77—fe$££ yh K3^^7't K377--t* (Dihydrofolate Dehydrogenase) lir h 7 t K3^$£7t Kort-7* $££ y t K 3 ij 77 ^ K7t K377-7* (Dihydrolipoamide Dehydrogenase) l£ 'J 7°7 i Kr't h*3 77-7*$££ y\z\)9^->V (Dipyridamole) QV 150 629 yt'Jy y t 'J y (Dipyrine) l£ 7 a 9 t° 'J x $ £ £ yfxx4 (Narceine) li/X7tx$££ y't°3X (Dipyrone) QY 95 x'7i-ii'7; x (Diphenylamine) %Wt- QV 632 y7i-K7> K(Diphenyl Oxides) (£7 x-/l/i-7 /u$££ i/'7x— /U t 7" X h 4 > (Diphenylhydantoim) {£ 7 x — Mx$££ •?7i-;i/1 Y 7 i > (Diphenylhydramin) l£y 7 x X t h*7i x$££ y"7x— )Vy'9 9'y (Diphenylbutazone) (£7x — JVy'9 7*X$££ y7xXth*7iX (Diphenhydramine) QV 157 y"7iXt Y 7 ^ x 7 4" y X— h (Diphenhydramine Theoclate) l£ x / X t K 'J 7- h $£ £ x7*7 4x (Dibucaine) QV 115 x7x- (Gypsies) l£*sTO£# fc *214^ WA 300^$ ££ y 7 7 'J 7 (Diphtheria) WC 320 77f 'J TM (Corynebacterium diphtheriae) QW 118 yyr'JTlif (Corynebacterium Diphtheriae Toxin) I£x7 7'J7^^$££ yyf^)TYj\%% (Diphtheria Antitoxin) WC 320 x 7 7 'J 7 h * 7 4 K (Diphtheria Toxoid) WC 320 yyy-\)T%% (Diphtheria Toxin) WC 320 -x77'J77y7x (Diphtheria Vaccine) l£x77 U 7 h*7 4 K$££ yy'yJV9JVB (Gibraltar Fever) l£7*/i/-fe 7*S$££ y 7 JV 3 jv Y d x (Diflucortolone) y4£ffl£7 4 - (Hurler's Syndrome) ItAo £*i*ml5!$£i mm&Bfc (Pneumonia, Lipid) WC 209 mmmit&V>) (Aliphatic Compounds) (iJ^PJrlt®^ \ fcjvATJVYh Y ; -h377x ; MmmcoX^fcWL ymztzimmmitfrVuZfix mmmfefe (Embolism, Fat) QZ 170 mWmfcVTz Y (Nylons) imitm tp ii8o.pss 'Wx.nBMizmmzti&m&uxmNizmiu, jfmh miz is it i> A: tlit WO 640IZ MH&ffi. (Adipose Tissue) QS 532.5.A3 mmmimmffi (Lipectomy) WO 600 itilJfl&iJJ^ (Cnidaria) QX 195 mWi^yx Y 3 7 4 - (Lipochondrodystrophy) liAn £*i*£IS$£i Wfam (Liposarcoma) QZ 345 »l4^fcoi£aHiSiJ{z SiHSllifcife (Pneumonia, Lipid) WC 209 mt^-m (Lipolysis) QU 85 miim (Steatorrhea) (£7 'J 7 -y 9m*flX mm&-& (Celiac Disease) l£7 ij 7-y y*^$££ Ktim (Mortality) HB 1321-1528 X'Jt HB 1323. C5 ?EH £$tsi%& WA 900 WMMtl WQ 225 ; ZVJtKXim HB 1323.14# ; &mmKt:% HB 1322.5^$ fc££ yfcXYy (Diphosgene) l£7.X7x$££ y fc X fc t ij x X y y X 7 7 Y (Diphosphopyridine Nucleotide) l£NAD$££ ^4"^ ft (Capital Expenditures) mm W 74 Arco^commtxmmiz, htummn^x «4^±^ (Capitalism) (£irxif7xX7A$££ ^f^l^ii (Fund Raising) mm WX 157 ZCOfaCOlfrftY \z-y 9 Xit, ±H)3iJtZ ;jT44If* (Funding, Capital) U^M'MX^££ 630 y-VijA t 4ifj$&fA'$)4£&& (Sister Chromatid Exchange) QH 445 xviJX (Tamias) li'JXf1-$££ y i T y 7 A JV X40 (Simian Virus 40) (£7 7 YT'JV fc 'J ■%--?7A /l/X$££ p||g (Lethargy) li!M5;<7)!£P£$£i iffgtt (Civil Rights) JC 577628 £f§9^l$££ ffjg#Jin (Citizen Participation) Ii(11^:f1-Jl®]$££ %M*fSm (Office Management) W 80 ftf4 WU 77 mm?* wu 77 fc m'At & #n^ffw % & $ fc £ £, (?iJx(i4ffWIS^I£ WM 30 ->Ay 7x14 (Simulium) l£73.ft$JE,£ 5P.I (Tinnitus) WV 272 y/JfxK (Dimexide) l£x/ 7/UX^u 7* x K$ ££ y/7x> (Cimetidine) QV 157 m&mmttx qv 69 y9 A-JVT 5. 9TY^.yAf> (Dimethylaminoazobenzene) QZ 202 yy1 7/1/7 i y 7x77X (Dimethylaminophenazone) It 7 ^ 9 t 0 X $£ £ Y-y9A-JVT i y^x-fe*X (p- Dimethylaminoazobenzene) QZ 202 y / 7 / u 7 7 — h9t — yy (Dimethylguanylguanidine) l£y h 7/1/^ x$££ y/7/l/xX74x (Dimethylcysteine) Ii^-y7/ $££ y9A-)VXivt^y Y (Dimethyl Sulfoxide) QV 60 y9 Y*yx Y 'J 3--X (Dimethoxystrychnine) UYJV yyfrfix y A \) y x (Zimelidine) l£ x s >V y X $ £ £ x / /I/ -> X (Zimeldine) fiLTOlt LT QV 77.5 x/XtK'J7-r (Dimenhydrinate) QV 73 tt$ (Fingerprints) (£**£'¥'$£ £ y^yxm (Simmonds' Disease) (£T^f4ttf&1£T*£$ ££ ttff (Visual Fields) WW 145 mil (Phorias) I£f4ffi$££ tt^mm (Social Medicine) WA 31 tt£ft (Socialization) HM 131 ^X WS 462 "hiE WS 105.5.S6 tt£KB (Social Class) HT 603-1445 WX WS 462 X'JL WS 105.5.S6 tt£1$f£ (Social Disorganization) Ii77;-*li Vi^mm (Social Sciences) H tt£¥ (Sociology) HM-HX tt^mm WA 31 ; 4h^*H W 322 ^ ; mwis^ti £*H WM 30.5$ fc££ tt£SJfc (Social Environment) HM 206 mwfax WM 31 tt£Mifimm (Socioenvironmental Therapy) WM 428 -445 ttikmmifc'm (Sociometric Techniques) HM 48 tt"£Hll$#'tg*jEfl£f¥ (Social Breakdown Syndrome) WM 600 nXM WS 463 yvmitmtm WS 350.8.S6 tk£7- HM 291 tt££*'ffi*£ (Phobia, Social) liiSfltP*W$££ tt^tlfii (Social Planning) HN tt£*i-i3tt*§ (Socioeconomic Status) (i4t^Pgl$££ fl £$£'!P£ W 322 1714 WA 310 mm W 322 5£«HfiJ7r^ WI n^m (Social Conditions) HN tt^ffi-Y- (Psychology, Social) HM 257291 nXM WS 462 fl'JLW tty'Jtm WS 105 tt^-'DSO^fiJifW^^ (Psychosocial Deprivation) HM 291 nX WS 462 X'Jl WS 105.5. D3 ^mmfo^m ws 105.5.D3 m± WA 320 tt^'DSW^t^lfllaSi (Psychosocial Support Systems) it tt£&^S$££ ti^iE^ (Social Justice) m*Y t-yyxl£, ±MJ3iJlZ ti^i&m (Social Policy) (iS4tjEkH$££ tt^litttE^ (Social Psychiatry) l£±tfe«ffiW[l^$££ tt^&B^fiJj (Deviant Behavior, Social) (i}±i&&^T »«$££ ti^W^lSiJ (Hierarchy, Social) HM 132 m%Y t-yyxl£, XMftliz ttll^ffifit (Social Values) HM 73 Q'&btyffiMMWi. (Social Identification) nXffl WS 462 ?Lieiwfc^iew ws 105.5.S6 4h£7-J*l?£ (Obligation, Social) l£tt£MJtft$££ ti^S^t (Reinforcement, Social) HM 291 tt^ftM (Social Distance) HM 132 nXM WM 462 Zl'JtWtWJtm WS 105.5. S6 4L£&^fUJ (Social Behavior) HM 251 m^ QL 775 nXW WS 462 fi'jtmtwjim ws 105.5.S6 tt^&^TjUjPf W (Social Behavior Disorders) #^JW WS 463 ?Lie«fc^^^ WS 350.8.S6 7ieifgJPf« WS 350.6$ fc££ fit^lS^ (-fe) WM 600 tt^m HM 291 yy\z-cofm HE 8700.6 ti^^llli: (Social Isolation) fl'Jimtih'Jim WS 105.5. D3 -fyi!^ BF 575.L7 631 y-t-hAT tr.£-l>*f ■? HM 291 tt£W*'8'J (Social Discrimination) (iil£$£i tt£tt£S (Social Support) ttfth t-yyxl£, iHS'JtZ tt^WKfitt (Dominance, Social) !£4t^^JfS^'l4$££ tt^fft^1£ (Social Responsibility) mfam W 50 rX¥flf£ W 20.5 WfrY t-yyxi£, ±HSiJlZ tt;£ftX?£ (Social Accountability) I£#i&ftft15$££ tt^WfflSftffl (Social Interaction) UkmMt%£ flX ti^WK74 (Social Alienation) nXm WS 463 ?Lie»fc^Jie^ WS 350.8.S6 mmm wm 6oo #<&m HM 291 tt^ftf&i (Social Facilitation) BF 774 tt-£ftSi£ (Degeneration, Social) litST;^-;njj #* ; tt£W»fl. ; }±£&^TlWfW$££ tt^fafcljl: (Social Perception) HM 132 tt^faM (Social Adjustment) HM 291 nXM WS 462 JlJfcKUfc&iMU WS 105.5. A8 #£Wmm (Social Conformity) HM 291 tt£ftf£flj (Role) ffi$ WS 105.5.F2 [1^ W 62 14'l>3^ BF 692-692.5 tt^W HM 131 SetSE^ BF697^$fc££ tt^ftfi mit (Social Dominance) A^^ ***J GN 479.5 5C±*|J GN 479.6 SMfclzfcJt* QL 775 n^m HM 132 'J-7x-7° BF 637.L4 iL£ft$*;£ (Social Desirability) HM 132 Qikco-h (Power, Social) (£f*tj (Aj>mm) $££ #A!?mWkfe (Sociopathic Personality) l£S4t^^jAt§ Pf*$££ tt^Sfct (Social Welfare) HV 1-4959 mm HV 30-31 HJSiJ HV 85-525 tt^Xffcft^ffc (Sociocultural Change) UXitM&Zfl £ tt£X© (Social Change) MP HM 101 &¥ HN tt^#ft (Social Service) (i4t^*H$££ tt^fSPf (Social Security) HD 7090-7250.7 mrn&H W 225-275 Medicare WT 31 $ fc £ £ ti^H (Social Problems) HN gAlz<l) WT 30 mm?.mm®%co wm 307.S6 X'JL9> WS 107.5. P8 #«iey> ws 105.5.S6 x ■*• #X<1>&^ (Cardiomyopathy, Chagas) (£Chagas#14 WW 276 yt7yyUK (Focal Epilepsy) (iJHl^-C>^3&»>e$■ ££ tt#*S (Glossodynia) !£§*&$££ £¥ttl»BS'J'7vf- (Arthritis, Juvenile Rheumatoid) WE 346 ^%l41f ttrngniil (Arthritis, Juvenile Chronic) (i^$ 14H5fp WU 58 mmco w 58 *^Pa WX 157 mm wy 77 mmm&m w 74fc^^m^#Hizi;iti>^^^$fc£ £ Ht*L<7>HlJK (Collection of Fees) (i^ttLfc*4£ ; #f4tMR %;mmM;mK*fix Sfi (Freedom) mhmm jc 585-599 #&m HM 271 ^ht°-yyxl£, 34§£'JlZ mm^% (Hospitals, Animal) SF 604.5 mmmftim (Anatomy, Veterinary) SF 767767 632 ya.vya imm$\m ql 801-950. 93? $ fc £ £ $$tm (Veterinary Medicine) SF 600-1100 ffc^f SF 756.3-756.37 %&m SF 757.2 %mt%wmm$k$ uh 650-655$ ££ >j\mm SF 911-914.4 &ZY \z^y 9 xRmhmntmt^ h%f-£®ty>]co vcom H^$fc££ gfcgqM&t (Education, Veterinary) SF 756.3-756.37 mmmU (Veterinary Schools) (£^[MA'7$££ ^[M^M^TOffiil (Abortion, Veterinary) SF 887 ^|Sr4f4^ (Surgery. Veterinary) SF 917914.4 ^E*fflfl'7 (Veterinary Bacteriology) (£*ffll%'^^T^^ mmm qw 70$££ H]BJ*)lJftg£ (Field-Block Anesthesia) (£fioi^B£$£ £ ^B*l^^ (Veterinary Histology) (£!FJJS^$££ gfcll*^ (Schools, Veterinary) SF 756.3-756.37 mmUfyim (Veterinary Toxicology) l£#^'^$££ mmftLXVnm (Veterinary Microbiology) UWXMm* ££ mmmmm (Pathology. Veterinary) SF 769 ifcg}£$iJ (Legislation, Veterinary) K 3615-3617 ftp (Mediastinum) WF 900 m&fc (Mediastinitis) WF 900 fitPifllil (Mediastinal Emphysema) WF 900 i&PifUi (Pneumomediastinum) (£fUilPME$££ t&mmfc^m (Mediastinoscopy) WF 900 %&Mm& (Mediastinal Diseases) WF 900 W&mm (Mediastinal Neoplasms) WF 900 itmWYJLm. (Child, Preschool) mm ws 440 -e-wftijioh t-yyxi£, wsfc l< umcoftm^fY-x, ± issijiz Mm^mm (Combined Modality Therapy) -fe WB 300 Wntzfoco QZ 266 mmmm (Mediastinal Cyst) WF 900 M-,7^7^ X (Dixamon Bromide) (£yyx7 0x$£ £ %\m (Bromides) QV 87 ^4(7##flztilt* WM 460.5.R3 f4S#14 (Residence Characteristics) kom HB 1951-2577 ft^S HD 7285-7391 &$tffixm&)%m WA 795 &4tfi^ HD 7288.77-7288.78 *£JS (Heavy Metals) l££JS$££ i&Wmm (Military Nursing) WY 130 fJcff WY 18-18.5 &mwkmm. wy 130 £jfiL (Hyperemia) QZ 170 mW)'\i.<7jiiCoui®nmz &&*&&& (Schistosomiasis) WC 810 ttJflLii&AJS (Schistosoma) QX 355 ■Hmm&Mm&WM (Statewide Health Coordinating Councils) UimmmnmWmiZZflX E£4* (Polymers) QD 380-388 mmftuzmitz, mtumm wui9o; mm qt 37.5.P7 l5WBmm%. (History of Medicine, 15th Cent.) WZ 56 W$Sl (Oxalates) mnmb lt qv 220 x\m QU 98 %)H'1X^$££ Umm9 iJ -y9m%&mU (Systolic Click-Murmur Syndrome) liftffl4H&l&$££ i|x^14'L»l5ffi (Cardiomyopathy, Restrictive) WG 280 JlXIStt'll'M^ (Pericarditis, Constrictive) WG 275 £*E$5*ft73*^ (Myasthenia Gravis) WE 555 s£$$ (Employment) 633 •>jL7xa (4.pTt» (Addresses) l£NLM'7IR^<7)ff^#^ 9 $££ MA (Prisoners) Att^S* QV 20.5 wzmmzisuz>A:fLU, xmmiz ffiftCO&mm BF 727.P7 cofrk HV 9261-9430.7 WKY tv 9 xii±Msijiz, mumkco^mmmu WM 420 P9 A±££ (Population Size) l£AP^S$££ mmmm (Group Therapy) l£Jferg*jf*i£f|?}£$££ %*Y (Concentration) (£j±S$££ %*¥\&m (Intensive Care) WX 218 K'Jtmb&j'Jtm WS 366 mm wy 154 7ie£JiI (Chorioepithelioma) liM^*S$££ $i4^I43*7 K hofy (Gonadotropins, Chorionic) WK 920 Wm.mm (Trophoblastic Tumor) it^mmmm WP 465 $££ ^€1414^*0^7/1/^ X (Gonadotropins, Chorionic) WK 920 !#4i14Wl^vy^FDhy (Somatomammotropin, Chorionic) teUfc&y 9 Y -Y'yfrflX W3SM (Chorionic Villi Sampling) WQ 209 m^mm (Chorioadenoma) l£fiS^I'|4ll^^at3$££ W.XM (Chorion) WQ 210 ®J^ QL 977 y&X.m QS 645 W$Mffi& (Chorionic Villi) WQ 210 W)ty) QL 977 ¥LX.m QS 645 mXm^XXk (Biopsy, Chorionic Villi) li**^fiJ$ ££ Hi^-MWc (Residential Facilities) X'Jtm WS 27-28 mnm^m wm 29 %mt^%m wb 29 SiL#!f HV 875^$fc££ tiU'&mm (Residential Treatment) mmm $££ mm.¥ (Weight Lifting) QT 260.5.W4 634 yzxyYy fftfcP'E (Weight Perception) WE 104 tft^'i'SaEift* (Osmolality) liftiSlft** H.J: 17J (Gravitation) QC 178 V&m¥ WD 720 xmmm qt 162.G7 x&mm wd 752 SS&Bii (Free Assiociation) WM 460.5. F8 W.tiA,M (Astringents) QV 65 lBMUS*^ (History of Medicine, 16th Cent.) WZ 56 7Mg5 (Wrist Joint) WE 830 j$H (Teaching) (NLM#Sl^T(£JE^#^-18) [SUfcLT W 88 mm wy 105 tkco HU 1618-2349 % < ttJgfb («e) (Atherosclerosis) WG 550 ffi'hfe&Jll (Hymenolepis) QX 400 I^SII (Miotics) QV 120 ifM (Feces, Impacted) WI 460 B$$#^SIlx (Skilled Nursing Facilities) WX 27-28 ^mmnU (Hand-Shoulder Syndrome) (iJx#l4^C^W *H4xX h37^f-$££ 7tS (Carpus) UX^ZflX ^ffiB^tJStf (Carpal Tunnel Syndrome) WL 500 71S# (Carpal Bones) WE 830 ii? (Rosacea) (£JB£14*$*S$££ )S? 14*1*1 (Acne Rosacea) WR 430 tfmmMftfam (Sheltered Workshops) mWW^cotzfrco WM 29 %Vmm%cotztt>co WB 29 87 (Seeds) mm^xumm^^m-kb lt wb 431 mum qk 661 Ymm% SB 113.2-118.46 M%co WD 500 W»& (Resins) ffc^ttffi TP 978-979.5 ftf^zfclti WU 190 S^J QV 785 ^£gtofz-f£fflt£*i£4i, XWAiz, miitX°m% ftiacofemizisuz, 6tt£#cftJ!'£ (Keratitis, Dendritic) WW 220 Stfeftffll^ (Dendritic Cells) QW 568 Xffim (Handwashing) ffifcV WX 165 xmmmx wa 240 4-ffi^ (Surgery, Operative) WO 500-517 7 r 7 X WO 517 rlf4 WQ 400 IfcE^ SF 911 W.W\]fc.coi)COUU\ift\iz XWim (Peroperative Period) lif-?>H'$££ X'^mmm (Perioperative Nursing) (£7-#r^#i£$££ Xffi^. (Operating Rooms) WX 200 &^aHffijfcM WX 140 X'ft-YX.mm (Operating Room Nursing) WY 162 mt WY 18-18.5 f-ffii^Ujf- (Operating Room Technicians) WY 162 X%y3$££ S4]l^7'J 7A7X7^£ X (Antimony Potassium Tartrate) QV 253 llnil^LT QV 73 mm (Racial Stocks) GN 537-673 mm GN 254 &fccoX?j¥fm Y t -y 9 X $ fc £ £ ±*fl$£il£44fl£4£ (Major Histocompatibility Complex) WO 680 %m (Conception) l£^ffi$££ %mmX (Fertility Factor) (iFB^$££ ftifiL (Hemorrhage) WO 700 UiaWtiliftJfiL WL 355$££ PPSiJ^ QV 195 frfc IZ is ItS WQ 330 #y>li#ftiL WV 320$££ WMco WP 320 mib14rft*S(imfb14rt*IftiflL WI 350$££ mm^umm&sk ww 270$££ < fcHITIi< fcHHTftJfn. WL 200$££ X'scoitX'eibsSs. WP 440$££ mmm sf sn ?Ym^ wp 200 635 yn-yry f4*lifi£ WP555$fc££ ftrfrt14HttF'?W (Hemorrhage, Eye) (iHSftlfn$£i 'hlfit14x 3 ••/ 9 (Shock, Hemorrhagic) HfrftflHiE WO 149 tufa WO 700 ftlll14lR*£^14^'^ (Hemorrhagic Nephroso- Nephritis) li^*£1^14ftifiL^*£JS^$££ ftjfit14^*£f^14^^7 4/i/X (Hemorrhagic Nephroso- Nephritis Virus) l£^xy-x74^X$££ ftjflLtt^H (Hemorrhagic Diathesis) WH 312-325 #^Pfl:(7)^^$fc££ ftjfo.14ii:ii!al§'£ (Proctocolitis, Hemorrhagic) l£rt*S 14Afli^$££ WikfeYfc^E (Postoperative Complications) WO 184- 185 mzcofrimu, SGfiWz W\kmm (Post-Surgical Nursing) UMW&mm* fl X Wik^m (Postoperative Care) WO 183 %kmm wo 950 x'jtmm wo 925 mmm wy i6i$fc££ Wfikm (Postoperative Period) WO 183 WikM^W^k (Postoperative Wound Infection) UXWi iULffl$££ Wi%M (Pain, Postoperative) WO 184 W&l&^aBiPiX: (Aphakia, Postcataract) WW 260 ftM (Birth) f£^r£;£^?g£$££ ft«f*Bg (Parental Leave) mil HD 6065-6065.5 &mmm (Childbirth Injuries) Uftmm^ \ ftWi&W *£$££ ftilKH£f*fi!£ (Infant, Low Birth Weight) WS 420 iY,m^i&i¥M.'^mB (Infant, Premature, Diseases) WS 410 ftrlfI7 7 (Prenatal Care) WQ 175 ibmmmWi (Prenatal Diagnosis) WQ 209 wizmmmfcizft ixcom& qz 50 &mX%p35XYlX (Maternal Age 35 and over) JE& fflll WQ 200 &m&iiffc WQ 240-260 ftfllfll (Induction of Labor) l£i^5BHfc$££ ft£B#f£S (Birth Weight) mX'Jt WS 420 *Eie WS 410 m ws i6 ft£UlftfJ (Birth Order) X'JtizisU&^mmtft^m WS 105.5.F2 ft^tPJl* (Birth Certificates) HA 38-39 &Xmmm (Diagnosis, Prenatal) I£ftii1fijll#$££ &X.m$£:g;&mM (Ultrasonography, Prenatal) WQ 209 &Xmt (Birth Statistics) (ift£$ ; AnDJlTOt$£ £ ft^JlIt (Birth Registration) Itft^fETO $££ ft£$ (Birth Rate) HB901-1108 mmXik^ (Surgical Scrub) (£44hM#$££ ffa'F'cMfSE (Intraoperative Complications) WO 181 WWY \zy9XU, ilO'Jlz ffity&ffi (Intraoperative Monitoring) WO 181 ftr^M (Intraoperative Care) WO 181 zxmm WO 950 Xvimm wo 925 ftj^Si^ (Peroperative Care) (iflH'M$&i fllfpt — 9 'J X7 (Monitoring, Intraoperative) (iffitji £*!$££ ftHSII (Publishing) Z 278-544 mm WZ 345 ftltSM (Book Imprints) Z 242.13 ftfiSti^gi* (Publishers'Catalogs) (iftj£g&$£i ftJStt-v-y (Printers' Marks) Z 235-236 ftJISBii (Catalogs, Publishers') Z 1217-4980 mWycV Z 998-1000.5 ifLitm^comytBm z 1036 W£X,M<7yiiC0U, ArcoXMizftfc&^m&^lz ftKfifmS (Ethics in Publishing) ii4ViEfi-^$£i y^ — T-ay (Deuterons) (£!iyfc^$££ *SIft-'f£#'l4;f& (Passive-Dependent Personality) (ifSft 14A^Pf*$££ ^Uj-JfcH'ffiAf&PfW (Passive-Aggressive Personality Disorder) WM 190 Sl^ftf^M (Passive Antibody Transfer) li^Uj& *£$££ %W)%M (Immunity, Passive) QW 553 SUj!5fe*5 (Immunization, Passive) QW 945 m*mmiztt-f&A:tiu, Azcomm %W)?i&mm (Immunotherapy, Passive) It #4-#,*£«&£ $££ Wfc¥kQ (Species Specificity) mmm qw 700 m*Y\i"y9XU, A:CO%m*m?Thh^U, f£W$ ^ittzxw-mz y^-Y^XX (Pseudomonas) QW 131 xj-— K:t7Xr^'ife-SE (Pseudomonas Infections) WC 330 mimW)^} (Animals, Suckling) %m.W\^JibLX QY 60.M2 mm sf 600-1100 m& sf ¥fX§m QL 700-739.8 XHmmn (Charge Nurses) !iM#H$££ ®* (Hobbies) QT 250 it* (Trees) »#?3I$££ mm (Neoplasms) QZ 200-380 mvvmm qz 267 mmrnm qv 269$fc££ nxm (-fe) qz 275 fl'Jtmbty'Jtm (-fe) QZ 275 mm wy 156 mm mm qz 266 m*Y \z-y9xu, xmmiz mmrnm QZ269 mmm sf 910.T8 RgJfH4cofc<7){£SlH£Si]lz 8t*SCFU^Jfii (Colony-Forming Units Assay, Tumor) ummm^mmT -y -fe 4 $ £ £ MDNA (DNA, Neoplasm) QZ 200 S*gRNA (RNA, Neoplasm) mmvtiztsuz, qz 206 mm&U (Neoplasm Transplantation) QZ 206 636 y a o -h A l«jtfE4- (Oncogens) li&flMMC* Ji VX (Tumor Viruses) Um.m%.X7 A >VX $£ £ Wfe7 A /1/X!S&*jE (Tumor Virus Infections) QZ 200 K*««5EH4-7/U7T (TNF-alpha) (iTNF$£i lg$m (Medical Oncology) QZ 200 Hm&Bm (Tumor Stem Cells) QZ 202 TiM&WMS.fttfxm (Neoplasm Stem Cell Assay) liif.*S g&«7y-fe4$££ K*gH5j3i1li©!/Ll§ (Tumor-Associated Carbohydrate Antigens) (i*tK«*«ll3&t/l)li$££ K#£#ffll&7 .y 7 4 (Tumor Stem Cell Assay) timmm<7j^iz&m$tiz>m& qv 269 8*l7 3-x)g14ifflBS^t*fii (Clonogenic Cell Assay, Tumor) lilt*£ffrfflJ&7 •/ -fe 4 $ £ £ 8*«J£14iftS$ (Tumorigenicity Tests) I£?§*&t4irt!i*$£ £ S*»#lH (Antigens, Neoplasm) QW 573 mmmmm qz 202 g*gffl£ QZ 206 mmViW- (Antibodies, Neoplasm) QW 575 mmmmm qz 202 ||3D-—J^fiSc^fit&^E (Colony-Forming Units, Neoplastic) l£S*«^*H)i&$££ S#ttM&£ (Cell Line, Tumor) (i^*IS*»Jfflll&$£i K*Siffl)!&Jf2Kfe& (Neoplastic Transformation, Cell) (i Ii14ttlfe^®fe&$££ S*SS^^*W(Remission, Spontaneous Neoplasm) l£8I **S**£ft$££ Hf *S g ftu&ff (Neoplasm Regression, Spontaneous) QZ 202 mmmnm (Neoplasm Staging) QZ 241 ll*SiiAl4 (Neoplasm Invasiveness) QZ 202 mm&i&iiX%i%m%ii (Gene Expression Regulation, Neoplastic) QZ 202 mm&ftfflm (Stem Cells, Neoplastic) Umm&mm£ ££ mm&M&& (Embolism, Tumor) itiksk^mmm $ £ £ fi*St4££4I-n4}r*jE (Pregnancy Complications, Neoplastic) WQ 240 Xmmm&jkfcXm&ft (Major Histocompatibility Complex) WO 680 m.mftmmfy)-?-7- (Tumor Metabolite Markers) Ii xy}mftmm-?-7-£fix mmSBM (Neoplasm Proteins) QZ 200 B*»*e$ (Neoplasm Metastasis) QZ 202 K*f 9^14#JX y ij -- X 77 X h (Drug Screening Tests, Tumor-Specific) (£t5tlfi*3l,%73^S$££ mmVtX.7A)VX (Oncogenic Viruses) QW 166 mmmm (Tumor Staging) (il!*«[TJg$£i mmnnrn (Oncolysis) litt*S$££ mm-?-7- (Markers, Tumor) UX^m^mm^-7 -$££ mmfflMi§LfcX (Genes, Suppressor, Tumor) Xti (Manual Communication) HV 2477-2480 xmnm hv 2474-2476 $fc££ Xmmm (Sign Language) HV 2474-2476 #® (Pornography) (£*f-fe*$££ Mil (Acclimatization) QT 145 %&f\m QT 160 &#mil£ QT 150 ®m%.m QT 150^ ; &ftf\m QT 150^$ fc££ SWit (Habituation (Psychophy- siology)) WL 103 JMfKfigM (Visiting Nurses) l£Jfe^1*«#a$££ flSJR (Circulation) lii^M ; BJtmmm \ mMWSk I Mmm ; Jfffinsn ; »'Mfsi; humus * a j- mWAWWg (Cyclothymic Disorder) WM 171 'tm'AW&tfinm (Cyclothymic Psychoses) itMk 1 ^m $££ IWSiSWW (Circulatory Disorders) it!Sa.mmM ; ASM ffiS ; fffWMSWTWWW WI 720$££ IffiMfifctftfi (Circulatory Function Tests) l£jfiL$tffS $££ mmm^mX (Thymic Factor, Circulating) WK 400 ISS* (Circulatory System) It-bmjbUgJh $ £ £ ISHlfif^* (Blood Volume) WG 106 $fftra» QY 408 ISSlfiL^tti^^ttx 37? (Hypovolemic Shock) (£x 3 •y9£flX mmmU (Nursing, Practical) WY 195 ffcW WY 18.8 mmmumm (Nursing, Practical) WY 195 UcW WY18.8 ISffll^ra (Blood Circulation Time) WG 103 iSSi14f& (Cyclothymic Personality) teMStflKPf *$ ££ mmfflBBffi (Anesthesia, Closed-Circuit) WO 277 #? Pi &m '£. (Keratoconjunctivitis, Vernal) (£ 7 x JV % -f4*£)il&$££ #?44*£IJI& (Conjunctivitis, Vernal) Ii7 X/l/3*-14*S B3I&$££ HIS (Adaptation, Biological) QH 546 ^E (Decompression) m^xsmm wd 710 j§4jg^: WD 650 A-comm* i-1 -y y x i£, * coxmm iz ^c[S (Physicians, Women) W 21 ii.il %& WZ 150 Mkco WZ 100 tS-^tztolt&^IS^KSt WZ 80.5.W5 mmnxcom* Y t v 9 X $ fc £ £ til (Optic Lobe) WL 310 #l±^« (Vasopressor Agents) (£JlilW^^*$££ ±& (Ependyma) WL 307 ±P@Jg (Nasopharynx) WV 410 RfP&lZtJltS WF 490 'M## (Nymphae) I£t4P#SI5$££ ^SS'ffifp^^ (Otitis Media, Serous) l£'41^:^$££ #¥ (Sublimation) WM 193.5.S8 #^W WS 463 fVJtmbWJtm WS 350.8.D3 mit (Digestion) WI 102 iZiSith^mtt WJ 704 mt (Purification) UkXWH \ i»Hc$££ 4:-M|kW*# (Dental Education, Continuing) itmmm mm&ntfix ^m^mmm (Dentistry for Disabled) UW-Wmmmm «?$££ 637 y 3 y * a Wti?i&mtils.m. (Sheltered Workshops) WWWXtiGOtztbco WM 29 iMW.'f-tfWfc*)*) WB 29 WyiTiCO-H^ (Offspring of Impaired Parents) l£Pf'#^ ?m*$££ PSlF^ffl3 $ i —7 —x 3 Xtilj]41: (Communication Aids for Disabled) n i i^y-xa ym^ntzthiz WL 340.2 1#'£y4 7°OffillJ]Jl:$fc££ m^mmmmm (Dental Care for Disabled) WU 470 Pffri$$.tzf|oi*- (Child of Impaired Parents) WS 105.5.F2 ft?* h t -y y X (£, itlSiJlZ 'h:$*M» (Minor Injuries) I£|ij^fctl1i$££ H3^fct@f£ (Referral and Consultation) %mmmmtt$££ mfb'l4ft*l (Peptic Ulcer) WI 350-370 i&4b14fft*SftlfiL (Peptic Ulcer Hamorrhage) WI 350 iifb14rt*^?L (Peptic Ulcer Perforation) WI 350 t73H* (Pineal Body) WK 350 fc-XttH (Pinealoma) WK 350 iBflxFA (Dyspepsia) WI 145 \tiitm (Digestants) (£1 Ji§^$££ XZWM-HmA (Sealants, Tooth) (ix-7>h$££ fttSiXH'^f^P^ (Health Insurance Reimbursement) ii &^fcfc'L^^«f^$££ WA (Nitrous Oxide) (£#.a£lb^$££ WA (Stream) TJ 268-280.7 7 4 y 7 X K5$i7§ WB 525 ; Ml WX 165^ $ H £ ftfXR yx\iy — 9 (Respirators, Air-Purifying) li»f n/4 1*^ffl^$££ lfc%& (Denture Bases) WU 500 ±7AiI®i£ (Upper Respiratory Infections) WS&Jg &*£$££ WAB (Paludism) l£^7'J7$££ \#m ('1>II¥) (Extinction (Psychology)) BF 319.5.E9 i^jll (Commerce) HF mil HF 1003-1008 MM 7 9 3 7 (Catalogs, Commercial) HF 5861-5862 y&X.m QS 626 mmm& w 26 $¥mWn (NLM^ITI£ff^#^-18.2) y£Xm QS 618.2 *I« QS 518.2 #H7yn7 W 26 mH9 AYco7 9 u ?%$:i>3ix j^Uffl^ift (Commercial Oils) (i^Hffl^$££ MUmm (Situational Therapy) (£^»&$££ •■\kUimm (Situational Ethics) (£fi£ai$££ MAi® (Vapor Baths) (iAi&$££ Xti&'YtiWc (Euthanasia, Passive) W 50 Xmm (Surgery, Minor) WO 192 mmXWKm (Anoci-Association) (£i*B^JtM$££ ^f47'lt('L.>il^) (Conditioning (Psychology) BF 319 ^ifcy'Umm (Conditioning Therapy) l£ft!JJ#S$££ £f4)x#t (Reflex, Conditioned) l££M^14-7lt$££ *EJi^^ (Semiology) l^lff^T^f^ WB 143 $££ mfcffi (Syndrome) QZ 140 ftzm&u, AzCom&X m&mnttmm (Matched Case-Control Studies) liffiffl ttmmtfix Xn±W)M (Aorta, Ascending) (£*fM$££ L t i M (Scarlet Fever) WC 214 £t# (Calcaneus) WE 880 !EtM%K (Evidential Material) l£j£[S^$££ 5&M (Tablets) QV 787 ftjzm&iztttzimnm&u, A:com&iz XMX (Brochures) l£^°X7 X -y Y $££ mm (Nitric Acid) l£«J&$££ mmm. (Nitrates) QV 156 Ki^^jfc lt ({ntummm^mmmizfemztih^ &) QV 612 mmm (Silver Nitrate) ^mrn qd i8i.A3 mmm qv 297 ±K (Upper Extremities) l£KK ; ft^iinZfoZflX ^5^'l44tP.| (Paramagnetic Resonance) (£m4"Xtx4t ».!$££ mXfc (Vitreous Body) WW 250 ■&m WW 250 mXiP$;yt±f%.9Ttft (Vitreous Fluorophotometry) Ii* KJtFtfrffittflX ffiXfcW&M (Vitrectomy) WW 250 638 X37- + j-fg-jjC-^i-s^x— (Shoulder-Girdle Neuropathy) Ii §05W*£*iS$£i Mil (Coleoptera) QX 555 B^()ft4f$|7f-) (Exposure (Radiology)) l£MK§sS: : " mm& - x %& $ £ £, m x i£mmrnm titm (Cautery) WO 198 7£R£ (Hypertropia) (££141$ ££ SSWftS (Food, Irradiated) li&HuM4t$££ # gift ft Hi (Absenteeism) $*g HD 5115-5115.2 3fcR WA 350 7+r4£Ii?lsf (Duodenal Papilla, Minor) (iP^$£ £ 77fiff (Surgey, Minor) WO 192 y s 7 y 3 7# (Pongidae) QL 737. P96 £S*iM*fcLT QY 60.P7 mm SF997.5.P7 xa7x3 7'-*x (Drosophila) QX 505 'p^M%M (Minority Groups) ^|f^l$££ ^ffiftfbSE(Keratosis, Palmoplantar) l£7$£L!KftJ£*iE $££ $!Kftf£*iE (Palmoplantar Keratoderma) UX^&l&Pl &&$££ ZXmWtfiXi (Diagnostic Tests, Routine) WB 200 ft£glft(;fiiffl§fi&^£-(£, -e<7)iMSiJlz ZMkn$& (Admission Tests, Routine) (i^f^tt S$££ ?M*S*£ (Palmoplantaris Pustulosis) l£M$££ fifefefo-a$ (Autosome Abnormalities) liifefef^Tl'*^ .£$££ gfltii (Portraits) N 7575-7624.5 mfflRvmmm&ftnA:tiu,wzcom.wti:i£ ie#^-iz Xk&m. (Vena Cava, Superior) WG 625.V3 ±7:^KJfiLr^*iE (Superior Vena Cava Thrombosis) li± k&m&mutfix XktfrW3JE$i%$ (Superior Vena Cava Syndrome) WG 625.V3 Xk&mfflM& (Superior Vena Cava Obstruction) (i± ±f§**£fl*^$£i £& (Tapeworms) l£^A^$££ WX (Injections, Intravenous) WB 354 £&$&*£ (Cestode Infections) WC 830-840 mmm sf sio.cs £&•£ (Taeniasis) WC 838 mmm sf 8io.cs £&H (Taenia) QX 400 £&!$&*£ (Taenia Infections) (£^-tl*£$££ B'X^lMiim (Substance Abuse, Intravenous) WM 270 m*ht^yxi£, ±M^iJlZ WXmtyJftLm (Intravenous Drug Abuse) l£»i±^/KSLffl $££ %&M (Cestoda) QX 400 If It (Emotions) (£lf|jj$££ 7S§ (Intestine, Small) WI 500-512 %X^com% (Interagency Relations) teSStifPl^lig^ $££ WmW%. (tmm) (Symbolism (Psychology)) BF 458 fdtif'^tJi'^ WM 460.5.D8 L&L WZ 334^$fc££ WJWr# (Emotional Disturbances) (£lfrfjj*£tt$££ ti'lMi^illiS (Emotional Maladjustment) l£'|f|JJ*£tt$£ £ m&XLfrL (Epilepsy, Focal) lig|$-5t^7^$££ ttfiH" (Emotions) BF 531-593 vmuwgmmik ws 3so.6^$££ nxm ws 462 aienufc^iew ws 105.5. es xmm wl 103 iffUJiifJ] (Saccades) WW 400 tfimmmm (Flooding) ummmmmzfix 'hsf*E (Microcephaly) QS 675 If IJjPfW (Affective Disorders) WM 171 MXm WS 463 ?L!AiWfc^Jjie»i WS 350.6 trfif'IJ*iivlJc (Affective Symptoms) fiXm WS 463 ^VMMbWMM WS 350.6 mi&.<7) WM 171 mwm\±JI(ftX h XX $ ££ ffflJj6^f111 (Impulsive Behavior) BF 575.146 ISlljIftAtS- (Impulse-Ridden Personality) (£Af&H?S$ ££ 74t$I (Oligosaccharides) QU 83 VMM (Disinfection) m^X WX 165 xrnmm WA 240 y\mm wo 113 m%m (Oxidizing Antiseptics) l^pTflftt/l^ife^ : ii^ 1L*^ ; &-vx7*xg£7 U 7A$££ mmm (Disinfectants) QV 220-239 'hie^ (Infanto Sexuality) Ii14$;f?ijig$£i 7!£ (Child) WS «9£3l$fc££ 'hie**:* (Child Nutrition) %m WS 130 ■-EMS* WS 115 'hie****Pf H' (Child Nutrition Disorders) WS 115 X'jmm (Pediatrics) WS yfrfft WO 440 mmmux'jimn wu 48o$££ A& • ttF/rii WS 22 #H(i'h^#^ WY 159 $££ mm ww 6oo nmnmmm wv mmrnm wn 240 >hmm wo 925 X'JimkZ -ftP/rii (Pediatricians, Directories) (£'hie mm*14&Ifo. **$££ 'h'/ii&t* (Tuberculosis in Childhood) WF 415 'WttB'fS (Child Language) WS 105.5.C8 'hiefrlWfW (Child Behavior Disorders) WS 350.6 X'RMm (Pediatric Dentistry) WU 480 #5* h t-y y X ;f?iJ^I£P)Sm^^T^ieaWU 113.6 $fc££ 'hie£f£*£ (Aphasia, Childhood) WL 340.5 tift (Molestation, Sexual, Child) (£14lft £mlfl#$££ X'Jlifcim (Weight Tables for Children) Utt-McoXco M WS 16$££ 'hie^tftfiJlilf (Child Advocacy) WA 320 WW Y t •y 9 uxmmz XW\1%S\ (Child Behavior) WS 105 'hie^Hii (Child Development) WS 105 £1^31$ fc££ X'fiUhm (Roseola Infantum) (£«$££ 'hieJxSPfW (Child Reactive Diaorders) WS 350.6 X'Jtmm (Child Neglect) l£iea)tt#$££ 'hief*flt*¥* (Puericulture) l£ie**^$££ X'Jtim (Custody, Child) I£iem1*^$££ 'hieti#y U-'y y (Child Guidance Clinics) WS 27 -28 A£ • mam. ws 22 X'Jtm (Infantile Paralysis) (£7U7$££ 'hieffl^-y K (Swing Beds) l£-<'y K3c4H$££ 'hie "J x^°'|4&Jfli*R (ALL, Childhood) (£Llt44 'J >'* 14£ufiL*?i$££ 'J>X4Y'1J (Juvenile Delinquency) mm$m (mmw). T/V7&im kf 184 m.&r/mm ws 463^ tt£ HV 9051-9230.7 tfflii (Camphor) QV 65 'hHia (Cerebellum) WL 320 'hflit£ (Cerebellar Nuclei) WL 320 XKuffim (Cerebellopontine Angle) WL 320 XMm.% (Cerebellar Diseases) WL 320 XHmmm (Cerebellar Neoplasms) WL 320 'WaMUj^P (Cerebellar Ataxia) WL 320 'hH14JJ£iM*g (Berry Aneurysm) l£flwiJjH*g$££ XHm&M (Cerebellar Cortex) WL 320 XU (Platelets) l£jfiL'htS$££ X& (Epithelium) &mm wr 101 m.$&m QS 532.5.E7 mm qz 365 iMIH^SW) (Consumer Participation) mWtj£ftiS{z£>lt.i) WM 30 ¥fft\C0W&XUW& (XtlcotuO mwrnmnmcotzfr wa 546 m^S^cofzabizU, 44HJ3IJIZ '$J%H£coM%.$kH£ (Consumer Satisfaction) mil HF 5415.3-5415.5 mmzMfcZ WX 158.5 f*3t7-tx, mmiznxzm w 85 mwmuiznxh wm 29.5 ^Wffecr>Ht-t*XXI£S^BaBlzMLTI£, XmMiz m»»«g& (Consumer Price Index) (i£J$^$££ m%%i%m (Consumer Advocacy) WA 288 TOffeM WA 670-847 -fe HC 79.C63 mmnmtxmmz m^^i^m (Consumer Protection) (i*fiJcKjh ; Mf * Hf*$££ iftt^M (Consumer Involvement) l£i81*3IUJ$££ X&m (Epithelioma) li*gS$£i XfcXVt (Parathyroid Glands) WK 300 ±&Xi^m^1lMm (Hyperparathyroidism) WK 300 iiJ£'hf£t£^1£T*E (Hypoparathyroidism) WK 300 X&Xfcm.% (Parathyroid Diseases) WK 300 X&XW-mm (Parathyroid Neoplasms) WK 300 XfeXfcfcJV*: x (Parathyroid Hormones) WK 300 mmt'&mmW (Consumption Coagulopathy) liDIC$ ££ ±J£14¥?#$$)8 (Leiomyoma, Epithelioid) QZ 340 Rg/lrt4wfc<7)l£S|3liJ3iJlz, fyijllilli WI 320 ±JJcftifS(5 (Epithelial Attachment) WU 240 X&fflm&M (Epithelium, Retinal Pigment) lilS^fe ILh&$££ %m%$wi& (Transport of Wounded and Sick) (i.$.£ m&zfix XfcmXffifom (Leiomyoblastoma) li±JJc144zit®®$ ££ fn¥amm (Information Science) If $gSf# Q 350-390 WmY\z-y9XU, XMftllz Iffg^ (Information Retrieval) l£lt^^)^^fctt^$ ££ Iftjtiyxf A (Information Retrieval Systems) lif IBxXrA$££ If^-if-tX (Information Services) Z 674.2-674.5 ^^^•fflz^lt-S-t-tXlt, xmrniz If^xXrA (Information Systems) Z 699 Xmm Z 699.5.A-Z mm (-fe) W 26.55.14 640 y 3 9 A x Wfamx.K'® (NLM^Si*T-li^A»^26.5) Bgjjf-?J»iJI W 26.55.A9^ ; 3Xt^-y- W 26.55.C7£ : MEDLARS W 26.55.14 $fc££ 7HS/k*t14£l#^& (Skin Diseases, Vesiculobullous) WR 200 'MSI* (Endoplasmic Reticulum) QH 603.E6 tflfittfft (Information Dissemination) li^Hx7—t*X$ ££ tffgg^ (Information Display) lif-^f-l X7°X 4 $ %%#£#& (NLM#«£"Cli^5£#726.5) tilg^fi (Semiochemicals) 7x3-tx$££ fffgSffc (Information Theory) Q 350-390 /h?§ft-T/l#^ (Petit Mai Epilepsy) l£ftWT/t*^$ ££ fgljg (Tunica Vaginalis) li*S&$££ &B (Veins) WG 600-625 gjfilff WG 300 ~fc«l:Sf8:*IJ*MKrtaL#r WB 354$££ HM WI 720 HMt (Venous Pressure) WG 106 HUH old (Venous Insufficiency) WG 600 IMK& (Phlebitis) WG 610 ffSl!Mfc& WJ 351 f^m^gf-fili, SPfiXijU §*£fM*« (Postphlebitic Ulcer) (ii*&?feffifr£g¥$ ££ IMfcifc&-l£& (Postphlebitic Disease) (£«Mfcifc?£*S1£S¥ $££ IMfciSflUElit* (Postphlebitic Syndrome) WG 610 BMikm (Venous Ulcer) lifMlfc*§t4rft*$££ BHfcjfiLl&£ (Phlebothrombosis) l±M.te»Wk'$.£M.£ mmm (Phlebography) WG 600 ftHJUHifc (Periphlebitis) UBmfcZflX BWiBWiCO!k^i$M (Venovenous Hemofiltration) (iJfiL ««§&$££ BWiWffl (Phlebotomy) l£L^JfiL$££ BWi^M (Venipuncture) (£StJflL$££ mmmm (Phlebography) WG 600 m^iiico iicoufttfixum&ftliz &Wimt (Venoclysis, Medication) immWXHt£ fl X §Mfa'|B|jfilt£*£ (Sinus Thrombosis) WL 355 &mmXMB (Sinus Arrhythmia) l£}|s]14^^M$££ »*rt***l*& (Intravenous Feeding) l£#M£l I4"#$£ £ l&IKl*M8K¥UB (Lipid Emulsions, Intravenous) (£#M ^IK?L«$££ &J&Ptt%Wfti& (Fat Emulsions, Intravenous) QU 86 JHtfMiSfcfcKfcltS WB 410 IIMl*liiJtf- (Injections, Intravenous) WB 354 ftMF*Ji£A (Infusions, Intravenous) WB 354 #Ml*JJi*fi£ (Anesthesia, Intravenous) WO 285 Bm^mmim (Drug Abuse, Intravenous) UWX.tyJi'g. SLffl$££ HMl*)DOS (Intravenous Drug Delivery Systems) I£i± A7'X7°$££ IBHK^-k (Venous Insufficiency) WG 600 foMMfa (Vein Anesthesia) (£la7PJfJ#B£$££ mkffi (Varicose Veins) WG 620 ttmm WQ 244 flMMB14t'a#$ (Varicose Ulcer) WG 620 mm (Lighting) m%ffiX. WA 470 m%£ QT 230 f£f? WA 350 tJUj <7)*tft WW 113 J!PJUl]7*Xtp& (Illuminating Gas Poisoning) li—8Mb KS'I'#$££ IBftffi (Marasmus) WD 105 ^■®m (Dermatoglyphics) wwmm& WR 101 im^kmtm hv 6074-6078 xmm^kmm gn 191-192 ^^» 7?&±iIt3PLTIiZ^#i££ YHM^rkb^W^^k (Abstracting and Indexing) Z 695.9-695.92 7BS (Upper Extremity) tiH£$£i ±lKx/U3*y h 'J 7X h (Arm Ergometry Test) ItJliJj m^$££ Xm& (Humerus) WE 810 ±K##tff (Humeral Fractures) WE 810 Xt%W&i% (Brachial Neuralgia) l£^l!fct*&*S$££ ±»5iJM (Brachial Artery) WG 595.B7 XmmmmX£&\$i%t (Brachial-Basilar Insuffi- ciency Syndrome) l£M#T!M&JfiL*Ef£i¥$££ &Mi'E(Aj>mm) (Desensitization (Psychology)) l£-C>S^ mtL!$i¥ WM 425.5.D4 MtUJ*J?& WM425$££ tiim'itUX-lfc^- (Early Gene Transcription) lijftfSltfg $s¥$££ tJimftgim (Incipient Schizophrenia) l£^fSi*??S! At&Pf W$££ x" a *' X 7 (Jogging) QT 260.5. J6 WMmm (Relaxation Therapy) l£^3fi«lj£$££ HMiiriaL* (Position Description) (£^^l£itt:$££ $|^7 ij xyf-y 3 XftlD (Orientation Programs, Employee) l£iH^^W$££ ffifkM¥H (Personnel Discipline) (i^MMll^$££ MmMMb&lWiXx. (Personnel Staffing and Scheduling) 641 y 3 9 x x mm WX 159 fi& WY 30 ffiMW* WM 30 ft til (Sodium Chloride) R* QU 130 7k • nmwxm qu 105 7k • *#K¥lKJItt WD 220 mmm qv 273 i§JR QV 786 i±A WB 354 Hi&MWMffi. (Hypertonic Solution, Saline) I£i!j!#lft^i i£$$££ H&M (Occupations) mmbkummmm hb 2581-2787 mzumu9Aymiz, mtitmmu wo 2iiz «!&&# HF 5381-5382.67^ $ fc £ £ W3S&UJ14 (Career Mobility) tt^ttSI HN «H*h# HF 5381-5382.5 sm^muxmMiz, mtumrn wy 16 M%'$lX (Occupational Health) WA 400-495 #f*h t-y yxl£, ±M^iJ(Z Hlifi4t-h*X (Occupational Health Services) WA 412 m*ffiX WA 495 m WffiXT- -1* X WM 30^ $ fc £ £ ¥SHS# (Job Application) *F5l% WX 159 mm WY 29 fSHfc LT<7)[S¥ W 21 ftSfc^Pli, ±MJ?iJ(z MFgl (Career Ladders) (£^H^iW4$££ Ifg3g7 7 X7 'J X y (Career Counseling) l£^Hta#$£ £ ^HI^W (Vocational Education) LC 1041-1048 H&ie LC 3976 ^Htf# (Vocational Guidance) HF 53875382.5 mnm wu 21 ft**J?» WB 400 "mkcOTztbco HV 1652-1658 W%3iJlz U^rY%m (Occupational Toxicology) li#^ ; %W4- $fc££ WHWH^*&# (Vocational Rehabilitation) itHM* U ^t*iJt-->3>^lJ: ^H6^J*^77 (Burnout, Professional) WM 172 Kldll'J^t'lf-ys X (Rehabilitation, Vocational) HD 7255-7256 if mmm wb 555^$fc££ ll/'fn-b* (Occupational Neuroses) (£$tl*R : M «Ij4e$££ ©tH*?! (Occupational Diseases) WA 400-495 SUffi W 925 mmm (-m wa 495 mmimm\mmm wy hi $££ mmm ww 505 t^RfcOTJ WA 412-495 ztmrnnz. w 925^; #K&wt§if hd 7103. 6-7103.65=1$ fc££ ^HSiJ^IMJi^ (Trade Unions) l£#fj]!fi^$££ i$m%Mmm (Occupational Health Nursing) WY 141 f&W WY 18-18.5 'k'ifW) (Feeding Behavior) 1*-g GT 2850-2960 Pf» (ttigffi) WM 175 &mm (Phagocytes) QW 690 fflW$ WH 650f£ ; ^9 uyy-y WH 650^ ; * m WH200^;W4>££ WH200^$fc££ &mm&ffiiPmWiZX3: (Phagocyte Bactericidal Dysfunction) QW 690 ftfT-ffl (Phagocytosis) QW 690 ft* (Feeding) (£'hie'£# ; &&&£ ; ?L!^**$££ ft*M (Diet, Formula) l£7 y 7U 7- h ftnDn$££ ft*P£ (Diet Surveys) QU 146 ft*77'£ (Feeding Methods (Non MeSH)) l£AX** ?L ; «?Ls£* : Ht^tttt** ; ig-f •*:**§£$££ ft-gflt (Food Habits) GT 2850-2960 ft*&j£ (Feeding Patterns) f£fttT®J$££ &^mm (Diet Therapy) WB 400-449 ?lie$fc#Jie»! WS 366 -kW^mmm (Dietetics) WB 400 fi^mb^^m WS 115 mm (Palpation) WB 275 ft^tSXH (Dietary Modification) !ift?ttB$££ mm (Bedsore) (£}i?*f 14Jt*$££ #S*f 14ft*S (Decubitus Ulcer) WR 598 fttp# (Food Poisoning) WC 268 mmm sf 757.5 ^/3^S WD 520; m.vu&X'n WD 500-530 642 >ray7*y g ; 7 jv * 4 7 ft * .Hi WC 268 ; 7 fc* -5 £fc ll 14. ft $£ WC 268 i $£ * 4 77)*# * fcli+Sf^HIH $ £ X %&M (Insectivora) QL 737.15-737.158 tit (Esophagus) WI 250 ftjt7#xx7 (Esophageal Achalasia) WI 250 ftitR+:HfJ§fU*£& (Esophagogastroduodenoscopy) (i}8fb8*&l*HSJtt& £$££ ftit^SSU) (Esophageal Dysmotility) liftitjIfJjRit $££ ftjtSgjPfS (Esophageal Motility Disorders) WI 250 ftit{fc (Esophagitis) WI 250 tittfvg* (Esophagotracheal Fistula) li£ffiS£fc'jy;u-7'(±, -?-WiJrt^M>l£7/U -7J5IJIZ tti£r&14RNA (RNA, Catalytic) QU 58.7 tt^ffl (Catalysis) mm QU 135 Mmm QD 281. C3 lfb¥ QV 25 ^smim QD 505 !&mu?mmwi wb 89o$££ ^coftbw^-fflzto'itl.Sffl(i, iS^iJlz tfi£ (Skin Grafts) li&J##tit$£i tt^ffi (Grafting, Skin) l£/£jf #tit$££ ft£ (Food) £1^1 $££ ftBnp7x/l/Jf*- (Food Hypersensitivity) (£ftpn14M*£ $££ ftpcp[l^a0n'fbffipcpfi(Food, Drug and Cosmetic Act) Ii mmmuzfix ftSf^ife (Food Contamination) WA 701 ~(z&|i|7M'iij;l£fti|'# WC 268^$££ ftSJjILX (Food Processing) liftpc?,ftia$£i ftnri^IPXX: (Food-Processing Industry) fb^tiiff TP 368-684 m~$m HD 9000-9440 mmrnm wa 400-495 m%mmv>) wa 788 ItSiWfe (Food Browning) (£MaillardJx4i>$££ ftuun 7 /!/ x 7 A (Dietary Calcium) l£ftffl 7 ;u x 7 A $ £ £ ftiSEtl (Food Inspection) WA 695 ftSUJi*^ (Food-Borne Diseases) itU'^m \ ftppffi Ife; ft'h!ii$££ ftS^^di'? (Food Parasitology) WA 701 ftpMftlS (Food Supply) mmm tx 351-354.5 &*ltj£(fi#^ WA 695-722 ftSI* (Food Technology) imim TP 368-465 ZlRffiXm^m WA 695-722 ftl*] WA 707^ ; ^■iOft!l^#'£ftpnp^«^$fc££ ftp?, n XX7 3-/1/ (Dietary Cholesterol) (iftffl3XX ra-/U$££ ftSfltBfi (Dietary Fats) QU 86 mmtfrttzummttFcoffi-kb lt wb 425 mmnucofzibcomm wb 425 ><9- QU 86# ; ftffl3XX73-^ QU95^;f£ SMft WD 210-212 ; -7-7*0 x QU 86lp$ fc ££ ftppHBJt (Food Irradiation) WA 710 ftp^H (Food Handling) XX Y7 ycoffiX WA 799 ffiX WA 695-722 ftffi TP 368-684 ftp'pttSixlE (Food Hypersensitivity) WD 310 ftpp^&SC (Dietary Proteins) QU 55 mw£tzummtf?Mt (Vitamin Content of Food) lit y ~ ycoxnttflt QU 160 ; **$££ t-FaWXtynm (Food Microbiology) QW 85 ftp^MWIW (Food Adulteration) l£ftpDpf^*$££ fto^tJf (Food Analysis) ^M^?l$££ ftp^S (Food Laws) (iftpap'iS$y$££ ftpan-i£SiJ (Legislation, Food) WA 697 ftppf*# (Food Preservation) WA 710 ftpDpf£#f4 (Food Preservatives) WA 712 tS>;77^li (Mineral Content of Food) U*&Yk K$££ Wm (Plants) QK itm QK 861-899 mmm qk 725 mmm qk 671 xXi(£7iJ-vJf QX 503^$££ wxmm qw 60 %mtM%Ym WD 500-530$££ tit^-7 4/l/X (Plant Viruses) QW 163 643 ys^yy WW?- (Botany) QK m&ft SB 107-109 mmmtxmm qv 752: mmm® qv 766^$££ W.VnWM (Plant Tumors) SB 741.5 ^ZmmcoArtlitATCom^iZ, mtittco&ZMU SB 767IZ ffiftttll* (Vegetative Nervous System) Ii g WW&Jk $££ ffi*M*«*4- (Plant Agglutinins) I£xy7x$££ tE^ttlliL^iim^ (Phytohemagglutinins) QK 898.P8 Jfil3*m& wb 425 m* WB 425 ftfflfe^ (Coloring Agents, Food) (iftJJj-tf&JN^ j££ ftffltg^ (Plants, Edible) QK 98.5 Mm&xummtffcomtib lt ftffl/^/Mb^ (Dietary Carbohydrates) QU 75 mm^t tzummtffcoffi& fc lt wb 427 fcMtifawmcotziihcomm wb 427 f*JtM*ft WD 210-212 $fc££ ftffl#fe*4 (Food Coloring Agents) WA 712 ft$* (Appetite) WI 102 ftgfcSciSIH (Appetite Suppressants) liftScWSiJU^aj: ft&Pf* (Appetite Disorders) (£f5ftP£*$££ Mkmffi (Appetite Regulation) WI 102 MkXM (Anorexia) WI 143 *«g14ft$xhlg$fc££ ft8W*IHM2£ (Appetite Depressants) QV 129 MM (Mentorships) lita#^$££ WMWi (Orchiectomy) WJ 868 &)&X (Coenzymes) QU 135 £8H4 (Vomer) li#4"fil$£i Bhmm (Midwifery) WQ 160-165 mmm wy i57$fc££ mmm (Nurse Midwives) WY 157 A* • mam WY 22 mmrnm wy 157^; mmm wq i6o-i65$fc££ iHS (Bibliography) ^M^l$££ 17\ fc leiioM (Forms and Records Control) W 80 #»#»{*, 3£MJ?'JIZ £7-fe1f*S (Nymphomania) (£'l4gJcfiJ^$££ IFISt'—7^—X (Databases, Bibliographic) Z egg- egg. 5 ±M(z£X Z 6gg.5.A-Z mm (-fe) W 26.55.14 A: commute ft?? (NLM#8^5$#^26.5) &MM (Deodorants) WA 744 %±~km (Hymen) WP 250 -kX9jffll% (Women, Working) m*Y t-yyxi£, xmmz fifcttH (Denervation) WL 368 £14 (Women) mmb LXcoArtlit-km W 21 : WZ 80.5.W5$££ mmmbLxcoA-tiuif&mmm wu 2i$££ mMiZtSith HD 6050-6220.7 mm!£«H WS 360 f^ WY 156.7 &®mm WY 157^$fc££ *444 WP 660 m WP 650 tfSlgfr* WJ 190 Umm<7> SF 871 it&Xfe&mm (Genital Neoplasms, Female) WP 145 *tt!51ttft (Homosexuality, Female) HQ 75.3-75.6 «ttlI¥W#£ WM 611 &140®Jft (Women's Health) WA 309 &t4<7)ttf'J (Women's Rights) HQ 1236-1236.5 £*f fc L T HD 6054.3-6054.4 fttttlX LB 2837 tUlztrltl) HD 6050-6220.7 TA U7&&H HQ 1236.5.U6 -km W 21^$fc££ £14*&*£ (Infertility. Female) WP 570 ^cttffljitt^: (Contraceptive Devices, Female) WP 640 i^fl&JI WP 640$fc££ &14fflJ8£E^ (Contraceptive Agents, Female) QV 177 f»S£^B# (Booksellers' Catalogs) li^»IS^gli$ ££ fc^l (Herbicides) ttfo&Jg SB 951.4 ft*«r4£ft#g WA 240 ^ltBWfFfE14#* (Resource-Based Relative Value Scale) umnm\mx±m^fix *iS» (Treatment Costs) (£f*®[I*J?m$££ B£&^ (Pyrethrum) S&tett&fcLT SB 292.P8 sutmxtfj^m WA 240 WR (Menarche) WP 540 Hflfc (Touch) WR 102 x 3 -y y (Shock) QZ 140 777^y^x-'l4^(£777^y^rx- QW 900$£ £ tfUi-tMII WD 602^$££ x a 7 y life (Shock Lung) lift AW&&&&1%&% ft £ y3-y9mm (Shock Therapy) l£W*l?J£$££ &*t (Sucrose) QU 83 X3-K3-X (Diodoquin) I£x3- Y t Fn ^rx^X$£ £ PJr^i (Income) ^M^?l$££ FJr#m (Income Tax) HJ 46274824 x 3— F*7 3 y y^^ifc (Receptors, Diiodotyrosine) Ii ¥ttJ!K7/^xS *##$££ x 3 — F* t F* d ^ x ^ X (Diiodohydroxyquin) l£ 3 — F* */-/V$££ Wl (Colostrum) WP 825 nf&An (Hot Climate) xmmmm qt 150 mm®\M. (Rigidity, Decerebrate) (il»l*7J$£i ^HwttJS (Decerebrate State) WL 340 &Mfc (Abreaction) WM 420.5.A2 tf.if (Book Reviews) Z 1035.Al tiMX-ntitM- (180l¥!4nij) WZ 294 '¥fx.XMizmtZ>mifIJ3> fettlb^* QD 181.S6 fttW QU 130.5 mw>m qv 6i8 x 'J 3 — x (Silicones) '>rYritm QD 139.S5 imXM TP 248.S5 &i$.m:A WO 600-640 Azxmxfem$tihm&uA:coxmx y\) a — yx-yT. Y'y' (Silicone Elastomers) AXfflJK&tlfJi (-fe) WO 176 itmX.m TP 248.S5 Mfflt4¥4 WU 190 Mf&m:A WO 600-640 A:com$*(7>xmx'($im$tiz>m&uA:coxmx y\)a-> 7A (Rubber Silicone) (£ x U 3 - x :£ 7 X F ■^$££ xij 3-x}ft (Silicone Oils) fb^XH TP 68 &MffiXtfj%m WA 722 mm$m WZ 334 x-/l/ CD 5005-6471 yjv7 7 7*A (Diltiazem) QV 150 x/i/- F*-y- F 7 x y F*^ (Gilles de la Tourette's Disease) (iTouretteffif£?£$££ y)VV7X&m (Sylvian Vein) IiAiw#M$>ii *3F!& (Fissure in Ano) WI 605 m&\ (Dention) WU 210 m^m (Dental Arch) WU 101 mtmX (Orthodontia) li&fBigiI:.$£i W& (Visual Pathways) WW 103 mm (Seborrhea) l£fltit14Jx-Ji*&$££ ¥Lhi (Adipocere) li5EM^1b$££ laJIttJ^lt-i? (Dermatitis, Seborrheic) WR 415 x n 7 4 7 'J 7 XS£ (Dirofilariasis) WC 880 x-X (Genes) QH 447-447.8 n-^tit (Renal Transplantation) li^Ji^ti$£i A^1£iU±i£ (Hypotension, Controlled) WO 350 '1>H14HI§ (Hearing Loss, Nonorganic) (it8&14H7j #!£$££ kmffiAt (Personnel Recruitment) (iAj!$££ WWi (Kidney Pelvis) WJ 301 ■pfS^ (Pyelitis) WJ 351 ^^.BUkfr (Pyelophlebitis) !£$*&$££ tSf^ (Pyelonephritis) WJ 351 B-Mi^£ (Pyelography) (imjt&itf^i$££ '^•X3—El'ffi (Echocardiography) WG 141.5.E2 n% (Nephritis) WJ 353 mmm sf 87i 'll># (Heart Sounds) xmm WG 106 •kmimm wg 141.5.A9; fr^m^m wg hi. 5.P4 $fc££ ; 'De'llltt^ji (Phonocardiography) WG 141.5.P4 Mit (Evolution) QH 359-425 7-7 ^ ycom% QH 365 mil QH 366-366.2 x.mWft'Vj}, m&, x 'J tjv 3 x y <> 3 x, ^fgii NLM5tlI(z £-§?-&(£ ^W&ttz Hflft-^4: QH 359-425^;^^514£ QH 367.5$ fc££ ft^S^f? (Nociceptors) WL102.9 ffW-g^t^ (Nociception Tests) (£^*iili|£$££ m^^m (Refuse Disposal) mmmmm qw 75 -fe WA 780 rl^O WA 788 mmbmtt.m.Mmco:&& (-fe) wa 778 Jg^fcli^Mo^gfcy4 7°$fc££, miw&% mm*®, mmmmvv, mmmmm, mmmM^m^ x X 7 4 X (Cincain) (£ x'77 4 X $£ £ tt*^ (Theology) (££$*$££ At§ (Personality) BF 698-698.9 f£# BF 575. D34 ttW^ttJflZtolt-?) WM 460.5. P3 Stt^AfePf W WM 190 ; ^fiAfft WM 173.6 ; tX7 'J -14Afe WM 173 ; ftmmnkfe WM 203 $fc££ Af&^S (Personality Disorders) -fe WM 190 nXm WS 463 ?Liei«fc^»l WS 350.8.P3 AfSJFM (Personality Development) BF 698 646 y>YA*r %Xm WS 462 zvmbXKm WS 105.5.P3 At&t^S (Personality Tests) k®.m BF 698.5-698.8 Mwrnm WM 145 £ftttl& (Eukaryotic Cells) QH 587581.2 At&StxE (Personality Assessment) SfttlS^WliH* WM 141 ^[M-T-Wtfc ft WM 145 kmmtY) BF 698.4-698.8 At&PftF (Personality Disorders) -fe WM 190 *^m WS 463 mmt'bmm ws 350.8.P3 At&^£$ (Depersonalization Desorder) WM 171 At&^Hii (Personality Development) BF 698 nXm WS 462 fi'jimbmm ws 105.5.P3 Af&fFfffi (Personality Assessment) mwmmtt)m& wm hi fifttH^ffJtfclt WM 145 •Lmm^ff BF 698.4-6g8.8 %Xm (Nephroblastoma) WJ 358 l^T-TJVm (Heart Catheterization) WG141.5.C2 mmm?) sf sn xX7 ij F"5^4£ (Sincalide Receptors) Ii3 x->X F * -x$-#f£$£i 'bAftL (Hypochondriasis) WM 178 L>}l14tt^*£ (Neurosis, Hypochondriacal) (i'£»f\SE$ ££ ff^14t£^lTiJj (Novelty-Seeking Behavior) UUWtt U)$££ •MUfttfcS (Heart Function Tests) WG 141.5.Fg &£t£2<0£t*$fc££ nMtffci: (Kidney Function Tests) QY 175 »ttfig*£ (Renal Insufficiency) {i&tt»*£ ; ttttff *£$££ -t'ffi (Myocardium) WG 280 Ay®Mm&XXm WG16g$fc££ 'DISifc (Myocarditis) WG 280 %Mm (Mycology) ^l§^l$££ 'b^^L^WXXWi (Myocardial Revascularization) WG 169 'bt&mm (Myocardial Infarction) WG 300 'l>£5t£*5fcfi*l>*I (Angina, Preinfarction) f£4^S#£ 4>*E$££ 't^^Mm&Wl^ (Myocardial Preinfarction Syndrome) (i4^f£3i$H>SE$££ 'frflSSllJJlE (Myocardial Reperfusion) WG 280 'kffljWMi/iiHWi (Myocardial Reperfusion Injury) WG 280 $£g«E (Argentaffinoma) Ii7/1/7X4 F*®*S$£i L'lSjfjiJif^J (Myocardial Stimulants) (i^4>^$££ '£>©*£.§ (Myocardial Diseases) WG 280 mmm sf sn '&8&JK8& (Myocardial Contraction) WG 280 'IM5TOTOJH (Myocardial Depressants) UtjXXmmm ZflX MM& (Mycoses) WC 450-475 mmm sf 780.7 ft )tl I'l- Ll *E WR300-340^ ; Jliti i't #j *£ WF 652 ; ft £ <7) * 1*144.*^ ,'i\ «0 £ «; $ fc £ £ 4>$5*£ (Cardiomyopathies) l£-l>j$*£.&$££ 'D^Pf',1,' (Myocardiopathies) (£8$*£f,$££ &BH4#lJ£ (Antigens, Fungal) QW 573 AlS14IJJll*g (Mycotic Aneurysm) (£!&ife14iM*S$£ £ &iS14flifi*£& (Lung Diseases, Fungal) WF 652 !7li14/£[*!$'&*jE (Mycotic Skin Infections) (iJ&Jt&S *3E$££ !'ll*i'l4ft)#*W(Skin Diseases, Fungal)'££!#*$*£$£ £ ■l>®51 (Myocardium) WG 280 toWjfo.'8#'X-¥-1R WG169$fc££ i%\'titi£ (Mycotoxins) QW 630.5.Mg nmmX (Fungal Spores) UMmmXZfLX H#l'7y7X (Fungal Vaccines) WC 450 M^mmW (Suction Curettage) (iH^ltfJIWf$££ SJIfc 'J 4 X (Bedding and Linens) WX 165 mkcomu.mm w 26 x X 7/1/7 * F XX * -y x 3 XCT (Single-Photon Emission-Computed Tomography) (iSPECT$££ xXy/l/7 * Y yx-5. -y y 3 XRCT (Radionuclide Tomography, Single-Photon Emission-Computed) l£SPECT$££ «>*£ (Nerves) lig^WH* ; #ig* ; *tff**&* ; £$ Wig* ; #£**&?>£«-££ «fc tti&Btei&llfc (Bladder, Neurogenic) WJ 500 ttl£4 X^7l/X (Nerve Impulses) liWHS^T^SI^ WL 102$££ W&m (Neurohumors) litM£fSJlt/®$£i WiUaS^ft: (Neurohumor Receptors) iitM&fEJi^iC -g$f*$££ tt*£& (Neuritis) WL 544 Jtfetj^H14(£»PM WD 122$££ mmwm& ww 28o$££ Wj&m%m (Neuroanatomy) WL101 n&&cox?)m%\m wLioi$fc££ tti&ffc^ (Neurochemistry) WL 104 tt&ffl«OT<7)##f WL 104$ fc £ £ Wmm (Neurosciences) WL 100 Hig^ (Neurology) WL ?Liewfc^ie»i WS 340 W&Xmmm (Neuroblastoma) QZ 380 vmnvjiicoumzwiz ttgT^f* (Neurohypophysis) (£T^f£f&^$££ Wig "18114 (Plasticity, Neuronal) (itt&*ffl)M:^t4$£ £ Mtf&rSUjfflftiJ (Neural Inhibition) WL 102.7-102.8 W&mmm (Neuro-Ophthalmology) (ilg<7)T^tW&^K ww 101-103; ismuj; «a »j$ ; ®wm&; ti tt*£$£i tt&W^ (Neural Tube Defects) WL 101 ftfe^M cotfo, f?ijxli4?l&*1^4^ WE730$fc££ W&^fflmX^: (Neural Tube Defects) WL 101 #£4^^£^$fc££, f?iJxl£'Wil^^^^li WE 730 Wi£^*£f- (Neuromuscular Diseases) WE 550-55g ?Liewfc^ie» ws 340 647 •xx4-4* Hfifttfff WW 400-475 tt*$.iBjI»f* (Neuromuscular Blocking Agents) QV 140 *#*&&■$£•$ (Neuromuscular Junction) WL 102.9 W&MtLftfem (Neuromuscular Depolarizing Agents) QV 140 WfeMMVLrrfam (Neuromuscular Nondepolarizing Agents) QV 140 ttfUfciBMi (Neuromuscular Spindles) (£&$JjM$££ tt&iK£ (Neuromuscular Agents) QV 140 Wt&k (Nervous System) m%\m WL 101 a&(ia#tt&* WL600-610$££ "Mfi WS 340-342 mmm qv 76.5 iS£3£ QV 101-107 ;#t!fcj£'14II*iSH QV 95-g8 ; «*#* qv 8i^; mmrnm qv 85; nmt&m QV 120 ; Bi BS £ fc i< ffi m QV 85-88 ; fl* m QV 89;ttniffiiR»riii qv 140; wmmtiLft&m qv 140$fc££ St*S (-fe) WL 160 IiJ£J8liSU£l8*M£* WL610$££ *??JI^ WL 140 £S^ WL 102 mm WL 368 £SBl±£lB*iM&* WL 610$££ wmmmm qz 38o; n&mmm (fn^A) wl 101 ; *M£M¥ (tn^A) WL 102 ; ttS^l- (# H*>A) WL 368 ; mim&?-c7)SBfl(z Wm%m (Glioma) QZ 380 ^Wi^cohcnit^m^z tt*l[p]147 4/UX!g^4; (Neurotropic Virus Infections) (£7 4 /I/X14*£.$.$££ n&BB.Vimmm (Astrocytoma) QZ 380 vmncoiiCOimiiLftuz tt££ft#f£# (Neural Conduction) WL 102.7-102.8 tt&ffi (Nerve Roots) li1*1Hrt«&|fi££ J: ttlUBifc (Radiculitis) WL 400 faH#£ (Nerve Regeneration) WL 102 4*^*HS& (Nerve Cells) l£-^-3X$££ M*fflJMM14 (Neuronal Plasticity) WL 102 W&yXT^mWt^T-JV (Neurologic Models) fit**!* 7/l/$££ ^^iiifiI*S}S (Neuroleptanalgesia) WO 297 tt&i£»fl! (Neuroleptics) UmnnmmZflX ttHK (Neuroma) QZ 380 ttig^-* (Nerve Endings) WL 102.9 tti&i&^li1 (Synaptosomes) WL 102.8 tt&g§ft: (Neuroreceptors) (ilBUfcgggfcJiJ: ttfcllf Sifetj-SE (Neurocirculatory Asthenia) WG 320 WHS (Neuroses) (£*M£PfW$££ ttHWW (Neurotic Disorders) WM 170-184 W¥W WS 463 ?Liewfc«?iew ws 350.6 g^XH WT 150 tt^PfW'l4PinPfW (Arthropathy, Neurogenic) WE 344 ttHM (Neurilemmoma) QZ 380 PSm4y)fcWl£g|3li«'J(z WUSe* (Neurologic Manifestations) WL 340 mmfcco WW 460 #£*&**> *flli, Arcom&iz mmmm wl 390; 4-m®>m& we 550-559^; n nifiMtw wm 197; mimmntfo* fc££ tt^*£14?o*^ (Depression, Neurotic) (£WH o14P$W $££ tt&ffite*£ttffi (Anxiety States, Neurotic) li*£PI W$££ ttH'frJl^ (Neuropsychology) WL 103.5 W%kAsmmtf:)%k:& (Neuropsychological Tests) mnmmiztsu& wm 145.5.N4 W&mizisUZ WL 141 ?Liewfc#iie&J ws 340 W&5SS (Neurasthenia) WM 174 ttlUEiilttt&aE (Neurasthenic Neuroses) litt&SH $££ tt^ttftfifc^ig (Anorexia Nervosa) WM 175 tt*l1±-fe o A Y 'J 7° 7 X 7 X - x X (Neuronal Ceroid- Lipofuscinosis) WD 205.5.L5 t*££14-t n 4 F* 'J 7°7X7 xit#*£ (Ceroid- Lipofuscinosis, Neuronal) littfc&tt-fe 3 4 F''J4°7X 7y-xX$££ tt&ritfiB^ (Nerve Growth Factors) WL 104 m&Xtynm (Neurobiology) WL 100-102 W&'&mWt (Bladder, Neurogenic) WJ 500 W&^mm (Neurophysiology) WL 102 W&#.<7)XcoX.mm WL102$fc££ tt&8& (Ganglia) WL 500 W&ffimVSrm (Ganglionic Blockers) QV 132 W&ffiW&m (Ganglioneuroma) QZ 380 648 y x a 7 * fog*** (Nerve Fibers) WL 102.5 ^^fSt (Neurofibroma) QZ 380 Rg^tt^fc^li^tisyiz ftll^iltltitK (Neurofibromatosis) QZ 380 tt&itBJtt (Nerve Tissue) WL 101-102 #0f WL 104 jjftt]^ WL 101 m&m QS 532.5.N3 S* QZ 380 ifcMm WL 102 *i|#ffl$slii*S (Neoplasms, Nerve Tissue) QZ 380 ttl£i|§8fclcr3fC (Nerve Tissue Proteins) WL 104 ttifcl+tg (Nerve Centers) (i-^-3X$££ ttftH&tWS (Neurenteric Cyst) (£^£14:234^ $ £ £ W&MffimX (Neuroregulators) l£t*&fcjt!$/R$££ ttHfilffiH^S^tt (Neuroregulator Receptors) l£tti& f£il^®£^f£$££ tt£* (Neuralgia) WL 544 S^li^B^ttig** WL 400$££ mmummw&m wl544$££ HXIiHXtt&ffi WL 544$££ t^«14S5^^ (Neuralgic Amyotrophy) UWMin&m $££ tt&* (Neural Crest) WL 101 UJ^ QL 938. N48 ttii&fEii (Neural Transmission) I£x77xf5it$££ W^ittlSC (Neurotransmitters) QV 126 ftm%nmm#. (Neurosecretory Systems) WL 102 ^jjg/^77 F* (Neuropeptides) WL 104 Mi-7X (Nervous Mice) littlB'^«flv7X $£ £ Wil^Si^ln (Neuroimmunomodulation) WL 102 &*£* $ mm l tzm& qw 504 t$*l:ft*£703-tx (Neuroimmune Processes) littfclftiS i^gfi$£i W&m (Nerve Net) WL 102 Wffi.^T'JV (Models, Neurological) ffift WL 20 m^bmt WL 18.2 tt^^Il^ (Neuropharmacology) QV 76.5 ttS&tTOJ (Inhibition, Neural) l£W^JSU]tfpSiJ$££ tM£'J X^HS (Neurolymphomatosis) l£Marek*^$£ £ tM&l!S (Neural Interconnections) (iW*£*£i&$££ ^^Recklinghausen*?! (Recklinghausen's Disease of Nerve) l£«M*£!f^$££ fBStli (&) (Tuberculosis, Renal) WJ 351 W-jfiLT?14ifj.lfiLl±*jE (Hypertension, Renovascular) WG 340 m£5 (Kidney Calculi) WJ 356 At# (Human Rights) mm (&$tm) kf 4741-4786 ^Wtt KF 4151-4155 m&mm jc 571-628 ftm Y t'y y X|£±M^JIZ, f?ij^l£'iemf*®7-txy) #m WA 320 mst# wm 30-321?; -k\i.comm hq 1236-1236.5$ fc£i -l>!£14x 3 -y9 (Shock, Cardiogenic) WG 300 mn (Religious Beliefs) Ii9£3&$££ AP (Population) HB 848-3697 *fS^(£mHlitfS^ QH 455^$££ ftZMm<^ (Prosthesis Loosening) UkX^^Wl &4^$££ kXAI&Mm (Pneumomediastinum, Diagnostic) WF 975 APJftM (Population Control) (£APttP$'J HB 848-871 $££ kXAftlfti (Pneumoperitoneunm, Artificial) WI 141 wzvm)IIffiaj»$££ kXmU (Kidney, Artificial) WJ 378 AXIl (Heart, Artificial) WG 169.5 AX-DUD^ (Pacing, Cardiac, Artificial) l£AX'b* ^-xXX7$££ AX'b>H^—xxy (Cardiac Pacing, Artificial) WG 168 AX^-X>-7- WG26$fc££ AX-b* (Heart, Mechanical) WG 169.5 kX^mmW. (Heart-Lung Machine) (£AX4>Jffi$££ AX^I*1^M-(Pancreas, Artificial Endocrine) l£ A x x ^ iJ Xi4AxX7A$££ jS1t'I41^XJ^*$ (Supranuclear Palsy, Progressive) WL 359 Jtir14£5#l?5*iE (Progressive Muscular Atrophy) U^M 85x7F37W-$££ iifrl4l5-xX F 0-7 4 — (Progressive Muscular Dystrophy) l£& x X F n 7 ,f - $ j?, £ kXmXMA (Impregnation, Artificial) (£AXt£*Pr$£ £ iiit'ttfl&W^sit*^ (Progressive Lipodystrophy) l£ U 7° -xX F37^f-$££ illf14^lfBi*£ (Fibromatosis, Aggressive) QZ 340 mm&<7)ii co umtNiz Jlirl4iJl^14i;£&*iE (Sclerosis, Progressive Systemic) (i£J§44&j£*S$£i MYr'&ifc9 o-y XT^K (Myoclonic Epilepsy, Progressive) l£ ~ fc9 3 y XT/l;5>A$££ iift141/ X X*t£$:14 (Progressive Lenticular Degeneration) liJff X x X4££14$ £ £ AP1#JJP (Population Growth) HB 848-871 AXAISI (Artificial Organs) WO 176 mi WO 23-24 #£AX)Hgs£$fc££ AXgJM£f&4^ (Prosthesis Failure) £W.X%$: (-fe) W 26 #^<7)ffl^^^rLl£, Arcoffil&iz AX&Jii£ (Artificial Intelligence) Q 334-341 mm (-fe) (Ztolt* W 26.55.A7 Arcomcoftmfrn (NLM#$t3lT(£JF^#^26.5) ^*ge^J(z4iJffl§^ll.ii^l£, 4MJIZ mmtim (Faith Cures) itmmmtflX APtUlt (Population Surveillance) mmbwg. WA 105 &x.9 aycom&cozfoz hfix, mummmtiu WA 900# APM (Census) (£AP^$££ AP|Jj?J (Population Dynamics) QH 352 ftmY \z-y9XU, XM^iJlz APlJj?J#cff (Vital Statistics) HB 848-3697 mt, mmwiz wa 900 m,xm hb 901-1108; mm hq 811-960.7; mm hb 1111-1317; «.*$ wa goo; j£ty$ hb 1321-1528^$ fc££ AX^BK-H; (Hibernation, Artificial) (£1£f4fij£$££ AXl*]^ (Cochlear Implant) WV 274 AXil (Tears, Artificial) l£*|g^J$££ AX£Bg4>#£ (Abortion, Induced) m&m • n^b^m hq 767-767.52 Xit WQ 440 AXSU (Oxygenators) WO 162 tmttmzmmzti&m&uArcoxmMiz, mmm* fflflz&tt-S^ftli WG 168 AXUfMS (Artificial Fever) Iirt44^£$££ APM (Population Distribution) (£AP^$££ AX5H& (Labor, Induced) WQ 440 ~cofz^commtx^!\mm qv 173 $££ AX-<-xy-7- (Pacemaker, Artificial) WG 26 AX4>M^-xX7 WG168$fc££ AX^-yfflli&(Beta Cell, Artificial) l£4 xx* 'J x& AxX7A$££ AXB1 (Membranes, Artificial) \m%L$l TP 15g.M4 ^t*flz^(tS db^XH) TP 156.D45 ifiLMtJflZfctt.?) WJ 378 i&7m& WA 687 »£gtoizi£ffl$ftsi^i£, xmmz 'MYrMW (Paralysis, General) (£4^fl**$$££ AP&)£ (Population Density) HB 1953 AXft*£ (Artificial Immunity) QW 551 APfflSiJ (Population Control) HB 848-871 APift^ HB 883.5 mmttm, HQ 763.5-767.7 $ fc £ £ AX)!ilM (Abortion, Induced) £?fcft • *t£W#g HQ 767 Xft WQ 440 kXmm (Artificial Tears) l£.£0fi#J$££ yy?7Ay (Cinchocain) Ii-x774>$££ x X 3 7 x x (Cinchophen) QV 95 nmmffi (Carcinoma, Renal Cell) WJ 358 650 y>-\iA y ^Wi^MM (Adenocarcinoma, Renal Cell) tetffcBDJ&ft'i $££ -&% (Physical Examination) WB 200-288 &* w 789 wmbwm ws 141 ^^^ WT 141 AVflift (Personnel Turnover) mm wx 159 mm wy 30 ftH|g¥ WM 30 ^^HSHIiiSSiJlz A^lfS(Personnel ManagemenOHF 5549.A2-5549.5 mm wx 159 mm wy 30 mfc#ffti3£HSiJlz, tfiRli'^Sftlili WY 105 t&ifctt (Kidney Glomerulus) WJ 301 ■t'fctt&S (Heartworm Disease) It 4 * **£&&$££ -I>1 (Heart Ventricle) WG 201-202 ■t>li£3I&#l§$t (Ventricular End-Diastolic Volume) li-@teai*$£i ■DlWfi) (Ventricular Fibrillation) WG 330 'l>lJ|5U8»»l$f* (Ventricular End-Systolic Volume) li-0tfiai»$£i 'Di^PSXlM (Heart Septal Defects, Ventricular) WG 220 'l>=ge>i[>£t§IJjgl (Ventricle-Assist Device) li-l>!H*§|Jj$SI $££ AS (Race) (i«S£$££ g»1£ (Invasiveness) l£fflffi ; ®*§ftSI14 $ £ £ g»14#8E (Invasive Mole) fiM14l!frbc:lrli6$£ £ ASM1SF, (Race Relations) HT 1503-1595 %Xm WS 462 'b'JL WS 105.5.S6 m^l (#MeSH«n) tfcWlzfclt* LC 212-212.73 sflftfcfcltS HD 4903-4g03.3 mUizisith HD 7288.75-7288.76 ^S^HM-feHzt;It* **Ui, SS'Jlz, D.Efc L < JiF^Slz KI*S (Cholesteatoma) QZ 365 vm&coi>cou^mi\iz kM'Omm (Race Psychology) liKJ£4>W$££ Blhmbm&m (Exudates and Transudates) QU 105 Eflcfcg QY 210 ^14* ¥£ (Otitis Media with Effusion) WV 232 ifefflteMHE (Enteropathy, Exudative) (i§&Sl£14)I§*£ $££ Attlz£^^,f. (Races, Diseases of) itm^coXcomA WB 720 $££ BK*S (Kidney Neoplasms) WJ 358 ffUS (Renal Circulation) WJ 301 mmi-Um (Infiltration anesthesia) liHjp/fJft#$ MJ: t*£fg14ffil(iLS*£f£££ (Hemorrhagic Fever with Renal Syndrome) WC 534 mmm sf sog.ms %&m£&fiL»im$i%£7 A JVX (Hemorrhagic Fever with Renal Syndrome Virus) (£^xy — X74/1/X$ ££ ttWYi (Physical Disability) (i#f44v:W'?i $££ #;'Y;'l4A*ti*#f (Pemphigus Vulgaris) f7A*S*f $££ WI4te*S (Acne Vulgaris) WR 430 #7'!ir (Labial Frenum) WI 200 tft.tt (Adrenal Glands) WK 700-7g0 ft»Wk (Renal Veins) WG 625.R3 &BcoX<7)\h®mZ WJ301$t££ 't^mm (Psychosomatic Medicine) WM go m&u^%m wm go^$££ 'll>#*E (Psychophysiologic Disorders) WM go ?Liewfc^ie« wm go ttfaW* WM 611 'll>#P#W (Psychosomatic Disorders) li'll>#£E$£i •bW&gmmmm (Dental Care for Handicapped) Ii Pr7#ffiM[SSg$££ 'l>4H*V£-#fflft£M£ (Dentistry for Handicapped) l£Pf 4l4SiK.>l;l*JJ£- (Vibrocardiography) U*fcY7ivyfc 9yy 4-*flX famm (Faith Healing) l±«ftt«ft£, *ifttte*lr$£i tfig® (Kidney Medulla) WJ 301 tf^lif (Hydronephrosis) WJ 300 WY-'tt 7/1/3 y9 9 YyyX (Lenses, Contact, Hydrophilic) (ii|/K143xyy Fxxx*$££ ^,7^143 xy y F x XX (Contact Lenses, Hydrophilic) WW 355 if 4m (Rickets, Renal) (itf14#xX F uy 4 -$ ££ A4E5&S& (Life Experiences) i£44St$5$;S:MiI$££ tf14it5Jfo.E;E (Hypertension, Renal) WG 340 tf14#JFMH7£*m (Renal Osteodystrophy) WD 200.5.C2 tf 14 # yXYvy 4- (Renal Osteodystrophy) WD 200.5.C2 ff£ie (Infant, Newborn) WS 420 x^commt£ w 78g mxm wq 450 #f£!£Stl& (Jaundice, Neonatal) WH 425 BSie*^**^ WH 425$fc££ Uf^ieib^^K^^fpX (Substance Withdrawal, Neonatal) (£fJf£iemiilf*£fi£^$££ ffiX'Jtm (Neonatology) WS 420 rr^ie ws 420^; mmrnm wq 210$ fc££ ^aX'JtWft (Asphyxia Neonatorum) WQ 450 ffiX'Jtmm (Neonatal Nursing) WY 157.3 %aX'JimffilXi%U (Neonatal Abstinence Syndrome) WS 421 fr^ieitj t ij JVh*>M (Hyperbilirubinemia, Neonatal) l£*/f4£ieM*a$££ ^f^iet^iftttllifijJfoJEE (Hypertension, Pulmonary, of Newborn, Persistent) l£PFCS$££ %aX'RM. (Hospital Nurseries) Umm^X^m^flX fJf4ie*££. (Infant, Newborn, Diseases) WS 421 rr£m£$ (Neonatal Mortality) l£?im£$$££ ff£ieS*£lf*& (Icterus Gravis Neonatorum) liBSJfcgfc 1RfcE$££ ffiX.'JtMfc'fem (Intensive Care, Neonatal) WS 421 651 y > -t a y Slf'l-:!/e.'hJfll14*£.£. (Hemorrhagic Disease of Newborn) WS 421 Uftlfi^lfiWfltni (Passive Addiction, Neonatal) l£P'\X ^ftiex 9 'J — — xy (Neonatal Screening) WXm&(z*J L T I£, A:com&X #f4ieMt£ft;£ (Docimasia, Pulmonary) (££iJtt ; X.W 5§4-:$££ #f4!£^Jfo. (Anemia, Neonatal) WS 421 #i£iefci#t5U*WS? (Infant Radiant Warmers) (£1*WSI $££ #t4£!/eigjfo.14#c.$. (Hemolytic Disease of Newborn) l£ 8S^*#:^*£$££ 0fX'/tmH&^U (Abstinence Syndrome, Neonatal) (i tax.'jtmmm&mzfix *14*Jfi.3*^te^lS (Red-Cell Aplasia, Pure) WH 155 MXZfiLfc (Polycythemia Vera) WH 180 ^X^tJilU (Neoplasm Antigens) l£IS*SM$££ ^X^YjXW- (Neoplasm Antibodies) I£)!*«t7if£$££ 4>jES: 1) ^(Inotropic Agents, Positive Cardiac) (£3£'D £$££ Wi%*v9 'J -y Y (Camelids, New World) QL 737.U54 mm SF gg7.5.C3 m^.W^A (Hookworm, New World) (£NecatorH$ ££ $aVkW7-'JV (Monkeys, New World) l£7 7 7+W4$ ££ \%^t £ (Immersion) ^&£tzumm<7>mmbLx qz 57 &W:bixxtz>smyamua:cowmiz, f^jxz im^ m WD 670^ tf£ (Renal Calculi) l£tf*££$££ tfS-ffi (Nephrolithiasis) (£tf*£5$££ tf^M-fi (Nephrocalcinosis) WJ 356 Mm (Tremor) WL 340 mmm sf sgs k'M (Personnel Selection) HF 554g.5.S38 »#ff(£±£i£i|tz MW.-£A,% (Delirium Tremens) (£7/1/3 -/l/M-tf/l^ $££ #f.*WSlfiL»& (Fresh Frozen Plasma) (£lfll^$££ AL>'£ib$j)Wm (Apex Cardiography) I£^f4- F 7 JVyfc9" yy 4-£flX Jg^{^*¥ (Paralysis Agitans) (£Parkinson*^$££ <1>!H (Heart) WG &m Pf» WG 330 xmm WG 202 ft & WG 106 ; M ft WB 282^ ; m. m WG 330$fc££ ie* WS 290 \mm qv 150 ^^m^$fc££ WJtcOUl&'Jl^m. WQ 210.5$££ xmmm wg 141.5.R2 mmmA9-yyy* wg 141.5.R3 gu^m^mm wg 141.5.A9;-c^git^is wg 141.5.P4$££ VSrMmm WG 141.5.T6 RH (Kidney) WJ 300-378 «&& WJ 301 tflMfc WG 595.R3 ; tf&M WG 625.R3$fc££ -b>lllt$tit (Heart Transplantation) WG 169 tfHt^tit (Kidney Transplantation) WJ 368 -DJU&A (Heart Enlargement) (i4>H)]eA$£i 4>H7r — TJVm (Catheterization, Heart) lil>7 7- 7/i/fS$££ ^m^B (Heart Abnormalities) lift?c144:>Hi^$ Jii 'l>HEi>#c?J (Cardiac Emergencies) WG 205 OmmXffi (Heart Surgery) WG 169 tvjmbwjm WS 290 tfM*£t£ (Tuberculosis, Renal) WJ 351 OmftL^lk (Cardiovascular System) WG ^ WG 220 d>ie WS 290 ~lzftmfcZ>m QV 150-156 nmtimft wg no X$m.& (-fe) WG 141.5.R2 mmrnm a 9-yy9' wg 141.5. R3 mm WG 168-169.5 wMmm WG 141.5.T6 'DSSlfllW^lot^ (Tuberculosis, Cardiovascular) WG 100 PS^'l4ofcy>lta3fiSiJ(z &M5k{j^?fcm& (Cardiovascular Diseases) WG mm WG 120 ?Liewfc«jiew ws 290 &mmiztsit&A:ti, u^mftL^ik&m&im wq 244 $££ mm (-fe) wg 120 mmmm.mm qz 340 $ fc £ £ mm wy 152.5 mmm sf sn L'HJfo/g^^c.t. (#H) (Cardiovascular Disease (Specialty)) li4>H*i^$££ •DHifiLl?^ F iJ'^V y — vJje (Trypanosomiasis, Cardiovascular) (£Chagas4xfl£*JE $ £ £ 'C,SlJfiL^^:ii:tB/B*1*rffi (Pregnancy Complications, Cardiovascular) WQ 244 ^msk^^.mm (Syphilis, Cardiovascular) WC 168 '^MsSa.^^T'JV (Models, Cardiovascular) WG 20, WfcXMcoArtiU, XMS'Jtz ^mst^m (Cardiovascular Agents) QV 150-156 'DMlfiDl (Hemopericardium) li4,>Hg&$££ tfHIS^ (Kidney Stones) (£tf *££$££ ^mmMUmih (Heart Conduction System) WG 201 -202 %B.m& (Kidney Diseases) WJ300-378 mm WJ 300 fVJtmbX'jim ws 320 mmmttm sf 87i nmmfc^m (End-Stage Renal Disease) I£ti14tf*£ $££ ^H^fts (Systole) WG 280 Om>&m& (Heart Contractility) (££$«*fe"$£i %mmm (Kidney Neoplasms) WJ 358 bmM&1fr (Cardiac Neurosis) UW&mmtetl&Z fl *■ 4>HAXtf- (Heart Valve Prosthesis) WG 169 652 yv9> AMMV& (Edema, Cardiac) WG 370 4>W«.fc (Asthma, Cardiac) (i&ffTW'W^^ .t'H#niSilSk (Cardiologists, Directories) (£'1>]R*iVF- cox§MI^£ (Heart Auscultation) WG 141.5.A9 4>tllH*if.3c WG 141.5.P4$fc££ .|>H(£tft£ (Ectopia Cordis) (£^^14-b>H^ff^$££ ■|>KtM*S (Heart Aneurysm) WG 300 ftfiigtfiiE (Kidney Concentrating Ability) WJ 303 ftffi&£ (Truth Disclosure) *1*ffl£lziSlt4 QV 20.5 mmWRizisitb W 20.5 *filifc WG 275$££ ttlilHrtt'L'-Bl* WG 420$ ££ iJ7-7 714li'J7^7'l4*^.t. WG 240$££ mmmn sf sn nmm (Kidney Diseases) WJ 300-378 mm wj 300 fVJtmRvty'Jim ws 320 mmm sf 87i ■mmm (Cardiology) WG a* • mam wg 22 3?!£ftffl3S WG 110 mm wg 100 ?L!e^fc«jieiw ws 2go mm WY 152.5 nmmm (Nephrology). WJ 300-378 mm wy 164 '1>M# (Heart Valves) WG 260-26g ■mirffiffi (Heart Valve Prosthesis) WG 169 -L'H^HUe (Heart Valve Diseases) WG 260-269 -t'KffiffllttS (Heart-Assist Devices) WG 169.5 •ommmfcyy (Pumps, Heart-Assist) ixommmms $££ tH^/i/^EX (Renal Hormones) itfcJVt X $££ 'DK$flt (Cardiac Volume) WG 106 'DRPickJS (Pick's Disease of Heart) (iJDtfgtt'bffllift* ££ «H?1£ (Kinship) (ilfoJi$££ M% (Ligaments) WE 300 Pg^14^fcC0liai1l«iJlz #f£JS®J (Exertion) mm WE 103 ft£ QT 255 X-7-7 QT 260 %Vfmmm (Kinesics) #^ffl WS 462 ?Lie$t#iie»i ws 105.5.C8 frmm BF 637.N66 tt&bmm HM 258 kfommm (Human Anatomy) lift?£ij$££ 4*f*fLWW (Somatization Disorder) (£#fW£14Pr#$ ££ ^W-\YMMM(Somatization Syndromes) (£4>#*iE$££ t*tmffi® (Body Buffer Zone) (ifPlA£f!U$££ yti^XMyn (Body vermin) IJ-/7; ; 7x*XAx$ ££ A.f£,iTfi< (Anthropometry) GN 51-59 imukmm hv 6035-6197^$££ #fWfc£ (Physical Examination) WB 200-288 X^<7>m&m±LCOtzSbco W 789 WJLmt'WJtm ws 141 H-ftt** (Body Composition) QU 100-110 kfoWfr (Human Experimentation) W 20.55.H9 $m$: f t°.yyxuxmmz, mtum^m^izisith QV 20.5 lrWW?# (Disabled) 3yg^l$££ IHWS'^J*: (Disability Evaluation) im^mmmmm w goo WH^tti«Wi£[^^W^iS W 925 ArCOfacoWmti: Y t-y y x|£7iM^J^, f?iJxli'T/l#^ wi 385; BM7^izt>it& ww 32; n^mmmmiz isiti, WV 32 #WIW(m (Insurance, Disability) Ity74 7 7$£ £ HWtWtift (Disability Compensation) litEM¥AUS*£ t*ir, #M&t4§i«$£i JHfrJftlSfl&^SrMK (Work Capacity Evaluation) $£E^Kj#8 W 925 »F t'yyxii, ±H£ij!Z H4£HIJj (Body Rocking) lifted 9 SrriJj$£i Af££*l¥ (Human Physiology) (££W$££ J§444fl (Body Image) BF 697.5.B63 mXm WS 462 ?L^Wfc^JieW WS 105.5. S3 H44Wy.7J (Physical Endurance) QT 255 Erflcr- t-yyxl£, ±II£iJ(Z H44«*114P$W (Somatoform Disorders) WM 170 #f£afif» (Body Burden) WN 660 Aft4!S (Manikins) QY 35 &B? (Diagnosis) WB 141-293 ILJf m& WP 815 't'HJfiL^*^* WG 141 ?*£/t WV 210 IRgtft WW 141-145 mt«.ft WI 141 »AI4«* WP 141 ?Lie«fc^iew ws 141 fifttPfW WM 141 S6#»*«.ft WE 141 mm qz 241 **&**£& WL 141 ?#P0P£*£.i. WV 150 &3ItfJ WB 200-288 WftttS WB205#$fc££ t&l)& WQ 202 tt*6£flrffi WQ 240 ; i&t&T X Y QY 335 ; 14'* £ WQ 206^$fc££ ihmmu&mmmm wq 209$££ yyfcTA 7 F-7° WN 445 653 y>9>A xu&wmu&jHy&wm wn 220$££ tokmit wr 141 WWm WR 143 wa«* wf 975 nn'xmit wu 141 tttt WF 220-225 MRS WJ 141 A:cofc<7)mm#^ H§£/z(i*£ir2?)#^-(z mffim$££ tmmxmmmmm (Radiology, Diagnostic X- Ray) (£XHtii>$££ mWmi$.m*-y Y (Reagent Kits, Diagnostic) QY 26 mx.tk^tz)9><7jmmuxMmz, ^uii-^yntx t&g QY 455 Aftl^ (Anthroposophy) *Sm BP 595-597 fttflSiflr WB 903 AS*iIf£ife14^.S (Zoonoses) WC 950 T-KfcitiiJE WA 110 k&U&m (Zoonoses) WC g50 xx77y 7 4 (Scintigraphy) UMfltmiA 9-yy 7$££ x >f?Ii (Scintiphotography) (£Jftl4l4t£fI4 A-y X7$££ 4>4'PiX41 (Heart Septal Defects) WG 220 #ft (Height) (if*fi$££ 'DS^gF/S (Echocardiography) WG 141.5.E2 #S, f£S, t£fi* (Height Weight-Growth Tables) (£ ftWfrM, fc&, 1£S, |g«T«i WS 16$££ ffft^tt (Receptors, Stretch) l£t£t*^#:$££ y X 7 X - x 3 XfffliJ (Scintillation Counting) WN 660 mmiimm (Tocography) (£*-yjx7$££ Ffffift (Tocodynamometry) UX'St — 9 U X7$££ P3>*S1£JIII (Oxytocics) QV 173-174 l^ffitWJ (Tocolysis) WQ 330 PltfStWJSiJ (Tocolytic Agents) mmm wk 102 -b^ih (Heart Arrest) WG 205 tftft (Nephrectomy) WJ 368 mmm sf 87i ■L^yfcWikX F xxPfW (Post-Traumatic Stress Disorders) U?YW&X Y xxP#W$££ Afi^J^J^ (Manpower) (£^/UX-^x^°7-$££ ktfj^MWlft (Human Resources Development) (£xy y7^H$££ xX7y-7* (Synthetases) l£'J7*--t$££ •C^Wmmm (Electrocardiography) WG 140 ivjimbwum ws 290 mmmn sf sn ftmUM (Reflex, Stretch) WL 106 BIj§ (Osmosis) xamwm QU 34 mmm qh 615 &mim qd 543 mnxmm qk 871 tgfc 1 (Concussion) (£JJB!g fc i WL 354 fc AtCOJ^co^H ^««$££, fflx(£Wf& tSiJ!j (Vibration) MWm (-») WD 640 ^*^W|gBt LT QZ 57 mn^co WD 735 ^HtztJltl) *£*?! WA 400 7-PSfcfliiJEE WA 470 &mmm wb 535 illxlEE (Osmotic Pressure) QD 543 ME14fiJJ3i^ (Diuretics, Osmotic) QV 160 MEPbp (Osmoregulation) (£7k-lPJC4z#r$££ mmJXmmm (Osmotic Diuretics) (£}f ^E14*']J13ii$£ £ MffiMxim (Oscillometry) xmmm qt 34 ifmm%. wg 106 jft^Ufi: (Osmolar Concentration) QD 541 m\\m QV 744 tflM (Renal Artery) WG 5g5.R3 tfHy>TOJfiL^^& WJ301$fc££ tffMfc#?M (Renal Artery Stenosis) (£tfIJ»]"**4.$ ££ tflMP^M (Renal Artery Obstruction) WJ 300 •bflBS (Endocardium) WG 285 blHm%. (Endocarditis) WG 285 4> l*)TOAtl (Endocardial Cushion Defects) WG 220 AIL (Milk, Human) ?Lietf?L WS 125 KM WP 825 tf?UI (Kidney Papilla) l£tfMK$££ tf?USit?E (Kidney Papillary Necrosis) WJ 351 tfmWlfwi (Renal Tubular Transport) WJ 301 tft4 (Kidney Calices) WJ 301 OB&U (Heart-Lung Transplantation) WG 169 H!it]*jE (Pneumoconiosis) WF 654 AjMiMXm (Cardiopulmonary Resuscitation) M&M WA 292 'b^l^li: (Cardiopulmonary Arrest) Ii4l47ih$££ 'C*|5]B#^tfi (Transplantation, Heart-Lung) l£4>Hif2 tS$££ 'b4GJ§WI4 (Chronotropism, Cardiac) l£4>ftft$££ -b>ft*i (Cardiac Output) WG 106 'Dftlfc (Heart Rate) WG 106 xx^°7x (Sympathins) (£77 ?-JVT i X$££ tf*£ (Kidney Pelvis) WJ 301 WUm (Occultism) mmmm wz 309 tf &SC (Kidney Cortex) WJ 301 m&Xm (Mysticism) BV 5070-5095 ~bm±Wi QD 23.3-26.5 ~b£)%m QV 77.7 4x4^£ (Cardiac Failure) l£^lM4'b>4^$£^xm %Y%co WZ 112-150 fHAW WZ 100 #$cF t-yyxli, i-li8ijiz ,|>7p -/9 (Heart Block) WG 330 $ffffl (Newspapers) HMFffi Z 6940-6967 mmbM&yy$f w 1 tffc ZW 1 Ax44¥ (Humanities) CB, AZ &I§^l$£i .[>£t7I4 (Inotropism, Cardiac) li4>f&54£&B$££ .|>J5I (Heart Atrium) WG 201-202 L>)f ffltft (Atrial Fibrillation) WG 330 fciffflft (Atrial Flutter) WG 330 -Dflf+PIfttl(Heart Septal Defects, Atrial) WG 220 •l>jf7 F 0 7A^JJ^HJf1 (Atrial Natriuretic Factor) QU 68 4>Jf 7 F 'J 7AfiJR/<7°7 K (Atrial Natriuretic Peptides) (i'L-ff 7 F 'J 7Afij^H41$£i g& (Submersion) (iff^5$££ '|>IH (Pericardium) WG 275 BB*tt3£ QY 210 -ft WG 275 -^^mmiz is it 6 WB 373 ■mm (Pericardial Effusion) WG 275 &m$& QY 210 •L'BSffc (Pericarditis) WG 275 ■mm&m (Pericardial Fluid) U^mC0Xc0frW£flX ■mmm (Pericardial Cyst) li«|£l!&$£i t/imm (Urticaria) WR 170 ('V7+-y (Heart Massage) WG 205 ?Jf^/i/7X±^ (Neomalthusianism) Ii A P UJJlg $ £ £ k& • mam (Directories) (NLM^mmxum^.^^22) Hfflflr Lfc5cJtTf.# (Credit and Collection, Patient) li.t.^WfffflJf L fcflXJtT $££ 4>£fll (Heart Volume) l£'l»H^$££ ■WWim (Cardiac Depressants) I£1ji^^MII$££ mmbMAhft (Reliability and Validity) (£*£3TOI14 $££ 4>S • tt£fomW%M'Mffi (Mental Retardation, Psychosocial) WM 300 nXm WS 463 fVJtmbtb'jim ws 107.5.ps ■bmm (Psychology) BF H& WM nxmuw^mm ws 462 $££ ^HfcLT BF 75-76 mi wz 100 a&kcomi bf 109 X'jtitx'jt^mm ws 105$££ #7X-t ij X7 WM 55 imimm^mm hv 608o-6ii3$££ g£3c HM 281-283 kt • ftffiHt BF 30 £A WT 145 ffc^mmiztSitZ WD 730 ^frl'TTtZtJlt-i) WD 754 %[-t\ HM 281-283 na WY 87 mmm<9> umnmmm wmvt $ £ £ ^%m-0O BF 204.5 £g^li*i'iWM-7' WL 103 $££ '14 BF 692 W.^U%Aymm U 22.3; 4xgi$ UB 275-277$££ ^mmYXfYco*$n%m iz to it & wk^mt (Experimental works in specialties other than psychology) UArCOfrffcoTZ fLX ,^mmm~^i (Psychological Theory) BF 38-64 ■bmmtftXH (Manipulation, Psychological) liv^f 7^ lJX*A$££ ■bmmfoxYyx (Stress, Psychological) WM 172 %i£\'miztiitZ> WD 730 ?L!/e$fc7iew ws 350 x&mmiztsith wd 754 ■bmm$M,&\YL (Desensitization, Psychologic) WM 425.5.D4 nXm WS 463 ?Lie»?fc#Jie»l WS 350.6 ■bmrnfoMfe (Interview, Psychological) mm^rnm bf 637.15 ?Lie$fc#J!£ffl WS 105 mmm wm hi >{j>mm&)*:T'JV (Models, Psychological) n^bmm BF 181-188 mwrnrnw mftizmm$tiz>t%& wm 20 nmizmm2tiz>m& wm is.2 Wx.XMcoA:tzU, XMftliz 't»B|*J (Psychodrama) WM 430.5. P8 ?Liewt^iew WS 350.2 ■kmmm (Psycholinguistics) BF 455-463 ?Liewfc^iew ws 105.5.cs SlflSii LB 1139. L3 >bW& (Psychological Warfare) UB 275-277 'H>S6^JXFXX (Stress, Psychological) WM 172 %a^mmizisuz> wd 730 fVJtmbwjm ws 350 x^mmiztsiti> wd 754 'b'S^tttt^Pft (Sexual Dysfunctions, Psychological) li144>St£fig#l?£$£i -b>a^JiiS (Adaptation, Psychological) BF 335 f[S WD 730 nXM WS 462 ¥LieWfc#7ie»! WS 105.5. A8 X^Wil WD 754 ZcofbcoWZXMU, Xmftliz 4>317XF (Psychological Tests) BF 176 ?Liewfc^ie» ws 105.5.E8 mmmiztsuz wm 145 tkfm WM 145.5. P8 mxxfbtix^z>) $££ mmm (Health Service Area) itmmm (f*«[SfJ?) $ 655 y > 'j a 7 £i &IKHI (fSfltE*) (Catchment Area (Health)) WA 541 zxmm wt 30 mm^l&Zb^^. (Rate Settiag and Review) -ft W 74 *?!P£ WX 157 mm'&yymm^ (Fee-Splitting) mmm wu 58 IM* W 58 mmmmn wu 77; mmm± w so; mtibm± W 74^$fc££ mmXifem&Yi (Physician Impairment) mm w 21 A: nAfticomf^iz is it h, mmn-imKim^mzft LTI£, #PmziI^&#^-(z3i8rf !> mmXx.%%m (Waiting Lists) *?!P£lztJlt6 WX 159 mmmm^m mmco wu 77 mmco wso m* (Forests) (£tSf*$££ kMi&Um (Genetics, Human) (iJtfS^ ; H£FJlf£^$ ££ kMm (Anthropology) GN J11IP HV 6035-6197 &bmm BF 1045. A65 &mm GN 502-517 kMGOmm (World Health) WA 530 'bSffi3S (Psychical Research) U&bmmtflX 'I>5±H (Spiritualism) BF 1228-1389 ■bMmm (Spiritual Healing) (£ffi#*j^£$££ WIS (Mythology) BL 300-325 mm&vm&ftffizts it z> wz 309 m (Uvula) WV 410 7kw (Swimming) QT 260.5.S9 *ift QT 260.5.Sg 4^77°—JV (Swimming Pools) WA 820 W<& (Pancreatic Juice) WI 802 ffilft£ (Cerebrospinal Fluid) WL 203 ffiflc##f QY 220 -#Wi*»r WB 377 W (W $£ (Pancreatic Fistula) WI 800 W'%. (Pancreatitis) WI 805 'ffoWm (Medulloblastoma) WL 358 W^ (Pancreatic Ducts) WI 802 TfclS (Hydrophthalmos) WW 290 WmtZffi.^. (Pancreatic Function Tests) WI 802 X4*'^7 (Buffaloes) QL 737.U5 mm SF 9g7.5.B8 EW'Hfr^ QL 737.U53 7fc38 (Mercury) QV 293 HiCWLt QV 261 7k£gtp$ (Mercury Poisoning) QV 293 7k$g|5]f±ft: (Mercury Isotopes) »S£3I$££ 7kMmW.m (Diuretics, Mercurial) QV 160 4^JFF& (Hepatitis, Water-Borne) (£ES3f^$££ ik&.m (Waterborne Diseases) Ufc&m ; jKKrS&fc.g, £ *X& (Dehydration) t£»f±y>4(^14 WB 158 7K • n.m%xmm%; iz is it z> wd 220 n&ii^ (Suction) XWiiztsitZ F'x7-x WO 188 mm iz ts u &%m urn) wb 373 7K^J (Solutions) QU 786 *$Hb (Hydroxylation) Mmm QD 281. H85 *mitT)Vi-72± (Aluminum Hydroxide) mco^mb LT QV 69 *mitT>vi-7^Y)V (Aluminum Hydroxide Gel) Ii 7k$Hb7/^-7A$££ 7k^{b7/i/x7A (Calcium Hydroxide) mmm wu 190 t&mm qd i8i.C2 mmm qv 276 fctititifa (Hydroxides) QV 280 7k$Hb-^7*4x7A (Magnesium Hydroxide) ftiJ^UfcLT QV 6g M (Pulp Chamber) (£«)£$££ 7kJCf*r$ (Water Pollution) WA 689 T?k WA 785^$fc££ *W&m'sfo'g. (Water Pollutants) WA 689 Wjzttmwjwcoz&ziifix MMmmm (Pheochromocytoma) QZ 380 P!JlH4^fc<7)(£MrJ3iJ(z tKMSiU (Wet Lung) (£JJi|j7kJII$££ 7k*^ (Hydrops) (£#)£$££ Silt (Myelin Sheath) WL 102.5 *MA (Steam) TJ 268-280.7 7 4 yyy YiKm& WB 525 ; mmm WX 165^$ fc££ 7kBBB#: (Lens, Crystalline) WW 260 7YaBft&m&t%Mfc (Retrolental Fibroplasia) (i^BiE mmmtfix 7kBBaft:>IJS (Lens Opacities) (iSflW$££ 7KBBfom& (Lens Diseases) WW 260 7kBBB#:^&K (Lens Proteins) U9 0 X9 U X$££ §ilfrl£3l*£.§. (Demyelinating Diseases) mm WL 140 mmcow%uA:commiz 7ktf*£ (Hydronephrosis) WJ 300 WWB (Pancreatectomy) WI 830 7KM (Hydrogen) *&mm QD 181. HI mmm qv 275 7k*4 7X (Hydrogen Ions) (iPI41$££ 7k^4 4"XjsS (Hydrogen-Ion Concentration) Ifvfb^ QD 562.H93 fMf W WD 220 f£$tzt>lt& QU 105 7KH4 7XATP7—t*g£4£ (H( + )ATPase Complex) liH-ATPxxy--t$££ WW (Pancreas) WI800-830 t4*4 (-fe) WI 830 ftlfe1£&iM£^ WI 820 ; Langerhans^ WK 800-885 $fc££ WMTJVyymm (Pancreatic Alpha Cells) (i Langerhans^ $ £ £ 656 X72JX BMI#tfi (Pancreas Transplantation) WI 830 |(|xJfX (Pancreatic Extracts) (iSTOtfltt^^ WWfc& (Pancreatic Diseases) WI 800-830 mm WI 800 fflijimm (Pancreatic Neoplasms) WI 810 ffiHtfMg^ (Mucoviscidosis) li*)&14«.*jE$££ I^Jiirtlrt}^ (Pancreatic Extracts) mmm qv 370 fcSWf'Jffl (-«!) WB 391 ftzvmnfemizmmzti&m&u, A:covm$tzu& IZ PH^)P^ifi^ (Insular Tissue, Pancreas) it Langerhans^ $ £ £ ^K^-^WiBa (Pancreatic Beta Cells) ItLangerhansft $££ PK-t/l/^EX (Pancreatic Hormones) WK 801 //U7 7x WK 801 ; 4 Xxj. ij X WK 820$ fc££ P£iIES£ (Insufflation Anesthesia) lin&Alfr{#$£i PR* (Pancreatic Fistula) WI 800 /k^lb (Hydrogenation) QD 281. H8 /***££• (Hydrogen Bonding) QD 464.HI *3&§fl: (Hydrogen Acceptors) (i^1bH7t:$£i §|(74S& (Extrapyramidal Tracts) WL 400 ItftW^PiW (Extrapyramidal Disorders) (iflgftttfl ©*££.$££ mft%X (Decussation, Pyramidal) liftf£&$££ £tfr# (Petrous Bone) WV 230 Hf4^*e (Petrous Pyramid) l£ftf£#$££ mmi%& (Petrous Bone) WV 230 ftfttffr (Pyramidal Tracts) WL 400 /K+ftS (Hydrogymnastics) (i7kte*M£$££ 7YfY&t.XVam (Water Microbiology) QW 80 7kte*J?ffi (Hydrotherapy) WB 520-525 Wh (Islands of Langerhans) (£Langerhansib$££ 7k*a (Chickenpox) WC 572 H¥Ibt£tit (Pancreatic Islets Transplantation) (£ Langerhans j| $ £ £ 7YM.7AJVX (Chickenpox Virus) lit Y^)V^X7 A JV X3$££ WhW&Mte. (Adenoma, Islet Cell) WK 885 /KIISe (Hydrocephalus) WL 350 7k*!/vi/^X7 4^X (Herpesvirus varicellae) l£ t F ^ )V-vx 3 $££ iSfiUllxEJS (Fracture Fixation, Intramedullary) WE 185 HF*liTEI£i£ (Intramedullary Nailing) (£Ml*)lS]£?£$ ££ ttla (Myelencephalon) UMcoX^^Xm WL 300$£ £ tllg (Afterbrain) !£7HB;1^$££ WMm (Pancreatic Cyst) WI 810 8?»l4ii$feE (Pancreatic Cystic Fibrosis) (*ftll&1£& I6*£$££ ^#^14'$UJ (Contingent Negative Variation) WL 102 mm (Essays) liNLM^HI^^f^- 9 $££ &Wfc (Extraction, Obstetrical) WQ 415 /k*g (Blister) WR 143 Rg/lrftwfc^liSMiS'Jfz 7m^ (Rales) imm^zfix **S14*ftlHl# (Acantholysis Bullosa) (i^j£7k*§*£$£ £ 4<*§14j£J#*£.& (Bullous Skin Diseases) li'H&**S14& )***;#.$££ * QT 265 BiBS^i (Sleep Therapy) lifr* ; t&«S**fflv^ QW 690 ftSfcF t>yyxli, iMSiJlz mmm^ (Illustrated Books) ItEUiSA D Ell:$££ X 7 7 - x •/ y° (Scholarships) (£ 7 x o - x -y 7° fc X 7 9 x-y7°$££ X*- (Skiing) QT 260.5.S6 x3f7X F-7A (Suxamethonium) l£xy x-/un ij x $££ X y 7 U- x (Squalene) QU 85 W^llb^ QD 416 xy ->— y y 7^f x7—7* (Succinic Oxidase) l£Cll£< mrh F*d77-7*$££ xy-> —/l/3ijx (Succinylcholine) QV 140 xy y-^yn ij x (Succinyldicholine) UX9 y—JV? iJ X$££ X y x x 4 ^ F* (Succinimides) QV 85 xy>X7*oA4^ Y (Succinbromimide) (£7*o*xy xx4 ^ K$££ xyy-t' (Sucrase) QU 136 xyyt-H-? (Scrapie Agent) I£7°'J7X$££ xyyt-74/l/X (Scrapie Virus) l£7°iJ4"X$££ X y 7 t-Ka#®$)KM (Scrapie-Associated Fibrils) (i 7'J7x$££ xyy/l/7r-F (Sucralfate) QV 66 mmmj]fa£: (Memory for Designs Test) l£#|£4xJl ^Jt£^$££ HJF^'xJj (Figural Aftereffect) WW 105 X7-0 xy (Scaling, Dental) (£#Pvttf WU 113 $ ££ X 3 ,7° 7 $ X (Scopolamine) QV 134 X 3 7° x i X - -^ /I/14- JfrBfc (Scopolamine-Morphine Anesthesia) l£^f4^B^ ; A*Bfr?u&ll $ £ £ X^7y s Xff#ffc(Scopolamine Derivatives) QV 134 fc-f (Tin) »»7C^fc LT QU 130.5 **4ffl WU 180 Mmm QV 618 wzfr(i, xmmiz AWl$fc££ x;7 (Styrenes) M®im QD 341. Hg mmm qv 633 MM (Headache) WL 342 mm WL 344$fc££ X7'y7°7XF (Step Test) li«UJttSf$££ Xro4 Y (Steroids) x.\m QU 85 Mmm QD 426-426.7 7/1/* X WK 150 ^SfeX7o4 K<7)£ft;$fc££, Wxlig&KlsHbXf d4 F' WK 150^$fc£i Xtd4 K^1jl&*ie^ (Anti-Inflammatory Agents, Steroidal) QV 247 X7n4 YMKV >7vfl (Anti-Rheumatic Agents, Steroidal) liXf^ F*^tt^*£^$££ X7o4 K^SBd^ (Abortifacient Agents, Steroidal) QV 175 Xtp4 KS^ffc (Receptors, Steroid) WK 150 X7 0-/W (Sterols) QU g5 XF7®^ (Stoicism) !£*£¥$££ XYyA* (Strikes, Employee) HD 5306-5450.7 *?!P£A* WX 159.8 nmmx7--\fx WA 412 S»i4t-h*X WA 495 mmm wy 30 mmx-cota® wx 159.8 ^f^trmmm, ^HfcL (Strychnine) QV 103 %mm QV 628 X F U - F t-7°^ (Street People) (£#££#$££ X F x X (Stress) QZ 160 Xmm QT 162.S8 m*Y \z-y9xu, xmwz X Y 1/XI6I (Stress Proteins) l£f&x 3 -y 9S&K$ ££ X F 1/7° F y*xx*i^*i*t (Streptozocin Diabetes) UWfc wmmmzfix X F X7° F 7 F x Xjf W*m (Streptozotocin Diabetes) Ii ^mwmmmttfix X Y yy Y F71/7-7' (Streptodomase) (£DN7--£*$£ £ x F x7°F F7i/7-7'fcX7 x7°F^7--t (Streptodomase and Streptokinase) QU 136 XFx7°F-v4xx (Streptomycin) QV 356 X F x7° F i -fex^4 (Streptomycetaceae) QW 125.5. S8 xFn"7r>7> (Strophanthins) QV 153 X F o y^jVXXfA (Strongyloidea) QX 243 X F n x 7 7 A (Strontium) t&mm QD 181. S8 ftm QU 130 mmm qv 275 X F o x77A|p]1ift: (Strontium Isotopes) &mm QD 181.S8 mmm qv 275 X F o X77 Ajft#H4|5Mtf£ (Strontium Radioisotopes) WN 420 mmrnm QC 796.S8 658 7.)[yfcs-)V teStttlsltif^T^** F t >y y X $ fc £ £ XfcfcXl (Mariones) (£7 X 74 X7*f|-$££ X7,j$ (Baths, Sand) l£#^*jgii$££ 8J>i$flft£ (Ammotherapy) WB 525 x77-vF (Rats, Sand) Ii7 x74 X'$ 4j>f1-$ £i Z,*- (Spider Monkey) Ii7 7 x7*/l/41-$ ££ X^4d/ F 'J— (Spirometry) HK&^-SW'Jtfc^ WB284 Wmmffi WF 141 X — /<7Jf x Kx*XAy — -t (Superoxide Dismutase) QU 140 IKgA'JEI* (Books, Illustrated) *t£ Z 1023 ^tt NC t#*y4 7°<7)Ell:l£, ±H£iJtz IffflOX Fl/-xaX WZ348l£$fc££ X't—$J& (Ancylostoma duodenale) (£§fc)&S$££ Xt'J/UA (Spirillum) QW 154 Xt'oft^Si (Spiro Compounds) FyxJrx47*fc LT QV 77.9 Mfeitm QD 341. Hg Xtn/yyFX (Spironolactone) QV 160 Xh°o^-y (Spirochaeta) QW 155 Xh'aA—yjiSifeSE (Spirochaetales Infections) WC 400-425 mm wc 400 i^IS^ SF 80g.S6 X¥v^-9&. (Spirochetosis) l£X t°o/\— y®ife^$ ££ Xto^-yl4l^-!H (Jaundice, Spirochetal) i£Weil*^$ ££ Xto^-y^ (Spirochaeta) QW 155 Xtn/x-y@ (Spirochaetales) QW 155 X toyy F X(Spirolactone)liX toy 7 9 Y X$££ Xh7|l (Spin Labels) XVumttiffift QH 324.g.S62 0lf (Pictorial Works) l£NLM-5HS^Ti£ff^#^T7, XliiI«J7LC#^$££ X 7 4 x 7fl|K (Sphingolipids) QU 85 X 7 4 x 7 $ x ij x (Sphingomyelins) QU g3 X 7 -f X 7 U t F* (Sphingolipids) QU 85 X 7 4 y 7 ij t Y& (Sphingolipidoses) WD 205.5. L5 W*mco%fo£iifLX, 15iJx(£Niemann-Pick*R WD 205.5.L5 X7x 0 7^-/1/XJ1 (Sphaerophoms) (i^^®M$££ X7in7^;Kliifeg (Sphaerophorus Infections) Ii7 VJ x $ £ £ X7/1/- (Sprue) li-fe 'J 7 -y y*S$££ X7o7xX (Suprofen) QV g5 X^4 y^kT9 ij 7 A (Hispanic Americans) E 184.S75 »Fh"7 7X(i, i»|iz &&) qd 305.S6 7?Wmit&V>l QD 341. S6 mmm qv 265 X/l/7 X7$ K (Sulfonamides) QV 265 XJVfc>m (Sulfonic Acids) QU 98 *&mim QD 181. SI Mmm IJ&IBfte QD 305.S3 ^#14 QD 341. S3 # (Back) WE 720-755 7*7 x X y X (Zearalenone) SnF-VxXfcLT QW 630.5.M9 xxFnrxfcLT WP 522 #5*r- t-y yxli, ±M^iJlz '14 (Sex) 3£M3I$££ lit (Taxes) -fe HJ 2240-7390 ftf* WU 77 *RPS WX 157 [S*J? W 74 mm WY 77 HftJ QV 736 3IM3l$fc££ 14HiF (Sex Factors) mm-^£ft;$&££ £fb^£ (Biochemists) (i^lb^OT'WfElr: ; A£-f|pjf Ii QU 22$££ XimW&ixm (Genetics, Biochemical) 4lb^gfz*tLT QU 4 JlfEiF-^gn QH 450-450.6 mm QH 430 AfUJ QH 431 JiJf^lzo^TO^^ WS 107.5.B4 wmY \zv9xu, xmmiz XimffiMMi (Biochemical Phenomena) (i£1b¥$££ Xitm^mm-^-7- (Tumor Markers, Biochemical) (i£W#JJ!i*§'V-7-$£i Xim&]-?—7- (Biochemical Markers) li^^jv -7-$££ 14f& (Character) BF 818-839 If £l£Jx#^jAfg- WM 190 ; AfcUft WM 190$ ££ 'ffit&ffM (Personality Development) BF 698 nXm WS 462 %1'jtmbX'jtm ws 105.5.P3 14f£f&^ (Personality Tests) >bmm BF 698.5-698.8 tf^H^ WM 145 14tmi4ilg^ (Personality Inventory) >bmm BF 698.5-6g8.8 mnmm wm 145 XiZ^m (Living Space) l£^^$££ X&coK (Quality of Life) WA 30 m*Y \z-y9Xit, ±jg#JtZ Xiim^. (Life Style) nX WS 462 JJP^- WT 30 Arcomcom* Y t>y y x|£±^iJlz,fyiJxl£X1bAII^ GN 315^ ; XimS. BJ 1545-1695 fe'StSoSMM (Life Change Events) nXm WS 462 tvjmbwjtm ws 105 %xm wt 104 #?#F \z>y9XU, 3£M£iJlz tf^ (Ductus Deferens) (£$81*1^ $££ ffil^P& (Vasectomy) WJ 780 fSiJ*Sli£ (Antineoplastic Agents) QV 269 femmm qz 267 vm.mmKxm'g. qv 269 $ fc £ £ 1431 (Genitalia) m^ SF 871 'hjfc WS 320 -izimt&m qv 170-177 mm (m&b-km&ix) wj 700 14J& WK 900$fc££ ■W.mmW (Sex Disorders) £14 WP 610 Utt WJ 709 660 •te4 x-a Wtta&S***^ WS 307.S3 tiiwxmmtft (-fe) wm 6ii INSISTS (Hypogonadism) WK 900 ttS^tUffi (Gonadal Dysgenesis) QS 677 ftg??!W^$X45 (Gonadal Dysgenesis, 45,X) (i TurnerfiEll£££$££ &S&WIISX045 (Gonadal Dysgnaesis, 45, XO) Ii Turner*£1t^Sf$££ ttft* (Sex Education) HQ 34-59 fttt?8&a»#*> LC 46074640.4Xli HQ 54.3 14Fp1SI WM 307.S3 mmm^ QT 225 ttSttft^ (Infantilism. Genital) (i14t^^1£T*^$£i g^*H4d£ (Orthopedics) WE 168-190 W)® SF 910.5 mil WE 168 ?vjimb®[jtm ws 270 mm wy 157.6 #£8«**W* WE 190 ft£<0#, H3ti5Xli*ig?>£t4$fc££ mtPt-mmm (Orthopedic Nursing) WY 157.6 QWA-mMfc^ (Orthopedic Fixation Devices) WE 185 e$ttf4W*!!:S (Manipulation, Orthopedic) WB 535 &x.Bmm&u, tmmwc Bl^^f4fflSft (Orthopedic Equipment) WTE 26 mm. we mil; w£9Ayco&fk, miu-%u we 185$fc££ ttJ^K (Sex Characteristics) #f£W QS, QT £14 WP 101 £14 WJ 101-102 ■bmm&) BF 692 ftftK (Cleanliness, Personal) UffiXcoXWmM QT 240 $££ 14'i&/E (Sex Determination) mmft WQ 206 &&1&XC0 QS 638 4tt (Biopsy) Bft&Br WB 379 m^mm wo 142 mmm sf 772 #£SM£(i&ff*'JJ;: ; WZm&um.&miz SiJRBxx F*y y X7 —-t (Restriction Endonucleases) DNABg£gf3?f$££ ^c^J (Success) (iBHiil£$££ tt£ (Coitus) mm (-fe) li£JJ£ QL 761 $££ km HQ 19-30.7 mnxmmtfirm wm 611 £14 WP 610 £14 wj 7og ttfrfc (Sex Behavior) kfM HQ 12-472 nXm WS 462 fl'Jtmbty'Jtm WS 105.5. S4 •bmm BF 692 14fr-&^ Uk& (Sexually Transmitted Diseases) WC 140-185 mm wc ho mm wc 150 *14fcfclt4 WP 157 1414-^^1 lilt (Sexual Partners) ift^F t'yyxi£, xmwz ■\£$.'&mft:m (Contraceptives, Postcoital) QV 177 'l-ftf&Jg&R (Biosynthetic Proteins) l£*fl^®&M$£ £ 'l4^***ifi*E (Dyspareunia) WP 610 X'ik7T (Postnatal Care) WQ 500 mmmmx'&mm wYi57.3$fc££ SHtl^i* (Osteopathic Medicine) WB 940 &ftXft (Osteopathic Manipulation) it^Mm^^W. $££ m^mmm (Osteopathy) (iC'<#|I^$£i 14H (Sex Differences) li14J12§C$££ Mm (Seminiferous Tubules) WJ 830 QkMcoy'OVikTK (Labels, Pharmaceutical) itm°a7^< /HS^$££ S^JttWJ (Pharmaceutic Aids) QV 800 $kW\l\%Mft\ (Preservatives, Pharmaceutical) QV 820 mm (Spermatic Cord) WJ 780 iBcfcifc^ (Policy Making) -fe H 97 nmv t-yyxii, xmmz mmmmm (Varicocele) WJ 780 ff^it:|E*£ (Spermatic Cord Torsion) WJ 780 ^m (Hydrocyanic Acid) QV 632 4£d14 (Productivity) liig^$££ Mmm (Antacids) QV 69 SiJlL (Omm) (Inhibition (Psychology)) BF 335-337 fl'Jtmbifi'Jtm WS 350.8.14 mX (Spermatozoa) WJ 834 ~zmmtzmumnxwis. qv i77$££ ~*x%Mm zmumxmmmmm qv m$£i Xm (Dentition) WU 210 mXMWlVVMViJK (Sperm Immobilizing Agents) QV 177 mm (Politics) j mmutti) m*Y \z-y9Xit, ±MSiJlz iftfeJSIlj (Political Activity) (ii#dS$£i m±m (Resting Phase) itmm^mmm^flX mX&tt. (Spermatogenesis) WJ 834 igacixX7A (Political Systems) JC mnfrffi, mn^mmm, xum^^am^mmzisit h WM 460.5.P7 ^*f t'yyxiz^^tsfc^ii, xmmz ^SxX7A<7)^ft;$fc£i,f?iJxli'4t^±*li HX 72 -73 ; 626-780.7^ mXMk (Sperm Penetration) fi«4-W44IS^ffl$£ £ ^K (Voice Quality) WV 501 &±n& (Resting Potentials) l£BISfi$££ ifeii'14#^'fb*£ (Osteosclerosis Fragilis) l£^caiS#*^$ ££ i&m^rMm (Teratoma, Mature) l£Hj£ft)&$££ !*&#§!! (Meiosis) QH 605.3 n&m (Youth) (£#¥^$££ SS (Bible) BS ~co*izts^x$mztiz>mm wz 330 m% y \z-y 9xu, xmsMzmummxnmfyKvmm &^«I£QV 766 661 ■t a y 3 y jESffrBSH^JOUHmt (Abruptio Placentae) WQ 212 $i'£[II4- (Lipoprotein Lipase) QU 136 il4y;ifa.vfr7n7*ij ymm (Normal Serum Globulin Therapy) l£-gDj&*£$££ H.*tttH& (Astrocytes) WL 102.5 M.tkmmM (Astrocytoma) QZ 380 fiB^14c7)fc<0(£SlKiWz M.tttt&g|i (Stellate Ganglion) WL 600 JEftffi. (Normal Values) (i#BBfit$£i jE&BSM (Placentoma, Normal) (£B£**$££ iE&fSB (Normal Range) (£#BBfii$££ Xfiii (Reproduction) ^IS^I$££ MM (Vocations) l£fyt$££ XM& (Genitalia) m^ SF 871 !£m WS 320 -izimt&m QV 170-177 mm (mat-kit, m&) wj 700 148* WK 900$fc££ £SSS* (Reproductive System) l±£J£g ; £JS ; «fS £«&*$££ Wfe^BKBlue Sclera) li&IRwTW^ WW 230$££ XMmimm (Germ-Line Cells) (££««$££ Xmmm (Germ Cells) WQ 205 Wfa QL g64-g66 Xmmm^.mXm (Germ Line Theory) liffitt^MfH** ££ SW# (Clergy) BV 659-683 4fcmP'C*3ffi^ WM 61$fc££ 4£mSM (Gonads) WK 900 ^m WP 320-322 § ; Itm WJ 820 m i *»IB WJ 868^$fc££ %M\¥U (Gonosomes) (£14ifefef4:$££ Xmfcll (Fertility) WP 565 %Wj\ m^ SF 871 mXco QP 273 -izftrntzm QV 170 mmj)%: WP 565 f!14 WJ 702 mm-Aj)^ wn 620 XMUB^^hmm (Genitourinary Neoplasms) UW-W.X m^mmzfix XmXHm (Sterility) WP 570 mmmft$? sf 87i mX-^XyXKi'tm (Sperm-Ovum Interactions) WQ 205 BScA (Adult) %&bmm BF 724.5-724.85 *¥ BF 724.6-724.65 Ar^^coW^Y t-yyx|£, ±gjgij{c Jjn«$ WT 104 $ fc £ £ mM%*m (Ataractics) i£F7x*74 7$££ mmm (Psychiatry) WM mxmimxmnmm ws 463$££ &£•?> WZ 112.5.P6 f®A<7) WZ 100 7-Xxy7>f WM 40-49 mWMffiiztsitZ WM 302 x'jtux'jtmwmm ws 350-350.8$££ 7 7x-t ij xy WM 55^ k% • mam wm 22 £1* WM 20 Xft WM 25 zkmmuzxmnmm wt 150$££ f^li*St#fHS*$f*P£ W 270^$££ mwm WM 32-33 SIS^liBj&WttlS* W 740$££ mmummmm wy i6o$££ mft^m wm 30 ^^ WT 150 XMimt&mnmm wm 31.5^$££ tt^iiftb««wis^ wm 30.6-31.5; tt^mmmm WM 428$££ mmnmm w 74o$fc££ ttt^[S^|5c^|S^7-tX (Emergency Services, Psychiatric) WM 401 mtmmti^M (Social Work, Psychiatric) WM 30.5 tf^E^y-x^/l/7-y (Psychiatric Social Work) Ii IIWIS^±^»II$££ mnmmbW±£^i± (Social Service, Psychiatric) (itS nmmtt^mzfix mWmmfomnR& (Psychiatric Status Rating Scales) WM 141 mnmmizis it Zmmmm (Drama Therapy in Psychiatry) l£-b>SiiJ$££ mnmmn&Hmm (Educational Therapy in Psychiatry) l£ff-»i£ I mWMffiW|$cW$££ mWmft^ftli (Insanity Defense) W 740 mW WM 32-33 mWmnWfim (Psychotomimetic Agents) l£iO^^J$M £ mW-Afcm (Psychogenetics) U'YrW&fcmZflX mWM$M* (Psychomotor Disorders) WM 197 ftM'Mffi'Jtco WS 107.5.P7 ^^^Pf»«$fc££ mWMM&l] (Psychomotor Perfofmance) WE 104 mWmX (Mental Health) WM 105 WmX WM 31 nxm ws 462 fvjmtwjm ws 105.5.M3 %X-m WT 145 ffimXco WA 495 WW.CO UH 629-629.5 mimim wm 75 H4t WA 390 mYZ. WA 352 ttOtmstftmx wm 31 ftZXMiM WA 305 £14 WA 309 mW&XT'-VX (Mental Health Services) WM 30 mmiztsuz WA 495 ivjimtwjm wm 30 W-m UH 629-629.5 m$c.yv9'7-i* tmtX*^ WA 352 m&±mt%.m±m wa 353 662 -fe4x-x7 mx®% WA 305 ffiWa^m (Psychoacoustics) WY 270 m?Ym (Alienists) umnmmnYGotim wz 112.5. p6^ ; ^^^coXk% • t4.P/?M WM 22$ ££ jtttf4lSB#fSArBra^ (Psychiatrist-Patient Relations) l±F&Mi-A#IKI kmffl& $ £ £ t(!tf44[S*JH*Pfc (Insurance, Psychiatric) W 270 *Sttft#H (Psychiatric Nursing) WY 160 ffcfc WY 18-18.5 m^mmmX (Psychiatric Aides) WY 160 ^ASW^jifiEf^ (Respiratory Distress Syndrome, Adult) WF 140 Wtt4Hfl$H (Hospital Psychiatric Department) (^PXfi'i W4SI3H$££ ffrtWI- (Psychosurgery) WL 370 fftW^ (Psychoactive Agents) (£fat^ttil$££ WtWfflU (Psychotropic Drugs) QV 77.2-77.9 *!*#$* (Mental Disorders) WM mm wm 40 $m WM 141 mwrnm wm 402 mmmx wm 31 mm wm 140 nxm ws 463 %VimbWjm WS 350-350.8 mw-miztsitz> WM 307.M5 %XM WT 150 &4IW WQ 240 m&muzimmwmm w 74o#$££ mmitmwmmm wy i6o$£i iJ^t'Jr-xa X WM 29 tt^mrMMX WM 31 &m WM 400# A:cofcogffccoWWnZfo*: fc££ InWM^&Mkm (Commitment of Mentally 111) WM 32-33 *P?tti!Kb<£ (Catharsis) l£7y/i/xX$££ ltttttSIX7->7L-;w (Mental Status Schedule) WM 141 mmm (Nervous Exhaustion) lit*££s§i$££ mWW&& (Psychoneuroses) f£/4o—1$££ IfftW^^S^ (Psychoneuroimmunology) WL 103.7 tnW^Vfmm (Psychosomatic Medicine) WM 90 *£.e.l£'l>lrfiE WM 90^$££ mWbmmtf) y 4 - Y '< -y 9 (Feedback, Psychophysiologic) li'<4 7 7 4 — Y'*"J 9 ('Omm) $££ mnXmm (Psychophysiology) WL 103 ^tfiXmmW (Psychophysiologic Disorders) WM go fV&mbX'jtm wm go imww wm 611 mW&ffi (Mental Retardation) WM 300-308 &#•£ WM 300 ^VRMbWUm WS 107 nxm ws 463 fi'Jtmbth'jim ws 107-107.5 mmrnm ws 107.5x2 mt#f* WM 307.M5 m.m^m hv 3005 #»£* ws 105.5.C3^; mw&'Mw^mfi lc 46074640.4$ fc££ MWifi*! (Mental Healing) WB 880-885 \mmm wb 885 9 ij X7^X74^XX WB 885^$fc££ mnMXm (Defectives, Mental) l£mttii^$££ h'rmm^ (Mentally Handicapped) itmWMffiZflX mm'M% (Mental Fatigue) WM 174 mm LO WA 4g5 h'nmAK^ (Reflex, Psychogalvanic) (£«;?4&)#Jx:j£ $££ mWm% (Mental Deficiency) fiti'lttStf!^^ mWMUft<7)$(.fi (Education of Mentally Defective) (i MtiMciIi»##5cff$££ UkkiitiLmtiMm (Diabetes Mellitus, Adult-Onset) l£ 4 xx 'J xJI4&rr7^#ltJ/li*«$££ mW%'MMffiri$t.fi (Education of Mentally Retarded) LC 4601-4640.4 'I4#ff HQ 54.3 mmnn lc 4613 m*m (Psychoses) itmWmim'WZ&X mWmm (Hospitals, Psychiatric) WM 27-28 M WM 30 A€ • 14.P4I* WM 22 m^mm wm 402 14'bS&vI^M^^ (Psychosexual Dysfunctions) WM 611 14'b>JIftPfW (Psychosexual Disorders) WM 611 14'b>a^J^it (Psychosexual Development) BF 692 nXm WS 462 ?L!£»lfc*&Je»l WS 105.5. P3 mnmm (Psychotherapy) WM 420 itXm WS 463 zvjmbwjtm ws 350.2 %xm WT 150 $AT*H!fe&ifo.*Fi-iJ yvx im (Adult T-Cell Leukemia-Lymphoma Virus I) (£HTLV-1$££ §£7kJ± (Hydrostatic Pressure) £SftilJ& WD 650 'I4£jSAH# (Sex Manuals) HQ 31 14l£?fc (Puberty) WS 450 $L%t( (Educational Achievement) l£=pS$££ jE*3Rfc (Normoblasts) (£*3RS$££ &£*itt$6 ('bmm) (Knowledge of Results (Psychology)) mm mn^mm) lb 1065 iJJttolf BF 501-505 m\y 4- \"%co%foZ fc££ %.Vfx.fcjv%-m (Bioenergetics) I£x7/l/^r-ft^t$£ £ XW-J&'gWlffi (Biological Response Modifiers) QW 800 4f4»£iJ (Vivisection) %%kmm WO 50 4t^ft#§* HV 4915 Xtt-mmmm (Antivivisection) (££1£ft?gi]$££ XW,m (Ecology) -fefclft^ QH 540-54g.5 ARU GF mil GF 31-48 mm QK 901-938 4:*J«^-y ij x7 (Ecological Monitoring) liSig* -y >jxy$£i Xfcmtimtil (Monitoring, Physiologic) WB 142 'DJKM9& WG 140 mv>ii&mikM wb 330 mxfemiztsitz wx 2i8# wzmmt, xmmiz Arco^comt, A:C03hizmitz5T®m*r)tk7£&J*, ii Slil41(z mm&Afi WN 650$ ££ X.m?k (Ecosystem) l££t^$££ XVfXm (Biomechanics) WE 103 4£f*4I?s;t4 (Homeostasis) QT 120 XWMftX (Biopolymers) Mmm QD 380-388 XW-ttf^WM. (Testing, Biocompatible Materials) (iW *4Ift§*$££ 664 AlA tx7 £ft|g]#]t4 (Bioperiodicity) li)S))Wt4$£i £(£$!£ (Biometry) QH 323.5 $¥&) WA 950 4f£*Il«fc$W$,J (Tissue Adhesives) WO 166 Sftil&ttt't (Biocompatible Materials) QT 34 ^^l^lzffiffl^ri^^^^H-lMSiJlz.^JxIiAT.BiS^ (-**) WO 176 £(£1^x4/1/3-"—W. (Bioelectric Energy Sources) QT 34 ftmnftizfem$tiz>*Bi&u, xmwz, mtu^-x /-7-li WG 26 Sf^W^flJ (Tissue Distribution) QY 38 44^ 1*1$lb (Biotransformation) ftm qu 120 mmm qv 38 F&Utz' (Vocal Fold) (i^^$££ £f£7 i - Y'*I¥) (Biofeedback (Psychology)) WL 103 mnmrn wm 420 p%B& (Vacal Cord Paralysis) WV 535 £f£$f)& (Biological Transport) QH 509 mmm qh 601 rem qu 120 §g QH 615^$fc££ XiYmtm (Biomaterials) l£EfflW*;t$££ JEtttS (Median Nerve) WL 400 |^$Tlt^3l'BW«^$fc££,f?iJxl£^li WE 830 lE+tt (Median Bar) lifJUA£!UM£.$$£ £ M.&& (Sipunculida) l£^A^$££ 14®C (Sex Dimorphism) Ii14ff^g$£i ifiift (Growth) JfiSW-lftWdcS WS 103 tJfttWfiSc:KI£]£a?§ii WS 105^$££ #f£ft WS 103 m. WS 16 SfiPf W (Growth Disorders) *?c14 WE 250 W#«£tt WK 550 IXRMbX'RM WS 104 «*^W^il QZ 190 mw.m QZ 45 SftPIW^K (Growth Inhibitors) QU 107 ^cfitS (Growth Plate) WE 200 *&*£ (Failure to Thrive) WS 104 #£&K (Growth Substances) QU 107 m®umm®.%mB'y>i'g. qk 745$££ l&firt/l/^x (Somatotropin) WK 515 Xg.*£ WK 550 ¥rfflm<7>W.mbLXC0A:tlU, AzW^iz f&jkfcJV^ y^^-W- (Receptors, Somatotropin) WK 515 fc&fcJV^yl&fcfflMfcJV^y (Somatotropin Release Inhibiting Hormone) !£X-^Fxy7x$££ ^fttfPSiJ^J (Growth Inhibitors) QU 107 SftPfW WE 250^$fc££ ttWiillt (Sex Deviations) (£'f4^fiJig$££ 14ft SS® (Autosexuality) l£SS®$££ iiWJtmMft (Child Abuse, Sexual) WA 320 f£&%co^mtt)%m WM 610 tt&WfW (Sex Disorders) £14 WP 610 911* WJ 709 Wttf8J4Ja«lr1t<7)|lSIlS WM 307.S3 mwxmmw (-fe) wm 6ii 1*Kj'W£*H>fcT £> (Child Molestation, Sexual) l£14ft !£m)ttf$££ ItWUMS (Sexual Adjustment) l£14(WfW : 144-4SAH ■Il:$££ 14fa#Jf#.*,K (Infantilism, Sexual) (£'|4t$^1£T*iE$££ tfcfelfcSIS (Transsexualism) WM 611 14151-tfc (Gender Identity) HQ 1075 ff^JOj WS 462 IVJimbty'Jim WS 105.5. P3 'b>fl'7(l'jf % BF 692.2 7/14 BF 692.5 Alt HQ 1206^ mm (Perversion, Sex) l£14^fiJfg$££ WJBMWtfi" (Diabetes, Bronze) (£lliL&^*£$££ lE^^Ji^f-lf (Due Process) l£&^$££ XmXrtW) (Innate Behavior) (i*^$££ MB±H (Antiemetics) QV 73 If 1*1 £ (Meat-Packing Industry) TS 1970-1973 mmrnm wa 400-495 mw&mto wa 788 Jtl*J*fcit WA 707 W^NW (Adolescence) WS 460-463 ttJEIiW^WttftE WS 462#$££ ^%l%\\%¥ (Adolescent Medicine) WS 460 m-Xm&bfc (Pregnancy in Adolescence) mmmi& ws 462 mmw$m wq 'L'StoBHH WS 462 *S*lh WA 310-352 #*MJJ<7)rriJj (Adolescent Behavior) WS 462 nX-Aj-mm (Adolescent Psychology) WS 462 ^Xmnmm (Adolescent Psychiatry) WS 463 MMt LT WS 463 tf ft (Seminal Vesicles) WJ 750 tfftifc (Vesiculitis, Seminal) l£tfft$££ 14<7)fflMflJj a (Counseling, Sex) (£7 -y 9 X 7 7 X-fe 'J X 7$££ t40f&»J (Sex Role) I£14|b]-14$££ WIS (Locus Coeruleus) WL 310 14mP (Sex Offenses) iHmm HV 6556-6593 mmmft^m w 795 14Jt (Sex Ratio) «$^l$££ 14#l (Venereal Diseases) l£14tf&$&*£$££ 14*^^ (Venereology) WC 140-185 14*S'I41*1 Wm (Granuloma Venereum) UM.'&MWm% ££ 14*i>rl4£Z.ta (Bubo, Venereal) l£14;(4^^ife*£$££ tt^'tt'J y^& (Lymphopathia Venerea) I£'14*^'I4'J X^|*J3H1$££ 14*F?14'J X'^IFIIi (Lymphogranuloma Venereum) WC 185 S£pb1*]^^ (Product Labeling) WA 250 m^%°aC0A:flit, ±S^iJlz mS,7-<)VMjX QV 835$fc££ 665 -fe47 ifrlff (Government) J miui (-**) uttmmmiz mm w 94 rmmmm^mm w %^t; wmmmmn uh 650-655$ fc££ mi7-tx wy 130 \mmm wy 130; zMrnxmrn wy ios^ ; # mwnftff WY 130^ $ fc £ £ iftffrfiHT^ (Government Publications) Yfik^'^-kmm W 2 *f£ Z 7164.G7 1@7 0SIZH|LT Z 1201-4980 mm&'kmm w 2 xm&*.co&ffom mftmxuxmmiz mkfmwi (mmbw&ftm wi $9tftmm7'—'£X (Government Nursing Services) lifii w.mn;&ifcWixmmt:iifix ift!frt$M (Government Agencies) JF 1501-1525 RtltffiX WA 540-546 mm.wkmm uh 460-485; &%.? Aycommzz fc ££ iftfl\fJI,5E (Government Regulations) !£££#: ', J%zL$tl%> gl&itzimnvZfoZflX, mx-l£\m& £$& qz 241 XVvmmm (Biological Products) QW 800 ftip WA 730 tmmib&yj} qv 370 mmm sf 918.B5 &ikfc>v^y WK 187$fc££ Xmm&smnmm (Biological Psychiatry) WM 102 ff?*F t-y yxi£, ±M#jlZ XfyjmWm^ (Biological Warfare) mmm&i^m qw 300 w-w^m ug 447.8 XmmtfXfcMWiik (Biological Transport, Active) QH sog mmm qh 601 Rm qu 120 XfyimmWk (Markers, Biological) UXmm#)-?-7- $££ XWimtfi'*-X 9 - 7 - (Pacemakers, Biological) (24 »ft$££ X.tyJJm&l&ft (Dressings, Biological) Ii4-:^t£fa$fc££ XtynmttlWA (Transport, Biological) l£4^^^$££ XVvmtfimmm (Bidogical Availability) QV 38 wwy \z-y9xu, xmmz XtynYkx. (Bioassay) l£^'4 77 -y 7 4 $££ XWA^it t&th (Biohazards Containment) li'<4 fc" T'-YcoZit&sbZflX Xmfcmiz X h&^m (Biological Dressings) WO 167 Xmttm<7>\%M- (Preservation, Biological) QH 324 lfiL^(£jflL®1*# WH 460!£$££ ^mtm^m^^m wa 844$££ IftlilftlTl QV 754^$££ ti&ii'k&im WA 710$££ Kfl {**&*&## WO 665^$££ XWmm (Biologies) l££^«i^j$££ Xtyj'&.m (Biomathematics) l£3&^$££ XtyMX (Beginning of Life) l£4^%£$££ Xtymtm (Biostatistics) l£#cft¥$££ X^mt (Biological Clocks) QT 167 a mmcoxwim y t -y y x $ fc £ £ Xtyco^HB (Metamorphosis, Biological) QL 981 MA QL 494.5 XtynM.Wfa'^m (Biological Waste Disposal) UmmfeM =l»l$££ XWAit (Bioluminescence) U)V ^4tXX$££ Xm^t^WM. (Bioluminescent Proteins) (£^*SfiK $££ Xmim^- (Biological Oscillators) Ii44*l#ft$£i XmftX (Biogenesis) QH 325 xmmxcommt± w 789 Xyntfamm (Biophysics) QT 34 mm wn no XW)5tM (Biodegradation) WA 671 Umm^M WA 778-788 f#5*F t^yxl£, i^iJlz XtyiWtffli (Bioprosthesis) •tm^-^tziheo WG 169 4>fllAl#$fc££ Xtyi^T-JV (Models, Biological) QH 324.8 m^xmcoAitiuxm^z, miukmma weio3 XVnmftim (Biopharmaceutics) QV 38 iftlfftilJj (Subsidies, Government) liS^WJi«rfgflJJ$ ££ 14^4b (Sex Differentiation) 666 -fe + 234-fe EJfM±W QS 640 tt^-fbPff (Sex Differentiation Disorders) WJ 712 mmm sf 87i g^Hjjfa. (Blood Component Transfusion) WB 356 *!& (Spermatophores) l£tf WMm $ £ £ ftWSS (Spermatocytes) WJ 834 ■(^rfc/l/^X (Sex Hormones) WK 900 £14 WP 520-530 814 WJ 875 £f£7;i^X<7)£1vP$fc££ |!i* (Bookbinding) Z 266-276 W&S7 ^ -/ 7 ^ x F ftft (Denture, Precision Attachment) WU 515 MtF*]!£#t (Injections, Intravenous) WB 354 4lfr (Life) uxmx ; £W : *£¥$££ ft£ (Names) ^|g^l$££ £fr, j£W?fjt (Life, Legal Establishment) Ii4:t%*£ 4 ; {b^SEBfl* : *r£i£ ; S^Jt$fr.$£i 4^*tft^M (Life Support Systems) WD 756 X^immmm (Life Support Care) WX 162 f&3HP3ffi W 50 g^W WT 31 mm wy 152 4lftW|eig (Origin of Life) l££^?§£$££ 4^* (Life Tables) AP^ HB 1322 ^4Ft-yyxi£, xmwz mmttfrtifiiifix X^myytiT (Life Table Analysis) (££%^$££ X^U^T'JV (Life Table Models) (££^$££ X^mk (Insurance, Life) HG 87579271 PW&* (Laryngismus) WX 500 ftS«TntffW WO 245$fc££ ISH-fb^ (Chemistry, Pharmaceutical) QV 744 Hmm (Pharmaceutics) l£^$££ KHftffi (Technology, Pharmaceutical) QV 778 %imm (Drug Industry) QV 736 tm QV 773 mm<7)fam QV 21$fc££ &mmm wa 400-495 mMmtfo wa 788 nmmS, (Supplies, Pharmaceutical) (£gffltl§t?fc«4f ms,; mmshsm; imm&nftfe*)?Ay, mtum Vn&mZflX %imimm (Pharmaceutical Ethics) !£^^W#S$££ Witfe (Oils, Essential) I£t¥%'t4jft $ £ £ S§^4 (Esthetic Surgery) I£jf^y4f4$££ ttfifc (Libido) tftt^t/f (¥) WM 460.5.S3 tt&ffllg (Paraphilias) WM 610 SHUSH (Leprostatic Agents) QV 259 XM (Menstruation) WP 550-560 nmmm wp 540 Xmim (Physiological Chemistry) l££1b^$££ Xmm (Physiology) QT mm qw 52 mi M&co WZ 112.5. P5 iMkco WZ 100 MtftAn QT 160 Rtomifc QT 150 a£ • mam qt 22 m^ SF 768-768.2 %m QT 25 S6!£ WQ 210.5 %BAm QT 150 \m (-fe) QT 104 97Ji!j WQ 305 ttl£^IJtt&£*l^ WL 102$ ££ mmrnm* x qt 104 ■bmmumwx.mm wl 103$££ m-\ wo 102 mxmwn QI>^ t*£w&, 7:f4T<7)l*£flfc tK^WB 26$££ *t4$^*£s (Infrared Spectroscopy) I£*y4^**)£ '£$££ fc9YB5rytitJg.m (Spectrophotometry, Infrared) Mmim QD 272.S57 ^M.m QC 457 667 ■b + ^J+a tm^HWlzftJH^ftS^liiBX'JC mt-it^co AWtiWWfc WA 754 *3Rfc (Erythroblasts) WH 150 *3FStttRjfiL(Erythroblastic Anemia) (i7 7-fe S 7$£ £ *##*> 7 (Pure Red-Cell Aplasia) li£tt*JfiU$l£&^ (&$££ **S (Red Nucleus) WL 310 #gfjRI (Chordoma) QZ 310 RgHrt4?)fco{£SlMi£iJlz ItmWlWn (Chordata) QL 605-739.8 sm%%m* ii fix, murnxm ql %sm fcXX (Red Cross) iff-h'X UH 535-537 ifcW HV 560-583 iW7-tX VG 457 #11 WY 137 *feft& (Red Marrow) l£#SI$££ IH& (Spinal Cord) WL 400 WMEE& (Spinal Cord Compression) WL 400 ffttJBEBE (Spinal Fluid Pressure) (£Si^M^J±$££ #M& (Myelitis) WL 400 WfiSKfiifc (Poliomyelitis) WC 555 T-Kfc$iJI± WC 556 WM$5#i?B*£ (Spinal Muscular Atrophy) (£WiS14®$^ *£*£$££ T^M^K (Syringomyelia) WL 400 Ifmtfcmftm (Myelodysplasia) li**&#ffl«£$£ £ ffMtlftS^ (Rhizanesthesia) (£fzoi «**¥$££ ~#M*£& (Spinal Cord Diseases) WL 400 1fMmm (Spinal Cord Neoplasms) WL 400 T?t6Pi1?14S5#liS (Myelopathic Muscular Atrophy) Ii ffM14^HS*S$£i ffflWiB (Spinal Nerves) WL 400 fftlttl&lB (Spinal Nerve Roots) WL 400 #ffittlB#ilfcS£ (Muscular Atrophy, Spinal) WE 550 Ifffi&Bm (Myelography) WL 405 fflffitgfil (Spinal Cord Injuries) WL 400 #M^I±ii. (Compression of the Spinal Cord) (£WME it$££ ftmmn (Spinal Cord Syphilis) li?Hffi$ •) $££ ffflSiJM (Spinal Accessory Nerve) (£IiJtt^$££ 1?mmi% (Meningocele) WL 200 #te€£*£ (Spinal Dysraphism) WE 730 W8S*S (Myelocele) (£MBI*M*g$££ 'ifm^ i (Tabes Dorsalis) WC 165 -fe ^r-fe 4 A X n (Budgerigar Fancier's Lung) l£ F U Sb1*N $££ =5J& (Coal) TP 325-326 t# QV 633 mm& WF 654&f>*[H^PfW$ fc££ CJKIfc (Carbolic Acid) (£7xX-/l/$££ WttW (Spinal Canal) WE 725 mmW (Spinal Stenosis) WE 725 ft&ffiXmm (Chiropractic) WB 905-905.9 #ttf**i£ (Kyphosis) WE 735 1=Pttf&!±fSfi£ (Manipulation, Chiropractic) (£7 4o7° yyr^r yy$££ mi.m9t& (Lordosis) WE735 l?t4fflij^*£ (Scoliosis) WE 735 Wt±fi£ (1*) SI (Spina Bifida) liftlHUf £•*£ WE 730 $££ fttt^lfi (Curvatures, Spinal) (i¥r4£f£W*JE : Wtllflij* *^;Wt4fUJW*£$£i *"<£ (Blood Sedimentation) QY 408 ft& (Spine) WE 725-740 1fm&&& (Spondy lolisthesis) WE 730 SFttifc (Spondylitis) WE 725 Wtt*£t£ (Tuberculosis, Spinal) WE 253 *Ft£*S!K*rJftBft£ (Epidural Anesthesia) ttttfflgftjftft* ££ T?t£#4Tf (Spinal Fractures) WE 725 Wtf #*i*it*£ (Spinal Osteophytosis) WE 725 mmm sf 901 #tt#S#1bP$W (Spondyloepiphyseal Dysplasia) li# &#JFMfl&S$££ l¥«tMffi (Spinal Fusion) WE 725 1fmm& (Spinal Diseases) WE 725 mmm sf 901 fffltffiH (Spinal Neoplasms) WE 725 T^tf-f^ 9 *£ (Spondylolisthesis) WE 730 IHSl^iJ (Spinal Puncture) mmmuitMw wo 305$££ mmm qy 220^ -fet&HJf WB 377 W&m iz is it Z> mmA:C0ttLC0Y \z-y9X%iiflX, fflx I£?§3^f4£ QL 959^ ^*&.Wfa7 AJVX (Vertebrate Viruses) Hie QW 164 DNAIiDNA7 4^X QW 165$££ RNAI£RNA7 4/i/X QW 168$££ A:COttico%fm%1?mm!fo7 A JVXeoZfo* fc££ 1tmfrm& (Spondylosis) l£W«l'tl#^ffi$££ '^m\^mwm (Paravertebral Anesthesia) (if£&#», tti7n .yy$££ 1tmmm (Anesthesia, Spinal) WO 305 l^it*1) (Antitussive Agents) QV 76 na (Liability) unamk; mm&mzfix namk (Insurance, Liability) HG gggo (NLM#MT'{£^Hi#^33fc L < l£33.1) S#!£ (Chalicosis) (£^)liti*E$££ SKI (Asbestos) 668 ■fe y y a 9 ~fcy)VtlX TN 930 km&yalitlX WA 754 itHllfcJtS WA 450 g^K't*^ WA 788 %W$ QV 610 HiMife (Asbestosis) WF 654 5$ (Petroleum) {imtm TP 690-699 gftf: QV 633 m (Dysentery) WC 280-285 mmmn sf 809.D87 *$$$&££ (Shigella Infections) I£*ffllit4*#il$££ mWZ (Shigella) QW 138.5.S4 fey' y^JV'^y X9 X F (Sexual Harassmeat) HD 6060.3 fe7'X7x (Secretin) WK 170 fe3/Vv 9-y—y^r 'J — (Second-Look Surgery) Ii H44R$£i fe->7A (Cesium) &mtm QD 181. C8 H3# QV 275 -tx>7A[s]tif£ (Cesium Isotopes) *t£1b¥ QD 181. C8 mmm qv 275 -fex7AftStt4[5]fif4 (Cesium Radioisotopes) WN 420 mnmm QC 7g6.C8 mtimmcoxv)^ y t •■, 9 x $ fc £ £ tf (Boils) l£7/UX7/l/ffi$££ § (Tongue) WI 210 SPBttS (Glossopharyngeal Nerve) WL 330 §& (Glossitis) WI 210 5K (Calcium) (£7/l/x7A QV 276$££ «ffl (Dissection) QS 130-132 iKE^S-ff SF 762 AXkti:m& (Calcinosis) WD 200.5.C2 femfilkfiE WE 740 mtfiit-W QZ 180$fc££ SSftlbfiE (Hyperkeratosis Linguae) (i4ilS"$£i ST#^ (Hypoglossal Nerve) WL 330 !&T!!fc (Sublingual Gland) WI 230 fTFSB (Sublingual Region) (£PlS$££ fe-yyx77x-feijxy (Sex Counseling) WM 55 *JfiL5£ (Erythrocytes) WH 150-180 %&mk& QY 402 fcimmAfcyWik^WS. (Erythrocyte Anion Transport Protein) (£'o#>£*?!$££ *g& (Fasting) WB 420 t£te$S£*£ (Hypersensitivity, Contact) (±#ctt14&I*!fc $££ ftttlBStt (Sensitivity, Contact) l£ttJ&14&]S&$££ &M&&& (Contagious Diseases) lif£^*^$££ ^ftftlftPt© (Food Intake Regulation) (£&$;pgn$£ £ tfftt?I*£ (Eczema, Contact) l£t£te14&Jti£$££ fg&Pf W (Eating Disorders) ?L!£Wfc^^W 7I£ WS 130 ?L16 WS 120 *£*?!§I&1b WI 143 filtt't'Jl^W WM 175 ftUM&£)tifc (Dermatitis, Contact) WR 175 fSj£#5iS (Food Deprivation) 3ll££1b^ QU 34 %mmmm qv 34 ^it QU 14631 £ fc££ 669 ■fe 7 x a 9 kite WD 105-155^ Yk*?y&M?l (Contact Tracing) Wx.WX-liglMiSiJlz fr^f&fti (Glossectomy) WI 210 t?Jfii| (Cutting Wounds) lif?il|i]$££ gfi£lM^ (Arthropods) QX 460-570 <%%, miURr/X^ WD 400-430 fcftm&nWMb LT WR 360-375 &W)ty)m QE 815-832 Wfam QL 434-599.82 t#5EB?i£ilJ^$fc££ gn£JJj^# (Arthropod Venoms) WD 400-430 Si'i/ii!Jj:fM?:7r7 4/i/X (Arthropod-Borne Viruses) l£7 -774/i/X$££ Wfflr (Embryotomy) WQ 435 ^iffft (Amputation) WE 170 VlMlm (Amputation Stumps) WE 172 S#S"J (Adhesives) TP 967-970 t£#«4:!£ (Twins, Conjoined) QS 675 iaMMmm (Eclecticism) WB 920 Sffi (Glossalgia) WI 210 %& (Stealing) (£&^$££ %&m (Kleptomania) (£WgjSiJfPPfW$££ SiMf (Tongue Habits) nXm WS 463 It AW WM 172 tvjmbwjim ws 350.6 xx»z&comm wu 440 WX (Persuasion) l£l^#^J^ ^^- —7 —xaX$££ !&!#(£)3;i-t-/3> (Persuasive Communication) BF 637.P4 W&.rHm (Abortion, Threatened) WQ 225 l&li$4M4 (Equipment Safety) Er£*)lS:1Sl±, A:C0W(.miz t£fit#fRxX t A (Equipment Alarm Systems) l£^fg^ 5fc£$££ lx1li!xft (Equipment Design) ¥fx.m&u, xmmz Az>)T>y9m (Celiac Disease) WD 175 -fe 'J 7 A (Cerium) mmm qd m.c4 mmm qv 290 -fe ij 7A[o]fif4: (Cerium Isotopes) mmm QD 181. C4 mmm qv 290 -fe 'J X (Serine) QU 60 fe ij X7°o77 — -fe(Serine Proteases) (£7 0 x7°DT/f 7-7'$££ -fe ij X7°n7 4 7--fe (Serine Proteinases) QU 136 -tJV Y ummm (Sertoli Cell Tumor) WJ 858 -fe/l/tx (Serpins) QU 136 ■\iJV\iyXm (Serpin Superfamily) l£-fe/l/tX$££ -b/l/7 7 7 (Self Care) WB 327 WZlkmizttfc&AztlU, Arcotkmiz 7/1/777 CJ^t'J 7-xa x) (Self Care (Rehabilitation)) l£ 0 &£iSiMf-$££ -fe/U7 7 7-^--y F (Self-Care Units) WX 200 -fe/l/7X7°7 4 xxyU77-ARNA (RNA, Ribosomal, Self-Splicing) l£tt(£)§14RNA$££ 7/1/X4 x^^ft: (Receptors, Caerulein) I£ni/->XF ^r->^§f*$££ -fe/l/o-x (Cellulose) Xim QU 83 X5. WD 105 Mmm QD 323 7°yx7'yy|^ii TP 1180.C6 ftwkizzhfemmm wb 427 ^g^tzi£ffl£ftx±j^i£±fpijiz, mutngim imizit WJ 356 -fe;uo7°7XxX (Ceruloplasmin) WH 400 Kil7^tJf QY 455 ■fe X =r* ij x (Selegiline) 670 fex*>-^* jjn'-Jf/V>l!: LT •feU/n&mz is it zfemzii fix m&Xm (Textile Industry) mm&m wa 485 mmrnm wa 400-495 mm^M^J WA 788 WBS. (Fibroma) QZ 340 mm& (Fibrosis) QZ 150 BB/i14<0fcW(£SMigi]lz »KEtt#lBi£Jlft (Fibrous Dysplasia of Bone) WE 250 mmamm (Fibroid Tumor) (£42?ti5«$££ UWIH (Cellulose) Xitm QU 83 k± WD 105 Wttfb^ QD 323 7°7X7'yy$£i£ TP 1180. C6 miJ^lz£^j^WfiJffl WB 427 mmmzfemztihm/&uxm\\iz,mtu,n&&fem iztsith WJ 356 mmm (Fibrin) WH 310 tetfc&g QY 410 mmMW. (Fibrinogen) WH 310 ffi*fc£ QY 410 mmffl5i$. (Fibrositis) (2 &£>£$& WE 544 $££ £&Sf 3?I&'l4?Llfel*£ (Fibrocystic Disease of Breast) WP 840 UmmZm (Fibrinolysis) WH 310 Umm&mm.X'VD'^ (Antifibrinolytic Agents) QV 195 Wm%\%m%% (Fibrinolytic Agents) QV 190 £gx;jwi/3r*-144 (Linear Energy Transfer) U^fcJV*' -f2Uj$££ 8&& (Adenitis) (£ U x^gi5£$££ M&itmW-ikM (Persistent Vegetative State) WB 182 Mm&m (Protracted Pregnancy) UU&'&'MZ flX #tJHfti (Paracentesis) (i^$ij$££ (ft Ytfifo (Adenohypophysis) it YA*ikmM$:&X !&*$ (Adenocarcinoma) QZ 365 RK^14ofcy>li$|51iJ5i|lz •fcHW& (Panophthalmitis) WW 140 liij*Mtt)^ (Precancerous Conditions) QZ 204 iftl&l*^ (Caisson Disease) lii$Ft*iE$£i m\UM (Anterior Chamber) WW 210 HUllM74Al£ (Endothelium, Anterior Chamber) lift US fl /£$££ ftM (Platelets, Blood) l£lfil7t/4$££ ftMi&'Ptf. (Thrombopenia) lilfo7t»>*iE$££ f££j<7xU-xX (Thrombocytapheresis) (ilfa.7tJst7 x V - x X $ £ £ 5§WI (Adenomyosis) Ii7'fifl)l#*nl$£i f!ij4K*l9lfe (Progenitor Cells) lilt«$££ 7lfa.3cl£$iijjfiL (Exchange Transfusion, Whole Blood) WB 356 RHH41 WH 425 MJxStitSii (Occult Blood) QY 160 i7fcP$iJ (Mouth washes) WU 113 mmm QV 50 WiMM (Proenzymes) l£^^fIIEf^$££ foitfrWc. (Optical Rotatory Dispersion) Vnmim QD 473 ^llfflS (Bibliography, National) Z 1201-4980 flll#^§Iy4JW@* (Anesthesia, Sacral Epidural) (£1llj#Ift S£$££ 1llJ#tt^ll (Sacral Plexus) l£KfllJ#Wmi$££ rn-Wm^- (Promyelocytes) l£ffili^$££ f|ll#SB (Sacral Region) (£1lljJl#g|3$££ ftfl#ifcBfc (Anesthesia, Caudal) WO 305 MM (Decoctions) !£}§"$$££ btSiJ (Detergents) QV 233 m&MWi. (Subconscious) UMMWk (frmm) $££ ifftW (4>B|^) (Latency Period (Psychology)) WS 105.5.P3 if &14lg?§II*S (Neoplasms, Occult Primary) UWMX mmm* fix m&i£1fmffi.&X3: (Occult Spinal Dysraphism) liif & 14-5)7ftt$£i if &141fMi£ (Occult Spina Bifida) l£if &'l4-#¥ftt $££ m&14r^7fftt (Spina Bifida Occulta) WE 730 if &'I4#mm (Schizophrenia, Latent) UftMmmAt&Pf t$££ ^$0 (Punctures) WB 373-377 Atf WB 377 8Gjj# WH 380 BM WB 377 ^7k^$u wa 209; fr£t£ wb 37g^ ; ~ifmwm WB 377#$fc££ mB (Forelimb) QL g50.7 mm (Puncture Fluids) lifrifc \ foMBW ', i#av$fc ?!&$$££ £%'£. (Panotitis) !£:?&$££ mm (Tapping) (£^$ij$££ miXYk (Puncture Biopsy) (£#r£tfc$££ FWf4ftj£*£fi£!¥ (Scalenus Anticus Syndrome) l£fl%||5ai 671 ■fexxJ. P*i4&&$££ mi. (Adenoma) QZ 365 £lfe (Collected works) *§&##(-£6 (NLMftmmxUM$:&^5) 1 k<7>%%iz X h (NLM#^TI£JF^#^- 7 ) mA'f'-fflw (Anterior Cruciate Ligament) WE 870 mm (Claustrum) l£fla^W^li5$££ UMt (Striated Border) U'0. t«» l ^$££ »#J (Cleansing Agenls) (£i*^J$££ m&fc (Corpus Striatum) WL 307 5^±^14St*S (Neoplasms, Glandular and Epithelial) QZ 365 HfeitH (M) (Detergents) QV 233 &fe® (Chromatin) QU 58 mmm QH 599 Sfefel* (Chromosomes) QH 600i£14ifefef£ QH 600.5 $fc££ UkQ.fcg'% (Chromosome Aberrations) QH 462.Al &&ftk2. QH 462.D4;M (itfs^O QH 462. 15 ; ftlM (itUm) QH 462. T7 $ fc £ £ ifefeffcHftflC-ft (Chromosome Abnormalities) QS 677 F 'J X 5- QH 461^$fc££ ifef*,f£7*1414:K (Extrachromosomal Inheritance) QW 51 ifefef4yV.£ (Chromosome Deletion) QH 462.D4 ifefef^BfeiioR (Chromosome Fragile Sites) QH 461. Al ytk&i¥i&M (Chromosome Mapping) QH 445.2 ^fif4$s(^ (Chromosomal Translocation) I££kM£ (jitfE m) $££ &fef£*$S8B (Fragile Sites, Chromosome) liifefeff Sfei|g|3$££ ifef*f£7°n — y' (Chromosomal Probes) (£DNA7°n—7 $££ &&,!£#& (Chromosome Banding) QH 600 ifefefi^ — 7— (Chromosome Markers) UikUX~? — 7 -$££ &fef£21 (Chromosome 21) l£ t F &f*f£21#$££ 14ifefef£ QH 600.5$ fc££ y^fet^feii (Stains and Staining) mmm qw 25 mmm^m (-&> qh 237 mmmfofc^. w 750 £#7 "J 77 XX* (Total Body Clearance Rate) lift M9 iJ77XXft$££ ^#ftft (Whole-Body Counting) WN 660 &m\Wm (Whole Body Counting) WN 650 "k^slbMm (Systemic Poisons) l£#^$££ £Jt\HB#t (Whole-Body Irradiation) Wt4?-ffl WN 620 &mmm wn 450 £#14^ 'J r'v F — 7X (Lupus Erythematosus, Systemic) WR 152 £JMt8&S£ (Scleroderma, Systemic) WR 260 £#'l4£rj*E'l4;S&*Jt (Lupus Erythematosus, Systemic) WR 152 £-S"l4®C#t^*£.f. (Generalized Radiation Sickness) Ii mmm-wzfix £%mH%mmm (Plethysmography, Whole Body) WF 141 £%X$MW (General Paralysis) (i^^^l"^$£i £Jr!frB£ (Anesthesia, General) WO 275 if 7k (Diving) QT 260.5.D6 *ift QT 260.3.D6 ~tM£ltz*m%& WD 650 rgH14*ift WA 485 m7kmbmm vm 975-989 if 7kmm (Submarine Medicine) WD 650 »*^&Jfr*fc0S.ft (Divers' Paralysis) (£i^r±^$££ if7ktp# (Depth Intoxication) UXi£H7"Xliimt:fit Mm (Caisson Disease) l£MJ±*£$££ AMffir (Astrology) BF 16571729 ~bm>Jt%m BF 1729. B4 ~bmm BF 1718 ~fct4 BF 1729.S4 mifcW®i (Pronormoblasts) (£*3R£$££ Iftifi&ffiK (Adenofibroma) QZ 310 mmMfeK (Prefrontal Cortex) WL 307 «#■ (War) U ; V 3IW3l$£i n^WSm (War Neuroses) UW.MmW$££ feM (Embolism) QZ 170 IM WG 540 Hwimmfe-fcbmtfB.fem wl 355 $££ SttlftlK wg 300 mutest. WG 420 AMR WG 610 *.S. (Asthma) fvff^ WF 553 't'HIif&ftMtiTOHSi WG 370$££ »ffi.&8f*&KSS (Status Asthmaticus) WF 553 ^.t.'ffixa v9 (Asthmatic Shock) l£»SLt4$*fttl$ 1 £ mmm)WX9\$mm'vAxWi$i. (Encephalitis, St. Louis) WC 542 -feX F/l/4xSB^7 4/i/X (Encephalitis Virus, St. Louis) QW 168.5. A7 B&mV»mifc7AJVX QW 168.5.A7fcLT ■b>|-D7i/7>y (Centrophenoxine) it 9 9 o "7 x 9 *7-F$££ mm (Glandular Fever) !£fsifet43M£*£$££ tfyi (Brainwashing) (il&fttfjn ii-7-X3X$££ mfSa (Prosencephalon) itmcoXm%£bfix, mtumm (i WY 16 ; -e<7)flfa<7)NLM^$i3sT(iJI^#v21 #P^ (Professions) liUHH^£!*$££, fyijxli^ #HlBt-.S#ffilAKWffi (Professional-Patient Relations) HfKJSJfflf£*# W 21.5 *R^A* WX 159 #H^fc£^fc^#^op^$fc££, m*.imt®-& %mkfflffli& W 62^ WHWKAKM'DK (Interprofessional Relations) mnm wu 6i mmiztsitZ WX 160 mmm wy 87 mm w 62 r4*4IS WO 62 Arcomxb LX^h^cohhm^Mz #H^^1t^7J (Professional Competence) W 21 mm wu 21 mmm wy i6 mmm QV 21 ^wa^fcLT '£*&!&& (NLM',>$JUiT4iff^&fe>18.2) #rTOfmS (Ethics, Professional) BJ 1725 ^*y/b-7°<7)^^(i, y/l/-7^?iJ(Z %Tf\Wm><9 — y (Practice Patterns, Professional) Ii E»^°y-x$£i #H^7J (Competence, Professional) (£#PW£rr&)j $££ WFimm (Hospitals, Special) (NLM^H^T(£ff^^#^-27-28) *g QZ 23-24 7XtX WX 28.6-28.62 Hii! WC 27-28 ^H£*?!l% WC 27-28 mm WQ 27-28 t£*£ WC 27-28 *£1£ WF 27-28 #H^-ff (Specialism) W 90 mmmmimmmm (PrecePtorshiP) mm wu 20 mm w 20 #!1 WY 18.5 mm qv 20 tKH^ SF 756.3-756.37 Arcoi&cofrffU, iJHS'Jtz mMALM (Anterior Perforated Substance) IinI^SS&$ ££ m& (Fibrinolysis) WH 310 S^tHftflS*S (Carcinoma, Adenoid Cystic) QZ 365 |5im40fcWl£^fiJ?iJlz Bfe^M (Fibrinolytic Agents) QV 190 WiMfcJV^y (Anterior Lobe Hormones) (i KHIfcflll 7/U^X$££ Bi&mm (Fibrinolytic Therapy) l£jfiLf£ig»S?i£$££ mm (Shivering) WB 152 itUAdH (Prostate) WJ 750 m±M (Prostatitis) WJ 752 m±Umtfc (Prostatic Hyperplasia) (£fIiz:)J*)]EA$£ £ m±r.mm& (Prostatic Diseases) WJ 752 miL^mm (Prostatic Neoplasms) WJ 752 miLUm®; (Prostatectomy) WJ 768 HiJiZlJDM&IS (Adenoma, Prostatic) !£BtJAdHI]eA$££ mALmrl± (Prostatic Hypertrophy) WJ 752 &£r (Dyes) tAii^^fcLT QV 235 mm, t/^H^fcLT QV 240 ftfcxmzmmzti&m&u, Azcoxmz &fe fc UifeiS QW 25^ $ fc £ £ Mm. (Radiation Dosage) iM£,f4^,££*im WN 655 femmmmw wn 25o^$fc££ $k1kAj)W:fflliMi& (Dose-Response Relationship, Radiation) «9i^l$££ HUgr»l7E^ppl4ffi(Drug Evaluation, Preclinical) liH^ xyu-^x7rxF$£i m^,W.m^mMm.^. (Evaluation Studies, Drug, Pre- Clinical) immx9 "--y9'fx F$££ 8&'J ym (Adenolymphoma) WI 230 Hijfl$S (Forearm) WE 820 674 V/x* jjijIlS&tlfM (Forearm Injuries) WE 820 fflS&wi (Adulteration of food) li^n?ri,;;+i$ ££ i.mt% (Adulteration of Drugs) lidSg^ft'ifc '. mXikU $££ m (Diathesis) li*^*R^^14$ ££ % (Elephants) QL 737.P98 mm SF gg7.5.E4 H-)^ (Manic-Depressive Psychosis) (£^tk!&1iW,H $££ iii^J (Contrast Media) mmmizisitz tw, ms, WN 150 1£fflt*{*T WN 160 &wmizmm$tiit%&u, Y.mmz §mV)&. (Debridement) WO 700 820 K^ttwfc^liSGfiS'Ji- QW 690 «f5*f \z-y9xu, xmmiz ikitifcMX (Chemotactic Factors) %&Kmz is it h QW 700 &\mizisitZ> QW 690 SiffFff (Hepatic Duct, Common) WI 750 *i^H (Sensibilisinogens) (£777 4 7 ^x-$££ tl^^K (Sensitizer) (it£f£$££ tffffi (Intubation) WB 365 &* WB 410 tfi^BfrS (Endotracheal Anesthesia) UA^foMmZfl X S.e (Recall) BF 370-385 ?LyS»fc^^W WS 105.5. M2 H£#tfi (Organ Transplantation) WO 660-690 HSi£S (Organ Temperature) (if4i£$££ U^mt (Organ Banks) l£ffl4&£gfi-$££ ^Mm^m&U (Wolff-Parkinson-White Syndrome) WG 330 MUWX (Organ regeneration) (£#4:$££ *mm (Denture, Complete) WU 530 »2lt!1£^ (Organ Donors) (£II^H#t#$££ BI£#gt4 (Organ Specificity) QW 700 ■wwy \z-y9xu, xmmz mmm)) (Extrasystole) WG 330 mtXX®. (Labor, Premature) WQ 330 *B1£ WS 410 $fc££ M.%k%M- (Organ Preservation) WO 665 ¥fx.m&iZ7.tfc&i>C0U, A:C0M%a- i%W^.% (Undertaking) (iyfcmi$B$££ flUttJfiW.'f (Bipolar Disorder) WM 207 n)fc.7^m (Depression, Bipolar) l£«fe!&1fPfVf$£ £ H^) (Conflict (Psychology)) (£1jjj§ (^mm) $££ JiJflL (Hematopoiesis) WH 140 iiJflL$tfflfla (Hematopoietic Stem Cells) WH 380 ialfo.^: (Hematopoietic System) WH 140 7!£ WS 300 -izimt&m QV 180 'MstmmiklimX (Hematopoietic Cell Growth Factors) WH 140 iaJfa.5t4MB)i& (Progenitor Cells, Hematopoietic) l£jiil $£«$££ iaJfiLt^SC (Hematopoietic Agents) l£jtlfll^$££ 'Mstm (Hematinics) QV 181 ialfllCFU (Colony-Forming Units, Hematopoietic) l£ia JfM^BI&$££ W.X®. (Denticle) l£*tt4HK1H$££ %£&mm$YW\ (Comprehensive Health Planning) Ui&t& 1*«ft@$££ *&&mmUM1&ffl (Comprehensive Health Planning Agencies) li1*@H«xX7Aft@^5I^M$£i H^H/i x X 7 A (Automated Multiphasic Health Testing) (iAPalF^y X$£i 't£&mmmm (Comprehensive Dental Care) WU 29 m&*m (Universities) LB 2301-2430 %%&mm (Hospitals, General) WX 27-28 MfclfMt WX 150-190 mmmbrnw: wx uo It^Si* (Catalogs, Union) m^xu-fa Z 6g5.83 ^-ktmm z 6g45 wzxmniicoii, Arcoxmzftt&^m&^iz ^SS^MMt&^ii (Microscopy, Electron, Scanning) QH 212.S3 ftzcoBMizmmzti&m&uxmwz, tmummtk ^com&u WU 230 mm (Labor, Premature) WQ330 XiWh'Jt WS 410$fc££ mm'Jt (Infant, Premature) WS 410 mm'Jtm.% (Infant, Premature, Diseases) WS 4110 WR. (Funeral Rites) &mm GN 486 ftmbmrn gt 3150-3390.5 675 vyyzi'y ■kmm BF 789. F8 miaBllfc (Paronychia) WR 475 ¥-& (Precocity) (i^m^ii$££ tMfcSR (Wound Infection) WC 255 ^ffifrl&vft WO 185$fc££ &\%%*n'& (Wounded, Transportation) li.f.^Hi^$£ £ HMKJS (Manic State) l£M$££ ftlffiftft (Wound Healing) WO 185 mmm qz iso XffiM WO 185 tiHifctliS (Wounds and Injuries) WO 700-820 mmniumb lt qz 55 mm wo 188 £#JxS QZ 160 mmKB qz 150 ?Etzo^T^i£[SW#^ W 843 7fi|H WA 292 xm:A WO 192 mmm sf 914.3-914.4 f-ffirii] LUfi WO 185 ; ^ffiriijjgift WO 185 ; fijffijg iJk WC 255; 3£?£&*47oiift£*fc{illCHX i£gi3ii^jiz, mtitmmmu wo82o;sra$ WE 706$fc££ iiJ^*4tiJ^ (Strapping, Wounds) (i^w$££ m^.mX (Growth Factors) (£^fi^M$££ mmm (Proliferative Phase) (£flig^»l$££ t#fiffiJi§fciS14 (Multiplication-Stimulating Activity) (i IGF2$££ MWtM (Bookplates) Z 993-996 mm WZ 340 ttfflS (Dipteia) QX 505 MX (Tooth Crowding) I£4^IEp$£>$££ MX*Jt (Twins) WQ 235 %Xm QS 642 -t»a^ WS 150.5. F2 WX'Jt)X9 (Relative Risk) (i ij X y $ £ £ mmmn&0: (Relative Value Scales) »§??3I$££ mm (Consultation) (£BS^fcff4i2$££ IgUI^ (Common Bile Duct) WI 750 *£Jfi^ii£TO (Common Bile Duct Calculi) WI 755 IgHlt^S (Common Bile Duct Diseases) WI 750 tiM^mm (Common Bile Duct Neoplasms) WI 765 Igfli^M (Gallstones, Common Bile Duct) I£I,?.)3IW *££*£$££ ISaiM^ (Cholelithiasis, Common Bile Duct) It® m'g&K&ZflX &W. (Apparatus) ligRimg fc«H48oap$££ ^ittititb^ (Malfunction, Equipment) (£^$4^^$ ££ SSfctt^ (Apparatus and Instruments) (ilMHUHjgJ: ^t4fflBap$££ ^I«5^tt (Device Safety) (i^:fi^^14$£i '£M.comm (Misuse, Equipment) (£SS4<9t£$££ ^WXtc^:(Equipment Failure)#£<7>g!Uifc^l£S|3fiJ?iJlz i&mmm wp 47o^$fc££ #-&l*S*£tJM# (Pre-Excitation Syndromes) WG 330 ¥Hte£i* (Dementia Praecox) (£ffiW^§i^$££ %&m (Elephantiasis) WH 700 %iWiX% (Device Failure) (£^M4^fc£$££ mm (Manic Disorder) WM 207 1$%m (Physiognomy) BF 840-865 jg!<7)3Mf WB 275 ^$t££ %&MIsM^MAJE (Persistent Common Atrioventricular Canal) (i4>l*ll]lJ7fttil$£i tetl#felli (Mitral Valve Prolapse) WG 262 fetiJtmk (Mitral Regurgitation) lifiH#BJfH*££ $££ mm#W& (Mitral Valve Stenosis) WG 262 ftffl#y 'J -y 9W%-mm (Mitral Click-Murmur Syndrome) l£1fipI4r^iSL$££ If ipl4rT7fliit4^*S (Mitral Valve Insufficiency) WG 262 tUffi-ifftrtf! (Debridement) WO 700-820 GSJlrt4ofc^(£SlH£Wz *f*¥*E (Pruritus) WR 282 77 iJ A ym (Paramecium) QX 151 li^E^ (Laminar Air-Flow Areas) (iAXS^$££ MM (Algae) QK 564-580.5 97JV7AJVX (Seoul Virus) l£^xy 74 /UX$££ JsSPffi (Ostomy) mi WI 900 t^y4 7°Ojg*ftfT$fc££, lyUliBt^Wft, !£* MAflYR (Retrospective Studies) &m WA 105 A:CO%co¥mY\i>y9XU, X^Wz &M%fi (Ankle Joint) WE 880 %.ffim& (Meduromycosis) WR 340 fss (siang) unw.nm ;!§*$££ Myt (Photometry) ftmm (-fe) QD 79.P46 itm qc 391 £574ff QD 117. P5 wfflmv&mzmmzti&m&u, Azconmtizit* 676 vy*VA IZ fcfilSIMBS (Tarsal Joint) WE 880 JEffitKMSS dntertarsal Joint) liJ£til|BHRIBK* ££ (M^gfC (Lateral Sclerosis) (£S5^iife44ffi^fb(E$£ £ £4f (Toes) WE 835 3rJ* WE 835 BPPfSi&l&SE (Hypersensitivity. Immediate) WD 300 -305 mi WD 300 mmwsx qw 900 gPR^fsjStfUlSf (Denture, Partial Immediate) WU 515 S4iJft (Toenails) (iJH$££ BPP£*£i£$f(Denture, Complete, Immediate) WU 530 {ffl'Dfr (Corpus Cardiacum) (£ttiS'9'^*$££ (PJ14 (Laterality) WL 335 wm kmm GN 233 £& (Embolus) l£*^£$££ Sftffi (Embolism) QZ 170 iWKW WG 540 mmmmtefcisxvitfem wl 355$££ SttlMK WG 300 m°|*|^fll (Lymphogranuloma Inguinale) Iit4#l '14'J X'-WIMf$£i fUI'J >yN4*l^)tt*m (Lymphogranulomatosis Inguinalis) I£14*M4 U X^°r*Iif-)l$££ R«$J£ (Rat-Bite Fever) WC 390 y>?7A70^yiJ7-F (Sodium Cromoglycate) (iy o*U x7 F 0 7A$££ tlUift (Organizations) HM 131 ft £ 9 A y'cotmoo ?-> ft, m x tf ffiftfSfltl* W WA l^s ; WHttffcoZfotii&X iBUft (Tissue) JjB*& WT 104 «U& QU 100 Vfit9 Ay° QS 532-532.5 !&7$'£14 QW 700 tStit WO 660-690 *il» ?• QS 504-539^ $ fc £ £ fcll#!ltli;.&'$:5E (Decision Making, Organizational) M HD 30.23 't>JI-7- BF 448 m*Y t-yyxl£, ±g|SiJlZ *I*Sz$tit (Tissue Transplantation) WO 660-6g0 ffif&HT- (Tissue Factor) l£ F n X 77°7 X 7 X $£ £ *fl$ji*X (Tissue Extracts) mmm qv 370 femmmm (-fe) wb 391 £H.$lfiSc¥ (Organizational Innovation) *i*!RfcM WX 150-190 fI4-h*X WY 105 £l£.mX'n$k WA 525-590 ^sy4 7°^n^ii, iia«ijg'Jt= *&*Mt3* (Histochemistry) !i*fiiai«{l:^$£i mm.m (Histology) QS 504-539 mmco wu 101 A£ • ttFJfii QS 22 Hi&tfJ QS 530 mmmT<7>*m F t >y y X $ fc £ £ kWm^iT'4 y9Y])- (Histologists, Directories) l£*l ifwrwA^ • mam qs 22$££ IMIfcWttffi (Histological Techniques) QS 525 %mMy°y X ~ 9-Y>ft&itifoB. (Plasminogen Activator, Tissue-Type) (i7/l/77°7--t$£i kmmm (Tissue Typing) (i*fl$5it£447X F $££ mm.B (Histiocytes) WH 650 ftftfflfcfclt* QW 690 llU&Jfc'ffi'J y^m (Lymphoma, Histiocytic) UM^m 'J X^AI$££ %m&igmmx (Histiocytosis X) WH 650 *HSt«tf (Tissue Banks) QS 523-524 m&rnn wo 23-24 mxma wu 24.5 TA'<>9 WW 23-24$ fc££ *!*&#&« (Basophils, Tissue) l£SEiifflflS$££ ffl*ft£HateiMfc(Crossmatching, Tissue) l£#I^]®^14 7X F$££ £tfeH$& (Ochronosis) WR 267 t$.Wmm{m (Histocytochemistry) mmm qh 613 677 yy+fy UUtt'? QS 531 *ltf&4£ fifrj (Tissue Adhesives) WO 166 mmtlll'm (Tissue Extracts) mmm qv 370 famwmm (-fe) wb 391 ¥fx.w}i<7):&miz®!.m$tihm&u, A:cowmxumz m.m&f£# (Tissue Donors) QS 523-524 &1M344 (Histocompatibility) WO 680 mtmam® wh 460 &«feil&tt#ttft£¥«'&f* (Histocompatibility Complex) (£MHC$££ ffl«fciI£te#L)I (Histocompatibility Antigens) QW 573.5.H6 &Wft&* WO 680 *I^ii^14tt)I y 7 X 2 (Histocompatibility Antigens Class II) QW 573.5.H6 ®m%.&m wo 680 ffl$ut£4£7X F (Histocompatibility Testing) WO 680 fflttlWWJ&Sllft (Financing, Organized) **Pit HG 177 *i^£ WX 157 mmmn (&m$tMtt^2o) flt*f*P& W \0X27mbA:COftLCO9Ay&m (Grafting of Tissue) (£M$££ *a«fe*S# (Tissue Culture) mi QS 530 Wm QK 725 ftffi QS 525 m.^mmm (Histopathoiogy) mm.mcoxoommm QZ 4$££ fflflfefEft (Organizational Change) (£*I1«^$££ ffl*$t*# (Tissue Preservation) %m.m QS 525 t£tl WO 665 m.m.mm (Tissue Therapy) WB 391 A: I + < (Mastication) WU 102 -?"L^X£%x 97 Y 7-/1/ (Softball) (i?FJfc$£i y -v F X y 7 x (Somatostatin) WK 515 y -^ F X y 7 X-14 (Somatostatin-14) l£ 9 ■? Y X 9 7 > $££ y-v F F n tx (Somatotropin) WK 515 k2& WK 550 t#£P*W^)SCBfc LXcoActlitAcom^iz y-v F F n tx^^fc (Somatotropin Receptors) (i*S 7/U^x^^f4:$££ WM x'XC (Somatomedin «) (£IGF I$££ X-^F/xXMSA (Somatomedin MSA) l£IGF$££ 9-?y (Soman) Xim QU 131 mmm qv 627 Z^tshXn (Favism) WD 515 y yxx^H^S (Psoralen Ultraviolet A Therapy) l£PUVA^i£$££ y/l/37ij-/l/ (Solcoseryl) (£ S 1021$££ 9>v\f.Y-iv (Sorbitol) QV 160 y/ut F-/W7t F*D77--t (Sorbitol Dehydrogenase) (£4 x F-/i/7t F* or7--t$££ 678 H3-7 frsftf 7'J /-7 X $££ ^2134- (Factor II) (£7o |. n x t X $££ ^2iSitf. (Epistropheus) !itttf-$££ %3mX (Factor III) l£ F o x 77°7 X7 x $££ ^4H4- (Factor IV) l£7/l/x7A$££ %em (Sixth Disease) Ii^5e14$§*£$£ £ % 7 SX (Factor VII) WH 310 BfctftS QY 410 £ 8 mXM£tilfe (Factor VIII-Related Antigen) (i von Willebrand*^ $ £ £ £13AH4- (Factor XHIa) lilfaf/'^;>*7v- 7/uy 5/u Fx XX7i7--tf$££ mmXY7yXT$9—t° (Factor XIII Transamidase) ligSR-TVl'* 5 > 7'y~?-9>v 9 i /uF7>X$£i SSii (Presentation, Fetal) (±#ttllSf££ J1J: fcWfc Fx —— x7 (Physical Education and Training) QT 255 fttlttteJfiLEE (Hypotension, Postural) l£*B7.141&Jfllffi $ ££ j&-ftffc£4* (Ferrous Compounds) Q\' 183 fcJtfS7*Jri£ (Somatic Gene Therapy) (iilfS 4^6*3?$ ££ ilF£ (Patient Discharge) WX 158 ilKffii (Discharge Planning) (£.g.#i!Rfc$££ AfllUW (Lunar Cycle) (£)!$££ ft$ (Body Fluids) QU 105 ffciftEH (Body Fluid Compartments) QU 105 (4$7ftf (Fluid Balance) l£7k-*»®4z^$££ *5ftft£ (Immunity, Humoral) (ittf4:ffM$£ £ 9A x .y F (Diet) QT 235 PJ&1*@fc WU 113.7 ®m*RW(£^m*^^ WK 818-8ig$££ ^mmizisitiixkmmm wb 4oo-44g$££ fi'jtmbib'jim ws 115-130 1S7F 'J7A(iM^t: WB 424$££ 4ftiS WB 432 ** QU 145 ; m&±iS WB 430;#l3iJ^(z1^ffl$ tim%.&£,% ; ^IM^k? ft £#£*££.$ fc££ 9A x .y F t. (Diet Fads) WB 44g kM (Rhubarb) mmWVnb LT QV 766 XMb IX QV 75 *JCJS (Rheum) l£*jf$££ 744JfxX (Dioxins) W8Ht¥ QD 405 *l& (Body Temperature) WB 270 ^tS§^l$££ f4imPSn (Body Temperature Regulation) QT 165 H4-fc LTWSlt WR 102 ttW (Embryo) QS 604 ®m mti SF 767.5 nX. QL 971 VY^i§h^UA:CO$miz f£?4lfo.J#$fJr (Dialysis, Extracorporeal) liJfo.$ii#f$£ £ f£ft'g*ft (Fertilization in Vitro) WQ 205 (kHffJ* (Extracorproreal Ciculation) WG 168 f^HffrSjfctftTiffif (Extracorporeal Shockwave Lithotripsy) (i^(ffi$£i i^'X'i&^a (Extracorporeal Dialysis) lilflliftiStrr$£i f£H^4: (Ectogenesis) WQ 205 iYtt (Body Build) tif^S$££ kmmmm%t.ff (Medical Education, Graduate) itmXi kmrmfft&x kmmmJfrtt.11 (Nursing Education, Graduate) itm mm±mmmfizfix kmmnH (Education, Graduate) LB 23772372 kmm&.H (Graduate Education) (£[Sf4A^Rfc$cW ; A: cowLco9\mm<7>mm%*fix A^fcffcWltfXDental Education, Graduate) itmmk mmniizfix kmXcomm (College Students, Health) itmX&mm f£$££ km km (College Admission Test) LB 2353-2353.8 ^lg^l$££ kmi%MmmX-¥X (University Health Services) it mximmmzfix 1*# (Trunk) (£$#*&*$££ y A fffn&i. (Opisthorchis viverrini) (£OpisthorchisR $ ££ kAJX (Atmospheric Pressure) mp~a WD 710 mm\zisiti> WA 450 A%m QC 885-896 7k X WD 650 AfVfSife (Air Pollution) WA 754 mmiztsitz wa 450 mm WA 32-33 AfV^ife^K (Air Pollutants) WA 754 t#£i7U^/Kw£ft;$fc££ kAMft-Min (Extraterrestrial Environment) WD758 kBm (Molar) WU 101 If mmm (Palliative Treatment) WB 310 kAmm(Aerotherapy) UmAcoXVfem WB 460$£ £ J1J3 (Boredom) ^Xrn WS 462 fl'Jtmbifi'Jtm WS 105.5. E5 ■kmm BF 575.B67 f£S (Somatotypes) GN 66.5 ifcmm (Typology) li1£S$££ W&Wn (Aschelminthes) (£Hfjll$££ AjfiL^iEli*^ (Transposition of Great Vessels) WG 220 ill 14 (A^mm) (Regression (Psychology)) WM 193.5. R2 nXm WS 463 ?l'Jimb£]]'Jtm WS 350.8.D3 679 H3-7* ifitfmi '->*i»j (Depression, Involutional) WM 207 jfiiT&iffiW*?? (Psychosis, Involutional) (±igff #B ^*pf $££ /4t)itTilJ (Agonistic Behavior) QL 758.5 *tttiS &*Jfc 1 ^TciJj'ii (Immunoelectrophoresis, Countercurrent) li77xy-4Ayxxy F o 7 X -> X$££ fcmmmi (Somatic Cell Hybrids) (i8MI*ffiI&$£i kmmVy^m (Lymphoma, Large-Cell) WH 525 &mmmm qz 350 im&niiCoumtNiz §& = #£&v» (Third-Party Payments) li&^ fc fc* L5\fit m f*flt$££ gH*F4it (Molar, Third) WU 101 W WU 101.5 titi* WU 605 H6!£ (Fetus) WQ 210-211 X&)ffi WQ 310 #ttl$3»£ WS 405 5i£^ QS 645 £S£ W 20.5 mi¥ WQ 415 HSJfcEffi, WQ 209 Jfemtfrmffeil WQ 307#$££ J&!e@(Sli^tt WQ 415^$££ BSiElHie (Version, Fetal) WQ 415 BSifcfeffi. (Monitoring, Fetal) M&'A*-? 'J X7$££ USy!,i?ll"M (Fetal Organ Maturity) WQ 210.5 BSIEflfcfiBJftlfc (Fetal Maturity, Functional) (£I)6]£2?W M$££ ^Jtmmt < coWMh^k (Prenatal Exposure Delayed Effects) WQ 210 USl/rlilt^S (Fetoscopy) WQ 209 HSMi#i.ft (Fetal Diseases) WQ 211 8S!£?EC: (Fetal Death) WQ 225 mmmumm qw 52$££ *£*?!^?£*JEfc LTiOPf* QZ 180 mm qu 120 ¥U£»IfcMW QU mmn^k wn 6io £J* WR 102 ftHti£141l: (Metabolic Activation) (£44*[*J'${[:$££ ftHtt^tt^^ (Antimetabolites) QV 38 w^Rmitrnmn ttflUHSEfciiM* (Clinical Trials, Controlled) liJtWBilli^ !$$££ &$ (Retirement) HQ 1062-1063.2 Sltl^llifcLT WT 30 -nfcAWttg HD 7287.9-7287.92 if.&M HD 7105-7105.45 ^^^ (Macrophages) WH 650 %\miz is it 6 QW 690 iHSt& (Retirement Benefits) (£¥&$££ j§tft&ffl$E7T-fexy (Continuing Care Retirement Centers) (i^ft&lifflft^ $ £ £ iI«^f*flttSS£7 X y (Life Care Centers, Retirement) (i^ift&^ffltt%"$£ £ S4i4ffHJ (Coping Behavior) liSfi'JiIfc$£i fA X (Soybeans) «*«F. fc L- < (i*^*^P*(z4;lt^ffi^fc LT WB 430 jftig SB 205.S7 ffiX^m WA 703 1=114HX (Resistance Factors) RB4-$££ WUB'^M^^.H (Evoked Potentials, Somatosensory) WL 102 f£14)fl:E&it (Somatosensory Cortex) WL 307 IH4fEJiH4- (Resistance Transfer Factor) (£FH4-$ ££ ^X%M (Embryotoxins) U\%WVi)W $ £ £ **jfiL£fct4i:ifiL (Anemia, Macrocytic) WH 165 fta£feft:M& (Autosome Abnormalities) QS 677 f£tx (Gymnastics) QT 255 mm$) WB 541 7tf (Cisterna Magna) WL 200 kWAf&i&iZm (Cisternography, Pneumoencephalographic) Ii f\Jiuy jai£'i£ $ £ £ Atf^lU (Cisternal Puncture) (£^|IJ$££ kYU'&Wm (Cisternography, Myelographic) it I xo 9 y~74-£flX All (Thigh) WE 865 itWmffi (Alternative Medicine) Vk&m WB 371 a« • mam wb 22 Afl&Hijgp (Hip Joint) WE 860 *eM®£& (Hip Prosthesis) All# (Femur) WE 865 AH#S (Femur Neck) WE 865 AK#aa#tJf (Femoral Neck Fractures) WE 865 ASS##tJf (Femoral Fractures) WE 865 ASI#Sl (Femur Head) WE 865 ASI#Jgg(5t§*g (Femoral Head Prosthesis) ttJKMSittf 3S$££ km&Wi (Femoral Vein) WG 625.F3 kmW& (Femoral Nerve) WL 400 AII1M (Femoral Artery) WG 595.F3 km^JV-T (Hernia, Femoral) WI 965 kirn (Intestine, Large) WI 400 i^st^ftj^i, mi-imm wi 520-529 ftS (Body Height) &k GN 66 fl'Jtmb^'jim WS 103 m ws 16 AI§& (Colitis) WI 522 7y-'<14(i7X-'7fc*iWC 285$££ WB 890-962 WE 860 kWM (Escherichia coli) QW 138.5.E8 AHftlW&ii: (Escherichia coli Infections) WC 290 mmmco sf 809.E82 7'9 SF 977.E83 kWj\'m (Coliform Bacilli) !iHl*]*lti$44$£i kW&M7T — y (Escherichia coli Phages) QW 161.5.C6 A;Bil7r--/T (Coliphages T) (£T7r-x$££ AflflS7r-xyAy (Coliphage lambda) U'<9yi)fc 7r--yyAy$££ kffimm (Colorectal Neoplasms) WI 529 B'* (Attitude) BF 327 $y?;^i$££ k$)M (Aorta) WG 410 kMi'%. (Aortitis) WG 410 AfJM&*£f£J$ (Aortitis Syndrome) l£AfM^«££$ ££ AIM • "MXk§M'vy4~y (Dynorphins) QU 68 74'lffi (-fe) WB 391 wmmnfemizmmzh&m&uzcovm, xumz BS^7/l/^X (Placental Hormones) WK 920 86187* F-7> (Placental Lactogen) WK 920 A*^ (Catastrophic Illness) wwy \zv9xu, xmmz mAZfc££ fcOTflt (Body Surface Area) GN 66 %£ SF 761 ffXW)^l QL 363 Nh*>7 (Diving) QT 260 3ygs^l$fc££ 74 7 7xii (Chaulmoogra Oil) QV 259 f£7°X7X^E7774— (Plethysmography, Whole Body) WF 141.5. P7 m* F t-y y X|£3£MSiJ(Z, mz-UA^m^XiZtSith ArtlU WF 490 HSffi (Meconium) WQ 210.5 AM (Feces) QY 160 ##f QY 160 EE«1* SF 772.7 AfH^cfg (Fecal Incontinence) WI 600 mm wi 6oo; jtx wi 600$fc£i A^efE (Grand Mai Attacks) li S iff. KftttT/,*»/, ££ £ Afl* (Hemp) Ii7x7tx^, $££ Afi^'Ji (Cannabis Smoking) it-? 'J 7 y 7^'M$£ £ B6BI (Fetal Membranes) mxm QS 645 $ax$M Q2 310 mm wq 210 mXM WQ 210#$fc££ AJftSLffl (Caanabis Abuse) li-v >J 7 r 7SLJB $ £ £ ^U (Thyme) (£^-7*$££ ftfflJfiLiS (Blood Substitutes) WH 450 kmitU (Sunlight) mmmmco&ntb lt qt 230 femmmuaitmm wb48o#$££ A^14!iU^ (Pneumonia, Lobar) WC 204 ftffl-v-7- (Surrogate Markers) itX^m^-^-7- $££ ^fflW (Abomasum) QL 862 ATC#*?i (Osteopetrosis) WE 250 ttAitfs^ (Alleles) QH 447 ftTO (Surrogate Mothers) HQ 759.5 ^^Ft-yyxi£, 4-:HJ3iJtz f£7J (Physical Fitness) QT 255 &ifc*i!(is<7)fctf> WA 275 ESlS^lz^lt-i) WD 705 X^mmizis it 6 WD 752 9 A y U 7*£ (Theileriasis) SF 809.T5 y4oX74x> (Tyrothricin) QV 350 y 7 'J X (Taurine) QU 60 Mmim QD 305.A8 77 ym$M (Down Syndrome) WS 107 ISA WM 300 mm (Saliva) QY 125 Di^lS^ (Salivary Duct Calculi) WI 230 (Salivary Glands) WI 230 -.7AJVX (Salivary Gland Viruses) (£74 F A 7 o74/l/Xjg3&E$££ MU7A JVXmfc (Salivary Gland Virus Disease) ii 74 FX7'o7 4/i/X^ifc*E$££ IMfrik (Sialadenitis) WI 230 ■M (Salivary Gland Diseases) WI 230 im (Salivary Gland Neoplasms) WI 230 m;M&fym (Sialography) WI 230 mmUM (Salivary Gland Fistula) WI 230 m'&frWKbu (Asialia) (£PI*l3£'li*E$££ m:t&5rWX$:& (Hyposalivation) (£PF*]^'Ji*ni$££ £ j% 1£*?I7 4 JV X (Polyhedrosis Viruses) QW 162 ^^Ji^Wjk\Yj^% (Polynuclear Aromatic Hydrocarbons) (££iii\K1b7Ksi?$££ $-mXf&ft\M1]~m (Fatty Acids, Polyunsaturated) Ii4^ ®Mmm*fix $-M^it^^ (Polycyclic Compounds) Mmm QD 341. Hg m^jm QV 633 $-M£.fiiit7Y-M (Polycyclic Hydrocarbons) QD 305.Hg yJWm QD 341. Hg nmm QV 633 £i4*E (Hyperhidrosis) WR 400 ZtikMmmi&tl yxf^ (Multi-Institutional Systems) -®kmm WX 157.4 1#£#fr(i, 4£J@Wz iSSil'l^ (Turbidimetry) liJt85##ffci«SiI^$££ MZ (ikUm) (Polymorphism (Genetics)) QH 455 ^OZYZM (Leukocytes, Polymorphonuclear) (iSf4>JS$ ££ ^Jl^1£r3lfiLJ£ (Polymorphonuclear Leukocytes) iiiffc- ££$££ £JF7f4M (Erythema Multiforme) WR 150 $-Mi£nmmm (Glioblastoma Multiforme) (i7'J4 vn*x F--^$££ 0-Skm (Polycythemia) WH 180 9-Y-y Y Y*yy (Targeted Toxins) (£&*£#!*$£ £ tzZ. (Callosities) WR 500 £ WE 880 fccotytS WE 835 Arcom^pa&umtwiz 682 ?/Ml47 £3?$ (Euphoria) BF 575.E5 £4Lg] WS 462 WJlWbWsim ws 105.5.E5 £g]!g#ft (Dictionaries, Polyglot) P 361 #£44ii^fc<7)li. ArCoXMiz ZMitmmm (Polychemotherapy) £8»JflrfflfKi££ Hi £8JWttB* (R Factors) QW 51 £%\i%mitmmm (Combination Chemotherapy) li^ftj ffffl*fii$££ £#J14ffl*Jft£ (Drug Therapy, Combination) WB 330 tmmoo QZ 267 Jt wd 220 Wmmm (Dehydrogenases) l£7 * x K V 9 9 9 -7*$ ££ IMS (Hernia) WI 950 &,i^l$££ Wk® (Trusses) WO 162 WL$Lfc>JV^y (Molting Hormone) (ixy-yyx$££ Mft%'\i.®J'Nimm (Depolarizing Muscle Relaxants) it mmmymmz fix Ut€ (Hair Removal) WR 450 Utfe (Alopecia) WR 460 77 7 (Jimsonweed) (£7 a 7-fe X777"4 $££ 77 7 (Datura) Ii7 3 77 X7774 $££ 8&&l]£ (Decidua) WQ 210 %X.m QS 645 HK4£B«IU!&))CS (Decidual Cell Reaction) l£ffl*f!7$£ £ Wlhm'E (Cataplexy) WM 197 ■f)V?yy°y-izW&Ltz WM 188 9T'm (Polygonum) (£^ffltit^$££ &mcoWWy» (Barriers, Architectural) U^MCOT 9 ^ x)t$££ $■$)]&.&%£ (Hyperkinetic Syndrome) liiSIJj«fiJ'l4iil; MW^ZflX Z«SM (Polysaccharides) QU 83 9-T-'m.\vm (Turner's syndrome) QS 677 777'-^ (Danazol) WP 522 9- (Mites) -fe QX 473 #h^A.jJi QX 475 :$£<7)7^co£*k$fc££,f0Jx.l£t-tx7-li QX 475 9— A yy x.Xt — y a y (Mite Infestations) mm WC 900 -fe WC 900 mmm sf sio.ms Wm WR 365^$fc££ y-m (Trombididae) (i7-$££ 7-« (Tick Control) QX 600 $mmH SF 810.T5 9-& (Acariasis) !£7-4x7xX7-X3X$££ 9-M (Acarus) li7-$££ 9-^AfmB (Tick-Borne Diseases) WC 600 r-mAtB'^. (Encephalitis, Tick-Borne) WC 542 mmm?) sf 809.E62 9-ll^Mm'^7A JVX (Encephalitis Viruses, Tick- Borne) QW 168.5. A7 y^^^ijy.y77S (Mite-Borne Rickettsial Fevers) (i >J 7 •yfTSK. ; #^^ifeffiO^^$£ £ 7-B (Acarina) Ii7-*I$££ 9-W. (Acari) QX 473 £%|47x/l/3f-14#i£ (Rhinitis, Allergic, Perennial) WV 335 ZW&M (Polycystic Kidney) l£^?!14ftBaW$££ £ftl]&14M*Ef£f¥ (Polycystic Ovary Syndrome) WP 320 yv\*3 (Tobacco) W% SB 273-278 1S# WM 290 mm WM 2g0$fc££ mmm qv 137 ^3f> QV 137 ; "J?'Ji WM 2go^$fc££ y^'3fS# (Tobacco Dependence) l£^S^'Ji$££ 683 ?/\3XX 9'$££ 9'<3&.f*i&ift<2: (Environmental Pollution, Tobacco Smoke) U9'<3$ft'S:$£i *'*3&&£ (Tobacco Smoke Pollution) WA 754 9'<3&kAft'& (Air Pollution, Tobacco Smoke) (i y'<3*f&W$££ fz(£Z\ffi (Tabacosis) liKBifi*E$£i y/<=7^-7/fy7/f/H,x (Tobacco Mosaic Virus) QW 163 ^Ig^JfiJ (Abnormalities, Multiple) QS 675 ZftW&K (Polyradiculoneuritis) WL 544 £fe14&fE'l4#ift#!S (Exostoses, Multiple Hereditary) WE 250 £%t4r4#*S (Exostoses, Multiple) (i£?g'l4a4Sl4##; #S$£i £fe14$4fi (Multiple Trauma) WO 700 £H14Mtn& (Polyarthritis) (i^ln^$£i £%14H3gii#jHB*£(Amyoplasia Congenita) UMB#)tfe& $££ £?e'l4&f?SHt;*^ (Paramyoclonus Multiplex) WE 550 ZW&MMmm (Neoplasms, Multiple Primary) QZ 200 ^H14^fb*E (Multiple Sclerosis) WL 360 £Ht4f£#l4#p* (Multi-Infarct Dementia) U^MtM «$££ Zfti&ftmm (Multiple Myeloma) WH 540 ^H14#^f^lS^S (Multiple Epiphyseal Dysplasia) (i #&#JFMJI;t*£$£i £3§14#&#K (Osteochondromas, Multiple) I££fe14 itfS'l4#^#S$££ £%14tt*l£ (Polyneuritis) WL 544 £?§'l4titi*MB& (Polyradiculitis) WL 400 £le'l4iijfg (Wounds, Multiple) (££H14^FfI$££ Zftimm (Injuries, Multiple) l££5et4^FH$££ £fe14iMJHH& (Periarteritis Nodosa) WG 518 £fEl4֮#*E (Exostoses, Multiple Cartilaginous) (i £ ?£'|4 JtfSl4#&#IS $ £ £ £!e14iifl&¥? (Kidney, Polycystic) WJ 358 £^14'-° 7 = fc9a-7X (Paramyoclonus Multiplex) WE 550 $>7MwUM'\XM%;(Dementia, Multi-Infarct) WM 220 9VA^Xi (Lemmings) (i^y 4-X ~ M*4$£i ZmmtfaljyXTA (Multi-Hospital Systems) l££t$H3 SffiTlyXfA^lJ; yr- (Toboo) GN 471.4 77° V X (Dapsone) QV 259 y 7 F x X (Tuftsin) QW 806 ftSWHT-fcLT WH 400 %%\\3&^ v--m$mX (Colony-Stimulating Factor, Multipotential) Ii4xy —□4;JrX3$££ £^jkm$T (Multivariate Analysis) QA 278 WVkY t-yyxi£±M^J(z £A£14teS? (Multimodal Treatment) i£^WS?i£$£ £ ijm% (Bruises) (£M$££ m (Egg) ummmzfix % (Eggs) mmtffttzummtffcomt.b lt 3 v X t o -;^Wf WB 425 M&1B*M& WB 426 ^5SK QU 55$fc££ ffiX^m WA 703 TOSSC (Egg Proteins) QU 55 &^mmiztsit& WB 426 ?■?** (Onions) li*^*!^^ y-i 7/1/7 7 (Terminal Care) ¥lJOJfci#!OH WS 200 mmw^m wb 310 #^ WY 152 ¥?x.m&co.$%coA:tlU, Azcom&x *E^)JS* BF 789.D4 ; 7XtX WX 28.6-28 62$ fc££ 9 — 5. 9 u y— (Terminology) (NLM^$IST(£J^S:#^-15) %XM (Hypertrichosis) WR 455 yjE;3rx7iX (Tamoxifen) mmfcjv^yYHmnbLx wp 522 fimmmmmts xt/xwizmmz ti&m& wp 870 yyffift (Cod Liver oil) QU 86 9 7-t^T (Thalassemia) WH170 yy 7° 4x^x3-- (Monkey, Talapoin) Ii fc 777VU *4$££ yyxFy* (Tarantulas) (£y^|g$££ y 7 X tx U X (Talampicillin) QV 354 9 'J 7 A (Thallium) j*1*r¥ QV 618 9 'J 7AjftH4l4|5]1Jf4: (Thallium Radioisotopes) WN 415-450 9-JV (Tars) QV 241 Kfemmb LT QV 60 3-JU9-JV QV 60^$fc££ y /l/7A tx ij X (Talampicillin) (£7 A tx 0 X QV354$££ y/l/y (Talc) Mmm WF 654 t£4^ QV 785 #? (Sputum) QY 120 Q&XM (Parthenogenesis) QH 487 ^--itXmW^ x t^-y®fJf til* (Tomography, Single-Photon, Emission-Computed)(iSPECT$££ ftiit (Carbonization) liM$££ BIWIH-T oil (Biliary Stasis, Extrahepatic) liff^li ^rmmttfix Rmfofc^m (Progressive Patient Care) W 84.7- 84.8 mm<7)&¥iC0 WX 162-162.5 ^t££fc*f JjPfiE (Infectious Mononucieosis) WC 522 JkILtK^! (Hydrocarbons) Mmitm mmmit&® qd 3os.H5-Hg ysmmt^m qd 341. H9 %^m qv 633 $iit7km%m% (Hydrocarbons, Polycyclic) li£^J\J£ 1t«$££ BfiW (Bile Ducts) WI 750 ISBSW wi 750; m<7jih F* 7 -7* (Carbonic Anhydrase) (i^S^KS? *$££ Kg?7Xt F*7--tPlf^J (Carbonic Anhydrase Inhibitors) QV 160 mmm qu 143 K^im (Carbonates) *&mm- QD 181. CI Mmm- QD 305.A2 mmm qv i38.ci l%m'&m-& (Hypercapnia) WE 140 fttf&T-X (Carbon Dioxide) QV 314 f#$4<4-J& (Bicarbonates) mmitm QD181.C1 m)im qvi38.ci m$7^mi- F ij 7A (Sodium Bicarbonate) lifiJ^i£$ ££ KfMVmM (Carbonate Dehydratase) QU 139 fc&WkmMA 9 2-yT'A A (Carbonate Dehydratase Isoenzymes) liJ*t$?JU£*&?^$£i fiimWY.&MW.'gM (Carbonate Dehydratase Inhibitors) liSMT/h Y 7-7'PIW^iJ$££ K$4&/KS£S-4 yxx-74 A (Carbonic Anhydrase Isoenzymes) (£7/1/77- F7t F'7 y--t$££ Wf£ (Fasting) WB 420 tl4"lli*I (Basidiomycetes) QW 180.5.B2 BfiH (Temperance) HV 57075722 BIi4 (Bile) WI 703 Mit1 oil (Cholestasis) WI 703 Mitd oi|'|4K*l: (Jaundice, Cholestatic) itm.it 1 iffi $££ BIrt-i£i)fL*£ (Bile Reflux) WI 703 fll?4^£ (Bile Salts) I£flli4^fc)1ii4^^$££ mitmbMitmi^ (Bile Acids and Salts) WI 703 BlttfeU? (Bile Pigments) WI 703 $&fcmmm qy 143 mttirWi&mm (Choleretics) I£4ij)ll*fcllii4#i#^$£ £ MitM (Biliary Fistula) WI 750 n-W7A)VX (Simplexvirus) QW 165.5.H3 ^MSl^T/lA^ (Epilepsy, Simple Partial) UU^tXk, A^$££ ^M^/U^X (Herpes Simplex) WC 578 mmmi%&u, -eotm-fc Ly/i/ (Tantalum) ■^ QD 181. T2 mmm qv 290 flfljl (Biliary Tract) WI 700-770 Bliiftfl (Biliary Tract Surgery) WI 770 B§if*£.f. (Biliary Tract Diseases) WI 700-770 mi WI 700 i&Mmm (Biliary Tract Neoplasms) WI 735 Bfiitfflil (Biliary Atresia) WI 750 ¥tf II (Monosaccharides) QU 75 ft% (Erysipelas) WC 234 WWmm (Solo Practice) (i1IflAI^$£i 7X F n x x (Dantrolene) QV 140 9 y — y (Tannins) QV 65 M (Gallbladder) WI 750 Ifift^ (Cholecystitis) WI 755 WMW (Cystic Duct) WI 750 M&m& (Gallbladder Diseases) WI 750 mMmm (Gallbladder Neoplasms) WI 765 mMWtfk (Cholecystectomy) WI 750 BfiHiai^S (Cholecystography) WI 750 BMftiaSIt (Cholecystostomy) WI 750 BMMfll (Empyema, Gallbladder) (iBift&$£i tlife (Short Waves) l£li&$££ M&Bft (Protein Sensitization) (£$§&£$££ M&W (Proteins) QU 55 tJimbm* QW 570-680 mmummmtam qws2$££ !fn.mU!k<&m&W QY 455#$££ *^'J7(£flu£SeK QU 55 $££ nmmmtnmm&m&w wl203#$££ tfitp^I&f QU 55 ^$££ mmmmm&s. ww ioi$££ ?Litl£MfiK WA 716^$££ ®mim$\g&n wesoo$££ ^mmwmunmmmon wh 54o$££ mmummm&w qz 2oo$££ nmmunmmmtiw wl io4$££ tl^l£titMl4K QK 898.P8 $££ 74/WX(£74/i/X§fiK QW 160$££ wzGomzMtzmmmxcoztiu, qviz Arcotiicovmiico ii y)(ig|3fi«ijiz Y&vjmmxm.Ytm.V)^* fc££ Sf4iC-^t#;is (Protein Structure, Primary) UT I 9 S£l£?iJ$£i g&M-^fcJV¥--%mmW (Protein-Energy Malnutrition) WD 105 m&W1m*5rmy>l (Protein Hydrolysates) QU 55 ^&K7 o "J -s£*Pf * (Protein-Calorie Malnutrition) itm^M-^fcJV^-^m^^flX WYaM-9'jv9 i. yt?y-?-9riv9 \jv y 7X7x7 7* (Protein-Glutamine gamma- Glutamyltransferase) WH 310 WMtk^. QY 410 mmm qv 195 t&WIS^ (Protein Binding) QU 55 W&H.&fr7 §.i\UfilitXTvA Y (Anabolic Steroids) WK 150 ftltt QU 120-$ ; &«7 x K a YX T fc <*> h WtX 7 a 4 K£$fc£i.WxliVyxF"aX7/nx WJ 875 l&®<7)itfsX^ (Genetic Engineering of Proteins) Ii SeKX7-$£i IcSIClitt (Protein Denaturation) QU 55 ifiSC/^MtSm (Protein Methylases) U^tYi'iAA- ll F7XX7x7--t$££ f gg/ 7;uF7XX7x7 -7' (Protein Methyltransferases) QU 141 ggfCPgAt®ia (Protein Structure, Quaternary) (ijgfl MHi*tijt$££ I6®ifW£ (Protein Conformation) QU 55 S&fCA (Protein A) l£.^fc -5 JfcffigFlHA $££ 3rf45S:£'l4)!ir*jE (Protein-Losing Enteropathies) WI 400 l&JR (Proteinuria) WJ 343 lfiRi^jfitEfctt4S4,#*ji- (Edema-Proteinuria- Hypertension Gestosis) (£B^^tt((g4'^*E$££ lfiSti?lLiiiJfo.Ete4g4,#£E (Proteinuria-Edema- Hypertension Gestosis) l£Bfc$j&itgtp**iE$££ l&#tWB£3£ (Proteolytic Enzymes) (£-^77 K t Y 7 - -tf$££ %&ftm&mtnt)imig. (Protease Antagonists) Ii7n7 7—tPJ4f^J$££ /ybyrSiS (Dumping Syndrome) WI 380 vt¥d&M& (Anthracosilicosis) WF 654 tit®m (Anthracosis) l^t&Sllte ; SBi1i*£$££ mm (Heating) WA 770 mmco WA 450 9 y fc-y (Tampons) y\m\zisith WO 162 S*tt (Computer Terminals) TK 7887.8.T4 KffiUS (Cross-Sectional Studies) WA g50 t#5*F t^XXli, Xmmz 7 7 y y (Thiazines) ££t QV 240 imam tp 9i« \m QD 441 MWtitm QD 403 y-T9 —tr (Cyanosis) WG 142 f T- to *)AMl (Thiamine Pyrophosphate) QU 135 47X7x-3-/l/ (Thiamphenicol) QV 350.5.C5 W&mm (Community Medicine) W 84.5 i&i&mmttm (Regional Medical Programs) WA 541 i&t&mmT-— tX (Community Health Services) WA 546 mmmm))% (Community Health Aides) W 21.5 Wi.mM%LH (Community Health Education) liMJtffc W$££ ^WmM^M^zy9 (Area Health Education Centers) W 19 *M@]4f1£flt[S**7-tX (Health Services, Indigenous) W 250 W&mmm (Community Dentistry) WU 113 &*&&&-Q^iWiWWlWiVk (Community-Institutional Relations) mm wx i6o Arcoiiico 9 A Yco&Mfimt, 4.8IWZ mm±%mW&Xmm7--\i'X (Community Mental Health Services) WM 30 '?VJtmbX 7 x-n-/i/ $££ 7 4 7 x X (Thiophenes) tt&*lCitUflt4 QV 76.5 ig&lUfc LT QV 253 Mmitm qd 403 A-fcy it xy y S. Y (Thiophosphamide) l£747',f$£ £ A-fc- y-^$££ A-fc Ay'~?-JV (Thiomebumal) l£74"-^xy-/!/$££ A-fc^kWSL (Thiosulfates) mmimQD i8i.si agJI^ QV 280 77-/1/ (Thiols) (£X/U7t K'J/Wli^!t^$££ 7 7 x K 3- x X (Thioredoxin) QU 55 7^% (Perception) 3tl§3?3l$££ MKlit (Sensory Thresholds) WL 705 ftiiS7X F BF 176^$ fc££ ftiSRft (Intelligence Tests) BF 437433 ft'Jtmbty'Jim BF 432.C48 1^147 A JV x£e (Slow Virus Diseases) WC 500 ftzmmntftZiifix, f?ijxii*y-/i/-ii wc 540 77X (Typhus) UiULftiiyy ;«f^f7X^Mi 77X0 (Typhoid Bacillus) liJii77X#]$££ &£ (Dementia) WM 220 mtmit^^kUm (Goiter, Endemic) WK 259 Jfe^fitt^tt&ifc (Polyneuritis Endemica) (£Pt4$£ £ 7 ^ x x (Thymidine) QU 57 %m.m QV 185 7i-y>Jr7--t" (Thymidine Kinase) QU 141 7 ^ X (Thymine) QU 58 7^X (Thymins) Ii74 ^fcA if X $££ 7-A#H (Team Nursing) l£7-A7-x x 7$££ 7-A7-xX7 (Nursing, Team) WY 125 f.#777-A W84.8#$fc££ 7*-7X (Zymogens) l£^^HtjSEf^$££ 7^xX (Thymosin) WK 400 7:tyJfxX (Thymotaxin) it-<-92S. 9 o 9"^y\) > $££ 7^-/1/ (Thymol) QV 250 f^v-jv (Timolol) QV 132 & (Tea) ®.m^xummtifCommz®im2ixz>m*b lt WB 438 mmrnmb lt qv 766 \mft.'ffi TP 650 Ym^mm sb 271-272 777^ 'J x QV 107$fc££ 7W—— X'NAxy — (Hamsters, Chinese) Ii CricetulusH $ £ £ ##t4 (Flavoring Agents) WA 712 mvnm QV 810 & ?M1)K%J) WA 712 $ fc £ £ #1* (Nidation) (ii3R#)^$£i ^fc'MM (Nidation, Delayed) l£i!M;ir!*$££ #1*7/1/^ X (Progestational Hormones) WP 530 tfe^ij (Coloring Agents) I£ifet4$££ 7^^-/1/ (Charcoal) QV 601 7 -v - F (Charts) mmm (NLM^-^iiTii, a^&^m XM, (Attention) BF 327323 X'Jt WS 105.5. C7 XM& BF 323.V5 i4#A4Pl4tfllj^& (Attention Deficit Hyperactivity Disorder) (ii£|lj$*iJ14i±£.m4>P#g$££ 4^7X 'J 7 7^ 'J74>7^7V (Amerinds, Central American) li**7X 'J 74 yY 4 T^$££ fp^^fMH^K^-tX (Centralized Hospital Services) WX 150 ff^Rfc (Hospital Services, Centralized) it'fc'&Mtylt *fiRfc7-t*X$££ "P&3 — o y 'N°BH'-!k7 A JVX (Encephalitis Virus, Central European) I£7-$^M1K&$££ fc^mm (Septal Nuclei) WL 314 ff PlffliJ^t^ (Nucleus Accumbens) WL 314 4M!!Hi7 4 7 * y Y (Intermediate Filaments) QH 603.C95 ^faJSteix (Halfway Houses) n^WM%tz>hC0 HV 9081-9920.5 m^m&^cotzibco WM 29 tflW (Intermediary Body) (ii&Jfo.^$££ M3fem (Day Care) %xm WT 29 mwm&ig?) wm 2g *s#fc#wr##^ wx 2g >JtsLY4 ■ 7T-ty9- WA 310-320^$ fc££ 4i[l][S^ (Medicine, Chinese Traditional) WZ 80.5.06 m.&ftbtlX^Z> WB 50 K£l£S£im WZ 70 fpS^7y'J7A (Chinese Americans) UTyT3hT9 'J7A$££ 44!*^ (Chinese Herbal Drugs) Iim4ftl^3ij$£ £ fpSA (Chinese) (£^x7o4 KAtl$££ fc^UUffimm (Traditional Medicine, Chinese) li^HIS ^$££ ^S^tS^/titt^ (Plant Extracts, Chinese) li^HtSt^ mizfix "p? (Ear, Middle) WV 230-233 tysyji (Otitis Media) WV 232 4'5tfc*l (Middle Ear Ventilation) WV 232 XWs (Injections) WB 354 &T WB 354 &m.m WB 354 i^Bi WB 344$fc££ mm (Syringes) W 26 mm&m (Syringe Sharing) f£i±#t#r*ffl$££ mtit^m (Needle Sharing) IfrWY \zy9Xit, ±SI£iJIZ Yk&mXM^. (Sampling Studies) &I§g{?3l$££ M&V>} (Extracts) lifflUx*x ; Bmfo&Vn ; %£*&&& w; w^tsa^; mmmmzfix ^Ajticte (Dental Occlusion, Centric) WU 440 fp'Di1 (Centrioles) QH 597 ip^Sf (Mesonephroma) WP 322 'l4Jffifl&1416$-'A (Hypoventilation, Central Alveolar) i£«mmUm $ £ £ &m (Appendix) WI 535 &H£ (Appendicitis) WI 535 689 f-i-yxA &W$,m (Appendiceal Neoplasms) WI 535 ASHBIifc (Appendectomy) WI 535 X¥.W&?k (Central Nervous System) WL 300-405 -izimtZm QV 76.5-H5 fptg^iS^^f. (Central Nervous System Diseases) WL 300-405 WftWm.% WW 460 mi WL 300 fl'Jtmbty'Jtm WS 340-342 mm wy 160.5 mmm sf 895 fc-WMtiklhmm (Central Nervous System Neoplasms) WL 358 ^^M^Xhm (Central Nervous System Agents) QV 76.5 BXm QV 100-107 famnm qv 77.2-77.9 fYUWgk#M^m (Central Nervous System Stimulants) UMXmZflX tYmmtmii^mWtimm (Centrally Acting Muscle Relaxants) (£tpflit4#f&&§li2M$££ fc-UW&#.fflMm (Central Nervous System Depressants) QV 80-98 mamm qv 110-115 immmn fc, tm 9 a ycowum $ fc £ £ rYUitftfeWiWlMm (Muscle Relaxants, Central) QV 140 m$iz is it & WO 297 fptEMPfPft (Apnea, Central) l£SiHSPW¥n&*£f^i#$ ££ tY¥M'sim& (Auditory Diseases, Central) WV 270 fc'WmmR. (History of Medicine, Medieval) WZ 54 4>'I44- (Neutrons) WN 415-420 -^XYZmmmiziSith QC 793.5.N462-7g3.5. N4629 \^mmmmizisiti> wn no ^HXIfrMltiTtfr (Neutron Activation Analysis) QD 606 ^^^KlzMLT(£, Zcotyniz tpHtXm (Literature, Medieval) M$. PN 661-694 tmY\z-y9xuxmmizxniityyTbmmuwz 330 tteffi (Litholapaxy) (£#44ffii$££ mi&mmmA (Dental Casting Investment) WU 180 4>£ (Metatarsus) WE 880 X%.^l$y (Metatarsal Deformity) (££c/)M#|S$££ + £# (Metatarsus) WE 880 ipS-i-P^IWIn (Intermetatarsal Joint) l£54fif:llip$£ £ +# (Poisoning) QV 600-667 mVnUMmm wd 400-430; mM wd 405; n^li bmm WD 400-430$££ -mimmu-mitmm^m qv 662$££ ^^mit^^it^Xm QV 282^$££ &BDn(£&fp# WC 268$££ ifXiirrx^n QV 662^$££ mM WA 465 mmmtfi^m w 925 §&(£$&*# QV 292$££ 7mu7mxn qv 293$££ *9=>ii*9 ntpil WD520$££ tfi^litif^'ffi^ WD 500-530$ ££ T/K^7tftli4;Rt7t4t WC 268$££ Mbi^m^mu^bi^mitt-^m wc 268$Mi mmm sf 757.5 :ft£<7)4fW!m *«, im*SC, MA, Ml*, 7-f/u x^o^g^fc, nvumftffZiifix 't'lfl-try;- (Poison Control Centers) QV 600 A£ • mam qv 605 *RPAlz£oltS wx 215 fpS'ttUTifc (Hepatitis, Toxic) WI 700 ff^ttEASSi (Megacolon, Toxic) WI 522 *W4x a >y y (Shock, Toxic) (£^Kll*£'t4x ry^g £ fp#'l4x a -y 9m%U (Toxic Shock Syndrome) liBfcjfii ffittx 3-yy$££ ^#1411^*^ (Psychoses, Toxic) ii^Kif HtftW*«$l £ ^#'l4S^^?Ei*P (Epidermal Necrolysis, Toxic) WR 165 4>M^ (School Dropouts) (£tp&il^£$££ rY&&m% (Student Dropouts) LC 142-145 ^xn'Ommbmmm ws 462-463 i±A (Infusion) liM$££ i±A|§- (Infusors) (£i±A7°X7°$££ i±A7°X7° (Infusion Pumps) WB 354 fyX (Middle Age) ?lii4>W BF 724.6 mmm&m wx 100 WWj:Y\z-y9XU, ±M£iJtz fc-B (Mesencephalon) WL 310 fpfliaM (Tectum Mesencephali) (i[gixf£$£i cpfla^KillSlHM&K (Periaqueductal Gray) WL 310 rpmX^ik&IS. (Midbrain Central Gray) (£4>JSi/fciil HM&K$££ fpEH (Mesoderm) WQ 205 4>Jk (Mesothelium) l£7j£$££ fc'fem (Mesothelioma) QZ 340 Xfemm (Neoplasms, Mesenchymal) l£*££4fi$fc!I*S$ ££ fpg|5 3 — o -y^JJirfc (Encephalitis, Central European) l£7-«£«&$££ $9£T A ij 7 4 >77 7> (Indians, Central American) F 1434-1435 RlfccoX^m Y t -y y X $ fc £ £ irWffi (Day Blindness) (£*&7jPfW$££ iiUfc^f* (Customized Drugs) l£7TM 7 F* 7 -y 7$££ It'JXA (Nyctohemeral Rhythm) liBIS]»J$£i Att^JB (Appendix) WI 535 &tf^*2& (Appendicitis) WI 535 7^. — 9— M (Preceptorship) mm WU 20 mm w 20 ^8m<7)^lf(£4£M«iJ(z 7x-7*tf A§c^?L#T (Tympanostomy Tube Insertion) l£fr1^:t^^$££ 7x-7*'J y (Tubulin) QU 55 H (Intestines) WI 400-650 690 t- a 9 x x #£?)2lir$fc££0 WxliiiYSf WI 600-650 7 3 7 (Butteflies) QX 560 |§7 ' —>*6£ (Intestinal Amebiasis) Ii7 A —'<#>*$!$£ £ ggtfjfKj® (Transcendental Meditation) (i§g'JS5lfe*SiJ<$ ££ &§& (Enteritis) WI 420 gjl (Ultracentrifugation) 41**WPf^ QH 324.9.C4 itmxm TP 159. C4 itmwftm QD 54.C4 BS*{fc¥ QY 90 £•!>#« QD 54.C4^$fc££ ^^t7'J7 (Vibrio parahaemolyticus) QW 141 fitilfc (Supersonic Waves) liSfri&tfciS : S#i&£ S.J: S^iS (Ultrasonics) xviy>mm QT 34 tfcBfWfJB ("fe) lifii'Yi***^ WN 208$££ t^a^ QC 244 ^w«iw»»BWJ=lieflB3a4*^li. ±MJ5iJlz MeifcA 9-y (Ultrasonic Imaging) (ig^i&tfcS&fc ££ atiftttSSS (Ultrasonography) WN 208 g^it^Sfff (Ultrasonic Lithotripsy) liftWffif$££ g^i^tbiifl^Slf (Prenatal Diagnosis, Ultrasonic) lifcb iii!@^i&l£®f$£i @t?£*^i& (Shockwaves, Ultrasonic) (£@#iS$££ StifciMBf (Ultrasonic Diagnosis) (iSlriftttltft $ £ £ Sa'iSBSt^Sii (Echoencephalography) WL 154 m^i&mm (Ultraslonic Therapy) WB 515 f&Ht (Hearing) WV 270-280 Ym WX 276 ttKHIt (Auditory Threshold) WV 272 ?im WJtmbtcofacoYJV-y WV 272 %%m (Audiology) WV 270-280 WSt WV 270-280$ fc££ 8#l*ari£ (Hearing Tests) WV 272 t§4xt-7xX7XF WV 272 ;%*«!£ WV 272; ^wfifew#^7x F^£ft$fc£i B1SM (Auditory Perceptual Disorders) WV 270 HTjPfW (Hearing Disorders) WV 270 fl'Jtmbty'Jim WV 271 l^SiJ^ (Audiometry) WV 272 T&mBmft&W) (Temporary Threshold Shift, Auditory) liliM?? $££ l%1£l£.& (Auditory Localization) (£:g:S13:$££ l%Wm^^^%KJ^ (Evoked Responses, Auditory, Brainstem) (£JJ2$£il£;li§?git1i$££ H^RIFt (Reflex, Acoustic) Wjffi/6 WV 274 Btffc&K (Auditory Cortex) WL 307 «*«# (Auditory Fatigue) WV 272 BJfcfSK* (Hearing Protective Devices) (i?<7)f*if:Sr $££ !$M£g (Auditory Prosthesis) (£AX(*1^"$££ lf:if^l1i (Evoked Potentials, Auditory) WV 270 Mim7Mk%$n.\i (Acoustic Evoked Brain Stem Potentials) \tm&&%M WLML $ £ £ %%mHJxS (Auditory Evoked Response) UW^WA '■li4>/:$££ WH£1» ( Auditory Pathways) WV 272 R&^Wfc'K* (Parenteral Feeding) (£#&P^#$££ WMBtUt (Acoustic Sense) liif§'j!;$££ HHrW"•& (Intestinal Absorption) WI 402 Sff^/l^X (Enteric Hormones) liiflftffjfcA'* >$£ £ mmm (Mesentery) WI 500 JfiLfflEffcte WI 500 If # WI 500 mmm qz 340 HJHllBSflSfia (Mesenteric Circulation) (£f*JiIfSfi$££ SfUMift* (Mesenteric Veins) WI 720 H&lHlWIfJM (Mesenteric Arteries) WG 595.M38 stwmcoxvjkmmz wi5oo$fc££ Sff!M#*te (Mesenteric Cyst) WI 500 If [IMMWI^P&iK (Mesenteric Vascular Occlusion) WI 500 IffUMiJ X'-fgfisfe (Mesenteric Lymphadenitis) WI 500 ftWAUj (Absenteeism) (iSgfi'jAIJj$££ &mfem (Long-Term Care) WX 162-162.5 %xm WT 31 mm WY 152 mmimAizffltx wm 30 &mi&mi%$k (Insurance, Long-Term Care) W 160 £Aiz*tLT WT 31 SWIM^SiJRB (Chronic Limitation of Activity) l£ B ISX iSIM4$££ Mttbft&M (Myenferic Plexus) WL 600 Sf y o Ag£fr]f4fflS& (Enterochromaffin Cells) WI 400 >£mm wi 402 matft (Sphenoid Bone) WE 705 m&Wm (Sphenoid Sinus) WV 358 ^SiJ (Sculpture) mmizM'Mfch WZ 330 mmmizM&t& wm 4g B§##IR (Iliac Vein) WG 625.15 &f#iJ]H (Iliac Artery) WG 595.15 mftl (Drug Compounding) QV 778 mmn& (Dispensing Fees) f£$i47£A/fl $££ m^tm (Survey Methods) (£7'-yj|X*$££ &m\zW (Superoxides) QV 312 m&ft (Superego) WM 460.5.R3 frXm WS 463 H'jtmtwjtxi ws 350.5 ftRWOtiEl (Electrocardiography, Dynamic) liMfP* -t>fl:El$££ ftP^fUMvl;!!!^ — 9 'J X7 (Monitoring, Ambulatory Electrocardiographic) li/£4f R^lM; M $ £ £ Sf*££. (Intestinal Diseases) WI 400-650 m~m WI 400 %VJtmbxxJtm ws 310-312 mmm sf ssi g# (Length of Life) I£ft4^$££ SfttlfiL!>&&*£ (Schistosomiasis, Intestinal) (£mansonift tfo.n)ijk*£$££ SfS^f*]E (Intussusception) WI 450 Sf mm (Intestinal Neoplasms) WI 435 »f4^fc^(£SIHiSiJ(z l%m (Auscultation) WB 278 691 f3-7-» 'L'Htt'OHaa* WG 141.5.A9$££ Vi^BMizfemztiztii&u, xmmz mW& (Auditory Nerve) li^?Wig$££ ftW&*&ft (Acoustic Nerve Diseases) WL 330 mtmm wv 2so$fc££ ttttM (Neuroma, Acoustic) WV 250 tttt&lSR (Neurilemmoma, Acoustic) tttttt&ffi&£ £ mMm (Stethoscopy) (iJlf£$£i &bmm (Parapsychology) BF 1009-1389 mm BF 1405-1999 l%HW.AfxJfc (Evoked Response Audiometry) lit&ftR SH4lt^$£i I§14SB#14i (Brain Stem Auditory Evoked Potentials) (iBStHi%&?g«& $ £ £ mffi&UX (Genes, Regulator) QH 450 ikUmffi QH 450-450.6 7 3 7-bx7T-#7 (Stramonium) QV 134 Sf ^?L (Intestinal Perforation) -fe WI 400 mm'\icoiiCou^nmiz WftM (Hemorrhagic Fever, Korean) (itfffil&ttft Jfil&*£1£i£$£i $Jlilftjfil*t7 4/l/X (Hemorrhagic Fever Virus, Korean) U'^y 9 — X7 4 JVX $££ l«¥A# (Ginseng) QV 766 Sf &mfT (Enterostomy) WI 480 fl&fcnlt (Auditory Perception) WV 272 fl'Jtm, QjyimbArCOtticoYJV-y WV 272 $m WV 272 S§7 7X (Typhoid) WC 270 Sf7 7Xl (Salmonella typhi) QW 138.5.S2 Sf7 7X'^7 7X-iI£-7y7x (Typhoid- Paratyphoid Vaccines) '■Sy + yxm WC 266 -fe&W7 7Xffl WC 270 SfISfp# (Allantiasis) (£77'JXA$££ m\H7A JVX (Enteroviruses) QW 168.5.P4 BfF*l7 4/l/X®3&!E (Enterovirus Infections) WC 500 mmmftm sf 809.E sg 'WZB'&&% $ fc £ £, Ml itfc U fc WC 555-556 lfl*P&& (Enteric Infections) liSfl*]$&^ ; xxro7 Ajvx®:&& ; %rX&\&mm& ; WZ!Byk9>%VfiZ fc£ i Sf f*]*H!£F (Enterobacteriaceae) QW138 Sf f*l*fflffi®i&K (Enterobacteriaceae Infections) WC 260-290 mmm sf sog.E63 Sfl*]i&fr#A#BffF& (Enterically-Transmitted Non- A, Non-B Hepatitis) liESfF&$££ ^B'|4J^^ (Ultradian Cycles) (iiSUj'147-4 9/U$££ Sf*S (Enteric Fever) (iSf7 7X$££ mmi (Voivuius) ummmuzfix @^7J (Extrasensory Perception) ti;tg31¥$££ Bf^ilUj (Intestinal Motility) (iP?S§JIiJj$££ B§5)4# (Intestinal Secretions) WI 400 Sf WM (Intestinal Atresia) WI 412 Sf I3IIK& (Intestinal Obstruction) WI 460 mmm sf ssi Sf &*5 WI 450 flMmi WI 300$fc££ ffimM (Obstruction, Intestinal) I i Iff M $)*•£$££ Sf fflS (Intestinal Atresia) WI 412 Bfffftflcflflf (Pneumatosis Cystoides Intestinalis) WI 400 Bt7°iJ-7° (Intestinal Polyps) WI 430 mmitniicoimmniz Sf fcjv^y (Intestinal Hormones) Ui^it^fcJVt x$£ X Sf 7/l/^EX-g^ft: (Intestinal Hormone Receptors) it)% iYj^fcJV^y^^W^flX S^dM- (Ultramicrotomy) immZWYfimm* ££ M%km (Condiments) mmtfexummMcowkb lt wb 447 wm TX 819 mmmyA jvx aouping in virus) u9-mfrm$.7A /l/X$££ mmm (Saiientia) immmtfix Sfi£14t£giJ (Tablets, Enteric Coated) QV 787 ffflm (Cookery) 3iM3l$££ Sf*g (Enterocele) (£^/l/-7$££ !&7J (Hearing) WV 270-280 f*!S WV 276 5S44 (Tensile Strength) xthmmm qt 34 # WE 103 MtimR (Audition, Limits of) liJ$/^1it$£i mtltk^. (Hearing Tests) WV 272 ^W4xt-yxxrxF wv 272; 7-x7y-?i* 4)tt^i£ WV 272 ; ArC0m<79ft%.yX FO£&$£ £ ,%M (Birds) %m%mb LT QY 60.B4 m^ SF 460-473 f?14Ujf* QL 671-699 .%M&^kiiU>-yi (Hypersensitivity Pneumonitis, Avian) (£ F USiU*?!$££ ,%mU&ii.AW^$.7A XJV (Infectious Bronchitis Virus of Birds) (£ F 'J imiXA^&7 A JVX $££ .%M*7 WI 650$ & £ il&IHIH*^ (Proctology) (ittfflfHM (#H) $££ MMmft (Rectal Diseases) WI 600 [ilSfli*! (Rectal Neoplasms) WI 610 Wk^L (Rectal Prolapse) WI 600 W^m (Rectovaginal Fistula) WP 180 g&i.Sll&A (Instillation, Rectal) (iifrSf t*)t*L *4$ ££ ifSfP*?^-^ (Administrdtion, Rectal) WB 344 jt&tl*)^ (Anesthesia, Rectal) WO 290 mmm (Proctology) li[i:Bf^4 (#F1) WI 650^$ ££ mm'Ytli'kX (Rectal Drug Administration) Ii ifrSfffitS: 4$£i fiSf* (Rectal Fistula) WI 605 jfHSl* WP 180$fc££ fiiftttf5! (Galvanosurgery) (i€^.fl44$££ i£)lf:$*Jft£ (Electric Countershock) WG 330 73nx-F (Chocolate) (i774$£i £(14S (Copyright) Z 557656 iimft (Eidetic Imagery) WL 705 *>^o£gi£- (Flicker Fusion) WW 105 fy^y (Tyramine) QV 174 t&mm (Geography) mmtbuAm wb 700-710; mm wa 900^; w^ &mzisitz>mm% wb 700-710^$fc££ mmmmm (Geopathoiogy) i£^.m; mm&M%; mmm 4$fc££ J&*ftff (Remedial Teaching) LB 1029.R4 t^5*/d:4fi(i,y47«ijiz1?ij^(£3|#(i HV2417-29g0.5 i&fJ^JjHI£ffit4 (Therapeutic Equivalency) QV 38 ip*JBfJJ^:|o]l£l4 (Equivalency, Therapeutic) (iVaS'xi)^: #1I14$££ iSSe^l^ieii (Treatment Protocols) U^,lM%mim^ ££ i^^7- tx (Dietary Service) mm WX 168 mtm-k^n wxi68$fc££ ZMffiXffi WA 6g5-722 t»mmm wb 400; && wa 350^$ fc££ teHf#J*|s]f£ (Therapeutic Community) WM 440 feSl&M&JlM (Thrombolysis, Therapeutic) (£lfiLt£i§ mmm* fix fem&)M&i (Hyperthermia, Therapeutic) U^it&m^: fix \m^)mM (Reading, Therapeutic) Iif7t#*3?i£$£i iamtftlfcm (Abortion, Therapeutic) WQ 440 &mco#£9 77'(Social Clubs, Therapeutic) (iSIJjy ^-7°$££ ipSTffi (Therapeutics) WB 300-962 Wk (BID SF 743-745 mvvmm sf 915-919.5 $ fc £ £ B8tm WO 375 ■bM!hi§3frm& WG 166 mm& ww 166 &§A*4*££. WP 650 mum wb 120 fcJV^y WK 190 fVJtmbwjtm ws 366 %Xm WT 166 *JfWf* WM 400-460.7 ?l!£Wfc«l!OJl WS 350.2 mi$*£& WU 166 WM QZ 266-269 t*W^ti^7W#i£ WB 460-545-^$££ SfcWttlnHftf* WN 450 y -x7A WN 340 Ux F7x$UiX$llei£- WN250.5.X7$££ lk)$m& WR 650-660 ftrftfrfclift^Plttr WB890-g62^ ; AzCoYkco'&mvytfc %9 Ayu^WAPflX mxm& WU 166 WM&m& WJ 166 *WfHL^*£&Ote*jg|zttLT(i*££, Stfc L < li*<7) ^ie#v$££ te!&i£-^S'.itiii|£xX7A (Dosimetric System of Therapeutics) (ift^Htlf $ £ £ femm&Mmm (Fungicides, Therapeutic) (£tt*lS*$ ££ femmmtM (Radiotherapy Dosage) mmrnm wn 450 7/7A WN 340 X*£ WN 250.5.X7 mtmm. wn 665$fc££ femm#fiffim (Patient Isolators) WX 147 £>*)£!£ (Goggles) (if£ff ^**;ra$£i 7 o 7 JV y Y — y (Thyrocalcitonin) Ii 7 JV x F — X $ £ £ 7 n * y x (Thyroxine) WK 202 7 o * x XlS-g-7n 7 'J X (Thyroxine-Binding Globulin) Ii7n * xXjg£-S&«$££ 7oJrxX|g-g'SQK (Thyroxine-Binding Proteins) WK 202 7 d * y xIS^7°X7/l/7 i X (Thyroxine-Binding Prealbumin) l£7n =r xX*S£-gi4R$££ fn^y^ffft: (Thyroxine Receptors) l£^^SM7/U *xS^f£$££ 7n*->x S'-Dia^lil (Thyroxine 5'- Deiodinase) (£ £ t Wzm^JVfc * x 7--tf $£ £ foif/>5-i7Di3^|^| (Thyroxine 5'- Monodeiodinase) l£ £ i itW^JVfc * x 7-7'$£ £ 7 d 7 o 7 'J X (Thyroglobulin) WK 202 7 o y y x (Tyrocidine) QV 220 7 o -> x (Tyrosine) QU 60 7 o yyTS.9 F 7 X X 7 i 7 — -t (Tyrosine Aminotransferase) Ii7n xX F 7 XX7 ^ 7 — 7*$£ £ 7 n -> x F v XX7 ^ 7 — 7' (Tyrosine Transaminase) QU 141 7 o F iJ x X (Tyrothricin) QV 350 7 o ij -; 0 X (Thyroliberin) (£7° n 7 X 'J X $ £ £ Igl^jg (Antitussive Agents) QV 76 7x=r$iJ (Tinctures, Pharmacy) (£)§$$££ «# (Wages) (£*St4i14Jjn!&¥4$££ mmm (Spasmolytics) liffi=» 0 xffHfjj3l$£i itl^^ (Precipitins) QW 640 !&l*1tSJ5tJ£ QY 265 mmm (Sedatives) (£{IHgmfc!»#*$££ 7x77 (Chinchilla) QL 737.R636 fBlW SF 405.C45 mm SF gg7.5.C5 693 =f->yyA? Sfl*S* (Analgesics) QV g5 itIS (Precipitation) QD 547 CllS QW 640 rX F QY 265 §ftn±H£ (Antiemetics) QV 73 7X'n°Xx— (Chimpansee troglodytas) QL 737.Pg tmmnbLX QY 60.P7 mm SF gg7.5.P7 7x>">°Xx —3 ij —-7H4- (Chimpanzee Coryza Agent) (iRS7 4^X$££ f-x'W3E (Follow-Up Studies) (NLMftnmxuam&^o) wz^-ffizis^xitArcom^^xmmiz, mtu^mm WG 210 *fJft£ (Paraplegia, Spastic) lijS|l#*$$£i ^l£*ift (Accidental Falls) mmn WA 288 tt&&¥% (Paired-Associate Learning) LB 1064 m&m (Emmenagogues) itft^M?St*K$££ iiUfffcTef (Correspondence Courses) (£#fcW$££ ii1i#B (Telecommunication Networks) itzi x 1:7-y 3 $ J.-7-X3 x4-y F7-y $££ ffiiA (Gout) WE 350 ihmmumMMm QV 98$££ mm.$mm (Gout Suppressants) QV 98 7X7x/y^7x/*. (Lunar Phases) !££$££ 7 y o 5 7 x x (Zuclomifene) liynS7x>$££ 7 y 7/i/xJ&Jfr5fc (Poison Ivy Dermatitis) Ii7/l/->&)|[ &$££ ± (Soil) s 59o-5gg.g £l# (Malleus) WV 230 VVtf&y (Trombiculid Mites) QX 483 7'97'A+ym (Trombiculiasis) WC g00 7'<* (Camellia) (£&$££ '9—^y 9 -9-^YJV (Two-Parameter Models) Ufa fttlS$££ •y/&Jt*£f. WR140$fc££ trj^^jfclll (Encounter Groups) mwmm wm 430.5. S3 4t£^ HM 134 X&i&mffi (Chiropody) (££*?!¥$££ YT ^ y TJV%— ys<9y°y y X (Deamino Arginine Vasopressin) (£7XJE7°X x X $££ WXm (Hypobaropathy) l£ifjUJ*??$££ ISISffcJfct* (Medically Underserved Area) W 76 %m&xm WA 3g5 mtmA:tiii}%v7n 7*') XjfiLSE (Hypogammaglobulinemia) (i te7'X^7o7'iJ xMe$££ ^JWfiJtrt* (Periodicals) WI £a§9^l$££ ZmWrrX^ (Documents, Serial) l£^Wfi]lf!t*$££ x.m$i& (Periodic Health Examination) ^H^tftfi $££ 74 7 7 (Day Care) %tffl WT 29 tlt*W*^*^lzo^T WM 2g %mimmb%wm%iz^^x wx 29 !£S74 7 77 x? WA 310-320^$ fc££ fgjfiLffi*^ (Hypotension) WG 340 f&MES (Hypotension, Controlled) WO 350 (gjfll^S (Hypoglycemia) WK 880 f&jfHg (Hyposomnia) (£4^HK*£$££ ®$*£ (Hypochlorhydria) l£4&$t*iii$££ fi$M-E (Hypoxemia) (£te$e^jfo.^$ ££ t^lfflSfe (Cell Hypoxia) QH 633 fS^^ffi (Hypoxia) (ilRt^^*£$£i ®tEH (Vision, Low) li3£iE?&»:E£ JI* fSfeHttglfo. (Anemia, Hypochromic) WH 160 T 4 y y 3 X 7 0 — (Decision Trees) &«ftf4 QA 27g.4 ft^F t^yx(£, iggijtz Y4 yy 3 X^Et*1) X7(Decision Modeling) (ilL&i&SE £l§txi£$£i 7>f ->y/l/3 x ti — y (Computers, Digital) linxt ^-y$££ '&&XWWJI (Infant, Low Birth Weight) WS 420 <&&X\YWJLm& (Infant, Premature, Diseases) WS 410 f;P/f#^mmYm. (Indigents, Medical Care) (i Medicaid ; [Sffet:E$££ ISPiftffiS (Low-Income Population) Ii1t[*l$£i fi'DWUlS (Low Cardiac Output) (£iStaaiS$££ f£f4£*£ (Hypothermia) WD 670 mum QZ 57 ^swaus qt 160 lf££i£ (Hypothermia, Induced) WO 350 XiMcommmcotziihcom^rizMLX WO 350 mmmco sf 914 aKfcttf* wo 510; Hisiaii wi 380; fif^st i fzu%nxffiu?$iTMizmiu}m,xmiztsithi&i& m WL 368 IEJK (Peat) S 592.85 ± S 592.85 mmm wb 525; xmwxmm qw 60$fc££ f£7 F 'J 7AjfiL^ (Hyponatremia) WD 220 1&7F iJ7At: (Diet, Sodium-Restricted) WB 424 nmm wb 424 IStfifti: (Cardiac Output, Low) WG 210 fg7°o F nxtxjfa.*JE (Hypoprothrombinemias) WH 322 Y4yu-?mffiLmmm$lM (Education, Nursing, Diploma Programs) WY 18 i&tt-f-ftM RNA (Low Molecular Weight Nuclear RNA) (£SnRNAR$££ ffi->>74^y,f'J X (Heparin, Low-Molecular- Weight) QV 193 i&fc9 y7Ajfli*jE(Hypopotassemia) (£1£7 'J 7Ajfo.*E$ ££ ffiffilfc 'J fc%P\'ft =» X X 7 n -JV (LDL Cholesterol) (i LDL3l/X7o-^iJ7Sl4?C$££ fft^fl'i'J 7®l"rrp5Wf^ (Receptors, Low Density Lipoprotein) (iLDL'2'#f4$££ dm (Mud Baths) l£i/giftt$i£-$££ IJEttHRiS (Mud Therapy) WB 525 fv^^Ul (Cryptorchidism) WJ 840 mmm sf 87i ttSW'ii (Cryptorchism) UW&SHL&&& Y 4 JV Y 'J X (Dieldrin) WA 240 Y4 y9 Y 'J— (Directories) (NLM^S^T(iJF^^#^-22) %Xm QS 622 mmm w 622 ttas WW 722 #t*^ QV 605 7 4 — vx- ycoWtik (Teenage Pregnancy) iX&Xm#£ 4S$££ 7'73rx7/l/y 3— ;H£ (Deoxyursocholic Acid) (£7/1/ 9 Yfc^y^-jvmz fix ft7/X7 F* 'J X (Deoxyephedrine) (£/ y X7 x y ~ X$££ Yfc^yyjva — X (Deoxyglucose) QU 75 y'fc 3fy3;i/f 3Xf n> (Deoxycorticosterone) lifV * -> aj v 7 3 X 7 d x $ £ £ 77^x7 ^ xX^-7 —-t (Deoxythymidine Kinase) Ii f; xX*7-^$££ 77 =r x 'J 74£l£ (Deoxyribonucleic Acid) l£DNA$£ £ Yfc*y iJ fcA 9VT-Ji (DNase) (iDN 7--£"$££ Yfc Y 7 X F (Deodorants) WA 744 yfcy 4 OX (Theophylline) QV 107 77 7 4 'J >"!§(t (Theophylline Receptors) (£7°'J X -gWf£$££ 7 77*n~x (Theobromine) QV 107 Xfr'fr') (Cues) 344JXJS BF 319 xn mmm) bc isi ?•## (Handwriting) mm BF 88g-gos i^ff Z 105-115.5 Bm®&)m&U, A:CoWmz 777-/1/ (Tegafur) QV 269 Y7 9 Y — 7 Afb'o'!)* (Decamethonium Compounds) QV 140 ft£ (Hostility) BF 575.H6 W¥ffi WS 462 ?U£Wlfc#J!£« WS 105.5. E5 fakMm&MJB (Hostility Catharsis) l£ft?P&JxS$££ ilStTllJ (Behavior, Adaptive) !£4>JI(ftiIS$££ ilSPiW (Adjustment Disorders) WM 171 mwmmtmwmimmm wm 207$££ iIS*£f£34 (Adaptation Syndrome) (iXFl/X$££ 695 t*Vj*9 Y*7-A9Vy (Dexamethasone) QV 60 i$?E (Drowning) mxm wa 292 mt HB 1323. D7 *■;**& QT 260.5. sg 7^fXFy7--t (Dextranase) QU 136 7'*XF7X (Dextrans) WH 450 7* X F 'J X (Dextrins) QU 83 r*XYu-X (Dextrose) {£7/1/3 -x $££ 7^-X F o x/l/7 x- F'-/l/(DextrosulfenidoD (£77 x 7x-3-yu$££ 7df-x7n7°7X d—;u (Dexpropranolol) {£7°n707V o-/l/$££ i!14t$S (Aptitude Tests) BF 431-433 mmmztsit&A-Mt,A:f-7Ayfl/>-;*x* X^J£ (Technetium Methylene Diphosphonate) (if ^ 4-77 A99mX F'n 7-F$££ 7 y 4 7 7 Aggm MDP (Tc-ggm MDP) (£ 7 7 4- 7 7 A ggmy F*o7-F$££ t9 477AggmX Ko7-F (Technetium Tc ggm Medronate) WN 420 mmrnm wn 445 r9 9u=y- (Technology) T-TX itm (-fe) TP 144-145 mi T 44-51 «F tvyxi£, XMMiZ X-g (Wrist) WE 830 X-gmi% (Wrist Injuries) WE 830 7*7*4 7 Y 7 -y 7 (Designer Drugs) am WM 270 mi QV 55 mmm qv 38 7-xy/Hi^-243I (Digital Signal Processing) linxt ^-ytt^feR|$£i 7y 9 JV 7 x fc 7 7 7 ^ - (Digital Radiography) l£ X H ffc<:$££ Yyy°7 5. X (Desipramine) QV 77.5 7X 4" ^ x 3 ;!✓ F X (Desoxycortone) lifV^fyn^fn X7ox$££ 7X fc * y "J 77 y X 7-7* (Desoxyribonucleases) Ii DN7—1*$££ 7 X F X 7 o x (Testosterone) WJ 875 7X7x'J7dr75x (Desferrioxamine) (£77 x rj^f-7 ^ >$££ YX ^ A-JVA S.y°y S. y (Desmethylimipramine) (£7x 7°7$X$££ 7X^E7°x->x (Desmopressin) WK 520 YX^y--t' (Desmolases) (£>J7--t$££ 7y^rx3/l/73X7nx (Desoxycorticosterone) WK 755 fV*y >) fcY$M (Desoxyribonucleic Acid) liDNA$£ £ 7-yxX7A (Data Systems) litit&xXr A$ j££ Y-9>\m (Data Collection) WA g50 #£o@ft(zouT(i, xmmiz Y-9Y4 xy'vA (Data Display) TK 7882.16 (NLM^-^^T(iJ^^#^26.5) *im%Y t-yyxizoi^TIi, xmmiz T9-- (Tetany) WD 200.5.C2 mmm sf 910.T47 7-y-<-X (Databases) it^WY-9^-X$££ f-^-XflyXjA (Database Management Systems) W 26.5 wzcoBWizmmztizm&u, xmmtz $k (Iron) mmm qv 183 ii-^HHS^ (Iron-Sulfur Proteins) QU 55 ft£ (Iron Salts) U$m%.coi*co£fft$£ £ S*^ (Philosophy) B-BD £&f£ B 69-5739 *^ (xmm) qh 501 f4^[;^t x Q 174-175.3 wzismcozfoziifix, mtu^xm b 105.E8 ^ ; ha-v^XA B 821 %%*y- Y (Iron Chelates) JUI*^ QV 183 ^m\\m QD 474 SkkZH^M. (Anemia, Iron-Deficiency) WH 160 Y -y 7~ X (Drawings) (NLM^iMgT(iff^^#^17) fH*fiSttf7iS (Diaphanography) li?i!-B8i£$££ lttl!H& (Transillumination) WW 143 A:com^m*KcBfr)izmm$tiz>m&u, xmwz &it*E (Siderosis) WF 654 mm'\i (Tetracycline) QV 360 7F77X-F (Tetracemate) (£x7F&$££ 7 F7 7^y4/i/7/u7-/i/7-ty-F (Tetradecanoylphorbol Acetate) H*g!r*KfcLT QZ 202 696 XX* 7 F 7 t K d 7 X 7 t / — >i (Tetrahydrocannabinol) QV 77.7 fF7tKo77y'JX (Tetrahydronaphthalenes) Mmm QD 391 %mm qv 241 7 F 7 t K a fi^f't K u 77 — 7* (Tetrahydrofolate Dehydrogenase) QU 140 7 F 7 t ^ 7S (Tetrahymena) QX 151 7 F7^> (Tetramon) lif F 7x7/1/7 X^-7Aftft t*$££ r F^'J X (Tetralins) l£7 F 7 t K o77 9 0 x $££ fhiJ^Tyt-7A (Tetrylammonium) (£7F"7x7 ;U7X^-7A{H^^$££ f 7 7*77/ (Hylobates) QL 737.P96 mm SF gg7.5.P7 %mS\mbLX QY 60.P7 7777*/l/S# (Symphalangy) UtY7*7*>v $££ 7-X (Tennis) QT 260.5.T3 ^<*0$tSJI# (Hand Deformities) WE 830 $<0\m (Disinfection, Hand) UX^mm^flX 7<7)tlH (Hand Injuries) WE 830 7<7)&J£*££> (Hand Dermatoses) WR 140 XcoXvj&Vk WE 832 $ fc £ £ XCOlht, (Palm of Hand) (£¥-$££ f'7xd-;u$££ 7*t F'oy 7/1/7 X Mfn x (Dehydromethyltestosterone) (£/yxF*nX7nx$ !£ 77 x o *7 ^ X (Deferoxamine) QV 183 77 X 7 'J x (Deprenalin) (£ -t X *' 'J X $ £ £ 77 v--JV (Deprenyl) (i-te X% 'J X $££ r'7x^/U (Deprenil) (£-t x Jf* ij x $££ 7—7°Ht:g: (Tape Recording) ~izwt'i>7yDys.t/i:^(NLM^-s^T-(£j^^;#^ 18.2) £^(i±g|£ijlz 77#J (Depot Preparations) (iii^14|il^J$£i f/f^xh" F'7-f on F;4>xx7ij vx7/l/3 -> F' (Demethyl Epipodophyllotoxin Ethylidine Glucoside) (£x F 7x F* $£ £ 7/7X (Abate) S3£ SB g52.P5 ZHtffiX WA 240 7x-iJ >ym (Duhring's Disease) (£*l^tt&Jlf^$£ £ 7'J-H (Delhi Sore) (£'J-x^^-7*£$££ r ij F iJ - (Territoriality) IM* QL 756.2 AFal HM 132 7/1/7 A^ (Dercum's disease) (£Wffifl!SfrS$££ 7JV9mX (Delta Agent) QW 170 YJV9W& (Delta Hepatitis) UY>v9W&ZflX Y)V9^Vk (Delta Infection) WC 536 YJV9ffi%.K& (Delta Superinfection) l£7/l/y^ife$£ £ Y)V9jmU^%-v^.y (Terpenes) 44b'? QU 85 &Wm QV 633 7/l/" (Dermotoxins) QW 630 yJVJV (Tellurium) ^* 3 X (Television) $(W (-fe) LB 1044.7-1044.8. ^%.^00%m WS 462 X'Jt^COfm WS 105.5. E9 %Lfi$££ *e*£ (Metastasis) (ifJl**$E^$££ »& (Breech Presentation) WQ 307 fe# (-OS^O (Transfer (Psychology)) LB 1059 feliHT- (Transposable Elements) (iDNAtf A^3l$£ £ U&MM (Transferases) QU 141 IS^RNA (Transfer RNA) l£tRNA$££ fg^iMS (Deafness, Conductive) (£fs*'l4li73tl^$£ £ mm (Electrolysis) QD 557575 n.Ammizisith wb 495 8fc€lz£o(t6 WR 450 m*Y \z-y9XU, ±{S«'J1Z %m% (Electrolytes) QV 270 %mm QD 139.E4 mmm qw 52 mAim QD 565 xmmmt}^ (-fe) QT 162.E4 7^-mmxm qu 105; j^-mmnxm^^ wd 220 $fc£i n.mfaX\ (Electrolytic Depilation) (£!«.€$££ T/vrt^ (Epilepsy) WL 385 %^coitmm WL 385^$££ ,£HH$ (Eyedrops) l£,£IB#J$££ £8B#J (Ophthalmic Solutions) WW 166 fst&Pf'f (Conversion Disorder) WM 173.5 ist^tX7'J- (Hysteria, Conversion) li$5UlPf'i:$£ £ %A (Weather) A%m mmm) QC 980-ggg mmbcom% wb 700-710 Wfam&uA:covm£tzimiz n.A7KtimWmmm^Wl (Electrohydraulic Shockwave Lithotripsy) l£#4jtfl!T$££ **Vl4Iilg (Electrosleep) (il:7vJt4S^$£i ^.AXmm (Electrophysiology) QT 34 IM* (-fe) QP 341 m^co SF 768 ffXco QP 341 xmm ( -fe) QH 517 f*££ WL 102 ttt* QK 845 A:comcomiA:co^.ttzUmiizMfclXmm 9- y?y9*%X ^.Aimp%i%xL (Titration, Conductometric) !£#$;>£# #n£$££ lfvf5#$ (Electric Conductivity) kfUco QT 34 V»mm QC 610.3-612 *fl#v1i (Burns, Electric) WO 704 MAiV&m (Electroacupuncture) WB 369 MAfeffiKfo (Galvanic Skin Response) mwmmfotk^. wm 145 MI4-7X F (-fe) WL 106 %A%m (Electrolysis) QD 551-5 %AmmiZtSith WB 495 nXWziSith WR 450 m*Y tyyxii, 44tIJ3iJ(z MAfa&t (Electronarcosis) mmm wo 275 mmm wm 412 ^ABWtm (Electroanesthesia) (ifi:flfi*g£$£i tmisffi (Electroanalgesia) imfowmmnmmkm* fl X W.AA X (Electrocautery) li€fW§[5li£$£i mA&hi£ (Electroplating) TS 670-693 St4&*JE1j£itt£7X F (Electroimmunodiffusion Test)li ft«fa£$££ f!#Aft*S:7*n -y Fm (Electroimmunoblotting) lift*&7n ■yy-4 y^ZflX It® (Electrodes) QD 571 xifcmmxm qt 36 mAmwmm iz is it i> wb 495 wzBMizmmzti&m&uxmmz, mx.imm* QY 185 »*«« QT 36^$fc££ tfl*Jr/£ (Electrotherapy) lif!fvJj!iJiM£$£i 7"xytfijfn.1^(Hemorrhagic Fever, Dengue) Ii7X7*fi $££ 7 x777JI (Amanita) QW 180.5.B2 7xy*v (Dengue) WC 528 tHH (Electric Burns) (imin.M$££ Wmm (Shock Therapy, Electric) UMAy a -y 9M £$££ lllXI&llft^ft^f (Spectrometry, X-Ray Emission, Electron Microscopic) l£^4-7°n— yxM ^tJf$££ l^XMiT^Jff (X-Ray Microanalysis, Electron Microscopic) U^Xy'v-yXUftYftZflX ^.it (Lightning) n,Am% WD 602 A%m qc g66-g66.7 fzclftJI (Communication Boards) (£P$W#ffl3 = x —7 -X3XMIJJ^$££ nmCMUm) (Translocation (Genetics)) QH 462.T7 XX (Genius) UXX'Z \ UliStt ; *TJ^$££ ^4^^ (Child, Gifted) ^!S^I$££ %iX (Trochanter) l£7clfcl#$££ MX; (Exhibits) T 391-999 (NLM#MT4£Jf^ #^727-28) 698 xxF7 r •&X (Electrons) WN 415-450 -mtVimmiztsltZ QC 793.5.E62-7g3.5.E62g \mVammizisit^ wn no |ix^^- (Electromagnetic Energy) (i#(l|4l&$£ £ $4LtS7E4tP| (Electron Nuclear Double Resonance) UM.X X t X 4tn.| $ £ £ ^^flf (Subtrochanteric Fractures) tiBS^gnglSiHlr $££ $54fBl#tJf (Intertrochanteric Fractures) liRBflBSSltft 4*f$££ %.$&Am (Electromagnetics) XtynWimm QT 34 SSlgl WE 500 f 44£#T (Electronics) TK 7800-8360 7xvy4X*^JI (Cavia) (£^/i/^ y Y $££ n.X$&m% (Electron Microscope) liliPglfi&Siit&Sa^ fix n.X^mi.^n.X (Microscopy, Electron) QH 212.E4 ffllj^lzfcttS QY gs ftZcoBtfjizmmzti&m&u. xmmz |S4-#t/f (Trochanteric Fractures) (iHSHiHnSl^tJf $£ £ ^.X^^&H^M (Electron Paramagnetic Resonance) Ii l^Xtx4tflt$££ %XX tx4tii| (Electron Spin Resonance Spectroscopy) x^mma% -fe QH 324.g.E36 itm QD 455.2 ftftBmzmmzti&mfruxmmiz t4-7-y^a (Electronic Data Processing) (igjB]7 -y5tiS$£i 7XxFy F 'J— (Densitometry) MX dtm) QC 391 XUm> WN 160 ft%&.coxm&%mmmmztii>?k$tzum&izn tl>X^tftl^#^-lz n.X?lmYk%>m (Xeromammography) WP 815 l^i& (Electromagnetic Waves) liJ##tf&$££ 7 (RNA Processing, Post- Transcriptional) QH 450.2 %iXm& (Transcriptases) (i RNA7 0 X y-7*$££ te'/iHISiiWf-(Transcriptional Regulatory Elements) (i ,!TO&f£4-$£i IT-^isi (Electron Transport) QU 125 .■Stt-M-i&lJFM^S (Dysplasia Epiphysialis Punctata) Ii ,'.'.';Uci|i7PrJFM^S*iH$££ SMfcM. (Petechiae) (£#?«$££ .£W£#JFMJI?£*£ (Chondrodysplasia Punctata) WE 250 fe*144f& (Hepatitis, Infectious) (iA5!!JJT& WC 536 $££ f£&'l4JIT&7 4/l/X (Hepatitis Virus, Infectious) l£^ ^°F74/XX$££ f£<£'l4-¥-$*£ (Infectious Monomucleosis) WC 522 iiyk'Mk^i (Molluscum Contagiosum) WC 584 fo'+^ti'iiftllf^E (Myxomatosis, Infectious) SF 9g7.5.R2 (7i44IH*ffi^ (Impetigo Contagiosa) l£4x-<7 3'$££ (Sifc14K*S (Ecthyma, Contagious) WC 584 f£'ifc141UIS&t4&)f & (Contagious Pustular Dermatitis) fiffi&ttlR*$££ H'^m (Communicable Diseases) WC mmzti&mM qv 250-268.5 mm wc 100 fVJtmb'Mm wc i£ditp(ittl(g^14*E$£i WQ 256 mm wy 153 xwjuiY&muw wa 110^; sak^ qx 600; m& WA 230^$££ rstt mmfo^m wa no *i^f£(SWMlJk QX 650 tttH QW 700 mmm sf 781-809 f£ife*^tlcttlKjlM' (Communicable Disease Contact Tracing) (i,i.^Ot#ttBi|g$£i fi4fe*i^4"K (Communicable Disease Control) WA 110 -240 ®& WA 240 mziY&mcomfo wa 55 *£*£ WA 230^ ; g4f<7)^K£$fc££,f?iJxli'^xF TKIi WA 240 fsilW (Anesthesia, Conduction) WO 300-340 tiif (Electrodeposition) liltA^o^ $££ 7X7-r 'J X F (Denturists) WU 150 7X7 X (Dentin) WU 220 7X7X3BHS& (Odontoblasts) WU 230 YyA-ym%$iWc>X. (Dentin Sensitivity) WU 220 8MWX (Intravenous Drip) (£iMill*])4A$££ £MXk (Drip Infusions) (£$«f*l)±A$££ UMtmm (Medicine, Traditional) i£fttT^^XT^S/?-)fll£li^iJlz WB 50 M$L WZ 309 &mmm (Spasmus Nutans) !£?L!£tt^;ttX$££ fg#141§4ltl#c (Hearing Loss, Conductive) WV 270 fcffiMWftmm (Oriental Medicine, Traditional) l£4i wmmzfix f£#fc mMM (Missions and Missionaries) W 323 mi mmizmxh^^) $HW WZ 112-150 699 xx r 77 Mkco WZ 100 &a.mmfi>m w 323$ fc £ £ fc#7*3 ■•/ yiftSH! (Conduction Blocking Anesthetics) l£/biP/fH*n7&$££ £sf?eft (Salaam Seizures) ?L^.«t ^fL/L $: M. <£ "tUP^t*?** (Conductometry) QD116.C65 ®,mitm QY 90 7 x F Xmm (Supratentorial Neoplasms) WL 358 km$i% (Natural Resources) (£g£M*af S 900-954IP &L*#^t,-«c^£&$££ kmW. (Smallpox ; Variola) WC 585-590 ^fKfcSiJE WC 588 kmia.7A)VX (Variola Virus) QW 165.5.P6 (StS (Transmission) &m&%m WA 110 mmmirm!k qx 650 mm qw 700 mmm sf 781-809 mfo (Radio Waves) QC 676-678.6 Mmm (-fe) wd 605 -feW'C'Jl'XJJ* QT 162.U4 RSIH3 (Buttocks) WE 750 mitX^ (Package Inserts) l£U[qanl*l'#^K$££ 7 x 7° X — F (Templates) x\m QU 58 **4oiiit*4fflt4*4 WU 190$£i jtfg^ QH 450.2 mn (Starch) QU 83 ^*S*f (Pemphigus) WR 200 A X/^7 3' WR 225$££ XXm (Astronomy) QB mi QB 42-43.2 W§H^S5c^4l^ (Electromagnetic Radiation, Ionizing) Ii 4 7 x \tmtB $ £ £ 7*-x*i4- (Dane Particle) BSJjf&7 4 JVX $££ fS^RNA (Messenger RNA) l£mRNA$££ F7vfti (German Measles) (iJ&*£$££ YA 7ULt>7Ajvx (Measles Virus, German) UMB 74/l/X$££ F4x-yF (Latrines) (iffip7f$£i W\ (Copper) QV 65 ftUt QU 130.5 IffiMiSX-'<-fc*yYyxL,9-Jz' (Cu-Zn Superoxide Dismutase)itX—^^—fc^y Y xAXy — 7*$££ ^7/1/3-;u (Sugar Alcohols) 44t^ QU 75 Mmm QD 305.A4 mmm qv 82 If7^3-/u7=rv Kxyyy—t (Sugar Alcohol Oxidoreductases) it^TJV 3 — jvf t K 3 7'7—1$£ £ $i7/i/3-^7't F* 3 77-7' (Sugar Alcohol Dehydrogenases) QU 140 [pHif^ (Isotopes) Mmm QD 181 Vnmitm qd 466.5 mtnummmmt wn 42o^$££ mmiztsitzmitmu, ±nwz [Bl-lt ('L>S^) (Identification (Psychology)) nxm ws 462 ¥L!OJ]fc*>j!£#l WS 105.5. P3 At&<7)?eii (-fe) BF 6g8 mrtfrtX WM 460.5.14 txf7i£ (Projective Techniques) WM 145.5,.P8 nXm WS 462 %1'JtmbWJim WS 105.5. E8 C'lfX F BF 176$fc££ [hHH (Assimilation) (£Xft^^$££ SfM (Cranium) l£sfM#$££ Sf SnBsf H (Craniopharyngioma) QZ 310 W&TfclklWlWi^A '*X (Extracranial-Intracranial Arterial Bypass) UBsk^nX^flX WM.m (Craniology) GN 71-131 Sf Hggffi^#gE (Craniofacial Dysostosis) WE 705 M~M\Um (Craniometry) GN 71-131 WM.% (Skull) WE 705 tJjif* QL m^co SF 901 ffXco QL 822 kmm GN 71-131 Sf M#®l[g^#*lE (Dysostosis, Craniofacial) lis! SH® H#*£$££ mm.^mm (Skull Neoplasms) WE 707 9f S#tJf (Skull Fractures) WL 354 Sf M#*lr£-*iE (Craniosynostoses) WE 705 SfMEfi§A*i (Basilar Impression) (£M4zSfMlS$££ MMtHWl&M.^O? (Intracranial Arteriovenous Malformations) l£SS|JjiflSJNrJ12 $ £ £ SfMWiJjM^g (Intracranial Aneurysm) (i)IBiM*g$£i Sf mm& (Cranial Sutures) WE 705 ' QW 25-26 }^l£$fc££ W&mn.Xmmftik^:m (Transmission Electron Microscopy) umxmmm^m* fix &&zi>}d^-9Bfrlttf^ (Tomography, Transmission Computed) liXISCT$£i fij^HSS (Nesidioblasts) l£LangerhansJ^$££ PHfcfFffl (Anabolism) !£fvJSt$££ [5]{bX7 3 4 F* (Steroids, Anabolic) liS&KlBHtXr ^A K$££ ^$14 (Permeability) ^HJflL^^^MlfiL^S^tt WG 700$££ mmummmm&it qh 6oi^$££ i^mif# QC 754.2.P4 Zcomcoftm Y \z-y9xit, ±M«iJlz i§.)lhffl1§Wi§tm (Tomography, Transmission) (iXfMKf !!»&$££ ^iam^Hait (Microscopy, Electron, Transmission) (i^4L^Sl:iat^^Ji$£i HllSWS (Oculomotor Nerve) WL 330 mmW&m%. (Oculomotor Paralysis) Ii TO &**-$£ J IJjt$o*!t (Motivation) BF 501-504 ifXm WS 462 flifimbWJim WS 105.5.M5 mnftffi WM 460.5.M6 gJliU (Mycetozoa) (i^tf£5$££ ifJi^^f^o'lt (Instrumental Learning) l£4-^7 > F $ 700 F-zx-x-fe fp7H-$££ #cft (Statistics) HA 4ft»'l£ (-fe) QH 323.5 &m#)*m (-fe) QA 276-280 mmw WA 900 WHfc L < li#£8S.«8'J WLMfrm$tXUfrA$"y 16) mrnbtm wa 950 #H«|J (NLM«-IB^-C{i^S#^ 25) f II WY 31 -tnjWi&jffX* w 2 £**>!* A PiftHttft- HB^$££ ^p^f t-yyxii, xmwz |b]^^cSS (Inbreeding) Ujt* SF 105 g**A«t¥ GN 252 tt^mmm HV 4981 mt^m(Bibliography, Statistical) liltl:S:ar#$£ £ [USttiM* (Homozygote) QH 447 *l^il^14 WO 680 ifcftfaHI'Jf (Statistical Regression) (£HM#'7t4$££ &ft-faftg (Statistical Computing) lift^tfJ3 x t°i- 9&m£flX fotttfiY—9miR. (Data Interpretatioa, Statistical) #*Ftyyx(i, iggijiz ffiff-ftf-y-frflf (Data Analysis Statistical) (£l£#Hft 7-yftf^$££ mm&mm (Head and Neck Neoplasms) WE 707 #cft41S (Models, Statistical) im^Bftizfemzti&mfru, xmmz ^11-^7/1/ (Statistical Models) (i#cfttlS!$£i #(*»'#£ fc-3'b!£lz|l!§LTIi, fW#WlfT it-fLJx^t (Reflex, Pupillary) WW 240 fcl# (Radius) WE 820 1###t*f (Radius Fractures) WE 820 F 7 7-t- X y 7 X (Lectin, Ricinus) (i U x X $ £ £ ftUtt (Porcelain) (i7-7XX$££ &*BB& (Nesidioblastoma) UmhmmUm*flX ^*fflS&M** (Islet Cell Tumor) (£P^*fflSafl*li$££ hmmm (Nesidioblastosis) (£Pll!*£&$£i HM (Sugar Acids) QU 84 ft* (Investments) HG 4501-5gg3 i§t& (Clairvoyance) (£i&I«$££ VM%n (Glycolipids) QU 85 |H]P#f^ (Concurrent Studies) (£3 7- F flf3S$££ 118% (Saccharides) U^^fYn \ -*££( I ¥*t« ; 'Ml St; £«f*I$££ «&R3/uf-3>f Vmttkfc (Glucocorticoid Analogs) (££• S/;^3^f3^ F*$£i %feW.mmM'M.ttM (Antigens, Tumor-Associated, Carbohydrate) QW 573 mim (Fluoroscopy) U&jt'&Wm* fl X mt (Projection) WM ig3.5.P7 ^Xm WS 463 ZVJLmbWJtm WS 350.8.D3 %tRii.MW) (Exercise, Isometric) l£xy 774 X*$££ =?R14JRIS (Isometric Contraction) WE 500 mmm^.WmYf (Allograft) I£l5]«#tt$££ lolS^til (Transplantation, Homologous) WO 660 mmm sf 911 l5JSf£HUS&*Fi (Homologous Wasting Disease) f±#tfg fttt^xm&zfix ffifflfcteK (Homograft) l£p]«$tit$££ PM#tfitfr'&# (Homograft Dressings) Ii£!f*41t4-lzi h&wmzfix PHUSi&ffi (Transplantation, Allogeneic) li[3]g^tE$ £ i Homologous l*MJfitffJnc& (Hepatitis, Homologous Serum) liBSff &$££ \alW.tfa.'M%Y'-fc7 A JVX (Hepatitis Virus, Homologous Serum) liBS!JrT&74 JVX $££ [HltfttJ^ (Isoantigens) QW 573 mWAXVt (Isoantibodies) QW 575 \%% (Frostbite) WG 530 fistt^ (Island Flaps) (i^44&Wtit#$£i SHBffi (Diaphanoscopy) UWMmZflX UjUM^J^ (Arteriovenous Malformations) WG 500 SBf£Ia!Jji*i^ WL 355$££ $))BB.5kWl$M (Arteriovenous Hemofiltration) (£jfir$ >!$$££ |Jj#Mn^/n' (Arteriovenous Anastomosis) WG 590 Wt&WM (Arteriovenous Aneurysm) l£Uj^M*l¥$££ W&Wm (Arteriovenous Fistula) WG 590 ft7Cl4ft& (Island Fever) (i;£jfclR$£i $J%aX (Gluconeogenesis) QU 75 701 YytzA tiSffcCAM (Saccharide-Mediated Cell Adhesion Molecules) (iCAM$£i [«114,;£ (Homosexuality) HQ 75-76.8 fttt[£¥ft-<$£ WM 611 rsJitftH (Gays) (i^14f5]14#$££ MUXftM (Arrhythmia, Sinus) WG 330 j§#f (Dialysis) XimWftffi QU 25 Mmm- (-fe) QD 281.D47 Itmj&tif WJ 378^$fc££ i$*t (Pernio) (£;Hlf»$££ *a*f (Smallpox) WC 585-590 ^KfcSSE WC 588 M (Chilblains) WG 530 *a*f7 4/i/X (Smallpox Virus) UXLmia.7 A JVX $££ il^JxS (Flight Reaction) (£ SSJxJS $ £ £ *l*f77 7x (Smallpox Vaccine) WC 588 zcottLoommco\&mx®.m$tihm&u, Arcommiz ^it"l^.i7liJ (Isotachophoresis) l£fli77tfic|Sl$££ W<± (i$Ll£m) (Selection (Genetics)) QH 455 &mmiR QH 375$fc££ $j)Mmmm (Kymography) 'll>)l^lz£o(t-l) WG 141.5. Kg xmmzmcoA:tiumA**9'774- wn ioo^$£ £ t$5E«.|WM!:«ffletl^^l£ ^comBXU^.iz fit^&K (Glycoproteins) QU 55 M&fCx7 iJ JV$mmm (Glycoprotein Sialyltransferases) (£x7U/l/F7XX7i7— 7* $ £ £ ^fWt& (Isotonic Solutions) QV 786 Sf Tf M (Parietal Lobe) WL 307 *?ffi (Pain) WL 704 &W£ WB 176 mmacoii co umtmiz mm WI 147$fc££ *£*ifi14® (Algolagnia) Ii14^ffij^$££ *£*iS14xX F 37 4 -m&U (Algodystrophic Syndrome) (iJxJt4f43c!S#*£14^XF37^-$££ *£*S147'y7 (Tic Douloureux) (£Zx^££*iS$££ *?*iffliJ^ (Pain Measurement) WL 704 ftx.m&izttfcZ>A:tiU, ZcomfcX *£ffiff4ffi (Pain Assessment) (i^*iaij^$£i ^rM&itmOfaM (Isoelectric Focusing Agents) I£j^'l41: mm&temzfix ^fM&irVSl (Isoelectric Focusing) yytiritm (-fe) QD 79.E44 Xim QU 25 v&mmmm qy 25 mx%»m qw 25 ^x&m QX 25 ¥fx.coBfacoTzsbcofemii, ±HWz #f:$^M*n£ (Conductometry) QD 116.C65 w»mm qy 90 jf^ (Morals) 3I«3I$££ i&.WMm (Metaethics) (£#S$££ ¥l%mm%hX]% (Formularies, Homeopathic) WB 930 ^W. (Glycosuria) WK 870 t§£R*pf (Diabetes Mellitus) WK 810-850 mmmfrwwmmm wk 835;&&mw** wq 248; mm%.mtkm WK 810$ fc £ £ mhXm&W®mm& (Obesity in Diabetes) WK 8.7 tfehXm'k (Diabetic Diet) WK 818-819 mhUmnmm (Diobetic Neuropathies) Um^mO.-^ -3^°->-$££ ttK^'g-SE (Diabetic Nephropathies) lit),'f'/R*^H:4 7n ^°x-$££ WhUm'&Ty Y-yx (Acidosis, Diabetic) (ifgfJ^ttr F7x K-vX$££ tt^^ttlflL^-ffi (Diabetic Angiopathies) WK 835 tfm*^147 F7x Y-yX (Diabetic Ketoacidosis) WK 830 *)fJ4t*i*jl4y F - x X (Diabetic Ketosis) (itJtm*fit47 F 7 xK-xX$££ tim*^14#ii (Diabetic Coma) WK 830 tf B.mii.7h^HW-iMit.& (Glomerulosclerosis, Diabetic) Ii mmmnA^ 7 3^>-$£ £ mw-mit&^mm (Foot uicer, Diabetic) immmag um&tfix m^miiS.^m.% (Diabetic Foot) WK 835 tfE*i»!l4— jL — n^y— (Diabetic Neuropathies) WK 835 ^WmitA-yusiy- (Diabetic Nephropathies) WK 835 ^h^.mHW(.X5k^m* (Microangiopathy, Diabetic) lift m*^'l4jfiLWPf*$£i *SR£H£*H1K*£ (Diabetic Retinopathy) WK 835 t%Bm 1 S (Diabetes Mellitus, Type 1) Ii4 XX 0 xf£ M-mm^mzfix ^W.m 2 m (Diabetes Mellitns, Type 2) it A XX 0 X# mM-mmmfiZfix Sf ^ (Scalp) WR 450 Sf Jkm& (Scalp Dermatoses) WR 450 JiJlJxJS (Escape Reaction) BF 319.5.Ag Sf SI3 (Head) WE 705-707 Sf£ WR 450$fc££ MUyfc% (Head Injuries) WE 706 mmma wl 354$fc££ tta^fJlitftiU* (Glucose Tolerance Test) QY 470 Sf^ft)liJ-i£ (Cephalometry) kmm (Xi&bmit) gn 71-131 -fe*##Sff WU 141.5. C3 wffimco&Mizfemzti&m&a, Azcommiz mX3-m%%£ (Sick Sinus Syndrome) WG 330 Wlfyj (Animals) 3IM3I$££ WfaWm (Animal Welfare) %mm QY 54 ArComcoW)^ HV 4701-4959 WYJJJ7AJVX (Animal Viruses) l£7 4/i/X$££ l^^* (Animal Nutrition) SF 95-99 IM*II<7)iM* (Animals, Zoo) QL 77.5 mm SF 996 &IM*<0£fa$fc££ §mm (Zoology) QL am %&CO QL 26 \MkCO WZ 100 m • \ft,i> QL 1 702 F-/377 U)!|*t8l3 ;i- 7 — x a X (Animal Communication) -fe QL 776 gh'fy&mnmm (Animal-Borne Diseases) (ifljW&'ffilS &£$E£ j#j'£4:& (Animal Parasites) (7ft4-:&$££ iJj^irfll (Behavior, Animal) QL 750-785.3 fflfa-fciv^ ?-7.'$'ifc*iK (Salmonella Infections, Animal) SF 809.S24 Uj^IrIW (Animal Culture) (£&;!$££ tllWikA (Magnetism, Animal) iitiW#i£$£i IMMKfl (Animal Magnetism) liffiBg ; fi'ittflfti$ £ £ iM*«fUHIRffi (Mesmerism) (£!$!&$££ i)jft*5iS1lxX7A (Animal Identification Systems) QL 60.5 Wl'^Mft^m (Animal Testing Alternatives) W 20.55.A5 &%Y\z-y9xU, XMMiz Wfamm^YJV (Disease Models, Animal) QV 58 |Jjft£ (Housing, Animal) SF gi %&$)¥>» QY 56 t#£iJ]t*^[i, |J]t*S'Jlz tM*tt«€*« (Zoonoses) WC g50 XVibUX. WA 110 ft£*££.fl£l (Animal Feed) SF g5-gg Wfa<7>¥aXYY (Animals, Newborn) Uj!(*WftiJj QL 751 ^fi^tTlJj QL 763-763.2 lIS^fFt* QL 50 iM&WteffiJb (Sex Behavior, Animal) QL 761 ^^ SF 195-518 fF£l)M* QL 364-739.3 Wfaco^&fcX (Helminthiasis, Animal (Non Mesh)) Ii ^&m.coxmmm sfsio.h44$££ Mnm\XY(Animals, Infancy oDUWn^WXYYZflX iMfcOSLMt (Mammary Glands, Animal) (£?UH$££ iM*«0?L& (Milk Fever, Animal) (£^^J#*$££ Wfa<7>W& (Pregnancy, Animal) SF 887 WYn^^X* (Vocalization, Animal) QL 765 Wltyjcomffl (Flight, Animal) IMS QL 6g8.7 -fe<7) QP 310.F5 Wkm (Animal Diseases) SF 600-1100 mvvmn®&& WC g50 $ fc £ £ %))%»mm (Hospitals, Animal) SF 604.5 iJJt*7r--xSB (Zoophaginae) (£7/f/l/X$££ WJlYmWtm.^ (Animal Care Committees) UWu^M $££ Sf§|3&fg (Tinea Capitis) WR 330 Vk%Wm%; (Head Protective Devices) mmizisith WA 485 \\Am^% (Sinoatrial Node) WG 201-202 tffJK (Molasses) W&tffXitmtmntifi'kb IX WB 447 §M (Arteries) WG 510-595 SfcKliiiilfiL'f WG 300$££ k§)MWG 410$fc££ §)M'%. (Arteritis) WG 515 'ni'ik WG 300 mm\Hm%. wg 515; wmmmmmK wg sis ; fHi|sfi!liJ]M^ WG 510$fc££ IMW (Ductus Arteriosus) WQ 210.5 IM^FWiY*,)- (Ductus Arteriosus, Patent) WG 220 IM5£4t*E (Arteriosclerosis) WG 550 Sii'iif'JMIitliii JiJj»iSl!lb*JE WL 355 $ £ £ mmm sf sn i'JjKfi!Hil:14'C>)l!*ii5 (Arteriosclerotic Heart Disease) (iS tt!M*%&$££ IMfiIKl:14*Jtn ^. (Arteriosclerotic Dementia) telfilfW* $££ IMS&IWJft (Fatty Streak, Arterial) I£77 3-A14UJ |R5M1H*£$££ IM*i& (Arterial Lines) l£SS77~7/l/$££ IJjSJRiai^S (Arteriography) UskWMU^flX mWilHB. (Intra-Arterial Lines) (£t1gM77-7/l/$££ iMfiiilht (Injections, Intra-Arterial) WB 354 §Ml*l;4A (Infusions, Intra-Arterial) WB 354 !MftBIi£ (Endarteritis) WG 515 IMfiBItTJI&ffi (Endarterectomy) WG 170 IMfflS*^.t. (Arterial Occlusive Diseases) WG 510 IM*g (Aneurysm) WG 580 A-iM^li*iM*S WG 410$££ IJ]ft*Wl£U]#SJilt* WG 590$££ omcou^mmmm wg 300$ ££ mcoumihWiig wl 354-355$££ ##St$fc££ *-BS (Hibernation) QL 755 mW% (Zona Pellucida) WQ 205 iJjt* QL g65 ^BflffPS (Septum Pellucidum) WL 314 F 7 ^E 3 a y (Corn) Mmtf?xummm<7jffi£.b lt wb 430 mm SB igi.M2, 351.C7 F7^E3=/->M (Zea) (£ F 7^E 3 a ->$££ f£* (Medication) J± £$***£ : ftmm&& : |iJt£^ ', S £&*$££ tS^S^ (Medication Errors) ^^HtLt QZ 42 mmtm qv 38 tS^ltO (Drug Administration Schedule) WB 340 ixmm. (Dosage) (itftmttiHi; mmrnm; as^-ex; J##t mm;mmmMtM*fix JTifi (Kerosine) {fc^ftffi TP 6g2.4.K4 %tfo¥ QV 633 ^■^[S^ (Medicine, Oriental Traditional) WZ 80.5.06 *a&fT*>*VC^"& WB 50 BSlfclilBJS'Jt- WZ 70 Mi¥ix$&mm (Traditional Medicine, Oriental) UMff mmtfix 703 Yya77 MftXttm (Philology, Oriental) PJ-PL mi PJ 10-187 \x£cox%f'£%.ftnmfix, miu^mm U PL 1001-2245 &tim (Kinetics) xwmmttm qu 25 mmm qu 135 mmm qv 38 Vvmim QD 502-502.2 »F -y yxii4£M«iJlz, ^JxliW^^lzioltS^WIi] tim WL 102 |5]^#^^P (Peer Review Organizations) UmmtkM t£HI$££ tf 'J /t& (Sugar Phosphates) QU 75 70-t 'j y«)A.m qu g3$fc££ £8 (Sugars) l£#t7ML1*$££ ^m (Registries) £M3I$££ Ytf7A)VXm (Togaviridae) QW 168.5.A7 F7*7 4/l/X44!l£ifeEE (Togaviridae Infections) WC 501 F 7*7 4 /l/X/i&*iE(Togavirus Infections) (£ F 7*7 A JV X*4!gifc*E$££ F 7 Ym (Lizards) QL 666.L2-666.L2g5 m.% SF gg7.5.R4 F ^7 7 x X (Toxaphene) JftH SB g52.C44 &%:ffiX WA 240 F ^r x 3 7x F* n XJlSJ^jfc (Toxicodendron Dermatitis) l£7/l/x£Jt&$ fc££ F =r x 7 ^ X (Doxylamine) QV 157 SMlW3Ji$££ Y*9y°yX-?l§.&W&& (Toxoplasma gondii Infection) (£ F * 9 7° 7 Xvg $ £ £ F* 77° 7 X*-^*£ (Toxoplasmosis) WC 725 F * 77°7X71 (Toxoplasma) QX 140 F*^y/l/txX (Doxorubicin) QV 26g K^riyxr —xaX (Documentation) Z 1001 IfftS (Venoms) fp# WD 400-430 itsmmmu, mm^MMb^hmm^^,^; K^mm WB 890^$££ ^^#^$fc££, f?iji(£i7^"7#l£ WD 430 mtfX (War Gases) (£1t^l$ffl!!*SC$££ ft& (Fishes, Poisonous) WD 406 %9 ^X% (Arachnidism) WD 420 #jfiL*£ (Toxemia) WC 240 ymmusmxn^. wq 2is$££ m CO WI 405 $m$LH (Education, Special) 3tMs$t3l$££ ^F545felx4X'# (Institutionalization) W 84.7 %kmm wt 31 tnto^Efc WM 27-28*$ ; km WX 158-158.5^$ i fix WVk'Jtm. (Child, Exceptional) 3I«3I$££ ^Sfcte^ (Cures, Special) (iitHISffi$£i ItcH (Reading) ?ScW (-fe) LB 1050-1050.75 mmtMm'jt lc 4704-4803 tf Wf *!£ LC 4620 iim$f4^ii^[S^j#g ww 480 -C>S^ BF 456.R2 Mm WL 340.6 ; ?£x44£i7C*£ WL 340.6$ fc££ ItciH5*HF (Dyslexia) *SW[S^#fr WM 475 te*J?$W LB1050.5 ItcM?* (Bibliotherapy) WM 450.5.B5 34Jr^ (Single Person) HQ 800-800.4 4c£Afcf^fc£> HQ 1058-1058.5 #^fcy>Ml^ WS 462 XxJLbcoM% WS 105.5. F2 IxWffi (Lipleading) HV 2487 ^rjm±Hf^ (Antitrust Liability) li^d5mih{S$£i t&£M±m (Antitrust Laws) (NLM^«T{£J^#^-32-33) #U (Toxins) QW 630 #£M<0£ffc$fc££ S^F-2 (F-2 Toxin) l£7*77xyx$££ 3MIJ73 (Creativeness) BF 408-426 i?Xm WS 462 zv&mbX'jim ws 105.5.C7 mmrffilztsitZ WM 460.5.C7 «*£-£ (Toxin Conjugates) lift*£^$££ S^t/tf^tlc^ (Toxin-Antibody Conjugates) itfd&MM $££ S^#l1$^4 7*iJ )mv qv mb^m 704 Y y 9 7 A QV 602$££ itHffiii WA 465 **t&^ QV 610-618 M***> QV 627-633 £*i*i£W#£ WA 730 t¥^14^ QV 633 $5i*&#!t*<7)£ft;$fc££ gftf: (Toxicology) QV 600-667 m%<7> WA 465 £|*v-jl7'W QV 602 j£E¥to#£ W 750 £Sc QV 602 flr=rXF QV 600 &*8r£&®\ftcotzfrcoiiCOU, #H«iJlz E£ fc^x4 — A (Anonyms and Pseudonyms) Z 1041 -1121 ttWm (Speechreading) l£M#j£$££ F-yxxny~- (Token Economy) BF 319.5. R48 ftmmmiztsith wm 425 F - y X faitm (Token Reinforcement) l£ F - 9 X x. a /^-$££ fct-TJlll (Sticklebacks) (£,%3i$££ ttJfit (Hematemesis) WI 146 Wx.commizMtz>ii<7~)U, Arcommiz Y^yyim (Cimex) (£7x=r x A->$££ fcCfri. (Bedsores) litH*f t4?t*S WR5g8$££ F'utX^ (Docosenoic Acids) (£i/l/7S£$££ F3 7x3-;i/ (Tocopherol) (£tyiXE$££ Ifcll (Barbering) MnXktl WR 465 mm^zMffixtYj^m wa 744 mmm&m wa 32 HtH (Uragoga) (£ F 3 x (x3y7°) $££ Fux (xny7) (Ipecac (Syrup)) QV 73 FnxJI (Cephaelis) (i F 3 x (x3.y7°) $££ mim (Abattoirs) WA 707 Hilll (Mountaineering) mfobmA QT 260.5.Mg ^Lll*^ WD 715 Joi^S WA 292 X7-7 QT 260.5. M9 UlYiffiX (Urban Health) WA 380 SBrUBflU (Urban Development) l£fI5rrT#^^$££ ^iti^tl*'! (City planning) HT 165.5-169.9 tilSfcJM* NA 9000-9428 ~tcfclt4&*ffi£W#* WA SGm4?ffl3S UT 170-178^$ fc££ m&nh'&^U (Locked-In Syndrome) UWmWZflX «Bifi#ffll8 (Urban Renewal) HT 170-178 t&^bXm NA 9000-9428 ~ iz is it Z&M'&XtiX^m WA HJ'rtiAP (Urban Population) AP^ HB 2161-2367 HWM WA 380 A:COifoco%®UXmmiz mt HD 257^ ; &*&% HD 7288.77-7288.78$ fc££ n±?g*5 (Tartar Emetic) Ii7x7:ex$£i i£¥4«& (Calisthenics) (if£tt$££ Slff (Books) &tg§^l$££ ±igr»?ife!t*« (Soil Pollutants) HfetfJfrS*:ffi£KJ#& WA 785 M4I4 WN 615 XmUX^m (Soil Microbiology) QW 60 g|*ffit& (Book Prices) Z 1000 SIM (Libraries) Z 665-997.2 H^ffJi'B; (Library Administration) Z 678-678.88 H»£t^ (Library Science) Z 665-718.8 BUtft-^R (Library Schools) Z 668-669.5 EH^fitlft-^ (Library Associations) Z 673 H*ff-7-tX (Library Services) Z 665-gg7 3*M?3I$££ H^ttWHW (Librarianship) UmWmZflX mmm& (Library Surveys) Z 721-871 MM$&t9 — 7JV7-— tx (Library Technical Services) Z 688.5 Kfftt^SIMb (Library Automation) Z 678.9 mWB& (Catalogs, Library) Z 881-980 ^1§^I$££ m^mm (Book Industry) Z 116.A2-656 El*i|Xm (Book Collecting) Z 987-gg7 H#tt Z 662-1000 ;#^y 4 7°«OEIl:tt$fc££ 01=31^ (Book Selection) Z 68g-68g.8 gl*c7)K{HL (Book Circulation) liEHfttT-- tx $£ £ M^9)^M (Book Ornamentation) Z 276 mmmAyxYy-y^y wz348$fc££ m^Wrt (Bookselling) Z 278-549 H#l&TCgii (Catalogs, Booksellers') Z 998-1000.5 mxw^vjm&Bm z 1036 t#S±M^fc^li, A:coXmz%fcfcZ>%n&!i=riz m^KM (Book Classification) Z 696-697 mm Z 697.M4 £# (Harelip) liP#g£$££ F — 9 tvn < i —7 —x a Xj£ (Total Communication Methods) li^rf^3 ~ a. — 'r-y a x$££ ±if|gffcS1R (Medicine, Indigenous) (£fS^c[S^$££ mf (Patents) T 207342 itmmn TP 210 mm QV 736 mm&n wLMfrnmxuM^^e) Y -y 77 4 -y y j- (Dogfish) QL 638.95. S84 705 F*y^7-t l.'j'i'jttWaj (Prolonged-Action Preparations) liiiSftltlli *<]$££ ^tSUn. (Death, Sudden) W 820 ft7 F Yz-y 9XUXmft\iz, ffli li*e#iM*£&$1#i b^f wc; 300 fU&E^S^E WS 430$fc£i ^*S*H (Mutation) flUt QH 3go itfs*^ QH 460-468 &ZXmztsitZ>A:tiU, Arcoxmz 9zt&%£&M-?7X (Mice, Mutant Strains) ^Sti^fcLT QY 60.R6 Hf&^Xfo (Mutagenesis) QH 460-468 HfK^mfc&y-y Y (Rats, Mutant Strains) t?aiJj!t*fcLT QY 60.R6 %m^%mmn^ (Mutagens) %yiixm%cowmb IX QS 67g ±Aft&WMbLX WA 754 {m^tx9cwm%.w-kizMfc-%mi qh 460 mw&mm wa 788 f7^xF (Tonofilaments) it^fSl^y 4 7 9 x F $££ K-'* (Dopa) WK 725 K— 'x zi -g|j£$£ £ F 7*7-^4 xX (Tobramycin) QV 350 F A y ymmm (Thomsonian Medicine) i£ft^[Sfl5T$£ £ Y7ATA (Dry Eye Syndromes) . ttbv:UKiE^^$££ Y7 9y9JVxm (Dracunculus) QX 203 F 7 3-v (Trachoma) WW 215 F 7 X* K x (Trazodone) YKi^mb LT QV 77.5 K 7 y 7X F 7 (Drug Stores) Ii* Jaj $ £ £ F* 7 y y 7-74 X (Drug Design) QV 744 F*7-y yy^U xy (Labeling, Drug) itmm>7-ovfe-^ $££ F7—/l/x7°3^x (Tranylcypromine) QV 77.5 Yy^OV (Emporiatrics) lijftlf$££ F 7X3-74-7 (Tranquilizing Agents) QV 77.9 mmmiztsith wo 297 F 7 XX7 ^ 7 — 7* (Transaminases) UT i 9 Y 7 XX 7i7-7*$££ F7 xx7/uy ^7-7* (Transglutaminase) (iS&R- y/uy i x7*x-v-y;uy ~ >v y 7 xx7xy--t$i i F 7 XX7 F 7-7* (Transketolase) QU 141 F 7 XX yx. — -y 9 WYvi (Animals, Transgenic) %likWfab LT QY 50 m.Um QH 442.6 F7XXxi —'yy-v7X (Mice, Transgenic) £i$!M*fc LT QY 60.R6 m.limtt)%M QH 442.6 F7XX7iyx3X (Transfection) QW 51 F7XX7x7-7* (Transferases) QU 141 F7XX7xiJX (Transferrin) WH 400 l&J734Jr QY 455 F y X X fc X fc "J y - 7* (Transphosphorylases) (i 7 X * F 7XX7x7-7*$££ F 7 X X 7° X* x (Transposons) iiDN Al? A1S3R $ £ £ F7XX777xTyl (Tyl Transposon) (£DNA4?A^ $££ F7Xt*7yJI (Trombicula) (£777*A->$££ F 'J 7 x/L/7 U 7 n -;u (Triacylglycerols) (£ F 'J 9 0 7 'J K$££ F 'J 7 x/l/7 'J 7 n -;i/ ij ^-7* (Triacylglycerol Lipase) (£0^°--1$££ F "J 7 x > (Triazines) £<*!!£ fcLT QV 95 fcfcJ^JfcLT WA 240H MYkitm QD 401 F >J 7 7-/1/ (Triazoles) W«1t^ QD 401 F ij 7 A x y o x (Triamcinolone) WK 757 FU7Axynx77F— F" (Triamcinolone Acetonide) WK 757 F>J7A7xx (Triamterene) QV 160 F U 4 X7/l/iX7*74/l/X (Influenza Virus, Avian) l£ F 'J a =r 9 AS74 JVX $££ F 'J 7 A (Thorium) WN 420 W.XYk%»mm QC 796.T5 mmmmcoycoww y t -y y x $ fc £ £ F iji7xx777xX7.7 i F* (Triethylenethiophosphoramide) (£747'*$££ HJxf l/>/?;> (Triethylenemelamine) QV 269 F '14-7-/1/ (Trional) I£x7/i/^ y xx/i/77- F$£ £ F 'J7/I/X i 3 7 74/l/XAS (Avian 706 F 'J 3 r -7 Orthomyxovirus Type A) (i F 'J S * 9 A S? 7 A JVX $ JL£ . ij + w A y (Triolein) QU 85 - iJ$SSd4Bifi& (Avian Hypersensitivity Pneumonitis) (£ F 'J Mm $ £ £ \. ij 7JVii>f—-fe* (Triglyceride Lipase) Ii 'J ^,— 7$££ F "J 9)VXXX\ (Trichuroidea) QX 207 \. ij 7 o /l/7*y y -/I/ (Trichlorbutanol) |£ y n n 7* ? y -;w$££ F 0 y 3/1// y X (Trichlormethane) Ii ? 3 o fc.JVA $£ £ \.\) 9 X3U3-9 y (Trichloroethanes) $ft^ QV 633 \.\) 9 uvx-f-yy (Trichloroethylene) QV 81 h ij 7 3 o B£$j (Trichloroacetic Acid) QU 98 Mmttm QD 305.A2 ^ ij 9nd y 7/1/?dd7^1/y 4 F (Trichloromethylchloroformate) (£ fc X 7 X $ £ £ F >J n 7 X 7 x (Trichosanthin) USS^fcLT QV 175 F 'J 3 7 -fc x (Trichothecenes) A>U*#fcLT QW 630.5.M9 F ij 3 7-txx7;3rx K (Trichothecene Epoxides) Ii F ij37-bx$££ F ij 3 ^7x^ife*£(Trichomonas Infections) WC 700 mmm sf 810.T73 F 0 ntfxg (Trichomoniasis) (i F 'J 3 ^E7X!Sik*iE $££ F'j3-t7xS (Trichomonas) QX 70 F "J 3^7x81 & (Trichomonas Vaginitis) WP 258 F UfflSf (Bird Fancier's Lung) WF 150 F0X7iX (Trisamine) (£F3/y^X$££ F iJ xmmm (Tris Buffer) fiF3yy~X$££ F iJ 9 = - (Trisomy) QH 461 %¥bM&t&%&uA:co3j%fX, mtim&ftm%m f.li QS 677 F iJ 9 i -21 (Trisomy 21) (iDown*£1^^$££ F'J7/i/^X (Triterpenes) Mmitm QD 416 xmm qv 752 mmm qv 66 F 'JfEife14*vg:£&7 4/l/X (Infectious Bronchitis Virus, Avian) QW 168.5.C8 F 'J 1*1 IS (Sarcoma, Avian) kt$cotz>sbco%Wimoo QZ 345 F 'J PM.7AJVX (Sarcoma Viruses, Avian) QW 166 F iJ l*)ti7 4/l/XB77 (Avian Sarcoma Virus B77) !£ F 01*1)17 A ^X$££ F iJ I*IS11 m7 A JVX (Chicken Tumor 1 Virus) l£ F 'J 1*1)17 4/l/X $££ F ij - F 3 y 'J -t "J X (Glyceryl Trinitrate) (£- F 3 9 'J7U X$££ F 'J &M.m (Avian Leukosis) SF 9g5.6.L4 F >J t3\tm7 A JVX (Leukosis Virus, Avian) QW 166 F iJ^VX-v^ (Trypanosomiasis) WC 705 mmm sf 807 F U^V 9—?m (Trypanosoma) QX 70 F iJ '< t iJ X (Tribavirin) Ii 'J '< t 0 X $ £ £ F \)><=> J-)V (Triparanol) QU g5 F 0'71.7 5 F* (Tryparsamide) QV 254 FUt7JS (Trichina) !iTrichinellaJI$£i F 'J7°xX (Trypsin) WI 802 F iJ7°xxPlW#J (Trypsin Inhibitors) WI 802 F0 7yxX (Triftazin) l£ F 0 y >v fc^y x X$££ F 'J7°y ^ X (Tryptamines) Xitm QU 61 Mmm qd 401 •fen h->iHtnM QV 126 F'J77'J7--b* (Tributyrinase) (£ 'J ^°--fe*$££ F 'J 7° F 7 r X (Tryptophan) QU 60 F 'J y° Y 7 7 x fc * y 77 - -fe* (Tryptophan Oxygenase) QU 140 F 'J 7° F 7 r X 13 7 —-t* (Tryptophan Pyrrolase) Ii F 'J 7° F 7 r yfc*x77--fe$££ F'J7^7-^7^X (Trifluoperazine) QV 77.9 F 'J yjlfczi^y yy (Trifluoroperazine) (i F 'J 7/1/7 ^ y x X $ £ £ F ij7/i/^iJ K-/1/ (Trifluperidol) QV 77.9 F 'J 7/1/7 iJ X (Trifluralin) &<r4:(ft#§l WA 240 $&¥ QV 633 F 'J fc X fc t 'J x X X y X fc 7 K (Triphosphopyridine Nucleotide) (£NADP$££ F iJ-7 7 0 7 (Malaria, Avian) SF gg5.6.M3 F 'J 5. % 9 Am7 A JVX (Orthomyxovirus Type A, Avian) QW 168.5.07 F 'J 5 7° 7 i X (Trimipramine) QV 77.5 fc')£> (Nyctalopia) (£&W*£$££ F 'J X F *yy s.fci-JVT \ X (Trimethoxyphenethylamine) t£ y X 7 'J X$££ F ij y F 7° iJ A (Trimethoprim) QV 256 F U Ay'y9-JV (Trimepranol) QV 132 F ij y7°ij ^ X (Trimeprimine) l£ F 'J 5 7°7 5 X $££ m% (Paint) itmftffi TP g34-g44 mmimxcoftimim wa 4oo-4gs i&4'# qv 2g2 Itftftr (Weights and Measures) QC 81-114 %mmft¥r QV 16 9-YJvm qc go.8-g4$fc££ ^tlufAinljk^ (Forced Expiratory Flow Rates) WF 102 f£#MfcLT WF 141 -mmmwtk^. wb 284 ^7^1^^^1^0.2-1.2 (Forced Expiratory Flow 0.2- 1.2) (i#±iftv})ft*$$£i ^ tl 9fAitim.^200-l200 (Forced Expiratory Flow 200- 1200) (i^4cn4f\jift**$££ %ftm$M (Effort Syndrome) liW*£1f4lfc7J*E$£i F 'J 3— Y^zMMW. (Triiodobenzoic Acids) xim QU gs mwfc&mmmbix qk 745 F ij 3- F*73^-X (Triiodothyronine) WK 202 707 r 'J 3 F * F 'J 3— Ff n-^ffft: (Triiodothyronine Receptors) (£fp"#cJ*7/i/* x£'#f£$££ F 'J 'J X'">°St*jM7 4/l'X (Lymphomatosis Virus, Avian) (i F 'J f3Uil*^7 A >vx $££ F*'J/i/ (Drill) (£tt$££ F Uli*£t£ (Tuberculosis, Avian) SF gg5.6.T8 F U x x x 4 V x77— F (Tolylene Diisocyanate) (£ F ;uxx2,4—x4 7x77- F $££ F "J o4 3—t (Leukosis, Avian) (£ F 'J &Jfo.*]>i$££ F/i/4 ^X7*/u-0 (Toluidine Blue O) IZi&it Y v-7 A$££ F/i/^-X (Toluene) *t^IH, ^^fcLT QV 240 M®itm QD 341. Hg m^m QV 633 F/l/XX2,4-x4 7x77- F (Toluene 2,4- Diisocyanate) QV 280 F/l/=/^ (Sella Turcica) WE 705 F/U3JES (Turkish Baths) (£Ai&$££ YJVy4 yfflmWl (Trephining) WE 705 F JVy'9 S. Y (Tolbutamide) WK 825 F*-/^7X (Dormice) i£tf-?M$££ F JV A 7 x (Tolmetin) QV g5 F/1/7M (Torula) (i CryptococcusH $ £ £ YJVayyxm (Torulopsis) (£ CandidaJI$££ Fxy-x (Tretamine) (i F iJ xf x X7 7 5 X$££ F X7X 4 X (Tretinoin) QU 167 Wx.<7y&j%mfcmfru, Arcomfciz Y y-y Y zJVtX Y (Treadmill Test) (£iifijjiffi$££ F*X7-x (Drainage) WO 188 RgJfrt4?)fc<7)(iMJ3iJ(z Yyy 4 ymwm (Trephining) WE 705 F yfcfc—? (Treponema) QW 155 F X fc 4 --vlgifegE (Treponemal Infections) WC 422 Fo^7A.yoUF* (Tolonium Chloride) QV 195 Fn77*yxF (Trophoblast) QS 645 F 3 77*7X FUSE**(Trophoblastic Tumor) WP 465 mmm qz 310 F 3 7 y 5 x (Tromethamine) mi&^XffiiZtSit & QU 105 Fnyy^-;u (Trometamol) (iF3yy~x$££ Fox^s-x (Thrombase) (£F3Xt*X$££ F 3 x t* X (Thrombin) QV 195 JfoMH^fSiz<!, WH310 F3X7^r7X (Thromboxanes) QU 90 mmrnm wq 210-211 Fnx7*+rxxX7y—fe* (Thromboxane Synthetase) QU 137 F3X73-+rxAxxy-7* (Thromboxane A Synthase) l£ F 3 x7^r+rXx X7y —7*$££ F 3X7*7XA2 (Thromboxane A2) QU 90 F o x 77X F (Thrombotest) (£7°3 F 3 x t XB#f!g$ ££ F d x 77°7 X 7 X (Thromboplastin) WH 310 Bi^#f QY 410 F3Xtf.X7XFy*77^- (Thromboelastography) it fiLfewmimmzfix i- ■kATyy (Niacin) U-zs^-yfa QU 193$££ ftmX (Intrinsic Factor) QU 195 1*11314-) -z>m (Depression, Endogenous) (iMH o14P|^ $A£ (^8144-t^-F (Opiates, Endogenous) fi4t°44F' ^7°7F*$££ ^B'ffil*®^^^ (Receptors, Endogenous Substances) (£*fflBS*ffl^'#f*:$££ P*lH14-v4 F xxX (Mitogens, Endogenous) Ufc&fy'M. $££ rt^fi^JSffeiJ (Internal-External Control) ^my>^ii WS 105.5. S6 m& WI 450 ^ffc^SlKili, miS'Jlz ffiJK&fiffi (Situs Inversus) QS 675 nWXh (Visceral Arches) liasaKi$££ 708 i-i9 fifcifliS* (Splanchnic Circulation) WI gOO flRttite (Splanchnic Nerves) WL 610 ffill'J — xa.-y—7*JE (Leishmaniasis, Visceral) WC 715 flfllT-E (Tibial Menisci) liSfffiiJ¥fl$££ [*)#* (Endotoxins) QW 630.5. E5 f*]#*x a "7 9 (Shock, Endotoxic) (iBfcMi!l4x s ■•/ 9 $££ [*]$#!£ (Enchondroma) (i|7tHi$£i ft%$U'i&l>X$j)^&W (Internal Mammary- Coronary Artery Anastomosis) WG 169 f*H£l (Endoderm) WQ 205 WE^iPIBt*^ (Endodermal Sinus Tumor) IRmizfclt* WP 322 \HE (Entropion) WW 205 |*JJx££ (Talipes Equinovarus) l£l*Ux£$££ \HK& (Clubfoot) WE 883 mmm sf 901 1*1 £ (Endothelium) imm QS 532.5.E7 %t#z<7>mm, mx.uftmft&u ww 22o$££ |*Jr£14'5tfe*SB4- (Endothelium-Derived Relaxing Factor) liEDRF$££ |*|&fi*JiiLf:4X#sH4- (Endothelium-Derived Vasoconstrictor Factors) l£iX F'-fe 0 X$££ nftitt (Internal Secretions) lif£H£ ; fcJV^y ; Sf-^# WI mRVWx. coftWco t, 14 $ £ £ Plft'<%m& (Endocrine Diseases) WK mi WK 140 ivjmbwjtm WS 330 mm wy 155 P\Atittmk£l-mam (Endocrinologists, Directories) Ii \nmm<7)X ; &fofcJV*y ; ft 0 X^° (Endolymph) WV 250 1*1 0 y«% (Endolymphatic Duct) WV 255 l*J 'J '/'<% (Endolymphatic Sac) WV 255 ft££ (Longevity) WT 116 ¥«J#^r WT 116^$fc££ ftTOH (Peer Group) nXm WS 462 fVJtmbty'jtm ws 105.5.15 ^sma<7)^^$fc££,^Jxi£[s^ w2i;mw.mco x<7jmmm&% wk sio at J (Crying) 'h!^. WS 105.5. E5 JSffi BF 575.C88 f,LA BF 575.G7 tt&*£ WM 170-184^ m$ (Mourning) (£^nl$££ 7-7'J-xy-/U (Nursery Schools) l£f*fr^^$££ 7-xX 77-A (Nursing Homes) WX 27-28 M WX 150 as -mam wx 22 Zkcotzthco WT 27-28 A£ • 147/fii WT 22 ArcotficoBMcofzishcoiiCOU, #PiSi|tz 7? 4 (Rapeseed) (£77*77^$££ 77X'A (Nazism) lijfttexX7A$££ 77^ y/l/^r7-WS&(Killer Cells, Natural) WH 200 Itmmkiz is it I QW 568 fc-y "AM (Nuts) Stflfiitii]K£: WB 425 MilKUm®. WB 426 7 F 'J 7 A (Sodium) &mm QD 181. N2 mmm qv 275 7 F 'J 7 A 4 4" X 7 -r X 4- ^ (Ion Channels, Sodium) (i 7 F 'J 7A7JrX4/l/$££ 7 F iJ 7A-7 iJ 7A7X7° (Sodium-Potassium Pump) (£NaK- ATP7~^*$££ 7 F 'J7A7-T yfcJV (Sodium Channels) QH 603.154 7 F U 7A|B]1lf£ (Sodium Isotopes) ^mm QD 181. N2 mmm 275 7 F 'J 7A#ttJ#jD (Natriuresis) WJ 303 7 F iJ 7A7°X7° (Sodium Pump) (£NaK- ATP7--fe* $££ 7 F 'J 7AfiJgiHX (Natriuretic Factor) (£7 F 'J 7AfiJ R7./l/^X$££ 7 F iJ 7AfiJJ3o7/l/;ex (Natriuretic Hormone) WK 185 77y'Jx (Naphthalenes) Mmm QD 391 mmm qv 241 77yxx-x74-X (Naphthalenediones) Ii7 7 F ^ 9 X $££ 77 F ^f-y X (Naphthoquinones) Yj\7A)VXmb LT QV 268.5 Mmm QD 341. Hg 77 Y-JV (Naphthols) QV 241 77°3^-tex (Naproxen) QV g5 77°'Jfft (Neapolitan Fever) Ii7*/i/-fe7!f£$££ £flij (Names) mfez (mmm) z 695.8 i&mtfi)%Vfi (-ft) G 104-108 wzcomu, ii«^Lc#^-iz ifczsm mk% Z 695.1.P4 Xt. (Raw Food Diet) U9'A^-"y F$££ IS (Lead) QV 2g2 l&tp# (Lead Poisoning) QV 292 m (Tears) WW 208 %-m WW 208 709 7>x it £ WS 105.5. E5^ $ fc £ £ fit>Y (Tanning) m.T:mm wa 400-495 7'J y*y& (Nalidixic Acid) QV 243 7'Jx*xX (Nalidixin) (£7'Jx=3rx^$££ 7/U3 7X (Narcotine) (£XX7tx$££ 7/hjx7°x- (Narcolepsy) WM 188 7/1/ F x Jf X x (Naltrexone) QV 89 7/1/77 4 y (Nalbuphine) QV g2 7x^rX-vy (Peanuts) SIS^lESt: WB 425 m&mm& WB 426 7 X * X A x (Bedbugs) QX 503 &-ff3iJ (Ointments) QV 785 &# (Cartilage) WE 300 %J\%Xmmm (Chondroblastoma) QZ 340 &#JFM4^£ (Dyschondroplasias) (£#^#^'S^*t*£$ ££ |7tJFM4^*£ (Achondroplasia) WE 250 &#*£& (Cartilage Diseases) WE 300 ll'Jimb&J'Jim WS 270 IX-S-Sf (Chondroma) QZ 340 *fc#l£ (Epiphyseal Plate) (£*ft*fi$££ It/£ (Dystocia) WQ 310 iHte14*?** (Pain, Intractable) WL 704 &14T*ff (Chancroid) WC 155 ft14T*f M (Haemophilus ducreyi) QW 139 mm.Xmt:b lt wb 426 ffifc WA 701 fcM-k WA 710 £$tffiX WA 707 faffiiW) (Physical Effort) (i#f£iiiJj$£i $lfcfoM$ (Restraint, Physical) mnm&% (Nicotine) QV 137 &M- WM 290 -3f>7; K (Nicotinamide) li-3f>^7; F*$£ £ -nf>7; K-77-Xv?y y X77 F (Nicotinamide-Adenine Dinucleotide) (£NAD$££ -3f>7; K77-XxX y X47K^SI (Nicotinamide-Adenine Dinucleotide Phosphate) Ii NADP$££ ^.37x^iJ (Nicotinic Agents) (£3 ij xf^ffl!f*®$£i -3f>i (Nicotinic Acid) (£74 7xX$££ -af^7; F* (Nicotinic Acids) QU 193 — a A-y^M\fc (Receptors, Nicotinic) WL 102.8 —W^Y^W^T X Y (Dichotic Listening Tests) WV 272 r.mm.M (Sulfur Dioxide) mmm QD 181. SI Wfam QV 618 ZM\Y3XM (Silicon Dioxide) mmm qd i8i.s6 ^f: QV 610 r.mt$iM (Carbon Dioxide) QV 314 —Wl\YMM (Nitrogen Dioxide) TtAfX&WlKblX WA 754 mmm qd isi.ni XM\YL9 A-yy (Methylene Bichloride) li^ltX 7 U > 710 -zL>yA> $££ ZkTtYJV&Aifcihm (Electrophoresis, Gel, Two- Dimensional) QU 25 }.WF t-y y-X(£, KUWz 7^7C'C.»X3— Mm (Echocardiography, Two- Dimensional) l£4>X3-g|;i£$M,£ ZLfctt Y7°y — 4>x3 — fA\m (Echocardiography, Two- Dimensional Doppler) l£Dopplepl>x a - MVX (Biundulant Meningo- Encephalitis Virus) U9-mfrB%.7A JVX $££ -V/l/xtx (Nisoldipine) QV 150 B%\mmf% (Hospital Shared Services) WX 150 Q^XiiW)i¥ (Activities of Daily Living) #f£IW& HV 3011 m& HV 3011 IA WT 120 ~cotzihnm¥m:mS; WE 172 -(OfzihcoBm WE 26 wft%%M$m£tzummu, xmmiz im%apmmizm ^ %^ww% y a ycomm, a$)i S'JIZ amS, (Household Supplies) li&mm Bffln^$££ -Hft (Corpora Bigemina) i£ffiH$££ U&TA 0 7 A (Japanese Americans) UTyT^hT9 U #A$££ -•y7)V (Nickel) mmim qd isi.n6 mmm qv 290 B* (Sunlight) mmmmcoshub lt qt 230 \mm'j jh ii b ±mm wb 480^ $ £ £ Q±m (Sun Fever) i£7'x7j&$££ Bft& (Sun Baths) it Bit ; BltmmZflX BftiS (Sunbathing) Ii B?fc*J?'H;$£i Bjtmm (Heliotherapy) -feE^ WB 480 Mi%£mmcotzsbiz WF 330 Ufl-Mrt (Sunstroke) WD 610 ®UX WD610$fc££ Umm (Circadian Rhythm) QT 167 WaM QP 84.6 xmm -fe QH 527 firfWJXA (Diurnal Rhythm) l£BJS1»j$££ rM%. (Disaccharides) QU 83 — YX)JV (Nitriles) tiimmmb lt qv 269 Mmtm SBflfi&lfc"^ QD 305.N7 f/Wmitftm QD 341. N7 - F 3 7 ij 7 ij X (Nitroglycerin) QV 156 &Wm QV 632 -F3-t;uo-x (Nitrocellulose) l£$1*$H$iJ$££ ^ F 3 y 7 ~ x (Nitrosamines) QZ 202 - F oVffc (Nitrosation) ixmm&b LT QU 120 MWtitm QD 281. N5 — F 3 y ft^-it* (Nitroso Compounds) ?e*g"l4t*JCfcLT QZ 202 Mmm MDmit&m QD 305.N8 yjmmit^^ QD 341. N8 — Y z>9 y9 A-JVT 5. y (Nitrosodiethylamine) I£xx7 )V- Y u9T I X$££ — F 37 x 'J x7— Y (Nitroferricyanide) it— Y d7°d xK$££ =-Y ■oyy 9'y (Nitrofurazone) QV 243 mwijxm&mbLx QV 225 -Yuyy-JV (Nitrofural) (£—F 3 77 7x$££ ;=. F 3 7 y X (Nitrofurans) QV 243 — Y£>y°JVyY (Nitroprusside) JfiL^fcMmb LT QV 156 :=. F n7°/i/x F7 F 'J 7 A (Sodium Nitroprusside) (£— F o7/i/x K$££ ^. F n/TW&g£ WZ 305.5 'JtmUkm'JLm: WS 105.5.H7$££ mrnxmim w i6o$££ @m WF 330 km.%% (Inpatients) WX 158.5 ^commmizMLxu, * *#$fc££ AKWr.il (Length of Stay) WX 158 m"\mmx-co (nlm#si^t(£^5$&^ 27-28) km'Jt^ (Child, Hospitalized) WS 105.5.H7 kmnX (Adolescent, Hospitalized) WS 460-463 kmmft&fem (Prehospital Emergency Care) UfrMM *&-7-tX$£i A^buS^I^ (Physical Examination, Preadmission) (£££l^l$g$££ ARc1*P& (Insurance, Hospitalization) W 160 \mW£ (School Admission Criteria) LB 2351-2351.6 (NLM#MT(£^5\#^T8) ?L1k^J (Emulsifying Agents) (£JSMJ$££ ?im&ffim (Lactobacillus) QW 142.5.A8 ?L^7 FX3 —Axyyy—7* (Lactic Cytochrome Reductase) (£¥LS£7t K nyt-fetlJ: ¥L$t7t F*3 77--fe* (Lactate Dehydrogenase) QU 140 ?l$7t F*3 77—fe*74 7-74 A (Lactate Dehydrogenase Isoenzymes) QU 140 ?li£ (Infant) WS m& WO 440 -fe WS 430 mmuxftmm wy isg$£i Xi|<f£ WN 240 Xffi WO 925 JfiWi^mMlt WA 310-320$ ££ frmmm wb 405^,-?-wffeai^T^^sf4«$fc£ £ ¥Ltt (Tooth, Deciduous) WU 480 ?l!£5£* (Infant Nutrition) && WS 120-125 <£>3j4 WS 115 ¥l!£s&»¥ (Infant Nutrition Disorders) WS 120 ¥L£:fcfro (Diapers, Infant) (£¥l^^$££ ?L^lt^a^ (Spasms, Infantile) WS 340 ?L'JtXffl& (Diarrhea, Infantile) WS 312 ?l!£gffl^ (Autism, Infantile) WM 203.5 ZUJtfttim (Infant Mortality) HB 1323.14 Km$:f;tsWjfr WA 900 HS^t WQ 225^$fc££ Zl'Jtt. (Infant Food) WS 115-125 fl'^'Cmm (Infant Psychology) l£i£mW$££ ?Ll£Htlt (Infant Welfare) &$tffiXW%m WA 310-320 4hi£ft#g HV 697-700 ?l!£1Sflt7-t*X (Infant Health Services) l£^a1*M7 -t*X$££ ?Ut (Milk) KYfx g&)R SF 251-262.5 Sl^mX WA 716 mm qw 85 &# (-fe) SF 221-275 £$tffiXtY]%m WA 715-719 ?A *>y Y (-fe) WB 428 ivjimbwim ws 120;ws 130 fcmcotzfocomm sf 259 £$tffiXtfi]%m WA 715-719 i&mm wa 719 ?Lit#M£ (Lactation) WP 825 DjI* m^ SF 768 ff£UJl* QP 246 ?LSfc SF890$fc££ ?litfti&$W (Lactation Disorders) WP 825 mmm sf 890 mfcfr'WXZ (Hypogalactia) (i?Ut^^Pf*$££ ?VJtmm (Infant Care) WS 113 ¥14*111*1 (Chylomicrons) QU 85 ¥LUJp° (Dairy Products) SF 250.5-275 «B#fc L < UmfcmziSlt&ffi'kb LT WB 428 mmm qw 85 m&m TX 759-759.5 ffiX WA 715 ¥LS& (Mammae) -fe SF 890 WrXWYvi QP 188. M3 ?UH (Mammary Glands) (£¥l/f ; ¥LII$££ ¥U&UUfM (Mammary Dysplasia) (£^iHS&'l4?LS^*£$ ££ %\M'$. (Mastitis) WP 840 flUM^fc-JV^y (Mammotropin) I£7°3yy7x$££ fmUW&miX (Fibrocystic Mastopathy) l£^*fftS&tt ¥LSJi*£$££ ?imm (Udder) l£¥LS&$££ AJlP'c-fe X y — (Admitting Department, Hospital) WX 158 mnmm (NLM#£|(ST(£Jl^#^-27-28) ftiWtfc (Emulsions) QV 785 ¥LS6K (Milk Proteins) WA 716 &mm SF 251 %\MM (Papillary Muscles) WG 201-202 ¥LsISI (Papilloma) QZ 365 R@)114WfcW(£g|$fi£iJtz ¥Uf #c 'J y^mamUm (Cystadenoma Lymphomatosum, Papillary) (iS& 'J X/"fSl$£i ¥LMM (Papilledema) WW 280 ¥L#tW14 (Lactose Intolerance) WD 200.5. M2 ?VJtmb$)>&m WD 200.5.M2 flXf (Chyle) WI 402 flt/m& (Chylothorax) WF 700 ¥Lt>1f (Cisterna Chyli) l£Sfi)W$££ f\M (Breast) WP 800-910 %immm%m (Breast Dysplasia) (£*£*£*S&14¥Llia*£ $££ flmW&W&M (Mastectomy, Radical) WP 910 %lBm& (Breast Diseases) WP 840-910 flmmm (Breast Neoplasms) WP 870 ^14 WP 870 f\M» (Mastectomy) WP 910 ¥LJf ~b*3 7 yfcYy 7 4 — (Breast Xeroradiography) Ii nxfimmzmttfix %\MUm& (Adenosis of Breast) li|£*if§S&14¥lll&*£$ ££ flB&¥m (Mammography) WP 815 ¥Uf IM (Mammary Arteries) WG 5g5.T4 %\MWk (Cystic Disease of Breast) liH*HiS&14¥L!l&*£ $££ %\MXUW%^ (Breast Xeroradiography) itn.XlXm^ 712 -7 r 'J &$££ JU&Jfc^&'E (Sudden Infant Death) WS 430 ?U*£*g (Mastoid) WE 705 tp^SB W\' 233 ?U$£i6lfc (Mastoiditis) WY 233 Ai§ (Baths) &£ QT 240 til±#ttr«S; WB 525$££ jB^ wb 525: m*mm wb 750$ fc££ -i_^7.yX/i/*R (Newcastle Disease) SF gg5.6.N4 ^JL_^,yX'W*^74/l/X (Newcastle Disease Virus) QW 168.5.P2 =-3.-XV 9- (Newsletters) li^^fiH]4*$£i -i-y;i.777 4 7(Neural Analyzers) WL 101-102 - ^-yji^.y Y7-9 (WSJ) (Neural Networks (Anatomic)) (ittM&iN3$£i =-:l — vy-yyy (Neurotensin) WL 104 Zi-n7'( xX (Neurophysins) QU 55 RWHJ3* WK 520 W&itm WL 104 ia-D/7,-fxOffft: (Neuromediator Receptors) litt^f5ii!t*KS'#f^$£i -jl-dx (Neurons) WL 102.5 -*-nxX1£ (Neuron Degeneration) I£W^^'I4$£ £ W. (Urine) ^-^(i^m QY 185$ ££ #«£ WJ 303 Hlil&m#f WK 810-850 ; WW- WK 870$££ ^HiSiift^H^ wb 89oi?$£i Biff (Ureter) WJ 400 Rf& (Ureteritis) l£mt:^.t.$££ Rf^f-f^ii (Catheterization, Ureteral) UW3&7 r-7/xS$£i Stf*££ (Ureteral Calculi) WJ 400 W.'gmfc (Ureteral Diseases) WJ 400 W-Wm (Ureteral Neoplasms) WJ 400 W.T^)^4 WJ 600$ ££ W#«E (Uremia) WJ 348 W&mX (Urine Concentrating Ability) (i^)HJl^^$ ££ K^*£ (Diabetes Insipidus) WK 550 WM (Allantois) KXm QS 645 W.m^- (Urachus) WQ 210.5 mifalim (Urodynamics) WJ 102 Ejl& (Urinary Tract) WJ m& SF 871 mmmim&ijiBykm qv 243$£i 'hiB WS 320-322 -izimtzmvnumrm qv i6o;^yrxxx QV 160^$££ yf-44 WJ 168 W.m (Urinary Fistula) WJ 140 mmm wj 500; mmrnm wp 180$ fc££ W$t7T — T>vm (Urinary Catheterization) WJ 441 WX&'B'ik& (Urinary Tract Infections) WJ 151 fVJtmbWJtm WS 320 mmm sf 87i W~'$iYjlWi£m (Anti-Infective Agents, Urinary) QV 243 Wfamfc (Urinary Tract Diseases) Ui&B.&m&Z fl X Wfo'-ikWm (Urography) WJ 141 fVJtmbyjijtm ws 320 n%Lmm% wj 302 SJ&^fLffiT (Urinary Diversion) ">^ (Calcium Diphosphate) lit°DU ^7/i/x7A$££ —$«$f^Hft*7X F (Bicycle Ergometry Test) (£3IIJJ t^$££ - 7 F 'J (Chickens) m&\m SF 767.P6 713 -7MJ^ firijf? SF 481-503.52 mm sf gg5-9g5.6 'YMm SF 768.2.P6 - 7 F 'J E (Chick Embryo) mi QL 959 f£&JjnA&Jif*Pfc (Health Insurance, Voluntary) UM wmtfix f4.1i®/if*Pt (Voluntary Health Insurance) (£@lt1*P& $££ &MM$.M%Lmm (Hospitals, Voluntary) itmm WX 27-28^$££ Y£&.\^mmm (Voluntary Health Agencies) WA 1 (NLMfrm%XUJ&3.&J*lr 1) ftXX HV 560-583 W ', #P1£ $ fc £ J ISfJ (Licensure) ^tSiT3l$££ Aff# (Puppets) (£jl®tJ7c4l:$££ AfmHH& (Interpersonal Relations) HM 132 frX-m WS 462 ?UJimbX'jtm ws 105.5.15 %.HS&[Jl WS 107.5.R4 ^ftlzfclt^, WX 160 $44HStzPLT WO 62 wm tc mMuxmm izm i ii, mmm - &%r$ am mm wu 6i; mm ws 105.5.F2^ AKttttt* (Man-Machine Systems) TA 167 xmmmftfr qt 36 tfBfch t-y yxl£, iJgSiJtz kWiXm (Human Engineering) TA 166-167 « f \zy 9xuxmmz,mtuxvfmmxm qt 36 ^ ; -7&fFHf WD 750-758 ktRXmm (Human Physiology) (££W$££ Afal K -y X (Multiphasic Screening) WA 245 AFalfc^'y F<7)£T& (Bonding, Human-Pet) WM 460.5.B7 kmcoXM (Human Reproduction) UXMiflX kfflcoftmXlkftyU (Physical Conditioning, Human) (£M«}£$££ kmcoWM (Human Development) BF 713 «$*£ WT 104 iWftHit WS 103 &m^fZtl^ (Maternal Mortality) HB 1322.5 ?EH $-£•&*<§-£(£ WA 900 <&mffi\%MX-\z°X (Maternal Health Services) WA 310 &Xm7T WQ 175 ; X\k7T WQ 500$ fc££ i£% (Cognition) BF 311-499 m^bX^- (fc&m) BF 724.55.C63 WXrn WS 462 fi'jtmbth'jim ws 105.5.C7 %Xm WT 145 sSliSiPflF (Cognition Disorders) -fe&Mtnma wm 204-205 zcofccoimy t-y yxi£±^ijiz, mium^m WM 173.7 nStiE (Certification) (NLM#3IfST(£J^#^-21) mXC0A-flii, -?-oy4 7°IZii^^-fe^#^-[; &4I (Pregnancy) WQ 200-260 -^Vjflm WP 825 mi WQ 200 mww^m w 791 mm wv 157 i§1SW!f* WQ 150 &I&&W:£e (Pregnancy Complications) WQ 240-260 mil WQ 240 mmm sf 887 SM*<7)lft*I SF887$fc£i j&t&iiMW& (Pregnancy in Diabetes) WQ 248 t&l&i&Mm (Fertility Agents) QV 170 £PiISf4K (Pregnancy Proteins) WK 920 t&V&XUfc (Pregnancy Toxemias) WQ 215 &&I7X F (Pregnancy Tests) QY 335 fcE&Hte'Jf (Pregnancy Outcome) WQ 240 Affl (Physiognomy) BF 840-861 m^mrn wb 275^$fc££ Wm'iilhmm (Behavior Therapy, Cognitive) (iaS&fjg &$££ Bfobmmm (Psychotherapy, Cognitive) (i!Mlffi$ ££ ISft&^tMP (Cognitive Dissonance) BF 337.C63 $l.^mm (Cognitive Therapy) WM 425.5.C6 ZVJtmbWJtm WS 350.6 -X-y (Garlic) @JtB# $ tz itmm<&coffi£: fc L T WB 430 mmmwibix qv 766 9 77 (Midges, Nonbiting) fi^-X ij 7f4$££ X 7 X7--fe* (Nucleases) UfcXfcyx.XTJVh F*37- ■vm&m ; -e^ftii^sij&x y ^r-wif,, f$u ii DN7-7*$££ X^Vt/F (Nucleosides) xim QU 57 ^Jl^ QV 185 itJflL WH 140 $fc££ Wfc9 9 x77 Y<7y&fo£iifLX 9 9yfcyY-0 A.mm (Nucleoside Diphosphate Sugars) X\m QU 57 mmm qv iss X y yfcA- Y (Nucleotides) Xim QU 57 mmm qv iss jglfo. WH 140$fc££ ^p^yy yfcA-YvZfoZiifix 9 9yfcA- Fg^iJ (Nucleotide Sequence) l£i&gg^iJ$£ £ &<^ (Theft) #3*F h"7^X(i, ±M(z 9- F'"V7X (Mice, Nude) ^J^Uj!t*fcLT QY 60.R6 9^.JV7A y (Nupercaine) I£x7"74>$££ iBlfe^ (Swamp Fever) (£7"vfEife'l4S:ifiL$££ 47 5 x (Neamin) l£4 4-v4xX$££ 4-77/i/X7i7^> (Neoarsphenamine) QV 262 fcfc7A y (Neocaine) (£7°374>$££ 4 4"X77 ^ > (Neostigmine) QV 124 fcfc-?A xx (Neomycin) QV 350 4 7^4x>A (Neomycin A) li44Wxx$££ 44-'J7-y77 (Neorickettsia) l£ U 7-y 77f4$££ 4- 7 x (Neon) 714 *x?4* *mitm qd i8i. N5 mmm qv 310 434g (Allium) ^ffltif^fcLT QV 766 mwm qk 4g5.L72 fl*B#^^(i*^^B#WffitfcLT WB 430 y(.9vA F'Afl (Negroid Race) kmm GN 645 g&WT^F^F t-y yx$fc£i 4 3 (Cats) nmm^bix QY 60.C2 m$\m QL 813. C38 gait SF 441-450 mAUA-zcomA SFg85-g86$££ ffttw QL 737.C23 4 3 ffuJii. (Opisthorchis felineus) ,'iOpisthorchisH$£ £ 4 3 $§Utl*]IS7 4 JV X (Feline Fibrosarcoma Virus) Ii 4 3i*)S74^X$££ St (Sleep Talking) (ilfllgPfW$££ ^3|*|M7 4/l/X (Sarcoma Virus, Feline) QW 166 ^?cr>mA (Cat Diseases) SF 985-986 4 3t>o*^*R (Cat-Scratch Disease) WC 593 4x1)y-7/u (Macaca nemestrina) QL 737.Pg3 mm sf gg7.5.P7 HUgj^fcLT QY 60.P7 47-4/1/7 (Porpoises) l£4/l/7$££ 47 = 14 (Murids) li4X*^®$££ 4Xi|g^ (Rodent Control) WA 240 4x*i SJfiL*^74/i/X (Murine Leukemia Viruses) liv r>XfijfiL*^7 4/l/X$££ T74Mf7X (Murine Typhus) (£Jtfet^l4X ^ »H «77X$££ 4X*~3I (Muridae) QL 737.R666 mm SF gg7.5.R64 !S£iJrt*fc LT QY 60.R6 & (Heat) ^Hm?l$££ SilEI-a (Thermocoagulation) (£*t$vl§[I]&$££ Sil4 (Heat Production) (if41&PSn$££ &*ffi! (Heatstroke) Ii«il£T$££ &fii##f (Thermogravimetry) QD 7g.T4 s&ikmmm iz is it & qy go Ws (Burns) WO 704 ~iz X&Ktl (mmmtY)%m) W 843 ^IJrttOfcOliSlStiWz H'J< WR 150$fc££ B-/3 7^f&f (Heat-Shock Proteins) QU 55 By a -y9SS3C70 (Heat-Shock Protein 70) li|->3 ■vy^&K$££ l/a "y9mYtM% (Heat-Shock Protein go) liffiya •yyS&K$£i *Sl4*5^ (Convulsions, Febrile) WL 340 WX%B7AJVX (Fever Blister Virus) UWtk7 A JVX $££ Bfch'k (Heat Loss) lift4&Pl@i5$£i &%mm (Tropical Medicine) WC 680 ?l'Jtmb%}'Jim WC 680 &%co WR 350 ftzmfccozfoziifix mmX (Tropical Hygiene) l£S^^fl^$££ m$Am (Tropical Climate) mm QT 150 A%m QC 993.5 x.mmm qt 150 *v-^'l4X7°/U- (Sprue, Tropical) WD 175 *MX%ft&d (Thermoelectric Power Plants) (iH'.t pir$££ #ii£Jfi (Thermopenetration) (ix<77/l/5 —$££ &)11£ (Scalds) (i*M*$££ 4 y F 7 — 9^m (Computer Network Management) Ii 3Xti-y3iJ.^y-x3x4'y F7-y$££ 4 -y F 7 —^Mfn7°n F 3^ (Network Communication Protocols) Ii3 x t j. — 9 ^ S. j- — 7 -X3x4'y F7-y$££ &j& (Heat Waves) Ii*m£$££ #v|£T (Heat Exhaustion) WD 610 llWi WD 610$££ $klim (Thermodynamics) xim QU 34 wwrnmim qd 504 tyiiWm QC 310.15-319 l^ftiMS (Calorimetry) QU 125 *yu $ 4 7 yxStlJ (Thermoluminescent Dosimetry) WN 660 4 7*'"?A (Nefopam) QV 95 4-7°7-7A (Neptunium) WN 420 mnmm qc 796.N7 JM4l4|B]fif4^TO#$c F t -y y X $ fc £ £ 477-V4 xX^6H4-(Nebramycin Factor 6) (i F7*7 -?Ayy*fix 7 7 3-7* (Nephrosis) WJ 340 fcya-^mW^ (Nephrotic Syndrome) WJ 340 fc 7 n X (Nephrons) WJ 301 fcJVj-iyy (Netilmicin) QV 350 %m (Mucus) QS 532.5.M8 tmt£Mi$i (Colitis, Mucous) l£^^14*S)li*^.t$££ ffiffifflMg (Myxobacterales) (£Myxococcales$££ ttffiflt (Myxoma) QZ 340 mWiiico ii vumiNiz W^fll7 4/l/X (Myxoma Virus) QW 165.5.P6 ^^mm.7A JVX (Myxomatosis Virus) UWt&m7 A JV X$££ tti^XKfli (Myxedema) WK 252 tt$8&€f!i& (Mucociliary Transport) UAmmmX;9 |J77XX$££ ttltH (Demulcents) QV 63 ¥i£ (Almanacs) AY 30-1730 *££ (Pensions) HD 7105-7105.45 %f-£%.m*n%Lbfch iiCouArcommmiz, i^ii^n izmmmmcotzioco iicou wy hi ; mmm~^co tzShcoiiCOU WY 77 j&ffifcM (Sprains and Strains) WE 175 1*14 (Viscosity) Jfo.$y> WH 400 [&J*M QY 408 AVfCO QC 167 mfcco QC 145.4. V5 W14*P3ffi (Slime Bacteria) Ii Myxococcales$££ XYtm (Chronology) CE 715 *x7* y 7£W D-F mmw wz 30 t,',fr14 (Adhesiveness) QC 183 ^T*$££ Busi^ (Encephalitis) WL 351 7v(i7-v)iisWl!i& SF959.E5#$££ Sg^(£fiSIJg!i*i& WL 351^$££ fta'£7 4A'X (Encephalitis Viruses) QW 168.5.A7 B£$*14S (Brain Injuries) WL 354 ¥l£#lfc #>!£#! WS 340 HusH^&fcftT (Gyrectomy) (itt££$4#$£i BS'ftl^' (Brain Chemistry) WL 300 HisTStfa (Hypophysis Cerebri) UXfcifc&flX ts# (Brain Stem) WL 310 Sa#tt*£ffi (Basal Ganglia) WL 307 Bi#W^an*^f. (Basal Ganglia Diseases) WL 307 mx.Wm<7>&fo*iiflX, f?iji (£Parkinson*^li WL 359 mmmnft&H (Evoked Potentials, Auditory, Brain Stem) WV 270 BAM (Pyopneumothorax) liMJ®$££ mm (Pyothorax) li^l|g$££ iuaflr (Cerebral Peduncle) (£cf1fli$££ HH (Agriculture) S mi S 491-494.5 HijSjfiL (Cerebral Ischemia) WI 355 B:^\\m (Chemistry, Agricultural) S 583-587.7 lalfiL^MH (Hemato-Encephalic Barrier) (£jf[L$J!KlllH $££ SaJfiL^llH (Cerebrovascular Circulation) WL 302 W^ WL 355 HilfiLl^fil (Brain Revascularization) liIaJfo/f?J£$£ £ WitisJgfMM (Cerebral Vasospasm) Ii—^'|4fli2^JfiL$£i WiMM^X (Cerebral Revascularization) WL 355 lalto-TOi* (Angiography, Cerebral) l£HSlfllWi£^$£ £ SiJflL^Pf W (Cerebrovascular Disorders) WL 355 HSiJfiLTfjai^ (Cerebral Angiography) WL 141 WtM& (Pyemia) (iSJCJfiL*£$£i laifiLte-lE (Cerebral Thrombosis) (£SBS^*£fcBaJflL^*S $££ m%mmmM.mX (Microsurgical Revascularization, Cerebral) (£fliaJlD.iS:#'4$££ BiifSlS (Cerebral Infarction) WL 355 ByZ (Brain Death) W 820 llultf&fillll'&jiE (Magnetoencephalography) WL 141 BM (Cerebral Ventricles) WL 307 Bm& (Brain Diseases) WL 348-362 fVJtmb&'^m ws 340 mmm sf 895 :ft£SB*££$fc££ BuaiE^ (Ventricular System) (£l!iiE$££ WiMM%ym (Ventriculography, Cerebral) l£flS^Jal^'S $££ MMmm (Cerebral Ventricle Neoplasms) WL 358 B&^stiiJ (Ventricular Puncture) (£^|IJ$££ BMfeWm (Cerebral Ventriculography) WL 141 fVJimbwjm ws 340 ft®14¥L^^ (Mastitis, Cystic) li^fft^14¥L)l**£$£ £ eaaiJfiL (Cerebral Hemorrhage) WL 355 GS)J7l4<7)fc<7)(£SlHi)5'Jtz mmm (Brain Neoplasms) WL 358 |5g^14«7)fc^l£SCfiS'Jlz 81 If (Pyonephrosis) l£^S:^^$££ BW& (Cranial Nerves) WL 330 1@7y>W^(i#^c7)^^^T$£i mmmfc (Cranial Nerve Diseases) WL 330 BW&mm (Cranial Nerve Neoplasms) WL 330 BaH fc l (Brain Concussion) WL 354 716 /yay R3?Klf (Brain Edema) WL 348 Baffin & (Cerebral Meningitis) (iM^^$££ Eft** (Cerebral Palsy) WS 342 lie AW WL 354 BS¥fi£$ (Cerebrospinal Fluid) WL 203 ttlfc^&f QY 220 HftW^Bf WB 377 KffffiJRE (Cerebrospinal Fluid Pressure) WL 203 la^Hife (Encephalomyelitis) WL 351 7vli7-?SslMfi& SF 95g.E5$££ litemb IX SF 80g.E7 ISWifiSfiK (Cerebrospinal Fluid Proteins) WL 203 ttfcfclt QY 220 K^lfi^Bt* (Meningeal Neoplasms) WL 200 &mmmm qz 380 KIMi (Cystadenoma) QZ 365 KJii14<7)fc<7)liSl3fiS'Jtz |f|*f (Ecthyma) WR 225 ISia^ (Encephalography) UHwtfl^feU ; K£ ; BcoX coxmmt WL 141 ; K'S^I^S$££ BSSl^*^ fc Iis.Un.teSE (Cerebral Embolism and Thrombosis) WI 355 Kfflffc&tfi (Brain Tissue Transplantation) WL 368 KtMSMSSffi (Grafting, Brain Tissue) l£Biaffi^^ti$ ££ itttAP (Rural Population) APf HB 2371-2577 ®israfiiiit*tfsii wa 3go$£i Arcofcco^mu, ±HSiJ(z mc HD 7289^ ; S*ft*€ HD 7288.77-7288.78$ fc ££ %^fc^mm (Pastoral Psychology) (ittgHiy7$££ mtmWmm (Pastoral Psychiatry) (£ftf5iP7 7$££ fcttlfctt (Rural Health) WA 3g0 mfc (Bladder Worm) li=fc&m$££ B5&1HHK (Basal Vein) l£*/JaiMil$££ liE^fiJ (Cisternal Puncture) li!#$ij$££ Va&Wi9k (Basilar Artery) WG 5g5.B2 llglSiJjIVf^fiE (Basilar Artery Insufficiency) (itt#Jla mmmmmxztfEZfix KKj#ifc:»rJl^ (Cerebral Arteriovenous Malformations) WL 355 m$]J$mit& (Cerebral Arteriosclerosis) WL 355 laUM*£.f. (Cerebral Artery Diseases) WL 355 flSiJjK*§ (Cerebral Aneurysm) WL 355 $4^14 WL 354 ffilftftS (Immunity, Active) QW 552 lgHl^.SfeS (Immunization, Active) UXWW&ZflX HZW)%L&mm (Immunotherapy, Active) QW 949 mmm sf 919 wzmmizfttzArtiu, Azcommx b£UJ*m& (Active Transport) Ii£!|*ftB£iJj*wu&$£i SiaP^GE (Intracerebral Pressure) (£fli2J±$££ HaWt (Softening, Brain) liHBtfcfbffi i 4^J#*$££ Mfrim. (Encephalomalaca) WL 348 mmm t mm l tzm& wl 355 mm (Pyuria) WJ 151 R$t^ QY 185 mcOJX'A (Compression of the Brain) (£f.'f4Bu374^$£ £ mmm (Brain Abscess) WL 351 BSiiJfc (Electroencephalography) WL 150 mmimm (Sphygmography) (£jfitr±)ll'5$££ B\ifofx.hB%t)Yk-£. (Audiometry, Electroencephalic Response) (£^Jx4i?I|§77t&g$££ WSC& (Pyoderma) WR 220 *4gjit (Cysticercus) QX 400 mnm (Cerebral Edema) ii)!B7K)l$££ &X:B (Farmer's Lung) WF 652 mmm<7) sf 83i Biij/s;u^7 (Encephalocele) % 714 WL 350 WI4 WL 354 ftTd (Cysts) QZ 200 fHi'itftJ'd! WE 258$ ££ ¥IM WP 840 3®*ttliffi**B& QZ 310$££ ^mum^ WJ 358$££ *$P&li*»iftJ& WF g00$££ m$m\*wmi&m wi 500$££ imifc-coiUYm^mm wu 28o$£i mw.ixliJlz ftl&f? (Kidney, Cystic) WJ 358 W&ttlMSiKiffi (Fibrocystic Disease of Pancreas) lift mummmzfix ftl&14!£*t*£ (Cystic Fibrosis) WI 820 ft^14^f14#^ (Osteitis Fibrosa Cystica) WK 300 ftl£14-^Hf44£ (Spina Bifida Cystica) WE 730 MmWt)% (Cystadenocarcinoma) QZ 365 Bg^14<7)fc?)l£3Bfi5iJlz Si-v-y \z°y9' (Brain Mapping) WL 335 UK*?! (Agricultural Workers' Diseases) WA 400 m*<7)) wo 140 HfllilifFfll* WI 730$ ££ mmvkto wf 65i$££ #*£ WP155 m&mmnum&mmmm wu 23o$££ mmco wq 505 mmmx^ummmxmm wi 575$££ ^.mm wo 140 717 / 7 l)'9 ^^ft<7)lujgCli^f.V8iJlz fit5*' (Efficiency) •:-i ICO T 58.8 ^llil^fjfeni BF 637.T5 'Ik, 7 (Corpus Callosum) WL 307 fi£;JjlzJ£o'< #t^ (Competency-Based Education) mi LC 1031-1034.5 #£#» (NLM#MT(iJf?:rX#^T8) BwPick*i*j (Pick's Disease of Brain) li*7j£143EQ'4i$£i 9 7JVyT'SVk& (Nocardia Infections) WC 302 mmm sf sog.N63 7X7Ii WR 340$fc££ / -7 x7*3 -y 7 4 x7 (Blotting, Northern) QH 441 /X7tX (Noscapine) QV 76 l?£ft£^4-#- (Child, Unwanted) HV 873 &m^/i/4- F (Noramidopyrine Methanesulfonate) !£ x* 13 x $£ £ 9jvx.9 y F'n3X (Norethandrolone) WJ 875 /;wx7X73X (Norethisterone) Ux.X — — >v9JVX 7 FX73X$££ /;ux7y Fx/l/ (Norethynodrel) WP 530 M&mb LT QV 177 y;ux7xF"nx (Norethindrone) WP 530 M&mb LT QV 177 y;uxt°4 7ijx (Norepinephrine) WK 725 9 JVYX Y yiv (Norgestrel) WP 530 m&mb IX QV 177 9ivYw*y (Nortropanes) Mmm QD 401 //l/7°xy4 —y o x (Norpregneninolone) U9 JVx.9 y F*3X$££ 9JVyn^T-yy (Norfloxacin) QV 250 9 JV A 9 y F*3ox (Normethandrolone) WP 530 /n-v-7/1/ (Loris, Slow) Ii3ijxf4$££ m (Tooth) WU §H4 WU 24.5 kitkm WU 101$££ fe'S(£#iS&?S*£ WU 230$££ mm wu iss mmmb^m w 705 mxfysm qw 65 mmm wu 140 Mf WU 640 m (Lung) WF 600-668 itmms wf 600 mmm qv 664 X^WlB WF 600 f-ff WF 668 muxmmmmz wf 225$ fc £ £ E (Embryo) QS 604 ^g SF 767.5 mXWlWl QL 971 #£fjj!|*(i, ArnmWliz Umm (Pulmonary Medicine) UBm.% (WH) $££ Mi&M (Lung Transplantation) WF 668 K#fit (Embryo Transfer) A1* WQ 205 Iffilttig (Pneumogastric Nerve) (i^^^^$££ lffi& (Pneumonia) WC 202-209 FriedlaenderHi^ WC 209 mmm sf 83i liti^^ffi^ife-ffi (Pneumococcal Infections) WC 217 XMiiMfc WC 204$fc££ Ii}i^^ffi14flil]'^ (Pneumonia, Pneumococcal) Uy)ffi£$£i H]^JSiIi^ffi^ife*E (Streptococcus pneumoniae Infections) (£|iti^^lii^*E$££ ^AfcT-y^A (Biological Assay) QV 771 7/1/tyCO QY 330 t*y $ yco QY 350 ,mbU, xmwz ><< fcy 4 - Y'k (Abortion, Septic) WQ 256 mmm sf 887 %-o A yJtkm^L (Coin Lesion, Pulmonary) WF 658 fid&SSAss (Drug Incompatibility) QV 746 BfiitjlflLlLiii (Hypertension, Pulmonary) WG 340 fiil&iM/W (Drug Combinations) QV 785 £MmWUi WB330 fcnzm'^co£ft;$ ?z it Arcomft mwuhhztizmmzii&x If^.|llIl'dJit*gfcll6^14)ffi*i (Neoplasms, Germ Cell and Embryonal) QZ 310 Kffllfettl*jHi (Sarcoma, Germinoblastic) (£'Jx^4f$ ££ fSSc (Trituration) I£l3?fij$££ mmm (Lung Irritants) (£«*$££ Ifa&ft (Lung Diseases) WF 600-668 IVJtmbWJim WS 280 mmm sf 83i ffi*£.f. (#H) (Pulmonary Disease (Specialty)) WF 100 %m-%tkBl) (Aid to the Totally Disabled) (iti^1*Pf $ ££ Umm (Lung Neoplasms) WF 658 5*5# (Prostitution) HQ 107440.7 ffifllSl (Pulmonary Circulation) WF 600 IffifiHIR (Pulmonary Veins) WG 625.P8 B CO X<7> !&&&£; WF 600 ; ffiHlg WF 600$ fc£ £ flifcXl.f-ifeSi-; (Mycotic Lung Infections) (£Iifi*l*£$£ £ Minn& (Lung Diseases, Fungal) WF 652 Bifcjctt (Pulmonary Edema) WF 600 fiffttt (Polyploidy) QH 461 te&M SB 123 E14*S)Sfflll& (Embryonal Carcinoma Cells) (ilif*lf£iffl !&$££ Iffitt't' (Cor Pulmonale) liBitrT44>*£.i$£i !ifi14*£f. (Pulmonary Heart Disease) WG 420 BW& (Pneumonectomy) WF 668 SMIft^Lolt (Toilet Training) WS 113 !iti^*t*£ (Pulmonary Fibrosis) WF 600 BUtM (Lung Lavage Fluid) (iBAL$$££ BM y X Y ~? (Paragonimus) QX 353 B%^& (Pulmonary Embolism) WG 420 ykffiMtybA. (Field Dependence-Independence) BF 323.F45 tgHfe (Culture Media) QW 25-26 14m (Back Pain) WE 720 mm WE 755$fc££ K*gf£ (Glycosides) QU75 't'Hfflli3jS'i:»E«lft:QV153 $££ K*Sft*L£1*K (Glycoside Antibiotics) l£7 $ 9 y*'J 3 IffifJjM (Pulmonary Artery) WG 5g5.P8 lit^T^MfftlS wf 600; DHfH wf 600$ fc£ £ BWlMMfelX (Pulmonary Embolism) WG420 B§M# (Pulmonary Valve) WG 269 BW)B4r&ifu& (Pulmonary Regurgitation) UBW)B4f mmx%'fc*fix 719 "A Y7i l*ft*#ftVffi (Pulmonary Valve Stenosis) WG 269 IrtilM^-^SE (Pulmonary Incompetence) UB$t]W.Ar mJ)1^^*ai$££ IfctlM^fflfl^SE (Pulmonary Valve Insufficiency) WG 269 Wi!iM#B£SE (Pulmonary Valve Incompetence) UBW) )!K#fflM77*£$££ mm (Syphilis) WC 160-170 mmm QV 261-262 m^mmt, mmn wc i65$££ m^mm wc 170 &ftg#J WQ 256 tfc^lfinf 7X F (Syphilis Serodiagnosis) QY 275 fl*#$ (Syphilids) li&J**#$££ ffc#147:iM!£ (Aortitis, Syphilitic) li'frRMaMfcft $££ WW. (Urination) WJ 146 J*RWW (Urination Disorders) WJ 146 EE-f* SF 871 SfRffi^Lolt (Toilet Training) WS 113 «*£ (Drainage) WO 188 |5g^'f4c7)fcO(£a3fi^lz Bmm (Lung Abscess) WF 651 ^4 ^-77°-7 (Hypercapnia) WF140 IffifiJBIiffir (Pneumonolysis) WF 668 /\/f y>°— 7 y y 9 — Yy (Hypertensinogen) (£7 X^r 4 7 xxy-rx$££ MWfeMW- (Implantation, Blastocyst) (£HH11J^$££ B^MiZOm'S. (Pulmonary Surfactants) WF 600 Bftm (Plmonary Edema) WF600 ^4 7'J -y F*JFM (Hybridization) QH421-425 WYJJi QH425 mm QK982 =nmx»;: QW 575.5.A6 K-fr (Minerals) 44t~f" QU 130 ffift*^ QE 351-399.2 #ct) WE 200 WM (Defecation) WI 600 &x wi 600; ±m^m WI 600$fc££ B-i%&u QS530; mxmmWi & QW 26 tg*«BI& (Cells, Cultured) QH 585.2-585.45 $m.m.*■*& &*E (Myiasis) WC 900 mmm sf sio.fs M, &MffiXtf]%m (Tombs, Public Health Aspects) !£*!#$££ QkMm&tt^ife (Hydatidiform Mole, Invasive) WP 465 mmm qz 310 $.Ukmfrmm (Hebephrenic Schizophrenia) tift?f£S!!# mmtfix ><—*-/ Y 'J y*m(Lymphoma, Burkitt's) liBurkitt "J X^°M$££ ><— % -y Y 'J y^± (Philanthropic Funds) li«»i$£i ^W (Malt) mmmxummmzisit&M'kb lt wb 431 T)V?-)Vimm TP 587 &WWWrffi (Leukotomy) (i*PrW*144$££ YXS.\tWm (Materia Alba) i*mv?->i ffimt WH 274 r3*^^14S:ifiL (Anemia, Leukoerythroblastic) li#fl 6^t4«JliL$£i MW ft {¥&'<£ (Thin Sectioning) (£ggf&fI«JMT-'£&$£ £ YAM (Tinea) WR 310 mmm sf 809.R55 &m& (Trichophytosis) I£r3*g$££ j!|JfyD-7Fy77/f— (Chromatography, Thin Layer) 720 i^9 iJV9 fittim QD 79.C8 Mmm QD 272.C45 B%X (Leukorrhea) WP 255 $l]$ (Deprivation) lif lJ«W y 4 7£ $ £ £, ffl i l£flr'|4 am, tt&'bmmmtt-g, mmwg% SHM14£l*?£ (Dermatitis, Exfoliative) WR 180 BM (Idiocy) l£ffittJi^$££ Si:^ (Day Dreams) ti^iB.$££ '<9t*)T (Bacteria) QW £lg^l$fc££ /< 9 7 'J fc y x (Bacteriocins) QY 350 ><9 7 'J fc 7 r - x (Bacteriophages) QW 161 ><9 7n 4 7*X^ife*i(Bacteroides Infections) WC 200 ffifftjtltt (Perfusion, Pulsatile) l£#lfM$££ ffilKft (Pulsatile Flow) WG 106 SflPf (Cataract) WW 260 fiflPfffi&f&/fci?Hf£«E (Aphakia, Postcataract) WW 260 SftPfJiStfJ (Cataract Extraction) WW 260 J§% (Explosions) ^Msf?-3I$££ !#%14iJSIi: (Explosive Decompression) (ifil±$£i *§fe&vAP*#;!in (Population Explosion) liAP*f JjP$£ £ YA%k (Leukoma) UPM^Mb PlgFlS£$£i &« (Vitiligo) WR 265 SIS (White Spots) l£ffi|!fe$££ &Um (Leukoplakia) QZ 204 js)&a. Q 105 nmmm (veiled ceiis) umk'tkmmzfix mmHi&m^^. (Glossitis Areata Exfoliativa) li&14# UJl4l§-^$£i mm. (Hordeolum) WW 205 'W\\m QD 77 mim QV 744 •Ymswizmmzti&m&u, xmwiz iff 7 7 y 7 X (Measles, Vaccine) WC 580 ^xx^SLffl (Hashish Abuse) li-v 'J 7 r7SLffl$££ 'yx£f (Bacillaceae) QW 127 /7 7/1/7 5 /7V /< X -t x $ £ £ Utzlivm^ (Barefoot Doctors) liJfet^[S«-7-tx $ ££ y<9X7JV (Erythrocebus patas) QL 737.Pg3 mm sf gg7.5.P7 H!?fclM*fc LT QY 60.P7 ^yx^EX^r- (Patas Monkey) (£^°y X77l/$££ ^9fcX~ (Voles) Ii^y4x*5^4$££ "9fcX = m:A (Microtinae) QL 737.R666 m& SF gg7.5.R3 ■Mmm^bLX QY 60.R6 s^ffcXiig, (Microtus) it'^9 fcXX S£F$££ '<9-iJV9 (Buttermilk) (£¥144$££ 721 t\9y-> '<9-y&$k (Pattern Recognition) 3>fa-^-If TK 7882.P3 (NLM*il^T-(i^^#^26.5) 80711 ho A (Aged, 80 and over) WT £ A X7)1 (Mus) (i4XiiI$££ 5e*S (Carcinogenesis) li8I*S$£i MA (Perspiration) liff$££ %ff (Sweating) WR 102 mim qv 122 ylifc^S*£ (Pompholyx) WR 200 y^MA-y x.-9- (Tumor Initiators) (iH*g!f*JC$£ £ ^*SH4- (Carcinogens) QZ 202 %ifcM£&. (Hyper hidrosis) WR 400 1%ifcU'X (Hypohidrosis) WR 400 &mm QV 122 ?§*g147 4 JVX (Oncogenis Viruese) QW 160 ftimmiMmmmi?; (Hidrotic Ectodermal Dysplasia) (i74K3tJIJfM*£$£i H*S'I4^^ (Carcinogenicity Tests) QZ 202 %)%%>)&. (Carcinogens) QZ 202 5e*&7°3^-y- (Tumor Promoters) (i?l*S!f*K$£i 5lfTKir,giJ (Antiperspirants) l£OTH$££ PI*g-v-7- (Carcinogen Markers) UXyvmffimm-?- 7-$££ Wfcm (Diaphoretics) UmfcWpcoXcofemm QV 122 $££ YXt (Platinum) S&mm QD 181.P8 mmm qv 2% Ya£M (Platinum Black) (£&£$££ '$E (Leukopenia) WH 200 YASkmtjiW. (Leukocyte Antigens) (£HLA1aJI$££ &llilifc*ffljj&*lijfo. (White Blood Cell Transfusion) (ifajfiL ££*iiJriL$££ SjflL^cL^jfiL (Leukopheresis) (i&Kn.i£#g|$£i ftlfll^lS- (Leukocyte Count) QV 402 YtltmnW-Z (White Blood Cell Count) {ir4jfiL£fcft$£ &ikm&mm®X (Leukocyte Adhesion Inhibitor) Ii A>y-34*x8$££ &ifi.2pg/j[]--£ (Leukocytosis) WH 200 mmm sf 769.5 &JfiLi£;t'ffc'l4 (Chemotaxis, Leukocyte) &{'YmizisitZ> QW 690 &JliLi$^14 (Leukotaxis) li&!fEJ£;£fl:14$£i Qlfo.l£14#TOJ7X F (Leukocyte Adherence Inhibition Test) QW 525.5. L6 SM55-ii (Differential Leukocyte Count) liSdUSft $££ FHfo.I^r'lt (Leukapheresis) WH 460 fijfltJ^^Jln. (Leukocyte Transfusion) WB 356 &JliL|*JJS (Leukosarcoma) WH 525 s&mmmm qz 350 &lfo.*?| (Leukemia) WH 250 $Mmmm qz 350 mmm sf 910.L4 fijfil*^74/l/X (Leukoviruses) Ii X F 3 74 /UXff$£ £ YAitmi£:mmtHfo& (Reticuloendotheliosis, Leukemic) l£^7'J-7/wfjJfiL*^$££ 5li# (Fermeatntion) QU 34 mmco QW 75 tmizHULT QW 85 y^itXBm (X-Ray Emission Spectrometry) (iX^Uft M347f$££ 3§*JlM (Photobacterium) QW 141 5e*MF1H (Luminescent Proteins) QU 55 y£&¥>i}W (Ferments) (£8?3|$££ 1km (Tooth Extraction) WU 605 ikmffli (Exodontics) Ii1**$££ A'r>7yi (Hashish) (£7x7tX^$££ &1W (Estrus) SF 105 %Himm (Estrous Cycle) li^'|f$££ y^WfcJV^y^^-ifc (Estrogen Receptors) lixx F37 ygmfcZfix yUfe (Exanthema) WR 220 mmmco sf 901 l&^77X (Typhus, Epidemic Louse-Borne) WC 605 -610 5%mm (Endemic Typhus) liit|}L*14X S^?ef£77X $££ WP (Phonation) WV 501 %Xm (Embryology) QS 604-681 A£ • ItFJrii QS 622 m^ SF 767.5 %%k QS 604 ftfAW WP 150 MlfelYfft QS 642 KXK WQ 235^ ; m&M WQ 235$ fc££ Wmm QL 951-991 mamn\m^x<7>^% y t-y y xii^SiHiiz |5g^'l4ofcOI£^1i^i|(z 7AXm^Y 4 y9Y U - (Embryologists, Directories) Ii ftXmcoycokt, • ftpJfii QS 622$££ %XW¥ (Pathogenesis of Disease) I£*?|5t.$££ 722 '^•>7t H^DHI* (Voice Training) WV 500 £j*P»W (Voice Disorders) WV 500 4>H14'7) WM 475 RXXtyim (Developmental Biology) QH 491 '&&m QH 453 £1 (Development) (£#%W : !/Em%it i i&l* ; Kl« 1; n^ffi^W ; Afeo?gii : 14-t>aw^ii$££ 5|jt14*l5t*£ (Dyslexia. Developmental) (£7,iU*,K$£ £ ^jittMilPflS(Reading Disability. Developmental) Ii &l5£*JE$££ ^°y77XF (Patch Tests) QY 260 ^yA-y9ycom (Hutchinson's Teeth) (ift^fF.+fc^ JL£ %*flf (Power Plants) TJ 164 #&fc*£*Sc7)7-Kfc3i']r± WA 440-495 ^JHi£±[l (Developing Countries) &{$ HC 59.6g.5g.72 zatrnx WA 3g5 -?-iOftb,o^-*F t-y yxii, 7HSIJIZ %|ft (Fever) WB 152 W»H(i}t&ffi14ifl*iai QV 95$££ fe«Wfi]ffl(£^f^iaii WB 469#$££ W>m% (Pyrogens) msWMiz*hfylWb LT WB 152 ft$*F tyyxii, ±fi£iJ'z %.mmm (Fever Therapy) Iiil5f4&£$£i %*S«ltPS (Disease Frequency Surveys) (i$f®P2 SF^$££ %mm (Morbidity) WAgOO iS^iS (Incidence Studies) Ii3 7-FflF3S$££ mmm (Vesication) li7K*S$££ mmm (Vesicants) (£!«*$££ tt€ (Epoilation) l£!ft^$££ mmmtltfi^m (Audiometry, Speech) WV 272 /s— F*7xT (Hardware, Computer) linyb'a-^ ££ ifeWlsl&m (Kymography) .C>li^|z^lt-?> WG141.5.K9 XmWi&myX WV 312 #*H? (Common Cold) WG510 '<7x7A (Vanadium) JfcMHb^ QD 181. V2 itUf QU 130.5 mmm qv 2go #jfiL (Nose Bleed) (£#aiJfll$££ ^'77 (Banana) UmMZflX WcomW£$k (Nasal Provocation Tests) &Tyjv¥-co&wizmm$ti&m&u wv 335 #7'J-7 (Nasal Polyps) WV 300 ><-*y (Bunion) (iy4JxI*Slh$£i ><-»/9 (Panic) WM 172 ,<=.*, ?%ft (Panic Attacks) liM14P#W$££ '<——.yyJL.Ur>i\3to (Fluoride Varnishes) (i/ejpJrffl^ -?ISfcli (Decay, Dental) liSilfife$£i HiOO^aZ (Tooth Abnormalities) WU 101.5 ftWttSI (Odontometry) WU 141.5.02 *OSift-9JB'Ji£ (Dental High Speed Technic) WU 25 *<7>#1£ (Tooth Replantation) WU 640 mX&%)) (Tooth Movement, Minor) WU 400 m<7>UB (Tooth Luxation) WU 158 mtOit^W (Dental Deposits) WU 250 ftWgrtg (Tooth Mobility) WU 102 #£H*JE WU 400 mmrnm wu 240 ft^e#f (Dental White Spots) iig£f£$££ m<7>W&ta (Tooth Fractures) WU 158 ><9 y^X%$$k%Zm (Radiography, Panoramic) WN 230 n (Mothers) HQ 75g-75g.5 m*Y \zv9Xit, 4JSJ5IJIZ '<'*A y (Papain) QU 136 mmitm (Mothers, Surrogate) (£ftjl^$££ ®m<7>ifcm. (Maternity Leave) l£aiiiiWfx$££ UUtz^mmiY (Floppy Mitral Valve) (i1fffl#&B£$ ££ '<'*9 xfMPappataci Fever) (£7x7 3 7> (Habilitation) l£ij^t*ij 7-x a X$ ££ /»"t3-v7 4/l/X (Papillomavirus) QW 165.5.P2 ^-7 (Herbs) QV 767 a-77<- (Herbal Teas) (£fi);*4$££ /s7° F 73 tx (Haptoglobins) WH 400 B&Jft&S QY 455 '7-7A (Hafnium) feftllx^ QD 181. H5 ^11^: QV 290 AX/7ffi (Babesiosis) SF 791 '<^vxm (Papovaviridae) QW 165.5.P2 "-?9y7 (Anopheles) QX 515 ftlft§ (Tooth Cleaning) (£7*7 y x X 7'S$££ mmm (Dentifrices) WU 113 '^t^yrt-fe' (Haem Oxygenase) U^A^fc^yY 7—1$££ /NAxy— (Hamsters) %®®V>]blX QY 60.R6 7$ (Speed) l£3ol#ift ; !FHTf&$££ *<7T i. 9&WM (para-Aminohippuric Acid) l£P-7 s y.ims£$££ fev> fc fc* LitteJUfSlffe (Insurance, Health, Reimbursement) W 100-275 ^°74X7/l/XX-7 (Parainfluenza) WC 518 /^y/f x 7/1/^x7*7 4 /l/X (Parainfluenza Viruses) QW 168.5.P2 > 7/1/^x7*7 4 JVX $££ ^°77*xyiJ7-"V (Paraganglioma) QZ 380 vmawii numtmiz a7/7 (Pellagra) WD 126 ><7&ttAR (Paratuberculosis) SF 809.J6 / (para-Dihydroxybenzenes) l£t F odf-y x$££ ><7 9AT (Paranoia) £*J141# ttl** $ £ £ '<7/>fTtt«tt« (Paranoid Psychoses) liS&teflttt PfW$££ >"?7t4" —-t (Parabiosis) %.&m QW 504 »»tt£]fc QS 675 ArnmcoWftY \z-y9XU, ±JSJgiJlz ^7 7^ (Paraffin) QV 800 J£*ttf4 WO 640 y*y \ * 9 yAJVXW&fe. (Paramyxovirus Infections) WC 518-520 mmm sf sog.P37 mm WC 580 $ fc £ £ '•*yAr4 7JV (Paramedics) UmmmSlim^ifit ^'7 X Y4 7 JVX 9 -y 7 (Paramedical Personnel) liftfS IH2f**#$£i ^°7%*3E73 7*>J XjfiL*£ (Paraimmunoglobulinemias) it H&g&JfJL-£$££ 'J7A (Barium) QV 618 mmmizisith'A%mblt wn 160 ^'J7-X (Hurricanes) §**&*$££ y<)VXfc*y9-9 (Pulse Oximetry) UWi%Wji.^flX '■zjvxmtUftm (Pulse Radiolysis) QD 643.P84 >^3— g]ji (Echocardiography, Doppler Pulsed) WG141.5.E2 y* Y^)yU (Bartholin's Glands) WP 200 '< jv\iy ivmrnmrn^fix y7!/77 4/l/X^i££E (Parvovirus Infections) U'*>vfc 7 4/i/Xf4®ife^$£i 724 >\yf-> Y A/l/774 JVXW, (Parvovirus) QW 165.5.P3 ^/U~7XS£ (Palmitic Acids) QU 90 M®itm QD 305.A2 ^7l/-Xt£3SS (Balloon Dilatation) WB 365 4>KJfiL^£*£&lz4;ttl> WC, 166.5. B2 %(r>tiL<7om&u, m&mz /OV-yJY (Balloon Valvotomy) li'<)V — X fc y\z.y 9m (Pumping, Intra-Aortic Balloon) itk:W)W^^ < >v - X fc X t x 7*£$ £ £ gig (Lacerations) litiJ^fcl-lfi ; #(rfc£4*fffi$££ 5SS (Rupture) QZ 55 RBHrttWfcOliSCfiSiJ'z ' (Halothane) QV 81 /nd^iJ Y-JV (Haloperidol) QV 77.9 '*y 9 X77 i y'ytMYX (Pancreozymin Receptors) (£3 XxxF*-x^f*$££ '77D7 YOMfom (Bancroftian Elephantiasis) (£7 4 7lJ7'l4mJi*N$££ XH-W (Semilunar Bone) WE 830 XHttfrft (Semilunar Cartilages) WE 870 KYjx (Hostility) BF575.H6 i'r4»l WS 462 ¥t!£»lfc'M£W WS 105.5. E5 7-'n-fiSc7y 7X (Semisynthetic Vaccines) it^^.7 9 7 X$££ >fci0ligfHi«'Jlz ilLW (Crime) IIV 6251-7220.5 m^^m^mxuA:coWM^iiz, mx.umst^m'W WL 355 Jx$l#f* (Ruminants) QL 737.U5 mm sf gg7.5.U5 Xmm SF 768.2.R8 Jx$IM*<7)l (Stomach, Ruminant) QL 862 m& SF 851 Jx$,m (Ruminantia) liJx$iM*$££ ifl.14 lfc9 v9 X'|4tt./vl?B (Myoclonic Jerking, Massive) (i¥ll£m>ttX$£i '7-ty^ (Hansen's Disease) li*H$££ *4||J# (Plaster, Adhesive) (££<£$££ ^fflijmff^li (Hemianopsia) WW 276 X\Umn (Hemiplegia) WL 346 mz\&mmm $££ ^y 97 A JVX (Hantavirus) QW 168.5. B9 4W (Judgment) BF 447 zvjimbyj'jtm ws 105.5.D2 ^y 9-y 7 A JVX (Hantaan Virus) QW 168.5.Bg 'N°X77— F*xX7A(Punched-Card Systems) Z 6g5. g2 m*Y t-y yx|£, ±HSi|(Z A>f >- F ym (Huntington Chorea) l£Huntington*p?$ 725 /^XT-** ££ jllitli&fi-ffcW (General Adaptation Syndrome) QZ 160 #.£##«*£ (Epiphyses, Stippled) li.£#c#-#^'£#t'f &$££ fft&m (Mai de Pinto) U\z°y9iflX 'i (Pantothenic Acid) QU 195 a> F*7''y y^i (Handbooks) ?y£i?3l$££ 'i£ (Hyaline Membrane Disease) WS 410 t7/l/3X^ (Hyaluronic Acid) QU 83 \zTy\z°i-- (Peer Review) (NLM4HI^TI£#^ WY 16$l&^3;#^-21) %-AfcyYLWMU (Radiation, Non-Ionizing) ~\zXhmm WD 605 f^WWJffl WB 288 -mmmmm wb 117 -t/kwxmmm qt 162.U4 &mtftmm wb 48o myz3tfi)izmmzti&%&u, xmm #44 yitmmnw£Ymco t,&$ fc £ 1, mmm WB 117^ 4Y-mYY?kA y9-ymtm (Internship, Nonmedical) mm WY 18.5 mm qv 20 A:cofa(yo5tmtXMizXZi #1111l/-/7y FflB£&l (Residency, Nonmedical) it immih Ay9-y mmm $ £ £ Wmmmmx9-yycom& (Medical Staff Privileges, Nonphysician) itmmx 9 y 7 7>4$tli$££ &mm. (Rhinopharynx) li£pgsl$£i 4YA x->* ij ytfLftmt$Jfcm (NIDDM) it A xxo x#ffi #S^m*^$££ #DB5I (Nasopharynx) WV 410 Bfn&lzioltl, WF 490 &mMm& (Nasopharyngeal Diseases) WV 410 #DSsI®*l (Nasopharyngeal Neoplasms) WV 410 t7x7 (Biureas) MMim QD 315 ft^mmifc (Nonprofit Organizations) li#F4X&ilfi$i$IE, £ #MX7/l/JJIW^(Fatty Acids, Nonesterified) QU 90 #£ (Rhinitis) WV 335 mmm sf 89i \zfc 9 9 — 7A7— 'J 7A (Pyoctanium aureum) !£/< X y*7xy44 7'A$££ t7Xx7^X (Hyoscyamine) (£7F3tX$££ t7XxX (Hyoscine) (iX37°y~x$££ t*77x (Biotin) QU 195 4Efc\zfcA Ymmm (Nonopioid Analgesics) Ii3|-*BW4 ilffi^$££ 14 7°7 'J X (Biopterin) 7°7'J yybtx QU 188 itSMfc LT QU 107 t7777X4 F (Bioflavonoids) QU 220 mm (Rhinology) I£^#pB^4^$££ ^m (Esthetics) BH JFMt4*4 WO 600 &W. WO 660 &14 HQ 1219-1220 tiMm&\m (Anatomy, Comparative) WA^ooh- QL 801-950.9 kfilbmm QS 124 it$&bmm (Psychology, Comparative) IM* (±fcLT) QL 751 A EH BF 660-685 l\MXmm (Physiology, Comparative) QT 4 m^coh* SF 768-768.2 mxmmcofr QP 33 mnm.m (Histology, Comparative) QS 504 Wfa?i- QL 807 WMMmm (Comparative Pathology) (i*Rffi^$£i ik^Xlb (Cross-Cultural Comparison) ^|g^l$££ i\MX\\M% (Transcultural Studies) t£J:b^Xft$££ lYM^MWk (Controlled Clinical Trials) mm QV 771 Arcofaco § muxmft\izt> h ^im%mynh & ^ux% (z£|> MM&?*: (East Coast Fever) it 9 A y 'J 7*£$££ 726 tyxA fcTftUafe^^t** (Subcutaneous Tissue, Medication) (iJ£T)±3'f$££ 4Ym%ik$hV>l (Animals. Nondomestic) Iifr7£jj!t*$£ £ & 7)41(4/ (Injections, Subcutaneous) WB 354 &T44A (Hypodermoclysis) li#illR)4.A ; f£ffl£ftl> mm t tziim&n * ft $ £ x „ mi u^itx f u 7 a •feTtt* (Hypodermic Medication) (i#*&P£4.A : fcX itW$£i * (Light) £!§s^l$££ )t^-S14PfW (Photosensitivity Disorders) WR160 *;ft@ (Light Coagulation) WW 166 &%.®&u, xm^uz ft$'#f4 (Photoreceptors) WL 102.9 itX^m (Photobiology) (i*$££ ^MlnS 0 7-^7 (Rheumatism, Peri-Extra- Articular) Ii'J 7 -^ 714 £ H148&JS $ £ i h^tfx/u (Bufonidae) QL 668.E227 HS*iJm>fcLT QY 60.A6 t*7^>vm (Bufo) (£t*7*x;uf4$££ t*7*x;ufc^x;u (Toads and Frogs) li*$JI!g$£i #*£fl&tt7WUdr*-tt#?fe (Rhinitis, Allergic, Nonseasonal) UZXiXT U^H**?* $££ WmtXM (Hypersplenism) WH 600 SJffti&^lfci* (Battered Child Syndrome) WA 320 t*77-K (Biguanides) QU 61 Mmm QD 305.A8 #!& (Nasal Cavity) WV 301 #J£l*!lx4 (Administration, Intranasal) WB 342 t??iJX (Bicuculline) QV 103 \i9 9yxM- (Pyknolepsy) UkWXLfrL^flX tyy-F (Picrates) QV 223 \z9 iJ ym (Picric Acid) (£tyy-F$££ \z9 3 F * y X (Picrotoxin) QV 103 4Y-9 nl*W&'&-'<7 7'y 9 'J fc — -v (Paraganglioma, Nonchromaffin) (iHmr4^77*xy >J 7-^$££ 4Y9uL,mMit,'*77-yy^)fcy (Paraganglia, Nonchromaffin) WL 600 4Y-9 "aA^fl]'f4ffttggl5 (Paraganglia, Nonchromaffin) WL 600 4Y9 3A$ftl14f§tti£gi5lii (Paraganglioma, Nonchromaffin) QZ 380 KSrl4Wfc<0(i£|HiJ3i]|z t7D7A (Picloram) £%:ffiX WA 240 tr (Beard) (i€$££ #iO*i (Parenteral Nutrition) WB 410 #N£P**S (Nutrition, Total Parenteral) (i#M&P£ 5&*$££ #£lP;tj7 3 ij -$m:&m (Hyperalimentation, Parenteral) (£#N&P £-*:#$££ *SPtt#FA*B 7 4/l/XfF^ (Hepatitis, Viral, Non- A, Non-B, Parenterally-Transmitted) (iCSfF^$ ££ #i£P£5£# (Parenteral Nutrition, Total) WB 410 #N&P£A (Infusions, Parenteral) WB 354 9JVzi-x WB 354 &M.m WB 354 ^ft7F'J7A WB354^$fc££ 4YM.\ I(i'7£*ffll*ft (Nutrition, Parenteral) (i#^P^# $££ 4YmvmMim (Drug Abuse, Parenteral) UUBXmr& SLffl$££ flJfM'fflT (Rhinoplasty) WV 312 4H5M7t 7477A (Total Parenteral Nutrition) (i#*£ P7*#$££ 4Y- n ,l£ftj 3ii — 7 — xgx (Nonverbal Communication) 3y?P&'3l$££ ft*P> (Turbinates) WV 301 *<*'ft*iif. (Rhinoscleroma) WV 300 Wtfflll (Aircraft) ^3/V*'JI$££ flltrtt'ftfflC (Air Travel, Accidents) (i#L'S¥i!&$£i HtftK*^ (Pityriasis) WR 204 -&(£&14»l4-£'& WI 210$££ 4t£mt£®tM (Social Control, Informal) HM 291 rgt&wa^, f?ijx(£y7- gn 493-495.2 *$5*F t"7 7Xli, P.MSiJlz ^^^^^^-^-(Drug Administration, Intranasal) li# fl£l*)&-'4$£i »# (Fibula) WE 870 ## (Nasal Bone) WV 301 £6# (Coccyx) WE 725 H#as (Coccygeal Region) Ii1lll^#gf5$££ M.'uXm (Caudal Anesthesia) li*I)Jl74M$£i K«ffl#ll^7-tX (Employee Health Services) liflS Hm4l7-t*X$£i WMmHWlffiM-tii (Employee Performance Appraisal) mm k^ WX 159 mm wy 30 mwmm wm 30 mmm^X Y7A* (Employee Strikes) l£X F 7 4 * $ ££ fSflEffl^c^lt (Employee Grievances) *?||S* WX 159 mm WY 30 fjf^g^ WM 30 ftfc<7)^-ff(£±MSiJlz t3;p77 4/l/Xf4 (Picornaviridae) QW 168.5.P4 \lojVt7 A ivxmW'kX. (Picornaviridae Infections) WC 501 t3;w7 7 4/i/Xi^ife*E (Picornavirus Infections) (£t 3 jvy 7 A jv x Y-Y®<£X $ £ £ H£ (Knee) WE 870 lfo.$1**£ WE 870 RffiiJHK WG5g5.P6; llf^i* WG 625.P6 $fc££ MflKllfl (Brain Dysfunction, Minimal) (£}SfJjj©iiJl4 &MM ipPft$££ t'7~X (Visammin) (£7iJX$££ M (Elbow) WE 820 Mfflffi (Elbow Joint) WE 820 &JJIJ? (Skinfold Thickness) ykm>kmfc WD 105 BE»BJr WD 210 #lf^*fej£ (Nondirective Therapy) WM420.5.N8 tx-7k (Vichy Water) (£££*$££ 727 tx-tM 9 # *14#7 (Nonodontogenic Cysts) WU 280 fcflgll* (Sebaceous Glands) WR 410 mik\%.mm (Sebaceous Gland Neoplasms) WR 410 |£K (Cortex) 'iSUIr&K ; %%M \ 'NB&K : *8a& ff : ¥r«&K ; «i»£R : tt-1±*n1£j£K : mtfc%*fl £ #*£& (Nose Diseases) WV 300-335 *81£ WY 300 IVJtmbWJtm WV 300-335 #H WY 158.5 mmm sf sgi SKffilft (Corticospinal Tracts) (£££f£i&$££ tx4X (Business) (£i&H$££ fcmmm (Sebaceous Cyst) (£^&I§II&$££ t-xX —xX (Byssinosis) WF 654 tx'<—JV (Picibanil) ijimmmbtx qv 26g #4L£ftAft (Dyssocial Behavior) (£Jx4±-£(ftAftPf * $££ Wm (Splenomegaly) WH 600 ISffttt&^ttliflRV-x-i-v-rffi WC 715$££ 4YW&&U, (Organizations, Nonprofit) WA 1# (NLNHMB^Tli^*^1) &Attfa.WMm (Nasal Decongestants) l±#JteB£jfiLffiHs'h H$££ ft to "5 € (Microvilli) QH 601 i£.%m%\\m (Anatomy, Artistic) NC 760-783.8 Hfflltt (Museums) mWl N 405-4040 mi AM mmoo Q105 A^JflL (Epistaxis) WV 320 AISJK (Nose Neoplasms) WV 300 UttS (Caudate Nucleus) WL 307 »'h*ff (Microtubules) QH 603.M44 ^'h^4t|a]gS© (Microtubule-Associated Proteins) QU 55 ft wb 495 m?vm4iz^ltl) WO 198 UXmmntnm (Hyperkinetic Syndrome) WS 340 BScAW WL 354 mmm. (Splenic Vein) WI 720 f&'WK^Mtt (Permeability, Microvascular) \i.%WMk ff^iai4$£i itfe^-tff (Colorimetry) QD 113 ES^S^ QY 90 #*i47£/tli£ (Drugs, Non-Prescription) QV 772 fcm (Eruption, Skin) tt%,& ; £%14*l*£$££ txX (Vidine) (£3 ij x$££ *fSH14#Sffi (Noninvasive Litholapaxy) fitf4i'j*fr$ ££ t*X (y ddX 7/1/) x-7/u (Bis (Chloromethyl) Ether) m&Vn'g.bLX QZ 202 t X y t 'J 7 ^ X (Histapyridamine) (£7x-7iX$£ £ txy 5 7-7*(Histaminase) UT i yfc*y9--V(m $M) $££ t X 9 5. X (Histamine) QV 157 44t¥ QU 61 txy = y$HYnM (Histamine Antagonists) QV 157 txy = X*££-lHtf± (Histamine Binding Sites) lit X9 $>«#$££ txy^X^^ft: (Receptors, Histamine) QV 157 txy $ ym^femmm Qvi57$fc££ txy ^ x;fcfctf} (Histamine Liberation) 7774 7*x-fc&$C*£tZ;klt.& QW 900 *#5*F t-yyx(£, ±^iJ(Z txy ^ Xjggt (Histamine Liberation) 777>f 7=rx-fc$$fc*Elz£ott6 QW g00 m*Y \z-y9XU, XMftliZ txy ^ yHlitiKm (Histamine HI Antagonists) QV 157 txy ^ >m&&ttt£tnM (Histamine HI Receptor Antagonists) (£ t X 9 z X H IjtijXm $ £ £ txy i >Hlg$ft*aBHBfi£ (Histamine HI Receptor Blockaders) l£ t X9 $ xHlj£ltl£$££ txy i yH2$atjXm (Histamine H2 Antagonists) QV 157 txy = XH2$^4£ (Receptors, Histamine H2) QV 157 txy ^ xH2^*#ft4£#tlg (Histamine H2 Receptor Antagonists) l£ tX 9 $ xH2l^lt^$££ txy ^ yH2^^WMMm (Histamine H2 Receptor Blockaders) (£ t X 9 I x H24£Jtl£ $ £ £ tX7xx (Histidine) QU 60 tXr'J- (Hysteria) WM 173-173.7 tXr'J-Jfc (Globus Hystericus) l£fc&P$W$££ tX7'J-Aft (Personality, Hysterical) li)f!ft14Aft PfW$££ t X 7 U -14 Aft- (Hysterical Personality) liiSftttAft PfW$££ tX7lJ-14Aft^'t (Personality Disorder, Histrionic) (£Jlt4i14AftP$W$££ t X 7 "J -tttt&SE (Hysterical Neuroses) Ii t X 7 U - $££ tXr 'J -ttSI (Dumbness, Hysteric) (i&t$E$££ 4Y-Xy-vA YJfctJifc&m (Anti-Inflammatory Agents, Non-Steroidal) QV 95 #^X7 3 4 F'^l/i'J 7^7H (Anti-Rheumatic Agents, Non-Steroidal) U4¥Xy-aA K&#L&^l£$£cfc 4\.7tuA YM^'&m (Non-Steroidal Anti- Inflammatory Agents) l£#X7 3 4 F*3M/LifcSE^$£ £ IFX7 3 4 YlkW&m (Abortifacient Agents, Non- Steroidal) QV 175 t X F 7 7 X -y& (Histoplasmosis) WC 465 728 t9 i> hXF*7x*jH (Histomoniasis) lili;t&@&*iH$ ££ tx F y (Histones) QU 56 t*X77 4/l/X(Visna Virus) lih'Xf-vxfy 7 A >V X$££ fXf-vxfy 74 JV X( Visna-Maedi Virus). QW 166 mfcfcb LXcoArtUt, A:%frcoxizhz>mxmm* hfix, muto QW65-,mmm qw,7A>vx m QW 160?)t # {a^^ftS (Microbiological Techniques) QW 25 85:41*3 7 77--t* (Microbial Collagenase) QU 136 mX'fymftm^iifc.y-X Y (Microbial Sensitivity Tests) QW 25.5.M6 WXfyimftl&^ifc.ftWm (Drug Sensitivity Assay, Microbial) lif&44*BI$iJ^147X F $££ '@.XtyimVa1tii£ (Drug Resistance, Microbial) QW 52 mv»mmiztsit& wb 330 ftZXtyjcottlU, Azcoxmz &x.mmzttt&A:tiu, A:commz 4\l4z9"7 (Harassment, Non-Sexual) (ith^WlfH]$ ££ y-^f^ (Mange, Sarcoptic) (i#F2g$££ t-fc*X 7- (Sarcoptes scabiei) QX 475 h-b*xy-^4 (Sarcoptidae) !£7-; t-t?x7-$££ 4mntfimmmm (Home Care, Non-Professional) (£|E *€#lf$££ y-S (Arsenic) QV 2g4 #*I (Glanders) WC 330 mmm sf 796 WU (Spleen) WH 600 JfiL$1£& WH 600 mm&tt (Tuberculosis, Splenic) WH 600 &f tfrffc (Skin Tests) QY 260 WB.m.% (Splenic Diseases) WH 600 mmmm (Splenic Neoplasms) WH 600 Mmifom (Splenic Rupture) WH 600 U%M (Arsenicals) QU 143 Cl7X-^-mfcLT QV 255 tmmmbLx qv 262 177 7 x X (Pizotifen) (i 177 'J X $ £ £ t°y*7iJ X (Pizotyline) to Y-y^iimbLX QV 126 HE A (Hypertrophy) QZ 190 X&M&Kk WP 470 ; *I*]J1EA WU 240 ; -DM k WG 210 ; (£*§14^& WG 280 ; m^mi k WJ 752$fc££ W.ks>kWrbfflFZmx. (Nephelometry and Turbidimetry) '>W\\m QD 79.P46 ^^W}Wmmizm\l^tlh^ftU, AzCOW^X XlYL'XW&tkWLm (Muscle Relaxants, Non- Depolarizing) imw&4nYL'>TW.m $ £ £ ¥9 5y (Vitamins) QU 160-220 34Jf QU 160 £1.1. QY 350 IM*'£* SF gs.vs §mxmm m^ SF 768-768.2 ffXmWl QP 771-772 8£)§14iO QU 165-181 my>lf£5T QK 8g8.V5 7YBO.C0 QU 185-210 W%¥9 = xw£*4$fc£i h7 i >X2*S (Avitaminosis) WD 105-155 mm^mmm-^. qz iog mmm sf 855.vss ftx.co¥9 5 x^5.*m£$fc££ ¥9 5 X7cl4£4*j^£(Megavitamin Therapy) UAfrX^ xmmzfix t y ^ x A (Vitamin A) QU 167 ¥9 5. /AX2i (Vitamin A Deficiency) WD 110 mmm sf 855.vss t*y i y AWl (Vitamin A Acid) (£ F X7y 4 X$££ t7 = yBX£i (Vitamin B Deficiency) WD 120- 126 ¥9 5 xB*SfM4 (Vitamin B Complex) QU 187 195 &%co¥9 a xo£fa$fc££ ty~XBT (Vitamin BT) (£7^-7x$££ ty iXBl (Vitamin Bl) l£77^X$££ ¥9 1 yBlk£.& (Thiamine Deficiency) WD 122 mmm sf 855.vss t*y = XB2 (Vitamin B2) l£'J77 7t*X$££ t y ~ X B6 (Vitamin B6) Ii t 0 F* * x X $ £ £ ¥9 5 XB6ft£*£ (Pyridoxine Deficiency) WD 120 ¥9 5 XB12 (Vitamin B12) QU 194 ¥95 yBUkZM(Vitamin B12 Deficiency) WD 120 ty^xC (Vitamin C) UTX aIV t*X6£$££ t*y ^ yCk£M(Ascorbic Acid Deficiency) WD 140 t*y i XD (Vitamin D) QU 173 ¥9 5 >D^££ (Vitamin D Deficiency) WD 145 ¥9 5 XD2 (Vitamin D2) I£x;u77/l/x7 x n-;u$£ £ ¥9 5 XD3(Vitamin D3) (£3 x7/l/x7x n-;u$££ t*y i XE (Vitamin E) QU 179 ¥9 5 >EX2*£ (Vitamin E Deficiency) WD 150 ty^xG (Vitamin G) l£'J 77 7 t*X $££ 729 t9 i> t?~xH (Vitamin H) (£t77x$££ ¥9 5 XK (Vitamin K) QU 181 ¥9 5 XKX£iE (Vitamin K Deficiency) WD 155 ¥9 ;>K1 (Vitamin Kl) (£7^ F7x7X$££ ty = xM (Vitamin M) l£H&$££ ¥9 5y Pm>i¥ (Vitamin P Complex) (£ t fc7 y fc9 A F*$££ t*y~XPP (Vitamin PP) l£-3 7 x@£7 ^ K $££ ¥9~y¥y (Vidarabine) QU 57 tt7AJVXmb LT QV 268.5 ^M (Grief) BF 575.G7 nxm ws 462 Zl'JtmbZh'Jim WS 105.5. E5 t7x F A X (Hydantoins) QV 85 4¥m& (Illegitimacy) HQ 998-ggg WX WS 462^ 'Jtm&mm WS 105.5. A8 ®am± wa 310 xm W 791 i£mfc^|iH¥> WS 105.5. F2 §"4PI (Nasal Septum) WV 320 iHfl§i±A (Parenteral Infusions) (£#N^n}4A$££ fafemife (Right to Treatment) (£.f.74X)t#fiJS|li$££ ¥-y 9t-JV7'JV (Monkey, Pig-Tailed) (£4 -x ij 77* ^$££ t7x (Sheep) mgco SF 371-379 ^|J=^ SF 767.S5 Xmm SF 768.2.S5 ffXco QL 737.U53 17 y 7 9 JV&. 7 A JV X (Ovine Catarrhal Fever Virus) ity'JV—9 xy*7 4/l/X$££ t7xJH&14&Jfi& (Dermatitis, Contagious Pustular) (£!§ife'l4H*$££ h-yycomA (Sheep Diseases) SF 968-g6g £'i7i/St (Amino Acids, Essential) QU 60 'Zmmmm. (Fatty Acids, Essential) QU go MmmMYaM (Integral Membrane Proteins) itmSYaM $££ 313ft')&£ (Tensile Strength) XVvVvmm QT 34 # WE 103 HbmJK (Hoof and Claw) QL 942 m'S SF 761-768 ■&WUW (Certificate of Need) nmmmm^ wx 157 llli«f«®ft@|l5jl WA 541 Azcofacommmt, xmmz ftxmmimwmm (Mastectomy, Modified Radical) WP 910 4Yx.m 5 ="<9 t iJ T!&I£1X (Mycobacterium Infections, Atypical) WC 302 #£14# (Homeless Persons) HV 4480-4630 wmy ¥-y9xu±MMiz, miu4¥x.&%coMmrm U WA 300-305 t7'47-A (Video Games) (£M$££ ¥Yfc*m (Tape Recording, Video) liVTR$££ ¥Yfc\hm (Videotherapy) mwmmiztsith wm 450.5.vs ¥YfcT4 xy&p| (Videodisc Recording) TK 6685 ~^MfcZ7 9a?&v%ftWLMftmMTimm^ 18.2) ^iyimmuxmmiz t*7'777 xy°y-%ti^ (Video Display Terminals) Ii *£*«$££ Wlfa&ffi (Splenectomy) WH 600 4¥mmn.mmtB (Electromagnetic Radiation, Non- Ionizing) u4YAfcy itmm $ £ £ (ftiJjJR (Splenic Artery) WG 5g5.S7 wmcoycoshmmifc wH6oo$fc££ t F fA (Hominidae) GN 51-289 tF74tX& (Itch Mites) (i t-tX 7-=-$££ tF^Uj"!* (Hominids) (£tF*4$££ #M#^%*£ (Immunity, Non-Specific) l£ §£$&*£$££ t F X y X 2ijXW. (Human Class II Antigens) liHLA- D4tl£$££ tF7*XA (Genome, Human) QH 447 t Fi^AllE (Uncinariasis, Human) li7X 'J7§fc)&*j!$ ££ t F 3 77 X 7 (Dromedary) l£ y 9 7$ £ £ t Fm%\XmmmfcJV^y (Gonadotropins, Chorionic, Human) UWX:i£m%mMfcJV*: X$££ t Y®,X;mmimmkfcJV*> (Chorionic Somatomammotropin, Human) l£!6vxffl&%m (Human Immunodeficiency Virus-Associated Nephropathy) lix4XM?NE$£i h F f&5cX$:7 A JVX 1 S (Human Immunodeficiency Virus Type 1) l£HIV-l$££ t F %MX5;7 A JVX 2 3H (Human Immunodeficiency Virus Type 2) liHIV2$££ hFARDS (ARDS, Human) lif£AS^^^i&&1^#$ ££ bFIatHltlg (la-Like Antigens, Human) (iHLA-Df/L !K$££ b FT'J X^°5fc$?147 4/l/X 4S (Human T- Lymphotropic Virus Type IV) (iHIV-2$££ hFTffl)l&7 4/l'XHIS (HTLV-III) (£HIV$££ h FTfflB(2SJfiL*^7 4 >vx (Leukemia Viruses, Human T-Cell) (i HTLV-BLV 7 4/i/X$££ tYTmmYtSkm7AJVX\m (Human T-Cell Leukemia Virus I) (£HTLY-I$££ b F T«FUfiL*?I ij ym7 A >v X (Human T-Cell Leukemia-Lymphoma Viruses) liHTLV-BLV7 4 JV X$££ b FTfflJfe'J x^N^*f147 4/i/X 3S (Human T-Cell Lymphotropic Virus Type III) (£HIV$££ b F T iJ X^Sfcfl447 4 JV X3S4tf£.rSifefiE (T- Lymphotropic Virus Type III Infections, Human) !iHIV.g&*£$££ b F T 'J ymWi£7A /t/X3Sl£f£ (T-Lymphotropic Virus Type III Antibodies, Human) !£HIVJtf£$£ £ b F74/l/Xl4flt'£ (Hepatitis, Viral, Human) WC 536 b F* y y x (Hydrazines) fii>°-*xy x^fc LT QV 80 xtm QU 60 Mmm mWimt&'Y'Jl QD 305.A8 mmmmm qz 202 7±-jv¥ Y'yyy QD 341.A8#$fc££ b Y 7 y y X (Hydralazine) QV 150 Ot/f ; y it&tyj (Hydroxyimino Compounds) (i 7*xA$££ bF*3dfxx^377Fyxx^ (Hydroxyeicosatetraenoic Acids) QU go b F*3dri/x7;u» (Hydroxyethyl Starch) ftffllfojg WH 450 41b# QU 83 b F* 3 if ->x7;wi/ F x F* (Hydroxyethylrutoside) QU 220 bF's^-v^ryiJX (Hydroxyquinolines) !/L.^*«fc LT QV 250 Mmtm qd 401 tF'ndfxynoJf-x (Hydroxychloroquine) QV 256 t F* 3 if -> y n n /< x -t* X (Hydroxychlorobenzenes) (i ?3n7xy-/l/$££ t Y 3 if x 3 ;u7 n x 7 3 4 F" (Hydroxycorticosteroids) WK 755 t F* 3*-> 3^737734 KffiiEM* (Hydroxycorticosteroid Analogs) UXlkt. Y'v^-y n;u7 3 77 3 4 F*$££ t F" o ^ x 3 x 7 /l/ x 7 x n —7U (Hydroxycholecalciferols) QU 173 t F* 3 ^ vift (Hydroxy Acids) QU g8 y&wm\t&m qd 305.A2 ^#$4t^1* QD 341. A2 tF*3Jf->x734 F*7t F* 3 77-7' (Hydroxysteroid Dehydrogenases) QU 140 t F* 3 if yf 7 ^ x (Hydroxytyramine) (i F*—'* i X$ ££ tK3ifv/7Fy74y'Jx (Hydroxytetracycline) itfc *xr F7747 'J X$££ t F'3if->77y XX (Hydroxynaphthalenes) (£77 F -/W$££ t K 3 if y ¥ 9 5 X D (Hydroxyvitamins D) Ii t F* 3 if x3 X7/i/x7xn-;u$££ t F'3if->7°n ij X (Hydroxyproline) QU 60 t F'3ifxA$c (Hydroxamic Acids) QU 60 Mmtm QD305.A8 t F"3if->y7/uy/wy ij ^CoAxyyy-^* (hmg CoA Reductases) l£HMG CoAX yy 9 —b*$££ t F'3if ->/7/1/7X FX73X (Hydroxymethyltestosterone) WJ 875 t F'3if y9 Y if->7x—/i/yij yt—jv (Hydroxymethoxyphenylglycol) (£X F if x t F*3if x7x-/l/yj a-JV£%X t K 3 if->|> (Hydroxybutyrates) mwmi'i.yyY-yx wk 830 Mmtm QD 305.A2 tF*3ifx7--t (Hydroxylases) QU 140 t F'3if yjVT 5 X (Hydroxylamines) QU 61 *&mm qd i8i.ni t F* 3 if y X (Hydroquinones) yfcfemftlbLX QV 60 Mmm QD 341. P5 b F* 3 y n d 7 7 y Y (Hydrochlorothizide) QV 160 bF*33;p7X*X (Hydrocortisone) WK 755 k2M WK 760 ^PfW^UHfc LTO^^L^^^PfWlZ b F* 3 F ^ x7 x -/i/7*y y*x (Hydroxyphenylbutazone) (£7 if x7 x X7*y X*X$ ££ b F*3 7--tf (Hydrolases) QU 136 &f*J)±IH- (Injections, Intradermal) WB 354 B f*l 'J X'A (Circadian Rhythm) QT 167 |Jj!|* QT 84.6 (£>&¥ (-fe) QH 527 t—7 -y 7 (Peanuts) 731 t7xx-\» BIKIiJKB^ WB 425 'MimMW& WB 426 &«■# (Refugees) f»«KS WA 300 mw$r4£P«isi WA 305 i&m HV 640-640.5 HJRSfl (Hospital Urology Department) UmmW-W»& #$££ MJBc&f*^ (Urology) WJ X'&m WS 320-322 WM%tm& (Urologic Diseases) WJ WW WJ 141 -fe WJ 140 mkmm wj igo ?LJ/aiwt«;iew WS 320-322 i&mm wq 260 #H WY 164 \hm WJ 166 mmm sf 87i i&Bc&Kli (Urologic Neoplasms) WJ 160 WtW\iX^!t*l£^Jiffl* QV 60-65$££ Ufa WR 101 &Jf M (Skin Transplantation) WO 610 ¥y 4 XXW (Bifidobacterium) QW 125.5.A2 4Y"kMf&kXWfn (Insemination, Artificial, Human Donor) l£#KMPB1AX45«$££ t7x-MM (Biphenyl Compounds) 5l»fCfcLT QZ 202 WL&ftlb LT WA 240 Mmtm qd 341. Hg mmm qv 633 ^^FxiJ7vF— 7*X (Lupus Erythematosus, Cutaneous) WR 152 ■£J§& (Dermatitis) WR 160-190 mi WR 160 M7^(£$ill14&J*& WR 600$££ fel%& (Skin Temperature) WR 102 feJ&mm (Skin Ulcer) WR 598 feMmm (Dermatology) WR !fia WS 260 A£ • 14PJ?# WR 22 mmmmm^ wy 154.5 fel%mm%VX>:S'kX (Dermatotropic Virus Infections) lilSSfett* *«* $ £ X fe$i£Xi8&. (Vigilance, Cortical) l£1£fil$££ &jff!ft (Skin Glands) li?4#V#8l$£i *£J#BI*H (Scrofuloderma) li&)**g#i$££ &$%&&. (Pruritus) WR 282 S«fX F (Skin Tests) QY 260 &lStt\fS#?& (Electric Conductance, Skin) l£t#3.£ )SJx4S$£i feffi^Aii^t} (Skin Electric Conductance) li^flffcllf Jx4i5$££ SlSflfUxS (Electrodermal Response) li^fUfcli&fRJiS $££ fe%m (Dermal Sinus) li?§&14-^tg$££ 4Y7'Y71$.ni£&ftm%mnU (Scalded Skin Syndrome, Nonstaphylococcal) UXmO.^.&^ttB $$££ SSftx4 (Administration, Cutaneous) WB 340 SltttHf'J — xjl"V—7*JE (Leishmaniasis, Mucocutaneous) WR 350 Slttfiif 'J X'->°Hi5*jElt£l!¥ (Mucocutaneous Lymph Node Syndrome) WH 700 Sl*y>PJiilX (Skin Absorption) WR 102 fe^WLb (Skin Wrinkling) U&ftZitZflX St^yt/JPftp (Photoaging of Skin) (£&j££lt$££ &%mm (Syphilis, Cutaneous) WC 160 &#Jx4£7X F (Diagnostic Skin Tests) (£dt/»7X F $ ££ fe%m (Dermatoses) (£&Jt*?tt.$££ &Jf14JSS?'B*£.i. (Skin Appendage Diseases) WR 390-475 £jf ^ - ij 7^ (Moniliasis, Cutaneous) (i/£J*7 X x 7 ^$££ fcfcmmMm (Cutaneous Drug Administration) fi&Jt &4$££ b°7°7 F*-/i/ (Pipradol) l£ t°7°7 F*3-/U$££ b*7*iJ7^4 (Vibrionaceae) QW 141 b7*iJ7^ifeS (Vibrio Infections) WC 200 mmm sf sog.vs2 3X7 WC 262-264$ fc££ b*7'J77'fyx (Vibrio fetus) ^Campylobacter fetus$££ ^Jf 0 — x x -v—7*£ (Cutaneous Leishmaniasis) l£ 'J — x^v^.7*£$££ £lf £lt (Skin Aging) WR 102 t^y-xOX (Piperacillin) QV 354 &S3i (Castor Oil) QV 75 191 L X y 7 X (Castor Bean Lectin) (£ 0 x X $ £ £ #$^t4II*&^ (Analgesics, Non-Narcotic) QV g5 KM (Obesity) WD 210-212 HEi^lH^ (Mast Cells) QS 532.5.C7 HEiiWfflH&J 3 o - - sWM P (Colony-Stimulating Factor, Mast-Cell) (£4>y-34ifX3$££ riiW&TOW 4" (Growth Factor, Mast-Cell) (£A >9 -34^f>3$££ HEll^ (Corpulence) l£3E)l$££ U*£/U4*S£*£ (Scleroderma, Diffuse) (i£4H43£/£=GE $££ t/^14)lw5J!lfc-rE (Cerebral Selerosis, Diffuse) WI 348 IftAsHmUmmmmfc (Mastocytosis, Diffuse Cutaneous) life ^14 LA, £*£$££ t/*£/x|4iJ X^Jli (Lymphoma, Diffuse) WH 525 smmmm qz 350 1/1/I'VYXewyXifcm (Diffuse Lewy Body Disease) (i Parkinson*^$££ W& (Confidentiality) mmmmm w 705 T9 ij 7£-&H KF 8958-8959.5 ji[S^_h^ (-fe) W 700 wmmmm w 740 f#&'lf£fi (Privileged Communication) (£$■&$££ flfP1KJif£j£ (Splenoportography) WI 710 ft&l (Nostrums) QV 772 #F^£iJ£44f (Prescriptions, Non-Drug) m^xmizmfchiiCou^(nxmiz, miumrn^ WV 274 W## (Centenarian) (ift##$££ t ^ y x XJS (Juniper) QV 766 Sum (Whooping Cough) WC 340 ~SUV%W (Bordetella pertussis) QW 131 SB^fil (Bordetella Pertussis Toxins) ifSBmm ^$££ SBmmM (Pertussis Toxins) WC 340 B"Bi*£7y7x (Pertussis Vaccine) WC 340 Bmt (Sunburn) WR 160 B'J^(t±^ (Sunscreening Agents) QV 63 ■gmW (Encyclopedias) AE (NLM^H^TI£J^S:#^-13) mm Q 121 A:co%coY¥>y9XU, iJHSiJlz ^*t-^'l4#?Jr (Fractures, Ununited) WE 180 ta-v-XA (Humanism) mmimmizis it i> w 50 mm*smizis\th w 6i i&iXco B 821 JVfc-yXyX B 778 ArComcoftffizts^XU, ±HSiJtz m (Tables) (NLM^HSTI£J1^S;#^16, £/c[£LC#*tSTI£fyiJxl£ mkwmt-mm Qi9g) ^com^A-Tsl (Outpatient Clinics, Hospital) WX 205 mmm (nlm^mt(£jf^#^-27-28) mmYkmmUf^ (Nuclear Medicine Department, Hospital) WN 27-28 mm&%$n (Hospital Departments) WX 200-225 &mmmmfY7>%fo$: fc££, miummmmmn WM 27-28 mm&J---y Y (Hospital Units) WX 200-218 7/1/7773.-.y F WX 200 mm WX 200 mmW^Mit(Landscaping, Hospital) UmmW^^mX ^H$££ mmmm"fc—¥X (Nursing Service, Hospital) WY 125 ^ m WY 105 mmmmx 9 yy (Nursing Staff, Hospital) WY 125 M WY 105 mmmm^n (Hospital Nursing Service) itmmmm.7- -t*X$££ mm-fc^f3Mi& (Hospital-Patient Relations) WX 158.5 mm^m (Hospital Administration) WX 150-190 «fc LT WX 155 wnmmizmlt (nlm^h^ti£ji^#^-27-28) *^t^lzMLT -tikmm wx 159 mwmm wm 30 mm^m^i (Hospital Administrators) WX 155 mm^MMmT-— t*X (Emergency Service, Hospital) WX 215 mm&&%m (Food Service, Hospital) WX 168 mm\&£ (Societies, Hospital) WX 1 mmilU (Hospital Records) WX 173 mm%ki$m (Economics, Hospital) WX 157 mmm'A-ffiF] (Surgery Department, Hospital) WO 27-28 mmtfk&Wi (Laboratories, Hospital) WX 207 mmxm (Engineering, Hospital) (i^F'^^r'^ffl l.'7S(J H$££ mmWJtmmiZiSit& WS 27-28 mmitW.7--¥ 7 (Laundry Service, Hospital) WX 165 ^m&U.bmm^m (Hospital Organization and Administration) li*i^SM $ £ £ mU £ ft &% (Hospital Diversification) (i*^^ '£$£ £ ^*f£$.tfm$ (Central Supply, Hospital) WX 165 *PfKjI1axX7A (Hospital Communication Systems) WX 150 <£gl$ wx 185 mm$x.myXtA* (Medication Systems, Hospital) WX 179 ^Kgltftl (Libraries, Hospital) Z 675.H7 «^K#«t Z 675. P27 mm?l7tJ£ (Hospital Shops) WX 161 mmftfr^itmJS (Hospital Gift Shops) UmmftycJg*: ££ mmkmtk^. (Hospital Admission Tests) (i^fMff^ g$££ mmE.^1 (Licensure, Hospital) WX 15 mm<7>9 \)-y9Y-¥X (Hospital Laundry service) ummmwy -1* X $ £ £ mmcoWcttblitsk. (Hospital Design and Construction) WX 140 #£#ffizisith (NLM^^gT(£JF^#^-27-28) mmco&^b'Sm (Organization and Administration, Hospital) (i*?il%M$£i mm&li& y X 7 A (Hospital Distribution Systems) WX 165 *?|^7xif-txygBH (Housekeeping, Hospital) WX 165 mmi-m^m(Urology Department, Hospital) WJ 27 -28 mmmM^f^ (Medical Records Department, Hospital) WX 173 mtmmmm^ff (Physical Therapy Department, Hospital) WX 223 mm-yyx(£, XMftliZ mmffi&imfc (Hospital Auxiliaries) WX 159.5 mmfcyyy- 4T (Hospital Volunteers) WX 159.5 mnmm wm 30.5 mm wy 193 mmtitlVt • Hi4:SlU"J (Hospital Anesthesia- Resuscitation Department) UmmmftW^ZflX mmm^H^n (Anesthesia Department, Hospital) WO 27-28 mmm®&n (Pharmacy Service, Hospital) WX 179 mmm^filfiiyXyA* (Hospital Drug Distribution Systems) (£*fiP%117JixX7A$££ mmmT»)7--¥X (Hospital Pharmacy Service) itmm «OT1$££ mmmm&b&Mmmi (Equipment and Supplies, Hospital) WX 147 Wx.OO,V, 11 $ fc £ £, m X U-< -y Y wx \wm *fiKJUitiiM (Hospital Groundskeeping) li^Pxl*^ >ir.'7-S[5Ptl$£i mm7 X F* 'J - (Laundries, Hospital) UlfcM ', '^7X% -¥y9£flX mmmmmmWl (Hospital Physical Therapy Department) itmm^mmmUn $ £ £ mmmmmt (Utilization Review) WX 153 WkmmcoArtiU, 9A7°mz mmrnm (Etiology) umAcoxGommm qz 4o-iog; m xmmzz fix mmME^n (Hospital Engineering) l£*^Ki^g|3P^$£ £ mmx^ (X-Ray Service, Hospital) UmmmtB.%& H$££ HMffiff^ (Evaluation Studies) i%mmmy-¥x w 84 *<-offo<*o$m& f- t'yyxi£, mmzti&xmmiz mA (Disease) -mxmm QZ 140-190 £14M QZ 180 mmm qz 40-109 &BM14W QZ 65 m% y ¥-y 9 xuxmmd, maumm^Mcoftmm WK 140 WVfcm. (Trustees) mm WX 150 A:COifot#^ii-fet7)#^-iz, f?iji immmm^ fFli^li WB 1 mAiztsit&ifef&XP] (Contact Prevention in Illness) (ife&*i^K ;£.#»; *&*£$££ HiSrll (Beauty Culture) ffiXW^m QT 275 ftMffiXbX^m WA 744 mmmmfk wa 32 M^ftm (Cosmetic Surgery) I£JFMt4*4$££ ^*IS (Phenotype) kMikUm QH 431 AM^H GN 62.8-263 '&$mmm gn 247 ifcm GN 66.5$ fc££ mW-MM (Pathogenic Fungi) QW 180 ^J£W^lo*E (Aphasia, Expressive) (iBroca^|f*£$£ £ tfflxJjJfUt (Cost Effectiveness) li«ffl*Jjm34Jr$££ WMlh%Rm (Indicator Dilution Techniques) WG 141 735 ta-y-x-v* ffS3ifo.$S: WG 106 fe**fli£- wg 1413 : tt#M4l«lti ?£*#*«£ wg 141^$fc££ &ffl#[S« (Employee Health) I^HISMIf $££ ttBJ#f*«tettfiia (Health Benefit Plants, Employee) W 100-275 ££ (Standards) (i, SlJM$14^z*I^0#H3-ff<0£ft $££, Aztivkux^hm&, mrnbLxcom^m (7)#^-, ^jiiiitwis^iz^v^T, mm;mmmmtktt mm-.&^mtfix mWM (Standard Preparations) l£H^nao$££ H3S»[I]'J§ (Linear Regression) (£0'Jf^W$££ H*Ppp (Reference Standards) mm QV 771 SlftlS (Mimetic Muscles) (£S1®£$$££ m$m. (Bed Size, Hospital) l£*7if%^-y F4&$££ mmm (Biographical Accounts of Disease) !£*£!?£$ ££, mtUmWM^ mmm (Biographical Clinics) fiW£ A ; tttt##ftt# W,mx.<7)k££flX m&mVk (Focal Infection) WC 230 m^YJiM^ (Dilatation, Pathologic) ^Bg^l$££ m$)\tft (Ossification, Pathologic) (£^pJrl41H#$££ mmtilffi (Bulimia) WM 175 mtY)^^ (Constriction, Pathologic) ifo/gO WG 560 x~mmco WI 505 &m y t -y y x i£, ±:iisijtz mm%.lki%%. (Decalcification, Pathologic) WE 250 mtimm (Toxins, Targeted) !£&*£«$££ mfomm (Obesity, Morbid) WD 210-212 mm (Wards, Hospital) Umm&*--y F$££ ; X^ -^TJVb SlfH«T^«fft F t -y y X $ fc £ £ (House Staff) (£4xy-xfcXx7xF BH£»1* ,£ eM (Ward Administration) Umm^mtflX *^t^l7J^ (Ward Attendants) l£TOIJjf- ; mffl&M. '. IS W4#IIIJJ^$££ ^t^M'S (Ward Secretaries) I£*r^^m$££ Sfflie^- (Cost Allocation) mm W 74 ZOOttLCO Y t.y y X(£±^^iJ|z, -feft£i§^l£&r£^ ±^as^#ti:*ats ^& (Epidermis) WR 101 ^^*^M*i (Epidermophytosis) t£&*Jg$££ B&iY-lM.tiE (Epidermolysis Bullosa) WR 200 S&lftfiB^Wft- (Epidermal Growth Factor Receptors) (£EGF-7 u7'X Y o X^*##:$££ S&HI'S (Epidermal Cyst) WR 420 *fflffi2£##r (Cost-Benefit Analysis) HD 47.4 Sffl^Hj (Cost Shifting) (£tffllE^-$££ h*m (Surveys) itmmmm&; mmm&; 0»§t^ £ ; *£*M ; AzCOftWZm^XM, mi(£'«$£ £ M?£14$iJ (Surface-Active Agents) QV233 HSMr&ttftK wf 600; mmMti qc 183$ fc£i MMtJi.%. (Antigens, Surface) QW 573 M.1HW&(Radiotherapy. Surface) liiaffiJfc'IWftKiJ- $££ Slif£6« (Surface Proteins) (£K^flH$££ ^M^kf) (Surface Tension) QC 183 !*^ffi?si4!f*w wf 600; wmmam qx 233$ 4 ££ Mtt£&5C (Surface Glycoproteins) (ilH**tgr3S$l £ Mffl&ii (Surface Properties) QD 506.A1A-508 mitm wu 170 ^<7)ftkO#[fr(i3£liJ5iJtz mmmm (Surface Anesthesia) (iJ57SBJfc&$£i mmm (Pathology) QZ mi %&co WZ 112.5.P2 mkco wz 100 'DRjflL'ff^ WG 142 ESI* QY tm qz 33 mmunmmmm wu 140 $££ exmm wr 105 k% • mam qz 22 ¥L^WfcM»§ ws 200 mmmmm qz 4^ es^w qy m ^wmoo QZ 140 %ifccomz, m.%, ttz\tmzts+i>mi<7>tt£t>% x mmm% (Pathologists) ummmx)JV¥y (Bilirubin) WI 703 fammmm qy 143 t*iJ/utxjfiL^E (Bilirubinemia) UM¥ 0 iv¥X !&.-"£$£ £ t'J/UtxJJBSE (Bilirubin Encephalopathy) i£l£J£*iL$ ££ tyu (Leeches) QX 451 t# WD 420 ¥-)V (Beer) fltJ«^X(i*^*^B#y)1i^fc LT WB 444 ft^ftftr TP 577 yim^UX^ QW 85 TJV^-jvfc^m WM 274 ; xf/i,7/^-;i' QV 84 ^$fc££ ¥>v (Pills) Itmm ;|£gij$££ t/M&ifo. (Leeching) (iL^KD.$££ \z)Vya.xyivy9~m (Hirschsprung Disease) (£5fc%14 UJz&mm WI 528$££ fcT./U'VU-y (Bilharzia) (£f±ifn.ii&ikM$£i t/U/N^7f4ifiliI&A*£ (Bilharziasis) (£ftJfili1&A*E$££ ¥lV¥yWs,. (Pyruvates) QU 98 Mmitm mwmit^m QD 305.A2 t/Ut*X^7=rx7--t (Pyruvate Oxidase) QU 140 ¥JvyTJVf¥ Y (Pyruvaldehyde) QU 98 ¥jv-<- Y (Pyruvates) QU 98 Mmitm mwmitft^ QD305.A2 ¥JVtH (Hirudinea) (it/U$££ t/UXXX (Virulence) QW 730 t X X -te* t X (Pirenzepine) im'&mmbLx qv m %.% (Exhaustion) imtl ; iftli'T ; *M£|li§$£i *I^#W (Fractures, Stress) WE 180 tD#7 3— jv (Pyrocatechols) U7 tzi — /!✓$££ tn/y^tx (Pilocarpine) QV 122 to/yD-yu (Pyrogallol) QV 223 to^xTyA (Piroxicam) QV g5 £*&Sffli«K (Agoraphobia) WM 178 ¥vy°yX-ym (Piroplasmosis) (£'<-< x7fiE$££ t o 7 X 7 r y --tf (Pyrophosphatases) QU 136 to ij y x (Pyrrolidines) mmrnmb lt qv 269 Mmitm qd 401 to i) /L&J& (Pyrophosphates) (£- 9 /CB^iii^^ J: h°n ^^^;i^y7A (Calcium Pyrophosphate) QV 285 to— jv (Pyrroles) 1/L'j7^7lililfcLT QV 95 ^AxRV-'fcJvy 4 'J yitmizisltZ WH 190 Mmitm QD 401 t*X7y7/i^o4 F* (Vinca Alkaloids) QV 269 t*y*lJa-377Xfy (Vincaleukoblastine) l£tX 7*7X7X$££ t X X "J X 7 X (Vincristine) QV 269 g;ifo. (Anemia) WH 155-175 CooleyS:ifill£7 7-fe5 7 WH 170$££ *3f2S14(£77-fe ~ 7 WH 170$££ &mm WQ 252 g*^^14l£7C*iiiL^'l4S:jrii WH 165$££ Miners^JflLiii^AfiifeiE WC 890l?$£i #5Mlb*£'l4(£, ^MAiiii^Sk WH 175$££ toskiinrnmskm wcs9o$££ Z\ ZiZ^-if titlX^%^%fZ£fo9 A yit, flRli'-N* yotxm*^ WJ 344$££ mmm (-fe) sf 76g.s ftW (Poverty) w&tkm HC 7g.P6 H#J HC 94-1085 tS*t HV 40-4630 nm^mm (Indigent Care) li[S*jmE$£i S.KM (Quality Control) ^pdp QV 771 £MffiXtY)%m WA 730 &S (JIM*, ££>,£*>(£) TP 372.5 £%;ffiXtY)%m WA 695-722 1*M[S^7-tX W 84 *?fl% WX 153 mmco %LM bum*) WX 153 $ fc £ £ mm wy i6 mmm wm 30 ffiX WA 672 -?- Wfffe#-£o^pap £ tz UXfiitXmm iz ^wHfaoHH^-EPIi^^HPIlziitS^^-lz, lyiRliHt Wli WU 21 737 tyyyfj 'n,M.!Smy-9JV (Management Quality Circles) mm wx 159 mm wy 30 ftm® (Edentata) QL 737.E2 t>X-mm (Medicine, Hindu) (£*ftt XX*-?fcf£[S ftr$££ txy (Pinta) WC 422 ppflS (Triplets) WQ 235 %Xm QS 462 Omm WS105.5.F2 mibUX&B. (Tachyarrhythmia) (£«$££ mmn& (Polymenorrhea) UR&mW£flX t'X7*7X7x (Vinblastine) QV 269 nZ. (Indigency) (£f:ffl$££ MB (Tachycardia) WG 300 WS.TJVa-jvfc'm^ (Skid Row Alcoholics) mmbx^m wm 274 tt^TWlfl HV 5050 RKHf (Poverty Areas) mmr$m (-fe) wa 30 m*Y ¥-y9XU, XMftliZ %X;ffl (Oligochaeta) QX 451 yyA'<-fc7Y 4 y9X (Fiber Optics) Q447.9-448.2 nmm&mizisit%> wbu\ mx.9 a yvftmftiztsit&mm* fc £ £ 7r-x (Phages) l£^*y 7 U 7 7 y- x$££ 7 r - -xSl^iJ (Phage Typing) U'<9 7 'J fc 7 y - xS#J $££ 77-y^ff (Phage Receptors) U7 A JVXg^PYZ ££ 7 7 xX (Fagine) I£o0x$££ yyX^fcyM, (Fasciola) QX 365 yy~T)Vm±^> (Vater's Ampulla) WI 750 7 r 7" ij 7- F &.£, (Food, Formulated) WB 447 M£y4 7V), ttzimftlBtYjcofzsbcoiiCOUXMM iz 7 7 -t 7 x* X (Famotidine) tlikmnb LT QV 69 Xr o-H$:ffi (Fallot's Tetralogy) (£FallotlZgM$£ £ X% (Anxiety) WM 172 WXm WS 463 ivjtmbwjm ws 350.6 nm&ux&nmM wm 172$££ 7 7 X n — -^.M. (Anemia Fanconi) !£FanconiS;jiit$ ££ X-WtW (Anxiety Disorders) WM 172 X^W&M (Anxiety Neuroses) UX^WW$££ X^x.%L^W*m (Diabetes Mellitus, Brittle) it A XX "J >1S#S^m*^$££ ^^-DSe (Angina, Unstable) WG 298 74 707*7)1 (Phialophora) QW 180.5. D38 7^X7/1^ (Fistula) ^IS^I$££ 7 7/Xf7;/ (Physostigmine) QV 124 7 4 7X (Phytin) (£7 4 7x$t$££ 7 4 t ym. (Phytic Acid) QU 75 y 4 YT7ivA--y (Phytagglutinins) (£xx7x$££ ^immiX^m^mm% (Site-Specific Mutagenesis) (i &ii®>im®^mm&$:fix 74 Fyo-A (Phytochrome) QK 898.P67 y 4 YY'yfcy (Phytonadione) QV 195 y 4- Y'*-7* (Fibrinoligase) itm&W9'JV9 5 x $££ 7 4 y' 'J > (Fibrin) WH 310 l&J*^ QY 410 y 4 7*iJ xigft? (Fibrinolysis) WH 310 7 4 7*0 y'Mm^aW. (Fibrinolytic Agents) QV 190 7 4 7'n 4- y 7 X (Fibronectins) QU 55 74 7'J7 (Filaria) Ii7 4 7 ij 7*4$££ X 4 7 iJ 7*4 (Filarioidea) QX 301 y 4 7 U 7*E (Filariasis) WC 880 X 4 7 'J TiiftLfcrn (Elephantiasis, Filarial) WC 880 74oJfyx (Phylloquinone) Ii7 * Y 7x4 X$££ 7 4o74y-7* (Philocytase) itmm, !&«$££ 7 4 >^*-7°iJ X FDNA (Fingerprints, DNA) Ii DNA7 4 X7y-7°i> X F$££ 7 4 >7X YRW& (Baths, Finnish) WB 525 m.m (Satire) U7 4 y Y fc^--^7$££ a^ (Rubella) WC 582 mM7A JVX (Rubella Virus) QW 168.5. R8 mm7 9Ty (Rubella Vaccine) WC 582 JS,±)iKJS (Acclimatization) QT 145 %^A^ QT 160 &mAm QT 150 W&Am QT 150^ ; m^AmQT 150^$ fc££ J4Af£ (Inclusion Bodies) QH 603.149 iikmSmti (Conjunctivitil, Inclusion) WW 212 ttkmmm (Blennorrhea, Inclusion) Ufikifc^m^ $££ Ukm (Inclusion Disease) (£74 F X 7"o 7 4 A'X.'Svft *£$££ Xmmm (Marital Therapy) WM 430.5.M3 y\mm% (Marital Relationship) (£££*§$££ y\$kt^kX¥xXn (Insemination, Artificial, Husband) Ii @ei8^fH3AXl£*if$££ 7x74 x (Fetuins) Ii7^7r7x F7°o74 x$££ 7xT4xX*A (mWmm) (Fetishism (Psychiatric)) WM 610 7x7X74 y (Phenacaine) (i^pJrl#5^^$£i 7x777> (Phenacetin) QV 95 7xf/Jfy (Fenazoxine) itfc 7 *',fA$££ 7 x 7 F* x (Phenadone) (£ X 9 Y x $ £ £ 738 79A>9 7x7xF4> (Phenantoin) (£7x-F4>$££ 7x7x F 'J xx (Phenanthridines) mmrnmbtx qv 269 Mmitm qd 401 7s.fcyYyy (Phenanthrenes) QV 138.Cl Mmitm QD 395 7x- F A y (Phenytoin) QV 85 7x — 7 5y (Pheniramine) Q\' 157 7x-/U777-F (Phenylacetates) QU 98 Mmitm QD 341.A2 7x-/WT$x (Phenylamines) (£7-'J XfL^!t*$££ 7x-^77-/ (Phenylalanine) QU 60 7x — jvz-A-JVT 5 X (Phenylethylamines) (£7x47/1' 7^x$££ 7ji^x-f^ (Phenyl Ethers) Mmitm QD 341.E7 &£@tolzteffl;?fil>it&(£. iHS'llz 7x^;wy*ij a— jvffc (Phenylglycolic Acid) livyf^ &$££ 7i-/^>Hi (Phenylketonuria) WD 205.5.A5 7i"^ft*^A'; F' (Phenylthiocarbamide) Ii 7 x — jvA-fcmmtfix 7x — JVA-fcW.^ (Phenylthiourea) ^■$.nmco%miztsith wk 25g v*.%<)V ¥ 9 —JV (Phenylbarbital) Ii7 x 9 '<)V ¥ 9 -/u$££ 7 x—)V t Y 7 y y (Phenylhydrazines) QX 180 Mmitm QD 341. AS 7jL-/U7'9Yy (Phenylbutazone) QV g5 7x-;Mf^7; > (Phenylmethylamine) (i-~$££ 7x — yy:yT5y (Phenylenediamines) QU 61 %mm?L QZ 202 7x47JVT5'y (Phenethylamines) QU 61 Mmitm QD 341. A8 7nfc-y-JV (Phenemal) (£7 x 9'<)V¥9 -/i-$££ 7x y 3- x^X-fi X (Phenoxybenzamine) QV 132 7x/77xX (Phenothiazines) QV 253 mmmmmizis it 6 sf gis.ps Mmitm qd 401 73.9y9TyyMjmY%mm (Antipsychotic Agents, Phenothiazine) QV 77.g 7xy77xX^F7X3-y4*7 (Phenothiazine Tranquilizers) (£ 7 x 9 7 7 x X ^iTtltW*^^ $ £ £ 7 x / 7 o —;u (Fenoterol) 7xy/<;wty-/U (Phenobarbital) QV 88 7 x 9'<)V¥ Y x (Phenobarbitone) it7 x y '<>v¥9 - ^$££ 7xy-/w (Phenols) mm&mb lt qv 223 Wltlt?* QD 341.P5 7xy-;W7yx4x (Phenolphthaleins) QV 75 7 x 'J 7 X (Ferritin) QV 183 7x ij7°o F fcjvy 4 'J X (Ferriprotoporphyrin) (£^^ ^$££ 7x "J A.^/o t* X (Ferrihemoglobin) (£X F ^t/D t 'Jx$££ 7°x;u F 'J 3 A (Puerto Ricans) UX-yF (Ferrets) QL 737.C25 %mimb LT QY 60.M2 ^y F fc LT SF 45g.F47 m& SF gg7.3 7 x X Y %y x (Ferredoxins) *ffll%4b'7-lZfclt-S QW 52 yt^rSlziiltl) QK 882 fy)fiti^)^pj* F t>y 9 Xit, 44H£iJlz 7inJfyf-(f (Ferroxidase) U-tJVay°y X 5 X$£ £ 7xo->7Xlb!l* (Ferrocyanides) te$HI:¥ QD 181. F4 mmm qv 183 7 x d — y y y fc X ^7 7 x y 7 (Fellowships and Scholarships) mmco WU 20 |^<7) W 20 mm WY 18.5 H!¥ QV 20 7 x o7°o Yfcjvy 4 'J x (Ferroprotoporphyrin) (£^i> $££ 7iDty (Pheromones) 3 $ x-7-->s X QL 776 ftU QP 190 7 x o ^E X^*#f£(Receptors, Pheromone) (^^S^ft $££ 7 x X x X 'J x X (Phencyclidine) QV 77.7 7 x X x y 'J x xSLffl (Phencyclidine Abuse) WM 270 7 x X x 'J x (Fendiline) QV 150 7 x.y9-)V (Fentanyl) QV 89 7xX7/U7^X (Fenfluramine) QV 129 7 x x fcjv 5 X (Phenformin) WK 825 y* F 3-^77 7 4 (Photokymography) iifllfl^7y 74-$££ 7 tJV9-yyJY$M (Volkmann Contracture) (inx^°- FXxF«SE$££ 14JJPI&14 (Fringe Benefits) (£*^4fc14JjP^14$££ X^YkT 5 9m (Essential Amino Acids) UMIMT 5 9 5t$££ fAffi&mm (Exercise Test) WG 141.5.F9 KiSfliHg (Sleep, REM) WL 108 XifiHT'xmS? (Inert Gas Narcosis) m^ts xt/xsmm wd 715 mjkmm wd 650 XiZiiitmM (Toxins, Deactivated) (£ F * 9 A Y $ £ £ WI4 (Frigidity) WP 610 X%^Mm (Fungi imperfecti) UX'm^mm^flX Xm^-.M (Deuteromycetes) QW 180.5.D38 X^&tkMM (Hyphomycetes) QW 180.5.D3 %-Rm (Innovation Diffusion) (iltl$f¥#Jf^f£l#$££ MUESerp (Physicians' Extenders) (£Hi3iIiffllJjM$££ 'lM.m.Wk (Veterans) UB 356-405 km UH 460-485 fl^A<7y'JX F UA 37-39 Y§.m.Wkcotzib9 UB 368-369.5 '&K$-kmm (Hospitals, Veterans) UH 460-485 M UH 460-465 mm WY 130 imv t y y xi£, ins'jiz IfeFg (Peritoneal Cavity) WI 575 mmm^m (Laparoscopy) WI 575 4§ kmrn^ff wp 141 ?L!£#JfcM$ WS 310 Htlgfff-ffiT (Surgery, Laparoscopic) *£!£ WO 500 Wx.com&ii, tcom&iz III!xMlx-\*X F (Peritoneovenous Shunt) ftte14§l7k7)teS? WI 575 UtJgiflDiUit7kx^ ^ r- (Ascites Shunt, Peritoneovenous) liW&#lBk x 7 x F $ £ £ itKtt^gn (Celiac Ganglia) (££M*£fp$££ If KIM (Celiac Artery) WG 595.C3 HfKfltQJfiL (Hemoperitoneum) Wl 575 HEJ^fliiA (Intra-Abdominal Infusions) l£#M&Pi4A$ ££ mJ&HM (Pregnancy, Abdominal) WQ 220 SiJ^A. (Epididymis) WJ 800 SiJ3c!§77*x7iJ7(Ganglia, Parasympathetic) WL 610 SiJ^C^tt'S^: (Parasympathetic Nervous System) WL 610 *i£ WS 340 &l$.!§W&!g:%m (Parasympathomimetics) QV 122 SiJ^WHitBr^ (Parasympathetic-Blocking Agents) l£tt="J Ximm$££ SiJ^^ttiSIn (Ganglia, Parasympathetic) WL 610 U^B (Abnormalities, Multiple) QS 675 SiJfffllH (Collateral Circulation) WG 103 giJ¥#c))& (Parathyroid Glands) WK 300 S>\\m^kWm^ycM& (Hyperparathyroidism) WK 300 ®\mmm&i&X'fc (Hypoparathyroidism) WK 300 SiJ¥#c!]£*£.i. (Parathyroid Diseases) WK 300 SiJ¥^JI®0 (Parathyroid Neoplasms) WK 300 ^im^^fcJV^y (Parathyroid Hormone) WK 300 m&1$R (Glycoconjugates) QU 75 m&%ffimM (Cocarcinogenesis) QZ 202 'fa&'tyimmm (Therapy, Combined Modality) U%m$) mmzfix ik&&W. (Saphenous Vein) WG 625.S2 Wk^a (Open Fractures) (£M!Jf $££ MX (Splints) WE 26 WSL (Diplopia) WW 410 Btf£#tt (Delivery, Abdominal) UftXWmZ flX m±mm (Welfare Work) Itfk&mM ; T±^^lh$££ $Sl«1*WS? (Radiant Warmers, Infant) (£1*^^$£ £ W$%±m (Copying Processes) Z 265-265.5 7 9yy (Fuchsins) f£o-7*- ij X^f4$££ 3Uff (Adrenal Glands) WK 700-790 S,\m7fc'<7 7'y9'ufc — -y (Paraganglioma, Extra- Adrenal) QZ 380 mmizwiiCoimYimiz IiJln*S (Carcinonma, Hypernephroid) WmMmiSZflX limitfISTLJi (Adrenal Gland Hyperfunction) WK 770 M^mnmX (Adrenal Gland Hyrpofunction) WK 765 SiJ^-^^^^r (Adrenal Insufficiency) liaijft$ftei£ F$ ££ SiJW^ (Accessory Nerve) WL 330 SiJ^.f. (Adrenal Gland Diseases) WK 700-790 SUM (Hypernephroma) (£E*»fl$££ 8iJM*S (Adrenal Gland Neoplasms) WK 780 Simt£K (Adrenal Medulla) WK 725 34^143li£1£fflE (Adrenogenital Syndrome) (i^tAttim ^fiSc$££ aiJfHPffittiHW* (Adrenomyeloneuropathy) liALD$ I £ 7 9yy'&m (Fuchsin Dyes) (io-7-iJ x^f|$££ SUEMBai (Adrenalectomy) WK 790 »Jtf&K (Adrenal Cortex) WK 750-770 Sim&K**figtfc£ (Adrenal Cortex Function Tests) WK 750 &l'n!kWmil&J%M (Adrenal Cortex Hyperfunction) (igij ^mmxm^fix ®lnfeKmii&i&T (Adrenal Cortex Hypofunction) liHJ ^«^1£T$£i ftmfeliMMfcJV*: X (Adrenocorticotropic Hormone) (£^/u7 o F o tx $££ liJtfftSCfljafc-ivi''* ytik&fcJV*: X (Cortiotropin Releasing Hormone) WK 515 sy^fC*^ (Adrenal Cortex Diseases) WK 760 IiJff&M* (Adrenal Cortex Neoplasms) WK 780 M'nfe'S.fcJV^y (Adrenal Cortex Hormones) WK 755 frl&co WK 757 WY (Ascitic Fluid) WI 575 WMftYfT QY 210 WY&. (Ascites) WI 575 MMm (Dental Pulp Capping) WU 230 n.mm%iz X hmnmm (Psychotherapy, Multiple) WM 420.5.P7 W&9SM (Duplicating Processes) (i^l¥^a$££ |g$| (Convergence, Ocular) WW 410 HR^fiJfg^ (Transvestism) WM 610 iB&l*J#r*ft (Convergent Strabismus) l£l*]£F$.$££ flSsSrHt'cH* (Heterocyclic Compounds) 7 $ 9MX{tmbfflMfc& iiCO QU 65 Mmitm qd 39g-406 ¥f%BtY)cotztbiz'mm$ti?zm&u, xmwuz #^1b^1*^^^$fc££ «*8i5!tg3&SMM* (Heterocyclic N-Oxides) (i^rXl mmitm* fix WzWYSk (Aorta, Abdominal) WG 410 m.1% (Abdominal Pain) WI 147 SiJf5#ift*£f£S¥ (Wolff-Parkinson-White Syndrome) WG 330 SiJ#K (Paranasal Sinuses) WV 340-358 m#m wv 355 ;mwm wv 350; ±nm wv 345 ; (HJ^iH WV 358$fc££ Sll#l&$ (Sinusitis) WV 340 M.U (Abdomen) WI 900-970 m:A WI 900-970 HI8B&* (Abdominal Cramps) l£*iH*S$££ m^mm (Abdominal Neoplasms) WI 970 m^mm (Abdominal Injuries) WI 900 m&X/lfr/l (Epilepsy, Abdominal) (£flMIT/U^ 740 7 9zx9y $££ K£ (Abdominal Wall) lifS&$££ 6*JI«M& (Laparotomy) WI 900 ||£g'vfW-7 (Hernia, Ventral) WI 955 UgHf (Peritoneum) WI 575 Vim® (Peritoneal Fluid) !!*$££ RR* (Peritonitis) WI 575 ItUf )!)!*£ (Peritoneal Dialysis) l£iS8I^l*f$££ KBEfi (Peritoneal Cavity) WI 575 IKIft&ft (Tuberculosis, Peritoneal) WI 575 mm&ln* (Retroperitoneal Space) WI 575 Umik&AfeWc&m (Retropneumoperitoneum) WI 575 W&'&mm (Retroperitoneal Neoplasms) WI 575 W&WM&itfc (Retroperitoneal Fibrosis) WI 575 Umm& (Peritoneal Diseases) WI 575 ItR®*! (Peritoneal Neoplasms) WI 575 Rll^tblS (Peritoneal Effusion) (iSt/k$££ Wfe&k (Peritoneal Infusions) l£4M£ni± A$££ KBISflf (Peritoneal Dialysis) WJ 378 %mmtt!Xv (Siamang) ti777y*-7/u$££ ^lt (Dandruff) Ii9f& &***?!$££ ffil&m (Excipients) QV 800 '£M (Paternity) mmmtb^m w 791 X« fc -SC^-T)-cfe £ h £* L $ fc £ £ *Htt)53IK* (Occult Primary Neoplasms) UW.WX- mmm* fix 7 ^ y JV Y 7 y X7 x-7 —•¥ (Fucosyltransf erases) QU 141 77 0 7AM (Fusarium) QW 180.5.D38 'JLXWSk (Father-Child Relations) WS 105.5.F2 7>x"X (Fucidin) Ii7 x~x X&£$£i 7yyym (Fusidic Acid) QV 350 7x7 7 (Barnacles) QX 463 j?tt (Edema) £1^31 $££ 1%-k (Corrosion) TA 462 mm iz is it 6 WU 180 mmm:Aiz is it 6 WE 26 Arcomcommt, xmmz Ut.m (Caustics) QV 612 f%t£.m (Humic Acids) ^Mitm QE 516-516.5 xmnmaiz (mm) s 593.5 %-km (Corrosive Poisons) (i#'t*$£i U&m (Cautery) WO 198 &§£#ff (Rape) mmm HV 6558-6569 mmmft^m w 795 ftW-tKfcrtaft* wm 401 Hkmm (Gynecology) WP X'jtmm ws 360 %M.m WP 505 mmmm wj 190 ffikmmfc (Gynecologic Diseases) U^UXM^mS- $ ££ ^kmmm (Gynecologic Neoplasms) l±*££«"&Kfl& $££ WA^flNS- (Working Women) l£^C74J7fiJ)#$££ 14KfiDNA (Satellite DNA) (£77 7 4 FDNA$££ 7"—X.y —ftJMl (Immunization, Booster) (£—#ft*g: $££ 7*Xtox (Buspirone) QV 77.9 y'XJVyyy (Busulfan) QV 269 mtmmm qz 267 ^Jl.lT^ (Scientific Misconduct) Q 175.37 m'MY ¥y 9 xit, 4£gMSi|lz ^JE"^ (Malocclusion) WU 440 SCttffifc (Paternal Behavior) WS 105.5.F2 4 sf 8og.F87 7°X7XX (Psoralens) QV 60 m±mb LT QV 63 7*y (Swine) Mffl¥ SF 767.S95 fiBlW SF 391-397.83 %mmb LT QY 60.S8 £mm SF 768.2.S95 y'9 A yyjvx.y7sAM7A JVX (Porcine Influenza Virus Type A) l£7*y fc)V9 5 *9 AS74^X$££ 7*y4 X7/l^iX-774/t'X (Influenza Virus, Porcine) I£7*y7^y $ *XAS74^X$££ 7*y 4 X7/Uxx-77 4/l^X (Swine Influenza Virus) Ii 7*y4/uy ^^yAS74^x$£i 7' 9 fc JV 9 5 * 9 A S 7 4 JV X (Orthomyxovirus Type A, Porcine) QW 168.5.07 7*y*7 4x (Butacaine) QV 115 7*y&&'i$ (Pig Skin Dressings) it&mffllz £ S&# &$££ it; (jRifi) (Twins) WQ 235 &£¥ QS 642 •bmm WS 105.5.F2 ^/ZC*7)*^.f, (Diseases in Twins) QZ 50 #£*££.!£, Arcom&iz 741 79Z1 \yy 79zivy (Hog Cholera) SF 973 7y/K*S*^ (Vesicular Exanthema of Swine) SF 977.V3 7yf£&14!l}§'fc (Gastroenteritis, Transmissible, of Swine) SF 977. T7 7*y?a74/UX (Swinepox Virus) (ix4 7°7yx74^ X$££ y 9 C0^W&YIY7° u y-— 7* (Porcine Xenograft Bioprosthesis) (£4;!t*tiil$££ y'9C0%W&W&% (Porcine Xenograft Dressings) (£4: mtfxzxh'iLwm^fix y'97^x>fAS (Myxovirus influenzae-A suis) (£7*y fcJVV 5 * 9 AS7 A JVX $ ££ y9)vm (Phthalic Acids) QU 98 Mmitm QD 341. A2 mmm qv 612 y9 ivW&iYm (Phthalic Anhydrides) QU 98 mmm QV 612 7 y JV yjVT y t y U X (Phthalidyl Ampicillin) l£ 9 7 XtxU X$££ 7y X4 xifef4 (Phthalein Dyes) QV 240 7'9ym (Butanoic Acids) l£8£^$££ m& (Head Nurses) U^mmmZflX y'A-JVT 5 X (Butylamines) QU 61 mpamstmb lt qv 115 y'j-JV7JV/<5 Y (Butylcarbamide) U7JVy'9 5 K$£ £ y~A-)V'<9 7 U 7 A (Butyribacterium) f£^- —'<9 7 U 7 A$££ 7*7/l^t F'o3rx7— 9—JV (Butylated Hydroxyanisole) mmm QV 632 &pnpf*#f4fcLT WA 712 7*7/1- t Y o 3- y Y JV3. x (Butylated Hydroxytoluene) ^pcB1*?4f4fc LT WA 712 7*7 o 7 x 7 X (Butyrophenones) QV 77.9 7*7 o 7 x y y%.ffimY$mm (Antipsychotic Agents, Butyrophenone) QV 77.9 7*7o7xyx^F7X3-74-7 (Butyrophenone Tranquilizers) (£77 o 7 x 9 X^4£*jf^**^^$££ 707o7°T7S (Phthiroptera) QX 501 7"7x (Butyn) (£7*y # 4 >$££ J^^itm (Fluorides) QV 282 J^^itmXm (Fluoride Poisoning) QV 282 *f4 WU 270 mmm sf 757.5 iL$l (Buddhism) BQ ~ fc mm*sm w 6i -bfcmm BQ 4570.P76 XM fc ^mm WM 61^ $ fc £ £ -bmttfttif WM 460.5.R3 ■XM^itm iz is it Z> mm WZ 330 US 15 (Abdominal Muscles) WI 900 7*7yxyF (Booklets) (£^°X7 x-y F $££ mWi&M- (Substance Dependence) WM 270-290 7yfc¥xm WM 276 3 77 4 X WM 280 lft£ WM 284 -yjA-y WM 290 m)AT)V7vA Y WM 286 ^o4>1£# WM288;^/Ut4 WM 286fc££ m%iXM (Metabolism) liftitt$££ mi&MWfnWm (Psychoses, Substance-Induced) WM 220 1*ICSLffl (Substance Abuse) WM 270-290 ~*mj£tZ>tzisbcomtfi WM 270-290 tt;£ft#m HV 5800-5840 Y-¥yy QT 261$fc££ ^HSLfflltft (Substance Abuse Detection) HV 5823 -5823.5 ^^m&b lt wb 430 m% SB 387-398 74 X WB444^$fc££ 4^iJJ (10 (Immobilization) WE 168 ■imumzmmzti&m&u, xmmiz & fc* i $m (Staphylococcus) QW 142.5.C6 742 7777D ^*fc*7$"lS (Seasickness) (£3lM*g£$££ 7*-77 4/i-X# (Bunyaviridae) QW 168.5.B9 7*—Y7A >VX&.Vk&. (Bunyaviridae Infections) WC 501 X'&XWs (Sterilization, Sexual) mmnm hq 767.7 £14 WP 660 £f* WP 660 ; Mam WP 660$ fc££ life QX 600 f§14 WJ 868 mm WJ 868 ; mWWfc WJ 780$ fc££ Xi&m (Infertility) WP 570 mmm sf 87i y9 4* x F o-^0 F 47 a (Pneumoretroperitoneum) !£f&JIU)11r4)I!i*iii$ £ £ 7*/XFA-|jE (Bunostomiasis) l£ffij &;$&*£$£ £ 7*/XFAAj|| (Bunostomum) {iffijjtlJ-.fi * £ £ 7*t^77 4x (Bupivacaine) QV 115 yy=> 9u-jv (Bupranolol) QV 132 7*7 v 9 JVy 4 x (Buprenorphine) QV 92 %ft&m (Partial Denture) (iJf|Py»7itf*f$£i %V>TYfc&m (Denture, Partial) WU 515 Sf''7fiW7& (Paralysins) (£&«$££ UttXLfrL (Epilepsy, Partial) WL 385 SBtf-Jftlft (Anesthesia, Regional) (£fcjlfl*fi£$££ SiJ5>ftl*W (Jaw, Edentulous, Partially) WU 140.5 gBtf * 77=- (Partial Monosomy) (iUifii^A'/A$£i ^lftLtiMBlW (Fats, Unsaturated) QU 86 ^-mfilflp-H/;^ (Fatty Acids, Unsaturated) QU 90 i-mWit-.'kuuWiW (Dietary Fats, Unsaturated) QU 86 m%tff$tzumm^-7 (Placebos) WB 330 7° 7 X 7 y9 (Plastics) itmtm TP 1101-1185 ¥m%miiz®.m$ft-&m&uxmmz, mtmm^ ffl£ WO 640 7°7X7y y^*7°X^,'ff (Plastic Casts) itm^^7°X^ -ff$££ 7*7 X F ;-tXi (Blastomycosis) WC 450 7'TXR-tXl (Blastomyces) QW 180.5.A8 7°7X^x7AH (Plasmodium) QX 135 77xv (Blood Plasma) (ilfo.**t$£i 7°7X-?mm (Plasma Cells) WH 400 7°7X-vigil3ij(Plasma Expanders) l£jl!u$ftJfl® $££ 77X7 F yyxY)V9 5 7--t* (Plasma Transglutaminase) (£HFlH-y/t-y i yify?-9'JV 9 i/l-F7XX7x7--t$££ 7°7X-?7xX — xX (Plasmapheresis) WH 460 7°7X-vi (Blood Plasma Volume) l£jfo.^fi$££ 7°7X-eo7'x (Plasmalogens) QU 93 743 77"^ i Y yyX5 Y (Plasmids) QW 51 Y7X5 9 *Y-A? (Plasminokinase) (iX F x7 F YJV 7-7*fcX F X7°F*7-t$££ 7yX59—Y'y (Plasminogen) m%m qu 142 itm&mm wh 310 77 X S X -YyiZmtmX (Plasminogen Activators) Xim QU 142 ihm'<%®m WH 310 7°7X ~ 9-YxffittltHTpPJTi^J (Plasminogen Activator Inhibitors) (£7°7 X ~ X-7XT4'S14f^$£ £ 7°7 X = 7 -YymiiitmXmm 3 (Plasminogen Activator Inhibitor 3) (£7°X7 4 X C Pl'SftJ $ £ £ 7°7 X ~ X -YyXifr&ifc (Plasminogen Inactivators) QU 136 7°7X^y-A (Plasmosome) Ii1£7f£$£i 7 7 XxX (Furazosin) (£7°7X*xX$££ 7°7y*xX (Prazosin) QV 150 7°7 77 (Platinum) (£[4&$££ 7°7 77A yy 5 9 y9 o ij K (Platinum Diamminodichloride) l£xX7°77x$££ 7'yy 97'JV (Ape, Black) (£+r/HI$££ 7*7 y 9yyy-9'AT^y F'SMfo. (Anemia, Diamond- Blackfan) (iFanconiH'.lfiL$£i y'yy yy?m (Toothbrushing) WU 113 7 7t*74/UX (Flavivirus) QW 168.5.A7 77 tx (Flavins) QU 110 77 tX-77-X^X 7 X77 K (Flavin-Adenine Dinucleotide) (£FAD$££ 77t*X^yyyx77K (Flavin Mononucleotide) (£ FMN$££ 7 7 X (Furans) Mmitm qd 405 i-IRf? (Incubators) (NLM #£lSTi£Jim#^ 26) "Mmmmizmmzti&m&u qs 530; wxmm^k &U QW26 7°7Xy FX (Plankton) 3tM3l$££ 77xyy (Frangula) U9 o 7X -^ F'=rJI$££ 7 7X^x7 (Frambesia) (£lt)li$££ 7°iJ7tXA (Priapism) WJ 790 7— ijxft?|/f (Fourier Analysis) QA 403.5-404.5 xmrnmnmx qt 35 7° 'J fc X (Prions) QU 55 7°iJ7X^SK (Prion Proteins) 7°'J7x$££ 7°iJ7x*^ (Prion Diseases) WL 300 7°ij7>-^4->x (Plicamycin) QV 269 7 'J -X y x K X 'J - 7 y X (Clinics, Free-Standing) !i yfcm&mmwLZfix 7 ij — X* F' 7 4 (Freeze Drying) Ifo.fi£ WH460 &.£, WA710 m^Xm QH324.9.C7 $m QS 525 *JI*&1*# WO 665^$fc££ 7 ij 7 7-M& (Flicker Fusion) WW 105 X'J-^x (Primaquine) QV 258 7'J-7-x^;i. (Free Radicals) (ii&8|J£$£ £ y 'J x (Purines) \m.C0M QU 58 Mmitm QD 401 mgm QV 107 7°'J yPyi'ifiY (Receptors, Purinergic PI) QU 58 7°0 XP2-^^f4: (Receptors, Purinergic P2) QU 58 7°iJX-g'#ft: (Receptors, Purinergic) QU 58 7°U XX y X7x K (Purine Nucleosides) QU 57 mmm qv iss y ij X X y x 7 x K 7 X 7 ij 7 —tr (Purine-Nucleoside Phosphorylase) QU 141 7°'JXX77°y (Purinergic Receptors) Ii7°ijx^§f^ $££ 7/1-7 ^-77 X (Fluoxetine) QV 126 Xitm QU 61 7 ;u 7 o jv Y o x (Fluocortolone) H&ffl^Jfc LT QV 60 7/U7o;uF ox 77 7°n« (Fluocortolone Caproate) (£7/1-7 o;u F o x $££ 7/W7X77^X (Fluostigmine) (£4X7/Uo7x-F $££ 7/I-7X7 4 y (Fluoresceins) QV 240 7/U7X7 4 yjkigfe&'m (Fluorescein Angiography) WG 500 mmrnm ww 141 7/1-7 XX (Fluorenes) QZ 202 7/1-7XX-2-4 77y ^ K (Fluoren-2-ylacetamide) (i 2-777/1-7 $/ 7^7 XX$££ 7/t-7o4Ay7y74 (Fluoroimmunoassay) QW 525.5.F6 &mmmm qy 250 mmmX (Fluphenazine) QV 77.9 Xjvy t-JV^Mit^-m (Sulfonylurea Compounds) 744 7UtA x «R41HT WK 825 Mmitm mumit&m qd 305.S6 7,K-yciy (Flubenisolone) (i7/U7 x7 x X $ W,£ y/l-y-tf—JV (Flumazenil) Q\' 77.9 y>i-y^¥iv (Flumazepil) li7/U-^-t*-/L-$ ££ 7)\,yA** (Flurbiprofen) QV 95 xim QU 98 7)Vy7>v& (Furunculosis) WK 235 7/vyfc)VU (Brunner's Glands) (£4-74ul^ WI 505$ $££ 7*1-4 xv-y tx 9 (Brain Electrical Activity Mapping) (iSK^ 7 t x 7 $ £ £ 7*w4-^4xX (Bleomycins) mmm qv 269 «l«Wf'JH! QZ 267 7V 7 iJ y u 4 > (Prekallikrein) QU 136 7w77xxX (Pregnadienes) WP 530 7X77X (Pregnanes) WP 530 7X77Xx7-/u (Pregnanediol) WP 530 7°w77x-y7x (Pregnanediones) QX 81 7°u77x F 'J fc — >V (Pregnanetriol) WP 530 7X7€-4 (Phlegmon) (£**1'^$££ 7°u7X^y*77 4 —(Plethysmography) WG 141.5.P7 $mY ¥-y 9xuxm%iiz, mt u sk^m*'<9 x» WC 526$££ 7°X-7iJx (Premarin) Uitl&^X Y o 7*X $£ £ 7X-A mm (Frames (Spectacles)) (i*W*4a$£i 7 v - 'J - F* -y 7 (Prairie Dogs) (i 'J X 44 $ £ £ *jt-§4Jf (Fractures, Ununited) WE 180 7°n A X -> j. 0 X (Proinsulin) WK 820 7°ot)4x (Procaine) QV 115 mmmmmiztsuz sf 918.P75 BKlSlftB^lzfelt* SF 914 Yu7JV'y yxii, xmmiz 7 d Jf -> 7 U x x (Floxuridine) QV 268.5 7 o y -y ij x (Furocoumarins) Ii7° X 7 X X $ £ £ yu9r7-l*mia (Programmed Instruction) LB 1028.5-1028.7 (NLM'7HEmT'(£Jf^#^T8.2) 7°'a9'7A,^mm^Xm^ (Textbooks, Programmed) (i 7°d yyA^|$£i 7°v97A±7>V%p-y — 9 (Calculators, Programmable) l£oxto. — y$££ 7°Dy7AMlf (Programming, Linear) T 57.74-57.79 m%Y ¥y9xu, xmwz 7°v9'7A*3KW.l&fr$!A XX ij X7°X7° (Programmable Implantable Insulin Pump) l£4 x x^l "J X}4AxX7A$££ 7□ y'yL.^m.tYh^-Wkm (Programmable Implantable Medication Systems)li^ttfffl<4A7x7 $££ 7 o 77 A,if jiOj (Program Fwaluation) vmmtiy-¥x w 84 A:CO%coym Y ¥-y 9xit, ,il4illi$'SltS YMWz 7 o 7/1-i Yl'U\Y (Proglumide Receptors) o xi-X F *->£>,4^$£i yuYXA-y (Progestins) (i)l^.llij'1017/1-^ x$£i 7°o7X7 y-<'Hi¥ (Progestin Receptors) (i7°orx7 n^*#M«l 7°o7X7ox (Progesterone) WP 530 7°oX X7o >Z'#f4: (Receptors, Progesterone) WP 530 70o7XF7> (Progestogens) it H&.mmfcJV*: > $£ £ 7d:>'<-7x (Proconvertin) li^7WP$££ 7o-7-f F A Y 0 — (Flow Cytometry) QH 585.5.F56 v&kmmm qy 95 7°d X9 9'yyyy (Prostaglandins) QU 90 7°o X 9 9y X x Xx x F*■ -'^ fc * y Y (Prostaglandin Endoperoxides) QU 90 7°DX?77Xxx-ix Y^jvfc*y Yyy9 —-t' (Prostaglandin-Endoperoxide Synthase) QU 140 7°oxy yy x-x X^ITl^K (Prostaglandin Antagonists) QU 90 7°o X X y*7 x x y^-l&itmmS. (Prostaglandin Synthesis Antagonists) (i#X7o 4 F**Dt^ffi^$£ £ 7°n x y 77 x x x 7;*#14 (Receptors, Prostaglandin) QU 90 7°oxy YyyyyW^m'K (Prostaglandin Inhibitors) l£7°o X9Yyy:9 x1££t!t*fC$£i 7°oxy y*7 XxX X-b7°y (Prostaglandin Receptors) l£7°oX 9 7*7 X x X-gW1£$££ 7°o X X y*7 X x X A (Prostaglandins A) QU 90 7°oxy 77 Xx"XE (Prostaglandins E) QU 90 7°oxy y*7X-^XEl (Prostaglandin El) |£7^7°oX y x/i-$££ 7°d X X y*7 X -y x F (Prostaglandins F) QU go 7°oxyy7XxXF2 (Prastaglandin F2) (£xy7oX F$££ 7°o X y y 7 X x XF27/I-7 y (Prostaglandin F2 alpha) li-xy7ox F$££ 7°oxyyyx^X I (Prostaglandins I)(£x77oX7 /-/!-$££ 7°oxyyyxxXl2 (Prostaglandins 12) |£x7°7°oX 7y-^$££ 7°oxyy7X-yxX (Prostaglandins X) |£x77°ox 7y-^$££ 7°oXy74y'Jx (Prostacyclins) |£x^7°nXf/- ^$££ 7°ux9ym (Prostanoic Acids) QU go 7 o -fe ~ F* (Furosemide) QV 160 7°o7xiJx (Protirelin) WK 515 7o.yy--xx (Frottage) !i'l4$-l3Jfg$££ 7°o7 7--b* (Proteases) (£-<7°7 F't F'D7--fe"$££ 7°o77-7*|51'#^J (Protease Inhibitors) QU 136 7°o7 4 7--fe4tPitii]B41 (Proteinase Inhibitors) (£7°o 77—b*|51-»^$££ 7° o 7 A X fc. X 7 7 y — -fe* (Protein Phosphatase) l£ ') ^ M&K7X7 7y--t$££ 745 7Dx4 x 7o74 >C (Protein C) mmmb IX QV 193 7o7 4 XCPIW^I (Protein C Inhibitor) QU 136 7o77X (Proteus) QW 138.5.P7 7 uy-fc 9{) 7 y (Proteoglycans) QU 55 7o rxy x YXM (Protestantism) (£*'J X Fffc$££ 7oF7?7-7A (Protactinium) WN 420 mmrnm qc 796.P2 mmwiLfooox^m y 17 y x $ fc £ £ 7°o F 4 X o -;✓- x (Proto-Oncogenes) QZ 202 7d F7°7X F (Protoplasts) flHft" QW 51 fidl'l* QK 725 7°o F^A (Protoheme) (£^-A$££ 7°o F 7/1-7 4 'J X (Protoporphyrins) -fe QU 110 m*9 A y°U, ArtltfmXZtlZ&X 7°d F* 7 7 7 (Prodrugs) QV 785 7°oFoxt*X (Prothrombin) WH 310 BiJ*##f QY 410 7°o FoxtXR^HH (Prothrombin Time) QY 410 7°o F X (Protons) WN 415-420 i^mmmmiz is it i wn no fcXmmmm (-fe) lz&tt& QC 793.5.P72-7g3.5. P72g 7°o F yB&XI&mytMiTtiT (Spectrometry, Proton- Induced X-Ray Emission) l&X&ftJtfr/tfttir$££ 7°u'^-yy (Properdin) WH 400 ^MftYfx QY 455 mmm qw 680 A: coi^coxmm^^mizis it 6 A: tut, xmmz 7°vs<:-yY* (Propanidid) QV 81 7°D'">V-/U (Propanol) l£7°o ¥)VT)Va -/U$££ Yw<9 — JVT 5 X (Propanolamines) W^1b^ QD 305.A4 ^mm QV 82 wzcoBfoizmmztx&m&uxmwz, ^uii^-y mwamu qv 132 7°o^°7xyx (Propafenone) QV 150 y°vy<5yy (Propamidine) (£#lJIjJi^$££ 7°oh77-F (Propionates) QU g8 7°o ¥fc—'<9 T 'J 7 A (Propionibacterium) QW 120 7°o t fc — '<9 T 'J 7 Af4 (Propionibacteriaceae) QW 120 7°ot4-4-F (Propionates) QU g8 7°o t fc 7 x y X (Propiophenones) Wtt1l7# QD 341. K2 *« QV 150 7ot7xg£ (Propionic Acids) QU g8 7ot°7xgt7X FX70X (Testosterone Propionate) l£7XFXrox$££ 7°o ¥)VT)V?—)V (Alcohol, Propyl) Mmitm QD 305.A4 &®& qv 82 7°D7 7-xiaiiA (Prophage Integration) l£i§)^14$ ££ 7o 7 4 7 'J X 'J x x (Profibrinolysin) (£7° 7 X;/- 7X$££ 7°D7x — 7 i X (Propheniramine) (£7x —7 i X$£ £ 7"o7x X t'J f; X (Prophenpyridamine) li7x-7 S>$££ 7d7*o-;u (Probucol) QU g5 Mmitm QD 341. P5 7°o7°7yo-;u (Propranolol) QV 132 7°o 7 7 t X (Proflavine) m^m®ykmbix qv 220 7°d7'J X (Propolis) tmutYjizmmzti&m&it, xmnuz 7d--v4 y 07/1-4 iJ x F 'J- (Flow Microfluorimetry) l£7o-74 FX F 'J-$££ 7*oAX o/U F 'J 7'U7xy X (Bromchlortrifluorethane) (£'^ o y X $ £ £ 7"oAX/l-77 x4 x (Bromsulphalein) I£X/1-77d^ 7yX4 >$££ 7*oA-xdfxX (Bromhexine) QV 76 70o7 77A (Promethium) WN 420 mmrnm qc 7g6.ps mtimmfccoxcom* y t -y y x $ fc £ £ 7*o^yiJ7°7X (Bromocriptine) QV 174 7"o^xyxX4 i K (Bromosuccinimide) QV 85 7°o^-y (itlS*^) (Promoter (Genetics)) (i7o€- 9WM (ikUm) $££ y°v*: — 9v&}& Cikizm) (Promoter Regions (Genetics)) QH 450.2 7n77f/-v (Prolactinoma) WK 585 7'o77f> (Prolactin) WK 515 mmm sf 768.3 7°o y 9 7 ymXYmtUm (Prolactin-Producing Pituitary Adenoma) (£7°o y 9 t9 --v$££ 70oyy7>^-'^T^f4^Si (Adenoma, Prolactin- Secreting, Pituitary) (£7°oyy7y—"^$££ 7D77-/1- (Florafur) (£7^*7-/l-$££ 7°d ij x (Proline) QU 60 7oxX4im*^ (Bronze Diabetes) I£lfo.fe3|*£$££ 9$i'k (Volcanic Eruption) $kM^m WA 292 mmnmmy-¥x wx 215 Mmm wb 105 Xit (Culture) CB MWm GN 301-499 Ml CB 23-113 tt^m HM 101-121 ftmW-% (Lyases) QU 139 MikM (Catabolism) l£ftlH$££ ftWMfe (Blastomycosis) WC 450 6rWmm (Blastomyces) QW 180.5.A8 %m (Literature P) mm\zxz> wz 350 fpffl'Ty PL 2250-3190 mi pn iJtM^Wim WS 105.5. Eg ~ iz is it immuxmiz is it imm wz 33o^$££ ~iztsithmm wz 330 mmmbxm wm 49 mwmmmmutmmm wm 450.5.bs$££ A: colfoco m ISizo«,»T l£il^ &U7x5Hi^T Arcoifocom* Y t°7 y Xl£, ±M8iJlz IfW^tffMf? WM 460.7$ fc££ ftm (Fractionation) (£^'J$££ 746 7y^>7 x--7lz4>tt&|1^ (Medicine in Literature) WZ 330 *ttlS¥W{;-8 WM 49 ftftfttixtfimK WM 460. 7^ $ fc £ £ XitkS. (Cultural Deprivation) f-^ WS 462 'hifi WS 105.5. D3 ffcW LC 4051-4100.4 fritmifc (Antigens, Differentiation) QW 573 Xitkmm (Anthropology, Cultural) GN 307-673 K$&l>«¥ GN 270-279$ fc££ Xittf)&%- (Cultural Evolution) HM 106 + 1#5* F t y 9 Xit, Xm^liZ XittY)¥fWi (Cultural Characteristics) $mY¥y9 7U, l-figijiz Xittf)Xm& (Cultural Disadvantagement) UXitXZ. $££ £{fcX§ (Acculturation) GN 366-367 ftZco^mnArtlU, XMMlz &%.A:tm. kmttzitmwz ftim-7- (Differentiation Markers) (£^1Lltl^$£ £ ft&HTz/WL (Amino Acids. Branched-Chain) QU 60 fl-SiBSftS* (Muscle Relaxants. Polarizing) littigjaj #&#«"£*£ J: Xmm (Philology) P 5*M?3I$££ XS^@# (Biobibliography) £!SP^I$££ ftKim^m (Spectroscopy) UX-<9 F /H$#f$££ ft±jt&m (Spectrophotometry) (£-y}}fcfii]#;$££ %1tM± (Spectrophotometry) mitm (-fe) QD 95 ZsiftYa QD 117. S64 smzBfoizmmzti&m&uxmmiz, mtufcjv* x5HJf(i QY 330 ®tt (Pulverization) itmm \ f^J$££ 5rtfcxX7A (Distributed Systems) (i^Xti —yo ~ j. —7 —x 3 x$££ frnkY-9'<—X (Databases Distributed) (£3Xt^- 9?ix-7-xa X$££ ftfkftYH (Analysis of Variance) QA 279 mn^mt, xm%^z ftXmm (Molecular Genetics) UXitmWMUmifl X ftXm$.mm (Orthomolecular Therapy) WB 330 mmmizts^x wm 402 34*7 F mW.& (Branched-Chain Ketoaciduria) (£X-7 ^i/D.y7°*£$££ ftXm'kM'A (Molecular Conformation) QC 179 fixers. (Molecular Structure) QD 461 frXW&Xmm (Molecular Neurobiology) (£#$££» $££ ftXXmm (Molecular Biology) QH 506 frX&!.&lY—9 (Molecular Sequence Data) m*miiizfflixu, Arcomnx %Xy o- 7 (Molecular Probes) QY 95 w%mmn&miz'mmztizt%&u, Arcommztzu& iz ftXWM (Models, Molecular) QD 480 •\m u d'j iz mm $ n h ty&u, ywa iz 'jJfc^YJV (Molecular Models) li-»4-^^$££ TOj-Ufcfcf (Injections, Jet) WB 354 X.'i-Kiifl (Word Processing) W£#fr (NLM^&T(iJf^#v26.5) V(XtitYuzmmzti&mfru, xmmiz %X <\.Witl- (Molecular Stereochemistry) UftXm-kWt i£$W,£ 3f!i« (Molecular Weight) QD 463-464 '1-fb-r- QU 25 37-7 77X (Molecular Vaccines) (i-ftlA<;7 y 7 X$£ £ tffJ? (Analysis) li'7UI4!7r' : omZtlZmnZ $££ ftftyitm (Chemistry, Analytical) tetik QD 71-142 smmmmiz is it s mk qy 90 ■£AC0 WA 750 ft&nu-k^ytft QU 50-^$ ££ Xtlco WA 716 /Ky> WA 686 fttftAymm (Analytical Psychology) (^itW'yrfJf $££ ^^A*£ (Strongyloidiasis) WC 865 3Bfaf£4- (Genes, Split) (£jtf£41$££ ftmZtltz'&HX (Split Genes) UiiiiXZflX X& (Grammar) UXmm \ ##H«T« "mmW $ ££, fyijxlill^ 5tWWM (Secretory Granules) (£fflI&KH*i$££ 5rWi£Xn%. (Otitis Media, Secretory) U'MibitX^i£ $££ ftWm. (Secretory Rate) QU 120 5tM (Fractionation) tmwmuArcommz, mtuskmm&Kirmm QY 455 mmfrmm qh 585.5. C43 $ fc £ £ frffi. (Labor) WQ 300-330 mmumrn wq 310$££ -fe WQ 300 #ifc (Childbirth) li#ifc ; teftgc-oTcoill^fNt* WQ 150; g**^-4£$££ #4fc (Delivery) WQ 415 immimmaimm qv 173$££ yym WQ 415-430 itT" WQ 425 ftXWWl WQ 430$fc££ Hits WQ 415 mmmn sf 887 r3**^H& WQ 152 ; mmfrWl WQl55$fc££ 5H£P4]#i (Labor Onset) WQ 305 3-«6^14*£ (Labor Complications) WQ 330 WM WP 170 ^mcox^im WP 170 ; ArnfacomiMBpa ; *<*Of||j ^fl!1I<0£ft;$fc££ ^(rftf&aiJfn. (Postpartum Hemorrhage) WQ 330 5>4fc034ifl (Birth Injuries) WS 405 ^jfijCTG (CTG, Antepartum) im'&Mbmmtt* ££ frMSii (Labor Presentation) WQ 307 %m SF 887 #(&14'i^ A (Traditional Birth Attendant) U&hmm* fit 747 ■7x^X7- tfttRif.''. (Labor Presentation, Breech) l£i!iffr$££ ,>WiiZ}sit&teiffim (Analgesia in Labor) l£»lf M^W$ ££ tttfc't*1* (Paralysis, Obstetric) WS 405 tftt-Sftfi (Labor, Induced) WQ 440 -cotz^commux^umm qv i73$££ ftfckS, (Floor) mimxummmnffi&b lt wb 431 mxMu WA 6g5-701 iftf$3l fc xULS (Nebulizers and Vaporizers) WB 342 ctffcfrj (Aerosols) mmm qv 220 n^nm qv 785 :Jl¥ (Psychology, Schizophrenic) U'XWm'bm *¥$££ -v7 'J -AzJVYatfkm (Leukemia, Hairy Cell) WH 250 $&mmmm qz 350 -n7 "J --tJV&tfn.m5ritmW-. (Differentiation Antigens, Hairy Cell Leukemia) UftitmU* fl X ffl&ifemm (Closed Cohort Studies) (£H]S§J#&^$££ ¥of$ (Muscle, Smooth) WE 500 ^14-7) fcc-0(£3311 JSiJlz Xffi&m (Leiomyoma) QZ 340 KS^14c7)fc^)(£a3liSiJ(z, mtUX^it WP 459 XffiSBfilM (Leiomyosarcoma) QZ 340 |sS^14X)fc<7)(ig['fiSiJlz ¥#!#-% (Life Expectancy) WT 116 i%Vkmtm HG 87878793 ^ WT 16 M&. (M) (Menopause) WP 580 ?%%£{& fc X t fc fc d — y x (Postmenopausal Osteoporosis) (iffi*H£ir*& L x i *ur.$ £ £ fflHfc#18fc (Bone Loss, Postmenopausal) UWW&ft $&L i T*i$££ ffl^ft#Bfe|g (Postmenopausal Bone Loss) liffl#4£# ILi 7*S$££ fflfc£f£#ffl L i. i *JE (Osteoporosis, Postmenopausal) WE 250 mmkfc-'V^yiX.it.mm (Postmenopausal Hormone Replacement Therapy)(£xx F o7xftft$ft£$£ £ Xffi (Equilibrium) WV 255 m-t&mxm qu 105; 7K-n.mnxm qu 105$ t ££ Xffiv%& (Dental Occlusion, Balanced) WU 440 *§74[SK£tJ*f*P£ (National Health Insurance, Non- U.S.) (£llgf*^Il^ftil$££ *[I]|lg1iJif*P£ffi (National Health Insurance, United States) W 275 ^H^HgfltJtfSPfcail (Federal Health Insurance Plans, United States) UXmMRMmkmZflX WM'ffil-im (Closure of Wounds) i£|iJlifcfI1I$££ fflmxm& (Ecological Systems, Closed) WD 756 mmxmfoX$immm (Closed Ecologic Life Support Systems) UfflffiXUB&ZflX fflm~frm (Spinal Bifida, Closed) Ii?§?4147x7rrt#: $££ fflffi&ft (Dressings, Occlusive) UftiiiUftmZflX fflFJrS'lf*£ (Claustrophobia) (£S'IHi|5f't$££ mmmtevfp& (Apnea, Obstructive) ^BiflgfHHWra?* £¥$££ mmmnB\HW (Glaucoma, Angle-Closure) WW 290 ffll'ltfl (Jaundice, Obstructive) (£lirF9o^$££ fflMUftiYt^fc (Thromboangiitis Obliterans) WG 520 mMi^WMitlX (Arteriosclerosis Obliterans) WG 550 fflmxmmfc (Lung Diseases, Obstructive) WF 600 Mfc&fr (Parabiosis) %j&m QW 504 mmmx'jt qs 675 ArCOi&comkY ¥y9XU, ±SISijCZ PMAy (Soldier's Heart) mm$$m%iyl&£ fl X i%mgLn'M-t:'>/v>^t7 o 0 F* BHC$££ -\3j--ifyno7xX (Hexachlorophene) QV 233 -\Jr7yoo-^x-fe*X (Hexachlorobenzene) 748 'N-'X'J X mmm qx 633 ~.*-vY7 F'o-'l (Hexadecadrol) (£7*^7 i 9 7*x$ E£ -N^f77X7>fit (Hexadecanoic Acid) U'/uxy*/UxX (Hexylresorcinol) QV 253 -N^-feX F o-/U (Hexestrol) WP 522 ^yJr7--fe (Hexokinase) QU 141 ✓s^X-X (Hexoses) QU 75 -^.3fy-X»)^St (Hexosephosphates) QU 75 -N.^-y-X-0/l®5r#& (Hexose Monophosphate Shunt) ti-<)V¥9—)V (Hexobarbital) QV SI ^liteUSe (Medically Underserved Area) W 76 ^Sii±a WA 3g5 ttt WA 3go H5HJ WA 380 -i (Besnoitiasis) Ii )§&;&&*£$££ -^—X9 —7— (Cardiac Pacemaker, Artificial) itkX -^-X/-yy--$£i ^Ar (Umbilicus) WI g40 81^ WQ 210$fc££ -<77-/i- (Bezoars) WI 300 S§<7) WI 400 mmm sf ssi ^-e^Olt (Umbilical Cord) WQ 210 -<—y 2 i y Dyo7'iJ X (Beta 2-Microglobulin) WH 400 ES*##f QY 455 ^•—9T F*x7 'J yMffltm (Beta-Adrenergic Blocking Agents) (£7 KX7U x-<-y^4t^$££ ^—y 7 F*X7'J X^*#14: (Receptors, Adrenergic, beta) WL 102.8 -<-9T F* x7 'J y-g&ifci'Emm (Beta-Adrenergic Receptor Agonists) (£7 F* X7 0 x-c-y T7-X Y $ ££ ^- y 7 F* x7 'J y&^WMMm (Beta-Adrenergic Receptor Blockaders) U-<~9T Y X7 'J ^f^ffltt^? (4«*$££ -<-y7y-x7 f y/i-y x-F7 ^/ Fyxx7xy- -fe* (Beta-Alanine Ketoglutarate Aminotransferase) Ii7;7 S&mT 5 9 F 7 x X 7 x 7 —b'$££ s<9 Ay (Betaine) QV 87 -<-y 7o7*U X (Beta Globulins) WH 400 mfcyyffi qy 455 ^-^ifffla&flili (Beta-Cell Tumor) it A > y * U 9—y $££ ^—y-S^f^ (Adrenergic Beta-Receptors) UT F*x7 ijx-<-y7-Wf^$£i ^-y*S (Beta Rays) WN 105 -A-tlU, ArCOfaWciz -<-y Ktic (Bed Capacity, Hospital) (i^Pa^y K&$£ £ -i7F AOT*£y7) £ (Pet-Human Bonding) l£AM fc^ ■y F^7£$££ -^■y F*'U7--fe* (Penicillinase) QU 136 -^— x U X§4I4 (Penicillin Resistance) mmm qw 51 mmrnm wb 330 mmm qv 354 749 ^-x'J X ^-x 'J ym (Penicillins) QV 354 ^-x'J XG (Penicillin G) QV 354 -<—'<7 4 y7'yv 9A-y (Lectins, Kidney Bean) lift! **14«.m£$£i *V X (Encephalitis Virus, Venezuelan Equine) QW 168.5.A7 ^<4 Xx7 7-^flutiT^ifi'£.7 A JVX (Encephalomyelitis \rirus, Venezuelan Equine) (£-<4- Xx-7 7 ■villa&7 4 ^X$££ -Ni—'*— y o-v F 777 4 — (Chromatography, Paper) ^JflL^ QD 79.C46 ^y (Pepsinogen) mmm qu 142 ^coxmm wi 302 -^7°xX (Pepsin) (£-^7°xXA$££ -^7°xXA (Pepsin A) mmm qu 136 picoxmm wi 302 ^7°7y-t*1fPiliiJ(a4- (Peptidase Inhibitors) (£7°o7 4 7-^41-S^$££ ^7° 7 K (Peptides) QU 68 ^7° 7 F*7/i-^x WK 185 4=rx FxX QV 173$ &££ ^7°7 F'xy*7/l-Sr:9iJ (Signal Sequences, Peptides) (£ y7t/K7*f K$££ -<7°7 Ft F'oy-7* (Peptide Hydrolases) QU 136 -?7°7 Ft F'oy-^PPSiJHi^ (Peptide Hydrolase Inhibitors) (£7°07 4 7-7*Pl-S^J$££ -^7° 7 K^7°7 K t F'o 7--fefflftiJHi*- (Peptide Peptidohydrolase Inhibitors) (£7°o 7 4 7 — -tPlWSiJ $££ ~zy°T Y fcJV^ x (Peptide Hormones) itfcjve X $£ £ -^7 Y^ y7X (Peptococcus) QW 142.5.C6 ^-^7X (Hematin) (£-^A$££ -n-v F y 'J y Y (Hematocrit) QY 408 mm. QY 26 -n.-v F fcA xf x (Hematopoietins) teMiifflMSBiP $££ -w F 7/1-7 4 'J y±itmmm (Photochemotherapy, Hematoporphyrin) (i'w F 7°/l-7 4 'J >^£,BS.H'$££ -w F t^7^ 'J XftHB.34- (Hematoporphyrin Photoradiation) WB 480 ^-y Y 7/1-7 4 'J >*^ (Hematoporphyria) (£7/1-7 4 'J >^$££ ^ x (Hemin) WH 190 ^A (Heme) WH 190 -\A7^i-77--fe* (Heme Oxygenase) QU 140 ^^IrtTES: (Hemeproteins) WH 190 BSftftft QY 455 -n^E7 7°X4x (Hemocuprein) ItX-'^fc * y Y > X2> y-fe*$££ ^^yot'X (Hemoglobins) WH 190 BSJ^ftS QY 455 ^t/ntyfS (Hemoglobins, Abnormal) WH 190 ^7ot7|iM (Oligochromemia) Ii1l:ifil$£i -N^y'Dtxftffl^ (Hemoglobin Substitutes) liftffllfil $$££ -N^yofxJ^S (Hemoglobinuria) WJ 344 ^■"E y*o t>K^» (Hemoglobinuric Fever) liv y ij 7 $££ -\*y*otxA (Hemoglobin A) WH 190 $JfcY$ff. QY 455 -v^y'otxC (Hemoglobin C) WH 190 ffiflctfclf: QY 455 ^.^ 7d t x F (Hemoglobin F) (£86!£-^ 7o t* > $£ £ ^7nvh->x (Hemochromatosis) WR 267 ^•>7-> (Hemocyanin) WH 190 SSflctfcS QY 455 -^■^xr'ijx (Hemosiderin) QV 183 "n^ x 7* U X }£#;££ (Hemosiderosis) QU 130.5 mmii# (Berylliosis) WF 654 -<|J-^ (Berries) I£77j$££ -^/l--u(£*^ (Verruga Peruana) ii'ifc*y r—trft ,4(77 (Peroxidase-Antiperoxidase Complex Technique) (iS*£ffif*4£$£i -ovfc^y 9—AfUgMHYm (Peroxidase-Labeled Antibody Technique) (igf 44i'liYik $ £ £ ^<)Vfc^y 9—^tfcMffiMm (Immunoperoxidase Techniques) im%tKtti£ $ £ £ ^t^fyf-t'I (Peroxidases) QU 140 -<;Ux7>ffyU (Belgian Hare) Ii77^$££ -x/uxX77 7-tX (Access to Health Care) (tl^*^7 -tx^ijltl^ti'l4$££ -v;ux7 7-g'#14 (Acceptability of Health Care) (i-N ^x^7.f.4l^'#l4$£i -wuX7-fxxxE<]11'!t (Libraries. Health Science) (i H^El»tt$£i ^)VX-yyy<7— (Health Manpower) W 76 gf!ip$^< W 21.5 g-#HlzioH>T UArcO'lj.nn&.&n&^n-y x >J| &MXiW#^-iz, f^Jt(£ir#PHPgfHzfc(t^vx^° 7- WV 21 <;i/fa7fi (Bertielliasis) (££ik!&4ifiE$££ -^/xy??£ (Hertzian Waves) (£1'ti;>!4"$££ ^iv-T (Hernia) WI 950 11X5 WP 250 WZco^JV-TCOZfr*; t££, fyiJ7.(£4tP§li1l^^-7 WF 810# ^,V-T'%m.fk$££ -NX7/1-X (Hallebore) (i-<7 F 7 A/l->x o 9 7$££ ^n4x (Heroin) (i v 7 ^7/1-^/1-7 4 x $££ -^n4xfix# (Heroin Dependence) WM 288 ^n7-/w (Veronal) it'OV¥"AJvm^MWM^flX fl (Feces) QY 160 ##f QY 160 gt[S^#U SF 772.7 # (Flaps) (£y4?4W#*it#$££ £H YMUm) (Variation (Genetics)) QH 401-411 IM* QH 408 wxmm.am mm qw 51 mm qw iso 7 4/l-X QW 160 mm QK 983 ?£{£ ('OBt^) (Displacement (Psychology)) WM 193.5.D5 nXm WS 463 1-VJimbWJim WS 350.8.D3 ^SJH (Mutagens) ycXit^M^W.m fc LT QS 679 kAXiXJmb LT WA 754 1t7'«S4fii{;:|jyt4«&sii QH 460 m%HLMm WA 788 7-f /1-X7- QW 160 '£?I)£14!&S$ (Mutagenicity Tests) QH 465 U1H& (Limbic System) WL 314 'Kitiitrttm (Spondylosis Deformans) liftW.ftWffi£ $££ £*P*'£ (Conversion Disorder) WM 173.5 -^X^r (Paint) ft--£ttftj TP 934-944 xzvmtmkii-$ wa 400-495 §S'P# QV 292 'A'ff^ffi (Slime Molds) (i'£Jf7|g*®$£i mmm (Myxomycetes) UmmMZflX mM'tM (Proteus) QW 138.5.P7 mtmti. (Myxomycota) QW 180.5.M9 »l4^gfi*iF. (Osteoarthritis) WE 348 Pfi^rtt^kOligl'fiS'Jtz mmm sf 901 $£&ii.%B%:M& (Dystonia Musculorum Deformans) WE 550 '^ttfl^gHm (Coxarthrosis) (iBSIHIi5^J^14l«gn*£$ ££ ^ff^14#^ (Osteitis Deformans) WE 250 »l4#H§gi5*iE (Osteoarthrosis Deformans) lifted? sp*e$££ mtim'Jt%A%m& (Myodystrophia Fetalis Deformans) (£l«gn1*jlS$££ mMiiim (Platyhelminths) QX 350-422 ti£ (Prejudice) BF 575.P9 nXm WS 462 IVJtmbVkJim WS 105.5. S6 ftswiiii, xmmz H^Sl^it (Polarization Microscopy) UmitmmWfc& }£$££ MytMWi^^m (Microscopy, Polarization) QH 212. P6 ^^tiw^ffiffl^aaii-^^iMsijic, mumfcmm mizis it i>m^u QY 95 ~X\$m$l- (Reimbursement Mechanisms) «#j3I$££ M&iimkmZfk'Mffi*.i£. (Eccentro- Osteochondrodysplasia) l£A o ^^*e4S $£ i -^-->U XG$££ ^yff x-^— x 'J XG (Penicillin G, Benzathine) QV 354 -y)v^ Xim- QU 61 ~*.Xx/U-^— x 'J x (Benzylpenicillin) (£-^—x 'J XG$ ££ -X«f4 ; 'J 7°4 F*-xX ; M£14 ; SB«14$££ XttMIii'fc (Arthritis, Degenerative) I£'£JF7I4I13K$ ££ -y*4^$££ -$££ *<>Vi]Ay (Benzocaine) QV 115 frffllte%*f**!K (Neuroma, Acoustic, Unilateral) (£111, #^S$££ tf4UJ4^It**$ (Hemiparesis) (£J4ft*#$££ -'77*txGABA-g^f* (Receptors, Benzodiazepine-GABA) !£GABA-ASW$£ £ -< X X* x 7 7* t X ^ F 7X^f747* (Benzodiazepine Tranquilizers) I£^xy*x7-fe'tx^4t^'g^$££ ^^f|:(Receptors, Benzodiazepine) (£ GABA-A-gWf4-$££ -< X 7*7 7 x 7 x X (Benzothiadiazines) W8Hb¥ QD 401 -< X X* 17 x (Benzopyrans) WflMfc^ QD 405 -< X 71 x x (Benzopyrenes) Wm»%b LT QZ 202 -< X 7*7 X.9A-A 7A (Benzophenoneidum) gjl*^ QV 632 mmmb lt qv 235 - (Callosities) WR 500 £ WE 880 fccotyV WE 835 A:COYkcopar£it, SflliJSiJlz ^xA-fc'%iY W 600 &&m W 32.5-32.6 $&££ f£[S'¥'lfo.(#f£"- (Forensic Examination of Blood) UsSo. mitmfc&Zfix mmm^f^m^>Y4 V 9 Y 'J- (Medicolegal Specialists, Directories) itmmm<7> F"7>Afc • t-fctfrS* \V 622 $££ mmmfoitm (Medicolegal Chemistry) UitmtflX mmmtfifc^. (Medicolegal Examination) (£gl]f£ : ;J4<£$£ £ >/v4147 i 9mW&mffiM (Amino Acid Decarboxylases, Aromatic) it^WffcT ^ 9mY7)Vfc *x7-f$££ JiWIkT 5 9mY7JVfc*yy--£ (Aromatic Amino Acid Decarboxylases) QU 139 '■ftftBiitftm (Aromatic Compounds) l£Jsj/Wftll§7 m ; 9 y y-jv ; 7 x y -/i- qv 223-#, Atf-tcoffeo fb^^ii^.fiy/,; Kft**; itfflatfML**; Mmitm ooXVjTjftmit&m QD330-341$££ mmn.% (Vesicovaginal Fistula) WP 180 mmtimfck (Instillation, Bladder) 'iKJflfcrW 7$£ £ WjmmWAYm:. (Bladder Neck Obstruction) WJ 500 WttLWk$ (Administration, Intravesical) WB 340 mm^immYi'j- (Intravesical Drug Administration) it flfllWkL4$££ WWtML^j&tHL (Vesico-Ureteral Reflux) WJ 500 ?L!£Wfc#j!£)W WJ 500 *fi-tt:W-# (Criminal Violence Victims) U4liif?$££ mm7 4Xy-)V (Vesical Fistula) (£K«t*i$££ m&m (Suture Techniques) WO 166 mmmm&X (Drug Administration, Bladder) itmmft t£4$££ mmm (Cystoceie) ummmfcZfix mmM (Bladder Fistula) WJ 500 MMM (Protective Clothing) WA 260 mMiZ is it h WA 485 i%mm (Oxyntic Cells) (£HfflI&$££ ilim (Boric Acids) QV 239 Uimfa (Borates) QD 181.Bl mmm qv 239 mx (Spores) QW 190 mm CO fr co A: tzii QW 51 mmm mmam c^Artiu qk 506 mm7*o •yX$££ 9?^*Sgp (Atrioventricular Node) WG 201-202 /yfiE'-li (Atrioventricular Bundle) (£His^$££ ^170 -y 9 (Atrioventricular Block) l£'l>7"o -y 9 $£ £ mtitm (Radiochemistry) QD 601-655 mtitfttif (Activation Analysis) QD 606 Mt®)Bmm (Radiesthesia) WB 960 mtWcil (Scattering, Radiation) xmrnrnx-mm wb 117 mmitm qc 427.4 mtttMWffl'lfc (Keratotomy, Radial) WW 220 m\imm& (Radiopharmaceuticals) itmmm \ M4I4 rsiiif*; mmrnm a 9-yyy, mta.mm.mtm L tzms,, itmm&^nzfozfix mmmm (Radionuclides) !£Jicl4l4|5]1i^$££ mt&mii.A 9-yyY (Radionuclide Imaging) WN 203 'L-MJfilf^^f. (-fe) WG141.5.R3 Rg^tt^t^ligMiSiJlz 753 xyyfc'Ai 'Mrtfcttf*zjy¥^-9W\m (Tomography, Radionuclide-Computed) (£x ~ -y y 3 xCT$ £ i W14f£4*:CATX=r^x (CAT Scan, Radionuclide) (i x~ y y3 XCT$££ te^14^^«^flr (Radial Keratotomy) itmtAkftmW ^ri$££ K-lt'ft^-oo 4 Y (Gold Colloid, Radioactive) WN 420 mmrnm qc 796.A9 WI4|5]1if£^T^#* F 17 X X $ fc £ £ mm&Xm (Radioactive Fallout) WN 610-650 mm?'m (Radioisotope Renography) WJ 302 mmxmWmn'M. (Soil Pollutants, Radioactive) WN 615 mm Fx -7 (Radioactive Tracers) WN 415-450 mmi%%m (Radioactive Waste) WA 788 «C#14t y7°7X (Radio-Hippuran) Us- Y^h^m^H X mmm^S; (Radioactive Substances) (£7x7A ; mi •I4(5]iif4; mmwwm■ mm*Axxmw; a fc yitmm wn ioo^^t>*#xE^*®7)«^, mum 1414^-0 0 4 K$£i mmxmi&ifc (Radiopaque Media) (£j£t^J$££ mmM'WlUMm (Hazardous Waste, Radioactive) it mmmmm* fix mtB (Radiation) WN mm<7>mmbLx (mmm) qz 57 mmmtY) (-fe) qc 474-496.9 mtBT yJV*'-mmtk^m (Radioallergosorbent Test) QW 525.5.R15 mtUmm (Radiology) WN mmm sf 757.8 mt%&mmYm%iyX7A (Radiology Information Systems) WN 26.5 mtBikUm (Radiation Genetics) WN |7J!|* WN 620 mz WN 610 WN 620 mm WN 630 Jft#fHf4 (Hospital Purchasing) itm?Jimm^?1*flX mmmmntmmWMffiB (Radionuclide Tomography, Computed) l£x ^ -y y 3 xCT$££ mtBmi%.i%^ (Picture Archiving, Radiologic) liftft ^E^'ff$gxX7A$££ mtU&M (Radiation Monitoring) WN 650 mt$&!&%i£ (Radiation Sensitivity) (£M4S&#tffi14$ ££ mtBftffli (Technology, Radiologic) WN 160 m&&m WN 150 mmm sf 757.8 Mti'M^E (Osteoradionecrosis) WE 250 mtB^m (Radiation Sickness) (iJft#H£1fW$££ mtBM^ (Radiation Injuries) WN 610-650 mMiz is it i> WA 470 ^Kfcf&iJE WN 650 mmm sf 757.8 xumioox^Mmm wn 200; mmmmcox^) WWfp-ffl WN 250 ; yy7A»<7>ycoMWm WN 300$fc££ mm&nm(Radiation Syndrome) l£J&IH>lf^'#$££ mtBXmm (Radiobiology) WN 600 mtBtg!&mM (Radiation-Sensitizing Agents) WN 610 mt^m^. (Radiometry) WN 660 mm wn iso mt%&Mx.& (Radiation Counters) Umt^it% m&mw wn 150; x x 7 y - y 3 ytm; ±mm $££ mtBA&mm (Radiation Tolerance) WN 650 m-jt'Akm^hmiz is it h^^it A: cotmiz, miumm nmmmmiztsu&m&u qz 269 mm^BW (Radiation Effects) WN 610-630 f&sfc-gH-ssir, xiY, itmmwmmhh^u-m.<» £ft-$fc££ mt^^^m (Leukemia, Radiation-Induced) 754 *77*-fe WH 250 6Stfc#i31-7: QZ 350 JkWH&SI^ (Radiodermatitis) WR 160 mtUmmm (Radiologic Physics) l£f£1$!f*W$££ MMftXXmm (Molecular Radiobiology) itm-YiUX. wmzfix Mtl&WjM (Radiation Protection) WN 650 mmzisitl WA 470 mmmmm w a 788 $ *> £ £ MtftMrnii (Radiation-Protective Agents) WN 650 ttW*&fc£^WE«. (Monitoring. Radioimmunologic) (£ ffcl&milft&til $ £ £ SS*.#t$l^f§*r^ (Abnormalities, Radiation-Induced) QS 681 MtBM^MM (Neoplasms, Radiation-Induced) QZ 200 MtUWii%.&M.m (Leukemia. Radiation-Induced) WH250 &w.mmm qz 350 SfcW&jt (Radiation Dosage) $AZ, 14$, £7*1^ WN 665 \mmmtmik WN250H$i££ W.kiUM.fX^>M% (Dose-Response Relationship, Radiation) 4YAfcyitmtB WB 460 S*34l4|5]fif£ WN 450 7x7A WN 340 XH WN 250.5X7 **MS WB 480 tcotiLC0W£9AYcommu, 9AYWZ &m$i±z>W£m.%u, A:com&iz Mfc&mm (Radiotherapy) Mfim WN 250 mmmrnu, mmnynmtmmm qz 269$££ $.mm wr 660 m?. WN 250 mmmmfcummmmYcoycofemfomm wn 450$££ 7x7Ai£yyyA*coyco\tMmm WN 340$££ mmm sf 757.8 xnmm WN 250.5.X7 ■m&co%fo*: t££ mtifc (Radioactivity) WN 415-450 %£MW. WN 650 mMizis it 6 mmm wa 788 mhlg WA 470 Mntftykmm. (Radioactive Pollutants) WN 615 mM WA 788 UXmW WN 610-650 mmztsitz, wa 470 mmmmm wa 788 ■ w&m'g.nmtco£ ? 4 7°w£ft;$&££ mtHmi&mn (Radioactive Pollution) itmmJzAtt mm. WQ 400 £$tffiXtY)%m WA 240 ftfrffl WO 113 !»)»"& (Antiseptics) U ft mfcim® &m £ fit Um (Methods) Q 180.55.M4 %f-£ft¥fizts^XU, ±M£iJ(z t#-# (Refugees) f*HPp1H WA 300 «ttfl&4MS WA 305 ^cm HV 640-645 i*B3€-aiJ» (Health Visitors) (£iifet^1*H#M$££ M$mt£Mi&i£ (Visiting Nurse Associations) (£74*€# ff-7-tX$££ <■£#: (Legislation) (NLM ftmm-Clffitt^ 32-33) *K^W±fiJi, Arbmm (-fe) bf 575.A3 tt^*# HM 281-283 IJ -) h 1 JC (Dental Enamel) WU 220 SfcRU WU 220$&££ Ii -5 -5 -5 Ji&M (Ameloblastoma) WU 280 f^ciml? (Incubators) (NLMmmXUfm$5r26) Mmmmizmmzti&m&u q 530; mxmm^m £•(£ QW 26 imi^'tkm (Carrier State) QW 700 mmm sf 757.2 WMYT (Pastoral Care) WM 61 ■XMbmm w 5o#; irMb^mm wm 6\m; m\% ftffimit WX 187$ &££ ft&iK>W (Psychology, Pastoral) littCT7 7$££ 7XxX7 (Boxing) QT 260.5.B7 AVkT 9 \)7AyY4Ty (Indians, North American) E 75-99 mffib LT mmm?. wz 150 M$. WZ 80.5.13 fiAfsie wz 100 Rmnynftftf 17 y x $ t £ £ 9 *y? F 1219-1220 Ii < h (Lentigo) WR 265 Uibm. (Lentiginosis) (£l£<6$££ \Wl (Insurance) HG 8016-9999 YJkmXkm.WM.W^A%^i (Allied Health Personnel) W 21.5 A£ • mam -fe W 22 m*9 A y°ooX 9 7 7 (£, A:com^cok x • ftpJr&& $*r4 W 18 fSffimSHifc (Health Occupations) W 21 ^Hli-tw^-EF"-:, fyiJxl£74f4 WO 21 mmco9AY W 87 ^^^n?'fo^^$t££, mt\xmm&$m W 21.5*1? ; *Ef£MI£ WA 840-847 i%mmmnmi¥ffc7°A Y7Ay (Health Planning Guidelines) i&Jfr WA 525-546 #?*F t°7yx(i, iJS^iJlz f*^H*leftiiJ'^"5fe (Health Plan Implementation) WA 525-546 w^y ¥-y9xu, xmmz i%mmmitmm%-£ (Health Planning Councils) WA 525-546 tmv ¥y9xuxmmz i^mmm&m (Health Care Costs) -&f§PJ?'3l$£i i%H£mmmm (Misuse of Health Services) (£1*flt!S*Jl7 -txc7)^ffl$££ U.WmmY-tX (Health Services) W 84-84.8 «(£±^1*117-tX WA 546$££ ik%u^M.mmy-¥x wx 215^$££ mm^M-mmy-¥x wx2i5$&££ !£m!z*tLT(£^f£fit7-t*X WA320^$££ £Alz*1LT WT 31 1SFJff#^lzMLT W 250 mmm w 25o^$^££ m$kmffl$££ i%MmmY-¥XCOmm (Health Services Misuse) 756 * 3 > /*} * \\ 8-1 84.8 ftSfcF t •/ 9XU, 31118']IZ f£«[M«7-t*X7>Hf4t (Health Care Delivery) itmm 7-t*X*tf£$££ \'{.$imm7-—¥XC0-l£%b^$i (Health Services Needs and Demand) ^SiJJ>*S^(iJii^:i. XmWiz \%&mm*i~ — ¥XCO&m (Abuse of Health Services) Ii %mmmy-¥xcomm*:fix \%V&mm7-¥7-y—TT 4 X7* (Marketing of Health Services) W 74 #**f¥y9xu. xmmz fc&mm'itM (Health Resources) W 74 m^ft^m WX 157 8£bw(>*>•£. xmmiz Vmmm3£& (Health Expenditures) W 74 Rfemmy XTA+itm (Health Systems Plans) WA 540-546 ft«g*y*7^ftHffl?gl*IW (Health Systems Agencies) WA 525-546 ftWS*!6a (Health Facilities) WX £15^1 $££ (S1l[I«!fctS:llfl?§ffB (Health Facility Planning) WX 140 &#H#ff ^SfeSffl5eftiS (£7<*o#P*1 iz, m*. li'CCU WG 27-28 %^mmMWc^m^i (Health Facility Administrators) WX 155 \« • ftP>rfffe WX 22 tfM.mmifeWLWm (Institutional Practice) W 96 mm WY 125 &&mmfaWc<7>)&& (Health Facility Size) WX 140 ft^AYnmmu. mttsm^m^z fcfemmi)tWccoft& (Health Facility Conversion) (if* m.mmm.m.mmtm^fix &M.mmi£M%i (Health Manpower) W 76 mmzw<, w 21.5 &m^izts^xu^(nm-rf\&\$J&!5co-?y'<7-Z: £i. mz.ummnm&u wu 77#, xuazco^ **4't»*'&li«kJI#^-lz, mtUJf&mmmizisit& vx^°7-(£ WV 21 YmmmMmYk (Schools, Health Occupations) W 19 YmmmWdfcUmmcomX (Students, Health Occupations) W 18 feWmmfc-1^ (Quality of Health Care) -fe W 84 mu WX 153 mk&m WB 50 &%:mX: WA 525-546 fcMmm&WUW (Need Certification, Health Care) l£ #giE^$££ ^Mmm-Hf^a.co-fk'^. (Determination of Health Care Needs) (ifSfitgfg-7-¥XCO£^ fcg5fc$££ %mmmmU (Health Legislation) .'£*£#$££ HcttHSfii+rti (Health Fairs) WA 590 tm y ¥y9xuxminz fcmmm&%.mil (Health Priorities) WA 525-546 %WfaX'm^., '£$}, %&. (Knowledge, Attitudes, Practice) £f£ F ty 7 XtzHSj^ ■&*#£•(£, 4£^8iJlz fit*-M7)*Jl3i W 85$t££ C^R-f&tt (Insurance Carriers) H*1*P#lzH|LT W 100-275 \'m&£. (Insurance Audit) lifS|iPfcIii*P:ft$£i ('^fit#fr (Education, Health) (ifl|J3mW$££ \m%?i (Insurers) ,'i(W#^tt$££ f^fllinEfc (Health Administration) WA 525-546 f*flt^f§ (Health Occupations) W 21 y%mm\*:iiflX iWfc'fe (Insurance Benefits) ft^'Wap*' HG 8751-9295 KUr$7)7-tXiitiBi W 100-275 WZcomY-mxztt LT!i, ±f§Wz ffcMlll&JTy 4 Y7Ay (Guidelines for Health Planning) (i'*1iN*£ft[ffiif'F'£$£i f*fitffl'& (Health Care Research) (if£Pfc[£Jf*-7- tx $ ££ ftttfrilJ (Health Behavior) W 85 m*Y ¥-y9Xlt, ±HSiJ(z f*P£^&^af:$"$e^ (Insurance Claim Reporting) mmmk w 100-275 WKY ¥-y9XU. xmmiz fcVk^m^m (Case Management, Insurance) itmm^ s7oyyA$££ f£P£sf i^^M (Insurance Claims Processing) !if&P£fS5£ «$££ f£P&ffll4^P]jlE (Insurance Claim Review) W 100-275 ¥Y£ WA 525-546 ftSfcr- t-yyx|£, xmwiz i^kmt'XYfx (Actuarial Analysis) HG 8779-8793 ^fS^-tXtfiijIzlllgl-S t^l£4£SSiJlz, f^Rli'lf? mmmmku w 270 f*@fc^11:14® (Planning, Health and Welfare) UUM lt@$££ fcmmmm (Health Physics) WN 110 mt (Gait) WE 103 ^Yt^tAj'^M (Electrocardiography, Ambulatory) WG 140 $4414 JUJj^ci^ffi (Locomotor Ataxia) liWtH^ 1 $££ mmm (Coenzymes) QU 135 mmmA (Coenzyme A) QU 135 ffimmM (Coenzyme M) (iMesna$££ mmmQ (Coenzyme Q) U^-1*9 X$££ mmm I (Coeazyme I) (£NAD$££ mmm 2 (Coenzyme ID (£NADP$££ fSH* (Protective Devices) WA 260 *j*fEfclztolt£ WX 185 X£.Ztsit& WA 485 *fC*£ WD 740 mmm ww 505 #HJf£ WA 487 mmiztsith (-fe) WW 113 ffBJk. WF 26 -ft£w#i4:s*H£ (±mzm^L*^m&) tztfLTIt, b co^-m^x iiB^&^zmmfc & f*H3iJ (Demulcents) l£y4iSffl^J$££ f&ff *>>*>*& (Eye Protective Devices) WW 113 757 70 X X X ffc&xxX (Safety Lenses) lif'7,$££ ftmm (Mother Cells) i£^*fflBS$££ ffflflt (Hallux) WE 835 feH&ih/4WiE (Hallux Abductovalgus) (£t4CT&I:$££ ®Xmi& (Mother-Child Relations) WS 105.5.F2 HXmm (Maternal-Child Nursing) WY 157.3 m&R'im (Thumbsucking) (£pMh*#$££ mxmm-ty9- (Maternal-Child Health Centers) (£ mmmwL wa 3io$££ ®Xm± (Maternal and Child Welfare) (£!£SfS*lt ; M 14fS*lh$££ mitt.^ (Food, Supplemented) U&it&&£flX mi&Xiit (Compensation, Disability) ii'&m.'W-kmmYk Bh ; $tim$wz.; mh^'&WMWiZflX flfrkftWl (Predatory Behavior) QL 758 ffilfiiSSg (Assisted Circulation) WG 168 ffiUj&^lt^xX7 A (Ancillary Information Systems) (i 1imxX7A$£i 7X7X (Phosgene) QV 664 7°X F ziT;m (Post and Core Technique) WU 515 fcX¥X (Hospices) WX 28.6-28.62 7XtX 7 7 (Hospice Care) WB 310 7 X tX7°o 7y A (Hospice Programs) (£ 7 X t X 7 7 $££ 7X 7 r y -■¥ (Phosphatases) !£ <0 /Llt^E 9 xx 7/1-1 Foy--b*$££ *X7rf yjv A 9 y Y-JV (Phosphatidylinositols) QU 93 T.X7 7 7x7l-o ij x (Phosphatidylcholines) QU 93 7X7 7 7x7Wxy 9-ivT ^ X (Phosphatidylethanolamines) QU 93 7 X 7 7 7 -x- x St 7 X 7 7 y -7* (Phosphatidate Phosphatase) QU 136 fcXyyi-Y-JVit^-m (Phosphatidal Compounds) (£ 7°7X-vo7x$££ 7 X 7 7 7 K (Phosphatides) (£ 'J A.BW $ £ £ fc X 7 7 7 Km fc X fc t K o y —¥ (Phosphatidate Phosphohydrolase) UfcXy y A-yymfcxy y 9—-¥ $££ *X7r; Y y (Phosphamidon) 9kM SB 952.P5 £$tffiX WA 240 7X7 4 > (Phosphines) §kmb LT WA 240 *&mitm QD 181. PI fcX- *J 7 X*yxxt7- 7* (Phosphodiesterases) (£ fc. X 7% -x xx7/l-t F"oy-7*$££ 7 X ,7x x x x 7 /l-1 F* o 7 — 7* (Phosphoric Diester Hydrolases) QU 136 7X7 F 7 X X 7 x 7 — -t (Phosphotransferases) QU141 fcXfc9-yA yy (Phosphonomycin) (i fc X fc-y A x X <• ££ 7 X 7 t F' o 7--b*(Phosphohydrolases) (i •) /Lrtfc^E / x X7/l-t F'D7--t$££ fcXfc^YA-Y (Phosphopeptides) QU 68 fcXfc-yAyy (Fosfomycin) QV 350 fc Xfcyy (Phosphoranes) &mitm QD 181. PI mmm qv i38.P4 7X7 0^-7* (Phospholipases) QU 136 7X7.0^-7* A (Phospholipases A) QU 136 7X7.'J^°--tA 1 (Phospholipase Al) (77X7 0^- t*A$££ 7 X 7 'J '<--¥A 2 (Phospholipase A2) Ii 7 X 7 0 s<- t*A$££ 7X7'J t°F (Phospholipids) QU 93 fcXfcym (Phosphonic Acids) i&mitm QD 181. PI mmm qv 138.P4 *I4 (Maternity) UM&& ; M \ Mm ; &4g$££ mfc.mm (Maternity Nursing) (£dfl#!f $££ *l41fgJ (Maternal Behavior) WS 105.5.F2 ^14flJ* (Maternal Deprivation) WS 105.5.D3 fttttB"tlt (Maternal Welfare) WA 310 m£i%M (Maternal Health) (i«14f§*lt$££ 7-7 XX (Dental Porcelain) WU 190 i%M-M (Preservatives) QV 820 i^M-i&Um (Dentistry, Operative) WU 300-360 K'JtmbX'Jtm WU 480 %xm WU 490 i^M-t. (Food, Preserved) (£&nDn1*#$££ mifc (Complement) QW 680 ffll^ffittlt. (Complement Activation) QW 680 Wifc-imitmm (Complement Activating Enzymes) QW 680 Xitm QU 135 mifc"<£Hit%—&$& (Complement Pathway, Classical) QW 680 Wm£&U.%k (Complement Fixation Tests) QY 265 ffift^W (Receptors, Complement) QW 680 ®m£'Jt?3$X%: (Maternal-Fetal Exchange) WQ 210.5 itmm^mx QW 553 ffiM&H (Complement Proteins) I£ffi1*$££ 4°yx7A7"7XXyx— F (Potassium Canrenoate) it7 yy9m7 'J7a$££ fc9)V (Fireflies) (£¥iWI$££ MM (Cemeteries) (££E14-*I#I!$££ mm& (Hearing Aids) WV 274 lt%YK (Arctic Regions) xmmmmbmfc qt 160 7°7yx74/l-X£|- (Poxviridae) QW 165.5.P6 fc-y 9 X7 A JVXmW^X (Poxviridae Infections) WC 584-590 (£°o < OlH (Death, Sudden) W 820 %V4]T^m¥L WS 430$ &££ m%Y¥y9xuxmmz, mumm&izm'&uztff WG 30 7 7 7- (Hockey) QT 260.5.H6 7AYY (Seizures) WL 340 ^l^ttlfiLfe^I^SE (Hemoglobinuria, Paroxysmal) 758 ■J^'Jx^u WJ 344 af^lffftWH (Dyspnea, Paroxysmal) WG 370 %fpffi»D*fift (Tachycardia, Paroxysmal) WG 330 £fp14Mtf4fi! (Paroxysmal Tachycardia) li&ft*14'L»«j #!$££ ^Ifpffi^^E 9o t xfcR*if. (Hemoglobinuria, Paroxysmal) WJ 344 i&&4-$T7o ¥JV (Propyl Gallate) ^*S=t*SfcLT QZ 202 %& (Exanthema) WR 220 mmmft?f sf 901 %ftm (Rubefacients) l£$ij$:*$££ fcy Y7 A y (Hotlines) mm y ty 9 x uxm^iiz, m 1 urnim-m^mmy -tX WM 401 77'JXA (Botulism) WC 268 7X'J3?Xffi (Clostridium botulinum) QW 127.5.C5 77 f 7X7—x (Body Language) li#f£jI|Jj'¥r$£i ffi$ (Prosthesis) WE 172 Kit'fliJflLWli^ WG 170$ ££ ammunm&x wv 44o$£i tmitmm&m WU 500-530$££ 4>8S#li4>liAI# WG 169$ ££ MEnliPlnffilS WE 312$ ££ TlfUiTlItfiSI WU 600$ ££ mmmummmmm. wu 6oo$££ I5l£liii8S WW 358 : ISi^^XXX WW 358$££ ft^li*SM^I WU 240$ ££ JFMfl44 WO 640 mmm sf 901 ffi*lfIPKr4^4 (Preprosthetic Oral Surgery) (£*fi|wHij &mb LT£-0PJgy4£r$^£ mtiim&W.bLXCoam'Xm (Surgery, Oral, Preprosthetic) WU 500 mWmWGfc (Prosthesis Design) WE 172 WiWiifc. £ £ *¥U® (Mammals) ■MmmmbLX QY 60.M2 mm sf 600-1100 m^ sf ffX§j)m QL 700-739.3 mmvm (Oviducts, Mammalian) (£W'f$££ # (Bone and Bones) WE 200-259 xmm WE 200 mm WE 168-190 &W. WE 190 ■§4£ WE 100-102$ k££ ftWOm (Osteotomy) WE 168 mi (Nevus) WR 500 mmm qz 310 fc¥- (Poppy) (£7x$££ 71* Y X (Povidone) WH 450 7" t F* x 3 — F* (Povidone-Iodine) tm&%t LT QV 231 m (Cheek) WE 705 7$*7 (Nux Vomica) (£X F 0 =r-X $££ *^t^^x^ (Homeostasis) QT 120 fc,9 7>*•>- (Homeopathy) WB 930 Hi* Ml WB 930 ivumbwum ws 366 t#',i:*'Ac*w"£tzU3k — ^llu'j^; (Pharmacopoeias, Homeopathic) WB 930 7* (Homosexuality) {£[5414*$ HQ 75-76.8$££ 7^E7t°xxx (Homo sapiens) (£tF*4$££ 7^ExX7X)^*ii! (Homocystinuria) WD 205.5.A5 7^E4£PH£ (Homozygote) QH 447 *MMt>14 WO 680 ffc£Jt!i (Resorts, Health) (£1**itilE:$££ (**itilE (Health Resorts) WB 760 ItfSt WB 760 7 — 70 y* 774— (Polarography) Mmftffi QD 272.E4 £it5rtJf QD 116. P64 7'7X (Boranes) QD 181.Bl mmm qv 239 77 X7 4 7 (Voluntary Workers) *i^ftlzfci£!>-eft[£*??P£77X74 7 WX 159.5^$£ £ mnrnmizisitz wm 30.5 tt3?mtizisitZ> HV 41 a:co%co'tt^u, xm.mz 7 'J 77*y x X- 9 /; ®? ij 7-X (Poly ADP Ribose) (i 7>JADPiJ7-X$££ 7°>J7i K (Polyamides) UmMltkfcVT 5 K$££ 7 ij 7 ^ x (Polyamines) QU 61 Mmitm HUffiS* QD 305.A8 3?#J£ QD 341. A8 7° 'J 7 X x 7 A (Polyangium) liMyxococcales$ £ £ 7° 'J 7 X -x7 Af4 (Polyangiaceae) l£Myxococcales$£ £ 7 iJ 4 X x7 x^ (Polyisocyanates) 7°iJ7xyx$££ 7 iJ A 97°V—JV t) Lm (Polyisoprenyl Phosphates) Xitm QU 85 mmm qv 633 7 'J 4 X 7°X — X 0 /CBt*ft (Polyisoprenyl Phosphate Sugars) QU 75 mmnbtx QU 85 fc ij 7 X y X (Polyurethanes) 1t74x^T TP 1180.P8 ^#gWlz1£ffi£;ri&J#^l£±lISiJ(z, fyiRlifvffffiSi ffl<-0l4ffi-t£ WF 490 7°ijx7xx (Polyethylenes) It^M TP 1180. P65 $mt>:Bfoizi§im2tiz>t%&uxmi\iz, fyijx.ii-p^f- WitfFnmmmxmmtz>m&u wv 230 7°iJx7XX7X7yx— F (Polyethylene Terephthalates) WM^>v-Ti!BU WI 960 759 *ijx;u + Sift TP 1180. P65 A:COttLCoWKBmz&mZtlZ>%i&U, xmwiz fc\)*jv*y (Polyergin) (£TGF-<-y$££ fc*)i&it¥->V (Polyvinyl Chloride) itmftffi TP 1180. V48 fc ij&ffct*7i — JV (Polychlorinated Biphenyls) 7xAW&m%bLX WA 754^ *Stffi$KfcLT WA 689 Mmitm QD 341. H9 mmm (-fe) qv 633 fc ij fc (Poliomyelitis) WC 555 7-KfcWE WC 556 fc\)fc7A)VX (Polioviruses) QW 168.5.P4 fc,\)fc-T7A JVX (Polyomavirus) QW 165.5.P2 7° ij fc ftJScJS (Poliomyelitis Immunzation) l£-7° 'J fcCOX coXXHbMiX WC 556$££ 7 'J fc 7 y 7 y (Poliovirus Vaccine) WC 556 7iJ^iDxy7x (Folliculostatin) (£4xttx$££ 7° ij 7>v o - x (Polyglucoses) l£ 7JV 7 X $ £ £ 4° "J 7/1-y i x^J& (Polyglutamate Folates) (£7° 7 o 4/i-7'jy/i-y ^ x^$££ 7ijyoox7xx (Polychloroethylene) l£ 7° )-y WI 529 ; 8§7° 'J -7° WI 430 ; #7°'J- 7° WV 300$*>££ 7 'J 7*o ^E 17 x —/l- (Polybrominated Biphenyls) m&mwbLx QZ 202 $$**¥* QV 633 *°iJ7oth'7x-JVit&m (Polybromobiphenyl Compounds) t£ 7° 'J 7* o ^E 17 x — /I- $ £ £ 7 'J -^7° 7 Y (Polypeptides) l£^7°7 F* $£ £ 7°'J7-xX (Polyposis) (£7°'J-7°$££ 7 'J •?- (Polymers) QD 380-388 7°'J~3-xXE (Polymyxin E) l£r"jX7x$££ fcv Ay-^mmfcm (pcrj i£pcr$££ 7°'J »)A.K£ (Polyphosphates) QV 285 fc 'J ADP U 7- X (Poly Adenosine Diphosphate Ribose) QU 57 7 "J ADP 'J 7- X -> x y - -t* (Poly ADP Ribose Synthetase) it N AD + ADP 'J fcyjv Y 7XX7x7--f $££ 7 'J ADP 'J 7-X fc i)Ay—f (Poly ADP Ribose Polymerase) (£ NAD 7 ADP 'J fcyjv Y 7 x X7 x 7- -t$££ 7 y I -C (Poly I-C) 7V&.m QW 800 mmm qv 268.5 7/uxo ij x (Forskolin) £1t*f* QU 85 Sf*^ QV 633 fc.iv 9-^-9 'J X7 (Holter Monitoring) it^Yf^-L^ ^$££ 7/1-7*7 7 (Bordetella) QW 131 fcJVYT7®i&lX. (Bordetella Infections) WC 340 7/1-7 4 'J y (Porphyrins) QU 110 m*9Ayu, A:ti&mx:zti2>jkmz, miu^^y v¥yizm&l?ziiCOit WH 190 7/1-7 4 'J >*£ (Porphyria) WD 205.5.P6 ftft9 A 7°l£A:ti&mX£ tlh*M(z 7/1-7-/1-XX7/1- (Phorbol Esters) mmrnmbtx qz 202 7/1-7-/1- i 'jX7-F7-ty-F (Phorbol Myristate Acetate) (£7 F 7Y7 9 A JVfcjvfc-jvy-¥9- Y $£ £ 7/i--viJx (Formalin) li7s/l-A7/l-7t F*$£i 7/1--^'J ym&L (Formalin Test) (£^*lj|i|^$££ N (5)-7-/1-^/1-7 F7tF*o7^X-F (N(5)-For myltetrahydrofolate) (£o4o,7'JX$££ 7/l-A7/W7*t F* (Formaldehyde) Mmitm QD 305.A6 mmm qv 225 N-7./1-A4 ^ K4/1-7x7-^4 yy (N- Formimidoylthienamycin) it A ^ ^ 4 A $ £ £ fcjVEy (Hormones) WK 5t$X QY 330-335 &14^(£147/n-:X WP 520-530^ ; b&ZfcJV±y% $££ mz WK 102 f§14<7)(£147/i-*x WJ 875^ ; b¥fx.oofc)V*yt* ££ %mco WK 180 ftW WK 102 X704 F* WK 150 \mmm wk 190 TYJV^y&M-mm (Hormone-Dependent Neoplasms) (£7/u*x1£#14M$££ fc.)V^:y^Mifc.mm (Neoplasms, Hormone- Dependent) QZ 200 WiftiXniiCOUUmiz fcJV*:y&QM&m (Contracaptives, Oral, Hormonal) QV 177 fcJV^yg&fo (Receptors, Hormone) WK 102 |g^14y>^c7)|£^1iJ?iJ[z ^^ 7/l-^E X ^*#ft:<7)-g ^. $ t £ £ fcJV* ymWAtt- (Hormone Analogs) U&fcfc->V*: X$£ £ 760 -?9t>A 7X'J 7®'&fiE (Borrelia Infections) WC 406 mmm sf 809.B67 fcsUijAyWt&M. (Holocaine Hydrochloride) liF»jl')rl# BNH$£i fc o 97 7 4 (Holography) |f# (^S-fO QC 244.5 fcjfl TA 1540-1555 1*3*^ QC 449-449.3 tfD-7A (Polonium) WN 420 mmrnm qc 796.P6 ftWUllBlfift-wTw^* r t' 7 ^ * $ ii £ £ tfotK'JK (Borohydrides) QD 181. Bl mmm qv 239 4'!i143'-3egjM& (Essential Polyarteritis) (£*£Kn14l*-fi !)«&$££ ^ffitt^St'ttSBSK^^ (Hyperlipidemia, Essential Familial) l£)l&Wlfil*£$££ fcyY7Ay (Pontocaine) (£7 F 7 # 4 X $££ 4^t (Instinct) mm QL 781 ,|\JI¥ BF 685 tt£«t»«¥ HM 255 4cc7)^aiL (Circulation of Books) liBM^-exw T^lttfiL Z 712-714$££ *Xt^r7y*x;u (Toads, True) (£13-77x71^4$ ££ 7X->y* (Protein Processing, Post- Translational) QH 450.6 SIR* (Translations) ^M^l$££ v4yo7x-7* (Microwaves) TK 7876 wmmm wb hi \hmmm wb 510 -?A 9 v7y-tJV (Microcapsules) (£x/7°-t/l-$££ -yA 9 -o7YJziv\t (Microencapsulation) (£P£iJ$££ ■?A9 v'&.jAMx.m (Microfluorometry) itmmit&Wlx. £$££ -?A 9 do y¥^. — 9 (Microcomputers) QA 75.5-76.95 WmfrffiztSitZmmb LT mm (-fe) iZisitl W 26.55.C7 (NLM^I®ST(iJl^S:#^-26.5) ?y¥i.-9Xm TK 7885-7895 oxt^-7$&££ -?A 9vy 4 JVA*it (Microfilming) TR 835 mWmiztsitl Z 681 fPBiJlzioltl) Z 265 -74707° o-fe7-7— (Microprocessors) (£■74 y d o x ¥^-9ZflX -yA zis<9 7 y 7-fex (Mycobacteriaceae) QW 125.5.M9 7^f 37°7X'v*|i^ (Mycoplasma Infections) WC 246 mrm sf 809.M9 -y A Z3y°y X-yW^k (Pneumonia, Mycoplasma) WC 209 -74o7°7X*-7g (Mycoplasmatales) QW 143 v4 o7°7X'-vg;gife^E (Mycoplasmatales Infections) WC 246 ^M (Burial) WA 846 *Jf£!&i7& (Funeral Directors) l£*Ef44Ii£lg$££ m&'gm. (Mortuary Customs) I£#j\$££ -y A Y y x X (Mitogens) QH 605.2 v4 Y-^Ayy (Mitomycins) QV 269 -^ AY— Y 7 y*y A 7* (Tranquilizing Agents, Minor) (£1t4^'$«$££ W.iktti (Tootah, Impacted) WU 101.5 •y7X (Mice) "nmmmb lt qy 60.R6 m& SF 997.5.M4 -77XWfj^7 4/l-X (Mouse Thymic Virus) l£-^/U-^X 74/l-X^4$££ -7 7X11*17 A JVX (Tumor Viruses, Murine) QW 166 v7Xf4Jfll*R7 4 JVX (Leukemia Viruses, Murine) QW 166 -7x7*4 74/1-X (Maedi Virus) l£ h'Xf-vxf-f 7 4/l-X$££ -yx-T'4 - ¥Xfc7 A JVX (Maedi-Visna Virus) (£t*X 7--vx7*4 74/l-X$££ m^%W&W$& (Prepaid Group Health Orgaizations) Ii1*flt*£*$«*»$ £ £ wi^^MM&mm (Prepaid Group Practice) li£pi:itij& ^mmm&mzfix f]lp]§|^^ (Prospective Studies) mmizis it i> WA 105 m*Y ¥y9xii, XMftliZ -y-7-mM (Marker Antigens) UAtitmUZflX v — 77*'J X (Margarine) mmtfrxummmzisit&ffitibix wb 425 Xitm QU 86 £$tffiXbX^m WA 722 -7-7^'X-yF (Marguerite) (£E&&^$££ -7^-7^'JXA (Machiavellianism) BF 698.35.M34 ■y*7'A (Snails) QX 675 ii (Membranes) *ffl8fel£*H)!^ QH 601^$££ ^'JtU^m QS 645 H$££ &U.m QS 532.5.M3 tmammm qs 532.5.ms $££ mm WU 240 x770Xl£x77°XH£ WL 102.8 $££ mmwumm we3oo$££ ^mmi&l&la- (Oxygenators, Membrane) WO 162 m*BtY)izmm2ti&t%&uxmmiz, mtumikyy l£ WO 184^ mmS (Hymenoptera) QX 565 8IM6K (Membrane Proteins) QU 55 8gJlS& (Membrane Channels) l£ 47x7^x4 JV $££ H'Sli (Membrane Potentials) xmmmm qt 34 mmm qh 601 ixm qu 120 xmm QS 532.5.M3 761 -79 Y09 'Ivft^taK (Membrane Glycoproteins) QU 55 ^^74^(4(Transmembrane Potentials) (£9f*€14$££ vr*-x7?L(Milk Of Magnesia) (£7K^1t^74x7 A $££ -y 9 fc y 7 A (Magnesium) im QU 130 mmm qv 278 mmm qv 278 -774x7A77XxX F 'J -fo^y-r 9— M. (Magnesium Adenosinetriphosphatase) (£Ca,Mg- ATP7—1$££ "^74- x 7 Aft5.SE (Magnesium Deficiency) WD 105 mmm sf 855.M34 -774x7AADP (Magnesium ADP) (£ ADP$££ -7 74 x7 AATP (Magnesium ATP) (£ ATP$££ -yYfcy7AATP7-7*(ATPase, Magnesium) (£Ca(2 + )Mg(27)ATP7-7*$££ mm& (Membrane Fusion) QH 601 mW)^ (Membrane Fluidity) QU 34 -v-y DyD7*y XKE-fE (Macroglobulinemia) (i Waldenstrom 77 oyo7*y XjflL^$££ -7 y d 7 7 — x (Macrophages) WH 650 ftimizts^X QW 690 -y 9 o 7 7 — xn&ttlt' (Macrophage Activation) QW 690 77n7r-^Hfe^lf#H^- (Macrophage- Granulocyte Inducer) (£CSF$££ -y9 D77 — -xS^y^lLH^- (Chemotactic Factor, Macrophage-Derived) (£4 xy — o4^fX8 $££ I#@£ (Anesthesia) WO 200-460 Mmm WO 245 omrm wg 46o ^^^^^^^{cA^ti^^o WO 245 nmu WO 235 ~$4:LI>*!t*(£l#g^^ QV 81^ ; ^FJrJwS* QV 110-115$££ %xm WO 445 tvjtmbwjm wo 440 *a*E»J{ii££Hft& WO 450$££ -zwrntzmmmummmnmrnm wy isi$££ ^aii)!t* QY 58 mmm sf 914 m%immm wo 200-222$ & £ £ l#B£[SH!$I (Anesthesia Recovery Period) WO 183 JftBH* (Anesthesiology) WO 200-460 'jtmbArcomnmmmu, wm^xmvjmbwjm ^$££ $mm®)X (Anesthesia Assistants) UmmMm.* flX M-W&mM (Postanesthesia Nursing) WY 154 fc8?m¥km (Preanesthetic Medication) WO 234 Ifr5W1#fl*f (Nurse Anesthetists) WY 151 !#«£• (Narcosynthesis) (£fi*Mi£$££ fc&m (Anesthetics) QV 81 mmfomrn WO 375 femftmm wo 375 m^uwipammm qv 115$££ mmm qv 95m tb fix Wf-f&mT y x.' WO 162 -yXX-<9 Foxot- (Mass Spectroscopy) (£RlrU ^y F/i-^-^$££ -yX9- Yit&m (Mustard Compounds) mmrnmb lt qv 269 itmmmmn qv 666 Mmitm mmwkit&m qd 305.hs -yX9- Y7'X (Mustard Gas) mmm^bix qz 202 itmmmmnbix qv 666 -yX9— Y^m (Nitrogen Mustard) i£Xyoxy~x; ■?x9-Yit&m; Tfcf><; Fyx7xxxy^x$ ££ -yX9-YmmNmitm (Nitrogen Mustard N- Oxide) (£X7oxy i X$££ ■vxy- Ymt&m (Nitrogen Mustard Compounds) QV 269 ^#-X>*XfcLT QV 666 -yxY5X (Mastomys) UfcX5M£flX -yX9Y4T (Mass Media) P 87-96 wwy ¥y9xu, xmmz -vXyJS. (Madura Foot) (£-7X7 ^ o -->x $££ -yXy 5? — yx (Maduromycosis) WR 340 -7XX7M (Madurella) (£^®*S$££ "77*xy (Magentas) (£0-7'- 'J Xife¥4$££ v/tXA (Masochism) WM 610 vf- (Ticks) QX 479 """*9 — A X7xX7 — x a X (Tick Infestations) WC 900 M WC 900 mmm sf sio.t5 SBeS* (Lacunar Dementia) (£MID$££ Wt>ftnmm (Qantum Theory) l£xX7A:gfj*J$££ flr-J< 914® (Town Planning) UUmMZflX ^.m^mm.% (Renal Disease, End-Stage) (£1t'l4^4^^ $££ Xim^X^: (Renal Failure, End-Stage) (£1i14^^^r$ ££ mX\ (Eyelashes) WW 205 -y-yY-y (Massage) WB 537 rfcX$7y- — TJvm (Catheterization, Peripheral) -fe WB 365 ^JfiLf^-t (Peripheral Vascular Diseases) WG 500 -700 me. WG 500 fVJtmb&h'Jtm ws 290 mmm sf sn ^fftlfiLM (Peripheral Angiopathies) l£*ffilfi-/g:*££.$ ££ %YHffrW.7T — Tivm (Venous Catheterization, Peripheral) ii^.^7 7-7/l-iS$££ ^ffWiii (Peripheral Nerves) WL 500-544 mw& WL 330 ; 1?mtt& WL 400$ iiflX fc^ffiW&.JX&.lXi&U (Nerve Compression Syndromes) WL 500 ^.tfm&?h (Peripheral Nervous System) WL 500-544 X-YHW&?km& (Peripheral Nervous System Diseases) WL 500-544 762 VX--&4 y fvmbWJtm ws 340 mfii&nii<7>UftX'Mlz mmm sf 895 £tf?ttt&&ft (Peripheral Nerve Diseases) 'i*tfTM"*|* i7S$££ ^ttWiSffi*! (Peripheral Nerve Neoplasms) WL 500 Pi^tt^tWli^fiSiJlz %t$1&m (Peripheral Resistance) liJfo.'*'f1&#l$£i fc^W)M.7T — TJVm (Arterial- Catheterization, Peripheral) 'i*t8-$r-7n-i£$££ -y7 9 7Y\ (Agaricales) QW 180.5. B2 fc-m WD 520 5MSJ74 * y 'J fc9 9 V fc 7 YU®mm (Terminal Deoxyribonucleotidyltransferase) (£DNA ? 9 yfcA-y ;nJfV F7XX7x7--t$££ ^itlwmm (Terminal Addition Enzyme) l£DNA* 9 ytA-y>V^*9 F7XX7x7--t*$££ •vyFxX (Mattresses) (£^<7F'$££ ftlt* (Crutches) WE 26 v.=.jl7/i- (Manuals) ^nmmfix -y-i.X9 'J 7 F (Manuscripts) Z 66076625 m^'&yx (Paralysants) QV 667 »*14^.S (Paralysis) WL 346 }g-£/ll£ Parkinson*£ WL 359$££ m®z®w& WL 610 mJY9\ (Maprotiline) QV 77.5 $im (Magic) g^co WZ 309 Wmm BF 1585-1628 -yfc9-y Yffc (Mohammedanism) (£4X7A$t$££ -y^ym.mm(Pit Viper Venoms) I£77-777-7^t*4#$ ££ 7A->i-b ij x7°o77 — -fe* (Agkistrodon Serine Proteinase) (£ 7 X X o -y F*$££ vX (Beans) !£Wf4$££ vy^fflg (Legumes) mm^Rt/mm^^m-kb lt wb 430 kmWmb LT SB 177.L45 Hffltg&fcLT QV 766 mmm qk 495.L52 Ifr*7>£ft;$&££ I^*1fil5L* (Narcotic Antagonists) QV 89 mmmmm (Narcotic Analgesics) Ufc¥fcA KfftffiH $££ «**»fS (Narcotic Addiction) (tft«f^#$££ itV&lk*H (Narcotic Control) (£[7&B^fc I#*OJiJ*Ji'-'J $££ mm^mk (Narcotic Laws) l£*-#*t±:fg$££ -yjVYxX^ (Malthusianism) (£AP®Jli$££ -yjv9—¥ (Maltases) l£7/l-7 7 7/1-o x7--fe*$££ -yJV9^. (Malta Fever) (i7"/l--t7*£$££ -yjvY-X (Maltose) QU 75 -yyA X®?x7 77°y JV (Enalapril Maleate) (ix7y7 'J/!-$££ -yyAym^ (Maleates) QU 98 Mmitm mmmt&m qd 305.A2 -yy—y! (Granulocytic Leukemia, Chronic) (£lf14#l£14l4JfiL*fi$££ 1i14l«J'!nlJ7-7 7 (Arthritis, Rheumatoid) WE 346 \m&m*.wm*mmm%m (infectious Mononucleosis-Like Syndrome, Chronic) I£1i14*i£l77 *£f£^$££ 1#14#fS!1413tfn.m (leukemia, aamyeloid, Chronic) QZ 250 $Mmmm qz 350 1f 14*£.£. (Chronic Disease) WT 500 %V)tmbWJim ws 200 mm wy 152 *7&P01H WT 30 tt14frl*ll&*£ (Renal Insufficiency, Chronic) l£1f14W 763 -7>-tA y 4^$££ 1#14TT4^ (Kidney Failure. Chronic) WJ 342 t#1t.AiMJ§]R]& (Periaortitis Chronic) (£?£ll£flll^*£-ffi $££ 1#14^14f4]ft.*rt (Leukemia, Monocytic, Chronic) WH 250 &ikmmm qz 350 t£14**4ig^ (Lichen Simplex Chronicus) l£ *>(•*£& It £ $££ tt14#^l14ll*H: (Jaundice, Chronic Idiopathic) WI 703 1114faX-m& (Granulomatous Disease, Chronic) QW 690 ti14liw1!1i (Brain Damage, Chronic) WL 354 ivjtmbwjm ws 340 1#144MLH14ffi£14ltJ§]& (Periodontitis Apical, Chronic Nonsuppurative) itm&fflm$lWm$: fl X ti14&)ifx "J t~? Y —YX (Lupus Erythematosus, Chronic Cutaneous) (£P445#cx iJ7^F-7X$££ i^.OM^&.i^M (Fatigue Syndrome, Chronic) 7A)VXiXm^.b LT WB 500 mmXW WC 146 •ht14P^14IiU*?7t. (Chronic Obstructive Pulmonary Disease) UmmitUmB $ £ £ 1t'l4'J Xy^J^'ffifiJflt*^ (Lymphoblastic Leukemia, Chronic) l£1f 14 'J X ' ^44|4 JfiL*?! $ £ £ 1114 0 X^14fijfil*F! (Leukemia, Lymphocytic, Chronic) WH 250 ®Mmmm qz 350 1t'l4Epstein-Barr7 4/l-X^fS^ (Epstein-Barr Virus Syndrome, Chronic) l£1f 14«*Sfl;g¥$££ ■yyYyY (Mandragora) QV 85 ■yyYJvm (Mandelic Acids) QV 243 v/fD- F 'J/i--<-y7'x77t7x F* (Mandelonitrile beta Gentiobioside) UT 5 YY^) X $££ -^xFtt (Hamadryas) l£tt$££ -7XF*iJ/i- (Mandrill) l£tt$££ -7X-F-/1- (Mannitol) QV 160 $ 7X7 "J X (Mianserin) mi^mbLX QV 77.5 ~ x o 77 7 4 (Myelography) WL 405 5fcA9yY—JV (Myoinositol) 4 X x F — /!-$££ 5fc9a — -X/lfrA, (Epilepsy, Myoclonic) WL 385 $ 7 y o - X X (Myoclonus) WE 550 ~ fc 9 o X XWM(Myoclonic Jerking) U5fc9v 9 XX ^^$££ ;t7D-7Xt^H (Epilepsy, Myoclonus) l£ i fc 7□--t^HJ£J: i47otx (Myoglobin) WH 190 1^34*4 QY 455 i-4 7ot*XiH£E (Myoglobinuria) WJ 344 i*r-- (Myotonia) WE 550 5fc'^'^^^,-^ (Prospectiva Payment Assessment Commission) £ iiii, v -> M L it (Reimbursement, Prospective) (£;£&!,> £&^3ns;$££ £Ji^3S^ (Prospective Reimbursement) (£;£&t>£i>i ^/7i\$££ yfciio^ (Unwed Fathers) l£#F4i§ai$££ Xircom (Unwed Mothers) l£#4jg,r,1$£ £ XzB'Ji (Infant, Premature) WS 410 X^WJtm^ (Infant, Premature, Diseases) WS 410 Xm'JtWfefc (Retinopathy of Prematurity) WW 270 7k (Water) ftYfc WA 686-689 mmm<^it7Ymxmm qw so$££ mmm qv 270-273 tfcl^kfc LTcT) WB 442 ffcffi WI 102 ; *&7k WA 675-690$ &££ «affi-¥*l£*f^f*^ QW 80$££ xmu7b-n.Mis.xffi qu ios$££ ¥»^^(£7k-'«^H¥»^^ WD 220$££ ftttt QU 120 ^47/M£!£7k WB 442$££ mW)7jco QV 785 mmm qv 270-273 te^^'Jffil^Ktefra- WB 520 ; &&¥ WB 525$ ££ &?k WB 525*^$ &££ ;X7-743r-x^ — x 3 X (Misarticulation) UffisW *#$££ & 7 ^g^fc&l: (Webbed Fingers and Toes) l£1f fc St^ X^^M WE 835$££ ;X'37I (Sphagnum) l£tfi^*$££ Mmi (Water Consumption) (£#*ffl$££ 7km^S (Water Intake) !£tfcffl$££ *-n.MMXffi (Water-Electrolyte Balance) QU 105 Jk-n.MKXffigft (Water-Electrolyte Imbalance) WD 220 7Ktfc"MTfiJ (Drinking Behavior) %M GT 2850-2930 7W&kX.mm (Water Microbiology) QW 80 ^foW&MU (Immaturity Syndromes) l£A1§^S$£ 764 i>9 X 5-t/V (Micelles) Xitm QU 133 i7v*7A (Midazolam) QV 85 HH& (Three-Day Fever) I£7x7 a 7' (Rubeola) (ifl**£$£i 7£o4- (Triplets) WQ 235 %Xm QS 642 Asmm WS 105.5.F2 ®mXW'7>aSi± (Centrifugation, Density Gradient) &mtm qy 90 *I^1L*^ QS 531 fc-offcoF t°7yxi£, iMS'Jtz &7tm (Street Drugs) SLffl WM 270 me QV 55 na^ QV 38 mTtmfcX Y (Street Drug Testing) !£!}*KSLffl1tai$£ £ ~ 7' 'J 77 F U'^V X — -y& (Trypanosomiasis, South American) (£chagas*S $ £ £ &7X ij 777*7 X F ifeXSE (Blastomycosis, South American) (£^°7 o y v v7 4 7X£e$££ 5fc9 9 Z^kY&UM. (Minnesota Multiphasic Personality Inventory) (£MMPI$££ 5 9*yy>V (Minoxidil) QV 150 i 7 74 y y X (Minocycline) QV 360 *&#fc4~:i|xA£ (Accounts Payable and Receivable) Ii^f4$££ ^ 7 x 7° 'J X F x (Mifepristone) SBSUfcLT QV 175 mxmb LT QV 177 m^Y ¥-y9xu, xmm\z #ffi0 (Gestures) ^Xm WS 462 %i'jimb&]>jtm ws 105.5.cs Asmm BF 637.N66 4h^C>a^ HM 258 ttitMmmm (Dysgerminoma) QZ 310 RB!!14'7Hc7)(£g[-tiSiJtz ttMWf£Wim7 A JVX (Vertebrate Viruses, Unclassified) QW 169 ytttrA (Widowhood) HQ 1058-1058.5 ftVkY ¥-y9Xit, XMWZ yktlkb^^iiih (Widows and Widowers) (i*t:A$ ££ fl%%m% (Guest Relations) UmUfc^Wimifc* fl X n (Ear) WV 200-290 n-m WV 200 IT&*> (Ear Wax) (£^iJg$££ UX' (Earthworms) (£»€*«$££ Jp.§ (Tinnitus) WV 272 Mcomm (Ear Protective Devices) WV 26 %jtmVL (Identification of Persons) itmmm W 786^ JkVttftitto mtmco % ft: $ £ £, PR li**^ ;tt7">S (Podophyllum) mmrnmb lt qv 269 xmb LT QV 75 mmrnmb lt qv 767 tp# WD 500 1^A P (Vascular Access Ports) (£^£77 7-7/l-$£ £ Hm% (Angiitis) U^'AZflX m^&mmm (Neoplasms, Vascular Tissue) QZ 340 m^ftfo (Endothelium, Vascular) WG 500-700 mmm QS 532.5.E7 M^X'®®, (Muscle, Smooth, Vascular) WE 500 IfaFJ (Pulse) •bHJliL'g'*&»f WG 141 -fetoH* WB 282 JfiLfflEfMffi WG 106 m&m. (Choroid Plexus) WL 307 m&m (Choroid) WW 245 nm WW 245 IB&BH& (Choroiditis) WW 245 m&mm& (Choroid Diseases) WW 245 Wi&Mmm (Choroid Neoplasms) WW 245 m%&mmffi (Detachment, Choroid) (£JIfc&)II$££ Wi&'fflM (Chorioretinitis) WW 270 ^ x— 0^*5707*0 X (Immunoglobulins, mu- Chain) QW 601 **£ (Taste Buds) WI 210 X%m (Futurology) (£4=-ai|$££ 5JV9-TJV7 y*Ef£g¥ (Milk-Alkali Syndrome) (£i^7 /l-x7Ajfn.*£$££ i/l-y7X (Miltown) I£X7°ovnV-F$££ ^ y-y 9 X (Mirex) jgH SB 952.C44 ZMffiX WA 240 Rfmm (Folk Medicine) UUmmmtflX Effflft (Privatization) ^*^-ff(i±is«ijiz, miumw&xy-¥xu WM 30*g S^fS* (Folklore) GR ^KiiCO WZ 308 mm-r ym^JVfc.7 A >vx (Aleutian Mink Disease Parvovirus) QW 165.5.P3 i y 9W&7 A JVX (Mink Encephalopathy Virus) Ii7° 'J4X$££ KS** (Ethnic Groups) 3y§s£-7l$££ &f&mm (Ethnomedicine) l£fS^c[S^$££ &mm (Ethnology) GN 307-673 mmmm (Ethnography) UXitkmmZflX &m^mm (Ethnopsychology) GN 270-279 faUM Ykmm) (Unconscious (Psychology)) BF 315 WXm WS 462 fVJtmb&h'jtm ws 105 ffi-f*##f WM 460.5. U6 fej&;& (Salt-Free Diet) i£M^^$££ te'JSyy,*o (Tobacco, Smokeless) fcM WM 290 mmm qv 137 M'M^mk (No-Fault Insurance) l£|(f£l£P£$££ A777 (Centipedes) I £ IS £f/)"(*$££ 4&m*m& (Granulocytopenia) (£SS^[^M^*S$££ fem474K^JFMfl$-'E (Anhidrotic Ectodermal Dysplasia) (£t4E^^JF^**£$££ te77*x-7yn7*y Xlfo.-'E (Agammaglobulinemia) WH 400 ^mAfcy (Inorganic Ions) (£4 7x$££ ^mitm (Chemistry, Inorganic) QD 146-197 &1*R (Minerals) Xitm QU 130 %Lmm QE 351-399.2 #(ZH5LT WE 200 ^mW^'VA-aA Y (Mineralocorticoids) WK 755 ^mWXitm(Inorganic Substances, Biochemistry) (£, 4£lb*^$££ S&mmm (Inorganic Poisons) (£#1*$££ &AB (Atelectasis) WF 645 fe^'lfc-'E (Anosmia) WV 301 ll^lvTX (Athymic Mice) (£* - F"-v7X $££ &**«£&*£ (Sulfates, Inorganic) l£6ft^il$££ &m »J /imiU. (Phosphates, Inorganic) (£ 9 /L^$£ £ fell (Asepsis) mm WU 300 yfcm WO 113 SSPE (Mouth, Edentulous) WU 140 -cotzibcomM WU 530 feS«E (Anodontia) WU 101.5 *Sffigj:|* (Germ-Free Life) %mm QY 56 ^^(Aj%mt, xmmz mmrnm qy 56 V<9> (Dropsy) l£M$££ feJ^Mlfo. (Aplastic Anemia) (£#4:4^14S:KiL$££ feJ3ig (Amenorrhea) WP 552 Mmsmm (Speech, Alaryngeal) WV 540 *Pf"ft (Apnea) WF 143 ^ "^ £"Ji*iE 1 S (Mucopolysaccharidosis I) WD 205.5.C2 ^ => £*f*iE 4 511 (Mucopolysaccharidosis IV) WD 205.5.C2 A o £*|f^ 5 59 (Mucopolysaccharidosis V) Ii A 3 £fl,i- *£1S$££ ^3IfiI (Mucoproteins) QU 55 MftfoitmiZtsit Z> QY 455 fes*£ (Mutism) mMbM&fchi%& WV 280 -C>H'|4y> WM 475 tX7'J-14c-0 WM 173.5 ^ft^'JO^O &£*#£(£, PJlSiJlZ fel7Jl4feM WL 348 ; b ■) & WV 280$ t££ temm& (Cell-Free System) QH 587581.2 felP-^lt (Randomization) (£#Sl^fiJ14lt$££ ^i¥^im,JfcU.m (Clinical Trials, Randomized) l£feft- &itmmm£fix Mt&itttmmmm (Controlled Clinical Trials, Randomized) iimWtmmm $ £ £ mt&ittmm&k (Randomized Controlled Trials) m*Y ¥-y9xu, xmm iz smmziifix Mff^tlJttlt (Random Allocation) (NLM^II^T(£Ji:^S^-20^20.5) f&m& (Achlorhydria) WI 308 4&mm$a.1iE (Anoxemia) WF 143 &mzM<zt%& WD 715 MAJ±izffi&Ltzm& WD 655 ^mm& (Anoxia) WF 143 frfZUMlUm WD 715$££ mtm^mm& wl 355$££ wjiim'jitemmm wq 211 $££ m7mm wd 655 4l$iJ$tL (Insect Bites and Stings) WD 430 $&iBfckmm (Nondirective Therapy) WM 420.5.N8 Aft (Dental Decay) (£^|4$££ A y^-)V^\fc- (Receptors, Muscimol) (£GABA-A5 W$££ fefciSfteSE (Aphakia) WW 260 ^fem (Carbonic Anhydride) (£-$*4U*2g$££ ^7Y.m (Anhydrides) Mmitm mnwat&m qd 305.A2 7?&mit&m QD 341. A2 mmMizmmzti&iij&uxmmz, miumtann mmwiw-^Moitz^co qu 55 AX^iJ X^Ia^J (Muscarinic Antagonists) QV 132 AX77 ij X^^ft: (Receptors, Muscarinic) WL 102.8 AX77 y x^f^ffl!)*® (Muscarinic Agents) l£o 'J xf^ffl 1*SC$££ AX7> (Mustine) (£xyDxy£x$££ l&lfWhmfcJV^y (Invertebrate Hormones) QL 364 Ay—t (Mutases) (£7 =r x F* y Y9 9 —1$££ mim (Whiplash Injuries) WE 725 A7x (Mucins) QU 55 feffilixX F (Analgesia Tests) l£*?ffiil^$££ feffi^Jtl7\$iJ^ (Analgesic Cutaneous Electrostimulation) imfem&n.W&mMm$: fl X iS*f m (Analgesia) WO 200 6tmzts^XUmmmm WO450$££ %j&m.m WO 297 mwtm&m wo 234 766 99>X)V mmm sf 914 MIMJcSI (Weightlessness) WD 752 UUXftif (Akinetic Petit Mai) liy\-#TA-rt^$££ *|Jj'f4feS*£ (Akinetic Mutism) WL 348 %M& (Anuria) WJ 303 m (Chest) (iWSB £ JU- JU* tt (Heartburn) WI 145 MK-fE (Anencephaly) QS 675 i&Wffll (Anovulation) WP 540 feferT*£ (Anhidrosis) (£5SH4$'>$££ fcf§1**i (Anestrus) SF 105 fSMSS (Anura) QL 668.E2-668K275 IISfcDj^fcLT QY 60.A6 mm SF 997.5.A45 te7 4 7*') 9—YytfaM (Afibrinogenemia) WH 322 &£8* (Innominate Veins) l±»uJKttlHK£ ££ te^gjK (Innominate Artery) (iBfc9fi|M$£ £ l?i§:*iE (Somnambulism) WM 188 £itt#i (Sleep Walking) (£#S*£$££ ti"^>§^^ (Lithospermum) QV 766 iJPI (Purple Membrane) (£-$££ &£t>M£ (Vagus Nerve) WL 330 &£W&%iM WL 330 &fcrt&WmWl (Vagotomy) WL 330 'w^m (Nomenclature) (NLM^IiaT(£J^^#^15) && (Labyrinth) WV 250-258 &¥&■$. (Otitis Interna) l£W¥^$££ *5&77*X (Labyrinthic Gases) UM&tmcoXT<7>f5Ic' WZ 112. 5.07^*5 XIIkZ • ifc.Pam WW 722$££ tbtfte'Khti (Optical Dispensing) l£tfcHM$££ J6**iiW (Opticians) !£ffclltt$££ < 7'fcJV YmiW^mm (Megavolt Radiotherapy) (£rt;x 4/u^f- mmrnm i: fix J%yziA^]) (Axolotl, Mexican) (£Ambystoma mexicanum$££ A 3r-xo3fy 7'J7v7 7x (Coendou) (£!foM$£ £ ^yyfy (Mexiletine) QV 150 /yyx7x (Meclastine) I£?XVX7X$££ /707X/3--7-F (Meclofenoxate) Xit'Y QU 98 mXMb LT QV 101 mmtkm'-Mb lt qk 745 /yo7n-yx (Mecloprodin) (£yx-7X7x$££ / 9 o x 9 5 X (Mechlorethamine) QV 269 ^x7itt (Medina Worm) l£ F* 7 9 X 9 JVXmt&X >< y -Y— Y y y %y A *f (Tranquilizing Agents, Major) um\mmm$:fix Ayy-Y (Mesylates) QU 98 Mmitm QD 305.S3 '-X (Mace) (£7 a Af9 o o 7-b F 7 x 9 X $££ /Xyy'J x (Mescaline) QV77.7 -Jtrx 'J 774 yY4 Ty^-XMizmm^tiim^- E98.R3 yX77'Jx (Mezcalin) I£/X77ijx$££ 9 X Y 7 9 -JV (Mestranol) WP 522 'Mi&mb LT QV 177 9 9 9 'J 7 y XI (Mesocricetus) QL 737.R666 mmrnmb tx qy 60.R6 -^•y F fc LT SF 459.H3 A 9Ty F* o X r X o x (Methandrostenolone) WJ 875 / y y 7 d x (Methaqualone) QV 85 yyj'^AX (Metagonimus) [£^JP&Jfif4-$££ 9 9 o y xfb^!l*(Methacholine Compounds) QV 122 / y — x t F'o Jf-v- (Methadone) QV 89 f£# WM 270 9 9 9 ><9t^)T (Methanobacteria) (£Xyx^lSffll $££ A9 9—JV (Methanol) l£ A j-jVTJV o-;w$££ 7y7°o7X/— JV (Metaproterenol) (£7/Ux7°x7'J X$££ A 9 59'—iv (Metamizole) (£-x'tDX$££ A 9 5 9 yT-¥fc^y Y (Methaminodiazepoxide) U9 u ivyT*£fc*y F*$££ A9yA»m (Methalamic Acid) Ii4 7y 7 A@£$££ yyo74 4 4x (Metallothionein) QU 55 7yo7°o77 —-t (Metalloproteases) xyo7°o7 4 7-7*$££ 7yo7°o747-7* (Metalloproteinases) QU 136 X y x (Methane) wxmitm QW 52 mmm qv 662 7yX77*X (Marsh Gas) (£XXX$££ 9 9yy x 9X (Methandienone) (£/y7XF*oX7y ox$££ 9 9 yXJVfcfc— Y (Methanesulfonates) it9 yy— Y $ 767 99 >-tA ££ A fyXl&mm (Methanogens) QW 50 v y x 7 'J X (Methantheline) QV 132 / 9 X t o x (Methampyrone) (£ y t o X $ £ £ ' y X 7 x 9 5 x (Methamphetamine) QV 102 iHM- WM 270 / 7 7- X (Methionine) QU 87 A A-yi) yim (Methicillin Resistance) mmm qw 51 mmrnm wb 330 mmm qv 354 X77°7Xo-;u (Metipranolol) (£ F 'J X 7° 7 X -/l-$ ££ / 77°Xy*y x (Methypregnone) (£X F* o Jf yynrx 7ox$££ N- s A-JV-DTX'<7 ¥*/&%&& (Receptors, N- Methyl-D-Aspartate) QU 60 w&immmbix QV 126 x77°Xfgit WL 102.8 9 A-JVTY— x$-f$4£ (Methyladenine Receptors) (£7° lJ>5'#^$££ y 7/1-7 SX (Methylamines) QU 61 Mmitm QD 305.A8 9fc)VTiva-jv (Alcohol, Methyl) QV 83 9A-JVX.-TJV (Methyl Ethers) QV 81 Mmitm QD 305. E7 ^A-jvx.jvzi')V7)V'<5 Y (Methylergol Carbamide) Ii 'JXU F*$££ 9A-JVit (Methylation) QD 281.M48 X 7/1-*Y X7 X^*#f£ (Methylxanthine Receptors) (£ 7°y x£*§-f4$££ y7/t-7'J4--r^/KMethylglyoxal)l£t/U77/l-7*t K $££ 7 7^Xoy F* (Methyl Chloride) IfcWtmb LT QV 115 Mmitm MDmit&m QD 305.H5 mmm qv 633 /7/l-oyxFxx (Methylcholanthrene) QZ 202 X7/l-777XiJx (Methylcephaeline) (£xX7x$£ £ X7/1-7/PD-X (Methylcellulose) T#J QV 75 mmm qv 787 X7/i-F*-7>? (Methyldopate) l£X 7/1- R^°$££ 9A-)VY'< (Methyldopa) QV 150 9T)V'7°o7X7DX (Methylhydroxyprogesterone) l£X Yu^yYuYX 7ox$££ 9A-JV7*-jvx.-t)V(Methylphenyl Ethers) l£7-7 -^$££ '7/i-7°x F'-7ox (Methylprednisolone) WK 757 x7/i-7°x f*—x*dx-n ; 7,9yy— y (Methylprednisolone Hemisuccinate) WK 757 '7XXX/U7 + 4-F (Methylenesulfonates) (i 9 y 9 -F$£i X7xxt*X (y do 7-Ox) (Methylenebis (chloroaniline)) ^*S=t*Kfc LT QZ 202 mmm qv 633 9A-yY5 Y (Metindamide) I£4x7'n°= F*$££ £>o£ (Metal Plating) (i^Uj^o # $££ M1S££ (Sterilization) MMztSith WU 300 m\Hiztsith WX 165 fEifcmmmizisiti> wa 840 B&®miz is it & WO 665 7-KE^lz£o(t^ WA 240 yfcmiz is it I WO 113 X>y7X-x7-RNA (mRNA) (£mRNA$££ X 7*4 77/Hr X x y y - (Medical Secretaries) W 80 ^7*4 7 7 (Medicare) WT 31 X7*'yyx (Medex) l£d$ipffi|Jjl$££ X77^X (Methenamine) QV 243 9Y*yyy (Methoxsalen) QV 63 IbffiS WA 744 X F^xt Y'a^yy 3.—JVY^) a—jv (Methoxyhydroxyphenylglycol) QV 82 XF^x7/l-7X (Methoxyflurane) QV 81 X F *^x^7^MMethoxyverapamil)(£77 o^s;u£ ££ X F F x Jf 7 — F (Methotrexate) mmYHmfc qu iss mmco'&mizisith qz 267 Ytco^% Y t y y x(£, xmwiz X F 7/1-77A (Methofluranum) l£X F-rx7/l-7X$ ££ X F7°od-;w (Metoprolol) QV 132 X F^^xy-/l- (Methohexital) QV 88 X F^^-xFx (Methohexitone) (£X F-^xy-/l-$ ££ X F^^EyotX (Methemoglobin) WH 190 X F'-^yo tXjfo.SE (Methemoglobinemia) WH 190 X F fcJV5 X (Metformin) WK 825 X Y7Y—JV (Metrazol) (£-<\)-y-jv (Meballymal) ii-t zt& (Mevalonic Acid) QU 98 Mmitm MDmit&m QD 305.A2 9¥'<7Ay (Mepivacaine) Q\' 115 7 7x7A$ (Mefenamic Acid) QV 95 9Y'v¥ 9 —JV $££ AY-y — JV (Mebumal) (i^X Y'v $££ i — 7°/l-xo y y°m (Maple Syrup Urine Disease) WD 205.5.A5 AYa^A-Y (Meprobamate) QV 77.9 A ~i "J x X (Meperidine) QV 89 #>3:V> (Vertigo) WV 255 ?14l£ Meniere*?? WV 258$££ mm (Melanins) QU 110 A y-y mm (Melanocytes) QS 532.5. E7 /y/y-A (Melanosomes) it A y-ymm^flX Ay9Yv¥y (Melanotropin) (£ MSH$££ 7 y x o y - (Melancholia) (iffll i o14Pf t $ £ £ AJV77°9 5 X (Mercaptamine) (£ x X 7 7 i X$££ X/U777°Fxy y — ;u (Mercaptoethanol) QV 84 ■ffttffr^ QD 305.A4 mmm qv 84 X /I-77 7° F xf^7 ^ X (Mercaptoethylamines) QU 61 Mmitm QD 305.A8 X)V7YYit&m (Mercapto Compounds) liX/U7t K 'J/HL^^$£i 9)V7YY'<'J X (Mercaptovaline) (£-<—x7 i X$£ £ IS (Cotton) ^lf^l$££ &*£ (Immunity) QW 540-949 £!§s£3l$££ ft&RNA&ft (Immune RNA Manipulation) (£$D]ft *£$££ 7t*^JtlS^ (Immunogenetics) QW 541 &S4 X X — 7 x o x (Interferon, Immune) l£4 X X — 7xox2S$££ 7\^&WAii,X (Immune Response Genes) l£MHCyy X2it1S4*-$££ ^A^&^MMfcnM (Immune-Response-Associated Antigens) mmm&iimW. 9 y X 2 $ £ £ ft&tiS&ttM. (Immune Response Antigens) l£IJi^ii^ 14l7tJ^y7X2$££ ft&itm (Immunochemistry) QW 504.5 t£*£^J£14 'J y^B& (Immunoblastic Lymphadenopathy) WH 700 %.&m (Immunology) l£7 x/l-**- fc &*£^$££ %)%$uMk (Immunodiffusion) QY 265 7l&m?i(lmmunologists)iifti'Simi- (Immunoassay) -1ft QW 525.5.13 7/H-rXi!iJ£ QY 330 #J*#IJ(zfclt4tM»f. ^E-y 0 >7& L< lia^ifig-M* lz1£ffl$ii4J»64i. ^w-*»t fe*£'Wv)Wt!Jli#l4 (Cytotoxicity, Immunologic) QW 568 TV&mMmmmiiTX Y (Cytotoxicity Tests, Immunologic) QW 568 ftZcoBtYiizmmZti&tJk&U, YMMlz rl&mW&mMiSii. (Tumoricidal Activity, Immunologic) Ii ftffi W«BII*ai*'l4 $ £ £ fr&mXlMM (Immunologic Stimulation) (££.*£?£$£ £ 7\Mm^)'M&:m (Contraception, Immunologic) WP 630 > m& $ £ £ %JM&ii.Wi (Immunoactivators) l£7x*x'^ff-f 4" y 4 7° (Immunoglobulin 769 >xx*y Idiotypes) QW 601 ft^/D 7y ym.'Y.mm (Immunoglobulin-Producing ceiis) umimxmmzfix fc*£7D7>J X'RSEdGA Nephropathy) (£ft*£7n7'J xA*£fWft&$££ &*§:7d 7 y X-77/#fcfflli& (Immunoglobulin-Secreting Cells) (£4if£it4-:«$££ 7fc*£7o7*y X*|ft£ (Immunoglobulin Therapy) (£^U) &*£$££ yt^yD7'iJ XA&W^i£ (Glomerulonephritis, IGA) WJ 353 &*£7o7yxE (IgE) QW 601 ft*£yn7*y XG (IgG) QW 601 ft*S:7o7*y X7o y 4 7° (Immunoglobulin Allotypes) QW 575 9tf£.3k (Immune System) QW 504 y^Si'Skit^MW^.^m (Immunofluorescence Microscopy) (£3£ytSfif$:if f£^i£ $ £ £ yt*$'St:^:'^frii (Immunofluorometric Assay) (£7/1-7 o4A77y74$££ ft&le'jtm (Immunofluorescence Technique) ii^itm f^7$££ 9iMM.m (Immune Sera) QW 815 %*s4&:i: (Immunologic Tests) BmiZtSitZim QY 250-275 Xft QW 525 WZfa£<7j%Vf$:iiflX 7\Mmmitm (Immunocytochemistry) UftMkWkitm* ££ fiAScY—^A 7 yX (Immunologic Surveillance) QW 568 ft^Jiffc (Immunostimulation) !£&*£££$££ 7tL*S$lJil^J (Immunostimulants) l£7xx'&mM*-9 y •xy', fc L < l£W1iffif* I^iz1£ffl$ri|,ti^|£, ArCOftZfX ftfSc^iAWX&m (Immunoelectroosmophoresis) (£7>7x y-4AyxxyFo7x->x$££ 7^*^1:^7*0 y F i£ (Immunoelectroblotting) (£&*S:7*o 774 >7$££ &*&#!* (Immunotoxins) QW 630.5.13 %Mffi.t) (Immunocompetence) QW 568 ftfSi'M'&m (Immunocontraception) U^.^miiXMt&m^ fix yt&m (Immunologic Diseases) WD 300-330 %.%£fe&ifcm (Immune Complex Diseases) WD 308 •^.S^^SeI^S^ (Immunologic Deficiency Syndromes) WD 308 ft&ftMmm (Immunologic Accessory Cells) UWf,i?£ ^«$££ 7tS7'o y 7 4 x y (Immunoblotting) QW 525.5.132 ft Kftffiz is it ZBffi, *-9>)yYiiL< Itttm&H lzfemZtLZ>t%£lt, Arcofrnx %Ml£.Wl$L'9t (Immunomodulators) (£7xx'm&u, xmwiz m (Omentum) WI 575 XM*fin. (Capillarity) QC 183 **& (Mongolism) (£Down*£f£S¥$££ XM^Sfeil14 (Capillary Fragility) WG 700 X^mWM&\i. (Permeability, Capillary) ii%mfo.W&& 14$££ XMUPlfc (Capillary Endothelium) UMMfofcZfl X X^msk^ (Capillaries) WG 700 770 ^EJVE'y Y ^*ffilfo.|?ra« (Telangiectasis) WG 700 l^lfiL^l< (Capillary Resistance) WG 106 €*ffllfit'g:Sii14 (Capillary Permeability) WG 700 43«B'J >'*& (Lymphatic Capillaries) (£ U X^°&$££ Hm\i (Dictyoptera) (£ii4aJI$££ iJS«*lfit^ (Reticulocytes) WH 150 WAftflJ (Aid to the Blind) l£tt^fyK<$££ %S (Tongue, Hairy) WI 210 &&%] (Hair Colorants) (£ LJy4iftJ$££ -r*J (Delusions) WM 204 SSWW (Paranoid Disorder, Shared) (£ ftftSfSHiW »$££ SlSlttflft (Paranoid Behavior) WM 205 ££1£WfttBW (Paranoid Disorders) WM 205 £ff.14#§HS (Paranoid Schizophrenia) (£(W#t5r^^i$ ££ %m® (Pilonidal Sinus) (i€:m*^$£i ^mftSS (Pilonidal Cyst) WE 750 %&&}£ (Ciliate Infections) li'<7 x7x*7 Afig WC ittxim^&mizx^xmztszziizzrx.ikm&z* ££ f m (Cecum) WI 530 WBH&ft (Cecal Diseases) WI 530 WStK** (Cecal Neoplasms) WI 530 jHl*]*Sr|J!&!tffiSE (Reticuloendothelial Cytomycosis) (i t XF7°7X-vS$££ %mm (Pilar Cyst) (£gS#i&$££ €^W5 (Hair Balls) (£-<77-/l-$££ €fS*l.ft (Hair Diseases) WR 450 X.%^ (Trichobezoars) l£-fc*)U ttffl'JSfrfll (Stereotyped Behavior) WM 165 Kfccoikmztsit&ArtiU, A:ComftX- * X o*o A Y \H (Mongoloid Race) A8r£ GN 548 &fcco T^m Ft^yx$&££ mm (Problems) (NLM^5i*T(£JF^^:#^-18.2) mmm^k (Problem Solving) BF 449 fVJtmbWJLm WS 105.5.D2 T%m^faim%mte& (Medical Records, Problem- Oriented) WX 173 mmem wx 173 Wx.Y ¥y9xit, xmwz ^yy-fcivum (Monte Carlo Method) QA 298 WKY ¥y9XU, XmftliZ HB (Portal Vein) WI 720 HME/LJi (Portal Hypertension) liP^Mr±/ut*iE$£i HMl±7tJi*£ (Hypertension, Portal) WI 720 PM* (Portal System) WI 720 P^M^flSlE (Portosystemic Encephalopathy) ^fFttflS^ $££ nmmzm (Portography) WI 720 H%}kifctfrB.tfy&Wi (Portosystemic Shunt, Surgical) (£t4 m$>Tm!fm*fix Xm (Illiteracy) l£^S$££ 'EXoJL (Foramen of Monro) l£IBM$££ A? «PBm4l (Night Vision) (£Bf)iiS$££ Y^Y (Goats) M^ SF 380-388 Y*?m (Goat Fever) (£7/1-7 7*£$££ Y^comm (Goat Diseases) SF 968-969 f?l£ (Baseball) QT 260.5.B2 WIS (Night Terrors) (£HiaSPf#$££ fcft& (Pavor Nocturnus) (£lillSPf'#$££ <&£ (Metallurgy) TN 600-799 mm wu iso m^mm wa 400-495 mmmmm wa 7ss '&m.i£ (Governing Board) mm WX 150 zcomnbmbmwLcoArtiu^mvj&^iz, (, liiw #^-^*^^t#^i£-jftw#^{;, mummmffl^v mm* wb 1 mm (Pharmacy) QV 701-835 && QV 26 Wm UH 420-425 :MW VG 270-275 mmmmm qv 704^ ZMffiXft^m WA 730 |ft|3£^ SF 915 mm$k^ (Education, Pharmacy) QV 18 mmflm. (Faculty, Pharmacy) (£ffcm$££ mmWkWfr.'M (Education, Pharmacy, Continuing) QV 20 mm7<.mVK$M (Education, Pharmacy, Graduate) QV 20 mmirnm (Ethics, Pharmacy) QV 21 m$\x--vY>vmm(Drug Aerosol Therapy) liUkkfit'j- $££ mM$ (Pharmacists) mmii $££ mmm (Apothecaries) (£H^$££ HSy&ip-f^ (Societies, Pharmaceutical) QV 701 mM3. (Expression, Pharmacy) l£IHffiJ$££ m%lM$hX (Pharmacists' Aides) QV 21.5 mMMl^i (Licensure, Pharmacy) QV 29 HftJirtt (Drug Tolerance) QV 38 mMWlM (Dispensing, Pharmaceutical) itmm : mt%m mm ;^*7-tX$££ mm^^-m (Sublimation, Drugs) (£P^j$££ ^3"JM (Comminution, Pharmaceutical) (£11^ $ £ £ H^-7-tX (Pharmaceutical Services) QV 737 mmummmm^n wx 179$££ imummy-¥xim w 265^$££ -Jft UH 420-425 mW VG 270-275 mmY—¥Xi%VX7A(Drug Infusion Systems) (ii4A7X7° $££ mtoRM (Drug Storage) QV 754 £-***£W#£ WA 730 mmWiXiX (Drug Resistance) WB 330 W£m$XzisitZ>A:tiU, A:Com&iz mmmmm (Kinetics, Drug) (i*^U)7J^$£i Kg^^BS^ (Artificial Hibernation) it AI3-Hgj£$££ mm&X&.& (Drug Administration Routes) WB 340 -356 mmmtim (Pharmacokinetics) QV 38 gHMMS 9 (Drug Regulations) Umm& bmm) $££ mm<7>%&bmyi<7)W%Jl (Fraud, Drug Manufacture and Sales) (iS^H$££ ^^UttK (Idiosyncrasy, Drug) UmmmtflX mmcom& (Excretion of Drugs) Ummc0X<7>ikM QV 38$££ mmc^^M. (Packaging, Drug) l£H'1*tl£l$££ mmc^^-T^-bYk (Drug Containers and Closures) itmm &§£$££ ^Bc^StS (Incompatibility of Drugs) (£ge^m.g$£ £ mm%m (Drug Exanthems) UmmtflX mmW£iffim (Drug Benefit Plans) (£H*-7-tXl£ P£$££ mmWiR (Drug Evaluation) QV 771 mmx9 "--yyyx y QV77i$&££ mmwm&n (Evaluation Studies, Drug) UmmWiMZ ££ mmmmit (Standardization, Drugs) itmmcoXcoMm it QV 771$££ mmiiMX'&Pi&M; (Intrauterine Devices, Medicated) WP 640 mmMi¥mi£&f8'£. (Dermatitis, Adverse Drug Reaction) (£!£*£$££ mmX&mmm (Drug Adulteration) itmmW&ZflX mmirffi (Separation, Drugs) l£P#J$££ mm%% (Drug Packaging) QV 825 mmmk (Drug Insurance) itmmY-tXl*P3?$££ mmm^^B (Abnormalities, Drug-Induced) QS 679 mmmWfx$6Wii%. (Dose-Response Relationship, Drug) QV 38 mm&m (Drug Abuse) (£^KSLffl$££ mm%Lmi&m (Drug Abuse Testing) li!|*SCiOtffca,l$£ £ mmM%L&M%$ (Substance Withdrawal Syndrome) WM 270-290 &^*iJffl$J$34iifi14 (Availability Equivalency) l£4£ SF 915.919.5 Wx.mmizW L T Ii, A:commfz mm®„lk$J)-!$:^Wft: (Clinical Equivalency) (i*fi*£2Jj^ 1d514$££ mmmm (Plants, Medicinal) QV 766-770 TY7X QV 717 &% SB 293-295 w*. oo m mmmoo % «- $«, £ £ mmmmm (Medical Botany) li^ffltit!t*'7;$£i mm% (Teas, Medicinal) (£t):*4$££ mmk^ (Ginseng) QV 766 mm^-7' (Medicinal Herbs) l£Hffl*it!|*$££ mmikUm (Pharmacogenetics) QV 38 mmm (Pharmacology) QV f*tf4 QV 50 mmitm qv 38 MM QV 34 mmmizisitz sf 915 mmmmm qv m mnmmm qv 77#$&££ mwm (Posoiogy) ummc^xcommixb^mw qv 748; S£7^^$££ SfUi^lt (Role Playing) WM 430.5.P8 tvjtmbwjm WS 350.2 nxm ws 463 SfUffi^ (Role Concept) (£tti£ftf£iij$££ ¥?M. (Vegetables) mmmxumm^^m-kb lt wb 430 m% SB 320-353.5 mmummWm QV 766^$££ Mm^uMmwm wd 500-530$££ JJPX TX 801-807 mT^(£T^J QV 75$££ ffiXRX/A:<7)ttL££ m^^m (Pharmacy Administration) QV 737 mmm sf 915 mtmrnm wx 179$&££ •£.JsjyV (Pharmacopoeias) QV 738 mmmm (Legislation, Pharmacy) QV 732-733 m^i/J'XM (Dispensatories) QV 740 7 7 X 7 7 *m (Lampreys) QL 638.2-638.25 %mmmb lt qy 60.F4 ¥?%m (Tularemia) WC 380 7 F* 'J 7—*£ (Gamasoidiasis) (£ 7 — 4 X 7 i X 7 — x a X$££ -^7^7 wz 112-150 A:C0Yky>ftmtYCftm.^XMmz 774 3 7 y 9 x mkco WZ 100 m& WZ 313 fj£*iflll& (Hair Cells) W\' 250 ggPI (Pylorus) WI 387 tSPI^ (Pyloric Stenosis) WI 387 |£|H*K$ (Pylorospasm) (M<*#$££ ilPIP (Pyloric Antrum) WI 387 3JEM|-£ (Free Radicals) QD 471 jfiUHgWIft (Free Fatty Acids) l±#xx7/HjfiBSHft*M £ tftHS (Transfusion) I£$f3lfo.$££ ttftffi& (Fluid Therapy) WD 220 X-7X7IB (Euglena) QX 50 a.- 7 o 7 0 x (Euglobulins) (£ Kn.oi 7o 7* i±ftuz i- F t°7 (Utopias) HX 806-811 1£ (Fingers) WE 835 2iM WE 835 mmm (Finger Joint) WE 835 ^.t*Jf7x (Ubiquitin) QU 56 xh'3-yx (Ubiquinone) QU 135 ta^liH (Finger Injuries) WE 835 tt#<7)Ji; (Fingernails) UXZflX W- (Dreams) %VJtmb<4)xJtm WS 105.5. D8 e,L»a^ BF 1074-1099 mWXffi WM 460.5.D8 jE&B£HK WL 108 x-*7 (Humor) l£7 4 7 F fcx-*7$ ££ WM'^ (Oviducts) %& SF 871 t KiWff WP 300^$££ IFl-liM* QL 881 xijfj (Allium sativum) (i-X~y$££ x ij f |- (Colchicum) QV 98 j- — o 17 A (Europium) ^mitrn qd i8i.E8 *J1^ QV 290 Pft-n-i'fHJi (Positive-Pressure Respiration) WF 145 &&*iit<^t> WA 292 ifcifc (Solutions) QV 786 mmYi (Solubility) QD 543 *ft'7- QV 744 3 711:xd77"^i-F (Echothiophate Iodide) QV 124 £ i itm (Iodides) QV 283 tfc&tzfcfLT; QV 261 £ i itm^<>V fc -r y 9—tdodide Peroxidase) QU 140 P£fe (Anode) li*tfe$££ mM (Bacteriolysis) QW 660 ffl^Sft (Device Design) t£i£litxHt$££ i§Ha (Hemolysis) *jfiL«iJ! WH 150 frlStm QW 660 iguMtJUa (Jaundice, Hemolytic) [£i'glfo.14S:ifo.$££ igjfiL'ffirtJfo. (Anemia, Hemolytic) WH 170 Ar^isbtYm WD515 ; ^/ntXifi WJ 344fc-£ COMoomk Ft-yyx$fc££ i'§Jt14-^7'J 7 (Malaria, Hemolytic) [£S/k#fc$££ i§lfiL^ (Hemolysins) QW 660 i§jfibI»[10K-432 (Streptococcal OK-432) l£tx'< -^$££ i§JflLaSB3*l3HI!lS"JOK-432 (Streptococcal Preparation OK-432) (£tx^-^$££ i§l£14 (Lysogeny) QW 660 #HfiM4^°y-> (Maternal Patterns of Care) li3M4fr IJ]$££ Mm (Folic Acid) QU 188 W&k2J& (Folic Acid Deficiency) WD 120 mmfc 'J 9>V9 A-Y (Folate Polyglutamates) l£7°7 o 4/P7 0 7/i-y i xfi$$££ UltX 99 9--¥ (Folic Acid Reductase) (£7 F 7 t F* njllfcft Ko77-^'$££ F§4" (Protons) WN 415-420 f*M*H'?l-^lt^ WN 110 tet*H7- (-fe) IZ fc It 4 QC 793.5. P72-793.5. P729 *44fIfl (Adoption) ^mmtY)%M WS 105.5.F2 tt£#ftJ#8 HV 874.8-875.7 mxmm&k (Adoptive Cell Transfer) l£^fJjft*£Srii $££ FiT-X txBlrllftl^i (Tomography, Proton Spin) (£ MRI$££ *&!/&14Wl£f£ (Sexual Abuse, Child) (£l4W!£aJt!#$ ££ FI4"iS1^ATP7 — 7* (Proton-Translocating ATPase Complex) l£H-ATP xxy-7*$££ ^Xlfc&mm (Immunotherapy, Adoptive) QW 940 775 ayyY9 tyftfcJV^y (Juvenile Hormones) SF 768.3 nmm ql 8ti8 t&mm (Phyllodes Tumor) WP 870 *7JcH8&'*]III (Cystosarcoma Phyllodes) (£^4fcHt*S$£ £ mXW]&X!&mitftVT (Proton-Induced X-Ray Emission Spectrometry) (iX^H^ft^tff$££ W£ (Prurigo) WR 282 #^K (Amniotic Fluid) mm%xm ql 975 kr*mxm qs 645 mm wq 210.5 mfcMYtM WQ244$&££ -£*#*|J (Amniocentesis) WQ 209 #xk^1£*E (Embolism, Amniotic Fluid) WQ 244 F«14$£1fc (Positive Reinforcement) U&it ('tmm) $ ££ #fltffft (Volume Index) (£1)fillflL#':S$££ mm (Welding) mM'&m WA 485 m%mm wa 400-495 If flii^M&SS (Lumbosacral Plexus) WL 400 flf M (Lumbosacral Region) WE 750-755 ill (Iodine) QV 283 MUmb LT QV 231 ftllt WK 202 £ l mmitW (Iodine Isotopes) QV 231 mmitm qd i8i.ii itm WK 202 £ -5 mmtitiWtifc (Iodine Radioisotopes) WN 420 mmrnm qc 796.11 Jft#l4[5]flftWTtz * &» F 17 y x $ fc £ £ #JH*E (Infantilism) WK 900 Xk& WE 250$fc££ If ft (Lumbar Vertebrae) WE 750 Iffitt^iPJ (Lumbar Puncture) (£Wtt^$iJ$££ If *S (Low Back Pain) WE 755 Pi*!4- (Positrons) l£«4L$££ Fim^-^aiilfHtf^a (Positron-Emission Tomography) l£x « -y y a XCT$££ i"&fi£ (Solvents) mitm qv 744 mmtm QD 544-544.5 mmm qv 633 USB (Lumbar Region) l£lf 1lljg|3$££ mm (Amnion) mm^xm ql 975 APB1fe4:^ QS 645 mm wq 210.5 mm&w (Amniotic Membrane Dressings) (££it*1414lz £6 £<££$££ m-X\ (Wool) SF 377 |J]!|*ftfglj^: QL 942 %% SF 761-767 mmmmm ts 1547 3 7*7-7/1- (Woolly Monkey) it7 7 7 7*/i-*4$££ JSMJE (Cot Death) (£?L^y&^^^$££ ^fi^X^E^ilft (Osmolarity) f£if jfillf $££ M&m (Chlorophyll) QK 898.C5 1&1£ (Chloroplasts) QK 898.C5 MUfc&'lxmX (Chloroplast Coupling Factor) liH(+) *tu2iATPxXy--t$££ 3/7* (Yoga) QT 255 *Sm B 132. Y6 te«r<£(£ftt§4Mfl'i WB 890^ $ £ £ WEE (Repression) WM 193.5.R4 nXm WS 463 IL^ffifc^IO] WS 350.8.D3 Wl^fXtk (Depressive Symptoms) I£t o#,j$|i£ n 1 o-|4Pf W (Depressive Disorder) WM 171 mwmn wn 207 ffll 7 0'f4*S1^?¥ (Depressive Syndrome) (£WH ottPfW $££ MHo14*M&^ (Neurosis, Depressive) (£WH o^Pf^ $££ Rf-g (Chiroptera) QL 737.C5 *£*?! SF 997.5.B38 MR* (Pterygium) WW 212 mum (Depressants) l£7/i-o-;u$- ; mmm : 1t*l* ^ ; iiasmfcifl^^ ; ¥rx.vnmitilSt BF 692 St'Rf^ (Frustration) BF 575. F7 nXm WS 462 ?L !£«!*:*&!/&»* WS 105.5. K5 -"fSfttttt* (Pregnancy. Unwanted) WQ 200 3 — F'T ■" — '•*& (Iodamoebiasis) (£7 ' -'<*ii$££ 3 - K * 9 - >l (Iodoquinol) QV 255 3— Y'9 £>>Vfc %-y%-9 iJ X (Iodochloroxyquinoline) Ii 9 'J4Jf7'-/i-$W.£ 3 — Y 9 & JV¥ Y"o %y 4- x (Iodochlorhydroxyquin) (i 9 Vfc*A -/!-$££ 3- YT-Av — ygJt37m&m (lodothyronine Deiodinase) l£ £ l itm^JV fc * y 9- -t $ £ £ 3- F-74 o^.x5'-|S£3 7S8ll? (IodothyronineS' Deiodinase) l£ £ T itm^ov 7 * x 9—1$ £ £ 3 — F"7 o y x 7* 3 — 9— -fc* (Iodotyrosine Deiodase) (i £ T fH*%-^<^*- 7 * y 7-7*$ £ £ 3-F7IRS*: (Iodohippuric Acid) WN 160 ^ItFi^fctzioltS QY 175 Mmitm QD 341. A7 ^£gft(zj£ffl-?il.-i>^£-t£, ilSS'Jlz 3-YMiW.mY F 'J 7 A (Sodium Iodohippurate) (£3- FHmS£$££ 3— K'^y-t: F (Iodopyracet) WJ 141 3 — F'-< X YA JV9]) yy (Iodobenzoylglycine) it 3 — YMmmtfix 3-^°Am (Iopanoic Acid) WI 750 3t>''7 (Yohimbans) 'DdlfrPg^ fc LT QV 150 Mmitm QD 421 3t>t*X (Yohimbine) QV 132 X^ (Prophylaxis) lift Pit*! ; XVj^imY'&lj Z i\X t> £*£.£$££ XPimm (Preventive Medicine) WA 108-245 XPj^X (Orthodontics, Preventive) WU 400 Xffimm (Preventive Dentistry) WU 113-113.7 XfJllnWmm (Preventive Psychiatry) WM 31.5 4^1fH (Preventive Inoculation) (£&*£•<£$££ Xtnm& (Vaccination) QW 806 BCG(iBCG7y7x WF250$££ zvjtmbwjim ws 135 7'J7l£7iJ7c7)T^7-Kt|ijr± WC 556$££ *!*tl£*!*f<'OT'7)T-Kfcil;i,J± WC 588$££ mmm sf 757.2 Arcomcommu, Azcommiz 7 y 7 x RU'Vlx. 9 A Yco 79fcy£iiflX XW^mmm-k (Vaccination Encephalitis) !£i44M14 flS1HS&'£$££ XMW%mmmY-¥X (Preventive Health Services) WA 108 7c*SJS QW 800-8151? $ ii fl X X^^M^tW (Prophylactic Immunization) (£if*K1fS $££ Ilc^lf^ (Literacy Programs) I£$CT4$££ XtfobXzL (Appointments and Schedules) mmzisuz WX 159 mfmm mmm wu 77 mm w so ft,AtU9A 7°»iJIZ, fyijlitmA ftM WY 127 3 — d y'<-yy97Y (Mandrake, European) I£vx7 7 7$££ ■7 M (Leprosy) WC 335 -izimfc&t'muiimmim qv 259$££ mmt WH^IE WC 27 28",';: ; ^,^Yi an-- WC 27-28^:$W,£ WMmmfc (Leprosaria) limumZ£**!&■?{3 o^-$ ££ i«-JD-- (Leper Colonies) WC27-28 £AI7r-ftl»l W 3231££ tfRlfl (Mycobacterium eprae) QW 125.5.M9 7-f y 7AJVX (Rhinovirus) QW 168.5.P4 Um^K. (Leper Hospitals) (£#1"]*^$ £ £ 747747XF* (Life Islands) (££41-417 4 X X-y- $££ 7 4 7X^4/1- (Life Style) nX- WS 462 AulH$ WT 30 *faifc% Y ¥y 9xUXMftliz, mtUXitkmm GN 315 ^ ; XiSm^. BJ 1545-1697 y A iJx77*J&JE (Raillietiniasis) [i^ife!® &*£$££ y-fijj_77S (Raillietina) £4jJ!$££ 7 7 fc JV y x (Rauwolscine) (£3tXtx$££ 77Xf*]il (Rous Sarcoma) l£ F 'J l*D!$££ 7 7X^817 4/l-X (Rous Sarcoma Virus) (i F 'J 1*111 74/l-X$££ 7^ (Rhonchi) (£Pfn&"i1$£i mm (Butyric Acids) QU 90 7 99 (Camels) QL 737.U54 mm SF 997.5.C3 7 y y - F (Lactates) QU 98 Mmitm mmmit&m qd 305.A2 7 9 9 A* (Lactams) QU 62 mxm% QV 350 ArC0mm^Y ¥y9XU, 3£®£iJlZ y 9 9 A,^mxmM. (Antibiotics, Lactam) QV 350 yy7o-X (Lactulose) QU 83 yy F7o7*y X (Lactoglobulins) QU 55 '714 SJS7- SF 251 S*Ht4: QW 601 7 9Y-X (Lactose) QU 83 Mr mmm SF 251 £l£ffiX WA 716 yyF77tx (Lactoflavin) l£'J7'77tx$££ 7 9 Y'OVfc^yy-H (Lactoperoxidase) QU 140 7 y F x (Lactones) Mmitm QD 305.A2 mfk (Dairying) SF 227250 &M%XM%m WA 715-719 i&&$m WA 719 ■feMm (Defoliants, Chemical) mmm^ sb 951.4 RMffiXAX^m WA 240 777 7 => y y y y YY "J •/ y/4 (Lagothrix) (£/7 7 7-7/i-f1$££ 7 y 7 A (Radium) WN 300-340 Mkitm wn 300 &$1t*¥* QD 181. Rl \mmi\m wn 340 7x7 (Radio) -te&Wlziolt-S LB 1044.5-1044.6 nW^#5*^ff(z£oltl) (NLM^-*tigT(£J^^#^18.2) ^XizmZfc%m WS 462 'J^iz/ilitf^ WS 105.5.E9 ft^Y ¥-y 9 Xit, iHS'Jlz 7x7747 F -YfcWMtmm (Radioisotope Brachytherapy) UmmmX&mm $ £ £ 7x7747 F — 7°X ^f 7 — x y (Radioisotope Scanning) liJAW14^14 /-xxX*$£i 7x774 X F -YXM?Mtm (Plaque Therapy, Radioisotope) ummPMr&mm* fix 7 yfc A A*9 7 y 74 (Radioimmunoassay) QW 525.5.R2 7/^X)HJ£ QY 330 \%n%^xcoym, *-9 y xy*xi£fF4ffliy>7x f iz® ffl-?ft&i§-g-l£, ^ffS'Jtz 7x77—F777-f— (Radioautography) l£7—F 7 >*77774-$££ 7x77774 y 9 faitX 9 >)—> (Radiographic Iatensifying Screens) l£ X Ul*t !§& $ £ £ 7x7x4-"^ F 97 7 4 — (Radiocinematography) (£X mmmmm* fix 7ft^^til (Transplantation, Islets of Langerhans) (£ LangerhansJb1$1i!$ £ £ fe-^S? (Spiral Organ) (£Corti§?'B $££ fe-£/LM (Spirillum) QW 154 f^Tr/U^ii: (Spiral Ganglion) WV 250 WifcXm (Nudism) QT 245 7 7 'J X A (Lathyrism) WD 500 7 y 7 — (Lacquer) itmXM TP 939 mrnxmm wa 465 &TWT (Parachuting) WD 700 *SC WD 740 &7E4: (Arachis) (£7xdrX^/$££ 7 y -t /U y 7 0 ^ t#F#PBl (Russell's Viper Venom Time) (£7°o FoxtXB#rBt!$££ 7 7 F (Rats) mm SF 997.5.R3 £J§3:fM*fcLT QY 60.R6 zMffixw^mutiXfrmm wa 24o$££ 77F74/1-X (Rat Virus) l£^°/l-4*7 4 JVX $££ (boIiSffi^H (Ear Trumpets) l£*§ID£§?$££ 7 7 7 y X (Latex) ttftffc*^ QK 898.L3 ^^^g^(z^ffl$ni)ii^l£iMSiJ(z, fyUliSEM QH 212.S3 777XXO-A (Latex Rubber) (£o*A$££ yY-yy^ivm (Rademacherism) (£ft^[Sffit$££ 77X7X y 77 A (Latinos) iiX^A >&T a ij 77A$£ £ 7 F* X (Radon) WN 300-340 me wn 300 tefJsWJffl WN 340 7 —7xX (Ranitidine) ^mfemrnb lt qv 69 7YY7A Jvxm (Rhabdoviridae) QW 168.5.R2 7- 7/l-^X<7)^^$t££ fpm**fi& WP 540 ~iZisit&&i&U, X'Syfctlim WQ220$££ WHi& (Oophoritis) WP 320 mW&ittfc^m (Ovarian Function Tests) WP 520 mmm (Cyanophyceae) i£M3S$££ WlH^M (Struma Ovarii) WP 322 IB3M&& (Ovarian Diseases) WP 320-322 m^mm (Ovarian Cycle) (£^^Jij»l$££ MH*S (Ovarian Neoplasms) WP 322 W%kmm (Ovarian Cysts) WP 322 g&£ (Cyanobacteria) QW 131 yy9-Y (Lanthanides) I£3j±*I#^$££ 7 x y X (Lanthanum) i&mitm QD 181. L2 mmm qv 290 WTO (Ovum Implantation) QS 645 778 y wax yyYm (Runt Disease) (£f*tit)Vi*f? i;4IIIWi$££ 7 X - X 7 (Running) QT 260.5. R9 JjpflSl4S (Egg White Proteins) (£WSl4H$££ y X t— X^fX*^ (Lumpy Skin Disease) WC 584 7X7*i)7)S (Lamblia) (£GiardiaM$££ yyY)VWfc\&&. (Giardiasis) WC 700 %m%WLTY>V^y (Follicle-Stimulating Hormone) l£ FSH$££ mmfc~'V^y (Estrogens) WP 522 ^mfc'i^yit,mm (Estrogen Antagonists) WP 522 Wl&Uffll&ffi (Thecoma) WP 322 *fl#*fflll& (Oocytes) WQ 205 Will (Fetal Membranes) %Xm QS 645 mm QZ 310 mm wq 210 mXM WQ 210^$ t££ SLffl14tSHnDp (Drugs of Abuse) (£*£7c*$££ 0 7-7* (Lyases) QU 139 i)77f (Rheumatism) (£ 0 7-^714*71$.$££ 'J 7-yA-mX (Rheumatoid Factor) WE 346 ij 7-77¥ (Rheumatology) WK 140 ftx.co®^te&m&comB $ h £ £ 0 7-^714*^f. (Rheumatic Diseases) WE 544 .%ttMSJO(J ij-7vf» WC 220$££ U 7-v714'H>*^.'£ (Rheumatic Heart Disease) WG 240 U 7-yfcH^m^. (Rheumatoid Spondylitis) (i&il44W tt£$££ 0 7-yfcH$XZMB$. (Polyarthritis Rheumatica) (£ 0 7-77S*$££ 0 7v7l4£?§14$Sffi (Polymyalgia Rheumatica) WE 550 'J7-V7*" (Rheumatic Fever) WC 220 >)7-yl-MMffi%. (Rheumatoid Arthritis) l£1#'ffiMlii 0 7^7$££ iJ774o —x (Liothyronine) (i F 'J 3—K7 o 4 x $ ££ f'l^Mffi (Conflict of Interest) W 50 m$m&)%m w ss mmmm (Physiotherapy) itmmmmZflX 'J77'—tf (Ligases) QU 138 *.*■* (Morbidity) WA 900 m&Wmm (Nursing, Military and Naval) UfeWmM $££ mWWk (Soldiers) (i¥A$££ mWmfjt (Hospitals, Military) UH 460-485 WW- VG 410-450 rnXMik (Track and Field) QT 260.5.T7 0 9— X (Lignin) Wmt. SF 98.L54 Xitm QU 83 mmitm qk 898.L5 'jyy774x (Lignocaine) l£'J Kt74x$££ 0 7 7 77^4 (Rickettsiaceae) QW 150 'J X 7 7Tf4H$ifc*jE (Rickettsiaceae Infections) WC 600-635 0 7 y TTf&Ukfe (Rickettsia Infections) WC 600-660 me WC 600 y-ih&Mfr WC 630-635 y-mfr WC 620-625 mmm sf 809.R52 0 7 7 77M (Rickettsia) QW 150 mm numb lt qz 65 0 7 -jtTYI (Rickettsialpox) WC 635 0 7-77711 (Rickettsiales) QW 150 iJ 7 y 7 7 Hi (Rickettsias) (£ 0 7 y 7 7 fc 9 7 5 -x 7 $ -\liz\W) Yki QW 149$££ 0 7>y 77777X (Rickettsial Vaccines) WC 600 ij o v 5 X (Lycoremine) (£77*7 X 9 5 X $££ H4ft (Divorce) HQ 817960.7 77 7X7 0 x7 WM 55 HX^ (Lysyl Bradykinin) l£77 0 xX$£ £ Oi-X (Lycine) l£- (Vasopressin, Lysine) (£ 'J 7° X x x $££ OX (Squirrels) Ii 0 X#$£i 0 Xff (Sciuridae) QL 737.R68 %m.mmb tx qy 60.R6 0 X y (Risk) #$* F t°7yxii, 4»Jlz \)X9^m (Risk Management) *SI% WX 157 Zcoikco Y ¥7 y x, ^^oti^(i±M«iJlz ; -fl£(ft£ ij^li3£^±^^£#^(z^i1-|> Oxy^f^ (Risk Behavior) (iftiPtJi11$£i 0 X7/1- (Saimiri) QL 737.P925 mm SF 997.5.P7 %mmmb lt qy 60.P7 0X70 7®ifc*£ (Listeria Infections) WC 242 mmm sf so9.ls 'J X 7 'J 71$ (Listeria monocytogenes) QW 142.5.A8 lJX7'J7Mlt£ (Meningitis,Listeria) WC 242 0XA14 (Rhythmicity) (£JS]ffl14$££ 0 XJ+m (Rhythm Method) WP 630 0 X y F" (Lisuride) QV 174 0 X y F* t F'o7'X-7X Xlt (Lysuride Hydrogen Maleate) (£'J X 0 K$££ 0 t/Udf F" (Lysergide) (£ 0 7 JV Ym x3 i 7 /l- 7 ^ K$£ £ ij 7/1- y*g£ xx 7/1-7 i F* (Lysergic Acid Diethylamide) QV 77.7 ijyy-AX (Lysosomes) QH 603.L9 779 y v-^a IJ77-A (Lysozyme) :iA7~7--t$££ ij 77X777x/l-o y X (Lysophosphatidylcholines) QU 93 0 7-/1- (Lysol) !£y XX*-/l-$££ iJ7Xx7x (Lysolecithins) (£ 'J 77.X7 y T'yJVzi U x$££ ij -7x77^^7° 7 F* (Leader Signal Peptides) (£x 77/1-^77 F*$££ 'J - 7x 7 Y (Leadership) BF 637. L4 ftfifcr- t°7yxl£, ±H#Jtz wmmm wy 105$ iifix mfcXm (Altruism) BJ 1474 WXX ¥-y9Xit, ±HSi|lz YYlXmbMit'yT'^m (Cholagogues and Choleretics) QV 66 IJ77A (Lithium) QV 77.9 ALifcim^. (Stereoscopy) (£yt*¥*$££ 34441 (Stereopsis) (£ifg^l^'M:$££ yLifc-W-MMM. (Stereophotogrammetry) (£¥Hs££ifrfii|J£ $££ ll.ifcB'm (Stereognosis) WR 102 aLW-^-9 F/i-'L>1tl21 (Spatial Vectorcardiography) !£^< y F/^0*«ia}£$££ 0 F*t>4x (Lidocaine) QV 115 0 F K'J X (Ritodrine) mmZmBY% tzthizfemZft-h 'J F'77xX (Lidoflazine) QV 150 0 Y>vm (Little's Disease) (£K14l#*#$££ mi (Weaning) WS 125 mmim (Diuresis) WJ 303 YVJfLm (Diuretics) QV 160 0 4X F xX -JV (Lynestrenol) WP 530 m&mbtx QV 177 iJ4x (Linens) liSEJIfc 'J fc X$££ 0 y X 7° 0 y 7 !*'■& (Rhinosporidiosis) WC 450 0^-7' (Lipase) QU 136 SHH (Barbering) i*o4Ari WR 465 >fcm t "J 7- x s X (Rehabilitation) WB 320 mm&'&Wk UB 360-366 fAMoo LC 4001-4824 ^wmmizmxhme wb 320 mBco HV 1573-2349 mmco WW 276 W*&t£bco HV 2353-2990.5^ mmtft y ^ t y 7 - y 3 x wv 270-280 ^J^74f4^S(£^^74f4fflSI4l: WE 172$££ M*l?j£ WB 460 %mm{}L ws 368 'DS-^WJII WS 105.5. H2 ft^mm'Jtumwmffi ws 107.5.R3$££ l±£mW%m HD 7255-7256 mmmiztsu&¥yfcfemm wm 450.5.vs w*%mmxu'*^!t*^##7)^^y) WM 29 #fW#44o/.;^y) WB 29 x (Lipidosis) l£'J,74 K-^x$££ 0 t*X77 4 JV (Living Wills) W 85.5 'J 7 7^4 xX (Rifamycins) QV 350 0 77XtxX (Rifampicin) (£077>tX$££ 0 7 7 X tx (Rifampin) QV 268 !J7*-74xX (Rifomycins) (i'J 7 7^4 x X $££ i; 7 \., QY 465 'J 7gr4Ky^°-7* (Lipoprotein Lipase) QU 136 iJ7xyx7--te* (Ribonucleases) QU 136 0 77 y x7-> K~ u ymyY9 9—¥ (Ribonucleoside Diphosphate Reductase) QU 140 0 fc¥ 0 X (Ribovirin) l£ 0 '<¥ 'J X$££ 0 fc 7 X 7 x (Lipofuscin) QU 110 0 77 7 t'X (Riboflavin) QU 191 iJ77 7txX5.*£ (Riboflavin Deficiency) WD 124 H&fg (Abbreviations) «*£<3I$££ S^ltxy oo yxf^ (Dichlorodiethyl Sulfide) (£vX X- F4Lr>!t*wT(7)^xy- F'zy'x QV666 $££ mt7^m (Hydrogen Sulfide) ^mitrn qd i8i.si mmm qv 662 iftlg (Grippe) (£4>7/l-xx-7$££ itiBfrmm (Hyposensitization Therapy) lilftSft * fl X ifafiLXlBmm (Neoplasm Circulating Cells) QZ 202 ))itlTl4^lnIf '£. (Keratoconjunctivitis, Infectious) mmm (-») sf 89i 7xlz£olt-i) 967. K47 t7x#(/-"7=r*!Ziott& SF 969.K47 itm4«ffi (Pleurodynia, Epidemic) WC 500 iUfflmmiX (Myalgia, Epidemic) U\k.'\liXmmMfl X 780 y x-»rx/*7 jjftiftt^Tlft^ (Mumps) WC 520 !4tff'l4?TS*^7y7x (Mumps Vaccine) WC 520 )liTl4triJfoB (Hemorrhagic Fever, Epidemic) li^SS^ 14ftifi***44£S*$£i )^;ff'l4yirflL^7 4/l-X (Hemorrhagic Fever Virus, Epidemic) l£^X 9 -X7 4 JVX $££ ii!liT'l4xy ^ WLAt-WfeA-y X (Typhus, Epidemic Louse-Borne) WC 605-610 iStTttillf '£. (Cerebrospinal Meningitis, Epidemic) (i •H^^i¥i14flaWfSlf^$£i lift 1414)13 •£ (Encephalitis, Epidemic) WC 542 !lft14l£b*^ (Roseola. Epidemic) (±!<44V$££ ift?f14#A#Bff£ (Epidemic Non-A, Non-B Hepatitis) (£ESyhc^$££ mrCO^mx^m (Filth, Epidemic Factor) Iif£^-fa' f pj;mmffix*fix im.Yrm$HX%k1>£ (Sanitary Conditions, Epidemic Factor) (£f£lfe*^T^K : tt£&^faH*W-r-V)&*ffi£ WA 30$££ mSt (Sulfuric Acids) QD 181. Si mmm qv 612 tittm (Abortion) WQ 225 m%fc&mum%m qvi?5 $££ mmm&%m w 867 £ffctfj • tt£fa#£ HQ 767-767.52 $&kT)l S.—7AX9U — X (Aluminum Sucrose Sulfate) (£xyy^77-F$££ fiK8££ (Sulfates) QV 280 ^7>vy 7 A, (Calcium Sulfate) itmztsith WU 190 mim&iztsith QY 35 ft-m*Yx&ftiztsitZ> WO 170 ^K^74->7A (Magnesium Sulfate) QV 75 ]m.mm (Abortifacient Agents) QV 175 &4-7JQitH (Particle Accelerators) QC 787.P3 mmmmmmiz is it 6 qz 269 &Xm TK 9340 ^M.7t — TJV (Catheters, Indwelling) (NLM^-*MaTli)F^^#^-26) m/?v&co%ft,£hflX feK (Particle Size) Y-Aft&mg. WA 754^ mZm TA 418.8^ M¥ QV 785 axxm atmxm) tp 156.P3 ijftfip<7*7 4 X (Liquid Paraffin) l£i£}fi$££ \HW)7-tYy (Petrolatum, Liquid) ££}&$££ i^filf (Flowmeters) tiX&m.&%mKfc h WG 106 $f£$i|iJ£1-£ TJ 935 YX*mx.fcZ> TJ 1025 7k$)li|£7£ TC 177 JjKfiftffl'l (Flowmetry) (£x7o-y-$££ iJi-oyyx7x (Leurocristine) Ii t x y y X 7 X $ ££ i^ISm (Vision, Binocular) WW 400 mm& (Binocular Vision) imm< \ HRSftHJ) * I8W ^fn;^-E$££ f'Pi:^ (Fee Schedules) *fg§&3l $££ IPtfia^^JfeLtJKfle (Group Practice, Prepaid) W 92 W&yfcm (Barber Surgeons) <£74fFr*$££ I^Kf^ (Amboceptor) liiS'ft" ; }*&JliL*£$£i feir-l]*aX|fg?|*'5)-yt^rr (Spectrometry, Particle- Induced X-Ray Emission) ttX$&###'7Hrf£J4«t itV7H (Quantum Theory) QC 173.96-174.52 \MU (Parents) HQ 755.7-759.92 -bM&ftX HQ 998-999 $mY¥y9xit, XMftliz &4> (Conscience) BJ 1471 WfW^Mff WM 460.5.R3 I*i14'g (Bisexuality) 7 4 7XX4/l-fc LT HQ 74 $}&&¥&&& WM 611 &14$'Ji)Jl4-3-'£ (Glossitis, Benign Migratory) WI 210 i^14HujtS^(]EA*,'i:. (Prostatic Hypertrophy, Benign) (i HiJazHI8E7<$££ nifcn.Wm&tem (Ampholyte Mixtures) QV 786 &ifcMM.PliX'fC'M;& (Benign Intracranial Hypertension) (£ Wifli*i $ £ £ Slit/ y D-7/i-77*x-v7D7*y xifn.*£j^ (Monoclonal Gammopathies, Benign) WH 400 mXW. (Amphibia) QL 640-669.3 %%kmmb LT QY 60.A6 \$XMm't& (Amphibian Venoms) WD 400 Po1IiJ14^.4lftl^ (Hearing Loss, Bilateral) WV 270 ^741 £ (Ambidexterity) Ii1lij14$££ mmb&MmtkMmn (Utilization and Quality Control Peer Review Organizations) UmmtfktfcWM $££ SBB14Bilg (Rhombencephalic Sleep) (£XASiRE$££ \tmW- (Paraplegia) WL 346 mftVM (Glaucoma) WW 290 Htli^i (Pseudomonas aeruginosa) QW 131 mt (Travel) QT 250 M^M WA 292 mm w io m®. W 10^$t££ 'J 7 y 9 X (Relaxation) ffiX QT 265 mwrnx WM 75^ mmrnm wb 545 *lfi£"E7/i- (Models, Theoretical) mn Y y-JVb LT (NLM^*l3gT(£ff^^#^-18.2) ^Yjvmm qa 9.7 ftmiWizmmzti&mfru, xmmz y^ (Phosphorus) ^1^-3I$££ M#j (Neisseria gonorrhoeae) QW 131 *) A,3k%k$i.m (Insecticides, Organophosphate) &M SB 952.P5 £MffiX WA 240 ij X7 (Apple) l£JI4*$££ 0A,yfe (Phosphorescence) l£/l- ^ 47 XX $££ ij x o -y A X x (Lincomycin) QV 350 ij x o )V 4 X x X (Lincolnensin) (£ 0 X o -y A x X $ £ £ 0/l$t (Phosphoric Acids) QD 181. PI ^H^ QV 138. P4 *) /.M (Phosphates) QV 285 9 A^1t (Phosphorylation) QD281.P46 781 y yyy-h 'J A,m7>vy7A (Calcium Phosphates) ^mitm qd isi.c2 It-Y'iA) WE 200 f*f^ WU 101 0 A-fl^/l-^X (Terpene Phosphates) (£7 0 4 X7°X- /i-y/,&$££ ') ^8■£;E 9 xx 7 7 — -t* (Phosphomonoesterases) (£ y A |t7xxf/i't FD7--t$££ UH;E7iXf/l'tFD7-t' (Phosphoric Monoester Hydrolases) QU 136 ') /UISC (Phospholipids) QU 93 itt*ii (Gonorrhea) WC 150 £14 WP 157 ftSlB (Lepidoptera) QX 560 %»Yfcmm (Clinical Medicine) WB 102 ^YUmPYW (Clinical Ladders) i£fl8H#!M4$££ VsMitm (Chemistry, Clinical) QY 90 mm<9-yPflX ^mwnmmm (Nurse Clinicians) WY 128 ®MmmMm (Pharmacy Service, Clinical) limfxMM S|3H$££ $M'fcrfctl (Clinical Competence) W 21 mnm^bLx -izMfchmi'Y (NLM^MT(£JF^#^T8) ■Jki&mm (NLM#«ugT(£JF^^§T8.2) $$,mW1 (Clinical Departments) (£*f!l%ftSl3H$££ ^fcYuYzuv (Protocols, Clinical) U&ffcMme&Z fit WJfc^-7- (Clinical Markers) UX.mmK)-?- 7 - £ ££ ®Jfcmmm (Pharmacology. Clinical) QV 38 mmrnm wb 330^$ hfix ^S,lfcm^y-¥X (Clinical Pharmacy Service) liftT** mzmzfix y AftlSIPf'# (Phosphorus Metabolism Disorders) WD 200.5.P4 >) /iS&'M.fcXyy 9--¥ (Phosphoprotein Phosphatase) QU 136 HSr3R*^*hKn7-e (Phosphoprotein Phosphohydrolase) (£ 'J /CM 14K7 X 7 7 y -7*$ £ £ 'JX7X (Lindane) li-0-fe'7's^t7 o y F*$£i D/u\p\ilLifc (Phosphorus Isotopes) Mmitm QD 181. PI (tit QU 130 mxmfm qw 52 #7) WE 200 mmm qv 138.P4 V>'< (Lymph) WH 700 y y^X^\±UM.m (Lymphoblastic Leukemia) it "J X ^14£M$££ 'J y 'm (Lymphography) WH 700 0 x^'f'fft&Jli (Lymphangioendothelioma) l£'J y'<$£ (B-Lymphocytes) WH 200 T y ym (T-Lymphocytes) WH 200 mm%.& QW 568 'J ym\ftMt (Lymphocyte Activation) (£0 >'<%%) ^4C$££ 0 xymiiiiitmX (Lymphocyte-Activating Factor) Ii 4 xy-o4*xl$££ ij X'^t&tjlpffl (Lymphocyte Cooperation) mmftfe. QW 568 'J >'*%&&&& (Lymphopenia) WH 200 0 ymfflM (Lymphocyte Stimulation) Ii "J y^W4)Yi 1k$££ y X7^|*f1J141ftf£(Lymphocytotoxic Antibodies) I £J/t y x^jfuiint$££ ij X^14»&iM & (Lymphocytic Choriomeningitis) WC 540 0 -y^1; FyxHi*- (Mitogenic Factors, Lymphocyte) (£4xy-o4;r>2$££ iJ>/^/f^i-^- (Lymphocyte Mediators) Ii U >7t^4x$££ ij ymM&5T$li%.M&X (Lymphocyte Mitogenic 782 jv y x x x Factor) (£4 x y-o 4 ^r > 2 $££ 0 X^££$lilfo. (Lymphocyte Transfusion) WB 356 ij x/<^ftl*W-4'^r?'rf,l:^77 F (Neutrophil- Vctivating Peptide, Lymphocyte-Derived) UA y 9 -o4*>8$££ ij x^MOTk (Lymphoid Cells) l£'JX^£fc$££ ij ym$j£it (Lymphocyte Transformation) &$&%&¥ QV 402 jfoffi^ WH 200 ffl&*A&m WO 680 |JX^°& (Lymphatic System) WH 700 7!£ WS 300 mm y x y)y<&jm. (Lymphoid Tissue) WH 700 ij yA;tlU WC 880 mmm sf 769.5 mWiacoiiC^unnmiz 0 y^i&Mft (Lymphatic Metastasis) WH 700 1*r£y4 77>a*|zHLT(iSlKiJ3iJlz, iyiUlfW'zfSL Tli Wl 320 'J X^14Sift.*?! (Leukemia. Lymphocytic) WH 250 fafcmmm qz 350 'J x^146ifo.*?1Ll (Lymphocytic Leukemia, Ll) tiLLH ■|4'Jx^°14fiJfiL*?1$£i 'J yl*£f£^$££ 'J x^^li5*iE[^^7 4 JVX (Lymphadenopathy- Associated Virus) HIV$££ 0 ycoumzmz 0 x/N°g^f&iW(Lymphadenectomy) (i y yiffiW&Zfl X ')y-'i£M (Lymphangiography) it 'J X^°f:£I£'£$£ £ 'J y^Mitm& (Lymphoproliferative Disorders) me wh 700 fi'jtmbty'Jtm ws 300 mm WY 152.5 mmm sf 769.5 ftZtmnZfoZiiflX, IriJxIiy x^°M(£ WH 525 'J y^ifcW (Status Lymphaticus) Ii'J X^*yti.$££ 'J X^^l^lfll (Lymphatic Sarcoma) (£<7£/v'|4'J x^°||i$ ££ 'J /L,*ic^-i'I'f:ImJf»Vf4^ (Phosphorus Radioisotopes) WN 420 ^4*fl'r- QC 796.PI hm\mim -y 9 X ; fj£?t ; I'^lm*! ; -?-c7)ft!l^ri^lffiO^Jl$££ *n&** (Parapsoriasis) WR 204 iKift (Lacrimal Apparatus) WW 208 8gm (Organoids) QH 587581.2 tfl^flf (Teratoid Tumor) (£^-JFM$££ iK-SM^I?. (Lacrimal Apparatus Diseases) WW 208 Jl*£M*,i::(Tuberculoid Infections) li#£S ^ ?'<9r 'J 7 !£'Mi$ ££ HfliM (Desmoid) (imm4^Sflt*J£$£i *I##fli (Osteoma, Osteoid) WE 258 vmi$.coiiv-y°®mikmffi (Loop Ileostomy) l£H]flf ii*tl$f$££ JV-yx&mfcfifc (Lupus Glomerulonephritis) l£/l-- 7x-t-yt$££ jV-Yx^'rk (Lupus Nephritis) WJ 353 783 )Vi Y)V IV5Y-JV (Luminal) l£7 x 9 '<)V ¥9 -/u$£ £ ^5 4 7 X X (Luminescence) £t§9^l$££ )V 5 4-tXXyt^ (Light, Luminescent) U>V5fcAiyx $££ /uy-OJx (Luliberin) (io'7 K ^ >J > $££ X7*'x (Reagins) QW 575 m'tfXbM&fcZ>%& QW 900 frit (Mm) (Maceration (Pharmacy)) (£P3>J$££ IrfM (Refrigeration) W^l$££ m&m (Primates) QL 737.P9-737.P968 %%kmmbLX QY 60.P7 mm SF 997.5.P7 kmY&mZfciX^ S±§^(£, NLM#*tIgTi£3£fl£iJ[z ftiifc&pTi (Frozen Foods) WA 710 tfj-i^SS4? (Anesthesia, Refrigeration) (£1g4fc&£$££ yfc7A)VX (Reoviruses) l£ x4*74 /uxf4$££ X77 4/UX# (Reoviridae) QW 168.5.R15 X777 7>f - (Rheography) (£4 Xt-y'XX7°X7X ^E7774-$££ Kn-7- (Rheology) QC 189.5 tf&m WG 106 X7x74/UX(Leon Virus) (£t F 7'J 77 4/UX1-3 $ ££ ^.$z%e& (Historiography) D 13-15 mm wu 26 MA (-J&) iz is Uh WO 511 mmm QC 685-689.5 •' 7 4 7 *?| $ £ £ y yfcfcym (Legionnaires' Disease) WC 200 x x77-7* (Lecithinases) UfcX 7 'J y<--fe"$ £ £ xx77-7*Al (Lecithinase Al) (£7X-7 y y<—¥A $ ££ xx77-7*A2 (Lecithinase A2) (£7X7 0 ^^--tA $ ££ X x 7 x (Lecithins) (£ 7 X 7 7 7 x/U o y x $ £ £ Xx7x7x/U F 7 XX7x7-7* (Lecithin Acyltransferase) QU 141 xx7xo vx7o— jvyyjv F 7 xx7x 7—7* (Lecithin Cholesterol Acyltransferase) l£ X y 7 X 7 x/u F7XX7x7--t$££ Xx-v— (Leisure Activities) QT 250 m^F t"7ni£ xmmz yxYyy (Restaurants) WA 799 xxt"7-XA (Lesbianism) l££14|5]'!4®$££ yx¥y-9 (Respirators) liitt^>f X-y $££ XX 'J X7 (Wrestling) QT 260.5.W9 X77°y-J&^-fi^-#A (Receptor-Mediated Signal Transduction) l£«1f fgfSit $ £ £ X77° F 7-A (Receptosomes) l£xxF*X-A$££ X77°F14# (Fees, Prescription) (£$i:£-tf/U'F$££ l/-fe^f> (Reserpine) QV 150 yYivy 9 —JV (Resorcinols) QV 223 X-7 (Radar) TK 6573-6595 m%Y ¥y9xu, xmmz yX9 A Y (Retinoids) QU 167 1^7 X 4 x^ (Retinoic Acid) l£Fx7X4x$££ X7X-/U (Retinol) (£ty ~ XA$££ X7x^ (Rhetinic Acid) l£yjxX7x^$££ mmmm (Fissure Sealants) I£x-7XF$££ mi^JV-T (Hiatal Hernia) (£&ii'fHWu-7$££ mm^m (Laceration Therapy) I£7r4f4^ ; tUffi^fflffi $££ %m& (Inferiority Complex) l£At&^*^$££ UM3k&W, (Diphyllobothrium) QX 400 X-yK^E^^r- (Red Monkey) l£^°X 9 YJVfrflX UtY fcXfcyyy^JV (Readiness Potential) liffift^ 14£Ul$££ xF'J/u (Laetrile) I£7i77y>$££ xFo74/ux^4 (Retroviridae) QW 168.5.R18 X F o74/i-Xf4J!Sife*iE (Retroviridae Infections) WC 502 X — 7 A (Rhenium) Mmitm QD 181. R4 mmm QV 290 X^X (Renin) WK 180 mmm qu 136 X-X (Rennin) it^t ->>$££ x—x7x^r4-7XxX7/u F'Xrox^ (Renin- Angiotensin-Aldosterone System) (i x — x — 7 x %fc yyyy^h^fix y — y — T y %fc T y y y?k (Renin-Angiotensin System) uyyytz. mxm qu 136 skm^sWz is it l WG 106 v=.y^g (Renin-Substrate) (£ T x ^f 7 7 x x / - r x $££ X—— >4H (Leninism) (£fti>i:4".H$££ V 9 y*7 7 i - (Renography) (£M4I4|5]1;-(7,4^1^^$ ££ U 7 7 U > Xfil (Reference Ranges) (i#>!«4i£$ £ £ v7°9 y'—jv (Leptazole) (i^ X 7 X X 7 F 7 Y—jv $ £ £ 1/74*17 7 X (Leptoconops) (i&J&ff $ £ £ U7°FXt7*?f (Leptospirosis) WC 420 J£*&14ftlfili}Weil*?i WC 420$££ mmm sf so9L4 V Y Y fc X (Leptophos) (£ fc X -< >v $ £ £ u7*o-X (Levulose) Ii7/u 7 F -X $££ VfcY'< (Levodopa) WK 725 y-X9)Vx. ¥fcy 'J X (Levonorepinephrine) (£y/U7F U7'J X$££ v fc-y A^fcy (Levomycetin) (i707A7x — o— ;u $££ 1-ABiBS (REM) WL 108 vYAiiX (rel Genes) (£*S*fgir-$££ m^Wi (Alchemy) QD 23.376.5 femm WB 890 M^-m^ (Association Learning) BF 319.5.P34 MA (ikiim) (Linkage (Genetics)) QH 445.2-445.5 jSiitEfcffilgifefiE (Streptococcal Infections) WC 210 ft-p§ WC 268 mmnW, (Streptococcus) QW 142.5.C6 m&)&m (Linkage Mapping) (iifefef4itfeM$£i l$g Ybmm) (Practice (Psychology)) m.fi-i>mm 111 LB 1061 teW. LB 1063 *Sm B 831.3 uxX (Lenses) QC 385-385.2 mmuo x y y f xxx ww 355; *>a*to WW350- 354$£i ffi$g mm) ww 358; rap^Pfffl ww 260 XXX& (Lentiform Nucleus) UUZkifciflX JSS (Association) Sft(£S-i3^S WM 460.5.F8$££ rn.it wmm) bf 365-395 fslrXHifllSfXh WM 145.5.W9^$££ &%!Li£.m&nm&m (Contraceptives, Oral, Sequential) QV 177 3llf F*7°7 —L'X o — HFtfc (Echocardiography, Continuous Doppler) (iDoppler-Oxo — [^j£$£i XX77X (Lentinan) QU 83 XX74Xx^yx (Insulin, Lente) WK 820 yyYYyU (Roentgen Rays) (£X^$££ V X F 7x^r^ji (Roentgenotherapy) (£XH5*J?}£$£ £ MmtklMWx. (Federal Regulations) Um'&co%fo ; *££ §a4MS*^(£#H$££, mtumm&bmmootti SiJ ^nfoMQiii^mt^ (Comprehensive Health Plans, State) (£'>H1*«Hj4;ltlil $ £ £ XX0X7 (Lathyrus) livy #!?£$££ o 7*4*ill (Loa loa) (£o7*«ifeJ^$££ vTmkikm (Loa) QX 301 o43Jf-X (Leukokinin) liy7FxX$££ o43-74y7xX-xX (Leukocytapheresis) l£ F4 Jflll^ tf8!$££ o A o F 'J x x (Leukotrienes) QU 90 o4oFyxxB (Leukotrienes B) Ii d A o F 'J x x B4$££ o 4 o F y xxB4 (Leukotriene B4) QU 90 o4 o,7'J X (Leucovorin) QU 195 o A ;yJV'<9 Yyy (Vasotocin, Leucyl) lit^f x F x X $££ o 4 x X (Leucine) QU 60 o 4 x X 7 ^ y -^7° 7 9—-fe* (Leucine Aminopeptidase) QU 136 ® (Phthisis) (£!ti*?i4£$££ 41 (Waxes) QU 85 ftnffi (Deaf-Mutism) liltfi ; &§*£$££ £1L (Senescence) (£JjnftD$££ £1L (Senility) (££A ; £A14*i!rW?5$££ *¥JL (Fistula) ^^^*3I$££ £*f (Presbyopia) WW 300 m&m (Transudates) (i-<#tf}"$fciiav$$£i £A (Aged) WT m$ WO 445 mmu^xmYf- wu 490$££ fitttfij^ WT 145 mmuzkmm wy i52$££ •**#£* ; **Pf *# WT 115 mm^^Mbmm wt hi ttWE^(i«^ffittIS'# WT 150$££ £A14#0* WT 155$ &££ .t»-ffi^ WT 145 -h-^ibui; mmm^. wt 30 t4W WO 950 femm (-fe) wt 166 zkmmziifix %kmm (Geriatrics) WT £A$t££ Zk^tib (Aged Abuse) f££A/t1#$££ %kmm%mfA& (Medicare Assignment) WT 31 =£A[*4Je7-t*X (Geriatric Health Services) l££A7> ^^^f*®7-t*X$££ Zkm (Arcus Senilis) WW 220 £ A8B4Hf*(Geriatric Ophthalmology) itmmm<^Xco^ Xm WW 620$££ Zkmm (Geriatric Nursing) WY 152 gAJtff (Elder Abuse) HV 6626.3 igftZiXX^&Zk WT 30 m&t h kcoiyj^mtm wm 600 Zkmm (Dentistry for Aged) £A*f4[S*Ji?$££ Zkmmm (Dental Care for Aged) WU 490 %kmm (Dentistry, Geriatric) l££¥l*447$££ £APf##fflfitif f*P£ (Insurance, Health, for Aged and Disabled) (£X7*^77$££ £ A14#*& LnS (Osteoporosis, Senile) (£#ffl Ln *£$££ ^A14#^?L*£ (Senile Osteoporosis) liflLi -,•£$ ££ 785 p «*> y y ti £AfSf*m'7 (Psychiatry, Geriatric) U&XffiMmm£ ££ £A14V4>HN' (Psychoses, Senile) <££ A14#o £$££ £A14*J5i£ (Dementia, Senile) WT 155 &kcotzShcoi%;MY-¥X (Health Services for the Aged) WT 31 £kM-i$i (Geriatric Assessment) WT 30 ZkYkSh (Old Age Assistance) WT 30 tt£1£pf HD 7090-7250 £Af*Ffc (Insurance, Old Age) it A y-y 7 7 ; #£$m $££ £A7.-A (Homes for the Aged) WT 27-28 $&*S (Lupus) WR 245 *7?fJ) (Work) i%MimMffiX WA 400-495l?$££ tYifc-mm WE 103 frmm BF 481 ■%fflMSk (Morale) BJ 45 m^ U 22 ffmmX (Occupational Hygiene) (£J$M4:$££ ■%M'ffiXmm (Occupational Nursing) !£$!!Sf£flt#!f $ ££ J7MB.& (Labor Unions) HD 6350-6940.7 mpjtbmfitkm wx 159.8 m%bimmmy-¥x wa 412 mnmxy-¥x wa 495 m%tmmim w 125-270 mmm WY30 mmzMi&t& wx 159.8 ^yfii&W (Accidents, Occupational) WA 485-491*^ mco WW 505-525 mWLC0Xx (Roxithromycin) QV 350.5.E7 &M (Video Recording) TK 6655.V5 &ii(£±flSij!z Mk-WTmm (Subchondral Cysts) (£#ftM$££ o o'7 7 t- (Logotherapy) WM 460.5.E8 o--7-y yUkfA (Rosaniline Dyes) QV 240 Dx7)lS (Russian Baths) (iAi&$££ Utti*^ (Exhibitionism) WM 610 d-x 3 x (Lotions) aims,; ftkmm; mim; nut lt±^$££ v-X'J y*m (Lymphoma, Follicular) WH 525 smmmm qz 350 o7'.y YXm (Robotics) TJ 210.2-211.47 x.ifcmmxm qt 36 wm% stYjizmmztiz,m&uxmmiz, mtimim ^nxmiztsuz>t%fru qy 23 o7Fi- (Lobotomy) UmttyfcmZflX ■a-yyxmXM.m (Philology, Romance) PC me PC 6-400 mm(nxmu,mtUXm^cox<7oyyyxm PC 2011 -3761$ &££ o 'J xm (Lorisidae) QL 737.P955 mm SF 997.5.P7 %m)imb LT QY 60.P7 mmm (Logic) BC ^X WS 462 X'Jt WS 105.5. D2 mm w 6i mmmm (Psychotherapy, Rational-Emotive) WM 420.5.P8 7 ^iiy}£ (Rejuvenation) WJ 875 ^co&m (Adolescent Pregnancy) (£#¥$&4S$£ £ b^coX (Armpit) (£S^^$££ 7 9y — T (Vaccinia) WC 584 7yx-774/UX (Vaccinia Virus) QW 165.5.P6 7 y 7 X (Vaccines) QW 805 Mffi14^(£^l'l47y7> WC200$££ BCG(£BCG7y7x WF 250$££ 7*/u7 7(£7/U7 7 7y7x WC 310$££ oxy(£oX77y7x WC 262$££ ffi<7>UMm79Yy WC 450$££ A X7/uxx7*l£4x7/uxx7"7y7x WC 515$£ £ m-mtmm7A)vx wc.58o$££ ^Bmii~gU®79Ty WC 340$££ ^XF(£^xF7y7> WC350$££ 7y774/uxi£7°iJ77y7x WC 556$££ &kmit&ytmy9Xy WC550$££ 786 B * 9 y 9 ij 7 y-f 7li WC 250 $ £ £ *S 14 (£ BCG 7 7 7 X W P 250 $ £ £ if7X-'-f747XliStt7X^'7f7Xfift7 7f X WC 270^$££ 74/uxt4x>l£74/ux777x WC 500$££ 7 77W&BS& (Encephalitis, Post-Vaccinal) (£2444/1 ai4HMi&$£i 777>*fo7 (Vaccine Therapy) I £?&#&*£$(<£$ MX 77 ¥^oifc%y 9— -b* (Horseradish Peroxidase) QU 140 7-X (Varnish) l£>'fTfl-$££ 7—IH (Alligators and Crocodiles) QL 666.C925 mm SF 997.5.R4 %u (Laughter) BF 575.L3 WXm WS 462 fVJtmbmim ws 105.5.es 7 7t- (Wallabies) (£7 X 7>*/u-$££ 7/U7t'JX (Warfarin) QV 193 WiiW&W. (Brachial Plexus) WL 400 3$&M§?K (Brachiocephalic Veins) WG 625. B7 KsIDjK (Brachiocephalic Trunk) WG 595.B72 1-9 l-4"r7-b77ox70|J X (1-Oxacephalosporin) l^^ 7yyrA$££ l-Sar-8-Ala 7 x ¥fc 7 x -> x 2 (l-Sar-8-Ala Angiotensin II) (£7 7 7 -> X $ £ £ l-7/l-o-> x-8-77-X7x777x->X 2 (1- Sarcosine-8-Alanine Angiotensin II) Ii7 7 7 x X $ ££ 1, 2---9-7 x F ox (l,8-Dihydroxy-9- anthrone) UT y Y 7 >) y £ fit 13-->X-X7x^(13-cis-Retinoic Acid) (£4 X F x7/ 4X££ 17 -<-y-xx F7x7-/U (17 beta-Estradiol) (£x X F7x7-/u$££ 17-7 FX7o A Y (17-Ketosteroids) WK 755 f>&£7> WK 757 17-43-XX7D4 Y (17-Oxosteroids) (£17-7 FX70 A F*$££ 2-7-fe F 7 ^ K7/U7XX (2-Acetamidofluorene) (£2-7 -fe7/U7 ~77/u7xx$££ 2-777/1-7^X7/U7XX (2-Acetylaminofluorene) QZ 202 2-T 5 93-A-JVA X77o^-7A7o-74 F* (2- Aminoethylisothiuronium Bromide) (£AET$££ 2-7'o^Ex;poy y 77x (2-Bromoergocryptine) l£7 D^ey >j7 7x$£i 2-yo;uxyy-;u (2-Chlorethanol) (£x7xxyoo t F*'J X$££ 2-yoo77F7x7X (2-Chloroacetophenone) itfc9 tf9' uuT^z F7x7x$££ 2-y oox7/U7/Uo-;u (2-Chloroethyl Alcohol) l£x 7ux?ootF*'J>$££ 2t F'odf >-7x4 7/u7 ^ X (2- Hydroxyphenethylamine) QU61 2-y"/U77 7"Fxy xx/u77- F (2- Mercaptoethanesulfonate) l£Mesna$££ 2-7 x— JVX. 9 9— JVT 5 X (2-Phenylethanolamine) it 2-t F*oJfx7x47/u7i x$££ 2',34^^ y X77 F*7X7xXX77-7* (2',3'- Cyclic-Nucleotide Phosphodiesterases) QU 136 2,4-1) (2,4-D) l£2,4--X7DD7xy Jfytt^WJ: 2,1 •>' 7oo7x/ * :yfHm (2,4- Dichlorophenoxyacetic Acid) 9k% SB 951.4 ZMffiX. WA 240 Mmitm QD 341.A2 2',5'-7'J 7TY-y- F7'J 9 7—fe' (2',5'- Oligoadenylate Polymerase) l£2',5'-4'J o'77-X- F xX7y--fe"$££ 2',5'-4 iJ 777-X- F xX7y-7* (2',5'- Oligoadenylate Synthetase) QU 141 2-5Ai-x7y--fe*(2-5A Synthetase) (£2',5'-7 y o*77 -x- FxX7y--fe*$££ 21- t Kodr->7o7X7ox (21- Hydroxyprogesterone) li7X "r x o jvf- o x 7 o x $ ££ 3-4 X o4 xX,8o4 xX ^X (3- Isoleucine,8-Leucine Vasopressin)(£7^x F xX$£ £ 3,4—?7^x7x7xy $ X (3,4- Methylenedioxyamphetamine) QV 102 YT5 9Mm (4-Aminobutyric Acid) l£GABA$££ 4-7 ^ / &bHm (4-Aminohippuric Acid) (£P-7 ^ 9 ,%W. !£$££ 5-HT (5-HT) !i-feoF-X$££ 5-HTI^It^ (5-HT Antagonists) (£-feo F-Xl?i4t*$ ££ 5-t F'o^-x F 'J7°y ^ X (5-Hydroxytryptamine) (£-fe o F — X$££ 5-1 F o df x F y 7°y ~ yftmm (5- Hydroxytryptamine Antagonists) (£-fe o F — x1§47l &$££ 5,12-diHETE (5, 12-diHETE) (£o4oFiJxxB4$ ££ 5,12-HETE(5, 12-HETE) (£04 o F 'JxxB 4 $££ 6- 9 JV 7 Y Y Y 'J y (6-Mercaptopurine) QV 269 7S RNA (7S RNA) (£snRNA$££ 8-t F*o Jf->Jf y y x (8-Hydroxyquinoline) Ufc%y$; 9 y X$££ 8- ^ F * yY9 7 V X (8-Methoxypsoralen) l£^ F "r7 UX$££ 8-^f/iJ 9-JV (8-Quinolinol) (£7^x^ /'J X $££ *HH£E^H«H#S>* W5JK 1996*^ 3 rl 310 flrr T113 0(03)3815-1942 *]SC«Ii«f^E*f«3-17-7 t 163-91 0(03) 3354-0131 (TCPv) «1ffi 19,570R(#ftl9,000R) NLM011941617